PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Perdomini, M; Belbellaa, B; Monassier, L; Reutenauer, L; Messaddeq, N; Cartier, N; Crystal, RG; Aubourg, P; Puccio, H				Perdomini, Morgane; Belbellaa, Brahim; Monassier, Laurent; Reutenauer, Laurence; Messaddeq, Nadia; Cartier, Nathalie; Crystal, Ronald G.; Aubourg, Patrick; Puccio, Helene			Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia	NATURE MEDICINE			English	Article							FE-S PROTEINS; IN-VIVO; CARDIAC-HYPERTROPHY; HUMAN FRATAXIN; IRON; DYSFUNCTION; DEFICIENCY; DISEASE; EXPRESSION; MATURATION	Cardiac failure is the most common cause of mortality in Friedreich's ataxia (FRDA), a mitochondrial disease characterized by neurodegeneration, hypertrophic cardiomyopathy and diabetes(1-3). FRDA is caused by reduced levels of frataxin (FXN), an essential mitochondrial protein involved in the biosynthesis of iron-sulfur (Fe-S) clusters(4-8). Impaired mitochondrial oxidative phosphorylation, bioenergetics imbalance, deficit of Fe-S cluster enzymes and mitochondrial iron overload occur in the myocardium of individuals with FRDA(9-12). No treatment exists as yet for FRDA cardiomyopathy(13,14). A conditional mouse model with complete frataxin deletion in cardiac and skeletal muscle (Mck-Cre-Fxn(L3/L-) mice) recapitulates most features of FRDA cardiomyopathy, albeit with a more rapid and severe course(15,16). Here we show that adeno-associated virus rh10 vector expressing human FXN injected intravenously in these mice fully prevented the onset of cardiac disease. Moreover, later administration of the frataxin-expressing vector, after the onset of heart failure, was able to completely reverse the cardiomyopathy of these mice at the functional, cellular and molecular levels within a few days. Our results demonstrate that cardiomyocytes with severe energy failure and ultrastructure disorganization can be rapidly rescued and remodeled by gene therapy and establish the preclinical proof of concept for the potential of gene therapy in treating FRDA cardiomyopathy.	[Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] IGBMC, Dept Med Translat & Neurogenet, Illkirch Graffenstaden, France; [Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] INSERM, U596, Illkirch Graffenstaden, France; [Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] CNRS, UMR7104, Illkirch Graffenstaden, France; [Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] Univ Strasbourg, Strasbourg, France; [Perdomini, Morgane; Belbellaa, Brahim; Reutenauer, Laurence; Messaddeq, Nadia; Puccio, Helene] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France; [Monassier, Laurent] Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Fac Med, Strasbourg, France; [Cartier, Nathalie; Aubourg, Patrick] INSERM, U986, F-94275 Le Kremlin Bicetre, France; [Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Aubourg, Patrick] Univ Paris 11, Paris, France; [Aubourg, Patrick] AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Cornell University; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP)	Puccio, H (corresponding author), IGBMC, Dept Med Translat & Neurogenet, Illkirch Graffenstaden, France.	patrick.aubourg@inserm.fr; hpuccio@igbmc.fr	Puccio, Hélène/G-1717-2013; cartier, nathalie/C-3103-2012; BELBELLAA, Brahim/AAR-6417-2020	Puccio, Hélène/0000-0003-4711-2248; cartier, nathalie/0000-0003-2298-5261; 	Association Francaise contre les Myopathies; US Friedreich Ataxia Research Alliance; European Community under the European Research Council [206634/ISCATAXIA]; Seventh Framework Programme [242193/EFACTS]; Association the Fondation Simone et Cino del Duca; Institut de France; Ledru family; French state fund through the Agence Nationale de la Recherche under the frame programme Investissements d'Avenir labeled [ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT]; Association Francaise pour l'Ataxie de Friedreich	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); US Friedreich Ataxia Research Alliance; European Community under the European Research Council; Seventh Framework Programme(European Commission); Association the Fondation Simone et Cino del Duca; Institut de France; Ledru family; French state fund through the Agence Nationale de la Recherche under the frame programme Investissements d'Avenir labeled(French National Research Agency (ANR)); Association Francaise pour l'Ataxie de Friedreich	We thank A. Martelli for help in vector construction and for fruitful discussions, P. Bougneres for fruitful discussions and insightful comments on the manuscript, and V. Blouin and P. Moullier (Institut de Recherche Therapeutique, INSERM UMR 1089) for vector production. This work was supported by the Association Francaise contre les Myopathies (to H.P.), the US Friedreich Ataxia Research Alliance (to H.P.), the European Community under the European Research Council (206634/ISCATAXIA; to H.P.), the Seventh Framework Programme (242193/EFACTS; to H.P.), the Association the Fondation Simone et Cino del Duca (to P.A.) and the Institut de France (to P.A.), by a personal donation from the Ledru family (to H.P.) and by a French state fund through the Agence Nationale de la Recherche under the frame programme Investissements d'Avenir labeled ANR-10-IDEX-0002-02 (ANR-10-LABX-0030-INRT). M.P. is a recipient of a PhD fellowship from the Association Francaise pour l'Ataxie de Friedreich.	BARRY WH, 1993, CIRCULATION, V87, P1806, DOI 10.1161/01.CIR.87.6.1806; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Dedobbeleer C, 2012, EUR HEART J-CARD IMG, V13, P346, DOI 10.1093/ejechocard/jer267; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hu CH, 2010, J GENE MED, V12, P766, DOI 10.1002/jgm.1496; Huang MLH, 2013, AM J PATHOL, V183, P745, DOI 10.1016/j.ajpath.2013.05.032; Lamarche J., 1993, HDB CEREBELLAR DIS, P453; Lodi R, 2001, CARDIOVASC RES, V52, P111, DOI 10.1016/S0008-6363(01)00357-1; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Perlman SL, 2012, J CHILD NEUROL, V27, P1217, DOI 10.1177/0883073812453872; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raman SV, 2011, EUR HEART J, V32, P561, DOI 10.1093/eurheartj/ehq443; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Sedlak TL, 2004, J HEART LUNG TRANSPL, V23, P1304, DOI 10.1016/j.healun.2003.09.015; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Sutton MS, 2014, ECHOCARDIOGR-J CARD, V31, P50, DOI 10.1111/echo.12287; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Vorgerd M, 2000, NEUROMUSCULAR DISORD, V10, P430, DOI 10.1016/S0960-8966(00)00108-5; Wagner GR, 2012, HUM MOL GENET, V21, P2688, DOI 10.1093/hmg/dds095; Wang G, 2010, CANCER GENE THER, V17, P559, DOI 10.1038/cgt.2010.11; Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilson RB, 2012, J CHILD NEUROL, V27, P1212, DOI 10.1177/0883073812449691	34	135	150	0	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					546	551		10.1038/nm.3510	http://dx.doi.org/10.1038/nm.3510			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24705334				2022-12-27	WOS:000335710700027
J	Clement, LC; Mace, C; Avila-Casado, C; Joles, JA; Kersten, S; Chugh, SS				Clement, Lionel C.; Mace, Camille; Avila-Casado, Carmen; Joles, Jaap A.; Kersten, Sander; Chugh, Sumant S.			Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome	NATURE MEDICINE			English	Article							LIPOPROTEIN-LIPASE; GENE-EXPRESSION; FATTY-ACIDS; ANGPTL4; GLOMERULI; INSIGHTS; ALBUMIN; BINDING; SERUM; MICE	The molecular link between proteinuria and hyperlipidemia in nephrotic syndrome is not known. We show in the present study that plasma angiopoietin-like 4 (Angptl4) links proteinuria with hypertriglyceridemia through two negative feedback loops. In previous studies in a rat model that mimics human minimal change disease, we observed localized secretion by podocytes of hyposialylated Angptl4, a pro-proteinuric form of the protein. But in this study we noted high serum levels of Angptl4 (presumably normosialylated based on a neutral isoelectric point) in other glomerular diseases as well. Circulating Angptl4 was secreted by extrarenal organs in response to an elevated plasma ratio of free fatty acids (FFAs) to albumin when proteinuria reached nephrotic range. In a systemic feedback loop, these circulating pools of Angptl4 reduced proteinuria by interacting with glomerular endothelial alpha(v)beta(5) integrin. Blocking the Angptl4-beta(5) integrin interaction or global knockout of Angptl4 or beta(5) integrin delayed recovery from peak proteinuria in animal models. But at the same time, in a local feedback loop, the elevated extrarenal pools of Angptl4 reduced tissue FFA uptake in skeletal muscle, heart and adipose tissue, subsequently resulting in hypertriglyceridemia, by inhibiting lipoprotein lipase (LPL)-mediated hydrolysis of plasma triglycerides to FFAs. Injecting recombinant human ANGPTL4 modified at a key LPL interacting site into nephrotic Buffalo Mna and Zucker Diabetic Fatty rats reduced proteinuria through the systemic loop but, by bypassing the local loop, without increasing plasma triglyceride levels. These data show that increases in circulating Angptl4 in response to nephrotic-range proteinuria reduces the degree of this pathology, but at the cost of inducing hypertriglyceridemia, while also suggesting a possible therapy to treat these linked pathologies.	[Clement, Lionel C.; Mace, Camille; Chugh, Sumant S.] Univ Alabama Birmingham, Glomerular Dis Therapeut Lab, Birmingham, AL 35294 USA; [Avila-Casado, Carmen] Univ Toronto, Toronto Gen Hosp, Dept Pathol, Toronto, ON M5G 1L7, Canada; [Avila-Casado, Carmen] Inst Nacl Cardiol, Dept Pathol, Mexico City, DF, Mexico; [Joles, Jaap A.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, Utrecht, Netherlands; [Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, NL-6700 AP Wageningen, Netherlands	University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; National Institute of Cardiology - Mexico; Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Chugh, SS (corresponding author), Univ Alabama Birmingham, Glomerular Dis Therapeut Lab, Birmingham, AL 35294 USA.	chugh@uab.edu	Joles, Jaap/AAX-3249-2020; Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734	US National Institutes of Health [R01DK077073, R01DK090035, K01DK096127, T32DK007545]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077073, R01DK101637, K01DK096127, P30DK079337, R01DK090035, T32DK007545] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank investigators of the FSGS clinical trial for providing baseline plasma and urine samples from patients with FSGS; M. del Nogal-Avila (University of Alabama at Birmingham (UAB)) for selected real-time PCR studies; H. Donoro (UAB) for assistance with animal colony management; E. Soria (Instituto Nacional de Cardiologia) for immunogold electron microscopy studies; H. Chung (UAB) for advice on LPL assays; V. Kumar (UAB) for help in collecting Institutional Review Board-approved patient sera from transplant patients; D. Salant (Boston University) for gamma 2-NTS; A. Koster (Eli Lilly) for Angptl4<SUP>-/-</SUP> mice; M. Mitsuyama (Kyoto University) for Buffalo Mna rats; J. Brunzell (University of Washington) for 5D2 monoclonal antibody; F. Danesh (MD Anderson Cancer Center) for cultured rat glomerular endothelial cells; UAB-University of California-San Diego George O'Brien Center Core C for measuring urine and serum creatinine by mass spectrometry; UAB Nephrology Research and Training Center for equipment use; and UAB Research Foundation for filing patent PCT/US2011/039255 for the use of ANGPTL4 mutants as therapeutic agents for nephrotic syndrome. This work is supported by the US National Institutes of Health (R01DK077073 and R01DK090035 to S.S.C., K01DK096127 to L.C.C. and T32DK007545 to C.M.).	Avila-Casado MD, 2004, KIDNEY INT, V66, P133, DOI 10.1111/j.1523-1755.2004.00715.x; Bengtsson-Olivecrona G., 1992, PRACTICAL APPROACH S, P169; Chang SF, 1998, J LIPID RES, V39, P2350; Chugh S, 2001, KIDNEY INT, V59, P601, DOI 10.1046/j.1523-1755.2001.059002601.x; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Clement LC, 2007, KIDNEY INT, V72, P337, DOI 10.1038/sj.ki.5002302; Clement LC, 2011, NAT MED, V17, P117, DOI 10.1038/nm.2261; Ferris M, 2013, CTS-CLIN TRANSL SCI, V6, P13, DOI 10.1111/cts.12003; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; GHIGGERI GM, 1987, KIDNEY INT, V32, P547, DOI 10.1038/ki.1987.243; Kersten S, 2009, ARTERIOSCL THROM VAS, V29, P969, DOI 10.1161/ATVBAHA.108.182147; KIKUCHI H, 1983, BIOCHIM BIOPHYS ACTA, V744, P165, DOI 10.1016/0167-4838(83)90086-9; Le Berre L, 2002, J CLIN INVEST, V109, P491, DOI 10.1172/JCI200212858; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu G, 2006, J BIOL CHEM, V281, P39681, DOI 10.1074/jbc.M606664200; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; MARSH JB, 1960, METABOLISM, V9, P946; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; NAGASE S, 1979, SCIENCE, V205, P590, DOI 10.1126/science.451621; NAKAMURA T, 1986, NEPHRON, V43, P50, DOI 10.1159/000183718; Neuger Lucyna, 2004, BMC Physiol, V4, P13, DOI 10.1186/1472-6793-4-13; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Shearer GC, 2006, KIDNEY INT, V70, P647, DOI 10.1038/sj.ki.5000318; Staiger H, 2009, DIABETES, V58, P579, DOI 10.2337/db07-1438; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Vaziri ND, 2003, KIDNEY INT, V63, P1964, DOI 10.1046/j.1523-1755.2003.00941.x; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; ZILLERUELO G, 1984, J PEDIATR-US, V104, P61, DOI 10.1016/S0022-3476(84)80590-9	33	101	118	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					37	+		10.1038/nm.3396	http://dx.doi.org/10.1038/nm.3396			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24317117	Green Accepted			2022-12-27	WOS:000329349400017
J	Canaud, G; Bienaime, F; Viau, A; Treins, C; Baron, W; Nguyen, C; Burtin, M; Berissi, S; Giannakakis, K; Muda, AO; Zschiedrich, S; Huber, TB; Friedlander, G; Legendre, C; Pontoglio, M; Pende, M; Terzi, F				Canaud, Guillaume; Bienaime, Frank; Viau, Amandine; Treins, Caroline; Baron, William; Nguyen, Clement; Burtin, Martine; Berissi, Sophie; Giannakakis, Konstantinos; Muda, Andrea Onetti; Zschiedrich, Stefan; Huber, Tobias B.; Friedlander, Gerard; Legendre, Christophe; Pontoglio, Marco; Pende, Mario; Terzi, Fabiola			AKT2 is essential to maintain podocyte viability and function during chronic kidney disease	NATURE MEDICINE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; DIABETIC-NEPHROPATHY; NEPHROTIC-SYNDROME; PROTEIN-KINASE; GLUCOSE-HOMEOSTASIS; ACTIN CYTOSKELETON; INSULIN-RESISTANCE; MTORC1 ACTIVATION; RENAL-DISEASE; MICE LACKING	In chronic kidney disease (CKD), loss of functional nephrons results in metabolic and mechanical stress in the remaining ones, resulting in further nephron loss. Here we show that Akt2 activation has an essential role in podocyte protection after nephron reduction. Glomerulosclerosis and albuminuria were substantially worsened in Akt2(-/-) but not in Akt1(-/-) mice as compared to wild-type mice. Specific deletion of Akt2 or its regulator Rictor in podocytes revealed that Akt2 has an intrinsic function in podocytes. Mechanistically, Akt2 triggers a compensatory program that involves mouse double minute 2 homolog (Mdm2), glycogen synthase kinase 3 (Gsk3) and Rac1. The defective activation of this pathway after nephron reduction leads to apoptosis and foot process effacement of the podocytes. We further show that AKT2 activation by mammalian target of rapamycin complex 2 (mTORC2) is also required for podocyte survival in human CKD. More notably, we elucidate the events underlying the adverse renal effect of sirolimus and provide a criterion for the rational use of this drug. Thus, our results disclose a new function of Akt2 and identify a potential therapeutic target for preserving glomerular function in CKD.	[Canaud, Guillaume; Bienaime, Frank; Viau, Amandine; Treins, Caroline; Baron, William; Nguyen, Clement; Burtin, Martine; Berissi, Sophie; Friedlander, Gerard; Legendre, Christophe; Pende, Mario; Terzi, Fabiola] Univ Paris 05, Hop Necker Enfants Malad, INSERM U845, Ctr Rech Croissance & Signalisat,Sorbonne Paris C, Paris, France; [Canaud, Guillaume; Legendre, Christophe] Hop Necker Enfants Malad, Serv Nephrol Transplantat Adultes, Paris, France; [Bienaime, Frank; Friedlander, Gerard] Hop Necker Enfants Malad, Serv Physiol Explorat Fonctionnelles, Paris, France; [Giannakakis, Konstantinos] Univ Roma La Sapienza, Dept Radiol Oncol & Pathol, I-00185 Rome, Italy; [Muda, Andrea Onetti] Campus Biomed Univ, Dept Pathol, Rome, Italy; [Zschiedrich, Stefan; Huber, Tobias B.] Univ Hosp Freiburg, Renal Div, Freiburg, Germany; [Zschiedrich, Stefan; Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Pontoglio, Marco] Univ Paris 05, Inst Cochin, INSERM U1016, CNRS UMR 8104, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Sapienza University Rome; University Campus Bio-Medico - Rome Italy; University of Freiburg; University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Terzi, F (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM U845, Ctr Rech Croissance & Signalisat,Sorbonne Paris C, Paris, France.	fabiola.terzi@inserm.fr	Terzi, Fabiola/N-5482-2018; Muda, Andrea Onetti/AAA-5105-2020; Onetti Muda, Andrea/G-5384-2012; Pende, Mario/AFR-1348-2022; Zschiedrich, Stefan/ABE-9871-2020	Onetti Muda, Andrea/0000-0002-0274-6178; Pende, Mario/0000-0002-7864-8937; Huber, Tobias B./0000-0001-7175-5062; Bienaime, Frank/0000-0002-8666-2042; Viau, Amandine/0000-0003-2890-7897; Friedlander, Gerard/0000-0002-6854-4261	INSERM; Universite Paris Descartes, Assistance Publique-Hopitaux de Paris (AP-HP); Agence National pour la Recherche; Fondation de la Recherche Medicale; Association pour l'Information et la Recherche sur les Maladies Renales Genetiques; Association pour l'Utilisation du rein Artificiel, Roche Laboratories; Excellence Initiative of the German Federal and State Governments [EXC 294]; European Community's Seventh Framework Program [241955]; SYSCILIA	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes, Assistance Publique-Hopitaux de Paris (AP-HP); Agence National pour la Recherche(French National Research Agency (ANR)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour l'Information et la Recherche sur les Maladies Renales Genetiques; Association pour l'Utilisation du rein Artificiel, Roche Laboratories; Excellence Initiative of the German Federal and State Governments; European Community's Seventh Framework Program(European Commission); SYSCILIA	We thank L.H. Noel and the clinicians of the Renal Transplant Department of Necker hospital for patient data and sample collection. We are grateful to M. J. Birnbaum (University of Pennsylvania) and M. Hall (Basel University) for Akt and Rictor mutant mice, respectively, C. Antignac (INSERM U983) for podocinspecific antibodies and R. Montjean (INSERM U983) for the PAK1-GST fusion protein expression vector. We thank M.C. Gubler, C. Antignac, C. Sumida and S. Harvey for critical advice. This work was supported by INSERM, Universite Paris Descartes, Assistance Publique-Hopitaux de Paris (AP-HP), Agence National pour la Recherche (to F.T. and M. Pontoglio), Fondation de la Recherche Medicale (to F.T. and M. Pontoglio), Association pour l'Information et la Recherche sur les Maladies Renales Genetiques, Association pour l'Utilisation du rein Artificiel, Roche Laboratories, the Excellence Initiative of the German Federal and State Governments EXC 294 (to T.B.H.) and European Community's Seventh Framework Program FP7/2009 -agreement number 241955, SYSCILIA (to M. Pontoglio).	Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Bonegio RGB, 2005, J AM SOC NEPHROL, V16, P2063, DOI 10.1681/ASN.2004030180; Ceci M, 2004, J MOL CELL CARDIOL, V37, P905, DOI 10.1016/j.yjmcc.2004.06.020; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chuang PY, 2009, NEPHRON PHYSIOL, V111, P9, DOI 10.1159/000191075; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Diekmann F, 2007, J AM SOC NEPHROL, V18, P2653, DOI 10.1681/ASN.2007010087; Faour WH, 2010, CELL SIGNAL, V22, P1222, DOI 10.1016/j.cellsig.2010.03.014; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403; Hostetter TH, 2003, SEMIN NEPHROL, V23, P194, DOI 10.1053/snep.2003.50017; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Kreis H, 2004, J AM SOC NEPHROL, V15, P809, DOI 10.1097/01.ASN.0000113248.59077.76; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laouari D, 2011, J AM SOC NEPHROL, V22, P327, DOI 10.1681/ASN.2010040356; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Letavernier E, 2005, TRANSPLANTATION, V80, P1198, DOI 10.1097/01.tp.0000185200.17589.74; Letavernier E, 2009, NEPHROL DIAL TRANSPL, V24, P630, DOI 10.1093/ndt/gfn574; Lindsley CW, 2008, CURR CANCER DRUG TAR, V8, P7, DOI 10.2174/156800908783497096; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Mollet G, 2009, J AM SOC NEPHROL, V20, P2181, DOI 10.1681/ASN.2009040379; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Naumovic R, 2007, AM J NEPHROL, V27, P379, DOI 10.1159/000103918; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Pillebout E, 2001, AM J PATHOL, V159, P547, DOI 10.1016/S0002-9440(10)61726-9; Rangan GK, 2007, NEPHROL DIAL TRANSPL, V22, P2175, DOI 10.1093/ndt/gfm191; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Scott RP, 2012, J AM SOC NEPHROL, V23, P1149, DOI 10.1681/ASN.2011121206; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shibata S, 2008, NAT MED, V14, P1370, DOI 10.1038/nm.1879; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496; Tejada T, 2008, KIDNEY INT, V73, P1385, DOI 10.1038/ki.2008.109; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; United States Renal Data System, 2010, USRDS 2010 ANNUAL DA; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075; YUMURA W, 1989, EXP GERONTOL, V24, P237, DOI 10.1016/0531-5565(89)90015-6; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	61	157	162	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2013	19	10					1288	+		10.1038/nm.3313	http://dx.doi.org/10.1038/nm.3313			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24056770				2022-12-27	WOS:000325531700028
J	Brabletz, T; Lyden, D; Steeg, PS; Werb, Z				Brabletz, Thomas; Lyden, David; Steeg, Patricia S.; Werb, Zena			Roadblocks to translational advances on metastasis research	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULATING TUMOR-CELLS; CANCER STEM-CELLS; BREAST-CANCER; DRUG-RESISTANCE; DOWN-REGULATION; COLONIZATION; MICROENVIRONMENT; PROGRESSION; MODEL		US Natl Canc Inst, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD USA; Univ Freiburg Med Ctr, Dept Gen & Visceral Surg, Ctr Comprehens Canc, Freiburg, Germany; Univ Freiburg Med Ctr, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; Univ Calif San Francisco, Dept Anat, San Francisco, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Freiburg; University of Freiburg; University of California System; University of California San Francisco	Brabletz, T (corresponding author), US Natl Canc Inst, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD USA.	thomas.brabletz@uniklinik-freiburg.de; dcl2001@med.cornell.edu; steegp@mail.nih.gov; zena.werb@ucsf.edu			NCI NIH HHS [R01 CA129523] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIASC000892, R01CA129523] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Aguirre-Ghiso JA, 2013, NAT MED, V19, P276, DOI 10.1038/nm.3120; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Y, 2013, J CLIN INVEST, V123, P2395, DOI 10.1172/JCI66553; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Guerin E, 2013, CANCER RES, V73, P2743, DOI 10.1158/0008-5472.CAN-12-4183; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hao JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040716; He SN, 2012, J PATHOL, V227, P431, DOI 10.1002/path.4013; Houthuijzen J, 2012, BRIT J CANCER, V106, P1901, DOI 10.1038/bjc.2012.201; Joosse SA, 2013, CANCER RES, V73, P8, DOI 10.1158/0008-5472.CAN-12-3422; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Kishida Y, 2007, CLIN CANCER RES, V13, P59, DOI 10.1158/1078-0432.CCR-06-1559; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-52; Liu SJ, 2012, AM J PATHOL, V181, P1823, DOI 10.1016/j.ajpath.2012.07.009; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; LoRusso PM, 2012, CLIN CANCER RES, V18, P6101, DOI 10.1158/1078-0432.CCR-12-2455; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; McMillin DW, 2013, NAT REV DRUG DISCOV, V12, P217, DOI 10.1038/nrd3870; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Moserle L, 2013, J INTERN MED, V273, P128, DOI 10.1111/joim.12018; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Palmieri D, 2009, CLIN CANCER RES, V15, P6148, DOI 10.1158/1078-0432.CCR-09-1039; Pantel K, 2012, CLIN CHEM, V58, P936, DOI 10.1373/clinchem.2011.175570; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Steeg PS, 2012, NATURE, V485, pS58, DOI 10.1038/485S58a; Stemmler HJ, 2007, ANTI-CANCER DRUG, V18, P23, DOI 10.1097/01.cad.0000236313.50833.ee; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Weiss L, 1990, Adv Cancer Res, V54, P159, DOI 10.1016/S0065-230X(08)60811-8	60	54	57	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1104	1109		10.1038/nm.3327	http://dx.doi.org/10.1038/nm.3327			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	24013756	Green Accepted			2022-12-27	WOS:000324083500023
J	Michalopoulos, GK; Grompe, M; Theise, ND				Michalopoulos, George K.; Grompe, Markus; Theise, Neil D.			Assessing the potential of induced liver regeneration	NATURE MEDICINE			English	Editorial Material							CELL-DERIVED HEPATOCYTES; STEM-CELLS; PANCREAS; MICE		[Michalopoulos, George K.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Grompe, Markus] Oregon Hlth & Sci Univ, Dept Pediat, Pape Family Pediat Res Inst, Oregon Stem Cell Ctr, Portland, OR 97201 USA; [Theise, Neil D.] Albert Einstein Coll Med, Liver & Stem Cell Res Lab, New York, NY USA; [Theise, Neil D.] Albert Einstein Coll Med, Beth Israel Med Ctr, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; Yeshiva University; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Michalopoulos, GK (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.			Grompe, Markus/0000-0002-6616-4345				Cayo MA, 2012, HEPATOLOGY, V56, P2163, DOI 10.1002/hep.25871; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Hoppo T, 2011, GASTROENTEROLOGY, V140, P656, DOI 10.1053/j.gastro.2010.11.006; JIRTLE RL, 1980, AM J PATHOL, V101, P115; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Ogawa S, 2013, DEVELOPMENT, V140, P3285, DOI 10.1242/dev.090266; Strom SC, 2010, METHODS MOL BIOL, V640, P491, DOI 10.1007/978-1-60761-688-7_27; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Theise ND, 2006, HANDB EXP PHARM, V174, P389; Theise ND, 2013, COMPLEXITY, V18, P11, DOI 10.1002/cplx.21453	11	6	6	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2013	19	9					1096	1097		10.1038/nm.3325	http://dx.doi.org/10.1038/nm.3325			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	24013747				2022-12-27	WOS:000324083500017
J	Xu, GL; Chen, JQ; Jing, G; Shalev, A				Xu, Guanlan; Chen, Junqin; Jing, Gu; Shalev, Anath			Thioredoxin-interacting protein regulates insulin transcription through microRNA-204	NATURE MEDICINE			English	Article							PANCREATIC BETA-CELL; MAFA EXPRESSION; GLUCOSE; GENES; ACTIVATION; MICE; RNA	Beta-cell dysfunction and impaired insulin production are hallmarks of diabetes', but despite the growing diabetes epidemic, the molecular mechanisms underlying this disease have remained unclear. We identified thioredoxin-interacting protein (TXNIP), a cellular redox regulator, as a crucial factor in beta-cell biology and show that beta-cell TXNIP is upregulated in diabetes, whereas TXNIP deficiency protects against diabetes by preventing beta-cell apoptosis(2,3). Here we show that TXNIP and diabetes induce beta-cell expression of a specific microRNA, miR-204, which in turn blocks insulin production by directly targeting and downregulating MAFA, a known insulin transcription factor. In particular, we first discovered the regulation of miR-204 by TXNIP by microarray analysis, followed by validation studies in INS-1 beta cells, islets of Txnip-deficient mice, diabetic mouse models and primary human islets. We then further found that TXNIP induces miR-204 by inhibiting the activity of signal transducer and activator of transcription 3 (STAT3), a transcription factor that is involved in miR-204 regulation(4,5). We also identified MAFA as a target that is downregulated by miR-204. Taken together, our results demonstrate that TXNIP controls microRNA expression and insulin production and that miR-204 is involved in beta-cell function. The newly identified TXNIP miR-204 MAFA insulin pathway may contribute to diabetes progression and provides new insight into TXNIP function and microRNA biology in health and disease.	[Xu, Guanlan; Chen, Junqin; Jing, Gu; Shalev, Anath] Univ Alabama Birmingham, Dept Med, Comprehens Diabet Ctr, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Shalev, A (corresponding author), Univ Alabama Birmingham, Dept Med, Comprehens Diabet Ctr, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA.	shalev@uab.edu			US National Institutes of Health [R01DK-078752]; American Diabetes Association [7-12-BS-167]; Juvenile Diabetes Research Foundation; JNJSI [40-2011-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); JNJSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to A.S. from the US National Institutes of Health (R01DK-078752), the American Diabetes Association (7-12-BS-167) and the Juvenile Diabetes Research Foundation and JNJSI (40-2011-1). A-ZIP/F mice were a generous gift of C. Vinson, US National Institutes of Health.	Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Clee Susanne M, 2005, Am J Ther, V12, P491, DOI 10.1097/01.mjt.0000178781.89789.25; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kostromina E, 2010, ENDOCRINOLOGY, V151, P2050, DOI 10.1210/en.2009-1199; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Le Lay J, 2006, J ENDOCRINOL, V188, P287, DOI 10.1677/joe.1.06510; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Minn AH, 2005, BIOCHEM BIOPH RES CO, V336, P770, DOI 10.1016/j.bbrc.2005.08.161; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; Paulin R, 2011, AM J PHYSIOL-HEART C, V301, pH1798, DOI 10.1152/ajpheart.00654.2011; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rani S, 2010, CELL PHYSIOL BIOCHEM, V25, P667, DOI 10.1159/000315086; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Sharma A, 1999, MOL CELL BIOL, V19, P704; Sun YQ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh186; Tattikota SG, 2011, EMBO J, V30, P797, DOI 10.1038/emboj.2011.31; Vanderford NL, 2007, J BIOL CHEM, V282, P1577, DOI 10.1074/jbc.M605064200; Vanhoose AM, 2008, J BIOL CHEM, V283, P22612, DOI 10.1074/jbc.M802902200; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xu GL, 2012, DIABETES, V61, P848, DOI 10.2337/db11-0955; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao XM, 2012, J BIOL CHEM, V287, P31155, DOI 10.1074/jbc.M112.362632	39	178	190	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1141	1146		10.1038/nm.3287	http://dx.doi.org/10.1038/nm.3287			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23975026	Green Accepted			2022-12-27	WOS:000324083500028
J	Murphy, AJ; Bijl, N; Yvan-Charvet, L; Welch, CB; Bhagwat, N; Reheman, A; Wang, YM; Shaw, JA; Levine, RL; Ni, HY; Tall, AR; Wang, N				Murphy, Andrew J.; Bijl, Nora; Yvan-Charvet, Laurent; Welch, Carrie B.; Bhagwat, Neha; Reheman, Adili; Wang, Yiming; Shaw, James A.; Levine, Ross L.; Ni, Heyu; Tall, Alan R.; Wang, Nan			Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis	NATURE MEDICINE			English	Article							BINDING CASSETTE TRANSPORTERS; RETICULATED PLATELETS; JAK2 INHIBITOR; LIPID RAFTS; HDL; ATHEROSCLEROSIS; ABCG1; PROLIFERATION; DEFICIENCY; ACTIVATION	Platelets have a key role in atherogenesis and its complications. Both hypercholesterolemia and increased platelet production promote atherothrombosis; however, a potential link between altered cholesterol homeostasis and platelet production has not been explored. Here we show that transplantation of bone marrow deficient in ABCG4, a transporter of unknown function, into LdIr(-/-) mice resulted in thrombocytosis, accelerated thrombosis and atherosclerosis. Although not detected in atherosclerotic lesions, Abcg4 was highly expressed in bone marrow megakaryocyte progenitors (MkPs). Abcg4(-/-) MkPs had defective cholesterol efflux to high-density lipoprotein (HDL), increased cell surface expression of the thrombopoietin (TPO) receptor (c-MPL) and enhanced proliferation. These consequences of ABCG4 deficiency seemed to reflect disruption of negative feedback regulation of c-MPL signaling by the E3 ligase c-CBL and the cholesterol-sensing LYN kinase. HDL infusion reduced platelet counts in LdIr(-/-) mice and in a mouse model of myeloproliferative neoplasm in an ABCG4-dependent fashion. HDL infusions may offer a new approach to reducing atherothrombotic events associated with increased platelet production.	[Murphy, Andrew J.; Bijl, Nora; Yvan-Charvet, Laurent; Welch, Carrie B.; Tall, Alan R.; Wang, Nan] Columbia Univ, Div Mol Med, Dept Med, New York, NY 10027 USA; [Bhagwat, Neha; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Bhagwat, Neha; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; [Reheman, Adili; Wang, Yiming; Ni, Heyu] Univ Toronto, Canadian Blood Serv, Toronto, ON M5B 1W8, Canada; [Reheman, Adili; Wang, Yiming; Ni, Heyu] Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Toronto, ON M5B 1W8, Canada; [Shaw, James A.] Alfred Hosp, Baker IDI Heart & Diabet Inst, Dept Cardiovasc Med, Melbourne, Vic, Australia	Columbia University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Canadian Blood Services; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Baker Heart and Diabetes Institute; Florey Institute of Neuroscience & Mental Health	Wang, N (corresponding author), Columbia Univ, Div Mol Med, Dept Med, New York, NY 10027 USA.	nw30@columbia.edu	levine, ross/AAE-7658-2019; Tall, Alan/AAT-8528-2021	Yvan-Charvet, Laurent/0000-0002-7748-4942; Wang, Yiming/0000-0001-8031-6184; Ni, Heyu/0000-0002-7621-2945; Murphy, Andrew/0000-0001-7039-7777	American Heart Association [12POST11890019]; US National Institutes of Health [HL107653]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107653] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	A.J.M. was supported by a postdoctoral fellowship from the American Heart Association (12POST11890019). This study was supported by US National Institutes of Health grant HL107653 (ART.). We thank A.L. DeFranco and C.A. Lowell of the University of California, San Francisco for providing Lyn<SUP>-/-</SUP> bone marrow cells and W Tong of the University of Pennsylvania for providing the antibody to c-MPL for flow cytometry analysis.	Annilo T, 2001, CYTOGENET CELL GENET, V94, P196, DOI 10.1159/000048816; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bojanic DD, 2010, J LIPID RES, V51, P169, DOI [10.1194/jlr.M900250-JLR200, 10.1194/M900250-JLR200]; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1980, J LIPID RES, V21, P505; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Coller BS, 2011, J THROMB HAEMOST, V9, P374, DOI 10.1111/j.1538-7836.2011.04356.x; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Frontelo P, 2007, BLOOD, V110, P3871, DOI 10.1182/blood-2007-03-082065; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Guthikonda S, 2008, J AM COLL CARDIOL, V52, P743, DOI 10.1016/j.jacc.2008.05.031; Hasselbalch HC, 2012, BLOOD, V119, P3219, DOI 10.1182/blood-2011-11-394775; Hitchcock IS, 2008, BLOOD, V112, P2222, DOI 10.1182/blood-2008-01-134049; Hunter S, 1999, J BIOL CHEM, V274, P2097, DOI 10.1074/jbc.274.4.2097; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Ingley E, 2005, ONCOGENE, V24, P336, DOI 10.1038/sj.onc.1208199; Kelemen E, 1999, ACTA HAEMATOL-BASEL, V101, P41, DOI 10.1159/000040919; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Labarthe DR, 2012, CIRCULATION, V125, P2667, DOI 10.1161/CIRCULATIONAHA.111.087726; Lakkis N, 2004, J AM COLL CARDIOL, V44, P2091, DOI 10.1016/j.jacc.2004.05.033; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; Lannutti BJ, 2003, EXP HEMATOL, V31, P1268, DOI 10.1016/j.exphem.2003.09.009; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Martin JF, 2012, NAT REV CARDIOL, V9, P658, DOI 10.1038/nrcardio.2012.131; Marty C, 2009, J BIOL CHEM, V284, P11781, DOI 10.1074/jbc.M808703200; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; MAZZONE A, 1993, CIRCULATION, V88, P358, DOI 10.1161/01.CIR.88.2.358; Meurs I, 2012, ATHEROSCLEROSIS, V221, P41, DOI 10.1016/j.atherosclerosis.2011.11.024; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nadeau S., 2012, BIOCHEM ANAL BIOCHEM, VS6; Nofer JR, 2011, CURR OPIN LIPIDOL, V22, P277, DOI 10.1097/MOL.0b013e32834701de; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Pathansali R, 2001, PLATELETS, V12, P292, DOI 10.1080/09537100120058810; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Saporito MS, 2012, J PHARMACOL EXP THER, V342, P15, DOI 10.1124/jpet.112.192096; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Shaw JA, 2008, CIRC RES, V103, P1084, DOI 10.1161/CIRCRESAHA.108.182063; Steinberg D, 2008, NEW ENGL J MED, V359, P1426, DOI 10.1056/NEJMp0806479; Stohlawetz P, 1998, TRANSFUSION, V38, P454, DOI 10.1046/j.1537-2995.1998.38598297214.x; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tall AR, 2012, ARTERIOSCL THROM VAS, V32, P2547, DOI 10.1161/ATVBAHA.112.300134; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Tiedt R, 2009, BLOOD, V113, P1768, DOI 10.1182/blood-2008-03-146084; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Villmow T, 2002, THROMB RES, V108, P139, DOI 10.1016/S0049-3848(02)00354-7; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Wolanskyj AP, 2006, MAYO CLIN PROC, V81, P159, DOI 10.4065/81.2.159; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	60	139	144	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					586	594		10.1038/nm.3150	http://dx.doi.org/10.1038/nm.3150			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23584088	Green Accepted			2022-12-27	WOS:000318583000030
J	Xiao, YC; Jin, J; Chang, MY; Chang, JH; Hu, HB; Zhou, XF; Brittain, GC; Stansberg, C; Torkildsen, O; Wang, XD; Brink, R; Cheng, XH; Sun, SC				Xiao, Yichuan; Jin, Jin; Chang, Mikyoung; Chang, Jae-Hoon; Hu, Hongbo; Zhou, Xiaofei; Brittain, George C.; Stansberg, Christine; Torkildsen, Oivind; Wang, Xiaodong; Brink, Robert; Cheng, Xuhong; Sun, Shao-Cong			Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; CELL-ACTIVATION; INNATE; RESPONSES; TLR	Nlicroglia are crucial for the pathogenesis of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). Here we show that the E3 ubiquitin ligase Peli1 is abundantly expressed in microglia and promotes microglial activation during the course of EAE induction. Peli1 mediates the induction of chemokines and proinflammatory cytokines in microglia and thereby promotes recruitment of T cells into the central nervous system. The severity of EAE is reduced in Peli1-deficient mice despite their competent induction of inflammatory T cells in the peripheral lymphoid organs. Notably, Peli1 regulates Toll-like receptor (TLR) pathway signaling by promoting degradation of TNF receptor-associated factor 3 (Traf3), a potent inhibitor of mitogen-activated protein kinase (MAPK) activation and gene induction. Ablation of Traf3 restores microglial activation and CNS inflammation after the induction of EAE in Peli1-deficient mice. These findings establish Peli1 as a microglia-specific mediator of autoimmune neuroinflammation and suggest a previously unknown signaling mechanism of Peli1 function.	[Xiao, Yichuan; Jin, Jin; Chang, Mikyoung; Chang, Jae-Hoon; Hu, Hongbo; Zhou, Xiaofei; Brittain, George C.; Cheng, Xuhong; Sun, Shao-Cong] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Stansberg, Christine] Univ Bergen, Dept Clin Med, Dr E Martens Res Grp Biol Psychiat, Bergen, Norway; [Stansberg, Christine] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Torkildsen, Oivind] Haukeland Hosp, Norwegian Multiple Sclerosis Competence Ctr, Dept Neurol, Bergen, Norway; [Torkildsen, Oivind] Univ Bergen, Kristian Gerhard Jebsen Mississippi Res Ctr, Dept Clin Med, Bergen, Norway; [Wang, Xiaodong] Nat Inst Biol Sci, Beijing, Peoples R China; [Brink, Robert] Garvan Inst Med Res, Immunol Res Program, Darlinghurst, NSW, Australia; [Sun, Shao-Cong] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Garvan Institute of Medical Research; University of Texas System; University of Texas Health Science Center Houston	Sun, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	ssun@mdanderson.org	Brink, Robert/B-7910-2010; Hu, Hongbo/J-8059-2016; zhou, xiaofei/A-9844-2013; Torkildsen, Øivind/A-1606-2008	Brink, Robert/0000-0002-9586-3655; Hu, Hongbo/0000-0002-8177-7641; Torkildsen, Øivind/0000-0001-5294-2866; Jin, Jin/0000-0001-7887-5972; Stansberg, Christine/0000-0002-3665-7843	US National Institutes of Health [AI057555, AI064639, GM84459, T32CA009598]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064639, R37AI064639, R01AI057555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084459] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Centenary Institute of Cancer Medicine and Cell Biology for Traf3-floxed mice; the Texas A&M Institute for Genomic Medicine for Peli1 knockout mice; S.H. Park (Sungkyunkwan University) for hemagglutinin (HA)-tagged Peli1 and Peli1 Delta C; R. Beyaert (Ghent University) for E-tag-Peli1; Z. Chen (University of Texas Southwestern Medical Center) for HA-tagged K63 ubiquitin; C. Du (University of Cincinnati College of Medicine) for Flag-c-IAP2; S. Akira (Osaka University) for Flag-IKKi; and X. Qin (Sun Yat-Sen University) for lentiviral packing plasmids. We also thank the personnel from the flow cytometry, DNA analysis, animal and histology core facilities at MD Anderson Cancer Center for technical assistance. This research was supported by grants from the US National Institutes of Health (AI057555, AI064639 and GM84459 to S.-CS. and T32CA009598 to G.C.B.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Almolda B, 2011, FRONT BIOSCI-LANDMRK, V16, P1157, DOI 10.2741/3781; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Chang M, 2009, NAT IMMUNOL, V10, P1089, DOI 10.1038/ni.1777; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Eisele S, 2012, BRAIN PATHOL, V22, P607, DOI 10.1111/j.1750-3639.2012.00564.x; Friese MA, 2007, BRAIN, V130, P2755, DOI 10.1093/brain/awm246; Gambuzza M, 2011, J NEUROIMMUNOL, V239, P1, DOI 10.1016/j.jneuroim.2011.08.010; Gao Z, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/383087; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goh ETH, 2012, BIOCHEM J, V441, P339, DOI 10.1042/BJ20111415; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jin W, 2012, CELL MOL IMMUNOL, V9, P113, DOI 10.1038/cmi.2011.60; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Libbey JE, 2011, VACCINE, V29, P3356, DOI 10.1016/j.vaccine.2010.08.103; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Schauvliege R, 2007, J CELL MOL MED, V11, P453, DOI 10.1111/j.1582-4934.2007.00040.x; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	36	125	138	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					595	602		10.1038/nm.3111	http://dx.doi.org/10.1038/nm.3111			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23603814	Green Accepted			2022-12-27	WOS:000318583000031
J	Broxmeyer, HE; Hoggatt, J; O'Leary, HA; Mantel, C; Chitteti, BR; Cooper, S; Messina-Graham, S; Hangoc, G; Farag, S; Rohrabaugh, SL; Ou, X; Speth, J; Pelus, LM; Srour, EF; Campbell, TB				Broxmeyer, Hal E.; Hoggatt, Jonathan; O'Leary, Heather A.; Mantel, Charlie; Chitteti, Brahmananda R.; Cooper, Scott; Messina-Graham, Steven; Hangoc, Giao; Farag, Sherif; Rohrabaugh, Sara L.; Ou, Xuan; Speth, Jennifer; Pelus, Louis M.; Srour, Edward F.; Campbell, Timothy B.			Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis	NATURE MEDICINE			English	Article							RECOMBINANT MURINE INTERLEUKIN-3; PROGENITOR CELLS; STEM-CELLS; CD26 INHIBITION; GM-CSF; ENHANCES ENGRAFTMENT; REPLATING CAPACITY; CD34(+) CELLS; IN-VITRO; MICE	Enhancement of hematopoietic recovery after radiation, chemotherapy, or hematopoietic stem cell (HSC) transplantation is clinically relevant. Dipeptidylpeptidase (DPP4) cleaves a wide variety of substrates, including the chemokine stromal cell-derived factor-1 (SDF-1). In the course of experiments showing that inhibition of DPP4 enhances SDF-1-mediated progenitor cell survival, ex vivo cytokine expansion and replating frequency, we unexpectedly found that DPP4 has a more general role in regulating colony-stimulating factor (CSF) activity. DPP4 cleaved within the N-termini of the CSFs granulocyte-macrophage (GM)-CSF, G-CSF, interleukin-3 (IL-3) and erythropoietin and decreased their activity. Dpp4 knockout or DPP4 inhibition enhanced CSF activities both in vitro and in vivo. The reduced activity of DPP4-truncated versus full-length human GM-CSF was mechanistically linked to effects on receptor-binding affinity, induction of GM-CSF receptor oligomerization and signaling capacity. Hematopoiesis in mice after radiation or chemotherapy was enhanced in Dpp4(-/-) mice or mice receiving an orally active DPP4 inhibitor. DPP4 inhibition enhanced engraftment in mice without compromising HSC function, suggesting the potential clinical utility of this approach.	[Broxmeyer, Hal E.; Hoggatt, Jonathan; O'Leary, Heather A.; Mantel, Charlie; Cooper, Scott; Messina-Graham, Steven; Hangoc, Giao; Rohrabaugh, Sara L.; Ou, Xuan; Speth, Jennifer; Pelus, Louis M.; Srour, Edward F.; Campbell, Timothy B.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Chitteti, Brahmananda R.; Farag, Sherif; Srour, Edward F.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; [Srour, Edward F.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Broxmeyer, HE (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu		O'Leary, Heather/0000-0003-1321-1520; Speth, Jennifer/0000-0002-7724-6995	US Health Service National Institutes of Health (NIH) [R01 HL056416, R01 HL067284, R01 HL112669]; Center of Excellence in Hematology [P01 DK090948, HL69669, HL96305]; NIH [T32 DK07519, T32 HL07910, R25 GM079657, T32 CA111198]; NATIONAL CANCER INSTITUTE [T32CA111198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067284, R01HL096305, R01HL112669, T32HL007910, R01HL067384, R01HL056416, R01HL069669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519, P30DK090948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079657] Funding Source: NIH RePORTER	US Health Service National Institutes of Health (NIH); Center of Excellence in Hematology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by US Health Service National Institutes of Health (NIH) grants R01 HL056416, R01 HL067284 and R01 HL112669 and a Center of Excellence in Hematology grant P01 DK090948 to H.E.B., and HL69669 and HL96305 to L.M.P.J.H. was supported as a doctoral candidate on NIH T32 DK07519 (to H.E.B.) and as a postdoc on NIH T32 HL07910 (to H.E.B.); H.A.O. was supported as a postdoc on NIH T32 DK07519; S.M.-G. was supported as a doctoral candidate on NIH R25 GM079657 (to H.E.B.); and T.B.C. was supported as a doctoral candidate on NIH T32 DK07519. S.L.R. was supported by NIH T32 CA111198 for parts of this study. We thank Y.-R. Zhou, The Feinstein Insitute for Medical Research, for the Cre<SUP>+</SUP> Cxcr4<SUP>F1/F1</SUP> mice.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Broxmeyer H.E., 2009, THOMAS HEMATOPOIETIC, P559; Broxmeyer HE, 2007, STEM CELLS DEV, V16, P589, DOI 10.1089/scd.2007.0044; Broxmeyer HE, 2011, BLOOD, V117, P4773, DOI 10.1182/blood-2011-01-330514; BROXMEYER HE, 1978, BLOOD, V51, P889; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; BROXMEYER HE, 1987, J CLIN INVEST, V79, P721, DOI 10.1172/JCI112877; BROXMEYER HE, 1987, P NATL ACAD SCI USA, V84, P3871, DOI 10.1073/pnas.84.11.3871; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; BROXMEYER HE, 1991, INT J HEMATOL, V54, P447; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Campbell TB, 2008, FRONT BIOSCI-LANDMRK, V13, P1795, DOI 10.2741/2800; Campbell TB, 2007, STEM CELLS DEV, V16, P347, DOI 10.1089/scd.2007.9995; CAROW CE, 1993, BLOOD, V81, P942; Chitteti B. R., 2011, CORD BLOOD BIOL TRAN, P75; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Cho SY, 2010, CANCER RES, V70, P3402, DOI 10.1158/0008-5472.CAN-09-3977; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Christopherson KW, 2007, STEM CELLS DEV, V16, P355, DOI 10.1089/scd.2007.9996; Christopherson KW, 2006, EXP HEMATOL, V34, P1060, DOI 10.1016/j.exphem.2006.03.012; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Gotoh A, 1996, BLOOD, V88, P138; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Haman A, 1999, J BIOL CHEM, V274, P34155, DOI 10.1074/jbc.274.48.34155; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Hercus TR, 2009, BLOOD, V114, P1289, DOI 10.1182/blood-2008-12-164004; Kajiyama H, 2002, CANCER RES, V62, P2753; Kawai T, 2007, STEM CELLS DEV, V16, P361, DOI 10.1089/scd.2007.9997; Kidd S, 2011, EXP HEMATOL, V39, P580, DOI 10.1016/j.exphem.2011.01.012; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Lee Y, 2002, BLOOD, V99, P4307, DOI 10.1182/blood.V99.12.4307; Lopez AF, 2010, IUBMB LIFE, V62, P509, DOI 10.1002/iub.350; Mantel C, 2008, CELL CYCLE, V7, P484, DOI 10.4161/cc.7.4.5316; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Niu LH, 1999, BLOOD, V94, P3748, DOI 10.1182/blood.V94.11.3748.423k16_3748_3753; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Peranteau WH, 2006, BLOOD, V108, P4268, DOI 10.1182/blood-2006-04-018986; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Shaheen MA, 2009, HEMATOLOGY BASIC PRI, P253; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Tian C, 2006, GENE THER, V13, P652, DOI 10.1038/sj.gt.3302695; Waterstrat A, 2010, BLOOD, V115, P408, DOI 10.1182/blood-2008-03-143370; Woodcock JM, 1999, INT J BIOCHEM CELL B, V31, P1017, DOI 10.1016/S1357-2725(99)00084-9; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Woodcock JM, 1997, BAILLIERE CLIN HAEM, V10, P507, DOI 10.1016/S0950-3536(97)80023-6; Wyss BK, 2009, EXP HEMATOL, V37, P814, DOI 10.1016/j.exphem.2009.03.005; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	55	165	169	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1786	+		10.1038/nm.2991	http://dx.doi.org/10.1038/nm.2991			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23160239	Green Accepted			2022-12-27	WOS:000311999800026
J	Han, SJ; Hawkins, SM; Begum, K; Jung, SY; Kovanci, E; Qin, J; Lydon, JP; DeMayo, FJ; O'Malley, BW				Han, Sang Jun; Hawkins, Shannon M.; Begum, Khurshida; Jung, Sung Yun; Kovanci, Ertug; Qin, Jun; Lydon, John P.; DeMayo, Francesco J.; O'Malley, Bert W.			A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; EPITHELIAL-CELLS; PROGESTERONE-RECEPTORS; OVARIAN ENDOMETRIOSIS; STROMAL CELLS; IN-VITRO; KAPPA-B; EXPRESSION; MODEL	Endometriosis is considered to be an estrogen-dependent inflammatory disease, but its etiology is unclear. Thus far, a mechanistic role for steroid receptor coactivators (SRCs) in the progression of endometriosis has not been elucidated. An SRC-1-null mouse model reveals that the mouse SRC-1 gene has an essential role in endometriosis progression. Notably, a previously unidentified 70-kDa SRC-1 proteolytic isoform is highly elevated both in the endometriotic tissue of mice with surgically induced endometriosis and in endometriotic stromal cells biopsied from patients with endometriosis compared to normal endometrium. Tnf(-/-) and Mmp9(-/-) mice with surgically induced endometriosis showed that activation of tumor necrosis factor alpha (TNF-alpha)-induced matrix metallopeptidase 9 (MMP9) activity mediates formation of the 70-kDa SRC-1 C-terminal isoform in endometriotic mouse tissue. In contrast to full-length SRC-1, the endometriotic 70-kDa SRC-1 C-terminal fragment prevents TNF-alpha-mediated apoptosis in human endometrial epithelial cells and causes the epithelial-mesenchymal transition and the invasion of human endometrial cells that are hallmarks of progressive endometriosis. Collectively, the newly identified TNF-alpha-MMP9-SRC-1 isoform functional axis promotes pathogenic progression of endometriosis.	[Han, Sang Jun; Begum, Khurshida; Jung, Sung Yun; Qin, Jun; Lydon, John P.; DeMayo, Francesco J.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hawkins, Shannon M.; Kovanci, Ertug] Baylor Coll Med, Dept Gynecol, Houston, TX 77030 USA; [Hawkins, Shannon M.; Kovanci, Ertug] Baylor Coll Med, Dept Obstet, Houston, TX 77030 USA; [Jung, Sung Yun; Qin, Jun] Baylor Coll Med, Dept Biochem & Mol Biol, Ctr Mol Discovery, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019; Hawkins, Shannon/AAX-5216-2020; Hawkins, Shannon M/B-7095-2015	DeMayo, Francesco/0000-0002-9480-7336; Hawkins, Shannon/0000-0002-0727-3971; Hawkins, Shannon M/0000-0002-0727-3971; Jung, Sung Yun/0000-0003-1521-7977	US National Institutes of Health-designated Diabetes; Endocrinology Research Center; Proteomics Core in the Dan L. Duncan Cancer Center at Baylor College of Medicine; US National Institute of Diabetes and Digestive and Kidney Diseases [U54HD0077495, 5K12HD050128, U54HD007495, R01 HD08188]; US National Cancer Institute [R01 CA077030]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857, U54HD007495, R03HD077495, R01HD008188] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD050128, P30HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077530, P50CA098258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	US National Institutes of Health-designated Diabetes; Endocrinology Research Center; Proteomics Core in the Dan L. Duncan Cancer Center at Baylor College of Medicine; US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C.J. Lockwood (Department of Obstetrics, Gynecology and Reproductive Science and Department of Genetics, Yale University School of Medicine) and T. Klonisch (Department of Human Anatomy and Cell Science, University of Manitoba) for providing immortalized human endometrial stromal and epithelial cells for this work. We thank M.J. Park for her technical support in animal experiments. We also thank the US National Institutes of Health-designated Diabetes and Endocrinology Research Center and the Proteomics Core in the Dan L. Duncan Cancer Center at Baylor College of Medicine for supporting this work. This work was supported by grants from the US National Institute of Diabetes and Digestive and Kidney Diseases (U54HD0077495 and 5K12HD050128 to S.M.H., U54HD007495 to F.J.D., R01 HD08188 to B.W.O. and a U54HD007495 pilot grant to S.J.H.) and a grant from the US National Cancer Institute (R01 CA077030 to J.P.L.).	Banu SK, 2009, FERTIL STERIL, V91, P2199, DOI 10.1016/j.fertnstert.2008.06.050; Bedaiwy MA, 2002, HUM REPROD, V17, P426, DOI 10.1093/humrep/17.2.426; Bergqvist A, 2001, FERTIL STERIL, V75, P489, DOI 10.1016/S0015-0282(00)01752-0; Berkkanoglu M, 2003, AM J REPROD IMMUNOL, V50, P48, DOI 10.1034/j.1600-0897.2003.00042.x; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chishima F, 2002, AM J REPROD IMMUNOL, V48, P50, DOI 10.1034/j.1600-0897.2002.01101.x; CUMMINGS AM, 1995, REPROD TOXICOL, V9, P233, DOI 10.1016/0890-6238(95)00004-T; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Efstathiou JA, 2005, FERTIL STERIL, V83, P171, DOI 10.1016/j.fertnstert.2004.06.058; Falconer H, 2006, HUM REPROD, V21, P1856, DOI 10.1093/humrep/del044; Fang ZJ, 2004, FERTIL STERIL, V82, P673, DOI 10.1016/j.fertnstert.2004.01.048; Fedele L, 2000, AM J OBSTET GYNECOL, V183, P1462, DOI 10.1067/mob.2000.108021; Fujimoto J, 1999, MOL HUM REPROD, V5, P742, DOI 10.1093/molehr/5.8.742; Grund EM, 2008, MOL PHARMACOL, V73, P1394, DOI 10.1124/mol.107.042176; Han SJ, 2005, MOL CELL BIOL, V25, P8150, DOI 10.1128/MCB.25.18.8150-8165.2005; Harris HA, 2005, HUM REPROD, V20, P936, DOI 10.1093/humrep/deh711; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Hirata T, 2011, FERTIL STERIL, V96, P113, DOI 10.1016/j.fertnstert.2011.04.060; Hombach-Klonisch S, 2005, J MOL ENDOCRINOL, V34, P517, DOI 10.1677/jme.1.01550; Imai A, 2000, AM J OBSTET GYNECOL, V182, P1142, DOI 10.1067/mob.2000.104804; Islimye M, 2011, EUR J OBSTET GYN R B, V159, P184, DOI 10.1016/j.ejogrb.2011.06.029; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Kumagami A, 2011, J OBSTET GYNAECOL RE, V37, P1269, DOI 10.1111/j.1447-0756.2010.01509.x; Leite RS, 2004, FASEB J, V18, P1418, DOI 10.1096/fj.04-1684fje; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Matsuzaki S, 2001, FERTIL STERIL, V75, P1198, DOI 10.1016/S0015-0282(01)01783-6; MELDRUM DR, 1982, J CLIN ENDOCR METAB, V54, P1081, DOI 10.1210/jcem-54-5-1081; Missmer SA, 2003, OBSTET GYN CLIN N AM, V30, P3; Nap AW, 2004, HUM REPROD, V19, P2180, DOI 10.1093/humrep/deh408; Noble LS, 1996, J CLIN ENDOCR METAB, V81, P174, DOI 10.1210/jc.81.1.174; Osteen KG, 2003, SEMIN REPROD MED, V21, P155; Overton C, 1996, HUM REPROD, V11, P380, DOI 10.1093/HUMREP/11.2.380; Pino M, 2009, REPRODUCTION, V138, P837, DOI 10.1530/REP-09-0196; Rubel CA, 2010, SEMIN REPROD MED, V28, P27, DOI 10.1055/s-0029-1242990; Sanz AB, 2008, J AM SOC NEPHROL, V19, P1634, DOI 10.1681/ASN.2007121336; Scott KA, 2004, ONCOGENE, V23, P6954, DOI 10.1038/sj.onc.1207915; Shakiba K, 2006, HUM REPROD, V21, P2417, DOI 10.1093/humrep/del179; Simsa P, 2007, WOMENS HEALTH, V3, P617, DOI 10.2217/17455057.3.5.617; Suzuki A, 2010, VIRCHOWS ARCH, V456, P433, DOI 10.1007/s00428-010-0884-x; Vilen ST, 2008, EXP CELL RES, V314, P914, DOI 10.1016/j.yexcr.2007.10.025; Wang Han-bi, 2005, Zhonghua Yi Xue Za Zhi, V85, P1555; Wang XL, 2009, MOL IMMUNOL, V46, P2413, DOI 10.1016/j.molimm.2009.04.014; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Zhang H, 2009, MOL HUM REPROD, V15, P653, DOI 10.1093/molehr/gap069	45	91	95	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1102	+		10.1038/nm.2826	http://dx.doi.org/10.1038/nm.2826			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22660634	Green Accepted			2022-12-27	WOS:000306121600040
J	Wynn, TA; Ramalingam, TR				Wynn, Thomas A.; Ramalingam, Thirumalai R.			Mechanisms of fibrosis: therapeutic translation for fibrotic disease	NATURE MEDICINE			English	Review							TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; IDIOPATHIC PULMONARY-FIBROSIS; HEPATIC STELLATE-CELLS; TISSUE GROWTH-FACTOR; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA EXPRESSION; ACTIVATED RECEPTOR-GAMMA; PLACEBO-CONTROLLED TRIAL; ACUTE LUNG INJURY	Fibrosis is a pathological feature of most chronic inflammatory diseases. Fibrosis, or scarring, is defined by the accumulation of excess extracellular matrix components. If highly progressive, the fibrotic process eventually leads to organ malfunction and death. Fibrosis affects nearly every tissue in the body. Here we discuss how key components of the innate and adaptive immune response contribute to the pathogenesis of fibrosis. We also describe how cell-intrinsic changes in important structural cells can perpetuate the fibrotic response by regulating the differentiation, recruitment, proliferation and activation of extracellular matrix-producing myofibroblasts. Finally, we highlight some of the key mechanisms and pathways of fibrosis that are being targeted as potential therapies for a variety of important human diseases.	[Wynn, Thomas A.; Ramalingam, Thirumalai R.] NIAID, Immunopathogenesis Sect, Program Barrier Immun & Repair, Parasit Dis Lab,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Wynn, TA (corresponding author), NIAID, Immunopathogenesis Sect, Program Barrier Immun & Repair, Parasit Dis Lab,NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	twynn@niaid.nih.gov	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731	US National Institutes of Health; National Institute of Allergy and Infectious Diseases; Pfizer; MedImmune; Amgen; Regeneron; Centocor; Genentech; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001019] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pfizer(Pfizer); MedImmune(AstraZenecaMedimmune); Amgen(Amgen); Regeneron(Regeneron); Centocor; Genentech(Roche HoldingGenentech); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to sincerely thank the past and present members of our laboratory for their guidance, comments and support. The Wynn laboratory is supported by the intramural research program of the US National Institutes of Health, National Institute of Allergy and Infectious Diseases and has benefited from cooperative research-and-development agreements with Pfizer, MedImmune, Amgen, Regeneron, Centocor and Genentech.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Anstee QM, 2008, J THROMB HAEMOST, V6, P1336, DOI 10.1111/j.1538-7836.2008.03015.x; Aoki Y, 2009, RESPIRATION, V77, P311, DOI 10.1159/000168676; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Bahcecioglu IH, 2008, INFLAMMATION, V31, P215, DOI 10.1007/s10753-008-9067-1; Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Baroni GS, 1996, HEPATOLOGY, V23, P1189; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Castano AP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000111; Chambers RC, 2008, BRIT J PHARMACOL, V153, pS367, DOI 10.1038/sj.bjp.0707603; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Claassen MAA, 2010, J HEPATOL, V52, P315, DOI 10.1016/j.jhep.2009.12.013; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coward WR, 2010, MOL CELL BIOL, V30, P2874, DOI 10.1128/MCB.01527-09; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; Dart ML, 2010, CIRC RES, V107, P1106, DOI 10.1161/CIRCRESAHA.110.221069; Diaz JA, 2009, AM J TRANSPLANT, V9, P1773, DOI 10.1111/j.1600-6143.2009.02706.x; Duffield JS, 2010, DRUG NEWS PERSPECT, V23, P305, DOI 10.1358/dnp.2010.23.5.1444206; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Ekert JE, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-23; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Estes JD, 2007, J INFECT DIS, V195, P551, DOI 10.1086/510852; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; Faust SM, 2009, J IMMUNOL, V183, P7297, DOI 10.4049/jimmunol.0902446; Feng WW, 2009, EXP MOL PATHOL, V87, P212, DOI 10.1016/j.yexmp.2009.06.001; Fine-Schi S, 2008, AM J RESP CELL MOL, V39, P458, DOI 10.1165/rcmb.2007-0320OC; Fiorucci S, 2004, HEPATOLOGY, V39, P365, DOI 10.1002/hep.20054; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Fuschiotti P, 2011, CYTOKINE, V56, P544, DOI 10.1016/j.cyto.2011.08.030; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gasse P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023185; Gilbert H S, 1984, Prog Clin Biol Res, V154, P3; GIRI SN, 1986, BIOCHEM MED METAB B, V36, P194, DOI 10.1016/0885-4505(86)90124-6; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; GURUJEYALAKSHMI G, 1995, EXP LUNG RES, V21, P791, DOI 10.3109/01902149509050842; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Han G, 2011, ONCOL REP, V26, P383, DOI 10.3892/or.2011.1300; Heise RL, 2011, J BIOL CHEM, V286, P17435, DOI 10.1074/jbc.M110.137273; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hemavathy K, 2009, CURR STEM CELL RES T, V4, P281, DOI 10.2174/157488809789649223; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Iglarz M, 2003, HYPERTENSION, V42, P737, DOI 10.1161/01.HYP.0000083511.91817.B1; Jeong WI, 2008, GASTROENTEROLOGY, V134, P248, DOI 10.1053/j.gastro.2007.09.034; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Jones LK, 2009, NEPHROL DIAL TRANSPL, V24, P3024, DOI 10.1093/ndt/gfp214; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kanellakis P, 2011, J HYPERTENS, V29, P1820, DOI 10.1097/HJH.0b013e328349c62d; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Kay J, 2008, ARTHRITIS RHEUM, V58, P2543, DOI 10.1002/art.23696; Keane MP, 2001, AM J PHYSIOL-LUNG C, V281, pL92, DOI 10.1152/ajplung.2001.281.1.L92; Kim JH, 2005, AM J PATHOL, V167, P1231, DOI 10.1016/S0002-9440(10)61211-4; Kinder BW, 2008, CHEST, V133, P226, DOI 10.1378/chest.07-1948; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kolodsick JE, 2004, J IMMUNOL, V172, P4068, DOI 10.4049/jimmunol.172.7.4068; Kono M, 2011, CLIN CHIM ACTA, V412, P2211, DOI 10.1016/j.cca.2011.08.008; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; Kraft M, 2011, NEW ENGL J MED, V365, P1141, DOI 10.1056/NEJMe1108666; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Laan M, 1999, J IMMUNOL, V162, P2347; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lee JH, 2001, AM J RESP CELL MOL, V25, P474, DOI 10.1165/ajrcmb.25.4.4522; Lee J, 2009, AM J PHYSIOL-LUNG C, V296, pL57, DOI 10.1152/ajplung.90411.2008; Levi-Schaffer F, 1999, P NATL ACAD SCI USA, V96, P9660, DOI 10.1073/pnas.96.17.9660; Levick SP, 2009, HYPERTENSION, V53, P1041, DOI 10.1161/HYPERTENSIONAHA.108.123158; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015404; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu T, 2006, AM J RESP CELL MOL, V34, P625, DOI 10.1165/rcmb.2005-0252OC; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu Y, 2011, J IMMUNOL, V187, P2814, DOI 10.4049/jimmunol.1003260; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; Mentink-Kane MM, 2011, GASTROENTEROLOGY, V141, P2200, DOI 10.1053/j.gastro.2011.08.008; Mentink-Kane MM, 2004, IMMUNOL REV, V202, P191, DOI 10.1111/j.0105-2896.2004.00210.x; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; MIYAZAKI Y, 1995, J CLIN INVEST, V96, P250, DOI 10.1172/JCI118029; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Murray LA, 2008, INT J BIOCHEM CELL B, V40, P2174, DOI 10.1016/j.biocel.2008.02.016; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Nakanishi H, 2007, AM J PHYSIOL-LUNG C, V293, pL151, DOI 10.1152/ajplung.00389.2006; Natsume M, 1999, J LEUKOCYTE BIOL, V66, P601, DOI 10.1002/jlb.66.4.601; Nawroth I, 2010, RADIOTHER ONCOL, V97, P143, DOI 10.1016/j.radonc.2010.09.010; Noble PW, 2011, AM J RESP CRIT CARE, V184, P4, DOI 10.1164/rccm.201105-0813ED; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogawa T, 2010, BIOCHEM BIOPH RES CO, V391, P316, DOI 10.1016/j.bbrc.2009.11.056; Oh MH, 2011, J IMMUNOL, V186, P7232, DOI 10.4049/jimmunol.1100504; Oldroyd SD, 1999, KIDNEY INT, V56, P2116, DOI 10.1046/j.1523-1755.1999.00775.x; Ong C, 1998, EUR J IMMUNOL, V28, P2619, DOI 10.1002/(SICI)1521-4141(199809)28:09<2619::AID-IMMU2619>3.0.CO;2-M; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pardo A, 2000, AM J RESP CRIT CARE, V161, P1698, DOI 10.1164/ajrccm.161.5.9907065; Park SW, 2009, J KOREAN MED SCI, V24, P614, DOI 10.3346/jkms.2009.24.4.614; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; PETERSON MW, 1987, CHEST, V92, P51, DOI 10.1378/chest.92.1.51; PIGUET PF, 1989, J EXP MED, V170, P655, DOI 10.1084/jem.170.3.655; PIGUET PF, 1990, NATURE, V344, P245, DOI 10.1038/344245a0; PIGUET PF, 1993, AM J PATHOL, V143, P651; Pockros PJ, 2007, HEPATOLOGY, V45, P569, DOI 10.1002/hep.21561; Pradere JP, 2007, J AM SOC NEPHROL, V18, P3110, DOI 10.1681/ASN.2007020196; Proctor CJ, 2002, MECH AGEING DEV, V123, P351, DOI 10.1016/S0047-6374(01)00380-3; Raghu G, 2008, AM J RESP CRIT CARE, V178, P948, DOI 10.1164/rccm.200709-1446OC; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Richeldi L, 2011, EXPERT REV RESP MED, V5, P473, DOI [10.1586/ers.11.52, 10.1586/ERS.11.52]; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sanders YY, 2008, AM J RESP CELL MOL, V39, P610, DOI 10.1165/rcmb.2007-0322OC; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Shimamura T, 2008, J IMMUNOL, V181, P4656, DOI 10.4049/jimmunol.181.7.4656; Sidharta PN, 2011, EUR J CLIN PHARMACOL, V67, P977, DOI 10.1007/s00228-011-1043-2; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tedstone JL, 2008, ULTRASOUND MED BIOL, V34, P1239, DOI 10.1016/j.ultrasmedbio.2008.01.013; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Verstovsek S, 2010, CLIN CANCER RES, V16, P1988, DOI 10.1158/1078-0432.CCR-09-2836; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang D, 2011, KIDNEY INT, V80, P1159, DOI 10.1038/ki.2011.255; Wang LY, 2011, INT J MOL MED, V27, P385, DOI 10.3892/ijmm.2011.594; WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1002/hep.1840210505; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934; Wilson MS, 2011, GASTROENTEROLOGY, V140, P254, DOI 10.1053/j.gastro.2010.09.047; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; WYNN TA, 1995, NATURE, V376, P594, DOI 10.1038/376594a0; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Yang L, 2010, INFLAMM RES, V59, P1061, DOI 10.1007/s00011-010-0226-0; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang JL, 2010, TRANSPL IMMUNOL, V24, P17, DOI 10.1016/j.trim.2010.09.002; ZHANG Y, 1993, J IMMUNOL, V150, P4188; Zhu FL, 2011, CLIN IMMUNOL, V141, P152, DOI 10.1016/j.clim.2011.07.003	181	1966	2092	41	565	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1028	1040		10.1038/nm.2807	http://dx.doi.org/10.1038/nm.2807			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772564	Green Accepted			2022-12-27	WOS:000306121600032
J	Avraham-Davidi, I; Ely, Y; Pham, VN; Castranova, D; Grunspan, M; Malkinson, G; Gibbs-Bar, L; Mayseless, O; Allmog, G; Lo, B; Warren, CM; Chen, TT; Ungos, J; Kidd, K; Shaw, K; Rogachev, I; Wan, WZ; Murphy, PM; Farber, SA; Carmel, L; Shelness, GS; Iruela-Arispe, ML; Weinstein, BM; Yaniv, K				Avraham-Davidi, Inbal; Ely, Yona; Pham, Van N.; Castranova, Daniel; Grunspan, Moshe; Malkinson, Guy; Gibbs-Bar, Liron; Mayseless, Oded; Allmog, Gabriella; Lo, Brigid; Warren, Carmen M.; Chen, Tom T.; Ungos, Josette; Kidd, Kameha; Shaw, Kenna; Rogachev, Ilana; Wan, Wuzhou; Murphy, Philip M.; Farber, Steven A.; Carmel, Liran; Shelness, Gregory S.; Iruela-Arispe, M. Luisa; Weinstein, Brant M.; Yaniv, Karina			ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1	NATURE MEDICINE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; ENDOTHELIAL-CELLS; APOLIPOPROTEIN-B; ZEBRAFISH; HYPERCHOLESTEROLEMIA; ABETALIPOPROTEINEMIA; METABOLISM; VERTEBRATE; PLASMA; GENES	Despite the clear major contribution of hyperlipidemia to the prevalence of cardiovascular disease in the developed world, the direct effects of lipoproteins on endothelial cells have remained obscure and are under debate. Here we report a previously uncharacterized mechanism of vessel growth modulation by lipoprotein availability. Using a genetic screen for vascular defects in zebrafish, we initially identified a mutation, stalactite (stl), in the gene encoding microsomal triglyceride transfer protein (mtp), which is involved in the biosynthesis of apolipoprotein B (ApoB)-containing lipoproteins. By manipulating lipoprotein concentrations in zebrafish, we found that ApoB negatively regulates angiogenesis and that it is the ApoB protein particle, rather than lipid moieties within ApoB-containing lipoproteins, that is primarily responsible for this effect. Mechanistically, we identified downregulation of vascular endothelial growth factor receptor 1 (VEGFR1), which acts as a decoy receptor for VEGF, as a key mediator of the endothelial response to lipoproteins, and we observed VEGFR1 downregulation in hyperlipidemic mice. These findings may open new avenues for the treatment of lipoprotein-related vascular disorders.	[Avraham-Davidi, Inbal; Ely, Yona; Grunspan, Moshe; Malkinson, Guy; Gibbs-Bar, Liron; Mayseless, Oded; Allmog, Gabriella; Yaniv, Karina] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Pham, Van N.; Castranova, Daniel; Lo, Brigid; Ungos, Josette; Kidd, Kameha; Shaw, Kenna; Weinstein, Brant M.] NICHHD, Mol Genet Lab, US Natl Inst Hlth NIH, Bethesda, MD USA; [Warren, Carmen M.; Chen, Tom T.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Rogachev, Ilana] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Wan, Wuzhou; Murphy, Philip M.] NIAID, Lab Mol Immunol, NIH, Bethesda, MD USA; [Farber, Steven A.] Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA; [Carmel, Liran] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, Jerusalem, Israel; [Shelness, Gregory S.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Carnegie Institution for Science; Hebrew University of Jerusalem; Wake Forest University; Wake Forest Baptist Medical Center	Yaniv, K (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	karina.yaniv@weizmann.ac.il	Farber, Steven A/G-5851-2012; Iruela-Arispe, M. Luisa/AAJ-1297-2020; Wan, Wuhzou/H-8556-2013	Farber, Steven A/0000-0002-8037-7312; Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Mayseless, Oded/0000-0002-9556-8541; Malkinson, Guy/0000-0001-7339-3659	Israel Science Foundation [748/2009]; Marie Curie Actions-International Reintegration [FP7-PEOPLE-2009-RG 256393]; Yeda-Sela Center; Israel Cancer Research Foundation; US National Institutes of Health (NIH) [RO1CA126935]; NIH [T32HL069766, HL049373, R56DK093399, R01GM063904]; Carnegie Institution for Science endowment; G. Harold and Leila Y. Mathers Charitable Foundation; National Institute of Child Health and Human Development, NIH,; Foundation Leducq; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001011] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA126935] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069766, P01HL049373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK093399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Marie Curie Actions-International Reintegration; Yeda-Sela Center; Israel Cancer Research Foundation; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carnegie Institution for Science endowment; G. Harold and Leila Y. Mathers Charitable Foundation; National Institute of Child Health and Human Development, NIH,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Foundation Leducq(Leducq Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank G. Palardy, R. Miyares, N. Nevo, I. Harel, T. Berkutzki, I. Raviv, R. Oren and C. Rot for technical assistance; A. Aharoni for help with GC-MS analyses; E. Zelzer (Weizmann Institute, Israel) for providing the Ldlr-null mice, K. Tordjman (Sourasky Medical Center, Israel) for providing the ApoE-null mice, S. Schulte-Merker (Hubrecht Institute) for providing the vegfr1 plasmid and the Tg(flt1: YFP)<SUP>hu4624</SUP> transgenic line; J. Berliner (University of California Los Angeles, California) for providing human aortic endothelial cells (HAECs); D. Haratz, I. Groskop and A. Shaish for advice regarding lipid analyses; A. Harmelin and N. Stettner for animal care; and I. B. Dawid, E. Tzahor, A. Gross, B. Shilo and J. Torres-Vazquez for critical reading of the manuscript. The authors are grateful to all the members of the Yaniv and Weinstein labs for discussion, technical assistance and continuous support. This work was supported in part by Israel Science Foundation 748/2009 (to K.Y.), Marie Curie Actions-International Reintegration grants FP7-PEOPLE-2009-RG 256393 (to K.Y.), the Yeda-Sela Center (to K.Y.), the Israel Cancer Research Foundation Postdoctoral Fellowship (to I.A.-D.), US National Institutes of Health (NIH) RO1CA126935 (to M. L. I.-A.), NIH T32HL069766 (training grant for T. T. C. and C. M. W.) and NIH HL049373 (to G. S. S.). S. A. F. is funded by the NIH (R56DK093399 and R01GM063904), the Carnegie Institution for Science endowment and the G. Harold and Leila Y. Mathers Charitable Foundation. B. M. W. is supported by the intramural program of the National Institute of Child Health and Human Development, NIH, and by the Foundation Leducq.	Amack JD, 2004, CURR BIOL, V14, P685, DOI 10.1016/j.cub.2004.04.002; Anderson JL, 2011, METHOD CELL BIOL, V101, P111, DOI 10.1016/B978-0-12-387036-0.00005-0; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Babin PJ, 2009, PROG LIPID RES, V48, P73, DOI 10.1016/j.plipres.2008.11.002; Babin PJ, 1997, P NATL ACAD SCI USA, V94, P8622, DOI 10.1073/pnas.94.16.8622; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breckenridge W C, 1986, Adv Exp Med Biol, V201, P211; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Chappell JC, 2009, DEV CELL, V17, P377, DOI 10.1016/j.devcel.2009.07.011; CONNELLY PW, 1987, J CLIN INVEST, V80, P1597, DOI 10.1172/JCI113246; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Fazio S, 2001, FRONT BIOSCI-LANDMRK, V6, pD515, DOI 10.2741/Fazio; Fraisl P, 2008, DEV CELL, V14, P313, DOI 10.1016/j.devcel.2008.02.009; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; HEGELE RA, 1991, DIS MARKERS, V9, P73; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; HENRY PD, 1993, AM J CARDIOL, V72, pC61, DOI 10.1016/0002-9149(93)90257-D; HESSLER JR, 1979, ATHEROSCLEROSIS, V32, P213, DOI 10.1016/0021-9150(79)90166-7; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P277, DOI 10.1097/MOL.0b013e3282feea85; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Itkin M, 2011, PLANT CELL, V23, P4507, DOI 10.1105/tpc.111.088732; Kearney JB, 2002, BLOOD, V99, P2397, DOI 10.1182/blood.V99.7.2397; Landmesser U, 2000, SEMIN THROMB HEMOST, V26, P529, DOI 10.1055/s-2000-13209; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Marza E, 2005, DEV DYNAM, V232, P506, DOI 10.1002/dvdy.20251; Nicoli S, 2009, J CELL MOL MED, V13, P2061, DOI 10.1111/j.1582-4934.2008.00432.x; Pham VN, 2007, DEV BIOL, V303, P772, DOI 10.1016/j.ydbio.2006.10.030; Pickart MA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000104; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; RADER DJ, 1993, JAMA-J AM MED ASSOC, V270, P865, DOI 10.1001/jama.270.7.865; Roman BL, 2002, DEVELOPMENT, V129, P3009; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Schlegel A, 2006, BIOCHEMISTRY-US, V45, P15179, DOI 10.1021/bi0619268; Sellers JA, 2003, J BIOL CHEM, V278, P20367, DOI 10.1074/jbc.M300271200; Sethuraman G, 2007, PEDIATR DERMATOL, V24, P230, DOI 10.1111/j.1525-1470.2007.00391.x; Shelness GS, 2003, J BIOL CHEM, V278, P44702, DOI 10.1074/jbc.M307562200; Shelton JM, 2000, J LIPID RES, V41, P532; SHIREMAN R, 1977, P NATL ACAD SCI USA, V74, P5150, DOI 10.1073/pnas.74.11.5150; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Takada N, 2010, DEV DYNAM, V239, P2041, DOI 10.1002/dvdy.22338; Thorpe JL, 2004, DEV CELL, V6, P295, DOI 10.1016/S1534-5807(04)00032-2; Usui R, 2007, EMBO REP, V8, P1155, DOI 10.1038/sj.embor.7401103; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Yla-Herttuala S, 2007, EMBO REP, V8, P1127, DOI 10.1038/sj.embor.7401124; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	53	86	90	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					967	+		10.1038/nm.2759	http://dx.doi.org/10.1038/nm.2759			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22581286	Green Accepted			2022-12-27	WOS:000305116600036
J	Kuipers, F; Groen, AK				Kuipers, Folkert; Groen, Albert K.			FXR: the key to benefits in bariatric surgery?	NATURE MEDICINE			English	Editorial Material							Y GASTRIC BYPASS; BILE-ACIDS; WEIGHT-LOSS; OBESITY; MICE; HOMEOSTASIS; GLUCOSE		[Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9700 AB Groningen, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 AB Groningen, Netherlands	University of Groningen; University of Groningen	Kuipers, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9700 AB Groningen, Netherlands.	f.kuipers@umcg.nl		Kuipers, Folkert/0000-0003-2518-737X				Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Cariou B, 2007, FEBS LETT, V581, P5191, DOI 10.1016/j.febslet.2007.09.064; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ryan K.K., 2014, NATURE          0326, DOI [10.1038/nature13135, DOI 10.1038/NATURE13135]; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361; Zhang YQ, 2012, MOL ENDOCRINOL, V26, P272, DOI 10.1210/me.2011-1157	16	28	28	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					337	338		10.1038/nm.3525	http://dx.doi.org/10.1038/nm.3525			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710375				2022-12-27	WOS:000334361500011
J	Schain, AJ; Hill, RA; Grutzendler, J				Schain, Aaron J.; Hill, Robert A.; Grutzendler, Jaime			Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENERATION MICROSCOPY; FLUORESCENT PROTEINS; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; CEREBRAL-CORTEX; BRAIN; MOUSE; DEMYELINATION; EXPRESSION	We report a newly developed technique for high-resolution in vivo imaging of myelinated axons in the brain, spinal cord and peripheral nerve that requires no fluorescent labeling. This method, based on spectral confocal reflectance microscopy (SCoRe), uses a conventional laser-scanning confocal system to generate images by merging the simultaneously reflected signals from multiple lasers of different wavelengths. Striking color patterns unique to individual myelinated fibers are generated that facilitate their tracing in dense axonal areas. These patterns highlight nodes of Ranvier and Schmidt-Lanterman incisures and can be used to detect various myelin pathologies. Using SCoRe we carried out chronic brain imaging up to 400 mu m deep, capturing de novo myelination of mouse cortical axons in vivo. We also established the feasibility of imaging myelinated axons in the human cerebral cortex. SCoRe adds a powerful component to the evolving toolbox for imaging myelination in living animals and potentially in humans.	[Schain, Aaron J.; Hill, Robert A.; Grutzendler, Jaime] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Grutzendler, Jaime] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA	Yale University; Yale University	Grutzendler, J (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	jaime.grutzendler@yale.edu		Hill, Robert/0000-0001-6080-8712	Cognitive Neurology and Alzheimer's disease Center (CNADC) at Northwestern University [AG13854];  [R01AG027855];  [R01HL106815]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS088411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027855] Funding Source: NIH RePORTER	Cognitive Neurology and Alzheimer's disease Center (CNADC) at Northwestern University; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the following grants: R01AG027855 and R01HL106815 (J.G.). We would like to thank J. Bewersdorf and D. Toomre for helpful discussions and P. Yuan for critical reading of the manuscript. We thank A. Nishiyama (University of Connecticut) and F. Kirchhoff (University of Saarland) for providing PLPDsRed mice. Postmortem human specimen was obtained from the brain bank in the Cognitive Neurology and Alzheimer's disease Center (CNADC) at Northwestern University (grant AG13854).	Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Ben Arous J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3650770; Binding J, 2011, OPT EXPRESS, V19, P4833, DOI 10.1364/OE.19.004833; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Farrar MJ, 2011, BIOPHYS J, V100, P1362, DOI 10.1016/j.bpj.2011.01.031; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fenrich KK, 2012, J PHYSIOL-LONDON, V590, P3665, DOI 10.1113/jphysiol.2012.230532; Filler TJ, 2000, J PATHOL, V190, P635; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fu Y, 2008, OPT EXPRESS, V16, P19396, DOI 10.1364/OE.16.019396; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; GOULD RM, 1995, J NEUROCYTOL, V24, P85, DOI 10.1007/BF01181552; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; HA H, 1970, J COMP NEUROL, V140, P227, DOI 10.1002/cne.901400206; Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Hong GS, 2012, NAT MED, V18, P1841, DOI 10.1038/nm.2995; Imitola J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3533312; JACOBSON S, 1963, J COMP NEUROL, V121, P5, DOI 10.1002/cne.901210103; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaya F, 2012, J NEUROSCI, V32, P12885, DOI 10.1523/JNEUROSCI.2252-12.2012; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Macleod HA, 2001, THIN FILM OPTICAL FI; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WAXMAN SG, 1975, NEUROSCI LETT, V1, P251, DOI 10.1016/0304-3940(75)90039-7; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Witte S, 2011, P NATL ACAD SCI USA, V108, P5970, DOI 10.1073/pnas.1018743108; Xiao J, 2006, BRAIN RES, V1077, P81, DOI 10.1016/j.brainres.2006.01.021; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	41	110	111	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					443	+		10.1038/nm.3495	http://dx.doi.org/10.1038/nm.3495			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24681598	Green Accepted			2022-12-27	WOS:000334361500027
J	Guo, JL; Lee, VMY				Guo, Jing L.; Lee, Virginia M. Y.			Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases	NATURE MEDICINE			English	Review							PATHOLOGICAL ALPHA-SYNUCLEIN; FRONTOTEMPORAL LOBAR DEGENERATION; PAIRED HELICAL FILAMENTS; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; LEWY BODY DISEASE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; PRION PROTEIN; NEURON TRANSMISSION	A common feature of many neurodegenerative diseases is the deposition of beta-sheet-rich amyloid aggregates formed by proteins specific to these diseases. These protein aggregates are thought to cause neuronal dysfunction, directly or indirectly. Recent studies have strongly implicated cell-to-cell transmission of misfolded proteins as a common mechanism for the onset and progression of various neurodegenerative disorders. Emerging evidence also suggests the presence of conformationally diverse 'strains' of each type of disease protein, which may be another shared feature of amyloid aggregates, accounting for the tremendous heterogeneity within each type of neurodegenerative disease. Although there are many more questions to be answered, these studies have opened up new avenues for therapeutic interventions in neurodegenerative disorders.	[Lee, Virginia M. Y.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Inst Aging, Philadelphia, PA 19104 USA.	vmylee@upenn.edu			NIH/NIA grants [AG17586, NS53488]; Marian S. Ware Alzheimer Program; Jeff and Anne Keefer Fund; Parkinson Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS053488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	NIH/NIA grants; Marian S. Ware Alzheimer Program; Jeff and Anne Keefer Fund; Parkinson Council; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank J.Q. Trojanowski for critical reading of the manuscript. This study was supported by NIH/NIA grants AG17586, NS53488 (V.M.Y.L.), the Marian S. Ware Alzheimer Program, the Jeff and Anne Keefer Fund and the Parkinson Council.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Braak H, 2009, ADV ANAT EMBRYOL CEL, V201, P1; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; BROWN P, 1985, NEW ENGL J MED, V313, P728, DOI 10.1056/NEJM198509193131205; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cearley CN, 2008, MOL THER, V16, P1710, DOI 10.1038/mt.2008.166; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Couch J.A., 2013, SCI TRANSL MED, V5; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dickson DW, 1999, J NEUROL, V246, P1211; DIETZSCHOLD B, 1985, J VIROL, V56, P12, DOI 10.1128/JVI.56.1.12-18.1985; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; GALLOWAY PG, 1989, NEUROSCI LETT, V100, P6, DOI 10.1016/0304-3940(89)90651-4; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goedert M, 1999, PHILOS T ROY SOC B, V354, P1101, DOI 10.1098/rstb.1999.0466; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guo JL, 2013, FEBS LETT, V587, P717, DOI 10.1016/j.febslet.2013.01.051; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Irwin DJ, 2013, JAMA NEUROL, V70, P462, DOI 10.1001/jamaneurol.2013.1933; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Korecka JA, 2007, REGEN MED, V2, P425, DOI 10.2217/17460751.2.4.425; KOSAKA K, 1988, CLIN NEUROPATHOL, V7, P299; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; MAYEUX R, 1992, ARCH NEUROL-CHICAGO, V49, P492, DOI 10.1001/archneur.1992.00530290076015; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Mollenhauer B, 2013, NEUROSCI LETT, V532, P44, DOI 10.1016/j.neulet.2012.11.004; Morozova OA, 2013, BIOCHEMISTRY-US, V52, P6960, DOI 10.1021/bi400866w; MORRIS JC, 1989, ARCH NEUROL-CHICAGO, V46, P651, DOI 10.1001/archneur.1989.00520420071025; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAN P, 2009, NAT CELL BIOL, V11, P219; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schenk DB, 2005, NEURODEGENER DIS, V2, P255, DOI 10.1159/000090365; SEMEN S, 2012, J BIOL CHEM, V287, P3842; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Thorpe J, 2008, J NEURAL TRANSM, V115, P1661, DOI 10.1007/s00702-008-0137-1; Thoulouze MI, 1998, J VIROL, V72, P7181, DOI 10.1128/JVI.72.9.7181-7190.1998; Tolnay M, 2003, IUBMB LIFE, V55, P299, DOI 10.1080/1521654032000114348; Ulusoy A, 2013, EMBO MOL MED, V5, P1119, DOI 10.1002/emmm.201302475; van Dijk KD, 2014, EUR J NEUROL, V21, P388, DOI 10.1111/ene.12176; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Weissmann C, 2002, P NATL ACAD SCI USA, V99, P16378, DOI 10.1073/pnas.172403799; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	134	426	437	4	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					130	138		10.1038/nm.3457	http://dx.doi.org/10.1038/nm.3457			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24504409	Green Accepted			2022-12-27	WOS:000330915000013
J	Filbin, MG; Dabral, SK; Pazyra-Murphy, MF; Ramkissoon, S; Kung, AL; Pak, E; Chung, J; Theisen, MA; Sun, YP; Franchetti, Y; Sun, Y; Shulman, DS; Redjal, N; Tabak, B; Beroukhim, R; Wang, Q; Zhao, J; Dorsch, M; Buonamici, S; Ligon, KL; Kelleher, JF; Segal, RA				Filbin, Mariella Gruber; Dabral, Sukriti K.; Pazyra-Murphy, Maria F.; Ramkissoon, Shakti; Kung, Andrew L.; Pak, Ekaterina; Chung, Jarom; Theisen, Matthew A.; Sun, Yanping; Franchetti, Yoko; Sun, Yu; Shulman, David S.; Redjal, Navid; Tabak, Barbara; Beroukhim, Rameen; Wang, Qi; Zhao, Jean; Dorsch, Marion; Buonamici, Silvia; Ligon, Keith L.; Kelleher, Joseph F.; Segal, Rosalind A.			Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities	NATURE MEDICINE			English	Article							CELL-CYCLE PROGRESSION; NEURONAL PRECURSORS; CORE PATHWAYS; CANCER-CELLS; STEM-CELLS; IN-VITRO; HEDGEHOG; KINASE; LINES; ANTAGONIST	In glioblastoma, phosphatidylinositol 3-kinase (PI3K) signaling is frequently activated by loss of the tumor suppressor phosphatase and tensin homolog (PTEN)(1). However, it is not known whether inhibiting PI3K represents a selective and effective approach for treatment. We interrogated large databases and found that sonic hedgehog (SHH) signaling is activated in PTEN-deficient glioblastoma. We demonstrate that the SHH and PI3K pathways synergize to promote tumor growth and viability in human PTEN-deficient glioblastomas. A combination of PI3K and SHH signaling inhibitors not only suppressed the activation of both pathways but also abrogated S6 kinase (S6K) signaling. Accordingly, targeting both pathways simultaneously resulted in mitotic catastrophe and tumor apoptosis and markedly reduced the growth of PTEN-deficient glioblastomas in vitro and in vivo. The drugs tested here appear to be safe in humans; therefore, this combination may provide a new targeted treatment for glioblastoma.	[Filbin, Mariella Gruber; Dabral, Sukriti K.; Pazyra-Murphy, Maria F.; Kung, Andrew L.; Pak, Ekaterina; Chung, Jarom; Sun, Yu; Shulman, David S.; Wang, Qi; Zhao, Jean; Segal, Rosalind A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Filbin, Mariella Gruber; Dabral, Sukriti K.; Pazyra-Murphy, Maria F.; Kung, Andrew L.; Pak, Ekaterina; Chung, Jarom; Sun, Yu; Shulman, David S.; Wang, Qi; Zhao, Jean; Segal, Rosalind A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Filbin, Mariella Gruber; Dabral, Sukriti K.; Pazyra-Murphy, Maria F.; Kung, Andrew L.; Pak, Ekaterina; Chung, Jarom; Sun, Yu; Shulman, David S.; Wang, Qi; Zhao, Jean; Segal, Rosalind A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Filbin, Mariella Gruber; Dabral, Sukriti K.; Pazyra-Murphy, Maria F.; Pak, Ekaterina; Chung, Jarom; Sun, Yu; Segal, Rosalind A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Filbin, Mariella Gruber] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Ramkissoon, Shakti; Theisen, Matthew A.; Tabak, Barbara; Beroukhim, Rameen; Ligon, Keith L.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Kung, Andrew L.; Sun, Yanping] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Franchetti, Yoko] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Franchetti, Yoko] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Redjal, Navid] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol Surg, Boston, MA USA; [Dorsch, Marion] Sanofi Aventis, Cambridge, MA USA; [Buonamici, Silvia; Kelleher, Joseph F.] Novartis Inst Biomed Res, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Medical University of Vienna; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; Sanofi-Aventis; Novartis	Segal, RA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	rosalind_segal@dfci.harvard.edu	Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022	Kung, Andrew L/0000-0002-9091-488X	Austrian Programme for Advanced Research and Technology (APART) fellowship of the Austrian Academy of Sciences; US National Institutes of Health; Novartis Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA172461, P01CA142536] Funding Source: NIH RePORTER	Austrian Programme for Advanced Research and Technology (APART) fellowship of the Austrian Academy of Sciences; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Pharmaceuticals(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank V. Monrose and K. Jones for technical assistance and C. Stiles for helpful discussions. We thank N. Gray (Dana-Farber Cancer Institute) for PF-4708671 and C. David James (University of California San Francisco) for the hBT70 and hBT75 lines. This work was supported by an Austrian Programme for Advanced Research and Technology (APART) fellowship of the Austrian Academy of Sciences (M.G.F.), grants from the US National Institutes of Health (R.A.S.) and Novartis Pharmaceuticals.	Barbus S, 2011, JNCI-J NATL CANCER I, V103, P598, DOI 10.1093/jnci/djr036; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Castellino RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010849; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choi HN, 2013, BIOCHEM BIOPH RES CO, V432, P123, DOI 10.1016/j.bbrc.2013.01.074; Dancey JE, 2005, EXPERT OPIN INV DRUG, V14, P313, DOI 10.1517/13543784.14.3.313; Eimer S, 2012, NEURO-ONCOLOGY, V14, P1441, DOI 10.1093/neuonc/nos266; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Ferruzzi P, 2012, INT J CANCER, V131, pE33, DOI 10.1002/ijc.27349; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Hsieh A, 2011, J CELL PHYSIOL, V226, P1118, DOI 10.1002/jcp.22433; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Masi A, 2005, BRIT J CANCER, V93, P781, DOI 10.1038/sj.bjc.6602775; Mizuarai S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-44; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Quant EC, 2010, NEUROIMAG CLIN N AM, V20, P425, DOI 10.1016/j.nic.2010.04.007; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Santoni M, 2013, CURR PROTEIN PEPT SC, V14, P133, DOI 10.2174/1389203711314020005; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tandon P, 2011, P NATL ACAD SCI USA, V108, P2361, DOI 10.1073/pnas.1013629108; Tremblay MR, 2010, CURR OPIN CHEM BIOL, V14, P428, DOI 10.1016/j.cbpa.2010.03.016; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Venere M, 2011, GLIA, V59, P1148, DOI 10.1002/glia.21185; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355; Xu QJ, 2008, STEM CELLS, V26, P3018, DOI 10.1634/stemcells.2008-0459	39	106	107	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1518	+		10.1038/nm.3328	http://dx.doi.org/10.1038/nm.3328			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24076665	Green Accepted			2022-12-27	WOS:000326920300030
J	Udagawa, T; Farny, NG; Jakovcevski, M; Kaphzan, H; Alarcon, JM; Anilkumar, S; Ivshina, M; Hurt, JA; Nagaoka, K; Nalavadi, VC; Lorenz, LJ; Bassell, GJ; Akbarian, S; Chattarji, S; Klann, E; Richter, JD				Udagawa, Tsuyoshi; Farny, Natalie G.; Jakovcevski, Mira; Kaphzan, Hanoch; Alarcon, Juan Marcos; Anilkumar, Shobha; Ivshina, Maria; Hurt, Jessica A.; Nagaoka, Kentaro; Nalavadi, Vijayalaxmi C.; Lorenz, Lori J.; Bassell, Gary J.; Akbarian, Schahram; Chattarji, Sumantra; Klann, Eric; Richter, Joel D.			Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology	NATURE MEDICINE			English	Article							MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; CAMKII MESSENGER-RNA; T-MAZE ALTERNATION; CYTOPLASMIC POLYADENYLATION; SYNAPTIC PLASTICITY; WORKING-MEMORY; MOUSE MODEL; TRANSLATION; HIPPOCAMPUS	Fragile X syndrome (FXS), the most common cause of inherited mental retardation and autism, is caused by transcriptional silencing of FMR1, which encodes the translational repressor fragile X mental retardation protein (FMRP). FMRP and cytoplasmic polyadenylation element-binding protein (CPEB), an activator of translation, are present in neuronal dendrites, are predicted to bind many of the same mRNAs and may mediate a translational homeostasis that, when imbalanced, results in FXS. Consistent with this possibility, Fmr1(-/y); Cpeb1(-/-) double-knockout mice displayed amelioration of biochemical, morphological, electrophysiological and behavioral phenotypes associated with FXS. Acute depletion of CPEB1 in the hippocampus of adult Fmr1(-/y) mice rescued working memory deficits, demonstrating reversal of this FXS phenotype. Finally, we find that FMRP and CPEB1 balance translation at the level of polypeptide elongation. Our results suggest that disruption of translational homeostasis is causal for FXS and that the maintenance of this homeostasis by FMRP and CPEB1 is necessary for normal neurologic function.	[Udagawa, Tsuyoshi; Farny, Natalie G.; Ivshina, Maria; Nagaoka, Kentaro; Lorenz, Lori J.; Richter, Joel D.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Jakovcevski, Mira; Akbarian, Schahram] Univ Massachusetts, Sch Med, Brudnik Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA USA; [Kaphzan, Hanoch; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Alarcon, Juan Marcos] Suny Downstate Med Ctr, Dept Pathol, Brooklyn, NY 11203 USA; [Anilkumar, Shobha; Chattarji, Sumantra] Inst Stem Cell Biol & Regenerat Med, Ctr Brain Dev & Repair, Bangalore, Karnataka, India; [Anilkumar, Shobha; Chattarji, Sumantra] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Hurt, Jessica A.] MIT, Dept Biol, Cambridge, MA USA; [Nalavadi, Vijayalaxmi C.; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Massachusetts Institute of Technology (MIT); Emory University	Richter, JD (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	joel.richter@umassmed.edu	Jakovcevski, Mira/M-1930-2018; Nagaoka, Kentaro/C-2019-2013; Farny, Natalie/ABD-4468-2020; Jakovcevski, Mira/N-2430-2019	Jakovcevski, Mira/0000-0003-2262-823X; Nagaoka, Kentaro/0000-0003-1038-1380; Farny, Natalie/0000-0003-1143-4560; Jakovcevski, Mira/0000-0003-2262-823X; Ivshina, Maria/0000-0002-0999-3470	FRAXA Research Foundation; US National Institutes of Health NRSA [F32GM095060]; NIH [GM46779, NS079415, MH086509]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095060, R01GM046779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079415] Funding Source: NIH RePORTER	FRAXA Research Foundation; US National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Dawra for technical assistance, P. Lombroso (Yale University) and C. Proud (University of Southampton) for kind gifts of antibodies (STEP and eEF2, respectively), J. Pelletier (McGill University) for the kind gift of hippuristanol and members of the Richter lab for helpful discussions. T.U. and N.G.F. gratefully acknowledge fellowships from the FRAXA Research Foundation. J.A.H. was supported by US National Institutes of Health NRSA Postdoctoral Fellowship F32GM095060. This work was supported by NIH grants GM46779 and NS079415 to J.D.R. and MH086509 to S. Akbarian.	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Avgustinovich DF, 2000, BEHAV GENET, V30, P101, DOI 10.1023/A:1001999020138; Baarendse PJJ, 2008, HIPPOCAMPUS, V18, P11, DOI 10.1002/hipo.20356; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; BRITO LSO, 1987, BRAZ J MED BIOL RES, V20, P125; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Engin E, 2007, BEHAV PHARMACOL, V18, P365, DOI 10.1097/FBP.0b013e3282de7929; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Laroche S, 2000, HIPPOCAMPUS, V10, P438; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; Morellini F, 2006, EUR J NEUROSCI, V23, P1255, DOI 10.1111/j.1460-9568.2006.04657.x; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Pfeiffer BE, 2007, J NEUROSCI, V27, P3120, DOI 10.1523/JNEUROSCI.0054-07.2007; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Raju R.T., 2004, BRAIN BEHAV; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; RICHTER JD, 1982, DEV BIOL, V89, P159, DOI 10.1016/0012-1606(82)90304-9; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Shang YZ, 2009, J NEUROCHEM, V111, P635, DOI 10.1111/j.1471-4159.2009.06314.x; Svitkin YV, 2007, METHOD ENZYMOL, V429, P53, DOI 10.1016/S0076-6879(07)29004-4; Udagawa T, 2012, MOL CELL, V47, P253, DOI 10.1016/j.molcel.2012.05.016; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	44	88	90	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1473	+		10.1038/nm.3353	http://dx.doi.org/10.1038/nm.3353			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24141422	Green Accepted			2022-12-27	WOS:000326920300024
J	Lovshin, JA; Drucker, DJ				Lovshin, Julie A.; Drucker, Daniel J.			Metabolic Disease Puts Up a Fight: Are diet and exercise helpful for the heart?	NATURE MEDICINE			English	Editorial Material							LIFE-STYLE INTERVENTION; TYPE-2; ASSOCIATION; OBESITY; ADULTS		[Lovshin, Julie A.; Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Dept Med, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Lovshin, JA (corresponding author), Univ Toronto, Mt Sinai Hosp, Dept Med, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	d.drucker@utoronto.ca	Drucker, Daniel J/A-4092-2010					Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Jakicic JM, 2013, DIABETES CARE, V36, P1297, DOI 10.2337/dc12-0712; Kuna ST, 2013, SLEEP, V36, P641, DOI 10.5665/sleep.2618; Lavie CJ, 2011, CLIN PHARMACOL THER, V90, P23, DOI 10.1038/clpt.2011.87; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Rejeski WJ, 2012, NEW ENGL J MED, V366, P1209, DOI 10.1056/NEJMoa1110294; Ribisl PM, 2012, J OBES, V2012, DOI 10.1155/2012/309196; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; Vest AR, 2012, HEART, V98, P1763, DOI 10.1136/heartjnl-2012-301778; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2013, DIABETES CARE, V36, P2937, DOI 10.2337/dc13-0315	14	3	3	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1216	1217		10.1038/nm.3370	http://dx.doi.org/10.1038/nm.3370			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100982				2022-12-27	WOS:000325531700015
J	Pietri, M; Dakowski, C; Hannaoui, S; Alleaume-Butaux, A; Hernandez-Rapp, J; Ragagnin, A; Mouillet-Richard, S; Haik, S; Bailly, Y; Peyrin, JM; Launay, JM; Kellermann, O; Schneider, B				Pietri, Mathea; Dakowski, Caroline; Hannaoui, Samia; Alleaume-Butaux, Aurelie; Hernandez-Rapp, Julia; Ragagnin, Audrey; Mouillet-Richard, Sophie; Haik, Stephane; Bailly, Yannick; Peyrin, Jean-Michel; Launay, Jean-Marie; Kellermann, Odile; Schneider, Benoit			PDK1 decreases TACE-mediated alpha-secretase activity and promotes disease progression in prion and Alzheimer's diseases	NATURE MEDICINE			English	Article							AMYLOID PRECURSOR PROTEIN; NECROSIS-FACTOR DEATH; SYSTEMIC INFLAMMATION; CONVERTING-ENZYME; MEMORY DEFICITS; BETA PROTEIN; A-BETA; CLEAVAGE; PLAQUES; PRP	alpha-secretase-mediated cleavage of amyloid precursor protein (APP) precludes formation of neurotoxic amyloid-beta (A beta) peptides, and alpha-cleavage of cellular prion protein (Pr-Pc) prevents its conversion into misfolded, pathogenic prions (PrPSc). The mechanisms leading to decreased alpha-secretase activity in Alzheimer's and prion disease remain unclear. Here, we find that tumor necrosis factor-alpha-converting enzyme (TACE)-mediated alpha-secretase activity is impaired at the surface of neurons infected with PrPSc or isolated from APP-transgenic mice with amyloid pathology. 3-phosphoinositide-dependent kinase-1 (PDK1) activity is increased in neurons infected with prions or affected by A beta deposition and in the brains of individuals with Alzheimer's disease. PDK1 induces phosphorylation and caveolin-l-mediated internalization of TACE. This dysregulation of TACE increases PrPSc and A beta accumulation and reduces shedding of TNF-alpha receptor type 1 (TNFR1). Inhibition of PDK1 promotes localization of TACE to the plasma membrane, restores TACE-dependent alpha-secretase activity and cleavage of APP, PrPC and TNFR1, and attenuates PrPSc- and A beta-induced neurotoxicity. In mice, inhibition or siRNA-mediated silencing of PDK1 extends survival and reduces motor impairment following PrPSc infection and in APP-transgenic mice reduces Alzheimer's disease-like pathology and memory impairment.	[Pietri, Mathea; Dakowski, Caroline; Alleaume-Butaux, Aurelie; Hernandez-Rapp, Julia; Mouillet-Richard, Sophie; Kellermann, Odile; Schneider, Benoit] INSERM, UMR S 747, Paris, France; [Pietri, Mathea; Dakowski, Caroline; Alleaume-Butaux, Aurelie; Hernandez-Rapp, Julia; Mouillet-Richard, Sophie; Kellermann, Odile; Schneider, Benoit] Univ Paris 05, Sorbonne Paris Cite, UMR S 747, Paris, France; [Hannaoui, Samia; Haik, Stephane] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, Equips Alzheimers & Prion Dis,UMR S 975, Paris, France; [Hannaoui, Samia; Haik, Stephane] INSERM, UMR S 975, Paris, France; [Hannaoui, Samia; Haik, Stephane] CNRS, UMR 7225, Paris, France; [Hernandez-Rapp, Julia] Univ Paris 11, Biosigne ED419, Orsay, France; [Ragagnin, Audrey; Bailly, Yannick] CNRS, UPR 3212, Inst Neurosci Cellulaires & Integrat, Strasbourg, France; [Peyrin, Jean-Michel] Univ Paris 06, CNRS, UMR 7102, Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, Assistance Publ Hop Paris, INSERM, Serv Biochim,UMR S 942, F-75475 Paris, France; [Launay, Jean-Marie] Hoffmann La Roche AG, Pharma Res Dept, Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Roche Holding	Schneider, B (corresponding author), INSERM, UMR S 747, Paris, France.	jean-marie.launay@lrb.aphp.fr; benoit.schneider@parisdescartes.fr	Schneider, Benoit/AAF-3850-2019; Haik, Stephane/M-7247-2018; Mouillet, Sophie/E-4960-2017	Mouillet, Sophie/0000-0002-8950-1949; ALLEAUME-BUTAUX, Aurelie/0000-0002-1134-4269; Schneider, Benoit/0000-0002-1377-2670; PIETRI, Mathea/0000-0002-1819-2878; Ragagnin, Audrey/0000-0002-2277-4029; Peyrin, Jean-Michel/0000-0002-8705-8672; Peyrin, Jean-Michel/0000-0002-0108-1266	French Agence Nationale pour la Recherche (PrionsSensiTNF) [1312 01]; INSERM; Domaine d'Interet Majeur - Maladies Infectieuses - Region Ile-de-France	French Agence Nationale pour la Recherche (PrionsSensiTNF)(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Domaine d'Interet Majeur - Maladies Infectieuses - Region Ile-de-France(Region Ile-de-France)	We thank G. Bombarde, V. Mutel, F. d'Agostini, G. Zurcher, E. Borroni, J.G. Richards, Z. Lam, M. Buhler, N. Pierron and R. Hochkoppler for skillful methodological assistance, C. Vidal for stereotaxic injection of prion strains in mice cerebella, H. Laude and V. Beringue for the use of P3 facilities and F. Brouillard for two-dimensional gel electrophoresis advice. We acknowledge S. Blanquet, M. Briley and A. Baudry for helpful discussions and critical reading of the manuscript. This work was supported by the French Agence Nationale pour la Recherche (Prions&SensiTNF, 1312 01) and INSERM. M.P. is a postdoctoral fellow of French Agence Nationale pour la Recherche. A.A.B. is funded by Domaine d'Interet Majeur - Maladies Infectieuses - Region Ile-de-France.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; 'Alessio AD, 2012, J CELL MOL MED, V16, P627, DOI 10.1111/j.1582-4934.2011.01353.x; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Benilova I, 2010, EMBO MOL MED, V2, P289, DOI 10.1002/emmm.201000088; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li R, 2004, J NEUROSCI, V24, P1760, DOI 10.1523/JNEUROSCI.4580-03.2004; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Manook A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031310; Mehlhorn G, 2000, INT J DEV NEUROSCI, V18, P423, DOI 10.1016/S0736-5748(00)00012-5; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Mouillet-Richard S, 2008, J BIOL CHEM, V283, P23782, DOI 10.1074/jbc.M802433200; Nixon RR, 2005, J BIOL CHEM, V280, P2455, DOI 10.1074/jbc.M410883200; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Pradines E, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.195; Pradines E, 2009, J NEUROCHEM, V110, P912, DOI 10.1111/j.1471-4159.2009.06176.x; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Vincent B, 2001, J BIOL CHEM, V276, P37743; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Wesson DW, 2011, BEHAV BRAIN RES, V216, P408, DOI 10.1016/j.bbr.2010.08.033; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Williams A, 1997, BRAIN RES, V754, P171, DOI 10.1016/S0006-8993(97)00067-X; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103	47	79	83	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1124	1131		10.1038/nm.3302	http://dx.doi.org/10.1038/nm.3302			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23955714				2022-12-27	WOS:000324083500026
J	Eddy, AA				Eddy, Allison A.			The origin of scar-forming kidney myofibroblasts	NATURE MEDICINE			English	Editorial Material							RENAL FIBROSIS; TISSUE FIBROSIS; BONE-MARROW; FIBROBLASTS; CELLS; DIFFERENTIATE; DEFICIENCY; TRANSITION; MODEL	Whereas diabetes and hypertension predominate as the etiology of chronic kidney disease (CKD), all primary causes share a common progression pathway due to scarring or fibrosis. Understanding what cells are the sources of scar-forming cells is of utmost importance (pages 1047-1053).	Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	University of British Columbia	Eddy, AA (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada.	allison.eddy@cw.bc.ca		Eddy, Allison/0000-0002-3560-7510				Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Eddy AA, 2012, PEDIATR NEPHROL, V27, P1233, DOI 10.1007/s00467-011-1938-2; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lopez-Guisa JM, 2012, J AM SOC NEPHROL, V23, P236, DOI 10.1681/ASN.2011030310; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Melchior-Becker A, 2011, J BIOL CHEM, V286, P17365, DOI 10.1074/jbc.M110.192682; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Reich B, 2013, KIDNEY INT, V84, P78, DOI 10.1038/ki.2013.84; Takeji M, 2006, J BIOL CHEM, V281, P40193, DOI 10.1074/jbc.M602182200; Tang WW, 1996, AM J PATHOL, V148, P1169; Yang L, 2012, AM J PATHOL, V181, P85, DOI 10.1016/j.ajpath.2012.03.014; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	16	29	30	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2013	19	8					964	966		10.1038/nm.3299	http://dx.doi.org/10.1038/nm.3299			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921738				2022-12-27	WOS:000322779600015
J	Baeten, DLP; Kuchroo, VK				Baeten, Dominique L. P.; Kuchroo, Vijay K.			Interleukin-17 and a tale of two autoimmune diseases	NATURE MEDICINE			English	Editorial Material							CYTOKINE GM-CSF; HELPER T-CELLS; T(H)17 CELLS; INTESTINAL INFLAMMATION; TH17 CELLS; INDUCTION		[Baeten, Dominique L. P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1012 WX Amsterdam, Netherlands; [Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Baeten, DLP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1012 WX Amsterdam, Netherlands.	vkuchroo@rics.bwh.harvard.edu						Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Baeten D., LANCET IN PRESS; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]	17	58	61	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2013	19	7					824	825		10.1038/nm.3268	http://dx.doi.org/10.1038/nm.3268			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836225				2022-12-27	WOS:000321557700025
J	Tonjes, M; Barbus, S; Park, YJ; Wang, W; Schlotter, M; Lindroth, AM; Pleier, SV; Bai, AHC; Karra, D; Piro, RM; Felsberg, J; Addington, A; Lemke, D; Weibrecht, I; Hovestadt, V; Rolli, CG; Campos, B; Turcan, S; Sturm, D; Witt, H; Chan, TA; Herold-Mende, C; Kemkemer, R; Konig, R; Schmidt, K; Hull, WE; Pfister, SM; Jugold, M; Hutson, SM; Plass, C; Okun, JG; Reifenberger, G; Lichter, P; Radlwimmer, B				Toenjes, Martje; Barbus, Sebastian; Park, Yoon Jung; Wang, Wei; Schlotter, Magdalena; Lindroth, Anders M.; Pleier, Sabrina V.; Bai, Alfa H. C.; Karra, Daniela; Piro, Rosario M.; Felsberg, Joerg; Addington, Adele; Lemke, Dieter; Weibrecht, Irene; Hovestadt, Volker; Rolli, Claudio G.; Campos, Benito; Turcan, Sevin; Sturm, Dominik; Witt, Hendrik; Chan, Timothy A.; Herold-Mende, Christel; Kemkemer, Ralf; Koenig, Rainer; Schmidt, Kathrin; Hull, William-Edmund; Pfister, Stefan M.; Jugold, Manfred; Hutson, Susan M.; Plass, Christoph; Okun, Juergen G.; Reifenberger, Guido; Lichter, Peter; Radlwimmer, Bernhard			BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1	NATURE MEDICINE			English	Article							BRANCHED-CHAIN AMINOTRANSFERASE; INTEGRATED GENOMIC ANALYSIS; ISOCITRATE DEHYDROGENASE 1; PRIMARY BRAIN-TUMORS; ALPHA-KETOGLUTARATE; GLUTAMINE-METABOLISM; MUTANT IDH1; 2 MUTATIONS; CANCER; GLIOBLASTOMA	Here we show that glioblastoma express high levels of branched-chain amino acid transaminase 1 (BCAT1), the enzyme that initiates the catabolism of branched-chain amino acids (BCAAs). Expression of BCAT1 was exclusive to tumors carrying wildtype isocitrate dehydrogenase 1 (IDH1) and IDH2 genes and was highly correlated with methylation patterns in the BCAT1 promoter region. BCAT1 expression was dependent on the concentration of a-ketoglutarate substrate in glioma cell lines and could be suppressed by ectopic overexpression of mutant IDH1 in immortalized human astrocytes, providing a link between IDH1 function and BCAT1 expression. Suppression of BCAT1 in glioma cell lines blocked the excretion of glutamate and led to reduced proliferation and invasiveness in vitro, as well as significant decreases in tumor growth in a glioblastoma xenograft model. These findings suggest a central role for BCAT1 in glioma pathogenesis, making BCAT1 and BCAA metabolism attractive targets for the development of targeted therapeutic approaches to treat patients with glioblastoma.	[Toenjes, Martje; Barbus, Sebastian; Wang, Wei; Schlotter, Magdalena; Pleier, Sabrina V.; Bai, Alfa H. C.; Weibrecht, Irene; Hovestadt, Volker; Sturm, Dominik; Witt, Hendrik; Pfister, Stefan M.; Lichter, Peter; Radlwimmer, Bernhard] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Park, Yoon Jung; Lindroth, Anders M.; Plass, Christoph] DKFZ, Div Epigenom & Canc Risk Factors, Heidelberg, Germany; [Park, Yoon Jung] Ewha Womans Univ, Coll Hlth Sci, Dept Nutr Sci & Food Management, Seoul, South Korea; [Pleier, Sabrina V.; Sturm, Dominik; Witt, Hendrik; Pfister, Stefan M.] DKFZ, Div Pediat Neurooncol, Heidelberg, Germany; [Karra, Daniela; Felsberg, Joerg; Reifenberger, Guido] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Piro, Rosario M.; Koenig, Rainer] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Bioinformat & Funct Genom, Heidelberg, Germany; [Piro, Rosario M.; Koenig, Rainer] Heidelberg Univ, Bioquant, Heidelberg, Germany; [Piro, Rosario M.; Koenig, Rainer] DKFZ, Div Theoret Bioinformat, Heidelberg, Germany; [Addington, Adele; Hutson, Susan M.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA USA; [Lemke, Dieter] DKFZ, Clin Cooperat Unit Neurooncol, Heidelberg, Germany; [Rolli, Claudio G.; Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Campos, Benito; Herold-Mende, Christel] Heidelberg Univ, Div Expt Neurosurg, Heidelberg, Germany; [Campos, Benito; Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Heidelberg, Germany; [Turcan, Sevin; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Sturm, Dominik; Witt, Hendrik; Pfister, Stefan M.] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany; [Kemkemer, Ralf] Reutlingen Univ Appl Sci, Reutlingen, Germany; [Schmidt, Kathrin; Okun, Juergen G.] Univ Childrens Hosp, Dept Gen Pediat, Heidelberg, Germany; [Hull, William-Edmund] DKFZ, Core Facil, Heidelberg, Germany; [Jugold, Manfred] DKFZ, Core Facil, Small Anim Imaging Ctr, Heidelberg, Germany; [Reifenberger, Guido] DKFZ, German Canc Consortium DKTK, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ewha Womans University; Helmholtz Association; German Cancer Research Center (DKFZ); Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Virginia Polytechnic Institute & State University; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Memorial Sloan Kettering Cancer Center; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Radlwimmer, B (corresponding author), German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany.	b.radlwimmer@dkfz-heidelberg.de	Hovestadt, Volker/ABG-2076-2021; Chan, Timothy A/ABD-5850-2021; Sturm, Dominik/AAL-3689-2020; Reifenberger, Guido/AAE-3599-2019; Park, Yoon Jung/AAW-2712-2020; Turcan, Sevin/AAF-1095-2019; Witt, Hendrik/L-7810-2015; Lindroth, Anders M/C-7744-2015; Piro, Rosario M./AAT-6937-2020; Radlwimmer, Bernhard F/I-3229-2013; Plass, Christoph/H-7192-2014; Pfister, Stefan M/F-6860-2013	Hovestadt, Volker/0000-0002-3480-6649; Sturm, Dominik/0000-0003-0250-1696; Turcan, Sevin/0000-0002-0885-5607; Lindroth, Anders M/0000-0002-8291-2745; Piro, Rosario M./0000-0002-3066-7397; Radlwimmer, Bernhard F/0000-0002-4553-7800; Pfister, Stefan M/0000-0002-5447-5322; Addington, Adele/0000-0002-4013-2484	German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network NGFNplus [01GS0883, 01GS0884]; Deutsche Krebshilfe [108456]; National Tumor Center Heidelberg; Roman Herzog research fellowship from the Hertie Foundation, Germany; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A120071-1211-0000200]; NATIONAL CANCER INSTITUTE [T32CA160001] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network NGFNplus(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); National Tumor Center Heidelberg; Roman Herzog research fellowship from the Hertie Foundation, Germany; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Todt for bioinformatic expertise, M. Kirchgassner, K. Pfleger, E. Wieland, A.-C. Klein, S. Emmerich and the DKFZ Light Microscopy Facility for excellent technical support, C. Schmidt (DKFZ) for providing the HEY1-pDest-vectors and A. von Deimling (University of Heidelberg) for providing the IDH1-specific antibodies. This work was supported by the German Federal Ministry of Education and Research (BMBF) within the National Genome Research Network NGFNplus (01GS0883 and 01GS0884) to B. R., P. L. and G. R., the German Cancer Aid (Deutsche Krebshilfe, grant number 108456) to B. R. and P. L. and the intramural funding program of the National Tumor Center Heidelberg. Y.J.P. was supported by the Roman Herzog research fellowship from the Hertie Foundation, Germany, and the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120071-1211-0000200).	Bai AHC, 2012, ACTA NEUROPATHOL, V123, P529, DOI 10.1007/s00401-011-0924-x; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Capper D, 2009, ACTA NEUROPATHOL, V118, P599, DOI 10.1007/s00401-009-0595-z; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davoodi J, 1998, J BIOL CHEM, V273, P4982, DOI 10.1074/jbc.273.9.4982; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Garcia-Espinosa MA, 2007, J NEUROCHEM, V100, P1458, DOI 10.1111/j.1471-4159.2006.04332.x; GOTO M, 1977, GANN, V68, P663; Goto M, 2005, J BIOL CHEM, V280, P37246, DOI 10.1074/jbc.M506486200; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Grzendowski M, 2009, PROTEOMICS, V9, P4985, DOI 10.1002/pmic.200800902; HALL TR, 1993, J BIOL CHEM, V268, P3092; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; HELENIUS A, 1972, J BIOL CHEM, V247, P3656; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Hutson SM, 1998, J NEUROCHEM, V71, P863; Hutson Susan M, 2006, Biochem J, V400, pe1; ICHIHARA A, 1966, J BIOCHEM-TOKYO, V59, P160, DOI 10.1093/oxfordjournals.jbchem.a128277; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Lieth E, 2001, J NEUROCHEM, V76, P1712, DOI 10.1046/j.1471-4159.2001.00156.x; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasquali M, 2006, AM J MED GENET C, V142C, P64, DOI 10.1002/ajmg.c.30086; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Rolli CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008726; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Sasaki M, 2012, NATURE, V488, P656, DOI 10.1038/nature11323; Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x; Schramm G, 2010, BIOINFORMATICS, V26, P1225, DOI 10.1093/bioinformatics/btq113; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Sontheimer H, 2008, J NEUROCHEM, V105, P287, DOI 10.1111/j.1471-4159.2008.05301.x; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; SZE DY, 1990, BIOCHIM BIOPHYS ACTA, V1054, P181, DOI 10.1016/0167-4889(90)90240-E; TAYLOR RT, 1966, J BIOL CHEM, V241, P4396; Toedt G, 2011, INT J CANCER, V128, P1095, DOI 10.1002/ijc.25448; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weggen S, 2001, ONCOGENE, V20, P2023, DOI 10.1038/sj.onc.1204287; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yoshikawa R, 2006, WORLD J GASTROENTERO, V12, P5884, DOI 10.3748/wjg.v12.i36.5884; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou W, 2007, ONCOL RES, V16, P405, DOI 10.3727/000000007783980873	70	303	318	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2013	19	7					901	+		10.1038/nm.3217	http://dx.doi.org/10.1038/nm.3217			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23793099	Green Accepted			2022-12-27	WOS:000321557700034
J	Chouchani, ET; Methner, C; Nadtochiy, SM; Logan, A; Pell, VR; Ding, SJ; James, AM; Cocheme, HM; Reinhold, J; Lilley, KS; Partridge, L; Fearnley, IM; Robinson, AJ; Hartley, RC; Smith, RAJ; Krieg, T; Brookes, PS; Murphy, MP				Chouchani, Edward T.; Methner, Carmen; Nadtochiy, Sergiy M.; Logan, Angela; Pell, Victoria R.; Ding, Shujing; James, Andrew M.; Cocheme, Helena M.; Reinhold, Johannes; Lilley, Kathryn S.; Partridge, Linda; Fearnley, Ian M.; Robinson, Alan J.; Hartley, Richard C.; Smith, Robin A. J.; Krieg, Thomas; Brookes, Paul S.; Murphy, Michael P.			Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I	NATURE MEDICINE			English	Article							ISCHEMIA-REPERFUSION INJURY; PROTEIN-KINASE-G; NITRIC-OXIDE; MEMBRANE-PROTEINS; IDENTIFICATION; NITROSOTHIOL; PROTECTION; DISEASE; ELECTROPHORESIS; NITROSYLATION	Oxidative damage from elevated production of reactive oxygen species (ROS) contributes to ischemia-reperfusion injury in myocardial infarction and stroke. The mechanism by which the increase in ROS occurs is not known, and it is unclear how this increase can be prevented. A wide variety of nitric oxide donors and S-nitrosating agents protect the ischemic myocardium from infarction, but the responsible mechanisms are unclear(1-6). Here we used a mitochondria-selective S-nitrosating agent, MitoSNO, to determine how mitochondrial S-nitrosation at the reperfusion phase of myocardial infarction is cardioprotective in vivo in mice. We found that protection is due to the S-nitrosation of mitochondrial complex I, which is the entry point for electrons from NADH into the respiratory chain. Reversible S-nitrosation of complex I slows the reactivation of mitochondria during the crucial first minutes of the reperfusion of ischemic tissue, thereby decreasing ROS production, oxidative damage and tissue necrosis. Inhibition of complex I is afforded by the selective S-nitrosation of Cys39 on the ND3 subunit, which becomes susceptible to modification only after ischemia. Our results identify rapid complex I reactivation as a central pathological feature of ischemia-reperfusion injury and show that preventing this reactivation by modification of a cysteine switch is a robust cardioprotective mechanism and hence a rational therapeutic strategy.	[Chouchani, Edward T.; Logan, Angela; Ding, Shujing; James, Andrew M.; Cocheme, Helena M.; Reinhold, Johannes; Fearnley, Ian M.; Robinson, Alan J.; Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge, England; [Chouchani, Edward T.; Methner, Carmen; Pell, Victoria R.; Krieg, Thomas] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Nadtochiy, Sergiy M.; Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Cocheme, Helena M.; Partridge, Linda] UCL, Dept Genet Evolut & Environm, Inst Hlth Ageing, London, England; [Lilley, Kathryn S.] Univ Cambridge, Dept Biochem, Cambridge Syst Biol Ctr, Cambridge CB2 1QW, England; [Hartley, Richard C.] Univ Glasgow, WestCHEM Sch Chem, Ctr Chem Res Ageing, Glasgow, Lanark, Scotland; [Smith, Robin A. J.] Univ Otago, Dept Chem, Dunedin, New Zealand	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Rochester; University of London; University College London; University of Cambridge; University of Glasgow; University of Otago	Murphy, MP (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge, England.	mpm@mrc-mbu.cam.ac.uk	James, Andrew M/A-2639-2015; Hartley, Richard/AAT-7834-2020; Chouchani, Edward/A-1733-2014; Partridge, Linda/E-7342-2015; Murphy, Michael P/C-2120-2009; Lilley, Kathryn/ABF-5787-2020; Hartley, Richard/E-3489-2010	James, Andrew M/0000-0002-0515-9649; Hartley, Richard/0000-0003-1033-5405; Murphy, Michael P/0000-0003-1115-9618; Lilley, Kathryn/0000-0003-0594-6543; Hartley, Richard/0000-0003-1033-5405; Partridge, Linda/0000-0001-9615-0094; Reinhold, Johannes/0000-0003-2412-2574; Krieg, Thomas/0000-0002-5192-580X; Cocheme, Helena/0000-0001-8637-0042; Brookes, Paul/0000-0002-8639-8413; Chouchani, Edward/0000-0002-9203-8094	UK Medical Research Council; UK Biotechnology and Biological Sciences Research Council [BB/I012923]; Gates Cambridge Trust; Canadian Institutes of Health Research; British Heart Foundation [PG/12/42/29655]; US National Institutes of Health [R01-HL071158]; International Society for Heart Research (ISHR-ES/SERVIER research fellowship); Biotechnology and Biological Sciences Research Council [BB/I012826/1, BB/I012923/1] Funding Source: researchfish; Medical Research Council [MC_U105674181, MC_U105663142] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071158] Funding Source: NIH RePORTER; BBSRC [BB/I012826/1, BB/I012923/1] Funding Source: UKRI; MRC [MC_U105674181, MC_U105663142] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gates Cambridge Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Heart Foundation(British Heart Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Society for Heart Research (ISHR-ES/SERVIER research fellowship); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the UK Medical Research Council and grants from the UK Biotechnology and Biological Sciences Research Council (BB/I012923 to M. P. M. and R. C. H.), the Gates Cambridge Trust and the Canadian Institutes of Health Research (doctoral scholarship and postdoctoral fellowship to E. T. C.), the British Heart Foundation (PG/12/42/29655 to T. K.), the US National Institutes of Health (R01-HL071158 to P. S. B.) and the International Society for Heart Research (ISHR-ES/SERVIER research fellowship to C. M.). We thank L. Sazanov and J. Hirst for helpful discussions.	Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bridges HR, 2011, BIOCHEM SOC T, V39, P799, DOI 10.1042/BST0390799; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chappell J.B., 1972, SUBCELLULAR COMPONEN, V77; Chouchani ET, 2011, CURR OPIN CHEM BIOL, V15, P120, DOI 10.1016/j.cbpa.2010.11.003; Chouchani ET, 2010, BIOCHEM J, V430, P49, DOI 10.1042/BJ20100633; Ciano M, 2013, FEBS LETT, V587, P867, DOI 10.1016/j.febslet.2013.02.039; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Cohen MV, 2010, AM J PHYSIOL-HEART C, V299, pH2028, DOI 10.1152/ajpheart.00527.2010; Costa ADT, 2005, CIRC RES, V97, P329, DOI 10.1161/01.RES.0000178451.08719.5b; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Gorenkova N., 2013, ANTIOXID REDOX SIGN, DOI [DOI 10.1089/ARS.2012.4698, 10.1089/ars.2012.4698]; Guo S, 2012, CIRC RES, V110, P948, DOI 10.1161/CIRCRESAHA.111.263715; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; Kettenhofen NJ, 2008, METHOD ENZYMOL, V441, P53, DOI 10.1016/S0076-6879(08)01204-4; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Methner C, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0337-1; Methner C, 2010, AM J PHYSIOL-HEART C, V299, pH1262, DOI 10.1152/ajpheart.00181.2010; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Murray CI, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004721; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Porteous CM, 2010, BBA-GEN SUBJECTS, V1800, P1009, DOI 10.1016/j.bbagen.2010.06.001; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; Requejo R, 2010, METHOD ENZYMOL, V474, P123, DOI 10.1016/S0076-6879(10)74008-8; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schmidt K, 2010, EUR HEART J, V31, P1655, DOI 10.1093/eurheartj/ehp555; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2009, BASIC RES CARDIOL, V104, P113, DOI 10.1007/s00395-009-0009-3; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2013, FREE RADICAL BIO MED, V54, P105, DOI 10.1016/j.freeradbiomed.2012.09.005; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Wang XD, 2008, FREE RADICAL BIO MED, V44, P1362, DOI 10.1016/j.freeradbiomed.2007.12.032; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	47	438	444	0	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					753	+		10.1038/nm.3212	http://dx.doi.org/10.1038/nm.3212			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23708290	Green Accepted, Green Published			2022-12-27	WOS:000319981600025
J	Jameson, KL; Mazur, PK; Zehnder, AM; Zhang, JJ; Zarnegar, B; Sage, J; Khavari, PA				Jameson, Katherine L.; Mazur, Pawel K.; Zehnder, Ashley M.; Zhang, Jiajing; Zarnegar, Brian; Sage, Julien; Khavari, Paul A.			IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors	NATURE MEDICINE			English	Article							PANCREATIC-CANCER; INHIBITION; TUMORIGENESIS; ASSOCIATION; HYPERPLASIA; PROGRESSION; RESISTANCE; NEOPLASIA; THERAPY; MOUSE	Upregulation of the ERK1 and ERK2 (ERK1/2) MAP kinase (MAPK) cascade occurs in >30% of cancers(1), often through mutational activation of receptor tyrosine kinases or other upstream genes, including KRAS and BRAF(2). Efforts to target endogenous MAPKs are challenged by the fact that these kinases are required for viability in mammals(3) (,4). Additionally, the effectiveness of new inhibitors of mutant BRAF has been diminished by acquired tumor resistance through selection for BRAF-independent mechanisms of ERK1/2 induction(2,5,6). Furthermore, recently identified ERK1/2-inducing mutations in MEK1 and MEK2 (MEK1/2) MAPK genes in melanoma confer resistance to emerging therapeutic MEK inhibitors, underscoring the challenges facing direct kinase inhibition in cancer(7,8). MAPK scaffolds, such as IQ motif-containing GTPase activating protein 1 (IQGAP1)(9,10), assemble pathway kinases to affect signal transmission(11-13), and disrupting scaffold function therefore offers an orthogonal approach to MAPK cascade inhibition. Consistent with this, we found a requirement for IQGAP1 in RAS-driven tumorigenesis in mouse and human tissue. In addition, the ERK1/2-binding(14) IQGAP1 WW domain peptide disrupted IQGAP1-ERK1/2 interactions, inhibited RAS- and RAF-driven tumorigenesis, bypassed acquired resistance to the BRAF inhibitor vemurafenib (PLX-4032) and acted as a systemically deliverable therapeutic to significantly increase the lifespan of tumor-bearing mice. Scaffold-kinase interaction blockade acts by a mechanism distinct from direct kinase inhibition and may be a strategy to target overactive oncogenic kinase cascades in cancer.	[Jameson, Katherine L.; Zehnder, Ashley M.; Zhang, Jiajing; Zarnegar, Brian; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Jameson, Katherine L.; Zehnder, Ashley M.; Khavari, Paul A.] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Mazur, Pawel K.; Sage, Julien] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Mazur, Pawel K.; Sage, Julien] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu	Mazur, Pawel K./AAU-6343-2021	Mazur, Pawel K./0000-0002-5820-8344	US Department of Veterans Affairs Office of Research and Development; US National Institutes of Health [R01 AR49737]; Lucile Packard Foundation for Children's Health; Leukemia and Lymphoma Society; National Institutes of Health under Ruth L. Kirschstein National Research Service [5T32 CA09302]; SPARK Program at Stanford; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA142635, P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049737] Funding Source: NIH RePORTER	US Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucile Packard Foundation for Children's Health; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health under Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPARK Program at Stanford; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Chang, T. Oro, P. Marinkovich, D. Felsher, S. Artandi, A. Sweet-Cordero, J. Ferrell, M. Diehn, A. Wong, Z. Siprashvili, J. Reuter, A. Ungewickell, D. Webster, K. Sarin, B. Sun, C. Lee, R. Flockhart, R. Spitale, K. Wang, S. Atwood and A. Barzel for critical comments and presubmission review; N. Phillips, F. Scholl, P. Dumesic, T. Ridky, K. Grimes and D. Mochley-Rosen for helpful discussions; A. Diep for review of histologic sections; S. Tao, L. Morcom, P. Bernstein and T. Doyle and the Stanford Small Animal Imaging Facility for administrative and technical support; A. Bernards (Harvard Medical School) for providing the Iqgap1 knockout mice; and G. Fisher for helpful advice and support. This work is supported by the US Department of Veterans Affairs Office of Research and Development and US National Institutes of Health grant R01 AR49737 (P.A.K.); the Lucile Packard Foundation for Children's Health and the Leukemia and Lymphoma Society (J.S.); and the National Institutes of Health under Ruth L. Kirschstein National Research Service Award 5T32 CA09302 and the SPARK Program at Stanford (K.L.J. and A.M.Z.).	Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Collins MA, 2012, J CLIN INVEST, V122, P639, DOI 10.1172/JCI59227; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Ferrell Jr J. E., 2000, SCI STKE, V2000, ppel; FUJIKI H, 1989, MOL CARCINOGEN, V2, P184, DOI 10.1002/mc.2940020403; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Liu Z, 2010, CLIN CANCER RES, V16, P6009, DOI 10.1158/1078-0432.CCR-10-1627; McCormick F, 2011, J SURG ONCOL, V103, P464, DOI 10.1002/jso.21749; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sato A, 2010, FEBS J, V277, P4464, DOI 10.1111/j.1742-4658.2010.07833.x; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Sugimoto N, 2001, J HUM GENET, V46, P21, DOI 10.1007/s100380170119; Tarutani M, 2003, CANCER RES, V63, P319; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007	30	137	144	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2013	19	5					626	630		10.1038/nm.3165	http://dx.doi.org/10.1038/nm.3165			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23603816	Green Accepted			2022-12-27	WOS:000318583000036
J	Gebeshuber, CA; Kornauth, C; Dong, LH; Sierig, R; Seibler, J; Reiss, M; Tauber, S; Bilban, M; Wang, SJ; Kain, R; Bohmig, GA; Moeller, MJ; Grone, HJ; Englert, C; Martinez, J; Kerjaschki, D				Gebeshuber, Christoph A.; Kornauth, Christoph; Dong, Lihua; Sierig, Ralph; Seibler, Jost; Reiss, Martina; Tauber, Stefanie; Bilban, Martin; Wang, Shijun; Kain, Renate; Boehmig, Georg A.; Moeller, Marcus J.; Groene, Hermann-Josef; Englert, Christoph; Martinez, Javier; Kerjaschki, Dontscho			Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1	NATURE MEDICINE			English	Article							GENE-EXPRESSION; MICE; MODEL; AMINONUCLEOSIDE; NEPHRIN; PROTEINURIA; PODOCALYXIN; CONTRIBUTE; GLOMERULI; PODOCYTES	Focal segmental glomerulosclerosis (FSGS) is a frequent and severe glomerular disease characterized by destabilization of podocyte foot processes. We report that transgenic expression of the microRNA miR-193a in mice rapidly induces FSGS with extensive podocyte foot process effacement. Mechanistically, miR-193a inhibits the expression of the Wilms' tumor protein (WT1), a transcription factor and master regulator of podocyte differentiation and homeostasis. Decreased expression levels of WT1 lead to downregulation of its target genes PODXL (podocalyxin) and NPHS1 (nephrin), as well as several other genes crucial for the architecture of podocytes, initiating a catastrophic collapse of the entire podocyte-stabilizing system. We found upregulation of miR-193a in isolated glomeruli from individuals with FSGS compared to normal kidneys or individuals with other glomerular diseases. Thus, upregulation of miR-193a provides a new pathogenic mechanism for FSGS and is a potential therapeutic target.	[Gebeshuber, Christoph A.; Kornauth, Christoph; Kain, Renate; Kerjaschki, Dontscho] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Gebeshuber, Christoph A.; Martinez, Javier] IMBA Inst Mol Biotechnol, Vienna, Austria; [Dong, Lihua; Sierig, Ralph; Englert, Christoph] Fritz Lipmann Inst eV, Leibniz Inst Altersforsch, Jena, Germany; [Seibler, Jost; Reiss, Martina] TaconicArtemis GmbH, Cologne, Germany; [Tauber, Stefanie] Univ Vienna, Max F Perutz Labs, Ctr Integrat Bioinformat, Vienna, Austria; [Tauber, Stefanie] Med Univ Vienna, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Wang, Shijun; Groene, Hermann-Josef] Deutsch Krebsforschungszentrum, Heidelberg, Germany; [Boehmig, Georg A.] Med Univ Vienna, Div Nephrol, Dept Internal Med 3, Vienna, Austria; [Moeller, Marcus J.] Rhein Westfal TH Aachen, Med Klin 2, Univ Klinikum, D-52062 Aachen, Germany	Medical University of Vienna; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Medical University of Vienna; Helmholtz Association; German Cancer Research Center (DKFZ); Medical University of Vienna; RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Kerjaschki, D (corresponding author), Med Univ Vienna, Clin Inst Pathol, Vienna, Austria.	dontscho.kerjaschki@meduniwien.ac.at	Kornauth, Christoph/AAA-3935-2022; Moeller, Marcus J/L-1836-2015; Kain, Renate/ACR-4709-2022	Kornauth, Christoph/0000-0003-0443-3498; Kain, Renate/0000-0002-2428-543X; Bilban, Martin/0000-0001-7043-7142; Martinez, Javier/0000-0001-9152-7323; Gebeshuber, Christoph A/0000-0003-3293-4572; Englert, Christoph/0000-0002-5931-3189	E-Rare JTC; European Research Projects on Rare Diseases [I 923-B13]; Deutsche Forschungsgemeinschaft [EN 280/8-1]; Austrian Science Fund (FWF) [I 923] Funding Source: researchfish	E-Rare JTC; European Research Projects on Rare Diseases; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported in part by E-Rare JTC 2011, European Research Projects on Rare Diseases, Project # I 923-B13 to D.K. and M.J.M. and a grant from the Deutsche Forschungsgemeinschaft (EN 280/8-1) to C.E. We thank A. Fogo (Vanderbilt University), J. Reiser (Rush University Medical Center) and C. Alpers (University of Washington) for sending us paraffin blocks of kidneys from animal models of proteinuria. Immortalized mouse podocytes were a kind gift of P. Mundel (MGH Boston). Immortalized human podocytes were a gift of L. Schaefer, University of Frankfurt. We thank K. Priessner, U. Rothermel, D. Kruspe, S. Krieger, H. Schachner, G. Asfour, I. Raab, M. Volz and A. Jager for expert technical assistance and A. Rees for critical reading of the manuscript. Cell sorting was performed by A. Spittler and G. Hofbauer from the Core Facility Cell Sorting, Medical University of Vienna.	Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Bennett MR, 2007, NEPHRON EXP NEPHROL, V107, pE30, DOI 10.1159/000106775; Binder CJ, 1999, AM J PATHOL, V154, P1067, DOI 10.1016/S0002-9440(10)65359-X; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Giannico G, 2009, CLIN J AM SOC NEPHRO, V4, P1747, DOI 10.2215/CJN.01510209; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Juhila J, 2010, AM J PATHOL, V176, P51, DOI 10.2353/ajpath.2010.080843; KAPLAN BS, 1976, LAB INVEST, V34, P174; KASHTAN C, 1986, J CLIN INVEST, V78, P1035, DOI 10.1172/JCI112658; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lenkkeri U, 1999, AM J HUM GENET, V64, P51, DOI 10.1086/302182; MICHAEL AF, 1970, LAB INVEST, V23, P649; Morrison AA, 2008, AM J PHYSIOL-RENAL, V295, pF12, DOI 10.1152/ajprenal.00597.2007; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Ohtaka A, 2002, NEPHROL DIAL TRANSPL, V17, P11, DOI 10.1093/ndt/17.suppl_9.11; Palmer RE, 2001, CURR BIOL, V11, P1805, DOI 10.1016/S0960-9822(01)00560-7; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Ratelade J, 2010, HUM MOL GENET, V19, P1, DOI 10.1093/hmg/ddp462; Ross MD, 2006, DEV DYNAM, V235, P3102, DOI 10.1002/dvdy.20934; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; Shi SL, 2008, J AM SOC NEPHROL, V19, P2159, DOI 10.1681/ASN.2008030312; Shigehara T, 2003, J AM SOC NEPHROL, V14, P1998, DOI 10.1681/ASN.V1481998; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; VENKATACHALAM MA, 1970, J EXP MED, V132, P1168, DOI 10.1084/jem.132.6.1168; Wagner N, 2004, J AM SOC NEPHROL, V15, P3044, DOI 10.1097/01.ASN.0000146687.99058.25; Wang SJ, 2010, DIS MODEL MECH, V3, P92, DOI 10.1242/dmm.003533; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Zhdanova O, 2011, KIDNEY INT, V80, P719, DOI 10.1038/ki.2011.122	51	162	175	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					481	+		10.1038/nm.3142	http://dx.doi.org/10.1038/nm.3142			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23502960				2022-12-27	WOS:000317109100034
J	Liew, CW; Boucher, J; Cheong, JK; Vernochet, C; Koh, HJ; Mallol, C; Townsend, K; Langin, D; Kawamori, D; Hu, J; Tseng, YH; Hellerstein, MK; Farmer, SR; Goodyear, L; Doria, A; Bluher, M; Hsu, SIH; Kulkarni, RN				Liew, Chong Wee; Boucher, Jeremie; Cheong, Jit Kong; Vernochet, Cecile; Koh, Ho-Jin; Mallol, Cristina; Townsend, Kristy; Langin, Dominique; Kawamori, Dan; Hu, Jiang; Tseng, Yu-Hua; Hellerstein, Marc K.; Farmer, Stephen R.; Goodyear, Laurie; Doria, Alessandro; Blueher, Matthias; Hsu, Stephen I-Hong; Kulkarni, Rohit N.			Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance	NATURE MEDICINE			English	Article							HORMONE-SENSITIVE LIPASE; WHITE ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; BR FAMILY; MICE; OVEREXPRESSION; TRANSCRIPTION; INFLAMMATION; COREGULATORS; HOMEOSTASIS	Obesity develops as a result of altered energy homeostasis favoring fat storage. Here we describe a new transcription co-regulator for adiposity and energy metabolism, SERTA domain containing 2 (TRIP-Br2, also called SERTAD2). TRIP-Br2 null mice are resistant to obesity and obesity-related insulin resistance. Adipocytes of these knockout mice showed greater stimulated lipolysis secondary to enhanced expression of hormone sensitive lipase (HSL) and beta 3-adrenergic (Adrb3) receptors. The knockout mice also have higher energy expenditure because of increased adipocyte thermogenesis and oxidative metabolism caused by upregulating key enzymes in their respective processes. Our data show that a cell-cycle transcriptional co-regulator, TRIP-Br2, modulates fat storage through simultaneous regulation of lipolysis, thermogenesis and oxidative metabolism. These data, together with the observation that TRIP-Br2 expression is selectively elevated in visceral fat in obese humans, suggests that this transcriptional co-regulator is a new therapeutic target for counteracting the development of obesity, insulin resistance and hyperlipidemia.	[Liew, Chong Wee; Boucher, Jeremie; Vernochet, Cecile; Koh, Ho-Jin; Townsend, Kristy; Kawamori, Dan; Hu, Jiang; Tseng, Yu-Hua; Goodyear, Laurie; Doria, Alessandro; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Cheong, Jit Kong] Duke Natl Univ Singapore, Grad Sch Med, Canc & Stem Cell Biol Program, Singapore, Singapore; [Vernochet, Cecile; Farmer, Stephen R.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Mallol, Cristina] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, E-08193 Barcelona, Spain; [Langin, Dominique] Inst Metab & Cardiovasc Dis, Obes Res Lab, INSERM, U1048, Toulouse, France; [Hellerstein, Marc K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04109 Leipzig, Germany; [Hsu, Stephen I-Hong] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Hsu, Stephen I-Hong] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Liew, Chong Wee] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; National University of Singapore; Boston University; Autonomous University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California Berkeley; Leipzig University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kulkarni, RN (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA.	clipcap2148@gmail.com; rohit.kulkarni@joslin.harvard.edu	Boucher, Jeremie/G-6602-2015; Doria, Alessandro/H-9157-2018; Tseng, Yu-Hua/AAE-6471-2021	Doria, Alessandro/0000-0002-3830-4304; Tseng, Yu-Hua/0000-0003-2053-9559; Farmer, Stephen/0000-0003-2483-2795; Mallol, Cristina/0000-0002-2920-9612; Langin, Dominique/0000-0002-2669-7825; Liew, Chong Wee/0000-0001-9904-0958	US National Institutes of Health (NIH) [RO1 DK 67536]; Joslin Graetz Bridge Funds; Joslin Diabetes and Endocrinology Research Center Specialized Assay and Advanced Microscopy Cores [NIH P30 DK36836]; Deutsche Forschungsgemeinschaft Clinical Research group 'Atherobesity' [KFO152, BL 833/1-1]; US National Institutes of Health Interdisciplinary training grant [1RL9EB008539-01]; Manpei Suzuki Diabetes Foundation, Japan; Juvenile Diabetes Research Foundation; Dialysis Center, Inc.; University of Florida, Division of Nephrology Gatorade Fund; NIH [K99 DK090210, R01 HL073168, DK51586, DK58825]; Clinical Translational Science Institute at the University of Florida;  [R00 DK090210]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [RL9EB008539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK067536, K99DK090210, R01DK058825, P30DK036836, R56DK051586, R00DK090210, R56DK058825, R01DK051586] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Graetz Bridge Funds; Joslin Diabetes and Endocrinology Research Center Specialized Assay and Advanced Microscopy Cores; Deutsche Forschungsgemeinschaft Clinical Research group 'Atherobesity'; US National Institutes of Health Interdisciplinary training grant; Manpei Suzuki Diabetes Foundation, Japan; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Dialysis Center, Inc.; University of Florida, Division of Nephrology Gatorade Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Translational Science Institute at the University of Florida; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank C.R. Kahn (Joslin Diabetes Center) for providing reagents and discussions, E. Rosen for discussions, E. Morgan and K. Parlee for excellent assistance in the preparation of this manuscript, H. Li for assistance with hormone assays, O.P. McGuinness for mouse metabolic phenotyping, L. Fajas (INSERM) for providing reagents, M. Mori (Joslin Diabetes Center) for providing samples and R. Zechner for providing the protocol for triglyceride hydrolase activities. Funds to generate some reagents used in this research were supported by US National Institutes of Health (NIH) grant RO1 DK 67536 (R.N.K.) and the Joslin Graetz Bridge Funds (R.N.K.), NIH grants R01 HL073168 (A.D.), K99 DK090210 (C.W.L.), DK51586 and DK58825 (S.R.F.) and the Joslin Diabetes and Endocrinology Research Center Specialized Assay and Advanced Microscopy Cores (NIH P30 DK36836). The human studies were supported by a grant of the Deutsche Forschungsgemeinschaft Clinical Research group 'Atherobesity' (KFO152; BL 833/1-1). C.W.L. was supported by a US National Institutes of Health Interdisciplinary training grant (1RL9EB008539-01) (SysCODE), K99 DK090210 and R00 DK090210. D.K. is the recipient of a research fellowship (Manpei Suzuki Diabetes Foundation, Japan) and a Juvenile Diabetes Research Foundation postdoctoral Fellowship. S.I.-H.H. and J.K.C. were supported by the R. Glenn Davis (Dialysis Center, Inc.) Endowed Professorship in Clinical and Translational Medicine and by the University of Florida, Division of Nephrology Gatorade Fund. S.I.-H.H. was supported as a Scholar of the Clinical Translational Science Institute at the University of Florida.	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Blanchet E, 2009, CELL CYCLE, V8, P4029, DOI 10.4161/cc.8.24.10110; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheong JK, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-8; Darwish H, 2007, ONCOGENE, V26, P4319, DOI 10.1038/sj.onc.1210195; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Hirose T, 2003, INT J MOL MED, V11, P705; Holm C, 2000, ANNU REV NUTR, V20, P365, DOI 10.1146/annurev.nutr.20.1.365; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE776, DOI 10.1152/ajpendo.1996.270.5.E776; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lai IL, 2007, GENE, V388, P102, DOI 10.1016/j.gene.2006.10.008; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lowell BB, 2003, J BIOL CHEM, V278, P29385, DOI 10.1074/jbc.R300011200; Lucas S, 2003, J LIPID RES, V44, P154, DOI 10.1194/jlr.M200250-JLR200; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosenbaum M, 1999, NEW ENGL J MED, V341, P913, DOI 10.1056/NEJM199909163411211; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sim KG, 2006, CELL CYCLE, V5, P1111, DOI 10.4161/cc.5.10.2797; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	49	55	60	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					217	226		10.1038/nm.3056	http://dx.doi.org/10.1038/nm.3056			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23291629	Green Accepted, Green Submitted			2022-12-27	WOS:000314675900030
J	Chowdhury, N				Chowdhury, Nupur			Poor definitions threaten drug trial safety in India	NATURE MEDICINE			English	Editorial Material								India has become a hotbed of clinical trials, but recent reports of safety lapses have prompted calls for better regulation in this area. Currently, trial requirements can be relaxed if doing so is in the 'public interest', but a clearer definition of what this means is needed before this provision should be used.	OP Jindal Global Univ, Jindal Global Law Sch, Sonipat, Haryana, India	O.P. Jindal Global University	Chowdhury, N (corresponding author), OP Jindal Global Univ, Jindal Global Law Sch, Sonipat, Haryana, India.			Chowdhury, Nupur/0000-0002-6747-0977				[Anonymous], 2012, HINDU; Das S., 2012, FINANCIAL EXPRE 0711	2	0	0	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2013	19	1					15	15		10.1038/nm0113-15	http://dx.doi.org/10.1038/nm0113-15			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23295999				2022-12-27	WOS:000313230300011
J	Siddiqui, S; Usmani, OS				Siddiqui, Salman; Usmani, Omar S.			Small airways, big challenge: measuring the unseen?	NATURE MEDICINE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; ASTHMA; VENTILATION; EMPHYSEMA; COPD	An imaging technique adapted to differentiate between chronic obstructive pulmonary disease phenotypes can identify small-airway pathophysiology, locate the disease and potentially track disease progression. This approach may be used as a biomarker to identify the small-airway lesion in chronic obstructive pulmonary disease, at an individual level in the clinic (pages 1711-1715).	[Siddiqui, Salman] Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Usmani, Omar S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Usmani, Omar S.] Royal Brompton Hosp, Airways Dis Sect, London SW3 6LY, England	University of Leicester; Imperial College London; Royal Brompton Hospital	Siddiqui, S (corresponding author), Univ Leicester, Inst Lung Hlth, Dept Infect Immun & Inflammat, Leicester, Leics, England.	salman95@yahoo.com		Siddiqui, Salman/0000-0003-3770-7870	National Institute for Health Research [CDF-2011-04-053, CL-2008-11-005] Funding Source: researchfish; Department of Health [CDF-2011-04-053] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Agusti A, 2011, AM J RESP CRIT CARE, V184, P507, DOI 10.1164/rccm.201103-0405PP; [Anonymous], 2011, GLOBAL STRATEGY DIAG; Bayat S, 2012, J APPL PHYSIOL, V113, P851, DOI 10.1152/japplphysiol.00713.2012; Brightling CE, 2012, CLIN EXP ALLERGY, V42, P638, DOI 10.1111/j.1365-2222.2011.03917.x; Butler JP, 2012, NEW ENGL J MED, V367, P244, DOI 10.1056/NEJMoa1203983; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Holguin F, 2005, CHEST, V128, P2005, DOI 10.1378/chest.128.4.2005; Marshall H, 2012, THORAX, V67, P613, DOI 10.1136/thoraxjnl-2011-200864; Martinez CH, 2012, THORAX, V67, P399, DOI 10.1136/thoraxjnl-2011-201185; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Politi AZ, 2010, J THEOR BIOL, V266, P614, DOI 10.1016/j.jtbi.2010.07.032; Usmani OS, 2012, ANN MED, V44, P146, DOI 10.3109/07853890.2011.585656; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490	16	9	9	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1619	1621		10.1038/nm.2981	http://dx.doi.org/10.1038/nm.2981			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135513				2022-12-27	WOS:000310837000018
J	Kamada, N; Chen, G; Nunez, G				Kamada, Nobuhiko; Chen, Grace; Nunez, Gabriel			Harnessing pathogen-commensal relations	NATURE MEDICINE			English	Editorial Material							HEMOLYTIC-UREMIC SYNDROME; VIRULENCE		[Kamada, Nobuhiko; Nunez, Gabriel] Univ Michigan, Dept Pathol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chen, Grace] Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kamada, N (corresponding author), Univ Michigan, Dept Pathol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014; Kamada, Nobuhiko/AAW-3299-2020	Kamada, Nobuhiko/0000-0002-1980-4178				Badger VO, 2012, JPEN-PARENTER ENTER, V36, P645, DOI 10.1177/0148607112446703; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; NATARO JP, 1994, J BACTERIOL, V176, P4691, DOI 10.1128/JB.176.15.4691-4699.1994; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	13	17	18	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1190	1191		10.1038/nm.2900	http://dx.doi.org/10.1038/nm.2900			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869189				2022-12-27	WOS:000307469300023
J	Zhu, Q; Talton, J; Zhang, GF; Cunningham, T; Wang, ZJ; Waters, RC; Kirk, J; Eppler, B; Klinman, DM; Sui, YJ; Gagnon, S; Belyakov, IM; Mumper, RJ; Berzofsky, JA				Zhu, Qing; Talton, James; Zhang, Guofeng; Cunningham, Tshaka; Wang, Zijian; Waters, Robert C.; Kirk, James; Eppler, Baerbel; Klinman, Dennis M.; Sui, Yongjun; Gagnon, Susan; Belyakov, Igor M.; Mumper, Russell J.; Berzofsky, Jay A.			Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection	NATURE MEDICINE			English	Article							IN-VIVO EVALUATION; T-CELL RESPONSES; DRUG-DELIVERY; PROTECTS MICE; RECTAL MUCOSA; IMMUNIZATION; COMPARTMENTALIZATION; TRANSMISSION; TECHNOLOGIES; PROTEINS	Both rectal and vaginal mucosal surfaces serve as transmission routes for pathogenic microorganisms. Vaccination through large intestinal mucosa, previously proven protective for both of these mucosal sites in animal studies, can be achieved successfully by direct intracolorectal (i.c.r.) administration, but this route is clinically impractical. Oral vaccine delivery seems preferable but runs the risk of the vaccine's destruction in the upper gastrointestinal tract. Therefore, we designed a large intestine-targeted oral delivery with pH-dependent microparticles containing vaccine nanoparticles, which induced colorectal immunity in mice comparably to colorectal vaccination and protected against rectal and vaginal viral challenge. Conversely, vaccine targeted to the small intestine induced only small intestinal immunity and provided no rectal or vaginal protection, demonstrating functional compartmentalization within the gut mucosal immune system. Therefore, using this oral vaccine delivery system to target the large intestine, but not the small intestine, may represent a feasible new strategy for immune protection of rectal and vaginal mucosa.	[Zhu, Qing; Cunningham, Tshaka; Sui, Yongjun; Gagnon, Susan; Belyakov, Igor M.; Berzofsky, Jay A.] NCI, Vaccine Branch, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Zhu, Qing] AF Gen Hosp, Dept Oncol, Beijing, Peoples R China; [Zhang, Guofeng] Natl Inst Biomed Imaging & Bioengn, Lab Bioengn & Phys Sci, US Natl Inst Hlth, Bethesda, MD USA; [Wang, Zijian] Jingmeng Res Ctr, Beijing, Peoples R China; [Klinman, Dennis M.] NCI, Expt Immunol Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Belyakov, Igor M.] Univ Michigan, Sch Med, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI USA; [Belyakov, Igor M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Mumper, Russell J.] Univ N Carolina, Eshelman Sch Pharm, Div Mol Pharmaceut, Ctr Nanotechnol Drug Delivery, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill	Zhu, Q (corresponding author), NCI, Vaccine Branch, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA.	qing20892@gmail.com; berzofsj@mail.nih.gov	Sui, Yongjun/AAA-3228-2019	Talton, James/0000-0002-4310-661X; Sui, Yongjun/0000-0002-1568-4607	Intramural Research Program of NIH; National Cancer Institute; Center for Cancer Research; Intramural AIDS Targeted Antiviral Program; National Natural Science Foundation of China [31170872]; Collaborative Research and Development Agreement with Nanotherapeutics Inc; NATIONAL CANCER INSTITUTE [ZIASC004020, ZIABC010852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000080] Funding Source: NIH RePORTER	Intramural Research Program of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Research and Development Agreement with Nanotherapeutics Inc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank B. Moss and P. Earl (US National Institutes of Health (NIH)) for generously providing vPE16, G. Cohen (University of Pennsylvania) for vaccinia antibodies, the NIH Tetramer Facility for tetramer P18-I10 and BEI Resources for vaccinia recombinant proteins. We also thank J. Hooper, D. Johnson, M. Dobrovolskaia, B. Zolnik, J. Gao and X. Liu for professional comments and help, and J. FitzGerald for electron microscopy. We appreciate Z. Xia, D. Pendleton, D. Li and L. Smith for their technical and secretarial assistance. This research was supported by the Intramural Research Program of NIH, the National Cancer Institute, the Center for Cancer Research and the Intramural AIDS Targeted Antiviral Program, a grant from the National Natural Science Foundation of China (31170872), and a Collaborative Research and Development Agreement with Nanotherapeutics Inc.	Belyakov IM, 2007, J IMMUNOL, V178, P7211, DOI 10.4049/jimmunol.178.11.7211; Belyakov IM, 1998, J CLIN INVEST, V102, P2072, DOI 10.1172/JCI5102; Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320; Bott C, 2004, ALIMENT PHARM THER, V20, P347, DOI 10.1111/j.1365-2036.2004.02033.x; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Cole ET, 2002, INT J PHARMACEUT, V231, P83, DOI 10.1016/S0378-5173(01)00871-7; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Cronkhite RI, 2004, VACCINE, V22, P2106, DOI 10.1016/j.vaccine.2003.12.012; Desai MP, 1996, PHARMACEUT RES, V13, P1838, DOI 10.1023/A:1016085108889; Ferre AL, 2010, J VIROL, V84, P10354, DOI 10.1128/JVI.00803-10; Fogg C, 2004, J VIROL, V78, P10230, DOI 10.1128/JVI.78.19.10230-10237.2004; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Han M, 2009, J PHARM SCI-US, V98, P2626, DOI 10.1002/jps.21627; Hooper JW, 2003, VIROLOGY, V306, P181, DOI 10.1016/S0042-6822(02)00038-7; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; Lehner T, 1996, NAT MED, V2, P767, DOI 10.1038/nm0796-767; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; McConnell EL, 2008, VACCINE, V26, P639, DOI 10.1016/j.vaccine.2007.11.071; Miller CJ, 1996, NAT MED, V2, P751, DOI 10.1038/nm0796-751; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; O'Hagan DT, 2006, METHODS, V40, P10, DOI 10.1016/j.ymeth.2006.05.017; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Schellekens RCA, 2008, J CONTROL RELEASE, V132, P91, DOI 10.1016/j.jconrel.2008.08.008; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Shang LM, 2008, GASTROENTEROLOGY, V135, P529, DOI 10.1053/j.gastro.2008.04.020; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Zhu Q, 2008, MUCOSAL IMMUNOL, V1, P78, DOI 10.1038/mi.2007.3; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105; Zhu Q, 2010, J CLIN INVEST, V120, P607, DOI 10.1172/JCI39293	32	126	131	11	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1291	+		10.1038/nm.2866	http://dx.doi.org/10.1038/nm.2866			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22797811	Green Submitted, Green Accepted			2022-12-27	WOS:000307469300037
J	Zhu, S; Pan, W; Song, XY; Liu, Y; Shao, XR; Tang, YJ; Liang, D; He, DY; Wang, HL; Liu, WJ; Shi, YF; Harley, JB; Shen, N; Qian, YC				Zhu, Shu; Pan, Wen; Song, Xinyang; Liu, Yan; Shao, Xinrui; Tang, Yuanjia; Liang, Dong; He, Dongyi; Wang, Honglin; Liu, Wenjun; Shi, Yufang; Harley, John B.; Shen, Nan; Qian, Youcun			The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha	NATURE MEDICINE			English	Article							CD4(+) T-CELLS; RHEUMATOID-ARTHRITIS; LUPUS NEPHRITIS; MESSENGER-RNA; EXPRESSION; INTERLEUKIN-17; PROTEIN; MECHANISMS; DISEASE; GENES	Inflammatory cytokines such as interleukin-17 (IL-17) promote inflammatory autoimmune diseases. Although several microRNAs (miRNAs) have been shown to regulate autoimmune pathogenesis by affecting lymphocyte development and function, the role of miRNAs in resident cells present in inflammatory lesions remains unclear. Here we show that miR-23b is downregulated in inflammatory lesions of humans with lupus or rheumatoid arthritis, as well as in the mouse models of lupus, rheumatoid arthritis or multiple sclerosis. IL-17 downregulates miR-23b expression in human fibroblast-like synoviocytes, mouse primary kidney cells and astrocytes and is essential for the downregulation of miR-23b during autoimmune pathogenesis. In turn, miR-23b suppresses IL-17-, tumor necrosis factor alpha (TNF-alpha)- or IL-1 beta-induced NF-kappa B activation and inflammatory cytokine expression by targeting TGF-beta-activated kinase 1/MAP3K7 binding protein 2 (TAB2), TAB3 and inhibitor of nuclear factor kappa-B kinase subunit alpha (IKK-alpha) and, consequently, represses autoimmune inflammation. Thus, IL-17 contributes to autoimmune pathogenesis by suppressing miR-23b expression in radio-resident cells and promoting proinflammatory cytokine expression.	[Zhu, Shu; Pan, Wen; Song, Xinyang; Liu, Yan; Shao, Xinrui; Shi, Yufang; Shen, Nan; Qian, Youcun] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Tang, Yuanjia; Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, Shanghai Inst Rheumatol, Shanghai 200030, Peoples R China; [Liang, Dong; Harley, John B.; Shen, Nan] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH USA; [Liang, Dong; Harley, John B.; Shen, Nan] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH USA; [Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [He, Dongyi] Guanghua Rheumatol Hosp, Shanghai, Peoples R China; [Liu, Wenjun] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Chinese Academy of Sciences; Shanghai Jiao Tong University; University of Manitoba; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Qian, YC (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai 200031, Peoples R China.	nanshensibs@gmail.com; ycqian@sibs.ac.cn	Pan, Wen/I-9965-2016; Song, Xinyang/AAL-7495-2021; Shen, Nan/AGK-6807-2022; Zhu, Shu/P-6163-2018; Shi, Yufang/AAE-4431-2020; WANG, Honglin/AAJ-2708-2020	Zhu, Shu/0000-0002-8163-0869; Shi, Yufang/0000-0001-8964-319X; WANG, Honglin/0000-0001-6302-6927; tang, yuan jia/0000-0002-2044-5424; Shen, Nan/0000-0002-5875-4417; Song, Xinyang/0000-0002-3422-6927	National Natural Science Foundation of China and 973 program [30930084, 2010CB529705, 91029708, 30871298]; Chinese Academy of Sciences [KSCX2-YW-R-146]; Science and Technology Commission of Shanghai Municipality [10JC1416600]; National Natural Science Foundation of China [30971632, 81025016]; Chinese Ministry of Health [201202008]; Program of the Shanghai Commission of Science and Technology [10JC1409300]	National Natural Science Foundation of China and 973 program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Health; Program of the Shanghai Commission of Science and Technology	We thank R. Flavell (Yale University) for providing Pi 17a-deficient mice. This work is supported by grants from National Natural Science Foundation of China and 973 program (30930084, 2010CB529705, 91029708 and 30871298), Chinese Academy of Sciences (KSCX2-YW-R-146) and the Science and Technology Commission of Shanghai Municipality (10JC1416600) to Y.Q.; as well as National Natural Science Foundation of China (30971632 and 81025016), Chinese Ministry of Health (201202008) and the Program of the Shanghai Commission of Science and Technology (10JC1409300) to N. S.	AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; De Santis G, 2010, J NEUROIMMUNOL, V226, P165, DOI 10.1016/j.jneuroim.2010.06.009; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Geyer M, 2010, CURR OPIN RHEUMATOL, V22, P246, DOI 10.1097/BOR.0b013e3283373fa0; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Moreth K, 2010, J CLIN INVEST, V120, P4251, DOI 10.1172/JCI42213; Nakamachi Y, 2009, ARTHRITIS RHEUM-US, V60, P1294, DOI 10.1002/art.24475; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qian YC, 2010, CELL MOL IMMUNOL, V7, P328, DOI 10.1038/cmi.2010.27; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Smolen JS, 2005, LUPUS, V14, P189, DOI 10.1191/0961203305lu2134oa; Sonder SU, 2011, J BIOL CHEM, V286, P12881, DOI 10.1074/jbc.M110.199547; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Williams RO, 2007, CURR OPIN PHARMACOL, V7, P412, DOI 10.1016/j.coph.2007.06.001; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	58	330	360	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1077	+		10.1038/nm.2815	http://dx.doi.org/10.1038/nm.2815			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22660635				2022-12-27	WOS:000306121600037
J	Newman, AM; Bratman, SV; To, J; Wynne, JF; Eclov, NCW; Modlin, LA; Liu, CL; Neal, JW; Wakelee, HA; Merritt, RE; Shrager, JB; Loo, BW; Alizadeh, AA; Diehn, M				Newman, Aaron M.; Bratman, Scott V.; To, Jacqueline; Wynne, Jacob F.; Eclov, Neville C. W.; Modlin, Leslie A.; Liu, Chih Long; Neal, Joel W.; Wakelee, Heather A.; Merritt, Robert E.; Shrager, Joseph B.; Loo, Billy W., Jr.; Alizadeh, Ash A.; Diehn, Maximilian			An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; SOMATIC MUTATIONS; PLASMA; REARRANGEMENTS; RESISTANCE; THERAPY; GENE	Circulating tumor DNA (ctDNA) is a promising biomarker for noninvasive assessment of cancer burden, but existing ctDNA detection methods have insufficient sensitivity or patient coverage for broad clinical applicability. Here we introduce cancer personalized profiling by deep sequencing (CAPP-Seq), an economical and ultrasensitive method for quantifying ctDNA. We implemented CAPP-Seq for non-small-cell lung cancer (NSCLC) with a design covering multiple classes of somatic alterations that identified mutations in >95% of tumors. We detected ctDNA in 100% of patients with stage II-IV NSCLC and in 50% of patients with stage I, with 96% specificity for mutant allele fractions down to similar to 0.02%. Levels of ctDNA were highly correlated with tumor volume and distinguished between residual disease and treatment-related imaging changes, and measurement of ctDNA levels allowed for earlier response assessment than radiographic approaches. Finally, we evaluated biopsy-free tumor screening and genotyping with CAPP-Seq. We envision that CAPP-Seq could be routinely applied clinically to detect and monitor diverse malignancies, thus facilitating personalized cancer therapy.	[Newman, Aaron M.; Bratman, Scott V.; Liu, Chih Long; Alizadeh, Ash A.; Diehn, Maximilian] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Newman, Aaron M.; Liu, Chih Long; Neal, Joel W.; Wakelee, Heather A.; Alizadeh, Ash A.] Stanford Univ, Dept Med, Div Oncol, Stanford Canc Inst, Stanford, CA 94305 USA; [Bratman, Scott V.; To, Jacqueline; Wynne, Jacob F.; Eclov, Neville C. W.; Modlin, Leslie A.; Loo, Billy W., Jr.; Diehn, Maximilian] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Merritt, Robert E.; Shrager, Joseph B.] Stanford Univ, Div Thorac Surg, Dept Cardiothorac Surg, Stanford Sch Med, Stanford, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Dept Med, Div Hematol, Stanford Canc Inst, Stanford, CA 94305 USA; [Diehn, Maximilian] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA	Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University	Diehn, M (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	arasha@stanford.edu; diehn@stanford.edu	Newman, Aaron M/ABE-1620-2021; Wakelee, Heather/P-2623-2019; Alizadeh, Ash A/C-5594-2009; wang, edwin/G-5372-2010; Eclov, Neville/AAG-1502-2020	Newman, Aaron M/0000-0002-1857-8172; Alizadeh, Ash A/0000-0002-5153-5625; Eclov, Neville/0000-0003-1454-006X; Bratman, Scott/0000-0001-8610-4908	US Department of Defense; US National Institutes of Health Director's New Innovator Award Program [1-DP2-CA186569]; Ludwig Institute for Cancer Research; Radiological Society of North America [RR1221]; Association of American Cancer Institutes Translational Cancer Research Fellowship; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; Doris Duke Clinical Scientist Development Awards; NATIONAL CANCER INSTITUTE [T32CA009302, DP2CA186569] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); US National Institutes of Health Director's New Innovator Award Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Radiological Society of North America; Association of American Cancer Institutes Translational Cancer Research Fellowship; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; Doris Duke Clinical Scientist Development Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank S. Quake and members of his lab for suggestions and N. Neff for technical assistance. This work was supported by the US Department of Defense (M.D., A.A.A., A.M.N.), the US National Institutes of Health Director's New Innovator Award Program (M.D.; 1-DP2-CA186569), the Ludwig Institute for Cancer Research (M.D., A.A.A.), the Radiological Society of North America (S.V.B.; #RR1221), an Association of American Cancer Institutes Translational Cancer Research Fellowship (S.V.B.) and a grant from both the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation (A.M.N.). A.A.A. and M.D. are supported by Doris Duke Clinical Scientist Development Awards.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Gautschi O, 2007, CANCER LETT, V254, P265, DOI 10.1016/j.canlet.2007.03.008; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; He J, 2011, ONCOTARGET, V2, P178; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Iyengar P, 2012, J NATL COMPR CANC NE, V10, P1514, DOI 10.6004/jnccn.2012.0157; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Narayan A, 2012, CANCER RES, V72, P3492, DOI 10.1158/0008-5472.CAN-11-4037; NESBITT JC, 1995, ANN THORAC SURG, V60, P466, DOI 10.1016/0003-4975(95)00169-L; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shiroguchi K, 2012, P NATL ACAD SCI USA, V109, P1347, DOI 10.1073/pnas.1118018109; Su ZL, 2011, J MOL DIAGN, V13, P74, DOI 10.1016/j.jmoldx.2010.11.010; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630	35	1335	1492	6	406	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2014	20	5					552	558		10.1038/nm.3519	http://dx.doi.org/10.1038/nm.3519			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AG9AK	24705333	Green Accepted			2022-12-27	WOS:000335710700028
J	Lipset, CH				Lipset, Craig H.			Engage with research participants about social media	NATURE MEDICINE			English	Editorial Material								A growing number of participants in clinical trials are sharing information about their health online. It's time that the drug development community starts to examine how this social media use might compromise the integrity of research studies and how it might also offer new opportunities.	Pfizer, Clin Innovat Worldwide Res & Dev, New York, NY USA	Pfizer	Lipset, CH (corresponding author), Pfizer, Clin Innovat Worldwide Res & Dev, New York, NY USA.							Glickman SW, 2012, J EMPIR RES HUM RES, V7, P71, DOI 10.1525/jer.2012.7.1.71; Heywood J., 2012, FIGSHARE        1025, DOI [10.6084/m9.figshare.96802, DOI 10.6084/M9.FIGSHARE.96802]; Talevi A, 2010, CURR DRUG SAF, V5, P314, DOI 10.2174/157488610792245957	3	15	15	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					231	231		10.1038/nm0314-231	http://dx.doi.org/10.1038/nm0314-231			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24603786				2022-12-27	WOS:000332595600008
J	Khalifeh-Soltani, A; McKleroy, W; Sakuma, S; Cheung, YY; Tharp, K; Qiu, YF; Turner, SM; Chawla, A; Stahl, A; Atabai, K				Khalifeh-Soltani, Amin; McKleroy, William; Sakuma, Stephen; Cheung, Yuk Yin; Tharp, Kevin; Qiu, Yifu; Turner, Scott M.; Chawla, Ajay; Stahl, Andreas; Atabai, Kamran			Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids	NATURE MEDICINE			English	Article							ALPHA(V)BETA(3) INTEGRIN; INSULIN; CD36; ADIPOCYTES; IDENTIFICATION; TRANSLOCATION; PHAGOCYTOSIS; LACTADHERIN; EXPRESSION; TRANSPORT	Fatty acids are integral mediators of energy storage, membrane formation and cell signaling. The pathways that orchestrate uptake of fatty acids remain incompletely understood. Expression of the integrin ligand Mfge8 is increased in human obesity and in mice on a high-fat diet, but its role in obesity is unknown. We show here that Mfge8 promotes the absorption of dietary triglycerides and the cellular uptake of fatty acid and that Mfge8-deficient (Mfge8(-/-)) mice are protected from diet-induced obesity, steatohepatitis and insulin resistance. Mechanistically, we found that Mfge8 coordinates fatty acid uptake through alpha(v)beta(3) integrin- and alpha(v)beta(5) integrin-dependent phosphorylation of Akt by phosphatidylinositide-3 kinase and mTOR complex 2, leading to translocation of Cd36 and Fatp1 from cytoplasmic vesicles to the cell surface. Collectively, our results imply a role for Mfge8 in regulating the absorption and storage of dietary fats, as well as in the development of obesity and its complications.	[Khalifeh-Soltani, Amin; McKleroy, William; Sakuma, Stephen; Cheung, Yuk Yin; Qiu, Yifu; Chawla, Ajay; Atabai, Kamran] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Khalifeh-Soltani, Amin; McKleroy, William; Sakuma, Stephen; Atabai, Kamran] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA; [Khalifeh-Soltani, Amin; McKleroy, William; Sakuma, Stephen; Cheung, Yuk Yin; Chawla, Ajay; Atabai, Kamran] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Tharp, Kevin; Stahl, Andreas] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Tharp, Kevin; Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Turner, Scott M.] KineMed Inc, Emeryville, CA USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Atabai, K (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	kamran.atabai@ucsf.edu	Sakuma, Stephen/AAH-1880-2020	Sakuma, Stephen/0000-0002-0779-5139; tharp, kevin/0000-0002-3543-3266; Qiu, Yifu/0000-0001-5645-3189	US National Institutes of Health [P30 DK 063-7202]; University of California, San Francisco (UCSF) Diabetes and Endocrinology Research Center; UCSF Cardiovascular Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, T32DK007202, T32DK061918, P30DK063720, R01DK066336] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco (UCSF) Diabetes and Endocrinology Research Center; UCSF Cardiovascular Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institutes of Health grant P30 DK 063-7202 and the University of California, San Francisco (UCSF) Diabetes and Endocrinology Research Center and UCSF Cardiovascular Research Institute startup funds (K.A.). We would like to thank K. Nguyen for help with flow cytometry studies, A. Atakilit and D. Sheppard (UCSF Lung Biology Center) for providing integrin-blocking antibodies, R. Silverstein for providing Cd36<SUP>-/-</SUP> mice (Cleveland Clinic Research Institute) and K. Ashrafi for thoughtful review of the manuscript.	Anderson CM, 2013, MOL ASPECTS MED, V34, P516, DOI 10.1016/j.mam.2012.07.010; Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Asano K, 2004, J EXP MED, V200, P459, DOI 10.1084/jem.20040342; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Berk PD, 1999, J BIOL CHEM, V274, P28626, DOI 10.1074/jbc.274.40.28626; Berk PD, 1997, J BIOL CHEM, V272, P8830, DOI 10.1074/jbc.272.13.8830; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Chabowski A, 2004, AM J PHYSIOL-ENDOC M, V287, pE781, DOI 10.1152/ajpendo.00573.2003; Cheng M, 2012, DIABETES RES CLIN PR, V95, P125, DOI 10.1016/j.diabres.2011.09.030; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Drover VA, 2008, J BIOL CHEM, V283, P13108, DOI 10.1074/jbc.M708086200; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Jain SS, 2009, FEBS LETT, V583, P2294, DOI 10.1016/j.febslet.2009.06.020; Kudo M, 2013, P NATL ACAD SCI USA, V110, P660, DOI 10.1073/pnas.1216673110; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Liu YY, 2010, ANTICANCER RES, V30, P369; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; POEHLMAN ET, 1994, ANN INTERN MED, V121, P860, DOI 10.7326/0003-4819-121-11-199412010-00006; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rolland Y, 2011, CURR OPIN CLIN NUTR, V14, P15, DOI 10.1097/MCO.0b013e328340c2c2; Ryeom SW, 1996, J CELL SCI, V109, P387; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Stump DD, 2001, J LIPID RES, V42, P509; Tanaka T, 2001, J LIPID RES, V42, P751; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Twito T, 2011, ANIM GENET, V42, P642, DOI 10.1111/j.1365-2052.2011.02191.x; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Yu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052541; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499; Zheng DQ, 1999, CANCER RES, V59, P1655	49	63	65	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					175	183		10.1038/nm.3450	http://dx.doi.org/10.1038/nm.3450			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24441829	Green Accepted			2022-12-27	WOS:000330915000019
J	Regard, JB; Malhotra, D; Gvozdenovic-Jeremic, J; Josey, M; Chen, M; Weinstein, LS; Lu, JM; Shore, EM; Kaplan, FS; Yang, YZ				Regard, Jean B.; Malhotra, Deepti; Gvozdenovic-Jeremic, Jelena; Josey, Michelle; Chen, Min; Weinstein, Lee S.; Lu, Jianming; Shore, Eileen M.; Kaplan, Frederick S.; Yang, Yingzi			Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification	NATURE MEDICINE			English	Article							PROTEIN-KINASE-A; SUPPRESSES OSTEOGENIC DIFFERENTIATION; MESENCHYMAL STEM-CELLS; STIMULATORY G-PROTEIN; BONE-FORMATION; OSTEOBLAST DIFFERENTIATION; IN-VIVO; CHONDROCYTE PROLIFERATION; PROMOTES PROLIFERATION; SKELETAL DEVELOPMENT	Heterotopic ossification, the pathologic formation of extraskeletal bone, occurs as a common complication of trauma or in genetic disorders and can be disabling and lethal. However, the underlying molecular mechanisms are largely unknown. Here we demonstrate that G alpha(s) restricts bone formation to the skeleton by inhibiting Hedgehog signaling in mesenchymal progenitor cells. In progressive osseous heteroplasia, a human disease caused by null mutations in GNAS, which encodes G alpha(s), Hedgehog signaling is upregulated in ectopic osteoblasts and progenitor cells. In animal models, we show that genetically-mediated ectopic Hedgehog signaling is sufficient to induce heterotopic ossification, whereas inhibition of this signaling pathway by genetic or pharmacological means strongly reduces the severity of this condition. As our previous work has shown that GNAS gain-of-function mutations upregulate WNT-beta-catenin signaling in osteoblast progenitor cells, resulting in their defective differentiation and fibrous dysplasia, we identify G alpha(s) as a key regulator of proper osteoblast differentiation through its maintenance of a balance between the Wnt-beta-catenin and Hedgehog pathways. Also, given the results here of the pharmacological studies in our mouse model, we propose that Hedgehog inhibitors currently used in the clinic for other conditions, such as cancer, may possibly be repurposed for treating heterotopic ossification and other diseases caused by GNAS inactivation.	[Regard, Jean B.; Malhotra, Deepti; Gvozdenovic-Jeremic, Jelena; Josey, Michelle; Yang, Yingzi] NHGRI, NIH, Bethesda, MD 20892 USA; [Chen, Min; Weinstein, Lee S.] NIDDK, NIH, Bethesda, MD 20892 USA; [Lu, Jianming] Codex BioSolut, Gaithersburg, MD USA; [Shore, Eileen M.; Kaplan, Frederick S.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Shore, Eileen M.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kaplan, Frederick S.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Yang, YZ (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	jean.regard@novartis.com; yingzi@mail.nih.gov	Weinstein, Lee S/I-5575-2015		intramural research program of NHGRI at the US National Institutes of Health (NIH); intramural research program of NIDDK at the US National Institutes of Health (NIH); Progressive Osseous Heteroplasia Association; University of Pennsylvania Center for Research in FOP and Related Disorders; Penn Center for Musculoskeletal Disorders (NIH NIAMS) [P30-AR050950]; Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine; NIH NIAMS [R01-AR046831, R01-AR41916]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200342, ZIAHG000187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041916, P30AR050950, R01AR046831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043313] Funding Source: NIH RePORTER	intramural research program of NHGRI at the US National Institutes of Health (NIH); intramural research program of NIDDK at the US National Institutes of Health (NIH); Progressive Osseous Heteroplasia Association; University of Pennsylvania Center for Research in FOP and Related Disorders; Penn Center for Musculoskeletal Disorders (NIH NIAMS); Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine; NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the entire Yang lab for stimulating discussions. We thank J. Fekecs and P. Andre for helping with the data illustration. The work in the Yang and Weinstein labs was supported by the intramural research programs of NHGRI and NIDDK at the US National Institutes of Health (NIH), respectively. We thank R. Caron for his work on the POH lesion histological analyses. The rabbit anti-Gli3 antibody was provided by S. Mackem (NIH NCI), and the dnPKA adenovirus was a gift from C.-M. Fan (Carnegie Institution for Science). The work in the Kaplan and Shore lab was supported by the Progressive Osseous Heteroplasia Association, the University of Pennsylvania Center for Research in FOP and Related Disorders, the Penn Center for Musculoskeletal Disorders (NIH NIAMS P30-AR050950), the Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine and NIH NIAMS (R01-AR046831 and R01-AR41916).	Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Cooper KL, 2011, SCIENCE, V332, P1083, DOI 10.1126/science.1199499; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174; de Boer J, 2004, BONE, V34, P818, DOI 10.1016/j.bone.2004.01.016; Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Huso DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021755; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Kaplan, 1994, J Am Acad Orthop Surg, V2, P288; KEELY SL, 1975, P NATL ACAD SCI USA, V72, P1501, DOI 10.1073/pnas.72.4.1501; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Long FX, 2001, DEVELOPMENT, V128, P5099; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nelson DK, 2004, DEV BIOL, V267, P72, DOI 10.1016/j.ydbio.2003.10.033; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Pignolo RJ, 2011, J BONE MINER RES, V26, P2647, DOI 10.1002/jbmr.481; Plagge A, 2008, J ENDOCRINOL, V196, P193, DOI 10.1677/JOE-07-0544; Regard JB, 2007, J CLIN INVEST, V117, P4034, DOI 10.1172/JCI32994; Regard JB, 2011, P NATL ACAD SCI USA, V108, P20101, DOI 10.1073/pnas.1114656108; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Riminucci M, 2010, J MOL ENDOCRINOL, V45, P355, DOI 10.1677/JME-10-0097; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rosello-Diez A, 2011, SCIENCE, V332, P1086, DOI 10.1126/science.1199489; Sakamoto A, 2005, J BONE MINER RES, V20, P663, DOI 10.1359/JBMR.041210; Sakamoto H, 2005, BIOCHEM BIOPH RES CO, V338, P578, DOI 10.1016/j.bbrc.2005.08.176; SEAMON K, 1981, J BIOL CHEM, V256, P9799; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; TRUEB RM, 1993, DERMATOLOGY, V186, P205, DOI 10.1159/000247347; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106	73	141	156	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1505	+		10.1038/nm.3314	http://dx.doi.org/10.1038/nm.3314			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24076664	Green Accepted			2022-12-27	WOS:000326920300028
J	Liang, TJ				Liang, T. Jake			Current progress in development of hepatitis C virus vaccines	NATURE MEDICINE			English	Review							T-CELL RESPONSES; ADAPTIVE IMMUNE-RESPONSES; NEUTRALIZING ANTIBODIES; SPONTANEOUS CLEARANCE; GENETIC-VARIATION; HCV INFECTION; CHIMPANZEES; VACCINATION; ANTIGEN; HIV	Despite major advances in the understanding and treatment of hepatitis C, a preventive vaccine remains elusive. The marked genetic diversity and multiple mechanisms of persistence of hepatitis C virus, combined with the relatively poor immune response of the infected host against the virus, are major barriers. The lack of robust and convenient model systems further hampers the effort to develop an effective vaccine. Advances in our understanding of virus-host interactions and protective immunity in hepatitis C virus infection provide an important roadmap to develop potent and broadly directed vaccine candidates targeting both humoral and cellular immune responses. Multiple approaches to generating and testing viral immunogens have met with variable success. Several candidates have advanced to clinical trials based on promising results in chimpanzees. The ultimate path to a successful preventive vaccine requires comprehensive evaluations of all aspects of protective immunity, innovative application of state-of-the-art vaccine technology and properly designed vaccine trials that can affirm definitive endpoints of efficacy.	NIDDK, Liver Dis Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liang, TJ (corresponding author), NIDDK, Liver Dis Branch, NIH, Bethesda, MD USA.	jliang@nih.gov	Cheng, Yushao/E-6256-2011		Intramural Research Program of the US National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054504, ZIADK054503] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the Intramural Research Program of the US National Institute of Diabetes and Digestive and Kidney Diseases.	Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bailey J, 2011, ATLA-ALTERN LAB ANIM, V39, P527, DOI 10.1177/026119291103900608; BARNABA V, 1990, NATURE, V345, P258, DOI 10.1038/345258a0; BARNES E, 2012, SCI TRANSL MED, V4; Barth H, 2008, J HEPATOL, V49, P134, DOI 10.1016/j.jhep.2008.03.012; Barth H, 2011, HEPATOLOGY, V54, P1135, DOI 10.1002/hep.24489; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; Bukh J, 2001, J VIRAL HEPATITIS, V8, P228, DOI 10.1046/j.1365-2893.2001.00284.x; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Buonaguro L, 2011, EXPERT REV VACCINES, V10, P1569, DOI [10.1586/ERV.11.135, 10.1586/erv.11.135]; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Caldeira JD, 2010, VACCINE, V28, P4384, DOI 10.1016/j.vaccine.2010.04.049; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chiarella P, 2010, CURR GENE THER, V10, P281, DOI 10.2174/156652310791823506; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Christie JML, 1997, CLIN EXP IMMUNOL, V110, P4; Cohen MS, 2012, AIDS, V26, P1585, DOI 10.1097/QAD.0b013e3283543e83; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Corey L, 2009, AIDS, V23, P3, DOI 10.1097/QAD.0b013e32830e6d6d; Crotta S, 2002, J EXP MED, V195, P35, DOI 10.1084/jem.20011124; Dahari H, 2010, GASTROENTEROLOGY, V139, P965, DOI 10.1053/j.gastro.2010.05.077; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Di Lorenzo C, 2011, VIRUSES-BASEL, V3, P2280, DOI 10.3390/v3112280; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Drane D, 2009, HUM VACCINES, V5, P151, DOI 10.4161/hv.5.3.6614; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Elmowalid GA, 2007, P NATL ACAD SCI USA, V104, P8427, DOI 10.1073/pnas.0702162104; FERRARI C, 1994, HEPATOLOGY, V19, P286; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Forns X, 2000, HEPATOLOGY, V32, P618, DOI 10.1053/jhep.2000.9877; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gilbert SC, 2012, IMMUNOLOGY, V135, P19, DOI 10.1111/j.1365-2567.2011.03517.x; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Habersetzer F, 2011, GASTROENTEROLOGY, V141, P890, DOI 10.1053/j.gastro.2011.06.009; Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018; Haller AA, 2007, VACCINE, V25, P1452, DOI 10.1016/j.vaccine.2006.10.035; Heeney JL, 2006, J VIROL, V80, P7208, DOI 10.1128/JVI.00382-06; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; Heller T, 2005, SEMIN LIVER DIS, V25, P7, DOI 10.1055/s-2005-864778; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Institute of Medicine, 2011, CHIMP BIOM BEH RES A; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Kim Y, 2011, J IMMUNOL METHODS, V374, P62, DOI 10.1016/j.jim.2010.10.010; Klade CS, 2008, GASTROENTEROLOGY, V134, P1385, DOI 10.1053/j.gastro.2008.02.058; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Kool M, 2012, J MED MICROBIOL, V61, P927, DOI 10.1099/jmm.0.038943-0; Krahn MD, 2005, VACCINE, V23, P1549, DOI 10.1016/j.vaccine.2004.09.023; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Lavillette D, 2005, J VIROL, V79, P6023, DOI 10.1128/JVI.79.10.6023-6034.2005; Leroux-Roels G, 2004, VACCINE, V22, P3080, DOI 10.1016/j.vaccine.2004.02.002; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; Meunier JC, 2011, J INFECT DIS, V204, P1741, DOI 10.1093/infdis/jir631; Meunier JC, 2011, J INFECT DIS, V204, P1186, DOI 10.1093/infdis/jir511; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Neumann-Haefelin C, 2010, HEPATOLOGY, V51, P54, DOI 10.1002/hep.23275; Nicholls EF, 2010, ANN NY ACAD SCI, V1213, P46, DOI 10.1111/j.1749-6632.2010.05787.x; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; Polakos NK, 2001, J IMMUNOL, V166, P3589, DOI 10.4049/jimmunol.166.5.3589; Post JJ, 2004, J INFECT DIS, V189, P1846, DOI 10.1086/383279; Raghuraman S, 2012, J INFECT DIS, V205, P763, DOI 10.1093/infdis/jir835; Rehermann B, 2007, SEMIN LIVER DIS, V27, P152, DOI 10.1055/s-2007-979468; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Rollier C, 2004, J VIROL, V78, P187, DOI 10.1128/JVI.78.1.187-196.2004; Rollier CS, 2007, HEPATOLOGY, V45, P602, DOI 10.1002/hep.21573; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Schaefer EAK, 2012, GASTROENTEROLOGY, V142, P1340, DOI 10.1053/j.gastro.2012.02.015; Schijns VEJC, 2011, EXPERT REV VACCINES, V10, P539, DOI [10.1586/erv.11.21, 10.1586/ERV.11.21]; Serra A, 2008, J IMMUNOL, V181, P174, DOI 10.4049/jimmunol.181.1.174; SHIMIZU YK, 1994, J VIROL, V68, P1494, DOI 10.1128/JVI.68.3.1494-1500.1994; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simonin Y, 2009, HEPATOLOGY, V50, P1370, DOI 10.1002/hep.23169; Southern WN, 2011, J VIRAL HEPATITIS, V18, P474, DOI 10.1111/j.1365-2893.2010.01327.x; Stamataki Z, 2011, J INFECT DIS, V204, P811, DOI 10.1093/infdis/jir399; Stramer SL, 2011, NEW ENGL J MED, V364, P236, DOI 10.1056/NEJMoa1007644; Strickland GT, 2008, LANCET INFECT DIS, V8, P379, DOI 10.1016/S1473-3099(08)70126-9; Strickland GT, 2006, HEPATOLOGY, V43, P915, DOI 10.1002/hep.21173; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Talaat M, 2006, AM J INFECT CONTROL, V34, P193, DOI 10.1016/j.ajic.2005.05.028; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tovey MG, 2010, METHODS MOL BIOL, V626, P287, DOI 10.1007/978-1-60761-585-9_19; VIDOVIC D, 1988, NATURE, V336, P222, DOI 10.1038/336222a0; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walker CM, 2010, ADV VIRUS RES, V78, P43, DOI 10.1016/S0065-3527(10)78002-7; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; Wolfl M, 2008, J IMMUNOL, V181, P6435, DOI 10.4049/jimmunol.181.9.6435; Yee LJ, 2004, GENES IMMUN, V5, P237, DOI 10.1038/sj.gene.6364090; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Youn JW, 2008, J VIROL, V82, P10896, DOI 10.1128/JVI.01179-08; Youn JW, 2005, HEPATOLOGY, V42, P1429, DOI 10.1002/hep.20934; Zhang P, 2009, P NATL ACAD SCI USA, V106, P7537, DOI 10.1073/pnas.0902749106; Zou SM, 2004, NEW ENGL J MED, V351, P751, DOI 10.1056/NEJMoa032510	121	122	131	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					869	878		10.1038/nm.3183	http://dx.doi.org/10.1038/nm.3183			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836237	Bronze, Green Accepted			2022-12-27	WOS:000321557700030
J	Cao, X; Li, LP; Wang, Q; Wu, Q; Hu, HH; Zhang, M; Fang, YY; Zhang, J; Li, SJ; Xiong, WC; Yan, HC; Gao, YB; Liu, JH; Li, XW; Sun, LR; Zeng, YN; Zhu, XH; Gao, TM				Cao, Xiong; Li, Liang-Ping; Wang, Qian; Wu, Qiong; Hu, Hong-Hai; Zhang, Meng; Fang, Ying-Ying; Zhang, Jie; Li, Shu-Ji; Xiong, Wen-Chao; Yan, Hua-Cheng; Gao, Yu-Bo; Liu, Ji-Hong; Li, Xiao-Wen; Sun, Li-Rong; Zeng, Yuan-Ning; Zhu, Xin-Hong; Gao, Tian-Ming			Astrocyte-derived ATP modulates depressive-like behaviors	NATURE MEDICINE			English	Article							PREFRONTAL CORTEX; SOCIAL DEFEAT; RECEPTORS; RELEASE; NEUROGENESIS; EXPRESSION; STRESS; MODEL	Major depressive disorder (MDD) is a cause of disability that affects approximately 16% of the world's population(1); however, little is known regarding the underlying biology of this disorder. Animal studies, postmortem brain analyses and imaging studies of patients with depression have implicated glial dysfunction in MDD pathophysiology(2-7). However, the molecular mechanisms through which astrocytes modulate depressive behaviors are largely uncharacterized. Here, we identified ATP as a key factor involved in astrocytic modulation of depressive-like behavior in adult mice. We observed low ATP abundance in the brains of mice that were susceptible to chronic social defeat. Furthermore, we found that the administration of ATP induced a rapid antidepressant-like effect in these mice. Both a lack of inositol 1,4,5-trisphosphate receptor type 2 and transgenic blockage of vesicular gliotransmission induced deficiencies in astrocytic ATP release, causing depressive-like behaviors that could be rescued via the administration of ATP. Using transgenic mice that express a G(q) G protein-coupled receptor only in astrocytes to enable selective activation of astrocytic Ca2+ signaling, we found that stimulating endogenous ATP release from astrocytes induced antidepressant-like effects in mouse models of depression. Moreover, we found that P2X2 receptors in the medial prefrontal cortex mediated the antidepressant-like effects of ATP. These results highlight astrocytic ATP release as a biological mechanism of MDD.	[Cao, Xiong; Li, Liang-Ping; Wang, Qian; Wu, Qiong; Hu, Hong-Hai; Zhang, Meng; Fang, Ying-Ying; Zhang, Jie; Li, Shu-Ji; Xiong, Wen-Chao; Yan, Hua-Cheng; Gao, Yu-Bo; Liu, Ji-Hong; Li, Xiao-Wen; Sun, Li-Rong; Zeng, Yuan-Ning; Zhu, Xin-Hong; Gao, Tian-Ming] Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Guangzhou, Guangdong, Peoples R China; [Cao, Xiong; Li, Liang-Ping; Wang, Qian; Wu, Qiong; Hu, Hong-Hai; Zhang, Meng; Fang, Ying-Ying; Zhang, Jie; Li, Shu-Ji; Xiong, Wen-Chao; Yan, Hua-Cheng; Gao, Yu-Bo; Liu, Ji-Hong; Li, Xiao-Wen; Sun, Li-Rong; Zeng, Yuan-Ning; Zhu, Xin-Hong; Gao, Tian-Ming] Southern Med Univ, Key Lab Neuroplast Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China; [Cao, Xiong; Zhu, Xin-Hong] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhu, XH (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Neurobiol, Guangzhou, Guangdong, Peoples R China.	zhuxh@smu.edu.cn; tgao@smu.edu.cn	Gao, Yu/HGE-1937-2022; Zhu, Xinhong/GOG-9417-2022	Xiong, Wen-Cheng/0000-0001-9071-7598; Li, Liangping/0000-0002-9406-4034; Cao, Xiong/0000-0002-1889-4255	National Natural Science Foundation of China [81171276, 8103002, U1201225]; Key Project of Guangdong Province [9351051501000003, CXZB1018]; Guangzhou Science and Technology Project [7411802013939]; Major State Basic Research Program of China [2012CB518203]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1142]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Guangdong Province; Guangzhou Science and Technology Project; Major State Basic Research Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme	We thank J. Chen (University of California, San Diego) for providing Itpr2<SUP>+/-</SUP> mice and P. G. Haydon (Tufts University School of Medicine, Boston) for providing GFAP-tTA and tetO. SNARE mouse lines. We thank L. Mei for his insightful suggestions. This work was partly supported by the National Natural Science Foundation of China (grants 81171276, 8103002 and U1201225), the Key Project of Guangdong Province (grants 9351051501000003 and CXZB1018), the Guangzhou Science and Technology Project (grant 7411802013939), the Major State Basic Research Program of China (grant 2012CB518203), the Program for Changjiang Scholars and Innovative Research Team in University (grant IRT1142) and the Project supported by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2011).	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Alonso R, 2004, MOL PSYCHIATR, V9, P278, DOI 10.1038/sj.mp.4001464; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Gever JR, 2010, BRIT J PHARMACOL, V160, P1387, DOI 10.1111/j.1476-5381.2010.00796.x; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hertle DN, 2007, NEUROSCIENCE, V150, P625, DOI 10.1016/j.neuroscience.2007.09.058; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Klempan TA, 2009, MOL PSYCHIATR, V14, P175, DOI 10.1038/sj.mp.4002110; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Marpegan L, 2011, J NEUROSCI, V31, P8342, DOI 10.1523/JNEUROSCI.6537-10.2011; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sharp AH, 1999, J COMP NEUROL, V406, P207; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Xiong KM, 1999, J NEUROPHYSIOL, V81, P2088, DOI 10.1152/jn.1999.81.5.2088; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zou CJ, 1998, NEUROREPORT, V9, P997, DOI 10.1097/00001756-199804200-00008	35	310	343	11	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					773	+		10.1038/nm.3162	http://dx.doi.org/10.1038/nm.3162			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23644515				2022-12-27	WOS:000319981600028
J	Golden, SA; Christoffel, DJ; Heshmati, M; Hodes, GE; Magida, J; Davis, K; Cahill, ME; Dias, C; Ribeiro, E; Ables, JL; Kennedy, PJ; Robison, AJ; Gonzalez-Maeso, J; Neve, RL; Turecki, G; Ghose, S; Tamminga, CA; Russo, SJ				Golden, Sam A.; Christoffel, Daniel J.; Heshmati, Mitra; Hodes, Georgia E.; Magida, Jane; Davis, Keithara; Cahill, Michael E.; Dias, Caroline; Ribeiro, Efrain; Ables, Jessica L.; Kennedy, Pamela J.; Robison, Alfred J.; Gonzalez-Maeso, Javier; Neve, Rachael L.; Turecki, Gustavo; Ghose, Subroto; Tamminga, Carol A.; Russo, Scott J.			Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression	NATURE MEDICINE			English	Article							SOCIAL DEFEAT STRESS; NUCLEUS-ACCUMBENS; SPINE PLASTICITY; DENDRITIC SPINES; RHO; GTPASE; KINASE; MODULATION; CHROMATIN; GLUTAMATE	Depression induces structural and functional synaptic plasticity in brain reward circuits, although the mechanisms promoting these changes and their relevance to behavioral outcomes are unknown. Transcriptional profiling of the nucleus accumbens (NAc) for Rho GTPase related genes, which are known regulators of synaptic structure, revealed a sustained reduction in RAS-related C3 botulinum toxin substrate 1 (Rac1) expression after chronic social defeat stress. This was associated with a repressive chromatin state surrounding the proximal promoter of Rac1. Inhibition of class 1 histone deacetylases (HDACs) with MS-275 rescued both the decrease in Rac1 transcription after social defeat stress and depression-related behavior, such as social avoidance. We found a similar repressive chromatin state surrounding the RAC1 promoter in the NAc of subjects with depression, which corresponded with reduced RAC1 transcription. Viral-mediated reduction of Rac1 expression or inhibition of Rac1 activity in the NAc increases social defeat induced social avoidance and anhedonia in mice. Chronic social defeat stress induces the formation of stubby excitatory spines through a Rac1-dependent mechanism involving the redistribution of synaptic cofilin, an actin-severing protein downstream of Rac1. Overexpression of constitutively active Rac1 in the NAc of mice after chronic social defeat stress reverses depression-related behaviors and prunes stubby spines. Taken together, our data identify epigenetic regulation of RAC1 in the NAc as a disease mechanism in depression and reveal a functional role for Rac1 in rodents in regulating stress-related behaviors.	[Golden, Sam A.; Christoffel, Daniel J.; Heshmati, Mitra; Hodes, Georgia E.; Magida, Jane; Davis, Keithara; Cahill, Michael E.; Dias, Caroline; Ribeiro, Efrain; Kennedy, Pamela J.; Robison, Alfred J.; Gonzalez-Maeso, Javier; Russo, Scott J.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Fishberg Dept Neurosci, New York, NY USA; [Golden, Sam A.; Christoffel, Daniel J.; Heshmati, Mitra; Hodes, Georgia E.; Magida, Jane; Davis, Keithara; Cahill, Michael E.; Dias, Caroline; Ribeiro, Efrain; Kennedy, Pamela J.; Robison, Alfred J.; Gonzalez-Maeso, Javier; Russo, Scott J.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Friedman Brain Inst, New York, NY USA; [Ables, Jessica L.] Rockefeller Univ, Mol Biol Lab, New York, NY 10021 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, McGovern Inst, Cambridge, MA 02139 USA; [Turecki, Gustavo] Douglas Mental Hlth Univ Inst, Depress Disorders Program, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Montreal, PQ, Canada; [Ghose, Subroto; Tamminga, Carol A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Massachusetts Institute of Technology (MIT); McGill University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Russo, SJ (corresponding author), Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, Fishberg Dept Neurosci, New York, NY USA.	scott.russo@mssm.edu	Hodes, Georgia/L-8022-2016; Ghose, Subroto/J-6732-2016; Turecki, Gustavo/K-5100-2015; Russo, Scott/R-7107-2019; Robison, Alfred J/P-8521-2018	Hodes, Georgia/0000-0002-1551-2178; Russo, Scott/0000-0002-6470-1805; Robison, Alfred J/0000-0002-4150-9570; Christoffel, Dan/0000-0002-6303-5134; Cahill, Michael/0000-0003-0574-2655; Ables, Jessica L./0000-0003-1818-3506; Turecki, Gustavo/0000-0003-4075-2736; Golden, Sam/0000-0002-2104-2272	US National Institute of Mental Health [R01 MH090264, P50 MH66172, P50MH096890]; Johnson and Johnson International Mental Health Research Organization Rising Star Award; US National Institutes of Health [T32 GM062754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090264, T32MH087004, P50MH096890, R01MH084894, P50MH066172] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson and Johnson International Mental Health Research Organization Rising Star Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Y. Zeng (University of Cincinnati) for providing Rac1<SUP>flox/flox</SUP> mice. This research was supported by US National Institute of Mental Health grant R01 MH090264, the Johnson and Johnson International Mental Health Research Organization Rising Star Award (S.J.R.), US National Institute of Mental Health grants P50 MH66172 and P50MH096890 (C.A.T.) and US National Institutes of Health grant T32 GM062754 (K.D.).	Andrus BM, 2012, MOL PSYCHIATR, V17, P49, DOI 10.1038/mp.2010.119; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bongmba OYN, 2011, BRAIN RES, V1399, P79, DOI 10.1016/j.brainres.2011.05.020; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Chen L, 2009, DEV BIOL, V325, P162, DOI 10.1016/j.ydbio.2008.10.023; Chen LY, 2010, J NEUROSCI, V30, P10977, DOI 10.1523/JNEUROSCI.1077-10.2010; Christoffel DJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2615, DOI 10.1038/npp.2012.121; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Dubos A, 2012, J NEUROSCI, V32, P519, DOI 10.1523/JNEUROSCI.3252-11.2012; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Fang J, 2012, SOC NEUR ABSTR, V458, p12/T7; Golden SA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011957; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kiraly DD, 2010, ACS CHEM NEUROSCI, V1, P348, DOI 10.1021/cn100012x; Koh CG, 2006, NEUROSIGNALS, V15, P228, DOI 10.1159/000101527; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; Martinez LA, 2011, NEUROPHARMACOLOGY, V61, P305, DOI 10.1016/j.neuropharm.2011.04.017; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Palucha A, 2005, DRUG NEWS PERSPECT, V18, P262, DOI 10.1358/dnp.2005.18.4.908661; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; SMITH RS, 1991, MED HYPOTHESES, V35, P298, DOI 10.1016/0306-9877(91)90272-Z; Stolzenburg S, 2010, METHODS MOL BIOL, V649, P117, DOI 10.1007/978-1-60761-753-2_7; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; TISSOT R, 1975, Neuropsychobiology, V1, P243, DOI 10.1159/000117498; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Vidal R, 2011, CURR PHARM DESIGN, V17, P521, DOI 10.2174/138161211795164086; Wei Q, 2012, BIOL PSYCHIAT, V71, P224, DOI 10.1016/j.biopsych.2011.07.009; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013	50	204	212	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					337	344		10.1038/nm.3090	http://dx.doi.org/10.1038/nm.3090			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23416703	Green Accepted			2022-12-27	WOS:000316040700027
J	Lentz, JJ; Jodelka, FM; Hinrich, AJ; McCaffrey, KE; Farris, HE; Spalitta, MJ; Bazan, NG; Duelli, DM; Rigo, F; Hastings, ML				Lentz, Jennifer J.; Jodelka, Francine M.; Hinrich, Anthony J.; McCaffrey, Kate E.; Farris, Hamilton E.; Spalitta, Matthew J.; Bazan, Nicolas G.; Duelli, Dominik M.; Rigo, Frank; Hastings, Michelle L.			Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness	NATURE MEDICINE			English	Article							USHER-SYNDROME; HAIR-BUNDLE; GENE-THERAPY; USH1C; CELL; MECHANISMS; FREQUENCY; HARMONIN; MUTATIONS; COHESION	Hearing impairment is the most common sensory disorder, with congenital hearing impairment present in approximately 1 in 1,000 newborns(1). Hereditary deafness is often mediated by the improper development or degeneration of cochlear hair cells(2). Until now, it was not known whether such congenital failures could be mitigated by therapeutic intervention(3-5). Here we show that hearing and vestibular function can be rescued in a mouse model of human hereditary deafness. An antisense oligonucleotide (ASO) was used to correct defective pre-mRNA splicing of transcripts from the USH1C gene with the c.216G>A mutation, which causes human Usher syndrome, the leading genetic cause of combined deafness and blindness(6,7). Treatment of neonatal mice with a single systemic dose of ASO partially corrects Ush1c c.216G>A splicing, increases protein expression, improves stereocilia organization in the cochlea, and rescues cochlear hair cells, vestibular function and low-frequency hearing in mice. These effects were sustained for several months, providing evidence that congenital deafness can be effectively overcome by treatment early in development to correct gene expression and demonstrating the therapeutic potential of ASOs in the treatment of deafness.	[Lentz, Jennifer J.; Farris, Hamilton E.; Spalitta, Matthew J.; Bazan, Nicolas G.] LSUHSC, Ctr Neurosci, New Orleans, LA USA; [Lentz, Jennifer J.; Farris, Hamilton E.; Spalitta, Matthew J.] LSUHSC, Dept Otorhinolaryngol & Biocommun, New Orleans, LA USA; [Jodelka, Francine M.; Hinrich, Anthony J.; McCaffrey, Kate E.; Hastings, Michelle L.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL USA; [Bazan, Nicolas G.] LSUHSC, Dept Ophthalmol, New Orleans, LA USA; [Duelli, Dominik M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cellular & Mol Pharmacol, N Chicago, IL USA; [Rigo, Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Chicago Medical School; Rosalind Franklin University Medical & Science; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Chicago Medical School; Rosalind Franklin University Medical & Science; Isis Pharmaceuticals Inc	Hastings, ML (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL USA.	jlentz@lsuhsc.edu; michelle.hastings@rosalindfranklin.edu	Bazan, Nicolas/AAN-4121-2020; Hastings, MICHELLE L./AAK-6627-2021	Bazan, Nicolas/0000-0002-9243-5444; Jodelka, Francine/0000-0001-9374-8437; Hastings, Michelle L./0000-0002-4253-9261	Hearing Health Foundation; Midwest Eye-Banks; National Organization for Hearing Research Foundation; Capita Foundation; US National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012596] Funding Source: NIH RePORTER	Hearing Health Foundation; Midwest Eye-Banks; National Organization for Hearing Research Foundation; Capita Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We gratefully acknowledge support from the Hearing Health Foundation, Midwest Eye-Banks, the National Organization for Hearing Research Foundation, Capita Foundation and the US National Institutes of Health. We thank D. Cunningham and E. Rubel for assistance with scanning electron microscopy analysis; A. Rosenkranz, R. Marr and M. Oblinger for use of equipment; J. Huang for assistance with open-field analysis, L. Ochoa for assistance with ABR analysis computer support, G. MacDonald for assistance with confocal imaging and deconvolution analysis, U. Wolfrum (Johannes Gutenberg University of Mainz) for harmonin b-specific antibodies, H. Thompson for statistical analysis, and A. Case, B. Keats and M. Havens for discussions and comments on the manuscript.	Bermingham-McDonogh O, 2011, NEURON, V71, P389, DOI 10.1016/j.neuron.2011.07.015; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; de Felipe MMC, 2011, HISTOL HISTOPATHOL, V26, P923, DOI 10.14670/HH-26.923; Di Domenico M, 2011, J CELL PHYSIOL, V226, P2494, DOI 10.1002/jcp.22617; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Ebermann I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r47; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Hall J, 2000, TLS-TIMES LIT SUPPL, P20; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lentz J, 2005, HUM GENET, V116, P225, DOI 10.1007/s00439-004-1217-4; Lentz J, 2007, MUTAT RES-FUND MOL M, V616, P139, DOI 10.1016/j.mrfmmm.2006.11.006; Lentz JJ, 2010, DEV NEUROBIOL, V70, P253, DOI 10.1002/dneu.20771; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Ouyang XM, 2003, CLIN GENET, V63, P150, DOI 10.1046/j.0009-9163.2002.00004.x; Peng AW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1533; Petit C, 2009, NAT NEUROSCI, V12, P703, DOI 10.1038/nn.2330; Uhlmann RA, 2010, CURR OPIN OBSTET GYN, V22, P155, DOI 10.1097/GCO.0b013e32833723b5; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362	28	140	149	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					345	350		10.1038/nm.3106	http://dx.doi.org/10.1038/nm.3106			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23380860	Green Accepted			2022-12-27	WOS:000316040700028
J	Hong, GS; Lee, JC; Robinson, JT; Raaz, U; Xie, LM; Huang, NF; Cooke, JP; Dai, HJ				Hong, Guosong; Lee, Jerry C.; Robinson, Joshua T.; Raaz, Uwe; Xie, Liming; Huang, Ngan F.; Cooke, John P.; Dai, Hongjie			Multifunctional in vivo vascular imaging using near-infrared II fluorescence	NATURE MEDICINE			English	Article							WALLED CARBON NANOTUBES; QUANTUM DOTS; CELLS; MICE; THICKNESS; TUMORS; MEDIA; CT	In vivo real-time epifluorescence imaging of mouse hind limb vasculatures in the second near-infrared region (NIR-II) is performed using single-walled carbon nanotubes as fluorophores. Both high spatial (similar to 30 mu m) and temporal (<200 ms per frame) resolution for small-vessel imaging are achieved at 1-3 mm deep in the hind limb owing to the beneficial NIR-II optical window that affords deep anatomical penetration and low scattering. This spatial resolution is unattainable by traditional NIR imaging (NIR-I) or microscopic computed tomography, and the temporal resolution far exceeds scanning microscopic imaging techniques. Arterial and venous vessels are unambiguously differentiated using a dynamic contrast-enhanced NIR-II imaging technique on the basis of their distinct hemodynamics. Further, the deep tissue penetration and high spatial and temporal resolution of NIR-II imaging allow for precise quantifications of blood velocity in both normal and ischemic femoral arteries, which are beyond the capabilities of ultrasonography at lower blood velocities.	[Hong, Guosong; Robinson, Joshua T.; Xie, Liming; Dai, Hongjie] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Lee, Jerry C.; Raaz, Uwe; Huang, Ngan F.; Cooke, John P.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Dai, HJ (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	ngantina@stanford.edu; jcooke@stanford.edu; hdai@stanford.edu	Xie, Liming/AAL-9554-2020; Hong, Guosong/A-7551-2013; Dai, Hongjie/ABC-4574-2021; Xie, Liming/C-4639-2011	Hong, Guosong/0000-0002-8858-4471; Xie, Liming/0000-0001-8190-8325; Huang, Ngan/0000-0003-2298-6790; Lee, Jerry/0000-0002-0354-5247; Cooke, John/0000-0003-0033-9138	National Cancer Institute of the US National Institutes of Health [5R01CA135109-02]; National Heart, Lung and Blood Institute of the US National Institutes of Health [U01HL100397, RC2HL103400, K99HL098688]; Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE [R01CA135109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL103400, U01HL100397, K99HL098688, R00HL098688] Funding Source: NIH RePORTER	National Cancer Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanford Graduate Fellowship(Stanford University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from the National Cancer Institute of the US National Institutes of Health to H.D. (5R01CA135109-02), the National Heart, Lung and Blood Institute of the US National Institutes of Health to J.P.C. (U01HL100397, RC2HL103400) and N.F.H. (K99HL098688) and a Stanford Graduate Fellowship to G.H.	Adams JY, 2002, NAT MED, V8, P891, DOI 10.1038/nm743; Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707; BURSTEIN P, 1984, NUCL INSTRUM METH A, V221, P207, DOI 10.1016/0167-5087(84)90201-1; Du YP, 2010, J AM CHEM SOC, V132, P1470, DOI 10.1021/ja909490r; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; GORDON R, 1974, INT REV CYTOL, V38, P111, DOI 10.1016/S0074-7696(08)60925-0; Greco A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/519238; Hillman EMC, 2007, NAT PHOTONICS, V1, P526, DOI 10.1038/nphoton.2007.146; Hong GS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1698; Hong GS, 2011, ANGEW CHEM INT EDIT, V50, P4644, DOI 10.1002/anie.201100934; Huang NF, 2010, ARTERIOSCL THROM VAS, V30, P984, DOI 10.1161/ATVBAHA.110.202796; InternationalAA Commission onAA Non-Ionizing RadiationAA Protection, 2000, HEALTH PHYS, V79, P431; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Lim Yong Taik, 2003, Mol Imaging, V2, P50, DOI 10.1162/153535003765276282; Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105; Liu Z, 2007, NAT NANOTECHNOL, V2, P47, DOI 10.1038/nnano.2006.170; Liu Z, 2011, MATER TODAY, V14, P316, DOI 10.1016/S1369-7021(11)70161-4; Liu Z, 2009, NAT PROTOC, V4, P1372, DOI 10.1038/nprot.2009.146; Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8; Niiyama Hiroshi, 2009, J Vis Exp, DOI 10.3791/1035; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pizzoferrato R, 2000, J LUMIN, V87-9, P748, DOI 10.1016/S0022-2313(99)00384-1; Ritman EL, 2011, ANNU REV BIOMED ENG, V13, P531, DOI 10.1146/annurev-bioeng-071910-124717; Robinson JT, 2010, NANO RES, V3, P779, DOI 10.1007/s12274-010-0045-1; Rufaihah AJ, 2011, ARTERIOSCL THROM VAS, V31, pE72, DOI 10.1161/ATVBAHA.111.230938; Saba L, 2010, NEURORADIOLOGY, V52, P75, DOI 10.1007/s00234-009-0589-5; Schipper ML, 2008, NAT NANOTECHNOL, V3, P216, DOI 10.1038/nnano.2008.68; Singh J, 2008, J NUCL MED TECHNOL, V36, P69, DOI 10.2967/jnmt.107.047621; Smith AM, 2009, NAT NANOTECHNOL, V4, P710, DOI 10.1038/nnano.2009.326; Tabakman SM, 2010, J PHYS CHEM C, V114, P19569, DOI 10.1021/jp106453v; Terentyuk GS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3122371; Toussaint JF, 1996, CIRCULATION, V94, P932, DOI 10.1161/01.CIR.94.5.932; Wang CH, 2011, J VASC SURG, V53, P1350, DOI 10.1016/j.jvs.2010.10.128; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Welsher K, 2011, P NATL ACAD SCI USA, V108, P8943, DOI 10.1073/pnas.1014501108; Welsher K, 2009, NAT NANOTECHNOL, V4, P773, DOI [10.1038/nnano.2009.294, 10.1038/NNANO.2009.294]; Willekens I, 2010, CONTRAST MEDIA MOL I, V5, P201, DOI 10.1002/cmmi.394; Zaheer A, 2001, NAT BIOTECHNOL, V19, P1148, DOI 10.1038/nbt1201-1148; Zhang Y, 2012, ACS NANO, V6, P3695, DOI 10.1021/nn301218z; Zhao LL, 2010, ENERG FUEL, V24, P5844, DOI 10.1021/ef100846r	40	667	675	37	689	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1841	+		10.1038/nm.2995	http://dx.doi.org/10.1038/nm.2995			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23160236	Green Accepted, Green Submitted			2022-12-27	WOS:000311999800033
J	Minamiyama, M; Katsuno, M; Adachi, H; Doi, H; Kondo, N; Iida, M; Ishigaki, S; Fujioka, Y; Matsumoto, S; Miyazaki, Y; Tanaka, F; Kurihara, H; Sobue, G				Minamiyama, Makoto; Katsuno, Masahisa; Adachi, Hiroaki; Doi, Hideki; Kondo, Naohide; Iida, Madoka; Ishigaki, Shinsuke; Fujioka, Yusuke; Matsumoto, Shinjiro; Miyazaki, Yu; Tanaka, Fumiaki; Kurihara, Hiroki; Sobue, Gen			Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract	NATURE MEDICINE			English	Article							BULBAR MUSCULAR-ATROPHY; GENE-RELATED PEPTIDE; TRANSGENIC MOUSE MODEL; HISTONE DEACETYLASE INHIBITORS; MUTANT ANDROGEN RECEPTOR; HUNTINGTONS-DISEASE; DEPENDENT NEURODEGENERATION; PHENOTYPIC-EXPRESSION; AXONAL-TRANSPORT; PROTEIN-KINASE	Spinal and bulbar muscular atrophy (SBMA) is a motor neuron disease caused by the expansion of the CAG triplet repeat within the androgen receptor (AR) gene. Here, we demonstrated that pathogenic AR upregulates the gene encoding calcitonin gene-related peptide alpha (CGRP1). In neuronal cells, overexpression of CGRP1 induced cellular damage via the activation of the c-Jun N-terminal kinase (JNK) pathway, whereas pharmacological suppression of CGRP1 or JNK attenuated the neurotoxic effects of pathogenic AR. The depletion of CGRP1 inactivated JNK and suppressed neurodegeneration in a mouse model of SBMA. Naratriptan, a serotonin 1B/1D (5-hydroxytryptamine 1B/1D, or 5-HT1B/1D) receptor agonist, decreased CGRP1 expression via the induction of dual-specificity protein phosphatase 1 (DUSP1), attenuated JNK activity and mitigated pathogenic AR-mediated neuronal damage in cellular and mouse SBMA models. These observations suggest that pharmacological activation of the 5-HT1B/1D receptor may be used therapeutically to treat SBMA and other polyglutamine-related neurodegenerative diseases.	[Minamiyama, Makoto; Katsuno, Masahisa; Adachi, Hiroaki; Doi, Hideki; Kondo, Naohide; Iida, Madoka; Ishigaki, Shinsuke; Fujioka, Yusuke; Matsumoto, Shinjiro; Miyazaki, Yu; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Tokyo, Japan	Nagoya University; University of Tokyo	Katsuno, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan.	ka2no@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp	Adachi, Hiroaki/I-2669-2012; iida, madoka/AAB-7707-2020; ISHIGAKI, Shinsuke/I-7305-2014; KATSUNO, MASAHISA/I-7502-2014; Adachi, Hiroaki/AAM-7812-2020	Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311; Adachi, Hiroaki/0000-0002-9302-4663; Kurihara, Hiroki/0000-0002-6476-5593; Ishigaki, Shinsuke/0000-0002-9555-0659	Center-of-Excellence, Ministry of Education, Culture, Sports, Science and Technology, Japan [22110005, 21229011, 21689024, 23390230]; Ministry of Health, Labor and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST); Kennedy Disease Association; Grants-in-Aid for Scientific Research [23659107, 23013007, 23390230] Funding Source: KAKEN	Center-of-Excellence, Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Kennedy Disease Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Center-of-Excellence grant, a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology" (No. 22110005) and Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Nos. 21229011, 21689024 and 23390230); grants from the Ministry of Health, Labor and Welfare, Japan; Core Research for Evolutional Science and Technology (CREST) from Japan Science and Technology Agency (JST); and a grant from the Kennedy Disease Association.	Adachi H, 2005, BRAIN, V128, P659, DOI 10.1093/brain/awh381; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Becanovic K, 2010, HUM MOL GENET, V19, P1438, DOI 10.1093/hmg/ddq018; Benemei S, 2007, NEUROL SCI, V28, pS89, DOI 10.1007/s10072-007-0757-5; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Di Angelantonio S, 2003, BRIT J PHARMACOL, V139, P1061, DOI 10.1038/sj.bjp.0705337; Disa J, 2000, NEUROPEPTIDES, V34, P229, DOI 10.1054/npep.2000.0810; Durham PL, 1998, MOL ENDOCRINOL, V12, P1002, DOI 10.1210/me.12.7.1002; Durham PL, 2002, PHARMACOL THERAPEUT, V94, P77, DOI 10.1016/S0163-7258(02)00173-0; EDVINSSON L, 1994, CEPHALALGIA, V14, P320, DOI 10.1046/j.1468-2982.1994.1405320.x; Fernandez-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5; Finsterer J, 2010, J NEUROL SCI, V298, P1, DOI 10.1016/j.jns.2010.08.025; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Jhee SS, 2001, CLIN PHARMACOKINET, V40, P189, DOI 10.2165/00003088-200140030-00004; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; Katsuno M, 2006, EXP NEUROL, V200, P8, DOI 10.1016/j.expneurol.2006.01.021; Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Ma W, 2003, NEUROSCIENCE, V120, P677, DOI 10.1016/S0306-4522(03)00159-3; Mehan S, 2011, J MOL NEUROSCI, V43, P376, DOI 10.1007/s12031-010-9454-6; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Mo KG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012922; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Nedelsky NB, 2010, NEURON, V67, P936, DOI 10.1016/j.neuron.2010.08.034; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Obrietan K, 2004, J NEUROSCI, V24, P791, DOI 10.1523/JNEUROSCI.3493-03.2004; Oh-hashi Y, 2001, CIRC RES, V89, P983, DOI 10.1161/hh2301.100812; Perrin V, 2009, EXP NEUROL, V215, P191, DOI 10.1016/j.expneurol.2008.10.008; POPPER P, 1989, NEUROENDOCRINOLOGY, V50, P338, DOI 10.1159/000125243; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Ringer C, 2012, NEUROBIOL DIS, V45, P547, DOI 10.1016/j.nbd.2011.09.011; Ringer C, 2009, NEUROBIOL DIS, V35, P286, DOI 10.1016/j.nbd.2009.05.011; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Takeyama K, 2002, NEURON, V35, P855, DOI 10.1016/S0896-6273(02)00875-9; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009; Zheng LF, 2008, BRAIN RES, V1187, P20, DOI 10.1016/j.brainres.2007.10.044	52	28	29	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1531	U131		10.1038/nm.2932	http://dx.doi.org/10.1038/nm.2932			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23023499				2022-12-27	WOS:000309587500032
J	Talukdar, S; Oh, DY; Bandyopadhyay, G; Li, DM; Xu, JF; McNelis, J; Lu, M; Li, PP; Yan, QY; Zhu, YM; Ofrecio, J; Lin, M; Brenner, MB; Olefsky, JM				Talukdar, Saswata; Oh, Da Young; Bandyopadhyay, Gautam; Li, Dongmei; Xu, Jianfeng; McNelis, Joanne; Lu, Min; Li, Pingping; Yan, Qingyun; Zhu, Yimin; Ofrecio, Jachelle; Lin, Michael; Brenner, Martin B.; Olefsky, Jerrold M.			Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase	NATURE MEDICINE			English	Article							T-CELLS; TUMOR-GROWTH; OBESITY; INFLAMMATION; INTERLEUKIN-8; MACROPHAGES; ACTIVATION; MECHANISMS; IMMUNITY	Chronic low-grade adipose tissue and liver inflammation is a major cause of systemic insulin resistance and is a key component of the low degree of insulin sensitivity that exists in obesity and type 2 diabetes(1,2). Immune cells, such as macrophages, T cells, B cells, mast cells and eosinophils, have all been implicated as having a role in this process(3-8). Neutrophils are typically the first immune cells to respond to inflammation and can exacerbate the chronic inflammatory state by helping to recruit macrophages and by interacting with antigen-presenting cells(9-11). Neutrophils secrete several proteases, one of which is neutrophil elastase, which can promote inflammatory responses in several disease models(12). Here we show that treatment of hepatocytes with neutrophil elastase causes cellular insulin resistance and that deletion of neutrophil elastase in high-fat-diet-induced obese (DIO) mice leads to less tissue inflammation that is associated with lower adipose tissue neutrophil and macrophage content. These changes are accompanied by improved glucose tolerance and increased insulin sensitivity. Taken together, we show that neutrophils can be added to the extensive repertoire of immune cells that participate in inflammation-induced metabolic disease.	[Talukdar, Saswata; Oh, Da Young; Bandyopadhyay, Gautam; Xu, Jianfeng; McNelis, Joanne; Lu, Min; Li, Pingping; Ofrecio, Jachelle; Lin, Michael; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Dongmei; Yan, Qingyun; Zhu, Yimin; Brenner, Martin B.] Pfizer Cardiovasc Metab & Endocrine Dis CVMED Dia, Cambridge, MA USA	University of California System; University of California San Diego; Pfizer	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Li, Pingping/F-1109-2019	Li, Pingping/0000-0003-0679-270X; Talukdar, Saswata/0000-0003-3042-0025	US National Institutes of Health (NIH) [DK033651, DK074868, T32 DK 007494, DK 090962, DK063491]; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R37DK033651, P01DK074868, T32DK007494, P30DK063491, R24DK090962] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to J.M.O. from the US National Institutes of Health (NIH): DK033651, DK074868, T32 DK 007494, DK 090962 and DK063491. This work was also supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH through cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research. We wish to thank S. Shapiro (University of Pittsburgh) for helpful comments over the course of the project, C. Pham (Washington University, St. Louis) for providing cathepsin G and neutrophil elastase double knockout mice, S. Nalbandian at University of California San Diego for breeding and caring for the NEKO mice and P. Bansal (Pfizer), B. Ghosh (Pfizer) and J. Wellen (Pfizer) for the neutrophil elastase activity imaging studies.	Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Devaney JM, 2003, FEBS LETT, V544, P129, DOI 10.1016/S0014-5793(03)00482-4; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Houghton AM, 2010, CELL CYCLE, V9, P1732, DOI 10.4161/cc.9.9.11297; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Kalupov T, 2009, J BIOL CHEM, V284, P34084, DOI 10.1074/jbc.M109.042903; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mcdonold SJF, 2001, BIOORG MED CHEM LETT, V11, P895, DOI 10.1016/S0960-894X(01)00078-6; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	25	607	628	3	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1407	+		10.1038/nm.2885	http://dx.doi.org/10.1038/nm.2885			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22863787	Green Accepted			2022-12-27	WOS:000308472300037
J	Schmidt, EP; Yang, YM; Janssen, WJ; Gandjeva, A; Perez, MJ; Barthel, L; Zemans, RL; Bowman, JC; Koyanagi, DE; Yunt, ZX; Smith, LP; Cheng, SS; Overdier, KH; Thompson, KR; Geraci, MW; Douglas, IS; Pearse, DB; Tuder, RM				Schmidt, Eric P.; Yang, Yimu; Janssen, William J.; Gandjeva, Aneta; Perez, Mario J.; Barthel, Lea; Zemans, Rachel L.; Bowman, Joel C.; Koyanagi, Dan E.; Yunt, Zulma X.; Smith, Lynelle P.; Cheng, Sara S.; Overdier, Katherine H.; Thompson, Kathy R.; Geraci, Mark W.; Douglas, Ivor S.; Pearse, David B.; Tuder, Rubin M.			The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis	NATURE MEDICINE			English	Article							HEPARAN-SULFATE; PROTEIN-KINASE; UNFRACTIONATED HEPARIN; IN-VIVO; CELL; ACTIVATION; LEUKOCYTES; MOLECULES; ICAM-1; MODEL	Sepsis, a systemic inflammatory response to infection, commonly progresses to acute lung injury (ALI), an inflammatory lung disease with high morbidity. We postulated that sepsis-associated ALI is initiated by degradation of the pulmonary endothelial glycocalyx, leading to neutrophil adherence and inflammation. Using intravital microscopy, we found that endotoxemia in mice rapidly induced pulmonary microvascular glycocalyx degradation via tumor necrosis factor-alpha (TNF-alpha)-dependent mechanisms. Glycocalyx degradation involved the specific loss of heparan sulfate and coincided with activation of endothelial heparanase, a TNF-alpha-responsive, heparan sulfate-specific glucuronidase. Glycocalyx degradation increased the availability of endothelial surface adhesion molecules to circulating microspheres and contributed to neutrophil adhesion. Heparanase inhibition prevented endotoxemia-associated glycocalyx loss and neutrophil adhesion and, accordingly, attenuated sepsis-induced ALI and mortality in mice. These findings are potentially relevant to human disease, as sepsis-associated respiratory failure in humans was associated with higher plasma heparan sulfate degradation activity; moreover, heparanase content was higher in human lung biopsies showing diffuse alveolar damage than in normal human lung tissue.	[Schmidt, Eric P.; Yang, Yimu; Gandjeva, Aneta; Perez, Mario J.; Bowman, Joel C.; Koyanagi, Dan E.; Smith, Lynelle P.; Geraci, Mark W.; Douglas, Ivor S.; Tuder, Rubin M.] Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm Sci & Crit Care Med,Dept Med, Aurora, CO USA; [Schmidt, Eric P.; Overdier, Katherine H.; Thompson, Kathy R.; Douglas, Ivor S.] Denver Hlth Med Ctr, Denver, CO USA; [Janssen, William J.; Barthel, Lea; Zemans, Rachel L.; Yunt, Zulma X.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Cheng, Sara S.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO USA; [Pearse, David B.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University	Schmidt, EP (corresponding author), Univ Colorado, Sch Med, Program Translat Lung Res, Div Pulm Sci & Crit Care Med,Dept Med, Aurora, CO USA.	eric.schmidt@ucdenver.edu	Douglas, Ivor S/AAC-6245-2021	Douglas, Ivor S/0000-0002-4541-1431; Schmidt, Eric/0000-0002-7360-0504	US National Institutes of Health (NIH) /National Heart, Lung and Blood Institute (NHLBI) [P30 HL101295, K08 HL105538]; Chronic Obstructive Pulmonary Disease Specialized Centers of Clinically Oriented Research [P01-NHLBI 085609, R01 ES016285]; Flight Attendant Medical Research Institute; Colorado Clinical and Translational Sciences Institute [UL1 RR025780]; NATIONAL CANCER INSTITUTE [R01CA164780] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL103772, R01HL109517, P30HL101295, K08HL105538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016285] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) /National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Chronic Obstructive Pulmonary Disease Specialized Centers of Clinically Oriented Research; Flight Attendant Medical Research Institute; Colorado Clinical and Translational Sciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J.P. Li (Uppsula University) for providing Hpse<SUP>-/-</SUP> mice, C. Silliman (University of Colorado) for providing human donor plasma samples and R. Coffman (DNAX Research Institute) for donation of a Gr-1-specific monoclonal antibody (RB6-8C5) hybridoma. MLE-15 cells were kindly provided by J. Whitsett (Children's Hospital Cincinnati). pHTS nuclear factor-kappa B reporter vector and pRL-TK vector were kindly provided by S. Biswal (Johns Hopkins University). We additionally thank W. Kuebler and A. Tabuchi for instruction on mouse lung IVM techniques, K. Queensland for instruction regarding cecal ligation and puncture, P. Henson and G. Downey for manuscript review and the Tuder lab for support and discussions of experimental design. This work was supported by the US National Institutes of Health (NIH) /National Heart, Lung and Blood Institute (NHLBI) grants P30 HL101295 (to E.P.S. and R.M.T.); K08 HL105538 (to E.P.S.); Chronic Obstructive Pulmonary Disease Specialized Centers of Clinically Oriented Research P01-NHLBI 085609 (to R.M.T.); and R01 ES016285 (to R.M.T.). Additional funding was provided by the Flight Attendant Medical Research Institute (to R.M.T.) and the Colorado Clinical and Translational Sciences Institute UL1 RR025780 (to E.P.S.).	ADAMSON RH, 1990, J PHYSIOL-LONDON, V428, P1; Aggarwal NR, 2010, AM J PHYSIOL-LUNG C, V298, pL371, DOI 10.1152/ajplung.00308.2009; Alvira CM, 2007, AM J RESP CRIT CARE, V175, P805, DOI 10.1164/rccm.200608-1162OC; Bagher P, 2011, JOVE-J VIS EXP, DOI 10.3791/2874; Bashenko Y, 2007, SHOCK, V28, P207, DOI 10.1097/shk.0b013e3180311d84; Berger G, 2011, AM J PHYSIOL-LUNG C, V301, pL23, DOI 10.1152/ajplung.00010.2010; Chappell D, 2008, BIOL CHEM, V389, P79, DOI 10.1515/BC.2008.005; Chappell D, 2010, SHOCK, V34, P133, DOI 10.1097/SHK.0b013e3181cdc363; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Doerschuk CM, 1999, CHEST, V116, p37S, DOI 10.1378/chest.116.suppl_1.37S-a; EVANS TJ, 1994, J EXP MED, V180, P2173, DOI 10.1084/jem.180.6.2173; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Heinzelmann M, 2005, J IMMUNOL, V174, P2280, DOI 10.4049/jimmunol.174.4.2280; Henninger DD, 1997, J IMMUNOL, V158, P1825; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hostettler N, 2007, FASEB J, V21, P3562, DOI 10.1096/fj.07-8450com; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Iscimen R, 2008, CRIT CARE MED, V36, P1518, DOI 10.1097/CCM.0b013e31816fc2c0; Jacob M, 2009, TRANSPLANTATION, V87, P956, DOI 10.1097/TP.0b013e31819c83b5; Javaid K, 2003, CIRC RES, V92, P1089, DOI 10.1161/01.RES.0000072971.88704.CB; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Lever R, 2000, BRIT J PHARMACOL, V129, P533, DOI 10.1038/sj.bjp.0703099; Marechal X, 2008, SHOCK, V29, P572, DOI 10.1097/SHK.0b013e318157e926; Massena S, 2010, BLOOD, V116, P1924, DOI 10.1182/blood-2010-01-266072; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Pries A. R., 2006, V176, P1; Rao G, 2011, DIABETOLOGIA, V54, P1527, DOI 10.1007/s00125-011-2110-z; Raschke R, 2003, ANN INTERN MED, V138, P720, DOI 10.7326/0003-4819-138-9-200305060-00008; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Roebuck KA, 1999, J LEUKOCYTE BIOL, V66, P876, DOI 10.1002/jlb.66.6.876; Schmidt EP, 2008, AM J PHYSIOL-LUNG C, V295, pL1056, DOI 10.1152/ajplung.90329.2008; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; Stephens RS, 2010, AM J PHYSIOL-LUNG C, V299, pL323, DOI 10.1152/ajplung.00442.2009; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Stevens AP, 2007, AM J PHYSIOL-LUNG C, V293, pL328, DOI 10.1152/ajplung.00390.2006; Tabuchi A, 2008, J APPL PHYSIOL, V104, P338, DOI 10.1152/japplphysiol.00348.2007; Takahashi H, 2005, BRIT J PHARMACOL, V146, P333, DOI 10.1038/sj.bjp.0706344; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Vlodavsky I, 2007, THROMB RES, V120, pS112, DOI 10.1016/S0049-3848(07)70139-1; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Wang JH, 1997, SHOCK, V8, P357, DOI 10.1097/00024382-199711000-00007; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Wu XY, 2009, AM J PHYSIOL-RENAL, V297, pF316, DOI 10.1152/ajprenal.00089.2009; Yang YM, 2007, COMP BIOCHEM PHYS A, V147, P84, DOI 10.1016/j.cbpa.2006.11.019; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	59	461	489	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1217	+		10.1038/nm.2843	http://dx.doi.org/10.1038/nm.2843			25	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22820644	Green Accepted			2022-12-27	WOS:000307469300027
J	Ruan, YC; Guo, JH; Liu, XM; Zhang, RJ; Tsang, LL; Dong, JD; Chen, H; Yu, MK; Jiang, XH; Zhang, XH; Fok, KL; Chung, YW; Huang, HF; Zhou, WL; Chan, HC				Ruan, Ye Chun; Guo, Jing Hui; Liu, Xinmei; Zhang, Runju; Tsang, Lai Ling; Dong, Jian Da; Chen, Hui; Yu, Mei Kuen; Jiang, Xiaohua; Zhang, Xiao Hu; Fok, Kin Lam; Chung, Yiu Wa; Huang, Hefeng; Zhou, Wen Liang; Chan, Hsiao Chang			Activation of the epithelial Na+ channel triggers prostaglandin E-2 release and production required for embryo implantation	NATURE MEDICINE			English	Article							UTERINE LUMINAL EPITHELIUM; DECIDUAL CELL REACTION; SODIUM-CHANNEL; IN-VITRO; PHOSPHOLIPASE A(2); GUINEA-PIG; MOUSE; ENAC; MICE; RAT	Embryo implantation remains a poorly understood process. We demonstrate here that activation of the epithelial Na+ channel (ENaC) in mouse endometrial epithelial cells by an embryo-released serine protease, trypsin, triggers Ca2+ influx that leads to prostaglandin E-2 (PGE(2)) release, phosphorylation of the transcription factor CREB and upregulation of cyclooxygenase 2, the enzyme required for prostaglandin production and implantation(1-3). We detected maximum ENaC activation, as indicated by ENaC cleavage(4), at the time of implantation in mice. Blocking or knocking down uterine ENaC in mice resulted in implantation failure. Furthermore, we found that uterine ENaC expression before in vitro fertilization (IVF) treatment is markedly lower in women with implantation failure as compared to those with successful pregnancy. These results indicate a previously undefined role of ENaC in regulating the PGE(2) production and release required for embryo implantation, defects that may be a cause of miscarriage and low success rates in IVF.	[Ruan, Ye Chun; Guo, Jing Hui; Tsang, Lai Ling; Dong, Jian Da; Chen, Hui; Yu, Mei Kuen; Jiang, Xiaohua; Zhang, Xiao Hu; Fok, Kin Lam; Chung, Yiu Wa; Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Ruan, Ye Chun; Dong, Jian Da; Zhou, Wen Liang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Xinmei; Zhang, Runju; Huang, Hefeng] Zhejiang Univ, Minist Educ Peoples Republ China, Dept Reprod Endocrinol, Sch Med,Key Lab Reprod Genet,Womens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Xiaohua; Chan, Hsiao Chang] Ji Nan Univ Chinese Univ Hong Kong, Minist Educ Peoples Republ China, Key Lab Regenerat Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Hsiao Chang] Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Chengdu, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University; Zhejiang University; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, HC (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China.	huanghefg@hotmail.com; lsszwl@yahoo.com.cn; hsiaocchan@cuhk.edu.hk	Huang, Hefeng/AAR-7184-2021; jiang, cynthia xiaohua/F-7580-2017; Huang, He-Feng/AAN-7985-2020; Ruan, Ye Chun/T-7531-2019; Huang, Hefeng/ABF-1117-2020; Dong, Jianda/C-3338-2018; Chan, Hsiao Chang/E-1507-2016; Fok, Ellis/M-2784-2019; RUAN, Ye Chun/T-5919-2017; Fok, Kin Lam/G-2757-2017	jiang, cynthia xiaohua/0000-0002-7372-4961; Huang, He-Feng/0000-0003-4344-8019; Ruan, Ye Chun/0000-0002-4266-6789; Dong, Jianda/0000-0001-5583-0210; Fok, Ellis/0000-0003-3038-1337; RUAN, Ye Chun/0000-0002-4266-6789; Fok, Kin Lam/0000-0003-3038-1337; Zhang, Xiaohu/0000-0002-5329-1599	National 973 projects of China [2012CB944900, 2009CB522102, 2010CB945403]; Natural Science Foundation of China [30770817, 81161120006, 31071019]; Fundamental Research Funds for the Central Universities (Ji Nan University); Focused Investment Scheme; Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong; Morningside Foundation	National 973 projects of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (Ji Nan University); Focused Investment Scheme; Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong(Chinese University of Hong Kong); Morningside Foundation	This work was supported in part by National 973 projects of China (2012CB944900, 2009CB522102, 2010CB945403), Natural Science Foundation of China (No. 30770817; No. 81161120006; No. 31071019), the Fundamental Research Funds for the Central Universities (Ji Nan University), the Focused Investment Scheme and Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong, and the Morningside Foundation.	Almog B, 2010, FERTIL STERIL, V94, P2026, DOI 10.1016/j.fertnstert.2009.12.075; ANSELL JD, 1974, J EMBRYOL EXP MORPH, V31, P223; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Chan LN, 2002, J MEMBRANE BIOL, V185, P165, DOI 10.1007/s00232-001-0117-y; Chan LN, 2000, BBA-MOL CELL RES, V1497, P261, DOI 10.1016/S0167-4889(00)00057-4; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Enders A C, 1978, Ciba Found Symp, P3; FINN CA, 1966, J ENDOCRINOL, V36, P239, DOI 10.1677/joe.0.0360239; Fronius M, 2008, PFLUG ARCH EUR J PHY, V455, P775, DOI 10.1007/s00424-007-0332-1; HEDLUND K, 1972, J REPROD FERTIL, V29, P131; Kawabe A, 2004, LIFE SCI, V75, P21, DOI 10.1016/j.lfs.2003.11.022; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kennedy TG, 2007, REPRODUCTION, V134, P635, DOI 10.1530/REP-07-0328; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P595, DOI 10.1161/01.ATV.0000116219.09040.8c; LEJEUNE B, 1982, J REPROD FERTIL, V66, P519; LEJEUNE B, 1981, J REPROD FERTIL, V61, P235; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; MARTIN L, 1970, J REPROD FERTIL, V21, P461; Nashta AAF, 2004, J ENDOCRINOL, V181, P477, DOI 10.1677/joe.0.1810477; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Nie HG, 2009, J PHYSIOL-LONDON, V587, P2663, DOI 10.1113/jphysiol.2009.170324; OREHEK J, 1975, J PHARMACOL EXP THER, V194, P554; Pakrasi PL, 2008, PLACENTA, V29, P523, DOI 10.1016/j.placenta.2008.03.001; PARKENING TA, 1979, J GERONTOL, V34, P335, DOI 10.1093/geronj/34.3.335; Rastogi P, 2008, AM J PHYSIOL-LUNG C, V295, pL925, DOI 10.1152/ajplung.90230.2008; Ruan YC, 2008, J PHYSIOL-LONDON, V586, P4843, DOI 10.1113/jphysiol.2008.154096; Ruan YC, 2011, PHYSIOLOGY, V26, P156, DOI 10.1152/physiol.00036.2010; Sakoff JA, 1996, BIOCHEM MOL MED, V57, P81, DOI 10.1006/bmme.1996.0013; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Salamonsen Lois A, 2002, Rev Endocr Metab Disord, V3, P133, DOI 10.1023/A:1015407012559; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; SAWADA H, 1990, J EXP ZOOL, V254, P83, DOI 10.1002/jez.1402540112; STRAUSS O, 1994, J CELL PHYSIOL, V160, P89, DOI 10.1002/jcp.1041600111; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Toth B, 2011, J REPROD IMMUNOL, V90, P117, DOI 10.1016/j.jri.2011.05.002; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Yang JZ, 2004, CELL BIOL INT, V28, P433, DOI 10.1016/j.cellbi.2004.03.011; YEE GM, 1993, PROSTAG OTH LIPID M, V46, P117, DOI 10.1016/0090-6980(93)90038-9	43	116	124	2	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1112	+		10.1038/nm.2771	http://dx.doi.org/10.1038/nm.2771			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22729284				2022-12-27	WOS:000306121600041
J	Vitner, EB; Salomon, R; Farfel-Becker, T; Meshcheriakova, A; Ali, M; Klein, AD; Platt, FM; Cox, TM; Futerman, AH				Vitner, Einat B.; Salomon, Ran; Farfel-Becker, Tamar; Meshcheriakova, Anna; Ali, Mohammad; Klein, Andres D.; Platt, Frances M.; Cox, Timothy M.; Futerman, Anthony H.			RIPK3 as a potential therapeutic target for Gaucher's disease	NATURE MEDICINE			English	Article							DOMAIN KINASE RIP; CELL-DEATH; INDUCED INFLAMMATION; NEURONOPATHIC FORMS; MOUSE MODEL; NECROSIS; NECROPTOSIS; APOPTOSIS; RIPOPTOSOME; INHIBITION	Gaucher's disease (GD), an inherited metabolic disorder caused by mutations in the glucocerebrosidase gene (GBA), is the most common lysosomal storage disease(1). Heterozygous mutations in GBA are a major risk factor for Parkinson's disease(2). GD is divided into three clinical subtypes based on the absence (type 1) or presence (types 2 and 3) of neurological signs. Type 1 GD was the first lysosomal storage disease (LSD) for which enzyme therapy became available, and although infusions of recombinant glucocerebrosidase (GCase) ameliorate the systemic effects of GD, the lack of efficacy for the neurological manifestations, along with the considerable expense(3) and inconvenience of enzyme therapy for patients, renders the search for alternative or complementary therapies paramount. Glucosylceramide and glucosylsphingosine accumulation in the brain leads to massive neuronal loss in patients with neuronopathic GD (nGD)(4) and in nGD mouse models(5-7). However, the mode of neuronal death is not known. Here, we show that modulating the receptor-interacting protein kinase-3 (Ripk3) pathway markedly improves neurological and systemic disease in a mouse model of GD. Notably, Ripk3 deficiency substantially improved the clinical course of GD mice, with increased survival and motor coordination and salutary effects on cerebral as well as hepatic injury.	[Vitner, Einat B.; Salomon, Ran; Farfel-Becker, Tamar; Meshcheriakova, Anna; Ali, Mohammad; Klein, Andres D.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Cox, Timothy M.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Weizmann Institute of Science; University of Oxford; University of Cambridge	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Bleiberg Vitner, Einat/0000-0001-8578-8551; Futerman, Anthony/0000-0003-0013-0115; KLEIN, ANDRES/0000-0002-9951-2174; Platt, Frances/0000-0001-7614-0403	Children's Gaucher Research Fund; Joseph Meyerhoff family; Royal Society; Medical Research Council [MR/K025570/1, MR/K015338/1] Funding Source: researchfish; MRC [MR/K025570/1, MR/K015338/1] Funding Source: UKRI	Children's Gaucher Research Fund; Joseph Meyerhoff family; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank B. Cachon-Gonzalez (University of Cambridge) for providing twitcher mouse tissue, D. Wallach (Weizmann Institute of Science, Israel) for providing Tnf and Ripk3 knockout mice, R. Schiffmann (Baylor Research Institute) for postmortem human brain tissue, V. Kiss (Weizmann Institute of Science) for help with fluorescence microscopy and N. Platt (University of Oxford) for helpful comments. This work was supported by the Children's Gaucher Research Fund. A.H.F. is the incumbent of an endowed professorial chair supported by the Joseph Meyerhoff family. F.M.P. is a Royal Society Wolfson Research Merit Award holder.	Chavez-Valdez R, 2012, NEUROSCIENCE, V219, P192, DOI 10.1016/j.neuroscience.2012.05.002; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cox TM, 2013, AM J HEMATOL, V88, P163, DOI 10.1002/ajh.23399; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Eblan MJ, 2005, NEW ENGL J MED, V352, P728; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Farfel-Becker T, 2011, DIS MODEL MECH, V4, P746, DOI 10.1242/dmm.008185; Farfel-Becker T, 2011, HUM MOL GENET, V20, P1375, DOI 10.1093/hmg/ddr019; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Jagtap PG, 2007, J MED CHEM, V50, P1886, DOI 10.1021/jm061016o; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; KANFER JN, 1975, BIOCHEM BIOPH RES CO, V67, P85, DOI 10.1016/0006-291X(75)90286-7; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; Lin J, 2013, CELL REP, V3, P200, DOI 10.1016/j.celrep.2012.12.012; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Rosenbaum DM, 2010, J NEUROSCI RES, V88, P1569, DOI 10.1002/jnr.22314; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Silke J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003845; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; SUZUKI K, 1995, MICROSC RES TECHNIQ, V32, P204, DOI 10.1002/jemt.1070320304; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vitner EB, 2012, BRAIN, V135, P1724, DOI 10.1093/brain/aws095; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Wallach D, 2011, TRENDS IMMUNOL, V32, P505, DOI 10.1016/j.it.2011.07.004; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Yang YH, 2004, J BIOL CHEM, V279, P38820, DOI 10.1074/jbc.M401663200; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhu S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.94	40	122	137	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					204	208		10.1038/nm.3449	http://dx.doi.org/10.1038/nm.3449			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24441827				2022-12-27	WOS:000330915000022
J	Joller, N; Kuchroo, VK				Joller, Nicole; Kuchroo, Vijay K.			Good guys gone bad: exT(reg) cells promote autoimmune arthritis	NATURE MEDICINE			English	Editorial Material							REGULATORY T-CELLS; FOXP3 EXPRESSION; IN-VIVO; INFLAMMATION; GENERATION; T(H)17		[Joller, Nicole; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Joller, N (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Joller, Nicole/G-7897-2015	Joller, Nicole/0000-0003-1996-1672				Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cvetanovich GL, 2010, CURR OPIN IMMUNOL, V22, P753, DOI 10.1016/j.coi.2010.08.012; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	16	17	19	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					15	17		10.1038/nm.3439	http://dx.doi.org/10.1038/nm.3439			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398957				2022-12-27	WOS:000329349400010
J	Wicha, MS				Wicha, Max S.			Targeting self-renewal, an Achilles' heel of cancer stem cells	NATURE MEDICINE			English	Editorial Material							BMI1		Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Wicha, MS (corresponding author), Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	mwicha@umich.edu	Wicha, Max/AAE-7268-2019					Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Cao LX, 2011, J CELL BIOCHEM, V112, P2729, DOI 10.1002/jcb.23234; Chen K, 2013, ACTA PHARMACOL SIN, V34, P732, DOI 10.1038/aps.2013.27; Enderling H, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00076; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Korkaya H, 2013, CANCER RES, V73, P3489, DOI 10.1158/0008-5472.CAN-13-0260; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schott AF, 2013, CLIN CANCER RES, V19, P1512, DOI 10.1158/1078-0432.CCR-11-3326; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siddique HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060664; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048	15	42	46	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					14	15		10.1038/nm.3434	http://dx.doi.org/10.1038/nm.3434			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398956				2022-12-27	WOS:000329349400009
J	Jain, N; Miu, B; Jiang, JK; McKinstry, KK; Prince, A; Swain, SL; Greiner, DL; Thomas, CJ; Sanderson, MJ; Berg, LJ; Kang, J				Jain, Nitya; Miu, Bing; Jiang, Jian-kang; McKinstry, Kai K.; Prince, Amanda; Swain, Susan L.; Greiner, Dale L.; Thomas, Craig J.; Sanderson, Michael J.; Berg, Leslie J.; Kang, Joonsoo			CD28 and ITK signals regulate autoreactive T cell trafficking	NATURE MEDICINE			English	Article							COSTIMULATORY MOLECULES; B7/CD28 COSTIMULATION; CTLA-4; ACTIVATION; ANTIGEN; MICE; MOUSE; STIMULATION; REQUIREMENT; LYMPHOCYTES	Activation of self-reactive T cells and their trafficking to target tissues leads to autoimmune organ destruction. Mice lacking the co-inhibitory receptor cytotoxic T lymphocyte antigen-4 (CTLA-4) develop fatal autoimmunity characterized by lymphocytic infiltration into nonlymphoid tissues. Here, we demonstrate that the CD28 co-stimulatory pathway regulates the trafficking of self-reactive Ctla4(-/-) T cells to tissues. Concurrent ablation of the CD28-activated Tec family kinase Ilk does not block spontaneous T cell activation but instead causes self-reactive Ctla4(-/-) T cells to accumulate in secondary lymphoid organs. Despite excessive spontaneous T cell activation and proliferation in lymphoid organs, Itk(-/-); Ctla4(-/-) mice are otherwise healthy, mount antiviral immune responses and exhibit a long lifespan. We propose that ITK specifically licenses autoreactive T cells to enter tissues to mount destructive immune responses. Notably, ITK inhibitors mimic the null mutant phenotype and also prevent pancreatic islet infiltration by diabetogenic T cells in mouse models of type 1 diabetes, highlighting their potential utility for the treatment of human autoimmune disorders.	[Jain, Nitya; Miu, Bing; McKinstry, Kai K.; Prince, Amanda; Swain, Susan L.; Berg, Leslie J.; Kang, Joonsoo] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Jiang, Jian-kang; Thomas, Craig J.] NIH, Chem Genom Ctr, Rockville, MD USA; [Greiner, Dale L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Sanderson, Michael J.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kang, J (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	joonsoo.kang@umassmed.edu		Thomas, Craig/0000-0001-9386-9001; kang, joonsoo/0000-0001-8419-7995	US National Institutes of Health (NIH) [AI46629, AI050864, AI046530, AI083505, RC1 DK086474]; Molecular Libraries Initiative; Intramural Research Program of the NIH National Human Genome Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629, R01AI083505, P01AI046530, U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086474, P30DK032520] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Libraries Initiative; Intramural Research Program of the NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. Huseby, B. Seed and R. Friedline for discussion, S. Turley for advice with stromal cells, T. Hunig (University of Wurzburg) for the SACD28 antibody, M. Coles for assistance with microscopy, M. Krummel for advice on imaging, D. Serreze for studies with diabetogenic CD8<SUP>+</SUP> T cells, E. Huseby (University of Massachusetts Medical School) for MHC class II-deficient Rag1<SUP>-/-</SUP> mice and R. Welsh for the LCMV infection protocol. Core resources supported by the University of Massachusetts Medical School Diabetes Endocrinology Research Center grant DK32520 were used. This work was supported by US National Institutes of Health (NIH) grants to D.L.G. (AI46629, AI050864), S.L.S. (AI046530), L.J.B. (AI083505) and J.K. (RC1 DK086474 and AI083505). US NIH Chemical Genomics Center was supported by the Molecular Libraries Initiative and the Intramural Research Program of the NIH National Human Genome Research Institute.	Bachmann MF, 1997, J VIROL, V71, P7253, DOI 10.1128/JVI.71.10.7253-7257.1997; Bachmann MF, 1998, J IMMUNOL, V160, P95; Bauer M, 2009, P NATL ACAD SCI USA, V106, P1920, DOI 10.1073/pnas.0808909106; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Fletcher AL, 2010, J EXP MED, V207, P689, DOI 10.1084/jem.20092642; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Goverman J, 1997, CRIT REV IMMUNOL, V17, P469; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Guo WC, 2012, MOL PHARMACOL, V82, P938, DOI 10.1124/mol.112.079889; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jain N, 2010, P NATL ACAD SCI USA, V107, P1524, DOI 10.1073/pnas.0910341107; Kondo S, 1996, J IMMUNOL, V157, P4822; Kreisel D, 2002, J IMMUNOL, V169, P6154, DOI 10.4049/jimmunol.169.11.6154; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Liu LP, 2005, CURR TOP DEV BIOL, V68, P149, DOI 10.1016/S0070-2153(05)68006-4; Lozanoska-Ochser B, 2008, J IMMUNOL, V181, P6109, DOI 10.4049/jimmunol.181.9.6109; Mandelbrot DA, 2001, J CLIN INVEST, V107, P881, DOI 10.1172/JCI11710; Marelli-Berg FM, 2007, TRENDS IMMUNOL, V28, P267, DOI 10.1016/j.it.2007.04.008; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Michel F, 2000, J IMMUNOL, V165, P3820, DOI 10.4049/jimmunol.165.7.3820; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Mirenda V, 2007, BLOOD, V109, P2968, DOI 10.1182/blood-2006-10-050724; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Perez VL, 1998, CELL IMMUNOL, V189, P31, DOI 10.1006/cimm.1998.1362; Peterson JD, 1996, DIABETES, V45, P328, DOI 10.2337/diabetes.45.3.328; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Riether D, 2009, BIOORG MED CHEM LETT, V19, P1588, DOI 10.1016/j.bmcl.2009.02.012; Salazar-Fontana LI, 2003, J IMMUNOL, V171, P2225, DOI 10.4049/jimmunol.171.5.2225; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Sanderson MJ, 2011, PULM PHARMACOL THER, V24, P452, DOI 10.1016/j.pupt.2011.05.001; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SHIMIZU Y, 1992, J EXP MED, V175, P577, DOI 10.1084/jem.175.2.577; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Thornton EE, 2012, J EXP MED, V209, P1183, DOI 10.1084/jem.20112667; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Yokosuka T, 2010, IMMUNITY, V33, P326, DOI 10.1016/j.immuni.2010.09.006	58	31	32	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1632	1637		10.1038/nm.3393	http://dx.doi.org/10.1038/nm.3393			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24270545	Green Accepted			2022-12-27	WOS:000328181400032
J	Chong, CR; Janne, PA				Chong, Curtis R.; Jaenne, Pasi A.			The quest to overcome resistance to EGFR-targeted therapies in cancer	NATURE MEDICINE			English	Review							EPIDERMAL-GROWTH-FACTOR; CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; PHASE-II TRIAL; FACTOR-RECEPTOR GENE; EPITHELIAL-MESENCHYMAL-TRANSITION; METASTATIC COLORECTAL-CANCER; CETUXIMAB PLUS IRINOTECAN; K-RAS MUTATIONS; ACQUIRED-RESISTANCE	All patients with metastatic lung, colorectal, pancreatic or head and neck cancers who initially benefit from epidermal growth factor receptor (EGFR)-targeted therapies eventually develop resistance. An increasing understanding of the number and complexity of resistance mechanisms highlights the Herculean challenge of killing tumors that are resistant to EGFR inhibitors. Our growing knowledge of resistance pathways provides an opportunity to develop new mechanism-based inhibitors and combination therapies to prevent or overcome therapeutic resistance in tumors. We present a comprehensive review of resistance pathways to EGFR-targeted therapies in lung, colorectal and head and neck cancers and discuss therapeutic strategies that are designed to circumvent resistance.	[Chong, Curtis R.; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Chong, Curtis R.; Jaenne, Pasi A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Jaenne, Pasi A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute	Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA.	pjanne@partners.org			US National Institutes of Health [RO1CA114465, R01CA135257, P01CA154303]; American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE [R01CA135257, P01CA154303, T32CA009172, R01CA114465] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by US National Institutes of Health grants RO1CA114465 (P.A.J.), R01CA135257 (P.A.J.) and P01CA154303 (P.A.J.) and by an American Society of Clinical Oncology Young Investigator Award (C.R.C.).	Alam N, 2010, CLIN LUNG CANCER, V11, pE1, DOI 10.3816/CLC.2010.n.046; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Arcila ME, 2013, MOL CANCER THER, V12, P220, DOI 10.1158/1535-7163.MCT-12-0620; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Atagi S., 2011, 14 WORLD C LUNG CANC; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Becker A, 2011, EUR J CANCER, V47, P2603, DOI 10.1016/j.ejca.2011.06.046; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Bivona TG, 2011, NATURE, V471, P523, DOI 10.1038/nature09870; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Bock C, 2012, NAT REV CANCER, V12, P494, DOI 10.1038/nrc3297; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Box C, 2013, EUR J CANCER, V49, P2512, DOI 10.1016/j.ejca.2013.03.011; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Brewer MR, 2013, CANCER DISCOV, V3, P138, DOI 10.1158/2159-8290.CD-12-0581; Bridges AJ, 1999, CURR MED CHEM, V6, P825; Budha NR, 2012, CLIN PHARMACOL THER, V92, P203, DOI 10.1038/clpt.2012.73; Campoli M, 2010, CLIN CANCER RES, V16, P11, DOI 10.1158/1078-0432.CCR-09-2345; CARPENTER G, 1978, NATURE, V276, P409, DOI 10.1038/276409a0; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Chaft JE, 2011, CLIN CANCER RES, V17, P6298, DOI 10.1158/1078-0432.CCR-11-1468; Chen ZY, 2012, ONCOLOGIST, V17, P978, DOI 10.1634/theoncologist.2011-0385; Cheung HW, 2011, CANCER DISCOV, V1, P608, DOI 10.1158/2159-8290.CD-11-0046; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Chmielecki J, 2010, CLIN CANCER RES, V16, P5371, DOI 10.1158/1078-0432.CCR-10-2405; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Chung KP, 2012, CLIN CANCER RES, V18, P3470, DOI 10.1158/1078-0432.CCR-11-2353; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; COHEN S, 1962, J BIOL CHEM, V237, P1555; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cortot AB, 2013, CANCER RES, V73, P834, DOI 10.1158/0008-5472.CAN-12-2066; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dienstmann R, 2012, MOL ONCOL, V6, P15, DOI 10.1016/j.molonc.2011.11.009; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Foo J, 2012, J THORAC ONCOL, V7, P1583, DOI 10.1097/JTO.0b013e31826146ee; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Godin-Heymann N, 2008, MOL CANCER THER, V7, P874, DOI 10.1158/1535-7163.MCT-07-2387; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Guilhot F, 2012, HAEMATOL-HEMATOL J, V97, P731, DOI 10.3324/haematol.2011.045666; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Harada D, 2012, CANCER SCI, V103, P1795, DOI 10.1111/j.1349-7006.2012.02363.x; He M, 2012, CLIN CANCER RES, V18, P1790, DOI 10.1158/1078-0432.CCR-11-2361; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hoellein A, 2011, ONCOTARGET, V2, P599; Holz C, 2011, RADIOTHER ONCOL, V101, P158, DOI 10.1016/j.radonc.2011.05.042; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; HUNTER T, 1981, CELL, V24, P741, DOI 10.1016/0092-8674(81)90100-8; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Janne PA, 2012, J CLIN ONCOL, V30, P2063, DOI 10.1200/JCO.2011.40.1315; Janjigian YY, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.7525; Janjigian YY, 2011, CLIN CANCER RES, V17, P2521, DOI 10.1158/1078-0432.CCR-10-2662; Johnson ML, 2011, J THORAC ONCOL, V6, P1128, DOI 10.1097/JTO.0b013e3182161508; KAMATA T, 1984, NATURE, V310, P147, DOI 10.1038/310147a0; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kuang Y, 2009, CLIN CANCER RES, V15, P2630, DOI 10.1158/1078-0432.CCR-08-2592; Kuiper JL, 2013, LUNG CANCER, V80, P102, DOI 10.1016/j.lungcan.2012.12.024; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Kwak E, 2011, ONCOLOGIST, V16, P1498, DOI 10.1634/theoncologist.2011-0087; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; La Fleur L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044071; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Lee HJ, 2013, CANCER DISCOV, V3, P168, DOI 10.1158/2159-8290.CD-12-0357; Lee JK, 2013, ANN ONCOL, V24, P2080, DOI 10.1093/annonc/mdt127; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Liska D, 2011, CLIN CANCER RES, V17, P472, DOI 10.1158/1078-0432.CCR-10-0568; Liu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055128; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Lynch TJ, 2010, J CLIN ONCOL, V28, P911, DOI 10.1200/JCO.2009.21.9618; Lynch TJ, 2009, J THORAC ONCOL, V4, P1002, DOI 10.1097/JTO.0b013e3181aba89f; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Milton DT, 2006, J CLIN ONCOL, V24, P4940, DOI 10.1200/JCO.2006.06.4410; Mink SR, 2010, MOL CANCER RES, V8, P809, DOI 10.1158/1541-7786.MCR-09-0460; Mir O, 2011, NEW ENGL J MED, V365, P379, DOI 10.1056/NEJMc1105083; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Montagut C, 2012, NAT MED, V18, P221, DOI 10.1038/nm.2609; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Ogawa T, 2012, CELL CYCLE, V11, P1656, DOI 10.4161/cc.20120; Ohashi K, 2013, J CLIN ONCOL, V31, P1070, DOI 10.1200/JCO.2012.43.3912; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Ou SHI, 2012, CRIT REV ONCOL HEMAT, V83, P407, DOI 10.1016/j.critrevonc.2011.11.010; Oxnard GR, 2013, J THORAC ONCOL, V8, P179, DOI 10.1097/JTO.0b013e3182779d18; Oxnard GR, 2012, J THORAC ONCOL, V7, P1049, DOI 10.1097/JTO.0b013e318250ed9d; Oxnard GR, 2011, CLIN CANCER RES, V17, P6322, DOI 10.1158/1078-0432.CCR-11-1080; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Petrelli F, 2012, LUNG CANCER, V78, P8, DOI 10.1016/j.lungcan.2012.06.009; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Ranson M., 2013, EUR CANC C AMST; Razak ARA, 2013, ANN ONCOL, V24, P761, DOI 10.1093/annonc/mds503; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Riely GJ, 2007, CLIN CANCER RES, V13, P5150, DOI 10.1158/1078-0432.CCR-07-0560; Rivera VM, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-1794; Robinson KW, 2013, ONCOLOGIST, V18, P115, DOI 10.1634/theoncologist.2012-0262; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Sato J D, 1983, Mol Biol Med, V1, P511; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2070, DOI 10.1200/JCO.2011.39.2993; Scartozzi M, 2009, J CLIN ONCOL, V27; Seiwert T., 2012, MULT HEAD NECK S LBP; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Sledge GW, 2012, J CLIN ONCOL, V30, P203, DOI 10.1200/JCO.2011.39.0088; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Suda K, 2012, LUNG CANCER, V76, P292, DOI 10.1016/j.lungcan.2011.11.007; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Sun LN, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-30; Taguchi F, 2007, J NATL CANCER I, V99, P838, DOI 10.1093/jnci/djk195; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Tallman MS, 1997, NEW ENGL J MED, V337, P1021, DOI 10.1056/NEJM199710093371501; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Terai H, 2013, MOL CANCER RES, V11, P759, DOI 10.1158/1541-7786.MCR-12-0652; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Uramoto H, 2010, ANTICANCER RES, V30, P2513; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Viloria-Petit A, 2001, CANCER RES, V61, P5090; Wakelee H., 2010, J CLIN ONCOL, V28, P3017; Wakeling AE, 1996, BREAST CANCER RES TR, V38, P67, DOI 10.1007/BF01803785; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; Weickhardt AJ, 2012, J CLIN ONCOL, V30, P1505, DOI 10.1200/JCO.2011.38.6599; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Won YW, 2011, J CLIN PATHOL, V64, P947, DOI 10.1136/jclinpath-2011-200169; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; Wu JY, 2011, CLIN CANCER RES, V17, P3812, DOI 10.1158/1078-0432.CCR-10-3408; Xie M, 2012, J CELL BIOCHEM, V113, P1501, DOI 10.1002/jcb.24019; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yang J-CH, 2012, J CLIN ONCOL, V30; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Yeh P, 2013, CLIN CANCER RES, V19, P1894, DOI 10.1158/1078-0432.CCR-12-1894; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Yu HA, 2013, J NATL COMPR CANC NE, V11, P161, DOI 10.6004/jnccn.2013.0024; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zakowski MF, 2006, NEW ENGL J MED, V355, P213, DOI 10.1056/NEJMc053610; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	192	684	717	12	235	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1389	1400		10.1038/nm.3388	http://dx.doi.org/10.1038/nm.3388			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202392	Green Accepted			2022-12-27	WOS:000326920300017
J	Vonderheide, RH; Nathanson, KL				Vonderheide, Robert H.; Nathanson, Katherine L.			The road to personalized cancer vaccines	NATURE MEDICINE			English	Editorial Material							IMMUNOTHERAPY; VACCINATION; ANTIGENS; MUTANOME	The field of tumor immunology has been flooded with exciting therapeutic advances on many fronts. Immunotherapies targeting T cell inhibitory molecules have proven highly effective in some cancers, but additional strategies to induce tumor immunity, such as cancer vaccination, could further increase tumor killing. The combination of both will probably be the way forward in future immunotherapy. In 'Bedside to Bench', Robert Vonderheide and Katherine Nathanson discuss the potential of cancer genomics to identify specific tumor mutations in patients that may be used as targets in cancer vaccines to overcome problems linked to self-antigen epitopes used nowadays. Despite the existing biological and technical hurdles, a framework to implement personalized cancer vaccines in the clinic may be worth considering. In 'Bench to Bedside', Glenn Dranoff peruses the clinical efficacy and detrimental effects of two T cell immune-checkpoint inhibitors, alone and in combination, in patients with melanoma. The studies underscore the need to continue investigating specific tumor events directly involving tumor evasion to develop combinatorial strategies that will reduce drug-related pathology while achieving anti-tumor efficacy.	[Vonderheide, Robert H.; Nathanson, Katherine L.] Univ Penn, Dept Med, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Vonderheide, RH (corresponding author), Univ Penn, Dept Med, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA.	rhv@exchange.upenn.edu		Nathanson, Katherine/0000-0002-6740-0901	NCI NIH HHS [R01 CA158186] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA158186] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Carbone DP, 2005, J CLIN ONCOL, V23, P5099, DOI 10.1200/JCO.2005.03.158; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Hacohen N, 2013, CANCER IMMUNOL RES, V1, P11, DOI 10.1158/2326-6066.CIR-13-0022; Kreiter S, 2012, ONCOIMMUNOLOGY, V1, P768, DOI 10.4161/onci.19727; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Predina J, 2013, P NATL ACAD SCI USA, V110, pE415, DOI 10.1073/pnas.1211850110; Riley JL, 2013, NEW ENGL J MED, V369, P187, DOI 10.1056/NEJMe1305484; Sampson JH, 2009, MOL CANCER THER, V8, P2773, DOI 10.1158/1535-7163.MCT-09-0124; Schlom J, 2012, JNCI-J NATL CANCER I, V104, P599, DOI 10.1093/jnci/djs033; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schultze JL, 2001, TRENDS IMMUNOL, V22, P516, DOI 10.1016/S1471-4906(01)02015-4; Segal NH, 2008, CANCER RES, V68, P889, DOI 10.1158/0008-5472.CAN-07-3095; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Vonderheide RH, 2013, CURR OPIN IMMUNOL, V25, P200, DOI 10.1016/j.coi.2013.01.006; Weden S, 2011, INT J CANCER, V128, P1120, DOI 10.1002/ijc.25449	16	40	40	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2013	19	9					1098	1100		10.1038/nm.3317	http://dx.doi.org/10.1038/nm.3317			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	24013748				2022-12-27	WOS:000324083500018
J	Daggett, A; Yang, W				Daggett, Anthony; Yang, William			Huntington's disease: easing the NMDAR traffic jam	NATURE MEDICINE			English	Editorial Material							MUTANT HUNTINGTIN; RECEPTOR; NEUROTOXICITY; INCREASE; MICE	Excitatory neurotransmission through NMDA receptors (NMDARs) has a pivotal role in healthy brain function, and its dysfunction has long been implicated in the pathogenesis of neurodegenerative disorders, including Huntington's disease. A new study uncovers a molecular link between mutant huntingtin and aberrant trafficking of an unconventional NDMAR subunit (GluN3A). Targeting this disease mechanism in a Huntington's disease mouse model had multiple therapeutic benefits (pages 1030-1038).	[Daggett, Anthony; Yang, William] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci,Ctr Neurobehav Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Daggett, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci,Ctr Neurobehav Genet, Los Angeles, CA 90095 USA.	xwyang@mednet.ucla.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074312] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS074312] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Marco S, 2013, NAT MED, V19, P1030, DOI 10.1038/nm.3246; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Raymond LA, 2011, NEUROSCIENCE, V198, P252, DOI 10.1016/j.neuroscience.2011.08.052; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008	12	2	2	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2013	19	8					971	973		10.1038/nm.3283	http://dx.doi.org/10.1038/nm.3283			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921742				2022-12-27	WOS:000322779600019
J	LeBleu, VS; Taduri, G; O'Connell, J; Teng, YQ; Cooke, VG; Woda, C; Sugimoto, H; Kalluri, R				LeBleu, Valerie S.; Taduri, Gangadhar; O'Connell, Joyce; Teng, Yingqi; Cooke, Vesselina G.; Woda, Craig; Sugimoto, Hikaru; Kalluri, Raghu			Origin and function of myofibroblasts in kidney fibrosis	NATURE MEDICINE			English	Article							TO-MESENCHYMAL TRANSITION; FIBROBLASTS; PERICYTES; CELLS; ADHESION; DIFFERENTIATION; IDENTIFICATION; ANGIOGENESIS; CONTRIBUTE; CANCER	Myofibroblasts are associated with organ fibrosis, but their precise origin and functional role remain unknown. We used multiple genetically engineered mice to track, fate map and ablate cells to determine the source and function of myofibroblasts in kidney fibrosis. Through this comprehensive analysis, we identified that the total pool of myofibroblasts is split, with 50% arising from local resident fibroblasts through proliferation. The nonproliferating myofibroblasts derive through differentiation from bone marrow (35%), the endothelial-to-mesenchymal transition program (10%) and the epithelial-to-mesenchymal transition program (5%). Specific deletion of Tgfbr2 in alpha-smooth muscle actin (alpha SMA)(+) cells revealed the importance of this pathway in the recruitment of myofibroblasts through differentiation. Using genetic mouse models and a fate-mapping strategy, we determined that vascular pericytes probably do not contribute to the emergence of myofibroblasts or fibrosis. Our data suggest that targeting diverse pathways is required to substantially inhibit the composite accumulation of myofibroblasts in kidney fibrosis.	[LeBleu, Valerie S.; Sugimoto, Hikaru; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA; [LeBleu, Valerie S.; Taduri, Gangadhar; O'Connell, Joyce; Teng, Yingqi; Cooke, Vesselina G.; Woda, Craig; Sugimoto, Hikaru; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kalluri, Raghu] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA	University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA.	rkalluri@mdanderson.org	LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X	US National Institutes of Health (NIH) [DK55001, DK81976, CA125550, CA155370, CA163191, CA151925]; Cancer Prevention and Research Institute of Texas; Metastasis Research Center at MD Anderson Cancer Center; NIH [2T32DK007760-11, 5T32HL007374-30, T32DK007726, 5F32DK082119-02]; US Department of Defense Breast Cancer Research [W81XWH-09-1-0008]; International Society of Nephrology Fellowship; NATIONAL CANCER INSTITUTE [P30CA016672, U54CA163191, R01CA125550, R01CA155370, U01CA151925] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007726, R01DK055001, F32DK082119, T32DK007760] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Metastasis Research Center at MD Anderson Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense Breast Cancer Research(United States Department of Defense); International Society of Nephrology Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by US National Institutes of Health (NIH) grants DK55001, DK81976, CA125550, CA155370, CA163191 and CA151925 (all to R.K.). R.K. is supported by the Cancer Prevention and Research Institute of Texas and the Metastasis Research Center at MD Anderson Cancer Center. V.S.L. was funded by the NIH Research Training Grant in Gastroenterology (2T32DK007760-11), V.G.C. was funded by the US National Research Service Award (NRSA) F32 Ruth Kirschstein Post-doctoral Fellowship from the NIH (5F32DK082119-02). H.S. was funded by the NIH Research Training Grant in Cardiovascular Biology (5T32HL007374-30). J.O. was funded by the US Department of Defense Breast Cancer Research Predoctoral Traineeship Award (W81XWH-09-1-0008). G.T. was funded by the International Society of Nephrology Fellowship. C.W. was funded by the NIH Research Training Grant in Pediatric Nephrology (T32DK007726). Pdgfrb-Cre mice were kindly provided by R. Adams, Max Planck Institute for Molecular Biomedicine. gamma GT-Cre mice were kindly provided by E. Neilson, Northwestern University. Tgfbr2<SUP>flox/flox</SUP> mice were kindly provided by H. Moses, Vanderbilt University.	Abraham S, 2008, CIRC RES, V102, P562, DOI 10.1161/CIRCRESAHA.107.167908; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Hall AP, 2006, TOXICOL PATHOL, V34, P763, DOI 10.1080/01926230600936290; Hashimoto N, 2010, AM J RESP CELL MOL, V43, P161, DOI 10.1165/rcmb.2009-0031OC; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LeBleu V, 2009, J AM SOC NEPHROL, V20, P2359, DOI 10.1681/ASN.2009010123; LeBleu VS, 2008, LAB INVEST, V88, P284, DOI 10.1038/labinvest.3700715; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Sugimoto H, 2012, NAT MED, V18, P396, DOI 10.1038/nm.2629; Tondreau T, 2004, CYTOTHERAPY, V6, P372, DOI 10.1080/14653240410004943; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2008, FRONT BIOSCI, V13, P6991	39	828	876	10	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1047	1054		10.1038/nm.3218	http://dx.doi.org/10.1038/nm.3218			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23817022	Green Accepted			2022-12-27	WOS:000322779600031
J	Lloyd, CM; Saglani, S				Lloyd, Clare M.; Saglani, Sejal			Eosinophils in the spotlight Finding the link between obesity and asthma	NATURE MEDICINE			English	Editorial Material							ALTERNATIVELY ACTIVATED MACROPHAGES; CELLS	How eosinophils function in different tissues during health and disease is not completely understood. On the one hand, they seem to be crucial in inflammatory disorders, which suggests that pathways related to their activation and regulation may be potential therapeutic targets. In asthma, the role of these cells is well known; however, airway inflammation owing to increased eosinophils in lung tissue in nonallergic asthma has only recently started to be in the limelight. In 'Bedside to Bench', Guy G. Brusselle, Tania Maes and Ken R. Bracke peruse the disease pathway triggering eosinophilic inflammation in nonallergic eosinophilic asthma and the potential targets that may lead to effective therapies. The authors also discuss a clinical study that highlights the need to phenotype patients using cellular and molecular markers to improve treatment responses. However, on the other hand, a recent study has also shown a homeostatic role of eosinophils in metabolism in fat tissue. In 'Bench to Bedside', Clare M. Lloyd and Sejal Saglani examine evidence that hints at the crucial role of the location of eosinophils in different tissues such as lung, where they cause inflammation, and visceral fat, where they improve glucose homeostasis. Clinical data that correlate lung tissue eosinophilia with obesity may spur new research to shed light on the role of these inflammatory cells in obese individuals with asthma and on how to improve treatments in these patients.	[Lloyd, Clare M.; Saglani, Sejal] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Imperial College London	Lloyd, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	c.lloyd@imperial.ac.uk	Saglani, Sejal/AAE-5072-2019	Lloyd, Clare/0000-0001-8977-6726	Wellcome Trust [087618] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Desai D., 2013, AM J RESP CRIT CARE, DOI DOI 10.1164/RCCM.201208-14700C; Fattouh R, 2011, AM J RESP CRIT CARE, V183, P179, DOI 10.1164/rccm.200905-0736OC; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Scanlon ST, 2012, CURR OPIN IMMUNOL, V24, P707, DOI 10.1016/j.coi.2012.08.009; Sutherland ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036631; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	10	26	26	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2013	19	8					976	977		10.1038/nm.3296	http://dx.doi.org/10.1038/nm.3296			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921744				2022-12-27	WOS:000322779600022
J	Chou, WC; Takeo, M; Rabbani, P; Hu, H; Lee, W; Chung, YR; Carucci, J; Overbeek, P; Ito, M				Chou, Wei Chin; Takeo, Makoto; Rabbani, Piul; Hu, Hai; Lee, Wendy; Chung, Young Rock; Carucci, John; Overbeek, Paul; Ito, Mayumi			Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling	NATURE MEDICINE			English	Article							HAIR-FOLLICLES; SKIN PIGMENTATION; HOMEOSTASIS; MOUSE; NICHE; REPIGMENTATION; INVOLVEMENT; VITILIGO; PROMOTER; HORMONE	During wound healing, stem cells provide functional mature cells to meet acute demands for tissue regeneration(1). Simultaneously, the tissue must maintain a pool of stem cells to sustain its future regeneration capability. However, how these requirements are balanced in response to injury is unknown. Here we demonstrate that after wounding or ultraviolet type B irradiation, melanocyte stem cells (McSCs) in the hair follicle(2) exit the stem cell niche before their initial cell division, potentially depleting the pool of these cells. We also found that McSCs migrate to the epidermis in a melanocortin 1 receptor (Mc1r)-dependent manner and differentiate into functional epidermal melanocytes, providing a pigmented protective barrier against ultraviolet irradiation over the damaged skin. These findings provide an example in which stem cell differentiation due to injury takes precedence over stem cell maintenance and show the potential for developing therapies for skin pigmentation disorders by manipulating McSCs.	[Chou, Wei Chin; Takeo, Makoto; Rabbani, Piul; Hu, Hai; Lee, Wendy; Chung, Young Rock; Carucci, John; Ito, Mayumi] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA; [Chou, Wei Chin; Takeo, Makoto; Rabbani, Piul; Hu, Hai; Lee, Wendy; Chung, Young Rock; Ito, Mayumi] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Overbeek, Paul] Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	New York University; New York University; Baylor College of Medicine	Ito, M (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY USA.	mayumi.ito@nyumc.org		Takeo, Makoto/0000-0002-5597-5994; Overbeek, Paul/0000-0001-9784-2084; Chung, Young Rock/0000-0001-5752-8322; Rabbani, Piul/0000-0001-8302-8225; Lee, Wendy/0000-0002-8807-0550	NYU Kimmel Stem Cell Center; NYSTEM [C026880]; US National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR059768-01A1]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059768] Funding Source: NIH RePORTER	NYU Kimmel Stem Cell Center; NYSTEM; US National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Follicle-derived epidermal melanocytes were initially observed at G. Cotsarelis' laboratory at the University of Pennsylvania, and this work benefited greatly from the mentorship and generosity of G. Cotsarelis. We thank P. Manga at New York University (NYU) for valuable discussion and for providing melan-a cells and antibody to mouse tyrosinase. We thank E. Hernando's lab at NYU for the protocol of the melanocyte migration assay. We thank the Microscopy Core of NYU for use of confocal microscopes (NCRRS10 RR023704-01A1). M. T. is supported by the NYU Kimmel Stem Cell Center and NYSTEM training grant C026880. M. I. is supported by US National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases grant 1R01AR059768-01A1 and the Ellison Medical Foundation.	BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; CUI J, 1991, J INVEST DERMATOL, V97, P410, DOI 10.1111/1523-1747.ep12480997; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gilchrest BA, 2011, J INVEST DERMATOL, V131, P6, DOI [10.1038/jid.2010.325, 10.1038/skinbio.2011.6]; Han R, 2002, PIGM CELL RES, V15, P290, DOI 10.1034/j.1600-0749.2002.02027.x; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; HUNT G, 1995, J INVEST DERMATOL, V104, P83, DOI 10.1111/1523-1747.ep12613565; Inoue K, 2003, J INVEST DERMATOL, V121, P165, DOI 10.1046/j.1523-1747.2003.12326.x; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; LICHTI U, 1993, J INVEST DERMATOL, V101, pS124, DOI 10.1111/1523-1747.ep12363165; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2011, PIGM CELL MELANOMA R, V24, P401, DOI 10.1111/j.1755-148X.2011.00855.x; ORTONNE JP, 1979, BRIT J DERMATOL, V101, P1, DOI 10.1111/j.1365-2133.1979.tb15285.x; Pharoah PDP, 2008, NAT GENET, V40, P817, DOI 10.1038/ng0708-817; Prouty SM, 1996, AM J PATHOL, V148, P1871; Rabbani P, 2011, CELL, V145, P941, DOI 10.1016/j.cell.2011.05.004; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Seong I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031477; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhao SL, 1999, DEV BIOL, V216, P154, DOI 10.1006/dbio.1999.9480	33	121	131	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					924	+		10.1038/nm.3194	http://dx.doi.org/10.1038/nm.3194			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23749232	Green Accepted			2022-12-27	WOS:000321557700037
J	Ahmadian, M; Suh, JM; Hah, N; Liddle, C; Atkins, AR; Downes, M; Evans, RM				Ahmadian, Maryam; Suh, Jae Myoung; Hah, Nasun; Liddle, Christopher; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.			PPAR gamma signaling and metabolism: the good, the bad and the future	NATURE MEDICINE			English	Review							ACTIVATED-RECEPTOR-GAMMA; KINASE-MEDIATED PHOSPHORYLATION; FAMILIAL PARTIAL LIPODYSTROPHY; MACROPHAGE-GENE-EXPRESSION; CAUSES INSULIN-RESISTANCE; TYPE-2 DIABETES-MELLITUS; BROWN ADIPOSE-TISSUE; TRANSCRIPTION FACTOR; LIPID-METABOLISM; SKELETAL-MUSCLE	Thiazolidinediones (TZDs) are potent insulin sensitizers that act through the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR gamma) and are highly effective oral medications for type 2 diabetes. However, their unique benefits are shadowed by the risk for fluid retention, weight gain, bone loss and congestive heart failure. This raises the question as to whether it is possible to build a safer generation of PPAR gamma-specific drugs that evoke fewer side effects while preserving insulin-sensitizing potential. Recent studies that have supported the continuing physiologic and therapeutic relevance of the PPAR gamma pathway also provide opportunities to develop newer classes of molecules that reduce or eliminate adverse effects. This review highlights key advances in understanding PPAR gamma signaling in energy homeostasis and metabolic disease and also provides new explanations for adverse events linked to TZD-based therapy.	[Ahmadian, Maryam; Suh, Jae Myoung; Hah, Nasun; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	Suh, Jae Myoung/B-3268-2015; Evans, Ronald/AAF-4001-2019	Suh, Jae Myoung/0000-0001-8097-4662; Evans, Ronald/0000-0002-9986-5965; Hah, Nasun/0000-0003-1509-2799; Atkins, Annette/0000-0003-2558-7058	US National Institutes of Health [DK057978, DK090962, HL088093, HL105278, ES010337]; Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure; Ellison Medical Foundation; Howard Hughes Medical Institute; National Health and Medical Research Council of Australia [512354, 632886, 1043199]; F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases); Pioneer Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090962, P30DK063491, R37DK057978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; Ipsen/Biomeasure(Ipsen); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases); Pioneer Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank R. Yu, C.D. De Magalhaes Filho and S. Sarshar for useful discussions and L. Ong and C. Brondos for administrative assistance. R.M.E. is an Investigator of the Howard Hughes Medical Institute at the Salk Institute and March of Dimes Chair in Molecular and Developmental Biology This work was supported by US National Institutes of Health grants to R.M.E. (DK057978, DK090962, HL088093, HL105278 and ES010337), the Glenn Foundation for Medical Research, the Leona M. and Harry B. Helmsley Charitable Trust, Ipsen/Biomeasure, The Ellison Medical Foundation and the Howard Hughes Medical Institute. C.L. and M.D. are funded by grants from the National Health and Medical Research Council of Australia Project Grants 512354, 632886 and 1043199. M.A. is supported by an F32 Ruth L. Kirschstein National Research Service Award (National Institute of Diabetes and Digestive and Kidney Diseases). N.H. is supported by the Pioneer Fund. We apologize for those references we could not include due to space limitations.	Agarwal AK, 2002, J CLIN ENDOCR METAB, V87, P408, DOI 10.1210/jc.87.1.408; Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Berkowitz R, 1996, DIABETES, V45, P1572; Borsting E, 2012, AM J PHYSIOL-RENAL, V302, pF540, DOI 10.1152/ajprenal.00306.2011; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; Camp HS, 1997, J BIOL CHEM, V272, P10811; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cariou B, 2012, TRENDS ENDOCRIN MET, V23, P205, DOI 10.1016/j.tem.2012.03.001; Cecil JE, 2006, PHYSIOL BEHAV, V88, P227, DOI 10.1016/j.physbeh.2006.05.028; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chappuis B, 2007, DIABETES-METAB RES, V23, P392, DOI 10.1002/dmrr.715; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; Deeg MA, 2007, DIABETES CARE, V30, P2458, DOI 10.2337/dc06-1903; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Edvardsson U, 1999, J LIPID RES, V40, P1177; European Medicines Agency, 2010, EUROPEAN MEDICINES A; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Finan B, 2012, NAT MED, V18, P1847, DOI 10.1038/nm.3009; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Forman BM, 1996, ANN NY ACAD SCI, V804, P266, DOI 10.1111/j.1749-6632.1996.tb18621.x; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Harmon GS, 2011, CHEM REV, V111, P6321, DOI 10.1021/cr2001355; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Higa M, 1999, P NATL ACAD SCI USA, V96, P11513, DOI 10.1073/pnas.96.20.11513; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; Iankova I, 2006, MOL ENDOCRINOL, V20, P1494, DOI 10.1210/me.2005-0222; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kallwitz ER, 2008, WORLD J GASTROENTERO, V14, P22, DOI 10.3748/wjg.14.22; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim JK, 2003, DIABETES, V52, P1311, DOI 10.2337/diabetes.52.6.1311; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; Larsen PJ, 2003, DIABETES, V52, P2249, DOI 10.2337/diabetes.52.9.2249; Lee CH, 2002, TRENDS ENDOCRIN MET, V13, P331, DOI 10.1016/S1043-2760(02)00668-9; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Lutchman G, 2007, HEPATOLOGY, V46, P424, DOI 10.1002/hep.21661; Marfella R, 2009, HEART, V95, P1020, DOI 10.1136/hrt.2009.165969; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Miller DL, 2000, MOL CELL BIOL, V20, P2260, DOI 10.1128/MCB.20.6.2260-2268.2000; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Nan YM, 2009, SCAND J GASTROENTERO, V44, P358, DOI 10.1080/00365520802530861; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rabol R, 2010, DIABETES OBES METAB, V12, P806, DOI 10.1111/j.1463-1326.2010.01237.x; Rangwala Shamina M, 2002, Sci STKE, V2002, ppe9, DOI 10.1126/stke.2002.121.pe9; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Rosenson RS, 2012, AM HEART J, V164, P672, DOI 10.1016/j.ahj.2012.06.023; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Sakamoto J, 2000, BIOCHEM BIOPH RES CO, V278, P704, DOI 10.1006/bbrc.2000.3868; Sanchez JC, 2003, PROTEOMICS, V3, P1500, DOI 10.1002/pmic.200300484; Saraf N, 2012, J PHARM PHARMACOL, V64, P161, DOI 10.1111/j.2042-7158.2011.01366.x; Sarafidis PA, 2011, CARDIOVASC THER, V29, P377, DOI 10.1111/j.1755-5922.2010.00222.x; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; Savage DB, 2003, DIABETES, V52, P910, DOI 10.2337/diabetes.52.4.910; Schmidt SF, 2012, TRANSCR-AUSTIN, V3, P19, DOI 10.4161/trns.3.1.19302; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Shimizu M, 2006, MOL CELL BIOCHEM, V286, P33, DOI 10.1007/s11010-005-9052-z; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Singh AB, 2012, J CELL PHYSIOL, V227, P2632, DOI 10.1002/jcp.23005; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Sugawara A, 1998, ENDOCRINOLOGY, V139, P3030, DOI 10.1210/en.139.6.3030; Sugii S, 2011, FEBS LETT, V585, P2121, DOI 10.1016/j.febslet.2011.05.007; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Sun K, 2012, CELL RES, V22, P1416, DOI 10.1038/cr.2012.94; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Szatmari I, 2006, ANN NY ACAD SCI, V1088, P207, DOI 10.1196/annals.1366.013; Szeles L, 2007, BBA-MOL CELL BIOL L, V1771, P1014, DOI 10.1016/j.bbalip.2007.02.005; Takada I, 2010, PPAR RES, V2010, DOI 10.1155/2010/341671; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Tavera-Mendoza LE, 2008, P NATL ACAD SCI USA, V105, P8250, DOI 10.1073/pnas.0709279105; Tomaru T, 2009, J BIOL CHEM, V284, P6116, DOI 10.1074/jbc.M808407200; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Vacca M, 2011, WIRES SYST BIOL MED, V3, P562, DOI 10.1002/wsbm.137; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Waite KJ, 2001, J BIOL CHEM, V276, P7062, DOI 10.1074/jbc.M007894200; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wei W, 2011, PPAR RES, V2011, DOI 10.1155/2011/867180; Wilcox R, 2008, AM HEART J, V155, P712, DOI 10.1016/j.ahj.2007.11.029; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102	144	1163	1203	9	400	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					557	566		10.1038/nm.3159	http://dx.doi.org/10.1038/nm.3159			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652116	Green Accepted			2022-12-27	WOS:000318583000027
J	Zhang, N; Francis, KP; Prakash, A; Ansaldi, D				Zhang, Ning; Francis, Kevin P.; Prakash, Arun; Ansaldi, Daniel			Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles	NATURE MEDICINE			English	Article							IN-VIVO; QUANTUM DOTS; AIRWAY INFLAMMATION; 3-CHLOROTYROSINE; INVOLVEMENT; PATHWAY; TARGETS; MARKER; MICE	A previous study reported the use of luminol for the detection of myeloperoxidase (MPO) activity using optical imaging in infiltrating neutrophils under inflammatory disease conditions. The detection is based on a photon-emitting reaction between luminol and an MPO metabolite. Because of tissue absorption and scattering, however, luminol-emitted blue light can be efficiently detected from superficial inflammatory foci only. In this study we report a chemiluminescence resonance energy transfer (CRET) methodology in which luminol-generated blue light excites nanoparticles to emit light in the near-infrared spectral range, resulting in remarkable improvement of MPO detectability in vivo. CRET caused a 37-fold increase in luminescence emission over luminol alone in detecting MPO activity in lung tissues after lipopolysaccharide challenge. We demonstrated a dependence of the chemiluminescent signal on MPO activity using MPO-deficient mice. In addition, co-administration of 4-aminobenzoic acid hydrazide (4-ABAH), an irreversible inhibitor of MPO, significantly attenuated luminescent emission from inflamed lungs. Inhibition of nitric oxide synthase with a nonspecific inhibitor, l-NAME, had no effect on luminol-mediated chemiluminescence production. Pretreatment of mice with MLN120B, a selective inhibitor of IKK-2, resulted in suppression of neutrophil infiltration to the lung tissues and reduction of MPO activity. We also demonstrated that CRET can effectively detect MPO activity at deep tissue tumor foci due to tumor development-associated neutrophil infiltration. We developed a sensitive MPO detection methodology that provides a means for visualizing and quantifying oxidative stress in deep tissue. This method is amenable to rapid evaluation of anti-inflammatory agents in animal models.	[Zhang, Ning; Francis, Kevin P.; Ansaldi, Daniel] Caliper Life Sci, Alameda, CA USA; [Prakash, Arun] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia & Perioperat Care, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Zhang, N (corresponding author), Pharmaron, In Vivo Pharmacol & Oncol, Beijing, Peoples R China.	ning.zhang@pharmaron.com	Hamblin, Michael R/H-2758-2019; Hamblin, Mike/AAB-2511-2022	Hamblin, Michael R/0000-0001-6431-4605; 				Altinoglu EI, 2010, WIRES NANOMED NANOBI, V2, P461, DOI 10.1002/wnan.77; Ansaldi D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025093; BOS A, 1978, BIOCHIM BIOPHYS ACTA, V525, P37, DOI 10.1016/0005-2744(78)90197-3; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Gao JH, 2010, BIOCONJUGATE CHEM, V21, P604, DOI 10.1021/bc900323v; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Haegens A, 2008, EUR RESPIR J, V31, P252, DOI 10.1183/09031936.00029307; Hahn MA, 2011, ANAL BIOANAL CHEM, V399, P3, DOI 10.1007/s00216-010-4207-5; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Homayoun H, 2002, EPILEPSY RES, V49, P131, DOI 10.1016/S0920-1211(02)00018-9; IRIE S, 1960, Curr Ther Res Clin Exp, V2, P107; Islam MS, 2008, BRIT J PHARMACOL, V154, P812, DOI 10.1038/bjp.2008.137; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; LINDEN M, 1993, AM REV RESPIR DIS, V148, P1226, DOI 10.1164/ajrccm/148.5.1226; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; NUCHPRAYOON I, 1994, MOL CELL BIOL, V14, P5558, DOI 10.1128/MCB.14.8.5558; O'Donnell C, 2010, COPD, V7, P411, DOI 10.3109/15412555.2010.528086; Orita T, 1997, J BIOL CHEM, V272, P23216, DOI 10.1074/jbc.272.37.23216; Sanders JM, 2000, XENOBIOTICA, V30, P263, DOI 10.1080/004982500237659; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Shen WF, 2009, PHARMACOL RES, V60, P296, DOI 10.1016/j.phrs.2009.04.007; So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188; Stroh M, 2005, NAT MED, V11, P678, DOI 10.1038/nm1247; Wang HQ, 2008, ANAL CHIM ACTA, V610, P68, DOI 10.1016/j.aca.2008.01.018; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764	32	87	94	16	160	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2013	19	4					500	+		10.1038/nm.3110	http://dx.doi.org/10.1038/nm.3110			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23455711	Green Published			2022-12-27	WOS:000317109100037
J	Polzer, B; Klein, CA				Polzer, Bernhard; Klein, Christoph A.			The challenges of targeting minimal residual cancer	NATURE MEDICINE			English	Editorial Material							BREAST-CANCER; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; SURVIVAL; GROWTH; TUMORS; CELLS		[Polzer, Bernhard; Klein, Christoph A.] Fraunhofer Inst Toxikol & Expt Med, Project Grp Personalized Tumor Therapy, Regensburg, Germany; [Klein, Christoph A.] Univ Regensburg, D-93053 Regensburg, Germany	Fraunhofer Gesellschaft; University of Regensburg	Polzer, B (corresponding author), Fraunhofer Inst Toxikol & Expt Med, Project Grp Personalized Tumor Therapy, Regensburg, Germany.	christoph.klein@ukr.de		Klein, Christoph A./0000-0001-7128-1725				Adam AP, 2009, CANCER RES, V69, P5664, DOI 10.1158/0008-5472.CAN-08-3820; Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Goss GD, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.lba7005; Gow CH, 2009, ANN ONCOL, V20, P696, DOI 10.1093/annonc/mdn679; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Schardt JA, 2005, CANCER CELL, V8, P227, DOI 10.1016/j.ccr.2005.08.003; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019	17	51	52	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					274	275		10.1038/nm.3121	http://dx.doi.org/10.1038/nm.3121			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23467237				2022-12-27	WOS:000316040700018
J	Carter, CS; Vogel, TW; Zhang, QH; Seo, S; Swiderski, RE; Moninger, TO; Cassell, MD; Thedens, DR; Keppler-Noreuil, KM; Nopoulos, P; Nishimura, DY; Searby, CC; Bugge, K; Sheffield, VC				Carter, Calvin S.; Vogel, Timothy W.; Zhang, Qihong; Seo, Seongjin; Swiderski, Ruth E.; Moninger, Thomas O.; Cassell, Martin D.; Thedens, Daniel R.; Keppler-Noreuil, Kim M.; Nopoulos, Peggy; Nishimura, Darryl Y.; Searby, Charles C.; Bugge, Kevin; Sheffield, Val C.			Abnormal development of NG2(+)PDGFR-alpha(+) neural progenitor cells leads to neonatal hydrocephalus in a ciliopathy mouse model	NATURE MEDICINE			English	Article							BIEDL-SYNDROME PROTEINS; UNITED-STATES; PRIMARY CILIA; CONGENITAL HYDROCEPHALUS; GLIA GENERATE; STEM-CELLS; DEFECTS; OLIGODENDROCYTES; PROLIFERATION; MUTATIONS	Hydrocephalus is a common neurological disorder that leads to expansion of the cerebral ventricles and is associated with a high rate of morbidity and mortality. Most neonatal cases are of unknown etiology and are likely to have complex inheritance involving multiple genes and environmental factors. Identifying molecular mechanisms for neonatal hydrocephalus and developing noninvasive treatment modalities are high priorities. Here we use a hydrocephalic mouse model of the human ciliopathy Bardet-Biedl Syndrome (BBS) and identify a role for neural progenitors in the pathogenesis of neonatal hydrocephalus. We found that hydrocephalus in this mouse model is caused by aberrant platelet-derived growth factor receptor alpha (PDGFR-alpha) signaling, resulting in increased apoptosis and impaired proliferation of chondroitin sulfate proteoglycan 4 (also known as neuron-glial antigen 2 or NG2)(+)PDGFR-alpha(+) neural progenitors. Targeting this pathway with lithium treatment rescued NG2(+)PDGFR-alpha(+) progenitor cell proliferation in BBS mutant mice, reducing their ventricular volume. Our findings demonstrate that neural progenitors are crucial in the pathogenesis of neonatal hydrocephalus, and we identify new therapeutic targets for this common neurological disorder.	[Zhang, Qihong; Swiderski, Ruth E.; Keppler-Noreuil, Kim M.; Nishimura, Darryl Y.; Searby, Charles C.; Bugge, Kevin; Sheffield, Val C.] Univ Iowa, Dept Pediat, Div Med Genet, Carver Coll Med, Iowa City, IA 52242 USA; [Carter, Calvin S.] Univ Iowa, Grad Program Neurosci, Carver Coll Med, Iowa City, IA 52242 USA; [Vogel, Timothy W.] Univ Iowa, Dept Neurosurg, Carver Coll Med, Iowa City, IA 52242 USA; [Zhang, Qihong; Seo, Seongjin; Swiderski, Ruth E.; Searby, Charles C.; Bugge, Kevin; Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Carver Coll Med, Iowa City, IA 52242 USA; [Seo, Seongjin] Univ Iowa, Dept Ophthalmol, Carver Coll Med, Iowa City, IA 52242 USA; [Moninger, Thomas O.] Univ Iowa, Cent Microscopy Res Facil, Carver Coll Med, Iowa City, IA 52242 USA; [Cassell, Martin D.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Dept Radiol, Carver Coll Med, Iowa City, IA 52242 USA; [Nopoulos, Peggy] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Div Med Genet, Carver Coll Med, Iowa City, IA 52242 USA.	val-sheffield@uiowa.edu		Searby, Charles/0000-0002-8108-8782; Sheffield, Val/0000-0002-6282-0835; Nopoulos, Peggy/0000-0001-8810-1903; Seo, Seongjin/0000-0002-7908-3210	US National Institutes of Health [R01EY110298, R01EY017168, R01EY022616]; Knight Templar Eye Foundation; Neurosurgery Research and Education Foundation; NATIONAL EYE INSTITUTE [R01EY011298, R01EY022616, R01EY017168] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knight Templar Eye Foundation; Neurosurgery Research and Education Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank L. Biesecker for help obtaining the human MRI scans. We thank K. Rahmouni and D.-F. Guo for help with quantitative RT-PCR and infusion experiments. We thank K. Agassandian for help with dye injection and CSF collection. We thank V. Buffard and L. Qian for their excellent technical assistance. We also appreciate valuable assistance from the University of Iowa Central Microscopy Research Facility. This work was supported in part by US National Institutes of Health grants R01EY110298 and R01EY017168 (to V.C.S.), R01EY022616 (to S.S.), the Knight Templar Eye Foundation (to S.S.) and the Neurosurgery Research and Education Foundation (to T.W.V.). C.S.C. is a National Science Foundation graduate research fellow, and V.C.S. is an Investigator of the Howard Hughes Medical Institute.	Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Baker K, 2011, AM J MED GENET A, V155A, P1, DOI 10.1002/ajmg.a.33773; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; BRUNI JE, 1985, BRAIN RES REV, V9, P1, DOI 10.1016/0165-0173(85)90016-5; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Chi JH, 2005, J NEUROSURG, V103, P113, DOI 10.3171/ped.2005.103.2.0113; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis RE, 2007, P NATL ACAD SCI USA, V104, P19422, DOI 10.1073/pnas.0708571104; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; Drake JM, 2008, NEUROSURGERY, V62, P633, DOI [10.1227/01.NEU.0000296952.38148.49, 10.1227/01.neu.0000316268.05338.5b]; Drake JM, 2000, CHILD NERV SYST, V16, P800, DOI 10.1007/s003810000351; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Keppler-Noreuil KM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-101; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lechtreck KF, 2008, J CELL BIOL, V180, P633, DOI 10.1083/jcb.200710162; Li HF, 2011, J CEREBR BLOOD F MET, V31, P2106, DOI 10.1038/jcbfm.2011.75; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ocbina PJR, 2011, NAT GENET, V43, P547, DOI 10.1038/ng.832; Patwardhan RV, 2005, NEUROSURGERY, V56, P139, DOI 10.1227/01.NEU.0000146206.40375.41; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shannon CN, 2011, J NEUROSURG-PEDIATR, V8, P593, DOI 10.3171/2011.9.PEDS11192; Simon TD, 2008, J NEUROS-PEDIATR, V1, P131, DOI 10.3171/PED/2008/1/2/131; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Su HX, 2007, EXP NEUROL, V206, P296, DOI 10.1016/j.expneurol.2007.05.018; Talos F, 2010, CELL DEATH DIFFER, V17, P1816, DOI 10.1038/cdd.2010.131; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; VANCAMP G, 1993, NAT GENET, V4, P421; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogel P, 2012, VET PATHOL, V49, P166, DOI 10.1177/0300985811415708; Vogel TW, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS12222; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Williams MA, 2007, J NEUROSURG, V107, P345, DOI 10.3171/PED-07/11/345; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5; Zhang QH, 2012, HUM MOL GENET, V21, P1945, DOI 10.1093/hmg/dds004	54	73	75	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1797	+		10.1038/nm.2996	http://dx.doi.org/10.1038/nm.2996			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23160237	Green Accepted			2022-12-27	WOS:000311999800027
J	Kentsis, A; Reed, C; Rice, KL; Sanda, T; Rodig, SJ; Tholouli, E; Christie, A; Valk, PJM; Delwel, R; Ngo, V; Kutok, JL; Dahlberg, SE; Moreau, LA; Byers, RJ; Christensen, JG; Woude, GV; Licht, JD; Kung, AL; Staudt, LM; Look, AT				Kentsis, Alex; Reed, Casie; Rice, Kim L.; Sanda, Takaomi; Rodig, Scott J.; Tholouli, Eleni; Christie, Amanda; Valk, Peter J. M.; Delwel, Ruud; Vu Ngo; Kutok, Jeffery L.; Dahlberg, Suzanne E.; Moreau, Lisa A.; Byers, Richard J.; Christensen, James G.; Woude, George Vande; Licht, Jonathan D.; Kung, Andrew L.; Staudt, Louis M.; Look, A. Thomas			Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia	NATURE MEDICINE			English	Article							CANCER-CELLS; INHIBITOR; SCREEN; AML; CLASSIFICATION; PATHWAYS; TARGETS; FLT3	Although the treatment of acute myeloid leukemia (AML) has improved substantially in the past three decades, more than half of all patients develop disease that is refractory to intensive chemotherapy(1,2). Functional genomics approaches offer a means to discover specific molecules mediating the aberrant growth and survival of cancer cells(3-8). Thus, using a loss-of-function RNA interference genomic screen, we identified the aberrant expression of hepatocyte growth factor (HGF) as a crucial element in AML pathogenesis. We found HGF expression leading to autocrine activation of its receptor tyrosine kinase, MET, in nearly half of the AML cell lines and clinical samples we studied. Genetic depletion of HGF or MET potently inhibited the growth and survival of HGF-expressing AML cells. However, leukemic cells treated with the specific MET kinase inhibitor crizotinib developed resistance resulting from compensatory upregulation of HGF expression, leading to the restoration of MET signaling. In cases of AML where MET is coactivated with other tyrosine kinases, such as fibroblast growth factor receptor 1 (FGFR1)(9), concomitant inhibition of FGFR1 and MET blocked this compensatory HGF upregulation, resulting in sustained logarithmic cell killing both in vitro and in xenograft models in vivo. Our results show a widespread dependence of AML cells on autocrine activation of MET, as well as the key role of compensatory upregulation of HGF expression in maintaining leukemogenic signaling by this receptor. We anticipate that these findings will lead to the design of additional strategies to block adaptive cellular responses that drive compensatory ligand expression as an essential component of the targeted inhibition of oncogenic receptors in human cancers.	[Kentsis, Alex; Reed, Casie; Sanda, Takaomi; Christie, Amanda; Moreau, Lisa A.; Kung, Andrew L.; Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kentsis, Alex; Reed, Casie; Sanda, Takaomi; Christie, Amanda; Moreau, Lisa A.; Kung, Andrew L.; Look, A. Thomas] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Hematol & Oncol, Boston, MA USA; [Rice, Kim L.; Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Rodig, Scott J.; Kutok, Jeffery L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tholouli, Eleni; Byers, Richard J.] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Royal Infirm, Dept Haematol, Manchester, Lancs, England; [Tholouli, Eleni; Byers, Richard J.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Christie, Amanda; Kung, Andrew L.] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Valk, Peter J. M.; Delwel, Ruud] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Vu Ngo] City Hope Natl Med Ctr, Div Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA; [Dahlberg, Suzanne E.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Byers, Richard J.] Univ Manchester, Fac Med & Human Sci, Sch Canc & Enabling Sci, Manchester, Lancs, England; [Christensen, James G.] Pfizer Global Res & Dev, Dept Res Pharmacol, La Jolla, CA USA; [Woude, George Vande] Van Andel Res Inst, Dept Mol Oncol, Grand Rapids, MI USA; [Staudt, Louis M.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Manchester; University of Manchester; Harvard University; Dana-Farber Cancer Institute; Erasmus University Rotterdam; Erasmus MC; City of Hope; Harvard University; Dana-Farber Cancer Institute; University of Manchester; Pfizer; Van Andel Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Look, AT (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	thomas_look@dfci.harvard.edu	Staudt, Louis/AAC-5324-2019; Valk, Peter/AAX-2823-2020; Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020; Rodig, Scott/Y-3889-2019; Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020; Dahlberg, Suzanne/L-2622-2019	Kung, Andrew L/0000-0002-9091-488X; Licht, Jonathan/0000-0002-3942-1369; Dahlberg, Suzanne/0000-0001-5139-831X; Ngo, Vu/0000-0002-9501-6990; Byers, Richard/0000-0003-0796-0365; Kentsis, Alex/0000-0002-8063-9191	US National Institutes of Health grant [K08CA160660]; William Lawrence and Blanche Hughes Foundation; Samuel Waxman Cancer Research Foundation; V Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011007, K08CA160660] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Foundation; Samuel Waxman Cancer Research Foundation; V Foundation; Intramural Research Program of the National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Gutierrez, M. Mansour and E. Gjini for critical discussions and J. Gilbert for editorial advice. This research was supported by the US National Institutes of Health grant K08CA160660 (A.K.), the William Lawrence and Blanche Hughes Foundation (T.S.), the Samuel Waxman Cancer Research Foundation (J.D.L.), the V Foundation (A.T.L.) and the Intramural Research Program of the National Cancer Institute, Center for Cancer Research (L.M.S.).	Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Bernards R, 2006, NAT METHODS, V3, P701, DOI 10.1038/NMETH921; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; CHEN W, 1989, LEUKEMIA, V3, P264; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Gu TL, 2006, BLOOD, V108, P4202, DOI 10.1182/blood-2006-06-026666; Haq R, 2002, CANCER RES, V62, P5076; Heinrichs S, 2009, LEUKEMIA, V23, P1605, DOI 10.1038/leu.2009.82; Loriaux MM, 2008, BLOOD, V111, P4788, DOI 10.1182/blood-2007-07-101394; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mathew P, 2001, NEOPLASIA, V3, P105, DOI 10.1038/sj.neo.7900146; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Sato T, 2011, BLOOD, V117, P3286, DOI 10.1182/blood-2010-01-266742; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Westbrook TF, 2005, COLD SH Q B, V70, P435, DOI 10.1101/sqb.2005.70.031; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Zheng R, 2004, LEUKEMIA RES, V28, P121, DOI 10.1016/S0145-2126(03)00184-X; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	25	137	150	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1118	+		10.1038/nm.2819	http://dx.doi.org/10.1038/nm.2819			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22683780	Green Accepted, Green Submitted			2022-12-27	WOS:000306121600042
J	Debnath, A; Parsonage, D; Andrade, RM; He, C; Cobo, ER; Hirata, K; Chen, S; Garcia-Rivera, G; Orozco, E; Martinez, MB; Gunatilleke, SS; Barrios, AM; Arkin, MR; Poole, LB; McKerrow, JH; Reed, SL				Debnath, Anjan; Parsonage, Derek; Andrade, Rosa M.; He, Chen; Cobo, Eduardo R.; Hirata, Ken; Chen, Steven; Garcia-Rivera, Guillermina; Orozco, Esther; Martinez, Maximo B.; Gunatilleke, Shamila S.; Barrios, Amy M.; Arkin, Michelle R.; Poole, Leslie B.; McKerrow, James H.; Reed, Sharon L.			A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target	NATURE MEDICINE			English	Article							THIOREDOXIN REDUCTASE; METRONIDAZOLE RESISTANCE; SUPEROXIDE-DISMUTASE; CYSTEINE PROTEINASE; OXIDATIVE STRESS; ARSENIC TRIOXIDE; IN-VITRO; METABOLISM; CELLS; GLUTATHIONE	Entamoeba histolytica, a protozoan intestinal parasite, is the causative agent of human amebiasis. Amebiasis is the fourth leading cause of death and the third leading cause of morbidity due to protozoan infections worldwide(1), resulting in similar to 70,000 deaths annually. E. histolytica has been listed by the National Institutes of Health as a category B priority biodefense pathogen in the United States. Treatment relies on metronidazole(2), which has adverse effects(3), and potential resistance of E. histolytica to the drug is an increasing concern(4,5). To facilitate drug screening for this anaerobic protozoan, we developed and validated an automated, high-throughput screen (HTS). This screen identified auranofin, a US Food and Drug Administration (FDA)-approved drug used therapeutically for rheumatoid arthritis, as active against E. histolytica in culture. Auranofin was ten times more potent against E. histolytica than metronidazole. Transcriptional profiling and thioredoxin reductase assays suggested that auranofin targets the E. histolytica thioredoxin reductase, preventing the reduction of thioredoxin and enhancing sensitivity of trophozoites to reactive oxygen-mediated killing. In a mouse model of amebic colitis and a hamster model of amebic liver abscess, oral auranofin markedly decreased the number of parasites, the detrimental host inflammatory response and hepatic damage. This new use of auranofin represents a promising therapy for amebiasis, and the drug has been granted orphan-drug status from the FDA.	[Andrade, Rosa M.; He, Chen; Cobo, Eduardo R.; Hirata, Ken; Reed, Sharon L.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Debnath, Anjan; Gunatilleke, Shamila S.; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94143 USA; [Parsonage, Derek; Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Andrade, Rosa M.; Reed, Sharon L.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Chen, Steven; Arkin, Michelle R.] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 94143 USA; [Garcia-Rivera, Guillermina; Orozco, Esther; Martinez, Maximo B.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Expt Pathol, Mexico City, DF, Mexico; [Barrios, Amy M.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	University of California System; University of California San Diego; University of California System; University of California San Francisco; Wake Forest University; University of California System; University of California San Diego; University of California System; University of California San Francisco; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Utah System of Higher Education; University of Utah	Reed, SL (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	anjan.debnath@ucsf.edu; slreed@ucsd.edu	Cobo, Eduardo R/AAF-2656-2021; arkin, michelle/AAN-4298-2021; Arkin, Michelle/AAO-2009-2021	Cobo, Eduardo R/0000-0001-5450-7673; arkin, michelle/0000-0002-9366-6770; Debnath, Anjan/0000-0001-9294-3927; Poole, Leslie/0000-0003-0334-7328	Sandler Foundation; US National Institute of Allergy and Infectious Diseases [5U01AI077822];  [R01 GM050389]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050389] Funding Source: NIH RePORTER	Sandler Foundation; US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Sandler Foundation and US National Institute of Allergy and Infectious Diseases grant 5U01AI077822; we also acknowledge support from R01 GM050389. E. histolytica microarray slides were kindly provided by S. L. Stanley Jr. (Stony Brook University, New York), and the E. histolytica thioredoxin-specific antibody was a kind gift from S. Adrian-Guerrero (Universidad Nacional del Litoral). We thank G. Hwang and C. Le for their help with the mouse surgery and K. Ang and J. Gut for sharing their expertise.	Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Arias DG, 2007, FREE RADICAL BIO MED, V42, P1496, DOI 10.1016/j.freeradbiomed.2007.02.012; Arnaud-Dabernat S, 2004, EXP CELL RES, V301, P293, DOI 10.1016/j.yexcr.2004.07.026; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Crechet JB, 2003, BIOCHEMISTRY-US, V42, P14903, DOI 10.1021/bi0349928; Davis PH, 2007, MOL BIOCHEM PARASIT, V151, P118, DOI 10.1016/j.molbiopara.2006.10.014; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; Freeman CD, 1997, DRUGS, V54, P679, DOI 10.2165/00003495-199754050-00003; Ghosh S, 2004, J MED CHEM, V47, P175, DOI 10.1021/jm030084x; GOTTLIEB NL, 1986, SCAND J RHEUMATOL, P19; He C, 2010, J BIOL CHEM, V285, P18516, DOI 10.1074/jbc.M109.086181; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; Houpt ER, 2002, J IMMUNOL, V169, P4496, DOI 10.4049/jimmunol.169.8.4496; Ilari A, 2012, AMINO ACIDS, V42, P803, DOI 10.1007/s00726-011-0997-9; Jeelani G, 2010, J BIOL CHEM, V285, P26889, DOI 10.1074/jbc.M110.106310; Krogstad D. J., 1988, Amebiasis: human infection by Entamoeba histolytica., P741; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lobanov AV, 2006, NUCLEIC ACIDS RES, V34, P4012, DOI 10.1093/nar/gkl541; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Makioka A, 2001, PARASITOL RES, V87, P833, DOI 10.1007/s004360100453; MARKIEWICZ VR, 1988, FUND APPL TOXICOL, V11, P277, DOI 10.1016/0272-0590(88)90152-2; Melendez-Lopez SG, 2007, EUKARYOT CELL, V6, P1130, DOI 10.1128/EC.00094-07; Mulrooney SB, 1997, PROTEIN EXPRES PURIF, V9, P372, DOI 10.1006/prep.1996.0698; PARKS RE, 1973, COMP BIOCHEM PHYSIOL, V45, P355, DOI 10.1016/0305-0491(73)90070-9; Samarawickrema NA, 1997, J ANTIMICROB CHEMOTH, V40, P833, DOI 10.1093/jac/40.6.833; Sannella AR, 2008, FEBS LETT, V582, P844, DOI 10.1016/j.febslet.2008.02.028; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Seifert K, 2001, ANTIMICROB AGENTS CH, V45, P1505, DOI 10.1128/AAC.45.5.1505-1510.2001; Sen A, 2007, EUKARYOT CELL, V6, P664, DOI 10.1128/EC.00308-06; Singh S, 2005, BIOORG MED CHEM LETT, V15, P5424, DOI 10.1016/j.bmcl.2005.08.103; Sok J, 2001, CELL STRESS CHAPERON, V6, P6, DOI 10.1379/1466-1268(2001)006<0006:AIRAPA>2.0.CO;2; Talbot S, 2008, BRIT J PHARMACOL, V154, P940, DOI 10.1038/bjp.2008.161; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Wassmann C, 1999, J BIOL CHEM, V274, P26051, DOI 10.1074/jbc.274.37.26051; WHO (World Health Organization), 1998, WORLD HLTH REP 1998; Williams CH, 2000, EUR J BIOCHEM, V267, P6110, DOI 10.1046/j.1432-1327.2000.01702.x	41	221	228	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					956	+		10.1038/nm.2758	http://dx.doi.org/10.1038/nm.2758			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22610278	Green Submitted, Green Accepted			2022-12-27	WOS:000305116600034
J	Bernet, JD; Doles, JD; Hall, JK; Tanaka, KK; Carter, TA; Olwin, BB				Bernet, Jennifer D.; Doles, Jason D.; Hall, John K.; Tanaka, Kathleen Kelly; Carter, Thomas A.; Olwin, Bradley B.			p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice	NATURE MEDICINE			English	Article							FIBROBLAST GROWTH-FACTORS; SATELLITE CELLS; HEPARAN-SULFATE; MYOBLAST PROLIFERATION; PROGENITOR CELLS; GENE-EXPRESSION; SARCOPENIA; YOUNG; REGENERATION; REQUIREMENT	Skeletal muscle aging results in a gradual loss of skeletal muscle mass, skeletal muscle function and regenerative capacity, which can lead to sarcopenia and increased mortality. Although the mechanisms underlying sarcopenia remain unclear, the skeletal muscle stem cell, or satellite cell, is required for muscle regeneration. Therefore, identification of signaling pathways affecting satellite cell function during aging may provide insights into therapeutic targets for combating sarcopenia. Here, we show that a cell-autonomous loss in self-renewal occurs via alterations in fibroblast growth factor receptor-1, p38 alpha and p38 beta mitogen-activated protein kinase signaling in satellite cells from aged mice. We further demonstrate that pharmacological manipulation of these pathways can ameliorate age-associated self-renewal defects. Thus, our data highlight an age-associated deregulation of a satellite cell homeostatic network and reveal potential therapeutic opportunities for the treatment of progressive muscle wasting.	[Bernet, Jennifer D.; Doles, Jason D.; Hall, John K.; Tanaka, Kathleen Kelly; Carter, Thomas A.; Olwin, Bradley B.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Olwin, BB (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	bradley.olwin@colorado.edu	Olwin, Bradley B/A-1333-2014	Carter, Thomas/0000-0001-7081-3259; Doles, Jason/0000-0002-6830-708X; Kelly, Kathleen/0000-0002-1102-6279	US National Institutes of Health [AR49446, AG040074]; Ellison Medical Foundation; National Institutes of Health [T32GM007135]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040074] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Olwin lab members, especially B. Pawlikowski, M. Hall and A. Cadwallader, for revising the manuscript and helpful discussions. We thank T. Vogler, T. McClure and M. Palmer for technical assistance. N. Dalla Betta helped with mouse maintenance. C. English and the University of Colorado Boulder Molecular, Cellular and Developmental Biology Light Microscopy Core provided facilities and assistance. D.M. Spencer developed the inducible FGFR1 construct available from Addgene. This work was supported by grants from the US National Institutes of Health (AR49446 and AG040074) and The Ellison Medical Foundation to B.B.O. and from the National Institutes of Health (T32GM007135) to J.D.B.	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Brien P, 2013, STEM CELLS, V31, P1597, DOI 10.1002/stem.1399; BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436; Carlson BM, 1996, J GERONTOL A-BIOL, V51, pB43, DOI 10.1093/gerona/51A.1.B43; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; Faulkner JA, 2007, CLIN EXP PHARMACOL P, V34, P1091, DOI 10.1111/j.1440-1681.2007.04752.x; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Hannon K, 1996, J CELL BIOL, V132, P1151, DOI 10.1083/jcb.132.6.1151; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805; Kudla AJ, 1998, J CELL BIOL, V142, P241, DOI 10.1083/jcb.142.1.241; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Marsh DR, 1997, J APPL PHYSIOL, V83, P1270, DOI 10.1152/jappl.1997.83.4.1270; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEACHIE JK, 1995, CELL TISSUE RES, V280, P277; Huynh MB, 2012, J BIOL CHEM, V287, P11363, DOI 10.1074/jbc.M111.335901; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Roubenoff R, 2000, J Nutr Health Aging, V4, P140; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; SADEH M, 1988, J NEUROL SCI, V87, P67, DOI 10.1016/0022-510X(88)90055-X; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Whitney ML, 2001, J BIOL CHEM, V276, P41191, DOI 10.1074/jbc.M103191200; Williamson KA, 2013, AGING CELL, V12, P139, DOI 10.1111/acel.12031; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	45	343	352	6	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					265	271		10.1038/nm.3465	http://dx.doi.org/10.1038/nm.3465			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24531379	Green Accepted			2022-12-27	WOS:000332595600021
J	Liu, YW; Carlsson, R; Comabella, M; Wang, JY; Kosicki, M; Carrion, B; Hasan, M; Wu, XD; Montalban, X; Dziegiel, MH; Sellebjerg, F; Sorensen, PS; Helin, K; Issazadeh-Navikas, S				Liu, Yawei; Carlsson, Robert; Comabella, Manuel; Wang, JunYang; Kosicki, Michael; Carrion, Belinda; Hasan, Maruf; Wu, Xudong; Montalban, Xavier; Dziegiel, Morten Hanefeld; Sellebjerg, Finn; Sorensen, Per Soelberg; Helin, Kristian; Issazadeh-Navikas, Shohreh			FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; REMITTING MULTIPLE-SCLEROSIS; ANTIGEN-PRESENTING CELLS; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTIONAL SIGNATURE; PD-L1 EXPRESSION; INTERFERON-BETA; IN-VIVO; ACTIVATION; INDUCTION	The defective generation or function of regulatory T (T-reg) cells in autoimmune disease contributes to chronic inflammation and tissue injury. We report the identification of FoxA1 as a transcription factor in T cells that, after ectopic expression, confers suppressive properties in a newly identified T-reg cell population, herein called FoxA1(+) T-reg cells. FoxA1 bound to the Pdl1 promoter, inducing programmed cell death ligand 1 (Pd-I1) expression, which was essential for the FoxA1(+) T-reg cells to kill activated T cells. FoxA1(+) T-reg cells develop primarily in the central nervous system in response to autoimmune inflammation, have a distinct transcriptional profile and are CD4(+)FoxA1(+)CD47(+)CD69(+)PD-L1(h1)FoxP3(-). Adoptive transfer of stable FoxA1(+) T-reg cells inhibited experimental autoimmune encephalomyelitis in a FoxA1-and Pd-I1-dependent manner. The development of FoxA1(+) T-reg cells is induced by interferon-beta (IFN-beta) and requires T cell-intrinsic IFN-alpha/beta receptor (Ifnar) signaling, as the frequency of FoxA1(+) T-reg cells was reduced in Ifnb(-/-) and Ifnar(-/-) mice. In individuals with relapsing-remitting multiple sclerosis, clinical response to treatment with IFN-beta was associated with an increased frequency of suppressive FoxA1(+) T-reg cells in the blood. These findings suggest that FoxA1 is a lineage-specification factor that is induced by IFN-beta and supports the differentiation and suppressive function of FoxA1(+) T-reg cells.	[Liu, Yawei; Carlsson, Robert; Wang, JunYang; Kosicki, Michael; Carrion, Belinda; Hasan, Maruf; Wu, Xudong; Helin, Kristian; Issazadeh-Navikas, Shohreh] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Comabella, Manuel; Montalban, Xavier] Univ Autonoma Barcelona, HUVH, Unitat Neuroimmunol Clin, Ctr Esclerosi Multiple Catalunya CEM Cat, E-08193 Barcelona, Spain; [Dziegiel, Morten Hanefeld] Copenhagen Univ Hosp, Blood Bank, Copenhagen, Denmark; [Sellebjerg, Finn; Sorensen, Per Soelberg] Univ Copenhagen, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark; [Sellebjerg, Finn; Sorensen, Per Soelberg] Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark	University of Copenhagen; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Issazadeh-Navikas, S (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	shohreh.issazadeh@bric.ku.dk	Issazadeh-Navikas, Shohreh/AAI-7900-2021; Helin, Kristian/HDM-8306-2022; Helin, Kristian/K-2526-2019; Montalban, Xavier/J-5938-2016; Wu, Xudong/ABG-3732-2020	Helin, Kristian/0000-0003-1975-6097; Montalban, Xavier/0000-0002-0098-9918; Wu, Xudong/0000-0001-9594-479X; Hasan, Maruf/0000-0001-9169-5423; Sellebjerg, Finn/0000-0002-1333-9623; Comabella Lopez, Manuel/0000-0002-2373-6657; Sorensen, Per Soelberg/0000-0002-2818-3780; Carrion, Belinda/0000-0002-4245-1139; Kosicki, Michael/0000-0001-7173-8852; Dziegiel, Morten Hanefeld/0000-0001-8034-1523; Carlsson, Robert/0000-0001-5955-2916	Lundbeck Foundation in Denmark; Danish Multiple Sclerosis Society; Danish Council for Independent Research-Medical Sciences; Danish Cancer Society; Swedish Research Council-Medicine; Bibi and Nils Jensen Foundation; Lundbeck Foundation [R108-2012-10312] Funding Source: researchfish	Lundbeck Foundation in Denmark; Danish Multiple Sclerosis Society; Danish Council for Independent Research-Medical Sciences(Det Frie Forskningsrad (DFF)); Danish Cancer Society(Danish Cancer Society); Swedish Research Council-Medicine(Swedish Research Council); Bibi and Nils Jensen Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from The Lundbeck Foundation in Denmark, The Danish Multiple Sclerosis Society, The Danish Council for Independent Research-Medical Sciences, The Danish Cancer Society, The Swedish Research Council-Medicine and the Bibi and Nils Jensen Foundation to S.I.-N. We thank H. Wekerle, U. Grohmann and M. Prinz for valuable discussion and suggestions.	Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Bach JF, 2003, ANN NY ACAD SCI, V998, P161, DOI 10.1196/annals.1254.017; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Hesse D, 2011, EUR J NEUROL, V18, P266, DOI 10.1111/j.1468-1331.2010.03116.x; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Himmel ME, 2012, IMMUNOLOGY, V136, P115, DOI 10.1111/j.1365-2567.2012.03572.x; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; JAIN JN, 1994, MOL CELL BIOL, V14, P1566, DOI 10.1128/MCB.14.3.1566; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Kaestner KH, 2010, CURR OPIN GENET DEV, V20, P527, DOI 10.1016/j.gde.2010.06.005; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kumar V, 1996, J EXP MED, V184, P1609, DOI 10.1084/jem.184.5.1609; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Liu YW, 2013, J NEUROSCI, V33, P14231, DOI 10.1523/JNEUROSCI.5812-12.2013; Liu YW, 2010, IMMUNOL CELL BIOL, V88, P468, DOI 10.1038/icb.2009.111; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Motallebipour M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r129; Nakshatri H, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001008; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Porrini AM, 1998, J NEUROIMMUNOL, V81, P109, DOI 10.1016/S0165-5728(97)00165-3; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; QIAN XB, 1995, MOL CELL BIOL, V15, P1364; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sandner SE, 2005, J IMMUNOL, V174, P3408, DOI 10.4049/jimmunol.174.6.3408; Sundrud MS, 2010, CURR OPIN IMMUNOL, V22, P286, DOI 10.1016/j.coi.2010.03.006; Taube JH, 2010, J BIOL CHEM, V285, P16135, DOI 10.1074/jbc.M109.088096; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Teige I, 2006, J IMMUNOL, V177, P3542, DOI 10.4049/jimmunol.177.6.3542; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226	53	111	116	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					272	282		10.1038/nm.3485	http://dx.doi.org/10.1038/nm.3485			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24531377				2022-12-27	WOS:000332595600022
J	Schwartz, MW; Tschop, M; Zeltser, LM				Schwartz, Michael W.; Tschoep, Matthias; Zeltser, Lori M.			A mother's influence on metabolic disorders	NATURE MEDICINE			English	Editorial Material							HYPOTHALAMIC NEURONS; LEPTIN; DIET	Human epidemiological studies have revealed that maternal obesity predisposes offspring to metabolic disorders, though little is known about the mechanism that causes this phenomenon. In a step forward, Vogt et al. have shown in mice that the offspring of mothers fed a high-fat diet during lactation show an alteration in the number of projections in nerves in the hypothalamus in the brain and in the pancreas. These offspring are predisposed to be obese and develop diabetes, and the mechanism by which these connections are altered seems to be through insulin signaling. Here we asked three experts what the implications of these findings might be to humans.	[Schwartz, Michael W.] Univ Washington, Seattle, WA 98195 USA; [Tschoep, Matthias] Tech Univ Munich, Helmholtz Diabet Ctr, Helmholtz Zentrum Munchen, D-80290 Munich, Germany; [Tschoep, Matthias] Tech Univ Munich, Div Metab Dis, D-80290 Munich, Germany; [Zeltser, Lori M.] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY USA; [Zeltser, Lori M.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Columbia University; Columbia University			Tschoep, Matthias H/I-5443-2014					Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Bouret SG, 2007, J NEUROENDOCRINOL, V19, P575, DOI 10.1111/j.1365-2826.2007.01563.x; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Bouyer K, 2013, J NEUROSCI, V33, P840, DOI 10.1523/JNEUROSCI.3215-12.2013; Carmody JS, 2011, OBESITY, V19, P492, DOI 10.1038/oby.2010.245; Figueroa D, 2013, OBSTET GYNECOL, V121, P1241, DOI 10.1097/AOG.0b013e31829277f5; Grayson BE, 2010, FRONT NEUROENDOCRIN, V31, P16, DOI 10.1016/j.yfrne.2009.10.001; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008	11	2	2	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					244	245		10.1038/nm.3502	http://dx.doi.org/10.1038/nm.3502			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24603795				2022-12-27	WOS:000332595600016
J	Chen, WQ; Wang, RW; Chen, BY; Zhong, XW; Kong, HH; Bai, YL; Zhou, Q; Xie, CH; Zhang, JQ; Guo, A; Tian, XX; Jones, PP; O'Mara, ML; Liu, YJ; Mi, T; Zhang, L; Bolstad, J; Semeniuk, L; Cheng, HQ; Zhang, JL; Chen, J; Tieleman, DP; Gillis, AM; Duff, HJ; Fill, M; Song, LS; Chen, SRW				Chen, Wenqian; Wang, Ruiwu; Chen, Biyi; Zhong, Xiaowei; Kong, Huihui; Bai, Yunlong; Zhou, Qiang; Xie, Cuihong; Zhang, Jingqun; Guo, Ang; Tian, Xixi; Jones, Peter P.; O'Mara, Megan L.; Liu, Yingjie; Mi, Tao; Zhang, Lin; Bolstad, Jeff; Semeniuk, Lisa; Cheng, Hongqiang; Zhang, Jianlin; Chen, Ju; Tieleman, D. Peter; Gillis, Anne M.; Duff, Henry J.; Fill, Michael; Song, Long-Sheng; Chen, S. R. Wayne			The ryanodine receptor store-sensing gate controls Ca2+ waves and Ca2+-triggered arrhythmias	NATURE MEDICINE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; RETICULUM CA2+-RELEASE CHANNEL; SPONTANEOUS CALCIUM-RELEASE; SARCOPLASMIC-RETICULUM; LUMINAL CA2+; CARDIAC-MUSCLE; SUDDEN-DEATH; CRYSTAL-STRUCTURE; PURKINJE-FIBERS; MOLECULAR-BASIS	Spontaneous Ca2+ release from intracellular stores is important for various physiological and pathological processes. In cardiac muscle cells, spontaneous store overload induced Ca2+ release (SOICR) can result in Ca2+ waves, a major cause of ventricular tachyarrhythmias (VTs) and sudden death. The molecular mechanism underlying SOICR has been a mystery for decades. Here we show that a point mutation, E4872A, in the helix bundle crossing region (the proposed gate) of the cardiac ryanodine receptor (RyR2) completely abolishes luminal, but not cytosolic, Ca2+ activation of RyR2. The introduction of metal-binding histidines at this site converts RyR2 into a lumina! Ni2+-gated channel. Mouse hearts harboring a heterozygous RyR2 mutation at this site (E4872Q) are resistant to SOICR and are completely protected against Ca2+-triggered VTs. These data show that the RyR2 gate directly senses lumina! (store) Ca2+, explaining the regulation of RyR2 by luminal Ca2+, the initiation of Ca2+ waves and Ca2+-triggered arrhythmias. This newly identified store-sensing gate structure is conserved in all RyR and inositol 1,4,5-trisphosphate receptor isoforms.	[Chen, Wenqian; Wang, Ruiwu; Zhong, Xiaowei; Kong, Huihui; Bai, Yunlong; Zhou, Qiang; Xie, Cuihong; Tian, Xixi; Jones, Peter P.; Liu, Yingjie; Mi, Tao; Zhang, Lin; Bolstad, Jeff; Semeniuk, Lisa; Gillis, Anne M.; Duff, Henry J.; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Chen, Biyi; Guo, Ang; Song, Long-Sheng] Univ Iowa, Dept Internal Med, Carver Coll Med, Di Cardiovasc Med, Iowa City, IA 52242 USA; [Zhang, Jingqun; Fill, Michael; Chen, S. R. Wayne] Rush Univ, Dept Mol Biophys & Physiol, Med Ctr, Chicago, IL 60612 USA; [O'Mara, Megan L.; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [O'Mara, Megan L.; Tieleman, D. Peter] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada; [Cheng, Hongqiang; Zhang, Jianlin; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Iowa; Rush University; University of Calgary; University of Calgary; University of California System; University of California San Diego	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.	swchen@ucalgary.ca	Chen, Ju/E-5579-2011; Tieleman, D. Peter/A-4790-2011; O'Mara, Megan/ABF-8913-2020; Jones, Peter P/G-2618-2013; Chen, Biyi/AAF-3077-2021; O'Mara, Megan/AAY-5934-2021; O'Mara, Megan L/A-4962-2011; Guo, Ang/M-3549-2013	Tieleman, D. Peter/0000-0001-5507-0688; O'Mara, Megan/0000-0002-8764-1585; O'Mara, Megan L/0000-0002-8764-1585; Song, Long-Sheng/0000-0002-6035-8106; Jones, Pete/0000-0001-7977-1737; Guo, Ang/0000-0002-5551-2279; Cheng, Hongqiang/0000-0001-9662-1570	Canadian Institutes of Health Research (CIHR); US National Institutes of Health; Heart and Stroke Foundation of Alberta; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Studentship Award; AIHS; Heart and Stroke Foundation; CIHR; AIHS Scientist Awards; Alberta Innovates [201400104, 201001238] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090905, R01HL066100, R01HL082902, R01HL106968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111397] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Alberta; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research; Alberta Innovates-Health Solutions (AIHS) Studentship Award; AIHS; Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR)); AIHS Scientist Awards; Alberta Innovates; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR) to H.J.D., D.P.T. and S.R.W.C., the US National Institutes of Health to J.C., L.-S.S., M.F. and S.R.W.C., the Heart and Stroke Foundation of Alberta to A.M.G., H.J.D. and S.R.W.C. and the Canada Foundation for Innovation (S.R.W.C.) and by the Heart and Stroke Foundation/Libin Cardiovascular Institute Professorship in Cardiovascular Research (S.R.W.C.). We are grateful for generous donations from the King family, the Howarth family and the Libin Cardiovascular Institute of Alberta. We are also grateful to W.C. Claycomb from the Louisiana State University Health Sciences Center for kindly providing the HL-1 cardiac cell line and to J. Lytton from the University of Calgary for the gift of the beta-actin-specific antibody. W.C., X.Z. and X.T. are recipients of the Alberta Innovates-Health Solutions (AIHS) Studentship Award; P.P.J. is a recipient of AIHS and Heart and Stroke Foundation Fellowship Awards; M.L.O. is the recipient of a CIHR Fellowship Award; and H.J.D., D.P.T. and S.R.W.C. are recipients of AIHS Scientist Awards.	BASSANI JWM, 1995, AM J PHYSIOL-CELL PH, V268, pC1313, DOI 10.1152/ajpcell.1995.268.5.C1313; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2002, CIRC RES, V90, P14, DOI 10.1161/res.90.1.14; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Dabertrand F, 2008, CELL CALCIUM, V44, P180, DOI 10.1016/j.ceca.2007.11.009; Diaz ME, 1997, J PHYSIOL-LONDON, V501, P3, DOI 10.1111/j.1469-7793.1997.003bo.x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eisner DA, 2009, CIRC J, V73, P1561, DOI 10.1253/circj.CJ-09-0478; FABIATO A, 1992, ADV EXP MED BIOL, V311, P245; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; KASS RS, 1982, BIOPHYS J, V38, P259, DOI 10.1016/S0006-3495(82)84557-8; Keller M, 2007, CARDIOVASC RES, V74, P39, DOI 10.1016/j.cardiores.2007.02.006; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; Kong HH, 2007, BIOPHYS J, V92, P2757, DOI 10.1529/biophysj.106.100545; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1; Liu YW, 2010, J GEN PHYSIOL, V135, P15, DOI 10.1085/jgp.200910273; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MARBAN E, 1986, J CLIN INVEST, V78, P1185, DOI 10.1172/JCI112701; MISSIAEN L, 1991, NATURE, V352, P241, DOI 10.1038/352241a0; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; MITCHELL RD, 1984, J BIOL CHEM, V259, P1073; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; NUNN DL, 1992, MOL PHARMACOL, V41, P115; ORCHARD CH, 1983, NATURE, V304, P735, DOI 10.1038/304735a0; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Schlotthauer K, 2000, CIRC RES, V87, P774, DOI 10.1161/01.RES.87.9.774; Sedej S, 2010, CARDIOVASC RES, V87, P50, DOI 10.1093/cvr/cvq007; Shannon TR, 2000, BIOPHYS J, V78, P334, DOI 10.1016/S0006-3495(00)76596-9; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; SITSAPESAN R, 1995, J MEMBRANE BIOL, V146, P133, DOI 10.1007/BF00238004; SITSAPESAN R, 1994, J MEMBRANE BIOL, V137, P215; Sitsapesan R, 1997, J MEMBRANE BIOL, V159, P179, DOI 10.1007/s002329900281; STERN MD, 1983, J GEN PHYSIOL, V82, P119, DOI 10.1085/jgp.82.1.119; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; WIER WG, 1983, P NATL ACAD SCI-BIOL, V80, P7367, DOI 10.1073/pnas.80.23.7367; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 1998, BIOPHYS J, V75, P2302, DOI 10.1016/S0006-3495(98)77674-X; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou JS, 2004, J GEN PHYSIOL, V124, P409, DOI 10.1085/jgp.200409105; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	58	130	132	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					184	192		10.1038/nm.3440	http://dx.doi.org/10.1038/nm.3440			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24441828	Green Accepted			2022-12-27	WOS:000330915000020
J	McMichael, A; Picker, LJ; Moore, JP; Burton, DR				McMichael, Andrew; Picker, Louis J.; Moore, John P.; Burton, Dennis R.			Another HIV vaccine failure: where to next?	NATURE MEDICINE			English	Editorial Material							TEST-OF-CONCEPT; EFFICACY; TRIAL; STEP		[McMichael, Andrew] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Moore, John P.] Weill Cornell Med Coll, New York, NY USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Oxford; Oregon Health & Science University; Cornell University; Scripps Research Institute	McMichael, A (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.							Ammann AJ, 2012, JAIDS-J ACQ IMM DEF, V61, pE8, DOI 10.1097/QAI.0b013e318253a5dc; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Gray G, 2010, CURR OPIN HIV AIDS, V5, P357, DOI 10.1097/COH.0b013e32833d2d2b; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lopker M, 2013, J VIROL, V87, P5477, DOI 10.1128/JVI.03419-12; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759	15	16	16	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1576	1577		10.1038/nm.3413	http://dx.doi.org/10.1038/nm.3413			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24309655	Bronze			2022-12-27	WOS:000328181400024
J	Lito, P; Rosen, N; Solit, DB				Lito, Piro; Rosen, Neal; Solit, David B.			Tumor adaptation and resistance to RAF inhibitors	NATURE MEDICINE			English	Review							SQUAMOUS-CELL CARCINOMAS; PROTEIN PHOSPHATASE 2A; CYSTEINE-RICH DOMAIN; B-RAF; ACQUIRED-RESISTANCE; FEEDBACK INHIBITION; ONCOGENIC RAS; PHOSPHORYLATION SITES; BIOLOGICAL-ACTIVITY; IMPROVED SURVIVAL	RAF kinase inhibitors have substantial therapeutic effects in patients with BRAF-mutant melanoma. However, only rarely do tumors regress completely, and the therapeutic effects are often temporary. Several mechanisms of resistance to RAF inhibitors have been proposed. The majority of these cause ERK signaling to become insensitive to treatment with RAF inhibitors by increasing the amount of RAF dimers in cells, whereas others bypass the dependence of the tumor on mutant RAF. One motivation for studying mechanisms of drug resistance is that such efforts may suggest new therapeutic targets or rational combination strategies that delay or prevent the emergence of drug-resistant clones. Here, we review the current model of RAF inhibitor resistance with a focus on the implications of this model on ongoing laboratory and clinical efforts to develop more effective therapeutic strategies for patients with BRAF-mutant tumors.	[Lito, Piro; Rosen, Neal; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Lito, Piro; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10021 USA; [Solit, David B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	solitd@mskcc.org	Solit, David B./AAC-5309-2019; Rosen, Neal/ABF-2677-2020					Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Andreadi C, 2012, GENE DEV, V26, P1945, DOI 10.1101/gad.193458.112; Antony R, 2013, CANCER RES, V73, P4840, DOI 10.1158/0008-5472.CAN-12-4089; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Callahan MK, 2012, NEW ENGL J MED, V367, P2316, DOI 10.1056/NEJMoa1208958; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chong HR, 2003, J BIOL CHEM, V278, P36269, DOI 10.1074/jbc.M212803200; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Douville E, 1997, ONCOGENE, V15, P373, DOI 10.1038/sj.onc.1201214; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; KOLCH W, 1991, NATURE, V349, P426, DOI 10.1038/349426a0; Kopetz S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3534; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lacouture ME, 2012, J CLIN ONCOL, V30, P329, DOI 10.1200/JCO.2011.38.2895; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Luo ZJ, 1996, NATURE, V383, P181, DOI 10.1038/383181a0; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nimnual Anjaruwee, 2002, Sci STKE, V2002, ppe36, DOI 10.1126/stke.2002.145.pe36; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; Planchard D, 2013, ASCO M, V31, P8009; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Sasaki A, 2003, CELL CYCLE, V2, P281, DOI 10.4161/cc.2.4.418; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shi HB, 2012, CANCER DISCOV, V2, P414, DOI 10.1158/2159-8290.CD-12-0022; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Smalley KSM, 2008, MOL CANCER THER, V7, P2876, DOI 10.1158/1535-7163.MCT-08-0431; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Udell CM, 2011, CELL MOL LIFE SCI, V68, P553, DOI 10.1007/s00018-010-0520-6; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Weisbart RH, 2013, MOL IMMUNOL, V55, P247, DOI 10.1016/j.molimm.2013.02.001; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whittaker S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000758; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yang H, 2012, CANCER RES, V72, P779, DOI 10.1158/0008-5472.CAN-11-2941; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	110	398	412	1	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1401	1409		10.1038/nm.3392	http://dx.doi.org/10.1038/nm.3392			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202393				2022-12-27	WOS:000326920300018
J	Nihalani, D; Susztak, K				Nihalani, Deepak; Susztak, Katalin			Sirt1-Claudin-1 crosstalk regulates renal function	NATURE MEDICINE			English	Editorial Material							DIABETIC-NEPHROPATHY; GLOMERULAR-DISEASE; PODOCYTES; APOPTOSIS; VIEW		[Nihalani, Deepak; Susztak, Katalin] Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Nihalani, D (corresponding author), Univ Penn, Renal Electrolyte & Hypertens Div, Perelman Sch Med, Philadelphia, PA 19104 USA.	ksusztak@mail.med.upenn.edu	Susztak, Katalin/ABE-7474-2021; nihalani, deepak/AAK-9453-2020	Susztak, Katalin/0000-0002-1005-3726; 				Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; Gart P, 2012, EXP CELL RES, V318, P955, DOI 10.1016/j.yexcr.2012.02.030; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Hall JA, 2013, J CLIN INVEST, V123, P973, DOI 10.1172/JCI64094; HARRIS PJ, 1986, J HYPERTENS, V4, pS424; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	13	19	19	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1371	1372		10.1038/nm.3386	http://dx.doi.org/10.1038/nm.3386			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202384				2022-12-27	WOS:000326920300013
J	Bittner, S; Ruck, T; Schuhmann, MK; Herrmann, AM; Maati, HMO; Bobak, N; Gobel, K; Langhauser, F; Stegner, D; Ehling, P; Borsotto, M; Pape, HC; Nieswandt, B; Kleinschnitz, C; Heurteaux, C; Galla, HJ; Budde, T; Wiendl, H; Meuth, SG				Bittner, Stefan; Ruck, Tobias; Schuhmann, Michael K.; Herrmann, Alexander M.; Maati, Hamid Moha Ou; Bobak, Nicole; Goebel, Kerstin; Langhauser, Friederike; Stegner, David; Ehling, Petra; Borsotto, Marc; Pape, Hans-Christian; Nieswandt, Bernhard; Kleinschnitz, Christoph; Heurteaux, Catherine; Galla, Hans-Joachim; Budde, Thomas; Wiendl, Heinz; Meuth, Sven G.			Endothelial TWIK-related potassium channel-1 (TREK 1) regulates immune-cell trafficking into the CNS	NATURE MEDICINE			English	Article							BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; FATTY-ACIDS	The blood-brain barrier (BBB) is an integral part of the neurovascular unit (NVU). The NVU is comprised of endothelial cells that are interconnected by tight junctions resting on a parenchymal basement membrane ensheathed by pericytes, smooth muscle cells and a layer of astrocyte end feet(1). Circulating blood cells, such as leukocytes, complete the NVU2. BBB disruption is common in several neurological diseases, but the molecular mechanisms involved remain largely unknown(3). We analyzed the role of TWIK-related potassium channel-1 (TREK1, encoded by KCNK2) in human and mouse endothelial cells and the BBB. TREK1 was downregulated in endothelial cells by treatment with interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha). Blocking TREK1 increased leukocyte transmigration, whereas TREK1 activation had the opposite effect. We identified altered mitogen-activated protein (MAP) kinase signaling, actin remodeling and upregulation of cellular adhesion molecules as potential mechanisms of increased migration in TREK1-deficient (Kcnk2(-/-)) cells. In Kcnk2(-/-) mice, brain endothelial cells showed an upregulation of the cellular adhesion molecules ICAM1, VCAM1 and PECAM1 and facilitated leukocyte trafficking into the CNS. Following the induction of experimental autoimmune encephalomyelitis (EAE) by immunization with a myelin oligodendrocyte protein (MOG)(35-55) peptide, Kcnk2(-/-) mice showed higher EAE severity scores that were accompanied by increased cellular infiltrates in the central nervous system (CNS). The severity of EAE was attenuated in mice given the amyotrophic lateral sclerosis drug riluzole or fed a diet enriched with linseed oil (which contains the TREK-1 activating omega-3 fatty acid alpha-linolenic acid). These beneficial effects were reduced in Kcnk2(-/-) mice, suggesting TREK-1 activating compounds may be used therapeutically to treat diseases related to BBB dysfunction.	[Bittner, Stefan; Ruck, Tobias; Schuhmann, Michael K.; Herrmann, Alexander M.; Bobak, Nicole; Goebel, Kerstin; Ehling, Petra; Wiendl, Heinz; Meuth, Sven G.] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Schuhmann, Michael K.; Langhauser, Friederike; Stegner, David; Kleinschnitz, Christoph] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Maati, Hamid Moha Ou; Borsotto, Marc; Heurteaux, Catherine] Univ Nice Sophia Antipolis, CNRS, Inst Pharmacol Mol & Cellulaire, Valbonne, France; [Stegner, David; Nieswandt, Bernhard] Univ Hosp Wurzburg, Chair Vasc Med, Wurzburg, Germany; [Stegner, David; Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Ehling, Petra] Univ Munster, Inst Physiol Neuropathophysiol 1, D-48149 Munster, Germany; [Galla, Hans-Joachim; Budde, Thomas] Univ Munster, Inst Physiol 1, D-48149 Munster, Germany; [Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster; University of Wurzburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Wurzburg; University of Wurzburg; University of Munster; University of Munster; University of Munster	Bittner, S (corresponding author), Univ Munster, Dept Neurol, D-48149 Munster, Germany.	stefan.bittner@ukmuenster.de; sven.meuth@ukmuenster.de	Stegner, David/AAA-4948-2019; BORSOTTO, Marc/M-5096-2016; Ruck, Tobias/AAH-4627-2021; Ruck, Tobias/AAQ-3703-2020; Wiendl, Heinz/AAX-6041-2021; HEURTEAUX, Catherine/M-4947-2016; Meuth, Sven G/HHM-8941-2022; Maati, Hamid Moha ou/M-2240-2019	Stegner, David/0000-0003-1059-9865; BORSOTTO, Marc/0000-0002-1302-7419; HEURTEAUX, Catherine/0000-0002-9741-9777; Meuth, Sven G/0000-0003-2571-3501; Maati, Hamid Moha ou/0000-0002-8711-1760; Bittner, Stefan/0000-0003-2179-3655; Kleinschnitz, Christoph/0000-0002-1650-8875; Wiendl, Heinz/0000-0003-4310-3432; Ruck, Tobias/0000-0001-6332-8650	Deutsche Forschungsgemeinschaft [SFB TR128, TP B1, TP B6, SFB 1009, TP A3, FOR1086, TP2, ME3283/2-1, SFB688 TP A13]; Bundesministerium fur Bildung und Forschung (Kompetenznetzwerk Multiple Sclerosis) [01G10907, 01DJ12103]; Else-Kroner-Fresenius Stiftung; Interdisciplinary Center for Clinical Research (IZKF) Munster [SEED 03/12]; excellence cluster 'Cells in motion' (CIM); CNRS; LabEx Ionic channel Science and Therapeutics; Agence Nationale de la Recherche-ANR Emergence [ANR-11-EMMA]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Kompetenznetzwerk Multiple Sclerosis)(Federal Ministry of Education & Research (BMBF)); Else-Kroner-Fresenius Stiftung; Interdisciplinary Center for Clinical Research (IZKF) Munster; excellence cluster 'Cells in motion' (CIM); CNRS(Centre National de la Recherche Scientifique (CNRS)); LabEx Ionic channel Science and Therapeutics; Agence Nationale de la Recherche-ANR Emergence(French National Research Agency (ANR))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TR128, TP B1 to H.W., SFB TR128, TP B6 to S.G.M., T.B. and H.-C.P.; SFB 1009, TP A3 to H.W.; FOR1086, TP2 to T.B. and S.G.M.; ME3283/2-1 to S.G.M.; and SFB688 TP A13 to C.K.), the Bundesministerium fur Bildung und Forschung (Kompetenznetzwerk Multiple Sclerosis, 01G10907 to H.W. and 01DJ12103 to TB. and S.G.M.), the Else-Kroner-Fresenius Stiftung (C.K., S.G.M. and S.B.), the Interdisciplinary Center for Clinical Research (IZKF) Munster (SEED 03/12 to S.B.), the excellence cluster 'Cells in motion' (CIM, to S.G.M., H.W., S.B., T.B. and H.-C.P.), the CNRS and the LabEx Ionic channel Science and Therapeutics (M.B. and C.H.) and the Agence Nationale de la Recherche-ANR Emergence (ANR-11-EMMA to H.M.o.M.). We thank B. Reuter, E. Nass and J. Budde for excellent technical assistance and the UK Multiple Sclerosis Tissue Bank (R. Reynolds) for human brain tissue. The endothelial cell line bEND.5 was a kind gift from D. Vestweber (Max Planck Institute for Molecular Biomedicine).	Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Duprat F, 2000, MOL PHARMACOL, V57, P906; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; Gilgun-Sherki Y, 2003, BRAIN RES, V989, P196, DOI 10.1016/S0006-8993(03)03343-2; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Mazella J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000355; Namiranian K, 2010, AM J PHYSIOL-REG I, V299, pR461, DOI 10.1152/ajpregu.00057.2010; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nguemeni C, 2010, PHARMACOL RES, V61, P226, DOI 10.1016/j.phrs.2009.12.007; Nordoy A, 1999, LIPIDS, V34, pS19, DOI 10.1007/BF02562223; Ovenngton J.P., 2006, NAT REV DRUG DISCOV, V5, P993; Schuhmann MK, 2010, J IMMUNOL, V184, P1536, DOI 10.4049/jimmunol.0902161; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022	19	110	113	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1161	1165		10.1038/nm.3303	http://dx.doi.org/10.1038/nm.3303			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23933981				2022-12-27	WOS:000324083500032
J	Robbins, CS; Hilgendorf, I; Weber, GF; Theurl, I; Iwamoto, Y; Figueiredo, JL; Gorbatov, R; Sukhova, GK; Gerhardt, LMS; Smyth, D; Zavitz, CCJ; Shikatani, EA; Parsons, M; van Rooijen, N; Lin, HY; Husain, M; Libby, P; Nahrendorf, M; Weissleder, R; Swirski, FK				Robbins, Clinton S.; Hilgendorf, Ingo; Weber, Georg F.; Theurl, Igor; Iwamoto, Yoshiko; Figueiredo, Jose-Luiz; Gorbatov, Rostic; Sukhova, Galina K.; Gerhardt, Louisa M. S.; Smyth, David; Zavitz, Caleb C. J.; Shikatani, Eric A.; Parsons, Michael; van Rooijen, Nico; Lin, Herbert Y.; Husain, Mansoor; Libby, Peter; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.			Local proliferation dominates lesional macrophage accumulation in atherosclerosis	NATURE MEDICINE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; MONOCYTE ACCUMULATION; MYOCARDIAL-INFARCTION; IN-VIVO; RECRUITMENT; PATTERN; MICE; ENHANCEMENT; CX3CR1; BLOOD	During the inflammatory response that drives atherogenesis, macrophages accumulate progressively in the expanding arterial wall(1,2). The observation that circulating monocytes give rise to lesional macrophages(3-9) has reinforced the concept that monocyte infiltration dictates macrophage buildup. Recent work has indicated, however, that macrophage accumulation does not depend on monocyte recruitment in some inflammatory contexts(10). We therefore revisited the mechanism underlying macrophage accumulation in atherosclerosis. In murine atherosclerotic lesions, we found that macrophages turn over rapidly, after 4 weeks. Replenishment of macrophages in these experimental atheromata depends predominantly on local macrophage proliferation rather than monocyte influx. The microenvironment orchestrates macrophage proliferation through the involvement of scavenger receptor A (SR-A). Our study reveals macrophage proliferation as a key event in atherosclerosis and identifies macrophage self-renewal as a therapeutic target for cardiovascular disease.	[Robbins, Clinton S.; Hilgendorf, Ingo; Weber, Georg F.; Theurl, Igor; Iwamoto, Yoshiko; Figueiredo, Jose-Luiz; Gorbatov, Rostic; Gerhardt, Louisa M. S.; Lin, Herbert Y.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Robbins, Clinton S.; Hilgendorf, Ingo; Weber, Georg F.; Theurl, Igor; Iwamoto, Yoshiko; Figueiredo, Jose-Luiz; Gorbatov, Rostic; Gerhardt, Louisa M. S.; Lin, Herbert Y.; Nahrendorf, Matthias; Weissleder, Ralph; Swirski, Filip K.] Harvard Univ, Sch Med, Boston, MA USA; [Robbins, Clinton S.; Smyth, David; Zavitz, Caleb C. J.; Shikatani, Eric A.; Husain, Mansoor] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Robbins, Clinton S.; Shikatani, Eric A.; Husain, Mansoor] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Robbins, Clinton S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Figueiredo, Jose-Luiz; Sukhova, Galina K.; Libby, Peter] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Parsons, Michael] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [van Rooijen, Nico] Free Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Harvard University; Brigham & Women's Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Vrije Universiteit Amsterdam; Harvard University; Harvard Medical School	Swirski, FK (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	clint.robbins@utoronto.ca; fswirski@mgh.harvard.edu	Hilgendorf, Ingo/AFM-6379-2022; Libby, Peter/AAY-6404-2021; Van Rooijen, Nico/Z-1578-2019; Swirski, Filip/AAF-1340-2019; Zavitz, Caleb CJ/D-4659-2009	Hilgendorf, Ingo/0000-0002-0024-1643; Libby, Peter/0000-0002-1502-502X; Zavitz, Caleb CJ/0000-0002-1097-041X; Husain, Mansoor/0000-0002-3740-6739; Swirski, Filip/0000-0002-3163-9152; /0000-0003-0828-4143; Robbins, Clinton/0000-0001-9848-1495; Theurl, Igor/0000-0003-3180-4784	US National Institutes of Health [1R01HL095612, HHSN 268201000044C, P01-A154904, U24-CA092782, P50-CA086355]; Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research; Department of Laboratory Medicine and Pathobiology, University of Toronto; Massachusetts General Hospital Executive Committee on Research (ECOR) Postdoctoral Award; German Research Foundation; Max Kade Foundation; Boehringer Ingelheim Funds; NATIONAL CANCER INSTITUTE [U24CA092782, P50CA127003, P50CA086355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI054904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071837, R01DK069533] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research; Department of Laboratory Medicine and Pathobiology, University of Toronto(University of Toronto); Massachusetts General Hospital Executive Committee on Research (ECOR) Postdoctoral Award; German Research Foundation(German Research Foundation (DFG)); Max Kade Foundation; Boehringer Ingelheim Funds(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Greene for secretarial assistance. We thank J. Whitsett at Cincinnati Children's Hospital Medical Center for providing Csf2rb<SUP>-/-</SUP> mice. This work was supported in part by US National Institutes of Health grants 1R01HL095612 (to F.K.S.) and HHSN 268201000044C, P01-A154904, U24-CA092782 and P50-CA086355 (to R.W.) and start-up funding provided by the Heart and Stroke Richard Lewar Centre of Excellence in Cardiovascular Research and the Department of Laboratory Medicine and Pathobiology, University of Toronto (to C.S.R.). C.S.R. was supported by the Massachusetts General Hospital Executive Committee on Research (ECOR) Postdoctoral Award. G.F.W. and I.H. were supported by the German Research Foundation. I.T. was supported by the Max Kade Foundation. L.M.S.G. was supported by the Boehringer Ingelheim Funds.	Aikawa M, 2001, CIRCULATION, V103, P276; Boesten LSM, 2006, FASEB J, V20, P953, DOI 10.1096/fj.05-4530fje; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Butcher MJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2848; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Diez-Juan A, 2004, BLOOD, V103, P158, DOI 10.1182/blood-2003-07-2319; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600; Gough PJ, 1999, ARTERIOSCL THROM VAS, V19, P461, DOI 10.1161/01.ATV.19.3.461; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hazen SL, 2008, J BIOL CHEM, V283, P15527, DOI 10.1074/jbc.R700054200; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; KATSUDA S, 1993, AM J PATHOL, V142, P1787; Kim CJ, 2000, ARTERIOSCL THROM VAS, V20, P1976, DOI 10.1161/01.ATV.20.8.1976; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lutgens E, 1999, CARDIOVASC RES, V41, P473, DOI 10.1016/S0008-6363(98)00311-3; Lutgens E, 1999, CIRCULATION, V99, P276, DOI 10.1161/01.CIR.99.2.276; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Psaltis PJ, 2012, CIRCULATION, V125, P592, DOI 10.1161/CIRCULATIONAHA.111.059360; REKHTER MD, 1995, AM J PATHOL, V147, P668; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Sakai M, 1996, J BIOL CHEM, V271, P27346, DOI 10.1074/jbc.271.44.27346; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 1999, ARTERIOSCL THROM VAS, V19, P1299, DOI 10.1161/01.ATV.19.5.1299; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866	37	681	703	10	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1166	1172		10.1038/nm.3258	http://dx.doi.org/10.1038/nm.3258			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23933982	Green Accepted, Green Submitted			2022-12-27	WOS:000324083500033
J	Brusselle, GG; Maes, T; Bracke, KR				Brusselle, Guy G.; Maes, Tania; Bracke, Ken R.			Eosinophilic airway inflammation in nonallergic asthma	NATURE MEDICINE			English	Editorial Material							INNATE LYMPHOID-CELLS		[Brusselle, Guy G.; Maes, Tania; Bracke, Ken R.] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Brusselle, Guy G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Brusselle, Guy G.] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands	Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Brusselle, GG (corresponding author), Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium.	guy.brusselle@ugent.be	Bracke, Ken R/GSN-7630-2022; Maes, Tania/M-8675-2016	Bracke, Ken R/0000-0001-5906-4605; Maes, Tania/0000-0002-3037-6928; Brusselle, Guy/0000-0001-7021-8505				Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Jatakanon A, 2000, AM J RESP CRIT CARE, V161, P64, DOI 10.1164/ajrccm.161.1.9809100; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Pavord ID, 2012, LANCET, V380, P651, DOI 10.1016/S0140-6736(12)60988-X; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678	11	201	213	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					977	979		10.1038/nm.3300	http://dx.doi.org/10.1038/nm.3300			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921745				2022-12-27	WOS:000322779600023
J	McCook, A				McCook, Alison			A future, on ICE	NATURE MEDICINE			English	News Item							SPERMATOGONIAL STEM-CELLS; FUNCTIONAL SPERM; MOUSE; TESTES											Barton S. E., 2013, LANCET ONCOL; Ginsberg JP, 2010, HUM REPROD, V25, P37, DOI 10.1093/humrep/dep371; Goossens E, 2011, HUM REPROD, V26, P3388, DOI 10.1093/humrep/der334; Hermann BP, 2012, CELL STEM CELL, V11, P715, DOI 10.1016/j.stem.2012.07.017; Lee JY, 2009, BIOL REPROD, V80, P518, DOI 10.1095/biolreprod.108.072330; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Ruutiainen T, 2013, AM J BIOETHICS, V13, P28, DOI 10.1080/15265161.2012.760672; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Wu X, 2012, HUM REPROD, V27, P1249, DOI 10.1093/humrep/des077	9	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2013	19	8					958	961		10.1038/nm0813-958	http://dx.doi.org/10.1038/nm0813-958			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921735				2022-12-27	WOS:000322779600012
J	Gulbins, E; Palmada, M; Reichel, M; Luth, A; Bohmer, C; Amato, D; Muller, CP; Tischbirek, CH; Groemer, TW; Tabatabai, G; Becker, KA; Tripal, P; Staedtler, S; Ackermann, TF; van Brederode, J; Alzheimer, C; Weller, M; Lang, UE; Kleuser, B; Grassme, H; Kornhuber, J				Gulbins, Erich; Palmada, Monica; Reichel, Martin; Lueth, Anja; Boehmer, Christoph; Amato, Davide; Mueller, Christian P.; Tischbirek, Carsten H.; Groemer, Teja W.; Tabatabai, Ghazaleh; Becker, Katrin A.; Tripal, Philipp; Staedtler, Sven; Ackermann, Teresa F.; van Brederode, Johannes; Alzheimer, Christian; Weller, Michael; Lang, Undine E.; Kleuser, Burkhard; Grassme, Heike; Kornhuber, Johannes			Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugs	NATURE MEDICINE			English	Article							NIEMANN-PICK-DISEASE; RICH MEMBRANE RAFTS; HIPPOCAMPAL NEUROGENESIS; MAJOR DEPRESSION; FLUOXETINE; MODEL; DIFFERENTIATION; IDENTIFICATION; SPHINGOLIPIDS; METAANALYSIS	Major depression is a highly prevalent severe mood disorder that is treated with antidepressants. The molecular targets of antidepressants require definition. We investigated the role of the acid sphingomyelinase (Asm)-ceramide system as a target for antidepressants. Therapeutic concentrations of the antidepressants amitriptyline and fluoxetine reduced Asm activity and ceramide concentrations in the hippocampus, increased neuronal proliferation, maturation and survival and improved behavior in mouse models of stress-induced depression. Genetic Asm deficiency abrogated these effects. Mice overexpressing Asm, heterozygous for acid ceramidase, treated with blockers of ceramide metabolism or directly injected with C16 ceramide in the hippocampus had higher ceramide concentrations and lower rates of neuronal proliferation, maturation and survival compared with controls and showed depression-like behavior even in the absence of stress. The decrease of ceramide abundance achieved by antidepressant-mediated inhibition of Asm normalized these effects. Lowering ceramide abundance may thus be a central goal for the future development of antidepressants.	[Gulbins, Erich; Palmada, Monica; Boehmer, Christoph; Becker, Katrin A.; Grassme, Heike] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Gulbins, Erich] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Reichel, Martin; Amato, Davide; Mueller, Christian P.; Tischbirek, Carsten H.; Groemer, Teja W.; Tripal, Philipp; Staedtler, Sven; Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Lueth, Anja; Kleuser, Burkhard] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Tabatabai, Ghazaleh; Weller, Michael] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Tabatabai, Ghazaleh] Neurosci Ctr Zurich, Zurich, Switzerland; [Ackermann, Teresa F.] Univ Tubingen, Dept Physiol 1, Tubingen, Germany; [van Brederode, Johannes; Alzheimer, Christian] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Lang, Undine E.] Univ Basel Hosp, Dept Psychiat & Psychotherapy, CH-4031 Basel, Switzerland	University of Duisburg Essen; University System of Ohio; University of Cincinnati; University of Erlangen Nuremberg; University of Potsdam; University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; University of Erlangen Nuremberg; University of Basel	Gulbins, E (corresponding author), Univ Duisburg Essen, Dept Mol Biol, Essen, Germany.	erich.gulbins@uni-due.de; johannes.kornhuber@uk-erlangen.de	Tabatabai, Ghazaleh/A-6365-2015; Lang, Undine Emmi E/K-5553-2015; Kornhuber, Johannes/B-9613-2014; Gulbins, Erich/L-6989-2014	Tabatabai, Ghazaleh/0000-0003-3702-923X; Lang, Undine Emmi E/0000-0002-3585-6533; Kornhuber, Johannes/0000-0002-8096-3987; Gulbins, Erich/0000-0002-3117-1342; Reichel, Martin/0000-0001-7886-2784; Muller, Christian/0000-0002-5325-9900; Kleuser, Burkhard/0000-0002-1888-9595; Tripal, Philipp/0000-0003-0568-1725; Tabatabai, Ghazaleh/0000-0002-3542-8782; Weller, Michael/0000-0002-1748-174X; Groemer, Teja/0000-0003-3854-716X	Deutsche Forschungsgemeinschaft [GU 335/23-1, KO 947/11-1, GRK 1302]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Asm-deficient mice and asm-1-deficient worms were provided by R. Kolesnick, Memorial Sloan Kettering Cancer Hospital, and E2A-Cre mice by R. Waldschutz, University Hospital Essen. The G4 antibody against Asm was provided by K. Sandhoff, University of Bonn. We thank S. Harde, B. Wilker, C. Sehl, S. Keitsch, M. Schafer, S. Muller and E. Naschberger for excellent technical help and F. Lang for valuable discussion. Parts of the work were supported by funding from Deutsche Forschungsgemeinschaft grants GU 335/23-1, KO 947/11-1 and GRK 1302.	Amato D, 2012, PSYCHOPHARMACOLOGY, V223, P457, DOI 10.1007/s00213-012-2735-8; Baumann Pierre, 2005, Dialogues Clin Neurosci, V7, P231; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Brink Christiaan B, 2006, Recent Pat CNS Drug Discov, V1, P29, DOI 10.2174/157488906775245327; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Franklin K., 2007, MOUSE BRAIN STEREOTA; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Hisaki H, 2004, BRAIN RES, V1018, P73, DOI 10.1016/j.brainres.2004.05.042; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; KIM MY, 1991, J BIOL CHEM, V266, P484; Kojima M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1018, DOI 10.1002/art.24647; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kornhuber J, 2008, J MED CHEM, V51, P219, DOI 10.1021/jm070524a; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lepple-Wienhues A, 1999, P NATL ACAD SCI USA, V96, P13795, DOI 10.1073/pnas.96.24.13795; Lozano J, 2001, CELL DEATH DIFFER, V8, P100, DOI 10.1038/sj.cdd.4400775; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; Muller N, 2010, CURR OPIN INVEST DR, V11, P31; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Perrotta C, 2010, J BIOL CHEM, V285, P40240, DOI 10.1074/jbc.M110.139287; Ranganathan R, 2001, J NEUROSCI, V21, P5871, DOI 10.1523/JNEUROSCI.21-16-05871.2001; Rudisch B, 2003, BIOL PSYCHIAT, V54, P227, DOI 10.1016/S0006-3223(03)00587-0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Stefanis DD, 2002, BIOL CHEM, V383, P989, DOI 10.1515/BC.2002.106; Tabas I, 2004, CIRCULATION, V110, P3400, DOI 10.1161/01.CIR.0000150861.98087.56; Walker JR, 2011, J RHEUMATOL, V38, P31, DOI 10.3899/jrheum.110900; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Zhang Y, 2008, J IMMUNOL, V181, P4247, DOI 10.4049/jimmunol.181.6.4247	38	242	249	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					934	+		10.1038/nm.3214	http://dx.doi.org/10.1038/nm.3214			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23770692	Green Accepted			2022-12-27	WOS:000321557700039
J	Mighiu, PI; Yue, JTY; Filippi, BM; Abraham, MA; Chari, M; Lam, CKL; Yang, CS; Christian, NR; Charron, MJ; Lam, TKT				Mighiu, Patricia I.; Yue, Jessica T. Y.; Filippi, Beatrice M.; Abraham, Mona A.; Chari, Madhu; Lam, Carol K. L.; Yang, Clair S.; Christian, Nikita R.; Charron, Maureen J.; Lam, Tony K. T.			Hypothalamic glucagon signaling inhibits hepatic glucose production	NATURE MEDICINE			English	Article							INSULIN-RESISTANCE; BLOOD-GLUCOSE; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; OBESITY; GENE	Glucagon activates hepatic protein kinase A (PKA) to increase glucose production(1,2), but the gluco-stimulatory effect is transient even in the presence of continuous intravenous glucagon infusion(3-5). Continuous intravenous infusion of insulin, however, inhibits glucose production through its sustained actions in both the liver(6) and the mediobasal hypothalamus (MBH)(7,8). In a pancreatic clamp setting, MBH infusion with glucagon activated MBH PKA and inhibited hepatic glucose production (HGP) in rats, as did central glucagon infusion in mice. Inhibition of glucagon receptor-PKA signaling in the MBH and hepatic vagotomy each negated the effect of MBH glucagon in rats, whereas the central effect of glucagon was diminished in glucagon receptor knockout mice. A sustained rise in plasma glucagon concentrations transiently increased HGP, and this transiency was abolished in rats with negated MBH glucagon action. In a nonclamp setting, MBH glucagon infusion improved glucose tolerance, and inhibition of glucagon receptor-PKA signaling in the MBH enhanced the ability of intravenous glucagon injection to increase plasma glucose concentrations. We also detected a similar enhancement of glucose concentrations that was associated with a disruption in MBH glucagon signaling in rats fed a high-fat diet. We show that hypothalamic glucagon signaling inhibits HGP and suggest that hypothalamic glucagon resistance contributes to hyperglycemia in diabetes and obesity.	[Mighiu, Patricia I.; Yue, Jessica T. Y.; Filippi, Beatrice M.; Abraham, Mona A.; Chari, Madhu; Lam, Carol K. L.; Yang, Clair S.; Christian, Nikita R.; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Mighiu, Patricia I.; Abraham, Mona A.; Chari, Madhu; Lam, Carol K. L.; Yang, Clair S.; Christian, Nikita R.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Yue, Jessica T. Y.; Filippi, Beatrice M.; Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Charron, Maureen J.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA; [Charron, Maureen J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	tony.lam@uhnres.utoronto.ca	Yue, Jessica/AAT-6056-2021	Filippi, Beatrice Maria/0000-0002-8816-1559; Lam, Carol/0000-0002-9736-3347	Canadian Diabetes Association; Ontario Graduate Scholarship; University of Toronto Banting and Best Diabetes Centre (BBDC); BBDC; University Health Network postdoctoral fellowship; BBDC scholarship; Canadian Institute of Health Research	Canadian Diabetes Association; Ontario Graduate Scholarship(Ontario Graduate Scholarship); University of Toronto Banting and Best Diabetes Centre (BBDC); BBDC; University Health Network postdoctoral fellowship; BBDC scholarship; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	We thank P.Y.T. Wang for technical assistance and D.J. Drucker from the Samuel Lunenfeld Research Institute for providing the Gcgr<SUP>-/-</SUP> and Gcgr<SUP>+/+</SUP> mice. This work was supported by a research grant from the Canadian Diabetes Association. P. I. M. was supported by an Ontario Graduate Scholarship and a scholarship from the University of Toronto Banting and Best Diabetes Centre (BBDC). J.T.Y.Y. is supported by a BBDC and University Health Network postdoctoral fellowship. M. A. A. is supported by a BBDC scholarship. M. C. was supported by an Ontario Graduate scholarship and a BBDC scholarship. C. K. L. L. and C.S.Y. were supported by graduate scholarships from the Canadian Institute of Health Research and the BBDC. T. K. T. L. holds the John Kitson McIvor (1915-1942) Endowed Chair in Diabetes Research and the Canada Research Chair in Obesity at the Toronto General Research Institute and the University of Toronto.	BANKS WA, 1985, BRAIN RES BULL, V15, P287, DOI 10.1016/0361-9230(85)90153-4; BEALE E, 1984, DIABETES, V33, P328, DOI 10.2337/diabetes.33.4.328; Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; BOMBOY JD, 1977, DIABETES, V26, P177, DOI 10.2337/diabetes.26.3.177; BRAND CL, 1994, DIABETOLOGIA, V37, P985, DOI 10.1007/BF00400461; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Chari M, 2008, DIABETES, V57, P836, DOI 10.2337/db07-1464; Chari M, 2011, DIABETES, V60, P1901, DOI 10.2337/db11-0120; CHERRINGTON AD, 1978, J CLIN INVEST, V62, P664, DOI 10.1172/JCI109174; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; EIGLER N, 1979, J CLIN INVEST, V63, P114, DOI 10.1172/JCI109264; FELIG P, 1976, J CLIN INVEST, V58, P761, DOI 10.1172/JCI108523; FERRANNINI E, 1982, AM J PHYSIOL, V242, pE73, DOI 10.1152/ajpendo.1982.242.2.E73; Filippi BM, 2012, CELL METAB, V16, P500, DOI 10.1016/j.cmet.2012.09.005; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; GEARY N, 1982, PHYSIOL BEHAV, V28, P313, DOI 10.1016/0031-9384(82)90081-6; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Honda K, 2012, COMP BIOCHEM PHYS A, V163, P260, DOI 10.1016/j.cbpa.2012.08.005; HOOSEIN NM, 1984, P NATL ACAD SCI-BIOL, V81, P4368, DOI 10.1073/pnas.81.14.4368; INOKUCHI A, 1986, AM J PHYSIOL, V250, pR120, DOI 10.1152/ajpregu.1986.250.1.R120; INOKUCHI A, 1984, PHYSIOL BEHAV, V33, P397, DOI 10.1016/0031-9384(84)90160-4; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; JOHNSON DG, 1982, SCIENCE, V215, P1115, DOI 10.1126/science.6278587; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; LANGHANS W, 1987, PHYSIOL BEHAV, V41, P31, DOI 10.1016/0031-9384(87)90127-2; LILJENQUIST JE, 1977, J CLIN INVEST, V59, P369, DOI 10.1172/JCI108649; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOK S, 1994, GENE, V140, P203, DOI 10.1016/0378-1119(94)90545-2; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Muse ED, 2007, J CLIN INVEST, V117, P1670, DOI 10.1172/JCI30440; NEELANDS PJ, 1983, BIOCHEM J, V212, P573, DOI 10.1042/bj2120573; Parker JC, 2002, BIOCHEM BIOPH RES CO, V290, P839, DOI 10.1006/bbrc.2001.6265; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Pocai A, 2009, DIABETES, V58, P2258, DOI 10.2337/db09-0278; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Sheriff S, 2003, PEPTIDES, V24, P245, DOI 10.1016/S0196-9781(03)00037-8; SHERWIN RS, 1976, NEW ENGL J MED, V294, P455, DOI 10.1056/NEJM197602262940901; Singhal NS, 2007, J NEUROSCI, V27, P12924, DOI 10.1523/JNEUROSCI.2443-07.2007; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; van den Hoek AM, 2004, DIABETES, V53, P2529, DOI 10.2337/diabetes.53.10.2529; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; WETSEL WC, 1993, ENDOCRINOLOGY, V132, P2360, DOI 10.1210/en.132.6.2360; Yang CS, 2010, DIABETES, V59, P2435, DOI 10.2337/db10-0221; YOUNG AA, 1993, AM J PHYSIOL, V264, pE943, DOI 10.1152/ajpendo.1993.264.6.E943; Yue JTY, 2012, CELL METAB, V15, P646, DOI 10.1016/j.cmet.2012.01.013; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	50	81	81	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					766	+		10.1038/nm.3115	http://dx.doi.org/10.1038/nm.3115			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23685839				2022-12-27	WOS:000319981600027
J	Warner-Schmidt, J				Warner-Schmidt, Jennifer			Short-circuiting depression	NATURE MEDICINE			English	Editorial Material							NUCLEUS-ACCUMBENS		Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Rockefeller University	Warner-Schmidt, J (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA.	jschmidt@rockefeller.edu						DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Hamani C, 2012, BIOL PSYCHIAT, V72, P916, DOI 10.1016/j.biopsych.2012.05.024; Heninger GR, 1996, PHARMACOPSYCHIATRY, V29, P2, DOI 10.1055/s-2007-979535; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kumar S, 2013, J NEUROSCI, V33, P1116, DOI 10.1523/JNEUROSCI.0092-12.2013; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; MACLEAN PD, 1952, ELECTROEN CLIN NEURO, V4, P407, DOI 10.1016/0013-4694(52)90073-4; Schmidt EF, 2012, CELL, V149, P1152, DOI 10.1016/j.cell.2012.03.038; Svenningsson P, 2007, CURR OPIN PHARMACOL, V7, P27, DOI 10.1016/j.coph.2006.10.001; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109; Yoshimura S, 2014, SOC COGN AFFECT NEUR, V9, P487, DOI 10.1093/scan/nst009	14	3	3	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					680	681		10.1038/nm.3215	http://dx.doi.org/10.1038/nm.3215			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744149				2022-12-27	WOS:000319981600016
J	Stuart, DD; Sellers, WR				Stuart, Darrin D.; Sellers, William R.			Targeting RAF-MEK-ERK kinase-scaffold interactions in cancer	NATURE MEDICINE			English	Editorial Material							BRAF; INHIBITION; MELANOMA; MUTATIONS; PHASE-2; IQGAP1		[Stuart, Darrin D.] Novartis Inst Biomed Res, Emeryville, CA USA; [Sellers, William R.] Novartis Inst Biomed Res, Cambridge, MA USA	Novartis; Novartis	Stuart, DD (corresponding author), Novartis Inst Biomed Res, Emeryville, CA USA.	darrin.stuart@novartis.com						Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	12	17	17	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2013	19	5					538	540		10.1038/nm.3195	http://dx.doi.org/10.1038/nm.3195			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652103				2022-12-27	WOS:000318583000022
J	Sherer, TB				Sherer, Todd B.			Money without collaboration won't bring cures	NATURE MEDICINE			English	Editorial Material								It's up to stakeholders at every stage of therapeutic development-industry and academic researchers, policymakers, patient foundations and even patients themselves-to embrace the power of collaboration. Only then will we enable translational research and push much-needed treatments to the clinic faster.	Michael J Fox Fdn Parkinsons Res, New York, NY USA		Sherer, TB (corresponding author), Michael J Fox Fdn Parkinsons Res, New York, NY USA.			Sherer, Todd/0000-0001-9667-6600					0	6	6	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					127	127		10.1038/nm0213-127	http://dx.doi.org/10.1038/nm0213-127			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389601	Bronze			2022-12-27	WOS:000314675900014
J	Streeck, H; D'Souza, MP; Littman, DR; Crotty, S				Streeck, Hendrik; D'Souza, M. Patricia; Littman, Dan R.; Crotty, Shane			Harnessing CD4(+) T cell responses in HIV vaccine development	NATURE MEDICINE			English	Article							MEMORY B-CELLS; LIVED PLASMA-CELLS; FOLLICULAR HELPER; NEUTRALIZING ANTIBODIES; CUTTING EDGE; POTENT NEUTRALIZATION; BROAD; INFECTION; IMMUNITY; ANTIGEN	CD4(+) T cells can perform a panoply of tasks to shape an effective response against a pathogen. Limited attention has been paid to the potential importance of functional CD4(+) T cell responses in the context of the development of next-generation vaccines, including HIV vaccines. Many CD4(+) T cell functions are newly appreciated and only partially understood. A workshop was held as a forum to bring together a small group of experts to exchange ideas on the role of CD4(+) T cells in developing durable functional antibody responses, via follicular helper T cells, as well as on the roles of CD4(+) T cells in other aspects of protective immunity. Here we discuss whether CD4(+) T cell responses may represent a beneficial component of an efficacious HIV vaccine.	[Streeck, Hendrik] Walter Reed Army Inst Res, Henry M Jackson Fdn, US Mil HIV Res Program, Silver Spring, MD USA; [D'Souza, M. Patricia] US Natl Inst Allergy & Infect Dis, Vaccine Clin Res Branch, Div Aids, Bethesda, MD USA; [Littman, Dan R.] New York Univ Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, Mol Pathogenesis Program, New York, NY USA; [Littman, Dan R.] New York Univ Sch Med, Howard Hughes Med Inst, New York, NY USA; [Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Crotty, Shane] Univ Calif San Diego Sch Med, Dept Med, La Jolla, CA USA; [Crotty, Shane] Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); New York University; Howard Hughes Medical Institute; New York University; La Jolla Institute for Immunology	Streeck, H (corresponding author), Walter Reed Army Inst Res, Henry M Jackson Fdn, US Mil HIV Res Program, Silver Spring, MD USA.	hstreeck@hivresearch.org; shane@liai.org	Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 	Division of AIDS of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (NIH); Ragon Institute; Center for HIV/AIDS Immunology and Immunogen Discovery; NIH [U19AI090970, P01AI096187]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; US Department of Defense;  [R01AI094602-01];  [R01 AI091450-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI090970, R01AI091450, U19AI096187, R01AI094602] Funding Source: NIH RePORTER	Division of AIDS of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (NIH); Ragon Institute; Center for HIV/AIDS Immunology and Immunogen Discovery; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense(United States Department of Defense); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The organizers thank all of the workshop speakers and participants. The speakers were R. Amara, D. Brooks, M. Cancro, S.C., A. Iwasaki, J. Kolls, R. Koup, D.R.L., J. Mascola, H.S., J. Wherry and E. Zuniga. This work was supported by the Division of AIDS of the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (NIH) and the Ragon Institute. S.C. was supported by the Center for HIV/AIDS Immunology and Immunogen Discovery and NIH U19AI090970 and NIH P01AI096187. H.S. is supported by R01AI094602-01, R01 AI091450-01 and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the US Department of Defense.	ALONSO MJ, 1993, PHARMACEUT RES, V10, P945, DOI 10.1023/A:1018942118148; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barr T, 2012, EUR J IMMUNOL, V42, P1977, DOI 10.1002/eji.201242755; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Crotty S, 2004, SEMIN IMMUNOL, V16, P197, DOI 10.1016/j.smim.2004.02.008; Crotty S, 2012, IMMUNOL REV, V247, P133, DOI 10.1111/j.1600-065X.2012.01117.x; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Dosenovic P, 2012, J IMMUNOL, V188, P6018, DOI 10.4049/jimmunol.1200466; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Havenar-Daughton C, 2006, J IMMUNOL, V176, P3315, DOI 10.4049/jimmunol.176.6.3315; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kumamoto Y, 2011, P NATL ACAD SCI USA, V108, P8749, DOI 10.1073/pnas.1100567108; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Pallikkuth S, 2012, BLOOD, V120, P985, DOI 10.1182/blood-2011-12-396648; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Plotkin SA, 2013, VACCINES; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qureshi H, 2012, J VIROL, V86, P2239, DOI 10.1128/JVI.06175-11; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Schaerli P, 2001, J IMMUNOL, V167, P6082, DOI 10.4049/jimmunol.167.11.6082; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Taub DD, 2008, AM J MED, V121, P1058, DOI 10.1016/j.amjmed.2008.08.019; Thaunat O, 2012, SCIENCE, V335, P475, DOI 10.1126/science.1214100; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vojnov L, 2012, J VIROL, V86, P4682, DOI 10.1128/JVI.06324-11; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weber JP, 2012, EUR J IMMUNOL, V42, P1981, DOI 10.1002/eji.201242540; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	99	73	75	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					143	149		10.1038/nm.3054	http://dx.doi.org/10.1038/nm.3054			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389614	Green Accepted			2022-12-27	WOS:000314675900022
J	[Anonymous]				[Anonymous]			Unlocking the mysterious mechanisms of Myc	NATURE MEDICINE			English	Editorial Material														Dang, Chi/0000-0002-4031-2522					0	10	10	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					26	27						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23296005				2022-12-27	WOS:000313230300017
J	Zhang, S; Liu, XB; Bawa-Khalfe, T; Lu, LS; Lyu, YL; Liu, LF; Yeh, ETH				Zhang, Sui; Liu, Xiaobing; Bawa-Khalfe, Tasneem; Lu, Long-Sheng; Lyu, Yi Lisa; Liu, Leroy F.; Yeh, Edward T. H.			Identification of the molecular basis of doxorubicin-induced cardiotoxicity	NATURE MEDICINE			English	Article							TOPOISOMERASE-II-BETA; INDUCED CARDIOMYOPATHY; HEART; GENE; TRANSCRIPTION; EXPRESSION; PREVENTION; PGC-1-BETA; APOPTOSIS; ADULT	Doxorubicin is believed to cause dose-dependent cardiotoxicity through redox cycling and the generation of reactive oxygen species (ROS). Here we show that cardiomyocyte-specific deletion of Top2b (encoding topoisomerase-II beta) protects cardiomyocytes from doxorubicin-induced DNA double-strand breaks and transcriptome changes that are responsible for defective mitochondrial biogenesis and ROS formation. Furthermore, cardiomyocyte-specific deletion of Top2b protects mice from the development of doxorubicin-induced progressive heart failure, suggesting that doxorubicin-induced cardiotoxicity is mediated by topoisomerase-II beta in cardiomyocytes.	[Zhang, Sui; Bawa-Khalfe, Tasneem; Yeh, Edward T. H.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA; [Liu, Xiaobing; Lu, Long-Sheng; Yeh, Edward T. H.] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX USA; [Liu, Xiaobing] Shanghai Jiao Tong Univ, Dept Vasc Surg, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Lyu, Yi Lisa; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	University of Texas System; UTMD Anderson Cancer Center; Saint Lukes Episcopal Hospital; Texas Heart Institute; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yeh, ETH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA.	etyeh@mdanderson.org		Liu, Leroy/0000-0001-9396-763X	Cancer Prevention Research Institute of Texas; McNair Medical Institute; US National Institutes of Health [CA102463]; New Jersey Commission on Cancer Research [06-2419-CCR-EO]; US Department of Defense [W81XWH-07-1-0407, W81XWH06-1-0514]; NATIONAL CANCER INSTITUTE [R01CA102463] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; McNair Medical Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. H. Ren for expert technical assistance and F. M. Lin and H. Dou for conducting studies on mitochondria DNA. W. C. Claycomb (Louisiana State University Health Science Center) provided HL-1 cells. This study is supported by the Cancer Prevention Research Institute of Texas and McNair Medical Institute (E.T.H.Y.), US National Institutes of Health grant CA102463 (to L. F. L.), the New Jersey Commission on Cancer Research Grant 06-2419-CCR-EO, US Department of Defense Idea Award W81XWH-07-1-0407 and Concept Award W81XWH06-1-0514 (to Y.L.L.).	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bawa-Khalfe T, 2007, J BIOL CHEM, V282, P37341, DOI 10.1074/jbc.M706978200; CAPRANICO G, 1992, BIOCHIM BIOPHYS ACTA, V1132, P43, DOI 10.1016/0167-4781(92)90050-A; Force T, 2011, NAT REV DRUG DISCOV, V10, P111, DOI 10.1038/nrd3252; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Liao Ronglih, 2007, V139, P251; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Lyu YL, 2003, P NATL ACAD SCI USA, V100, P7123, DOI 10.1073/pnas.1232376100; Martin E, 2009, TOXICOLOGY, V255, P72, DOI 10.1016/j.tox.2008.10.011; MYERS C, 1983, SEMIN ONCOL, V10, P53; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Plesca D, 2008, METHOD ENZYMOL, V446, P107, DOI 10.1016/S0076-6879(08)01606-6; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wang JX, 2010, CIRC RES, V106, P1904, DOI 10.1161/CIRCRESAHA.110.221762; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	24	1105	1144	13	244	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1639	+		10.1038/nm.2919	http://dx.doi.org/10.1038/nm.2919			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23104132				2022-12-27	WOS:000310837000023
J	Hahn, AS; Kaufmann, JK; Wies, E; Naschberger, E; Panteleev-Ivlev, J; Schmidt, K; Holzer, A; Schmidt, M; Chen, J; Konig, S; Ensser, A; Myoung, J; Brockmeyer, NH; Sturzl, M; Fleckenstein, B; Neipel, F				Hahn, Alexander S.; Kaufmann, Johanna K.; Wies, Effi; Naschberger, Elisabeth; Panteleev-Ivlev, Julia; Schmidt, Katharina; Holzer, Angela; Schmidt, Martin; Chen, Jin; Koenig, Simone; Ensser, Armin; Myoung, Jinjong; Brockmeyer, Norbert H.; Stuerzl, Michael; Fleckenstein, Bernhard; Neipel, Frank			The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma-associated herpesvirus	NATURE MEDICINE			English	Article							HEPARAN-SULFATE; GLYCOPROTEIN-B; DNA-SEQUENCES; EPITHELIAL-CELLS; GENE-EXPRESSION; ENTRY RECEPTOR; SIMPLEX-VIRUS; TARGET-CELLS; IN-VITRO; HUMAN-HERPESVIRUS-8	Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma(1), a highly vascularized tumor originating from lymphatic endothelial cells, and of at least two different B cell malignancies(2,3). A dimeric complex formed by the envelope glycoproteins H and L (gH-gL) is required for entry of herpesviruses into host cells(4). We show that the ephrin receptor tyrosine kinase A2 (EphA2) is a cellular receptor for KSHV gH-gL. EphA2 co-precipitated with both gH-gL and KSHV virions. Infection of human epithelial cells with a GFP-expressing recombinant KSHV strain, as measured by FACS analysis, was increased upon overexpression of EphA2. Antibodies against EphA2 and siRNAs directed against EphA2 inhibited infection of endothelial cells. Pretreatment of KSHV with soluble EphA2 resulted in inhibition of KSHV infection by up to 90%. This marked reduction of KSHV infection was seen with all the different epithelial and endothelial cells used in this study. Similarly, pretreating epithelial or endothelial cells with the soluble EphA2 ligand ephrinA4 impaired KSHV infection. Deletion of the gene encoding EphA2 essentially abolished KSHV infection of mouse endothelial cells. Binding of gH-gL to EphA2 triggered EphA2 phosphorylation and endocytosis, a major pathway of KSHV entry(5,6). Quantitative RT-PCR and in situ histochemistry revealed a close correlation between KSHV infection and EphA2 expression both in cultured cells derived from human Kaposi's sarcoma lesions or unaffected human lymphatic endothelium, and in situ in Kaposi's sarcoma specimens, respectively. Taken together, our results identify EphA2, a tyrosine kinase with known functions in neovascularization and oncogenesis, as an entry receptor for KSHV.	[Hahn, Alexander S.; Kaufmann, Johanna K.; Wies, Effi; Panteleev-Ivlev, Julia; Schmidt, Katharina; Holzer, Angela; Schmidt, Martin; Ensser, Armin; Fleckenstein, Bernhard; Neipel, Frank] Univ Klinikum Erlangen, Inst Virol, Erlangen, Germany; [Naschberger, Elisabeth; Stuerzl, Michael] Univ Klinikum Erlangen, Abt Mol & Expt Chirurg, Erlangen, Germany; [Chen, Jin] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN USA; [Chen, Jin] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Canc Biol, Nashville, TN USA; [Chen, Jin] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Cell Biol, Nashville, TN USA; [Chen, Jin] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Dev Biol, Nashville, TN USA; [Chen, Jin] Tennessee Valley Healthcare Syst, Vet Affairs Med Ctr, Nashville, TN USA; [Koenig, Simone] Univ Munster, Interdisciplinary Ctr Clin Res, Munster, Germany; [Myoung, Jinjong] Novartis Inst Biomed Res, Emeryville, CA USA; [Brockmeyer, Norbert H.] Ruhr Univ Bochum, St Josef Hosp, Dept Dermatol, Bochum, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Munster; Novartis; Ruhr University Bochum	Neipel, F (corresponding author), Univ Klinikum Erlangen, Inst Virol, Erlangen, Germany.	frank.neipel@viro.med.uni-erlangen.de	Hahn, Alexander/ABE-5642-2021; Stürzl, Michael/B-3019-2015; König, Simone/B-6504-2008; Naschberger, Elisabeth/AAV-5289-2021	Hahn, Alexander/0000-0003-4171-2744; Stürzl, Michael/0000-0002-9276-2824; König, Simone/0000-0003-0672-7246; Naschberger, Elisabeth/0000-0003-1291-622X; Chen, Jin/0000-0002-5557-2079; Schmidt, Katharina/0000-0003-2797-9952	Akademie der Wissenschaften und der Literatur (Mainz); European Community; Deutsche Forschungsgemeinschaft [643, 1071]; interdisciplinary center for clinical research at the University Hospital of the University of Erlangen; German Cancer Aid; NATIONAL CANCER INSTITUTE [R01CA095004] Funding Source: NIH RePORTER	Akademie der Wissenschaften und der Literatur (Mainz); European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); interdisciplinary center for clinical research at the University Hospital of the University of Erlangen; German Cancer Aid(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Akademie der Wissenschaften und der Literatur (Mainz), the European Community research project TargetHerpes, Deutsche Forschungsgemeinschaft center grant 643 and graduate school grant 1071 "viruses of the immune system." M. Sturzl, E.N. and F.N. were supported by the interdisciplinary center for clinical research at the University Hospital of the University of Erlangen. M. Sturzl and E.N. were supported by the German Cancer Aid. We thank L. Wall for experimental assistance and R. C. Desrosiers for helpful discussions and critical reading of the manuscript. KSImm cells were kindly provided by A. Albini (Science and Technology Pole, IRCCS MultiMedica). 4G10 mouse hybridoma supernatant was kindly provided by B. Biesinger (Virologisches Institut, Universitatsklinikum Erlangen).	Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; Akula SM, 2001, VIROLOGY, V284, P235, DOI 10.1006/viro.2001.0921; Albini A, 1997, AIDS, V11, P713, DOI 10.1097/00002030-199706000-00003; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Campadelli-Fiume G, 2007, REV MED VIROL, V17, P313, DOI 10.1002/rmv.546; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Chandran B, 2010, J VIROL, V84, P2188, DOI 10.1128/JVI.01334-09; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Cheng N, 2002, MOL CANCER RES, V1, P2; Chesnokova LS, 2011, J VIROL, V85, P13214, DOI 10.1128/JVI.05580-11; Chesnokova LS, 2009, P NATL ACAD SCI USA, V106, P20464, DOI 10.1073/pnas.0907508106; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Ensser A, 1999, J VIROL, V73, P10551, DOI 10.1128/JVI.73.12.10551-10555.1999; Garrigues HJ, 2008, J VIROL, V82, P1570, DOI 10.1128/JVI.01673-07; Glykofrydes D, 2000, J VIROL, V74, P11919, DOI 10.1128/JVI.74.24.11919-11927.2000; Hahn A, 2009, J VIROL, V83, P396, DOI 10.1128/JVI.01170-08; HERNDIER BG, 1994, AIDS, V8, P575, DOI 10.1097/00002030-199405000-00002; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Kaleeba JAR, 2006, VIROLOGY, V354, P7, DOI 10.1016/j.virol.2006.06.009; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Konig S, 2003, ELECTROPHORESIS, V24, P751, DOI 10.1002/elps.200390090; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Matsuura H, 2010, P NATL ACAD SCI USA, V107, P22641, DOI 10.1073/pnas.1011806108; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Naschberger E, 2008, INT J CANCER, V123, P2120, DOI 10.1002/ijc.23764; Ogawa K, 2000, ONCOGENE, V19, P6043, DOI 10.1038/sj.onc.1204004; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Ryckman BJ, 2008, P NATL ACAD SCI USA, V105, P14118, DOI 10.1073/pnas.0804365105; Scehnet JS, 2009, BLOOD, V113, P254, DOI 10.1182/blood-2008-02-140020; Schmidt K, 2011, J VIROL, V85, P4530, DOI 10.1128/JVI.02123-10; Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; STURZL M, 1995, ONCOGENE, V10, P2007; Vanarsdall AL, 2011, J VIROL, V85, P11638, DOI 10.1128/JVI.05659-11; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Vleck SE, 2011, P NATL ACAD SCI USA, V108, P18412, DOI 10.1073/pnas.1111333108; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wang FZ, 2001, J VIROL, V75, P7517, DOI 10.1128/JVI.75.16.7517-7527.2001; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wickramasinghe SR, 2005, BIOTECHNOL BIOENG, V92, P199, DOI 10.1002/bit.20599; Zhu LJ, 1999, VIROLOGY, V262, P237, DOI 10.1006/viro.1999.9900; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	48	125	129	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					961	+		10.1038/nm.2805	http://dx.doi.org/10.1038/nm.2805			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22635007	Green Accepted			2022-12-27	WOS:000305116600035
J	Yusuf, RZ; Wang, YH; Scadden, DT				Yusuf, Rushdia Z.; Wang, Ying-Hua; Scadden, David T.			Metabolic priming for AML	NATURE MEDICINE			English	Editorial Material							MYELOID-LEUKEMIA; IDH2 MUTATIONS; THERAPY; CELL		[Yusuf, Rushdia Z.; Wang, Ying-Hua; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02115 USA; [Yusuf, Rushdia Z.; Wang, Ying-Hua; Scadden, David T.] Harvard Univ, Ctr Canc, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University	Yusuf, RZ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02115 USA.	dscadden@mgh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100402, R01HL044851] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL044851, U01 HL100402] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davies SM, 2001, MED PEDIATR ONCOL, V36, P536, DOI 10.1002/mpo.1126; Felix CA, 2001, MED PEDIATR ONCOL, V36, P525, DOI 10.1002/mpo.1125; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li L, 2011, CANCER CELL, V20, P591, DOI 10.1016/j.ccr.2011.09.011; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Rowe JM, 2002, LEUKEMIA, V16, P748, DOI 10.1038/sj.leu.2402456; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; WARBURG O, 1956, Oncologia, V9, P75; Zhang W, 2012, NAT CELL BIOL, V14, P276, DOI 10.1038/ncb2432	18	13	13	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					865	867		10.1038/nm.2831	http://dx.doi.org/10.1038/nm.2831			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673998	Green Accepted			2022-12-27	WOS:000305116600023
J	Wenzel, SE				Wenzel, Sally E.			Asthma phenotypes: the evolution from clinical to molecular approaches	NATURE MEDICINE			English	Review							EXHALED NITRIC-OXIDE; PREDNISONE-DEPENDENT ASTHMA; LEUKOTRIENE C-4 SYNTHASE; NECROSIS-FACTOR-ALPHA; SPUTUM CELL COUNTS; BODY-MASS INDEX; AIRWAY INFLAMMATION; MONOCLONAL-ANTIBODY; BRONCHIAL BIOPSIES; RISK-FACTORS	Although asthma has been considered as a single disease for years, recent studies have increasingly focused on its heterogeneity. The characterization of this heterogeneity has promoted the concept that asthma consists of multiple phenotypes or consistent groupings of characteristics. Asthma phenotypes were initially focused on combinations of clinical characteristics, but they are now evolving to link biology to phenotype, often through a statistically based process. Ongoing studies of large-scale, molecularly and genetically focused and extensively clinically characterized cohorts of asthma should enhance our ability to molecularly understand these phenotypes and lead to more targeted and personalized approaches to asthma therapy.	[Wenzel, Sally E.] Univ Pittsburgh, Asthma Inst, UPMC, Pittsburgh, PA 15260 USA; [Wenzel, Sally E.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wenzel, SE (corresponding author), Univ Pittsburgh, Asthma Inst, UPMC, Pittsburgh, PA 15260 USA.	wenzelse@upmc.edu		Wenzel, Sally/0000-0002-4242-0164				Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; [Anonymous], 2006, LANCET, V368, P705; Arron J, 2011, AM J RESP CRIT CARE, V183, pA4455; Bachert C, 1997, J ALLERGY CLIN IMMUN, V99, P837, DOI 10.1016/S0091-6749(97)80019-X; Baines KJ, 2011, J ALLERGY CLIN IMMUN, V127, P153, DOI 10.1016/j.jaci.2010.10.024; Belda J, 2000, AM J RESP CRIT CARE, V161, P475, DOI 10.1164/ajrccm.161.2.9903097; Berry M, 2007, THORAX, V62, P1043, DOI 10.1136/thx.2006.073429; Bisgaard H, 2010, J ALLERGY CLIN IMMUN, V126, P187, DOI 10.1016/j.jaci.2010.07.011; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; Black JL, 2009, CLIN EXP ALLERGY, V39, P962, DOI 10.1111/j.1365-2222.2009.03270.x; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Bourgeois EA, 2011, EUR J IMMUNOL, V41, P299, DOI 10.1002/eji.201040647; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; Busacker A, 2009, CHEST, V135, P48, DOI 10.1378/chest.08-0049; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chibana K, 2008, CLIN EXP ALLERGY, V38, P936, DOI 10.1111/j.1365-2222.2008.02969.x; Chibana K., 2008, AM J RESP CRIT CARE, V177, pA975; Choi JH, 2004, HUM GENET, V114, P337, DOI 10.1007/s00439-004-1082-1; CHRISTIE PE, 1991, AM REV RESPIR DIS, V143, P1025, DOI 10.1164/ajrccm/143.5_Pt_1.1025; Chu H. W., 2002, Clinical and Experimental Allergy, V32, P1558, DOI 10.1046/j.1365-2222.2002.01477.x; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Cowburn AS, 1998, J CLIN INVEST, V101, P834, DOI 10.1172/JCI620; Dahlen B, 1998, AM J RESP CRIT CARE, V157, P1187, DOI 10.1164/ajrccm.157.4.9707089; Dahlen SE, 2002, AM J RESP CRIT CARE, V165, P9, DOI 10.1164/ajrccm.165.1.2010080; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Djukanovic R, 1997, AM J RESP CRIT CARE, V155, P826, DOI 10.1164/ajrccm.155.3.9117012; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P863, DOI 10.1164/ajrccm/142.4.863; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Dougherty RH, 2010, J ALLERGY CLIN IMMUN, V125, P1046, DOI 10.1016/j.jaci.2010.03.003; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Eiwegger T, 2011, EUR J IMMUNOL, V41, P1535, DOI 10.1002/eji.201141668; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Fei MJ, 2011, P NATL ACAD SCI USA, V108, P5360, DOI 10.1073/pnas.1015476108; FINNERTY JP, 1992, AM REV RESPIR DIS, V145, P746, DOI 10.1164/ajrccm/145.4_Pt_1.746; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; Fitzpatrick AM, 2011, J ALLERGY CLIN IMMUN, V127, P382, DOI 10.1016/j.jaci.2010.11.015; Flood-Page P, 2007, AM J RESP CRIT CARE, V176, P1062, DOI 10.1164/rccm.200701-085OC; Gamble C, 2010, J ALLERGY CLIN IMMUN, V126, P1149, DOI 10.1016/j.jaci.2010.08.049; Gauvreau GM, 2011, AM J RESP CRIT CARE, V183, P1007, DOI 10.1164/rccm.201008-1210OC; Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09; Gibson PG, 2003, THORAX, V58, P116, DOI 10.1136/thorax.58.2.116; Global Initiative for Asthma, 2008, GLOB STRAT ASTHM MAN, P93; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Gupta S, 2009, CHEST, V136, P1521, DOI 10.1378/chest.09-0174; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hallstrand TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008583; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P586, DOI 10.1016/j.jaci.2005.04.035; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Hanania NA, 2011, ANN INTERN MED, V154, P573, DOI 10.7326/0003-4819-154-9-201105030-00002; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Helenius IJ, 1998, J ALLERGY CLIN IMMUN, V101, P646, DOI 10.1016/S0091-6749(98)70173-3; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Holt PG, 2011, CHEST, V139, P1165, DOI 10.1378/chest.10-2397; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Humbert M, 2008, ALLERGY, V63, P592, DOI 10.1111/j.1398-9995.2008.01654.x; Humbert M, 1996, AM J RESP CRIT CARE, V153, P1931, DOI 10.1164/ajrccm.153.6.8665058; Humbert M, 1996, AM J RESP CRIT CARE, V154, P1497, DOI 10.1164/ajrccm.154.5.8912771; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Karjalainen EM, 2000, AM J RESP CRIT CARE, V161, P2086, DOI 10.1164/ajrccm.161.6.9907025; Kato T, 1995, NAT IMMUN, V14, P198; Kharitonov S A, 1996, Monaldi Arch Chest Dis, V51, P533; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Komakula S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-32; KUNICKA JE, 1993, CELL IMMUNOL, V149, P39, DOI 10.1006/cimm.1993.1134; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Locke GR, 1999, AM J MED, V106, P642, DOI 10.1016/S0002-9343(99)00121-7; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Lugogo NL, 2010, J APPL PHYSIOL, V108, P729, DOI 10.1152/japplphysiol.00845.2009; Maestrelli P, 2009, J ALLERGY CLIN IMMUN, V123, P531, DOI 10.1016/j.jaci.2009.01.057; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Martin PE, 2011, J ALLERGY CLIN IMMUN, V127, P1473, DOI 10.1016/j.jaci.2011.02.041; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; MERRIAM-WEBSTER, 2008, MERR WEBST COLL DICT; Miranda C, 2004, J ALLERGY CLIN IMMUN, V113, P101, DOI 10.1016/j.jaci.2003.10.041; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Murdock BJ, 2011, INFECT IMMUN, V79, P125, DOI 10.1128/IAI.00508-10; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; National Heart Lung and Blood Institute, 2007, NIH PUBL; Nilsson M, 2003, JAMA-J AM MED ASSOC, V290, P66, DOI 10.1001/jama.290.1.66; Pakhale S, 2010, CHEST, V137, P1316, DOI 10.1378/chest.09-2491; Parker JM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-14; Pearce N, 2000, THORAX, V55, P424, DOI 10.1136/thorax.55.5.424; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Pizzichini MMM, 1999, EUR RESPIR J, V13, P15, DOI 10.1183/09031936.99.13101599; RACKEMANN FM, 1947, AM J MED, V3, P601, DOI 10.1016/0002-9343(47)90204-0; Reddy RC, 2011, OBES SURG, V21, P200, DOI 10.1007/s11695-010-0155-6; Reiss TF, 1997, THORAX, V52, P1030, DOI 10.1136/thx.52.12.1030; Saha SK, 2008, J ALLERGY CLIN IMMUN, V121, P685, DOI 10.1016/j.jaci.2008.01.005; SAMTER M, 1967, J ALLERGY, V40, P281, DOI 10.1016/0021-8707(67)90076-7; Sanak M, 1997, LANCET, V350, P1599, DOI 10.1016/S0140-6736(05)64015-9; Sanchez-Segura A, 1998, J ALLERGY CLIN IMMUN, V102, P953, DOI 10.1016/S0091-6749(98)70333-1; Scheerens H, 2011, J ALLERGY CLIN IMMUN, V127, pAB164, DOI 10.1016/j.jaci.2010.12.651; SCHLEIMER RP, 1989, J PHARMACOL EXP THER, V250, P598; SCHLEIMER RP, 1994, J ALLERGY CLIN IMMUN, V94, P1202, DOI 10.1016/0091-6749(94)90333-6; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Simpson JL, 2005, AM J RESP CRIT CARE, V172, P559, DOI 10.1164/rccm.200503-369OC; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Sin DD, 2002, ARCH INTERN MED, V162, P1477, DOI 10.1001/archinte.162.13.1477; Singh AM, 2007, AM J RESP CRIT CARE, V175, P108, DOI 10.1164/rccm.200603-435PP; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Slager RE, 2011, AM THOR SOC INT C MA, pA1332; Slager RE, 2010, J ALLERGY CLIN IMMUN, V126, P875, DOI 10.1016/j.jaci.2010.08.001; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Spanevello A, 2000, AM J RESP CRIT CARE, V162, P1172, DOI 10.1164/ajrccm.162.3.9908057; Stankovic KM, 2008, LARYNGOSCOPE, V118, P881, DOI 10.1097/MLG.0b013e31816b4b6f; Stirling RG, 1998, THORAX, V53, P1030, DOI 10.1136/thx.53.12.1030; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; ten Brinke A, 2004, AM J RESP CRIT CARE, V170, P601, DOI 10.1164/rccm.200404-440OC; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Thomson NC, 2009, CURR OPIN PULM MED, V15, P39, DOI 10.1097/MCP.0b013e32831da894; van den Berge M, 2009, CLIN EXP ALLERGY, V39, P1477, DOI 10.1111/j.1365-2222.2009.03354.x; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; van Veen IH, 2009, J ALLERGY CLIN IMMUN, V124, P615, DOI 10.1016/j.jaci.2009.06.029; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P505, DOI 10.1164/ajrccm.157.2.9703070; Wenzel S, 2011, AM J RESP CRIT CARE, V183; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Woolley KL, 1996, AM J RESP CRIT CARE, V154, P237, DOI 10.1164/ajrccm.154.1.8680686; WU CY, 1991, EUR J IMMUNOL, V21, P2645, DOI 10.1002/eji.1830211053; Yamamoto M, 2012, CLIN EXP ALLERGY, V42, P760, DOI 10.1111/j.1365-2222.2011.03860.x; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3	143	1502	1577	6	203	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					716	725		10.1038/nm.2678	http://dx.doi.org/10.1038/nm.2678			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561835				2022-12-27	WOS:000303763500039
J	Paulson, RF				Paulson, Robert F.			Targeting a new regulator of erythropoiesis to alleviate anemia	NATURE MEDICINE			English	Editorial Material							INEFFECTIVE ERYTHROPOIESIS		Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Paulson, RF (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.	rfp5@psu.edu			NIDDK NIH HHS [R01 DK080040] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Dicato M, 2010, CURR OPIN ONCOL, V22, P307, DOI 10.1097/CCO.0b013e32833aa9de; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Rivella S, 2012, BLOOD REV, V26, pS12, DOI 10.1016/S0268-960X(12)70005-X; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; Shander A, 2011, BRIT J ANAESTH, V107, P41, DOI 10.1093/bja/aer350; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Tanno Toshihiko, 2010, Adv Hematol, V2010, P358283, DOI 10.1155/2010/358283	12	23	26	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					334	335		10.1038/nm.3524	http://dx.doi.org/10.1038/nm.3524			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710373				2022-12-27	WOS:000334361500009
J	Ramkhelawon, B; Hennessy, EJ; Menager, M; Ray, TD; Sheedy, FJ; Hutchison, S; Wanschel, A; Oldebeken, S; Geoffrion, M; Spiro, W; Miller, G; McPherson, R; Rayner, KJ; Moore, KJ				Ramkhelawon, Bhama; Hennessy, Elizabeth J.; Menager, Mickael; Ray, Tathagat Dutta; Sheedy, Frederick J.; Hutchison, Susan; Wanschel, Amarylis; Oldebeken, Scott; Geoffrion, Michele; Spiro, Westley; Miller, George; McPherson, Ruth; Rayner, Katey J.; Moore, Kathryn J.			Netrin-1 promotes adipose tissue macrophage retention and insulin resistance in obesity	NATURE MEDICINE			English	Article							NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; ISCHEMIA-REPERFUSION INJURY; FREE FATTY-ACIDS; WEIGHT-LOSS; ATHEROSCLEROSIS REGRESSION; INFLAMMATORY RESPONSE; PROTECTS KIDNEY; T-CELLS; MICE	During obesity, macrophage accumulation in adipose tissue propagates the chronic inflammation and insulin resistance associated with type 2 diabetes. The factors, however, that regulate the accrual of macrophages in adipose tissue are not well understood. Here we show that the neuroimmune guidance cue netrin-1 is highly expressed in obese but not lean adipose tissue of humans and mice, where it directs the retention of macrophages. Netrin-1, whose expression is induced in macrophages by the saturated fatty acid palmitate, acts via its receptor Unc5b to block their migration. In a mouse model of diet-induced obesity, we show that adipose tissue macrophages exhibit reduced migratory capacity, which can be restored by blocking netrin-1. Furthermore, hematopoietic deletion of Ntn1 facilitates adipose tissue macrophage emigration, reduces inflammation and improves insulin sensitivity. Collectively, these findings identify netrin-1 as a macrophage retention signal in adipose tissue during obesity that promotes chronic inflammation and insulin resistance.	[Ramkhelawon, Bhama; Hennessy, Elizabeth J.; Ray, Tathagat Dutta; Sheedy, Frederick J.; Hutchison, Susan; Wanschel, Amarylis; Oldebeken, Scott; Spiro, Westley; Moore, Kathryn J.] NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med,Marc & Ruti Bell Program Vasc Biol & Dis, New York, NY 10003 USA; [Menager, Mickael] NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY USA; [Geoffrion, Michele] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [Miller, George; McPherson, Ruth; Rayner, Katey J.] NYU, Sch Med, Dept Surg, New York, NY USA	New York University; New York University; University of Ottawa; University of Ottawa Heart Institute; New York University	Moore, KJ (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med,Marc & Ruti Bell Program Vasc Biol & Dis, New York, NY 10003 USA.	kathryn.moore@nyumc.org	Ménager, Mickaël M/L-2334-2017; Wanschel, Amarylis/A-8452-2013; Wanschel, Amarylis/B-3591-2019; Hennessy, Elizabeth/AAJ-4800-2021; Moore, Kathryn/ABE-6416-2020	Wanschel, Amarylis/0000-0001-7307-915X; Wanschel, Amarylis/0000-0002-5603-7983; Hennessy, Elizabeth/0000-0002-1231-5777; Moore, Kathryn/0000-0003-2505-2547; Sheedy, Frederick/0000-0003-2645-8493; Rayner, Katey/0000-0001-6230-426X; Sheedy, Frederick/0000-0002-4722-3135	US National Institutes of Health [RC1HL100815, T32HL098129]; American Heart Association [13POST14490016]; Canadian Institutes of Health Research [MOP-2390941]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098129, RC1HL100815] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this work came from the US National Institutes of Health (RC1HL100815 to K.J.M. and T32HL098129 to E.J.H.), the American Heart Association (13POST14490016 to B.R.) and the Canadian Institutes of Health Research (MOP-2390941 to R.M.).	Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Boden G, 2002, CURR OPIN CLIN NUTR, V5, P545, DOI 10.1097/00075197-200209000-00014; Chakrabarti SK, 2011, AM J PHYSIOL-ENDOC M, V300, pE175, DOI 10.1152/ajpendo.00203.2010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jung DY, 2013, AM J PHYSIOL-ENDOC M, V304, pE964, DOI 10.1152/ajpendo.00462.2012; Khan JA, 2011, GENE THER, V18, P437, DOI 10.1038/gt.2010.155; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Koppaka S, 2013, DIABETES, V62, P1843, DOI 10.2337/db12-0868; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kovacikova M, 2011, INT J OBESITY, V35, P91, DOI 10.1038/ijo.2010.112; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Ranganathan PV, 2013, KIDNEY INT, V83, P1087, DOI 10.1038/ki.2012.423; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Salminen M, 2000, DEVELOPMENT, V127, P13; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang WW, 2009, AM J PATHOL, V175, P1010, DOI 10.2353/ajpath.2009.090224; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001	61	168	176	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					377	+		10.1038/nm.3467	http://dx.doi.org/10.1038/nm.3467			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24584118	Green Accepted			2022-12-27	WOS:000334361500018
J	Lin, PL; Ford, CB; Coleman, MT; Myers, AJ; Gawande, R; Ioerger, T; Sacchettini, J; Fortune, SM; Flynn, JL				Lin, Philana Ling; Ford, Christopher B.; Coleman, M. Teresa; Myers, Amy J.; Gawande, Richa; Ioerger, Thomas; Sacchettini, James; Fortune, Sarah M.; Flynn, JoAnne L.			Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing	NATURE MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CYNOMOLGUS MACAQUES; INFECTION; BIOMARKERS; DYNAMICS; MODEL	Over 30% of the world's population is infected with Mycobacterium tuberculosis (Mtb), yet only similar to 5-10% will develop clinical disease(1). Despite considerable effort, researchers understand little about what distinguishes individuals whose infection progresses to active tuberculosis (TB) from those whose infection remains latent for decades. The variable course of disease is recapitulated in cynomolgus macaques infected with Mtb(2). Active disease occurs in similar to 45% of infected macaques and is defined by clinical, microbiologic and immunologic signs, whereas the remaining infected animals are clinically asymptomatic(2,3). Here, we use individually marked Mtb isolates and quantitative measures of culturable and cumulative bacterial burden to show that most lung lesions are probably founded by a single bacterium and reach similar maximum burdens. Despite this observation, the fate of individual lesions varies substantially within the same host. Notably, in active disease, the host sterilizes some lesions even while others progress. Our data suggest that lesional heterogeneity arises, in part, through differential killing of bacteria after the onset of adaptive immunity. Thus, individual lesions follow diverse and overlapping trajectories, suggesting that critical responses occur at a lesional level to ultimately determine the clinical outcome of infection. Defining the local factors that dictate outcome will be useful in developing effective interventions to prevent active TB.	[Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Med Ctr, Pittsburgh, PA 15213 USA; [Ford, Christopher B.; Gawande, Richa; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Ford, Christopher B.; Fortune, Sarah M.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Coleman, M. Teresa] Univ Pittsburgh, Sch Med, Dept Radiol, Positron Emiss Tomog Res Ctr, Pittsburgh, PA USA; [Myers, Amy J.; Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Ioerger, Thomas] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX USA; [Sacchettini, James] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Fortune, Sarah M.] Ragon Inst MGH MIT & Harvard, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Fortune, SM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	sfortune@hsph.harvard.edu; joanne@pitt.edu	Flynn, JoAnne/ABC-7371-2020	Fortune, Sarah/0000-0001-7565-9975; , Richa/0000-0002-1831-0977	Bill & Melinda Gates Foundation; Otis Childs Trust of the Children's Hospital of Pittsburgh Foundation; US National Institutes of Health, National Institute of Allergy and Infectious Diseases DAIT; US National Institutes of Health [HL106804, AI094745, HL110811, DP2 0D001378, AI076217]; Howard Hughes Medical Institute, the Physician Scientist Early Career Award; Harvard Merit Fellowship; Burroughs Wellcome Foundation Investigator in the Pathogenesis of Infectious Diseases Fellowship; Robert A. Welch Foundation; Melvin J. and Geraldine L. Glimcher Associate Professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106804, R01HL110811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007638, R01AI094745, U19AI076217] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001378] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Otis Childs Trust of the Children's Hospital of Pittsburgh Foundation; US National Institutes of Health, National Institute of Allergy and Infectious Diseases DAIT; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute, the Physician Scientist Early Career Award; Harvard Merit Fellowship; Burroughs Wellcome Foundation Investigator in the Pathogenesis of Infectious Diseases Fellowship; Robert A. Welch Foundation(The Welch Foundation); Melvin J. and Geraldine L. Glimcher Associate Professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were funded by the Bill & Melinda Gates Foundation (grants to J.L.F. and P.L.L.), the Otis Childs Trust of the Children's Hospital of Pittsburgh Foundation (P.L.L.), US National Institutes of Health, National Institute of Allergy and Infectious Diseases DAIT BAA-05-10 (J.L.F.), US National Institutes of Health grants HL106804 (J.L.F.), AI094745 (J.L.F.), HL110811 (J.L.F.), DP2 0D001378 (S.M.F.) and AI076217 (S.M.F.), the Howard Hughes Medical Institute, the Physician Scientist Early Career Award (S.M.F.), the Harvard Merit Fellowship (C.B.F.), the Burroughs Wellcome Foundation Investigator in the Pathogenesis of Infectious Diseases Fellowship (S.M.F.), the Robert A. Welch Foundation (J.S.) and the Melvin J. and Geraldine L. Glimcher Associate Professorship (S.M.F.). We are grateful to E. Klein and C. Janssen for conducting necropsies, C. Scanga for coordination of studies, M. Rodgers, C. Cochran and C. Bigbee for excellent technical assistance, M. O'Malley, P. Johnston, J. Tomko, D. Fillmore and J. Frye for outstanding veterinary technical assistance, the members of the Flynn and Fortune labs for helpful discussions and B. Bloom, D. Young and E. Rubin for helpful comments on the manuscript.	Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Canetti G., 1955, TUBERCLE BACILLUS; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KENNEDY HE, 1958, AM REV TUBERC PULM, V77, P802; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lin PL, 2013, ANTIMICROB AGENTS CH, V57, P4237, DOI 10.1128/AAC.00277-13; Lin PL, 2012, P NATL ACAD SCI USA, V109, P14188, DOI 10.1073/pnas.1121497109; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; VANDIVIERE H M, 1956, Am J Med Sci, V232, P30, DOI 10.1097/00000441-195607000-00006; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	20	311	321	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					75	+		10.1038/nm.3412	http://dx.doi.org/10.1038/nm.3412			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24336248	Green Submitted, Green Accepted, Bronze			2022-12-27	WOS:000329349400022
J	Bookout, AL; de Groot, MHM; Owen, BM; Lee, S; Gautron, L; Lawrence, HL; Ding, XS; Elmquist, JK; Takahashi, JS; Mangelsdorf, DJ; Kliewer, SA				Bookout, Angie L.; de Groot, Marleen H. M.; Owen, Bryn M.; Lee, Syann; Gautron, Laurent; Lawrence, Heather L.; Ding, Xunshan; Elmquist, Joel K.; Takahashi, Joseph S.; Mangelsdorf, David J.; Kliewer, Steven A.			FGF21 regulates metabolism and circadian behavior by acting on the nervous system	NATURE MEDICINE			English	Article							GROWTH-FACTOR 21; BETA-KLOTHO; PERIPHERAL CLOCKS; FOOD-INTAKE; BRAIN; FIBROBLAST-GROWTH-FACTOR-21; EXPRESSION; STARVATION; NEURONS; FAMINE	Fibroblast growth factor 21 (FGF21) is a hepatokine that acts as a global starvation signal to modulate fuel partitioning and metabolism and repress growth(1); however, the site of action of these diverse effects remains unclear. FGF21 signals through a heteromeric cell-surface receptor composed of one of three FGF receptors (FGFR1c, FGFR2c or FGFR3c) in complex with beta-Klotho(2-4), a single-pass transmembrane protein that is enriched in metabolic tissues(5). Here we show that in addition to its known effects on peripheral metabolism, FGF21 increases systemic glucocorticoid levels, suppresses physical activity and alters circadian behavior, which are all features of the adaptive starvation response. These effects are mediated through beta-Klotho expression in the suprachiasmatic nucleus of the hypothalamus and the dorsal vagal complex of the hindbrain. Mice lacking the gene encoding beta-Klotho (Klb) in these regions are refractory to these effects, as well as those on metabolism, insulin and growth. These findings demonstrate a crucial role for the nervous system in mediating the diverse physiologic and pharmacologic actions of FGF21.	[Bookout, Angie L.; Owen, Bryn M.; Lawrence, Heather L.; Ding, Xunshan; Mangelsdorf, David J.; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Bookout, Angie L.; Lee, Syann; Gautron, Laurent; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [de Groot, Marleen H. M.; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [de Groot, Marleen H. M.; Takahashi, Joseph S.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Ding, Xunshan; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mangelsdorf, DJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu; steven.kliewer@utsouthwestern.edu	gautron, laurent/AAQ-5983-2021; Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Mangelsdorf, David/0000-0002-4355-0796; Owen, Bryn/0000-0001-5296-7553	US National Institutes of Health [R01DK067158, P20RR20691, 1RL1GM084436-01, U19DK62434, P01DK088761, RL1DK081185, GM007062]; Robert A. Welch Foundation [I-1558, I-1275]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RL1DK081185, U19DK062434, R01DK067158, P01DK088761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084436, T32GM007062] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Zhang, K. Vale and E. Borowicz for help with mouse studies, X. Wang and Y. Wan for tibia measurements, D. Lauzon and C. Lee for in situ hybridization, M. Izumo for Camk2a-Cre mice (University of Texas Southwestern Medical Center), M. Scott for Phox2b-Cre mice (University of Virginia), C, Cummins for advice on glucocorticoid and ACTH assays and all members of the Takahashi, Elmquist and Mango/Kliewer laboratories for critical discussions. This work was supported by US National Institutes of Health grants R01DK067158, P20RR20691 and 1RL1GM084436-01 (to S.A.K. and D.J.M.), U19DK62434 (to J.K.E. and D.J.M.), P01DK088761 and RL1DK081185 (to J.K.E.) and GM007062 (to A.L.B.), the Robert A. Welch Foundation (grant I-1558 to S.A.K. and grant I-1275 to D.J.M.) and the Howard Hughes Medical Institute (to J.S.T. and D.J.M.).	Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; BUIJS RM, 1993, AM J PHYSIOL, V264, pR1186, DOI 10.1152/ajpregu.1993.264.6.R1186; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Hakansson ML, 1998, J NEUROSCI, V18, P559; Hsuchou H, 2007, PEPTIDES, V28, P2382, DOI 10.1016/j.peptides.2007.10.007; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Lowey A.D., 1990, CENTRAL REGULATION A; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Owen BM, 2013, NAT MED, V19, P1153, DOI 10.1038/nm.3250; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Ritter S, 2000, BRAIN RES, V856, P37, DOI 10.1016/S0006-8993(99)02327-6; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tan BK, 2011, DIABETES, V60, P2758, DOI 10.2337/db11-0672; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Yang CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033870; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	30	352	360	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1147	1152		10.1038/nm.3249	http://dx.doi.org/10.1038/nm.3249			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23933984	Green Accepted, Green Submitted			2022-12-27	WOS:000324083500029
J	Emblem, KE; Mouridsen, K; Bjornerud, A; Farrar, CT; Jennings, D; Borra, RJH; Wen, PY; Ivy, P; Batchelor, TT; Rosen, BR; Jain, RK; Sorensen, AG				Emblem, Kyrre E.; Mouridsen, Kim; Bjornerud, Atle; Farrar, Christian T.; Jennings, Dominique; Borra, Ronald J. H.; Wen, Patrick Y.; Ivy, Percy; Batchelor, Tracy T.; Rosen, Bruce R.; Jain, Rakesh K.; Sorensen, A. Gregory			Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy	NATURE MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MAGNETIC-SUSCEPTIBILITY; ANTIANGIOGENIC THERAPY; GLIOBLASTOMA PATIENTS; TUMOR ANGIOGENESIS; KINASE INHIBITOR; MR CONTRAST; VASCULATURE; MICROCIRCULATION; MECHANISMS	Measurement of vessel caliber by magnetic resonance imaging (MRI) is a valuable technique for in vivo monitoring of hemodynamic status and vascular development, especially in the brain. Here, we introduce a new paradigm in MRI termed vessel architectural imaging (VAI) that exploits an overlooked temporal shift in the magnetic resonance signal, forming the basis for vessel caliber estimation, and show how this phenomenon can reveal new information on vessel type and function not assessed by any other noninvasive imaging technique. We also show how this biomarker can provide new biological insights into the treatment of patients with cancer. As an example, we demonstrate using VAI that anti-angiogenic therapy can improve microcirculation and oxygen saturation and reduce vessel calibers in patients with recurrent glioblastomas and, more crucially, that patients with these responses have prolonged survival. Thus, VAI has the potential to identify patients who would benefit from therapies.	[Emblem, Kyrre E.; Mouridsen, Kim; Farrar, Christian T.; Jennings, Dominique; Borra, Ronald J. H.; Rosen, Bruce R.; Sorensen, A. Gregory] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Emblem, Kyrre E.; Mouridsen, Kim; Farrar, Christian T.; Jennings, Dominique; Borra, Ronald J. H.; Rosen, Bruce R.; Sorensen, A. Gregory] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Emblem, Kyrre E.; Mouridsen, Kim; Farrar, Christian T.; Jennings, Dominique; Borra, Ronald J. H.; Wen, Patrick Y.; Batchelor, Tracy T.; Rosen, Bruce R.; Jain, Rakesh K.; Sorensen, A. Gregory] Harvard Univ, Sch Med, Boston, MA USA; [Emblem, Kyrre E.; Bjornerud, Atle] Oslo Univ Hosp, Intervent Ctr, Oslo, Norway; [Mouridsen, Kim] Univ Aarhus, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Mouridsen, Kim] Univ Aarhus, MINDLab, Aarhus, Denmark; [Bjornerud, Atle] Univ Oslo, Dept Phys, Oslo, Norway; [Borra, Ronald J. H.] Turku Univ Hosp, Med Imaging Ctr Southwest Finland, FIN-20520 Turku, Finland; [Wen, Patrick Y.] Dana Farber Brigham & Womens Canc Ctr, Ctr Neurooncol, Boston, MA USA; [Ivy, Percy] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [Batchelor, Tracy T.; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; [Batchelor, Tracy T.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sorensen, A. Gregory] Siemens Healthcare Hlth Serv, Malvern, PA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Oslo; Aarhus University; Aarhus University; University of Oslo; University of Turku; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Siemens AG	Emblem, KE (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.	kyrre@mmr.mgh.harvard.edu	Emblem, Kyrre E/H-6691-2012; Wen, Patrick/AAE-3776-2022; Jain, Rakesh K/I-1384-2017	Emblem, Kyrre E/0000-0002-6580-9519; Jain, Rakesh K/0000-0001-7571-3548; Borra, Ronald/0000-0001-8072-1243; Farrar, Christian/0000-0001-6623-8220	US Public Health Service [R21CA117079, S10RR023401, S10RR019307, S10RR019254, S10RR023043, S10RR021110, R01CA137254, R01CA129371, 5R01NS060918, K24CA125440, P0ICA80124, K25AG029415]; US National Cancer Institute [NCT00035656]; SAIC-Frederick Inc. [26XS263]; Norwegian Research Council [191088/F20]; South-Eastern Norway Regional Health Authority Grant [2013069]; Danish Research Foundation (Center of Functionally Integrative Neuroscience); Ministry of Science, Innovation and Technology Denmark (Investment Capital for University Research); Sigrid Juselius Foundation; Instrumentarium Research Foundation; Academy of Finland; Paulo Foundation; Finnish Medical Foundation; Harvard Catalyst Harvard Clinical and Translational Science Center (US National Institutes of Health Award) [UL1 RR 025758, M01-RR-01066]; Harvard University; NATIONAL CANCER INSTITUTE [R01CA137254, R01CA129371, P01CA080124, R21CA117079, K24CA125440, U01CA154601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019254, S10RR019307, M01RR001066, UL1RR025758, S10RR023401, S10RR023043, S10RR021110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG029415] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SAIC-Frederick Inc.; Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority Grant; Danish Research Foundation (Center of Functionally Integrative Neuroscience); Ministry of Science, Innovation and Technology Denmark (Investment Capital for University Research); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Instrumentarium Research Foundation; Academy of Finland(Academy of Finland); Paulo Foundation; Finnish Medical Foundation; Harvard Catalyst Harvard Clinical and Translational Science Center (US National Institutes of Health Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank T. Stylianopoulos (Department of Mechanical and Manufacturing Engineering, University of Cyprus) and J.W. Baish (Department of Mechanical and Biomedical Engineering, Bucknell University) for critical reading of this manuscript. This work was funded by the US Public Health Service (grants R21CA117079, S10RR023401, S10RR019307, S10RR019254, S10RR023043, S10RR021110, R01CA137254, R01CA129371, 5R01NS060918, K24CA125440, P0ICA80124 and K25AG029415), by the US National Cancer Institute (http://www.clinicaltrials.gov/, NCT00035656); SAIC-Frederick Inc. grant 26XS263; Norwegian Research Council grant 191088/F20; South-Eastern Norway Regional Health Authority Grant 2013069; the Danish Research Foundation (Center of Functionally Integrative Neuroscience); the Ministry of Science, Innovation and Technology Denmark (Investment Capital for University Research); the Sigrid Juselius Foundation; the Instrumentarium Research Foundation; the Academy of Finland; the Paulo Foundation; and the Finnish Medical Foundation. This work was conducted with support from Harvard Catalyst Harvard Clinical and Translational Science Center (US National Institutes of Health Award nos. UL1 RR 025758 and M01-RR-01066 and financial contributions from Harvard University and its affiliated academic healthcare centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the US National Center for Research Resources or the US National Institutes of Health.	Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Beaumont M, 2009, J CEREBR BLOOD F MET, V29, P1714, DOI 10.1038/jcbfm.2009.86; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Bulnes S, 2009, HISTOL HISTOPATHOL, V24, P693, DOI 10.14670/HH-24.693; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; DVORAK HF, 1995, AM J PATHOL, V146, P1029; FISEL CR, 1991, MAGNET RESON MED, V17, P336, DOI 10.1002/mrm.1910170206; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; KENNAN RP, 1994, MAGNET RESON MED, V31, P9, DOI 10.1002/mrm.1910310103; Kiselev VG, 2005, MAGNET RESON MED, V53, P553, DOI 10.1002/mrm.20383; LESS JR, 1991, CANCER RES, V51, P265; Pries AR, 2010, NAT REV CANCER, V10, P587, DOI 10.1038/nrc2895; Schmainda K, 2005, AM J NEURORADIOL, V26, P686; SHARAN M, 1989, ANN BIOMED ENG, V17, P13, DOI 10.1007/BF02364271; Sorensen AG, 2012, CANCER RES, V72, P402, DOI 10.1158/0008-5472.CAN-11-2464; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; WEISSKOFF RM, 1993, MAGN RESON MED, V29, P553, DOI 10.1002/mrm.1910290420; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Zwick S, 2009, J MAGN RESON IMAGING, V29, P1125, DOI 10.1002/jmri.21710	27	156	161	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2013	19	9					1178	1183		10.1038/nm.3289	http://dx.doi.org/10.1038/nm.3289			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23955713	Green Accepted, Green Submitted			2022-12-27	WOS:000324083500035
J	Walker-Samuel, S; Ramasawmy, R; Torrealdea, F; Rega, M; Rajkumar, V; Johnson, SP; Richardson, S; Goncalves, M; Parkes, HG; Arstad, E; Thomas, DL; Pedley, RB; Lythgoe, MF; Golay, X				Walker-Samuel, Simon; Ramasawmy, Rajiv; Torrealdea, Francisco; Rega, Marilena; Rajkumar, Vineeth; Johnson, S. Peter; Richardson, Simon; Goncalves, Miguel; Parkes, Harold G.; Arstad, Erik; Thomas, David L.; Pedley, R. Barbara; Lythgoe, Mark F.; Golay, Xavier			In vivo imaging of glucose uptake and metabolism in tumors	NATURE MEDICINE			English	Article							WHOLE-BODY MRI; MAGNETIZATION-TRANSFER; PROCEDURE GUIDELINE; FDG-PET; CANCER; SPECTROSCOPY; XENOGRAFTS; RESONANCE; DISEASE; CELLS	Tumors have a greater reliance on anaerobic glycolysis for energy production than normal tissues. We developed a noninvasive method for imaging glucose uptake in vivo that is based on magnetic resonance imaging and allows the uptake of unlabeled glucose to be measured through the chemical exchange of protons between hydroxyl groups and water. This method differs from existing molecular imaging methods because it permits detection of the delivery and uptake of a metabolically active compound in physiological quantities. We show that our technique, named glucose chemical exchange saturation transfer (glucoCEST), is sensitive to tumor glucose accumulation in colorectal tumor models and can distinguish tumor types with differing metabolic characteristics and pathophysiologies. The results of this study suggest that glucoCEST has potential as a useful and cost-effective method for characterizing disease and assessing response to therapy in the clinic.	[Walker-Samuel, Simon; Ramasawmy, Rajiv; Torrealdea, Francisco; Richardson, Simon; Goncalves, Miguel; Lythgoe, Mark F.] UCL, Ctr Adv Biomed Imaging, Div Med, London, England; [Walker-Samuel, Simon; Ramasawmy, Rajiv; Torrealdea, Francisco; Richardson, Simon; Goncalves, Miguel; Lythgoe, Mark F.] Inst Child Hlth, London, England; [Torrealdea, Francisco; Rega, Marilena; Thomas, David L.; Golay, Xavier] UCL Inst Neurol, London, England; [Rajkumar, Vineeth; Johnson, S. Peter; Pedley, R. Barbara] UCL Canc Inst, London, England; [Parkes, Harold G.] Canc Res UK, Sutton, Surrey, England; [Parkes, Harold G.] Inst Canc Res, Canc Imaging Ctr, EPSRC, Sutton, Surrey, England; [Parkes, Harold G.] Royal Marsden Natl Hlth Serv Fdn Trust, Sutton, Surrey, England; [Arstad, Erik] UCL, Dept Chem, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Cancer Research UK; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; University College London	Walker-Samuel, S (corresponding author), UCL, Ctr Adv Biomed Imaging, Div Med, London, England.	simon.walkersamuel@ucl.ac.uk	Golay, Xavier/AAJ-8094-2021; Parkes, Harold G/I-7412-2012	Golay, Xavier/0000-0002-6447-4446; Arstad, Erik/0000-0002-3240-2106; Thomas, David/0000-0003-1491-1641; Parkes, Harold/0000-0003-4981-864X; Lythgoe, Mark/0000-0002-4945-0171	King's College London; UCL Comprehensive Cancer Imaging Centre; The Institute of Cancer Research Cancer Imaging Centre; Cancer Research UK; EPSRC; Department of Health (England) [C1060/A10334, C1519/A10331, C16412/A6269, C309/A8274]; British Heart Foundation; Cancer Research UK [16464, 16463] Funding Source: researchfish; Medical Research Council [G1001497, 1028351] Funding Source: researchfish; MRC [G1001497] Funding Source: UKRI	King's College London; UCL Comprehensive Cancer Imaging Centre; The Institute of Cancer Research Cancer Imaging Centre; Cancer Research UK(Cancer Research UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Health (England); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by King's College London and UCL Comprehensive Cancer Imaging Centre, and The Institute of Cancer Research Cancer Imaging Centre, Cancer Research UK and EPSRC in association with the Medical Research Council (MRC), the Department of Health (England) (C1060/A10334, C1519/A10331, C16412/A6269 and C309/A8274) and the British Heart Foundation and was supported by researchers at the National Institute for Health Research UCL Hospital Biomedical Research Centre.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Antoch G, 2003, JAMA-J AM MED ASSOC, V290, P3199, DOI 10.1001/jama.290.24.3199; Belle V, 1998, JMRI-J MAGN RESON IM, V8, P1240, DOI 10.1002/jmri.1880080610; Burre JS, 2011, MAGN RESON MED, V66, P227, DOI 10.1002/mrm.22779; Campbell A. E., 2011, J CARDIOVASC MAGN S1, V13, P60; Campbell-Washburn AE, 2013, MAGN RESON MED, V69, P238, DOI 10.1002/mrm.24243; Chan KWY, 2011, P 19 ANN M ISMRM MON, P551; Dearling JLJ, 2004, J NUCL MED, V45, P101; Delbeke D, 2006, J NUCL MED, V47, P885; Eary JF, 1998, J NUCL MED, V39, P250; El Emir E, 2007, CANCER RES, V67, P11896, DOI 10.1158/0008-5472.CAN-07-2967; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Gloor M, 2011, MAGN RESON MED, V65, P1113, DOI 10.1002/mrm.22694; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARIHARAN R, 1995, CIRCULATION, V91, P2435, DOI 10.1161/01.CIR.91.9.2435; John SA, 2008, PFLUG ARCH EUR J PHY, V456, P307, DOI 10.1007/s00424-007-0395-z; KALDERON B, 1989, P NATL ACAD SCI USA, V86, P4690, DOI 10.1073/pnas.86.12.4690; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Kunnecke B, 2000, MAGNET RESON MED, V44, P556, DOI 10.1002/1522-2594(200010)44:4<556::AID-MRM9>3.0.CO;2-3; Parker JA, 1996, J NUCL MED, V37, P2087; Plathow C, 2008, RADIOLOGE, V48, P384, DOI 10.1007/s00117-007-1547-z; Ranjeva JP, 1997, MAGN RESON MATER PHY, V5, P259, DOI 10.1007/BF02595043; Shortt CP, 2009, AM J ROENTGENOL, V192, P980, DOI 10.2214/AJR.08.1633; Tyler DJ, 2005, MAGN RESON MED, V53, P103, DOI 10.1002/mrm.20323; UGURBIL K, 1978, P NATL ACAD SCI USA, V75, P3742, DOI 10.1073/pnas.75.8.3742; Vallabhajosula S, 2009, MOLECULAR IMAGING: RADIOPHARMACEUTICALS FOR PET AND SPECT, P1, DOI 10.1007/978-3-540-76735-0; Waker-Samuel S, 2011, MAGN RESON MED, V65, P438, DOI 10.1002/mrm.22572; Walker-Samuel S, 2006, PHYS MED BIOL, V51, P3593, DOI 10.1088/0031-9155/51/14/021; Walker-Samuel S., 2011, P 19 SCI M INT SOC M, P182; Walker-Samuel S, 2012, NMR BIOMED, V25, P829, DOI 10.1002/nbm.1798; Walker-Samuel S, 2012, INT J CANCER, V130, P1284, DOI 10.1002/ijc.26112; Ward KM, 2000, MAGN RESON MED, V44, P799, DOI 10.1002/1522-2594(200011)44:5<799::AID-MRM18>3.0.CO;2-S; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zaidi H., 2005, QUANTITATIVE ANAL NU; Zhou JY, 2004, MAGN RESON MED, V51, P945, DOI 10.1002/mrm.20048; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	38	334	342	7	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1067	+		10.1038/nm.3252	http://dx.doi.org/10.1038/nm.3252			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23832090	Green Accepted			2022-12-27	WOS:000322779600034
J	Diana, J; Simoni, Y; Furio, L; Beaudoin, L; Agerberth, B; Barrat, F; Lehuen, A				Diana, Julien; Simoni, Yannick; Furio, Laetitia; Beaudoin, Lucie; Agerberth, Birgitta; Barrat, Franck; Lehuen, Agnes			Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes	NATURE MEDICINE			English	Article							INTERFERON-ALPHA; T-CELLS; APOPTOTIC CELLS; VIRAL-INFECTION; B-CELLS; MELLITUS; ONSET; ACTIVATION; ACID; MICE	Type 1 diabetes develops over many years and is characterized ultimately by the destruction of insulin-producing pancreatic beta cells by autoreactive T cells. Nonetheless, the role of innate cells in the initiation of this disease remains poorly understood. Here, we show that in young female nonobese diabetic mice, physiological beta cell death induces the recruitment and activation of B-la cells, neutrophils and plasmacytoid dendritic cells (pDCs) to the pancreas. Activated B-1a cells secrete IgGs specific for double-stranded DNA. IgGs activate neutrophils to release DNA-binding cathelicidin-related antimicrobial peptide (CRAMP), which binds self DNA. Then, self DNA, DNA-specific IgG and CRAMP peptide activate pDCs through the Toll-like receptor 9-myeloid differentiation factor 88 pathway, leading to interferon-alpha production in pancreatic islets. We further demonstrate through the use of depleting treatments that B-1a cells, neutrophils and IFN-alpha-producing pDCs are required for the initiation of the diabetogenic T cell response and type 1 diabetes development. These findings reveal that an innate immune cell crosstalk takes place in the pancreas of young NOD mice and leads to the initiation of T1D.	[Diana, Julien; Simoni, Yannick; Beaudoin, Lucie; Lehuen, Agnes] INSERM, U986, Paris, France; [Diana, Julien; Simoni, Yannick; Furio, Laetitia; Beaudoin, Lucie; Lehuen, Agnes] Univ Paris Descartes Sorbonne Paris Cite, Lab Excellence Inflamex, Paris, France; [Furio, Laetitia] Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Agerberth, Birgitta] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Barrat, Franck] Dynavax Technol Corp, Berkeley, CA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet	Lehuen, A (corresponding author), INSERM, U986, Paris, France.	julien.diana@inserm.fr; agnes.lehuen@inserm.fr	DIANA, Julien/A-2873-2014	DIANA, Julien/0000-0001-7542-042X; SIMONI, Yannick/0000-0002-9086-3680; Lehuen, Agnes/0000-0002-0450-3321	INSERM, Centre National de la Recherche Scientifique [ANR-05-PCOD009-01, ANR-09-GENO-023]; Labex INFLAMEX; APHP-CNRS Contrat Hospitalier de Recherche Translationelle	INSERM, Centre National de la Recherche Scientifique(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Labex INFLAMEX; APHP-CNRS Contrat Hospitalier de Recherche Translationelle	We thank N. Charles (INSERM UMR-S 699, Paris Diderot University) for dsDNA-specific immunoglobulin ELISA, M. Colonna (Department of Pathology and Immunology, Washington University School of Medicine) for m927 mAb, S. Mecheri (Biology of Host Parasite Interactions Unit, Pasteur Institute) for NIMP-14 mAb, S. Muller (CNRS, Institut de Biologie Moleculaire et Cellulaire, UPR9021) for serum from NZB/W F1 mice, J. Ravetch (Laboratory of Molecular Genetics and Immunology, Rockefeller University) for Fc gamma RIV-specific mAb, N. Thieblemont (CNRS UMR 8147, Paris Descartes University) for Myd88<SUP>-/-</SUP> NOD mice and all for their expertise. We thank F. Boutillon for technical assistance and the staff of the INSERM U986 mouse facility for help in animal care. Y.S. is supported by a doctoral fellowship from the Region Ile de France. This work was supported by funds from INSERM, Centre National de la Recherche Scientifique, ANR-05-PCOD009-01, ANR-09-GENO-023 and Labex INFLAMEX to A.L. A.L. is recipient of an APHP-CNRS Contrat Hospitalier de Recherche Translationelle.	Alba A, 2004, J IMMUNOL, V173, P6667, DOI 10.4049/jimmunol.173.11.6667; Allen JS, 2009, DIABETES, V58, P138, DOI 10.2337/db08-0964; AUNE TM, 1982, P NATL ACAD SCI-BIOL, V79, P3808, DOI 10.1073/pnas.79.12.3808; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bock T, 2003, J ENDOCRINOL, V179, P245, DOI 10.1677/joe.0.1790245; Brod SA, 1998, DIABETOLOGIA, V41, P1227, DOI 10.1007/s001250051056; BURASTERO SE, 1988, J EXP MED, V168, P1979, DOI 10.1084/jem.168.6.1979; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; De Filippo G, 1997, ACTA DIABETOL, V34, P271, DOI 10.1007/s005920050087; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; EWEL CH, 1992, DIABETES, V41, P1016, DOI 10.2337/diabetes.41.8.1016; Fabris P, 1998, J HEPATOL, V28, P514, DOI 10.1016/S0168-8278(98)80328-0; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; GUERCI AP, 1994, LANCET, V343, P1167, DOI 10.1016/S0140-6736(94)90276-3; Guiducci C, 2010, J EXP MED, V207, P2931, DOI 10.1084/jem.20101048; Habib T, 2012, J IMMUNOL, V188, P487, DOI 10.4049/jimmunol.1102176; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HUANG XJ, 1994, IMMUNITY, V1, P469, DOI 10.1016/1074-7613(94)90089-2; Kared H, 2005, DIABETES, V54, P78, DOI 10.2337/diabetes.54.1.78; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kendall PL, 2004, EUR J IMMUNOL, V34, P2387, DOI 10.1002/eji.200324744; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lande R, 2010, ANN NY ACAD SCI, V1183, P89, DOI 10.1111/j.1749-6632.2009.05152.x; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Li Q, 2011, CLIN IMMUNOL, V140, P3, DOI 10.1016/j.clim.2011.04.010; Mallone R, 2011, DIABETES, V60, P2020, DOI 10.2337/db11-0700; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mujtaba MG, 1997, J NEUROIMMUNOL, V75, P35, DOI 10.1016/S0165-5728(96)00231-7; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Peng RH, 2006, ANN NY ACAD SCI, V1079, P99, DOI 10.1196/annals.1375.013; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Saxena V, 2007, J IMMUNOL, V179, P5041, DOI 10.4049/jimmunol.179.8.5041; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; SHIRAI T, 1992, ANN NY ACAD SCI, V651, P509; Sobel DO, 1998, J AUTOIMMUN, V11, P343, DOI 10.1006/jaut.1998.0203; Sobel DO, 1998, DIABETES, V47, P1867, DOI 10.2337/diabetes.47.12.1867; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Tanaka-Kataoka M, 1999, J INTERF CYTOK RES, V19, P877, DOI 10.1089/107999099313398; Teige I, 2006, J IMMUNOL, V177, P3542, DOI 10.4049/jimmunol.177.6.3542; Theofilopoulos AN, 2011, J INTERF CYTOK RES, V31, P867, DOI 10.1089/jir.2011.0092; Thomas JW, 2002, J IMMUNOL, V169, P6617, DOI 10.4049/jimmunol.169.11.6617; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Winkler C, 2011, DIABETES, V60, P685, DOI 10.2337/db10-1269; Zhou RB, 2007, J IMMUNOL, V178, P2141, DOI 10.4049/jimmunol.178.4.2141	55	309	318	4	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					65	73		10.1038/nm.3042	http://dx.doi.org/10.1038/nm.3042			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23242473				2022-12-27	WOS:000313230300027
J	Chen, L; Reiss, AL; Sudhof, TC; Neul, JL; Murphy, DG; Ecker, C				Chen, Lu; Reiss, Allan L.; Sudhof, Thomas C.; Neul, Jeffrey L.; Murphy, Declan G.; Ecker, Christine			Trialing targeted therapies for autism	NATURE MEDICINE			English	Editorial Material								Researchers are beginning to decipher the genetics underlying and create better animal models for autism spectrum disorders (ASDs), but the development of new drugs for these conditions has been considerably slower. Two recent studies describing the effects of the GABA(B) receptor agonist STX209 (arbaclofen) in fragile X syndrome (FXS) illustrate some of the complexities of designing targeted therapies in this field. Henderson et al.(1) tested this treatment in a mouse model of fragile X and found that it led to improvements in synaptic dysfunction and behavior in this model. In a phase 2 trial, Berry-Kravis et al.(2) tested arbaclofen in 63 people aged 6 to 39 who carry a full FMR1 mutation. Although the authors did not detect a significant improvement compared with placebo for the primary endpoint of the trial, they did see improvements in the treated subjects in other analyses. We asked experts to comment on these studies and their implications for the development of new therapies to treat ASDs.					Ecker, Christine/E-5194-2010; Neul, Jeffrey/AAF-5324-2020	Ecker, Christine/0000-0002-1003-5931; Murphy, Declan/0000-0002-6664-7451; Neul, Jeffrey/0000-0002-5628-5872	Department of Health [RP-PG-0606-1045] Funding Source: Medline	Department of Health		Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Ecker C, 2013, MOL PSYCHIATR, V18, P435, DOI 10.1038/mp.2012.102; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hall SS, 2012, J INTELL DISABIL RES, V56, P947, DOI 10.1111/j.1365-2788.2012.01560.x; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Mendez MA, 2013, NEUROPHARMACOLOGY, V68, P195, DOI 10.1016/j.neuropharm.2012.04.008; Soden ME, 2010, J NEUROSCI, V30, P16910, DOI 10.1523/JNEUROSCI.3660-10.2010	12	0	0	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1746	1747		10.1038/nm.3027	http://dx.doi.org/10.1038/nm.3027			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23223062				2022-12-27	WOS:000311999800017
J	Van Hoecke, A; Schoonaert, L; Lemmens, R; Timmers, M; Staats, KA; Laird, AS; Peeters, E; Philips, T; Goris, A; Dubois, B; Andersen, PM; Al-Chalabi, A; Thijs, V; Turnley, AM; van Vught, PW; Veldink, JH; Hardiman, O; Van Den Bosch, L; Gonzalez-Perez, P; Van Damme, P; Brown, RH; van den Berg, LH; Robberecht, W				Van Hoecke, Annelies; Schoonaert, Lies; Lemmens, Robin; Timmers, Mieke; Staats, Kim A.; Laird, Angela S.; Peeters, Elke; Philips, Thomas; Goris, An; Dubois, Benedicte; Andersen, Peter M.; Al-Chalabi, Ammar; Thijs, Vincent; Turnley, Ann M.; van Vught, Paul W.; Veldink, Jan H.; Hardiman, Orla; Van Den Bosch, Ludo; Gonzalez-Perez, Paloma; Van Damme, Philip; Brown, Robert H., Jr.; van den Berg, Leonard H.; Robberecht, Wim			EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans	NATURE MEDICINE			English	Article							GENE-EXPRESSION PROFILES; RECEPTOR TYROSINE KINASE; SPINAL-CORD; CORTICOSPINAL TRACT; SELECTIVE LOSS; MOTONEURON; ZEBRAFISH; BLOOD; SCHIZOPHRENIA; TDP-43	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons. Disease onset and progression are variable, with survival ranging from months to decades. Factors underlying this variability may represent targets for therapeutic intervention. Here, we have screened a zebrafish model of ALS and identified Epha4, a receptor in the ephrin axonal repellent system, as a modifier of the disease phenotype in fish, rodents and humans. Genetic as well as pharmacological inhibition of Epha4 signaling rescues the mutant SOD1 phenotype in zebrafish and increases survival in mouse and rat models of ALS. Motor neurons that are most vulnerable to degeneration in ALS express higher levels of Epha4, and neuromuscular re-innervation by axotomized motor neurons is inhibited by the presence of Epha4. In humans with ALS, EPHA4 expression inversely correlates with disease onset and survival, and loss-of-function mutations in EPHA4 are associated with long survival. Furthermore, we found that knockdown of Epha4 also rescues the axonopathy induced by expression of mutant TAR DNA-binding protein 43 (TDP-43), another protein causing familial ALS, and the axonopathy induced by knockdown of survival of motor neuron 1, a model for spinomuscular atrophy. This suggests that Epha4 generically modulates the vulnerability of (motor) neurons to axonal degeneration and may represent a new target for therapeutic intervention.	[Van Hoecke, Annelies; Schoonaert, Lies; Lemmens, Robin; Timmers, Mieke; Staats, Kim A.; Philips, Thomas; Thijs, Vincent; Van Den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim] VIB, Vesalius Res Ctr, Neurobiol Lab, Louvain, Belgium; [Van Hoecke, Annelies; Schoonaert, Lies; Lemmens, Robin; Timmers, Mieke; Staats, Kim A.; Philips, Thomas; Thijs, Vincent; Van Den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim] Univ Leuven KU Leuven, Expt Neurol & Leuven Res Inst Neurodegenerat Dis, Louvain, Belgium; [Lemmens, Robin; Peeters, Elke; Dubois, Benedicte; Thijs, Vincent; Van Damme, Philip; Robberecht, Wim] Katholieke Univ Leuven Hosp, Dept Neurol, Louvain, Belgium; [Laird, Angela S.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2006, Australia; [Goris, An; Dubois, Benedicte] Katholieke Univ Leuven, Lab Neuroimmunol, Expt Neurol, Louvain, Belgium; [Andersen, Peter M.] Umea Univ, Inst Pharmacol & Clin Neurosci, Umea, Sweden; [Al-Chalabi, Ammar] Kings Coll London, Dept Clin Neurosci, MRC, Ctr Neurodegenerat Res, London WC2R 2LS, England; [Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [van Vught, Paul W.; Veldink, Jan H.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Hardiman, Orla] Trinity Coll Dublin, Sch Med, Sect Neurol, Dublin, Ireland; [Gonzalez-Perez, Paloma; Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; KU Leuven; Umea University; University of London; King's College London; University of Melbourne; Utrecht University; Utrecht University Medical Center; Trinity College Dublin; University of Massachusetts System; University of Massachusetts Worcester	Robberecht, W (corresponding author), VIB, Vesalius Res Ctr, Neurobiol Lab, Louvain, Belgium.	wim.robberecht@vib-kuleuven.be	Thijs, Vincent/C-3647-2009; Hardiman, Orla/Y-3441-2019; Al-Chalabi, Ammar/E-5361-2010; Research Institute, ANZAC/CAE-9030-2022; Phillips, Thomas/AAG-3230-2021; Van Damme, Philip/A-6464-2009; Goris, An/L-5852-2019; Goris, An/F-2943-2010; Dubois, Benedicte/A-4338-2019	Thijs, Vincent/0000-0002-6614-8417; Hardiman, Orla/0000-0003-2610-1291; Al-Chalabi, Ammar/0000-0002-4924-7712; Phillips, Thomas/0000-0001-8936-6575; Van Damme, Philip/0000-0002-4010-2357; Goris, An/0000-0002-1276-6682; Goris, An/0000-0002-1276-6682; Veldink, Jan/0000-0001-5572-9657; Turnley, Ann/0000-0002-8442-127X; Dubois, Benedicte/0000-0003-0604-8702; Staats, Kim/0000-0001-8392-7992; Van Den Bosch, Ludo/0000-0003-0104-4067; Laird, Angela/0000-0002-6860-9192; Lemmens, Robin/0000-0002-4948-5956	Flanders Institute for Biotechnology (VIB); University of Leuven [GOA 11/014]; Life Sciences Research Partners, Research Foundation Flanders (FWO-Vlaanderen) [G.0695.10]; Interuniversity Attraction Poles program of the Belgian Federal Science Policy Office [P7/16]; Robert Packard Center for ALS Research; Association Belge contre les Maladies Musculaires; ALS League Belgium; Thierry Latran Foundation; European Community [259867]; E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders at the University of Leuven; Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen); Research Fund KU Leuven; Alfonso Martin Escudero Foundation; UK National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London; King's College London; US National Institute for Neurological Disease and Stroke (NINDS) [5RO1-NS050557-05]; Angel Fund; ALS Association; Pierre L. de Bourgknecht ALS Research Foundation; ALS Therapy Alliance; Maudsley National Health Service (NHS) Foundation Trust; NINDS American Recovery and Reinvestment Act Award [RC2-NS070-342]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050557, RC2NS070342, R01NS079836] Funding Source: NIH RePORTER	Flanders Institute for Biotechnology (VIB); University of Leuven(KU Leuven); Life Sciences Research Partners, Research Foundation Flanders (FWO-Vlaanderen)(FWO); Interuniversity Attraction Poles program of the Belgian Federal Science Policy Office; Robert Packard Center for ALS Research; Association Belge contre les Maladies Musculaires; ALS League Belgium; Thierry Latran Foundation; European Community(European Commission); E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders at the University of Leuven; Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Fund KU Leuven(KU Leuven); Alfonso Martin Escudero Foundation; UK National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London; King's College London(General Electric); US National Institute for Neurological Disease and Stroke (NINDS); Angel Fund; ALS Association; Pierre L. de Bourgknecht ALS Research Foundation; ALS Therapy Alliance; Maudsley National Health Service (NHS) Foundation Trust; NINDS American Recovery and Reinvestment Act Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by grants from the Flanders Institute for Biotechnology (VIB), the University of Leuven (GOA 11/014), Life Sciences Research Partners, Research Foundation Flanders (FWO-Vlaanderen; G.0695.10), the Interuniversity Attraction Poles program P7/16 of the Belgian Federal Science Policy Office, the Robert Packard Center for ALS Research, the Association Belge contre les Maladies Musculaires, the ALS League Belgium and the Thierry Latran Foundation. The research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) under grant agreement number 259867. W.R. is supported by the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders at the University of Leuven. A.V.H. is supported by the Agency for Innovation by Science and Technology in Flanders (IWT-Vlaanderen). R.L., P.V.D., V.T. and B.D. hold a clinical investigatorship of FWO-Vlaanderen. R. L. is supported by Research Fund KU Leuven. P.G.-P. is supported by the Alfonso Martin Escudero Foundation. A.A.-C. receives salary support from the UK National Institute for Health Research (NIHR) Dementia Biomedical Research Unit at South London and Maudsley National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. R.H.B. Jr. is supported by the US National Institute for Neurological Disease and Stroke (NINDS) (5RO1-NS050557-05) and NINDS American Recovery and Reinvestment Act Award RC2-NS070-342 and acknowledges generous support from the Angel Fund, the ALS Association, P2ALS, Project ALS, the Pierre L. de Bourgknecht ALS Research Foundation and the ALS Therapy Alliance.	BAKELS R, 1993, J PHYSIOL-LONDON, V463, P307, DOI 10.1113/jphysiol.1993.sp019596; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; DeJesus Hernandez M., 2011, NEURON, V72, P245; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fogh I, 2007, NEUROGENETICS, V8, P235, DOI 10.1007/s10048-007-0092-2; Frey D, 2000, J NEUROSCI, V20, P2534; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; GARDINER PF, 1993, J NEUROPHYSIOL, V69, P1160, DOI 10.1152/jn.1993.69.4.1160; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Kim W, 2007, J CLIN NEUROL, V3, P38, DOI 10.3988/jcn.2007.3.1.38; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lemmens R, 2007, HUM MOL GENET, V16, P2359, DOI 10.1093/hmg/ddm193; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Penco S, 2011, J MOL NEUROSCI, V44, P25, DOI 10.1007/s12031-010-9480-4; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; Xu QL, 1995, DEVELOPMENT, V121, P4005	38	200	208	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1418	+		10.1038/nm.2901	http://dx.doi.org/10.1038/nm.2901			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22922411				2022-12-27	WOS:000308472300039
J	Jakovcevski, M; Akbarian, S				Jakovcevski, Mira; Akbarian, Schahram			Epigenetic mechanisms in neurological disease	NATURE MEDICINE			English	Review							HISTONE DEACETYLASE INHIBITORS; MECP2 DUPLICATION SYNDROME; NEURAL PROGENITOR CELLS; HUMAN PREFRONTAL CORTEX; CPG-BINDING PROTEIN-2; DNA METHYLTRANSFERASE; HUNTINGTONS-DISEASE; HUMAN BRAIN; L1 RETROTRANSPOSITION; ANGELMAN SYNDROME	The exploration of brain epigenomes, which consist of various types of DNA methylation and covalent histone modifications, is providing new and unprecedented insights into the mechanisms of neural development, neurological disease and aging. Traditionally, chromatin defects in the brain were considered static lesions of early development that occurred in the context of rare genetic syndromes, but it is now clear that mutations and maladaptations of the epigenetic machinery cover a much wider continuum that includes adult-onset neurodegenerative disease. Here, we describe how recent advances in neuroepigenetics have contributed to an improved mechanistic understanding of developmental and degenerative brain disorders, and we discuss how they could influence the development of future therapies for these conditions.	[Jakovcevski, Mira; Akbarian, Schahram] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Akbarian, S (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA.	schahram.akbarian@mssm.edu	Jakovcevski, Mira/N-2430-2019; Jakovcevski, Mira/M-1930-2018	Jakovcevski, Mira/0000-0003-2262-823X; Jakovcevski, Mira/0000-0003-2262-823X	US National Institutes of Health (National Institute of Neurological Disorders and Stroke, National Institute of Mental Health, National Institute on Drug Abuse); US Defense Advanced Research Projects Agency; Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093332, R01MH086509, P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076958] Funding Source: NIH RePORTER	US National Institutes of Health (National Institute of Neurological Disorders and Stroke, National Institute of Mental Health, National Institute on Drug Abuse); US Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the authors' laboratory is supported by funds from the US National Institutes of Health (National Institute of Neurological Disorders and Stroke, National Institute of Mental Health, National Institute on Drug Abuse), the US Defense Advanced Research Projects Agency and Autism Speaks.	Adegbola A, 2008, AM J MED GENET A, V146A, P505, DOI 10.1002/ajmg.a.32142; Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Baltan S, 2011, J NEUROSCI, V31, P3990, DOI 10.1523/JNEUROSCI.5379-10.2011; Baumann C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001137; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Chao HT, 2012, NAT NEUROSCI, V15, P176, DOI 10.1038/nn.3027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chestnut BA, 2011, J NEUROSCI, V31, P16619, DOI 10.1523/JNEUROSCI.1639-11.2011; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Chouery E, 2012, CLIN GENET, V82, P489, DOI 10.1111/j.1399-0004.2011.01783.x; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Copray S, 2009, GLIA, V57, P1579, DOI 10.1002/glia.20881; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; de Greef JC, 2011, AM J HUM GENET, V88, P796, DOI 10.1016/j.ajhg.2011.04.018; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Desplats P, 2011, J BIOL CHEM, V286, P9031, DOI 10.1074/jbc.C110.212589; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Ehrlich M, 2008, AUTOIMMUNITY, V41, P253, DOI 10.1080/08916930802024202; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Fuentes P, 2012, CEREB CORTEX, V22, P1431, DOI 10.1093/cercor/bhr218; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Han J, 2010, EUR J PHARMACOL, V642, P93, DOI 10.1016/j.ejphar.2010.05.050; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hu Y, 2011, P NATL ACAD SCI USA, V108, P17141, DOI 10.1073/pnas.1104409108; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kazemi-Esfarjani P, 2010, EMBO MOL MED, V2, P335, DOI 10.1002/emmm.201000092; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kleefstra T, 2009, J MED GENET, V46, P598, DOI 10.1136/jmg.2008.062950; Klein CJ, 2011, NAT GENET, V43, P595, DOI 10.1038/ng.830; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Libert S, 2011, CELL, V147, P1459, DOI 10.1016/j.cell.2011.10.054; Liu J, 2010, TRENDS NEUROSCI, V33, P193, DOI 10.1016/j.tins.2010.01.007; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Michelson DJ, 2011, NEUROLOGY, V77, P1629, DOI 10.1212/WNL.0b013e3182345896; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Miskiewicz K, 2011, NEURON, V72, P776, DOI 10.1016/j.neuron.2011.10.010; Morris MJ, 2010, BEHAV PHARMACOL, V21, P409, DOI 10.1097/FBP.0b013e32833c20c0; Munsie L, 2011, HUM MOL GENET, V20, P1937, DOI 10.1093/hmg/ddr075; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2009, HIPPOCAMPUS, V19, P1002, DOI 10.1002/hipo.20564; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; PEARSON EC, 1984, EUR J BIOCHEM, V144, P353, DOI 10.1111/j.1432-1033.1984.tb08471.x; Pedre X, 2011, J NEUROSCI, V31, P3435, DOI 10.1523/JNEUROSCI.4507-10.2011; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Percy AK, 2011, ARCH NEUROL-CHICAGO, V68, P985, DOI 10.1001/archneurol.2011.149; Pereira PM, 2010, EUR J HUM GENET, V18, P627, DOI 10.1038/ejhg.2009.189; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Roelfsema Jeroen H., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000415; Rohrer JD, 2011, BRAIN, V134, P2565, DOI 10.1093/brain/awr198; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Salerno S, 2010, CURR MED CHEM, V17, P4270, DOI 10.2174/092986710793361252; Samaco RC, 2012, NAT GENET, V44, P206, DOI 10.1038/ng.1066; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008; Shioda N, 2011, J NEUROSCI, V31, P346, DOI 10.1523/JNEUROSCI.4816-10.2011; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Singleton MK, 2011, NEUROBIOL DIS, V43, P190, DOI 10.1016/j.nbd.2011.03.011; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stack EC, 2007, HUM MOL GENET, V16, P1164, DOI 10.1093/hmg/ddm064; Stadler F, 2005, J NEUROCHEM, V94, P324, DOI 10.1111/j.1471-4159.2005.03190.x; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Tang B, 2009, AGING CELL, V8, P339, DOI 10.1111/j.1474-9726.2009.00468.x; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsou AY, 2009, CNS DRUGS, V23, P213, DOI 10.2165/00023210-200923030-00003; Verhoeven WMA, 2011, AM J MED GENET A, V155A, P2409, DOI 10.1002/ajmg.a.34186; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang CM, 2010, BIOGERONTOLOGY, V11, P87, DOI 10.1007/s10522-009-9231-5; Wilburn B, 2011, NEURON, V70, P427, DOI 10.1016/j.neuron.2011.03.021; Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	155	296	307	0	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1194	1204		10.1038/nm.2828	http://dx.doi.org/10.1038/nm.2828			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869198	Green Accepted			2022-12-27	WOS:000307469300024
J	Peinado, H; Aleckovic, M; Lavotshkin, S; Matei, I; Costa-Silva, B; Moreno-Bueno, G; Hergueta-Redondo, M; Williams, C; Garcia-Santos, G; Ghajar, CM; Nitadori-Hoshino, A; Hoffman, C; Badal, K; Garcia, BA; Callahan, MK; Yuan, JD; Martins, VR; Skog, J; Kaplan, RN; Brady, MS; Wolchok, JD; Chapman, PB; Kang, YB; Bromberg, J; Lyden, D				Peinado, Hector; Aleckovic, Masa; Lavotshkin, Simon; Matei, Irina; Costa-Silva, Bruno; Moreno-Bueno, Gema; Hergueta-Redondo, Marta; Williams, Caitlin; Garcia-Santos, Guillermo; Ghajar, Cyrus M.; Nitadori-Hoshino, Ayuko; Hoffman, Caitlin; Badal, Karen; Garcia, Benjamin A.; Callahan, Margaret K.; Yuan, Jianda; Martins, Vilma R.; Skog, Johan; Kaplan, Rosandra N.; Brady, Mary S.; Wolchok, Jedd D.; Chapman, Paul B.; Kang, Yibin; Bromberg, Jacqueline; Lyden, David			Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET	NATURE MEDICINE			English	Article							PREMETASTATIC NICHE; RELEASED EXOSOMES; SIGNALING PATHWAY; C-MET; CANCER; MICROVESICLES; GROWTH; RECRUITMENT; EXPRESSION; MECHANISM	Tumor-derived exosomes are emerging mediators of tumorigenesis. We explored the function of melanoma-derived exosomes in the formation of primary tumors and metastases in mice and human subjects. Exosomes from highly metastatic melanomas increased the metastatic behavior of primary tumors by permanently 'educating' bone marrow progenitors through the receptor tyrosine kinase MET. Melanoma-derived exosomes also induced vascular leakiness at pre-metastatic sites and reprogrammed bone marrow progenitors toward a pro-vasculogenic phenotype that was positive for c-Kit, the receptor tyrosine kinase Tie2 and Met. Reducing Met expression in exosomes diminished the pro-metastatic behavior of bone marrow cells. Notably, MET expression was elevated in circulating CD45(-)C-KIT(low/+)TIE2(+) bone marrow progenitors from individuals with metastatic melanoma. RAB1A, RAB5B, RAB7 and RAB27A, regulators of membrane trafficking and exosome formation, were highly expressed in melanoma cells. Rab27A RNA interference decreased exosome production, preventing bone marrow education and reducing, tumor growth and metastasis. In addition, we identified an exosome-specific melanoma signature with prognostic and therapeutic potential comprised of TYRP2, VLA- 4, HSP70, an HSP90 isoform and the MET oncoprotein. Our data show that exosome production, transfer and education of bone marrow cells supports tumor growth and metastasis, has prognostic value and offers promise for new therapeutic directions in the metastatic process.	[Callahan, Margaret K.; Wolchok, Jedd D.; Chapman, Paul B.; Bromberg, Jacqueline] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Peinado, Hector; Matei, Irina; Costa-Silva, Bruno; Williams, Caitlin; Garcia-Santos, Guillermo; Nitadori-Hoshino, Ayuko; Badal, Karen; Lyden, David] Weill Cornell Med Coll, Dept Pediat, Childrens Canc & Blood Fdn Labs, New York, NY USA; [Peinado, Hector; Matei, Irina; Costa-Silva, Bruno; Williams, Caitlin; Garcia-Santos, Guillermo; Nitadori-Hoshino, Ayuko; Badal, Karen; Lyden, David] Weill Cornell Med Coll, Dept Cell, Childrens Canc & Blood Fdn Labs, New York, NY USA; [Peinado, Hector; Matei, Irina; Costa-Silva, Bruno; Williams, Caitlin; Garcia-Santos, Guillermo; Nitadori-Hoshino, Ayuko; Badal, Karen; Lyden, David] Weill Cornell Med Coll, Dept Dev Biol, Childrens Canc & Blood Fdn Labs, New York, NY USA; [Aleckovic, Masa; Garcia, Benjamin A.; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Lavotshkin, Simon] Columbia Univ, Coll Phys & Surg, Dept Surg, New York, NY USA; [Costa-Silva, Bruno; Martins, Vilma R.] AC Camargo Hosp, Int Ctr Res & Educ, Sao Paulo, Brazil; [Moreno-Bueno, Gema; Hergueta-Redondo, Marta] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, IdiPAZ Inst Invest Sanitaria La Paz, CSIC,Dept Bioquim, Madrid, Spain; [Moreno-Bueno, Gema; Hergueta-Redondo, Marta] Fdn MD Anderson Canc Ctr, Madrid, Spain; [Ghajar, Cyrus M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Hoffman, Caitlin] Weill Cornell Med Coll, Dept Neurosurg, New York, NY USA; [Yuan, Jianda; Wolchok, Jedd D.] Sloan Kettering Inst, Ludwig Ctr Canc Immunotherapy, Dept Immunol, New York, NY USA; [Skog, Johan] Exosome Diagnost Inc, New York, NY USA; [Kaplan, Rosandra N.] NCI, Pediat Oncol Branch, NIH, Bethesda, MD 20892 USA; [Brady, Mary S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Kang, Yibin] Canc Inst New Jersey, Genom Instabil & Tumor Progress Program, New Brunswick, NJ USA; [Kang, Yibin; Lyden, David] Champalimaud Metastasis Programme, Lisbon, Portugal; [Lyden, David] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Princeton University; Columbia University; A.C.Camargo Cancer Center; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Cornell University; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Fundacao Champalimaud; Memorial Sloan Kettering Cancer Center	Bromberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	bromberj@mskcc.org; dcl2001@med.cornell.edu	Martins, Vilma R/E-2547-2012; Peinado, Hector/A-6417-2013; Hoshino, Ayuko/AHD-6448-2022; Moreno-Bueno, Gema/K-9354-2016; Neurociencia, Inct/I-1011-2013; Costa-Silva, Bruno/AAY-2266-2020; Martins, Vilma/N-5446-2019; Garcia-Santos, Guillermo/ABG-4631-2020	Martins, Vilma R/0000-0002-2909-8502; Peinado, Hector/0000-0002-4256-3413; Hoshino, Ayuko/0000-0003-4149-5073; Moreno-Bueno, Gema/0000-0002-5030-6687; Garcia-Santos, Guillermo/0000-0002-4755-2430; Skog, Johan/0000-0002-0926-1691; Costa-Silva, Bruno/0000-0002-5932-6211; Kang, Yibin/0000-0002-1626-6730; Aleckovic, Masa/0000-0001-5653-8502	Children's Cancer and Blood Foundation; Manning Foundation; Hartwell Foundation; Pediatric Oncology Experimental Therapeutics Investigators Consortium; Stavros S. Niarchos Foundation; Champalimaud Foundation; Nancy C. and Daniel P. Paduano Foundation; Mary Kay Foundation; American Hellenic Educational Progressive Association; Malcolm Hewitt Wiener Foundation; George Best Costacos Foundation; NCI [NCI-R01CA 098234-01]; National Foundation for Cancer Research; Susan G. Komen for the Cure; Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia; Fundacion Universidad de Oviedo; Beth C. Tortolani Foundation; Sussman Family Fund; Charles and Marjorie Holloway Foundation; Manhassat Breast Cancer Fund; NIH [CA87637, R01-CA134519, R01-CA141062]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); National Science Foundation [CBET-0941143]; American Society;  [NCI-U54-CA143836]; NATIONAL CANCER INSTITUTE [R01CA087637, R01CA098234, R01CA141062, R01CA134519, U54CA143836, ZIABC011334, ZIABC011332] Funding Source: NIH RePORTER	Children's Cancer and Blood Foundation; Manning Foundation; Hartwell Foundation; Pediatric Oncology Experimental Therapeutics Investigators Consortium; Stavros S. Niarchos Foundation; Champalimaud Foundation; Nancy C. and Daniel P. Paduano Foundation; Mary Kay Foundation; American Hellenic Educational Progressive Association; Malcolm Hewitt Wiener Foundation; George Best Costacos Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia(Principality of Asturias); Fundacion Universidad de Oviedo; Beth C. Tortolani Foundation; Sussman Family Fund; Charles and Marjorie Holloway Foundation; Manhassat Breast Cancer Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Science Foundation(National Science Foundation (NSF)); American Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We dedicate this work to the memory of James A. Paduano. We thank M. J. Bissell, A. Cano, J. Wels and S.R. Granitto for critical reading of this paper and suggestions. We also thank the members of our laboratories for helpful discussions and the members of the Weill Cornell Medical College electron microscopy and microarray core facilities for their support. We thank V. Hearing, (US National Institutes of Health (NIH), National Cancer Institute (NCI)) for providing the antibody to TYRP2 and D.C. Bennett (St. George's University of London) for providing the melan-a cell line. Our work is supported by grants from the Children's Cancer and Blood Foundation (H.P. and D.L.), The Manning Foundation (B.C.-S. and D.L.), The Hartwell Foundation (D.L.), Pediatric Oncology Experimental Therapeutics Investigators Consortium (H.P. and D.L.), Stavros S. Niarchos Foundation (D.L.), Champalimaud Foundation (H.P., Y.K. and D.L.), The Nancy C. and Daniel P. Paduano Foundation (H.P. and D.L.), The Mary Kay Foundation (A.N.-H. and D.L.), American Hellenic Educational Progressive Association 5th District (D.L.), The Malcolm Hewitt Wiener Foundation (D.L.), The George Best Costacos Foundation (D.L.), NCI (D.L., grant NCI-R01CA 098234-01), National Foundation for Cancer Research (D.L.), Susan G. Komen for the Cure (H.P. and D.L.), NCI-U54-CA143836 training grant (C.M.G. and D.L.), Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (G.G.-S.), Fundacion Universidad de Oviedo (G.G.-S.), The Beth C. Tortolani Foundation (H.P., D.L. and J.B.), Sussman Family Fund (J.B.), Charles and Marjorie Holloway Foundation (J.B.), Manhassat Breast Cancer Fund (J.B.), NIH-CA87637 (J.B.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, V.R.M. and B.C.-S.), NIH (Y.K., grants R01-CA134519 and R01-CA141062), National Science Foundation grant CBET-0941143 and an American Society for Mass Spectrometry research award (B.A.G.).	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Aliotta JM, 2007, STEM CELLS, V25, P2245, DOI 10.1634/stemcells.2007-0128; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Braeuer RR, 2011, SEMIN CANCER BIOL, V21, P83, DOI 10.1016/j.semcancer.2010.12.007; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Ewing J, 1928, NEOPLASTIC DIS TREAT; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Fidler IJ, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P203; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Grammatikakis N, 2002, J BIOL CHEM, V277, P8312, DOI 10.1074/jbc.M109200200; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Hao S., 2006, Experimental Oncology, V28, P126; Hendrix A, 2010, JNCI-J NATL CANCER I, V102, P866, DOI 10.1093/jnci/djq153; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Jalili A, 2010, STEM CELLS DEV, V19, P1143, DOI 10.1089/scd.2009.0376; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jung T, 2009, NEOPLASIA, V11, P1093, DOI 10.1593/neo.09822; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041; Liu YL, 2010, AM J PATHOL, V176, P2490, DOI 10.2353/ajpath.2010.090777; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Nazarenko I, 2010, CANCER RES, V70, P1668, DOI 10.1158/0008-5472.CAN-09-2470; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Peruzzi B, 2006, CLIN CANCER RES, V12, P3657, DOI 10.1158/1078-0432.CCR-06-0818; Psaila Bethan, 2006, Breast Dis, V26, P65; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stella GM, 2010, EXPERT OPIN INV DRUG, V19, P1381, DOI 10.1517/13543784.2010.522988; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; TAYLOR DD, 1988, INT J CANCER, V41, P629, DOI 10.1002/ijc.2910410425; Tesio M, 2011, BLOOD, V117, P419, DOI 10.1182/blood-2009-06-230359; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wang JS, 2008, MOL CANCER RES, V6, P372, DOI 10.1158/1541-7786.MCR-07-0162; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	58	2459	2547	28	725	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					883	+		10.1038/nm.2753	http://dx.doi.org/10.1038/nm.2753			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22635005	Green Accepted, Green Submitted			2022-12-27	WOS:000305116600025
J	Henderson, NC; Arnold, TD; Katamura, Y; Giacomini, MM; Rodriguez, JD; McCarty, JH; Pellicoro, A; Raschperger, E; Betsholtz, C; Ruminski, PG; Griggs, DW; Prinsen, MJ; Maher, JJ; Iredale, JP; Lacy-Hulbert, A; Adams, RH; Sheppard, D				Henderson, Neil C.; Arnold, Thomas D.; Katamura, Yoshio; Giacomini, Marilyn M.; Rodriguez, Juan D.; McCarty, Joseph H.; Pellicoro, Antonella; Raschperger, Elisabeth; Betsholtz, Christer; Ruminski, Peter G.; Griggs, David W.; Prinsen, Michael J.; Maher, Jacquelyn J.; Iredale, John P.; Lacy-Hulbert, Adam; Adams, Ralf H.; Sheppard, Dean			Targeting of alpha(v) integrin identifies a core molecular pathway that regulates fibrosis in several organs	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; ACTIVATES LATENT TGF-BETA-1; RAT HEPATIC LIPOCYTES; INCREASED EXPRESSION; FACTOR RECEPTOR; IN-VIVO; LIVER; INDUCTION; COLLAGEN; CELLS	Myofibroblasts are the major source of extracellular matrix components that accumulate during tissue fibrosis, and hepatic stellate cells (HSCs) are believed to be the major source of myofibroblasts in the liver. To date, robust systems to genetically manipulate these cells have not been developed. We report that Cre under control of the promoter of Pdgfrb (Pdgfrb-Cre) inactivates loxP-flanked genes in mouse HSCs with high efficiency. We used this system to delete the gene encoding alpha(v) integrin subunit because various alpha(v)-containing integrins have been suggested as central mediators of fibrosis in multiple organs. Such depletion protected mice from carbon tetrachloride-induced hepatic fibrosis, whereas global loss of beta(3), beta(5) or beta(6) integrins or conditional loss of beta(8) integrins in HSCs did not. We also found that Pdgfrb-Cre effectively targeted myofibroblasts in multiple organs, and depletion of the alpha(v) integrin subunit using this system was protective in other models of organ fibrosis, including pulmonary and renal fibrosis. Pharmacological blockade of alpha(v)-containing integrins by a small molecule (CWHM 12) attenuated both liver and lung fibrosis, including in a therapeutic manner. These data identify a core pathway that regulates fibrosis and suggest that pharmacological targeting of all alpha(v) integrins may have clinical utility in the treatment of patients with a broad range of fibrotic diseases.	[Henderson, Neil C.; Katamura, Yoshio; Giacomini, Marilyn M.; Rodriguez, Juan D.; Sheppard, Dean] Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA; [Henderson, Neil C.; Pellicoro, Antonella; Iredale, John P.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Arnold, Thomas D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [McCarty, Joseph H.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Raschperger, Elisabeth; Betsholtz, Christer] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Raschperger, Elisabeth; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Ruminski, Peter G.; Griggs, David W.; Prinsen, Michael J.] St Louis Univ, Edward A Doisy Res Ctr, Ctr World Hlth & Med, St Louis, MO 63103 USA; [Maher, Jacquelyn J.] Univ Calif San Francisco, Ctr Liver, Dept Med, San Francisco, CA 94143 USA; [Lacy-Hulbert, Adam] Massachusetts Gen Hosp, Dept Pediat, Program Dev Immunol, Boston, MA 02114 USA; [Lacy-Hulbert, Adam] Harvard Univ, Sch Med, Boston, MA USA; [Adams, Ralf H.] Univ Munster, Fac Med, Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany	University of California System; University of California San Francisco; University of Edinburgh; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; Uppsala University; Karolinska Institutet; Saint Louis University; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Max Planck Society; University of Munster	Henderson, NC (corresponding author), Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94143 USA.	neil.henderson@ed.ac.uk; dean.sheppard@ucsf.edu	Adams, Ralf H/AAE-9274-2019; Prinsen, Michael/AAB-3228-2020	Iredale, John/0000-0003-2174-5127; Lacy-Hulbert, Adam/0000-0003-2162-0156	Wellcome Trust Intermediate Clinical Fellowship [085187]; National Institutes of Health [HL102292, HL53949, AI077439]; University of California, San Francisco (UCSF) Liver Center Tool and Technology grant; UCSF Liver Center [P30 DK026743]; Medical Research Council [MR/J010766/1, G0901697] Funding Source: researchfish; MRC [G0901697, G0600033, MR/J010766/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053949, R37HL053949, P01HL108794, R01HL102292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK093695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078402] Funding Source: NIH RePORTER	Wellcome Trust Intermediate Clinical Fellowship(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Francisco (UCSF) Liver Center Tool and Technology grant; UCSF Liver Center; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Wellcome Trust Intermediate Clinical Fellowship (ref. 085187) to N.C.H., National Institutes of Health grants HL102292, HL53949 and AI077439 (to D.S.), a University of California, San Francisco (UCSF) Liver Center Tool and Technology grant (to N.C.H) and P30 DK026743 (UCSF Liver Center). We thank K. Thorn at the UCSF Nikon Imaging Center for assistance with image analysis. We also thank C. Her, N. Wu, S. Huling, D. Rodrigues and R. Aucott for expert technical assistance. We also acknowledge the contribution of M. Singh (chemical synthesis of compounds CWHM 12 and CWHM 96), D. Tajfirouz, S. Freeman and M. Yates at Saint Louis University for technical assistance in conducting integrin functional assays to characterize compound activities. L. Reichardt (UCSF) provided Itgb8<SUP>flox/flox</SUP> mice and R. Hynes (Massachusetts Institute of Technology) provided Itgb3<SUP>-1-</SUP> mice on 129/svJae background. S. Violette (Biogen Idee) provided antibody to alpha<INF>v</INF>beta<INF>6</INF> (human/mouse chimeric 2A1), W. Stallcup (Sanford-Burnham Medical Research Institute) provided antibody to PDGFR-beta and H. Yagita (Juntendo University) provided antibody to a, integrin (clone RMV-7).	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Abraham S, 2008, CIRC RES, V102, P562, DOI 10.1161/CIRCRESAHA.107.167908; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; BREUSS JM, 1995, J CELL SCI, V108, P2241; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Coin PG, 1996, J IMMUNOL, V156, P4797; DELEEUW AM, 1984, HEPATOLOGY, V4, P392; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ikura Y, 1997, J GASTROENTEROL, V32, P496, DOI 10.1007/BF02934089; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Ma LJ, 2003, AM J PATHOL, V163, P1261, DOI 10.1016/S0002-9440(10)63486-4; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Patsenker E, 2009, HEPATOLOGY, V50, P1501, DOI 10.1002/hep.23144; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Pinzani M, 1996, AM J PATHOL, V148, P785; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Zhu JW, 2002, DEVELOPMENT, V129, P2891	41	524	558	9	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1617	1624		10.1038/nm.3282	http://dx.doi.org/10.1038/nm.3282			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24216753	Green Accepted, Green Submitted			2022-12-27	WOS:000328181400030
J	Kolodziej, M; Klein, I; Reisman, L				Kolodziej, Michael; Klein, Ira; Reisman, Lonny			A new value proposition	NATURE MEDICINE			English	Editorial Material									[Kolodziej, Michael; Klein, Ira; Reisman, Lonny] Aetna, Hartford, CT USA		Kolodziej, M (corresponding author), Aetna, Hartford, CT USA.								0	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1365	1365		10.1038/nm1113-1365	http://dx.doi.org/10.1038/nm1113-1365			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202379				2022-12-27	WOS:000326920300009
J	Schett, G; Elewaut, D; McInnes, IB; Dayer, JM; Neurath, MF				Schett, Georg; Elewaut, Dirk; McInnes, Iain B.; Dayer, Jean-Michel; Neurath, Markus F.			Toward a cytokine-based disease taxonomy	NATURE MEDICINE			English	Editorial Material							TUMOR-NECROSIS-FACTOR		[Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, Erlangen, Germany; [Elewaut, Dirk] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium; [McInnes, Iain B.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Dayer, Jean-Michel] Univ Geneva, Fac Med, Geneva, Switzerland; [Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Internal Med 1, Erlangen, Germany	University of Erlangen Nuremberg; Ghent University; Ghent University Hospital; University of Glasgow; University of Geneva; University of Erlangen Nuremberg	Schett, G (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Erlangen, Germany.	georg.schett@uk-erlangen.de	Elewaut, Dirk/K-6831-2014	McInnes, Iain/0000-0002-6462-4280				BROUCKAERT P, 1989, J EXP MED, V169, P2257, DOI 10.1084/jem.169.6.2257; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Wekerle H, 2012, NAT MED, V18, P66, DOI 10.1038/nm.2635	16	269	289	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					822	824		10.1038/nm.3260	http://dx.doi.org/10.1038/nm.3260			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836224				2022-12-27	WOS:000321557700024
J	Bush, JR; Beier, F				Bush, Jason R.; Beier, Frank			TGF-beta and osteoarthritis-the good and the bad	NATURE MEDICINE			English	Editorial Material							OSTEOPHYTE FORMATION; ARTICULAR-CARTILAGE; BONE; DISEASE; DIFFERENTIATION		[Bush, Jason R.; Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario)	Bush, JR (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada.	fbeier@uwo.ca	Beier, Frank/G-4595-2013; Beier, Frank/T-4734-2019	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537				Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130; Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005; Felson DT, 2013, OSTEOARTHR CARTILAGE, V21, P10, DOI 10.1016/j.joca.2012.09.012; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Scharstuhl A, 2003, ARTHRITIS RHEUM-US, V48, P3442, DOI 10.1002/art.11328; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; van der Kraan PM, 2012, CELL TISSUE RES, V347, P257, DOI 10.1007/s00441-011-1194-6; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Whyte MP, 2011, J BONE MINER RES, V26, P920, DOI 10.1002/jbmr.283; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	16	45	45	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					667	669		10.1038/nm.3228	http://dx.doi.org/10.1038/nm.3228			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744142				2022-12-27	WOS:000319981600009
J	Meng, ZX; Li, SM; Wang, L; Ko, HJ; Lee, Y; Jung, DY; Okutsu, M; Yan, Z; Kim, JK; Lin, JDD				Meng, Zhuo-Xian; Li, Siming; Wang, Lin; Ko, Hwi Jin; Lee, Yongjin; Jung, Dae Young; Okutsu, Mitsuharu; Yan, Zhen; Kim, Jason K.; Lin, Jiandie D.			Baf60c drives glycolytic metabolism in the muscle and improves systemic glucose homeostasis through Deptor-mediated Akt activation	NATURE MEDICINE			English	Article							SKELETAL-MUSCLE; INSULIN-RESISTANCE; MITOCHONDRIAL-FUNCTION; PGC-1-ALPHA; RECEPTOR; OVEREXPRESSION; DYSFUNCTION; EFFICIENCY; HUMANS; GENES	A shift from oxidative to glycolytic metabolism has been associated with skeletal muscle insulin resistance in type 2 diabetes(1-5). However, whether this metabolic switch is deleterious or adaptive remains under debate(6-8), in part because of a limited understanding of the regulatory network that directs the metabolic and contractile specification of fast-twitch glycolytic muscle. Here we show that Baf60c (also called Smarcd3), a transcriptional cofactor enriched in fast-twitch muscle, promotes a switch from oxidative to glycolytic myofiber type through DEP domain-containing mTOR-interacting protein (Deptor)-mediated Akt activation. Muscle-specific transgenic expression of Baf60c activates a program of molecular, metabolic and contractile changes characteristic of glycolytic muscle. In addition, Baf60c is required for maintaining glycolytic capacity in adult skeletal muscle in vivo. Baf60c expression is significantly lower in skeletal muscle from obese mice compared to that from lean mice. Activation of the glycolytic muscle program by transgenic expression of Baf60c protects mice from diet-induced insulin resistance and glucose intolerance. Further mechanistic studies revealed that Deptor is induced by the Baf60c-Six4 transcriptional complex and mediates activation of Akt and glycolytic metabolism by Baf60c in a cell-autonomous manner. This work defines a fundamental mechanism underlying the specification of fast-twitch glycolytic muscle and illustrates that the oxidative-to-glycolytic metabolic shift in skeletal muscle is potentially adaptive and beneficial in the diabetic state.	[Meng, Zhuo-Xian; Li, Siming; Wang, Lin; Lin, Jiandie D.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Meng, Zhuo-Xian; Li, Siming; Wang, Lin; Lin, Jiandie D.] Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Ko, Hwi Jin; Lee, Yongjin; Jung, Dae Young; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Program Mol Med, Worcester, MA USA; [Ko, Hwi Jin; Lee, Yongjin; Jung, Dae Young; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA USA; [Okutsu, Mitsuharu; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA USA; [Okutsu, Mitsuharu; Yan, Zhen] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Okutsu, Mitsuharu; Yan, Zhen] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Ctr Skeletal Muscle Res, Charlottesville, VA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Virginia; University of Virginia; University of Virginia	Lin, JDD (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	jdlin@umich.edu		Kim, Jason/0000-0002-7185-042X; Yan, Zhen/0000-0002-4826-9813	Michigan Diabetes Research and Training Center [DK020572]; Nutrition Obesity Research Center [DK089503]; US National Institutes of Health (NIH) [DK095151, DK077086]; American Heart Association; NIH [U24-DK093000, R01-DK080756, AR050429]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, U24DK093000, P30DK020572, P30DK089503, R01DK080756, R01DK077086, R01DK095151] Funding Source: NIH RePORTER	Michigan Diabetes Research and Training Center; Nutrition Obesity Research Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Gu and C. Rut for assistance in experiments and lab members for discussion. We thank J. Nalbantoglu and P.C. Holland (McGill University) for the gift of the MCK-CAR transgenic mouse strain. We thank the staff at the University of Michigan Transgenic Animal Core for the generation of MCK-Baf60c transgenic mice and D. Sorenson for help with electron microscopy study and acknowledge support from the Michigan Diabetes Research and Training Center (DK020572) and the Nutrition Obesity Research Center (DK089503). This work was supported by the US National Institutes of Health (NIH) (DK095151 and DK077086 to J.D.L.). Z.-X.M. and S.L. are supported by a Postdoctoral Fellowship and a Scientist Development Grant from the American Heart Association, respectively. Clamp studies were performed at the University of Massachusetts Mouse Metabolic Phenotyping Center and were supported by the NIH (U24-DK093000 and R01-DK080756 to J.K.K.). M.O. and Z.Y. are supported by the NIH (AR050429).	Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Civitarese AE, 2010, CELL METAB, V11, P412, DOI 10.1016/j.cmet.2010.04.004; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Gordon BA, 2009, DIABETES RES CLIN PR, V83, P157, DOI 10.1016/j.diabres.2008.11.024; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lavery GG, 2008, J BIOL CHEM, V283, P8453, DOI 10.1074/jbc.M710067200; LeBrasseur NK, 2011, AM J PHYSIOL-ENDOC M, V300, pE3, DOI 10.1152/ajpendo.00512.2010; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; Nalbantoglu J, 2001, J VIROL, V75, P4276, DOI 10.1128/JVI.75.9.4276-4282.2001; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Niro C, 2010, DEV BIOL, V338, P168, DOI 10.1016/j.ydbio.2009.11.031; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009	30	87	93	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2013	19	5					640	645		10.1038/nm.3144	http://dx.doi.org/10.1038/nm.3144			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23563706	Green Accepted			2022-12-27	WOS:000318583000039
J	Nam, YJ; Song, KH; Olson, EN				Nam, Young-Jae; Song, Kunhua; Olson, Eric N.			Heart repair by cardiac reprogramming	NATURE MEDICINE			English	Editorial Material							FIBROBLASTS; CARDIOMYOCYTES; CELLS; CONVERSION; EXPRESSION; MYOCYTES		[Nam, Young-Jae; Song, Kunhua; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Nam, YJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu			NHLBI NIH HHS [K08 HL111420, R01 HL093039, R01 HL077439, U01 HL100401, R01 HL111665] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077439, R01HL111665, R01HL093039, K08HL111420, U01HL100401] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bakker ML, 2012, CARDIOVASC RES, V94, P439, DOI 10.1093/cvr/cvs120; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Liao SY, 2010, HEART RHYTHM, V7, P1852, DOI 10.1016/j.hrthm.2010.09.006; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Mathison M, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005652; Nam Y.-J., P NATL ACAD SCI US; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rentschler S, 2012, CIRCULATION, V126, P1058, DOI 10.1161/CIRCULATIONAHA.112.103390; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100	16	36	36	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					413	415		10.1038/nm.3147	http://dx.doi.org/10.1038/nm.3147			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23558630	Green Accepted			2022-12-27	WOS:000317109100024
J	Idris, NM; Gnanasammandhan, MK; Zhang, J; Ho, PC; Mahendran, R; Zhang, Y				Idris, Niagara Muhammad; Gnanasammandhan, Muthu Kumara; Zhang, Jing; Ho, Paul C.; Mahendran, Ratha; Zhang, Yong			In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers	NATURE MEDICINE			English	Article							PHOTOSENSITIZERS; DELIVERY; CELLS; VITRO; DRUG	Conventional photodynamic therapy (PDT) is limited by the penetration depth of visible light needed for its activation. Here we used mesoporous-silica-coated upconversion fluorescent nanoparticles (UCNs) as a nanotransducer to convert deeply penetrating near-infrared light to visible wavelengths and a carrier of photosensitizers. We also used the multicolor-emission capability of the UCNs at a single excitation wavelength for simultaneous activation of two photosensitizers for enhanced PDT. We showed a greater PDT efficacy with the dual-photosensitizer approach compared to approaches using a single photosensitizer, as determined by enhanced generation of singlet oxygen and reduced cell viability. In vivo studies also showed tumor growth inhibition in PDT-treated mice by direct injection of UCNs into melanoma tumors or intravenous injection of UCNs conjugated with a tumor-targeting agent into tumor-bearing mice. As the first demonstration, to the best of our knowledge, of the photosensitizer-loaded UCN as an in vivo-targeted PDT agent, this finding may serve as a platform for future noninvasive deep-cancer therapy.	[Idris, Niagara Muhammad; Gnanasammandhan, Muthu Kumara; Zhang, Yong] Natl Univ Singapore, Fac Engn, Dept Bioengn, Singapore 117548, Singapore; [Zhang, Jing; Ho, Paul C.] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore; [Mahendran, Ratha] Natl Univ Singapore, Fac Med, Dept Surg, Singapore 117548, Singapore; [Zhang, Yong] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Singapore 117548, Singapore; [Zhang, Yong] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Zhang, Y (corresponding author), Natl Univ Singapore, Fac Engn, Dept Bioengn, Singapore 117548, Singapore.	biezy@nus.edu.sg	Jayakumar, Muthu kumara Gnanasammandhan/G-4965-2016; Ho, Paul C/O-9652-2014; Zhang, Yong/F-2803-2010; Mahendran, Ratha/B-3827-2012	Jayakumar, Muthu kumara Gnanasammandhan/0000-0003-2524-9104; Ho, Paul C/0000-0001-9213-7116; Zhang, Yong/0000-0002-1303-0458; Muhammad Idris, Niagara/0000-0002-9722-1410	Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) Biomedical Research Council [R-397-000-062-305, R-397-000-119-305]; National University of Singapore	Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) Biomedical Research Council; National University of Singapore(National University of Singapore)	We thank Z.Q. Li, A. Priyam and C. X. Li (Department of Bioengineering, Faculty of Engineering, National University of Singapore) for synthesis of the nanoparticles and S. Rajan for technical support in preparing the schematic illustration. We also acknowledge financial support from the Agency for Science, Technology and Research (A<SUP>star</SUP>STAR) Biomedical Research Council (grants R-397-000-062-305 and R-397-000-119-305) and National University of Singapore.	Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g; Chatteriee DK, 2008, BIOMATERIALS, V29, P937, DOI 10.1016/j.biomaterials.2007.10.051; Chatterjee DK, 2008, NANOMEDICINE-UK, V3, P73, DOI 10.2217/17435889.3.1.73; Cheng LA, 2011, J PHYS CHEM C, V115, P2686, DOI 10.1021/jp111006z; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Gao D, 2006, NANO LETT, V6, P2383, DOI 10.1021/nl0617179; Guo H, 2009, OPT MATER, V31, P583, DOI 10.1016/j.optmat.2008.06.011; Guo HC, 2010, NANOMED-NANOTECHNOL, V6, P486, DOI 10.1016/j.nano.2009.11.004; Heer S, 2004, ADV MATER, V16, P2102, DOI 10.1002/adma.200400772; Idris NM, 2009, BIOMATERIALS, V30, P5104, DOI 10.1016/j.biomaterials.2009.05.062; Joensen J, 2011, PHOTOMED LASER SURG, V29, P145, DOI 10.1089/pho.2010.2793; Kim S, 2007, J AM CHEM SOC, V129, P2669, DOI 10.1021/ja0680257; Konan YN, 2002, J PHOTOCH PHOTOBIO B, V66, P89, DOI 10.1016/S1011-1344(01)00267-6; Kuznetsova NA, 2001, RUSS J GEN CHEM+, V71, P36, DOI 10.1023/A:1012369120376; Laser Institute of America, 2000, Z13612000 ANSI LAS I; Li X, 2011, INT J NANOMED, V6, P1167, DOI 10.2147/IJN.S21445; Li ZQ, 2006, ANGEW CHEM INT EDIT, V45, P7732, DOI 10.1002/anie.200602975; Li ZQ, 2008, ADV MATER, V20, P4765, DOI 10.1002/adma.200801056; Mohapatra S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/38/385102; Nyk M, 2008, NANO LETT, V8, P3834, DOI 10.1021/nl802223f; Prasad P. N., 2003, INTRO BIOPHOTONICS; Qian HS, 2009, SMALL, V5, P2285, DOI 10.1002/smll.200900692; Wang C, 2011, BIOMATERIALS, V32, P1110, DOI 10.1016/j.biomaterials.2010.09.069; Wang M, 2009, J PHYS CHEM C, V113, P19021, DOI 10.1021/jp906394z; Xiong LQ, 2009, BIOMATERIALS, V30, P5592, DOI 10.1016/j.biomaterials.2009.06.015; Xiong LQ, 2009, ANAL CHEM, V81, P8687, DOI 10.1021/ac901960d; Zhang P, 2007, J AM CHEM SOC, V129, P4526, DOI 10.1021/ja0700707	27	1102	1139	32	1317	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1580	U190		10.1038/nm.2933	http://dx.doi.org/10.1038/nm.2933			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22983397				2022-12-27	WOS:000309587500038
J	Wolgemuth, DJ; Griswold, MD; Grimes, DA				Wolgemuth, Debra J.; Griswold, Michael D.; Grimes, David A.			Parsing the potential of a new male contraceptive	NATURE MEDICINE			English	Editorial Material							ACID RECEPTOR-ALPHA; 1ST BROMODOMAIN; SPERMATOGENESIS; TESTIS; EXPRESSION; BRDT; MICE	In contrast to the range of contraceptives available to women, contraceptive options for men are limited to condoms or a vasectomy-thus, a pharmacological, reversible method of male contraception has been a long-standing quest in medicine. Spermatogenic-specific proteins have been pursued as potential targets, and the bromodomain and extraterminal (BET) family member BRDT has come to attention in two recent studies(1,2). Matzuk et al.(2) have now described the effects of a small-molecule inhibitor of the BET family, JQ1, as a contraceptive in male mice. They showed that JQ1 can inhibit BRDT and is also able to cross the blood-testis barrier. JQ1 treatment had a complete contraceptive effect, and importantly, when JQ1 administration was stopped, the mice could recover spermatogenesis with no obvious effects on their testes or on their offspring. We asked three experts to comment on the results of this study and their implications.							NICHD NIH HHS [U01 HD060479] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060479] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Berkovits BD, 2011, DEV BIOL, V360, P358, DOI 10.1016/j.ydbio.2011.10.005; Chung SSW, 2011, ENDOCRINOLOGY, V152, P2492, DOI 10.1210/en.2010-0941; Chung SSW, 2009, DEVELOPMENT, V136, P2091, DOI 10.1242/dev.020040; Fox M., 2012, NBC NEWS        0816; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Goodman A., 2008, TIME; Grimes DA, 2012, COCHRANE DB SYST REV, V3; Lopez LM, 2005, OBSTET GYNECOL SURV, V60, P746, DOI 10.1097/01.ogx.0000182905.71077.13; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Skoogh J, 2011, INT J ANDROL, V34, P183, DOI 10.1111/j.1365-2605.2010.01073.x	15	2	3	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1466	1467		10.1038/nm.2970	http://dx.doi.org/10.1038/nm.2970			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042348				2022-12-27	WOS:000309587500017
J	Dolgin, E				Dolgin, Elie			First therapy targeting Parkinson's proteins enters clinical trials	NATURE MEDICINE			English	News Item																		2005, NEURON, V46, P857	1	5	5	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					992	993		10.1038/nm0712-992b	http://dx.doi.org/10.1038/nm0712-992b			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772533				2022-12-27	WOS:000306121600006
J	Hersher, R				Hersher, Rebecca			Pharma backs latest attempt at a global health R & D treaty	NATURE MEDICINE			English	News Item																		2012, PLOS MED, V9	1	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					838	838		10.1038/nm0612-838a	http://dx.doi.org/10.1038/nm0612-838a			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673977	Bronze			2022-12-27	WOS:000305116600003
J	Kim, DK; Jeong, JH; Lee, JM; Kim, KS; Park, SH; Kim, YD; Koh, M; Shin, M; Jung, YS; Kim, HS; Lee, TH; Oh, BC; Kim, JI; Park, HT; Jeong, WI; Lee, CH; Park, SB; Min, JJ; Jung, SI; Choi, SY; Choy, HE; Choi, HS				Kim, Don-Kyu; Jeong, Jae-Ho; Lee, Ji-Min; Kim, Kwang Soo; Park, Seung-Hwan; Kim, Yong Deuk; Koh, Minseob; Shin, Minsang; Jung, Yoon Seok; Kim, Hyung-Seok; Lee, Tae-Hoon; Oh, Byung-Chul; Kim, Jae Il; Park, Hwan Tae; Jeong, Won-Il; Lee, Chul-Ho; Park, Seung Bum; Min, Jung-Joon; Jung, Sook-In; Choi, Seok-Yong; Choy, Hyon E.; Choi, Hueng-Sik			Inverse agonist of estrogen-related receptor gamma controls Salmonella typhimurium infection by modulating host iron homeostasis	NATURE MEDICINE			English	Article							ERR-GAMMA; HEPATIC GLUCONEOGENESIS; KEY REGULATOR; LIVER-INJURY; MACROPHAGES; HEPCIDIN; GROWTH; FERROPORTIN; METABOLISM; EXPRESSION	In response to microbial infection, expression of the defensin-like peptide hepcidin (encoded by Hamp) is induced in hepatocytes to decrease iron release from macrophages(1). To elucidate the mechanism by which Salmonella enterica var. Typhimurium (S. typhimurium), an intramacrophage bacterium, alters host iron metabolism for its own survival, we examined the role of nuclear receptor family members belonging to the NR3B subfamily in mouse hepatocytes. Here, we report that estrogen-related receptor gamma (ERR gamma, encoded by Esrrg) modulates the intramacrophage proliferation of S. typhimurium by altering host iron homeostasis, and we demonstrate an antimicrobial effect of an ERR gamma inverse agonist. Hepatic ERR gamma expression was induced by S. typhimurium-stimulated interleukin-6 signaling, resulting in an induction of hepcidin and eventual hypoferremia in mice. Conversely, ablation of ERR gamma mRNA expression in liver attenuated the S. typhimurium-mediated induction of hepcidin and normalized the hypoferremia caused by S. typhimurium infection. An inverse agonist of ERR gamma ameliorated S. typhimurium-mediated hypoferremia through reduction of ERR gamma-mediated hepcidin mRNA expression and exerted a potent antimicrobial effect on the S. typhimurium infection, thereby improving host survival. Taken together, these findings suggest an alternative approach to control multidrug-resistant intracellular bacteria by modulating host iron homeostasis.	[Kim, Don-Kyu; Lee, Ji-Min; Kim, Yong Deuk; Shin, Minsang; Jung, Yoon Seok; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Natl Creat Res Initiat, Ctr Nucl Receptor Signals, Kwangju, South Korea; [Kim, Don-Kyu; Lee, Ji-Min; Kim, Yong Deuk; Shin, Minsang; Jung, Yoon Seok; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Jeong, Jae-Ho; Kim, Kwang Soo; Choy, Hyon E.] Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju, South Korea; [Jeong, Jae-Ho; Kim, Kwang Soo; Lee, Tae-Hoon; Min, Jung-Joon; Jung, Sook-In; Choy, Hyon E.] Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21plus, Kwangju, South Korea; [Park, Seung-Hwan; Min, Jung-Joon] Chonnam Natl Univ, Sch Med, Dept Nucl Med, Kwangju, South Korea; [Koh, Minseob; Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea; [Kim, Hyung-Seok] Chonnam Natl Univ, Sch Med, Dept Forens Med, Kwangju, South Korea; [Lee, Tae-Hoon] Chonnam Natl Univ, Dent Sci Res Inst, Dept Oral Biochem, Kwangju, South Korea; [Oh, Byung-Chul] Gachon Univ, Grad Sch Med, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Kim, Jae Il] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Kim, Jae Il] AnyGen, Jeonnam NanoBioRes Ctr, Jangseong Gun, South Korea; [Park, Hwan Tae] Dong A Univ, Coll Med, Mitochondria Hub Regulat Ctr, Dept Physiol, Pusan, South Korea; [Jeong, Won-Il] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea; [Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Jung, Sook-In] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea; [Choi, Seok-Yong] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Kwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Seoul National University (SNU); Chonnam National University; Chonnam National University; Gachon University; Gwangju Institute of Science & Technology (GIST); Dong A University; Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Chonnam National University; Chonnam National University	Choy, HE (corresponding author), Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju, South Korea.	hyonchoy@jnu.ac.kr; hsc@chonnam.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Park, Seung Bum/N-1901-2014; JEONG, WON IL/B-6615-2011	Lee, Tae-Hoon/0000-0003-0105-1750; Park, Seung Bum/0000-0003-1753-1433; Jeong, Jae-Ho/0000-0002-5544-9572; Park, Seung-Hwan/0000-0003-4613-4680; Koh, Minseob/0000-0003-1935-4776; Shin, Minsang/0000-0001-8679-446X; Oh, Byung-Chul/0000-0002-4277-7083; Choi, Seok-Yong/0000-0001-7193-292X	National Research Foundation of Korea [20110018305, 20100019512, 2012-0006073]; Korean government (Ministry of Science, ICT & Future Planning)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (Ministry of Science, ICT & Future Planning)(Korean Government)	We would like to thank D. Moore, S. Adhya and E.-K. Jo for critical reading of the manuscript, K.A. Cho for technical assistance and M. Shong (Chungnam National University) for providing the TEL-JAK2 construct. This work was supported by a National Creative Research Initiatives Grant (20110018305) and the Future-based Technology Development Program (BIO Fields) (20100019512) through the National Research Foundation of Korea (funded by the Korean government (Ministry of Science, ICT & Future Planning)) (H.-S.C.) and by the National Research Foundation of Korea (no. 2012-0006073) (H.E.C.).	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Byun JS, 2013, J HEPATOL, V58, P342, DOI 10.1016/j.jhep.2012.09.016; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Collins HL, 2008, EUR J IMMUNOL, V38, P1803, DOI 10.1002/eji.200838505; Fritsche G, 2012, J LEUKOCYTE BIOL, V92, P353, DOI 10.1189/jlb.1111554; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Kim DK, 2013, DIABETES, V62, P3093, DOI 10.2337/db12-0946; Kim DK, 2013, GUT, V62, P1044, DOI 10.1136/gutjnl-2012-303347; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Min JJ, 2008, NAT PROTOC, V3, P629, DOI 10.1038/nprot.2008.32; Min JJ, 2008, MOL IMAGING BIOL, V10, P54, DOI 10.1007/s11307-007-0120-5; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Paradkar PN, 2008, BLOOD, V112, P866, DOI 10.1182/blood-2007-12-126854; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939	25	106	109	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					419	+		10.1038/nm.3483	http://dx.doi.org/10.1038/nm.3483			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658075				2022-12-27	WOS:000334361500023
J	[Anonymous]				[Anonymous]			Keeping pace with cancer	NATURE MEDICINE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1380	1380		10.1038/nm.3395	http://dx.doi.org/10.1038/nm.3395			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202390	Bronze			2022-12-27	WOS:000326920300015
J	Hochmair, I				Hochmair, Ingeborg			The importance of being flexible	NATURE MEDICINE			English	Editorial Material							COCHLEAR IMPLANT; STIMULATION; RECOGNITION; INSERTION; SYSTEM		MED EL Med Elect GmbH, Innsbruck, Austria		Hochmair, I (corresponding author), MED EL Med Elect GmbH, Innsbruck, Austria.	ingeborg.hochmair@medel.com			Austrian Research Council	Austrian Research Council	I would like to thank my closest research partner, my husband Erwin Hochmair, for the many years of joint research and other adventures. I also thank F. Paschke, former head of the General EE Department at the TU Vienna, for his support and encouragement, and the late K. Burian, former head of the ENT University Clinic Vienna, and his successors. I wish to acknowledge the early pioneer patients, in particular C. K., S. O., H. D. and M. H., who spent countless hours performing psychophysical and speech- perception tests in our lab. I thank C. Zierhofer, now professor at the University of Innsbruck, for all his creativity and friendship, B. Wilson for our fruitful collaboration and friendship, J. Helms, former head of the ENT University Clinic Wurzburg, and the 50 investigators of the COMBI 40 clinical study. Most of our early work was funded by the Austrian Research Council.	Desoyer I., 1977, PROC EUROP SOLID STA, V77, P87; Gstoettner WK, 1997, LARYNGOSCOPE, V107, P544, DOI 10.1097/00005537-199704000-00022; Helms J, 1997, ORL J OTO-RHINO-LARY, V59, P23, DOI 10.1159/000276901; Hochmair I, 2003, ACTA OTO-LARYNGOL, V123, P612, DOI 10.1080/00016480310001844; Hochmair-Desoyer I., 1979, TECHNISCHE REALISIER; HOCHMAIRDESOYER IJ, 1981, MED PROG TECHNOL, V8, P107; HOCHMAIRDESOYER IJ, 1989, BIOMED TECH, V34, P168, DOI 10.1515/bmte.1989.34.7-8.168; HOCHMAIRDESOYER IJ, 1993, PROG BRAIN RES, V97, P291; KIANG NYS, 1972, ANN OTO RHINOL LARYN, V81, P714, DOI 10.1177/000348947208100513; MICHELSON RP, 1981, LARYNGOSCOPE, V91, P38; Schoen F, 2005, OTOL NEUROTOL, V26, P429, DOI 10.1097/01.mao.0000169772.16045.86; TYLER RS, 1988, ARCH OTOLARYNGOL, V114, P1123; von Ilberg C, 1999, ORL J OTO-RHINO-LARY, V61, P334, DOI 10.1159/000027695; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0	14	12	12	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1240	1244		10.1038/nm.3341	http://dx.doi.org/10.1038/nm.3341			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100995				2022-12-27	WOS:000325531700021
J	Bacman, SR; Williams, SL; Pinto, M; Peralta, S; Moraes, CT				Bacman, Sandra R.; Williams, Sion L.; Pinto, Milena; Peralta, Susana; Moraes, Carlos T.			Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs	NATURE MEDICINE			English	Article							TARGETED RESTRICTION-ENDONUCLEASE; DNA COPY NUMBER; MTDNA HETEROPLASMY; HUMAN BRAIN; MUTATION; DELETIONS; DELIVERY; MICE	Mitochondrial diseases are commonly caused by mutated mitochondrial DNA (mtDNA), which in most cases coexists with wild-type mtDNA, resulting in mtDNA heteroplasmy. We have engineered transcription activator-like effector nucleases (TALENs) to localize to mitochondria and cleave different classes of pathogenic mtDNA mutations. Mitochondria-targeted TALEN (mitoTALEN) expression led to permanent reductions in deletion or point-mutant mtDNA in patient-derived cells, raising the possibility that these mitochondrial nucleases can be therapeutic for some mitochondrial diseases.	[Bacman, Sandra R.; Williams, Sion L.; Pinto, Milena; Peralta, Susana; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA	University of Miami; University of Miami	Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	cmoraes@med.miami.edu	Moraes, Carlos/AAT-3818-2021; Pinto, Milena/K-6095-2017	Pinto, Milena/0000-0001-9202-1527	US National Institutes of Health [5R01EY010804, 1R01AG036871, 1R01NS079965]; Muscular Dystrophy Association; JDM Fund; NATIONAL EYE INSTITUTE [R01EY010804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG036871] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); JDM Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US National Institutes of Health grants 5R01EY010804, 1R01AG036871 and 1R01NS079965, the Muscular Dystrophy Association and The JDM Fund. We thank M. Hirano (Columbia University) for the G14459A cells, F. Delacote (Cellectis bioresearch) for expert assistance in designing TALENs, G. Zhai for critically reading the manuscript and A. Pickrell for critical scientific suggestions.	Bacman SR, 2012, GENE THER, V19, P1101, DOI 10.1038/gt.2011.196; Bacman SR, 2010, GENE THER, V17, P713, DOI 10.1038/gt.2010.25; Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004; Comte C, 2013, NUCLEIC ACIDS RES, V41, P418, DOI 10.1093/nar/gks965; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Jun AS, 1996, MOL CELL BIOL, V16, P771; Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313; Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; SOONG NW, 1992, NAT GENET, V2, P318; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586	17	249	270	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2013	19	9					1111	1113		10.1038/nm.3261	http://dx.doi.org/10.1038/nm.3261			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23913125	Green Accepted			2022-12-27	WOS:000324083500024
J	Rehermann, B				Rehermann, Barbara			Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells	NATURE MEDICINE			English	Review							NATURAL-KILLER-CELLS; ADAPTIVE IMMUNE-RESPONSES; ACTIVATED STELLATE CELLS; VIRUS-INFECTED CELLS; C VIRUS; B-VIRUS; INTERFERON-ALPHA; HCV INFECTION; EX-VIVO; FUNCTIONAL RESTORATION	Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for 57% of cases of liver cirrhosis and 78% of cases of primary liver cancer worldwide and cause a million deaths per year. Although HBV and HCV differ in their genome structures, replication strategies and life cycles, they have common features, including their noncytopathic nature and their capacity to induce chronic liver disease, which is thought to be immune mediated. However, the rate of disease progression from chronic hepatitis to cirrhosis varies greatly among infected individuals, and the factors that regulate it are largely unknown. This review summarizes our current understanding of the roles of antigen-specific and nonspecific immune cells in the pathogenesis of chronic hepatitis B and C and discusses recent findings that identify natural killer cells as regulators of T cell function and liver inflammation.	NIDDK, Immunol Sect, Liver Dis Branch, NIH,Dept Hlth & Human Serv, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rehermann, B (corresponding author), NIDDK, Immunol Sect, Liver Dis Branch, NIH,Dept Hlth & Human Serv, Bethesda, MD USA.	rehermann@nih.gov		Rehermann, Barbara/0000-0001-6832-9951	National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054509, ZIADK054508, ZIADK054516] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the intramural research program of the National Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health.	Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Alatrakchi N, 2007, J VIROL, V81, P5882, DOI 10.1128/JVI.02202-06; ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Boni C, 2012, GASTROENTEROLOGY, V143, P963, DOI 10.1053/j.gastro.2012.07.014; Bonorino P, 2009, J HEPATOL, V51, P458, DOI 10.1016/j.jhep.2009.05.030; Bozzano F, 2011, EUR J IMMUNOL, V41, P2905, DOI 10.1002/eji.201041361; Bucks CM, 2009, J IMMUNOL, V182, P6697, DOI 10.4049/jimmunol.0800997; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Callendret B, 2011, J VIROL, V85, P11833, DOI 10.1128/JVI.02654-10; Cao DY, 2013, INFLAMMATION, V36, P110, DOI 10.1007/s10753-012-9525-7; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Cavanaugh VJ, 1997, J VIROL, V71, P3236, DOI 10.1128/JVI.71.4.3236-3243.1997; Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778; Chang KM, 2001, HEPATOLOGY, V33, P267, DOI 10.1053/jhep.2001.21162; Chen CH, 2006, HEPATOLOGY, V44, P1171, DOI 10.1002/hep.21379; Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; Cook KD, 2013, J IMMUNOL, V190, P641, DOI 10.4049/jimmunol.1202448; Cox AL, 2005, HEPATOLOGY, V42, P104, DOI 10.1002/hep.20749; Crotta S, 2010, J HEPATOL, V52, P183, DOI 10.1016/j.jhep.2009.11.003; Dabbouseh NM, 2013, NAT REV GASTRO HEPAT, V10, P268, DOI 10.1038/nrgastro.2013.17; Das A, 2008, J EXP MED, V205, P2111, DOI 10.1084/jem.20072076; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Dazert E, 2009, J CLIN INVEST, V119, P376, DOI 10.1172/JCI36587; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Duramad O, 2003, BLOOD, V102, P4487, DOI 10.1182/blood-2003-07-2465; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; Fisicaro P, 2012, GASTROENTEROLOGY, V143, P1576, DOI 10.1053/j.gastro.2012.08.041; Fitzmaurice K, 2011, GUT, V60, P1563, DOI 10.1136/gut.2010.228403; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Fuller MJ, 2010, HEPATOLOGY, V51, P378, DOI 10.1002/hep.23319; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Glassner A, 2012, LAB INVEST, V92, P967, DOI 10.1038/labinvest.2012.54; Golden-Mason L, 2011, HEPATOLOGY, V54, P1559, DOI 10.1002/hep.24556; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Groux H, 1998, J IMMUNOL, V160, P3188; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Heise T, 2001, J VIROL, V75, P6874, DOI 10.1128/JVI.75.15.6874-6883.2001; Heise T, 1999, J VIROL, V73, P474, DOI 10.1128/JVI.73.1.474-481.1999; Heise T, 1999, J VIROL, V73, P5767, DOI 10.1128/JVI.73.7.5767-5776.1999; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; JIN Y, 1988, J EXP MED, V168, P293, DOI 10.1084/jem.168.1.293; Jo J, 2009, GASTROENTEROLOGY, V136, P1391, DOI 10.1053/j.gastro.2008.12.034; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Kaplan DE, 2007, GASTROENTEROLOGY, V132, P654, DOI 10.1053/j.gastro.2006.11.044; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lang PA, 2012, P NATL ACAD SCI USA, V109, P1210, DOI 10.1073/pnas.1118834109; Larrubia JR, 2013, J VIRAL HEPATITIS, V20, P85, DOI 10.1111/j.1365-2893.2012.01618.x; Lau D.T., 2012, GASTROENTEROLOGY, V144; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lopes AR, 2008, J CLIN INVEST, V118, P1835, DOI 10.1172/JCI33402; Losikoff PT, 2012, VIRULENCE, V3, P610, DOI 10.4161/viru.21823; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Manigold T, 2006, BLOOD, V107, P4424, DOI 10.1182/blood-2005-09-3903; McGilvray I, 2012, GASTROENTEROLOGY, V142, P1122, DOI 10.1053/j.gastro.2012.01.028; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; MILICH DR, 1990, P NATL ACAD SCI USA, V87, P6599, DOI 10.1073/pnas.87.17.6599; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Miyagi T, 2010, J HEPATOL, V53, P424, DOI 10.1016/j.jhep.2010.03.018; Morishima C, 2006, HEPATOLOGY, V43, P573, DOI 10.1002/hep.21073; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Nattermann J, 2006, GUT, V55, P869, DOI 10.1136/gut.2005.076463; Neumann-Haefelin C, 2011, HEPATOLOGY, V54, P1157, DOI 10.1002/hep.24541; Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; Norris S, 1998, J HEPATOL, V28, P84, DOI 10.1016/S0168-8278(98)80206-7; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Oliviero B, 2013, J HEPATOL, V59, P38, DOI 10.1016/j.jhep.2013.03.003; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Peppa D, 2013, J EXP MED, V210, P99, DOI 10.1084/jem.20121172; Peppa D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001227; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Publicover J, 2011, J CLIN INVEST, V121, P1154, DOI 10.1172/JCI44198; Rabinovich BA, 2003, J IMMUNOL, V170, P3572, DOI 10.4049/jimmunol.170.7.3572; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Radziewicz H, 2010, J IMMUNOL, V184, P2410, DOI 10.4049/jimmunol.0902994; Raue HP, 2013, IMMUNITY, V38, P131, DOI 10.1016/j.immuni.2012.09.019; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; REHERMANN B, 1995, J CLIN INVEST, V96, P1527, DOI 10.1172/JCI118191; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Rossol S, 1997, J CLIN INVEST, V99, P3025, DOI 10.1172/JCI119498; Rutebemberwa A, 2008, J IMMUNOL, V181, P8215, DOI 10.4049/jimmunol.181.12.8215; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Schlaphoff V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002045; Schurich A, 2011, HEPATOLOGY, V53, P1494, DOI 10.1002/hep.24249; Semmo N, 2006, BLOOD, V107, P4570, DOI 10.1182/blood-2005-11-4522; Sene D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001184; Shetty S, 2008, TOXICOLOGY, V254, P136, DOI 10.1016/j.tox.2008.08.003; Shields PL, 1999, J IMMUNOL, V163, P6236; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Shin EC, 2011, GASTROENTEROLOGY, V141, P686, DOI 10.1053/j.gastro.2011.05.006; Shoukry NH, 2004, J IMMUNOL, V172, P483, DOI 10.4049/jimmunol.172.1.483; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Sitia G, 2004, J CLIN INVEST, V113, P1158, DOI 10.1172/JCI200421087; Sitia G, 2002, P NATL ACAD SCI USA, V99, P13717, DOI 10.1073/pnas.172521999; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Taimr P, 2003, HEPATOLOGY, V37, P87, DOI 10.1053/jhep.2003.50002; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Tan AT, 2010, J HEPATOL, V52, P330, DOI 10.1016/j.jhep.2009.12.015; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Tjwa ETTL, 2011, J HEPATOL, V54, P209, DOI 10.1016/j.jhep.2010.07.009; Tu Z, 2008, J EXP MED, V205, P233, DOI 10.1084/jem.20072195; Urbani S, 2002, J VIROL, V76, P12423, DOI 10.1128/JVI.76.24.12423-12434.2002; Urbani S, 2005, HEPATOLOGY, V41, P826, DOI 10.1002/hep.20614; Varchetta S, 2012, HEPATOLOGY, V56, P841, DOI 10.1002/hep.25723; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Welsh RM, 2013, VIROLOGY, V435, P37, DOI 10.1016/j.virol.2012.10.005; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Winau F, 2008, CURR OPIN IMMUNOL, V20, P68, DOI 10.1016/j.coi.2007.10.006; Wolfl M, 2008, J IMMUNOL, V181, P6435, DOI 10.4049/jimmunol.181.9.6435; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yoon JC, 2011, J VIROL, V85, P12557, DOI 10.1128/JVI.00838-11; Yoon JC, 2009, HEPATOLOGY, V49, P12, DOI 10.1002/hep.22624; Zeissig S, 2012, NAT MED, V18, P1060, DOI 10.1038/nm.2811; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614; Zignego AL, 1999, J HEPATOL, V31, P369, DOI 10.1016/S0168-8278(99)80239-6	165	336	354	1	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					859	868		10.1038/nm.3251	http://dx.doi.org/10.1038/nm.3251			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836236	Green Accepted			2022-12-27	WOS:000321557700029
J	Soh, J; Iqbal, J; Queiroz, J; Fernandez-Hernando, C; Hussain, MM				Soh, James; Iqbal, Jahangir; Queiroz, Joyce; Fernandez-Hernando, Carlos; Hussain, M. Mahmood			MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion	NATURE MEDICINE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; APOLIPOPROTEIN-B; INHIBITION; PLASMA; MIR-30; LIVER; IDENTIFICATION; CONTRIBUTES; TRANSPORT; MULTIPLE	Hyperlipidemia is a risk factor for various cardiovascular and metabolic disorders. Overproduction of lipoproteins, a process that is dependent on microsomal triglyceride transfer protein (MTP), can contribute to hyperlipidemia. We show that microRNA-30c (miR-30c) interacts with the 3' untranslated region of MTP mRNA and induces its degradation, leading to reductions in MTP activity and in apolipoprotein B (APOB) secretion. miR-30c also reduces lipid synthesis independently of MTP. Hepatic overexpression of miR-30c reduced hyperlipidemia in Western diet-fed mice by decreasing lipid synthesis and the secretion of triglyceride-rich ApoB-containing lipoproteins and decreased atherosclerosis in Apoe(-/-) mice. Furthermore, inhibition of hepatic miR-30c by anti-miR-30c increased hyperlipidemia and atherosclerosis. Therefore, miR-30c coordinately reduces lipid biosynthesis and lipoprotein secretion, thereby regulating hepatic and plasma lipid concentrations. Raising miR-30c levels might be useful in treating hyperlipidemias and associated disorders.	[Soh, James] Suny Downstate Med Ctr, Program Mol & Cell Biol, Sch Grad Studies, Brooklyn, NY 11203 USA; [Soh, James; Iqbal, Jahangir; Queiroz, Joyce; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Med, New York, NY USA; [Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	mhussain@downstate.edu	Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271	US National Institutes of Health [DK-46900, HL-95924]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK046900, R01DK046900, R56DK046900] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001728] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by US National Institutes of Health grants DK-46900 and HL-95924 to M. M. H. Mttp<SUP>flox/flox</SUP> mice were from L. Chan (Baylor University).	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Burnett JR, 2007, EXPERT OPIN THER TAR, V11, P181, DOI 10.1517/14728222.11.2.181; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Dai KZ, 2010, ARTERIOSCL THROM VAS, V30, P568, DOI 10.1161/ATVBAHA.109.198135; FOLCH J, 1957, J BIOL CHEM, V226, P497; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P277, DOI 10.1097/MOL.0b013e3282feea85; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2012, CIRC RES, V110, P1575, DOI 10.1161/CIRCRESAHA.112.264283; IRITANI N, 1976, J BIOCHEM-TOKYO, V80, P217, DOI 10.1093/oxfordjournals.jbchem.a131267; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Rava P, 2005, J LIPID RES, V46, P1779, DOI 10.1194/jlr.D400043-JLR200; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Samaha FF, 2008, NAT CLIN PRACT CARD, V5, P497, DOI 10.1038/ncpcardio1250; Sellers JA, 2003, J BIOL CHEM, V278, P20367, DOI 10.1074/jbc.M300271200; STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Westerterp M, 2006, J LIPID RES, V47, P1203, DOI 10.1194/jlr.M500434-JLR200; Wu XJ, 1996, J BIOL CHEM, V271, P10277, DOI 10.1074/jbc.271.17.10277; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zsigmond E, 1998, J LIPID RES, V39, P1852	43	207	218	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					892	+		10.1038/nm.3200	http://dx.doi.org/10.1038/nm.3200			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23749231	Green Accepted, Green Published			2022-12-27	WOS:000321557700033
J	Lodygin, D; Odoardi, F; Schlager, C; Korner, H; Kitz, A; Nosov, M; van den Brandt, J; Reichardt, HM; Haberl, M; Flugel, A				Lodygin, Dmitri; Odoardi, Francesca; Schlaeger, Christian; Koerner, Henrike; Kitz, Alexandra; Nosov, Michail; van den Brandt, Jens; Reichardt, Holger M.; Haberl, Michael; Fluegel, Alexander			A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity	NATURE MEDICINE			English	Article							DENDRITIC CELLS; LYMPH-NODES; MULTIPLE-SCLEROSIS; IMMUNOLOGICAL SYNAPSES; ANTIGEN; ENCEPHALOMYELITIS; ORGANS; GENES; MOUSE; MICE	Multiple sclerosis is an autoimmune disease of the central nervous system (CNS) that is initiated when self-reactive T cells enter the brain and become locally activated after encountering their specific nervous antigens. When and where the disease-relevant antigen encounters occur is unclear. Here we combined fluorescently labeled nuclear factor of activated T cells (NFAT) with histone protein H2B to create a broadly applicable molecular sensor for intravital imaging of T cell activation. In experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, we report that effector T cells entering the CNS become activated after short contacts with leptomeningeal phagocytes. During established disease, the activation process is extended to the depth of the CNS parenchyma, where the cells form contacts with microglia and recruited phagocytes. We show that it is the activation processes during the preclinical phase rather than during established disease that are essential for the intensity and duration of the disease bout.	[Lodygin, Dmitri; Odoardi, Francesca; Schlaeger, Christian; Koerner, Henrike; Kitz, Alexandra; Haberl, Michael; Fluegel, Alexander] Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Gottingen, Germany; [Lodygin, Dmitri; Odoardi, Francesca; Schlaeger, Christian; Koerner, Henrike; Kitz, Alexandra; Haberl, Michael; Fluegel, Alexander] Gemeinnutzige Hertie Stiftung, Dept Neuroimmunol, Gottingen, Germany; [Lodygin, Dmitri; Odoardi, Francesca; Schlaeger, Christian; Koerner, Henrike; Kitz, Alexandra; Haberl, Michael; Fluegel, Alexander] Univ Med Ctr Gottingen, Gottingen, Germany; [Nosov, Michail] Natl Univ Ireland, Regenerat Med Inst, Galway, Ireland; [van den Brandt, Jens] Ernst Moritz Arndt Univ Greifswald, Sch Med, Cent Core & Res Facil Lab Anim, Greifswald, Germany; [van den Brandt, Jens; Reichardt, Holger M.] Univ Med Ctr Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany	University of Gottingen; Ollscoil na Gaillimhe-University of Galway; Ernst Moritz Arndt Universitat Greifswald; University of Gottingen	Flugel, A (corresponding author), Gemeinnutzige Hertie Stiftung, Inst Multiple Sclerosis Res, Gottingen, Germany.	fluegel@med.uni-goettingen.de	Reichardt, Holger/AAF-3048-2020; Reich, Daniel S./E-5701-2010	Reichardt, Holger/0000-0003-4647-057X; Reich, Daniel S./0000-0002-2628-4334	Deutsche Forschungsgemeinschaft [FOR 1336, FL 377/2-7, TRR-SFB43 B10, TRR-SFB43 B11, RE 1631/10-1, SFB-TRR43 B13]; Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS'); Hertie Foundation [1.01.1/11/004]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS')(Federal Ministry of Education & Research (BMBF)); Hertie Foundation	We thank N. Meyer, S. Hamann, A. Stas and M. Weig for excellent technical assistance. We thank R. Tsien (Department of Chemistry and Biochemistry, University of California at San Diego, La Jolla) for providing mCherry complementary DNA (cDNA). We also thank C. Ludwig for text editing and M. B. Graeber and F. Luhder for critical reading of the manuscript. D. L., F.O. and A. F. were supported by the Deutsche Forschungsgemeinschaft (FOR 1336, FL 377/2-7; TRR-SFB43 B10 and B11), the Bundesministerium fur Bildung und Forschung ('UNDERSTAND MS') and the Hertie Foundation (grant 1.01.1/11/004). The work of H.M.R.'s lab was supported by the Deutsche Forschungsgemeinschaft (RE 1631/10-1; SFB-TRR43 B13).	Azar GA, 2010, P NATL ACAD SCI USA, V107, P3675, DOI 10.1073/pnas.0905901107; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chastain EML, 2011, BBA-MOL BASIS DIS, V1812, P265, DOI 10.1016/j.bbadis.2010.07.008; Croxford AL, 2011, IMMUNOLOGY, V132, P1, DOI 10.1111/j.1365-2567.2010.03372.x; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hirasawa T, 2005, J NEUROSCI RES, V81, P357, DOI 10.1002/jnr.20480; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kang SS, 2011, J EXP MED, V208, P747, DOI 10.1084/jem.20101295; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kondo T, 2001, NAT IMMUNOL, V2, P932, DOI 10.1038/ni711; LASSMANN H, 1978, ACTA NEUROCHIR, V43, P35; Loh C, 1996, MOL CELL BIOL, V16, P3945; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; MOOLTEN FL, 1986, CANCER RES, V46, P5276; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; Schubert DA, 2012, J EXP MED, V209, P335, DOI 10.1084/jem.20111485; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; Thauland TJ, 2010, IMMUNOLOGY, V131, P466, DOI 10.1111/j.1365-2567.2010.03366.x; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381	36	78	79	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					784	+		10.1038/nm.3182	http://dx.doi.org/10.1038/nm.3182			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23624600				2022-12-27	WOS:000319981600030
J	Arck, PC; Hecher, K				Arck, Petra C.; Hecher, Kurt			Fetomaternal immune cross-talk and its consequences for maternal and offspring's health	NATURE MEDICINE			English	Review							REGULATORY T-CELLS; DECIDUAL STROMAL CELLS; NATURAL-KILLER-CELLS; CHEMOKINE CXCL12 PROMOTES; EARLY-PREGNANCY LOSS; CLASS-I ANTIGEN; DENDRITIC CELLS; NK CELLS; PERIPHERAL-BLOOD; HLA-C	An improved mechanistic understanding of the adaptational processes mounted during mammalian reproduction is emerging. Intricate pathways occurring at the fetomaternal interface, such as the formation of a functional synapse between invading fetal trophoblast cells, and the involvement of various maternal immune cell subsets and epigenetically modified decidual stromal cells have now been identified. These complex pathways synergistically create a tolerogenic niche in which the semiallogeneic fetus can develop. New insights into fetomaternal immune cross-talk may help us to understand the pathogenesis of pregnancy complications as well as poor postnatal health. Moreover, the effects of maternal immune adaptation to pregnancy on autoimmune disease activity are becoming increasingly evident. Thus, insights into fetomaternal immune cross-talk not only advance our understanding of pregnancy-related complications but also may be informative on how immune tolerance can be modulated in clinical settings outside the context of reproduction.	[Arck, Petra C.; Hecher, Kurt] Univ Med Ctr Hamburg, Dept Obstet & Fetal Med, Lab Expt Fetomaternal Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Arck, PC (corresponding author), Univ Med Ctr Hamburg, Dept Obstet & Fetal Med, Lab Expt Fetomaternal Med, Hamburg, Germany.	p.arck@uke.de; k.hecher@uke.de		Arck, Petra/0000-0002-2932-926X	German Research Foundation [AR232/19]; Foundation for Research and Science Hamburg [1232/102]; Werner Otto Foundation [4/79]; AllerGen NCE [09B6]; World Health Organization [A65097]	German Research Foundation(German Research Foundation (DFG)); Foundation for Research and Science Hamburg; Werner Otto Foundation; AllerGen NCE; World Health Organization(World Health Organization)	The writing of this review article was made possible by grants provided by the German Research Foundation (AR232/19), the Foundation for Research and Science Hamburg (1232/102), the Werner Otto Foundation (4/79), AllerGen NCE (09B6) and the World Health Organization (A65097) to P.C.A. and K.H.	Ait-Azzouzene D, 2001, BIOL REPROD, V65, P337, DOI 10.1095/biolreprod65.2.337; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Andersen KG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00113; APLIN JD, 1988, CELL TISSUE RES, V253, P231; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Arck PC, 2008, REPROD BIOMED ONLINE, V17, P101, DOI 10.1016/S1472-6483(10)60300-8; Artlett CM, 1998, NEW ENGL J MED, V338, P1186, DOI 10.1056/NEJM199804233381704; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bai X, 2009, PLACENTA, V30, P855, DOI 10.1016/j.placenta.2009.07.006; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Bloch Evan M, 2011, Chimerism, V2, P6, DOI 10.4161/chim.2.1.15151; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Blois SM, 2004, J IMMUNOL, V172, P5893, DOI 10.4049/jimmunol.172.10.5893; Blois SM, 2004, BIOL REPROD, V70, P1018, DOI 10.1095/biolreprod.103.022640; Bockle BC, 2008, PLACENTA, V29, P187, DOI 10.1016/j.placenta.2007.11.003; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brannon PM, 2012, P NUTR SOC, V71, P205, DOI 10.1017/S0029665111003399; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cannizzo ES, 2011, J PROTEOMICS, V74, P2313, DOI 10.1016/j.jprot.2011.06.005; Cavanagh PC, 2009, AM J PHYSIOL-CELL PH, V297, pC17, DOI 10.1152/ajpcell.00013.2009; Chan WFN, 2012, ARTHRITIS RHEUM-US, V64, P380, DOI 10.1002/art.33358; Chantakru S, 2001, J REPROD IMMUNOL, V49, P33, DOI 10.1016/S0165-0378(00)00076-0; Chaouat G, 2001, AM J REPROD IMMUNOL, V45, P108, DOI 10.1111/j.8755-8920.2001.450208.x; Chaouat G, 2007, SEMIN IMMUNOPATHOL, V29, P95, DOI 10.1007/s00281-007-0069-0; CHARD T, 1991, BAILLIERE CLIN OB GY, V5, P179, DOI 10.1016/S0950-3552(05)80077-X; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; CLARK DA, 1987, J REPROD IMMUNOL, V10, P79, DOI 10.1016/0165-0378(87)90052-0; Clark DA, 2008, AM J REPROD IMMUNOL, V59, P277, DOI 10.1111/j.1600-0897.2008.00580.x; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Croy BA, 2006, IMMUNOL REV, V214, P161; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Man YA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1241, DOI 10.1002/art.24003; Dotan I, 2010, INFLAMM BOWEL DIS, V16, P583, DOI 10.1002/ibd.21106; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Dutta P, 2009, BLOOD, V114, P3578, DOI 10.1182/blood-2009-03-213561; Elliot MG, 2006, AM NAT, V168, P114, DOI 10.1086/505162; Erlebacher A, 2004, J CLIN INVEST, V114, P39, DOI 10.1172/JC1200420645; Erlebacher A, 2007, J CLIN INVEST, V117, P1399, DOI 10.1172/JCI28214; Ernest JM, 2011, SEMIN REPROD MED, V29, P522, DOI 10.1055/s-0031-1293206; Ferreira GB, 2012, J PROTEOME RES, V11, P941, DOI 10.1021/pr200724e; Garcia-Lopez MA, 2001, LAB INVEST, V81, P409, DOI 10.1038/labinvest.3780248; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hartwig IRV, 2013, HUM REPROD, V28, P77, DOI 10.1093/humrep/des367; Hiby SE, 2008, HUM REPROD, V23, P972, DOI 10.1093/humrep/den011; Huang Y, 2008, J IMMUNOL, V180, P2367, DOI 10.4049/jimmunol.180.4.2367; Hunt JS, 1997, J IMMUNOL, V158, P4122; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Jeschke U, 2010, J REPROD IMMUNOL, V85, P99, DOI 10.1016/j.jri.2009.10.012; Jin LP, 2009, CLIN IMMUNOL, V133, P402, DOI 10.1016/j.clim.2009.08.009; Kallikourdis M, 2007, P NATL ACAD SCI USA, V104, P594, DOI 10.1073/pnas.0604268104; Kammerer U, 2000, AM J PATHOL, V157, P159, DOI 10.1016/S0002-9440(10)64527-0; Kammerer U, 2003, AM J PATHOL, V162, P887, DOI 10.1016/S0002-9440(10)63884-9; Karimi K, 2012, J MOL MED, V90, P1047, DOI 10.1007/s00109-012-0872-5; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P339, DOI 10.1016/j.bbi.2009.09.015; Keskin DB, 2007, P NATL ACAD SCI USA, V104, P3378, DOI 10.1073/pnas.0611098104; Kim MR, 2005, MOL HUM REPROD, V11, P801, DOI 10.1093/molehr/gah240; King A, 2000, PLACENTA, V21, P376, DOI 10.1053/plac.1999.0496; King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M; Klintschar M, 2001, J CLIN ENDOCR METAB, V86, P2494, DOI 10.1210/jc.86.6.2494; Kopcow HD, 2008, P NATL ACAD SCI USA, V105, P18472, DOI 10.1073/pnas.0809233105; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Kruse A, 1999, EUR J IMMUNOL, V29, P1116, DOI 10.1002/(SICI)1521-4141(199904)29:04<1116::AID-IMMU1116>3.0.CO;2-4; Kuroki M, 2002, ANN RHEUM DIS, V61, P1041, DOI 10.1136/ard.61.12.1041; Lateef A, 2012, NAT REV RHEUMATOL, V8, P710, DOI 10.1038/nrrheum.2012.133; LeMaoult J, 2004, P NATL ACAD SCI USA, V101, P7064, DOI 10.1073/pnas.0401922101; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; LIN H, 1993, J IMMUNOL, V151, P4562; Liu AX, 2006, BIOL REPROD, V75, P414, DOI 10.1095/biolreprod.105.049379; Lockwood CJ, 2008, ANN NY ACAD SCI, V1127, P67, DOI 10.1196/annals.1434.013; Lyall F, 1999, AM J PATHOL, V154, P1105, DOI 10.1016/S0002-9440(10)65363-1; Madeja Z, 2011, P NATL ACAD SCI USA, V108, P4012, DOI 10.1073/pnas.1005342108; Mao GP, 2010, ENDOCRINOLOGY, V151, P5477, DOI 10.1210/en.2010-0426; Marleau AM, 2003, LAB INVEST, V83, P673, DOI 10.1097/01.LAB.0000067500.85003.32; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; MEDINA KL, 1993, J EXP MED, V178, P1507, DOI 10.1084/jem.178.5.1507; Mjosberg J, 2010, BIOL REPROD, V82, P698, DOI 10.1095/biolreprod.109.081208; Mjosberg J, 2009, J IMMUNOL, V183, P759, DOI 10.4049/jimmunol.0803654; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Moldenhauer LM, 2010, J IMMUNOL, V185, P7085, DOI 10.4049/jimmunol.1001374; Moldenhauer LM, 2010, J REPROD IMMUNOL, V87, P1, DOI 10.1016/j.jri.2010.05.007; Munoz-Suano A, 2012, J AUTOIMMUN, V38, pJ103, DOI 10.1016/j.jaut.2011.09.007; Nagamatsu T, 2009, HUM REPROD, V24, P3160, DOI 10.1093/humrep/dep308; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Nelson JL, 2007, P NATL ACAD SCI USA, V104, P1637, DOI 10.1073/pnas.0606169104; Norton MT, 2010, IMMUNOLOGY, V131, P426, DOI 10.1111/j.1365-2567.2010.03316.x; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Patas K, 2013, J REPROD IMMUNOL, V97, P140, DOI 10.1016/j.jri.2012.10.005; Pearce WJ, 2009, AM J PHYSIOL-CELL PH, V297, pC4, DOI 10.1152/ajpcell.00209.2009; Penna G, 2007, J IMMUNOL, V178, P145, DOI 10.4049/jimmunol.178.1.145; Petroff MG, 2005, AM J PATHOL, V167, P465, DOI 10.1016/S0002-9440(10)62990-2; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Ponsonby AL, 2012, NEUROLOGY, V78, P867, DOI 10.1212/WNL.0b013e31824c4648; Rai R, 2006, LANCET, V368, P601, DOI 10.1016/S0140-6736(06)69204-0; Red-Horse K, 2001, AM J PATHOL, V159, P2199, DOI 10.1016/S0002-9440(10)63071-4; Red-Horse K, 2006, J CLIN INVEST, V116, P2643, DOI 10.1172/JC127306; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ren L, 2012, HUM REPROD, V27, P366, DOI 10.1093/humrep/der395; Rieger L, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-132; Robertson SA, 2009, J REPROD IMMUNOL, V83, P109, DOI 10.1016/j.jri.2009.08.003; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044; Scherjon S, 2011, PLACENTA, V32, pS291, DOI 10.1016/j.placenta.2011.03.014; Segerer SE, 2012, HUM REPROD, V27, P200, DOI 10.1093/humrep/der358; Shao L, 2005, J IMMUNOL, V174, P7539, DOI 10.4049/jimmunol.174.12.7539; Sharkey AM, 2008, J IMMUNOL, V181, P39, DOI 10.4049/jimmunol.181.1.39; Shimada S, 2006, AM J REPROD IMMUNOL, V56, P193, DOI 10.1111/j.1600-0897.2006.00417.x; Smyth A, 2010, CLIN J AM SOC NEPHRO, V5, P2060, DOI 10.2215/CJN.00240110; Solano ME, 2011, J REPROD IMMUNOL, V90, P3, DOI 10.1016/j.jri.2011.01.023; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Taglauer ES, 2009, J REPROD IMMUNOL, V80, P12, DOI 10.1016/j.jri.2008.12.001; Thiele K, 2013, J REPROD IMMUNOL, V97, P128, DOI 10.1016/j.jri.2012.10.014; Thorsby E, 2009, TISSUE ANTIGENS, V74, P101, DOI 10.1111/j.1399-0039.2009.01291.x; Thuere C, 2007, AM J REPROD IMMUNOL, V58, P514, DOI 10.1111/j.1600-0897.2007.00538.x; Tilburgs T, 2006, PLACENTA, V27, pS47, DOI 10.1016/j.placenta.2005.11.008; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108; Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107; van der Meer A, 2004, MOL HUM REPROD, V10, P189, DOI 10.1093/molehr/gah032; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Veltman-Verhulst SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001838.pub4; Vukusic S, 2004, BRAIN, V127, P1353, DOI 10.1093/brain/awh152; Wienecke J, 2012, PLACENTA, V33, P39, DOI 10.1016/j.placenta.2011.10.014; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Yan Z, 2011, ARTHRITIS RHEUM-US, V63, P640, DOI 10.1002/art.30160; Ye Y, 2012, RHEUMATOLOGY, V51, P987, DOI 10.1093/rheumatology/ker430; Zhang JH, 2012, J LEUKOCYTE BIOL, V91, P417, DOI 10.1189/jlb.1011501; Zhao JX, 2007, J REPROD IMMUNOL, V75, P71, DOI 10.1016/j.jri.2007.06.052; Zhou WH, 2008, HUM REPROD, V23, P2669, DOI 10.1093/humrep/den308; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	148	382	400	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					548	556		10.1038/nm.3160	http://dx.doi.org/10.1038/nm.3160			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652115				2022-12-27	WOS:000318583000026
J	Chow, A; Huggins, M; Ahmed, J; Hashimoto, D; Lucas, D; Kunisaki, Y; Pinho, S; Leboeuf, M; Noizat, C; van Rooijen, N; Tanaka, M; Zhao, ZJ; Bergman, A; Merad, M; Frenette, PS				Chow, Andrew; Huggins, Matthew; Ahmed, Jalal; Hashimoto, Daigo; Lucas, Daniel; Kunisaki, Yuya; Pinho, Sandra; Leboeuf, Marylene; Noizat, Clara; van Rooijen, Nico; Tanaka, Masato; Zhao, Zhizhuang Joe; Bergman, Aviv; Merad, Miriam; Frenette, Paul S.			CD169(+) macrophages provide a niche promoting erythropoiesis under homeostasis and stress	NATURE MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; ERYTHROBLASTIC ISLANDS; CELL TRANSPLANTATION; IRON HOMEOSTASIS; MICE; ANEMIA; BINDING; MODEL; EXPRESSION; INTEGRINS	A role for macrophages in erythropoiesis was suggested several decades ago when erythroblastic islands in the bone marrow, composed of a central macrophage surrounded by developing erythroblasts, were described. However, the in vivo role of macrophages in erythropoiesis under homeostatic conditions or in disease remains unclear. We found that specific depletion of CD169(+) macrophages markedly reduced the number of erythroblasts in the bone marrow but did not result in overt anemia under homeostatic conditions, probably because of concomitant alterations in red blood cell clearance. However, CD169(+) macrophage depletion significantly impaired erythropoietic recovery from hemolytic anemia, acute blood loss and myeloablation. Furthermore, macrophage depletion normalized the erythroid compartment in a JAK2(V617F)-driven mouse model of polycythemia vera, suggesting that erythropoiesis in polycythemia vera remains under the control of macrophages in the bone marrow and splenic microenvironments. These results indicate that CD169(+) macrophages promote late erythroid maturation and that modulation of the macrophage compartment may be a new strategy to treat erythropoietic disorders.	[Chow, Andrew; Huggins, Matthew; Ahmed, Jalal; Lucas, Daniel; Kunisaki, Yuya; Pinho, Sandra; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Reger, Bronx, NY 10467 USA; [Chow, Andrew; Ahmed, Jalal; Hashimoto, Daigo; Leboeuf, Marylene; Noizat, Clara; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Chow, Andrew; Ahmed, Jalal; Hashimoto, Daigo; Leboeuf, Marylene; Noizat, Clara; Merad, Miriam] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Noizat, Clara] Univ Paris 06, Dept Med, Paris, France; [Noizat, Clara] Inst Pasteur, Dept Immunol, F-75724 Paris, France; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Amsterdam, Netherlands; [Tanaka, Masato] RIKEN Res Ctr Allergy & Immunol, Lab Innate Cellular Immun, Yokohama, Kanagawa, Japan; [Tanaka, Masato] Tokyo Univ Pharm & Life Sci, Lab Immune Regulat, Sch Life Sci, Tokyo, Japan; [Zhao, Zhizhuang Joe] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Sanofi-Aventis; Sanofi France; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Vrije Universiteit Amsterdam; RIKEN; Tokyo University of Pharmacy & Life Sciences; University of Oklahoma System; University of Oklahoma Health Sciences Center; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Reger, Bronx, NY 10467 USA.	miriam.merad@mssm.edu; paul.frenette@einstein.yu.edu	Hashimoto, Daigo/O-1013-2013; Pinho, Sandra/GWC-8029-2022; Lucas, Daniel/ABB-6893-2021; Frenette, Paul S/J-8272-2012; Van Rooijen, Nico/Z-1578-2019	Hashimoto, Daigo/0000-0001-9489-9704; Lucas, Daniel/0000-0002-0147-5425; Frenette, Paul S/0000-0003-0862-9922; Huggins, Matthew/0000-0003-2964-8719; Pinho, Sandra/0000-0002-5241-7364; Chow, Andrew/0000-0003-1151-2450	US National Institutes of Health [HL097700, HL069438, DK056638, R01CA112100, R01HL116340]; National Heart, Lung and Blood Institute [5F30HL099028]; National Institute of General Medical Sciences [T32GM062754]; Fundacion Ramon Areces; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [R01CA112100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097819, R01HL116340, R01HL097700, F30HL099028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23390095] Funding Source: KAKEN	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fundacion Ramon Areces; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank C. Prophete, N. Dholakia, the Mount Sinai School of Medicine (MSSM) Microscopy Shared Resource Facility, J. Qi and S. Kim-Schulze at the MSSM Human Immune Monitoring Center, J. Ochando and X. Qiao at the MSSM Flow Cytometry Shared Resource Center and L. Tesfa at the Albert Einstein College of Medicine Flow Cytometry Sorting Facility for providing reagents, technical assistance and guidance. This work was supported by US National Institutes of Health grants (R01 grants HL097700, HL069438 and DK056638 to P.S.F., R01CA112100 to M.M. and R01HL116340 to P.S.F. and M.M.). A.C., J.A., D.L. and Y.K. were supported by fellowships from the National Heart, Lung and Blood Institute (5F30HL099028, A.C.), the National Institute of General Medical Sciences (T32GM062754, J.A.), Fundacion Ramon Areces (D.L.) and the Japan Society for the Promotion of Science (Y.K.).	Barbe E, 1996, J CELL SCI, V109, P2937; BESSIS M, 1958, Rev Hematol, V13, P8; Bungartz G, 2006, BLOOD, V108, P1857, DOI 10.1182/blood-2005-10-007658; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; COLEMAN DL, 1969, GENETICS, V61, P631; CROCKER PR, 1990, BLOOD, V76, P1131; GOOI HC, 1983, EUR J IMMUNOL, V13, P306, DOI 10.1002/eji.1830130407; Hanspal M, 1998, BLOOD, V92, P2940, DOI 10.1182/blood.V92.8.2940.420k31_2940_2950; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Heuser M, 2006, ANN HEMATOL, V85, P69, DOI 10.1007/s00277-005-1086-5; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Manwani D, 2008, CURR TOP DEV BIOL, V82, P23, DOI 10.1016/S0070-2153(07)00002-6; MILLER CB, 1992, BLOOD, V80, P2677; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; MOHANDAS N, 1978, BLOOD, V51, P633; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Ramos P, 2013, NAT MED, V19, P437, DOI 10.1038/nm.3126; Ramos P, 2011, BLOOD, V117, P1379, DOI 10.1182/blood-2010-09-307462; Reddy MM, 2012, EXPERT OPIN THER TAR, V16, P313, DOI 10.1517/14728222.2012.662956; Reeves JP, 2001, CURR PROTOC IMMUNOL, V10, P1; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; SADAHIRA Y, 1995, J EXP MED, V181, P411, DOI 10.1084/jem.181.1.411; SADAHIRA Y, 1989, BRIT J HAEMATOL, V71, P469, DOI 10.1111/j.1365-2141.1989.tb06304.x; Sadahira Y, 2000, J LEUKOCYTE BIOL, V68, P464; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; SCHROIT AJ, 1985, J BIOL CHEM, V260, P5131; Scott LM, 2003, MOL CELL BIOL, V23, P9349, DOI 10.1128/MCB.23.24.9349-9360.2003; Seggewiss R, 2007, SEMIN HEMATOL, V44, P203, DOI 10.1053/j.seminhematol.2007.04.009; Tefferi A, 2007, BLOOD, V110, P1092, DOI 10.1182/blood-2007-04-083501; Thiele I, 2000, LEUKEMIA, V14, P1378, DOI 10.1038/sj.leu.2401838; Thiele J, 2000, VIRCHOWS ARCH, V437, P160, DOI 10.1007/s004280000224; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Ulyanova T, 2011, BLOOD, V117, P975, DOI 10.1182/blood-2010-05-283218; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zhan Huichun, 2009, Clin Adv Hematol Oncol, V7, P334; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324	47	287	297	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					429	+		10.1038/nm.3057	http://dx.doi.org/10.1038/nm.3057			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23502962	Green Accepted			2022-12-27	WOS:000317109100027
J	Chen, LL; Li, Y; Lin, CH; Chan, THM; Chow, RKK; Song, YY; Liu, M; Yuan, YF; Fu, L; Kong, KL; Qi, LH; Li, Y; Zhang, N; Tong, AHY; Kwong, DLW; Man, K; Lo, CM; Lok, S; Tenen, DG; Guan, XY				Chen, Lei Lei; Li, Yan; Lin, Chi Ho; Chan, Tim Hon Man; Chow, Raymond Kwok Kei; Song, Yangyang; Liu, Ming; Yuan, Yun-Fei; Fu, Li; Kong, Kar Lok; Qi, Lihua; Li, Yan; Zhang, Na; Tong, Amy Hin Yan; Kwong, Dora Lai-Wan; Man, Kwan; Lo, Chung Mau; Lok, Si; Tenen, Daniel G.; Guan, Xin-Yuan			Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma	NATURE MEDICINE			English	Article							ANTIZYME INHIBITOR; GLUR-B; DEGRADATION; EVOLUTION; CANCER; PATHOGENESIS; EXPRESSION; ENTRY	A better understanding of human hepatocellular carcinoma (HCC) pathogenesis at the molecular level will facilitate the discovery of tumor-initiating events. Transcriptome sequencing revealed that adenosine-to-inosine (A -> I) RNA editing of AZIN1 (encoding antizyme inhibitor 1) is increased in HCC specimens. A -> I editing of AZIN1 transcripts, specifically regulated by ADAR1 (encoding adenosine deaminase acting on RNA-1), results in a serine-to-glycine substitution at residue 367 of AZIN1, located in beta-strand 15 (beta 15) and predicted to cause a conformational change, induced a cytoplasmic-to-nuclear translocation and conferred gain-of-function phenotypes that were manifested by augmented tumor-initiating potential and more aggressive behavior. Compared with wild-type AZIN1 protein, the edited form has a stronger affinity to antizyme, and the resultant higher AZIN1 protein stability promotes cell proliferation through the neutralization of antizyme-mediated degradation of ornithine decarboxylase (ODC) and cyclin D1 (CCND1). Collectively, A -> I RNA editing of AZIN1 may be a potential driver in the pathogenesis of human cancers, particularly HCC.	[Chen, Lei Lei; Li, Yan; Chan, Tim Hon Man; Chow, Raymond Kwok Kei; Song, Yangyang; Liu, Ming; Fu, Li; Kong, Kar Lok; Kwong, Dora Lai-Wan; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Chen, Lei Lei; Chan, Tim Hon Man; Qi, Lihua; Tenen, Daniel G.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Chen, Lei Lei; Li, Yan; Chan, Tim Hon Man; Song, Yangyang; Liu, Ming; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Lin, Chi Ho; Zhang, Na; Lok, Si] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Yuan, Yun-Fei; Li, Yan; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Amy Hin Yan] Chinese Univ Hong Kong, Li Ka Shing Inst Med Sci, Hong Kong, Hong Kong, Peoples R China; [Man, Kwan; Lo, Chung Mau] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; National University of Singapore; University of Hong Kong; University of Hong Kong; Sun Yat Sen University; Chinese University of Hong Kong; University of Hong Kong	Guan, XY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China.	csidgt@nus.edu.sg; xyguan@hkucc.hku.hk	Fu, Li/F-7182-2010; Qi, LI/AAF-3389-2019; Song, Yang/HGU-4953-2022; Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Fu, Li/0000-0003-2643-6278; Tenen, Daniel/0000-0002-6423-3888; LIU, MING/0000-0003-3222-8715; Chen, Polly Leilei/0000-0002-1987-3878; Guan, Xin-Yuan/0000-0002-4485-6017; Yuan, Yunfei/0000-0003-2467-3683; /0000-0003-1874-9805	Hong Kong Research Grant Council [T12-403/11, HKBU5/CRF/10, HKU7/CRG/09, HKU3/CRF/11R]; General Research Fund [HKU/766811M]; China National Basic Research Program [2012CB967001]; Sun Yat-Sen University [85000-3171311]; China National Key Science-Technology Special Project of Infectious Diseases [2008ZX10002-022]; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; NATIONAL CANCER INSTITUTE [P01CA066996, R01CA118316] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112719, R01HL056745] Funding Source: NIH RePORTER	Hong Kong Research Grant Council(Hong Kong Research Grants Council); General Research Fund; China National Basic Research Program(National Basic Research Program of China); Sun Yat-Sen University; China National Key Science-Technology Special Project of Infectious Diseases; Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank and acknowledge the patients for tumor tissue donation to our tissue bank and M. Fullwood (Cancer Science Institute of Singapore, National University of Singapore, Singapore) for providing complementary DNA (cDNA) samples of normal tissues. We thank K. Man and C.M. Lo (Department of Surgery, The University of Hong Kong) for providing healthy human liver tissues. This work was supported by Hong Kong Research Grant Council grants, including the Theme-based Research Scheme Fund (T12-403/11) (X.-Y.G.), Collaborative Research Funds (HKBU5/CRF/10, HKU7/CRG/09 and HKU3/CRF/11R) (X.-Y.G.), the General Research Fund (HKU/766811M) (X.-Y.G.), the China National Basic Research Program (2012CB967001) (X.-Y.G.), the 'Hundred Talents Program' at Sun Yat-Sen University (85000-3171311) (X.-Y.G.), the China National Key Science-Technology Special Project of Infectious Diseases (2008ZX10002-022) (X.-Y.G.) and the Singapore Ministry of Health's National Medical Research Council under its Singapore Translational Research (STaR) Investigator Award (D.G.T.).	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; Cenci C, 2008, J BIOL CHEM, V283, P7251, DOI 10.1074/jbc.M708316200; Farajollahi S, 2010, TRENDS GENET, V26, P221, DOI 10.1016/j.tig.2010.02.001; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Gallo A, 2008, RNA BIOL, V5, P135, DOI 10.4161/rna.5.3.6739; Gommans WM, 2009, BIOESSAYS, V31, P1137, DOI 10.1002/bies.200900045; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mangold U, 2008, ONCOGENE, V27, P604, DOI 10.1038/sj.onc.1210685; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Mattick JS, 2008, TRENDS NEUROSCI, V31, P227, DOI 10.1016/j.tins.2008.02.003; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Olsen RR, 2011, MOL CANCER RES, V9, P1285, DOI 10.1158/1541-7786.MCR-11-0178; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paz N, 2007, GENOME RES, V17, P1586, DOI 10.1101/gr.6493107; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Reenan RA, 2005, NATURE, V434, P409, DOI 10.1038/nature03364; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Young M, 1999, PROTEIN SCI, V8, P1752, DOI 10.1110/ps.8.9.1752	37	318	332	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					209	216		10.1038/nm.3043	http://dx.doi.org/10.1038/nm.3043			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23291631	Green Accepted			2022-12-27	WOS:000314675900029
J	Alvarez-Breckenridge, CA; Yu, JH; Price, R; Wojton, J; Pradarelli, J; Mao, HY; Wei, M; Wang, Y; He, S; Hardcastle, J; Fernandez, SA; Kaur, B; Lawler, SE; Vivier, E; Mandelboim, O; Moretta, A; Caligiuri, MA; Chiocca, EA				Alvarez-Breckenridge, Christopher A.; Yu, Jianhua; Price, Richard; Wojton, Jeffrey; Pradarelli, Jason; Mao, Hsiaoyin; Wei, Min; Wang, Yan; He, Shun; Hardcastle, Jayson; Fernandez, Soledad A.; Kaur, Balveen; Lawler, Sean E.; Vivier, Eric; Mandelboim, Ofer; Moretta, Alessandro; Caligiuri, Michael A.; Chiocca, E. Antonio			NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors	NATURE MEDICINE			English	Article							HERPES-SIMPLEX-VIRUS; VESICULAR STOMATITIS-VIRUS; HUMAN DENDRITIC CELLS; KILLER-CELLS; TUMOR MICROENVIRONMENT; DEPENDENT MECHANISMS; TRIGGERING RECEPTOR; GLIOMA VIROTHERAPY; ONCOLYTIC VIRUSES; IMMUNE-RESPONSES	The role of the immune response to oncolytic Herpes simplex viral (oHSV) therapy for glioblastoma is controversial because it might enhance or inhibit efficacy. We found that within hours of oHSV infection of glioblastomas in mice, activated natural killer (NK) cells are recruited to the site of infection. This response substantially diminished the efficacy of glioblastoma virotherapy. oHSV-activated NK cells coordinated macrophage and microglia activation within tumors. In vitro, human NK cells preferentially lysed oHSV-infected human glioblastoma cell lines. This enhanced killing depended on the NK cell natural cytotoxicity receptors (NCRs) NKp30 and NKp46, whose ligands are upregulated in oHSV-infected glioblastoma cells. We found that HSV titers and oHSV efficacy are increased in Ncr1(-/-) mice and a Ncr1(-/-) NK cell adoptive transfer model of glioma, respectively. These results demonstrate that glioblastoma virotherapy is limited partially by an antiviral NK cell response involving specific NCRs, uncovering new potential targets to enhance cancer virotherapy.	[Alvarez-Breckenridge, Christopher A.; Price, Richard; Wojton, Jeffrey; Pradarelli, Jason; Wang, Yan; Hardcastle, Jayson; Kaur, Balveen; Lawler, Sean E.; Chiocca, E. Antonio] Ohio State Univ, Med Ctr, Dept Neurol Surg, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA; [Alvarez-Breckenridge, Christopher A.; Yu, Jianhua; Price, Richard; Wojton, Jeffrey; Pradarelli, Jason; Mao, Hsiaoyin; Wei, Min; Wang, Yan; He, Shun; Hardcastle, Jayson; Fernandez, Soledad A.; Kaur, Balveen; Lawler, Sean E.; Caligiuri, Michael A.; Chiocca, E. Antonio] James Canc Hosp, Columbus, OH USA; [Alvarez-Breckenridge, Christopher A.; Yu, Jianhua; Price, Richard; Wojton, Jeffrey; Pradarelli, Jason; Mao, Hsiaoyin; Wei, Min; Wang, Yan; He, Shun; Hardcastle, Jayson; Fernandez, Soledad A.; Kaur, Balveen; Lawler, Sean E.; Caligiuri, Michael A.; Chiocca, E. Antonio] Solove Res Inst, Columbus, OH USA; [Alvarez-Breckenridge, Christopher A.; Price, Richard] Ohio State Univ, Med Ctr, Med Scientist Training Program, Columbus, OH 43210 USA; [Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, Med Ctr, Div Hematol, Columbus, OH 43210 USA; [Yu, Jianhua; Mao, Hsiaoyin; Wei, Min; He, Shun; Fernandez, Soledad A.; Kaur, Balveen; Caligiuri, Michael A.; Chiocca, E. Antonio] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Fernandez, Soledad A.] Ohio State Univ, Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Vivier, Eric] Univ Aix Marseille 2, INSERM, U631, Ctr Immunol Marseille Luminy, Marseille, France; [Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Moretta, Alessandro] Univ Genoa, Dipartimento Med Sperimentale, Genoa, Italy; [Moretta, Alessandro] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy; [Chiocca, E. Antonio] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Sch Med,Dept Neurosurg, Boston, MA 02115 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Hebrew University of Jerusalem; University of Genoa; University of Genoa; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Chiocca, EA (corresponding author), Ohio State Univ, Med Ctr, Dept Neurol Surg, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA.	michael.caligiuri@osumc.edu; eachiocca@partners.org	kaur, Balveen/E-3355-2011; He, Shun/K-7448-2014; Vivier, Eric/F-8939-2010; Wei, Min/GSI-8510-2022	Vivier, Eric/0000-0001-7022-8287; Mandelboim, Ofer/0000-0002-9354-1855	US National Institutes of Health [7U01NS061811, CA069246, CA068458, CA095426, TL1RR025753, CA163205]; American Medical Association Foundation Seed Grant; Dardinger Neuro-oncology Laboratory; NATIONAL CANCER INSTITUTE [R01CA068458, P01CA163205, R01CA150153, R37CA068458, R01CA098472, P01CA095426, P30CA016058, P01CA069246, R01CA155521] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS061811, R01NS064607] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Medical Association Foundation Seed Grant; Dardinger Neuro-oncology Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health grants 7U01NS061811 (to E.A.C.), CA069246 (to E.A.C.), CA068458 (to M.A.C.), CA095426 (to M.A.C.), TL1RR025753 (to C.A.A.-B.) and CA163205 (to E.A.C., M.A.C. and B.K.). C.A.A.-B. was supported by an American Medical Association Foundation Seed Grant. This work was also supported by the Dardinger Neuro-oncology Laboratory.	Aghi M, 2008, ONCOGENE, V27, P4249, DOI 10.1038/onc.2008.53; Altomonte J, 2009, CANCER GENE THER, V16, P266, DOI 10.1038/cgt.2008.74; Altomonte J, 2008, MOL THER, V16, P146, DOI 10.1038/sj.mt.6300343; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Chiocca EA, 2008, CURR OPIN MOL THER, V10, P38; Chiocca EA, 2002, NAT REV CANCER, V2, P938, DOI 10.1038/nrc948; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; DeRubertis BG, 2007, CANCER GENE THER, V14, P590, DOI 10.1038/sj.cgt.7701053; Errington F, 2008, J IMMUNOL, V180, P6018, DOI 10.4049/jimmunol.180.9.6018; Farrell CJ, 2008, CLIN CANCER RES, V14, P7711, DOI 10.1158/1078-0432.CCR-08-1364; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Friedman A, 2006, CANCER RES, V66, P2314, DOI 10.1158/0008-5472.CAN-05-2661; Fulci G, 2007, CANCER RES, V67, P9398, DOI 10.1158/0008-5472.CAN-07-1063; Fulci G, 2006, P NATL ACAD SCI USA, V103, P12873, DOI 10.1073/pnas.0605496103; Galivo F, 2010, GENE THER, V17, P158, DOI 10.1038/gt.2009.161; Galivo F, 2010, HUM GENE THER, V21, P439, DOI 10.1089/hum.2009.143; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Ghiasi H, 2000, ANTIVIR RES, V45, P33, DOI 10.1016/S0166-3542(99)00075-3; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Ikeda K, 1999, NAT MED, V5, P881, DOI 10.1038/11320; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; Kottke T, 2008, MOL THER, V16, P1910, DOI 10.1038/mt.2008.212; Kottke T, 2009, CLIN CANCER RES, V15, P561, DOI 10.1158/1078-0432.CCR-08-1688; Kurozumi K, 2007, JNCI-J NATL CANCER I, V99, P1768, DOI 10.1093/jnci/djm229; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Prestwich RJ, 2009, J IMMUNOL, V183, P4312, DOI 10.4049/jimmunol.0901074; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Stanford MM, 2008, CURR OPIN MOL THER, V10, P32; Taylor MA, 2002, EUR J IMMUNOL, V32, P793, DOI 10.1002/1521-4141(200203)32:3<793::AID-IMMU793>3.0.CO;2-M; Todo T, 2001, P NATL ACAD SCI USA, V98, P6396, DOI 10.1073/pnas.101136398; Trotta R, 1998, J IMMUNOL, V161, P6648; Varghese S, 2006, CLIN CANCER RES, V12, P2919, DOI 10.1158/1078-0432.CCR-05-1187; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wakimoto H, 2004, GENE THER, V11, P214, DOI 10.1038/sj.gt.3302143; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Weiner NE, 1999, J NEUROPATH EXP NEUR, V58, P54, DOI 10.1097/00005072-199901000-00007; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Yoshino H, 2000, BONE MARROW TRANSPL, V26, P1211, DOI 10.1038/sj.bmt.1702702; Yu JH, 2011, J CLIN INVEST, V121, P1456, DOI 10.1172/JCI43242; Yu JH, 2010, BLOOD, V115, P274, DOI 10.1182/blood-2009-04-215491	59	138	141	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2012	18	12					1827	+		10.1038/nm.3013	http://dx.doi.org/10.1038/nm.3013			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23178246	Green Accepted			2022-12-27	WOS:000311999800031
J	Giambra, V; Jenkins, CR; Wang, HF; Lam, SH; Shevchuk, OO; Nemirovsky, O; Wai, C; Gusscott, S; Chiang, MY; Aster, JC; Humphries, RK; Eaves, C; Weng, AP				Giambra, Vincenzo; Jenkins, Christopher R.; Wang, Hongfang; Lam, Sonya H.; Shevchuk, Olena O.; Nemirovsky, Oksana; Wai, Carol; Gusscott, Sam; Chiang, Mark Y.; Aster, Jon C.; Humphries, R. Keith; Eaves, Connie; Weng, Andrew P.			NOTCH1 promotes T cell leukemia-initiating activity by RUNX-mediated regulation of PKC-theta and reactive oxygen species	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; KINASE-C-THETA; HEMATOPOIETIC STEM-CELLS; GAMMA-SECRETASE INHIBITORS; CENTRAL DNA FLAP; TUMOR-SUPPRESSOR; LENTIVIRUS VECTOR; NUCLEAR IMPORT; GENE DELIVERY; IN-VIVO	Reactive oxygen species (ROS), a byproduct of cellular metabolism, damage intracellular macromolecules and, when present in excess, can promote normal hematopoietic stem cell differentiation and exhaustion(1-3). However, mechanisms that regulate the amount of ROS in leukemia-initiating cells (LICs) and the biological role of ROS in these cells are largely unknown. We show here that the ROSlow subset of CD44(+) cells in T cell acute lymphoblastic leukemia (T-ALL), a malignancy of immature T cell progenitors, is highly enriched in the most aggressive LICs and that ROS accumulation is restrained by downregulation of protein kinase C theta (PKC-theta). Notably, primary mouse T-ALLs lacking PKC-theta show improved LIC activity, whereas enforced PKC-theta expression in both mouse and human primary T-ALLs compromised LIC activity. We also show that PKC-theta is regulated by a new pathway in which NOTCH1 induces runt-related transcription factor 3 (RUNX3), RUNX3 represses RUNX1 and RUNX1 induces PKC-theta. NOTCH1, which is frequently activated by mutation in T-ALL4-6 and required for LIC activity in both mouse and human models(7,8), thus acts to repress PKC-theta. These results reveal key functional roles for PKC-theta and ROS in T-ALL and suggest that aggressive biological behavior in vivo could be limited by therapeutic strategies that promote PKC-theta expression or activity, or the accumulation of ROS.	[Giambra, Vincenzo; Jenkins, Christopher R.; Lam, Sonya H.; Shevchuk, Olena O.; Nemirovsky, Oksana; Wai, Carol; Gusscott, Sam; Humphries, R. Keith; Eaves, Connie; Weng, Andrew P.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Wang, Hongfang; Aster, Jon C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Chiang, Mark Y.] Univ Michigan, Ctr Comprehens Canc, Div Hematol Oncol, Ann Arbor, MI 48109 USA	British Columbia Cancer Agency; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan	Weng, AP (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	aweng@bccrc.ca	Weng, Andrew P/I-5015-2014; Giambra, Vincenzo/H-8296-2012; Giambra, Vincenzo/ABG-8306-2021	Giambra, Vincenzo/0000-0003-2607-2080; Giambra, Vincenzo/0000-0003-2607-2080; Chiang, Mark/0000-0003-2099-0956; Humphries, Richard/0000-0003-0540-7005; Eaves, Connie/0000-0002-3452-1926	Canadian Institutes of Health Research/Terry Fox Foundation; Leukemia and Lymphoma Society of Canada; Cancer Research Society; Lymphoma Foundation Canada; US National Cancer Institute [P01CA119070, K08CA120544]; NATIONAL CANCER INSTITUTE [K08CA120544, K22CA112538, P01CA119070] Funding Source: NIH RePORTER	Canadian Institutes of Health Research/Terry Fox Foundation(Canadian Institutes of Health Research (CIHR)); Leukemia and Lymphoma Society of Canada; Cancer Research Society; Lymphoma Foundation Canada; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Z. Sun (City of Hope, Duarte, California) for providing PKC-theta knockout mice, J. Fletcher and W. Ou (Brigham and Women's Hospital, Boston, Massachusetts) for PKC-theta shRNA lentivectors, E. Kieff (Brigham and Women's Hospital, Boston, Massachusetts) for CSL antibody, I. Bernstein (Fred Hutchinson Cancer Research Center, Seattle, Washington) for Ig-DL1 ligand, F. Pflumio (Commissariat a l'Energie Atomique Fontenay-aux-Roses, France) for the MS5-DL1 cell line and E. Martignani for help with immunofluorescence. We would also like to thank P. Ballerini (Hopital Armand Trousseau, Paris, France), T. Leblanc (Hopital Saint-Louis, Paris, France), L. Matherly (Karmanos Cancer Institute, Detroit, Michigan) and M. J. You (MD Anderson Cancer Center, Houston, Texas) for providing patient T-ALL samples. This work was supported by grants from the Canadian Institutes of Health Research/Terry Fox Foundation, the Leukemia and Lymphoma Society of Canada, the Cancer Research Society, the Lymphoma Foundation Canada (to A. P. W.) and the US National Cancer Institute (P01CA119070 to J. C. A.). M.Y.C. was supported by a career development award from the US National Cancer Institute (K08CA120544). A.P.W. was a Michael Smith Foundation for Health Research Scholar.	Adly A.M., 2010, J IMMUNOL, V3, P129; Armstrong F, 2009, BLOOD, V113, P1730, DOI 10.1182/blood-2008-02-138172; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Chiu PPL, 2010, BLOOD, V116, P5268, DOI 10.1182/blood-2010-06-292300; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Cox CV, 2007, BLOOD, V109, P674, DOI 10.1182/blood-2006-06-030445; Dallas MH, 2007, BLOOD, V109, P3579, DOI 10.1182/blood-2006-08-039842; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Felli MP, 2005, ONCOGENE, V24, P992, DOI 10.1038/sj.onc.1208302; Gerby B, 2011, LEUKEMIA, V25, P1249, DOI 10.1038/leu.2011.93; Grossmann V, 2011, HAEMATOL-HEMATOL J, V96, P1874, DOI 10.3324/haematol.2011.043919; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Gutierrez A, 2011, BLOOD, V118, P4169, DOI 10.1182/blood-2010-11-318873; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Logan AC, 2004, HUM GENE THER, V15, P976, DOI 10.1089/hum.2004.15.976; Medyouf H, 2010, BLOOD, V115, P1175, DOI 10.1182/blood-2009-04-214718; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ou WB, 2008, ONCOGENE, V27, P5624, DOI 10.1038/onc.2008.177; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Robbins PB, 1998, P NATL ACAD SCI USA, V95, P10182, DOI 10.1073/pnas.95.17.10182; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sirven A, 2000, BLOOD, V96, P4103; Spender LC, 2005, ONCOGENE, V24, P1873, DOI 10.1038/sj.onc.1208404; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tatarek J, 2011, BLOOD, V118, P1579, DOI 10.1182/blood-2010-08-300343; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tremblay M, 2010, GENE DEV, V24, P1093, DOI 10.1101/gad.1897910; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Winter SS, 2007, BLOOD, V110, P1429, DOI 10.1182/blood-2006-12-059790; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	59	63	67	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1693	+		10.1038/nm.2960	http://dx.doi.org/10.1038/nm.2960			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23086478	Green Submitted, Green Accepted			2022-12-27	WOS:000310837000031
J	Laimer, D; Dolznig, H; Kollmann, K; Vesely, PW; Schlederer, M; Merkel, O; Schiefer, AI; Hassler, MR; Heider, S; Amenitsch, L; Thallinger, C; Staber, PB; Simonitsch-Klupp, I; Artaker, M; Lagger, S; Turner, SD; Pileri, S; Piccaluga, PP; Valent, P; Messana, K; Landra, I; Weichhart, T; Knapp, S; Shehata, M; Todaro, M; Sexl, V; Hofler, G; Piva, R; Medico, E; Ruggeri, BA; Cheng, MG; Eferl, R; Egger, G; Penninger, JM; Jaeger, U; Moriggl, R; Inghirami, G; Kenner, L				Laimer, Daniela; Dolznig, Helmut; Kollmann, Karoline; Vesely, Paul W.; Schlederer, Michaela; Merkel, Olaf; Schiefer, Ana-Iris; Hassler, Melanie R.; Heider, Susi; Amenitsch, Lena; Thallinger, Christiane; Staber, Philipp B.; Simonitsch-Klupp, Ingrid; Artaker, Matthias; Lagger, Sabine; Turner, Suzanne D.; Pileri, Stefano; Piccaluga, Pier Paolo; Valent, Peter; Messana, Katia; Landra, Indira; Weichhart, Thomas; Knapp, Sylvia; Shehata, Medhat; Todaro, Maria; Sexl, Veronika; Hoefler, Gerald; Piva, Roberto; Medico, Enzo; Ruggeri, Bruce A.; Cheng, Mangeng; Eferl, Robert; Egger, Gerda; Penninger, Josef M.; Jaeger, Ulrich; Moriggl, Richard; Inghirami, Giorgio; Kenner, Lukas			PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas	NATURE MEDICINE			English	Article							LARGE-CELL LYMPHOMA; ACTIVATING MUTATIONS; C-JUN; KINASE; GENE; INHIBITION; FUSION; PROLIFERATION; TRANSCRIPTION; IMATINIB	Anaplastic large cell lymphoma (ALCL) is an aggressive non-Hodgkin's lymphoma found in children and young adults. ALCLs frequently carry a chromosomal translocation that results in expression of the oncoprotein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK). The key molecular downstream events required for NPM-ALK-triggered lymphoma growth have been only partly unveiled. Here we show that the activator protein 1 family members JUN and JUNB promote lymphoma development and tumor dissemination through transcriptional regulation of platelet-derived growth factor receptor-beta (PDGFRB) in a mouse model of NPM-ALK-triggered lymphomagenesis. Therapeutic inhibition of PDGFRB markedly prolonged survival of NPM-ALK transgenic mice and increased the efficacy of an ALK-specific inhibitor in transplanted NPM-ALK tumors. Notably, inhibition of PDGFRA and PDGFRB in a patient with refractory late-stage NPM-ALK+ ALCL resulted in rapid, complete and sustained remission. Together, our data identify PDGFRB as a previously unknown JUN and JUNB target that could be a highly effective therapy for ALCL.	[Laimer, Daniela; Schiefer, Ana-Iris; Hassler, Melanie R.; Heider, Susi; Amenitsch, Lena; Simonitsch-Klupp, Ingrid; Egger, Gerda; Kenner, Lukas] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Dolznig, Helmut; Weichhart, Thomas] Med Univ Vienna, Inst Med Genet, Vienna, Austria; [Kollmann, Karoline; Sexl, Veronika] Vet Univ Vienna, Inst Pharmacol & Toxicol, A-1030 Vienna, Austria; [Vesely, Paul W.; Hoefler, Gerald] Med Univ Graz, Inst Pathol, Graz, Austria; [Schlederer, Michaela; Moriggl, Richard; Kenner, Lukas] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Merkel, Olaf] Paracelsus Med Univ, Dept Med 3, Lab Immunol & Mol Canc Res, Salzburg, Austria; [Hassler, Melanie R.; Thallinger, Christiane] Med Univ Vienna, Dept Internal Med 1, Div Oncol, Vienna, Austria; [Staber, Philipp B.] Med Univ Graz, Div Hematol, Graz, Austria; [Staber, Philipp B.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA USA; [Artaker, Matthias; Lagger, Sabine] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Med Biochem, Vienna, Austria; [Turner, Suzanne D.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Mol Histopathol, Cambridge CB2 2QQ, England; [Pileri, Stefano; Piccaluga, Pier Paolo] Univ Bologna, S Orsola Malpighi Hosp, Dept Hematol & Oncol L&A Seragnoli, Pathol & Hematopathol Unit, Bologna, Italy; [Valent, Peter; Shehata, Medhat; Jaeger, Ulrich] Med Univ Vienna, Ctr Comprehens Canc, Dept Internal Med 1,Drug & Target Screening Unit, Div Hematol & Hemostaseol, Vienna, Austria; [Valent, Peter] Ludwig Boltzmann Cluster Oncol, Vienna, Austria; [Messana, Katia; Landra, Indira; Todaro, Maria; Piva, Roberto; Inghirami, Giorgio] Univ Turin, Ctr Expt Res & Med Studies, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Knapp, Sylvia] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Knapp, Sylvia] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Piva, Roberto] NYU, Sch Med, Dept Pathol, New York, NY USA; [Piva, Roberto] NYU, Sch Med, Ctr Canc, New York, NY USA; [Medico, Enzo; Inghirami, Giorgio] Univ Turin, Dept Oncol Sci, Turin, Italy; [Medico, Enzo] Inst Canc Res & Treatment, Lab Oncogenom, Candiolo, Italy; [Ruggeri, Bruce A.; Cheng, Mangeng] Cephalon Inc, Worldwide Discovery Res, W Chester, PA USA; [Eferl, Robert] Med Univ Vienna, Ctr Comprehens Canc, Inst Canc Res, Dept Internal Med 1, Vienna, Austria; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Graz; Ludwig Boltzmann Institute; Paracelsus Private Medical University; Medical University of Vienna; Medical University of Graz; Harvard University; Harvard Medical School; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Medical University of Vienna; Ludwig Boltzmann Institute; University of Turin; Austrian Academy of Sciences; Medical University of Vienna; New York University; New York University; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Teva Pharmaceutical Industries; Cephalon Inc.; Medical University of Vienna; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Kenner, L (corresponding author), Med Univ Vienna, Clin Inst Pathol, Vienna, Austria.	lukas.kenner@meduniwien.ac.at	Weichhart, Thomas/J-3531-2014; Staber, Philipp Bernhard/ADK-1536-2022; Valent, Peter/B-8533-2016; Schiefer, Ana-Iris/AAX-8123-2020; Test, PV/U-9451-2019; Medico, Enzo/AAC-3185-2021; Gamperl, Susi/V-2715-2019; Test, Test/Y-7921-2019; Piccaluga, Pier Paolo/H-7132-2019; Dolznig, Helmut/L-7005-2015; Piva, Roberto/H-7315-2013; Egger, Gerda/B-7177-2013; Knapp, Sylvia/J-3973-2013; Vesely, Paul/AAO-1286-2020; Penninger, Josef M/I-6860-2013; Turner, Suzanne Dawn/K-4405-2013; Moriggl, Richard/H-8118-2019; Lagger, Sabine/GQP-6676-2022; Sexl, Veronika/B-8657-2016; Piva, Roberto/B-9580-2018	Weichhart, Thomas/0000-0002-4349-0797; Staber, Philipp Bernhard/0000-0001-6729-7708; Valent, Peter/0000-0003-0456-5095; Medico, Enzo/0000-0002-3917-2438; Gamperl, Susi/0000-0003-0456-5095; Piccaluga, Pier Paolo/0000-0002-9432-0595; Dolznig, Helmut/0000-0002-6063-3585; Knapp, Sylvia/0000-0001-9016-5244; Penninger, Josef M/0000-0002-8194-3777; Turner, Suzanne Dawn/0000-0002-8439-4507; Moriggl, Richard/0000-0003-0918-9463; Kollmann, Karoline/0000-0002-7937-4245; Shehata, Medhat/0000-0001-6891-646X; Kenner, Lukas/0000-0003-2184-1338; Egger, Gerda/0000-0003-2489-155X; Eferl, Robert/0000-0002-6074-7144; Vesely, Paul Willibald/0000-0003-3608-1060; Sexl, Veronika/0000-0001-9363-0412; Merkel, Olaf/0000-0001-5089-344X; Piva, Roberto/0000-0002-2273-3470; Lagger, Sabine/0000-0002-3032-9910; Amenitsch, Lena/0000-0003-4873-1155	Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P-18478-B12]; Genome Research in Austria InflammoBiota project; FWF [SFB-F28, 19723]; Elise Richter Fellowship [FWF V102-B12]; FP7 Marie Curie International Reintegration Grant [IRG 230984]; Herzfelder Family Foundation; Niederosterreichische Forschungs- und Bildungsges.m.b.H.P.W.V.; Jubil umsfonds of the sterreichische Nationalbank [P-12147]; Else-Kroner Fresenius Stiftung; Italian Association for Cancer Research (AIRC) Special Program in Clinical Molecular Oncology, Milan [10007]; Regione Piemonte (ONCOPROT) [CIPE 25/2005]; ImmOnc ('Innovative approaches to bust the immune responses', Programma Operativo Regionale, Piattaforme Innovative BIO) [LR 34/2004];  [J 2922]	Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF)); Genome Research in Austria InflammoBiota project; FWF(Austrian Science Fund (FWF)); Elise Richter Fellowship; FP7 Marie Curie International Reintegration Grant; Herzfelder Family Foundation; Niederosterreichische Forschungs- und Bildungsges.m.b.H.P.W.V.; Jubil umsfonds of the sterreichische Nationalbank; Else-Kroner Fresenius Stiftung; Italian Association for Cancer Research (AIRC) Special Program in Clinical Molecular Oncology, Milan(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte (ONCOPROT)(Regione Piemonte); ImmOnc ('Innovative approaches to bust the immune responses', Programma Operativo Regionale, Piattaforme Innovative BIO); 	We thank E. F. Wagner for providing the JUNB<SUP>flox/flox</SUP> and JUN<SUP>flox/flox</SUP> mice, A. Ostman for helpful discussions and technical help with PDGFRB analysis, and S. Reichmann for technical help with soluble-CD30 and PDGFB assays. L. K. is supported by the Fonds zur Forderung der wissenschaftlichen Forschung (FWF, P-18478-B12) and the Genome Research in Austria InflammoBiota project. R. M., V. S. and R. E. are supported by the FWF (SFB-F28) and V. S. is supported by FWF project 19723. G. E. is supported by an Elise Richter Fellowship (FWF V102-B12) and an FP7 Marie Curie International Reintegration Grant (IRG 230984). H. D. is supported by the Herzfelder Family Foundation and the Niederosterreichische Forschungs- und Bildungsges.m.b.H.P.W.V. and P. B. S. were supported by Jubil umsfonds of the sterreichische Nationalbank (P-12147), and P. W. V. was awarded an E. Schroedinger Grant (J 2922). T. W. is supported by the Else-Kroner Fresenius Stiftung. S. P. and G. I. are supported by Italian Association for Cancer Research (AIRC) Special Program in Clinical Molecular Oncology, Milan (5x1000 No. 10007). G. I. is supported by Regione Piemonte (ONCOPROT, CIPE 25/2005); ImmOnc ('Innovative approaches to bust the immune responses', Programma Operativo Regionale, Piattaforme Innovative BIO F. E. S. R. 2007/13, Asse 1 'Ricerca e innovazione' della LR 34/2004) and the Oncology Program of Compagnia di San Paolo, Torino. R. P. is supported by AIRC grant IG-8675. R. E. is supported by the FWF Doktoratskolleg-plus Inflammation and Immunity grant, the Comprehensive Cancer Center Vienna Research Grant and the Austrian Federal Ministry of Science and Research GENAU Austromouse grant. J. M. P. is supported by the Austrian Academy of Sciences and an Advanced Grant from the European Research Council. This study was performed on behalf of the European Research Initiative on ALCL (ERIA).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheng MG, 2012, MOL CANCER THER, V11, P670, DOI 10.1158/1535-7163.MCT-11-0776; Chiarle R, 2003, BLOOD, V101, P1919, DOI 10.1182/blood-2002-05-1343; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Claesson-Welsh Lena, 1994, Progress in Growth Factor Research, V5, P37, DOI 10.1016/0955-2235(94)90016-7; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Ergin M, 2001, EXP HEMATOL, V29, P1082, DOI 10.1016/S0301-472X(01)00688-9; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gunby RH, 2006, J MED CHEM, V49, P5759, DOI 10.1021/jm060380k; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Iqbal J, 2010, BLOOD, V115, P1026, DOI 10.1182/blood-2009-06-227579; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; KADIN ME, 1994, J CLIN ONCOL, V12, P884, DOI 10.1200/JCO.1994.12.5.884; KADIN ME, 1994, ANN ONCOL, V5, pS25, DOI 10.1093/annonc/5.suppl_1.S25; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pardanani A, 2004, BLOOD, V104, P1931, DOI 10.1182/blood-2004-01-0246; Pflegerl P, 2009, P NATL ACAD SCI USA, V106, P20423, DOI 10.1073/pnas.0910371106; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Pietras K, 2002, CANCER RES, V62, P5476; Piva R, 2010, J CLIN ONCOL, V28, P1583, DOI 10.1200/JCO.2008.20.9759; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Stein H, 2000, BLOOD, V96, P3681; Stover EH, 2005, BLOOD, V106, P3206, DOI 10.1182/blood-2005-05-1932; Sumida T, 2011, INT J CANCER, V128, P2050, DOI 10.1002/ijc.25812; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294	38	92	93	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1699	+		10.1038/nm.2966	http://dx.doi.org/10.1038/nm.2966			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23064464	Green Submitted			2022-12-27	WOS:000310837000032
J	Langedijk, JPM; Schuitemaker, H				Langedijk, Johannes P. M.; Schuitemaker, Hanneke			A sweet surprise for HIV broadly neutralizing antibodies	NATURE MEDICINE			English	Editorial Material							POTENT	The production of cross-reactive neutralizing antibodies is the ultimate goal in HIV vaccine development, but no immunogen other than HIV itself has been able to elicit this type of humoral immunity. In natural HIV infections, these antibodies take several years to develop. A new study sheds light on what may be causing this delay in neutralizing antibody development (pages 1688-1692).	[Langedijk, Johannes P. M.; Schuitemaker, Hanneke] Crucell Holland BV, Leiden, Netherlands; [Schuitemaker, Hanneke] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Johnson & Johnson; University of Amsterdam; Academic Medical Center Amsterdam	Langedijk, JPM (corresponding author), Crucell Holland BV, Leiden, Netherlands.	hlangedi@its.jnj.com; hschuite@its.jnj.com						Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Euler Z, 2012, J VIROL, V86, P2045, DOI 10.1128/JVI.06091-11; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746	9	3	6	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1616	1617		10.1038/nm.2993	http://dx.doi.org/10.1038/nm.2993			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135511	Bronze			2022-12-27	WOS:000310837000016
J	Ito, K; Carracedo, A; Weiss, D; Arai, F; Ala, U; Avigan, DE; Schafer, ZT; Evans, RM; Suda, T; Lee, CH; Pandolfi, PP				Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Arai, Fumio; Ala, Ugo; Avigan, David E.; Schafer, Zachary T.; Evans, Ronald M.; Suda, Toshio; Lee, Chih-Hao; Pandolfi, Pier Paolo			A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-DELTA; ENERGY-METABOLISM; MAMMALIAN TARGET; LIPID-METABOLISM; SKELETAL-MUSCLE; INHIBITION; BETA; DIFFERENTIATION; MODULATION; QUIESCENCE	Stem-cell function is an exquisitely regulated process. Thus far, the contribution of metabolic cues to stem-cell function has not been well understood. Here we identify a previously unknown promyelocytic leukemia (PML)-peroxisome proliferator-activated receptor delta (PPAR-delta)-fatty-acid oxidation (FAO) pathway for the maintenance of hematopoietic stem cells (HSCs). We have found that loss of PPAR-delta or inhibition of mitochondrial FAO induces loss of HSC maintenance, whereas treatment with PPAR-delta agonists improved HSC maintenance. PML exerts its essential role in HSC maintenance through regulation of PPAR signaling and FAO. Mechanistically, the PML-PPAR-delta-FAO pathway controls the asymmetric division of HSCs. Deletion of Ppard or Pml as well as inhibition of FAO results in the symmetric commitment of HSC daughter cells, whereas PPAR-delta activation increased asymmetric cell division. Thus, our findings identify a metabolic switch for the control of HSC cell fate with potential therapeutic implications.	[Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Ala, Ugo; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Genet, Boston, MA 02215 USA; [Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Ala, Ugo; Pandolfi, Pier Paolo] Harvard Univ, Canc Genet Program, Boston, MA 02215 USA; [Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Ala, Ugo; Pandolfi, Pier Paolo] Harvard Univ, Dept Med, Boston, MA 02215 USA; [Ito, Keisuke; Carracedo, Arkaitz; Weiss, Dror; Ala, Ugo; Pandolfi, Pier Paolo] Harvard Univ, Dept Pathol, Boston, MA 02215 USA; [Arai, Fumio; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol, Tokyo, Japan; [Avigan, David E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol & Oncol, Boston, MA 02215 USA; [Schafer, Zachary T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Lee, Chih-Hao] Harvard Univ, Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Harvard University; Keio University; Harvard University; Beth Israel Deaconess Medical Center; University of Notre Dame; Howard Hughes Medical Institute; Salk Institute; Harvard University; Harvard T.H. Chan School of Public Health	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Genet, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Carracedo, Arkaitz/F-7029-2011; Arai, Fumio/J-5241-2013; Suda, Toshio/H-6761-2013; Ala, Ugo/K-2029-2016; Evans, Ronald/AAF-4001-2019	Carracedo, Arkaitz/0000-0001-5957-1260; Arai, Fumio/0000-0003-1936-4907; Suda, Toshio/0000-0001-7540-1771; Ala, Ugo/0000-0001-5408-6397; Evans, Ronald/0000-0002-9986-5965; Pandolfi, Pier Paolo/0000-0002-5352-5295	K99 US National Institutes of Health (NIH); EMBO; Ramon y Cajal award (Spanish Ministry of Education); Instituto de Salud Carlos III [PI10/01484]; Marie Curie Reintegration grant [277043]; Basque Government [PI2012-03]; NIH; NATIONAL CANCER INSTITUTE [R00CA139009, R01CA142780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER	K99 US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); Ramon y Cajal award (Spanish Ministry of Education); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Marie Curie Reintegration grant(European Commission); Basque Government(Basque Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the members of the Pandolfi laboratory for comments and discussion. We especially thank K. Hosokawa for technical advice on asymmetric division, M. Alberich-Jorda and A.M. Zubiaga for technical help and critical discussions, and P. Puigserver and M.C. Haigis for technical support with the metabolic analysis. K.I. was supported by a K99 US National Institutes of Health (NIH) grant. The work of A.C. was supported by EMBO, the Ramon y Cajal award (Spanish Ministry of Education), Instituto de Salud Carlos III (PI10/01484), the Marie Curie Reintegration grant (277043) and the Basque Government (PI2012-03). This work was supported by NIH grants to P.P.P.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Clapham JC, 2007, DIABETES OBES METAB, V9, P259, DOI 10.1111/j.1463-1326.2006.00608.x; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Ergen AV, 2010, EXP GERONTOL, V45, P286, DOI 10.1016/j.exger.2009.12.010; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lansdorp P M, 1997, Biol Blood Marrow Transplant, V3, P171; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lemischka IR, 2003, NATURE, V425, P778, DOI 10.1038/425778a; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Metcalf D, 1998, IMMUNOL CELL BIOL, V76, P441, DOI 10.1046/j.1440-1711.1998.00761.x; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ogawa M, 1999, INT J HEMATOL, V69, P2; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Takahashi S, 2007, ENDOCR J, V54, P347, DOI 10.1507/endocrj.KR-99; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; TUTWILER GF, 1985, P SOC EXP BIOL MED, V178, P288; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Wang ZG, 1998, SCIENCE, V279, P1547; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; WOLF HPO, 1992, HORM METAB RES, V26, P62; WOLF NS, 1974, CELL TISSUE KINET, V7, P89, DOI 10.1111/j.1365-2184.1974.tb00402.x; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Wurch T, 2002, N-S ARCH PHARMACOL, V365, P133, DOI 10.1007/s00210-001-0504-z	58	470	486	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1350	+		10.1038/nm.2882	http://dx.doi.org/10.1038/nm.2882			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22902876	Green Accepted			2022-12-27	WOS:000308472300030
J	Bullen, CK; Laird, GM; Durand, CM; Siliciano, JD; Siliciano, RF				Bullen, C. Korin; Laird, Gregory M.; Durand, Christine M.; Siliciano, Janet D.; Siliciano, Robert F.			New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo	NATURE MEDICINE			English	Article							HISTONE DEACETYLASE INHIBITORS; CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; ACTIVATION; REACTIVATION; EXPRESSION; RESERVOIR; PROSTRATIN; REPLICATION; STABILITY	HIV-1 persists in a latent reservoir despite antiretroviral therapy (ART)(1-5). This reservoir is the major barrier to HIV-1 eradication(6,7). Current approaches to purging the latent reservoir involve pharmacologic induction of HIV-1 transcription and subsequent killing of infected cells by cytolytic T lymphocytes (CTLs) or viral cytopathic effects(8-10). Agents that reverse latency without activating T cells have been identified using in vitro models of latency. However, their effects on latently infected cells from infected individuals remain largely unknown. Using a new ex vivo assay, we demonstrate that none of the latency-reversing agents (LRAs) tested induced outgrowth of HIV-1 from the latent reservoir of patients on ART. Using a quantitative reverse transcription PCR assay specific for all HIV-1 mRNAs, we demonstrate that LRAs that do not cause T cell activation do not induce substantial increases in intracellular HIV-1 mRNA in patient cells; only the protein kinase C agonist bryostatin-1 caused significant increases. These findings demonstrate that current in vitro models do not fully recapitulate mechanisms governing HIV-1 latency in vivo. Further, our data indicate that non-activating LRAs are unlikely to drive the elimination of the latent reservoir in vivo when administered individually.	[Bullen, C. Korin; Laird, Gregory M.; Durand, Christine M.; Siliciano, Janet D.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu		Devadason, Caroline/0000-0002-2204-8174; Durand, Christine M./0000-0003-2605-9257	Martin Delaney Collaboratory of AIDS Researchers for Eradication; Delaney AIDS Research Enterprise (US National Institutes of Health) [AI096113, AI096109]; Foundation for AIDS Research [108165-50-RGRL, 108707-54-RKRL]; Johns Hopkins Center for AIDS Research; US National Institutes of Health [43222]; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043222, U19AI096113, U19AI096109, P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	Martin Delaney Collaboratory of AIDS Researchers for Eradication; Delaney AIDS Research Enterprise (US National Institutes of Health); Foundation for AIDS Research; Johns Hopkins Center for AIDS Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. McHugh and A. Devadason for assistance with study participants. Funding was provided by the Martin Delaney Collaboratory of AIDS Researchers for Eradication and the Delaney AIDS Research Enterprise (US National Institutes of Health grants AI096113 and AI096109 (R.F.S.)), the Foundation for AIDS Research grants 108165-50-RGRL (R.F.S.) and 108707-54-RKRL (C.M.D.), the Johns Hopkins Center for AIDS Research (J.D.S.), US National Institutes of Health grant 43222 (R.F.S.) and the Howard Hughes Medical Institute (R.F.S.).	Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Baba M, 2000, AIDS RES HUM RETROV, V16, P935, DOI 10.1089/08892220050058344; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Choudhary SK, 2011, ANNU REV PHARMACOL, V51, P397, DOI 10.1146/annurev-pharmtox-010510-100237; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; DeChristopher BA, 2012, NAT CHEM, V4, P705, DOI [10.1038/nchem.1395, 10.1038/NCHEM.1395]; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Doyon G, 2013, AIDS, V27, pF7, DOI 10.1097/QAD.0b013e3283570620; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hakre S, 2012, FEMS MICROBIOL REV, V36, P706, DOI 10.1111/j.1574-6976.2012.00335.x; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; KINTER AL, 1990, J VIROL, V64, P4306, DOI 10.1128/JVI.64.9.4306-4312.1990; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Li ZC, 2013, NUCLEIC ACIDS RES, V41, P277, DOI 10.1093/nar/gks976; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Moriuchi H, 1999, J IMMUNOL, V162, P7543; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P790, DOI 10.4161/hv.23202; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shan L, 2013, J VIROL, V87, P6521, DOI 10.1128/JVI.00006-13; Shirakawa K, 2013, TRENDS MICROBIOL, V21, P277, DOI 10.1016/j.tim.2013.02.005; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Spivak AM, 2014, CLIN INFECT DIS, V58, P883, DOI 10.1093/cid/cit813; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	37	366	381	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					425	+		10.1038/nm.3489	http://dx.doi.org/10.1038/nm.3489			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658076	Green Accepted			2022-12-27	WOS:000334361500024
J	Cosgrove, BD; Gilbert, PM; Porpiglia, E; Mourkioti, F; Lee, SP; Corbel, SY; Llewellyn, ME; Delp, SL; Blau, HM				Cosgrove, Benjamin D.; Gilbert, Penney M.; Porpiglia, Ermelinda; Mourkioti, Foteini; Lee, Steven P.; Corbel, Stephane Y.; Llewellyn, Michael E.; Delp, Scott L.; Blau, Helen M.			Rejuvenation of the muscle stem cell population restores strength to injured aged muscles	NATURE MEDICINE			English	Article							SKELETAL-MUSCLE; SATELLITE-CELL; SELF-RENEWAL; LIFE-SPAN; P38 MAPK; INHIBITORS; EXPRESSION; PROLIFERATION; EXPANSION; MODEL	The elderly often suffer from progressive muscle weakness and regenerative failure. We demonstrate that muscle regeneration is impaired with aging owing in part to a cell-autonomous functional decline in skeletal muscle stem cells (MuSCs). Two-thirds of MuSCs from aged mice are intrinsically defective relative to MuSCs from young mice, with reduced capacity to repair myofibers and repopulate the stem cell reservoir in vivo following transplantation. This deficiency is correlated with a higher incidence of cells that express senescence markers and is due to elevated activity of the p38 alpha and p38 beta mitogen-activated kinase pathway. We show that these limitations cannot be overcome by transplantation into the microenvironment of young recipient muscles. In contrast, subjecting the MuSC population from aged mice to transient inhibition of p38 alpha and p38 beta in conjunction with culture on soft hydrogel substrates rapidly expands the residual functional MuSC population from aged mice, rejuvenating its potential for regeneration and serial transplantation as well as strengthening of damaged muscles of aged mice. These findings reveal a synergy between biophysical and biochemical cues that provides a paradigm for a localized autologous muscle stem cell therapy for the elderly.	[Cosgrove, Benjamin D.; Gilbert, Penney M.; Porpiglia, Ermelinda; Mourkioti, Foteini; Lee, Steven P.; Corbel, Stephane Y.; Blau, Helen M.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Cosgrove, Benjamin D.; Gilbert, Penney M.; Porpiglia, Ermelinda; Mourkioti, Foteini; Lee, Steven P.; Corbel, Stephane Y.; Blau, Helen M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Gilbert, Penney M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Gilbert, Penney M.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Llewellyn, Michael E.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Sch Med, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Toronto; University of Toronto; Stanford University; Stanford University	Blau, HM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	penney.gilbert@utoronto.ca; hblau@stanford.edu	Cosgrove, Benjamin/A-9810-2016	Cosgrove, Benjamin/0000-0003-2164-350X; Delp, Scott/0000-0002-9643-7551; Gilbert, Penney/0000-0001-5509-9616; Mourkioti, Foteini/0000-0002-7119-6640; Porpiglia, Ermelinda/0000-0003-2652-899X	US National Institutes of Health (NIH) [R25CA118681, K99AG042491]; NIH [T32CA009151, K99AR061465, U01HL100397, U01HL099997, R01AG020961, R01HL096113, R01AG009521]; California Institute for Regenerative Medicine [TG2-01159, RT1-01001, TR3-05501]; IBM Faculty Award; Baxter Foundation; NATIONAL CANCER INSTITUTE [T32CA009151, R25CA118681] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL099997, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR061465, R01AR063963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG042491, R01AG009521, R21AG044815, R01AG020961] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); IBM Faculty Award(International Business Machines (IBM)); Baxter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Koleckar, P. Kraft, N. Nguyen, A. Thayer, C. Marceau, K. Magnusson and A. Ho for technical assistance; K. Havenstrite and R. Haynes for polymer synthesis; and the Stanford Center for Innovation in In-Vivo Imaging (SCI<SUP>3</SUP>), the Stanford Shared FAGS Facility (SSFF) and IBM Almaden for technical support. This work was funded by US National Institutes of Health (NIH) training grant R25CA118681 and grant K99AG042491 (B.D.C.); NIH training grant T32CA009151 and grant K99AR061465 and California Institute for Regenerative Medicine training grant TG2-01159 (P.M.G.); and NIH grants U01HL100397, U01HL099997, R01AG020961, R01HL096113 and R01AG009521, an IBM Faculty Award, California Institute for Regenerative Medicine grants RT1-01001 and TR3-05501 and the Baxter Foundation (H.M.B.).	Arpke RW, 2013, STEM CELLS, V31, P1611, DOI 10.1002/stem.1402; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beccafico S, 2011, AGE, V33, P523, DOI 10.1007/s11357-010-9197-x; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brien P, 2013, STEM CELLS, V31, P1597, DOI 10.1002/stem.1399; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004; Darabi R, 2011, STEM CELLS, V29, P777, DOI 10.1002/stem.625; Di Marco S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1899; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lefkovits I., 1999, LIMITING DILUTION AN; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mouly V, 2005, ACTA PHYSIOL SCAND, V184, P3, DOI 10.1111/j.1365-201X.2005.01417.x; Page TH, 2010, ARTHRITIS RHEUM-US, V62, P3221, DOI 10.1002/art.27631; Parham DM, 2006, ARCH PATHOL LAB MED, V130, P1454; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Sakuma Kunihiro, 2010, Curr Aging Sci, V3, P90; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; THOMPSON LV, 1994, PHYS THER, V74, P71, DOI 10.1093/ptj/74.1.71; Tivey HSE, 2013, J GERONTOL A-BIOL, V68, P1001, DOI 10.1093/gerona/gls336; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; Wong ESM, 2009, DEV CELL, V17, P142, DOI 10.1016/j.devcel.2009.05.009; Zou J, 2012, ANN HEMATOL, V91, P813, DOI 10.1007/s00277-011-1397-7	55	393	406	6	119	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					255	264		10.1038/nm.3464	http://dx.doi.org/10.1038/nm.3464			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24531378	Green Accepted			2022-12-27	WOS:000332595600020
J	Dembele, L; Franetich, JF; Lorthiois, A; Gego, A; Zeeman, AM; Kocken, CHM; Le Grand, R; Dereuddre-Bosquet, N; van Gemert, GJ; Sauerwein, R; Vaillant, JC; Hannoun, L; Fuchter, MJ; Diagana, TT; Malmquist, NA; Scherf, A; Snounou, G; Mazier, D				Dembele, Laurent; Franetich, Jean-Francois; Lorthiois, Audrey; Gego, Audrey; Zeeman, Anne-Marie; Kocken, Clemens H. M.; Le Grand, Roger; Dereuddre-Bosquet, Nathalie; van Gemert, Geert-Jan; Sauerwein, Robert; Vaillant, Jean-Christophe; Hannoun, Laurent; Fuchter, Matthew J.; Diagana, Thierry T.; Malmquist, Nicholas A.; Scherf, Artur; Snounou, Georges; Mazier, Dominique			Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures	NATURE MEDICINE			English	Article							PLASMODIUM-VIVAX; EXOERYTHROCYTIC PARASITES; 2 POPULATIONS; CYNOMOLGI; FORMS; DISCOVERY; RELAPSE; MATRIX; GEL	Malaria relapses, resulting from the activation of quiescent hepatic hypnozoites of Plasmodium vivax and Plasmodium ovale, hinder global efforts to control and eliminate malaria. As primaquine, the only drug capable of eliminating hypnozoites, is unsuitable for mass administration, an alternative drug is needed urgently. Currently, analyses of hypnozoites, including screening of compounds that would eliminate them, can only be made using common macaque models, principally Macaca rhesus and Macaca fascicularis, experimentally infected with the relapsing Plasmodium cynomolgi. Here, we present a protocol for long-term in vitro cultivation of P cynomolgi-infected M. fascicularis primary hepatocytes during which hypnozoites persist and activate to resume normal development. In a proof-of-concept experiment, we obtained evidence that exposure to an inhibitor of histone modification enzymes implicated in epigenetic control of gene expression induces an accelerated rate of hypnozoite activation. The protocol presented may further enable investigations of hypnozoite biology and the search for compounds that kill hypnozoites or disrupt their quiescence.	[Dembele, Laurent; Franetich, Jean-Francois; Lorthiois, Audrey; Gego, Audrey; Snounou, Georges; Mazier, Dominique] Univ Paris 06, Sorbonne Univ, UMR S945, Paris, France; [Dembele, Laurent; Franetich, Jean-Francois; Lorthiois, Audrey; Gego, Audrey; Snounou, Georges; Mazier, Dominique] INSERM, U945, Paris, France; [Zeeman, Anne-Marie; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Le Grand, Roger; Dereuddre-Bosquet, Nathalie] Commissariat Energie Atom & Energies Alternat, Inst Emerging Dis & Innovat Therapies, Div Immunovirol, Fontenay Aux Roses, France; [Le Grand, Roger; Dereuddre-Bosquet, Nathalie] Univ Paris 11, UMRE01, Orsay, France; [van Gemert, Geert-Jan; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Vaillant, Jean-Christophe; Hannoun, Laurent] Hop La Pitie Salpetriere, Serv Chirurg Digest Hepatobiliopancreat & Transpl, Paris, France; [Fuchter, Matthew J.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Diagana, Thierry T.] Novartis Inst Trop Dis, Singapore, Singapore; [Malmquist, Nicholas A.; Scherf, Artur] Inst Pasteur, Unite Biol Interact Hote Paras, Paris, France; [Malmquist, Nicholas A.; Scherf, Artur] CNRS, Unite Rech Associee 2581, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Imperial College London; Novartis; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Snounou, G (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S945, Paris, France.	georges.snounou@upmc.fr	Franetich, Jean-François/GZA-9674-2022; Sauerwein, Robert/C-8519-2013; Snounou, Georges/F-3352-2011	DEMBELE, LAURENT/0000-0001-9087-8439; Kocken, Clemens/0000-0002-4784-1734; Malmquist, Nicholas/0000-0003-2822-8245; Zeeman, Anne-Marie/0000-0002-0157-4669; Snounou, Georges/0000-0002-6133-6398; Fuchter, Matthew/0000-0002-1767-7072; Scherf, Artur/0000-0003-2411-3328	Wellcome Trust [WT078285]; Medicines for Malaria Venture; Biomedical Primate Research Centre (the Netherlands); Universite Pierre et Marie Curie-Paris 6 (France); Seventh Framework Programme EU European Research Council Executive Agency Advanced Grant [250320]; Laboratoires d'Excellence (LABEX) grant from the Agence Nationale de la Recherche (France) [ANR-11-LABX0024]	Wellcome Trust(Wellcome TrustEuropean Commission); Medicines for Malaria Venture; Biomedical Primate Research Centre (the Netherlands)(Netherlands Government); Universite Pierre et Marie Curie-Paris 6 (France); Seventh Framework Programme EU European Research Council Executive Agency Advanced Grant; Laboratoires d'Excellence (LABEX) grant from the Agence Nationale de la Recherche (France)(French National Research Agency (ANR))	This work was supported in part by a translational research grant (WT078285) from the Wellcome Trust, a grant from the Medicines for Malaria Venture to the Novartis Institute for Tropical Diseases (Singapore), the Biomedical Primate Research Centre (the Netherlands), the Universite Pierre et Marie Curie-Paris 6 (France), a Seventh Framework Programme EU European Research Council Executive Agency Advanced Grant (Plasmoescape 250320) to A.S. and a Laboratoires d'Excellence (LABEX) grant (ANR-11-LABX0024) from the Agence Nationale de la Recherche (France). We are grateful to T.A. Moss (Imperial College London) for the chemical synthesis of TM2-115. HepaRG cells were provided by C. Guguen-Guillouzo (Biopredic International). pTRIP-CMV-GFP Delta U3 vector was provided by P. Ravassard (le Centre de Recherche de I'Institut du Cerveau et de la Moelle Epiniere). We thank the staff of the Flow Cytometry Core CyPS at the Universite Pierre et Marie Curie (Pitie-Salpetriere Hospital, Paris, France) for their help and assistance. Finally, we thank A.C. Gruner for her excellent critical comments on the manuscript.	ATKINSON CT, 1989, AM J TROP MED HYG, V40, P131, DOI 10.4269/ajtmh.1989.40.131; Barter ZE, 2007, CURR DRUG METAB, V8, P33, DOI 10.2174/138920007779315053; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; Bray R. S., 1957, STUDIES EXOERYTHROCY; Chattopadhyay R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014275; CLEMENT B, 1984, HEPATOLOGY, V4, P373, DOI 10.1002/hep.1840040305; COATNEY GR, 1971, PRIMATE MALARIAS; COGSWELL FB, 1992, CLIN MICROBIOL REV, V5, P26, DOI 10.1128/CMR.5.1.26-35.1992; Dembele L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018162; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; Garnham PCC., 1966, MALARIA PARASITES OT; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, V640, P1, DOI 10.1007/978-1-60761-688-7_1; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HOLLINGDALE MR, 1986, AM J TROP MED HYG, V35, P275, DOI 10.4269/ajtmh.1986.35.275; HOLLINGDALE MR, 1985, AM J TROP MED HYG, V34, P216, DOI 10.4269/ajtmh.1985.34.216; Kocken CHM, 2009, ANTIMICROB AGENTS CH, V53, P421, DOI 10.1128/AAC.00576-08; Kono Y, 1997, IN VITRO CELL DEV-AN, V33, P467; KROTOSKI WA, 1980, BMJ-BRIT MED J, V280, P153, DOI 10.1136/bmj.280.6208.153-a; KROTOSKI WA, 1982, AM J TROP MED HYG, V31, P24, DOI 10.4269/ajtmh.1982.31.24; Liu Duo, 1995, Chinese Journal of Parasitology & Parasitic Diseases, V13, P86; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Malmquist NA, 2012, P NATL ACAD SCI USA, V109, P16708, DOI 10.1073/pnas.1205414109; MAZIER D, 1984, NATURE, V307, P367, DOI 10.1038/307367a0; Mazier D, 2009, NAT REV DRUG DISCOV, V8, P854, DOI 10.1038/nrd2960; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; SCHMIDT LH, 1982, AM J TROP MED HYG, V31, P609, DOI 10.4269/ajtmh.1982.31.609; SHORTT HE, 1948, BRIT MED J, V1, P1225, DOI 10.1136/bmj.1.4564.1225; Shu H, 1995, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V13, P185; SHUTE PG, 1976, T ROY SOC TROP MED H, V70, P474, DOI 10.1016/0035-9203(76)90132-2; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Voorberg-van der Wel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054888; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297	35	132	134	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					307	312		10.1038/nm.3461	http://dx.doi.org/10.1038/nm.3461			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24509527				2022-12-27	WOS:000332595600027
J	Tahara, N; Mukherjee, J; de Haas, HJ; Petrov, AD; Tawakol, A; Haider, N; Tahara, A; Constantinescu, CC; Zhou, J; Boersma, HH; Imaizumi, T; Nakano, M; Finn, A; Fayad, Z; Virmani, R; Fuster, V; Bosca, L; Narula, J				Tahara, Nobuhiro; Mukherjee, Jogeshwar; de Haas, Hans J.; Petrov, Artiom D.; Tawakol, Ahmed; Haider, Nezam; Tahara, Atsuko; Constantinescu, Cristian C.; Zhou, Jun; Boersma, Hendrikus H.; Imaizumi, Tsutomu; Nakano, Masataka; Finn, Aloke; Fayad, Zahi; Virmani, Renu; Fuster, Valentin; Bosca, Lisardo; Narula, Jagat			2-deoxy-2[F-18]fluoro-D-mannose positron emission tomography imaging in atherosclerosis	NATURE MEDICINE			English	Article							NONINVASIVE DETECTION; GLUCOSE TRANSPORTERS; PLAQUE INFLAMMATION; DISEASE; FLUORODEOXYGLUCOSE; MACROPHAGES; MECHANISMS	Progressive inflammation in atherosclerotic plaques is associated with increasing risk of plaque rupture. Molecular imaging of activated macrophages with 2-deoxy-2[F-18]fluoro-D-glucose ([F-18]FDG) has been proposed for identification of patients at higher risk for acute vascular events. Because mannose is an isomer of glucose that is taken up by macrophages through glucose transporters and because mannose receptors are expressed on a subset of the macrophage population in high-risk plaques, we applied F-18-labeled mannose (2-deoxy-2[F-18]fluoro-D-mannose, [F-18]FDM) for targeting of plaque inflammation. Here, we describe comparable uptake of [F-18]FDM and [F-18]FDG in atherosclerotic lesions in a rabbit model; [F-18]FDM uptake was proportional to the plaque macrophage population. Our FDM competition studies in cultured cells with 2-deoxy-2-[C-14]carbon-D-glucose ([C-14]2DG) support at least 35% higher [F-18]FDM uptake by macrophages in cell experiments. We also demonstrate that FDM restricts binding of anti mannose receptor antibody to macrophages by approximately 35% and that mannose receptor targeting may provide an additional avenue for imaging of plaque inflammation.	[Tahara, Nobuhiro; Tahara, Atsuko; Imaizumi, Tsutomu] Kurume Univ, Sch Med, Kurume, Fukuoka 830, Japan; [Mukherjee, Jogeshwar; Constantinescu, Cristian C.; Zhou, Jun] Univ Calif Irvine, Irvine, CA USA; [de Haas, Hans J.; Petrov, Artiom D.; Haider, Nezam; Fayad, Zahi; Fuster, Valentin; Narula, Jagat] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [de Haas, Hans J.; Boersma, Hendrikus H.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Tawakol, Ahmed] Harvard Univ, Sch Med, Boston, MA USA; [Tawakol, Ahmed] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Nakano, Masataka; Virmani, Renu] CVPath Inst, Gaithersburg, MD USA; [Finn, Aloke] Emory Univ, Sch Med, Atlanta, GA USA; [Fuster, Valentin] Ctr Nacl Invest Cardiovasc Carlos III, Madrid, Spain; [Bosca, Lisardo] Univ Autonoma Madrid, Inst Invest Biomed Alberto Sols, Ctr Mixto, Consejo Super Invest Cient, Madrid, Spain	Kurume University; University of California System; University of California Irvine; Icahn School of Medicine at Mount Sinai; University of Groningen; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; CVPath Institute; Emory University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)	Narula, J (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.	narula@mountsinai.org	Fayad, Zahi/Z-3272-2019; Bosca, Lisardo/A-2059-2008; Mukherjee, Jogeshwar/O-1320-2013; Fuster, Valentin/H-4319-2015; Boersma, Hendrikus/AAF-8139-2020	Fayad, Zahi/0000-0002-3439-7347; Bosca, Lisardo/0000-0002-0253-5469; Mukherjee, Jogeshwar/0000-0003-1009-877X; Fuster, Valentin/0000-0002-9043-9986; Boersma, Hendrikus/0000-0003-1892-9830	International Research Fund for Subsidy of Kyusyu University School of Medicine Alumni; Banyu Fellowship Program; Banyu Life Science Foundation International; foundation De Drie Lichten; Dutch Heart Association; Spanish Government [BFU2011-24760, RD12/0042/0019]; US National Institutes of Health from the US National Center for Research Resources [S10RR019269]; US National Institute of Biomedical Imaging and Bioengineering [R01 EB006110]; US National Institutes of Health [1RO1-HL68657]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019269] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006110] Funding Source: NIH RePORTER	International Research Fund for Subsidy of Kyusyu University School of Medicine Alumni; Banyu Fellowship Program; Banyu Life Science Foundation International(Banyu Life Science Foundation International); foundation De Drie Lichten; Dutch Heart Association; Spanish Government(Spanish GovernmentEuropean Commission); US National Institutes of Health from the US National Center for Research Resources; US National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank E. Lopez-Collazo for help in the preparation of human macrophages. Additionally, we thank T. Yamald, D.S. Mohar, S. Pandey, M. Pan, R. Kant and R. Coleman for their help in development of tracer labeling and [<SUP>18</SUP>F]FDM imaging. Finally, we thank C. Minh and J. Song for their valuable help with analyzing PET images. This research was supported by a research grant from the International Research Fund for Subsidy of Kyusyu University School of Medicine Alumni and the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International to N.T., research grants from the foundation De Drie Lichten and the Dutch Heart Association (Dr. E. Dekker student grant) to H.J.d.H., grants BFU2011-24760 and RD12/0042/0019 from the Spanish Government to L.B., US National Institutes of Health grant S10RR019269 from the US National Center for Research Resources and grant R01 EB006110 from the US National Institute of Biomedical Imaging and Bioengineering to J.M. and US National Institutes of Health grant 1RO1-HL68657 to J.N.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; Finn AV, 2012, J AM COLL CARDIOL, V59, P166, DOI 10.1016/j.jacc.2011.10.852; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartung D, 2007, J NUCL MED, V48, P1816, DOI 10.2967/jnumed.107.043463; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Kietselaer BLJH, 2004, NEW ENGL J MED, V350, P1472, DOI 10.1056/NEJM200404013501425; Kolodgie FD, 2003, CIRCULATION, V108, P3134, DOI 10.1161/01.CIR.0000105761.00573.50; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Narula J, 2008, NAT CLIN PRACT CARD, V5, pS2, DOI 10.1038/ncpcardio1247; Narula J, 2007, NAT MED, V13, P532, DOI 10.1038/nm0507-532; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Otsuka F, 2012, MT SINAI J MED, V79, P641, DOI 10.1002/msj.21353; Rogers IS, 2010, JACC-CARDIOVASC IMAG, V3, P388, DOI 10.1016/j.jcmg.2010.01.004; Rudd JHF, 2010, J AM COLL CARDIOL, V55, P2527, DOI 10.1016/j.jacc.2009.12.061; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Tahara N, 2006, J AM COLL CARDIOL, V48, P1825, DOI 10.1016/j.jacc.2006.03.069; Tsimikas S, 2002, AM J CARDIOL, V90, p22L, DOI 10.1016/S0002-9149(02)02958-2; Villanueva FS, 1998, CIRCULATION, V98, P1, DOI 10.1161/01.CIR.98.1.1	20	127	130	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					215	219		10.1038/nm.3437	http://dx.doi.org/10.1038/nm.3437			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412923				2022-12-27	WOS:000330915000024
J	Knoepfler, PS				Knoepfler, Paul S.			Scientists: you really need to get out of the lab more	NATURE MEDICINE			English	Editorial Material								There is no rulebook for how to be a scientist advocate, but that shouldn't stop researchers from engaging with the broader community. In fact, it's an essential part of being a good steward of your science.	Univ Calif Davis, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis	Knoepfler, PS (corresponding author), Univ Calif Davis, Sch Med, Davis, CA 95616 USA.	knoepfler@ucdavis.edu		Knoepfler, Paul/0000-0001-5444-334X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100782] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM100782] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Riggs JW, 2013, STEM CELLS DEV, V22, P37, DOI 10.1089/scd.2012.0375	1	0	0	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2013	19	9					1086	1086		10.1038/nm0913-1086	http://dx.doi.org/10.1038/nm0913-1086			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	24013741	Green Accepted, Bronze			2022-12-27	WOS:000324083500012
J	Lee, AS; Tang, C; Rao, MS; Weissman, IL; Wu, JC				Lee, Andrew S.; Tang, Chad; Rao, Mahendra S.; Weissman, Irving L.; Wu, Joseph C.			Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies	NATURE MEDICINE			English	Article							EMBRYONIC STEM; COPY NUMBER; EXPRESSION; GENERATION; TERATOMA; MYC; DIFFERENTIATION; IMMUNOGENICITY; INSTABILITY; ENGRAFTMENT	Human pluripotent stem cells (PSCs) are a leading candidate for cell-based therapies because of their capacity for unlimited self renewal and pluripotent differentiation. These advances have recently culminated in the first-in-human PSC clinical trials by Geron, Advanced Cell Technology and the Kobe Center for Developmental Biology for the treatment of spinal cord injury and macular degeneration. Despite their therapeutic promise, a crucial hurdle for the clinical implementation of human PSCs is their potential to form tumors in vivo. In this Perspective, we present an overview of the mechanisms underlying the tumorigenic risk of human PSC-based therapies and discuss current advances in addressing these challenges.	[Lee, Andrew S.; Tang, Chad; Weissman, Irving L.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lee, Andrew S.; Wu, Joseph C.] Stanford Sch Med, Stanford Cardiovasc Inst, Stanford, CA USA; [Lee, Andrew S.; Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA; [Tang, Chad] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Rao, Mahendra S.] NIH, Natl Ctr Regenerat Med, Bethesda, MD 20892 USA	Stanford University; Stanford University; Stanford University; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA	Wu, JC (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	mahendra.rao@nih.gov; irv@stanford.edu; joewu@stanford.edu	Lee, Andrew/GVU-2817-2022; Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041	US National Institutes of Health [HL093172, HL099117, EB009689]; Burroughs Wellcome Fund Career Award in the Biomedical Sciences, American Heart Association [EIA14420025]; California Institute of Regenerative Medicine (CIRM) [DR2-05394, TR3-05556]; CIRM Tools Technology II; Bio-X graduate student fellowship; Howard Hughes Medical Institute research training fellowships; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093172, RC1HL099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009689] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Career Award in the Biomedical Sciences, American Heart Association; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); CIRM Tools Technology II; Bio-X graduate student fellowship; Howard Hughes Medical Institute research training fellowships(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank A. Morris and J. Wha-Rhee for preparing the illustrations. Because of space constraints, we were unable to include all relevant studies regarding the tumorigenicity of pluripotent stem cells; we apologize to those investigators whose valuable work we have omitted. This work was supported in part by US National Institutes of Health grants HL093172, HL099117 and EB009689, the Burroughs Wellcome Fund Career Award in the Biomedical Sciences, American Heart Association grant EIA14420025 and California Institute of Regenerative Medicine (CIRM) grants DR2-05394 and TR3-05556 (J.C.W.); CIRM Tools & Technology II (I.L.W.); a Bio-X graduate student fellowship (A.S.L.); and Howard Hughes Medical Institute research training fellowships (A.S.L. and C.T.).	Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Choo AB, 2008, STEM CELLS, V26, P1454, DOI 10.1634/stemcells.2007-0576; Cui L, 2013, J CLIN INVEST, V123, P1647, DOI 10.1172/JCI65048; Cyranoski D, 2013, NATURE, V494, P413, DOI 10.1038/494413a; Cyranoski D, 2010, NATURE, V465, P997, DOI 10.1038/465997a; de Almeida PE, 2013, CIRC RES, V112, P549, DOI 10.1161/CIRCRESAHA.111.249243; DeFrancesco L., 2009, NAT BIOTECHNOL, V27, P877; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Desponts C, 2010, METHODS MOL BIOL, V636, P207, DOI 10.1007/978-1-60761-691-7_13; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Doi D, 2012, STEM CELLS, V30, P935, DOI 10.1002/stem.1060; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Drukker M, 2002, P NATL ACAD SCI USA, V99, P9864, DOI 10.1073/pnas.142298299; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Herszfeld D, 2006, NAT BIOTECHNOL, V24, P351, DOI 10.1038/nbt1197; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Hyka-Nouspikel N, 2012, STEM CELLS, V30, P1901, DOI 10.1002/stem.1177; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Lee TKW, 2013, CANCER LETT, V338, P101, DOI 10.1016/j.canlet.2012.05.001; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Ohm JE, 2010, CANCER RES, V70, P7662, DOI 10.1158/0008-5472.CAN-10-1361; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; PECKHAM MJ, 1979, LANCET, V2, P267; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Strauss S, 2010, NAT BIOTECHNOL, V28, P989, DOI 10.1038/nbt1010-989; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Tang C, 2011, NAT BIOTECHNOL, V29, P829, DOI 10.1038/nbt.1947; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	68	400	417	6	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					998	1004		10.1038/nm.3267	http://dx.doi.org/10.1038/nm.3267			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921754	Green Accepted			2022-12-27	WOS:000322779600025
J	Daley, GQ; Pasque, V; Plath, K				Daley, George Q.; Pasque, Vincent; Plath, Kathrin			A new route to human embryonic stem cells	NATURE MEDICINE			English	Editorial Material							NUCLEAR TRANSFER		[Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA USA; [Pasque, Vincent; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Inst Mol Biol,Jonsson Comprehens Canc Ctr,Dept Bi, Los Angeles, CA 90095 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Daley, GQ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA.		Pasque, Vincent/M-8231-2017; Pasque, Vincent/X-6720-2019	Pasque, Vincent/0000-0002-5129-0146; Pasque, Vincent/0000-0002-5129-0146; Plath, Kathrin/0000-0001-7796-3372				Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Narbonne P, 2012, CURR OPIN GENET DEV, V22, P450, DOI 10.1016/j.gde.2012.09.002; Tachibana M, 2013, CELL, V153, P1228, DOI 10.1016/j.cell.2013.05.006; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024	10	4	4	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2013	19	7					820	821		10.1038/nm.3266	http://dx.doi.org/10.1038/nm.3266			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836223				2022-12-27	WOS:000321557700023
J	Levesque, JP; Winkler, IG				Levesque, Jean-Pierre; Winkler, Ingrid G.			It takes nerves to recover from chemotherapy	NATURE MEDICINE			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; BONE-MARROW TRANSPLANTATION; MOBILIZATION; SYSTEM; NICHE		[Levesque, Jean-Pierre; Winkler, Ingrid G.] Mater Res, Woolloongabba, Qld, Australia; [Levesque, Jean-Pierre; Winkler, Ingrid G.] Univ Queensland, Woolloongabba, Qld, Australia	Mater Research; University of Queensland	Levesque, JP (corresponding author), Mater Res, Woolloongabba, Qld, Australia.	jplevesque@mmri.mater.org.au; ingrid.winkler@mmri.mater.org.au	Levesque, Jean-Pierre/C-5426-2011; Winkler, Ingrid G/F-3263-2011	Levesque, Jean-Pierre/0000-0002-7299-6025; Winkler, Ingrid G/0000-0001-6026-3572				Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Clark RE, 1998, BONE MARROW TRANSPL, V22, P859, DOI 10.1038/sj.bmt.1701461; Elmaagacli AH, 2007, BONE MARROW TRANSPL, V40, P659, DOI 10.1038/sj.bmt.1705786; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Levesque JP, 2008, CURR OPIN ORGAN TRAN, V13, P53, DOI 10.1097/MOT.0b013e3282f42473; Levesque JP, 2013, BIOESSAYS, V35, P183, DOI 10.1002/bies.201200111; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; PHILIP T, 1995, NEW ENGL J MED, V333, P1540, DOI 10.1056/NEJM199512073332305; To LB, 2011, BLOOD, V118, P4530, DOI 10.1182/blood-2011-06-318220; Tournilhac O, 2004, BLOOD, V103, P363, DOI 10.1182/blood-2003-05-1449; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969	13	14	14	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					669	671		10.1038/nm.3231	http://dx.doi.org/10.1038/nm.3231			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744143				2022-12-27	WOS:000319981600010
J	Schiffer, JT; Corey, L				Schiffer, Joshua T.; Corey, Lawrence			Rapid host immune response and viral dynamics in herpes simplex virus-2 infection	NATURE MEDICINE			English	Article							CD8(+) T-CELLS; LATENCY-ASSOCIATED TRANSCRIPT; RECURRENT GENITAL HERPES; LYMPHOCYTE-ASSOCIATED ANTIGEN; PLASMACYTOID DENDRITIC CELLS; TYPE-2 INFECTION; TRIGEMINAL GANGLIA; GUINEA-PIGS; GAMMA-INTERFERON; EPIDERMAL-CELLS	Herpes simplex virus-2 (HSV-2) is periodically shed throughout the human genital tract. Although a high viral load correlates with the development of genital ulcers, shedding also commonly occurs even when ulcers are absent, allowing for silent transmission during coitus and contributing to high seroprevalence of HSV-2 worldwide. Frequent viral reactivation occurs within ganglia despite diverse and complementary host and viral mechanisms that predispose toward latency, suggesting that viral replication may be constantly occurring in a small minority of neurons at these sites. Within genital mucosa, the in vivo expansion and clearance rates of HSV-2 are extremely rapid. Resident dendritic cells and memory HSV-2 specific T cells persist at prior sites of genital tract reactivation and, in conjunction with prompt innate recognition of infected cells, lead to rapid containment of infected cells. The fact that immune responses usually control viral replication in genital skin before lesions develop provides hope that enhancing such responses could lead to effective vaccines and immunotherapies.	[Schiffer, Joshua T.; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Schiffer, Joshua T.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Schiffer, JT (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jschiffe@fhcrc.org	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	US National Institutes of Health [P01 AI030731, R37 AI042528, K23 AI087206]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, R37AI042528, R01AI042528, K23AI087206] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to M. Miner for her contribution in the editorial preparation of the manuscript and to our reviewers for their insightful suggestions. This work was supported by US National Institutes of Health grants P01 AI030731, R37 AI042528 and K23 AI087206.	Abbo L, 2007, CLIN INFECT DIS, V44, pE25, DOI 10.1086/510426; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Alsallaq RA, 2010, SEX TRANSM DIS, V37, P290, DOI 10.1097/OLQ.0b013e3181d3d023; Aubert M, 2009, J VIROL, V83, P6171, DOI 10.1128/JVI.02163-08; Awasthi S, 2011, J VIROL, V85, P10472, DOI 10.1128/JVI.00849-11; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bertke AS, 2007, J VIROL, V81, P6605, DOI 10.1128/JVI.02701-06; Beutner KR, 1995, ANTIVIR RES, V28, P281, DOI 10.1016/0166-3542(95)00066-6; Bosnjak L, 2005, J IMMUNOL, V174, P2220, DOI 10.4049/jimmunol.174.4.2220; Bourne N, 2005, J INFECT DIS, V192, P2117, DOI 10.1086/498247; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; Bourne N, 2002, J GEN VIROL, V83, P2797, DOI 10.1099/0022-1317-83-11-2797; Brown EL, 2007, ACTA OBSTET GYN SCAN, V86, P523, DOI 10.1080/00016340601151949; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; BROWN ZA, 1987, NEW ENGL J MED, V317, P1246, DOI 10.1056/NEJM198711123172002; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Chen XP, 2002, J NEUROVIROL, V8, P204, DOI 10.1080/13550280290049642; Cirelli R, 1996, ANTIVIR RES, V29, P141, DOI 10.1016/0166-3542(95)00941-8; COHEN GH, 1984, J VIROL, V49, P102, DOI 10.1128/JVI.49.1.102-108.1984; Cohen J, 2010, SCIENCE, V330, P304, DOI 10.1126/science.330.6002.304; Collins WJ, 2003, J VIROL, V77, P2686, DOI 10.1128/JVI.77.4.2686-2695.2003; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; COREY L, 1983, ANN INTERN MED, V98, P958, DOI 10.7326/0003-4819-98-6-958; Corey L, 1999, SEX TRANSM DIS, V3rd, P285; Crespi CM, 2007, SEX TRANSM INFECT, V83, P359, DOI 10.1136/sti.2006.022020; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; Dalloul A, 2004, J CLIN VIROL, V30, P329, DOI 10.1016/j.jcv.2003.11.014; Decman V, 2005, J VIROL, V79, P10339, DOI 10.1128/JVI.79.16.10339-10347.2005; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; Donaghy H, 2009, J VIROL, V83, P1952, DOI 10.1128/JVI.01578-08; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; FLEWETT TH, 1969, J CLIN PATHOL, V22, P60, DOI 10.1136/jcp.22.1.60; Frank GM, 2010, J IMMUNOL, V184, P277, DOI 10.4049/jimmunol.0902373; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Garssen J, 2000, PHOTOCHEM PHOTOBIOL, V72, P645, DOI 10.1562/0031-8655(2000)072<0645:EOUIOS>2.0.CO;2; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gonzalez JC, 2005, J INFECT DIS, V191, P243, DOI 10.1086/426944; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Hargett D, 2006, J VIROL, V80, P10565, DOI 10.1128/JVI.01119-06; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hill JM, 1996, J VIROL, V70, P3137, DOI 10.1128/JVI.70.5.3137-3141.1996; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hoshino Y, 2008, VIROLOGY, V372, P56, DOI 10.1016/j.virol.2007.10.031; Hoshino Y, 2007, J VIROL, V81, P8157, DOI 10.1128/JVI.00474-07; HULL HF, 1984, J PEDIATR-US, V104, P211, DOI 10.1016/S0022-3476(84)80994-4; Iijima N, 2008, J EXP MED, V205, P3041, DOI 10.1084/jem.20082039; Jiang XZ, 2011, J VIROL, V85, P2325, DOI 10.1128/JVI.01791-10; Johnston C, 2012, LANCET, V379, P641, DOI 10.1016/S0140-6736(11)61750-9; Kaneko K, 2008, J IMMUNOL, V181, P217, DOI 10.4049/jimmunol.181.1.217; Knickelbein JE, 2008, SCIENCE, V322, P268, DOI 10.1126/science.1164164; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Koelle DM, 2008, ANNU REV MED, V59, P381, DOI 10.1146/annurev.med.59.061606.095540; KOELLE DM, 1994, J INFECT DIS, V169, P956, DOI 10.1093/infdis/169.5.956; Koelle DM, 2006, J VIROL, V80, P2863, DOI 10.1128/JVI.80.6.2863-2872.2006; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Koelle DM, 2001, J IMMUNOL, V166, P4049, DOI 10.4049/jimmunol.166.6.4049; Koelle DM, 2002, J CLIN INVEST, V110, P537, DOI [10.1172/JCI200215537, 10.1172/JCI0215537]; Kwant-Mitchell A, 2009, J VIROL, V83, P10664, DOI 10.1128/JVI.02584-08; Langenberg AGM, 1999, NEW ENGL J MED, V341, P1432, DOI 10.1056/NEJM199911043411904; Lee HK, 2009, J EXP MED, V206, P359, DOI 10.1084/jem.20080601; Leoni V, 2012, J VIROL, V86, P6555, DOI 10.1128/JVI.00295-12; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Liu T, 2001, J VIROL, V75, P11178, DOI 10.1128/JVI.75.22.11178-11184.2001; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Lubinski J, 1999, J EXP MED, V190, P1637, DOI 10.1084/jem.190.11.1637; Lubinski JM, 2002, J VIROL, V76, P9232, DOI 10.1128/JVI.76.18.9232-9241.2002; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; Mackay LK, 2012, J IMMUNOL, V188, P2173, DOI 10.4049/jimmunol.1102719; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Mark KE, 2007, J INFECT DIS, V195, P1324, DOI 10.1086/513276; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; McGraw HM, 2009, J VIROL, V83, P8315, DOI 10.1128/JVI.00633-09; McGraw HM, 2009, J VIROL, V83, P4791, DOI 10.1128/JVI.02341-08; MERTZ GJ, 1985, SEX TRANSM DIS, V12, P33, DOI 10.1097/00007435-198501000-00007; Mikloska Z, 1999, J VIROL, V73, P5934, DOI 10.1128/JVI.73.7.5934-5944.1999; Mikloska Z, 1998, J INFECT DIS, V177, P827, DOI 10.1086/515236; Mikloska Z, 2001, J VIROL, V75, P11821, DOI 10.1128/JVI.75.23.11821-11826.2001; Mueller SN, 2003, J VIROL, V77, P2445, DOI 10.1128/JVI.77.4.2445-2451.2003; Mueller SN, 2002, J EXP MED, V195, P651, DOI 10.1084/jem.20012023; Murray JM, 2005, P NATL ACAD SCI USA, V102, P17780, DOI 10.1073/pnas.0508913102; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Niehues T, 2004, J ALLERGY CLIN IMMUN, V114, P1456, DOI 10.1016/j.jaci.2004.08.047; Ohashi M, 2011, J VIROL, V85, P3030, DOI 10.1128/JVI.02426-10; Okuku HS, 2011, SEX TRANSM DIS, V38, P837, DOI 10.1097/OLQ.0b013e31821a6225; OTANI T, 1987, ARCH VIROL, V96, P1, DOI 10.1007/BF01310986; OVERALL JC, 1981, J INFECT DIS, V143, P543, DOI 10.1093/infdis/143.4.543; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Peng T, 2009, J VIROL, V83, P12559, DOI 10.1128/JVI.00939-09; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Phipps W, 2011, J INFECT DIS, V203, P180, DOI 10.1093/infdis/jiq035; Polcicova K, 2005, J VIROL, V79, P11990, DOI 10.1128/JVI.79.18.11990-12001.2005; Posavad CM, 1997, P NATL ACAD SCI USA, V94, P10289, DOI 10.1073/pnas.94.19.10289; Puttur FK, 2010, J IMMUNOL, V185, P477, DOI 10.4049/jimmunol.0904106; Reyes M, 2003, ARCH INTERN MED, V163, P76, DOI 10.1001/archinte.163.1.76; Roizman B, 2007, FIELDS VIROLOGY, V2, P2501, DOI DOI 10.1148/RADIOL.14144045; Sacks SL, 2004, ANTIVIR RES, V63, pS3, DOI 10.1016/j.antiviral.2004.06.002; Sancho-Shimizu V, 2007, CURR OPIN ALLERGY CL, V7, P495, DOI 10.1097/ACI.0b013e3282f151d2; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Schiffer JT, 2011, J ANTIMICROB CHEMOTH, V66, P2593, DOI 10.1093/jac/dkr346; Schiffer JT, 2011, J INFECT DIS, V204, P554, DOI 10.1093/infdis/jir314; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; SCRIBA M, 1976, MED MICROBIOL IMMUN, V162, P201, DOI 10.1007/BF02120998; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Sloan DD, 2006, J IMMUNOL, V176, P1825, DOI 10.4049/jimmunol.176.3.1825; Snyder A, 2008, J VIROL, V82, P10613, DOI 10.1128/JVI.01241-08; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; STANBERRY LR, 1985, INTERVIROLOGY, V24, P226, DOI 10.1159/000149647; STANBERRY LR, 1982, J INFECT DIS, V146, P397, DOI 10.1093/infdis/146.3.397; STEVENS JG, 1971, SCIENCE, V173, P843, DOI 10.1126/science.173.3999.843; STEVENS JG, 1988, J INFECT DIS, V158, P117, DOI 10.1093/infdis/158.1.117; Stock AT, 2011, IMMUNOL CELL BIOL, V89, P143, DOI 10.1038/icb.2010.66; Tata S, 2010, J INFECT DIS, V201, P499, DOI 10.1086/650302; Tobian AAR, 2012, J INFECT DIS, V205, P486, DOI 10.1093/infdis/jir767; Tobian AAR, 2009, J INFECT DIS, V199, P945, DOI 10.1086/597074; TORSETH JW, 1987, J INFECT DIS, V155, P641, DOI 10.1093/infdis/155.4.641; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; Umbach JL, 2010, J VIROL, V84, P1189, DOI 10.1128/JVI.01712-09; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Verjans GMGM, 2007, P NATL ACAD SCI USA, V104, P3496, DOI 10.1073/pnas.0610847104; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wakim LM, 2008, IMMUNOL CELL BIOL, V86, P666, DOI 10.1038/icb.2008.47; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Wang KN, 2005, J VIROL, V79, P14079, DOI 10.1128/JVI.79.22.14079-14087.2005; Weiss Helen, 2004, Herpes, V11 Suppl 1, p24A; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; WHITLEY RJ, 1995, CLIN INFECT DIS, V20, P414, DOI 10.1093/clinids/20.2.414; Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	149	66	70	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					280	290		10.1038/nm.3103	http://dx.doi.org/10.1038/nm.3103			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23467247	Green Accepted, Bronze			2022-12-27	WOS:000316040700020
J	Parpaleix, A; Houssen, YG; Charpak, S				Parpaleix, Alexandre; Houssen, Yannick Goulam; Charpak, Serge			Imaging local neuronal activity by monitoring PO2 transients in capillaries	NATURE MEDICINE			English	Article							CEREBRAL-BLOOD-FLOW; TISSUE OXYGENATION; INTRINSIC SIGNALS; OLFACTORY-BULB; BARREL CORTEX; RAT MESENTERY; ACTIVATION; SPECTROSCOPY; CONSUMPTION; MICROSCOPY	Two-photon phosphorescence lifetime microscopy (2PLM) has been used recently for depth measurements of oxygen partial pressure (PO2) in the rodent brain. In capillaries of olfactory bulb glomeruli, 2PLM has also allowed simultaneous measurements of PO2 and blood flow and revealed the presence of erythrocyte-associated transients (EATs), which are PO2 gradients that are associated with individual erythrocytes. We investigated the extent to which EAT properties in capillaries report local neuronal activity. We find that at rest, PO2 at EAT peaks overestimates the mean PO2 by 35 mm Hg. PO2 between two EAT peaks is at equilibrium with, and thus reports, PO2 in the neuropil. During odor stimulation, there is a small PO2 decrease before functional hyperemia, showing that the initial dip in PO2 is present at the level of capillaries. We conclude that imaging oxygen dynamics in capillaries provides a unique and noninvasive approach to map neuronal activity.	[Parpaleix, Alexandre; Houssen, Yannick Goulam; Charpak, Serge] INSERM, U603, Paris, France; [Parpaleix, Alexandre; Houssen, Yannick Goulam; Charpak, Serge] CNRS, UMR 8154, Paris, France; [Parpaleix, Alexandre; Houssen, Yannick Goulam; Charpak, Serge] Univ Paris 05, Lab Neurophysiol & New Microscopies, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Charpak, S (corresponding author), INSERM, U603, Paris, France.	serge.charpak@parisdescartes.fr	Charpak, Serge/M-9412-2017	GOULAM HOUSSEN, Yannick/0000-0002-1220-5105; PARPALEIX, Alexandre/0000-0001-9007-3155	INSERM; CNRS; Leducq Foundation; Human Frontier Science Program Organization (HSFPO); Agence Nationale de la Recherche; Fondation pour la Recherche Medicale	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Leducq Foundation(Leducq Foundation); Human Frontier Science Program Organization (HSFPO); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank S. Vinogradov (Department of Biochemistry and Biophysics, University of Pennsylvania) for providing PtP-C343 through the intermediate of Oxygen Enterprises. We also thank G. Bouchery and A. Virolle for help in animal surgery, S. Sasnouski for software improvements and M. Ducros, B. Weber and U. Lindauer for critical comments. Support was provided by INSERM, CNRS, the Leducq Foundation, the Human Frontier Science Program Organization (HSFPO), the Agence Nationale de la Recherche and the Fondation pour la Recherche Medicale.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Devor A, 2011, J NEUROSCI, V31, P13676, DOI 10.1523/JNEUROSCI.1968-11.2011; ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122; FEDERSPIEL WJ, 1986, MICROVASC RES, V32, P164, DOI 10.1016/0026-2862(86)90052-X; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Golub AS, 2008, AM J PHYSIOL-HEART C, V294, pH2905, DOI 10.1152/ajpheart.01347.2007; Golub AS, 2005, AM J PHYSIOL-HEART C, V288, pH2735, DOI 10.1152/ajpheart.00711.2004; Groebe K, 1989, Adv Exp Med Biol, V248, P175; HELLUMS JD, 1977, MICROVASC RES, V13, P131, DOI 10.1016/0026-2862(77)90122-4; HOMER LD, 1981, MICROVASC RES, V22, P308, DOI 10.1016/0026-2862(81)90099-6; Hudetz AG, 1997, MICROCIRCULATION, V4, P233, DOI 10.3109/10739689709146787; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Lecoq J, 2011, NAT MED, V17, P893, DOI 10.1038/nm.2394; Lecoq J, 2009, J NEUROSCI, V29, P1424, DOI 10.1523/JNEUROSCI.4817-08.2009; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Lindauer U, 2010, J CEREBR BLOOD F MET, V30, P757, DOI 10.1038/jcbfm.2009.259; Livneh Y, 2012, NAT NEUROSCI, V15, P26, DOI 10.1038/nn.2980; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Shepherd GM, 2008, NEURON, V58, P827, DOI 10.1016/j.neuron.2008.06.005; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Thompson JK, 2004, NAT NEUROSCI, V7, P919, DOI 10.1038/nn1308; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tsai AG, 2005, AM J PHYSIOL-HEART C, V289, pH1777, DOI 10.1152/ajpheart.00503.2005; WANG CH, 1993, MATH BIOSCI, V116, P89, DOI 10.1016/0025-5564(93)90062-F; Weber B, 2004, EUR J NEUROSCI, V20, P2664, DOI 10.1111/j.1460-9568.2004.03735.x	34	87	88	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					241	246		10.1038/nm.3059	http://dx.doi.org/10.1038/nm.3059			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23314058				2022-12-27	WOS:000314675900034
J	Ito, N; Ruegg, UT; Kudo, A; Miyagoe-Suzuki, Y; Takeda, S				Ito, Naoki; Ruegg, Urs T.; Kudo, Akira; Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi			Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy	NATURE MEDICINE			English	Article							NITRIC-OXIDE SYNTHASE; UP-REGULATION; IN-VIVO; ATROPHY; MTOR; PGC-1-ALPHA; PHYSIOLOGY; MECHANISM; PATHWAY	Skeletal muscle atrophy occurs in aging and pathological conditions, including cancer, diabetes and AIDS(1). Treatment of atrophy is based on either preventing protein-degradation pathways, which are activated during atrophy, or activating protein-synthesis pathways, which induce muscle hypertrophy(2). Here we show that neuronal nitric oxide synthase (nNOS) regulates load-induced hypertrophy by activating transient receptor potential cation channel, subfamily V, member 1 (TRPV1). The overload-induced hypertrophy was prevented in nNOS-null mice. nNOS was transiently activated within 3 min after overload. This activation promoted formation of peroxynitrite, a reaction product of nitric oxide with superoxide(3), which was derived from NADPH oxidase 4 (Nox4). Nitric oxide and peroxynitrite then activated Trpv1, resulting in an increase of intracellular Ca2+ concentration ([Ca2+](i)) that subsequently triggered activation of mammalian target of rapamycin (mTOR). Notably, administration of the TRPV1 agonist capsaicin induced hypertrophy without overload and alleviated unloading- or denervation-induced atrophy. These findings identify nitric oxide, peroxynitrite and [Ca2+](i) as the crucial mediators that convert a mechanical load into an intracellular signaling pathway and lead us to suggest that TRPV1 could be a new therapeutic target for treating muscle atrophy.	[Ito, Naoki; Miyagoe-Suzuki, Yuko; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1870031, Japan; [Ito, Naoki; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Yokohama, Kanagawa 227, Japan; [Ruegg, Urs T.] Univ Geneva, Geneva Lausanne Sch Pharmaceut Sci, Geneva, Switzerland	National Center for Neurology & Psychiatry - Japan; Tokyo Institute of Technology; University of Geneva	Takeda, S (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1870031, Japan.	takeda@ncnp.go.jp	Ito, Naoki/K-9327-2018; Kudo, Akira/C-7340-2015	Ito, Naoki/0000-0002-1884-8494; Kudo, Akira/0000-0001-6289-3391; RUEGG, Urs/0000-0001-6078-8280	Association Francaise contre les Myopathies (AFM, France)	Association Francaise contre les Myopathies (AFM, France)(Association Francaise contre les Myopathies)	We thank M. Kotlikoff (Department of Biomedical Science, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA) for providing pCAGGS-GCaMP2 mice, K.-H. Krause (Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland) for Nox4-null mice, Y. Ono for the technical support to isolate satellite cells and GenKyoTex (Geneva, Switzerland) for supplying GKT136901. We also thank D. Glass, I. Kii, V. Ullrich, B. Gahwiler and Y. Aoki for reading the manuscript and contributing to valuable discussions. This work was supported by a Grant-in-Aid for Scientific Research (B), a Grant-in-Aid for Japan Society for the Promotion of Science Fellows and a grant from the Association Francaise contre les Myopathies (AFM, France).	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Goodman CA, 2010, MOL BIOL CELL, V21, P3258, DOI 10.1091/mbc.E10-05-0454; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Heck DE, 2001, ANTIOXID REDOX SIGN, V3, P249, DOI 10.1089/152308601300185205; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Kemp-Harper B, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.19pe12; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Luo ZD, 2012, CELL RES, V22, P551, DOI 10.1038/cr.2011.205; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Pietri-Rouxel F, 2010, EMBO J, V29, P643, DOI 10.1038/emboj.2009.366; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sellman JE, 2006, J APPL PHYSIOL, V100, P258, DOI 10.1152/japplphysiol.00936.2005; Soltow QA, 2006, MED SCI SPORT EXER, V38, P840, DOI 10.1249/01.mss.0000218142.98704.66; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Wozniak AC, 2007, DEV DYNAM, V236, P240, DOI 10.1002/dvdy.21012; Xin H, 2005, BIOCHEM BIOPH RES CO, V332, P756, DOI 10.1016/j.bbrc.2005.05.016; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	199	209	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2013	19	1					101	106		10.1038/nm.3019	http://dx.doi.org/10.1038/nm.3019			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23202294				2022-12-27	WOS:000313230300031
J	McIntyre, JC; Davis, EE; Joiner, A; Williams, CL; Tsai, IC; Jenkins, PM; McEwen, DP; Zhang, L; Escobado, J; Thomas, S; Szymanska, K; Johnson, CA; Beales, PL; Green, ED; Mullikin, JC; Sabo, A; Muzny, DM; Gibbs, RA; Attie-Bitach, T; Yoder, BK; Reed, RR; Katsanis, N; Martens, JR				McIntyre, Jeremy C.; Davis, Erica E.; Joiner, Ariell; Williams, Corey L.; Tsai, I-Chun; Jenkins, Paul M.; McEwen, Dyke P.; Zhang, Lian; Escobado, John; Thomas, Sophie; Szymanska, Katarzyna; Johnson, Colin A.; Beales, Philip L.; Green, Eric D.; Mullikin, James C.; Sabo, Aniko; Muzny, Donna M.; Gibbs, Richard A.; Attie-Bitach, Tania; Yoder, Bradley K.; Reed, Randall R.; Katsanis, Nicholas; Martens, Jeffrey R.		NISC Comparative Sequencing Prog	Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model	NATURE MEDICINE			English	Article							INTRAFLAGELLAR TRANSPORT PROTEIN; MOUSE; MUTATIONS; ANOSMIA; ABNORMALITIES; DEGENERATION; EXPRESSION; SURVIVAL; MOTILITY; ALLELES	Cilia are evolutionarily conserved microtubule-based organelles that are crucial for diverse biological functions, including motility, cell signaling and sensory perception(1). In humans, alterations in the formation and function of cilia manifest clinically as ciliopathies, a growing class of pleiotropic genetic disorders(2-4). Despite the substantial progress that has been made in identifying genes that cause ciliopathies, therapies for these disorders are not yet available to patients. Although mice with a hypomorphic mutation in the intraflagellar transport protein IFT88 (Ift88(Tg737Rpw) mice, also known as ORPK mice)(5) have been well studied, the relevance of IFT88 mutations to human pathology is unknown. We show that a mutation in IFT88 causes a hitherto unknown human ciliopathy. In vivo complementation assays in zebrafish and mIMCD3 cells show the pathogenicity of this newly discovered allele. We further show that ORPK mice are functionally anosmic as a result of the loss of cilia on their olfactory sensory neurons (OSNs). Notably, adenoviral-mediated expression of IFT88 in mature, fully differentiated OSNs of ORPK mice is sufficient to restore ciliary structures and rescue olfactory function. These studies are the first to use in vivo therapeutic treatment to reestablish cilia in a mammalian ciliopathy. More broadly, our studies indicate that gene therapy is a viable option for cellular and functional rescue of the complex ciliary organelle in established differentiated cells.	[McIntyre, Jeremy C.; Joiner, Ariell; Williams, Corey L.; Jenkins, Paul M.; McEwen, Dyke P.; Zhang, Lian; Escobado, John; Martens, Jeffrey R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Davis, Erica E.; Tsai, I-Chun; Katsanis, Nicholas] Duke Univ, Med Ctr, Ctr Human Dis Modeling, Durham, NC USA; [Davis, Erica E.; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Davis, Erica E.; Tsai, I-Chun; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Thomas, Sophie; Attie-Bitach, Tania] Univ Paris 05, Dept Genet, Paris, France; [Thomas, Sophie; Attie-Bitach, Tania] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Szymanska, Katarzyna; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Beales, Philip L.] UCL, Mol Med Unit, Inst Child Hlth, London, England; [Green, Eric D.; Mullikin, James C.; NISC Comparative Sequencing Prog] NHGRI, US Natl Inst Hlth Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL USA; [Sabo, Aniko; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Reed, Randall R.] Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD USA	University of Michigan System; University of Michigan; Duke University; Duke University; Duke University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Saint James's University Hospital; University of Leeds; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; Johns Hopkins University	Martens, JR (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	martensj@umich.edu	thomas, sophie/GVS-1279-2022; Jenkins, Paul/C-9098-2015; ATTIE-BITACH, Tania/K-1453-2017; Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012; THOMAS, Sophie/F-4492-2017	Jenkins, Paul/0000-0002-4207-5823; ATTIE-BITACH, Tania/0000-0002-1155-3626; THOMAS, Sophie/0000-0002-8569-3277; Katsanis, Nicholas/0000-0002-2480-0171; Johnson, Colin/0000-0002-2979-8234; Davis, Erica/0000-0002-2412-8397	US National Institutes of Health [R01DC009606, F32DC011990, R01DC004553, R01DC008295, R01DK75996, R01EY021872, R01HD04260, R01DK072301, R01DK075972]; l'Agence National pour la Recherche (ANR) [2010 FOETOCILPATH 1122 01]; University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center [DK074083]; European Community's Seventh Framework Programme [241955]; MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021872] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, U54HG003273, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK094578, R01DK075996, R01DK075972, R01DK072301, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC011990, R01DC004553, R01DC008295, T32DC000011, R01DC009606] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); l'Agence National pour la Recherche (ANR)(French National Research Agency (ANR)); University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center; European Community's Seventh Framework Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was support by US National Institutes of Health grants R01DC009606 (J.R.M.), F32DC011990 (J.C.M.), R01DC004553, R01DC008295 (R.R.R.), R01DK75996 (B.K.Y.), R01EY021872 (E.E.D.), R01HD04260, R01DK072301 and R01DK075972 (N.K.), by l'Agence National pour la Recherche (ANR) 2010 FOETOCILPATH 1122 01 (T.A.-B.) and by the University of Alabama at Birmingham Hepatorenal Fibrocystic Disease Core Center (DK074083). E.E.D., C.A.J., P.L.B. and N.K. are supported by the European Community's Seventh Framework Programme FP7/2009 under grant agreement 241955, SYSCILIA. N.K. is a Distinguished Jean and George W. Brumley Professor. We thank P. Loget for referring the family for this study, S. Dugan-Rocha, U. Nagaswamy and A. Hawes for assistance with mutational screening and R. Margolskee (Mount Sinai School of Medicine of New York University) for providing antibodies.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Arts HH, 2011, J MED GENET, V48, P390, DOI 10.1136/jmg.2011.088864; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; BAKER H, 1983, J NEUROSCI, V3, P69; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Bennett MK, 2010, MOL CELL NEUROSCI, V43, P353, DOI 10.1016/j.mcn.2010.01.002; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Bredrup C, 2011, AM J HUM GENET, V89, P634, DOI 10.1016/j.ajhg.2011.10.001; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Coon BG, 2012, HUM MOL GENET, V21, P1835, DOI 10.1093/hmg/ddr615; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Friedland-Little JM, 2011, HUM MOL GENET, V20, P3725, DOI 10.1093/hmg/ddr241; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Ivic L, 2000, NAT NEUROSCI, V3, P1113, DOI 10.1038/80632; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lehman JM, 2008, DEV DYNAM, V237, P1960, DOI 10.1002/dvdy.21515; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; MALICK LE, 1975, STAIN TECHNOL, V50, P265, DOI 10.3109/10520297509117069; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; RISSER JM, 1987, PHYSIOL BEHAV, V40, P545, DOI 10.1016/0031-9384(87)90042-4; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Simons DL, 2011, P NATL ACAD SCI USA, V108, P6276, DOI 10.1073/pnas.1019222108; Sommardahl CS, 1997, PEDIATR NEPHROL, V11, P728, DOI 10.1007/s004670050376; Tadenev ALD, 2011, P NATL ACAD SCI USA, V108, P10320, DOI 10.1073/pnas.1016531108; Tsujikawa M, 2004, NEURON, V42, P703, DOI 10.1016/S0896-6273(04)00268-5; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; VARENDI H, 1994, LANCET, V344, P989, DOI 10.1016/S0140-6736(94)91645-4; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; Willaredt MA, 2008, J NEUROSCI, V28, P12887, DOI 10.1523/JNEUROSCI.2084-08.2008; Zaghloul NA, 2010, P NATL ACAD SCI USA, V107, P10602, DOI 10.1073/pnas.1000219107; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	40	74	78	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1423	+		10.1038/nm.2860	http://dx.doi.org/10.1038/nm.2860			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22941275	Green Accepted			2022-12-27	WOS:000308472300040
J	Bernard, JJ; Cowing-Zitron, C; Nakatsuji, T; Muehleisen, B; Muto, J; Borkowski, AW; Martinez, L; Greidinger, EL; Yu, BD; Gallo, RL				Bernard, Jamie J.; Cowing-Zitron, Christopher; Nakatsuji, Teruaki; Muehleisen, Beda; Muto, Jun; Borkowski, Andrew W.; Martinez, Laisel; Greidinger, Eric L.; Yu, Benjamin D.; Gallo, Richard L.			Ultraviolet radiation damages self noncoding RNA and is detected by TLR3	NATURE MEDICINE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; DNA-DAMAGE; SKIN; ACTIVATION; LIGHT; IRRADIATION; CELLS; GENE; PART	Exposure to ultraviolet B (UVB) radiation from the sun can result in sunburn, premature aging and carcinogenesis, but the mechanism responsible for acute inflammation of the skin is not well understood. Here we show that RNA is released from keratinocytes after UVB exposure and that this stimulates production of the inflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) from nonirradiated keratinocytes and peripheral blood mononuclear cells (PBMCs). Whole-transcriptome sequencing revealed that UVB irradiation of keratinocytes induced alterations in the double-stranded domains of some noncoding RNAs. We found that this UVB-damaged RNA was sufficient to induce cytokine production from nonirradiated cells, as UVB irradiation of a purified noncoding RNA (U1 RNA) reproduced the same response as the one we observed to UVB-damaged keratinocytes. The responses to both UVB-damaged self-RNAs and UVB-damaged keratinocytes were dependent on Toll-like receptor 3 (TLR3) and Toll-like receptor adaptor molecule 1 (TRIF). In response to UVB exposure, Tlr3(-/-) mice did not upregulate TNF-alpha in the skin. Moreover, TLR3 was also necessary for UVB-radiation-induced immune suppression. These findings establish that UVB damage is detected by TLR3 and that self-RNA is a damage-associated molecular pattern that serves as an endogenous signal of solar injury.	[Bernard, Jamie J.; Cowing-Zitron, Christopher; Nakatsuji, Teruaki; Muehleisen, Beda; Muto, Jun; Borkowski, Andrew W.; Yu, Benjamin D.; Gallo, Richard L.] Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA; [Bernard, Jamie J.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ USA; [Martinez, Laisel; Greidinger, Eric L.] Miami Vet Affairs Med Ctr, Miami, FL USA; [Greidinger, Eric L.] Univ Miami, Miller Sch Med, Div Rheumatol, Miami, FL 33136 USA; [Gallo, Richard L.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; Rutgers State University New Brunswick; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Gallo, RL (corresponding author), Univ Calif San Diego, Div Dermatol, San Diego, CA 92103 USA.	rgallo@ucsd.edu	Gallo, Richard L/A-8931-2009; Nakatsuji, Teruaki/O-6794-2014	Gallo, Richard L/0000-0002-1401-7861; Nakatsuji, Teruaki/0000-0002-6187-2991; Yu, Benjamin/0000-0001-6663-6616; Martinez, Laisel/0000-0002-3009-8761; Bernard, Jamie/0000-0002-3800-2576; Greidinger, Eric/0000-0003-3473-3846	US National Institutes of Health (NIH) [R01-AR052728, NIH R01-AI052453, R01 AI0833358]; Veterans Affairs Merit Award [NIH R01-AR056667]; US National Institute of Environmental Health Sciences (NIEHS) [ES007148]; NIEHS Center [ES005022]; Department of Veterans Affairs [NIH AR48805]; Lupus Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052453, R37AI052453, R01AI083358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056667, R01AR052728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022, T32ES007148] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); US National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Veterans Affairs(US Department of Veterans Affairs); Lupus Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Head from The Scripps Research Institute DNA Core Facility for performing RNA-Seq. We thank B. Gilchrest (Boston University, Boston, MA) for telomere oligonucleotides and advice, J. Laskin for advice and helpful discussion and M. Karin (University of California, San Diego, San Diego, CA) for providing Il1r<SUP>-/-</SUP> mice and for helpful discussion. This work was supported by US National Institutes of Health (NIH) grants R01-AR052728, NIH R01-AI052453 and R01 AI0833358 and a Veterans Affairs Merit Award to R. L. G., NIH R01-AR056667 to B.D.Y., the US National Institute of Environmental Health Sciences (NIEHS) Training Grant ES007148 and the NIEHS Center Grant ES005022 supporting J. J. B., and the Department of Veterans Affairs, NIH AR48805 and the Lupus Research Institute to E. L. G.	AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; DEFABO EC, 1983, J EXP MED, V158, P84, DOI 10.1084/jem.158.1.84; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilchrest BA, 2009, J INVEST DERM SYMP P, V14, P25, DOI 10.1038/jidsymp.2009.9; GRISWOLD DE, 1991, J INVEST DERMATOL, V97, P1019, DOI 10.1111/1523-1747.ep12492422; Hoffman RW, 2004, ARTHRITIS RHEUM-US, V50, P2891, DOI 10.1002/art.20428; Kosmadaki MG, 2004, MICRON, V35, P155, DOI 10.1016/j.micron.2003.11.002; KUTSCH CL, 1993, J INVEST DERMATOL, V101, P79, DOI 10.1111/1523-1747.ep12360119; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; MURPHY GM, 1989, PHOTODERMATOLOGY, V6, P268; NORVAL M, 1989, PHOTODERMATOLOGY, V6, P142; SCHWARZ A, 1995, J INVEST DERMATOL, V104, P922, DOI 10.1111/1523-1747.ep12606202; SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363; SONTAG Y, 1995, J INVEST DERMATOL, V104, P734, DOI 10.1111/1523-1747.ep12606971; VERMEER M, 1990, PHOTODERMATOL PHOTO, V7, P258; VINCEK V, 1993, CANCER RES, V53, P728; WALSH LJ, 1995, IMMUNOL CELL BIOL, V73, P226, DOI 10.1038/icb.1995.37; Wei YD, 1999, CHEM-BIOL INTERACT, V118, P127, DOI 10.1016/S0009-2797(98)00118-5; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]	27	272	275	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1286	+		10.1038/nm.2861	http://dx.doi.org/10.1038/nm.2861			18	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22772463	Green Accepted			2022-12-27	WOS:000307469300036
J	Dulauroy, S; Di Carlo, SE; Langa, F; Eberl, G; Peduto, L				Dulauroy, Sophie; Di Carlo, Selene E.; Langa, Francina; Eberl, Gerard; Peduto, Lucie			Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury	NATURE MEDICINE			English	Article							CREST STEM-CELLS; NEURAL CREST; MUSCLE REGENERATION; SKELETAL-MUSCLE; MELTRIN ALPHA; IN-VIVO; EXPRESSION; BETA; MOUSE; DIFFERENTIATION	Profibrotic cells that develop upon injury generate permanent scar tissue and impair organ recovery, though their origin and fate are unclear. Here we show that transient expression of ADAM12 (a disintegrin and metalloprotease 12) identifies a distinct proinflammatory subset of platelet-derived growth factor receptor-alpha-positive stromal cells that are activated upon acute injury in the muscle and dermis. By inducible genetic fate mapping, we demonstrate in vivo that injury-induced ADAM12(+) cells are specific progenitors of a major fraction of collagen-overproducing cells generated during scarring, which are progressively eliminated during healing. Genetic ablation of ADAM12(+) cells, or knockdown of ADAM12, is sufficient to limit generation of profibrotic cells and interstitial collagen accumulation. ADAM12(+) cells induced upon injury are developmentally distinct from muscle and skin lineage cells and are derived from fetal ADAM12(+) cells programmed during vascular wall development. Thus, our data identify injury-activated profibrotic progenitors residing in the perivascular space that can be targeted through ADAM12 to limit tissue scarring.	[Dulauroy, Sophie; Di Carlo, Selene E.; Eberl, Gerard; Peduto, Lucie] Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France; [Dulauroy, Sophie; Di Carlo, Selene E.; Eberl, Gerard; Peduto, Lucie] CNRS, Unite Rech Associee URA 1961, Paris, France; [Langa, Francina] Inst Pasteur, Ctr Ingn Genet Murine, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Peduto, L (corresponding author), Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France.	lucie.peduto@pasteur.fr	Eberl, Gerard/A-1160-2013	Peduto, Lucie/0000-0003-2414-4407; Eberl, Gerard/0000-0002-1119-5638; di carlo, selene/0000-0001-5315-102X	Institut Pasteur; Mairie de Paris; Agence Nationale de la Recherche; European Commission; La Ligue contre le Cancer	Institut Pasteur(European Commission); Mairie de Paris(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); La Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was funded by the Institut Pasteur, grants from the Mairie de Paris, the Agence Nationale de la Recherche and an Excellence grant from the European Commission. S.E.D.C. is funded by La Ligue contre le Cancer. We thank H.-J. Fehling (University Clinics Ulm, Ulm, Germany) for providing the Rosa26<SUP>floxSTOP-RFP</SUP> mice, H. Bujard (ZMBH, Heidelberg, Germany) for providing the LC-1 mice and A. Farr (University of Washington, Seattle) for gp38-specific antibody. We thank L. Polomack and the team of the Centre d'Ingenierie Genetique Murine for technical assistance and members of the Development of Lymphoid Tissue Unit for discussions.	Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Atfi A, 2007, J CELL BIOL, V178, P201, DOI 10.1083/jcb.200612046; Betancur P, 2010, ANNU REV CELL DEV BI, V26, P581, DOI 10.1146/annurev.cellbio.042308.113245; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Buchstaller J, 2004, J NEUROSCI, V24, P2357, DOI 10.1523/JNEUROSCI.4083-03.2004; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Griffin JW, 2008, GLIA, V56, P1518, DOI 10.1002/glia.20778; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jorgensen LH, 2007, AM J PATHOL, V171, P1599, DOI 10.2353/ajpath.2007.070435; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023; Le Pabic H, 2003, HEPATOLOGY, V37, P1056, DOI 10.1053/jhep.2003.50205; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; PAPPENHEIMER AM, 1982, J INFECT DIS, V145, P94, DOI 10.1093/infdis/145.1.94; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Real C, 2005, INT J DEV BIOL, V49, P151, DOI 10.1387/ijdb.041940cr; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Skubitz KM, 2004, J LAB CLIN MED, V143, P89, DOI 10.1016/j.lab.2003.10.002; Solomon E, 2010, J BIOL CHEM, V285, P21969, DOI 10.1074/jbc.M110.133314; Sparwasser T, 2004, GENESIS, V38, P39, DOI 10.1002/gene.10249; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003	57	279	284	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1262	+		10.1038/nm.2848	http://dx.doi.org/10.1038/nm.2848			20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22842476	Green Published			2022-12-27	WOS:000307469300033
J	Birsoy, K; Sabatini, DM; Possemato, R				Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard			Targeting cancer metabolism: a bedside lesson	NATURE MEDICINE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; PANCREATIC-CANCER; DIABETIC-PATIENTS; BREAST-CANCER; CELL-GROWTH; METFORMIN; PROLIFERATION; RESTRICTION; MUTATIONS; MECHANISM		[Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] MIT, Dept Biol, Cambridge, MA USA; [Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] Broad Inst, Cambridge, MA USA; [Birsoy, Kivanc; Sabatini, David M.; Possemato, Richard] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Birsoy, K (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	posse@wi.mit.edu		Possemato, Richard/0000-0002-2401-0030; /0000-0002-1446-7256	NCI NIH HHS [K99 CA168940] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K99CA168940] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; BROOME JD, 1981, CANCER TREAT REP, V65, P111; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Clark RAF, 2009, J INVEST DERMATOL, V129, P529, DOI 10.1038/jid.2008.441; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Sanli Y, 2012, ANN NUCL MED, V26, P345, DOI 10.1007/s12149-012-0579-2; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Seyfried BTN, 2009, J CANCER RES THER, V5, P7, DOI 10.4103/0973-1482.55134; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	21	51	53	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1022	1023		10.1038/nm.2870	http://dx.doi.org/10.1038/nm.2870			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772555				2022-12-27	WOS:000306121600030
J	Zilinskas, RA				Zilinskas, Raymond A.			Take Russia to 'task' on bioweapons transparency	NATURE MEDICINE			English	Editorial Material								In the run-up to his reelection, Russian president Vladimir Putin outlined 28 tasks to be undertaken by his administration, including one that commanded the development of weapons based on "genetic principles." Political pressure must be applied by governments and professional societies to ensure that there is not a modern reincarnation of the Soviet biological warfare program.	Monterey Inst Int Studies, Chem & Biol Weap Nonproliferat Program, Monterey, CA 93940 USA		Zilinskas, RA (corresponding author), Monterey Inst Int Studies, Chem & Biol Weap Nonproliferat Program, Monterey, CA 93940 USA.								0	2	2	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					850	850		10.1038/nm0612-850	http://dx.doi.org/10.1038/nm0612-850			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673989	Bronze			2022-12-27	WOS:000305116600015
J	Schober, A; Nazari-Jahantigh, M; Wei, YY; Bidzhekov, K; Gremse, F; Grommes, J; Megens, RTA; Heyll, K; Noels, H; Hristov, M; Wang, SS; Kiessling, F; Olson, EN; Weber, C				Schober, Andreas; Nazari-Jahantigh, Maliheh; Wei, Yuanyuan; Bidzhekov, Kiril; Gremse, Felix; Grommes, Jochen; Megens, Remco T. A.; Heyll, Kathrin; Noels, Heidi; Hristov, Michael; Wang, Shusheng; Kiessling, Fabian; Olson, Eric N.; Weber, Christian			MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1	NATURE MEDICINE			English	Article							ARTERIAL ENDOTHELIUM; CELL REPAIR; IN-VIVO; APOPTOSIS; MIR-126; ACTIVATION; INJURY; FLOW; REPLICATION; DYSFUNCTION	Atherosclerosis, a hyperlipidemia-induced chronic inflammatory process of the arterial wall, develops preferentially at sites where disturbed laminar flow compromises endothelial cell (EC) function. Here we show that endothelial miR-126-5p maintains a proliferative reserve in ECs through suppression of the Notch1 inhibitor delta-like 1 homolog (Dlk1) and thereby prevents atherosclerotic lesion formation. Endothelial recovery after denudation was impaired in Mir126(-/-) mice because lack of miR-126-5p, but not miR-126-3p, reduced EC proliferation by derepressing Dlk1. At nonpredilection sites, high miR-126-5p levels in endothelial cells confer a proliferative reserve that compensates for the antiproliferative effects of hyperlipidemia, such that atherosclerosis was exacerbated in Mir126(-/-) mice. In contrast, downregulation of miR-126-5p by disturbed flow abrogated EC proliferation at predilection sites in response to hyperlipidemic stress through upregulation of Dlk1 expression. Administration of miR-126-5p rescued EC proliferation at predilection sites and limited atherosclerosis, introducing a potential therapeutic approach.	[Schober, Andreas; Nazari-Jahantigh, Maliheh; Wei, Yuanyuan; Bidzhekov, Kiril; Megens, Remco T. A.; Heyll, Kathrin; Hristov, Michael; Weber, Christian] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Schober, Andreas; Nazari-Jahantigh, Maliheh; Wei, Yuanyuan; Heyll, Kathrin; Noels, Heidi; Weber, Christian] Rheinisch Westfal Tech Hsch RWTH Aachen Univ, Inst Mol Cardiovasc Res, Aachen, Germany; [Schober, Andreas; Weber, Christian] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Gremse, Felix; Kiessling, Fabian] Rhein Westfal TH Aachen, Dept Expt Mol Imaging, Aachen, Germany; [Grommes, Jochen] Rhein Westfal TH Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany; [Grommes, Jochen] Med Univ Maastricht, Maastricht, Netherlands; [Wang, Shusheng] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Weber, Christian] Univ Maastricht, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	University of Munich; RWTH Aachen University; German Centre for Cardiovascular Research; Munich Heart Alliance; RWTH Aachen University; Maastricht University; RWTH Aachen University; Maastricht University; Maastricht University Medical Centre (MUMC); Tulane University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Maastricht University	Schober, A (corresponding author), Univ Munich, Inst Cardiovasc Prevent, Munich, Germany.	aschober@med.lmu.de; chweber@med.lmu.de	Wei, Yuanyuan/H-7963-2014; Jahantigh, Maliheh Nazari/B-4304-2013; Noels, Heidi/AAQ-2622-2020; Weber, Christian/AAW-2153-2020; Kiessling, Fabian/Y-2417-2019; Schober, Andreas/B-2866-2013	Wei, Yuanyuan/0000-0003-0635-6879; Jahantigh, Maliheh Nazari/0000-0002-1094-107X; Weber, Christian/0000-0003-4610-8714; Kiessling, Fabian/0000-0002-7341-0399; Schober, Andreas/0000-0001-7798-136X; Grommes, Jochen/0000-0002-6419-6802; megens, remco/0000-0001-9871-6696	Deutsche Forschungsgemeinschaft, Germany [FOR809, WE1913/11-2, SCHO1056/3-2]; German Federal Ministry of Education and Research [01KU1213A]; German Centre for Cardiovascular Research [MHA VD1.2]; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany; NATIONAL EYE INSTITUTE [R01EY021862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093039, R01HL077439, R01HL111665, U01HL100401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Centre for Cardiovascular Research; Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.S., F.K. and C.W. are funded by the Deutsche Forschungsgemeinschaft, Germany (FOR809, WE1913/11-2 and SCHO1056/3-2). A.S. and C.W. are funded by the German Federal Ministry of Education and Research (01KU1213A) and by the German Centre for Cardiovascular Research (MHA VD1.2). M.N.-J. was funded by the Interdisciplinary Centre for Clinical Research within the Faculty of Medicine at RWTH Aachen University, Germany. We thank J. Schmidt (University of Illinois) and R. H. Adams (Max-Planck-Institute for Molecular Biomedicine) for providing Dlk1<SUP>flox</SUP> and Bmx-Cre<SUP>ERT2</SUP> mice, respectively. We thank L. Natarelli, L. Pawig, J. Corbalan Campos, R. Soltan, M. Garbe, C. Geissler, P. Hartmann and S. Elbin for technical assistance.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Akhtar S, 2013, ARTERIOSCL THROM VAS, V33, P679, DOI 10.1161/ATVBAHA.112.301162; Ando J, 2011, ANTIOXID REDOX SIGN, V15, P1389, DOI 10.1089/ars.2010.3361; Appelbe OK, 2013, MECH DEVELOP, V130, P143, DOI 10.1016/j.mod.2012.09.010; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bidzhekov K, 2007, J CELL MOL MED, V11, P1395, DOI 10.1111/j.1582-4934.2007.00123.x; Chen CH, 2000, CIRCULATION, V101, P171, DOI 10.1161/01.CIR.101.2.171; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Colles SM, 2001, TRENDS CARDIOVAS MED, V11, P131, DOI 10.1016/S1050-1738(01)00106-2; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Foteinos G, 2008, CIRCULATION, V117, P1856, DOI 10.1161/CIRCULATIONAHA.107.746008; Gremse F, 2011, RADIOLOGY, V260, P709, DOI 10.1148/radiol.11110069; HANSSON GK, 1985, AM J PATHOL, V121, P123; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Itoh Y, 2010, ARTERIOSCL THROM VAS, V30, P1725, DOI 10.1161/ATVBAHA.110.207365; Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720; Kaiser D, 1997, BIOCHEM BIOPH RES CO, V231, P586, DOI 10.1006/bbrc.1997.6146; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lechman ER, 2012, CELL STEM CELL, V11, P799, DOI 10.1016/j.stem.2012.09.001; Mocharla P, 2013, BLOOD, V121, P226, DOI 10.1182/blood-2012-01-407106; Mortensen SB, 2012, DIABETES, V61, P2814, DOI 10.2337/db12-0176; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Neth P, 2013, CARDIOVASC RES, V99, P294, DOI 10.1093/cvr/cvt096; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Nielsen LB, 1996, ATHEROSCLEROSIS, V123, P1, DOI 10.1016/0021-9150(96)05802-9; Nuovo GJ, 2009, BIOTECHNIQUES, V46, P115, DOI 10.2144/000113068; Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155; Rodriguez P, 2012, CARDIOVASC RES, V93, P232, DOI 10.1093/cvr/cvr296; Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje; Schmitt MMN, 2014, CIRCULATION, V129, P66, DOI 10.1161/CIRCULATIONAHA.113.004149; Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A; SCHWARTZ SM, 1977, CIRC RES, V41, P248, DOI 10.1161/01.RES.41.2.248; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wei YY, 2013, CIRCULATION, V127, P1609, DOI 10.1161/CIRCULATIONAHA.112.000736; Wei YY, 2013, ARTERIOSCL THROM VAS, V33, P449, DOI 10.1161/ATVBAHA.112.300279; WRIGHT HP, 1968, NATURE, V220, P78, DOI 10.1038/220078a0; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	47	456	476	7	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					368	+		10.1038/nm.3487	http://dx.doi.org/10.1038/nm.3487			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24584117	Green Accepted			2022-12-27	WOS:000334361500017
J	Kim, HY; Lee, HJ; Chang, YJ; Pichavant, M; Shore, SA; Fitzgerald, KA; Iwakura, Y; Israel, E; Bolger, K; Faul, J; DeKruyff, RH; Umetsu, DT				Kim, Hye Young; Lee, Hyun Jun; Chang, Ya-Jen; Pichavant, Muriel; Shore, Stephanie A.; Fitzgerald, Katherine A.; Iwakura, Yoichiro; Israel, Elliot; Bolger, Kenneth; Faul, John; DeKruyff, Rosemarie H.; Umetsu, Dale T.			Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity	NATURE MEDICINE			English	Article							BODY-MASS INDEX; DIET-INDUCED OBESITY; ROR-GAMMA-T; ALLERGIC-ASTHMA; INSULIN-RESISTANCE; ADAPTIVE IMMUNITY; ADIPOSE-TISSUE; ALUMINUM ADJUVANT; TH17 CELLS; MICE	Obesity is associated with the development of asthma, which is often difficult to control. To understand the immunological pathways that lead to obesity-associated asthma, we fed mice a high-fat diet for 12 weeks, which resulted in obesity and the development of airway hyperreactivity (AHR), a cardinal feature of asthma. This AHR was independent of adaptive immunity, as it occurred in obese Rag1(-/-) mice, which lack B and T cells, and was dependent on interleukin-17A (IL-17A) and the NLRP3 inflammasome, as it did not develop in obese Il17a(-/-) or Nlrp3(-/-) mice. AHR was also associated with the expansion of CCR6(+) type 3 innate lymphoid cells (ILCs) producing IL-17A (ILC3 cells) in the lung, which could by themselves mediate AHR when adoptively transferred into Rag2(-/-) ; Il2rg(-/-) mice treated with recombinant IL-1 beta. Macrophage-derived IL-1 beta production was induced by HFD and expanded the number of lung ILC3 cells. Blockade of IL-1 beta with an IL-1 receptor antagonist abolished obesity-induced AHR and reduced the number of ILC3 cells. As we found ILC3-like cells in the bronchoalveolar lavage fluid of individuals with asthma, we suggest that obesity-associated asthma is facilitated by inflammation mediated by NLRP3, IL-1 beta and ILC3 cells.	[Kim, Hye Young; Lee, Hyun Jun; Chang, Ya-Jen; Pichavant, Muriel; DeKruyff, Rosemarie H.; Umetsu, Dale T.] Harvard Univ, Sch Med, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA; [Shore, Stephanie A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo, Japan; [Israel, Elliot] Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care, Sch Med,Dept Med, Boston, MA 02115 USA; [Bolger, Kenneth; Faul, John] Connolly Hosp Blanchardstown, Resp Dept, Dublin, Ireland	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Umetsu, DT (corresponding author), Harvard Univ, Sch Med, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA.	umetsud@gene.com	Pichavant, Muriel/B-9036-2018; Kim, Hye Young/AAF-7609-2020; Fitzgerald, Katherine/ABE-6317-2020; Chang, Ya-Jen/O-1584-2018; Iwakura, Yoichiro/E-5457-2011	Pichavant, Muriel/0000-0002-1315-4397; Kim, Hye Young/0000-0001-5978-512X; Chang, Ya-Jen/0000-0003-1377-6142; Iwakura, Yoichiro/0000-0002-9934-5775; Fitzgerald, Kate/0000-0003-3175-609X	US National Institutes of Health [RO1AI068085, RO1HL62348, ES013307]; D. and D. Bunning Food Allergy Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R01AI068085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013307] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D. and D. Bunning Food Allergy Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the National Institutes of Health Tetramer Facility, Emory University, Atlanta, Georgia, for providing CD1d tetramers. This work was supported by grants RO1AI068085, RO1HL62348 and ES013307 from the US National Institutes of Health and with funds from The D. and D. Bunning Food Allergy Project.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Allen IC, 2012, J IMMUNOL, V188, P2884, DOI 10.4049/jimmunol.1102488; Arteaga-Solis E, 2013, CELL METAB, V17, P35, DOI 10.1016/j.cmet.2012.12.004; Besnard AG, 2011, ALLERGY, V66, P1047, DOI 10.1111/j.1398-9995.2011.02586.x; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Calixto MC, 2010, BRIT J PHARMACOL, V159, P617, DOI 10.1111/j.1476-5381.2009.00560.x; Camargo CA, 1999, ARCH INTERN MED, V159, P2582, DOI 10.1001/archinte.159.21.2582; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chen Y, 2006, CHEST, V130, P890, DOI 10.1378/chest.130.3.890; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Dixon AE, 2011, J ALLERGY CLIN IMMUN, V128, P508, DOI 10.1016/j.jaci.2011.06.009; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farah CS, 2012, RESPIROLOGY, V17, P412, DOI 10.1111/j.1440-1843.2011.02080.x; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lu FL, 2006, AM J PHYSIOL-LUNG C, V290, pL856, DOI 10.1152/ajplung.00386.2005; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Scott HA, 2011, EUR RESPIR J, V38, P594, DOI 10.1183/09031936.00139810; Shore SA, 2010, J APPL PHYSIOL, V108, P735, DOI 10.1152/japplphysiol.00749.2009; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Sutherland ER, 2009, J ALLERGY CLIN IMMUN, V123, P1328, DOI 10.1016/j.jaci.2009.04.005; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Williams AS, 2013, PULM PHARMACOL THER, V26, P444, DOI 10.1016/j.pupt.2012.05.001; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wolterink RGJK, 2012, EUR J IMMUNOL, V42, P1106, DOI 10.1002/eji.201142018	64	410	429	4	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					54	+		10.1038/nm.3423	http://dx.doi.org/10.1038/nm.3423			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24336249	Green Accepted, Green Submitted			2022-12-27	WOS:000329349400019
J	Hackl, MJ; Burford, JL; Villanueva, K; Lam, L; Susztak, K; Schermer, B; Benzing, T; Peti-Peterdi, J				Hackl, Matthias J.; Burford, James L.; Villanueva, Katie; Lam, Lisa; Susztak, Katalin; Schermer, Bernhard; Benzing, Thomas; Peti-Peterdi, Janos			Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags	NATURE MEDICINE			English	Article							URETERAL OBSTRUCTION; ATUBULAR GLOMERULI; NEPHROTIC SYNDROME; PODOCYTES; INJURY; MICE; RECOMBINASE; RECRUITMENT; PROTEINURIA; REVEALS	Podocytes are critical in the maintenance of a healthy glomerular filter; however, they have been difficult to study in the intact kidney because of technical limitations. Here we report the development of serial multiphoton microscopy (MPM) of the same glomeruli over several days to visualize the motility of podocytes and parietal epithelial cells (PECs) in vivo. In podocin-GFP mice, podocytes formed sporadic multicellular clusters after unilateral ureteral ligation and migrated into the parietal Bowman's capsule. The tracking of single cells in podocin-confetti mice featuring cell-specific expression of CFP, GFP, YFP or RFP revealed the simultaneous migration of multiple podocytes. In phosphoenolpyruvate carboxykinase (PEPCK)-GFP mice, serial MPM found PEC-to-podocyte migration and nanotubule connections. Our data support a highly dynamic rather than a static nature of the glomerular environment and cellular composition. Future application of this new approach should advance our understanding of the mechanisms of glomerular injury and regeneration.	[Hackl, Matthias J.; Burford, James L.; Villanueva, Katie; Lam, Lisa; Peti-Peterdi, Janos] Univ So Calif, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Hackl, Matthias J.; Burford, James L.; Villanueva, Katie; Lam, Lisa; Peti-Peterdi, Janos] Univ So Calif, Dept Med, Los Angeles, CA USA; [Hackl, Matthias J.; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Dept Internal Med 2, D-50931 Cologne, Germany; [Hackl, Matthias J.; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA	University of Southern California; University of Southern California; University of Cologne; University of Cologne; University of Pennsylvania	Peti-Peterdi, J (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90089 USA.	petipete@usc.edu	Susztak, Katalin/ABE-7474-2021; Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014	Susztak, Katalin/0000-0002-1005-3726; Schermer, Bernhard/0000-0002-5194-9000; Burford, James/0000-0001-9714-8578; Hackl, Matthias/0000-0002-4199-3374; Peti-Peterdi, Janos/0000-0003-4092-6185	US National Institutes of Health [DK64324, DK076077]; American Diabetes Association [1-11-BS-121]; University Kidney Research Organization; Deutsche Forschungsgemeinschaft [SFB635, HA-6212]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076077, R01DK064324] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); University Kidney Research Organization; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by US National Institutes of Health grant DK64324, American Diabetes Association grant 1-11-BS-121 and the University Kidney Research Organization to J.P.-P., Deutsche Forschungsgemeinschaft grant SFB635 to T.B. and US National Institutes of Health grant DK076077 to K.S. M.J.H. was supported by Deutsche Forschungsgemeinschaft grant HA-6212. We thank M. Hammerschmidt and H.-M. Pogoda (Institute of Developmental Biology, University of Cologne) for granting access to their imaging facility. We thank ER. Danesh (Baylor College of Medicine) and V. Haase (Vanderbilt University) for providing podocin-iCreER<SUP>T2</SUP> and PEPCK-Cre mice, respectively.	Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Benigni A, 2011, AM J PATHOL, V179, P628, DOI 10.1016/j.ajpath.2011.04.003; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Dai CS, 2010, KIDNEY INT, V77, P962, DOI 10.1038/ki.2010.40; Devi S, 2013, NAT MED, V19, P107, DOI 10.1038/nm.3024; Forbes MS, 2011, AM J PHYSIOL-RENAL, V301, pF110, DOI 10.1152/ajprenal.00022.2011; Gibson IW, 1996, J PATHOL, V179, P421; Grgic I, 2012, J AM SOC NEPHROL, V23, P785, DOI 10.1681/ASN.2011100988; Hohne M, 2013, AM J PATHOL, V182, P332, DOI 10.1016/j.ajpath.2012.11.002; Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kang JJ, 2006, AM J PHYSIOL-RENAL, V291, pF495, DOI 10.1152/ajprenal.00521.2005; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoury CC, 2012, BIOCHEM BIOPH RES CO, V427, P525, DOI 10.1016/j.bbrc.2012.09.089; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakano D, 2012, J AM SOC NEPHROL, V23, P1847, DOI 10.1681/ASN.2012010078; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Peti-Peterdi J, 2012, AM J PHYSIOL-RENAL, V302, pF227, DOI 10.1152/ajprenal.00561.2011; Peti-Peterdi J, 2010, J AM SOC NEPHROL, V21, P1835, DOI 10.1681/ASN.2010040378; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Reiser J, 2004, J BIOL CHEM, V279, P34827, DOI 10.1074/jbc.M401973200; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Salmon AHJ, 2012, J AM SOC NEPHROL, V23, P1339, DOI 10.1681/ASN.2012010017; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schiessl IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052499; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Wang JR, 2010, GENESIS, V48, P446, DOI 10.1002/dvg.20635; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215	40	123	123	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1661	1666		10.1038/nm.3405	http://dx.doi.org/10.1038/nm.3405			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24270544	Green Accepted			2022-12-27	WOS:000328181400037
J	Linnemann, C; Heemskerk, B; Kvistborg, P; Kluin, RJC; Bolotin, DA; Chen, XJ; Bresser, K; Nieuwland, M; Schotte, R; Michels, S; Gomez-Eerland, R; Jahn, L; Hombrink, P; Legrand, N; Shu, CJ; Mamedov, IZ; Velds, A; Blank, CU; Haanen, JBAG; Turchaninova, MA; Kerkhoven, RM; Spits, H; Hadrup, SR; Heemskerk, MHM; Blankenstein, T; Chudakov, DM; Bendle, GM; Schumacher, TNM				Linnemann, Carsten; Heemskerk, Bianca; Kvistborg, Pia; Kluin, Roelof J. C.; Bolotin, Dmitriy A.; Chen, Xiaojing; Bresser, Kaspar; Nieuwland, Marja; Schotte, Remko; Michels, Samira; Gomez-Eerland, Raquel; Jahn, Lorenz; Hombrink, Pleun; Legrand, Nicolas; Shu, Chengyi Jenny; Mamedov, Ilgar Z.; Velds, Arno; Blank, Christian U.; Haanen, John B. A. G.; Turchaninova, Maria A.; Kerkhoven, Ron M.; Spits, Hergen; Hadrup, Sine Reker; Heemskerk, Mirjam H. M.; Blankenstein, Thomas; Chudakov, Dmitriy M.; Bendle, Gavin M.; Schumacher, Ton N. M.			High-throughput identification of antigen-specific TCRs by TCR gene capture	NATURE MEDICINE			English	Article							T-CELL-RECEPTORS; CANCER REGRESSION; MONOCLONAL-ANTIBODIES; IMMUNE-SYSTEM; THERAPY; MELANOMA; GENERATION; LYMPHOCYTES; REPERTOIRE; EXPRESSION	The transfer of T cell receptor (TCR) genes into patient T cells is a promising approach for the treatment of both viral infections and cancer. Although efficient methods exist to identify antibodies for the treatment of these diseases, comparable strategies to identify TCRs have been lacking. We have developed a high-throughput DNA-based strategy to identify TCR sequences by the capture and sequencing of genomic DNA fragments encoding the TCR genes. We establish the value of this approach by assembling a large library of cancer germline tumor antigen-reactive TCRs. Furthermore, by exploiting the quantitative nature of TCR gene capture, we show the feasibility of identifying antigen-specific TCRs in oligoclonal T cell populations from either human material or TCR-humanized mice. Finally, we demonstrate the ability to identify tumor-reactive TCRs within intratumoral T cell subsets without knowledge of antigen specificities, which may be the first step toward the development of autologous TCR gene therapy to target patient-specific neoantigens in human cancer.	[Linnemann, Carsten; Heemskerk, Bianca; Kvistborg, Pia; Bresser, Kaspar; Schotte, Remko; Michels, Samira; Gomez-Eerland, Raquel; Shu, Chengyi Jenny; Blank, Christian U.; Haanen, John B. A. G.; Bendle, Gavin M.; Schumacher, Ton N. M.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands; [Kluin, Roelof J. C.; Nieuwland, Marja; Velds, Arno; Kerkhoven, Ron M.] Netherlands Canc Inst, Cent Genom Facil, Amsterdam, Netherlands; [Bolotin, Dmitriy A.; Mamedov, Ilgar Z.; Turchaninova, Maria A.; Chudakov, Dmitriy M.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Chen, Xiaojing; Blankenstein, Thomas] Max Delbruck Ctr Mol Med, Berlin, Germany; [Chen, Xiaojing; Blankenstein, Thomas] Charite Campus Benjamin Franklin, Inst Immunol, Berlin, Germany; [Schotte, Remko; Legrand, Nicolas; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Ctr Immunol Amsterdam, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Jahn, Lorenz; Hombrink, Pleun; Heemskerk, Mirjam H. M.] Leiden Univ, Dept Hematol, Lab Expt Hematol, Med Ctr, Leiden, Netherlands; [Legrand, Nicolas; Spits, Hergen] AIMM Therapeut, Amsterdam, Netherlands; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Hadrup, Sine Reker] Herlev Hosp, Ctr Canc Immune Therapy, Copenhagen, Denmark	Netherlands Cancer Institute; Netherlands Cancer Institute; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Copenhagen; Herlev & Gentofte Hospital	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	g.bendle@bham.ac.uk; t.schumacher@nki.nl	Legrand, Nicolas/B-1794-2009; Haanen, John/AAD-8578-2022; Haanen, John/AAD-8534-2022; Turchaninova, Maria/AAN-7375-2020; Heemskerk, Mirjam H.M./ABI-2336-2020; Bolotin, Dmitry/AAN-7763-2020; Schumacher, Ton/Y-2432-2019; Legrand, Nicolas/B-1794-2009; Chudakov, Dmitriy/G-7741-2014; Hadrup, Sine Reker/P-3388-2014	Legrand, Nicolas/0000-0002-0236-7653; Haanen, John/0000-0001-5884-7704; Turchaninova, Maria/0000-0002-8874-0286; Heemskerk, Mirjam H.M./0000-0001-6320-9133; Bolotin, Dmitry/0000-0002-8484-6067; Schumacher, Ton/0000-0003-0517-8804; Jahn, Lorenz/0000-0002-9880-7026; Legrand, Nicolas/0000-0002-0900-3051; Velds, Arno/0000-0003-4333-8872; Chudakov, Dmitriy/0000-0003-0430-790X; Mamedov, Ilgar/0000-0002-3992-9285; Hadrup, Sine Reker/0000-0002-5937-4344; Kluin, Roel/0000-0002-5133-142X; Bresser, Kaspar/0000-0001-7113-0476	Boehringer Ingelheim Fonds - Foundation for Basic Research in Biomedicine; Molecular and Cell Biology program of the Russian Academy of Sciences RFBR [12-04-33139, 12-04-00229-a]; Leukaemia and Lymphoma Research Bennett Senior Non-clinical Fellowship [12004]; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich TR36]; Dutch Cancer Society [NKI 2009-4282, NKI 2006-3530]; Danish Council for Strategic Research [09-065152]	Boehringer Ingelheim Fonds - Foundation for Basic Research in Biomedicine; Molecular and Cell Biology program of the Russian Academy of Sciences RFBR; Leukaemia and Lymphoma Research Bennett Senior Non-clinical Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dutch Cancer Society(KWF Kankerbestrijding); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	We are grateful to A. Pfauth, F. van Diepen and B. Hooibrink for assistance with flow cytometry and to M. Nagasawa, T. Heidebrecht, E. Siteur-van Rijnstra, K. Weijer, M. Bohne, M. van der Maas, W. van de Kasteele and T. de Jong for technical assistance. The Bloemenhove Clinic (Heemstede, The Netherlands) provided fetal tissues. We thank A. Kaiser, S. Naik and J. Rohr for critical discussions. C. L. is a fellow in the PhD Fellowship Program of Boehringer Ingelheim Fonds - Foundation for Basic Research in Biomedicine. M. A. T., I.Z.M., D. A. B. and D. M. C. are supported by the Molecular and Cell Biology program of the Russian Academy of Sciences RFBR 12-04-33139 and 12-04-00229-a. G. M. B. is the recipient of a Leukaemia and Lymphoma Research Bennett Senior Non-clinical Fellowship (12004). T. B. is supported by the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich TR36. This work was supported by grants from the Dutch Cancer Society (NKI 2009-4282 to T.N.M.S., J. B. A. G. H. and G. M. B. and NKI 2006-3530 to T.N.M.S. and H. S.) and the Danish Council for Strategic Research (09-065152 to S. R. H. and T.N.M.S.).	Amir AL, 2011, CLIN CANCER RES, V17, P5615, DOI 10.1158/1078-0432.CCR-11-1066; Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Bolotin DA, 2012, EUR J IMMUNOL, V42, P3073, DOI 10.1002/eji.201242517; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; de Witte MA, 2008, J IMMUNOL, V180, P6365, DOI 10.4049/jimmunol.180.9.6365; Derbinski J, 2010, CURR OPIN IMMUNOL, V22, P592, DOI 10.1016/j.coi.2010.08.003; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Friedman KM, 2012, J IMMUNOTHER, V35, P400, DOI 10.1097/CJI.0b013e31825898c5; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Heemskerk MHM, 2007, BLOOD, V109, P235, DOI 10.1182/blood-2006-03-013318; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hombrink P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022523; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Jorritsma A, 2007, BLOOD, V110, P3564, DOI 10.1182/blood-2007-02-075010; Kalos M, 2011, SCI TRANSL MED, V3; Kebriaei P, 2012, HUM GENE THER, V23, P444, DOI 10.1089/hum.2011.167; Kieback E, 2008, P NATL ACAD SCI USA, V105, P623, DOI 10.1073/pnas.0710198105; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LP, 2010, NAT MED, V16, P1029, DOI 10.1038/nm.2197; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Linnemann C, 2011, J INVEST DERMATOL, V131, P1806, DOI 10.1038/jid.2011.160; Mamedov IZ, 2011, EMBO MOL MED, V3, P201, DOI 10.1002/emmm.201100129; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Sadovnikova E, 1996, P NATL ACAD SCI USA, V93, P13114, DOI 10.1073/pnas.93.23.13114; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Schiavetti F, 2002, CANCER RES, V62, P5510; Schumacher TNM, 2002, NAT REV IMMUNOL, V2, P512, DOI 10.1038/nri841; Seitz S, 2006, P NATL ACAD SCI USA, V103, P12057, DOI 10.1073/pnas.0604247103; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Spits H., 1996, Methods (Orlando), V9, P416, DOI 10.1006/meth.1996.0047; Stanislawski T, 2001, NAT IMMUNOL, V2, P962, DOI 10.1038/ni1001-962; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; van Lent AU, 2010, METHODS MOL BIOL, V595, P87, DOI 10.1007/978-1-60761-421-0_6; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wilde S, 2009, BLOOD, V114, P2131, DOI 10.1182/blood-2009-03-209387; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; YSSEL H, 1984, J IMMUNOL METHODS, V72, P219, DOI 10.1016/0022-1759(84)90450-2	48	125	159	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1534	+		10.1038/nm.3359	http://dx.doi.org/10.1038/nm.3359			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24121928				2022-12-27	WOS:000326920300033
J	Demichelis, F; Attard, G				Demichelis, Francesca; Attard, Gerhardt			A step toward functionally characterized prostate cancer molecular subtypes	NATURE MEDICINE			English	Editorial Material							ANDROGEN RECEPTOR; TMPRSS2-ERG; ETV1; ERG	ETS gene fusions and PTEN loss are common events in prostate cancer, but their interactions are not well understood. A new study in mice suggests that overexpression of ETS in the setting of PTEN loss increases androgen receptor binding and restores androgen receptor transcriptional activity (pages 1023-1029).	[Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, Povo, Trento, Italy; [Attard, Gerhardt] Inst Canc Res & Royal Marsden, Sutton, Surrey, England	University of Trento; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Demichelis, F (corresponding author), Univ Trento, Ctr Integrat Biol, Povo, Trento, Italy.	demichelis@science.unitn.it; gerhardt.attard@icr.ac.uk	Demichelis, Francesca/J-9829-2016	Demichelis, Francesca/0000-0002-8266-8631; Attard, Gerhardt/0000-0002-4811-7983	Cancer Research UK [13239] Funding Source: Medline; National Institute for Health Research [CL-2008-22-001] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))		Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baena E, 2013, GENE DEV, V27, P683, DOI 10.1101/gad.211011.112; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018	13	5	5	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2013	19	8					966	967		10.1038/nm.3285	http://dx.doi.org/10.1038/nm.3285			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921739				2022-12-27	WOS:000322779600016
J	Lima, DS; Costa, DL; Carregaro, V; Cunha, LD; Silva, ALN; Mineo, TWP; Gutierrez, FRS; Bellio, M; Bortoluci, KR; Flavell, RA; Bozza, MT; Silva, JS; Zamboni, DS				Lima-Junior, Djalma S.; Costa, Diego L.; Carregaro, Vanessa; Cunha, Larissa D.; Silva, Alexandre L. N.; Mineo, Tiago W. P.; Gutierrez, Fredy R. S.; Bellio, Maria; Bortoluci, Karina R.; Flavell, Richard A.; Bozza, Marcelo T.; Silva, Joao S.; Zamboni, Dario S.			Inflammasome-derived IL-1 beta production induces nitric oxide-mediated resistance to Leishmania	NATURE MEDICINE			English	Article							NALP3 INFLAMMASOME; MAJOR AMASTIGOTES; IMMUNE-RESPONSES; SUSCEPTIBILITY; ACTIVATION; RECEPTOR; MICE; MACROPHAGES; INNATE; INTERLEUKIN-1-BETA	Parasites of the Leishmania genus are the causative agents of leishmaniasis in humans, a disease that affects more than 12 million people worldwide. These parasites replicate intracellularly in macrophages, and the primary mechanisms underlying host resistance involve the production of nitric oxide (NO). In this study we show that the Nlrp3 inflammasome is activated in response to Leishmania infection and is important for the restriction of parasite replication both in macrophages and in vivo as demonstrated through the infection of inflammasome-deficient mice with Leishmania amazonensis, Leishmania braziliensis and Leishmania infantum chagasi. Inflammasome-driven interleukin-1 beta (IL-1 beta) production facilitated host resistance to infection, as signaling through IL-1 receptor (IL-1R) and MyD88 was necessary and sufficient to trigger inducible nitric oxide synthase (NOS2)-mediated production of NO. In this manuscript we identify a major signaling platform for host resistance to Leishmania spp. infection and describe the molecular mechanisms underlying Leishmania-induced NO production.	[Lima-Junior, Djalma S.; Cunha, Larissa D.; Silva, Alexandre L. N.; Zamboni, Dario S.] Univ Sao Paulo, Dept Biol Celular Mol & Bioagentes Patogencios, BR-14049 Ribeirao Preto, SP, Brazil; [Lima-Junior, Djalma S.; Costa, Diego L.; Carregaro, Vanessa; Mineo, Tiago W. P.; Gutierrez, Fredy R. S.; Silva, Joao S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, SP, Brazil; [Bellio, Maria; Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Imunol, Rio De Janeiro, Brazil; [Bortoluci, Karina R.] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [Bortoluci, Karina R.] Univ Fed Sao Paulo, Ctr Terapia Celular & Mol, Sao Paulo, Brazil; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Yale University; Howard Hughes Medical Institute; Yale University	Zamboni, DS (corresponding author), Univ Sao Paulo, Dept Biol Celular Mol & Bioagentes Patogencios, BR-14049 Ribeirao Preto, SP, Brazil.	dszamboni@fmrp.usp.br	Gutierrez, Fredy R.S./C-3911-2009; Bortoluci, Karina/C-6018-2012; Costa, Diego/F-7168-2019; Bortoluci, Karina/P-9296-2019; Bellio, Maria/N-8525-2018; Lima-Junior, Djalma/H-4833-2013; Cunha, Larissa D/I-4204-2012; Mineo, Tiago W. P./B-4153-2009; Silva, Joao/A-4484-2008; Zamboni, Dario S/D-3024-2012; Carregaro, Vanessa/D-2913-2012	Gutierrez, Fredy R.S./0000-0001-9873-8342; Bortoluci, Karina/0000-0001-6780-5397; Costa, Diego/0000-0002-9440-2814; Bortoluci, Karina/0000-0001-6780-5397; Bellio, Maria/0000-0002-3360-2740; Lima-Junior, Djalma/0000-0002-2092-8047; Mineo, Tiago W. P./0000-0002-2339-2743; Silva, Joao/0000-0002-3410-3927; Zamboni, Dario S/0000-0002-7856-7512; Dias da Cunha, Larissa/0000-0002-1290-0263; Bozza, Marcelo/0000-0003-3683-7550; Carregaro, Vanessa/0000-0002-8435-0766	Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq); Nucleo de Apoio a Pesquisa em Doencas Inflamatorias (NAPDIN) [11.1.21625.01.0]; Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Special Programme for Research and Training in Tropical Diseases/World Health Organization (TDR/WHO) [A60999]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/52867-4, 2009/05054-6]	Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Nucleo de Apoio a Pesquisa em Doencas Inflamatorias (NAPDIN); Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA); Special Programme for Research and Training in Tropical Diseases/World Health Organization (TDR/WHO); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We are grateful to M. Nakamura for technical assistance, F. Cunha (Universidade de Sao Paulo, Brazil) for providing IL-1Ra and V. Dixit (Genentech, USA) for providing us with the Nlrp3<SUP>-/-</SUP> mice and the antibody to caspase-1 p20. This work was supported by grants from Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV/CNPq), Nucleo de Apoio a Pesquisa em Doencas Inflamatorias (NAPDIN, grant 11.1.21625.01.0), Fundacao de Amparo ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA), Special Programme for Research and Training in Tropical Diseases/World Health Organization (TDR/WHO, grant A60999 to D.S.Z.) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant 2006/52867-4 to D.S.Z.). D. L. C., V. C., L. D. C., A.L.N.S. and D.S.L.-J. (grant 2009/05054-6) are supported by fellowships from FAPESP. R. A. F. is an Investigator of the Howard Hughes Medical Institute. D.S.Z., M. B., M. T. B. and J.S.S. are Research Fellows from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil.	AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; ANDRADE ZA, 1984, AM J PATHOL, V114, P137; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Bosque F, 2000, SCAND J IMMUNOL, V51, P533; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Debus A, 2003, INFECT IMMUN, V71, P7215, DOI 10.1128/IAI.71.12.7215-7218.2003; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fernandez-Figueroa EA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001533; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; GREEN LC, 1981, SCIENCE, V212, P56, DOI 10.1126/science.6451927; GREEN SJ, 1990, J IMMUNOL, V145, P4290; GREEN SJ, 1990, J IMMUNOL, V144, P278; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Hamon MA, 2011, INFECT IMMUN, V79, P2839, DOI 10.1128/IAI.01243-10; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kautz-Neu K, 2011, EXP DERMATOL, V20, P77, DOI 10.1111/j.1600-0625.2010.01172.x; Kostka SL, 2006, J INVEST DERMATOL, V126, P1582, DOI 10.1038/sj.jid.5700309; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MONCADA S, 1991, PHARMACOL REV, V43, P109; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Moravej A, 2012, MOL BIOL REP, V39, P6907, DOI 10.1007/s11033-012-1517-z; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukbel RM, 2007, AM J TROP MED HYG, V76, P669, DOI 10.4269/ajtmh.2007.76.669; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Satoskar AR, 1998, EUR J IMMUNOL, V28, P2066, DOI 10.1002/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Soong L, 2008, J IMMUNOL, V180, P4355, DOI 10.4049/jimmunol.180.7.4355; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; WERNERFELMAYER G, 1990, J EXP MED, V172, P1599, DOI 10.1084/jem.172.6.1599; Xin LJ, 2008, MOL IMMUNOL, V45, P3371, DOI 10.1016/j.molimm.2008.04.018; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	51	245	249	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					909	+		10.1038/nm.3221	http://dx.doi.org/10.1038/nm.3221			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23749230				2022-12-27	WOS:000321557700035
J	Camus, G; Ott, M				Camus, Gregory; Ott, Melanie			How the antiviral immune response boosts liver fat	NATURE MEDICINE			English	Editorial Material							BOX RNA HELICASE; LIPID DROPLET; HEPATITIS; DDX3; STEATOSIS	Liver steatosis is a characteristic feature of hepatitis C virus (HCV) infection, and the virus itself is known to alter the lipid metabolism of infected hepatocytes. A recent study shows that HCV co-opts the antiviral innate immune response to stimulate the production of hepatic fat droplets, which it can then use to complete its own life cycle and spread (pages 722-729).	[Camus, Gregory; Ott, Melanie] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Camus, G (corresponding author), Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA.	mott@gladstone.ucsf.edu		Ott, Melanie/0000-0002-5697-1274				Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Chang PC, 2006, ONCOGENE, V25, P1991, DOI 10.1038/sj.onc.1209239; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Harris C, 2011, J BIOL CHEM, V286, P42615, DOI 10.1074/jbc.M111.285148; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Oshiumi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014258; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659	14	1	1	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					671	672		10.1038/nm.3226	http://dx.doi.org/10.1038/nm.3226			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744144				2022-12-27	WOS:000319981600011
J	Grainger, JR; Wohlfert, EA; Fuss, IJ; Bouladoux, N; Askenase, MH; Legrand, F; Koo, LY; Brenchley, JM; Fraser, IDC; Belkaid, Y				Grainger, John R.; Wohlfert, Elizabeth A.; Fuss, Ivan J.; Bouladoux, Nicolas; Askenase, Michael H.; Legrand, Fanny; Koo, Lily Y.; Brenchley, Jason M.; Fraser, Iain D. C.; Belkaid, Yasmine			Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection	NATURE MEDICINE			English	Article							PATHOGEN TOXOPLASMA-GONDII; T-CELL RESPONSES; DENDRITIC CELLS; IMMUNE-RESPONSES; SMALL-INTESTINE; DEPENDENT MECHANISM; LY6C(HI) MONOCYTES; RETINOIC-ACID; BOWEL-DISEASE; NITRIC-OXIDE	The commensal flora can promote both immunity to pathogens and mucosal inflammation. How commensal-driven inflammation is regulated in the context of infection remains poorly understood. Here, we show that during acute mucosal infection of mice with Toxoplasma gondii, inflammatory monocytes acquire a tissue-specific regulatory phenotype associated with production of the lipid mediator prostaglandin E-2 (PGE(2)). Notably, in response to commensals, inflammatory monocytes can directly inhibit neutrophil activation in a PGE(2)-dependent manner. Further, in the absence of inflammatory monocytes, mice develop severe neutrophil-mediated pathology in response to pathogen challenge that can be controlled by PGE(2) analog treatment. Complementing these findings, inhibition of PGE(2) led to enhanced neutrophil activation and host mortality after infection. These data demonstrate a previously unappreciated dual action of inflammatory monocytes in controlling pathogen expansion while limiting commensal-mediated damage to the gut. Collectively, our results place inflammatory monocyte-derived PGE(2) at the center of a commensal-driven regulatory loop required to control host-commensal dialog during pathogen-induced inflammation.	[Grainger, John R.; Wohlfert, Elizabeth A.; Bouladoux, Nicolas; Askenase, Michael H.; Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Parasit Dis Lab,NIH, Bethesda, MD 20892 USA; [Fuss, Ivan J.] NIAID, Mucosal Immun Sect, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Askenase, Michael H.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Legrand, Fanny] NIAID, Eosinophil Pathol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Koo, Lily Y.] NIAID, NIAID Biol Imaging Facil, NIH, Bethesda, MD 20892 USA; [Brenchley, Jason M.] NIAID, Program Barrier Immun & Repair, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Fraser, Iain D. C.] NIAID, Signaling Syst Unit, Lab Syst Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Parasit Dis Lab,NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	wohlfert, beth/ABA-2255-2020; Brenchley, Jason/AAC-5085-2019; Fraser, Iain DC/L-4735-2017; Legrand, Fanny/I-4880-2017	Fraser, Iain DC/0000-0003-2272-3907; Grainger, John/0000-0002-4052-5923; Legrand, Fanny/0000-0001-9373-7789; Bouladoux, Nicolas/0000-0003-1593-671X; Brenchley, Jason/0000-0001-8357-2984; Belkaid, Yasmine/0000-0001-9962-3571	Division of Intramural Research, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, ZIAAI001132, ZIAAI001107, ZIAAI001106, ZIAAI001029, ZICAI001051, ZIAAI001194] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, NIAID. We thank members of the Belkaid lab for thoughtful discussion and critical reading of the manuscript, K. Holmes, E. Stregevsky and the NIAID Sorting Facility, K. Beacht and J. Konkel for technical assistance, C. Brown for assistance with tissue staining, O. Schwartz and the NIAID Biological Imaging Facility for assistance with confocal microscopy, T. Meyers and the NIAID Genomic Technologies Section for microarray processing, J. Skinner and the NIAID Bioinformatics and Computational Bioscience Branch for assistance with microarray analysis and L. Hooper and the University of Texas Southwestern Medical Center for sharing protocols. ME-49 clone C1 of T. gondii was provided by M. E. Grigg, NIAID, NIH.	Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Benson A, 2012, J IMMUNOL, V188, P800, DOI 10.4049/jimmunol.1100769; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cassatella MA, 1998, INT J CLIN LAB RES, V28, P148, DOI 10.1007/s005990050036; Cerutti A, 2008, NAT REV IMMUNOL, V8, P421, DOI 10.1038/nri2322; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; CRONSTEIN BN, 1990, J CLIN INVEST, V85, P1150, DOI 10.1172/JCI114547; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Grunvald E, 1996, INFECT IMMUN, V64, P2010, DOI 10.1128/IAI.64.6.2010-2018.1996; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Jebbari H, 1998, PARASITE IMMUNOL, V20, P231, DOI 10.1046/j.1365-3024.1998.00152.x; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim YG, 2011, IMMUNITY, V34, P769, DOI 10.1016/j.immuni.2011.04.013; Kuhl AA, 2007, GASTROENTEROLOGY, V133, P1882, DOI 10.1053/j.gastro.2007.08.073; Lanas A, 2009, AM J MED SCI, V338, P96, DOI 10.1097/MAJ.0b013e3181ad8cd3; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Molloy MJ, 2012, SEMIN IMMUNOL, V24, P58, DOI 10.1016/j.smim.2011.11.008; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Naito Y, 2007, J GASTROENTEROL, V42, P787, DOI 10.1007/s00535-007-2096-y; OBANION MK, 1991, J BIOL CHEM, V266, P23261; OHNO H, 1978, J BIOCHEM-TOKYO, V84, P1485, DOI 10.1093/oxfordjournals.jbchem.a132272; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SchartonKersten TM, 1997, J EXP MED, V185, P1261, DOI 10.1084/jem.185.7.1261; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Troy AE, 2009, J IMMUNOL, V183, P2037, DOI 10.4049/jimmunol.0802918; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; WERTHEIM WA, 1993, J IMMUNOL, V151, P2166; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	65	189	190	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					713	+		10.1038/nm.3189	http://dx.doi.org/10.1038/nm.3189			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23708291	Green Accepted			2022-12-27	WOS:000319981600020
J	Wright, GD; Hung, DT; Helmann, JD				Wright, Gerard D.; Hung, Deborah T.; Helmann, John D.			How antibiotics kill bacteria: new models needed?	NATURE MEDICINE			English	Editorial Material							CELL-DEATH		[Wright, Gerard D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Hung, Deborah T.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Hung, Deborah T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Hung, Deborah T.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Hung, Deborah T.] Broad Inst MIT & Harvard, Program Infect Dis, Boston, MA USA; [Helmann, John D.] Cornell Univ, Dept Microbiol, New York, NY 10021 USA	McMaster University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University	Wright, GD (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.		Wright, G/ABB-7666-2021	Wright, Gerard/0000-0002-9129-7131; Helmann, John/0000-0002-3832-3249	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047446] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brook I, 2011, EXPERT OPIN PHARMACO, V12, P1691, DOI 10.1517/14656566.2011.576672; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Wang XH, 2010, J ANTIMICROB CHEMOTH, V65, P520, DOI 10.1093/jac/dkp486	7	14	15	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					544	545		10.1038/nm.3198	http://dx.doi.org/10.1038/nm.3198			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652106				2022-12-27	WOS:000318583000025
J	Bianco, P; Cao, X; Frenette, PS; Mao, JJ; Robey, PG; Simmons, PJ; Wang, CY				Bianco, Paolo; Cao, Xu; Frenette, Paul S.; Mao, Jeremy J.; Robey, Pamela G.; Simmons, Paul J.; Wang, Cun-Yu			The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine	NATURE MEDICINE			English	Article							BONE-MARROW; HEMATOPOIETIC STEM; STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; STEM/PROGENITOR CELLS; FIBROUS DYSPLASIA; IN-VITRO; ADULT; TRANSPLANTATION; THERAPY	Mesenchymal stem cells (MSCs) are the focus of intensive efforts worldwide directed not only at elucidating their nature and unique properties but also developing cell-based therapies for a diverse range of diseases. More than three decades have passed since the original formulation of the concept, revolutionary at the time, that multiple connective tissues could emanate from a common progenitor or stem cell retained in the postnatal bone marrow. Despite the many important advances made since that time, substantial ambiguities still plague the field regarding the nature, identity, function, mode of isolation and experimental handling of MSCs. These uncertainties have a major impact on their envisioned therapeutic use.	[Bianco, Paolo] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Cao, Xu] Johns Hopkins Univ, Dept Orthoped Surg, Baltimore, MD USA; [Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Dept Cell Biol, Dept Med, New York, NY USA; [Mao, Jeremy J.] Columbia Univ, Coll Dent Med, Ctr Craniofacial Regenerat, New York, NY USA; [Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Simmons, Paul J.] Mesoblast Ltd, Melbourne, Vic, Australia; [Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol, Lab Mol Signaling, Los Angeles, CA 90024 USA	Sapienza University Rome; Johns Hopkins University; Yeshiva University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of California System; University of California Los Angeles	Bianco, P (corresponding author), Univ Roma La Sapienza, Dept Mol Med, Rome, Italy.	paolo.bianco@uniroma1.it	Frenette, Paul S/J-8272-2012; Robey, Pamela Gehron/H-1429-2011	Frenette, Paul S/0000-0003-0862-9922; Robey, Pamela Gehron/0000-0002-5316-5576	Telethon [GGP09227]; Fondazione Roma; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Ministero della Salute; EU (Angioscaff); Fondazione Institut Pasteur-Cenci Bolognetti; US National Institutes of Health (NIH) [R01 DK056638, HL69438, HL097819, HL097700, HL116340]; NIH [DK57501, R01 DE018248, R01 EB009663]; National Institute of Dental and Craniofacial Research (NIDCR), NIH [DE019412, DE016513]; Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, Department of Health and Human Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097819, R01HL116340, R01HL097700, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016513, ZIADE000380, R01DE019412, R01DE018248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); Fondazione Roma(Fondazione RomaEuropean Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy); EU (Angioscaff); Fondazione Institut Pasteur-Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research (NIDCR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, Department of Health and Human Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Note that the authors are listed in alphabetical order in the author list. This work was supported in part by grants from Telethon (GGP09227), Fondazione Roma, Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Ministero della Salute, EU (Angioscaff) and Fondazione Institut Pasteur-Cenci Bolognetti (to P.B.), the US National Institutes of Health (NIH) (R01 DK056638, HL69438, HL097819, HL097700, HL116340 to P.S.F.), NIH DK57501 (to X.C.), the National Institute of Dental and Craniofacial Research (NIDCR), NIH (DE019412 and DE016513 to C.-Y.W.), NIH R01 DE018248 and R01 EB009663 to J.J.M. and the Division of Intramural Research, NIDCR of the Intramural Research Program, NIH, Department of Health and Human Services (to P.G.R.).	Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Arai F, 2002, J EXP MED, V195, P1549, DOI 10.1084/jem.20011700; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361; Bianco P, 1999, CRIT REV EUKAR GENE, V9, P159, DOI 10.1615/CritRevEukarGeneExpr.v9.i2.30; BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P183, DOI 10.1177/41.2.8419458; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco Paolo, 2015, Development, V142, P1023, DOI 10.1242/dev.102210; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Bush Vannevar, 1945, ATLANTIC, P101, DOI DOI 10.1145/227181.227186; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; DELUCA M, 1992, BURNS, V18, pS16, DOI 10.1016/0305-4179(92)90105-4; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; GREEN H, 1989, LAB INVEST, V60, P583; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Horwitz EM, 2001, BLOOD, V97, P1227, DOI 10.1182/blood.V97.5.1227; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kuznetsov S., 2006, CELL BIOL LAB MANUAL, P79; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Niibe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017610; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Park D, 2012, FRONT BIOSCI-LANDMRK, V17, P30, DOI 10.2741/3913; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Piersanti S, 2010, J BONE MINER RES, V25, P1103, DOI 10.1359/jbmr.091036; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; STREETER GL, 1949, CONTRIB EMBRYOL, V33, P151; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TAVASSOLI M, 1968, SCIENCE, V161, P54, DOI 10.1126/science.161.3836.54; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; WILLINGHAM MC, 1975, J CELL BIOL, V67, P146, DOI 10.1083/jcb.67.1.146; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	64	839	898	6	237	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					35	42		10.1038/nm.3028	http://dx.doi.org/10.1038/nm.3028			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23296015	Green Accepted			2022-12-27	WOS:000313230300023
J	Deeks, S; Drosten, C; Picker, L; Subbarao, K; Suzich, J				Deeks, Steven; Drosten, Christian; Picker, Louis; Subbarao, Kanta; Suzich, Joann			Roadblocks to translational challenges on viral pathogenesis	NATURE MEDICINE			English	Article							SYNCYTIAL VIRUS-INFECTION; INFLUENZA-VIRUSES; ENHANCED DISEASE; TRANSMISSION; VACCINE; PREVENTION; ORIGIN; LIVE; RSV; IDENTIFICATION		[Deeks, Steven] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Suzich, Joann] Medimmune Inc, Gaithersburg, MD 20878 USA; [Picker, Louis] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Drosten, Christian] Univ Bonn, Inst Virol, Bonn, Germany; [Subbarao, Kanta] NIAID, National Institutes Health, Bethesda, MD USA	University of California System; University of California San Francisco; AstraZeneca; Medimmune; Oregon Health & Science University; University of Bonn; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Deeks, S (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.	sdeeks@php.ucsf.edu; drosten@virologybonn.de; pickerl@ohsu.edu; ksubbarao@niaid.nih.gov; suzichj@medimmune.com		Subbarao, Kanta/0000-0003-1713-3056				Allander T, 2008, NEW ENGL J MED, V358, P2638, DOI 10.1056/NEJMc080743; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brahic M, 2010, ANN NEUROL, V68, P6, DOI 10.1002/ana.22057; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chen GL, 2011, P NATL ACAD SCI USA, V108, P1140, DOI 10.1073/pnas.1009908108; Chun TW, 2012, AIDS, V26, P1261, DOI 10.1097/QAD.0b013e328353f3f1; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Connor E, 1997, PEDIATRICS, V99, P93; Corey L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001863; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Denton PW, 2012, TRENDS MICROBIOL, V20, P268, DOI 10.1016/j.tim.2012.03.007; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fauci AS, 2012, JAMA-J AM MED ASSOC, V308, P343, DOI 10.1001/jama.2012.8142; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Lakdawala SS, 2012, NAT MED, V18, P1468, DOI 10.1038/nm.2953; Lauber C, 2012, J VIROL, V86, P3905, DOI 10.1128/JVI.07174-11; Lifson JD, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007310; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Marsh GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002836; Mejias A, 2008, BIOL-TARGETS THER, V2, P433; Morens DM, 2012, NATURE, V486, P335, DOI 10.1038/nature11170; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Murata Y, 2007, ANTIVIR THER, V12, P659; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pike BL, 2010, CLIN INFECT DIS, V50, P1636, DOI 10.1086/652860; Power K.A., 2012, SCI TRANSL MED, V4; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sikkel MB, 2008, PEDIATR INFECT DIS J, V27, pS63, DOI 10.1097/INF.0b013e3181684d67; Tang RS, 2008, VACCINE, V26, P6373, DOI 10.1016/j.vaccine.2008.09.018; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Van Rompay KKA, 2012, AIDS RES HUM RETROV, V28, P16, DOI [10.1089/AID.2011.0234, 10.1089/aid.2011.0234]; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walsh EE, 2004, J MED VIROL, V73, P295, DOI 10.1002/jmv.20090; Wright PF, 2007, VACCINE, V25, P7372, DOI 10.1016/j.vaccine.2007.08.014; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	54	6	6	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					30	34		10.1038/nm.3050	http://dx.doi.org/10.1038/nm.3050			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23296014	Bronze, Green Published			2022-12-27	WOS:000313230300022
J	Mundel, T				Mundel, Trevor			Global health needs to fill the innovation gap	NATURE MEDICINE			English	Editorial Material								In recent years, the pharmaceutical industry has struggled to deliver new therapies, especially for diseases that affect the most vulnerable in developing countries. The global health community can fill this vacuum by catalyzing innovative partnerships across academia, government and the private sector, fostering a more rigorous environment for scientific decision making and creating the tools and infrastructure to conduct effective translational research.	[Mundel, Trevor] Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA; [Mundel, Trevor] Novartis, Basel, Switzerland	Bill & Melinda Gates Foundation	Mundel, T (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA USA.								0	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2012	18	12					1735	1735		10.1038/nm1212-1735	http://dx.doi.org/10.1038/nm1212-1735			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23223055				2022-12-27	WOS:000311999800010
J	Brown, DD				Brown, Donald D.			Developmental biology using purified genes	NATURE MEDICINE			English	Editorial Material							DIRECTS SPECIFIC INITIATION; XENOPUS-LAEVIS; TRANSCRIPTION FACTOR; CONTROL REGION; RIBOSOMAL-RNA; OOCYTES; BINDING; BORDER		Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA	Carnegie Institution for Science	Brown, DD (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD USA.	brown@ciwemb.edu						BIRKENMEIER EH, 1978, CELL, V15, P1077, DOI 10.1016/0092-8674(78)90291-X; BOGENHAGEN DF, 1980, CELL, V19, P27, DOI 10.1016/0092-8674(80)90385-2; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; BROWN DD, 1964, P NATL ACAD SCI USA, V51, P139, DOI 10.1073/pnas.51.1.139; BROWN DD, 1984, CELL, V37, P359, DOI 10.1016/0092-8674(84)90366-0; Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021; BROWN RD, 1971, P NATL ACAD SCI USA, V68, P3175, DOI 10.1073/pnas.68.12.3175; ELSDALE TR, 1958, EXP CELL RES, V14, P642, DOI 10.1016/0014-4827(58)90175-7; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; GALL JG, 1968, P NATL ACAD SCI USA, V60, P553, DOI 10.1073/pnas.60.2.553; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MILLER JR, 1978, CELL, V13, P717; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; SAKONJU S, 1981, CELL, V23, P665, DOI 10.1016/0092-8674(81)90429-3; SAKONJU S, 1980, CELL, V19, P13, DOI 10.1016/0092-8674(80)90384-0; SUZUKI Y, 1972, J MOL BIOL, V63, P409, DOI 10.1016/0022-2836(72)90437-8; WALLACE H, 1966, BIOCHIM BIOPHYS ACTA, V114, P296, DOI 10.1016/0005-2787(66)90311-X	17	0	0	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1496	1498		10.1038/nm.2929	http://dx.doi.org/10.1038/nm.2929			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042361				2022-12-27	WOS:000309587500026
J	Kang, HJ; Voleti, B; Hajszan, T; Rajkowska, G; Stockmeier, CA; Licznerski, P; Lepack, A; Majik, MS; Jeong, LS; Banasr, M; Son, H; Duman, RS				Kang, Hyo Jung; Voleti, Bhavya; Hajszan, Tibor; Rajkowska, Grazyna; Stockmeier, Craig A.; Licznerski, Pawel; Lepack, Ashley; Majik, Mahesh S.; Jeong, Lak Shin; Banasr, Mounira; Son, Hyeon; Duman, Ronald S.			Decreased expression of synapse-related genes and loss of synapses in major depressive disorder	NATURE MEDICINE			English	Article							PREFRONTAL CORTEX; TRANSCRIPTION FACTORS; PROTEIN; STRESS; ABNORMALITIES; ANTIDEPRESSANT; PROLIFERATION; ENVIRONMENT; CALMODULIN; VESICLES	Previous imaging and postmortem studies have reported a lower brain volume and a smaller size and density of neurons in the dorsolateral prefrontal cortex (dlPFC) of subjects with major depressive disorder (MDD)(1,2). These findings suggest that synapse number and function are decreased in the dlPFC of patients with MDD. However, there has been no direct evidence reported for synapse loss in MDD, and the gene expression alterations underlying these effects have not been identified. Here we use microarray gene profiling and electron microscopic stereology to reveal lower expression of synaptic-function-related genes (CALM2, SYN1, RAB3A, RAB4B and TUBB4) in the dlPFC of subjects with MDD and a corresponding lower number of synapses. We also identify a transcriptional repressor, GATA1, expression of which is higher in MDD and that, when expressed in PFC neurons, is sufficient to decrease the expression of synapse-related genes, cause loss of dendritic spines and dendrites, and produce depressive behavior in rat models of depression.	[Kang, Hyo Jung; Voleti, Bhavya; Licznerski, Pawel; Lepack, Ashley; Banasr, Mounira; Duman, Ronald S.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Hajszan, Tibor] Yale Univ, Dept Obstet & Gynecol, New Haven, CT 06520 USA; [Hajszan, Tibor] Hungarian Acad Sci, Biol Res Ctr, Dept Biophys, H-6701 Szeged, Hungary; [Rajkowska, Grazyna; Stockmeier, Craig A.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Majik, Mahesh S.; Jeong, Lak Shin] Ewha Womans Univ, Coll Pharm, Dept Bioinspired Sci, Seoul, South Korea; [Son, Hyeon] Hanyang Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 133791, South Korea; [Duman, Ronald S.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; Yale University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Mississippi; University of Mississippi Medical Center; Ewha Womans University; Hanyang University; Yale University	Duman, RS (corresponding author), Yale Univ, Dept Psychiat, New Haven, CT 06520 USA.	ronald.duman@yale.edu	Majik, Mahesh/AAS-1659-2021	Licznerski, Pawel/0000-0003-2761-8428; Majik, Mahesh/0000-0002-8255-0895	US Public Health Service [MH45481, 2 P01 MH25642, MH67996, P20 RR17701]; Connecticut Mental Health Center; National Research Foundation of Korea (NRF) [2011-0028317]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045481, R01MH067996, R29MH045481, R37MH045481, P01MH025642] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Mental Health Center; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by US Public Health Service grants MH45481 (R.S.D.), 2 P01 MH25642 (R.S.D.), MH67996 (C.A.S.) and P20 RR17701 (C.A.S.), the Connecticut Mental Health Center (R.S.D.) and a National Research Foundation of Korea grant (NRF, 2011-0028317; H.S.). We acknowledge the invaluable contributions made by the families consenting to donate brain tissue and be interviewed. We also thank the Cuyahoga County Coroner and staff, Cleveland, Ohio, for their willing assistance. We thank J. Overholser, G. Jurjus, H. Meltzer, L. Konick, L. Dieter, N. Herbst, G. Mahajan, H. Kooiman and J. Cobb for their contributions to the psychiatric assessment and human tissue dissection and preparation. We thank T.H. Kim (Yale University) for his advice and suggestions regarding the binding motif analysis and chromatin immunoprecipitation. The pXM-GATA1 plasmid was provided by A.B. Cantor (Harvard University), and the pAAV-eGFP-pA vector was provided by R.J. Dileone (Yale University). The GATA1-specific antibody was provided by E.H. Bresnick (University of Wisconsin).	Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Barabassy A, 2010, PSYCHIAT RES, V176, P26, DOI 10.1016/j.psychres.2008.06.045; Belizaire R, 2004, J COMP NEUROL, V470, P266, DOI 10.1002/cne.20008; Bianchi M., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P597; Boyle LL, 2010, J CLIN PSYCHIAT, V71, P74, DOI 10.4088/JCP.08m04724gry; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; Cole SW, 2010, P NATL ACAD SCI USA, V107, P5681, DOI 10.1073/pnas.0911515107; DECAMILLI P, 1986, BIOCHEM PHARMACOL, V35, P4349, DOI 10.1016/0006-2952(86)90747-1; DELORENZO RJ, 1978, BIOCHEM BIOPH RES CO, V80, P183, DOI 10.1016/0006-291X(78)91121-X; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Drevets WC, 2000, PROG BRAIN RES, V126, P413; El Wakil A, 2006, DEVELOPMENT, V133, P2155, DOI 10.1242/dev.02377; Elferink LA, 1995, PROG BRAIN RES, V105, P79; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Gorwood P, 2009, ENCEPHALE, V35, pS306, DOI 10.1016/S0013-7006(09)73492-X; Hajszan T, 2010, BIOL PSYCHIAT, V67, P168, DOI 10.1016/j.biopsych.2009.08.017; Hajszan T, 2009, BIOL PSYCHIAT, V65, P392, DOI 10.1016/j.biopsych.2008.09.031; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; HOFFMAN PN, 1988, CIBA F SYMP, V138, P192; Hoogenraad CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000283; Johnson KD, 2006, P NATL ACAD SCI USA, V103, P15939, DOI 10.1073/pnas.0604041103; Kala K, 2009, DEVELOPMENT, V136, P253, DOI 10.1242/dev.029900; Kang HJ, 2007, J NEUROSCI, V27, P13329, DOI 10.1523/JNEUROSCI.4083-07.2007; Kim S, 2011, MOL PSYCHIATR, V16, P452, DOI 10.1038/mp.2010.23; Kim S, 2010, MOL PSYCHIATR, V15, P326, DOI 10.1038/mp.2008.99; Lecrubier Y, 2001, J CLIN PSYCHIAT, V62, P4; Levens SM, 2009, DEPRESS ANXIETY, V26, P403, DOI 10.1002/da.20565; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Matthews G, 2001, NEURON, V32, P962, DOI 10.1016/S0896-6273(01)00546-3; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Noh JS, 1997, EXP NEUROL, V146, P604, DOI 10.1006/exnr.1997.6569; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; SHOLL DA, 1953, J ANAT, V87, P387; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Valentine G, 2008, PSYCHOPHARMACOLOGY, V200, P585, DOI 10.1007/s00213-008-1239-z; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Zhong L, 2009, EMBO J, V28, P3027, DOI 10.1038/emboj.2009.236	47	457	474	4	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1413	+		10.1038/nm.2886	http://dx.doi.org/10.1038/nm.2886			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22885997	Green Accepted			2022-12-27	WOS:000308472300038
J	Rangachari, M; Zhu, C; Sakuishi, K; Xiao, S; Karman, J; Chen, A; Angin, M; Wakeham, A; Greenfield, EA; Sobel, RA; Okada, H; McKinnon, PJ; Mak, TW; Addo, MM; Anderson, AC; Kuchroo, VK				Rangachari, Manu; Zhu, Chen; Sakuishi, Kaori; Xiao, Sheng; Karman, Jozsef; Chen, Andrew; Angin, Mathieu; Wakeham, Andrew; Greenfield, Edward A.; Sobel, Raymond A.; Okada, Hitoshi; McKinnon, Peter J.; Mak, Tak W.; Addo, Marylyn M.; Anderson, Ana C.; Kuchroo, Vijay K.			Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion	NATURE MEDICINE			English	Article							CHRONIC VIRAL-INFECTION; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE INHIBITORY RECEPTORS; TH1/TH2 CELLS; UP-REGULATION; TIM-3; ACTIVATION; EXPRESSION; PROTEIN; VIRUS	T cell immunoglobulin and mucin domain-containing 3 (Tim-3) is an inhibitory receptor that is expressed on exhausted T cells during infection with HIV-1 and hepatitis C virus. By contrast, Tim-3 expression and function are defective in multiple human autoimmune diseases. However, the molecular mechanisms modulating Tim-3 function are not well understood. Here we show that human leukocyte antigen B (HLA-B)-associated transcript 3 (Bat3) binds to, and represses the function of, Tim-3. Bat3 protects T helper type 1 (T(H)1) cells from galectin-9-mediated cell death and promotes both proliferation and proinflammatory cytokine production. Bat3-deficient T cells have elevated expression of exhaustion-associated molecules such as Tim-3, Lag3, Prdm1 and Pbx3, and Bat3 knockdown in myelin-antigen-specific CD4(+) T cells markedly inhibits the development of experimental autoimmune encephalomyelitis while promoting the expansion of a dysfunctional Tim-3(hi), interferon-gamma (IFN-gamma)(lo)CD4(+) cell population. Furthermore, expression of Bat3 is reduced in exhausted Tim-3(+) T cells from mouse tumors and HIV-1-infected individuals. These data indicate that Bat3 acts as an inhibitor of Tim-3-dependent exhaustion and cell death. Bat3 may thus represent a viable therapeutic target in autoimmune disorders, chronic infections and cancers.	[Rangachari, Manu; Zhu, Chen; Sakuishi, Kaori; Xiao, Sheng; Karman, Jozsef; Chen, Andrew; Anderson, Ana C.; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Angin, Mathieu; Addo, Marylyn M.] Ragon Inst MGH MIT & Harvard, Charlestown, MA USA; [Wakeham, Andrew; Okada, Hitoshi; Mak, Tak W.] Princess Margaret Hosp, Campbell Family Breast Canc Res Inst, Toronto, ON M4X 1K9, Canada; [Greenfield, Edward A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Sobel, Raymond A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Okada, Hitoshi] Ontario Canc Inst, Div Signaling Biol, Toronto, ON M4X 1K9, Canada; [Okada, Hitoshi] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [McKinnon, Peter J.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Harvard University; Dana-Farber Cancer Institute; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; St Jude Children's Research Hospital	Kuchroo, VK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	vkuchroo@rics.bwh.harvard.edu	Addo, Marylyn M./GNP-2548-2022; Anderson, Ana C/ABD-6829-2021	Anderson, Ana C/0000-0002-0877-2932; Angin, Mathieu/0000-0002-6867-4680; Addo, Marylyn/0000-0003-2836-9224; Sobel, Raymond/0000-0002-0477-9002	Multiple Sclerosis Society of Canada (MSSOC); Canadian Institutes of Health Research (CIHR); EMD Serono, Canada; Multiple Sclerosis Scientific Research Foundation; Sankyo Foundation of Life Science; US National Institutes of Health [NS045937, AI073748, NS038037, K01DK090105]; Ragon Institute of MGH; MIT; Harvard; American Cancer Society; Harvard University Center for AIDS Research [P30 AI060354]; MSSOC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI074405, P30AI060354, P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037, R01NS037956, R01NS030843, R01NS045937] Funding Source: NIH RePORTER	Multiple Sclerosis Society of Canada (MSSOC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EMD Serono, Canada; Multiple Sclerosis Scientific Research Foundation; Sankyo Foundation of Life Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH; MIT; Harvard; American Cancer Society(American Cancer Society); Harvard University Center for AIDS Research; MSSOC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Kozoriz, D. Lee, J. Sullivan and M. King for technical assistance; J. Zhang (Brigham and Women's Hospital, Boston) for reagents; B.H. Waksman for valuable guidance and discussion; and B. Walker for critical reading of the manuscript. M. R. was previously supported by Fellowships from the Multiple Sclerosis Society of Canada (MSSOC) and the Canadian Institutes of Health Research (CIHR) and is currently supported by the EMD Serono, Canada and an MS Research and Training Network Transitional Career Development Award from the MSSOC and the Multiple Sclerosis Scientific Research Foundation. K.S. holds a Fellowship from the Sankyo Foundation of Life Science. These studies were funded by grants from the US National Institutes of Health to V.K.K. (NS045937, AI073748 and NS038037) and S.X. (K01DK090105), the Ragon Institute of MGH, MIT and Harvard (V.K.K., C.Z. and M.M.A.), the American Cancer Society (A.C.A.) and the Harvard University Center for AIDS Research (M.M.A.; P30 AI060354).	Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; de Weyer PSV, 2006, BIOCHEM BIOPH RES CO, V351, P571, DOI 10.1016/j.bbrc.2006.10.079; DEGLIESPOSTI MA, 1992, IMMUNOGENETICS, V36, P345; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Dunn GP, 2005, IMMUNOL RES, V32, P231, DOI 10.1385/IR:32:1-3:231; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Hara H, 2002, J IMMUNOL, V168, P2288, DOI 10.4049/jimmunol.168.5.2288; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; KUCHROO VK, 1992, J IMMUNOL, V148, P3776; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Morimoto K, 2011, SCAND J GASTROENTERO, V46, P701, DOI 10.3109/00365521.2011.568518; Moss RB, 2004, EXPERT OPIN BIOL TH, V4, P1887, DOI 10.1517/14712598.4.12.1887; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; Myrmel H, 2009, APMIS, V117, P427, DOI 10.1111/j.1600-0463.2009.02454.x; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Priatel JJ, 2007, J IMMUNOL, V179, P2143, DOI 10.4049/jimmunol.179.4.2143; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Tsunoda I, 1996, J NEUROPATH EXP NEUR, V55, P673, DOI 10.1097/00005072-199606000-00001; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	46	221	241	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1394	+		10.1038/nm.2871	http://dx.doi.org/10.1038/nm.2871			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22863785	Green Accepted			2022-12-27	WOS:000308472300035
J	Howitt, MR; Garrett, WS				Howitt, Michael R.; Garrett, Wendy S.			A complex microworld in the gut Gut microbiota and cardiovascular disease connectivity	NATURE MEDICINE			English	Editorial Material							OBESITY; MICE	Millions of healthy bacteria colonize our guts from the moment we are born. Changes in the composition and abundance of these commensals affect the entire immune system and can predispose us to a variety of diseases, including intestinal infections, inflammatory and metabolic diseases, and cancer. The gut microbiome interacts not only with the host mucosa but also with potential pathogens; understanding what interactions and pathways are crucial for maintaining homeostasis and protecting the host from harmful bacteria and diseases can open new avenues to developing gut microbiota-based therapeutic approaches. In 'Bench to Bedside', Michael R. Howitt and Wendy S. Garrett examine the importance of metabolic crosstalk between the microbiota and the host in human metabolism and the development of cardiovascular disease. This adds one more layer of complexity to understanding what contributes to this pathology and how to harness the microbiota and their metabolic pathways to prevent it. In 'Bedside to Bench', Nobuhiko Kamada, Grace Chen and Gabriel Nunez discuss how targeting interactions between commensals and bacteria causing intestinal disease can lead to effective therapies to control these infections, which currently seem to lack an adequate treatment. Unraveling how commensals help the host prevent or block colonization of these pathogens can suggest new ways to increase our armamentarium to deal with these sometimes deadly intestinal infections.	[Howitt, Michael R.; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Sch Med, Boston, MA 02115 USA; [Howitt, Michael R.; Garrett, Wendy S.] Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Howitt, MR (corresponding author), Harvard Univ, Sch Publ Hlth, Sch Med, 665 Huntington Ave, Boston, MA 02115 USA.	wgarrett@hsph.harvard.edu		Garrett, Wendy/0000-0002-5092-0150	NIAID NIH HHS [K08 AI078942] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI078942] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922	16	61	73	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1188	1189		10.1038/nm.2895	http://dx.doi.org/10.1038/nm.2895			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869188				2022-12-27	WOS:000307469300022
J	Kuhn, R; Beall, RF				Kuhn, Randall; Beall, Reed F.			The time for pharmaceutical compulsory licensing has expired	NATURE MEDICINE			English	Editorial Material								The compulsory license mechanism is broken and will not bring drug access to the world's poorest nations. it's time to consider another option-a tax levied on patents-to fund drugs for developing countries, rather than the erratic compulsory licensing mechanism.	[Kuhn, Randall] Univ Denver, Josef Korbel Sch Int Studies, Global Hlth Affairs Program, Denver, CO 80208 USA; [Beall, Reed F.] Univ Ottawa, Populat Hlth Program, Ottawa, ON, Canada	University of Denver; University of Ottawa	Kuhn, R (corresponding author), Univ Denver, Josef Korbel Sch Int Studies, Global Hlth Affairs Program, Denver, CO 80208 USA.			Kuhn, Randall/0000-0001-5664-6933					0	6	6	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1168	1168		10.1038/nm0812-1168	http://dx.doi.org/10.1038/nm0812-1168			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869177	Bronze			2022-12-27	WOS:000307469300011
J	Geiger, H; Pawar, SA; Kerschen, EJ; Nattamai, KJ; Hernandez, I; Liang, HPH; Fernandez, JA; Cancelas, JA; Ryan, MA; Kustikova, O; Schambach, A; Fu, Q; Wang, JR; Fink, LM; Petersen, KU; Zhou, DH; Griffin, JH; Baum, C; Weiler, H; Hauer-Jensen, M				Geiger, Hartmut; Pawar, Snehalata A.; Kerschen, Edward J.; Nattamai, Kalpana J.; Hernandez, Irene; Liang, Hai Po H.; Fernandez, Jose A.; Cancelas, Jose A.; Ryan, Marnie A.; Kustikova, Olga; Schambach, Axel; Fu, Qiang; Wang, Junru; Fink, Louis M.; Petersen, Karl-Uwe; Zhou, Daohong; Griffin, John H.; Baum, Christopher; Weiler, Hartmut; Hauer-Jensen, Martin			Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; SOLUBLE HUMAN THROMBOMODULIN; VASCULAR ENDOTHELIUM; EXTRACELLULAR HISTONES; IONIZING-RADIATION; THROMBIN RECEPTOR; DENDRITIC CELLS; RAT MODEL; MICE; APOPTOSIS	Tissue damage induced by ionizing radiation in the hematopoietic and gastrointestinal systems is the major cause of lethality in radiological emergency scenarios and underlies some deleterious side effects in patients undergoing radiation therapy(1,2). The identification of target-specific interventions that confer radiomitigating activity is an unmet challenge. Here we identify the thrombomodulin (Thbd)-activated protein C (aPC) pathway as a new mechanism for the mitigation of total body irradiation (TBI)-induced mortality. Although the effects of the endogenous Thbd-aPC pathway were largely confined to the local microenvironment of Thbd-expressing cells, systemic administration of soluble Thbd or aPC could reproduce and augment the radioprotective effect of the endogenous Thbd-aPC pathway. Therapeutic administration of recombinant, soluble Thbd or aPC to lethally irradiated wild-type mice resulted in an accelerated recovery of hematopoietic progenitor activity in bone marrow and a mitigation of lethal TBI. Starting infusion of aPC as late as 24 h after exposure to radiation was sufficient to mitigate radiation-induced mortality in these mice. These findings suggest that pharmacologic augmentation of the activity of the Thbd-aPC pathway by recombinant Thbd or aPC might offer a rational approach to the mitigation of tissue injury and lethality caused by ionizing radiation.	[Geiger, Hartmut; Nattamai, Kalpana J.; Cancelas, Jose A.; Ryan, Marnie A.] Univ Cincinnati, Div Expt Hematol & Canc Biol, Canc & Blood Dis Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Pawar, Snehalata A.; Fu, Qiang; Wang, Junru; Zhou, Daohong; Hauer-Jensen, Martin] Univ Arkansas Med Sci, Coll Pharm, Div Radiat Hlth, Little Rock, AR 72205 USA; [Kerschen, Edward J.; Hernandez, Irene; Liang, Hai Po H.; Weiler, Hartmut] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Kerschen, Edward J.; Hernandez, Irene; Liang, Hai Po H.; Weiler, Hartmut] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Fernandez, Jose A.; Griffin, John H.] Scripps Res Inst, La Jolla, CA USA; [Kustikova, Olga; Schambach, Axel; Baum, Christopher] Hannover Med Sch, Dept Expt Hematol, D-3000 Hannover, Germany; [Fink, Louis M.] Desert Res Inst, Las Vegas, NV USA; [Petersen, Karl-Uwe] PAION Deutschland GmbH, Aachen, Germany; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Surg Serv, Little Rock, AR USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Ulm University; University of Arkansas System; University of Arkansas Medical Sciences; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Scripps Research Institute; Hannover Medical School; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Geiger, H (corresponding author), Univ Cincinnati, Div Expt Hematol & Canc Biol, Canc & Blood Dis Inst, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	hartmut.geiger@cchmc.org	Schambach, Axel/C-5491-2011; Cancelas, Jose/AAR-9324-2020; Fernandez, Jose A/A-3211-2008; Pawar, Snehalata/ABD-4557-2020	Fernandez, Jose A/0000-0002-0804-1865; Pawar, Snehalata/0000-0003-3992-2494; Griffin, John/0000-0002-4302-2547	US National Institutes of Health [CA71382, AI67798, AI080557, HL31950, HL052246, HL44612, CA122023, AI080421]; Edward P. Evans Foundation; Ziegler Family Chair for Research; Veterans Administration; Comprehensive Mouse and Cancer Core at Cincinnati Children's Hospital Medical Center (CCHMC); NATIONAL CANCER INSTITUTE [R01CA122023, R37CA071382, R01CA071382] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, R01HL052246, P01HL031950, R37HL052246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, R21AI080557, R33AI080557, R01AI080421] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation; Ziegler Family Chair for Research; Veterans Administration(US Department of Veterans Affairs); Comprehensive Mouse and Cancer Core at Cincinnati Children's Hospital Medical Center (CCHMC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US National Institutes of Health (grants CA71382 and AI67798 to M.H.-J., AI080557 to H.W., J.A.F. and H.G., HL31950 and HL052246 to J.H.G., HL44612 to H.W. and CA122023 and AI080421 to D.Z.), the Edward P. Evans Foundation (M.H.-J., D.Z. and H.G.), the Ziegler Family Chair for Research (H.W.) and the Veterans Administration. We thank J. Bailey and V. Summey from the Comprehensive Mouse and Cancer Core at Cincinnati Children's Hospital Medical Center (CCHMC) for their support and services. We are grateful to M. Monestier (Temple University School of Medicine, Philadelphia, Pennsylvania, USA) for the BWA3 antibody, S.J. Kennel (University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, USA) for the antibodies to Thbd (273-34A and 411-201B) and D. Gailani and A. Gruber (Vanderbilt University, Nashville, Tennessee, USA) for providing the 14E11 antibody.	BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; CONWAY EM, 1992, BLOOD, V80, P1254; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; ESMON CT, 1982, J BIOL CHEM, V257, P7944; ESMON NL, 1982, J BIOL CHEM, V257, P859; Foley JH, 2012, BLOOD, V119, P3622, DOI 10.1182/blood-2011-11-392308; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; Gupta PK, 2011, ANAL METHODS-UK, V3, P1759, DOI 10.1039/c1ay05213f; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Ismail JA, 2003, CARDIOVASC PATHOL, V12, P82, DOI 10.1016/S1054-8807(02)00166-7; Iwaki T, 2005, BLOOD, V105, P2364, DOI 10.1182/blood-2004-06-2456; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kanzawa T, 2006, ONCOGENE, V25, P3638, DOI 10.1038/sj.onc.1209414; KENNEL SJ, 1988, LAB INVEST, V59, P692; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kerschen E, 2010, J CLIN INVEST, V120, P3167, DOI 10.1172/JCI42629; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kodell RL, 2010, BIOMETRICS, V66, P239, DOI 10.1111/j.1541-0420.2009.01236.x; Kustikova OS, 2007, BLOOD, V109, P1897, DOI 10.1182/blood-2006-08-044156; Kustikova OS, 2009, MOL THER, V17, P1537, DOI 10.1038/mt.2009.134; Langberg CW, 1996, RADIOTHER ONCOL, V41, P249, DOI 10.1016/S0167-8140(96)01809-9; Luo DY, 2012, INFECT IMMUN, V80, P91, DOI 10.1128/IAI.05568-11; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Modlich U, 2006, BLOOD, V108, P2545, DOI 10.1182/blood-2005-08-024976; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2009, BLOOD, V113, P5970, DOI 10.1182/blood-2008-10-183327; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ross CC, 2008, RADIAT RES, V169, P408, DOI 10.1667/RR1148.1; Rotolo JA, 2010, CANCER RES, V70, P957, DOI 10.1158/0008-5472.CAN-09-1562; Schuller BW, 2006, P NATL ACAD SCI USA, V103, P3787, DOI 10.1073/pnas.0600133103; SOLIS MM, 1994, THROMB RES, V73, P385, DOI 10.1016/0049-3848(94)90040-X; Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x; Tanaka KA, 2006, BRIT J HAEMATOL, V132, P197, DOI 10.1111/j.1365-2141.2005.05855.x; van Iersel T, 2011, THROMB HAEMOSTASIS, V105, P302, DOI 10.1160/TH10-05-0287; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Weiler H, 2001, ARTERIOSCL THROM VAS, V21, P1531, DOI 10.1161/hq0901.094496; Weiler H, 2004, THROMB HAEMOSTASIS, V92, P467, DOI 10.1160/TH04-05-0307; Weiler H, 2010, CRIT CARE MED, V38, pS18, DOI 10.1097/CCM.0b013e3181c9cbb5; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; WeilerGuettler H, 1996, CIRC RES, V78, P180, DOI 10.1161/01.RES.78.2.180; Weisel JW, 1996, J BIOL CHEM, V271, P31485, DOI 10.1074/jbc.271.49.31485; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yerkovich ST, 2009, J ALLERGY CLIN IMMUN, V123, P209, DOI 10.1016/j.jaci.2008.09.009; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278	53	81	84	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1123	+		10.1038/nm.2813	http://dx.doi.org/10.1038/nm.2813			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22729286	Green Accepted			2022-12-27	WOS:000306121600043
J	Miyazaki, Y; Adachi, H; Katsuno, M; Minamiyama, M; Jiang, YM; Huang, Z; Doi, H; Matsumoto, S; Kondo, N; Iida, M; Tohnai, G; Tanaka, F; Muramatsu, S; Sobue, G				Miyazaki, Yu; Adachi, Hiroaki; Katsuno, Masahisa; Minamiyama, Makoto; Jiang, Yue-Mei; Huang, Zhe; Doi, Hideki; Matsumoto, Shinjiro; Kondo, Naohide; Iida, Madoka; Tohnai, Genki; Tanaka, Fumiaki; Muramatsu, Shin-ichi; Sobue, Gen			Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2	NATURE MEDICINE			English	Article							BULBAR MUSCULAR-ATROPHY; TRANSGENIC MOUSE MODEL; MOTOR-NEURON DEGENERATION; ANDROGEN RECEPTOR PROTEIN; NEURODEGENERATION; MICRORNAS; MICE; OVEREXPRESSION; PROGRESSION; SEQUENCE	Spinal and bulbar muscular atrophy (SBMA) is an inherited neurodegenerative disorder caused by the expansion of the polyglutamine (polyQ) tract of the androgen receptor (AR-polyQ)(1,2). Characteristics of SBMA include proximal muscular atrophy, weakness, contraction fasciculation and bulbar involvement(3). MicroRNAs (miRNAs) are a diverse class of highly conserved small RNA molecules that function as crucial regulators of gene expression in animals and plants(4). Recent functional studies have shown the potent activity of specific miRNAs as disease modifiers both in vitro and in vivo(5-8). Thus, potential therapeutic approaches that target the miRNA processing pathway have recently attracted attention(9,10). Here we describe a novel therapeutic approach using the adeno-associated virus (AAV) vector-mediated delivery of a specific miRNA for SBMA. We found that miR-196a enhanced the decay of the AR mRNA by silencing CUGBP, Elav-like family member 2 (CELF2). CELF2 directly acted on AR mRNA and enhanced the stability of AR mRNA. Furthermore, we found that the early intervention of miR-196a delivered by an AAV vector ameliorated the SBMA phenotypes in a mouse model. Our results establish the proof of principle that disease-specific miRNA delivery could be useful in neurodegenerative diseases.	[Miyazaki, Yu; Adachi, Hiroaki; Katsuno, Masahisa; Minamiyama, Makoto; Jiang, Yue-Mei; Huang, Zhe; Doi, Hideki; Matsumoto, Shinjiro; Kondo, Naohide; Iida, Madoka; Tohnai, Genki; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan; [Muramatsu, Shin-ichi] Jichi Med Univ, Dept Med, Div Neurol, Shimotsuke, Tochigi, Japan	Nagoya University; Jichi Medical University	Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4648601, Japan.	sobueg@med.nagoya-u.ac.jp	Adachi, Hiroaki/I-2669-2012; iida, madoka/AAB-7707-2020; Adachi, Hiroaki/AAM-7812-2020; Muramatsu, Shin-ichi/K-9420-2013; KATSUNO, MASAHISA/I-7502-2014; Muramatsu, Shinichi/ABC-6093-2021	Adachi, Hiroaki/0000-0002-9302-4663; Adachi, Hiroaki/0000-0002-9302-4663; Muramatsu, Shin-ichi/0000-0002-3185-7790; KATSUNO, MASAHISA/0000-0001-9453-9311; Muramatsu, Shinichi/0000-0002-3185-7790	Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Center-of-Excellence (COE) grant; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [23390231] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center-of-Excellence (COE) grant; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to T. Cooper (Department of Pathology and Immunology, Baylor College of Medicine) for kindly providing the plasmid expressing human CELF2. We also thank N. Takino, H. Miyauchi and K. Ayabe (Division of Neurology, Department of Medicine, Jichi Medical University) for their help with the production of the AAV vectors and Y. Kondo and K. Shinjo (Division of Molecular Oncology, Aichi Cancer Center Research Institute) for expert technical support and helpful discussions. This work was supported by grants from the Ministry of Health, Labor and Welfare; grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; a Center-of-Excellence (COE) grant; a Grant-in-Aid for Scientific Research on Innovated Areas "Foundations of Synapse and Neurocircuit Pathology"; and the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST).	Adachi H, 2003, J NEUROSCI, V23, P2203; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Boudreau RL, 2011, HUM MOL GENET, V20, pR21, DOI 10.1093/hmg/ddr137; Dhaenens CM, 2011, BBA-MOL BASIS DIS, V1812, P732, DOI 10.1016/j.bbadis.2011.03.010; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fu HY, 2011, MOL THER, V19, P1025, DOI 10.1038/mt.2011.34; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Katsuno M, 2010, J NEUROSCI, V30, P5702, DOI 10.1523/JNEUROSCI.0388-10.2010; Kennedy WR, 1998, NEUROLOGY, V50, P583, DOI 10.1212/WNL.50.3.583; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Li XG, 2006, MOL THER, V13, P160, DOI 10.1016/j.ymthe.2005.08.009; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Natarajan G, 2008, AM J PHYSIOL-GASTR L, V294, pG1235, DOI 10.1152/ajpgi.00037.2008; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Roshan R, 2009, DRUG DISCOV TODAY, V14, P1123, DOI 10.1016/j.drudis.2009.09.009; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; Subramaniam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016958; Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	35	115	120	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1136	+		10.1038/nm.2791	http://dx.doi.org/10.1038/nm.2791			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22660636				2022-12-27	WOS:000306121600045
J	Sherlock, JP; Joyce-Shaikh, B; Turner, SP; Chao, CC; Sathe, M; Grein, J; Gorman, DM; Bowman, EP; McClanahan, TK; Yearley, JH; Eberl, G; Buckley, CD; Kastelein, RA; Pierce, RH; LaFace, DM; Cua, DJ				Sherlock, Jonathan P.; Joyce-Shaikh, Barbara; Turner, Scott P.; Chao, Cheng-Chi; Sathe, Manjiri; Grein, Jeff; Gorman, Daniel M.; Bowman, Edward P.; McClanahan, Terrill K.; Yearley, Jennifer H.; Eberl, Gerard; Buckley, Christopher D.; Kastelein, Robert A.; Pierce, Robert H.; LaFace, Drake M.; Cua, Daniel J.			IL-23 induces spondyloarthropathy by acting on ROR-gamma t(+) CD3(+)CD4(-)CD8(-) entheseal resident T cells	NATURE MEDICINE			English	Article							LIGAMENT-BONE INTERFACE; EXPRESSION IN-VIVO; ANKYLOSING-SPONDYLITIS; ACHILLES-TENDON; PROINFLAMMATORY IL-17(+); DISTINCT FIBROCARTILAGES; IL-17-PRODUCING CELLS; RHEUMATOID-ARTHRITIS; DISEASE; COLLAGENS	The spondyloarthropathies are a group of rheumatic diseases that are associated with inflammation at anatomically distal sites, particularly the tendon-bone attachments (entheses) and the aortic root. Serum concentrations of interleukin-23 (IL-23) are elevated and polymorphisms in the IL-23 receptor are associated with ankyosing spondylitis, however, it remains unclear whether IL-23 acts locally at the enthesis or distally on circulating cell populations. We show here that IL-23 is essential in enthesitis and acts on previously unidentified IL-23 receptor (IL-23R)(+), RAR-related orphan receptor gamma t (ROR-gamma t)(+)CD3(+)CD4(-)CD8(-), stem cell antigen 1 (Sca1)(+) entheseal resident T cells. These cells allow entheses to respond to IL-23 in vitro-in the absence of further cellular recruitment-and to elaborate inflammatory mediators including IL-6, IL-17, IL-22 and chemokine (C-X-C motif) ligand 1 (CXCL1). Notably, the in vivo expression of IL-23 is sufficient to phenocopy the human disease, with the specific and characteristic development of enthesitis and entheseal new bone formation in the initial complete absence of synovitis. As in the human condition, inflammation also develops in vivo at the aortic root and valve, which are structurally similar to entheses. The presence of these entheseal resident cells and their production of IL-22, which activates signal transducer and activator of transcription 3 (STAT3)-dependent osteoblastmediated bone remodeling, explains why dysregulation of IL-23 results in inflammation at this precise anatomical site.	[Sherlock, Jonathan P.; Joyce-Shaikh, Barbara; Turner, Scott P.; Chao, Cheng-Chi; Sathe, Manjiri; Grein, Jeff; Gorman, Daniel M.; Bowman, Edward P.; McClanahan, Terrill K.; Yearley, Jennifer H.; Kastelein, Robert A.; Pierce, Robert H.; LaFace, Drake M.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA USA; [Sherlock, Jonathan P.] Univ Oxford, Trinity Coll, Oxford, England; [Sherlock, Jonathan P.; Buckley, Christopher D.] Univ Birmingham, Birmingham, W Midlands, England; [Eberl, Gerard] Inst Pasteur, Paris, France	Merck & Company; University of Oxford; University of Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cua, DJ (corresponding author), Merck Res Labs, Palo Alto, CA USA.	daniel.cua@merck.com	Buckley, Christopher/AAN-6378-2021; Eberl, Gerard/A-1160-2013	Buckley, Christopher/0000-0001-6924-6402; Pierce, MD, Robert Hamilton/0000-0002-2677-144X; Eberl, Gerard/0000-0002-1119-5638	Merck Research Laboratories; Medical Research Council [G9818340B] Funding Source: researchfish; National Institute for Health Research [CL-2011-09-004(1)] Funding Source: researchfish; Versus Arthritis [19791] Funding Source: researchfish	Merck Research Laboratories(Merck & Company); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	We are grateful for the assistance of S. Jungers for flow cytometric sorting. We also thank P. Bowness, H. Gaston, A. van der Merwe and A. Cooke for helpful comments on this study. This research was funded by and conducted within Merck Research Laboratories. We thank Z.-Y. Chen (Departments of Pediatrics and Genetics, Stanford University School of Medicine) for the minicircle vector plasmid.	Alonzo ES, 2011, CURR OPIN IMMUNOL, V23, P220, DOI 10.1016/j.coi.2010.12.016; Appel H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2035; Appel H, 2006, ARTHRITIS RHEUM-US, V54, P2845, DOI 10.1002/art.22060; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Bellow M, 2000, ANN RHEUM DIS, V59, P135, DOI 10.1136/ard.59.2.135; Benjamin M, 2007, ARTHRITIS RHEUM, V56, P224, DOI 10.1002/art.22290; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fukuta S, 1998, MATRIX BIOL, V17, P65, DOI 10.1016/S0945-053X(98)90074-9; Gao J, 1996, ANAT EMBRYOL, V194, P399; GILLET P, 1989, J RHEUMATOL, V16, P721; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Grateau G, 2010, BEST PRACT RES CL RH, V24, P401, DOI 10.1016/j.berh.2009.12.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kruithof E, 2005, ARTHRITIS RES THER, V7, pR569, DOI 10.1186/ar1698; KUMAGAI J, 1994, J ANAT, V185, P279; Lambert RGW, 2007, ARTHRITIS RHEUM, V56, P4005, DOI 10.1002/art.23044; Ling E, 2007, AUTOIMMUN REV, V6, P237, DOI 10.1016/j.autrev.2006.08.008; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lories RJU, 2010, BEST PRACT RES CL RH, V24, P625, DOI 10.1016/j.berh.2010.05.005; Maksymowych WP, 2010, NAT REV RHEUMATOL, V6, P75, DOI 10.1038/nrrheum.2009.258; May E, 2003, J IMMUNOL, V170, P1099, DOI 10.4049/jimmunol.170.2.1099; McGonagle D, 1998, LANCET, V352, P1137, DOI 10.1016/S0140-6736(97)12004-9; McGonagle D, 1998, ARTHRITIS RHEUM, V41, P694, DOI 10.1002/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#; McGonagle D, 2002, ANN RHEUM DIS, V61, P534, DOI 10.1136/ard.61.6.534; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Melis L, 2010, ANN RHEUM DIS, V69, P618, DOI 10.1136/ard.2009.107649; MIELANTS H, 1995, J RHEUMATOL, V22, P2279; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Niyibizi C, 1996, BIOCHEM BIOPH RES CO, V222, P584, DOI 10.1006/bbrc.1996.0787; Palazzi C, 2011, JOINT BONE SPINE, V78, P451, DOI 10.1016/j.jbspin.2010.11.003; Rahman P, 2008, ARTHRITIS RHEUM-US, V58, P1020, DOI 10.1002/art.23389; Rahman P, 2009, J RHEUMATOL, V36, P137, DOI 10.3899/jrheum.080458; RALPHS JR, 1994, J ANAT, V184, P503; RALPHS JR, 1992, ANAT EMBRYOL, V185, P181; Riol-Blanco L, 2010, J IMMUNOL, V184, P1710, DOI 10.4049/jimmunol.0902796; RUFAI A, 1992, ANAT EMBRYOL, V186, P611; SAKAMOTO A, 1992, ARTHRITIS RHEUM, V35, P944, DOI 10.1002/art.1780350815; Taurog JD, 2009, ARTHRITIS RHEUM, V60, P1977, DOI 10.1002/art.24599; van der Heijde D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2794; Venzor J, 1997, AM J MED SCI, V313, P236, DOI 10.1097/00000441-199704000-00007; Visconti CS, 1996, ARCH BIOCHEM BIOPHYS, V328, P135, DOI 10.1006/abbi.1996.0153; Waggett AD, 1998, MATRIX BIOL, V16, P457, DOI 10.1016/S0945-053X(98)90017-8; Wang XW, 2009, RHEUMATOL INT, V29, P1343, DOI 10.1007/s00296-009-0883-x; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; WOFSY D, 1984, J IMMUNOL, V132, P2686	54	722	757	2	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1069	+		10.1038/nm.2817	http://dx.doi.org/10.1038/nm.2817			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772566				2022-12-27	WOS:000306121600036
J	Ratner, M; Schwartz, J				Ratner, Mark; Schwartz, Joseph			Straight talk with. . . Joseph Schwartz	NATURE MEDICINE			English	Editorial Material									[Schwartz, Joseph] Leerink Swann, Boston, MA USA										0	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					846	846		10.1038/nm0612-846	http://dx.doi.org/10.1038/nm0612-846			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673987	Bronze			2022-12-27	WOS:000305116600013
J	Mapstone, M; Cheema, AK; Fiandaca, MS; Zhong, XG; Mhyre, TR; MacArthur, LH; Hall, WJ; Fisher, SG; Peterson, DR; Haley, JM; Nazar, MD; Rich, SA; Berlau, DJ; Peltz, CB; Tan, MT; Kawas, CH; Federoff, HJ				Mapstone, Mark; Cheema, Amrita K.; Fiandaca, Massimo S.; Zhong, Xiaogang; Mhyre, Timothy R.; MacArthur, Linda H.; Hall, William J.; Fisher, Susan G.; Peterson, Derick R.; Haley, James M.; Nazar, Michael D.; Rich, Steven A.; Berlau, Dan J.; Peltz, Carrie B.; Tan, Ming T.; Kawas, Claudia H.; Federoff, Howard J.			Plasma phospholipids identify antecedent memory impairment in older adults	NATURE MEDICINE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS ASSOCIATION WORKGROUPS; CEREBROSPINAL-FLUID; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; FOLLOW-UP; DISEASE; BIOMARKERS; RECOMMENDATIONS; CLASSIFICATION	Alzheimer's disease causes a progressive dementia that currently affects over 35 million individuals worldwide and is expected to affect 115 million by 2050 (ref. 1). There are no cures or disease-modifying therapies, and this may be due to our inability to detect the disease before it has progressed to produce evident memory loss and functional decline. Biomarkers of preclinical disease will be critical to the development of disease-modifying or even preventative therapies(2). Unfortunately, current biomarkers for early disease, including cerebrospinal fluid tau and amyloid-beta levels(3), structural and functional magnetic resonance imaging(4) and the recent use of brain amyloid imaging(5) or inflammaging(6), are limited because they are either invasive, time-consuming or expensive. Blood-based biomarkers may be a more attractive option, but none can currently detect preclinical Alzheimer's disease with the required sensitivity and specificity(7). Herein, we describe our lipidomic approach to detecting preclinical Alzheimer's disease in a group of cognitively normal older adults. We discovered and validated a set of ten lipids from peripheral blood that predicted phenoconversion to either amnestic mild cognitive impairment or Alzheimer's disease within a 2-3 year timeframe with over 90% accuracy. This biomarker panel, reflecting cell membrane integrity, may be sensitive to early neurodegeneration of preclinical Alzheimer's disease.	[Mapstone, Mark] Univ Rochester, Sch Med, Dept Neurol, Rochester, NY USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20007 USA; [Fiandaca, Massimo S.; Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Fiandaca, Massimo S.; Mhyre, Timothy R.; MacArthur, Linda H.; Federoff, Howard J.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Zhong, Xiaogang; Tan, Ming T.] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA; [Hall, William J.] Univ Rochester, Sch Med, Dept Med, Rochester, NY USA; [Fisher, Susan G.] Univ Rochester, Sch Med, Dept Publ Hlth Sci, Rochester, NY USA; [Peterson, Derick R.] Univ Rochester, Sch Med, Dept Biostat & Computat Biol, Rochester, NY USA; [Haley, James M.] Unity Hlth Syst, Dept Med, Rochester, NY USA; [Nazar, Michael D.] Unity Hlth Syst, Dept Family Med, Rochester, NY USA; [Rich, Steven A.] Rochester Gen Hosp, Div Long Term Care & Senior Serv, Rochester, NY 14621 USA; [Berlau, Dan J.; Peltz, Carrie B.; Kawas, Claudia H.] Univ Calif Irvine, Sch Med, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of Rochester; Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; University of Rochester; University of Rochester; University of Rochester; Rochester General Hospital; University of California System; University of California Irvine	Federoff, HJ (corresponding author), Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA.	hjf8@georgetown.edu	Singh, Rajbir/HHN-9064-2022; Peterson, Derick/W-5240-2019	Peterson, Derick/0000-0001-8603-660X; Cheema, Amrita/0000-0003-4877-7583; Berlau, Daniel/0000-0003-3727-952X; Kawas, Claudia/0000-0001-9577-230X; Fiandaca, Massimo/0000-0002-8376-1934	US National Institutes of Health [R01AG030753]; DOD [W81XWH-09-1-0107]; NATIONAL INSTITUTE ON AGING [R01AG030753] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Johnson and D. Greenia for study coordination; P. Bailie, M. Patel and A. Balasubramanian for assistance with data collection; and A. Almudevar for statistical support. We also thank R. Padilla and I. Conteh for processing the blood samples and R. Singh and P. Kaur for technical assistance in developing the lipidomics data. This work was funded by US National Institutes of Health grants R01AG030753 and DOD W81XWH-09-1-0107 to H.J.F.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Doecke JD, 2012, ARCH NEUROL-CHICAGO, V69, P1318, DOI 10.1001/archneurol.2012.1282; Espinosa A, 2013, J ALZHEIMERS DIS, V34, P769, DOI 10.3233/JAD-122002; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hastie T., 2008, ELEMENTS STAT LEARNI; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Irizarry Michael C, 2004, NeuroRx, V1, P226; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; KORDOWER JH, 1994, P NATL ACAD SCI USA, V91, P10898, DOI 10.1073/pnas.91.23.10898; KORDOWER JH, 1990, J COMP NEUROL, V298, P443, DOI 10.1002/cne.902980406; Liu ZQ, 2008, BIOMETRICS, V64, P1155, DOI 10.1111/j.1541-0420.2008.01015.x; Ma SG, 2005, BIOINFORMATICS, V21, P4356, DOI 10.1093/bioinformatics/bti724; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mulder C, 2003, J NEURAL TRANSM, V110, P949, DOI 10.1007/s00702-003-0007-9; NITSCH RM, 1992, P NATL ACAD SCI USA, V89, P1671, DOI 10.1073/pnas.89.5.1671; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pettegrew JW, 2001, NEUROCHEM RES, V26, P771, DOI 10.1023/A:1011603916962; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Roe CM, 2011, NEUROLOGY, V76, P501, DOI 10.1212/WNL.0b013e31820af900; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Small SA, 1999, ANN NEUROL, V45, P466, DOI 10.1002/1531-8249(199904)45:4<466::AID-ANA8>3.0.CO;2-Q; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Thambisetty M, 2010, BIOMARK MED, V4, P65, DOI 10.2217/BMM.09.84; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Walter A, 2004, NEUROBIOL AGING, V25, P1299, DOI 10.1016/j.neurobiolaging.2004.02.016; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	40	696	725	6	270	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					415	+		10.1038/nm.3466	http://dx.doi.org/10.1038/nm.3466			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24608097	Green Accepted, Green Submitted			2022-12-27	WOS:000334361500022
J	Adkins, B; Levy, O; Betz, AG				Adkins, Becky; Levy, Ofer; Betz, Alexander G.			A new unexpected twist in newborn immunity	NATURE MEDICINE			English	Editorial Material							MICROBIOTA; RESPONSES; CELLS		[Adkins, Becky] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Levy, Ofer] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Betz, Alexander G.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Miami; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; MRC Laboratory Molecular Biology	Adkins, B (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.		Betz, Alexander/GQQ-2221-2022	Levy, Ofer/0000-0002-5859-1945	Medical Research Council [MC_U105184296] Funding Source: Medline; MRC [MC_U105184296] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adkins B, 2013, IMMUNOL RES, V57, P246, DOI 10.1007/s12026-013-8439-2; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2014, PEDIATR RES, V75, P184, DOI 10.1038/pr.2013.214; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212	10	2	2	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					22	23		10.1038/nm.3448	http://dx.doi.org/10.1038/nm.3448			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398960				2022-12-27	WOS:000329349400013
J	Carbone, F; De Rosa, V; Carrieri, PB; Montella, S; Bruzzese, D; Porcellini, A; Procaccini, C; La Cava, A; Matarese, G				Carbone, Fortunata; De Rosa, Veronica; Carrieri, Pietro B.; Montella, Silvana; Bruzzese, Dario; Porcellini, Antonio; Procaccini, Claudio; La Cava, Antonio; Matarese, Giuseppe			Regulatory T cell proliferative potential is impaired in human autoimmune disease	NATURE MEDICINE			English	Article							2 FOXP3 ISOFORMS; SUPPRESSIVE FUNCTION; SPLICE VARIANTS; EXPRESSION; LEPTIN; TOLERANCE; IL2RA; REG	Human CD4(+)CD25(high)CD127(-)FoxP3(+) regulatory T (Treg) cells suppress immune responses in vitro and in vivo(1). Reduced suppressive function and/or number of peripheral T-reg cells has been previously reported in autoimmune disorders(2,3). T-reg cells represent the most actively replicating compartment within the CD4(+) cells in vivo, but they are hyporesponsive to classical T cell receptor (TCR) stimulation in vitro, a condition that is secondary to their overactive metabolic state(4,5). Here we report that proliferation of T-reg cells after TCR stimulation is impaired in subjects with relapsing-remitting multiple sclerosis (RRMS) because of altered interleukin-2 (IL-2) secretion and IL-2 receptor (IL-2R)-signal transducer and activator of transcription 5 (STAT5) signaling. This is associated with decreased expression of the forkhead box P3 (FoxP3) 44- and 47-kDa splicing forms, overactivation of S6 ribosomal protein (a downstream target of the mammalian target of rapamycin, mTOR) and altered activity of the cyclin-dependent kinase inhibitor p27 (p27(kip1)) and extracellular signal-related kinases 1 and 2 (ERK1/2). The impaired capacity of T-reg cells to proliferate in RRMS correlates with the clinical state of the subject, where increasing disease severity is associated with a decline in T-reg cell expansion. These results suggest a previously unrecognized mechanism that may account for the progressive loss of T-reg cells in autoimmune disease.	[Carbone, Fortunata; De Rosa, Veronica; Procaccini, Claudio] Consiglio Nazl Ric IEOS CNR, Lab Immunol, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Carbone, Fortunata; Procaccini, Claudio; Matarese, Giuseppe] Univ Salerno, Dipartimento Med & Chirurg, I-84100 Salerno, Italy; [De Rosa, Veronica] Ist Ricovero & Cura Carattere Sci IRCCS Fdn Santa, Unita NeuroImmunol, Rome, Italy; [Carrieri, Pietro B.; Montella, Silvana] Univ Naples Federico II, Dipartimento Neurosci, Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dipartimento Sci Med Prevent, Naples, Italy; [Porcellini, Antonio] Univ Naples Federico II, Dipartimento Biol, Complesso Univ Monte St Angelo, Naples, Italy; [La Cava, Antonio] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Matarese, Giuseppe] IRCCS MultiMed, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Salerno; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; IRCCS Multimedica	Matarese, G (corresponding author), Univ Salerno, Dipartimento Med & Chirurg, Baronissi Campus, I-84100 Salerno, Italy.	gmatarese@unisa.it	Carbone, Fortunata/K-3176-2016; Porcellini, Antonio/AAC-6097-2019; /AAG-9576-2020; Procaccini, Claudio/AAB-3696-2019; Matarese, Giuseppe/AAO-4077-2021; Porcellini, Antonio/E-1900-2011	Carbone, Fortunata/0000-0003-4299-6515; /0000-0002-8839-0933; Matarese, Giuseppe/0000-0001-9429-0616; Porcellini, Antonio/0000-0001-6882-9518; Bruzzese, Dario/0000-0001-9911-4646; PROCACCINI, CLAUDIO/0000-0002-2184-0442	Fondazione Italiana Sclerosi Multipla (FISM) [2012/R/11]; European Union IDEAS Programme European Research Council Starting Grant [310496]; Ministero della Salute [GR-2010-2315414]; Fondo per gli Investimenti della Ricerca di Base (FIRB) [RBFR12I3UB_004]; US National Institutes of Health [AI95921]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI095921] Funding Source: NIH RePORTER	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); European Union IDEAS Programme European Research Council Starting Grant; Ministero della Salute(Ministry of Health, Italy); Fondo per gli Investimenti della Ricerca di Base (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by grants from Fondazione Italiana Sclerosi Multipla (FISM) 2012/R/11, the European Union IDEAS Programme European Research Council Starting Grant "menTORingTregs" 310496, the Ministero della Salute Grant GR-2010-2315414 and the Fondo per gli Investimenti della Ricerca di Base (FIRB) grant RBFR12I3UB_004; A.L.C. is supported by the US National Institutes of Health grant AI95921. The authors thank S. De Simone and M. Galgani from the MoFlo Cell Sorting Facility and C. La Rocca for assistance in the T<INF>reg</INF> cell isolations. This work is dedicated to the memory of E. Papa and S. Zappacosta.	Allan SE, 2005, J CLIN INVEST, V115, P3276, DOI 10.1172/JCI24685; Batocchi AP, 2003, J NEUROIMMUNOL, V139, P150, DOI 10.1016/S0165-5728(03)00154-1; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Cavanillas ML, 2010, EUR J HUM GENET, V18, P794, DOI 10.1038/ejhg.2010.15; Cheng GY, 2013, J IMMUNOL, V190, P1567, DOI 10.4049/jimmunol.1201218; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Fisson S, 2003, J EXP MED, V198, P737, DOI 10.1084/jem.20030686; Guo WG, 2009, BIOMETRIKA, V96, P1012, DOI 10.1093/biomet/asp048; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; James MJ, 2003, BLOOD, V102, P2173, DOI 10.1182/blood-2003-02-0637; Kaur G, 2010, MOL IMMUNOL, V48, P321, DOI 10.1016/j.molimm.2010.07.008; Kofler DM, 2011, J IMMUNOL, V187, P3286, DOI 10.4049/jimmunol.1100626; Lechler R, 2001, IMMUNOLOGY, V103, P262, DOI 10.1046/j.1365-2567.2001.01250.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; LOMBARDI G, 1994, SCIENCE, V264, P1587, DOI 10.1126/science.8202711; Long SA, 2011, J IMMUNOL, V187, P2061, DOI 10.4049/jimmunol.1003224; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lord JD, 2012, DIGEST DIS SCI, V57, P2846, DOI 10.1007/s10620-012-2292-3; Mailer RKW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006104; Maruyama T, 2011, SEMIN IMMUNOL, V23, P418, DOI 10.1016/j.smim.2011.06.005; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Murdoch DJ, 1996, AM STAT, V50, P178, DOI 10.2307/2684435; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Procaccini C, 2012, TRENDS IMMUNOL, V33, P1, DOI 10.1016/j.it.2011.09.002; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Smith EL, 2006, IMMUNOLOGY, V119, P203, DOI 10.1111/j.1365-2567.2006.02425.x; Suzuki K, 2011, INT J IMMUNOPATH PH, V24, P7, DOI 10.1177/039463201102400102; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941	35	155	156	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					69	+		10.1038/nm.3411	http://dx.doi.org/10.1038/nm.3411			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24317118				2022-12-27	WOS:000329349400021
J	Kreso, A; van Galen, P; Pedley, NM; Lima-Fernandes, E; Frelin, C; Davis, T; Cao, LX; Baiazitov, R; Du, W; Sydorenko, N; Moon, YC; Gibson, L; Wang, YD; Leung, C; Iscove, NN; Arrowsmith, CH; Szentgyorgyi, E; Gallinger, S; Dick, JE; O'Brien, CA				Kreso, Antonija; van Galen, Peter; Pedley, Nicholas M.; Lima-Fernandes, Evelyne; Frelin, Catherine; Davis, Thomas; Cao, Liangxian; Baiazitov, Ramil; Du, Wu; Sydorenko, Nadiya; Moon, Young-Choon; Gibson, Lianne; Wang, Yadong; Leung, Cherry; Iscove, Norman N.; Arrowsmith, Cheryl H.; Szentgyorgyi, Eva; Gallinger, Steven; Dick, John E.; O'Brien, Catherine A.			Self-renewal as a therapeutic target in human colorectal cancer	NATURE MEDICINE			English	Article							STEM-CELLS; INITIATING CELLS; BMI1; CHEMOTHERAPY; IDENTIFICATION; MAINTENANCE; POPULATION; PROTEINS; CAPACITY	Tumor recurrence following treatment remains a major clinical challenge. Evidence from xenograft models and human trials indicates selective enrichment of cancer-initiating cells (CICs) in tumors that survive therapy. Together with recent reports showing that CIC gene signatures influence patient survival, these studies predict that targeting self-renewal, the key 'stemness' property unique to CICs, may represent a new paradigm in cancer therapy. Here we demonstrate that tumor formation and, more specifically, human colorectal CIC function are dependent on the canonical self-renewal regulator BMI-1. Downregulation of BMI-1 inhibits the ability of colorectal CICs to self-renew, resulting in the abrogation of their tumorigenic potential. Treatment of primary colorectal cancer xenografts with a small-molecule BMI-1 inhibitor resulted in colorectal CIC loss with long-term and irreversible impairment of tumor growth. Targeting the BMI-1-related self-renewal machinery provides the basis for a new therapeutic approach in the treatment of colorectal cancer.	[Kreso, Antonija; van Galen, Peter; Pedley, Nicholas M.; Frelin, Catherine; Gibson, Lianne; Wang, Yadong; Leung, Cherry; Iscove, Norman N.; Arrowsmith, Cheryl H.; Dick, John E.; O'Brien, Catherine A.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Kreso, Antonija; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Pedley, Nicholas M.; Gibson, Lianne; Wang, Yadong; Leung, Cherry; O'Brien, Catherine A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lima-Fernandes, Evelyne; Arrowsmith, Cheryl H.] Struct Genom Consortium, Toronto, ON, Canada; [Frelin, Catherine; Iscove, Norman N.; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Davis, Thomas; Cao, Liangxian; Baiazitov, Ramil; Du, Wu; Sydorenko, Nadiya; Moon, Young-Choon] PTC Therapeut, South Plainfield, NJ USA; [Iscove, Norman N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Szentgyorgyi, Eva] Toronto Gen Hosp, Dept Pathol, Toronto, ON, Canada; [Gallinger, Steven; O'Brien, Catherine A.] Toronto Gen Hosp, Dept Surg, Toronto, ON, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred Litwin Ctr Canc Genet, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	jdick@uhnres.utoronto.ca	Gallinger, Steven/E-4575-2013	Dick, John/0000-0002-9527-8317; Lima Fernandes, Evelyne/0000-0002-3628-9745; O'Brien, Catherine/0000-0003-0682-3879; Arrowsmith, Cheryl/0000-0002-4971-3250; van Galen, Peter/0000-0002-0735-1570	Wellcome Trust; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Canadian Institutes for Health Research; Canada Research Chair; Princess Margaret Hospital Foundation; Fonds National de la Recherche, Luxembourg; Marie Curie Actions of the European Commission (FP7-COFUND) [PDR 2012-2 4735314]; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Wellcome Trust(Wellcome TrustEuropean Commission); Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Princess Margaret Hospital Foundation; Fonds National de la Recherche, Luxembourg(Luxembourg National Research Fund); Marie Curie Actions of the European Commission (FP7-COFUND); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank R. Lopez and P. Lo from the Animal Research Centre, University Health Network and A. Khandani, P. Penttila, and S. Zhao from the Sickkids Flow Cytometry facility for their skillful assistance. We are grateful to all members of the Dick lab, especially M. Anders, E. Laurenti, N. Mbong, S. Doulatov, M. Milyavsky and F. Notta, as well as C. Gedye and J. Wang for their advice and critical comments. We thank E. Lechman (University Health Network, Toronto), J. Moffat (University of Toronto) and T. Chiba (Chiba University) for lentiviral vectors expressing shRNAs to BMI1. We also thank members from the Department of Pathology (Toronto General Hospital), including F. Meng, M. Sukhram, V. Son, H. Begley and P. Shaw, for providing colon cancer samples. This work was supported by funds to PTC Therapeutics from the Wellcome Trust and to J.E.D. from Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research and a Summit Award with funds from the province of Ontario, the Canadian Institutes for Health Research, a Canada Research Chair, the Princess Margaret Hospital Foundation and funds to E.L.-F. by Fonds National de la Recherche, Luxembourg and the Marie Curie Actions of the European Commission (FP7-COFUND, PDR 2012-2 4735314). This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Du JJ, 2010, MED ONCOL, V27, P1273, DOI 10.1007/s12032-009-9373-y; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kim JH, 2004, CANCER LETT, V203, P217, DOI 10.1016/j.canlet.2003.07.009; Kreso A., 2008, CURR PROTOC STEM CEL, V7; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kvinlaug BT, 2007, EXPERT OPIN THER TAR, V11, P915, DOI 10.1517/14728222.11.7.915; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tateishi K, 2006, CLIN CANCER RES, V12, P6960, DOI 10.1158/1078-0432.CCR-06-0449; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wang JCY, 2007, CELL STEM CELL, V1, P497, DOI 10.1016/j.stem.2007.10.005	42	353	373	2	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					29	+		10.1038/nm.3418	http://dx.doi.org/10.1038/nm.3418			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24292392				2022-12-27	WOS:000329349400016
J	Park, SH; Veerapu, NS; Shin, EC; Biancotto, A; McCoy, JP; Capone, S; Folgori, A; Rehermann, B				Park, Su-Hyung; Veerapu, Naga Suresh; Shin, Eui-Cheol; Biancotto, Angelique; McCoy, J. Philip; Capone, Stefania; Folgori, Antonella; Rehermann, Barbara			Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection	NATURE MEDICINE			English	Article							INJECTION-DRUG USERS; IMMUNE-RESPONSES; REGULATORY CELLS; PERSISTENCE; GENERATION; PROTECTION; CLEARANCE; INDUCTION; EFFECTOR; KINETICS	Hepatitis C virus (HCV) is endemic in many countries due to its high propensity for establishing persistence(1). The presence of HCV-specific T cells in subjects repeatedly exposed to HCV who test negative for HCV RNA and antibodies and who do not have any history of HCV infection has been interpreted as T cell-mediated protection(2-5). Here, we show in nonhuman primates that repeated exposure to human plasma with trace amounts of HCV induced HCV-specific T cells without seroconversion and systemic viremia but did not protect upon subsequent HCV challenge. Rather, HCV-specific recall and de novo T cell responses, as well as intrahepatic T cell recruitment and interferon-gamma (IFN-gamma) production, were suppressed upon HCV challenge, concomitant with quantitative and qualitative changes in regulatory T cells (T-reg cells) that occurred after subinfectious HCV exposure and increased after HCV challenge. In vitro T-reg cell depletion restored HCV-specific T cell responses. Thus, T cells primed by trace amounts of HCV do not generate effective recall responses upon subsequent HCV infection. Subinfectious HCV exposure predisposes to T-reg cell expansion, which suppresses effector T cells during subsequent infection. Strategies to reverse this exposure-induced immune suppression should be examined to aid in the development of T cell-based vaccines against HCV and other endemic pathogens.	[Park, Su-Hyung; Veerapu, Naga Suresh; Shin, Eui-Cheol; Rehermann, Barbara] NIDDK, Immunol Sect, Liver Dis Branch, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Biancotto, Angelique; McCoy, J. Philip] NHLBI, Flow Cytometry Core Facil, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Capone, Stefania; Folgori, Antonella] Okairos, Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rehermann, B (corresponding author), NIDDK, Immunol Sect, Liver Dis Branch, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	rehermann@nih.gov	biancotto, angelique/C-4632-2011; mccoy, john philip/ABD-9348-2021; Park, Su-Hyung/N-3514-2014; Shin, Eui-Cheol/C-1690-2011	biancotto, angelique/0000-0003-2271-009X; Park, Su-Hyung/0000-0001-6363-7736; Shin, Eui-Cheol/0000-0002-6308-9503; Rehermann, Barbara/0000-0001-6832-9951; Capone, Stefania/0000-0002-2272-120X	intramural research program of the NIDDK; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054508] Funding Source: NIH RePORTER	intramural research program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T.J. Rowell, J. Fontenot and the staff at New Iberia Research Center for the care of the chimpanzees and technical support and L. Holz (NIDDK) and W. Kastenmuller (NIAID) for discussion and reading of the manuscript. This work was supported by the intramural research program of the NIDDK.	Al-Sherbiny M, 2005, AM J TROP MED HYG, V73, P44; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Biancotto A, 2012, CYTOM PART A, V81A, P15, DOI 10.1002/cyto.a.21158; Black GF, 2001, J INFECT DIS, V184, P322, DOI 10.1086/322042; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; de Herve MGD, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1992; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; Freeman AJ, 2004, J INFECT DIS, V190, P1093, DOI 10.1086/422605; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Heller T, 2013, J INFECT DIS, V208, P1020, DOI 10.1093/infdis/jit270; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kryczek I, 2006, J IMMUNOL, V177, P40, DOI 10.4049/jimmunol.177.1.40; Lanford RE, 2004, J VIROL, V78, P1575, DOI 10.1128/JVI.78.3.1575-1581.2004; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Li S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000707; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Mizukoshi E, 2008, J INFECT DIS, V198, P203, DOI 10.1086/589510; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scognamiglio P, 1999, J IMMUNOL, V162, P6681; Shin EC, 2008, J VIROL, V82, P9782, DOI 10.1128/JVI.00475-08; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Surls J, 2010, VACCINE, V28, P7319, DOI 10.1016/j.vaccine.2010.08.074; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Thurairajah PH, 2008, J INFECT DIS, V198, P1749, DOI 10.1086/593337; Veerapu NS, 2011, GASTROENTEROLOGY, V140, P676, DOI 10.1053/j.gastro.2010.10.048; Zeremski M, 2009, J VIRAL HEPATITIS, V16, P10, DOI 10.1111/j.1365-2893.2008.01016.x	40	36	42	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1638	1642		10.1038/nm.3408	http://dx.doi.org/10.1038/nm.3408			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24270546	Green Accepted			2022-12-27	WOS:000328181400033
J	Thrane, VR; Thrane, AS; Wang, FS; Cotrina, ML; Smith, NA; Chen, M; Xu, QW; Kang, N; Fujita, T; Nagelhus, EA; Nedergaard, M				Thrane, Vinita Rangroo; Thrane, Alexander S.; Wang, Fushun; Cotrina, Maria L.; Smith, Nathan A.; Chen, Michael; Xu, Qiwu; Kang, Ning; Fujita, Takumi; Nagelhus, Erlend A.; Nedergaard, Maiken			Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering	NATURE MEDICINE			English	Article							CAT MOTOR CORTEX; NA-K-2CL COTRANSPORTER; HYPERAMMONEMIA; BRAIN; MICE; HOMEOSTASIS; REVEALS; SODIUM; CELLS; NKCC1	Ammonia is a ubiquitous waste product of protein metabolism that can accumulate in numerous metabolic disorders, causing neurological dysfunction ranging from cognitive impairment to tremor, ataxia, seizures, coma and death(1). The brain is especially vulnerable to ammonia as it readily crosses the blood-brain barrier in its gaseous form, NH3, and rapidly saturates its principal removal pathway located in astrocytes(2). Thus, we wanted to determine how astrocytes contribute to the initial deterioration of neurological functions characteristic of hyperammonemia in vivo. Using a combination of two-photon imaging and electrophysiology in awake head-restrained mice, we show that ammonia rapidly compromises astrocyte potassium buffering, increasing extracellular potassium concentration and overactivating the Na+-K+-2Cl(-) cotransporter isoform 1 (NKCC1) in neurons. The consequent depolarization of the neuronal GABA reversal potential (E-GABA) selectively impairs cortical inhibitory networks. Genetic deletion of NKCC1 or inhibition of it with the clinically used diuretic bumetanide potently suppresses ammonia-induced neurological dysfunction. We did not observe astrocyte swelling or brain edema in the acute phase, calling into question current concepts regarding the neurotoxic effects of ammonia(3.4). Instead, our findings identify failure of potassium buffering in astrocytes as a crucial mechanism in ammonia neurotoxicity and demonstrate the therapeutic potential of blocking this pathway by inhibiting NKCC1.	[Thrane, Vinita Rangroo; Thrane, Alexander S.; Wang, Fushun; Cotrina, Maria L.; Smith, Nathan A.; Chen, Michael; Xu, Qiwu; Kang, Ning; Fujita, Takumi; Nagelhus, Erlend A.; Nedergaard, Maiken] Univ Rochester, Ctr Translat Neuromed, Div Glial Dis & Therapeut, Rochester, NY 14627 USA; [Thrane, Vinita Rangroo; Thrane, Alexander S.; Nagelhus, Erlend A.] Univ Oslo, Inst Basic Med Sci, Letten Ctr, Oslo, Norway; [Thrane, Vinita Rangroo; Thrane, Alexander S.] Univ Oslo, Ctr Mol Med Norway, Oslo, Norway; [Thrane, Vinita Rangroo; Thrane, Alexander S.] Haukeland Hosp, Dept Ophthalmol, N-5021 Bergen, Norway; [Smith, Nathan A.] Univ Utah, Inst Brain, Lab Glial Neuronal Interact Epilepsy, Salt Lake City, UT USA; [Nagelhus, Erlend A.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway	University of Rochester; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; Utah System of Higher Education; University of Utah; University of Oslo	Thrane, AS (corresponding author), Univ Rochester, Ctr Translat Neuromed, Div Glial Dis & Therapeut, Rochester, NY 14627 USA.	alexander.thrane@gmail.com	Smith, Nathan Anthony/AAF-8573-2020; Thrane, Alexander S/G-4124-2011	Smith, Nathan Anthony/0000-0002-9254-5360; Thrane, Alexander S/0000-0001-5646-1111	US National Institutes of Health [NS078304, NS078167, F31NS073390]; Research Council of Norway (NevroNor FRIMEDBIO grants); European Commission [FP7-ICT-9-601055]; Molecular Life Science program at the University of Oslo; Letten Foundation; Fulbright Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078167, F31NS073390, R01NS056188, R01NS075177, R01NS078304, P01NS050315] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway (NevroNor FRIMEDBIO grants)(Research Council of Norway); European Commission(European CommissionEuropean Commission Joint Research Centre); Molecular Life Science program at the University of Oslo; Letten Foundation; Fulbright Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A.J. Cooper for discussion of the study, S. Kennedy for help with <SUP>1</SUP>H-NMR experiments, L.K. Bekar for help with electrophysiology, J. Chang for designing MatLab software, D. Wang for advice regarding electroencephalogram analysis, J.M. Wilson (University of Pennsylvania) for providing the Otc<SUP>spf-ash</SUP> mice, J.D. Rothstein (Johns Hopkins University) for providing Glt1-eGFP BAC transgenic mice and C. Nicholson and S. Hrabetova for advice on fabrication and use of ion-sensitive electrodes. This work was supported by the US National Institutes of Health (grants NS078304 and NS078167 to M.N. and F31NS073390 to N.A.S.), Research Council of Norway (NevroNor FRIMEDBIO grants to E.A.N.), European Commission FP7-ICT-9-601055 to E.A.N., the Molecular Life Science program at the University of Oslo, the Letten Foundation and the Fulbright Foundation.	BENJAMIN AM, 1978, J NEUROCHEM, V30, P131, DOI 10.1111/j.1471-4159.1978.tb07044.x; Borgdorff AJ, 2007, J NEUROPHYSIOL, V97, P2992, DOI 10.1152/jn.00013.2007; Butterworth RF, 2002, METAB BRAIN DIS, V17, P221, DOI 10.1023/A:1021989230535; Cagnon L, 2007, BRAIN RES REV, V56, P183, DOI 10.1016/j.brainresrev.2007.06.026; Cooper AJL, 2011, NEUROCHEM INT, V59, P456, DOI 10.1016/j.neuint.2010.11.011; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2010, J NEUROSCI, V30, P11745, DOI 10.1523/JNEUROSCI.1769-10.2010; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Hannaert P, 2002, N-S ARCH PHARMACOL, V365, P193, DOI 10.1007/s00210-001-0521-y; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; JAVAHERI S, 1993, J NEUROCHEM, V61, P1525, DOI 10.1111/j.1471-4159.1993.tb13648.x; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Lichter-Konecki U, 2008, GLIA, V56, P365, DOI 10.1002/glia.20624; LUX HD, 1971, SCIENCE, V173, P555, DOI 10.1126/science.173.3996.555; Marcaggi P, 2004, EUR J NEUROSCI, V19, P966, DOI 10.1111/j.0953-816X.2004.03165.x; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; NICHOLSON C, 1993, J NEUROSCI METH, V48, P199, DOI 10.1016/0165-0270(93)90092-6; RAABE W, 1975, J NEUROPHYSIOL, V38, P347, DOI 10.1152/jn.1975.38.2.347; RAABE WA, 1981, BRAIN RES, V210, P311, DOI 10.1016/0006-8993(81)90904-5; RATNAKUMARI L, 1992, BIOCHEM BIOPH RES CO, V184, P746, DOI 10.1016/0006-291X(92)90653-3; RATNAKUMARI L, 1995, NEUROSCI LETT, V197, P89, DOI 10.1016/0304-3940(95)11906-D; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Stephan J, 2012, GLIA, V60, P965, DOI 10.1002/glia.22328; SZERB JC, 1992, PROG NEUROBIOL, V39, P135, DOI 10.1016/0301-0082(92)90008-3; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; Thrane VR, 2012, NEUROSCIENCE, V220, P247, DOI 10.1016/j.neuroscience.2012.06.022; WALL SM, 1994, AM J PHYSIOL-RENAL, V267, pF660, DOI 10.1152/ajprenal.1994.267.4.F660; Wang FS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002334; WANIEWSKI RA, 1992, J NEUROCHEM, V58, P167, DOI 10.1111/j.1471-4159.1992.tb09292.x; Xiong ZQ, 2000, J NEUROPHYSIOL, V83, P1443, DOI 10.1152/jn.2000.83.3.1443; Yamamoto Y, 2013, EPILEPSIA, V54, P983, DOI 10.1111/epi.12125; Ye XH, 1997, PEDIATR RES, V41, P527, DOI 10.1203/00006450-199704000-00012	39	162	168	4	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1643	1648		10.1038/nm.3400	http://dx.doi.org/10.1038/nm.3400			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24240184	Green Accepted			2022-12-27	WOS:000328181400034
J	Taniguchi, CM; Finger, EC; Krieg, AJ; Wu, C; Diep, AN; LaGory, EL; Wei, K; McGinnis, LM; Yuan, J; Kuo, CJ; Giaccia, AJ				Taniguchi, Cullen M.; Finger, Elizabeth C.; Krieg, Adam J.; Wu, Colleen; Diep, Anh N.; LaGory, Edward L.; Wei, Kevin; McGinnis, Lisa M.; Yuan, Jenny; Kuo, Calvin J.; Giaccia, Amato J.			Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes	NATURE MEDICINE			English	Article							ERYTHROPOIESIS; INACTIVATION; SUBSTRATE-2; ROLES; IRS-2	Signaling initiated by hypoxia and insulin powerfully alters cellular metabolism. The protein stability of hypoxia-inducible factor-1 alpha (Hif-1 alpha) and Hif-2 alpha is regulated by three prolyl hydroxylase domain-containing protein isoforms (Phd1, Phd2 and Phd3). Insulin receptor substrate-2 (Irs2) is a critical mediator of the anabolic effects of insulin, and its decreased expression contributes to the pathophysiology of insulin resistance and diabetes1. Although Hif regulates many metabolic pathways2, it is unknown whether the Phd proteins regulate glucose and lipid metabolism in the liver. Here, we show that acute deletion of hepatic Phd3, also known as Egln3, improves insulin sensitivity and ameliorates diabetes by specifically stabilizing Hif-2 alpha, which then increases Irs2 transcription and insulin-stimulated Akt activation. Hif-2 alpha and Irs2 are both necessary for the improved insulin sensitivity, as knockdown of either molecule abrogates the beneficial effects of Phd3 knockout on glucose tolerance and insulin-stimulated Akt phosphorylation. Augmenting levels of Hif-2 alpha through various combinations of Phd gene knockouts did not further improve hepatic metabolism and only added toxicity. Thus, isoform-specific inhibition of Phd3 could be exploited to treat type 2 diabetes without the toxicity that could occur with chronic inhibition of multiple Phd isoforms.	[Taniguchi, Cullen M.; Finger, Elizabeth C.; Wu, Colleen; Diep, Anh N.; LaGory, Edward L.; Giaccia, Amato J.] Ctr Clin Sci Res, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA USA; [Krieg, Adam J.] Univ Kansas, Med Ctr, Dept Obstet & Gynecol, Kansas City, KS 66103 USA; [Wei, Kevin; McGinnis, Lisa M.; Yuan, Jenny; Kuo, Calvin J.] Stanford Univ, Div Hematol, Stanford, CA 94305 USA	University of Kansas; University of Kansas Medical Center; Stanford University	Giaccia, AJ (corresponding author), Ctr Clin Sci Res, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA USA.	giaccia@stanford.edu		Taniguchi, Cullen/0000-0002-8052-3316; LaGory, Edward/0000-0002-0552-1695; Krieg, Adam/0000-0002-3069-0378; Kuo, Calvin/0000-0002-7427-5985	Radiological Society of North America Research Resident grants [1018, 1111]; US National Cancer Institute Training Grant [CA121940]; Canadian Institutes of Health and Research; Comparative Animal Medicine at Stanford University; US National Institute of General Medical Sciences (NIGMS) [P20 GM104936]; NIGMS Stanford Medical Scientist Training Program [GM007365]; Stanford Medical Science Training Program [5T32AI07290]; US National Institutes of Health (NIH) [R01HL074267, R01NS064517, R01CA158528]; NIH [CA67166, CA88480]; Sidney Frank Foundation; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA158528, P01CA067166, T32CA121940, R01CA088480, R37CA088480] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064517] Funding Source: NIH RePORTER	Radiological Society of North America Research Resident grants; US National Cancer Institute Training Grant; Canadian Institutes of Health and Research(Canadian Institutes of Health Research (CIHR)); Comparative Animal Medicine at Stanford University; US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS Stanford Medical Scientist Training Program; Stanford Medical Science Training Program; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Frank Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Takeda and G.- H. Fong (University of Connecticut) for their generous gift of the Phd1<SUP>fl/fl</SUP>, Phd2<SUP>fl/fl</SUP> and Phd3<SUP>fl/fl</SUP> mice. We thank J. Boucher (Joslin Diabetes Center, Boston, MA) for sharing qPCR primer sequences and his critical reading of the manuscript. We thank S. Biddinger (Boston Children's Hospital, Boston, MA) for providing the Fao hepatoma cells. C. M. T. was supported by Radiological Society of North America Research Resident grants 1018 and 1111. E. C. F. and E. L. L. were supported by US National Cancer Institute Training Grant CA121940. C. W. was supported by a training grant from the Canadian Institutes of Health and Research. A. N. D. was supported by a T32 training grant in Comparative Animal Medicine at Stanford University. A. J. K. was supported by grant P20 GM104936 from the US National Institute of General Medical Sciences (NIGMS). Fellowship support was from the NIGMS Stanford Medical Scientist Training Program grant T32 GM007365 (K. W.), Stanford Medical Science Training Program funding (K. W. and L. M. M.), Molecular and Cellular Immunobiology Program training grant 5T32AI07290 (L. M. M.), and US National Institutes of Health (NIH) R01HL074267, R01NS064517 and R01CA158528 (C. J. K.). A. J. G. was supported by NIH grants CA67166 and CA88480 and the Sidney Frank Foundation.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Vassen L, 1999, DIABETES, V48, P1877, DOI 10.2337/diabetes.48.9.1877; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295	24	104	106	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1325	+		10.1038/nm.3294	http://dx.doi.org/10.1038/nm.3294			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24037093	Green Accepted			2022-12-27	WOS:000325531700033
J	Scheel, TKH; Rice, CM				Scheel, Troels K. H.; Rice, Charles M.			Understanding the hepatitis C virus life cycle paves the way for highly effective therapies	NATURE MEDICINE			English	Review							TREATMENT-NAIVE PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; BROADLY NEUTRALIZING ANTIBODIES; HCV GENOTYPE 1; B TYPE-I; RNA REPLICATION; NS5A INHIBITOR; CRYSTAL-STRUCTURE; GLYCOPROTEIN E2; CORE PROTEIN	More than two decades of intense research has provided a detailed understanding of hepatitis C virus (HCV), which chronically infects 2% of the world's population. This effort has paved the way for the development of antiviral compounds to spare patients from life-threatening liver disease. An exciting new era in HCV therapy dawned with the recent approval of two viral protease inhibitors, used in combination with pegylated interferon-a and ribavirin; however, this is just the beginning. Multiple classes of antivirals with distinct targets promise highly efficient combinations, and interferon-free regimens with short treatment duration and fewer side effects are the future of HCV therapy. Ongoing and future trials will determine the best antiviral combinations and whether the current seemingly rich pipeline is sufficient for successful treatment of all patients in the face of major challenges, such as HCV diversity, viral resistance, the influence of host genetics, advanced liver disease and other co-morbidities.	[Scheel, Troels K. H.; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA; [Scheel, Troels K. H.] Copenhagen Univ Hosp, Copenhagen Hepatitis C Program, Dept Infect Dis, Hvidovre, Denmark; [Scheel, Troels K. H.] Copenhagen Univ Hosp, Copenhagen Hepatitis C Program, Clin Res Ctr, Hvidovre, Denmark; [Scheel, Troels K. H.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark	Rockefeller University; University of Copenhagen; University of Copenhagen; University of Copenhagen	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	ricec@rockefeller.edu		Scheel, Troels/0000-0003-1545-4067	US Public Health Service, the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases [AI099284, AI072613, AI075099, AI091707, AI090055]; Office of the Director through the NIH Roadmap for Medical Research [DK085713]; US National Cancer Institute [CA057973]; Rockefeller University Center for Clinical and Translational Science [UL1RR024143]; Center for Basic and Translational Research on Disorders of the Digestive System through Leona M. and Harry B. Helmsley Charitable Trust; Greenberg Medical Research Institute; Starr Foundation; Danish Council for Independent Research; Novo Nordisk Fonden [NNF12OC0002037] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA057973] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099284, R01AI072613, R01AI090055, R01AI091707, R01AI075099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085713] Funding Source: NIH RePORTER	US Public Health Service, the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases; Office of the Director through the NIH Roadmap for Medical Research; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rockefeller University Center for Clinical and Translational Science; Center for Basic and Translational Research on Disorders of the Digestive System through Leona M. and Harry B. Helmsley Charitable Trust; Greenberg Medical Research Institute; Starr Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to I. M. Jacobson for critical reading of the manuscript. Our research is supported by grants from the US Public Health Service, the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (AI099284, AI072613, AI075099, AI091707, AI090055), Office of the Director through the NIH Roadmap for Medical Research (DK085713), US National Cancer Institute (CA057973), The Rockefeller University Center for Clinical and Translational Science (UL1RR024143), the Center for Basic and Translational Research on Disorders of the Digestive System through the generosity of the Leona M. and Harry B. Helmsley Charitable Trust, the Greenberg Medical Research Institute and the Starr Foundation. T. K. H. S. is supported by a postdoctoral fellowship and a Sapere Aude Research Talent Award from The Danish Council for Independent Research. We apologize to the many HCV investigators whose work could not be cited owing to space restrictions.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Arnold JJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003030; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bassendine MF, 2011, J HEPATOL, V55, P1428, DOI 10.1016/j.jhep.2011.06.004; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Bianco A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002576; Bishe B, 2012, VIRUSES-BASEL, V4, P2340, DOI 10.3390/v4102340; Bitzegeio J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000978; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Bukh J, 2002, P NATL ACAD SCI USA, V99, P14416, DOI 10.1073/pnas.212532699; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Chockalingam K, 2010, P NATL ACAD SCI USA, V107, P3764, DOI 10.1073/pnas.0915117107; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Clark VC, 2013, LIVER INT, V33, P80, DOI 10.1111/liv.12061; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Counihan NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002302; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Durantel D, 2009, CURR OPIN INVEST DR, V10, P860; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; El Omari K, 2013, CELL REP, V3, P30, DOI 10.1016/j.celrep.2012.12.001; Esser-Nobis K, 2013, HEPATOLOGY, V57, P953, DOI 10.1002/hep.26260; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Everson GT, 2013, J HEPATOL, V58, pS573, DOI 10.1016/S0168-8278(13)61422-1; Farci P, 1996, P NATL ACAD SCI USA, V93, P15394, DOI 10.1073/pnas.93.26.15394; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Feld JJ, 2012, HEPATOLOGY, V56, p231A; Ferenci P, 2013, J HEPATOL, V58, pS569, DOI 10.1016/S0168-8278(13)61415-4; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Galun E, 2007, J HEPATOL, V46, P37, DOI 10.1016/j.jhep.2006.08.019; Gane EJ, 2013, J HEPATOL, V58, pS6, DOI 10.1016/S0168-8278(13)60016-1; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2010, J VIROL, V84, P10999, DOI 10.1128/JVI.00526-10; Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gottwein JM, 2008, ADV VIRUS RES, V71, P51, DOI 10.1016/S0065-3527(08)00002-X; Gottwein JM, 2010, J VIROL, V84, P5277, DOI 10.1128/JVI.02667-09; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Harrison SA, 2010, HEPATOLOGY, V52, P864, DOI 10.1002/hep.23787; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Hoffman B, 2011, LIVER INT, V31, P1449, DOI 10.1111/j.1478-3231.2011.02543.x; Hopkins S, 2012, J HEPATOL, V57, P47, DOI 10.1016/j.jhep.2012.02.024; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hunt Douglas, 2013, Curr Gastroenterol Rep, V15, P303, DOI 10.1007/s11894-012-0303-3; Imhof I, 2010, J VIROL, V84, P4597, DOI 10.1128/JVI.02698-09; Jacobson I, 2013, J HEPATOL, V58, pS574, DOI 10.1016/S0168-8278(13)61424-5; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2012, HEPATOLOGY, V56, p308A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Kapoor A, 2011, P NATL ACAD SCI USA, V108, P11608, DOI 10.1073/pnas.1101794108; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Kaul A, 2007, J VIROL, V81, P13168, DOI 10.1128/JVI.01362-07; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Kowdley KV, 2013, J HEPATOL, V58, pS2, DOI 10.1016/S0168-8278(13)60005-7; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lemon SM, 2010, ANTIVIR RES, V86, P79, DOI 10.1016/j.antiviral.2010.02.003; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li YP, 2012, P NATL ACAD SCI USA, V109, P19757, DOI 10.1073/pnas.1218260109; Li YP, 2012, P NATL ACAD SCI USA, V109, pE1101, DOI 10.1073/pnas.1203829109; Li YP, 2011, P NATL ACAD SCI USA, V108, P4991, DOI 10.1073/pnas.1016606108; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Li Y, 2013, P NATL ACAD SCI USA, V110, P6805, DOI 10.1073/pnas.1300524110; Liang TJ, 2013, NAT MED, V19, P869, DOI 10.1038/nm.3183; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu R, 2010, ANTIVIR RES, V86, P172, DOI 10.1016/j.antiviral.2010.02.316; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Lok AS, 2012, HEPATOLOGY, V56, p230A; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Manns M, 2013, J HEPATOL, V58, pS568, DOI 10.1016/S0168-8278(13)61412-9; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McPhee F, 2013, HEPATOLOGY, V58, P902, DOI 10.1002/hep.26388; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Meuleman P, 2012, HEPATOLOGY, V55, P364, DOI 10.1002/hep.24692; Meuleman P, 2011, HEPATOLOGY, V53, P755, DOI 10.1002/hep.24171; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Muir AJ, 2012, HEPATOLOGY, V56, p299A; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Negro F, 2012, J VIRAL HEPATITIS, V19, P42, DOI 10.1111/j.1365-2893.2011.01523.x; Ohara E, 2011, J HEPATOL, V54, P872, DOI 10.1016/j.jhep.2010.08.033; Olsen DB, 2011, ANTIMICROB AGENTS CH, V55, P937, DOI 10.1128/AAC.00990-10; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Pawlotsky JM, 2012, HEPATOLOGY, V56, p309A; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Pol S, 2012, LANCET INFECT DIS, V12, P671, DOI 10.1016/S1473-3099(12)70138-X; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Rai R, 2011, ANTIVIR RES, V90, P93, DOI 10.1016/j.antiviral.2011.01.009; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Rosnoblet C, 2012, J BIOL CHEM, V287, P44249, DOI 10.1074/jbc.M112.392209; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Scheel TKH, 2011, GASTROENTEROLOGY, V140, P1032, DOI 10.1053/j.gastro.2010.11.036; Sharma NR, 2011, J BIOL CHEM, V286, P30361, DOI 10.1074/jbc.M111.263350; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Shulla A, 2012, CURR OPIN VIROL, V2, P725, DOI 10.1016/j.coviro.2012.09.013; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; Sulkowski MS, 2013, J HEPATOL, V58, pS570, DOI 10.1016/S0168-8278(13)61416-6; Sulkowski MS, 2012, HEPATOLOGY, V56, P1516; Syder AJ, 2011, J HEPATOL, V54, P48, DOI 10.1016/j.jhep.2010.06.024; Tanwandee T, 2012, HEPATOLOGY, V56, P1530; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Thompson AJ, 2012, HEPATOLOGY, V56, p556A; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Vaillancourt FH, 2012, J VIROL, V86, P11595, DOI 10.1128/JVI.01320-12; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Zeuzem S, 2013, J HEPATOL, V58, pS498, DOI 10.1016/S0168-8278(13)61228-3; Zeuzem S, 2012, HEPATOLOGY, V56, p308A; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102; Zhu HH, 2012, J INFECT DIS, V205, P656, DOI 10.1093/infdis/jir802	178	407	425	2	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					837	849		10.1038/nm.3248	http://dx.doi.org/10.1038/nm.3248			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836234	Green Accepted			2022-12-27	WOS:000321557700027
J	Thomas, DL				Thomas, David L.			Global control of hepatitis C: where challenge meets opportunity	NATURE MEDICINE			English	Review							SUSTAINED VIROLOGICAL RESPONSE; INJECTION-DRUG USERS; QUALITY-OF-LIFE; HUMAN-IMMUNODEFICIENCY-VIRUS; TO-INFANT TRANSMISSION; ALL-CAUSE MORTALITY; PLUS RIBAVIRIN; UNITED-STATES; LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA	We are entering an important new chapter in the story of hepatitis C virus (HCV) infection. There are clear challenges and opportunities. On the one hand, new HCV infections are still occurring, and an estimated 185 million people are or have previously been infected worldwide. Most HCV-infected persons are unaware of their status yet are at risk for life-threatening diseases such as cirrhosis and hepatocellular carcinoma (HCC), whose incidences are predicted to rise in the coming decade. On the other hand, new HCV infections can be prevented, and those that have already occurred can be detected and treated-viral eradication is even possible. How the story ends will largely be determined by the extent to which these rapidly advancing opportunities overcome the growing challenges and by the vigor of the public health response.	Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Thomas, DL (corresponding author), Johns Hopkins Sch Med, Div Infect Dis, Baltimore, MD USA.	dthomas@jhmi.edu			US National Institutes of Health [R01 DA013324]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013324] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by US National Institutes of Health grant R01 DA013324.	AGNELLO V, 1992, NEW ENGL J MED, V327, P1490, DOI 10.1056/NEJM199211193272104; AKAHANE Y, 1994, ANN INTERN MED, V120, P748, DOI 10.7326/0003-4819-120-9-199405010-00005; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Baillargeon J, 2003, PUBLIC HEALTH, V117, P43, DOI 10.1016/S0033-3506(02)00009-4; Barrett S, 2001, GUT, V49, P423, DOI 10.1136/gut.49.3.423; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Bernstein D, 2002, HEPATOLOGY, V35, P704, DOI 10.1053/jhep.2002.31311; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Chou R, 2013, ANN INTERN MED, V158, P101, DOI 10.7326/0003-4819-158-2-201301150-00574; Conrad S, 2006, CHRONIC ILLN, V2, P121, DOI 10.1179/174592006X110996; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Cottrell EB, 2013, ANN INTERN MED, V158, P109, DOI 10.7326/0003-4819-158-2-201301150-00575; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Deuffic S, 1999, HEPATOLOGY, V29, P1596, DOI 10.1002/hep.510290528; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; Doerrbecker J, 2013, J INFECT DIS, V207, P281, DOI 10.1093/infdis/jis677; Dore GJ, 1997, BRIT MED J, V315, P333; Dowdle WR, 2011, VACCINE, V29, pD70, DOI 10.1016/j.vaccine.2011.04.006; Edlin BR, 2011, NATURE, V474, pS18, DOI 10.1038/474S18a; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; ESTEBAN JI, 1991, ANN INTERN MED, V115, P443, DOI 10.7326/0003-4819-115-6-443; Farci P, 2012, P NATL ACAD SCI USA, V109, P14562, DOI 10.1073/pnas.1210592109; Fierer DS, 2008, J INFECT DIS, V198, P683, DOI 10.1086/590430; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Goedert JJ, 2002, BLOOD, V100, P1584; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; Guadagnino V, 2013, DIGEST LIVER DIS, V45, P403, DOI 10.1016/j.dld.2012.10.014; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; HAGAN H, 1995, AM J PUBLIC HEALTH, V85, P1531, DOI 10.2105/AJPH.85.11.1531; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; HAYASHI J, 1995, AM J GASTROENTEROL, V90, P794; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; John-Baptiste AA, 2009, AM J GASTROENTEROL, V104, P2439, DOI 10.1038/ajg.2009.346; KO YC, 1992, J MED VIROL, V38, P288, DOI 10.1002/jmv.1890380411; Kramer JR, 2012, J HEPATOL, V56, P320, DOI 10.1016/j.jhep.2011.05.032; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Lehman EM, 2009, J VIRAL HEPATITIS, V16, P650, DOI 10.1111/j.1365-2893.2009.01115.x; Leigh JP, 2001, ARCH INTERN MED, V161, P2231, DOI 10.1001/archinte.161.18.2231; Lettmeier B, 2008, J HEPATOL, V49, P528, DOI 10.1016/j.jhep.2008.04.021; Liang J., 2013, NAT MED, V19, paaa; Liao SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034779; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magiorkinis G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002876; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mariano A, 2009, SCAND J INFECT DIS, V41, P689, DOI 10.1080/00365540903095358; Martinez-Bauer E, 2008, J HEPATOL, V48, P20, DOI 10.1016/j.jhep.2007.07.031; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Mehta SH, 2000, ANN INTERN MED, V133, P592, DOI 10.7326/0003-4819-133-8-200010170-00009; Mehta SH, 2011, J INFECT DIS, V203, P587, DOI 10.1093/infdis/jiq112; Mendel I, 1997, J MED VIROL, V51, P231, DOI 10.1002/(SICI)1096-9071(199703)51:3&lt;231::AID-JMV15&gt;3.0.CO;2-N; Mosley JW, 2005, HEPATOLOGY, V42, P86, DOI 10.1002/hep.20742; Paintsil E, 2010, J INFECT DIS, V202, P984, DOI 10.1086/656212; Patel PR, 2006, JAMA-J AM MED ASSOC, V296, P2005, DOI 10.1001/jama.296.16.2005; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; SARTORI M, 1993, SCAND J INFECT DIS, V25, P270, DOI 10.3109/00365549309008497; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; SEEFF LB, 1991, ANN INTERN MED, V115, P411, DOI 10.7326/0003-4819-115-5-411_1; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; Shivkumar S, 2012, ANN INTERN MED, V157, P558, DOI 10.7326/0003-4819-157-8-201210160-00006; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Spiegel BMR, 2005, HEPATOLOGY, V41, P790, DOI 10.1002/hep.20659; Strickland GT, 2006, HEPATOLOGY, V43, P915, DOI 10.1002/hep.21173; Sulkowski MS, 2012, HIGH RATE SUSTAINED, V1; Tanaka Y, 2006, GASTROENTEROLOGY, V130, P703, DOI 10.1053/j.gastro.2006.01.032; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; Thomas DL, 1998, J INFECT DIS, V177, P1480, DOI 10.1086/515315; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; THOMAS DL, 1995, J INFECT DIS, V171, P768, DOI 10.1093/infdis/171.4.768; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van de Laar TJW, 2011, SEX TRANSM DIS, V38, P102, DOI 10.1097/OLQ.0b013e3181ec9de5; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Williams IT, 2011, ARCH INTERN MED, V171, P242, DOI 10.1001/archinternmed.2010.511; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; ZANETTI AR, 1995, LANCET, V345, P289, DOI 10.1016/S0140-6736(95)90277-5	101	222	236	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					850	858		10.1038/nm.3184	http://dx.doi.org/10.1038/nm.3184			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836235	Green Accepted, Bronze			2022-12-27	WOS:000321557700028
J	Zhen, GH; Wen, CY; Jia, XF; Li, Y; Crane, JL; Mears, SC; Askin, FB; Frassica, FJ; Chang, WZ; Yao, J; Carrino, JA; Cosgarea, A; Artemov, D; Chen, QM; Zhao, ZH; Zhou, XD; Riley, L; Sponseller, P; Wan, M; Lu, WW; Cao, X				Zhen, Gehua; Wen, Chunyi; Jia, Xiaofeng; Li, Yu; Crane, Janet L.; Mears, Simon C.; Askin, Frederic B.; Frassica, Frank J.; Chang, Weizhong; Yao, Jie; Carrino, John A.; Cosgarea, Andrew; Artemov, Dmitri; Chen, Qianming; Zhao, Zhihe; Zhou, Xuedong; Riley, Lee; Sponseller, Paul; Wan, Mei; Lu, William Weijia; Cao, Xu			Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis	NATURE MEDICINE			English	Article							HYPERTROPHIC DIFFERENTIATION; CARTILAGE DEGRADATION; OSTEOPHYTE FORMATION; ARTICULAR-CARTILAGE; SYNOVIAL-FLUID; MARROW LESIONS; IN-VIVO; KNEE; EXPRESSION; INCREASE	Osteoarthritis is a highly prevalent and debilitating joint disorder. There is no effective medical therapy for the condition because of limited understanding of its pathogenesis. We show that transforming growth factor beta 1 (TGF-beta 1) is activated in subchondral bone in response to altered mechanical loading in an anterior cruciate ligament transection (ACLT) mouse model of osteoarthritis. TGF-beta 1 concentrations are also high in subchondral bone from humans with osteoarthritis. High concentrations of TGF-beta 1 induced formation of nestin-positive mesenchymal stem cell (MSC) clusters, leading to formation of marrow osteoid islets accompanied by high levels of angiogenesis. We found that transgenic expression of active TGF-beta 1 in osteoblastic cells induced osteoarthritis, whereas inhibition of TGF-beta activity in subchondral bone attenuated the degeneration of articular cartilage. In particular, knockout of the TGF-beta type II receptor (TbRII) in nestin-positive MSCs led to less development of osteoarthritis relative to wild-type mice after ACLT. Thus, high concentrations of active TGF-beta 1 in subchondral bone seem to initiate the pathological changes of osteoarthritis, and inhibition of this process could be a potential therapeutic approach to treating this disease.	[Zhen, Gehua; Crane, Janet L.; Mears, Simon C.; Frassica, Frank J.; Chang, Weizhong; Carrino, John A.; Cosgarea, Andrew; Riley, Lee; Sponseller, Paul; Wan, Mei; Cao, Xu] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA; [Zhen, Gehua; Crane, Janet L.; Chang, Weizhong; Wan, Mei; Cao, Xu] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD USA; [Wen, Chunyi; Yao, Jie; Lu, William Weijia] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Pokfulam, Peoples R China; [Wen, Chunyi; Lu, William Weijia] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Human Tissues & Organs Degenerat, Shenzhen, Peoples R China; [Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Li, Yu; Chen, Qianming; Zhao, Zhihe; Zhou, Xuedong] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; [Askin, Frederic B.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Carrino, John A.; Artemov, Dmitri] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Johns Hopkins University; Sichuan University; Johns Hopkins University; Johns Hopkins University	Cao, X (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21218 USA.	xcao11@jhmi.edu	WEN, Chunyi/P-4168-2017; Li, Yu/G-6649-2011; ZHOU, XUE/F-6129-2013; Jia, Xiaofeng/B-2145-2008	WEN, Chunyi/0000-0003-1949-7822; Jia, Xiaofeng/0000-0003-1445-8525; Crane, Janet/0000-0001-7713-0936; Zhao, Zhihe/0000-0003-2955-1706; Li, Yu/0000-0001-8578-7268; Zhou, Xuedong/0000-0002-9319-7302	US National Institutes of Health [DK 057501, DK 08098]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057501, T32DK007751, R01DK080898, Z01DK057501] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institutes of Health grants DK 057501 and DK 08098 (both to X. C.). We thank R. Luck and L. Sakowski for collecting samples.	Amin S, 2008, OSTEOARTHR CARTILAGE, V16, P897, DOI 10.1016/j.joca.2007.11.005; Berenbaum F, 2011, OSTEOARTHR CARTILAGE, V19, P361, DOI 10.1016/j.joca.2011.01.019; Burr DB, 2003, RHEUM DIS CLIN N AM, V29, P675, DOI 10.1016/S0889-857X(03)00061-9; Cao X, 2011, P NATL ACAD SCI USA, V108, P1609, DOI 10.1073/pnas.1015350108; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005; Davidson ENB, 2009, J IMMUNOL, V182, P7937, DOI 10.4049/jimmunol.0803991; DOWNS EC, 1992, J CELL PHYSIOL, V152, P422, DOI 10.1002/jcp.1041520225; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring SR, 2012, THER ADV MUSCULOSKEL, V4, P249, DOI 10.1177/1759720X12437353; Goldring SR, 2009, MED CLIN N AM, V93, P25, DOI 10.1016/j.mcna.2008.09.006; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Guiducci S, 2011, ANN RHEUM DIS, V70, P2011, DOI 10.1136/ard.2011.150607; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Hawker GA, 2011, OSTEOARTHR CARTILAGE, V19, P366, DOI 10.1016/j.joca.2011.01.021; Hill CL, 2005, ARTHRITIS RHEUM, V52, P794, DOI 10.1002/art.20943; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P1529, DOI 10.1002/art.21789; Hunter DJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2601; Jones MD, 2010, ARTHRITIS RHEUM-US, V62, P2726, DOI 10.1002/art.27595; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Koyama N, 2011, LIFE SCI, V89, P741, DOI 10.1016/j.lfs.2011.09.005; Lee JH, 2009, OSTEOARTHR CARTILAGE, V17, P1350, DOI 10.1016/j.joca.2009.03.019; Li BH, 1997, ANN RHEUM DIS, V56, P247, DOI 10.1136/ard.56.4.247; Li TF, 2006, J BONE MINER RES, V21, P4, DOI 10.1359/JBMR.050911; Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Lotz M, 2012, OSTEOARTHR CARTILAGE, V20, P192, DOI 10.1016/j.joca.2011.11.015; Ma Y, 2009, YAKUGAKU ZASSHI, V129, P851, DOI 10.1248/yakushi.129.851; Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moller KA, 2008, J NEUROSCI METH, V174, P1, DOI 10.1016/j.jneumeth.2008.06.017; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Scharstuhl A, 2003, ARTHRITIS RHEUM-US, V48, P3442, DOI 10.1002/art.11328; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Stein V, 2012, RHEUMATOL INT, V32, P1197, DOI 10.1007/s00296-010-1749-y; Suri S, 2012, BONE, V51, P204, DOI 10.1016/j.bone.2011.10.010; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tchetina EV, 2011, ARTHRITIS, DOI 10.1155/2011/683970; van den Berg WB, 2011, OSTEOARTHR CARTILAGE, V19, P338, DOI 10.1016/j.joca.2011.01.022; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; van der Kraan PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2896; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Whyte MP, 2011, J BONE MINER RES, V26, P920, DOI 10.1002/jbmr.283; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wu QQ, 2008, ARTHRITIS RHEUM-US, V58, P3132, DOI 10.1002/art.23946; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhang M, 2010, J BIOL CHEM, V285, P8703, DOI 10.1074/jbc.M109.093526	61	581	622	24	290	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					704	+		10.1038/nm.3143	http://dx.doi.org/10.1038/nm.3143			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23685840	Green Accepted			2022-12-27	WOS:000319981600019
J	Cypess, AM; White, AP; Vemochet, C; Schulz, TJ; Xue, RD; Sass, CA; Huang, TL; Roberts-Toler, C; Weiner, LS; Sze, C; Chacko, AT; Deschamps, LN; Herder, LM; Truchan, N; Glasgow, AL; Holman, AR; Gavrila, A; Hasselgren, PO; Mori, MA; Molla, M; Tseng, YH				Cypess, Aaron M.; White, Andrew P.; Vemochet, Cecile; Schulz, Tim J.; Xue, Ruidan; Sass, Christina A.; Huang, Tian Liang; Roberts-Toler, Carla; Weiner, Lauren S.; Sze, Cathy; Chacko, Aron T.; Deschamps, Laura N.; Herder, Lindsay M.; Truchan, Nathan; Glasgow, Allison L.; Holman, Ashley R.; Gavrila, Alina; Hasselgren, Per-Olof; Mori, Marcelo A.; Molla, Michael; Tseng, Yu-Hua			Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; NONSHIVERING THERMOGENESIS; ADIPOCYTES; COLD; DISTINCT; IDENTIFICATION; CELL; PROGENITORS; ACTIVATION; RESPONSES	The imbalance between energy intake and expenditure is the underlying cause of the current obesity and diabetes pandemics. Central to these pathologies is the fat depot: white adipose tissue (WAT) stores excess calories, and brown adipose tissue (BAT) consumes fuel for thermogenesis using tissue-specific uncoupling protein 1 (UCP1)(1,2). BAT was once thought to have a functional role in rodents and human infants only, but it has been recently shown that in response to mild cold exposure, adult human BAT consumes more glucose per gram than any other tissue(3). In addition to this nonshivering thermogenesis, human BAT may also combat weight gain by becoming more active in the setting of increased whole-body energy intake(4-7). This phenomenon of BAT-mediated diet-induced thermogenesis has been observed in rodents(8) and suggests that activation of human BAT could be used as a safe treatment for obesity and metabolic dysregulation(9). In this study, we isolated anatomically defined neck fat from adult human volunteers and compared its gene expression, differentiation capacity and basal oxygen consumption to different mouse adipose depots. Although the properties of human neck fat vary substantially between individuals, some human samples share many similarities with classical, also called constitutive, rodent BAT.	[Cypess, Aaron M.; Vemochet, Cecile; Schulz, Tim J.; Xue, Ruidan; Sass, Christina A.; Huang, Tian Liang; Roberts-Toler, Carla; Weiner, Lauren S.; Sze, Cathy; Truchan, Nathan; Holman, Ashley R.; Mori, Marcelo A.; Tseng, Yu-Hua] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab,Res Div, Boston, MA 02115 USA; [White, Andrew P.; Chacko, Aron T.; Deschamps, Laura N.; Herder, Lindsay M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Orthopaed Surg, Boston, MA 02215 USA; [Glasgow, Allison L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Harvard Thorndike Clin Res Ctr, Sch Med, Boston, MA 02215 USA; [Gavrila, Alina] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Endocrinol, Boston, MA 02215 USA; [Hasselgren, Per-Olof] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Molla, Michael] Harvard Univ, Sch Med, Joslin Diabet Ctr, Bioinformat Core,Res Div, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Cypess, AM (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Integrat Physiol & Metab,Res Div, Boston, MA 02115 USA.	aaron.cypess@joslin.harvard.edu	Mori, Marcelo A/R-2881-2018; Schulz, Tim/F-4842-2013; Tseng, Yu-Hua/AAE-6471-2021	Mori, Marcelo A/0000-0001-7112-5263; Schulz, Tim/0000-0002-8413-3972; Tseng, Yu-Hua/0000-0003-2053-9559	US National Institutes of Health (NIH) from the National Institute of Diabetes and Digestive and Kidney Diseases [DK087317, DK081604, DK046200, DK077097, P30 DK036836, KL2 RR025757]; National Center for Research Resources, Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH) [UL1RR025758, UL1 RR 025758]; Harvard University; Harvard Stem Cell Institute; Eli Lilly Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, KL2RR025757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075112, R01DK077097, K23DK081604, ZIADK075116, P30DK036836, RC1DK087317, P30DK046200, R01DK082659] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) from the National Institute of Diabetes and Digestive and Kidney Diseases; National Center for Research Resources, Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH); Harvard University; Harvard Stem Cell Institute; Eli Lilly Foundation(Eli Lilly); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health (NIH) grants DK087317, DK081604, DK046200, DK077097 and P30 DK036836 from the National Institute of Diabetes and Digestive and Kidney Diseases KL2 RR025757 and the Clinical Translational Science Award UL1RR025758 to Harvard University and Beth Israel Deaconess Medical Center from the National Center for Research Resources, Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers), as well as the Harvard Stem Cell Institute and Eli Lilly Foundation. We thank Y.I. Chen and K.K. Kwong for the magnetic resonance imaging; K. Chaudhary for assistance in figure design; M. Mittleman, H. Keenan and E. Wilker for biostatistical advice; J. Skupien for advice on factor analysis; H. Sacks for insights into the role of brown fat in warming blood; C. Cahill at the Joslin Diabetes Center Microscopy Core for expertise in histology; M. Rourk and G. Smyth for assistance in conducting the rodent studies; the teams of operating room nurses for assistance in tissue collection; and C.R. Kahn for input in preparing this manuscript. Finally, we are grateful to our volunteers for their commitment to the studies.	Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FOSTER DO, 1978, CAN J PHYSIOL PHARM, V56, P110, DOI 10.1139/y78-015; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; HEATON JM, 1972, J ANAT, V112, P35; Lee P, 2011, ENDOCRINOLOGY, V152, P3597, DOI 10.1210/en.2011-1349; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Morrison SF, 2011, J APPL PHYSIOL, V110, P1137, DOI 10.1152/japplphysiol.01227.2010; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SMITH RE, 1964, SCIENCE, V146, P1686, DOI 10.1126/science.146.3652.1686; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Vernochet C, 2010, DRUG NEWS PERSPECT, V23, P409, DOI 10.1358/dnp.2010.23.7.1487083; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Walden TB, 2010, BIOCHEM BIOPH RES CO, V397, P146, DOI 10.1016/j.bbrc.2010.05.053; Wijers SLJ, 2007, J CLIN ENDOCR METAB, V92, P4299, DOI 10.1210/jc.2007-1065; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	31	488	496	0	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					635	639		10.1038/nm.3112	http://dx.doi.org/10.1038/nm.3112			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23603815	Green Accepted, Green Submitted			2022-12-27	WOS:000318583000038
J	Mummery, CL; Lee, RT				Mummery, Christine L.; Lee, Richard T.			Is heart regeneration on the right track?	NATURE MEDICINE			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; MYOCARDIAL-INFARCTION; MOUSE HEART; CARDIOMYOCYTES; TRIAL; THERAPY; MATURE	How to mend a broken heart Myocardial infarction can cause irreversible heart muscle cell damage and lingering cardiac problems that can eventually lead to heart failure. For over a decade, researchers have been trying to coax stem cells to differentiate into cardiomyocytes to repair damaged heart tissue, with limited success. In 'Bedside to Bench', Christine L. Mummery and Richard T. Lee lay out a framework for re-evaluating cardiac cell therapies in the context of two recent clinical trials, in which autologous cardiac stem cells derived from heart biopsies were transferred into patients, with promising, albeit difficult to interpret, results. Results from previous clinical trials using autologous bone marrow-derived adult stem cells to induce cardiac regeneration add to the debate about how to cautiously move forward in the cardiac regeneration field and to the questions that need to be urgently answered at the bench. In 'Bench to Bedside', Young-Jae Nam, Kunhua Song and Eric N. Olson discuss a number of recent studies in rodents showing that cardiac fibroblasts can be reprogrammed, via miRNAs and a transcription factor 'cocktail', to express cardiac genes, which resulted in improved cardiac function in the animals, suggesting a new way forward for fixing damaged heart tissue.	[Mummery, Christine L.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Lee, Richard T.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Lee, Richard T.] Harvard Stem Cell Inst, Boston, MA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Mummery, CL (corresponding author), Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands.	c.l.mummery@lumc.nl		Mummery, Christine/0000-0002-4549-6535; Lee, Richard/0000-0003-4687-1381				Ardehali R, 2013, P NATL ACAD SCI USA, V110, P3405, DOI 10.1073/pnas.1220832110; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; Davis DR, 2010, STEM CELLS, V28, P903, DOI 10.1002/stem.413; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Marban E, 2012, JAMA-J AM MED ASSOC, V308, P2405, DOI 10.1001/jama.2012.64751; Martin-Rendon E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub2; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9	16	14	14	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2013	19	4					412	413		10.1038/nm.3158	http://dx.doi.org/10.1038/nm.3158			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23558629				2022-12-27	WOS:000317109100023
J	Papadakis, M; Hadley, G; Xilouri, M; Hoyte, LC; Nagel, S; McMenamin, MM; Tsaknakis, G; Watt, SM; Drakesmith, CW; Chen, RL; Wood, MJA; Zhao, ZH; Kessler, B; Vekrellis, K; Buchan, AM				Papadakis, Michalis; Hadley, Gina; Xilouri, Maria; Hoyte, Lisa C.; Nagel, Simon; McMenamin, M. Mary; Tsaknakis, Grigorios; Watt, Suzanne M.; Drakesmith, Cynthia Wright; Chen, Ruoli; Wood, Matthew J. A.; Zhao, Zonghang; Kessler, Benedikt; Vekrellis, Kostas; Buchan, Alastair M.			Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy	NATURE MEDICINE			English	Article							FOCAL CEREBRAL-ISCHEMIA; TRANSIENT FOREBRAIN ISCHEMIA; DELAYED NEURONAL DEATH; HEAT-SHOCK PROTEIN; RAPAMYCIN PROTECTS; BRAIN-INJURY; RAT MODEL; CA1; HIPPOCAMPUS; ACTIVATION	Previous attempts to identify neuroprotective targets by studying the ischemic cascade and devising ways to suppress it have failed to translate to efficacious therapies for acute ischemic stroke(1). We hypothesized that studying the molecular determinants of endogenous neuroprotection in two well-established paradigms, the resistance of CA3 hippocampal neurons to global ischemia(2) and the tolerance conferred by ischemic preconditioning (IPC)(3), would reveal new neuroprotective targets. We found that the product of the tuberous sclerosis complex 1 gene (TSC1), hamartin, is selectively induced by ischemia in hippocampal CA3 neurons. In CA1 neurons, hamartin was unaffected by ischemia but was upregulated by IPC preceding ischemia, which protects the otherwise vulnerable CA1 cells. Suppression of hamartin expression with TSC1 shRNA viral vectors both in vitro and in vivo increased the vulnerability of neurons to cell death following oxygen glucose deprivation (OGD) and ischemia. In vivo, suppression of TSC1 expression increased locomotor activity and decreased habituation in a hippocampal-dependent task. Overexpression of hamartin increased resistance to OGD by inducing productive autophagy through an mTORC1-dependent mechanism.	[Papadakis, Michalis; Hadley, Gina; Hoyte, Lisa C.; Nagel, Simon; Chen, Ruoli; Buchan, Alastair M.] Univ Oxford, Nuffield Dept Clin Med, Acute Stroke Programme, Lab Cerebral Ischemia, Oxford, England; [Xilouri, Maria; Vekrellis, Kostas] Acad Athens, Biomed Res Fdn, Div Basic Neurosci, Athens, Greece; [Nagel, Simon] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [McMenamin, M. Mary; Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Tsaknakis, Grigorios; Watt, Suzanne M.] Natl Hlth Serv Blood & Transplant, Stem Cell Res Lab, Oxford, England; [Tsaknakis, Grigorios; Watt, Suzanne M.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England; [Drakesmith, Cynthia Wright; Kessler, Benedikt] Univ Oxford, Nuffield Dept Med, Cent Prote Facil, Oxford, England; [Chen, Ruoli] Keele Univ, Sch Pharm, Keele, Staffs, England; [Zhao, Zonghang] Univ Calgary, Hotchkiss Brain Inst, Calgary Stroke Program, Calgary, AB, Canada; [Zhao, Zonghang] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada	University of Oxford; Academy of Athens; Ruprecht Karls University Heidelberg; University of Oxford; NHS Blood & Transplant (NHSBT); University of Oxford; University of Oxford; Keele University; University of Calgary; University of Calgary	Buchan, AM (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Acute Stroke Programme, Lab Cerebral Ischemia, Oxford, England.	alastair.buchan@medsci.ox.ac.uk	Watt, Suzanne/AAV-4908-2021; Wood, Matthew/HDN-1469-2022; Nagel, Simon/AAB-9266-2022; Kessler, Benedikt/AAY-8614-2021; Buchan, Alastair M/B-9095-2009	Nagel, Simon/0000-0003-2471-6647; Kessler, Benedikt/0000-0002-8160-2446; Buchan, Alastair M/0000-0002-2918-5200; Wood, Matthew/0000-0002-5436-6011; Xilouri, Maria/0000-0001-7038-0780; Watt, Suzanne/0000-0001-7684-8022	UK Medical Research Council [G0500495]; Dunhill Medical Trust; Fondation Leducq; NIHR Integrated Academic Training Programme; Oxford University Clinical Academic Graduate School; NIHR Biomedical Research Centre; Deutsche Forschungsgemeinschaft; National Health Service Blood and Transplant; NIHR under its Programme Grants Scheme (NIHR Programmes) [RP-PG-0310-10001, -10003]; MRC [G0900887] Funding Source: UKRI; Medical Research Council [G0900887, G0500495] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10213, RP-PG-0310-1003] Funding Source: researchfish; Parkinson&quot;s UK [G-0503] Funding Source: researchfish; The Dunhill Medical Trust [OSRP1/1006] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); Fondation Leducq(Leducq Foundation); NIHR Integrated Academic Training Programme; Oxford University Clinical Academic Graduate School; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Health Service Blood and Transplant; NIHR under its Programme Grants Scheme (NIHR Programmes); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); The Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported by the UK Medical Research Council grant G0500495 and by the Dunhill Medical Trust. A.M.B. is a senior investigator of the UK National Institute for Health Research (NIHR) and received funding from Fondation Leducq for neurovascular coupling. G.H. was funded through the NIHR Integrated Academic Training Programme and Oxford University Clinical Academic Graduate School. B.K. and C.W.D. were supported by the NIHR Biomedical Research Centre. S.N. was supported by the Deutsche Forschungsgemeinschaft. G.T. and S.M.W. received funding from National Health Service Blood and Transplant and the NIHR under its Programme Grants Scheme (NIHR Programmes RP-PG-0310-10001 and -10003). We would also like to thank R. Deacon from the Department of Experimental Psychology, University of Oxford, for providing us with the open-field apparatus and for his guidance with the behavioral experiments. We thank E. Martin Rendon for her input concerning the lentiviral vectors and J. Peeling for his evaluation of the manuscript. We dedicate this paper to the memory of our colleague and mentor, John P. MacManus.	Andersen MB, 1997, BEHAV NEUROSCI, V111, P1205, DOI 10.1037/0735-7044.111.6.1205; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chauhan A, 2011, BEHAV BRAIN RES, V225, P603, DOI 10.1016/j.bbr.2011.08.035; Chen J, 1996, J NEUROCHEM, V67, P64; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Colbourne F, 1999, STROKE, V30, P662, DOI 10.1161/01.STR.30.3.662; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Gabryel B, 2012, PHARMACOL REP, V64, P1; Gozal E, 2002, J NEUROCHEM, V83, P331, DOI 10.1046/j.1471-4159.2002.01134.x; KAWAGOE J, 1992, BRAIN RES, V587, P195, DOI 10.1016/0006-8993(92)90997-N; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; KINOUCHI H, 1993, J CEREBR BLOOD F MET, V13, P105, DOI 10.1038/jcbfm.1993.13; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Liu CL, 2010, J NEUROCHEM, V115, P68, DOI 10.1111/j.1471-4159.2010.06905.x; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; MILESON BE, 1991, NEUROSCI LETT, V128, P71, DOI 10.1016/0304-3940(91)90762-I; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; PETITO CK, 1987, NEUROLOGY, V37, P1281, DOI 10.1212/WNL.37.8.1281; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Shioda N, 2008, NEUROSCIENCE, V155, P876, DOI 10.1016/j.neuroscience.2008.05.056; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; van den Ouweland AMW, 2011, EUR J HUM GENET, V19, P157, DOI 10.1038/ejhg.2010.156; Wang P, 2012, AUTOPHAGY, V8, P77, DOI 10.4161/auto.8.1.18274; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Yang SS, 2010, PHARMAZIE, V65, P760, DOI 10.1691/ph.2010.0576; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zheng YQ, 2009, ACTA PHARMACOL SIN, V30, P919, DOI 10.1038/aps.2009.79	33	161	175	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2013	19	3					351	357		10.1038/nm.3097	http://dx.doi.org/10.1038/nm.3097			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23435171	Green Accepted, Green Submitted			2022-12-27	WOS:000316040700029
J	Miller, LH; Ackerman, HC; Su, XZ; Wellems, TE				Miller, Louis H.; Ackerman, Hans C.; Su, Xin-zhuan; Wellems, Thomas E.			Malaria biology and disease pathogenesis: insights for new treatments	NATURE MEDICINE			English	Review							PLASMODIUM-FALCIPARUM MALARIA; ARTEMISININ-RESISTANT MALARIA; NITRIC-OXIDE BIOAVAILABILITY; TISSUE FACTOR EXPRESSION; VON-WILLEBRAND-FACTOR; SICKLE-CELL-DISEASE; CHLOROQUINE-RESISTANCE; ENDOTHELIAL-CELLS; AFRICAN CHILDREN; CEREBRAL MALARIA	Plasmodium falciparum malaria, an infectious disease caused by a parasitic protozoan, claims the lives of nearly a million children each year in Africa alone and is a top public health concern. Evidence is accumulating that resistance to artemisinin derivatives, the frontline therapy for the asexual blood stage of the infection, is developing in southeast Asia. Renewed initiatives to eliminate malaria will benefit from an expanded repertoire of antimalarials, including new drugs that kill circulating P. falciparum gametocytes, thereby preventing transmission. Our current understanding of the biology of asexual blood-stage parasites and gametocytes and the ability to culture them in vitro lends optimism that high-throughput screenings of large chemical libraries will produce a new generation of antimalarial drugs. There is also a need for new therapies to reduce the high mortality of severe malaria. An understanding of the pathophysiology of severe disease may identify rational targets for drugs that improve survival.	[Miller, Louis H.; Ackerman, Hans C.; Su, Xin-zhuan; Wellems, Thomas E.] NIAID, Lab Malaria & Vector Res, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Miller, LH (corresponding author), NIAID, Lab Malaria & Vector Res, Rockville, MD USA.	lmiller@niaid.nih.gov	Ackerman, Hans/U-9621-2019	Ackerman, Hans/0000-0003-4940-3305; Su, Xinzhuan/0000-0003-3246-3248	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI000483, ZIAAI000892, ZIAAI001150] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This review was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, US National Institutes of Health. We thank S.K. Pierce, S. Desai and C. Pola for critical comments and figure design.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Baird JK, 2008, NEW ENGL J MED, V359, P2601, DOI 10.1056/NEJMe0808729; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Beare NA, 2004, ARCH OPHTHALMOL-CHIC, V122, P1141, DOI 10.1001/archopht.122.8.1141; Biagini GA, 2012, P NATL ACAD SCI USA, V109, P8298, DOI 10.1073/pnas.1205651109; Bouloc N, 2008, BIOORG MED CHEM LETT, V18, P5294, DOI 10.1016/j.bmcl.2008.08.043; Bridges DJ, 2010, BLOOD, V115, P1472, DOI 10.1182/blood-2009-07-235150; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Burgess SJ, 2006, J MED CHEM, V49, P5623, DOI 10.1021/jm060399n; Burrows JN, 2011, CURR TOP MED CHEM, V11, P1226; Burstein ES, 2006, CURR PHARM DESIGN, V12, P1717, DOI 10.2174/138161206776873662; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Cauwels A, 2009, J EXP MED, V206, P2915, DOI 10.1084/jem.20091236; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Chen L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002199; Cheng Q, 2012, INT J PARASITOL-DRUG, V2, P249, DOI 10.1016/j.ijpddr.2012.01.001; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Codd A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-56; Conroy AL, 2012, CRIT CARE MED, V40, P952, DOI 10.1097/CCM.0b013e3182373157; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; COWMAN AF, 1991, J CELL BIOL, V113, P1033, DOI 10.1083/jcb.113.5.1033; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Davids M, 2012, AM J PHYSIOL-HEART C, V302, pH1762, DOI 10.1152/ajpheart.01205.2011; De DY, 1996, AM J TROP MED HYG, V55, P579, DOI 10.4269/ajtmh.1996.55.579; de Mast Q, 2009, AM J TROP MED HYG, V80, P492, DOI 10.4269/ajtmh.2009.80.492; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Desoubzdanne D, 2008, J NAT PROD, V71, P1189, DOI 10.1021/np8000909; Dive D, 2008, CHEMMEDCHEM, V3, P383, DOI 10.1002/cmdc.200700127; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; Doerig C, 2010, BBA-PROTEINS PROTEOM, V1804, P604, DOI 10.1016/j.bbapap.2009.10.009; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Eastman RT, 2013, ANTIMICROB AGENTS CH, V57, P425, DOI 10.1128/AAC.00920-12; Erez A, 2011, NAT MED, V17, P1619, DOI 10.1038/nm.2544; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1982, ANTIMICROB AGENTS CH, V21, P819, DOI 10.1128/AAC.21.5.819; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Francischetti IMB, 2012, ARTERIOSCL THROM VAS, V32, P786, DOI 10.1161/ATVBAHA.111.240291; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gao M, 2012, P NATL ACAD SCI USA, V109, P3784, DOI 10.1073/pnas.1117768109; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Goldberg DE, 1997, J BIOL CHEM, V272, P6567, DOI 10.1074/jbc.272.10.6567; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hartwig CL, 2009, BIOCHEM PHARMACOL, V77, P322, DOI 10.1016/j.bcp.2008.10.015; Hawley SR, 1996, ANTIMICROB AGENTS CH, V40, P2345, DOI 10.1128/AAC.40.10.2345; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; HEMMER CJ, 1991, AM J TROP MED HYG, V45, P608, DOI 10.4269/ajtmh.1991.45.608; Hoshen MB, 2000, PARASITOLOGY, V121, P237, DOI 10.1017/S0031182099006332; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Hwang JY, 2011, J MED CHEM, V54, P7084, DOI 10.1021/jm200636z; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Janka JJ, 2010, J INFECT DIS, V202, P791, DOI 10.1086/655225; Jefford CW, 2012, CURR TOP MED CHEM, V12, P373; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; Kannan R, 2002, CHEM BIOL, V9, P321, DOI 10.1016/S1074-5521(02)00117-5; Kato GJ, 2009, BRIT J HAEMATOL, V145, P506, DOI 10.1111/j.1365-2141.2009.07658.x; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; LaCrue AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026689; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Laurent D, 2006, BIOORGAN MED CHEM, V14, P4477, DOI 10.1016/j.bmc.2006.02.026; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; Le Roch K, 2000, J BIOL CHEM, V275, P8952, DOI 10.1074/jbc.275.12.8952; Lehane AM, 2012, INT J PARASITOL-DRUG, V2, P47, DOI 10.1016/j.ijpddr.2011.11.001; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Lemercier G, 2009, BIOCHEMISTRY-US, V48, P6379, DOI 10.1021/bi9005122; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; LI GQ, 1994, T ROY SOC TROP MED H, V88, P5, DOI 10.1016/0035-9203(94)90460-X; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Mack AK, 2008, BRIT J HAEMATOL, V142, P971, DOI 10.1111/j.1365-2141.2008.07259.x; Madrid PB, 2006, J MED CHEM, V49, P4535, DOI 10.1021/jm0600951; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Minneci PC, 2008, AM J PHYSIOL-HEART C, V295, pH743, DOI 10.1152/ajpheart.00151.2008; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; Mombo-Ngoma G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-53; Mu JB, 2003, MOL MICROBIOL, V49, P977, DOI 10.1046/j.1365-2958.2003.03627.x; Mzayek Fawaz, 2007, PLoS Clin Trials, V2, pe6, DOI 10.1371/journal.pctr.0020006; Nakazawa S, 1995, EXP PARASITOL, V81, P556, DOI 10.1006/expr.1995.1149; Nakazawa S, 2002, ANTIMICROB AGENTS CH, V46, P958, DOI 10.1128/AAC.46.4.958-965.2002; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; Nosten F, 2010, J INFECT DIS, V202, P1300, DOI 10.1086/656478; O'Neill PM, 2009, J MED CHEM, V52, P1408, DOI 10.1021/jm8012618; O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c; Omodeo-Sale F, 2010, AM J PHYSIOL-CELL PH, V299, pC148, DOI 10.1152/ajpcell.00405.2009; Peatey CL, 2011, MOL BIOCHEM PARASIT, V180, P127, DOI 10.1016/j.molbiopara.2011.09.002; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Planche T, 2004, PLOS MED, V1, P56, DOI 10.1371/journal.pmed.0010018; Pou S, 2012, ANTIMICROB AGENTS CH, V56, P3475, DOI 10.1128/AAC.00100-12; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Serghides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027714; Serirom S, 2003, AM J PATHOL, V162, P1651, DOI 10.1016/S0002-9440(10)64299-X; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Sowunmi A, 2005, ANN TROP MED PARASIT, V99, P331, DOI 10.1179/136485905X36226; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Taoufiq Z, 2008, J INFECT DIS, V197, P1062, DOI 10.1086/528988; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Thapar MM, 2005, T ROY SOC TROP MED H, V99, P62, DOI 10.1016/j.trstmh.2004.01.016; Tucker MS, 2012, ANTIMICROB AGENTS CH, V56, P302, DOI 10.1128/AAC.05540-11; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; van Pelt-Koops JC, 2012, ANTIMICROB AGENTS CH, V56, P3544, DOI 10.1128/AAC.06377-11; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Veiga MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012408; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Vogetseder A, 2004, TROP MED INT HEALTH, V9, P767, DOI 10.1111/j.1365-3156.2004.01265.x; Vouret-Craviari V, 2003, J THROMB HAEMOST, V1, P1103, DOI 10.1046/j.1538-7836.2003.00238.x; Walther M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002579; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; Wojciak-Stothard B, 2007, J CELL SCI, V120, P929, DOI 10.1242/jcs.002212; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Xiao ZL, 2001, BIOORG MED CHEM LETT, V11, P2875, DOI 10.1016/S0960-894X(01)00578-9; Yang Y, 2000, CIRCULATION, V101, P2144, DOI 10.1161/01.CIR.101.18.2144; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2007, J EXP MED, V204, P2693, DOI 10.1084/jem.20070819; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Yeo TW, 2009, J INFECT DIS, V200, P1522, DOI 10.1086/644641; Yu B, 2008, CIRCULATION, V117, P1982, DOI 10.1161/CIRCULATIONAHA.107.729137; Yuan J, 2011, SCIENCE, V333, P724, DOI 10.1126/science.1205216; Yuan J, 2009, NAT CHEM BIOL, V5, P765, DOI 10.1038/nchembio.215; Zishiri VK, 2011, J MED CHEM, V54, P6956, DOI 10.1021/jm2009698	154	372	380	1	289	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					156	167		10.1038/nm.3073	http://dx.doi.org/10.1038/nm.3073			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389616	Green Accepted			2022-12-27	WOS:000314675900024
J	Becher, B; Pantelyushin, S				Becher, Burkhard; Pantelyushin, Stanislav			Hiding under the skin Interleukin-17-producing gamma delta T cells go under the skin?	NATURE MEDICINE			English	Editorial Material							MONOCLONAL-ANTIBODY; PSORIASIS; ETANERCEPT; IMIQUIMOD; MODERATE; PLACEBO	Despite the irrefutable role of inflammation in psoriasis, a complete knowledge of what immune cells and cytokines are involved during initiation and progression of this skin disease is lacking. Moreover, the complexities of the immune cell network and potential differences between mice and humans have led to translational failures. It is therefore important that we acquire indepth understanding of what inflammatory players, of the many involved, are crucial, if we wish to develop effective therapies. In 'Bedside to Bench', James Krueger discusses how a subset of T cells, T(H)17 cells, which release interleukin-17 in humans, seem to be essential for pathogenesis of psoriasis. The interplay between interleukin-17 and other cytokines that may potentially be involved in psoriasis also needs further investigation. Additionally, there are open questions as to what subset of T cells, other than T(H)17, also produce interleukin-17 and when. In 'Bench to Bedside', Burkhard Becher and Stanislav Pantelyushin examine this issue by looking at a mouse model of skin inflammation that resembles psoriasis in humans. A class of skin-invading innate immune cells called gamma delta T cells was shown to drive skin inflammation in this model, particularly during the early stages of the disease, suggesting that innate immunity plays an important part in the initiation of psoriasis.	[Becher, Burkhard; Pantelyushin, Stanislav] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	becher@immunology.uzh.ch	Pantelyushin, Stanislav/AAH-8637-2021; Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Pantelyushin, Stanislav/0000-0002-3490-3860				Antoniu SA, 2012, EXPERT OPIN INV DRUG, V21, P1607, DOI 10.1517/13543784.2012.712112; Bissonnette R, 2010, J AM ACAD DERMATOL, V62, P427, DOI 10.1016/j.jaad.2009.05.042; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Eberl G, 2012, IMMUNOL REV, V245, P177, DOI 10.1111/j.1600-065X.2011.01071.x; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Gottlieb AB, 2011, BRIT J DERMATOL, V165, P652, DOI 10.1111/j.1365-2133.2011.10418.x; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Guo LY, 2012, TRENDS IMMUNOL, V33, P598, DOI 10.1016/j.it.2012.07.006; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999	18	60	65	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1748	1750		10.1038/nm.3016	http://dx.doi.org/10.1038/nm.3016			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23223063				2022-12-27	WOS:000311999800021
J	Schattling, B; Steinbach, K; Thies, E; Kruse, M; Menigoz, A; Ufer, F; Flockerzi, V; Bruck, W; Pongs, O; Vennekens, R; Kneussel, M; Freichel, M; Merkler, D; Friese, MA				Schattling, Benjamin; Steinbach, Karin; Thies, Edda; Kruse, Martin; Menigoz, Aurelie; Ufer, Friederike; Flockerzi, Veit; Brueck, Wolfgang; Pongs, Olaf; Vennekens, Rudi; Kneussel, Matthias; Freichel, Marc; Merkler, Doron; Friese, Manuel A.			TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis	NATURE MEDICINE			English	Article							GRAY-MATTER ATROPHY; MITOCHONDRIAL DYSFUNCTION; CELL-ACTIVATION; GLUTAMATE; INJURY; DISABILITY; LESIONS; BRAINS; MODEL; MICE	In multiple sclerosis, an inflammatory disease of the central nervous system (CNS), axonal and neuronal loss are major causes for irreversible neurological disability. However, which molecules contribute to axonal and neuronal injury under inflammatory conditions remains largely unknown. Here we show that the transient receptor potential melastatin 4 (TRPM4) cation channel is crucial in this process. TRPM4 is expressed in mouse and human neuronal somata, but it is also expressed in axons in inflammatory CNS lesions in experimental autoimmune encephalomyelitis (EAE) in mice and in human multiple sclerosis tissue. Deficiency or pharmacological inhibition of TRPM4 using the antidiabetic drug glibenclamide resulted in reduced axonal and neuronal degeneration and attenuated clinical disease scores in EAE, but this occurred without altering EAE-relevant immune function. Furthermore, Trpm4(-/-) mouse neurons were protected against inflammatory effector mechanisms such as excitotoxic stress and energy deficiency in vitro. Electrophysiological recordings revealed TRPM4-dependent neuronal ion influx and oncotic cell swelling upon excitotoxic stimulation. Therefore, interference with TRPM4 could translate into a new neuroprotective treatment strategy.	[Schattling, Benjamin; Steinbach, Karin; Thies, Edda; Ufer, Friederike; Friese, Manuel A.] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Forschergrp Neuroimmunol, Hamburg, Germany; [Steinbach, Karin; Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland; [Steinbach, Karin; Merkler, Doron] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Thies, Edda; Kneussel, Matthias] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Inst Mol Neurogenet, Hamburg, Germany; [Kruse, Martin; Pongs, Olaf] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Inst Neurale Signalverarbeitung, Hamburg, Germany; [Menigoz, Aurelie; Vennekens, Rudi] Katholieke Univ Leuven, Lab Ion Channel Res, Dept Mol & Cellular Biol, Louvain, Belgium; [Flockerzi, Veit] Univ Saarland, Homburg, Germany; [Brueck, Wolfgang; Merkler, Doron] Univ Gottingen, Univ Med Gottingen, Inst Neuropathol, Gottingen, Germany; [Freichel, Marc] Heidelberg Univ, Inst Pharmakol, D-6900 Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Geneva; University of Geneva; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; KU Leuven; Saarland University; University of Gottingen; Ruprecht Karls University Heidelberg	Friese, MA (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Forschergrp Neuroimmunol, Hamburg, Germany.	manuel.friese@zmnh.uni-hamburg.de	Vennekens, Rudi/AAQ-1664-2020; Merkler, Doron/N-9157-2016	Vennekens, Rudi/0000-0002-2564-5150; Merkler, Doron/0000-0002-0247-2007; Kneussel, Matthias/0000-0003-4900-366X; Friese, Manuel A./0000-0001-6380-2420	Deutsche Forschungsgemeinschaft Emmy Noether-Programme [FR1720/3-1]; Gemeinnutzige Hertie-Stiftung [1.01.1/11/003]; Swiss National Science Foundation [PP00P3_128372]	Deutsche Forschungsgemeinschaft Emmy Noether-Programme(German Research Foundation (DFG)); Gemeinnutzige Hertie-Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	M.A.F. is supported by the Deutsche Forschungsgemeinschaft Emmy Noether-Programme (FR1720/3-1) and the Gemeinnutzige Hertie-Stiftung (1.01.1/11/003). D.M. is supported by the Swiss National Science Foundation (PP00P3_128372). O.P. is supported by the Gemeinnutzige Hertie-Stiftung. We would like to thank N. Lin Marq and N. Kursawe for excellent technical assistance.	Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; Armstrong WE, 2010, J NEUROENDOCRINOL, V22, P330, DOI 10.1111/j.1365-2826.2010.01989.x; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Baranzini SE, 2010, BRAIN, V133, P2603, DOI 10.1093/brain/awq192; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Basso AS, 2008, J CLIN INVEST, V118, P1532, DOI 10.1172/JCI33464; Becerra A, 2011, CARDIOVASC RES, V91, P677, DOI 10.1093/cvr/cvr135; Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109; Chen MK, 2003, J NEUROSCI, V23, P8568; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; Demion M, 2007, CARDIOVASC RES, V73, P531, DOI 10.1016/j.cardiores.2006.11.023; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Fisher E, 2007, ANN NEUROL, V62, P219, DOI 10.1002/ana.21113; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Groom AJ, 2003, ANN NY ACAD SCI, V993, P229, DOI 10.1111/j.1749-6632.2003.tb07533.x; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau A, 2010, PFLUG ARCH EUR J PHY, V460, P525, DOI 10.1007/s00424-010-0809-1; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Mironov SL, 2008, J PHYSIOL-LONDON, V586, P2277, DOI 10.1113/jphysiol.2007.149021; Murakami M, 2003, BIOCHEM BIOPH RES CO, V307, P522, DOI 10.1016/S0006-291X(03)01186-0; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Schinder AF, 1996, J NEUROSCI, V16, P6125; Shpak G, 2012, J NEUROSCI, V32, P6251, DOI 10.1523/JNEUROSCI.4397-11.2012; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Stover JF, 1997, EUR J CLIN INVEST, V27, P1038, DOI 10.1046/j.1365-2362.1997.2250774.x; Sun L, 2007, J PHYSIOL-LONDON, V583, P537, DOI 10.1113/jphysiol.2007.136788; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; Vergo S, 2011, BRAIN, V134, P571, DOI 10.1093/brain/awq337; Weber KS, 2010, J IMMUNOL, V185, P2836, DOI 10.4049/jimmunol.1000880; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; Yoo JC, 2010, BIOCHEM BIOPH RES CO, V391, P806, DOI 10.1016/j.bbrc.2009.11.142; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	58	137	142	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2012	18	12					1805	+		10.1038/nm.3015	http://dx.doi.org/10.1038/nm.3015			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23160238				2022-12-27	WOS:000311999800028
J	Yang, N; Wernig, M				Yang, Nan; Wernig, Marius			A case for neural stem cell therapy	NATURE MEDICINE			English	Editorial Material							OLIGODENDROCYTE PROGENITOR CELLS		[Yang, Nan; Wernig, Marius] Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University	Yang, N (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	wernig@stanford.edu	Yang, Nan/H-3174-2012	Yang, Nan/0000-0003-3663-1288				Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Inoue K, 1999, ANN NEUROL, V45, P624, DOI 10.1002/1531-8249(199905)45:5<624::AID-ANA11>3.3.CO;2-T; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Potts Matthew B, 2013, Surg Neurol Int, V4, pS22, DOI 10.4103/2152-7806.109190; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564	10	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1580	1581		10.1038/nm.3425	http://dx.doi.org/10.1038/nm.3425			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24309657				2022-12-27	WOS:000328181400026
J	Wang, QA; Tao, C; Gupta, RK; Scherer, PE				Wang, Qiong A.; Tao, Caroline; Gupta, Rana K.; Scherer, Philipp E.			Tracking adipogenesis during white adipose tissue development, expansion and regeneration	NATURE MEDICINE			English	Article							INSULIN SENSITIVITY; BROWN ADIPOCYTES; FAT-CONTENT; CELLS; IDENTIFICATION; EXPRESSION; OBESITY; ORIGIN; DEPOTS; MOUSE	White adipose tissue displays high plasticity. We developed a system for the inducible, permanent labeling of mature adipocytes that we called the AdipoChaser mouse. We monitored adipogenesis during development, high- fat diet (HFD) feeding and cold exposure. During cold- induced ` browning' of subcutaneous fat, most ` beige' adipocytes stem from de novo- differentiated adipocytes. During HFD feeding, epididymal fat initiates adipogenesis after 4 weeks, whereas subcutaneous fat undergoes hypertrophy for a period of up to 12 weeks. Gonadal fat develops postnatally, whereas subcutaneous fat develops between embryonic days 14 and 18. Our results highlight the extensive differences in adipogenic potential in various fat depots.	[Wang, Qiong A.; Tao, Caroline; Gupta, Rana K.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scherer, PE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	philipp.scherer@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012; Gupta, Rana/R-3051-2019	Scherer, Philipp E/0000-0003-0680-3392; Wang, Qiong/0000-0003-2224-4287; Gupta, Rana/0000-0002-9001-4531	US National Institutes of Health (NIH) [R01-DK55758, P01-DK088761, R01-DK099110]; American Diabetes Association [7-11-MN-47]; NIH [K01-DK090120-02, R03-DK099428]; Searle Scholars Program (Chicago, Illinois); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055758, R01DK099110, K01DK090120, P01DK088761, R03DK099428] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program (Chicago, Illinois); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the University of Texas Southwestern Histology Core for assistance in embedding and processing tissue samples, especially J. M. Shelton for suggestions and discussions on the protocol of LacZ staining of adipose tissues. We also thank A. S. Greenberg from Tufts University for providing perilipin antibody. This study was supported by US National Institutes of Health (NIH) grants R01-DK55758, P01-DK088761 and R01-DK099110 (P. E. S.). Q. A. W. is supported by a postdoctoral fellowship from the American Diabetes Association (7-11-MN-47). R. K. G. is supported by NIH grants K01-DK090120-02 and R03-DK099428 and the Searle Scholars Program (Chicago, Illinois).	ABATE N, 1995, J CLIN INVEST, V96, P88, DOI 10.1172/JCI118083; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Grundy Scott M., 2008, Metabolic Syndrome and Related Disorders, V6, P281, DOI 10.1089/met.2008.0026; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P109, DOI 10.1016/0889-1605(88)90001-8; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; MILLER WH, 1982, AM J PHYSIOL, V242, pE93, DOI 10.1152/ajpendo.1982.242.2.E93; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	39	786	805	9	145	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1338	+		10.1038/nm.3324	http://dx.doi.org/10.1038/nm.3324			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	23995282	Green Accepted			2022-12-27	WOS:000325531700035
J	Kaeppel, C; Beattie, SG; Fronza, R; van Logtenstein, R; Salmon, F; Schmidt, S; Wolf, S; Nowrouzi, A; Glimm, H; von Kalle, C; Petry, H; Gaudet, D; Schmidt, M				Kaeppel, Christine; Beattie, Stuart G.; Fronza, Raffaele; van Logtenstein, Richard; Salmon, Florence; Schmidt, Sabine; Wolf, Stephan; Nowrouzi, Ali; Glimm, Hanno; von Kalle, Christof; Petry, Harald; Gaudet, Daniel; Schmidt, Manfred			A largely random AAV integration profile after LPLD gene therapy	NATURE MEDICINE			English	Article							VIRUS VECTOR INTEGRATION; MOUSE MODEL; EVENTS; CANCER; NUMTS; LIVER; MICE	The clinical application of adeno-associated virus vectors (AAVs) is limited because of concerns about AAV integration-mediated tumorigenicity. We performed integration-site analysis after AAV1-LPLS447X intramuscular injection in five lipoprotein lipase-deficient subjects, revealing random nuclear integration and hotspots in mitochondria. We conclude that AAV integration is potentially safe and that vector breakage and integration may occur from each position of the vector genome. Future viral integration-site analyses should include the mitochondrial genome.	[Kaeppel, Christine; Fronza, Raffaele; Nowrouzi, Ali; Glimm, Hanno; von Kalle, Christof; Schmidt, Manfred] Natl Ctr Tumor Dis, Heidelberg, Germany; [Kaeppel, Christine; Fronza, Raffaele; Nowrouzi, Ali; Glimm, Hanno; von Kalle, Christof; Schmidt, Manfred] German Canc Res Ctr, Heidelberg, Germany; [Beattie, Stuart G.; van Logtenstein, Richard; Salmon, Florence; Petry, Harald] UniQure, Amsterdam, Netherlands; [Schmidt, Sabine; Wolf, Stephan] German Canc Res Ctr, Genom & Prote Core Facil, Heidelberg, Germany; [Gaudet, Daniel] Univ Montreal, Dept Med, ECOGENE Clin Res Ctr 21, Chicoutimi, PQ, Canada	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Universite de Montreal	Schmidt, M (corresponding author), Natl Ctr Tumor Dis, Heidelberg, Germany.	manfred.schmidt@nct-heidelberg.de	Beattie, Stuart Gavin/AFK-4415-2022; Beattie, Stuart Gavin/AAG-3146-2022	Beattie, Stuart Gavin/0000-0002-5735-3881; Beattie, Stuart Gavin/0000-0002-5735-3881	European Commission [FP7-HEALTH-2010-261506]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study has been supported by funds from the European Commission project with short name AIPGENE (grant FP7-HEALTH-2010-261506).	Abel U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000570; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Calabrese FM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S15; Carpentier AC, 2012, J CLIN ENDOCR METAB, V97, P1635, DOI 10.1210/jc.2011-3002; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; High KA, 2011, METHODS MOL BIOL, V807, P429, DOI 10.1007/978-1-61779-370-7_18; Inagaki K, 2007, J VIROL, V81, P11290, DOI 10.1128/JVI.00963-07; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HJ, 2011, BLOOD, V117, P3311, DOI 10.1182/blood-2010-08-302729; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Nakai H, 2003, NAT GENET, V34, P297, DOI 10.1038/ng1179; Nowrouzi A, 2012, MOL THER, V20, P1177, DOI 10.1038/mt.2012.47; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Ramos A, 2011, MITOCHONDRION, V11, P946, DOI 10.1016/j.mito.2011.08.009; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosas LE, 2012, MOL THER, V20, P2098, DOI 10.1038/mt.2012.197; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu XL, 2006, VIROLOGY, V344, P292, DOI 10.1016/j.virol.2005.08.047; Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	25	117	126	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					889	+		10.1038/nm.3230	http://dx.doi.org/10.1038/nm.3230			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23770691				2022-12-27	WOS:000321557700032
J	Thathiah, A; Horre, K; Snellinx, A; Vandewyer, E; Huang, YH; Ciesielska, M; De Kloe, G; Munck, S; De Strooper, B				Thathiah, Amantha; Horre, Katrien; Snellinx, An; Vandewyer, Elke; Huang, Yunhong; Ciesielska, Marta; De Kloe, Gerdien; Munck, Sebastian; De Strooper, Bart			beta-arrestin 2 regulates A beta generation and gamma-secretase activity in Alzheimer's disease	NATURE MEDICINE			English	Article							PROTEIN-COUPLED RECEPTORS; LIPID RAFTS; ACTIVATION; BETA-ARRESTIN-2; PRESENILIN-1; REVEALS; DESENSITIZATION; THERAPEUTICS; CONTRIBUTES; DEFICIENCY	beta-arrestins are associated with numerous aspects of G protein-coupled receptor (GPCR) signaling and regulation and accordingly influence diverse physiological and pathophysiological processes. Here we report that beta-arrestin 2 expression is elevated in two independent cohorts of individuals with Alzheimer's disease. Overexpression of beta-arrestin 2 leads to an increase in amyloid-beta (A beta) peptide generation, whereas genetic silencing of Arrb2 (encoding beta-arrestin 2) reduces generation of A beta in cell cultures and in Arrb2(-/-) mice. Moreover, in a transgenic mouse model of Alzheimer's disease, genetic deletion of Arrb2 leads to a reduction in the production of A beta(40) and A beta(42). Two GPCRs implicated previously in Alzheimer's disease (GPR3 and the beta(2)-adrenergic receptor) mediate their effects on A beta generation through interaction with beta-arrestin 2. beta-arrestin 2 physically associates with the Aph-1a subunit of the gamma-secretase complex and redistributes the complex toward detergent-resistant membranes, increasing the catalytic activity of the complex. Collectively, these studies identify beta-arrestin 2 as a new therapeutic target for reducing amyloid pathology and GPCR dysfunction in Alzheimer's disease.	[Thathiah, Amantha; Horre, Katrien; Snellinx, An; Vandewyer, Elke; Huang, Yunhong; Ciesielska, Marta; De Kloe, Gerdien; Munck, Sebastian; De Strooper, Bart] VIB, Ctr Biol Dis, Louvain, Belgium; [Thathiah, Amantha; Horre, Katrien; Snellinx, An; Vandewyer, Elke; Huang, Yunhong; Ciesielska, Marta; Munck, Sebastian; De Strooper, Bart] Univ Leuven KU Leuven, Ctr Human Genet, Louvain, Belgium; [Thathiah, Amantha; Horre, Katrien; Snellinx, An; Vandewyer, Elke; Huang, Yunhong; Ciesielska, Marta; Munck, Sebastian; De Strooper, Bart] Univ Leuven KU Leuven, LIND, Louvain, Belgium; [De Kloe, Gerdien] Janssen Pharmaceut, Dept Neurosci, Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Johnson & Johnson; Janssen Pharmaceuticals	Thathiah, A (corresponding author), VIB, Ctr Biol Dis, Louvain, Belgium.	amantha.thathiah@cme.vib.kuleuven.be; bart.destrooper@cme.vib-kuleuven.be	Huang, Yunhong/V-9329-2018; de+Strooper, Bart/Z-1638-2019	Horre, Katrien/0000-0002-6801-3137; Vandewyer, Elke/0000-0003-1774-1764; Munck, Sebastian/0000-0002-5182-5358	Alzheimer's Association; Fund for Scientific Research Flanders, KU Leuven; Methusalem grant from the KU Leuven; Flemish government; Foundation for Alzheimer Research (SAO/FRMA)	Alzheimer's Association(Alzheimer's Association); Fund for Scientific Research Flanders, KU Leuven; Methusalem grant from the KU Leuven; Flemish government(European Commission); Foundation for Alzheimer Research (SAO/FRMA)	We are grateful to R.J. Lefkowitz and S. Ahn (Duke University Medical Center, Durham, North Carolina, USA) for the generous gift of the beta-arrestin 2 wild-type and knockout mouse embryonic fibroblasts, the Arrb1<SUP>-/-</SUP> and Arrb2<SUP>-/-</SUP> mice, the beta-arrestin 2-GFP-Flag cDNA and helpful discussion. We thank M. Jucker (University of Tubingen, Germany) for the gift of APP/PS1 transgenic mice. We greatly appreciate the kind gift of human control and Alzheimer's disease brain samples from K. Bossers and D.F. Swaab (Netherlands Institute for Neuroscience, Amsterdam, The Netherlands) and C. Troakes (the London Neurodegenerative Diseases Brain Bank, London, UK). We thank M. Mercken (Johnson & Johnson Pharmaceuticals Research and Development, Beerse, Belgium) for the antibodies to A beta. We are grateful to Y. Li (Memorial Sloan Kettering Cancer Center, New York, USA) for the kind initial gift of JC-8. This work was supported by a Mentored New Investigator Research grant from the Alzheimer's Association to A.T., the Fund for Scientific Research Flanders, KU Leuven, a Methusalem grant from the KU Leuven and the Flemish government, and the Foundation for Alzheimer Research (SAO/FRMA) to B.D.S. B.D.S. is the Arthur Bax and Anna Vanluffelen chair for Alzheimer's disease.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Chau DM, 2012, J BIOL CHEM, V287, P17288, DOI 10.1074/jbc.M111.300483; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Chun J, 2004, J ORG CHEM, V69, P7344, DOI 10.1021/jo0486948; Conner DA, 1997, CIRC RES, V81, P1021; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gotz J, 2012, BRIT J PHARMACOL, V165, P1246, DOI 10.1111/j.1476-5381.2011.01713.x; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003529; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Olson KR, 2007, ASSAY DRUG DEV TECHN, V5, P137, DOI 10.1089/adt.2006.052; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Watson S.A.S., 1994, G PROTEIN COUPLED RE; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200	52	118	121	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					43	49		10.1038/nm.3023	http://dx.doi.org/10.1038/nm.3023			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23202293				2022-12-27	WOS:000313230300024
J	Baldauf, HM; Pan, XY; Erikson, E; Schmidt, S; Daddacha, W; Burggraf, M; Schenkova, K; Ambiel, I; Wabnitz, G; Gramberg, T; Panitz, S; Flory, E; Landau, NR; Sertel, S; Rutsch, F; Lasitschka, F; Kim, B; Konig, R; Fackler, OT; Keppler, OT				Baldauf, Hanna-Mari; Pan, Xiaoyu; Erikson, Elina; Schmidt, Sarah; Daddacha, Waaqo; Burggraf, Manja; Schenkova, Kristina; Ambiel, Ina; Wabnitz, Guido; Gramberg, Thomas; Panitz, Sylvia; Flory, Egbert; Landau, Nathaniel R.; Sertel, Serkan; Rutsch, Frank; Lasitschka, Felix; Kim, Baek; Koenig, Renate; Fackler, Oliver T.; Keppler, Oliver T.			SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DENDRITIC CELLS; RODENT CELLS; TYPE-1; VPX; REPLICATION; ACTIVATION; PROTEIN; GENE; TRANSDUCTION	Unlike activated CD4(+) T cells, resting CD4(+) T cells are highly resistant to productive HIV-1 infection(1-8). Early after HIV-1 entry, a major block limits reverse transcription of incoming viral genomes. Here we show that the deoxynucleoside triphosphate triphosphohydrolase SAMHD1 prevents reverse transcription of HIV-1 RNA in resting CD4(+) T cells. SAMHD1 is abundantly expressed in resting CD4(+) T cells circulating in peripheral blood and residing in lymphoid organs. The early restriction to infection in unstimulated CD4(+) T cells is overcome by HIV-1 or HIV-2 virions into which viral Vpx is artificially or naturally packaged, respectively, or by addition of exogenous deoxynucleosides. Vpx-mediated proteasomal degradation of SAMHD1 and elevation of intracellular deoxynucleotide pools precede successful infection by Vpx-carrying HIV. Resting CD4(+) T cells from healthy donors following SAMHD1 silencing or from a patient with Aicardi-Goutieres syndrome homozygous for a nonsense mutation in SAMHD1 were permissive for HIV-1 infection. Thus, SAMHD1 imposes an effective restriction to HIV-1 infection in the large pool of noncycling CD4(+) T cells in vivo. Bypassing SAMHD1 was insufficient for the release of viral progeny, implicating other barriers at later stages of HIV replication. Together, these findings may unveil new ways to interfere with the immune evasion and T cell immunopathology of pandemic HIV-1.	[Baldauf, Hanna-Mari; Pan, Xiaoyu; Erikson, Elina; Schmidt, Sarah; Schenkova, Kristina; Ambiel, Ina; Fackler, Oliver T.; Keppler, Oliver T.] Heidelberg Univ, Dept Infect Dis Virol, Heidelberg, Germany; [Baldauf, Hanna-Mari; Erikson, Elina; Ambiel, Ina; Keppler, Oliver T.] Goethe Univ Frankfurt, Inst Med Virol, Frankfurt, Germany; [Daddacha, Waaqo; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Burggraf, Manja; Koenig, Renate] Paul Ehrlich Inst, Res Grp Host Pathogen Interact, D-6070 Langen, Germany; [Wabnitz, Guido] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany; [Gramberg, Thomas] Univ Erlangen Nurnberg, Inst Virol, D-91054 Erlangen, Germany; [Panitz, Sylvia; Flory, Egbert] Paul Ehrlich Inst, Div Med Biotechnol, D-6070 Langen, Germany; [Landau, Nathaniel R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Sertel, Serkan] Heidelberg Univ, Dept Otorhinolaryngol Head & Neck Surg, Heidelberg, Germany; [Rutsch, Frank] Univ Munster, Childrens Hosp, Dept Gen Pediat, Munster, Germany; [Lasitschka, Felix] Heidelberg Univ, Inst Pathol, D-6900 Heidelberg, Germany; [Kim, Baek] Kyung Hee Univ, Dept Pharm, Coll Pharm, Seoul, South Korea; [Koenig, Renate] Sanford Burnham Med Res Inst, Infectious & Inflammatory Dis Ctr, La Jolla, CA USA	Ruprecht Karls University Heidelberg; Goethe University Frankfurt; University of Rochester; Paul Ehrlich Institute; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Paul Ehrlich Institute; New York University; Ruprecht Karls University Heidelberg; University of Munster; Ruprecht Karls University Heidelberg; Kyung Hee University; Sanford Burnham Prebys Medical Discovery Institute	Fackler, OT (corresponding author), Heidelberg Univ, Dept Infect Dis Virol, Heidelberg, Germany.	oliver.fackler@med.uni-heidelberg.de; oliver.keppler@kgu.de	König, Renate/AAB-8918-2019; Gramberg, Thomas/AAW-8706-2020	König, Renate/0000-0003-4882-9179; Wabnitz, Guido/0000-0001-5101-9885; Fackler, Oliver Till/0000-0003-2982-4209	Deutsche Forschungsgemeinschaft [KE742/4-1]; SFB [938/Z2]; US National Institutes of Health [GM1041981, AI049781, F31 GM095190]; Medical Faculty of the University of Heidelberg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R56AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM095190, R01GM104198] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SFB(Austrian Science Fund (FWF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Faculty of the University of Heidelberg; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Emerman (Fred Hutchinson Cancer Research Center, Seattle, USA; for pROD9, pROD9-Delta Env-GFP, pROD9-Delta Env-delVpx-GFP), M. Fujita (Research Institute for Drug Discovery, Kumamoto University, Japan; for pEF-FVpxHIV-2<INF>GH1</INF>), H.-G. Krausslich (Department of Infectious Diseases, Virology, University of Heidelberg, Germany; for AMD3100), B. Muller (Department of Infectious Diseases, Virology, University of Heidelberg, Germany; for pDisplay GFP and sheep anti-HIV-1 p24 antibody) and J. Munch (Institute of Molecular Virology, University Hospital Ulm, Germany; for HIV-1 GFP) for reagents. We thank T. Adam, A. Imle, P. Klein, S. Kutscheidt, A. Ruggieri and the Nikon Imaging Center at University of Heidelberg for technical assistance, and G. Howard for editorial assistance. This work was in part funded by the Deutsche Forschungsgemeinschaft (O.T.K., grant KE742/4-1), SFB 938/Z2 (F. L.) and the US National Institutes of Health (GM1041981 and AI049781 to B. K.; and F31 GM095190 to W. D.). O.T.F. and O.T.K. are members of the CellNetworks Cluster of Excellence EXC81 and the German Centre for Infection Research, University of Heidelberg. H.-M. B. is recipient of a fellowship of the Medical Faculty of the University of Heidelberg.	Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berger A, 2010, J BIOL CHEM, V285, P12248, DOI 10.1074/jbc.M109.090977; Berger G, 2009, GENE THER, V16, P159, DOI 10.1038/gt.2008.128; Dai JH, 2009, J VIROL, V83, P4528, DOI 10.1128/JVI.01910-08; de Sio FRS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006571; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Geuenich S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-27; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; Goffinet C, 2010, J VIROL, V84, P11374, DOI 10.1128/JVI.01067-10; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2008, J VIROL, V82, P12335, DOI 10.1128/JVI.01181-08; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Keppler OT, 2006, J LEUKOCYTE BIOL, V79, P616, DOI 10.1189/jlb.0805461; Keppler OT, 2005, J VIROL, V79, P1655, DOI 10.1128/JVI.79.3.1655-1665.2005; Keppler OT, 2001, J VIROL, V75, P8063, DOI 10.1128/JVI.75.17.8063-8073.2001; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Plesa G, 2007, J VIROL, V81, P13938, DOI 10.1128/JVI.01745-07; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ruggieri A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-17; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tervo HM, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-58; Thiele H, 2010, HUM MUTAT, V31, pE1836, DOI 10.1002/humu.21357; Verhoeyen E, 2003, BLOOD, V101, P2167, DOI 10.1182/blood-2002-07-2224; Wabnitz GH, 2010, EUR J IMMUNOL, V40, P2437, DOI 10.1002/eji.201040345; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	47	432	446	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1682	+		10.1038/nm.2964	http://dx.doi.org/10.1038/nm.2964			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	22972397	Green Accepted			2022-12-27	WOS:000310837000029
J	Karsten, CM; Pandey, MK; Figge, J; Kilchenstein, R; Taylor, PR; Rosas, M; McDonald, JU; Orr, SJ; Berger, M; Petzold, D; Blanchard, V; Winkler, A; Hess, C; Reid, DM; Majoul, IV; Strait, RT; Harris, NL; Kohl, G; Wex, E; Ludwig, R; Zillikens, D; Nimmerjahn, F; Finkelman, FD; Brown, GD; Ehlers, M; Kohl, J				Karsten, Christian M.; Pandey, Manoj K.; Figge, Julia; Kilchenstein, Regina; Taylor, Philip R.; Rosas, Marcela; McDonald, Jacqueline U.; Orr, Selinda J.; Berger, Markus; Petzold, Dominique; Blanchard, Veronique; Winkler, Andre; Hess, Constanze; Reid, Delyth M.; Majoul, Irina V.; Strait, Richard T.; Harris, Nathaniel L.; Koehl, Gabriele; Wex, Eva; Ludwig, Ralf; Zillikens, Detlef; Nimmerjahn, Falk; Finkelman, Fred D.; Brown, Gordon D.; Ehlers, Marc; Koehl, Joerg			Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fc gamma RIIB and dectin-1	NATURE MEDICINE			English	Article							IN-VIVO; AUTOIMMUNE ARTHRITIS; RECEPTOR DECTIN-1; C5A ANAPHYLATOXIN; IMMUNE-RESPONSES; COMPLEMENT; INDUCTION; MICE; NEUTROPHILS; DISEASE	Complement is an ancient danger-sensing system that contributes to host defense, immune surveillance and homeostasis(1). C5a and its G protein-coupled receptor mediate many of the proinflammatory properties of complement(2). Despite the key role of C5a in allergic asthma(3), autoimmune arthritis(4), sepsis(5) and cancer(6), knowledge about its regulation is limited. Here we demonstrate that IgG1 immune complexes (ICs), the inhibitory IgG receptor Fc gamma RIIB and the C-type lectin-like receptor dectin-1 suppress C5a receptor (C5aR) functions. IgG1 ICs promote the association of Fc gamma RIIB with dectin-1, resulting in phosphorylation of Src homology 2 domain-containing inositol phosphatase (SHIP) downstream of Fc gamma RIIB and spleen tyrosine kinase downstream of dectin-1. This pathway blocks C5aR-mediated ERK1/2 phosphorylation, C5a effector functions in vitro and C5a-dependent inflammatory responses in vivo, including peritonitis and skin blisters in experimental epidermolysis bullosa acquisita. Notably, high galactosylation of IgG N-glycans is crucial for this inhibitory property of IgG1 ICs, as it promotes the association between Fc gamma RIIB and dectin-1. Thus, galactosylated IgG1 and Fc gamma RIIB exert anti-inflammatory properties beyond their impact on activating Fc gamma Rs.	[Karsten, Christian M.; Figge, Julia; Kilchenstein, Regina; Koehl, Gabriele; Ehlers, Marc; Koehl, Joerg] Med Univ Lubeck, Inst System Inflammat Res, D-23538 Lubeck, Germany; [Pandey, Manoj K.; Harris, Nathaniel L.; Finkelman, Fred D.; Koehl, Joerg] Univ Cincinnati, Coll Med, Div Cellular & Mol Immunol, Cincinnati, OH USA; [Taylor, Philip R.; Rosas, Marcela; McDonald, Jacqueline U.; Orr, Selinda J.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, S Glam, Wales; [Berger, Markus; Petzold, Dominique; Blanchard, Veronique] Charite, Cent Inst Lab Med & Pathobiochem, D-13353 Berlin, Germany; [Winkler, Andre; Hess, Constanze; Ehlers, Marc] German Rheumatism Res Ctr, Lab Tolerance & Autoimmun, Berlin, Germany; [Reid, Delyth M.; Brown, Gordon D.] Univ Aberdeen, Sect Infect & Immun, Aberdeen, Scotland; [Majoul, Irina V.] Med Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biol, D-23538 Lubeck, Germany; [Strait, Richard T.] Univ Cincinnati, Coll Med, Div Emergency Med, Cincinnati, OH USA; [Wex, Eva] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Resp Dis Res, Biberach, Germany; [Ludwig, Ralf; Zillikens, Detlef] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Nimmerjahn, Falk] Univ Erlangen Nurnberg, Dept Biol, Chair Genet, D-91054 Erlangen, Germany; [Finkelman, Fred D.] Univ Cincinnati, Coll Med, Div Immunol, Cincinnati, OH USA; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr Cincinnati, Dept Med, Cincinnati, OH USA	University of Lubeck; University System of Ohio; University of Cincinnati; Cardiff University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); University of Aberdeen; University of Lubeck; University System of Ohio; University of Cincinnati; Boehringer Ingelheim; University of Lubeck; University of Erlangen Nuremberg; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Kohl, J (corresponding author), Med Univ Lubeck, Inst System Inflammat Res, D-23538 Lubeck, Germany.	joerg.koehl@uksh.de	Rosas Nexticapa, Marcela/HGU-1088-2022; Majoul, Irina V/K-5339-2013; Ludwig, Ralf/F-3996-2018; Nimmerjahn, Falk/J-4986-2013; Koehl, Joerg/C-8531-2011; Karsten, Christian/J-4372-2013; Zillikens, Detlef/C-8572-2011; Ludwig, Ralf J/A-2629-2008; Pandey, Manoj Kumar/V-4557-2019; Ehlers, Marc/C-9441-2011	Ludwig, Ralf/0000-0002-1394-1737; Koehl, Joerg/0000-0003-1121-3178; Ludwig, Ralf J/0000-0002-1394-1737; Pandey, Manoj Kumar/0000-0002-0495-830X; Ehlers, Marc/0000-0002-5383-8603; Taylor, Philip/0000-0003-0163-1421; Braumann, Dominique/0000-0001-9987-0257; Wex, Eva/0000-0002-4643-1899; Orr, Selinda/0000-0001-8539-7825; brown, gordon/0000-0002-0287-5383; Blanchard, Veronique/0000-0002-5980-6450; Nimmerjahn, Falk/0000-0002-5418-316X	German Research Foundation (Deutsche Forschungsgemeinschaft) [GRK1727, SFB/TR22, A21, EXC306/1, EH221-5]; Wellcome Trust; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, GRK1727; project 8 and SFB/TR22; project A21) to J.K., EXC306/1 to D.Z., R.L. and J.K., and by Deutsche Forschungsgemeinschaft EH221-5 to M.E. P.R.T. is a Medical Research Council (UK) Senior Fellow (G0601617). G.D.B. was supported by the Wellcome Trust. We thank T. Kohli for technical assistance with the surface plasmon resonance analysis, T. Gutsmann for help with the fluorescence spectroscopy measurements, T. Peters and L. Wollin for helpful discussions and B. Heyman (Uppsala University, Sweden) for providing the H5 and the 7B4 hybridoma clones.	Agarwal S, 2009, CURR ALLERGY ASTHM R, V9, P347, DOI 10.1007/s11882-009-0051-0; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Barb AW, 2011, NAT CHEM BIOL, V7, P147, DOI 10.1038/NCHEMBIO.511; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Dennehy KM, 2011, J IMMUNOL, V186, P657, DOI 10.4049/jimmunol.0904117; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Godau J, 2004, J IMMUNOL, V173, P3437, DOI 10.4049/jimmunol.173.5.3437; Goodridge HS, 2011, NATURE, V472, P471, DOI 10.1038/nature10071; GRAHAM IL, 1994, J CELL BIOL, V127, P1139, DOI 10.1083/jcb.127.4.1139; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Jones SL, 1998, J BIOL CHEM, V273, P10556, DOI 10.1074/jbc.273.17.10556; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn Falk, 2008, V415, P151, DOI 10.1007/978-1-59745-570-1_9; Otto M, 2004, J BIOL CHEM, V279, P142, DOI 10.1074/jbc.M310078200; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wedepohl S, 2010, J PROTEOME RES, V9, P3403, DOI 10.1021/pr100170c; Wenderfer SE, 2005, J AM SOC NEPHROL, V16, P3572, DOI 10.1681/ASN.2005040373; Wernersson S, 1999, J IMMUNOL, V163, P618; Wex E, 2011, EUR J IMMUNOL, V41, P3208, DOI 10.1002/eji.201141502; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758	39	304	309	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1401	+		10.1038/nm.2862	http://dx.doi.org/10.1038/nm.2862			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22922409	Green Accepted			2022-12-27	WOS:000308472300036
J	Lee, VMY; Citron, M; Kosik, KS				Lee, Virginia M-Y; Citron, Martin; Kosik, Kenneth S.			Tracking the insidious course of Alzheimer's disease	NATURE MEDICINE			English	Editorial Material							THERAPEUTICS	Determining the sequence of events that occurs in Alzheimer's disease and the extent of the pathological changes involved will be essential for devising appropriate therapeutic strategies for this disease, but these parameters are not well defined. In a recent prospective, longitudinal study to compare individuals who were either carriers or noncarriers of dominantly inherited Alzheimer's disease, Bateman et al.(1) analyzed a number of clinical, cognitive and biological biomarkers allowing them to trace the series of pathological changes that occur over time in Alzheimer's disease. Notably, the authors found that some changes could be observed 25 years before the expected onset of symptoms. These findings may have important implications for the design of clinical trials to test Alzheimer's disease therapies. We asked three experts to comment on the results of this study.										Acosta-Baena N, 2011, LANCET NEUROL, V10, P213, DOI 10.1016/S1474-4422(10)70323-9; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Lopera F, 1997, JAMA-J AM MED ASSOC, V277, P793, DOI 10.1001/jama.277.10.793; US Food and Drug Administration (FDA), 2007, GUID IND CLIN TRIAL	7	1	1	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1342	1343		10.1038/nm.2922	http://dx.doi.org/10.1038/nm.2922			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22961163				2022-12-27	WOS:000308472300026
J	Wu, W; Allen, RA; Wang, YD				Wu, Wei; Allen, Robert A.; Wang, Yadong			Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery	NATURE MEDICINE			English	Article							SMALL-INTESTINAL SUBMUCOSA; ENGINEERED BLOOD-VESSELS; SMALL-DIAMETER; VASCULAR GRAFTS; SAPHENOUS-VEIN; CAROTID-ARTERY; SURFACE; REGENERATION; COLLAGEN; INJURY	Host remodeling is important for the success of medical implants, including vascular substitutes. Synthetic and tissue-engineered grafts have yet to show clinical effectiveness in arteries smaller than 5 mm in diameter. We designed cell-free biodegradable elastomeric grafts that degrade rapidly to yield neoarteries nearly free of foreign materials 3 months after interposition grafting in rat abdominal aorta. This design focuses on enabling rapid host remodeling. Three months after implantation, the neoarteries resembled native arteries in the following aspects: regular, strong and synchronous pulsation; a confluent endothelium and contractile smooth muscle layers; expression of elastin, collagen and glycosaminoglycan; and tough and compliant mechanical properties. Therefore, future studies employing large animal models more representative of human vascular regeneration are warranted before clinical translation. This cell-free approach represents a philosophical shift from the prevailing focus on cells in vascular tissue engineering and may have an impact on regenerative medicine in general.	[Wu, Wei; Allen, Robert A.; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Wu, Wei] Fourth Mil Med Univ, Qindu Hosp, Dept Maxillofacial Surg, Xian 710032, Peoples R China; [Wang, Yadong] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Wang, Yadong] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Air Force Military Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, YD (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	yaw20@pitt.edu	Wang, Yadong/AAC-3381-2020	Wang, Yadong/0000-0003-2067-382X; Allen, Robert/0000-0003-2885-1758	US National Institutes of Health (NIH) grant [HL089658]; American Heart Association award [0730031N]; US NIH training grant [2T32HL076124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124, R01HL089658] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association award(American Heart Association); US NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported by US National Institutes of Health (NIH) grant HL089658, American Heart Association award 0730031N and US NIH training grant 2T32HL076124. We thank S. Shroff for insightful discussions on mechanical testing of arteries, W. Wagner for access to the laser Doppler ultrasound and K. Kim for assistance with ultrasound imaging. We greatly appreciate R. Wagner and D. Rossi for performing angiography, M. Witt for DNA quantification, and D. Stolz, M. Sun and D. Clay for performing transmission electron microscopy.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bezuidenhout D, 2010, J BIOMATER APPL, V24, P401, DOI 10.1177/0885328208097565; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010; Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426; DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Hashi CK, 2010, ARTERIOSCL THROM VAS, V30, P1621, DOI 10.1161/ATVBAHA.110.208348; He W, 2010, BIOMATERIALS, V31, P8235, DOI 10.1016/j.biomaterials.2010.07.034; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; L'Heureux N, 2007, NEW ENGL J MED, V357, P1451, DOI 10.1056/NEJMc071536; Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lee KW, 2011, P NATL ACAD SCI USA, V108, P2705, DOI 10.1073/pnas.1017834108; Li L, 2008, KIDNEY INT, V74, P1247, DOI 10.1038/ki.2008.318; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Neff LP, 2011, J VASC SURG, V53, P426, DOI 10.1016/j.jvs.2010.07.054; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Pavcnik D, 2009, CARDIOVASC INTER RAD, V32, P106, DOI 10.1007/s00270-008-9449-7; PREVEL CD, 1994, MICROSURG, V15, P586, DOI 10.1002/micr.1920150812; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064; SANDUSKY GE, 1992, AM J PATHOL, V140, P317; Soletti L, 2011, J BIOMED MATER RES A, V96A, P436, DOI 10.1002/jbm.a.32997; Torikai K, 2008, J THORAC CARDIOV SUR, V136, P37, DOI 10.1016/j.jtcvs.2007.06.039; Turner NA, 2007, ATHEROSCLEROSIS, V193, P36, DOI 10.1016/j.atherosclerosis.2006.08.017; VEITH FJ, 1986, J VASC SURG, V3, P104; Verrier ED, 1996, ANN THORAC SURG, V62, P915; Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534; WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816; Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058; Zhu CH, 2008, BIOMATERIALS, V29, P2628, DOI 10.1016/j.biomaterials.2008.03.005; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	40	298	307	4	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1148	+		10.1038/nm.2821	http://dx.doi.org/10.1038/nm.2821			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22729285	Green Accepted			2022-12-27	WOS:000306121600047
J	Taur, Y; Pamer, EG				Taur, Ying; Pamer, Eric G.			Fixing the microbiota to treat Clostridium difficile infections	NATURE MEDICINE			English	Editorial Material							SPORE GERMINATION; BILE-SALTS; EPIDEMIOLOGY		[Taur, Ying; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Taur, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA.	taury@mskcc.org		Taur, Ying/0000-0002-6601-8284	NIAID NIH HHS [R01 AI095706, K23 AI095398] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095398, R01AI095706] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Emanuelsson F, 2014, SCAND J INFECT DIS, V46, P89, DOI 10.3109/00365548.2013.858181; Fimlaid KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003660; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Giel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008740; Kassam Z, 2013, AM J GASTROENTEROL, V108, P1538, DOI 10.1038/ajg.2013.214; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; TVEDE M, 1989, LANCET, V1, P1156; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	18	34	63	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					246	247		10.1038/nm.3492	http://dx.doi.org/10.1038/nm.3492			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24603796	Green Accepted			2022-12-27	WOS:000332595600017
J	Haris, M; Singh, A; Cai, KJ; Kogan, F; McGarvey, J; DeBrosse, C; Zsido, GA; Witschey, WRT; Koomalsingh, K; Pilla, JJ; Chirinos, JA; Ferrari, VA; Gorman, JH; Hariharan, H; Gorman, RC; Reddy, R				Haris, Mohammad; Singh, Anup; Cai, Kejia; Kogan, Feliks; McGarvey, Jeremy; DeBrosse, Catherine; Zsido, Gerald A.; Witschey, Walter R. T.; Koomalsingh, Kevin; Pilla, James J.; Chirinos, Julio A.; Ferrari, Victor A.; Gorman, Joseph H.; Hariharan, Hari; Gorman, Robert C.; Reddy, Ravinder			A technique for in vivo mapping of myocardial creatine kinase metabolism	NATURE MEDICINE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; ENERGY PHOSPHATE METABOLITES; FAILING HUMAN MYOCARDIUM; CONTRAST; VIABILITY; EXCHANGE; MRI; SPECTROSCOPY; INFARCTION; QUANTIFICATION	ATP derived from the conversion of phosphocreatine to creatine by creatine kinase provides an essential chemical energy source that governs myocardial contraction. Here, we demonstrate that the exchange of amine protons from creatine with protons in bulk water can be exploited to image creatine through chemical exchange saturation transfer (CrEST) in myocardial tissue. We show that CrEST provides about two orders of magnitude higher sensitivity compared to H-1 magnetic resonance spectroscopy. Results of CrEST studies from ex vivo myocardial tissue strongly correlate with results from 1H and P-31 magnetic resonance spectroscopy and biochemical analysis. We demonstrate the feasibility of CrEST measurement in healthy and infarcted myocardium in animal models in vivo on a 3-T clinical scanner. As proof of principle, we show the conversion of phosphocreatine to creatine by spatiotemporal mapping of creatine changes in the exercised human calf muscle. We also discuss the potential utility of CrEST in studying myocardial disorders.	[Haris, Mohammad; Singh, Anup; Cai, Kejia; Kogan, Feliks; DeBrosse, Catherine; Witschey, Walter R. T.; Hariharan, Hari; Reddy, Ravinder] Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA; [McGarvey, Jeremy; Zsido, Gerald A.; Witschey, Walter R. T.; Koomalsingh, Kevin; Pilla, James J.; Gorman, Joseph H.; Gorman, Robert C.] Univ Penn, Dept Surg, Gorman Cardiovasc Res Grp, Philadelphia, PA 19104 USA; [Chirinos, Julio A.] Philadelphia Vet Affairs Med Ctr, Dept Med, Philadelphia, PA USA; [Chirinos, Julio A.; Ferrari, Victor A.] Univ Penn, Dept Med, Div Cardiovasc, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Reddy, R (corresponding author), Univ Penn, Dept Radiol, Ctr Magnet Resonance & Opt Imaging, Philadelphia, PA 19104 USA.	krr@mail.med.upenn.edu	Kogan, Feliks/AAH-5814-2019	Haris, Mohammad/0000-0002-4945-2935; Reddy, Ravinder/0000-0003-4580-2392; Hariharan, Hari/0000-0002-7032-6968; Kogan, Feliks/0000-0003-0580-7308; Singh, Anup/0000-0001-6744-8326; Ferrari, Victor/0000-0001-8696-3243	National Institutes of Health [P41 EB015893, P41 E5015893S1, R21DA032256-01]; Translational Biomedical Imaging Center of the Institute for Translational Medicine and Therapeutics of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL108157, R00HL108157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA032256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Translational Biomedical Imaging Center of the Institute for Translational Medicine and Therapeutics of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants P41 EB015893, P41 E5015893S1 and R21DA032256-01 and a pilot grant from the Translational Biomedical Imaging Center of the Institute for Translational Medicine and Therapeutics of the University of Pennsylvania. The authors acknowledge W Liu and S. Pickup for technical assistance in using the 9.4-T NMR spectrometer, K. Nath for assistance with biochemical analysis and D. Reddy for help with regulatory protocol.	ARUS C, 1984, FEBS LETT, V165, P231, DOI 10.1016/0014-5793(84)80175-1; BALABAN RS, 1991, RADIOLOGY, V180, P671, DOI 10.1148/radiology.180.3.1871277; Bax J.J, 1997, INT J CARD IMAGING, V13, P157; Bax JJ, 1997, INT J CARDIAC IMAG, V13, P145, DOI 10.1023/A:1005744810876; Bax JJ, 2000, EUR HEART J, V21, P961, DOI 10.1053/euhj.2000.2110; Bax JJ, 1999, JMRI-J MAGN RESON IM, V10, P418; Beek AM, 2003, J AM COLL CARDIOL, V42, P895, DOI 10.1016/S0735-1097(03)00835-0; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; BONOW RO, 1991, SEMIN NUCL MED, V21, P230, DOI 10.1016/S0001-2998(05)80043-1; Bottomley PA, 1998, LANCET, V351, P714, DOI 10.1016/S0140-6736(97)06402-7; Bottomley PA, 1997, RADIOLOGY, V204, P403, DOI 10.1148/radiology.204.2.9240527; Bottomley PA, 1996, MAGNET RESON MED, V35, P664, DOI 10.1002/mrm.1910350507; Bottomley PA, 2001, RADIOLOGY, V219, P411, DOI 10.1148/radiology.219.2.r01ma39411; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; CRANE P, 1993, EUR J NUCL MED, V20, P20, DOI 10.1007/BF02261241; Dzeja P P, 2000, Curr Cardiol Rep, V2, P212, DOI 10.1007/s11886-000-0071-9; Francescato MP, 2008, J APPL PHYSIOL, V105, P158, DOI 10.1152/japplphysiol.00007.2008; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Hans M., 2011, NEUROIMAGE, V54, P2079; Haris M, 2012, NMR BIOMED, V25, P1305, DOI 10.1002/nbm.2792; Hu QS, 2006, AM J PHYSIOL-HEART C, V291, pH648, DOI 10.1152/ajpheart.01387.2005; Kim HW, 2009, J AM COLL CARDIOL, V55, P1, DOI 10.1016/j.jacc.2009.06.059; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kitagawa K, 2003, RADIOLOGY, V226, P138, DOI 10.1148/radiol.2261012108; Lamb HJ, 1997, CIRCULATION, V96, P2969, DOI 10.1161/01.CIR.96.9.2969; Laser A, 1996, J MOL CELL CARDIOL, V28, P1531, DOI 10.1006/jmcc.1996.0143; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; Liu GS, 2010, CONTRAST MEDIA MOL I, V5, P162, DOI 10.1002/cmmi.383; Metzler B, 2002, J CARDIOVASC MAGN R, V4, P493, DOI 10.1081/JCMR-120016387; Nakae I, 2003, J AM COLL CARDIOL, V42, P1587, DOI 10.1016/j.jacc.2003.05.005; Neubauer S, 2000, MAGN RESON MATER PHY, V11, P73; REIJENGA JC, 1986, J CHROMATOGR, V374, P162, DOI 10.1016/S0378-4347(00)83266-1; REIMER KA, 1983, AM J CARDIOL, V52, pA72; Schroeder MA, 2011, CIRCULATION, V124, P1580, DOI 10.1161/CIRCULATIONAHA.111.024919; Schwitter J, 2011, EUR HEART J, V32, P799, DOI 10.1093/eurheartj/ehq481; Song HK, 2000, MAGNET RESON MED, V44, P825, DOI 10.1002/1522-2594(200012)44:6<825::AID-MRM2>3.0.CO;2-D; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; VANVAALS JJ, 1993, JMRI-J MAGN RESON IM, V3, P671, DOI 10.1002/jmri.1880030419; Woo DC, 2010, APPL MAGN RESON, V38, P65, DOI 10.1007/s00723-009-0055-x; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	40	130	133	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					209	214		10.1038/nm.3436	http://dx.doi.org/10.1038/nm.3436			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412924	Green Accepted			2022-12-27	WOS:000330915000023
J	Lee, RE; Hurdle, JG; Liu, JY; Bruhn, DF; Matt, T; Scherman, MS; Vaddady, PK; Zheng, Z; Qi, JJ; Akbergenov, R; Das, S; Madhura, DB; Rathit, C; Trivedi, A; Villellas, C; Lee, RB; Rakesh; Waidyarachchi, SL; Sun, DQ; McNeil, MR; Ainsa, JA; Boshoff, HI; Gonzalez-Juarrero, M; Meibohm, B; Bottger, EC; Lenaerts, AJ				Lee, Richard E.; Hurdle, Julian G.; Liu, Jiuyu; Bruhn, David F.; Matt, Tanja; Scherman, Michael S.; Vaddady, Pavan K.; Zheng, Zhong; Qi, Jianjun; Akbergenov, Rashid; Das, Sourav; Madhura, Dora B.; Rathit, Chetan; Trivedi, Ashit; Villellas, Cristina; Lee, Robin B.; Rakesh; Waidyarachchi, Samanthi L.; Sun, Dianqing; McNeil, Michael R.; Ainsa, Jose A.; Boshoff, Helena I.; Gonzalez-Juarrero, Mercedes; Meibohm, Bernd; Boettger, Erik C.; Lenaerts, Anne J.			Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux	NATURE MEDICINE			English	Article							MEDICINAL CHEMISTS GUIDE; 16S RIBOSOMAL-RNA; MYCOBACTERIUM-TUBERCULOSIS; SPECTINOMYCIN MODIFICATION; RESISTANCE; GLYCYLCYCLINE; ANTIBIOTICS; SELECTIVITY; INHIBITION; PUMP	Although the classical antibiotic spectinomycin is a potent bacterial protein synthesis inhibitor, poor antimycobacterial activity limits its clinical application for treating tuberculosis. Using structure-based design, we generated a new semisynthetic series of spectinomycin analogs with selective ribosomal inhibition and excellent narrow-spectrum antitubercular activity. In multiple murine infection models, these spectinamides were well tolerated, significantly reduced lung mycobacterial burden and increased survival. In vitro studies demonstrated a lack of cross resistance with existing tuberculosis therapeutics, activity against multidrug-resistant (MDR) and extensively drug-resistant tuberculosis and an excellent pharmacological profile. Key to their potent antitubercular properties was their structural modification to evade the Rv1258c efflux pump, which is upregulated in MDR strains and is implicated in macrophage-induced drug tolerance. The antitubercular efficacy of spectinamides demonstrates that synthetic modifications to classical antibiotics can overcome the challenge of intrinsic efflux pump-mediated resistance and expands opportunities for target-based tuberculosis drug discovery.	[Lee, Richard E.; Hurdle, Julian G.; Liu, Jiuyu; Bruhn, David F.; Zheng, Zhong; Qi, Jianjun; Das, Sourav; Lee, Robin B.; Rakesh; Waidyarachchi, Samanthi L.; Sun, Dianqing] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Matt, Tanja; Akbergenov, Rashid; Boettger, Erik C.] Univ Zurich, Inst Med Mikrobiol, Natl Zentrum Mykobakterien, Zurich, Switzerland; [Scherman, Michael S.; McNeil, Michael R.; Gonzalez-Juarrero, Mercedes] Colorado State Univ, Dept Microbiol, Mycobacterial Res Labs, Ft Collins, CO 80523 USA; [Vaddady, Pavan K.; Madhura, Dora B.; Rathit, Chetan; Trivedi, Ashit; Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Villellas, Cristina; Ainsa, Jose A.] Univ Zaragoza, Dept Microbiol Med Prevent & Salud Publ, Zaragoza, Spain; [Ainsa, Jose A.] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Boshoff, Helena I.] NIAID, TB Res Stn, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	St Jude Children's Research Hospital; University of Zurich; Colorado State University; University of Tennessee System; University of Tennessee Health Science Center; University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lee, RE (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.lee@stjude.org	Lee, Richard/J-4997-2013; Lenaerts, Anne/F-1353-2017; Ainsa, Jose A/G-5635-2010; McNeil, Michael/G-3325-2019; Lee, Richard/AAX-3996-2021; Böttger, Erik C./F-6175-2011	Lee, Richard/0000-0002-2397-0443; Ainsa, Jose A/0000-0003-2076-844X; Lee, Richard/0000-0002-2397-0443; Meibohm, Bernd/0000-0003-3923-3648; Vaddady, Pavan/0000-0002-7369-6649; Das, Sourav/0000-0003-1759-0345; Trivedi, Ashit/0000-0002-5040-5722; hurdle, julian/0000-0003-2214-8105; gonzalez-juarrero, mercedes/0000-0002-4045-2365	US National Institutes of Health (NIH) [AI090810]; National Institute of Allergy and Infectious Diseases (NIAID) Indefinite Delivery Indefinite Quantity (IDIQ); Contract Task Order [HHSN272201000009I/01]; American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital (SJCRH); Intramural Research Program of the NIAID, NIH; Spanish Government [BIO-2009-09405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000693, ZIAAI000734, R01AI090810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103466] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID) Indefinite Delivery Indefinite Quantity (IDIQ); Contract Task Order; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital (SJCRH); Intramural Research Program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Spanish Government(Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US National Institutes of Health (NIH) grant AI090810 (R.E.L., E.C.B., A.J.L. and B.M.), the National Institute of Allergy and Infectious Diseases (NIAID) Indefinite Delivery Indefinite Quantity (IDIQ) (R.E.L. and M.G.) Contract Task Order HHSN272201000009I/01, the American Lebanese Syrian Associated Charities (ALSAC) and St. Jude Children's Research Hospital (SJCRH) (R.E.L.) and in part by the Intramural Research Program of the NIAID, NIH (H.I.B.) and the Spanish Government (grant BIO-2009-09405) (J.A.A.). We thank L. Yang and J. Scarborough from SJCRH for their help with analysis of the final compounds, M. Maddox from SJCRH for technical assistance in determining MIC values, J. Ryman from the University of Tennessee Health Science Center for technical assistance in the performance of pharmacokinetic studies in mice, M. Butler from Microbiotix for coordination of the MDR tuberculosis testing and E. Tuomanen from SJCRH for critical evaluation of this manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Akbergenov R, 2011, ANTIMICROB AGENTS CH, V55, P4712, DOI 10.1128/AAC.00628-11; Akiyoshi M, 1976, Jpn J Antibiot, V29, P771; Balganesh M, 2012, ANTIMICROB AGENTS CH, V56, P2643, DOI 10.1128/AAC.06003-11; Barnhill AE, 2012, ANTIMICROB AGENTS CH, V56, P4046, DOI 10.1128/AAC.00678-12; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Dartois V, 2013, BIOORG MED CHEM LETT, V23, P4741, DOI 10.1016/j.bmcl.2013.07.006; Drusano GL, 2004, NAT REV MICROBIOL, V2, P289, DOI 10.1038/nrmicro862; FOLEY L, 1979, J ANTIBIOT, V32, P418, DOI 10.7164/antibiotics.32.418; FOLEY L, 1978, J ANTIBIOT, V31, P979, DOI 10.7164/antibiotics.31.979; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Galimand M, 2000, ANTIMICROB AGENTS CH, V44, P1365, DOI 10.1128/AAC.44.5.1365-1366.2000; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; Hobbie SN, 2007, NUCLEIC ACIDS RES, V35, P6086, DOI 10.1093/nar/gkm658; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Kuhn B, 2010, J MED CHEM, V53, P2601, DOI 10.1021/jm100087s; Lee RE, 1996, CURR TOP MICROBIOL, V215, P1; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJM, 2003, ANTIMICROB AGENTS CH, V47, P783, DOI 10.1128/AAC.47.2.783-785.2003; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Madhura DB, 2013, PHARMAZIE, V68, P675, DOI 10.1691/ph.2013.3501; MAIER R, 1981, J ANTIBIOT, V34, P16, DOI 10.7164/antibiotics.34.16; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Noskin GA, 2005, CLIN INFECT DIS, V41, pS303, DOI 10.1086/431672; NOVAK E, 1974, J CLIN PHARMACOL, V14, P442, DOI 10.1002/j.1552-4604.1974.tb02326.x; Projan SJ, 2000, PHARMACOTHERAPY, V20, p219S, DOI 10.1592/phco.20.14.219S.35046; Ramon-Garcia S, 2012, ANTIMICROB AGENTS CH, V56, P2074, DOI 10.1128/AAC.05946-11; ROSENBROOK W, 1975, J ANTIBIOT, V28, P953, DOI 10.7164/antibiotics.28.953; Shcherbakov D, 2010, MOL MICROBIOL, V77, P830, DOI 10.1111/j.1365-2958.2010.07218.x; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; THOMAS RC, 1985, J ANTIBIOT, V38, P208, DOI 10.7164/antibiotics.38.208; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; WILEY PF, 1963, J AM CHEM SOC, V85, P2652, DOI 10.1021/ja00900a028; WOITUN E, 1981, J ANTIBIOT, V34, P22, DOI 10.7164/antibiotics.34.22; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894; ZURENKO GE, 1988, ANTIMICROB AGENTS CH, V32, P216, DOI 10.1128/AAC.32.2.216	44	125	127	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					152	158		10.1038/nm.3458	http://dx.doi.org/10.1038/nm.3458			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24464186	Green Accepted			2022-12-27	WOS:000330915000016
J	Liehl, P; Zuzarte-Luis, V; Chan, JN; Zillinger, T; Baptista, F; Carapau, D; Konert, M; Hanson, KK; Carret, C; Lassnig, C; Muller, M; Kalinke, U; Saeed, M; Chora, AF; Golenbock, DT; Strobl, B; Prudencio, M; Coelho, LP; Kappe, SH; Superti-Furga, G; Pichlmair, A; Vigario, AM; Rice, CM; Fitzgerald, KA; Barchet, W; Mota, MM				Liehl, Peter; Zuzarte-Luis, Vanessa; Chan, Jennie; Zillinger, Thomas; Baptista, Fernanda; Carapau, Daniel; Konert, Madlen; Hanson, Kirsten K.; Carret, Celine; Lassnig, Caroline; Mueller, Mathias; Kalinke, Ulrich; Saeed, Mohsan; Chora, Angelo Ferreira; Golenbock, Douglas T.; Strobl, Birgit; Prudencio, Miguel; Coelho, Luis P.; Kappe, Stefan H.; Superti-Furga, Giulio; Pichlmair, Andreas; Vigario, Ana M.; Rice, Charles M.; Fitzgerald, Katherine A.; Barchet, Winfried; Mota, Maria M.			Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection	NATURE MEDICINE			English	Article							DOUBLE-STRANDED-RNA; RIG-I; HEPATITIS-C; ADAPTER PROTEIN; RECOGNITION; INTERFERON; MALARIA; BERGHEI; HEPATOCYTES; RECEPTORS	Before they infect red blood cells and cause malaria, Plasmodium parasites undergo an obligate and clinically silent expansion phase in the liver that is supposedly undetected by the host. Here, we demonstrate the engagement of a type I interferon (IFN) response during Plasmodium replication in the liver. We identified Plasmodium RNA as a previously unrecognized pathogen-associated molecular pattern (PAMP) capable of activating a type I IFN response via the cytosolic pattern recognition receptor Mda5. This response, initiated by liver-resident cells through the adaptor molecule for cytosolic RNA sensors, Mavs, and the transcription factors Irf3 and Irf7, is propagated by hepatocytes in an interferon-alpha/beta receptor-dependent manner. This signaling pathway is critical for immune cell-mediated host resistance to liver-stage Plasmodium infection, which we find can be primed with other PAMPs, including hepatitis C virus RNA. Together, our results show that the liver has sensor mechanisms for Plasmodium that mediate a functional antiparasite response driven by type I IFN.	[Liehl, Peter; Zuzarte-Luis, Vanessa; Baptista, Fernanda; Carapau, Daniel; Konert, Madlen; Hanson, Kirsten K.; Carret, Celine; Chora, Angelo Ferreira; Prudencio, Miguel; Coelho, Luis P.; Vigario, Ana M.; Mota, Maria M.] Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal; [Chan, Jennie; Golenbock, Douglas T.; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA USA; [Zillinger, Thomas; Barchet, Winfried] Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Lassnig, Caroline; Mueller, Mathias; Strobl, Birgit] Austria Univ Vet Med Vienna, Inst Anim Breeding & Genet & Biomodels, Vienna, Austria; [Kalinke, Ulrich] Hannover Med Sch, Inst Expt Infect Res, TWINCORE, Ctr Expt & Clin Infect Res, Hannover, Germany; [Kalinke, Ulrich] Helmholtz Ctr Infect Res, Hannover, Germany; [Saeed, Mohsan; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10021 USA; [Kappe, Stefan H.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Superti-Furga, Giulio; Pichlmair, Andreas] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Vigario, Ana M.] Univ Madeira, Unidade Ciencias Med, Ctr Compentencia Ciencias Vida, Funchal, Portugal	Universidade de Lisboa; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Rockefeller University; Center for Infectious Disease Research; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Universidade da Madeira	Mota, MM (corresponding author), Univ Lisbon, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal.	mmota@fm.ul.pt	Mota, Maria/AAF-2048-2019; Carapau, Daniel/J-3966-2012; Superti-Furga, Giulio/F-4755-2015; Prudêncio, Miguel/ABD-9282-2021; Ferreira Chora, Angelo/AAZ-6503-2021; Zuzarte-Luis, Vanessa/M-9105-2013; Fitzgerald, Katherine/ABE-6317-2020; Zillinger, Thomas/AAD-7320-2020; Coelho, Luis Pedro/D-1260-2009; Superti-Furga, Giulio/AAE-5681-2019; Saeed, Mohsan/AAM-8375-2021	Carapau, Daniel/0000-0001-8888-6333; Superti-Furga, Giulio/0000-0002-0570-1768; Prudêncio, Miguel/0000-0003-1746-6029; Ferreira Chora, Angelo/0000-0002-7941-7196; Zuzarte-Luis, Vanessa/0000-0003-0023-5953; Zillinger, Thomas/0000-0002-0866-4835; Coelho, Luis Pedro/0000-0002-9280-7885; Fitzgerald, Kate/0000-0003-3175-609X; Kalinke, Ulrich/0000-0003-0503-9564; Barchet, Winfried/0000-0002-6745-6606; Mota, Maria Manuel/0000-0002-2858-1041; LASSNIG, Caroline/0000-0001-7905-3620; Vigario, Ana Margarida/0000-0001-5679-1196; Hanson, Kirsten/0000-0002-0154-0979; Muller, Mathias/0000-0002-7879-3552; Strobl, Birgit/0000-0001-5716-3212	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PTDC/SAU-GMG/100313/2008, PTDC/SAU-GMG/104392/2008, PTDC/SAU-MIC/113697/2009]; European Research Council [ERC-2012-StG_20111109]; European Community's Seventh Framework Programme [242095]; US National Institutes of Health [AI079293]; Austrian Science Fund [SFB F28]; Deutsche Forschungs Gesellschaft [BA3544/1-1, SFB704]; Starr Foundation; Greenberg Medical Research Institute; Bill & Melinda Gates Foundation [OPP1021571, R10291, M11R11017]; Fondation pour la Recherche Medicale; FCT [SFRH/BPD/41547/2007, SFRH/BPD/64626/2009, SFRH/BPD/40965/2007]; European Molecular Biology Organization [ALTF357-2009]; Digestive System at The Rockefeller University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079293, T32AI095213, R56AI067497] Funding Source: NIH RePORTER	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); European Research Council(European Research Council (ERC)European Commission); European Community's Seventh Framework Programme(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Deutsche Forschungs Gesellschaft(German Research Foundation (DFG)); Starr Foundation; Greenberg Medical Research Institute; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Digestive System at The Rockefeller University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Mavs<SUP>-/-</SUP> mice were from Z.J. Chen (South Western Medical School). Mda5<SUP>-/-</SUP> mice were from M. Colonna (Washington University). Rig-I<SUP>-/-</SUP>, Tlr3<SUP>-/-</SUP>, Tlr4<SUP>-/-</SUP>, Trif<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice were a gift from S. Akira (Osaka University). Trif<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice were used for generating Trif<SUP>-/-</SUP>; Myd88<SUP>-/-</SUP> mice. Irf7<SUP>-/-</SUP> and Irf3<SUP>-/-</SUP> mice were kindly provided by T. Taniguchi (University of Tokyo). We would like to thank A. Parreira for Anopheles stephensi production and infection, M. Rebelo for help with P. falciparum in vitro cultures, J. Ribot for help with chimeric mice and A. Zaidman-Remy for critical reading of the manuscript. We are grateful to M. Seabra (CEDOC, Faculdade de Ciencias Medicas) and A. Holder (UK Medical Research Council National Institute for Medical Research) for providing antisera. This work was supported by Fundacao para a Ciencia e Tecnologia (FCT, Portugal) grants (PTDC/SAU-GMG/100313/2008 to M.M.M., PTDC/SAU-GMG/104392/2008 to C.C. and PTDC/SAU-MIC/113697/2009 to V.Z.-L., and also by the European Research Council grant ERC-2012-StG_20111109 to M.M.M., the European Community's Seventh Framework Programme (FP7/2007-2013) grant agreement 242095 to M.M.M., US National Institutes of Health grant AI079293 to K.A.F. and D.T.G., Austrian Science Fund grant SFB F28 to M.M. and B. S., Deutsche Forschungs Gesellschaft grants BA3544/1-1 and SFB704 (to W.B.), the Starr Foundation, the Greenberg Medical Research Institute and Bill & Melinda Gates Foundation grant OPP1021571 (subcontract R10291, M11R11017, all to C.M.R.). P.L. was supported by Fondation pour la Recherche Medicale and FCT (fellowship SFRH/BPD/41547/2007). V.Z.-L. was supported by European Molecular Biology Organization fellowship ALTF357-2009. D.C. and C.C. were supported by FCT fellowships (SFRH/BPD/64626/2009 and SFRH/BPD/40965/2007, respectively). M.S. was supported in part by a Helmsley Postdoctoral Fellowship for Basic and Translational Research on Disorders of the Digestive System at The Rockefeller University.	Andrade BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019841; [Anonymous], PLOS MED; Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; da Silva ML, 2012, TRAFFIC, V13, P1351, DOI 10.1111/j.1600-0854.2012.01398.x; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Epiphanio S, 2008, CELL HOST MICROBE, V3, P331, DOI 10.1016/j.chom.2008.04.003; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Goncalves LA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-169; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KHAN ZM, 1992, INFECT IMMUN, V60, P264, DOI 10.1128/IAI.60.1.264-270.1992; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Liehl P, 2012, INT J PARASITOL, V42, P557, DOI 10.1016/j.ijpara.2012.04.006; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Ouwe-Missi-Oukem-Boyer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016034; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sriprawat K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-115; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037103	52	176	184	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					47	+		10.1038/nm.3424	http://dx.doi.org/10.1038/nm.3424			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24362933	Green Accepted, Bronze			2022-12-27	WOS:000329349400018
J	Wilson, CB				Wilson, Cecil B.			An updated Declaration of Helsinki will provide more protection	NATURE MEDICINE			English	Editorial Material									World Med Assoc, Ferney Voltaire, France		Wilson, CB (corresponding author), World Med Assoc, Ferney Voltaire, France.								0	14	16	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					664	664		10.1038/nm0613-664	http://dx.doi.org/10.1038/nm0613-664			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744139				2022-12-27	WOS:000319981600007
J	De Sousa E Melo, F; Wang, X; Jansen, M; Fessler, E; Trinh, A; de Rooij, LPMH; de Jong, JH; de Boer, OJ; van Leersum, R; Bijlsma, MF; Rodermond, H; van der Heijden, M; van Noesel, CJM; Tuynman, JB; Dekker, E; Markowetz, F; Medema, JP; Vermeulen, L				De Sousa E Melo, Felipe; Wang, Xin; Jansen, Marnix; Fessler, Evelyn; Trinh, Anne; de Rooij, Laura P. M. H.; de Jong, Joan H.; de Boer, Onno J.; van Leersum, Ronald; Bijlsma, Maarten F.; Rodermond, Hans; van der Heijden, Maartje; van Noesel, Carel J. M.; Tuynman, Jurriaan B.; Dekker, Evelien; Markowetz, Florian; Medema, Jan Paul; Vermeulen, Louis			Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions	NATURE MEDICINE			English	Article							COLORECTAL-CANCER; GENE-EXPRESSION; BREAST-CANCER; METHYLATION; METASTASIS; SIGNATURE; SURVIVAL; MUTATION; CELLS	Colon cancer is a clinically diverse disease. This heterogeneity makes it difficult to determine which patients will benefit most from adjuvant therapy and impedes the development of new targeted agents(1). More insight into the biological diversity of colon cancers, especially in relation to clinical features, is therefore needed. We demonstrate, using an unsupervised classification strategy involving over 1,100 individuals with colon cancer, that three main molecularly distinct subtypes can be recognized. Two subtypes have been previously identified and are well characterized (chromosomal-instable and microsatellite-instable cancers)(2). The third subtype is largely microsatellite stable and contains relatively more CpG island methylator phenotype positive carcinomas but cannot be identified on the basis of characteristic mutations. We provide evidence that this subtype relates to sessile-serrated adenomas, which show highly similar gene expression profiles, including upregulation of genes involved in matrix remodeling and epithelial-mesenchymal transition. The identification of this subtype is crucial, as it has a very unfavorable prognosis and, moreover, is refractory to epidermal growth factor receptor targeted therapy.	[De Sousa E Melo, Felipe; Fessler, Evelyn; de Rooij, Laura P. M. H.; de Jong, Joan H.; van Leersum, Ronald; Bijlsma, Maarten F.; Rodermond, Hans; van der Heijden, Maartje; Medema, Jan Paul; Vermeulen, Louis] Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, Amsterdam, Netherlands; [Wang, Xin; Trinh, Anne; Markowetz, Florian] Univ Cambridge, Canc Res UK Cambridge Inst, Computat Biol Res Grp, Cambridge, England; [Jansen, Marnix; de Boer, Onno J.; van Noesel, Carel J. M.] AMC, Dept Pathol, Amsterdam, Netherlands; [van der Heijden, Maartje; Vermeulen, Louis] Univ Cambridge, Cambridge Inst, Lab Intestinal Stem Cell Biol, Cambridge, England; [Tuynman, Jurriaan B.] Oxford Univ Hosp, Dept Colorectal Surg, Oxford, England; [Dekker, Evelien] AMC, Dept Gastroenterol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam	Medema, JP (corresponding author), Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, Amsterdam, Netherlands.	j.p.medema@amc.uva.nl; louis.vermeulen@cruk.cam.ac.uk	Tuynman, JB/AAS-7745-2020; de Rooij, Laura/GZH-0307-2022; Wang, Xin/A-1130-2012; Tuynman, J/X-2465-2019; Vermeulen, Louis/B-7488-2008; Markowetz, Florian/H-6883-2019	Tuynman, JB/0000-0001-5952-8000; de Rooij, Laura/0000-0002-1810-4620; Wang, Xin/0000-0002-5122-2418; Vermeulen, Louis/0000-0002-6066-789X; Markowetz, Florian/0000-0002-2784-5308; de Boer, Onno/0000-0001-8844-1326; Dekker, Evelien/0000-0002-4363-0745; Medema, Jan Paul/0000-0003-3045-2924; Jansen, Marnix/0000-0003-0645-564X; Trinh, Anne/0000-0001-7261-6734	Vici grant from the Netherlands Organisation for Scientific Research; Dutch Cancer Society [2009-4416, 2012-5735]; Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society Fellowship); Cancer Research UK [17044] Funding Source: researchfish	Vici grant from the Netherlands Organisation for Scientific Research; Dutch Cancer Society(KWF Kankerbestrijding); Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society Fellowship); Cancer Research UK(Cancer Research UK)	We wish to thank P. van Sluijs and R. Volckmann for assistance with deriving gene expression profiles, J. Lascorz for sharing his collection of prognostic signatures, S. Kozar for important comments on the manuscript, and K. Punt, I. Nagtegaal and P. Kuppen for valuable insights from their patient cohorts. This work was supported by a Vici grant from the Netherlands Organisation for Scientific Research to J.P.M. and Dutch Cancer Society grants (2009-4416 and 2012-5735). L.V. is supported by a Koningin Wilhelmina Fonds (KWF, Dutch Cancer Society Fellowship).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Boparai KS, 2011, AM J PATHOL, V178, P2700, DOI 10.1016/j.ajpath.2011.02.023; Bruna A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2039; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Curran S, 2004, CLIN CANCER RES, V10, P8229, DOI 10.1158/1078-0432.CCR-04-0424; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Gray RG, 2011, J CLIN ONCOL, V29, P4611, DOI 10.1200/JCO.2010.32.8732; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Lascorz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018867; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shioiri M, 2006, BRIT J CANCER, V94, P1816, DOI 10.1038/sj.bjc.6603193; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053/j.gastro.2008.02.098	29	536	544	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					614	618		10.1038/nm.3174	http://dx.doi.org/10.1038/nm.3174			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23584090				2022-12-27	WOS:000318583000034
J	Wang, X; Zhao, YJ; Zhang, XF; Badie, H; Zhou, Y; Mu, YL; Loo, LS; Cai, L; Thompson, RC; Yang, B; Chen, YM; Johnson, PF; Wu, CB; Bu, GJ; Mobley, WC; Zhang, DX; Gage, FH; Ranscht, B; Zhang, YW; Lipton, SA; Hong, WJ; Xu, HX				Wang, Xin; Zhao, Yingjun; Zhang, Xiaofei; Badie, Hedieh; Zhou, Ying; Mu, Yangling; Loo, Li Shen; Cai, Lei; Thompson, Robert C.; Yang, Bo; Chen, Yaomin; Johnson, Peter F.; Wu, Chengbiao; Bu, Guojun; Mobley, William C.; Zhang, Dongxian; Gage, Fred H.; Ranscht, Barbara; Zhang, Yun-wu; Lipton, Stuart A.; Hong, Wanjin; Xu, Huaxi			Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome	NATURE MEDICINE			English	Article							C/EBP-BETA; POTASSIUM CHANNELS; RETROMER COMPLEX; MEMORY DEFICITS; MOUSE MODEL; TS65DN; VPS35; HAPLOINSUFFICIENCY; CONSOLIDATION; TRAFFICKING	Sorting nexin 27 (SNX27), a brain-enriched PDZ domain protein, regulates endocytic sorting and trafficking. Here we show that Snx27(-/-) mice have severe neuronal deficits in the hippocampus and cortex. Although Snx27(+/-) mice have grossly normal neuroanatomy, we found defects in synaptic function, learning and memory and a reduction in the amounts of ionotropic glutamate receptors (NMDA and AMPA receptors) in these mice. SNX27 interacts with these receptors through its PDZ domain, regulating their recycling to the plasma membrane. We demonstrate a concomitant reduced expression of SNX27 and CCAAT/enhancer binding protein beta (C/EBP beta) in Down's syndrome brains and identify C/EBP beta as a transcription factor for SNX27. Down's syndrome causes overexpression of miR-155, a chromosome 21-encoded microRNA that negatively regulates C/EBP beta, thereby reducing SNX27 expression and resulting in synaptic dysfunction. Upregulating SNX27 in the hippocampus of Down's syndrome mice rescues synaptic and cognitive deficits. Our identification of the role of SNX27 in synaptic function establishes a new molecular mechanism of Down's syndrome pathogenesis.	[Wang, Xin; Zhao, Yingjun; Zhang, Xiaofei; Thompson, Robert C.; Yang, Bo; Chen, Yaomin; Zhang, Dongxian; Zhang, Yun-wu; Lipton, Stuart A.; Xu, Huaxi] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Wang, Xin; Zhou, Ying] Sanford Burnham Med Res Inst, Grad Sch Biomed Sci, La Jolla, CA USA; [Zhao, Yingjun; Bu, Guojun; Zhang, Yun-wu; Xu, Huaxi] Xiamen Univ, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Coll Med, Xiamen, Peoples R China; [Badie, Hedieh; Ranscht, Barbara] Sanford Burnham Med Res Inst, Tumor Microenvironm Program, La Jolla, CA USA; [Mu, Yangling; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Loo, Li Shen; Cai, Lei; Hong, Wanjin] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Johnson, Peter F.] NCI, Lab Canc Prevent, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Wu, Chengbiao; Mobley, William C.; Lipton, Stuart A.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Hong, Wanjin] Xiamen Univ, Inst Biomed Res, Sch Pharmaceut Sci, Xiamen, Peoples R China	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; Xiamen University	Xu, HX (corresponding author), Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA.	xuh@sanfordburnham.org	Wang, Xin/A-8119-2017; Chen, Yaomin/I-6192-2013; Xu, Huaxi/AAV-7177-2021; Chen, Yaomin/H-5205-2013; Zhao, Yingjun/G-9173-2016; Johnson, Peter/A-1940-2012	Lipton, Stuart/0000-0002-3490-1259; Zhang, Yun-wu/0000-0002-7152-7630; Zhao, Yingjun/0000-0003-2832-6590; Johnson, Peter/0000-0002-4145-4725	US National Institutes of Health [R01 AG038710, R01 AG021173, R01 NS046673, R01 AG030197, R01 AG044420, P01 HD29587, P01 ES016738, P30 NS076411]; Alzheimer's Association; American Health Assistance Foundation; National Natural Science Foundation of China [30973150, 81161120496]; 973 Prophase Project [2010CB535004]; Natural Science Funds for Distinguished Young Scholar of Fujian Province [2009J06022]; Program for New Century Excellent Talents in Universities (NCET); Fundamental Research Funds for the Central Universities; Fok Ying Tung Education Foundation; Intramural Research Program of the US National Institutes of Health, US National Cancer Institute and Center for Cancer Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411, R01NS046673, P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038710, RF1AG046205, R01AG021173, P01AG030128, R01AG027924, R01AG035355, R01AG044420, R01AG030197, R01AG046205] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Prophase Project(National Basic Research Program of China); Natural Science Funds for Distinguished Young Scholar of Fujian Province; Program for New Century Excellent Talents in Universities (NCET)(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Intramural Research Program of the US National Institutes of Health, US National Cancer Institute and Center for Cancer Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank P. Slesinger (Mount Sinai School of Medicine) for providing the rabbit SNX27-specific antibody and helpful discussion, A. Roberts and the Scripps behavioral core for mouse behavioral analysis, T. Golde and C. Ceballos (University of Florida) for generating AAV, E. Masliah (University of California, San Diego) for providing human brain specimens, P. Greengard (The Rockfeller University) for providing GluR1 and GluR2 constructs, K. Wright (University of California, San Diego) for helping in the transfer of Ts65Dn mice, S. Huang (Sanford-Burnham Medical Research Institute) for helping with statistical analysis, K. Saylor (US National Institutes of Health) for C/EBP beta knockout mouse breeding and tissue collection and A. Brzozowska-Prechtl and L. Lacarra for technical help. This work was supported in part by US National Institutes of Health grants (R01 AG038710, R01 AG021173, R01 NS046673, R01 AG030197 and R01 AG044420 to H.X.; and P01 HD29587, P01 ES016738, P30 NS076411 to S.A.L.) and grants from the Alzheimer's Association (to H.X. and Y. Zhang), the American Health Assistance Foundation (to H.X.), National Natural Science Foundation of China (30973150 and 81161120496 to Y. Zhang), the 973 Prophase Project (2010CB535004 to Y. Zhang) and Natural Science Funds for Distinguished Young Scholar of Fujian Province (2009J06022 to Y. Zhang). Y. Zhang is supported by the Program for New Century Excellent Talents in Universities (NCET), the Fundamental Research Funds for the Central Universities and Fok Ying Tung Education Foundation. This research was supported in part by the Intramural Research Program of the US National Institutes of Health, US National Cancer Institute and Center for Cancer Research.	ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Balana B, 2011, P NATL ACAD SCI USA, V108, P5831, DOI 10.1073/pnas.1018645108; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Best TK, 2007, J NEUROPHYSIOL, V97, P892, DOI 10.1152/jn.00626.2006; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Cramer NP, 2010, ADV PHARMACOL, V58, P397, DOI 10.1016/S1054-3589(10)58015-3; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Elton TS, 2010, RNA BIOL, V7, P540, DOI 10.4161/rna.7.5.12685; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Galdzicki Z, 2001, BRAIN RES REV, V35, P115, DOI 10.1016/S0926-6410(00)00074-4; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Keck-Wherley J, 2011, DEV NEUROSCI-BASEL, V33, P451, DOI 10.1159/000330884; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Liu Y, 2009, J BIOL CHEM, V284, P12145, DOI 10.1074/jbc.M808497200; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; Malinow R, 2012, CURR OPIN NEUROBIOL, V22, P559, DOI 10.1016/j.conb.2011.09.001; Merhav M, 2006, LEARN MEMORY, V13, P571, DOI 10.1101/lm.282406; Milekic MH, 2007, LEARN MEMORY, V14, P504, DOI 10.1101/lm.598307; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; PETIT TL, 1984, EXP NEUROL, V83, P13, DOI 10.1016/0014-4886(84)90041-4; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; REYNOLDS GP, 1988, NEUROSCI LETT, V94, P224, DOI 10.1016/0304-3940(88)90299-6; Risser D, 1997, LIFE SCI, V60, P1231, DOI 10.1016/S0024-3205(97)00067-2; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Siarey RJ, 1997, NEUROPHARMACOLOGY, V36, P1549, DOI 10.1016/S0028-3908(97)00157-3; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2008, ARCH NEUROL-CHICAGO, V65, P323, DOI 10.1001/archneurol.2007.64; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	45	167	177	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					473	+		10.1038/nm.3117	http://dx.doi.org/10.1038/nm.3117			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23524343	Green Accepted			2022-12-27	WOS:000317109100033
J	Hope, BT; Skinner, MK; Kenny, PJ; Akbarian, S				Hope, Bruce T.; Skinner, Michael K.; Kenny, Paul J.; Akbarian, Schahram			Exploring the epigenetics of cocaine resistance	NATURE MEDICINE			English	Editorial Material							TRANSGENERATIONAL ACTIONS; BDNF; RELAPSE	Drug addiction is known to have a heritable component and to run in families. However, a recent study in rats by Vassoler et al.(1) shows an unexpected result-that the sons of males who had self-administered cocaine had a reduced propensity to take this drug and a delay in their acquisition of drug-seeking behavior. The authors linked these behavioral changes to epigenetic changes in the sperm from cocaine-exposed males and in the brains of their male offspring. We asked four experts to comment on the results of this study and their implications for understanding how addictive phenotypes are inherited.	[Hope, Bruce T.] NIDA, Intramural Res Program, NIH, Baltimore, MD USA; [Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Kenny, Paul J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Kenny, Paul J.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Akbarian, Schahram] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Washington State University; Scripps Research Institute; Scripps Research Institute; Icahn School of Medicine at Mount Sinai	Hope, BT (corresponding author), NIDA, Intramural Res Program, NIH, Baltimore, MD USA.		Hope, Bruce T/A-9223-2010	Hope, Bruce T/0000-0001-5804-7061	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000467] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Berglind WJ, 2007, EUR J NEUROSCI, V26, P757, DOI 10.1111/j.1460-9568.2007.05692.x; Bonduriansky R, 2012, TRENDS ECOL EVOL, V27, P330, DOI 10.1016/j.tree.2012.02.003; D'Sa C, 2011, BIOL PSYCHIAT, V70, P706, DOI 10.1016/j.biopsych.2011.05.013; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Ghitza UE, 2010, NEUROSCI BIOBEHAV R, V35, P157, DOI 10.1016/j.neubiorev.2009.11.009; Gogineni A, 2006, ALCOHOL CLIN EXP RES, V30, P377, DOI 10.1111/j.1530-0277.2006.00042.x; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Pawlow IP, 1923, SCIENCE, V58, P359, DOI 10.1126/science.58.1506.359; Shulha HP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001427; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280	14	3	3	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					136	137						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389607				2022-12-27	WOS:000314675900019
J	Bruchard, M; Mignot, G; Derangere, V; Chalmin, F; Chevriaux, A; Vegran, F; Boireau, W; Simon, B; Ryffel, B; Connat, JL; Kanellopoulos, J; Martin, F; Rebe, C; Apetoh, L; Ghiringhelli, F				Bruchard, Melanie; Mignot, Gregoire; Derangere, Valentin; Chalmin, Fanny; Chevriaux, Angelique; Vegran, Frederique; Boireau, Wilfrid; Simon, Benoit; Ryffel, Bernhard; Connat, Jean Louis; Kanellopoulos, Jean; Martin, Francois; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois			Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth	NATURE MEDICINE			English	Article							ANTITUMOR IMMUNITY; T-CELLS; CANCER-CHEMOTHERAPY; BEARING MICE; GEMCITABINE; INHIBITION; BETA; MICROENVIRONMENT; 5-FLUOROURACIL; ANGIOGENESIS	Chemotherapeutic agents are widely used for cancer treatment. In addition to their direct cytotoxic effects, these agents harness the host's immune system, which contributes to their antitumor activity. Here we show that two clinically used chemotherapeutic agents, gemcitabine (Gem) and 5-fluorouracil (5FU), activate the NOD-like receptor family, pyrin domain containing-3 protein (Nlrp3)-dependent caspase-1 activation complex (termed the inflammasome) in myeloid-derived suppressor cells (MDSCs), leading to production of interleukin-1 beta (IL-beta), which curtails anticancer immunity. Chemotherapy-triggered IL-1 beta secretion relied on lysosomal permeabilization and the release of cathepsin B, which bound to Nlrp3 and drove caspase-1 activation. MDSC-derived IL-1 beta induced secretion of IL-17 by CD4(+) T cells, which blunted the anticancer efficacy of the chemotherapy. Accordingly, Gem and 5FU exerted higher antitumor effects when tumors were established in Nlrp3(-/-) or Casp1(-/-) mice or wild-type mice treated with interleukin-1 receptor antagonist (IL-1Ra). Altogether, these results identify how activation of the Nlrp3 inflammasome in MDSCs by 5FU and Gem limits the antitumor efficacy of these chemotherapeutic agents.	[Connat, Jean Louis; Ghiringhelli, Francois] Univ Bourgogne, Inst Federat Rech IFR Sante Sci & Tech Informat &, Lab Physiopathol & Pharmacol Cardiovasc Expt, Fac Med,INSERM U866, Dijon, France; [Bruchard, Melanie; Mignot, Gregoire; Derangere, Valentin; Chalmin, Fanny; Chevriaux, Angelique; Vegran, Frederique; Martin, Francois; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois] Univ Bourgogne, Fac Med & Pharm, Dijon, France; [Chevriaux, Angelique; Rebe, Cedric; Apetoh, Lionel; Ghiringhelli, Francois] Ctr Georges Francois Leclerc, Dijon, France; [Boireau, Wilfrid; Simon, Benoit] Univ Franche Comte, Franche Comte Elect Mecan Therm & Opt Sci & Techn, F-25030 Besancon, France; [Ryffel, Bernhard] CNRS, Lab Mol Immunol & Embryol, UMR 6218, F-45071 Orleans, France; [Kanellopoulos, Jean] Univ Paris 11, UMR 8619, Orsay, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Ghiringhelli, F (corresponding author), Univ Bourgogne, Inst Federat Rech IFR Sante Sci & Tech Informat &, Lab Physiopathol & Pharmacol Cardiovasc Expt, Fac Med,INSERM U866, Dijon, France.	fghiringhelli@cgfl.fr	Bruchard, Melanie/E-6508-2017; VEGRAN, Frédérique/H-4792-2017; Apetoh, Lionel/G-3310-2014; Mignot, Grégoire/R-4976-2017; Apetoh, Lionel/AIC-2384-2022; Connat, Jean-Louis/GWR-0438-2022; REBE, Cédric/AAD-4316-2019; VEGRAN, Frederique/O-9986-2018	Bruchard, Melanie/0000-0003-0004-2887; Apetoh, Lionel/0000-0002-2774-438X; Mignot, Grégoire/0000-0002-0682-0152; Apetoh, Lionel/0000-0002-2774-438X; REBE, Cédric/0000-0001-8831-145X; VEGRAN, Frederique/0000-0002-4377-1441; ghiringhelli, francois/0000-0002-5465-8305; Chalmin, Fanny/0000-0002-0855-9453; Connat, Jean-Louis/0000-0002-2885-2323	Fondation pour la Recherche Medicale (FRM); Association pour le Recherche Contre le Cancer (ARC); Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa); Ligue Regionale Contre le Cancer Comite Grand-Est; Fondation de France; Agence Nationale de la Recherche (ANR) [ANR-10-PDOC-014-01]; European Commission (Marie Curie Fellowship) [PCIG10-GA-2011-303719]; Ministere de l'Enseignement Superieur et de la Recherche; INSERM; Region Bourgogne; LabEx [ANR-11-LABX-0021]	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour le Recherche Contre le Cancer (ARC); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Regionale Contre le Cancer Comite Grand-Est; Fondation de France(Fondation de France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Commission (Marie Curie Fellowship)(European Commission); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bourgogne(Region Bourgogne-Franche-Comte); LabEx	The authors of this work are supported by the Fondation pour la Recherche Medicale (FRM) (F.G.), the Association pour le Recherche Contre le Cancer (ARC) (F.G., G.M. and M.B.), the Ligue Nationale Contre le Cancer (F.V.), the Institut National du Cancer (INCa) (F.G.), the Ligue Regionale Contre le Cancer Comite Grand-Est (F.G., C.R. and L.A.), the Fondation de France (F.G.), the Agence Nationale de la Recherche (ANR, ANR-10-PDOC-014-01) (L.A.), the European Commission (Marie Curie Fellowship PCIG10-GA-2011-303719) (L.A.), the Ministere de l'Enseignement Superieur et de la Recherche (M.B.), INSERM and Region Bourgogne (F.C.) and LabEx ANR-11-LABX-0021. We thank P. Schneider (Biochemistry Department, Universite de Lausanne), V. Bronte (Istituto Oncologico, Padova, Italy) and T. Reinheckel (Institute of Molecular Medicine and Cell Research Freiburg, Germany) for providing essential material.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Apetoh L, 2011, CURR MOL MED, V11, P365, DOI 10.2174/156652411795976574; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D; Carmi Y, 2011, J IMMUNOL, V186, P3462, DOI 10.4049/jimmunol.1002901; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Hagemann T, 2007, CANCER CELL, V12, P300, DOI 10.1016/j.ccr.2007.10.005; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Le HK, 2009, INT IMMUNOPHARMACOL, V9, P900, DOI 10.1016/j.intimp.2009.03.015; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Mattarollo SR, 2011, CANCER RES, V71, P4809, DOI 10.1158/0008-5472.CAN-11-0753; Menard C, 2008, CANCER IMMUNOL IMMUN, V57, P1579, DOI 10.1007/s00262-008-0505-6; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Mundy-Bosse BL, 2011, CANCER RES, V71, P5101, DOI 10.1158/0008-5472.CAN-10-2670; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Qin HW, 2009, J IMMUNOL, V183, P97, DOI 10.4049/jimmunol.0801986; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	44	507	534	8	178	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2013	19	1					57	64		10.1038/nm.2999	http://dx.doi.org/10.1038/nm.2999			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23202296				2022-12-27	WOS:000313230300026
J	Muramatsu, R; Takahashi, C; Miyake, S; Fujimura, H; Mochizuki, H; Yamashita, T				Muramatsu, Rieko; Takahashi, Chisato; Miyake, Shuzo; Fujimura, Harutoshi; Mochizuki, Hideki; Yamashita, Toshihide			Angiogenesis induced by CNS inflammation promotes neuronal remodeling through vessel-derived prostacyclin	NATURE MEDICINE			English	Article							SPINAL-CORD-INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; CORTICOSPINAL NEURONS; ANIMAL-MODEL; CONNECTIONS; RECOVERY; GUIDANCE; RATS; REGENERATION	Angiogenesis is a prominent feature of central nervous system (CNS) disease and has roles in both the continued promotion of inflammation and the subsequent repair processes. Here we report that prostacyclin (or prostaglandin I-2 (PGI(2))) derived from new vessels promotes axonal remodeling of injured neuronal networks after CNS inflammation. In a localized model of experimental autoimmune encephalomyelitis (EAE), new vessels formed around the inflammatory lesion, followed by sprouting of adjacent corticospinal tract (CST) fibers. These sprouting fibers formed a compensatory motor circuit, leading to recovery of motor function. Capillary endothelial cell-derived prostacyclin bound to its receptor, the type I prostaglandin receptor (IP receptor), on CST neurons, promoting sprouting of CST fibers and contributing to the repair process. Inhibition of prostacyclin receptor signaling impaired motor recovery, whereas the IP receptor agonist iloprost promoted axonal remodeling and motor recovery after the induction of EAE. These findings reveal an important function of angiogenesis in neuronal rewiring and suggest that prostacyclin is a promising molecule for enhancing functional recovery from CNS disease.	[Muramatsu, Rieko; Takahashi, Chisato; Miyake, Shuzo; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Muramatsu, Rieko; Takahashi, Chisato; Miyake, Shuzo; Mochizuki, Hideki; Yamashita, Toshihide] Japan Sci & Technol Agcy, Tokyo, Japan; [Fujimura, Harutoshi] Toneyama Natl Hosp, Toyonaka, Osaka, Japan; [Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Muramatsu, Rieko/F-4109-2014	Muramatsu, Rieko/0000-0001-5342-7823; Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Sciences [23122512]; Core Research for Evolutional Science and Technology from Japan Science and Technology Agency	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology from Japan Science and Technology Agency	The authors are grateful to N. Takakura, H. Kidoya and M. Ueno for helpful comments and M. Niwa and S. Nakagawa for technical advice on culturing of endothelial cells. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (23122512) from the Japan Society for the Promotion of Sciences to R. M. and the Core Research for Evolutional Science and Technology from Japan Science and Technology Agency to T.Y.	Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Black JA, 2006, BRAIN, V129, P3196, DOI 10.1093/brain/awl216; Buddeberg BS, 2004, J NEUROIMMUNOL, V153, P158, DOI 10.1016/j.jneuroim.2004.05.006; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; DeLuca GC, 2004, BRAIN, V127, P1009, DOI 10.1093/brain/awh118; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Fokman J., 1992, INFLAMMATION BASIC P, P821; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hino T, 2006, BIOCHEM BIOPH RES CO, V340, P263, DOI 10.1016/j.bbrc.2005.11.173; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jung S, 1997, J AUTOIMMUN, V10, P519, DOI 10.1006/jaut.1997.0159; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kirk S, 2004, J NEUROL SCI, V217, P125, DOI 10.1016/j.jns.2003.10.016; Kirk SL, 2003, J AUTOIMMUN, V21, P353, DOI 10.1016/S0896-8411(03)00139-2; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; MENETREY D, 1985, NEUROSCI LETT, V58, P257, DOI 10.1016/0304-3940(85)90174-0; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Uesugi N, 2009, BIOCHEM BIOPH RES CO, V383, P509, DOI 10.1016/j.bbrc.2009.04.085; VANE JR, 1995, AM J CARDIOL, V75, pA3, DOI 10.1016/S0002-9149(99)80377-4; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087	32	74	76	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1658	+		10.1038/nm.2943	http://dx.doi.org/10.1038/nm.2943			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23042236				2022-12-27	WOS:000310837000026
J	Bidwell, BN; Slaney, CY; Withana, NP; Forster, S; Cao, Y; Loi, S; Andrews, D; Mikeska, T; Mangan, NE; Samarajiwa, SA; de Weerd, NA; Gould, J; Argani, P; Moller, A; Smyth, MJ; Anderson, RL; Hertzog, PJ; Parker, BS				Bidwell, Bradley N.; Slaney, Clare Y.; Withana, Nimali P.; Forster, Sam; Cao, Yuan; Loi, Sherene; Andrews, Daniel; Mikeska, Thomas; Mangan, Niamh E.; Samarajiwa, Shamith A.; de Weerd, Nicole A.; Gould, Jodee; Argani, Pedram; Moeller, Andreas; Smyth, Mark J.; Anderson, Robin L.; Hertzog, Paul J.; Parker, Belinda S.			Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape	NATURE MEDICINE			English	Article							SUPPRESSOR-CELLS; MAMMARY CARCINOMAS; GENE-EXPRESSION; I INTERFERONS; MOLECULAR PORTRAITS; ADAPTIVE IMMUNITY; GENOMIC ANALYSIS; TUMORS; BETA; METHYLATION	Breast cancer metastasis is a key determinant of long-term patient survival. By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7. Restoration of Irf7 in tumor cells or administration of interferon led to reduced bone metastases and prolonged survival time. In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells. We confirmed the clinical relevance of these findings in over 800 patients in which high expression of Irf7-regulated genes in primary tumors was associated with prolonged bone metastasis-free survival. This gene signature may identify patients that could benefit from IFN-based therapies. Thus, we have identified an innate immune pathway intrinsic to breast cancer cells, the suppression of which restricts immunosurveillance to enable metastasis.	[Bidwell, Bradley N.; Slaney, Clare Y.; Withana, Nimali P.; Cao, Yuan; Andrews, Daniel; Mikeska, Thomas; Moeller, Andreas; Smyth, Mark J.; Anderson, Robin L.; Parker, Belinda S.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Bidwell, Bradley N.; Cao, Yuan; Andrews, Daniel; Moeller, Andreas; Parker, Belinda S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Slaney, Clare Y.; Andrews, Daniel; Smyth, Mark J.; Anderson, Robin L.; Parker, Belinda S.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Withana, Nimali P.; Mikeska, Thomas; Moeller, Andreas; Anderson, Robin L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Forster, Sam; Mangan, Niamh E.; Samarajiwa, Shamith A.; de Weerd, Nicole A.; Gould, Jodee; Hertzog, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [Loi, Sherene] Inst Jules Bordet, Breast Canc Translat Res Lab, B-1000 Brussels, Belgium; [Samarajiwa, Shamith A.] Canc Res UK, Cambridge Res Inst, Dept Oncol, Cambridge, England; [Argani, Pedram] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Monash University; Institut Jules Bordet; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Johns Hopkins University; Johns Hopkins Medicine	Parker, BS (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	paul.hertzog@monash.edu	Hertzog, Paul J/I-7053-2013; Loi, Sherene/H-1979-2016; Anderson, Robin/I-2306-2013; de Weerd, Nicole/X-5886-2019; Samarajiwa, Shamith/B-1601-2013; Mikeska, Thomas/B-4876-2008; Smyth, Mark J/H-8709-2014; Anderson, Robin/K-6966-2019; Möller, Andreas/O-1063-2015; Slaney, Clare/AHC-2382-2022; Hertzog, Paul J/G-6734-2013; Forster, Samuel C/F-4206-2014; Anderson, Robin/S-1005-2017	Hertzog, Paul J/0000-0002-1373-8472; Loi, Sherene/0000-0001-6137-9171; de Weerd, Nicole/0000-0002-7985-189X; Samarajiwa, Shamith/0000-0003-1046-0601; Mikeska, Thomas/0000-0003-1318-0859; Smyth, Mark J/0000-0001-7098-7240; Möller, Andreas/0000-0002-8618-6998; Hertzog, Paul J/0000-0002-1373-8472; Forster, Samuel C/0000-0003-4144-2537; Andrews, Dan/0000-0002-5896-7885; Mangan, Niamh/0000-0003-3844-0709; Parker, Belinda/0000-0002-8333-1926; Slaney, Clare/0000-0002-6986-6115; Anderson, Robin/0000-0002-6841-7422	Cancer Council Victoria; Australian National Health and Medical Research Council (NHMRC); Association of International Cancer Research (AICR); Operational Infrastructure Scheme of the Victorian State government Department of Business and Innovation; Australian Research Council (ARC) Centre for Structural and Functional Microbial Genomics; Australian National Breast Cancer Foundation, NBCF; NBCF; NBCF, Cure Cancer Australia; Cancer Research UK [19556] Funding Source: researchfish; National Breast Cancer Foundation [PF-12-14] Funding Source: researchfish	Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Association of International Cancer Research (AICR); Operational Infrastructure Scheme of the Victorian State government Department of Business and Innovation; Australian Research Council (ARC) Centre for Structural and Functional Microbial Genomics(Australian Research Council); Australian National Breast Cancer Foundation, NBCF; NBCF; NBCF, Cure Cancer Australia; Cancer Research UK(Cancer Research UK); National Breast Cancer Foundation	This work was supported by the Cancer Council Victoria (B.S.P.), the Australian National Health and Medical Research Council (NHMRC) (P.J.H.), the Association of International Cancer Research (AICR) (A.M.), the Operational Infrastructure Scheme of the Victorian State government Department of Business and Innovation, the Australian Research Council (ARC) Centre for Structural and Functional Microbial Genomics and fellowship support for B.S.P. (NHMRC), R.L.A. (Australian National Breast Cancer Foundation, NBCF), A.M. (NBCF), C.Y.S. (NBCF, Cure Cancer Australia). We thank P. Hill (St Vincent's Pathology, St Vincent's Hospital, Fitzroy, Australia) for providing archived human breast cancer tissues assistance in the pathological assessment of immunohistochemistry staining and B. Haibe-Kains for assistance with codes in R. We also thank F. Miller (Karmanos Cancer Institute, Detroit, MI) for providing 66cl4 and 4T1 cell lines.	Adeegbe D, 2011, CELL TRANSPLANT, V20, P941, DOI 10.3727/096368910X540621; American Cancer Society, 2012, BREAST CANC FACTS FI; Bi XH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3053; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Chin AI, 2010, CANCER RES, V70, P2595, DOI 10.1158/0008-5472.CAN-09-1162; Cimino A, 2010, BREAST CANCER RES TR, V123, P701, DOI 10.1007/s10549-009-0671-z; Coleman RE, 2011, NEW ENGL J MED, V365, P1396, DOI 10.1056/NEJMoa1105195; Coppin C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006017.pub2; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Fehm T, 2008, APMIS, V116, P742, DOI 10.1111/j.1600-0463.2008.01047.x; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Garbe C, 2008, MELANOMA RES, V18, P61, DOI 10.1097/CMR.0b013e3282f0c893; Gnant M, 2011, LANCET ONCOL, V12, P631, DOI 10.1016/S1470-2045(11)70122-X; Hadden JW, 1999, INT J IMMUNOPHARMACO, V21, P79, DOI 10.1016/S0192-0561(98)00077-0; Haibe-Kains B, 2012, JNCI-J NATL CANCER I, V104, P311, DOI 10.1093/jnci/djr545; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Maher SG, 2007, CURR MED CHEM, V14, P1279, DOI 10.2174/092986707780597907; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Mikeska T, 2011, METHODS MOL BIOL, V791, P33, DOI 10.1007/978-1-61779-316-5_4; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Noppert SJ, 2007, IMMUNOL CELL BIOL, V85, P446, DOI 10.1038/sj.icb.7100099; Oruc MT, 2004, LIVER TRANSPLANT, V10, P1, DOI 10.1002/lt.20025; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Parker BS, 2004, CANCER RES, V64, P7857, DOI 10.1158/0008-5472.CAN-04-1976; PENN I, 1988, ANNU REV MED, V39, P63, DOI 10.1146/annurev.me.39.020188.000431; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Repetto L, 1996, BREAST CANCER RES TR, V39, P235, DOI 10.1007/BF01806190; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; St Croix B, 2000, SCIENCE, V289, P1197; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Wu L, 2002, APPL IMMUNOHISTO M M, V10, P269, DOI 10.1097/00022744-200209000-00015; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	66	297	315	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1224	1231		10.1038/nm.2830	http://dx.doi.org/10.1038/nm.2830			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22820642				2022-12-27	WOS:000307469300028
J	Gembarska, A; Luciani, F; Fedele, C; Russell, EA; Dewaele, M; Villar, S; Zwolinska, A; Haupt, S; de Lange, J; Yip, D; Goydos, J; Haigh, JJ; Haupt, Y; Larue, L; Jochemsen, A; Shi, HB; Moriceau, G; Lo, RS; Ghanem, G; Shackleton, M; Bernal, F; Marine, JC				Gembarska, Agnieszka; Luciani, Flavie; Fedele, Clare; Russell, Elisabeth A.; Dewaele, Michael; Villar, Stephanie; Zwolinska, Aleksandra; Haupt, Sue; de Lange, Job; Yip, Dana; Goydos, James; Haigh, Jody J.; Haupt, Ygal; Larue, Lionel; Jochemsen, Aart; Shi, Hubing; Moriceau, Gatien; Lo, Roger S.; Ghanem, Ghanem; Shackleton, Mark; Bernal, Federico; Marine, Jean-Christophe			MDM4 is a key therapeutic target in cutaneous melanoma	NATURE MEDICINE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; IN-VIVO; MALIGNANT-MELANOMA; P53 PATHWAY; N-RAS; METASTATIC MELANOMA; BREAST-CANCER; STAPLED P53; CELL-DEATH; BRAF	The inactivation of the p53 tumor suppressor pathway, which often occurs through mutations in TP53 (encoding tumor protein 53) is a common step in human cancer. However, in melanoma-a highly chemotherapy-resistant disease-TP53 mutations are rare, raising the possibility that this cancer uses alternative ways to overcome p53-mediated tumor suppression. Here we show that Mdm4 p53 binding protein homolog (MDM4), a negative regulator of p53, is upregulated in a substantial proportion (similar to 65%) of stage I-IV human melanomas and that melanocyte-specific Mdm4 overexpression enhanced tumorigenesis in a mouse model of melanoma induced by the oncogene Nras. MDM4 promotes the survival of human metastatic melanoma by antagonizing p53 proapoptotic function. Notably, inhibition of the MDM4-p53 interaction restored p53 function in melanoma cells, resulting in increased sensitivity to cytotoxic chemotherapy and to inhibitors of the BRAF (V600E) oncogene. Our results identify MDM4 as a key determinant of impaired p53 function in human melanoma and designate MDM4 as a promising target for antimelanoma combination therapy.	[Gembarska, Agnieszka; Luciani, Flavie; Dewaele, Michael; Zwolinska, Aleksandra; Marine, Jean-Christophe] VIB, Lab Mol Canc Biol, Ctr Biol Dis, Louvain, Belgium; [Gembarska, Agnieszka; Luciani, Flavie; Dewaele, Michael; Zwolinska, Aleksandra; Marine, Jean-Christophe] Katholieke Univ KU Leuven, Ctr Human Genet, Louvain, Belgium; [Fedele, Clare; Shackleton, Mark] Peter MacCallum Canc Ctr, Melanoma Res Lab, Melbourne, Australia; [Fedele, Clare; Shackleton, Mark] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Russell, Elisabeth A.; Bernal, Federico] NCI, Metab Branch, Ctr Canc Res, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Villar, Stephanie] Int Agcy Res Canc IARC CIRC, Lyon, France; [Haupt, Sue; Haupt, Ygal; Shackleton, Mark] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Haupt, Sue; Haupt, Ygal] Peter MacCallum Canc Ctr, Div Res, Melbourne, Australia; [Jochemsen, Aart] Univ Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Yip, Dana; Goydos, James] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Haigh, Jody J.] VIB, Dept Mol Biomed Res, Vasc Cell Biol Unit, Ghent, Belgium; [Haigh, Jody J.] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Haupt, Ygal] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Larue, Lionel] CNRS, INSERM, U1021, Inst Curie,UMR3347, F-91405 Orsay, France; [Shi, Hubing; Moriceau, Gatien; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Med,Div Dermatol, Los Angeles, CA 90095 USA; [Shi, Hubing; Moriceau, Gatien; Lo, Roger S.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Ghanem, Ghanem] Inst Jules Bordet, B-1000 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Peter Maccallum Cancer Center; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); World Health Organization; International Agency for Research on Cancer (IARC); Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Flanders Institute for Biotechnology (VIB); Ghent University; Monash University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Institut Jules Bordet	Marine, JC (corresponding author), VIB, Lab Mol Canc Biol, Ctr Biol Dis, Louvain, Belgium.	jeanchristophe.marine@cme.vib-kuleuven.be	Marine, Jean Christophe/J-2237-2015; Larue, Lionel/F-7355-2013; Marine, Jean-Christophe/K-3292-2016; Shi, Hubing/B-8445-2014; Larue, Lionel/I-6532-2016; Goydos, James/AAR-8990-2020	Marine, Jean-Christophe/0000-0003-2433-9837; Goydos, James/0000-0001-9811-939X; Haupt, Ygal/0000-0001-5925-0096; Shi, Hubing/0000-0002-2926-3440; de Lange, Job/0000-0002-9002-8829; haigh, jody/0000-0002-7319-8922; Luciani, Flavie/0000-0002-6130-0889	'Het Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO)' scholarship; Clare Oliver Memorial Fellowship from the Victorian Cancer Agency; Pfizer Australia; Victorian Endowment for Science, Knowledge and Innovation (VESKI); Australian National Health and Medical Research Council [509197, 1026990, 628426]; Stand Up to Cancer; Joint Center for Translational Medicine; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Seaver Institute; US National Institutes of Health; National Cancer Institute; Association for International Cancer Research (AICR); Melbourne Melanoma Project; Victorian Cancer Agency; Belgian Foundation against Cancer; NATIONAL CANCER INSTITUTE [ZIABC011261] Funding Source: NIH RePORTER	'Het Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO)' scholarship(FWO); Clare Oliver Memorial Fellowship from the Victorian Cancer Agency; Pfizer Australia(PfizerPfizer Australia); Victorian Endowment for Science, Knowledge and Innovation (VESKI); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Stand Up to Cancer; Joint Center for Translational Medicine; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; Seaver Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Association for International Cancer Research (AICR); Melbourne Melanoma Project; Victorian Cancer Agency; Belgian Foundation against Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank O.Van Goethem for excellent technical assistance. We thank P. Agostinis, P. Wolter and M. Skipper for helpful discussions and comments on the manuscript. We thank M. Cario-Andre and A. Taied for materials from human nevi. A. Zwolinska is a recipient of a 'Het Fonds Wetenschappelijk Onderzoek-Vlaanderen (FWO)' scholarship. C. Fedele was supported by a Clare Oliver Memorial Fellowship from the Victorian Cancer Agency. M. Shackleton was supported by fellowships from Pfizer Australia and the Victorian Endowment for Science, Knowledge and Innovation (VESKI). Y. and S. Haupt were supported by the Australian National Health and Medical Research Council (nos. 509197, 1026990 and 628426) and VESKI. R.S. Lo was supported by Stand Up to Cancer, the Joint Center for Translational Medicine, the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, and the Seaver Institute. This work was supported by the Intramural Research Program of the US National Institutes of Health and the National Cancer Institute, the Association for International Cancer Research (AICR), the Melbourne Melanoma Project, the Victorian Cancer Agency and the 'Belgian Foundation against Cancer'.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bernal F, 2010, CANCER CELL, V18, P411, DOI 10.1016/j.ccr.2010.10.024; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Canner JA, 2009, BRIT J CANCER, V101, P774, DOI 10.1038/sj.bjc.6605199; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Clercq S, 2010, MOL CELL BIOL, V30, P5394, DOI 10.1128/MCB.00330-10; Demunter A, 2001, J INVEST DERMATOL, V117, P1483, DOI 10.1046/j.0022-202x.2001.01601.x; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Fedorenko IV, 2011, BIOCHEM PHARMACOL, V82, P201, DOI 10.1016/j.bcp.2011.05.015; Ferguson B, 2010, PIGM CELL MELANOMA R, V23, P771, DOI 10.1111/j.1755-148X.2010.00752.x; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Goel VK, 2009, ONCOGENE, V28, P2289, DOI 10.1038/onc.2009.95; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Hedstrom E, 2009, EXP CELL RES, V315, P451, DOI 10.1016/j.yexcr.2008.11.009; Houben R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022096; Ibrahim N, 2009, ANNU REV PATHOL-MECH, V4, P551, DOI 10.1146/annurev.pathol.3.121806.151541; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Lam S, 2010, ONCOGENE, V29, P2415, DOI 10.1038/onc.2009.522; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Marine JC, 2011, CURR TOP DEV BIOL, V94, P45, DOI 10.1016/B978-0-12-380916-2.00003-6; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Muthusamy V, 2006, GENE CHROMOSOME CANC, V45, P447, DOI 10.1002/gcc.20310; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Papp T, 1999, J MED GENET, V36, P610; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529	53	220	223	5	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1239	+		10.1038/nm.2863	http://dx.doi.org/10.1038/nm.2863			24	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22820643	Green Accepted			2022-12-27	WOS:000307469300030
J	Koyama, R; Tao, K; Sasaki, T; Ichikawa, J; Miyamoto, D; Muramatsu, R; Matsuki, N; Ikegaya, Y				Koyama, Ryuta; Tao, Kentaro; Sasaki, Takuya; Ichikawa, Junya; Miyamoto, Daisuke; Muramatsu, Rieko; Matsuki, Norio; Ikegaya, Yuji			GABAergic excitation after febrile seizures induces ectopic granule cells and adult epilepsy	NATURE MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; HIGH-FREQUENCY OSCILLATIONS; POSTNATAL SUBVENTRICULAR ZONE; GABA(A) RECEPTOR ACTIVATION; INDUCED STATUS EPILEPTICUS; RAT DENTATE GYRUS; NEURONAL MIGRATION; PYRAMIDAL CELLS; ANIMAL-MODEL; CORTICAL MALFORMATIONS	Temporal lobe epilepsy (TLE) is accompanied by an abnormal location of granule cells in the dentate gyrus. Using a rat model of complex febrile seizures, which are thought to be a precipitating insult of TLE later in life, we report that aberrant migration of neonatal-generated granule cells results in granule cell ectopia that persists into adulthood. Febrile seizures induced an upregulation of GABA(A) receptors (GABA(A)-Rs) in neonatally generated granule cells, and hyperactivation of excitatory GABA(A)-Rs caused a reversal in the direction of granule cell migration. This abnormal migration was prevented by RNAi-mediated knockdown of the Na(+)K(+)2Cl(-) co-transporter (NKCC1), which regulates the excitatory action of GABA. NKCC1 inhibition with bumetanide after febrile seizures rescued the granule cell ectopia, susceptibility to limbic seizures and development of epilepsy. Thus, this work identifies a previously unknown pathogenic role of excitatory GABA(A)-R signaling and highlights NKCC1 as a potential therapeutic target for preventing granule cell ectopia and the development of epilepsy after febrile seizures.	[Koyama, Ryuta; Tao, Kentaro; Sasaki, Takuya; Ichikawa, Junya; Miyamoto, Daisuke; Muramatsu, Rieko; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan	University of Tokyo	Koyama, R (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo, Japan.	rkoyama@mol.f.u-tokyo.ac.jp	Tao, Kentaro/Q-5647-2017; Miyamoto, Daisuke/I-2195-2016; Miyamoto, Daisuke/AAG-4537-2020; Sasaki, Takuya/J-3283-2015	Tao, Kentaro/0000-0002-8845-6891; Miyamoto, Daisuke/0000-0003-4735-9240; Ikegaya, Yuji/0000-0003-2260-8191	Ministry of Education, Culture, Sports, Science and Technology of Japan [19790048, 22115003]; Research Foundation for Pharmaceutical Sciences; Funding Program for Next Generation World-Leading Researchers [LS023]; Grants-in-Aid for Scientific Research [10J10641] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Pharmaceutical Sciences; Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Science Research on Young Scientists (B) (19790048) and on Innovative Areas 'Mesoscopic Neurocircuitry' (22115003) from The Ministry of Education, Culture, Sports, Science and Technology of Japan; the Research Foundation for Pharmaceutical Sciences; and the Funding Program for Next Generation World-Leading Researchers (LS023).	Behar TN, 2000, CEREB CORTEX, V10, P899, DOI 10.1093/cercor/10.9.899; Behar TN, 1996, J NEUROSCI, V16, P1808; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bender RA, 2004, ADV EXP MED BIOL, V548, P213; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chevassus-au-Louis N, 1999, EPILEPSIA, V40, P811, DOI 10.1111/j.1528-1157.1999.tb00786.x; Chevassus-Au-Louis N, 1998, J COMP NEUROL, V394, P520, DOI 10.1002/(SICI)1096-9861(19980518)394:4<520::AID-CNE9>3.0.CO;2-3; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Dyhrfjeld-Johnsen J, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.002.2008; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; ECKENHOFF MF, 1984, J COMP NEUROL, V223, P1, DOI 10.1002/cne.902230102; Engel J, 2009, EPILEPSIA, V50, P598, DOI 10.1111/j.1528-1167.2008.01917.x; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Frotscher M, 2003, CEREB CORTEX, V13, P634, DOI 10.1093/cercor/13.6.634; Fukuda A, 1998, J NEUROPHYSIOL, V79, P439, DOI 10.1152/jn.1998.79.1.439; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; HOUSER CR, 1990, BRAIN RES, V535, P195, DOI 10.1016/0006-8993(90)91601-C; Ibarz JM, 2010, J NEUROSCI, V30, P16249, DOI 10.1523/JNEUROSCI.3357-10.2010; Jacobs KM, 1999, EPILEPSY RES, V36, P165, DOI 10.1016/S0920-1211(99)00050-9; Kahle KT, 2009, J CHILD NEUROL, V24, P572, DOI 10.1177/0883073809333526; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Koyama R, 2007, J PHARMACOL SCI, V104, P191, DOI 10.1254/jphs.SC0070119; Koyama R, 2010, J PHARMACOL SCI, V113, P14, DOI 10.1254/jphs.09R19FM; Lee KS, 1997, J NEUROSCI, V17, P6236; Lurton D, 1998, J NEUROL SCI, V154, P133, DOI 10.1016/S0022-510X(97)00220-7; Manent JB, 2005, J NEUROSCI, V25, P4755, DOI 10.1523/JNEUROSCI.0553-05.2005; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; McCloskey DP, 2006, EUR J NEUROSCI, V24, P2203, DOI 10.1111/j.1460-9568.2006.05101.x; Muramatsu R, 2007, NEUROSCIENCE, V148, P593, DOI 10.1016/j.neuroscience.2007.06.040; Muramatsu R, 2008, EXP NEUROL, V211, P503, DOI 10.1016/j.expneurol.2008.02.026; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; PATEL S, 1988, BEHAV BRAIN RES, V31, P165, DOI 10.1016/0166-4328(88)90019-8; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Romo-Parra H, 2003, J NEUROPHYSIOL, V89, P3155, DOI 10.1152/jn.00985.2002; ROPER SN, 1995, EPILEPSY RES, V21, P205, DOI 10.1016/0920-1211(95)00027-8; Safiulina VF, 2006, J NEUROSCI, V26, P597, DOI 10.1523/JNEUROSCI.4493-05.2006; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman HE, 2002, NEUROSCIENCE, V111, P71, DOI 10.1016/S0306-4522(01)00599-1; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Sullivan JE, 1996, CLIN PHARMACOL THER, V60, P405, DOI 10.1016/S0009-9236(96)90197-6; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Wang DD, 2003, J PHYSIOL-LONDON, V550, P785, DOI 10.1113/jphysiol.2003.042572; Worrell GA, 2008, BRAIN, V131, P928, DOI 10.1093/brain/awn006; Yamada RX, 2008, J NEUROSCI, V28, P4613, DOI 10.1523/JNEUROSCI.0019-08.2008	58	121	125	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1271	+		10.1038/nm.2850	http://dx.doi.org/10.1038/nm.2850			28	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22797810				2022-12-27	WOS:000307469300034
J	Mouw, JK; Yui, Y; Damiano, L; Bainer, RO; Lakins, JN; Acerbi, I; Ou, GQ; Wijekoon, AC; Levental, KR; Gilbert, PM; Hwang, ES; Chen, YY; Weaver, VM				Mouw, Janna K.; Yui, Yoshihiro; Damiano, Laura; Bainer, Russell O.; Lakins, Johnathon N.; Acerbi, Irene; Ou, Guanqing; Wijekoon, Amanda C.; Levental, Kandice R.; Gilbert, Penney M.; Hwang, E. Shelley; Chen, Yunn-Yi; Weaver, Valerie M.			Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression	NATURE MEDICINE			English	Article							BREAST; TARGETS; INTERFERENCE; PHENOTYPE; MIR-17-92; PATHWAYS; SUBTYPES; DENSITY; GROWTH; FORCE	Tissue mechanics regulate development and homeostasis and are consistently modified in tumor progression. Nevertheless, the fundamental molecular mechanisms through which altered mechanics regulate tissue behavior and the clinical relevance of these changes remain unclear. We demonstrate that increased matrix stiffness modulates microRNA expression to drive tumor progression through integrin activation of beta-catenin and MYC. Specifically, in human and mouse tissue, increased matrix stiffness induced miR-18a to reduce levels of the tumor suppressor phosphatase and tensin homolog ( PTEN), both directly and indirectly by decreasing levels of homeobox A9 (HOXA9). Clinically, extracellular matrix stiffness correlated directly and significantly with miR-18a expression in human breast tumor biopsies. miR-18a expression was highest in basal-like breast cancers in which PTEN and HOXA9 levels were lowest, and high miR-18a expression predicted poor prognosis in patients with luminal breast cancers. Our findings identify a mechanically regulated microRNA circuit that can promote malignancy and suggest potential prognostic roles for HOXA9 and miR-18a levels in stratifying patients with luminal breast cancers.	[Mouw, Janna K.; Yui, Yoshihiro; Damiano, Laura; Bainer, Russell O.; Lakins, Johnathon N.; Acerbi, Irene; Ou, Guanqing; Wijekoon, Amanda C.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Levental, Kandice R.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Gilbert, Penney M.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Hwang, E. Shelley] Duke Univ, Ctr Comprehens Canc, Dept Surg, Durham, NC USA; [Chen, Yunn-Yi] UCSF, Dept Pathol, San Francisco, CA USA; [Weaver, Valerie M.] UCSF, Dept Anat, San Francisco, CA USA; [Weaver, Valerie M.] UCSF, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Weaver, Valerie M.] UCSF, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Weaver, Valerie M.] UCSF, UCSF Helen Diller Comprehens Canc Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; University of Toronto; Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA.	valerie.weaver@ucsfmedctr.org	Acerbi, Irene/AAA-3120-2019	Gilbert, Penney/0000-0001-5509-9616; Yui, Yoshihiro/0000-0002-5806-7801; Levental, Kandice/0000-0002-2234-3683; Mouw, Janna K/0000-0002-9846-8466; Weaver, Valerie marie/0000-0003-4786-6752	US Department of Defense Breast Cancer Research Program (DOD BCRP) [W81XWH-07-1-0538]; Susan G. Komen Postdoctoral Fellowship [PDF12230246]; US National Science Foundation; DOD BCRP [W81XWH-05-1-0330, W81XWH-13-1-0216]; US National Institutes of Health NCI [R01 CA138818, U54 CA143836, R01 CA085492, U01 ES019458]; Susan G. Komen grant [KG110560PP]; NATIONAL CANCER INSTITUTE [R01CA085492, R01CA138818, U54CA143836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER	US Department of Defense Breast Cancer Research Program (DOD BCRP)(United States Department of Defense); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); US National Science Foundation(National Science Foundation (NSF)); DOD BCRP(United States Department of Defense); US National Institutes of Health NCI; Susan G. Komen grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the members of the Weaver and N. Boudreau labs for helpful discussions. Atomic force microscopy analysis of the PyMT samples was performed by H. Yu. Animal handling was supported by L. Korets. miRNA and antagomir constructs were provided by M. Scherr at the Medical School Hannover. PTEN proximal promoter constructs were provided by C. Eng at the Genomic Medical Institute. LOX inhibitory antibodies were provided by A. Giaccia at the Stanford University School of Medicine. HOXA9 was provided by T. Nakamura at the Japanese Foundation for Cancer Research. This work was supported by US Department of Defense Breast Cancer Research Program (DOD BCRP) grant W81XWH-07-1-0538 (J.K.M.), Susan G. Komen Postdoctoral Fellowship PDF12230246 (I.A.), US National Science Foundation Graduate Research Fellowship (G.O.), DOD BCRP grants W81XWH-05-1-0330 and W81XWH-13-1-0216 (V.M.W.), US National Institutes of Health NCI grants R01 CA138818, U54 CA143836, R01 CA085492 and U01 ES019458 (V.M.W.) and Susan G. Komen grant KG110560PP (V.M.W. and E.S.W.).	Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Chang JM, 2013, EUR RADIOL, V23, P2450, DOI 10.1007/s00330-013-2866-2; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Delmas P, 2013, CELL, V155, P278, DOI 10.1016/j.cell.2013.09.026; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Enright AJ, 2004, GENOME BIOL, V5; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; Fasching PA, 2006, EUR J RADIOL, V60, P398, DOI 10.1016/j.ejrad.2006.08.002; Gan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025809; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Jin Yi, 2013, Methods Mol Biol, V936, P117; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krasilnikov MA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P59; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lakins Johnathon N, 2012, Methods Mol Biol, V916, P317, DOI 10.1007/978-1-61779-980-8_24; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li YM, 2012, BLOOD, V119, P4486, DOI 10.1182/blood-2011-09-378687; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Neth P, 2013, CARDIOVASC RES, V99, P294, DOI 10.1093/cvr/cvt096; Olive V, 2013, IMMUNOL REV, V253, P158, DOI 10.1111/imr.12054; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Paszek MJ, 2012, NAT METHODS, V9, DOI [10.1038/nmeth.2077, 10.1038/NMETH.2077]; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suarez Y, 2008, P NATL ACAD SCI USA, V105, P14082, DOI 10.1073/pnas.0804597105; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; von Minckwitz G, 2013, J CLIN ONCOL, V31, P3623, DOI 10.1200/JCO.2012.45.0940; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang ZG, 2013, COMPR PHYSIOL, V3, P599, DOI 10.1002/cphy.c110002; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Yehya N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-154; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	53	275	281	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					360	+		10.1038/nm.3497	http://dx.doi.org/10.1038/nm.3497			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24633304	Green Accepted			2022-12-27	WOS:000334361500016
J	Torres-Rosas, R; Yehia, G; Pena, G; Mishra, P; Thompson-Bonilla, MD; Moreno-Eutimio, MA; Arriaga-Pizano, LA; Isibasi, A; Ulloa, L				Torres-Rosas, Rafael; Yehia, Ghassan; Pena, Geber; Mishra, Priya; del Rocio Thompson-Bonilla, Maria; Adan Moreno-Eutimio, Mario; Andrea Arriaga-Pizano, Lourdes; Isibasi, Armando; Ulloa, Luis			Dopamine mediates vagal modulation of the immune system by electroacupuncture	NATURE MEDICINE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; TUMOR-NECROSIS-FACTOR; VAGUS NERVE; REGULATORY LYMPHOCYTES; SEVERE SEPSIS; SEPTIC SHOCK; DOUBLE-BLIND; ACUPUNCTURE; STIMULATION; FENOLDOPAM	Previous anti-inflammatory strategies against sepsis, a leading cause of death in hospitals, had limited efficacy in clinical trials, in part because they targeted single cytokines and the experimental models failed to mimic clinical settings(1-3). Neuronal networks represent physiological mechanisms, selected by evolution to control inflammation, that can be exploited for the treatment of inflammatory and infectious disorders(3). Here, we report that sciatic nerve activation with electroacupuncture controls systemic inflammation and rescues mice from polymicrobial peritonitis. Electroacupuncture at the sciatic nerve controls systemic inflammation by inducing vagal activation of aromatic L-amino acid decarboxylase, leading to the production of dopamine in the adrenal medulla. Experimental models with adrenolectomized mice mimic clinical adrenal insufficiency(4), increase the susceptibility to sepsis and prevent the anti-inflammatory effects of electroacupuncture. Dopamine inhibits cytokine production via dopamine type 1 (D1) receptors. D1 receptor agonists suppress systemic inflammation and rescue mice with adrenal insufficiency from polymicrobial peritonitis. Our results suggest a new anti-inflammatory mechanism mediated by the sciatic and vagus nerves that modulates the production of catecholamines in the adrenal glands. From a pharmacological perspective, the effects of selective dopamine agonists mimic the anti-inflammatory effects of electroacupuncture and can provide therapeutic advantages to control inflammation in infectious and inflammatory disorders.	[Torres-Rosas, Rafael; Yehia, Ghassan; Pena, Geber; Mishra, Priya; del Rocio Thompson-Bonilla, Maria; Ulloa, Luis] Rutgers State Univ, New Jersey Med Sch, Dept Surg, Lab Antiinflammatory Signaling, Newark, NJ 07102 USA; [Torres-Rosas, Rafael; Andrea Arriaga-Pizano, Lourdes; Isibasi, Armando] Natl Med Ctr Siglo XXI, Med Res Unit Immunochem, Mexico City, DF, Mexico; [del Rocio Thompson-Bonilla, Maria] Inst Social Secur & Serv States Employees Res Ins, Mexico City, DF, Mexico; [Adan Moreno-Eutimio, Mario] Hosp Juarez Mexico, Lab Immunobiol, Mexico City, DF, Mexico; [Ulloa, Luis] Rutgers State Univ, New Jersey Med Sch, Ctr Immunol & Inflammat, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ulloa, L (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Surg, Lab Antiinflammatory Signaling, Newark, NJ 07102 USA.	mail@luisulloa.com	pena, Geber/AAD-5890-2019; Arriaga-Pizano, Lourdes/AAI-9628-2021; Torres-Rosas, Rafael/G-6936-2019; Ulloa, Luis/AAE-8751-2019; Moreno-Eutimio, Mario Adán/E-6899-2019	Arriaga-Pizano, Lourdes/0000-0003-4433-2106; Torres-Rosas, Rafael/0000-0002-5934-003X; Ulloa, Luis/0000-0002-7702-7549; Moreno-Eutimio, Mario Adán/0000-0002-9955-8498	Mexican National Council for Science and Technology; Department of Surgery of the New Jersey Medical School; Foundation of University of Medicine and Dentistry of New Jersey; US National Institutes of Health [RO1-GM084125]; University Autonoma Benito Juarez de Oaxaca; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084125] Funding Source: NIH RePORTER	Mexican National Council for Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Department of Surgery of the New Jersey Medical School; Foundation of University of Medicine and Dentistry of New Jersey; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Autonoma Benito Juarez de Oaxaca; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Morcillo, J.M. Inclan-Rico and J.R. Berlin for their comments and suggestions and M. Marks (University of Colorado) and B. Kobilka (Stanford University) for the alpha<INF>7</INF>nAChR and beta<INF>2</INF>AR knockout mice. R.T.-R. was supported by the University Autonoma Benito Juarez de Oaxaca. M.d.R.T.-B. was supported by the Mexican National Council for Science and Technology. L.U. is supported by the faculty program of the Department of Surgery of the New Jersey Medical School, the Foundation of University of Medicine and Dentistry of New Jersey and US National Institutes of Health grant RO1-GM084125.	Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Altavilla D, 2006, SHOCK, V25, P500, DOI 10.1097/01.shk.0000209539.91553.82; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Annane D, 2008, CURR PHARM DESIGN, V14, P1882, DOI 10.2174/138161208784980626; Bernik TR, 2002, J VASC SURG, V36, P1231, DOI 10.1067/mva.2002.129643; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cal B., 2009, J CELL MOL MED, V13, P3774; COUPLAND RE, 1989, J ANAT, V163, P173; DENEF C, 1980, NATURE, V285, P243, DOI 10.1038/285243a0; Ernst E, 2011, PAIN, V152, P755, DOI 10.1016/j.pain.2010.11.004; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; GORISSEN H, 1979, NATURE, V279, P72, DOI 10.1038/279072a0; GRENADER A, 1991, J PHARMACOL EXP THER, V258, P193; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; LEE A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003281.PUB2; Morelli A, 2005, CRIT CARE MED, V33, P2451, DOI 10.1097/01.CCM.0000186413.04875.EF; Napadow V, 2004, J ALTERN COMPLEM MED, V10, P565, DOI 10.1089/1075553041323849; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pena G, 2011, J IMMUNOL, V187, P718, DOI 10.4049/jimmunol.1100013; PULLAN RD, 1994, NEW ENGL J MED, V330, P811, DOI 10.1056/NEJM199403243301202; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Ulloa L, 2009, CURR PHARM DESIGN, V15, P1918, DOI 10.2174/138161209788453248; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Vida G, 2011, FASEB J, V25, P4476, DOI 10.1096/fj.11-191007; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WEBER RR, 1988, BRIT J CLIN PHARMACO, V25, P17, DOI 10.1111/j.1365-2125.1988.tb03276.x; Wu HM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004131.pub2	33	329	368	12	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					291	295		10.1038/nm.3479	http://dx.doi.org/10.1038/nm.3479			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24562381	Green Accepted			2022-12-27	WOS:000332595600024
J	Li, PS; Fu, ZY; Zhang, YY; Zhang, JH; Xu, CQ; Ma, YT; Li, BL; Song, BL				Li, Pei-Shan; Fu, Zhen-Yan; Zhang, Ying-Yu; Zhang, Jin-Hui; Xu, Chen-Qi; Ma, Yi-Tong; Li, Bo-Liang; Song, Bao-Liang			The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1	NATURE MEDICINE			English	Article							FATE DETERMINANT NUMB; N-TERMINAL DOMAIN; UBIQUITIN LIGASE; EZETIMIBE BLOCKS; MAMMALIAN NUMB; PROTEIN; BINDING; INTERNALIZATION; PHOSPHORYLATION; IDENTIFICATION	Hypercholesterolemia, typically due to excessive cholesterol uptake, is a major risk factor for cardiovascular disease, which is responsible for similar to 50% of all deaths in developed societies. Although it has been shown that intestinal cholesterol absorption is mediated by vesicular endocytosis of the Niemann-Pick C1-like 1 (NPC1L1) protein(1,2), the mechanism of sterol-stimulated NPC1L1 internalization is still mysterious. Here, we identified an endocytic peptide signal, YVNXXF (where X stands for any amino acid), in the cytoplasmic C-terminal tail of NPC1L1. Cholesterol binding on the N-terminal domain of NPC1L1 released the YVNXXF-containing region of NPC1L1 from association with the plasma membrane and enabled Numb binding. We also found that Numb, a clathrin adaptor, specifically recognized this motif and recruited clathrin for internalization. Disrupting the NPC1L1-Numb interaction decreased cholesterol uptake. Ablation of Numb in mouse intestine significantly reduced dietary cholesterol absorption and plasma cholesterol level. Together, these data show that Numb is a pivotal protein for intestinal cholesterol absorption and may provide a therapeutic target for hypercholesterolemia.	[Li, Pei-Shan; Fu, Zhen-Yan; Zhang, Ying-Yu; Zhang, Jin-Hui; Xu, Chen-Qi; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Fu, Zhen-Yan; Ma, Yi-Tong] Xinjiang Med Univ, Dept Cardiovasc Med, Affiliated Hosp 1, Urumqi, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Xinjiang Medical University	Song, BL (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	blsong@sibcb.ac.cn	zhang, jinhui/GXF-6528-2022; zhang, jin/GXV-9154-2022	Xu, Chenqi/0000-0002-4968-6782; Song, Bao-Liang/0000-0002-6397-5935; Li, Peishan/0000-0002-6881-396X	Ministry of Science and Technology of China [2009CB919000, 2011CB910900, 2012CB524900]; National Natural Science Foundation of China [30925012, 31230020, 81260041, 81270155, 91213306]; Shanghai Science and Technology Committee [11JC1414100]; Xinjiang Science and Technology Department [2013911111]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Xinjiang Science and Technology Department	We thank Y.-X. Qu, J. Xu and J. Qin for technical assistance. We thank W. Qi for helpful discussion and revision of the paper. We thank S. Robine (Institut Curie) for the gift of transgenic mice (heterozygous for villin-Cre-ERT2). We thank S. Kathiresan, X. Lin and X.-F. Lu for discussions. This work was supported by grants from the Ministry of Science and Technology of China (2009CB919000, 2011CB910900 and 2012CB524900), National Natural Science Foundation of China (30925012, 31230020, 81260041, 81270155 and 91213306), Shanghai Science and Technology Committee (11JC1414100) and Xinjiang Science and Technology Department (2013911111).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Chang TY, 2008, CELL METAB, V7, P469, DOI 10.1016/j.cmet.2008.05.001; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2009, BBA-MOL CELL BIOL L, V1791, P679, DOI 10.1016/j.bbalip.2009.01.002; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Klein AL, 2004, DEV BIOL, V266, P161, DOI 10.1016/j.ydbio.2003.10.017; Kwon HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018722; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; SALISBURY BG, 1995, ATHEROSCLEROSIS, V115, P45, DOI 10.1016/0021-9150(94)05499-9; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Susini L, 2001, P NATL ACAD SCI USA, V98, P15067, DOI 10.1073/pnas.261571998; Tang JJ, 2011, CELL METAB, V13, P44, DOI 10.1016/j.cmet.2010.12.004; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Tong X, 2010, MOL BIOL CELL, V21, P802, DOI 10.1091/mbc.E09-09-0831; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Wang LJ, 2012, BBA-MOL CELL BIOL L, V1821, P964, DOI 10.1016/j.bbalip.2012.03.004; Wang LJ, 2011, J BIOL CHEM, V286, P7397, DOI 10.1074/jbc.M110.178368; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Xie C, 2012, J LIPID RES, V53, P2092, DOI 10.1194/jlr.M027359; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yogosawa S, 2003, BIOCHEM BIOPH RES CO, V302, P869, DOI 10.1016/S0006-291X(03)00282-1; Zhang JH, 2011, J BIOL CHEM, V286, P25088, DOI 10.1074/jbc.M111.244475	39	59	70	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					80	+		10.1038/nm.3417	http://dx.doi.org/10.1038/nm.3417			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24336247				2022-12-27	WOS:000329349400023
J	Sudhof, TC				Suedhof, Thomas C.			A molecular machine for neurotransmitter release: synaptotagmin and beyond	NATURE MEDICINE			English	Editorial Material							SYNAPTIC-VESICLE FUSION; BINDING; EXOCYTOSIS; PROTEINS; DOMAIN; SNARE; SENSOR; RIM		[Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Sudhof, TC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA.				Howard Hughes Medical Institute; NIMH and NINDS, US National Institutes of Health	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH and NINDS, US National Institutes of Health	I thank my lifelong mentors in science M.S. Brown, V.P. Whittaker and J.L. Goldstein for continuous advice, and my co-workers and collaborators for invaluable guidance and support, in particular R. Jahn, R.E. Hammer and J.Rizo. I am grateful to the Howard Hughes Medical Institute and the NIMH and NINDS, US National Institutes of Health, for financial support.	BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cao P, 2011, CELL, V145, P300, DOI 10.1016/j.cell.2011.03.034; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004	22	122	123	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1227	1231		10.1038/nm.3338	http://dx.doi.org/10.1038/nm.3338			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100992				2022-12-27	WOS:000325531700018
J	Jourdan, T; Godlewski, G; Cinar, R; Bertola, A; Szanda, G; Liu, J; Tam, J; Han, T; Mukhopadhyay, B; Skarulis, MC; Ju, C; Aouadi, M; Czech, MP; Kunos, G				Jourdan, Tony; Godlewski, Grzegorz; Cinar, Resat; Bertola, Adeline; Szanda, Gergo; Liu, Jie; Tam, Joseph; Han, Tiffany; Mukhopadhyay, Bani; Skarulis, Monica C.; Ju, Cynthia; Aouadi, Myriam; Czech, Michael P.; Kunos, George			Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes	NATURE MEDICINE			English	Article							THIOREDOXIN-INTERACTING PROTEIN; INDUCED INSULIN-RESISTANCE; CB1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTORS; ADIPOSE-TISSUE; OBESITY; EXPRESSION; LIVER; DEATH; DYSREGULATION	Type 2 diabetes mellitus (T2DM) progresses from compensated insulin resistance to beta cell failure resulting in uncompensated hyperglycemia, a process replicated in the Zucker diabetic fatty (ZDF) rat, The Nlrp3 inflammasome has been implicated in obesity-induced insulin resistance and beta cell failure. Endocannabinoids contribute to insulin resistance through activation of peripheral CB1 receptors (CB(1)Rs) and also promote beta cell failure. Here we show that beta cell failure in adult ZDF rats is not associated with CB1R signaling in beta cells, but rather in M1 macrophages infiltrating into pancreatic islets, and that this leads to activation of the Nlrp3-ASC inflammasome in the macrophages. These effects are replicated in vitro by incubating wild-type human or rodent macrophages, but not macrophages from CB1R-deficient (Cnr1(-/-)) or Nirp3(-/-) mice, with the endocannabinoid anandamide. Peripheral CB1R blockade, in vivo depletion of macrophages or macrophage-specific knockdown of CB1R reverses or prevents these changes and restores normoglycemia and glucose-induced insulin secretion. These findings implicate endocannabinoids and inflammasome activation in beta cell failure and identify macrophage-expressed CB1R as a therapeutic target in T2DM.	[Jourdan, Tony; Godlewski, Grzegorz; Cinar, Resat; Szanda, Gergo; Liu, Jie; Tam, Joseph; Han, Tiffany; Mukhopadhyay, Bani; Kunos, George] NIAAA, Lab Physiol Studies, US Natl Inst Hlth, Bethesda, MD USA; [Bertola, Adeline] NIAAA, Lab Liver Dis, US Natl Inst Hlth, Bethesda, MD USA; [Skarulis, Monica C.] NIDDK, Diabet Endocrinol & Obes Branch, US Natl Inst Hlth, Bethesda, MD USA; [Ju, Cynthia] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA; [Aouadi, Myriam; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Massachusetts System; University of Massachusetts Worcester	Jourdan, T (corresponding author), NIAAA, Lab Physiol Studies, US Natl Inst Hlth, Bethesda, MD USA.	jourdant@mail.nih.gov; george.kunos@nih.gov	Cinar, Resat/H-7219-2019	Cinar, Resat/0000-0002-8597-7253; Bertola, Adeline/0000-0002-4885-8423; Jourdan, Tony/0000-0001-7955-8127	intramural NIH funds; NIH [DK085753, AI046629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085753, ZIADK075007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350] Funding Source: NIH RePORTER	intramural NIH funds(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank J.F. McElroy and R.J. Chorvat (Jenrin Discovery) for providing the CB<INF>1</INF>R antagonist JD5037 and its inactive diastereomer, O. Gavrilova (NIDDK, US National Institutes of Health (NIH)) for advice on pancreatic islet isolation, J. Harvey-White for technical assistance, D. Feng for FACS analyses, R. Kechrid for assistance with the animal studies and P. Staker for collecting human blood specimens. This study was supported by intramural NIH funds. The work from M.P.C.'s laboratory was supported by grants from the NIH (DK085753 and AI046629).	Addy C, 2008, CELL METAB, V7, P68, DOI 10.1016/j.cmet.2007.11.012; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Calegari VC, 2011, J BIOL CHEM, V286, P12870, DOI 10.1074/jbc.M110.173021; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Geurts L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055963; Goossens GH, 2012, MOL IMMUNOL, V50, P142, DOI 10.1016/j.molimm.2012.01.005; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Han KH, 2009, CARDIOVASC RES, V84, P378, DOI 10.1093/cvr/cvp240; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jourdan T, 2012, HEPATOLOGY, V55, P790, DOI 10.1002/hep.24733; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Kharroubi I, 2003, BIOCHEM BIOPH RES CO, V312, P1118, DOI 10.1016/j.bbrc.2003.11.042; Kim W, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002519; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Le Foll B, 2009, PSYCHOPHARMACOLOGY, V205, P171, DOI 10.1007/s00213-009-1506-7; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lerner AG, 2012, CELL METAB, V16, P250, DOI 10.1016/j.cmet.2012.07.007; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Mukhopadhyay B, 2010, J BIOL CHEM, V285, P19002, DOI 10.1074/jbc.M109.068460; O'Hare JD, 2011, DIABETES, V60, P1055, DOI 10.2337/db10-0962; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Osundiji MA, 2012, DIABETES, V61, P321, DOI 10.2337/db11-1050; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Rohrbach K, 2012, DIABETES OBES METAB, V14, P555, DOI 10.1111/j.1463-1326.2012.01563.x; Rosenstock J, 2008, DIABETES CARE, V31, P2169, DOI 10.2337/dc08-0386; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tang YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042134; Tesz GJ, 2011, BIOCHEM J, V436, P351, DOI 10.1042/BJ20110352; Topp BG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1730, DOI 10.1152/ajpendo.00572.2007; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Vilches-Flores A, 2013, CLIN SCI, V124, P467, DOI 10.1042/CS20120447; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Youm YH, 2011, ENDOCRINOLOGY, V152, P4039, DOI 10.1210/en.2011-1326; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	59	288	309	0	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1132	1140		10.1038/nm.3265	http://dx.doi.org/10.1038/nm.3265			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23955712	Green Accepted			2022-12-27	WOS:000324083500027
J	Marco, S; Giralt, A; Petrovic, MM; Pouladi, MA; Martinez-Turrillas, R; Martinez-Hernandez, J; Kaltenbach, LS; Torres-Peraza, J; Graham, RK; Watanabe, M; Lujan, R; Nakanishi, N; Lipton, SA; Lo, DC; Hayden, MR; Alberch, J; Wesseling, JF; Perez-Otano, I				Marco, Sonia; Giralt, Albert; Petrovic, Milos M.; Pouladi, Mahmoud A.; Martinez-Turrillas, Rebeca; Martinez-Hernandez, Jose; Kaltenbach, Linda S.; Torres-Peraza, Jesus; Graham, Rona K.; Watanabe, Masahiko; Lujan, Rafael; Nakanishi, Nobuki; Lipton, Stuart A.; Lo, Donald C.; Hayden, Michael R.; Alberch, Jordi; Wesseling, John F.; Perez-Otano, Isabel			Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models	NATURE MEDICINE			English	Article							YAC128 MOUSE MODEL; NR3A-CONTAINING NMDA RECEPTORS; KNOCK-IN MICE; MUTANT HUNTINGTIN; POLYGLUTAMINE EXPANSION; QUINOLINIC ACID; TRANSGENIC MICE; SUBUNIT NR3A; CAG REPEAT; BRAIN	Huntington's disease is caused by an expanded polyglutamine repeat in the huntingtin protein (HTT), but the pathophysiological sequence of events that trigger synaptic failure and neuronal loss are not fully understood. Alterations in N-methyl-D-aspartate (NMDA)-type glutamate receptors (NMDARs) have been implicated. Yet, it remains unclear how the HTT mutation affects NMDAR function, and direct evidence for a causative role is missing. Here we show that mutant HTT redirects an intracellular store of juvenile NMDARs containing GluN3A subunits to the surface of striatal neurons by sequestering and disrupting the subcellular localization of the endocytic adaptor PACSIN1, which is specific for GluN3A. Overexpressing GluN3A in wild-type mouse striatum mimicked the synapse loss observed in Huntington's disease mouse models, whereas genetic deletion of GluN3A prevented synapse degeneration, ameliorated motor and cognitive decline and reduced striatal atrophy and neuronal loss in the YAC128 Huntington's disease mouse model. Furthermore, GluN3A deletion corrected the abnormally enhanced NMDAR currents, which have been linked to cell death in Huntington's disease and other neurodegenerative conditions. Our findings reveal an early pathogenic role of GluN3A dysregulation in Huntington's disease and suggest that therapies targeting GluN3A or pathogenic HTT-PACSIN1 interactions might prevent or delay disease progression.	[Marco, Sonia; Petrovic, Milos M.; Martinez-Turrillas, Rebeca; Wesseling, John F.; Perez-Otano, Isabel] CIMA, Cellular Neurobiol & Neurophysiol Labs, Pamplona, Spain; [Marco, Sonia; Petrovic, Milos M.; Martinez-Turrillas, Rebeca; Wesseling, John F.; Perez-Otano, Isabel] Univ Navarra, E-31080 Pamplona, Spain; [Giralt, Albert; Torres-Peraza, Jesus; Alberch, Jordi] Univ Barcelona, Sch Med, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Dept Cellular Biol Immunol & Neurosci, Barcelona, Spain; [Petrovic, Milos M.] Univ Belgrade, Sch Med, Inst Med Physiol, Belgrade, Serbia; [Pouladi, Mahmoud A.; Graham, Rona K.; Hayden, Michael R.] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Pouladi, Mahmoud A.; Hayden, Michael R.] Natl Univ Singapore, Dept Med, TLGM, Singapore 117548, Singapore; [Pouladi, Mahmoud A.; Hayden, Michael R.] ASTAR, Singapore, Singapore; [Martinez-Hernandez, Jose; Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, CRIB, Albacete, Spain; [Kaltenbach, Linda S.; Lo, Donald C.] Duke Univ, Med Ctr, Ctr Drug Discovery, Durham, NC USA; [Kaltenbach, Linda S.; Lo, Donald C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 060, Japan; [Nakanishi, Nobuki; Lipton, Stuart A.] Sanford Burnham Med Res Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA USA; [Hayden, Michael R.] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel	University of Navarra; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Belgrade; Child & Family Research Institute; University of British Columbia; National University of Singapore; Agency for Science Technology & Research (A*STAR); Universidad de Castilla-La Mancha; Duke University; Duke University; Hokkaido University; Sanford Burnham Prebys Medical Discovery Institute; Teva Pharmaceutical Industries	Perez-Otano, I (corresponding author), CIMA, Cellular Neurobiol & Neurophysiol Labs, Pamplona, Spain.	otano@unav.es	Wesseling, John F/AAB-7941-2019; Giralt, Albert/AAA-5308-2020; Marco, Sonia/AAB-4691-2019; Martinez-Hernandez, Jose/ABE-3991-2020; Martinez-Hernandez, Jose/A-6760-2012; Alberch, Jordi/K-5702-2014; Pouladi, Mahmoud A/B-8743-2016; Hayden, Michael R/D-8581-2011; Graham, Rona K/R-7358-2018; Lujan, Rafael/G-2555-2015; Giralt, Albert/M-7672-2015; Watanabe, Masahiko/S-3614-2019; Perez-Otano, Isabel/S-9613-2017; Marco, Sonia/AAA-6591-2019	Wesseling, John F/0000-0002-7565-2594; Marco, Sonia/0000-0001-5930-9553; Martinez-Hernandez, Jose/0000-0002-5017-2877; Martinez-Hernandez, Jose/0000-0002-5017-2877; Alberch, Jordi/0000-0002-8684-2721; Pouladi, Mahmoud A/0000-0002-9030-0976; Hayden, Michael R/0000-0001-5159-1419; Graham, Rona K/0000-0003-3722-6241; Giralt, Albert/0000-0001-5334-0963; Watanabe, Masahiko/0000-0001-5037-7138; Perez-Otano, Isabel/0000-0002-7222-8202; Marco, Sonia/0000-0001-5930-9553; Martinez, Rebeca/0000-0003-1013-7898; Lipton, Stuart/0000-0002-3490-1259; Lujan Miras, Rafael/0000-0003-2001-9545	Union Temporal de Empresas (UTE) project at the Centro de Investigacion Medica Aplicada; Spanish Ministry of Science [SAF2010-20636, CSD2008-00005, BFU2009-12160, SAF2011-29507]; Hereditary Disease Foundation; US National Institutes of Health [P01 HD29587, P01 ES016738, R01 EY05477]; Cure Huntington's Disease Initiative; Canadian Institutes of Health Research; Gobierno de Navarra; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY005477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016738] Funding Source: NIH RePORTER	Union Temporal de Empresas (UTE) project at the Centro de Investigacion Medica Aplicada; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Hereditary Disease Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Huntington's Disease Initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Gobierno de Navarra; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Finkbeiner (Gladstone Institute, University of California San Francisco), H. Zoghbi (Baylor College of Medicine), T. Yamamoto (University of Tokyo) and M. Ehlers (Pfizer Neuroscience) for providing reagents, A. Zandueta, C. Rodr guez-Vina, F. Ballesteros, X. Remirez and M. Montanana for excellent technical help, M. Galarraga for advice with image analysis, and M. Ehlers, M. Arrasate, T. Aragon, J.A. Esteban and B. D. Philpot for critical readings of the manuscript. This work was funded by the Union Temporal de Empresas (UTE) project at the Centro de Investigacion Medica Aplicada, Gobierno de Navarra, and Spanish Ministry of Science grants (SAF2010-20636 and CSD2008-00005 to I.P.-O., BFU2009-12160 to J.F.W. and SAF2011-29507 to J.A.), grants from the Hereditary Disease Foundation (to I.P.-O. and D.C.L.), US National Institutes of Health grants P01 HD29587, P01 ES016738 and R01 EY05477 (to S.A.L.) and grants from the Cure Huntington's Disease Initiative and the Canadian Institutes of Health Research (to M.R.H.). M.R.H., a Killam University Professor, holds a Canada Research Chair in Human Genetics.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Cepeda C, 2007, PROG NEUROBIOL, V81, P253, DOI 10.1016/j.pneurobio.2006.11.001; Cummings DM, 2010, ASN NEURO, V2, P147, DOI 10.1042/AN20100007; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Giralt A, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-71; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; Graham RK, 2009, J NEUROSCI, V29, P2193, DOI 10.1523/JNEUROSCI.5473-08.2009; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Grosshans D.R., 2002, SCI STKE, V2002, P18, DOI DOI 10.1126/stke.2002.137.pl8; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Henson MA, 2010, PROG NEUROBIOL, V91, P23, DOI 10.1016/j.pneurobio.2010.01.004; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Li JY, 2003, TRENDS MOL MED, V9, P414, DOI 10.1016/j.molmed.2003.08.006; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li XY, 2009, MOL CELL BIOL, V29, P6106, DOI 10.1128/MCB.00420-09; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martinez-Turrillas R, 2012, NEUROBIOL DIS, V48, P290, DOI 10.1016/j.nbd.2012.07.001; Mazarakis NK, 2005, J NEUROSCI, V25, P3059, DOI 10.1523/JNEUROSCI.4320-04.2005; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Modregger J, 2002, HUM MOL GENET, V11, P2547, DOI 10.1093/hmg/11.21.2547; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Nakanishi N, 2009, J NEUROSCI, V29, P5260, DOI 10.1523/JNEUROSCI.1067-09.2009; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Qin ZH, 2004, J NEUROSCI, V24, P269, DOI 10.1523/JNEUROSCI.1409-03.2004; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Reinhart PH, 2011, NEUROBIOL DIS, V43, P248, DOI 10.1016/j.nbd.2011.03.017; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Rudnicki DD, 2008, J NEUROPATH EXP NEUR, V67, P366, DOI 10.1097/NEN.0b013e31816b4aee; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Starling AJ, 2005, J NEUROSCI RES, V82, P377, DOI 10.1002/jnr.20651; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Wong HK, 2002, J COMP NEUROL, V450, P303, DOI 10.1002/cne.10314; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3	59	78	80	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1030	+		10.1038/nm.3246	http://dx.doi.org/10.1038/nm.3246			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23852340	Green Accepted, Green Published			2022-12-27	WOS:000322779600029
J	Ranasinghe, S; Cutler, S; Davis, I; Lu, R; Soghoian, DZ; Qi, Y; Sidney, J; Kranias, G; Flanders, MD; Lindqvist, M; Kuhl, B; Alter, G; Deeks, SG; Walker, BD; Gao, XJ; Sette, A; Carrington, M; Streeck, H				Ranasinghe, Srinika; Cutler, Sam; Davis, Isaiah; Lu, Richard; Soghoian, Damien Z.; Qi, Ying; Sidney, John; Kranias, Gregory; Flanders, Michael D.; Lindqvist, Madelene; Kuhl, Bjorn; Alter, Galit; Deeks, Steven G.; Walker, Bruce D.; Gao, Xiaojiang; Sette, Alessandro; Carrington, Mary; Streeck, Hendrik			Association of HLA-DRB1-restricted CD4(+) T cell responses with HIV immune control	NATURE MEDICINE			English	Article							INFECTION; PROGRESSION; MOLECULES; PROTEINS; EPITOPES	The contribution of HLA class II-restricted CD4(+) T cell responses to HIV immune control is poorly defined. Here, we delineated previously uncharacterized peptide-DRB1 restrictions in functional assays and analyzed the host genetic effects of HLA-DRB1 alleles on HIV viremia in a large cohort of HIV controllers and progressors. We found distinct stratifications in the effect of HLA-DRB1 alleles on HIV viremia, with HLA-DRB1*15:02 significantly associated with low viremia and HLA-DRB1*03:01 significantly associated with high viremia. Notably, a subgroup of HLA-DRB1 variants linked with low viremia showed the ability to promiscuously present a larger breadth of peptides with lower functional avidity when compared to HLA-DRB1 variants linked with high viremia. Our data provide systematic evidence that HLA-DRB1 variant expression has a considerable impact on the control of HIV replication, an effect that seems to be mediated primarily by the protein specificity of CD4(+) T cell responses to HIV Gag and Nef.	[Ranasinghe, Srinika; Cutler, Sam; Davis, Isaiah; Lu, Richard; Soghoian, Damien Z.; Kranias, Gregory; Flanders, Michael D.; Lindqvist, Madelene; Kuhl, Bjorn; Alter, Galit; Walker, Bruce D.; Carrington, Mary; Streeck, Hendrik] MIT, Ragon Inst MGH, Cambridge, MA 02139 USA; [Ranasinghe, Srinika; Cutler, Sam; Davis, Isaiah; Lu, Richard; Soghoian, Damien Z.; Kranias, Gregory; Flanders, Michael D.; Lindqvist, Madelene; Kuhl, Bjorn; Alter, Galit; Walker, Bruce D.; Carrington, Mary; Streeck, Hendrik] Harvard Univ, Cambridge, MA 02138 USA; [Qi, Ying; Gao, Xiaojiang; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, Sci Applicat Int Corp Frederick, Frederick, MD 21701 USA; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); La Jolla Institute for Immunology; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Streeck, H (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Henry M Jackson Fdn, Silver Spring, MD USA.	hstreeck@hivresearch.org	Sette, Alessandro/AFO-8916-2022		US National Institutes of Health (NIH) [R01 AI091450, R01 AI094602]; Henry M. Jackson Foundation; US Department of Defense [W81XWH-07-2-0067]; NIH/National Institute of Allergy and Infectious Diseases (NIAID) [5P30AI060354-09]; Center for HIV/AIDS Immunology and Immunogen Discovery (CHAVI-ID); MGH Executive Committee on Research Fund for Medical Discovery; US Intramural Research Program of the US National Institutes of Health, National Cancer Institute (NCI), Center for Cancer Research [HHSN261200800001E]; Centers for AIDS Research at UCSF [PO AI27763]; CFAR Network of Integrated Systems [R24 AI067039]; UCSF Clinical and Translational Science Institute [UL1 RR024131]; NIAID [RO1 AI087145, K24 AI069994]; Mark and Lisa Schwartz Foundation; Bill & Melinda Gates Foundation; AIDS Healthcare Foundation; CFAR, an NIH [P30 AI060354]; NIH; NIAID; NCI; National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; National Institute on Drug Abuse; National Institute of Mental Health; National Institute on Aging; Fogarty International Center; Organization for Autism Research; NATIONAL CANCER INSTITUTE [ZICBC011237, ZIABC010791] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094602, R24AI067039, R01AI091450, K24AI069994, P30AI027763, P30AI060354, R01AI087145] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry M. Jackson Foundation; US Department of Defense(United States Department of Defense); NIH/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV/AIDS Immunology and Immunogen Discovery (CHAVI-ID); MGH Executive Committee on Research Fund for Medical Discovery; US Intramural Research Program of the US National Institutes of Health, National Cancer Institute (NCI), Center for Cancer Research; Centers for AIDS Research at UCSF; CFAR Network of Integrated Systems; UCSF Clinical and Translational Science Institute; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mark and Lisa Schwartz Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); AIDS Healthcare Foundation; CFAR, an NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Organization for Autism Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all individuals whose participation enabled this study. This study was funded by the US National Institutes of Health (NIH) (R01 AI091450 and R01 AI094602). H. S. is funded through R01 AI091450 and R01 AI094602 and the Henry M. Jackson Foundation by a cooperative agreement between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the US Department of Defense (W81XWH-07-2-0067). S. R. is supported by a Harvard CFAR Scholar Award (NIH/National Institute of Allergy and Infectious Diseases (NIAID) 5P30AI060354-09), Center for HIV/AIDS Immunology and Immunogen Discovery (CHAVI-ID) and MGH Executive Committee on Research Fund for Medical Discovery. This project has also been funded in part with federal funds from the US Intramural Research Program of the US National Institutes of Health, National Cancer Institute (NCI), Center for Cancer Research, under contract HHSN261200800001E. The UCSF SCOPE cohort was supported by the Centers for AIDS Research at UCSF (PO AI27763), CFAR Network of Integrated Systems (R24 AI067039), the UCSF Clinical and Translational Science Institute (UL1 RR024131), and NIAID (RO1 AI087145 and K24 AI069994). The MGH cohort was supported by the Mark and Lisa Schwartz Foundation and the Collaboration of AIDS Vaccine Discovery of the Bill & Melinda Gates Foundation. This research has been supported in part by the International HIV Controllers Study, funded by the Bill & Melinda Gates Foundation, the AIDS Healthcare Foundation and CFAR, an NIH-funded program (P30 AI060354) that is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Institute of Mental Health, National Institute on Aging, Fogarty International Center and Organization for Autism Research. We thank M. Ghebremichael for statistical assistance and Y. Yuki for HLA genotyping. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.	Apps R, 2013, SCIENCE, V340, P87, DOI 10.1126/science.1232685; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Carrington M, 2012, ANNU REV MED, V63, P131, DOI 10.1146/annurev-med-062909-130018; Caserta S, 2010, J IMMUNOL, V185, P6545, DOI 10.4049/jimmunol.1001867; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gerlach JT, 2005, J VIROL, V79, P12425, DOI 10.1128/JVI.79.19.12425-12433.2005; Julg B, 2011, J INFECT DIS, V203, P803, DOI 10.1093/infdis/jiq122; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Mallone R, 2005, BLOOD, V106, P2798, DOI 10.1182/blood-2004-12-4848; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Southwood S, 1998, J IMMUNOL, V160, P3363; Streeck H, 2013, NAT MED, V19, P143, DOI 10.1038/nm.3054; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	21	68	70	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2013	19	7					930	+		10.1038/nm.3229	http://dx.doi.org/10.1038/nm.3229			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23793098	Green Submitted, Green Accepted			2022-12-27	WOS:000321557700038
J	Busquets-Garcia, A; Gomis-Gonzalez, M; Guegan, T; Agustin-Pavon, C; Pastor, A; Mato, S; Perez-Samartin, A; Matute, C; de la Torre, R; Dierssen, M; Maldonado, R; Ozaita, A				Busquets-Garcia, Arnau; Gomis-Gonzalez, Maria; Guegan, Thomas; Agustin-Pavon, Carmen; Pastor, Antoni; Mato, Susana; Perez-Samartin, Alberto; Matute, Carlos; de la Torre, Rafael; Dierssen, Mara; Maldonado, Rafael; Ozaita, Andres			Targeting the endocannabinoid system in the treatment of fragile X syndrome	NATURE MEDICINE			English	Article							GABA(A) RECEPTOR; MICE LACKING; MEMORY; MECHANISMS; PLASTICITY; MODEL; FMRP	Fragile X syndrome (FXS), the most common monogenic cause of inherited intellectual disability and autism(1), is caused by the silencing of the FMR1 gene, leading to the loss of fragile X mental retardation protein (FMRP)(2), a synaptically expressed RNA-binding protein regulating translation(3). The Fmr1 knockout model recapitulates the main traits of the disease(4). Uncontrolled activity of metabotropic glutamate receptor 5 (mGluR5)(5,6) and mammalian target of rapamycin (mTOR) signaling(7-9) seem crucial in the pathophysiology of this disease. The endocannabinoid system (ECS) is a key modulator of synaptic plasticity, cognitive performance, anxiety, nociception and seizure susceptibility(10), all of which are affected in FXS. The ECS receptors, CB1 (CB1R) and CB2 (CB2R), are activated by phospholipid-derived endocannabinoids. Synaptic activation of mGluR5 initiates the synthesis of endocannabinoids(10,11) and promotes CB1R-driven long-term depression of synaptic strength(10). Notably, mGluR5 activation is altered in several brain areas of Fmr1 knockout mice(12-14). We found that CB1R blockade in male Fmr1 knockout (Fmr1-(/y)) mice through pharmacological and genetic approaches normalized cognitive impairment, nociceptive desensitization, susceptibility to audiogenic seizures, overactivated mTOR signaling and altered spine morphology, whereas pharmacological blockade of CB2R normalized anxiolytic-like behavior. Some of these traits were also reversed by pharmacological inhibition of mTOR or mGluR5. Thus, blockade of ECS is a potential therapeutic approach to normalize specific alterations in FXS.	[Busquets-Garcia, Arnau; Gomis-Gonzalez, Maria; Guegan, Thomas; de la Torre, Rafael; Maldonado, Rafael; Ozaita, Andres] UPF, Dept Ciencies Experimentals Salut DCEXS, Barcelona, Spain; [Agustin-Pavon, Carmen; Dierssen, Mara] Ctr Genom Regulat CRG, Barcelona, Spain; [Agustin-Pavon, Carmen; Dierssen, Mara] UPF, Barcelona, Spain; [Pastor, Antoni; de la Torre, Rafael] Inst Hosp Mar Investigac Med IMIM, Grup Recerca Clin Farmacol Humana Neurociencies, Barcelona, Spain; [Pastor, Antoni] Univ Autonoma Barcelona, Fac Med, E-08193 Barcelona, Spain; [Mato, Susana; Perez-Samartin, Alberto; Matute, Carlos] Univ Basque Country, Dept Neurociencias, Neurobiol Lab, Leioa, Spain; [Mato, Susana; Perez-Samartin, Alberto; Matute, Carlos] Achucarro Basque Ctr Neurosci, Zamudio, Spain; [Mato, Susana; Perez-Samartin, Alberto; Matute, Carlos] Inst Salud Carlos III, Ctr Investigac Biomed Red Enfermedades Neurodegen, Leioa, Spain; [de la Torre, Rafael] Univ Santiago de Compostela, Hosp Clin, CIBER Fisiopatol Obesidad & Nutr CB06 03 CIBEROBN, Santiago De Compostela, Spain; [Dierssen, Mara] CIBER Enfermedades Raras CIBERER, Barcelona, Spain	Pompeu Fabra University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Autonomous University of Barcelona; University of Barcelona; University of Basque Country; CIBERNED; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Ozaita, A (corresponding author), UPF, Dept Ciencies Experimentals Salut DCEXS, Barcelona, Spain.	andres.ozaita@upf.edu	Ozaita, Andres/H-3411-2015; Agustín-Pavón, Carmen/ABA-8740-2021; Maldonado, Rafael/F-5657-2014; Samartín, Alberto Pérez/AAB-6428-2019; Samartín, Alberto Pérez/AAB-1336-2019; Agustín-Pavón, Carmen/A-5638-2013; Busquets-Garcia, Arnau/A-7307-2018; de la Torre, Rafael/D-3561-2018; Matute, Carlos/N-5559-2014; Busquets-Garcia, Arnau/Y-5856-2019; Pastor, Antoni/AAD-4638-2020; Dierssen, Mara/G-3552-2015; Mato, Susana/AAU-3129-2020	Ozaita, Andres/0000-0002-2239-7403; Maldonado, Rafael/0000-0002-4359-8773; Samartín, Alberto Pérez/0000-0003-0834-0424; Agustín-Pavón, Carmen/0000-0002-6725-6954; Busquets-Garcia, Arnau/0000-0002-7100-8873; de la Torre, Rafael/0000-0002-6765-1866; Matute, Carlos/0000-0001-8672-711X; Busquets-Garcia, Arnau/0000-0002-7100-8873; Pastor, Antoni/0000-0003-3692-0696; Dierssen, Mara/0000-0003-0853-6865; Mato, Susana/0000-0002-2005-9793; Guegan, Thomas/0000-0001-5433-408X	Ministerio de Ciencia e Innovacion [SAF2009-07309, BFU2012-33500, SAF2011-29864, SAF2010-21547]; CureFXS E-Rare EU/FIS [PS09102673]; Instituto de Salud Carlos III [RD06/0001/0001]; PLAN E (Plan Espanol para el Estimulo de la Economia y el Empleo); Generalitat de Catalunya [SGR-2009-00731, SGR-2009-00718]; ICREA (Institucio Catalana de Recerca i Estudis Avancats) Academia; Ministerio de Educacion y Cultura; Fundacio La Marato de TV3 [090910]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CureFXS E-Rare EU/FIS; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); PLAN E (Plan Espanol para el Estimulo de la Economia y el Empleo); Generalitat de Catalunya(Generalitat de Catalunya); ICREA (Institucio Catalana de Recerca i Estudis Avancats) Academia(ICREA); Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Fundacio La Marato de TV3	We thank C. Fernandez-Aviles, D. Real, M. Linares and H. Gomez for expert technical assistance and O.J. Manzoni for helpful comments. Fmr1 knockout mice in the C57BL/6J background were kindly provided by D. Nelson at Baylor College of Medicine. A.B.-G. is the recipient of a predoctoral fellowship (Ministerio de Educacion y Cultura). S.M. is the recipient of a Ramon y Cajal contract (Ministerio de Educacion y Cultura). This study was supported by grants from Fundacio La Marato de TV3 (090910 to A.O.), Grants from the Ministerio de Ciencia e Innovacion (SAF2009-07309 and BFU2012-33500 to A.O., SAF2011-29864 to R.M. and SAF2010-21547 to C.M.), CureFXS E-Rare EU/FIS PS09102673 to M.D., Instituto de Salud Carlos III (RD06/0001/0001 to R.M.), PLAN E (Plan Espanol para el Estimulo de la Economia y el Empleo), Generalitat de Catalunya (SGR-2009-00731 to R.M. and SGR-2009-00718 to R.d.I.T.) and ICREA (Institucio Catalana de Recerca i Estudis Avancats) Academia to R.M.	Troca-Marin JA, 2012, PROG NEUROBIOL, V96, P268, DOI 10.1016/j.pneurobio.2012.01.005; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bhattacharya A, 2012, NEURON, V76, P325, DOI 10.1016/j.neuron.2012.07.022; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; D'Hulst C, 2007, TRENDS NEUROSCI, V30, P425, DOI 10.1016/j.tins.2007.06.003; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; de Vries BBA, 1998, J MED GENET, V35, P579, DOI 10.1136/jmg.35.7.579; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Jung KM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2045; Kang-Park MH, 2007, J NEUROPHYSIOL, V98, P1223, DOI 10.1152/jn.00091.2007; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Price TJ, 2007, J NEUROSCI, V27, P13958, DOI 10.1523/JNEUROSCI.4383-07.2007; Puighermanal E, 2012, PHILOS T R SOC B, V367, P3254, DOI 10.1098/rstb.2011.0384; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wei HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036981; Zhang LH, 2010, J NEUROSCI, V30, P5724, DOI 10.1523/JNEUROSCI.0795-10.2010	30	154	158	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					603	607		10.1038/nm.3127	http://dx.doi.org/10.1038/nm.3127			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23542787	Green Accepted			2022-12-27	WOS:000318583000032
J	Lu, GM; DeGuzman, FR; Hollenbach, SJ; Karbarz, MJ; Abe, K; Lee, G; Luan, P; Hutchaleelaha, A; Inagaki, M; Conley, PB; Phillips, DR; Sinha, U				Lu, Genmin; DeGuzman, Francis R.; Hollenbach, Stanley J.; Karbarz, Mark J.; Abe, Keith; Lee, Gail; Luan, Peng; Hutchaleelaha, Athiwat; Inagaki, Mayuko; Conley, Pamela B.; Phillips, David R.; Sinha, Uma			A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa	NATURE MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; PROTHROMBIN COMPLEX CONCENTRATE; INCOMPLETE REVERSAL; FACTOR VIIA; IN-VIVO; ANTITHROMBIN; RIVAROXABAN; PROTAMINE; ACTIVATION; ENOXAPARIN	Inhibitors of coagulation factor Xa (fXa) have emerged as a new class of antithrombotics but lack effective antidotes for patients experiencing serious bleeding. We designed and expressed a modified form of fXa as an antidote for fXa inhibitors. This recombinant protein (r-Antidote, PRT064445) is catalytically inactive and lacks the membrane-binding gamma-carboxyglutamic acid domain of native fXa but retains the ability of native fXa to bind direct fXa inhibitors as well as low molecular weight heparin-activated antithrombin III (ATIII). r-Antidote dose-dependently reversed the inhibition of fXa by direct fXa inhibitors and corrected the prolongation of ex vivo clotting times by such inhibitors. In rabbits treated with the direct fXa inhibitor rivaroxaban, r-Antidote restored hemostasis in a liver laceration model. The effect of r-Antidote was mediated by reducing plasma anti-fXa activity and the non-protein bound fraction of the fXa inhibitor in plasma. In rats, r-Antidote administration dose-dependently and completely corrected increases in blood loss resulting from ATIII-dependent anticoagulation by enoxaparin or fondaparinux. r-Antidote has the potential to be used as a universal antidote for a broad range of fXa inhibitors.	[Lu, Genmin; Karbarz, Mark J.; Luan, Peng; Conley, Pamela B.; Phillips, David R.; Sinha, Uma] Portola Pharmaceut Inc, Dept Biol, San Francisco, CA 94080 USA; [DeGuzman, Francis R.; Hollenbach, Stanley J.; Abe, Keith; Lee, Gail] Portola Pharmaceut Inc, Dept Pharmacol, San Francisco, CA USA; [Hutchaleelaha, Athiwat; Inagaki, Mayuko] Portola Pharmaceut Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA USA		Sinha, U (corresponding author), Portola Pharmaceut Inc, Dept Biol, San Francisco, CA 94080 USA.	usinha@portola.com		DeGuzman, Francis/0000-0002-4479-1129				ANDRASSY K, 1994, THROMB RES, V73, P85, DOI 10.1016/0049-3848(94)90083-3; BANG CJ, 1991, HAEMOSTASIS, V21, P155; Bershad EM, 2010, NEUROCRIT CARE, V12, P403, DOI 10.1007/s12028-009-9310-0; Bianchini EP, 2011, BLOOD, V117, P2054, DOI 10.1182/blood-2010-06-288522; CAROTHERS AM, 1983, NUCLEIC ACIDS RES, V11, P1997, DOI 10.1093/nar/11.7.1997; CAROTHERS AM, 1990, P NATL ACAD SCI USA, V87, P5464, DOI 10.1073/pnas.87.14.5464; Chawla LS, 2004, OBES SURG, V14, P695, DOI 10.1381/096089204323093516; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Crowther MA, 2009, J THROMB HAEMOST, V7, P107, DOI 10.1111/j.1538-7836.2009.03429.x; Crowther MA, 2002, BRIT J HAEMATOL, V116, P178, DOI 10.1046/j.1365-2141.2002.03233.x; Crowther MA, 2008, BLOOD, V111, P4871, DOI 10.1182/blood-2007-10-120543; DEJANA E, 1982, THROMB HAEMOSTASIS, V48, P108; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Godier A, 2012, ANESTHESIOLOGY, V116, P94, DOI 10.1097/ALN.0b013e318238c036; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Huntington JA, 2003, J THROMB HAEMOST, V1, P1535, DOI 10.1046/j.1538-7836.2003.00305.x; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; Kuziej J, 2010, CLIN APPL THROMB-HEM, V16, P377, DOI 10.1177/1076029610366439; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Lauritzen B, 2008, J THROMB HAEMOST, V6, P804, DOI 10.1111/j.1538-7836.2008.02933.x; Levi M, 2004, SEMIN HEMATOL, V41, P65, DOI 10.1053/j.seminhematol.2003.11.013; MANN KG, 1990, BLOOD, V76, P1; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P198, DOI 10.1016/S1050-1738(02)00160-3; Paolucci F, 2002, CLIN PHARMACOKINET, V41, P11, DOI 10.2165/00003088-200241002-00002; Perzborn E, 2005, J THROMB HAEMOST, V3, P514, DOI 10.1111/j.1538-7836.2005.01166.x; Pinto DJP, 2007, J MED CHEM, V50, P5339, DOI 10.1021/jm070245n; Pryzdial ELG, 1996, J BIOL CHEM, V271, P16621, DOI 10.1074/jbc.271.28.16621; Pryzdial ELG, 1996, J BIOL CHEM, V271, P16614, DOI 10.1074/jbc.271.28.16614; SINHA U, 1992, PROTEIN EXPRES PURIF, V3, P518, DOI 10.1016/1046-5928(92)90070-D; Sinha U, 2006, BLOOD, V108, p272A; SMITH TW, 1976, NEW ENGL J MED, V294, P797, DOI 10.1056/NEJM197604082941501; Weitz JI, 2010, THROMB HAEMOSTASIS, V104, P633, DOI 10.1160/TH10-01-0066	35	498	526	2	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					446	+		10.1038/nm.3102	http://dx.doi.org/10.1038/nm.3102			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23455714	Green Published			2022-12-27	WOS:000317109100029
J	Doan, PL; Himburg, HA; Helms, K; Russell, JL; Fixsen, E; Quarmyne, M; Harris, JR; Deoliviera, D; Sullivan, JM; Chao, NJ; Kirsch, DG; Chute, JP				Doan, Phuong L.; Himburg, Heather A.; Helms, Katherine; Russell, J. Lauren; Fixsen, Emma; Quarmyne, Mamle; Harris, Jeffrey R.; Deoliviera, Divino; Sullivan, Julie M.; Chao, Nelson J.; Kirsch, David G.; Chute, John P.			Epidermal growth factor regulates hematopoietic regeneration after radiation injury	NATURE MEDICINE			English	Article							EX-VIVO CULTURE; FACTOR RECEPTOR; ENDOTHELIAL-CELLS; STEM-CELLS; PROGENITOR CELLS; EGF RECEPTOR; REPOPULATING CAPACITY; SOLUBLE FACTORS; DNA-DAMAGE; ACTIVATION	The mechanisms that regulate hematopoietic stem cell (HSC) regeneration after myelosuppressive injury are not well understood. We identified epidermal growth factor (EGF) to be highly enriched in the bone marrow serum of mice bearing deletion of Bak and Bax in TIE2-expressing cells in Tie2Cre; Bak1(-/-); Bax(flox/-) mice. These mice showed radioprotection of the HSC pool and 100% survival after a lethal dose of total-body irradiation (TBI). Bone marrow HSCs from wild-type mice expressed functional EGF receptor (EGFR), and systemic administration of EGF promoted the recovery of the HSC pool in vivo and improved the survival of mice after TBI. Conversely, administration of erlotinib, an EGFR antagonist, decreased both HSC regeneration and the survival of mice after TBI. Mice with EGFR deficiency in VAV-expressing hematopoietic cells also had delayed recovery of bone marrow stem and progenitor cells after TBI. Mechanistically, EGF reduced radiation-induced apoptosis of HSCs and mediated this effect through repression of the proapoptotic protein PUMA. Our findings show that EGFR signaling regulates HSC regeneration after myelosuppressive injury.	[Doan, Phuong L.; Himburg, Heather A.; Helms, Katherine; Russell, J. Lauren; Fixsen, Emma; Harris, Jeffrey R.; Deoliviera, Divino; Chao, Nelson J.; Chute, John P.] Duke Univ, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA; [Quarmyne, Mamle; Kirsch, David G.; Chute, John P.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Sullivan, Julie M.; Kirsch, David G.] Duke Univ, Dept Radiat Oncol, Durham, NC USA; [Chao, Nelson J.] Duke Univ, Dept Immunol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Chute, JP (corresponding author), Duke Univ, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA.	john.chute@duke.edu	Doan, Phuong L./Q-2093-2019	Doan, Phuong L./0000-0003-1361-2068	National Heart, Lung and Blood Institute [HL-086998-01]; National Institute of Allergy and Infectious Diseases (NIAID) [AI-067798-06]; NIAID Centers for Medical Countermeasures [AI-067798-01]; US National Institutes of Health [T32 HL0070757-33]; Barton Haynes Award; Duke Cancer Center Seed Grant (Duke University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798, K02AI093866] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Centers for Medical Countermeasures; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barton Haynes Award; Duke Cancer Center Seed Grant (Duke University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Heart, Lung and Blood Institute grant HL-086998-01 (J.P.C.), National Institute of Allergy and Infectious Diseases (NIAID) grant AI-067798-06 (J.P.C.) and a pilot project from the NIAID Centers for Medical Countermeasures grant AI-067798-01 (D.G.K.). P.L.D. was supported by US National Institutes of Health training grant T32 HL0070757-33, the Barton Haynes Award and a Duke Cancer Center Seed Grant (Duke University).	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; Boehrer S, 2011, CELL CYCLE, V10, P3168, DOI 10.4161/cc.10.18.16599; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Cao C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000118; Cardo-Vila M, 2010, P NATL ACAD SCI USA, V107, P5118, DOI 10.1073/pnas.0915146107; Chan G, 2009, P NATL ACAD SCI USA, V106, P22369, DOI 10.1073/pnas.0908787106; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Chute JP, 2005, BLOOD, V105, P576, DOI 10.1182/blood-2004-04-1467; Chute JP, 2004, EXP HEMATOL, V32, P308, DOI 10.1016/j.exphem.2003.12.002; Chute JP, 2002, BLOOD, V100, P4433, DOI 10.1182/blood-2002-04-1238; Coloff JL, 2011, J BIOL CHEM, V286, P5921, DOI 10.1074/jbc.M110.179101; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Doan PL, 2013, STEM CELLS, V31, P327, DOI 10.1002/stem.1275; DOOLEY DC, 1995, J CELL PHYSIOL, V165, P386, DOI 10.1002/jcp.1041650220; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Hashimoto M, 2002, J BIOL CHEM, V277, P32985, DOI 10.1074/jbc.M202803200; Herodin F, 2003, BLOOD, V101, P2609, DOI 10.1182/blood-2002-06-1634; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kirsch DG, 2010, SCIENCE, V327, P593, DOI 10.1126/science.1166202; Kriegs M, 2010, DNA REPAIR, V9, P889, DOI 10.1016/j.dnarep.2010.05.005; Leibowitz BJ, 2011, MOL CANCER RES, V9, P616, DOI 10.1158/1541-7786.MCR-11-0052; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Minder P, 2012, J BIOL CHEM, V287, P35201, DOI 10.1074/jbc.M112.368910; Montfort MJ, 2002, EXP HEMATOL, V30, P950, DOI 10.1016/S0301-472X(02)00813-5; Muramoto GG, 2006, BIOL BLOOD MARROW TR, V12, P530, DOI 10.1016/j.bbmt.2005.12.039; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; PAIN B, 1991, CELL, V65, P37, DOI 10.1016/0092-8674(91)90405-N; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Quelle FW, 1998, GENE DEV, V12, P1099, DOI 10.1101/gad.12.8.1099; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Shao LJ, 2010, BLOOD, V115, P4707, DOI 10.1182/blood-2009-10-248872; Shen HM, 2012, BLOOD, V119, P3629, DOI 10.1182/blood-2011-08-373621; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; SINCLAIR WK, 1968, RADIAT RES, V33, P620, DOI 10.2307/3572419; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; Takahashi T, 1998, BLOOD, V91, P4509, DOI 10.1182/blood.V91.12.4509.412a01_4509_4515; VONRUDEN T, 1988, EMBO J, V7, P2749, DOI 10.1002/j.1460-2075.1988.tb03129.x; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; ZSEBO KM, 1992, P NATL ACAD SCI USA, V89, P9464, DOI 10.1073/pnas.89.20.9464	60	128	132	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					295	304		10.1038/nm.3070	http://dx.doi.org/10.1038/nm.3070			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23377280	Green Accepted, Green Submitted			2022-12-27	WOS:000316040700022
J	Price, JV; Tangsombatvisit, S; Xu, GY; Yu, JT; Levy, D; Baechler, EC; Gozani, O; Varma, M; Utz, PJ; Liu, CL				Price, Jordan V.; Tangsombatvisit, Stephanie; Xu, Guangyu; Yu, Jiangtao; Levy, Dan; Baechler, Emily C.; Gozani, Or; Varma, Madoo; Utz, Paul J.; Liu, Chih Long			On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions	NATURE MEDICINE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATIC-DISEASES; HISTONE H2B; DIAGNOSIS; ARRAYS; METHYLTRANSFERASE; METHYLATION; SIGNATURE; RESPONSES; CHROMATIN	We developed a new, silicon-based peptide array for a broad range of biological applications, including potential development as a real-time point-of-care platform. We used photolithography on silicon wafers to synthesize microarrays (Intel arrays) that contained every possible overlapping peptide within a linear protein sequence covering the N-terminal tail of human histone H2B. These arrays also included peptides with acetylated and methylated lysine residues, reflecting post-translational modifications of H2B. We defined minimum binding epitopes for commercial antibodies recognizing the modified and unmodified H2B peptides. We further found that this platform is suitable for the highly sensitive characterization of methyltransferases and kinase substrates. The Intel arrays also revealed specific H2B epitopes that are recognized by autoantibodies in individuals with systemic lupus erythematosus who have elevated disease severity. By combining emerging nonfluorescence-based detection methods with an underlying integrated circuit, we are now poised to create a truly transformative proteomics platform with applications in bioscience, drug development and clinical diagnostics.	[Price, Jordan V.; Tangsombatvisit, Stephanie; Utz, Paul J.; Liu, Chih Long] Stanford Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA USA; [Xu, Guangyu; Yu, Jiangtao; Varma, Madoo] Intel Corp, Santa Clara, CA USA; [Levy, Dan; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Baechler, Emily C.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA	Stanford University; Intel Corporation; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Price, JV (corresponding author), Stanford Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA USA.	jvprice@stanford.edu; pjutz@stanford.edu	Gillespie, Emily/N-1265-2013; Levy, Dan/A-3226-2013; Gozani, Or P/I-6157-2013	Gillespie, Emily/0000-0001-5261-3931; Levy, Dan/0000-0003-0719-0305; Gozani, Or/0000-0002-1365-4463	US National Science Foundation Graduate Research Fellowship (NSF GRFP); Stanford Genome Training Program (SGTP; US National Institutes of Health (NIH), US National Human Genome Research Institute); European Molecular Biology Organization; Human Frontier Science Program; Machiah Foundation; Ellison Senior Scholar Award; Donald E. and Delia B. Baxter Foundation; National Heart, Lung, and Blood Institute (NHLBI) [HHSN288201000034C]; Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension; NIH [5 U19-AI082719, 5 U19-AI050864, 5 U19-AI056363, 1 U19 AI090019, 4 U19 AI090019, R01 GM079641]; Canadian Institutes of Health Research [2 OR-92141]; Alliance for Lupus Research [21858]; European Union [261382]; NIH National Research Service Award Fellowship [5 F32 AI-080086-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864, T32AI007290, U19AI056363, U19AI082719, F32AI080086, U19AI090019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	US National Science Foundation Graduate Research Fellowship (NSF GRFP); Stanford Genome Training Program (SGTP; US National Institutes of Health (NIH), US National Human Genome Research Institute); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Machiah Foundation; Ellison Senior Scholar Award(Lawrence Ellison Foundation); Donald E. and Delia B. Baxter Foundation; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alliance for Lupus Research; European Union(European Commission); NIH National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Lee, J. Zhu and the other members of the peptide array team at Biomedical Life Science at Digital Health Intel for development of the early peptide array process and G. Credo for help with the Online Methods section of the manuscript. We thank D. Hall, K.C. Garcia, S. Sidhu, J. Haddon, J. Jarrell and other members of our laboratories for helpful discussion. J.V.P. was funded by a US National Science Foundation Graduate Research Fellowship (NSF GRFP) and is supported by the Stanford Genome Training Program (SGTP; US National Institutes of Health (NIH), US National Human Genome Research Institute). D.L. is supported by the European Molecular Biology Organization, the Human Frontier Science Program and the Machiah Foundation. O.G. is a recipient of an Ellison Senior Scholar Award and is funded by a grant from the NIH (R01 GM079641). P.J.U. is the recipient of a Donald E. and Delia B. Baxter Foundation Career Development Award and is supported by National Heart, Lung, and Blood Institute (NHLBI) Proteomics contract HHSN288201000034C, Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension; grants from the NIH (5 U19-AI082719, 5 U19-AI050864, 5 U19-AI056363, 1 U19 AI090019 and 4 U19 AI090019); Canadian Institutes of Health Research (2 OR-92141); Alliance for Lupus Research (grant number 21858); a gift from the Ben May Trust and a gift from the Floren Family Trust. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement number 261382. C.L.L. is a recipient of an NIH National Research Service Award Fellowship (5 F32 AI-080086-02).	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bailey RC, 2010, NAT CHEM BIOL, V6, P857, DOI 10.1038/nchembio.488; Baker M, 2005, NAT BIOTECHNOL, V23, P1065, DOI 10.1038/nbt0905-1065; Barone AD, 2001, NUCLEOS NUCLEOT NUCL, V20, P525, DOI 10.1081/NCN-100002328; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cortese DA, 2007, CLIN PHARMACOL THER, V82, P491, DOI 10.1038/sj.clpt.6100390; de Vegvar HEN, 2003, J VIROL, V77, P11125, DOI 10.1128/JVI.77.20.11125-11138.2003; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Dieker JW, 2007, ARTHRITIS RHEUM-US, V56, P1921, DOI 10.1002/art.22646; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gao XL, 2003, PROTEOMICS, V3, P2135, DOI 10.1002/pmic.200300597; Garren H, 2008, ANN NEUROL, V63, P611, DOI 10.1002/ana.21370; Gaster RS, 2011, LAB CHIP, V11, P950, DOI [10.1039/c0lc00534g, 10.1039/c01c00534g]; Haab BB, 2005, MOL CELL PROTEOMICS, V4, P377, DOI 10.1074/mcp.M500010-MCP200; Hoffman IEA, 2005, CLIN CHEM, V51, P261; Kattah MG, 2008, NAT MED, V14, P1284, DOI 10.1038/nm.1755; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee DM, 2003, ANN RHEUM DIS, V62, P870, DOI 10.1136/ard.62.9.870; Lee MS, 1999, MASS SPECTROM REV, V18, P187, DOI 10.1002/(SICI)1098-2787(1999)18:3/4<187::AID-MAS2>3.0.CO;2-K; Levy D, 2011, NAT IMMUNOL, V12, P29, DOI 10.1038/ni.1968; Liskamp RMJ, 2011, CHEMBIOCHEM, V12, P1626, DOI 10.1002/cbic.201000717; Monestier M, 2000, J BIOL CHEM, V275, P13558, DOI 10.1074/jbc.275.18.13558; Obermoser G, 2010, LUPUS, V19, P1012, DOI 10.1177/0961203310371161; Petri M, 2000, RHEUM DIS CLIN N AM, V26, P199, DOI 10.1016/S0889-857X(05)70135-6; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Shin DS, 2010, J COMB CHEM, V12, P463, DOI 10.1021/cc100009g; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Bavel CC, 2011, ANN RHEUM DIS, V70, P201, DOI 10.1136/ard.2010.129320; van Bavel CC, 2009, MOL IMMUNOL, V47, P511, DOI 10.1016/j.molimm.2009.08.009; Vigh-Conrad KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010174; Volta U, 2010, J CLIN GASTROENTEROL, V44, P186, DOI 10.1097/MCG.0b013e3181c378f6; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	39	78	87	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1434	+		10.1038/nm.2913	http://dx.doi.org/10.1038/nm.2913			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22902875	Green Accepted			2022-12-27	WOS:000308472300042
J	Fromy, B; Lingueglia, E; Sigaudo-Roussel, D; Saumet, JL; Lazdunski, M				Fromy, Berengere; Lingueglia, Eric; Sigaudo-Roussel, Dominique; Saumet, Jean Louis; Lazdunski, Michel			Asic3 is a neuronal mechanosensor for pressure-induced vasodilation that protects against pressure ulcers	NATURE MEDICINE			English	Article							SENSING ION CHANNELS; SENSORY NEURONS; NA+ CHANNEL; ACID; PAIN; MICE; EXPRESSION; NEUROPATHY; HYPOXIA; PATHWAY	Pressure-induced vasodilation (PIV) delays the decrease in cutaneous blood flow produced by local application of low pressure to the skin, a physiologically appropriate adjustment of local vasomotor function. Individuals without a normal PIV response have a high risk of ulceration. Here we demonstrate that acid-sensing ion channel 3 (Asic3) is an essential neuronal sensor for the vasodilation response to direct pressure in both humans and rodents and for protecting against pressure ulcers in mice.	[Lingueglia, Eric; Lazdunski, Michel] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, F-06560 Valbonne, France; [Lingueglia, Eric; Lazdunski, Michel] Univ Nice Sophia Antipolis, UMR 7275, Valbonne, France; [Lingueglia, Eric] LabEx ICST Valbonne, Valbonne, France; [Fromy, Berengere; Sigaudo-Roussel, Dominique; Saumet, Jean Louis] CNRS, Inst Biol & Chim Prot, FRE 3310, Lyon, France; [Fromy, Berengere; Sigaudo-Roussel, Dominique; Saumet, Jean Louis] Univ Lyon 1, FRE 3310, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Lazdunski, M (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR 7275, 660 Route Lucioles, F-06560 Valbonne, France.	jean-louis.saumet@univ-lyon1.fr; lazdunski@ipmc.cnrs.fr	LINGUEGLIA, Eric/F-5509-2013	LINGUEGLIA, Eric/0000-0003-3902-3405; Fromy, Berengere/0000-0003-2457-0334	Fondation pour la Recherche Medicale and Prevention Education Recherche Soins Escarres	Fondation pour la Recherche Medicale and Prevention Education Recherche Soins Escarres	We would like to thank the subjects who participated in this study. We thank C. Viart-Ferber, A. Josset-Lamaugarny, G. James and N. Pleche (AnexPeau facility, Lyon) for helpful assistance in human and rodent studies. We are very grateful to S. Diochot and E. Deval (CNRS UMR 7275) for providing APETx2 and knockout mice, to P. Inquimbert, V. Friend (CNRS UMR 7275) and N. Gadot (Anipath facility, Lyon) for histological studies, and to R. Buttin and D. Katz for technical support for Perimed equipment. We also thank Fondation pour la Recherche Medicale and Prevention Education Recherche Soins Escarres for financial support.	Allman R M, 1999, Adv Wound Care, V12, P22; ALLMAN RM, 1989, NEW ENGL J MED, V320, P850; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Costa R, 2008, BRIT J PHARMACOL, V154, P1094, DOI 10.1038/bjp.2008.172; Demiot C, 2006, DIABETES, V55, P1478, DOI 10.2337/db05-1433; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2011, J NEUROSCI, V31, P6059, DOI 10.1523/JNEUROSCI.5266-10.2011; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diochot S, 2007, TOXICON, V49, P271, DOI 10.1016/j.toxicon.2006.09.026; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Fromy B, 2000, BRAIN RES PROTOC, V5, P198, DOI 10.1016/S1385-299X(00)00013-1; Fromy B, 1998, BRAIN RES, V811, P166, DOI 10.1016/S0006-8993(98)00973-1; Fromy B, 2000, BRIT J PHARMACOL, V131, P1161, DOI 10.1038/sj.bjp.0703685; Fromy B, 2010, J INVEST DERMATOL, V130, P849, DOI 10.1038/jid.2009.279; Garry A, 2007, EMBO REP, V8, P354, DOI 10.1038/sj.embor.7400916; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Koitka A, 2004, DIABETES, V53, P721, DOI 10.2337/diabetes.53.3.721; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Page AJ, 2005, GUT, V54, P1408, DOI 10.1136/gut.2005.071084; Potter C, 2004, CELL CYCLE, V3, P164; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reddy M, 2008, JAMA-J AM MED ASSOC, V300, P2647, DOI 10.1001/jama.2008.778; Sigaudo-Roussel D, 2004, DIABETES, V53, P1564, DOI 10.2337/diabetes.53.6.1564; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wultsch T, 2008, PAIN, V134, P245, DOI 10.1016/j.pain.2007.04.025; Wykoff CC, 2000, CANCER RES, V60, P7075	32	70	71	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1205	+		10.1038/nm.2844	http://dx.doi.org/10.1038/nm.2844			17	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22842475				2022-12-27	WOS:000307469300025
J	Walter, S; Weinschenk, T; Stenzl, A; Zdrojowy, R; Pluzanska, A; Szczylik, C; Staehler, M; Brugger, W; Dietrich, PY; Mendrzyk, R; Hilf, N; Schoor, O; Fritsche, J; Mahr, A; Maurer, D; Vass, V; Trautwein, C; Lewandrowski, P; Flohr, C; Pohla, H; Stanczak, JJ; Bronte, V; Mandruzzato, S; Biedermann, T; Pawelec, G; Derhovanessian, E; Yamagishi, H; Miki, T; Hongo, F; Takaha, N; Hirakawa, K; Tanaka, H; Stevanovic, S; Frisch, J; Mayer-Mokler, A; Kirner, A; Rammensee, HG; Reinhardt, C; Singh-Jasuja, H				Walter, Steffen; Weinschenk, Toni; Stenzl, Arnulf; Zdrojowy, Romuald; Pluzanska, Anna; Szczylik, Cezary; Staehler, Michael; Brugger, Wolfram; Dietrich, Pierre-Yves; Mendrzyk, Regina; Hilf, Norbert; Schoor, Oliver; Fritsche, Jens; Mahr, Andrea; Maurer, Dominik; Vass, Verona; Trautwein, Claudia; Lewandrowski, Peter; Flohr, Christian; Pohla, Heike; Stanczak, Janusz J.; Bronte, Vincenzo; Mandruzzato, Susanna; Biedermann, Tilo; Pawelec, Graham; Derhovanessian, Evelyna; Yamagishi, Hisakazu; Miki, Tsuneharu; Hongo, Fumiya; Takaha, Natsuki; Hirakawa, Kosei; Tanaka, Hiroaki; Stevanovic, Stefan; Frisch, Juergen; Mayer-Mokler, Andrea; Kirner, Alexandra; Rammensee, Hans-Georg; Reinhardt, Carsten; Singh-Jasuja, Harpreet			Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival	NATURE MEDICINE			English	Article							REGULATORY T-CELLS; COLONY-STIMULATING FACTOR; MYELOID SUPPRESSOR-CELLS; DENDRITIC CELLS; TUMOR-ANTIGEN; MELANOMA PATIENTS; HIGH-FREQUENCIES; PEPTIDE VACCINE; CUTTING EDGE; IDENTIFICATION	IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs) confirmed to be naturally presented in human cancer tissue. We treated a total of 96 human leukocyte antigen A (HLA-A)*02(+) subjects with advanced RCC with IMA901 in two consecutive studies. In the phase 1 study, the T cell responses of the patients to multiple TUMAPs were associated with better disease control and lower numbers of prevaccine forkhead box P3 (FOXP3)(+) regulatory T (T-reg) cells. The randomized phase 2 trial showed that a single dose of cyclophosphamide reduced the number of T-reg cells and confirmed that immune responses to multiple TUMAPs were associated with longer overall survival. Furthermore, among six predefined populations of myeloid-derived suppressor cells, two were prognostic for overall survival, and among over 300 serum biomarkers, we identified apolipoprotein A-I (APOA1) and chemokine (C-C motif) ligand 17 (CCL17) as being predictive for both immune response to IMA901 and overall survival. A randomized phase 3 study to determine the clinical benefit of treatment with IMA901 is ongoing.	[Walter, Steffen; Weinschenk, Toni; Mendrzyk, Regina; Hilf, Norbert; Schoor, Oliver; Fritsche, Jens; Mahr, Andrea; Maurer, Dominik; Vass, Verona; Trautwein, Claudia; Lewandrowski, Peter; Flohr, Christian; Frisch, Juergen; Mayer-Mokler, Andrea; Kirner, Alexandra; Reinhardt, Carsten; Singh-Jasuja, Harpreet] Immat Biotechnol GmbH, Tubingen, Germany; [Stenzl, Arnulf] Univ Tubingen, Dept Urol, Tubingen, Germany; [Zdrojowy, Romuald] Univ Med, Dept Urol & Urol Oncol, Wroclaw, Poland; [Pluzanska, Anna] Uniwersytetu Med, Klin Chemiotherapii Nowotworow UM, Lodz, Poland; [Szczylik, Cezary] Mil Inst Med, Dept Oncol, Warsaw, Poland; [Staehler, Michael] Univ Munich, IZN, Munich, Germany; [Brugger, Wolfram] Univ Freiburg, Schwarzwald Baar Klinikum, Dept Hematol Oncol & Immunol, Villingen Schwenningen, Germany; [Brugger, Wolfram] Univ Freiburg, Acad Teaching Hosp, Villingen Schwenningen, Germany; [Dietrich, Pierre-Yves] Univ Hosp Geneva, Ctr Oncol, Lab Tumour Immunol, Geneva, Switzerland; [Pohla, Heike] Univ Munich, LIFE Ctr, Lab Tumor Immunol, Munich, Germany; [Pohla, Heike] Helmholtz Ctr, Inst Mol Immunol, Munich, Germany; [Stanczak, Janusz J.] Hosp Infect Dis, Mol Diagnost Lab, Warsaw, Poland; [Bronte, Vincenzo] Verona Univ Hosp, Dept Pathol & Diagnost, Verona, Italy; [Mandruzzato, Susanna] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Mandruzzato, Susanna] IRCCS, IOV, Padua, Italy; [Biedermann, Tilo] Univ Tubingen, Dept Dermatol, Tubingen, Germany; [Pawelec, Graham; Derhovanessian, Evelyna] Univ Tubingen, Med Res Ctr, Dept Internal Med 2, Tubingen, Germany; [Yamagishi, Hisakazu] Kyoto Prefectural Univ Med, Dept Surg, Kyoto 602, Japan; [Miki, Tsuneharu; Hongo, Fumiya; Takaha, Natsuki] Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan; [Hirakawa, Kosei; Tanaka, Hiroaki] Osaka City Univ, Dept Surg Oncol, Osaka 558, Japan; [Stevanovic, Stefan; Rammensee, Hans-Georg] Univ Tubingen, Dept Immunol, Tubingen, Germany	Immatics Biotechnologies GmbH; Eberhard Karls University of Tubingen; Wroclaw Medical University; Military Institute of Aviation Medicine; University of Munich; University of Freiburg; University of Freiburg; University of Geneva; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Osaka Metropolitan University; Eberhard Karls University of Tubingen	Singh-Jasuja, H (corresponding author), Immat Biotechnol GmbH, Tubingen, Germany.	singh@immatics.com	Pohla, Heike/GRS-3277-2022; Staehler, Michael/AGY-6799-2022; Pawelec, Graham/H-2713-2019; Bronte, Vincenzo/K-7902-2016; Tanaka, Hiroaki/V-8501-2019	Staehler, Michael/0000-0002-4574-6522; Pawelec, Graham/0000-0002-3600-0163; Bronte, Vincenzo/0000-0002-3741-5141; Szczylik, Cezary/0000-0002-2524-2810; MANDRUZZATO, SUSANNA/0000-0002-0707-995X; Fritsche, J./0000-0002-5557-8577; Biedermann, Tilo/0000-0002-5352-5105	German 'Forderprogramm Biotechnologie Baden-Wurttemberg' [720.830-1-1/46b, 720.830-3-9]; German 'Fortune' project [1862-0-0]; German 'Deutsche Forschungsgemeinschaft' [Sonderforschungsbereich 685]; German 'Bundesministerium fur Bildung und Forschung' [0315890F]; Italian 'Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona'; Italian 'Associazione Italiana Ricerca sul Cancro' [6599]	German 'Forderprogramm Biotechnologie Baden-Wurttemberg'; German 'Fortune' project; German 'Deutsche Forschungsgemeinschaft'(German Research Foundation (DFG)); German 'Bundesministerium fur Bildung und Forschung'(Federal Ministry of Education & Research (BMBF)); Italian 'Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona'; Italian 'Associazione Italiana Ricerca sul Cancro'(Fondazione AIRC per la ricerca sul cancro)	We thank all investigators and patients participating in the clinical studies. Samples of healthy donors were kindly provided by D. Wernet (Institute of Clinical and Experimental Transfusion Medicine, Tubingen). The cell line K562-A2 was kindly provided by C. Britten (Tumorvakzinezentrum Mainz). This work was supported by the German 'Forderprogramm Biotechnologie Baden-Wurttemberg' projects 720.830-1-1/46b and 720.830-3-9, the German 'Fortune' project 1862-0-0, the German 'Deutsche Forschungsgemeinschaft Sonderforschungsbereich 685' projects A6, C5 and C9, the German 'Bundesministerium fur Bildung und Forschung' project 0315890F, the Italian 'Fondazione Cassa di Risparmio di Verona, Vicenza, Belluno e Ancona' and the Italian 'Associazione Italiana Ricerca sul Cancro' (grant 6599). We thank H. Schild for providing critical input to the manuscript and the members of the Immatics' Scientific Advisory Board and the Data Safety Monitoring Board for critical input throughout the development program.	Andrew DP, 2001, J IMMUNOL, V166, P103, DOI 10.4049/jimmunol.166.1.103; Baumgaertner P, 2006, CANCER RES, V66, P1912, DOI 10.1158/0008-5472.CAN-05-3793; Bertoletti A, 1997, HEPATOLOGY, V26, P1027, DOI 10.1002/hep.510260435; Boss CN, 2007, CLIN CANCER RES, V13, P3347, DOI 10.1158/1078-0432.CCR-06-2156; Britten CM, 2008, CANCER IMMUNOL IMMUN, V57, P289, DOI 10.1007/s00262-007-0378-0; Britten CM, 2002, J IMMUNOL METHODS, V259, P95, DOI 10.1016/S0022-1759(01)00499-9; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bronte V, 2005, J EXP MED, V201, P1257, DOI 10.1084/jem.20042028; Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108; Brossart P, 1999, BLOOD, V93, P4309, DOI 10.1182/blood.V93.12.4309.412k19_4309_4317; Brossart P, 2001, CANCER RES, V61, P6846; Burger Danielle, 2002, Autoimmunity Reviews, V1, P111, DOI 10.1016/S1568-9972(01)00018-0; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chianese-Bullock KA, 2005, J IMMUNOL, V174, P3080, DOI 10.4049/jimmunol.174.5.3080; Dengjel J, 2006, CLIN CANCER RES, V12, P4163, DOI 10.1158/1078-0432.CCR-05-2470; Derhovanessian E, 2009, INT J CANCER, V125, P1372, DOI 10.1002/ijc.24497; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Finke JH, 2008, CLIN CANCER RES, V14, P6674, DOI 10.1158/1078-0432.CCR-07-5212; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Ikezawa Y, 2005, J DERMATOL SCI, V39, P105, DOI 10.1016/j.jdermsci.2005.02.002; Kanagawa N, 2007, INT J CANCER, V121, P2013, DOI 10.1002/ijc.22908; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kirkwood JM, 2009, CLIN CANCER RES, V15, P1443, DOI 10.1158/1078-0432.CCR-08-1231; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Kruger T, 2005, CANCER IMMUNOL IMMUN, V54, P826, DOI 10.1007/s00262-004-0650-5; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Lienard Danielle, 2004, Cancer Immun, V4, P4; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Mahnke YD, 2007, CLIN LAB MED, V27, P469, DOI 10.1016/j.cII.2007.05.002; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Mathiassen S, 2001, EUR J IMMUNOL, V31, P1239, DOI 10.1002/1521-4141(200104)31:4<1239::AID-IMMU1239>3.0.CO;2-C; Mirza N, 2006, CANCER RES, V66, P9299, DOI 10.1158/0008-5472.CAN-06-1690; Motoyoshi Y, 2006, ONCOL REP, V16, P141; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Muntoni S, 2009, NUTR METAB CARDIOVAS, V19, P218, DOI 10.1016/j.numecd.2008.06.002; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Rammensee HG, 2002, IMMUNOL REV, V188, P164, DOI 10.1034/j.1600-065X.2002.18815.x; Real E, 2004, J IMMUNOL, V173, P50, DOI 10.4049/jimmunol.173.1.50; Rini B. I., 2011, J CLIN ONCOL S15, V29; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Sadovnikova E, 1998, EUR J IMMUNOL, V28, P193, DOI 10.1002/(SICI)1521-4141(199801)28:01<193::AID-IMMU193>3.3.CO;2-B; Schag K, 2004, CLIN CANCER RES, V10, P3658, DOI 10.1158/1078-0432.CCR-03-0640; Schmidt SM, 2004, CANCER RES, V64, P1164, DOI 10.1158/0008-5472.CAN-03-2538; Schmielau J, 2001, CANCER RES, V61, P4756; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Singh-Jasuja H, 2004, CANCER IMMUNOL IMMUN, V53, P187, DOI 10.1007/s00262-003-0480-x; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Tuovinen H, 2008, IMMUNOL LETT, V117, P146, DOI 10.1016/j.imlet.2008.01.004; Walker EB, 2004, CLIN CANCER RES, V10, P668, DOI 10.1158/1078-0432.CCR-0095-03; Walter S, 2005, EUR J IMMUNOL, V35, P2876, DOI 10.1002/eji.200526207; Walter S, 2003, J IMMUNOL, V171, P4974, DOI 10.4049/jimmunol.171.10.4974; Weinschenk T, 2002, CANCER RES, V62, P5818; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060	72	589	677	0	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1254	+		10.1038/nm.2883	http://dx.doi.org/10.1038/nm.2883			23	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22842478	Bronze			2022-12-27	WOS:000307469300032
J	Jimenez-Mateos, EM; Engel, T; Merino-Serrais, P; McKiernan, RC; Tanaka, K; Mouri, G; Sano, T; O'Tuathaigh, C; Waddington, JL; Prenter, S; Delanty, N; Farrell, MA; O'Brien, DF; Conroy, RM; Stallings, RL; DeFelipe, J; Henshall, DC				Jimenez-Mateos, Eva M.; Engel, Tobias; Merino-Serrais, Paula; McKiernan, Ross C.; Tanaka, Katsuhiro; Mouri, Genshin; Sano, Takanori; O'Tuathaigh, Colm; Waddington, John L.; Prenter, Suzanne; Delanty, Norman; Farrell, Michael A.; O'Brien, Donncha F.; Conroy, Ronan M.; Stallings, Raymond L.; DeFelipe, Javier; Henshall, David C.			Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects	NATURE MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; LONG-TERM POTENTIATION; STATUS-EPILEPTICUS; DENDRITIC SPINES; IN-VIVO; SYNAPTIC REORGANIZATION; ELECTROGRAPHIC SEIZURES; BRAIN-DAMAGE; KAINIC ACID; CELL-DEATH	Temporal lobe epilepsy is a common, chronic neurological disorder characterized by recurrent spontaneous seizures. MicroRNAs (miRNAs) are small, noncoding RNAs that regulate post-transcriptional expression of protein-coding mRNAs, which may have key roles in the pathogenesis of neurological disorders. In experimental models of prolonged, injurious seizures (status epilepticus) and in human epilepsy, we found upregulation of miR-134, a brain-specific, activity-regulated miRNA that has been implicated in the control of dendritic spine morphology. Silencing of miR-134 expression in vivo using antagomirs reduced hippocampal CA3 pyramidal neuron dendrite spine density by 21% and rendered mice refractory to seizures and hippocampal injury caused by status epilepticus. Depletion of miR-134 after status epilepticus in mice reduced the later occurrence of spontaneous seizures by over 90% and mitigated the attendant pathological features of temporal lobe epilepsy. Thus, silencing miR-134 exerts prolonged seizure-suppressant and neuroprotective actions; determining whether these are anticonvulsant effects or are truly antiepileptogenic effects requires additional experimentation.	[Jimenez-Mateos, Eva M.; Engel, Tobias; McKiernan, Ross C.; Tanaka, Katsuhiro; Mouri, Genshin; Sano, Takanori; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Jimenez-Mateos, Eva M.; Engel, Tobias; McKiernan, Ross C.; Tanaka, Katsuhiro; Mouri, Genshin; Sano, Takanori; Henshall, David C.] Royal Coll Surgeons Ireland, Ctr Study Neurol Disorders, Dublin 2, Ireland; [Merino-Serrais, Paula; DeFelipe, Javier] Univ Politecn Madrid, Inst Cajal CSIC, Madrid, Spain; [Merino-Serrais, Paula; DeFelipe, Javier] Univ Politecn Madrid, Ctr Tecnol Biomed, Lab Cajal Circuitos Corticales, Madrid, Spain; [Delanty, Norman] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Farrell, Michael A.] Beaumont Hosp, Dept Pathol, Dublin 9, Ireland; [O'Brien, Donncha F.] Beaumont Hosp, Dept Neurol Surg, Dublin 9, Ireland; [Conroy, Ronan M.] Royal Coll Surgeons Ireland, Div Populat Hlth Sci, Dublin 2, Ireland; [Stallings, Raymond L.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Henshall, DC (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	dhenshall@rcsi.ie	Merino-Serrais, Paula/X-5970-2019; Conroy, Ronan/C-6416-2008; Jimenez-Mateos, Eva/AAG-8072-2019; DEFELIPE, JAVIER/D-1195-2014; Stallings, Raymond/A-7213-2008	Conroy, Ronan/0000-0001-5983-8682; DEFELIPE, JAVIER/0000-0001-5484-0660; Delaney, Norman/0000-0002-3953-9842; Engel, Tobias/0000-0001-9137-0637; Henshall, David/0000-0001-6237-9632; Merino-Serrais, Paula/0000-0002-1842-9476; Jimenez-Mateos, Eva/0000-0001-6417-6580; O'Tuathaigh, Colm/0000-0003-1365-1606	NINDS NIH HHS [R56 NS073714] Funding Source: Medline; PHS HHS [R56 073714] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS073714] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Araki T, 2002, J NEUROSCI RES, V69, P614, DOI 10.1002/jnr.10356; Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Ballesteros-Yanez I, 2010, P NATL ACAD SCI USA, V107, P11567, DOI 10.1073/pnas.1006269107; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Brandt C, 2003, NEUROSCIENCE, V118, P727, DOI 10.1016/S0306-4522(03)00027-7; CAVAZOS JE, 1991, J NEUROSCI, V11, P2795; Christensen M, 2010, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.016.2009; DeFelipe J, 1999, BRAIN, V122, P1807, DOI 10.1093/brain/122.10.1807; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Engel T, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.55; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Halpain S, 1998, J NEUROSCI, V18, P9835; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Jimenez-Mateos EM, 2010, NEUROSCIENCE, V171, P556, DOI 10.1016/j.neuroscience.2010.09.003; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kim CH, 1999, J NEUROSCI, V19, P4314; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Mathern G.W., 1997, EPILEPSY COMPREHENSI, P133; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCNAMARA JO, 2006, SCI STKE, pRE12, DOI DOI 10.1126/STKE.3562006RE12; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Merino-Serrais P, 2011, HIPPOCAMPUS, V21, P1037, DOI 10.1002/hipo.20861; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; MULLER M, 1993, P NATL ACAD SCI USA, V90, P257, DOI 10.1073/pnas.90.1.257; Murphy BM, 2010, CELL DEATH DIFFER, V17, P459, DOI 10.1038/cdd.2009.134; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nairismagi J, 2004, EPILEPSIA, V45, P1024, DOI 10.1111/j.0013-9580.2004.08904.x; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; Pavlowsky A, 2010, CURR BIOL, V20, P103, DOI 10.1016/j.cub.2009.12.030; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pitkanen A, 2005, EPILEPSY RES, V63, P27, DOI 10.1016/j.eplepsyres.2004.10.003; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Rensing N, 2005, ANN NEUROL, V58, P888, DOI 10.1002/ana.20658; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Segal M, 2010, EUR J NEUROSCI, V31, P2178, DOI 10.1111/j.1460-9568.2010.07270.x; Shinoda S, 2004, J NEUROSCI RES, V76, P121, DOI 10.1002/jnr.20064; Sierra-Paredes G, 2006, J MOL NEUROSCI, V28, P151, DOI 10.1385/JMN:28:2:151; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wermeling DP, 2009, NEUROTHERAPEUTICS, V6, P352, DOI 10.1016/j.nurt.2009.01.002; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	60	338	357	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1087	+		10.1038/nm.2834	http://dx.doi.org/10.1038/nm.2834			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22683779	Green Accepted			2022-12-27	WOS:000306121600038
J	Saher, G; Rudolphi, F; Corthals, K; Ruhwedel, T; Schmidt, KF; Lowel, S; Dibaj, P; Barrette, B; Mobius, W; Nave, KA				Saher, Gesine; Rudolphi, Fabian; Corthals, Kristina; Ruhwedel, Torben; Schmidt, Karl-Friedrich; Loewel, Siegrid; Dibaj, Payam; Barrette, Benoit; Moebius, Wiebke; Nave, Klaus-Armin			Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet	NATURE MEDICINE			English	Article							TRANSGENIC MOUSE MODEL; BLOOD-BRAIN-BARRIER; PROTEOLIPID PROTEIN; PERFRINGOLYSIN-O; MYELIN; ACCUMULATION; DYSFUNCTION; NEURODEGENERATION; OVEREXPRESSION; TRAFFICKING	Duplication of PLP1 (proteolipid protein gene 1) and the subsequent overexpression of the myelin protein PLP (also known as DM20) in oligodendrocytes is the most frequent cause of Pelizaeus-Merzbacher disease (PMD), a fatal leukodystrophy(1) without therapeutic options(2,3). PLP binds cholesterol and is contained within membrane lipid raft microdomains(4). Cholesterol availability is the rate-limiting factor of central nervous system myelin synthesis(5). Transgenic mice with extra copies of the Plp1 gene(6) are accurate models of PMD. Dysmyelination(6-8) followed by demyelination(9,10), secondary inflammation and axon damage contribute to the severe motor impairment in these mice(9,10). The finding that in Plp1-transgenic oligodendrocytes, PLP and cholesterol accumulate in late endosomes and lysosomes (endo/lysosomes)(9,11-13), prompted us to further investigate the role of cholesterol in PMD. Here we show that cholesterol itself promotes normal PLP trafficking and that dietary cholesterol influences PMD pathology. In a preclinical trial, PMD mice were fed a cholesterol-enriched diet. This restored oligodendrocyte numbers and ameliorated intracellular PLP accumulation. Moreover, myelin content increased, inflammation and gliosis were reduced and motor defects improved. Even after onset of clinical symptoms, cholesterol treatment prevented disease progression. Dietary cholesterol did not reduce Plp1 overexpression but facilitated incorporation of PLP into myelin membranes. These findings may have implications for therapeutic interventions in patients with PMD.	[Saher, Gesine; Rudolphi, Fabian; Corthals, Kristina; Ruhwedel, Torben; Dibaj, Payam; Barrette, Benoit; Moebius, Wiebke; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Schmidt, Karl-Friedrich; Loewel, Siegrid] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany	Max Planck Society; University of Gottingen	Saher, G (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	saher@em.mpg.de; nave@em.mpg.de	Dibaj, Payam/AAS-5479-2021; Saher, Gesine/AAH-1826-2021; Dibaj, Payam/GQH-9423-2022	Saher, Gesine/0000-0003-3507-9604; Dibaj, Payam/0000-0003-1585-6330; /0000-0002-2902-7165; Ruhwedel, Torben/0000-0002-9535-9395	PMD foundation; Deutsche Forschungsgemeinschaft [SA2114/1-1]; EU-FP7; Bundesministerium fur Bildung und Forschung (BMBF); European Research Council (ERC) Advanced Grant; BMBF [01GQ0810]	PMD foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU-FP7(European Commission); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); European Research Council (ERC) Advanced Grant(European Research Council (ERC)); BMBF(Federal Ministry of Education & Research (BMBF))	We dedicate this work to the memory of Jim Garbern for his support of PMD research. We are grateful to A. Fahrenholz, T. Freerck, M. Schildmann, M. Matthes and A. Kanbach for technical support and thank J. Edgar for helpful comments on the manuscript. We thank M. Grebe (Umea University) for providing the BC theta expression construct and Pfizer for the generous gift of the squalestatin CP-340868. This work was funded by the PMD foundation and the Deutsche Forschungsgemeinschaft (SA2114/1-1) to G.S.K.-A.N. is supported by the EU-FP7 (Leukotreat, Ngidd), the Bundesministerium fur Bildung und Forschung (BMBF; Leukonet) and a European Research Council (ERC) Advanced Grant. Support of the BMBF to S.L. and K.-F.S. is gratefully acknowledged (01GQ0810).	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Anderson TJ, 1998, J COMP NEUROL, V394, P506, DOI 10.1002/(SICI)1096-9861(19980518)394:4<506::AID-CNE8>3.0.CO;2-5; Anderson TJ, 1999, ANN NY ACAD SCI, V883, P234, DOI 10.1111/j.1749-6632.1999.tb08585.x; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Edgar JM, 2010, EMBO MOL MED, V2, P42, DOI 10.1002/emmm.200900057; Garbern JY, 2007, CELL MOL LIFE SCI, V64, P50, DOI 10.1007/s00018-006-6182-8; Goetze B, 2010, NEUROIMAGE, V49, P1622, DOI 10.1016/j.neuroimage.2009.10.019; Hawes CM, 2010, J NEUROCHEM, V114, P311, DOI 10.1111/j.1471-4159.2010.06768.x; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Ip CW, 2008, MOL CELL NEUROSCI, V38, P489, DOI 10.1016/j.mcn.2008.04.009; Jung M, 1996, J NEUROSCI, V16, P7920; Karim SA, 2007, GLIA, V55, P341, DOI 10.1002/glia.20465; Karim SA, 2010, GLIA, V58, P1727, DOI 10.1002/glia.21043; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; Kramer EM, 2001, MICROSC RES TECHNIQ, V52, P656, DOI 10.1002/jemt.1050; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Otomo T, 2011, J BIOL CHEM, V286, P35283, DOI 10.1074/jbc.M111.267930; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Qin CB, 2006, ARTERIOSCL THROM VAS, V26, P372, DOI 10.1161/01.ATV.0000197848.67999.e1; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Saher G, 2009, J NEUROSCI, V29, P6094, DOI 10.1523/JNEUROSCI.0686-09.2009; SEITELBERGER F, 1995, BRAIN PATHOL, V5, P267, DOI 10.1111/j.1750-3639.1995.tb00603.x; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Simons M, 2002, J CELL BIOL, V157, P327, DOI 10.1083/jcb.200110138; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Stolp HB, 2009, NEUROPATH APPL NEURO, V35, P132, DOI 10.1111/j.1365-2990.2008.01005.x; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; Woodward Karen J., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000677; Xie CL, 2003, J LIPID RES, V44, P1780, DOI 10.1194/jlr.M300164-JLR200	36	78	78	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1130	+		10.1038/nm.2833	http://dx.doi.org/10.1038/nm.2833			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22706386				2022-12-27	WOS:000306121600044
J	Bierhaus, A; Fleming, T; Stoyanov, S; Leffler, A; Babes, A; Neacsu, C; Sauer, SK; Eberhardt, M; Schnolzer, M; Lasischka, F; Neuhuber, WL; Kichko, TI; Konrade, I; Elvert, R; Mier, W; Pirags, V; Lukic, IK; Morcos, M; Dehmer, T; Rabbani, N; Thornalley, PJ; Edelstein, D; Nau, C; Forbes, J; Humpert, PM; Schwaninger, M; Ziegler, D; Stern, DM; Cooper, ME; Haberkorn, U; Brownlee, M; Reeh, PW; Nawroth, PP				Bierhaus, Angelika; Fleming, Thomas; Stoyanov, Stoyan; Leffler, Andreas; Babes, Alexandru; Neacsu, Cristian; Sauer, Susanne K.; Eberhardt, Mirjam; Schnoelzer, Martina; Lasischka, Felix; Neuhuber, Winfried L.; Kichko, Tatjana I.; Konrade, Ilze; Elvert, Ralf; Mier, Walter; Pirags, Valdis; Lukic, Ivan K.; Morcos, Michael; Dehmer, Thomas; Rabbani, Naila; Thornalley, Paul J.; Edelstein, Diane; Nau, Carla; Forbes, Josephine; Humpert, Per M.; Schwaninger, Markus; Ziegler, Dan; Stern, David M.; Cooper, Mark E.; Haberkorn, Uwe; Brownlee, Michael; Reeh, Peter W.; Nawroth, Peter P.			Methylglyoxal modification of Na(v)1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy	NATURE MEDICINE			English	Article							ROOT GANGLION NEURONS; RESISTANT SODIUM-CHANNELS; GLYOXALASE-I; PERIPHERAL NEUROPATHY; SENSITIVE METHOD; BLOOD-FLOW; RAT; ACTIVATION; EXPRESSION; FOREBRAIN	This study establishes a mechanism for metabolic hyperalgesia based on the glycolytic metabolite methylglyoxal. We found that concentrations of plasma methylglyoxal above 600 nM discriminate between diabetes-affected individuals with pain and those without pain. Methylglyoxal depolarizes sensory neurons and induces post-translational modifications of the voltage-gated sodium channel Na(v)1.8, which are associated with increased electrical excitability and facilitated firing of nociceptive neurons, whereas it promotes the slow inactivation of Na(v)1.7. In mice, treatment with methylglyoxal reduces nerve conduction velocity, facilitates neurosecretion of calcitonin gene-related peptide, increases cyclooxygenase-2 (COX-2) expression and evokes thermal and mechanical hyperalgesia. This hyperalgesia is reflected by increased blood flow in brain regions that are involved in pain processing. We also found similar changes in streptozotocin-induced and genetic mouse models of diabetes but not in Na(v)1.8 knockout (Scn10(-/-)) mice. Several strategies that include a methylglyoxal scavenger are effective in reducing methylglyoxal-and diabetes-induced hyperalgesia. This previously undescribed concept of metabolically driven hyperalgesia provides a new basis for the design of therapeutic interventions for painful diabetic neuropathy.	[Bierhaus, Angelika; Fleming, Thomas; Stoyanov, Stoyan; Konrade, Ilze; Lukic, Ivan K.; Morcos, Michael; Humpert, Per M.; Nawroth, Peter P.] Univ Heidelberg Hosp, Dept Med & Clin Chem 1, Heidelberg, Germany; [Leffler, Andreas] Hannover Med Sch, Dept Anesthesiol & Intens Care, D-3000 Hannover, Germany; [Leffler, Andreas; Nau, Carla] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; [Babes, Alexandru; Sauer, Susanne K.; Eberhardt, Mirjam; Neuhuber, Winfried L.; Kichko, Tatjana I.; Reeh, Peter W.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany; [Babes, Alexandru; Neacsu, Cristian] Univ Bucharest, Fac Biol, Dept Physiol & Biophys, Bucharest, Romania; [Schnoelzer, Martina] German Canc Res Ctr, Core Facil Prot Anal W120, D-6900 Heidelberg, Germany; [Lasischka, Felix] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Konrade, Ilze] Stradins Univ, Riga Eastern Clin Univ Hosp, Riga, Latvia; [Elvert, Ralf] Sanofi Aventis Deutschland, Frankfurt, Germany; [Mier, Walter; Haberkorn, Uwe] Univ Heidelberg Hosp, Dept Nucl Med, Heidelberg, Germany; [Pirags, Valdis] Latvian State Univ, Pauls Stradins Clin Univ Hosp, LV-1063 Riga, Latvia; [Lukic, Ivan K.] Biosistemi Doo, Zagreb, Croatia; [Dehmer, Thomas] Zentrum Psychiat Sudwurttemberg, Zwiefalten, Germany; [Rabbani, Naila; Thornalley, Paul J.] Univ Warwick, Univ Hosp, Clin Sci Res Inst, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Edelstein, Diane; Brownlee, Michael] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Forbes, Josephine; Cooper, Mark E.] Baker Int Diabet Inst, Heart & Diabet Inst, Melbourne, Vic, Australia; [Schwaninger, Markus] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, Lubeck, Germany; [Ziegler, Dan] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Stern, David M.] Univ Tennessee, Coll Med, Memphis, TN USA	Ruprecht Karls University Heidelberg; Hannover Medical School; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bucharest; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Riga East University Hospital; Riga Stradins University; Sanofi-Aventis; Ruprecht Karls University Heidelberg; Pauls Stradins Clinical University Hospital; University of Latvia; University of Warwick; Yeshiva University; Albert Einstein College of Medicine; Baker Heart and Diabetes Institute; University of Lubeck; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Tennessee System; University of Tennessee Health Science Center	Nawroth, PP (corresponding author), Univ Heidelberg Hosp, Dept Med & Clin Chem 1, Heidelberg, Germany.	peter.nawroth@med.uni-heidelberg.de	Babes, Alexandru/A-6212-2010; Forbes, Josephine M/A-4569-2012; Reeh, Peter W./J-8981-2012; Babes, Alexandru/ABB-9128-2021; Pirags, Valdis/AAQ-5492-2020; Cooper, Mark/AAC-5326-2020; Sauer, Susanne/K-1145-2012; Leffler, Andreas/K-1191-2012	Forbes, Josephine M/0000-0002-5595-8174; Reeh, Peter W./0000-0002-4367-094X; Babes, Alexandru/0000-0002-7110-6908; Pirags, Valdis/0000-0002-3650-7394; Leffler, Andreas/0000-0003-1121-6387; Thornalley, Paul/0000-0001-7659-443X; Sauer, Susanne Katharina/0000-0002-9734-885X; Schwaninger, Markus/0000-0002-4510-9718; Rabbani, Naila/0000-0002-5819-2506	Juvenile Diabetes Research Foundation (JDRF); Deutsche Forschungsgemeinschaft [BI-1281/3-1, LU728/3-1, NA-350/3-2 in KFO 130]; US National Institutes of Health [2R56DK33861-21]; European Foundation for the Study of Diabetes (EFSD); German Diabetes Association (DDG); Manfred-Lautenschlager-Stiftung for Diabetes (LSD); Dietmar-Hopp-Stiftung; Network Aging Research (NAR); Romanian Research Council (CNCSIS) [PN2 164/2007]; Alexander von Humboldt Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK033861] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Foundation for the Study of Diabetes (EFSD); German Diabetes Association (DDG); Manfred-Lautenschlager-Stiftung for Diabetes (LSD); Dietmar-Hopp-Stiftung; Network Aging Research (NAR); Romanian Research Council (CNCSIS)(Consiliul National al Cercetarii Stiintifice (CNCS)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank S. Kaymak for immunohistochemistry, A. Buhl and K. Leotta for assistance in the cerebral blood flow experiments, L. Werner for support with bregma gradings and X. Du and A. Erhardt for the daily care of the mice. A. Bierhaus, J.F., M. E. C., M. B. and P.P.N. were supported by a Centre grant from the Juvenile Diabetes Research Foundation (JDRF). This work was also supported in part by grants from the Deutsche Forschungsgemeinschaft (BI-1281/3-1 to A. Bierhaus; LU728/3-1 and NA-350/3-2 in KFO 130 to P. W. R., C. Nau and A. L.), the US National Institutes of Health (2R56DK33861-21 to M. B.), the European Foundation for the Study of Diabetes (EFSD/Lilly-Programme, to A. Bierhaus), the German Diabetes Association (DDG, Christian-Hagedorn-Award to A. Bierhaus), the Manfred-Lautenschlager-Stiftung for Diabetes (LSD, to P.P.N.), the Dietmar-Hopp-Stiftung (to A. Bierhaus, P. M. H. and P.P.N.) and the Network Aging Research (NAR, to A. Bierhaus). A. Babes and C.N. were supported by grant PN2 164/2007 from the Romanian Research Council (CNCSIS). A. Babes also received support from the Alexander von Humboldt Foundation.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calcutt NA, 2002, INT REV NEUROBIOL, V50, P205; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; ERICKSON BR, 1957, P SOC EXP BIOL MED, V94, P1, DOI 10.3181/00379727-94-22840; Fuchs D, 2010, PAIN, V151, P496, DOI 10.1016/j.pain.2010.08.010; GRAFE P, 1994, J PHYSIOL-LONDON, V480, P297, DOI 10.1113/jphysiol.1994.sp020360; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hirade M, 1999, NEUROSCIENCE, V90, P933, DOI 10.1016/S0306-4522(98)00486-2; Hong SS, 2008, J NEUROCHEM, V105, P1212, DOI 10.1111/j.1471-4159.2008.05220.x; Hong SS, 2004, J BIOL CHEM, V279, P29341, DOI 10.1074/jbc.M404167200; Humpert PM, 2009, PAIN MED, V10, P413, DOI 10.1111/j.1526-4637.2008.00557.x; Jack MM, 2011, DIABETOLOGIA, V54, P2174, DOI 10.1007/s00125-011-2196-3; Karachalias N, 2003, BIOCHEM SOC T, V31, P1423; Kellogg AP, 2008, CURR DRUG TARGETS, V9, P68; Konrade I., 2007, DIABETOL STOFFWECHS, V2, pP98; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Menendez L, 2002, J NEUROSCI METH, V113, P91, DOI 10.1016/S0165-0270(01)00483-6; Misawa S, 2005, CLIN NEUROPHYSIOL, V116, P1181, DOI 10.1016/j.clinph.2004.12.019; MIYOSHI T, 1973, ELECTROEN CLIN NEURO, V35, P125, DOI 10.1016/0013-4694(73)90168-5; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Morrow TJ, 1998, PAIN, V75, P355, DOI 10.1016/S0304-3959(98)00016-5; Morrow TJ, 2000, EXP NEUROL, V161, P220, DOI 10.1006/exnr.1999.7246; Nawroth PP, 2010, EXP CLIN ENDOCR DIAB, V118, P1, DOI 10.1055/s-0029-1246117; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Paulson PE, 2007, EXP NEUROL, V208, P305, DOI 10.1016/j.expneurol.2007.09.001; Quasthoff S, 1998, MUSCLE NERVE, V21, P1246, DOI 10.1002/(SICI)1097-4598(199810)21:10<1246::AID-MUS2>3.0.CO;2-B; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Shah BS, 2001, NEUROSCI LETT, V309, P1, DOI 10.1016/S0304-3940(01)01976-0; Silos-Santiago I, 2008, CURR OPIN INVEST DR, V9, P83; Stucky CL, 1999, J NEUROSCI, V19, P6497; Sullivan KA, 2007, NEUROBIOL DIS, V28, P276, DOI 10.1016/j.nbd.2007.07.022; Suzuki Y, 2002, NEUROSCI RES, V43, P171, DOI 10.1016/S0168-0102(02)00033-0; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; Thornalley PJ, 2005, ANN NY ACAD SCI, V1043, P111, DOI 10.1196/annals.1333.014; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Vareniuk I, 2008, DIABETOLOGIA, V51, P2126, DOI 10.1007/s00125-008-1136-3; Zhang YM, 1996, J CLIN INVEST, V97, P2213, DOI 10.1172/JCI118662	46	332	342	6	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					926	+		10.1038/nm.2750	http://dx.doi.org/10.1038/nm.2750			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22581285				2022-12-27	WOS:000305116600030
J	Breen, DM; Rasmussen, BA; Kokorovic, A; Wang, RNA; Cheung, GWC; Lam, TKT				Breen, Danna M.; Rasmussen, Brittany A.; Kokorovic, Andrea; Wang, Rennian; Cheung, Grace W. C.; Lam, Tony K. T.			Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes	NATURE MEDICINE			English	Article							GASTRIC BYPASS; FATTY-ACIDS; FOOD-INTAKE; CHOLECYSTOKININ; GUT; HOMEOSTASIS; MECHANISMS; EXCLUSION; SATIETY; DELTA	Gastrointestinal bypass surgeries restore metabolic homeostasis in patients with type 2 diabetes and obesity(1), but the underlying mechanisms remain elusive. Duodenal-jejunal bypass surgery (DJB), an experimental surgical technique that excludes the duodenum and proximal jejunum from nutrient transit(1,2), lowers glucose concentrations in nonobese type 2 diabetic rats(2-5). Given that DJB redirects and enhances nutrient flow into the jejunum and that jejunal nutrient sensing affects feeding(6,7), the repositioned jejunum after DJB represents a junction at which nutrients could regulate glucose homeostasis. Here we found that intrajejunal nutrient administration lowered endogenous glucose production in normal rats through a gut-brain-liver network in the presence of basal plasma insulin concentrations. Inhibition of jejunal glucose uptake or formation of long chain fatty acyl-coA negated the metabolic effects of glucose or lipid, respectively, in normal rats, and altered the rapid (2 d) glucose-lowering effect induced by DJB in streptozotocin (STZ)-induced uncontrolled diabetic rats during refeeding. Lastly, in insulin-deficient autoimmune type 1 diabetic rats and STZ-induced diabetic rats, DJB lowered glucose concentrations in 2 d independently of changes in plasma insulin concentrations, food intake and body weight. These data unveil a glucoregulatory role of jejunal nutrient sensing and its relevance in the early improvement of glycemic control after DJB in rat models of uncontrolled diabetes.	[Breen, Danna M.; Rasmussen, Brittany A.; Kokorovic, Andrea; Cheung, Grace W. C.; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Breen, Danna M.; Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Rasmussen, Brittany A.; Kokorovic, Andrea; Cheung, Grace W. C.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Physiol, London, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Pharmacol, London, ON, Canada; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto	Lam, TKT (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada.	tony.lam@uhnres.utoronto.ca	Wang, Rennian/N-3879-2015	Breen, Danna/0000-0002-6460-8555	Canadian Institutes of Health Research [MOP-82701]; University Health Network; Banting and Best Diabetes Centre (BBDC), University of Toronto; BBDC; John Kitson McIvor Endowed Chair in Diabetes Research; Toronto General Research Institute and the University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University Health Network; Banting and Best Diabetes Centre (BBDC), University of Toronto(University of Toronto); BBDC; John Kitson McIvor Endowed Chair in Diabetes Research; Toronto General Research Institute and the University of Toronto	We are extremely grateful to P.Y.T. Wang for excellent technical assistance. This work was supported by a research grant to T. K. T. L. from the Canadian Institutes of Health Research (MOP-82701). D. M. B. is supported by a post-doctoral fellowship from the University Health Network and the Banting and Best Diabetes Centre (BBDC), University of Toronto. B. A. R. is supported by a BBDC graduate scholarship. A. K. and G. W. C. C. were supported by Canadian Institutes of Health Research and BBDC graduate scholarships. T. K. T. L. holds the John Kitson McIvor (1915-1942) Endowed Chair in Diabetes Research and the Canada Research Chair in Obesity at the Toronto General Research Institute and the University of Toronto.	Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Breen DM, 2011, DIABETES, V60, P3148, DOI 10.2337/db11-0852; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Cohen Ricardo, 2006, Surg Obes Relat Dis, V2, P401, DOI 10.1016/j.soard.2006.02.011; Cohen R, 2012, SURG OBES RELAT DIS, V8, P375, DOI 10.1016/j.soard.2012.01.017; Cohen RV, 2007, SURG OBES RELAT DIS, V3, P195, DOI 10.1016/j.soard.2007.01.009; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cox JE, 2004, PHYSIOL BEHAV, V81, P29, DOI 10.1016/j.physbeh.2003.12.012; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; DREWE J, 1992, GASTROENTEROLOGY, V102, P1654, DOI 10.1016/0016-5085(92)91726-K; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; GREENBERG D, 1990, AM J PHYSIOL, V259, pR110, DOI 10.1152/ajpregu.1990.259.1.R110; Kim Z, 2011, WORLD J SURG, V35, P631, DOI 10.1007/s00268-010-0909-2; Kindel TL, 2009, J GASTROINTEST SURG, V13, P1762, DOI 10.1007/s11605-009-0912-9; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; Lal S, 2001, AM J PHYSIOL-GASTR L, V281, pG907, DOI 10.1152/ajpgi.2001.281.4.G907; Lam TKT, 2010, NAT MED, V16, P392, DOI 10.1038/nm0410-392; Matzinger D, 2000, GUT, V46, P688, DOI 10.1136/gut.46.5.689; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Ogawa N, 2008, NEUROSCI LETT, V433, P38, DOI 10.1016/j.neulet.2007.12.036; Pacheco D, 2007, AM J SURG, V194, P221, DOI 10.1016/j.amjsurg.2006.11.015; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Randich A, 2004, AM J PHYSIOL-REG I, V286, pR166, DOI 10.1152/ajpregu.00431.2003; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Rubino F, 2010, ANNU REV MED, V61, P393, DOI 10.1146/annurev.med.051308.105148; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Troy S, 2008, CELL METAB, V8, P201, DOI 10.1016/j.cmet.2008.08.008; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Wang TT, 2008, ANN SURG, V247, P968, DOI 10.1097/SLA.0b013e318172504d; WATKINS JB, 1987, DRUG METAB DISPOS, V15, P177	33	151	158	1	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					950	+		10.1038/nm.2745	http://dx.doi.org/10.1038/nm.2745			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22610279				2022-12-27	WOS:000305116600033
J	Sheng, L; Zhou, YJ; Chen, Z; Ren, DC; Cho, KW; Jiang, L; Shen, H; Sasaki, Y; Rui, LY				Sheng, Liang; Zhou, Yingjiang; Chen, Zheng; Ren, Decheng; Cho, Kae Won; Jiang, Lin; Shen, Hong; Sasaki, Yoshiteru; Rui, Liangyou			NF-kappa B-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action	NATURE MEDICINE			English	Article							INDUCED INSULIN-RESISTANCE; CREB-BINDING-PROTEIN; HEPATIC GLUCONEOGENESIS; IKK-BETA; COACTIVATOR PGC-1; PHOSPHORYLATION; INFLAMMATION; ACTIVATION; DISRUPTION; METABOLISM	The canonical inhibitor of nuclear factor kappa B kinase subunit beta (IKK-beta)-nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kappa B1) pathway has been well documented to promote insulin resistance; however, the noncanonical NF-kappa B-inducing kinase (NIK)-NF-kappa B2 pathway is not well understood in obesity. Additionally, the contribution of counter-regulatory hormones, particularly glucagon, to hyperglycemia in obesity is unclear. Here we show that NIK promotes glucagon responses in obesity. Hepatic NIK was abnormally activated in mice with dietary or genetic obesity. Systemic deletion of Map3k14, encoding NIK, resulted in reduced glucagon responses and hepatic glucose production (HGP). Obesity is associated with high glucagon responses, and liver-specific inhibition of NIK led to lower glucagon responses and HGP and protected against hyperglycemia and glucose intolerance in obese mice. Conversely, hepatocyte-specific overexpression of NIK resulted in higher glucagon responses and HGP. In isolated mouse livers and primary hepatocytes, NIK also promoted glucagon action and glucose production, at least in part by increasing cAMP response element-binding (CREB) stability. Therefore, overactivation of liver NIK in obesity promotes hyperglycemia and glucose intolerance by increasing the hyperglycemic response to glucagon and other factors that activate CREB.	[Sheng, Liang; Zhou, Yingjiang; Chen, Zheng; Ren, Decheng; Cho, Kae Won; Jiang, Lin; Shen, Hong; Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sasaki, Yoshiteru] RIKEN, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan	University of Michigan System; University of Michigan; RIKEN	Rui, LY (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ruily@umich.edu	shen, hong/I-6179-2016; chen, zheng/J-4600-2014; Jiang, Lin/E-7468-2012	chen, zheng/0000-0003-2161-6106; , zheng/0000-0001-7129-6644; SHEN, HONG/0000-0002-1559-3633	US National Institutes of Health (NIH) [DK 065122, DK073601]; American Diabetes Association [1-09-RA-156]; Michigan Diabetes Research and Training Center; NIH [5P60 DK20572, 5 P30 CA46592, P30AG013283, DK34933]; University of Michigan's Cancer Center; University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK091591, R01DK073601, P60DK020572, R01DK065122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Michigan Diabetes Research and Training Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); University of Michigan Nathan Shock Center; University of Michigan Gut Peptide Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank H. Su, Z. Li, C. Duan, D. Morris and S. Wang for assistance and discussion. We thank R. Schreiber (Washington University School of Medicine, St. Louis, Missouri) for providing NIK knockout mice and K. Rajewsky (Immune Disease Institute, Harvard Medical School, Boston, Massachusetts) for providing STOP-NIK mice. Generation of the NIK knockout mice was supported by Amgen Inc., Thousand Oaks, California. This study was supported by grants DK 065122 and DK073601 from the US National Institutes of Health (NIH) and by research award 1-09-RA-156 from the American Diabetes Association. This work used the cores supported by the Michigan Diabetes Research and Training Center (funded by NIH 5P60 DK20572), the University of Michigan's Cancer Center (funded by NIH 5 P30 CA46592), the University of Michigan Nathan Shock Center (funded by NIH P30AG013283) and the University of Michigan Gut Peptide Research Center (funded by NIH DK34933).	Aoki K, 1999, DIABETES, V48, P1579, DOI 10.2337/diabetes.48.8.1579; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cho KW, 2011, MOL CELL BIOL, V31, P450, DOI 10.1128/MCB.00459-10; Cummings BP, 2011, P NATL ACAD SCI USA, V108, P14670, DOI 10.1073/pnas.1107163108; Denroche HC, 2011, DIABETES, V60, P1414, DOI 10.2337/db10-0958; Duan CJ, 2004, MOL CELL BIOL, V24, P7435, DOI 10.1128/MCB.24.17.7435-7443.2004; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang W, 2004, J BIOL CHEM, V279, P21695, DOI 10.1074/jbc.M401546200; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; Murray SE, 2011, J CLIN INVEST, V121, P4775, DOI 10.1172/JCI44943; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Sheng L, 2011, J BIOL CHEM, V286, P38128, DOI 10.1074/jbc.M111.256677; Shoelson SE, 2009, NAT MED, V15, P373, DOI 10.1038/nm0409-373; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Thu YM, 2010, CYTOKINE GROWTH F R, V21, P213, DOI 10.1016/j.cytogfr.2010.06.002; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou XY, 2004, NAT MED, V10, P633, DOI 10.1038/nm1050; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	37	75	78	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					943	+		10.1038/nm.2756	http://dx.doi.org/10.1038/nm.2756			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22581287	Green Accepted			2022-12-27	WOS:000305116600032
J	Amakye, D; Jagani, Z; Dorsch, M				Amakye, Dereck; Jagani, Zainab; Dorsch, Marion			Unraveling the therapeutic potential of the Hedgehog pathway in cancer	NATURE MEDICINE			English	Review							SMALL-MOLECULE INHIBITORS; BASAL-CELL CARCINOMAS; PHASE-II TRIAL; SONIC-HEDGEHOG; MOUSE MODEL; STEM-CELLS; HUMAN HOMOLOG; MEDULLOBLASTOMA FORMATION; SMOOTHENED MUTATION; SIGNALING PATHWAY	Major progress has been made in recent years in the development of Hedgehog (Hh) pathway inhibitors for the treatment of patients with cancer. Promising clinical trial results have been obtained in cancers that harbor activating mutations of the Hh pathway, such as basal cell carcinoma and medulloblastoma. However, for many cancers, in which Hh ligand overexpression is thought to drive tumor growth, results have been disappointing. Here we review the preclinical data that continue to shape our understanding of the Hh pathway in tumorigenesis and the emerging clinical experience with smoothened inhibitors.	[Amakye, Dereck] Novartis Pharmaceut, E Hanover, NJ USA; [Jagani, Zainab] Novartis Inst Biomed Res, Cambridge, MA USA; [Dorsch, Marion] Agios Pharmaceut, Cambridge, MA USA	Novartis; Novartis; Agios Pharmaceuticals	Dorsch, M (corresponding author), Agios Pharmaceut, Cambridge, MA USA.	marion.dorsch@agios.com			Novartis Pharmaceuticals Corporation	Novartis Pharmaceuticals Corporation(Novartis)	We thank S. Buonamici for her contributions to the figure design and J. Brechbiel for medical editorial assistance with this manuscript. Financial support for editorial assistance was provided by Novartis Pharmaceuticals Corporation.	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Aberger F, 2012, VITAM HORM, V88, P25, DOI 10.1016/B978-0-12-394622-5.00002-X; Amakye D., 2012, CANC RES S1, V72; Amakye D., 2013, NEURO ONCOL S1, V15; Antonarakis ES, 2013, ONCOLOGIST, V18, P163, DOI 10.1634/theoncologist.2012-314; Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Atwood SX, 2012, J CELL BIOL, V199, P193, DOI 10.1083/jcb.201207140; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Barreto DC, 2000, J DENT RES, V79, P1418, DOI 10.1177/00220345000790061101; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Blotta S, 2012, BLOOD, V120, P5002, DOI 10.1182/blood-2011-07-368142; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Brugieres L, 2012, J CLIN ONCOL, V30, P2087, DOI 10.1200/JCO.2011.38.7258; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; CBTRUS, 2012, CBTRUS STAT REP PRIM; Chang ALS, 2012, ARCH DERMATOL, V148, P1324, DOI 10.1001/archdermatol.2012.2354; Chang Q, 2013, INT J CANCER, V133, P225, DOI 10.1002/ijc.28006; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cohen DJ, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.4_suppl.67; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Corcoran RB, 2001, J NEURO-ONCOL, V53, P307, DOI 10.1023/A:1012260318979; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Eimer S, 2012, NEURO-ONCOLOGY, V14, P1441, DOI 10.1093/neuonc/nos266; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Ferruzzi P, 2012, INT J CANCER, V131, pE33, DOI 10.1002/ijc.27349; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Gajjar AJ, 2013, J CLIN ONCOL, V31; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; GURNEY JG, 1995, CANCER, V75, P2186, DOI 10.1002/1097-0142(19950415)75:8<2186::AID-CNCR2820750825>3.0.CO;2-F; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Hassounah NB, 2012, CLIN CANCER RES, V18, P2429, DOI 10.1158/1078-0432.CCR-11-0755; Huff C.A., 2011, 53 ASH ANN M EXP; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jagani Z, 2010, CELL CYCLE, V9, P3449, DOI 10.4161/cc.9.17.12945; Jamieson C, 2011, ASH ANNUAL MEETING A, V118, P424; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jimeno A, 2013, CLIN CANCER RES, V19, P2766, DOI 10.1158/1078-0432.CCR-12-3654; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Karamboulas C, 2013, BBA-GEN SUBJECTS, V1830, P2481, DOI 10.1016/j.bbagen.2012.11.008; Kaye SB, 2012, CLIN CANCER RES, V18, P6509, DOI 10.1158/1078-0432.CCR-12-1796; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Kimura H, 2008, CANCER CELL, V13, P249, DOI 10.1016/j.ccr.2008.01.027; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lam CW, 1999, ONCOGENE, V18, P833, DOI 10.1038/sj.onc.1202360; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mangelberger D, 2012, FRONT BIOSCI-LANDMRK, V17, P90, DOI 10.2741/3917; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; McNeil DE, 2002, MED PEDIATR ONCOL, V39, P190, DOI 10.1002/mpo.10121; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Peukert S, 2010, CHEMMEDCHEM, V5, P500, DOI 10.1002/cmdc.201000011; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Raffel C, 1997, CANCER RES, V57, P842; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Ramaswamy B, 2012, CANCER RES, V72, P5048, DOI 10.1158/0008-5472.CAN-12-1248; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Reifenberger J, 1998, CANCER RES, V58, P1798; Richards DA, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.4_suppl.213; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2012, CLIN CANCER RES, V18, P3218, DOI 10.1158/1078-0432.CCR-12-0568; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Siu L.L., 2010, J CLIN ONCOL S, V28; Slade I, 2011, FAM CANCER, V10, P337, DOI 10.1007/s10689-010-9411-0; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stone DM, 1999, J CELL SCI, V112, P4437; Sun LS, 2008, J DENT RES, V87, P575, DOI 10.1177/154405910808700616; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Tao HY, 2011, CHEM BIOL, V18, P432, DOI 10.1016/j.chembiol.2011.01.018; Tawbi H. A., 2011, J CLIN ONCOL, V29, P3062; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vorechovsky I, 1997, ONCOGENE, V15, P361, DOI 10.1038/sj.onc.1201340; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wang Y, 2012, CHEM BIOL, V19, P972, DOI 10.1016/j.chembiol.2012.06.012; Wang Y, 2012, ACS CHEM BIOL, V7, P1040, DOI 10.1021/cb300028a; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wetmore C, 2000, CANCER RES, V60, P2239; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Wu VM, 2012, P NATL ACAD SCI USA, V109, P13644, DOI 10.1073/pnas.1207170109; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	124	407	419	1	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1410	1422		10.1038/nm.3389	http://dx.doi.org/10.1038/nm.3389			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202394				2022-12-27	WOS:000326920300019
J	Degenhardt, K; Singh, MK; Aghajanian, H; Massera, D; Wang, QH; Li, J; Li, L; Choi, C; Yzaguirre, AD; Francey, LJ; Gallant, E; Krantz, ID; Gruber, PJ; Epstein, JA				Degenhardt, Karl; Singh, Manvendra K.; Aghajanian, Haig; Massera, Daniele; Wang, Qiaohong; Li, Jun; Li, Li; Choi, Connie; Yzaguirre, Amanda D.; Francey, Lauren J.; Gallant, Emily; Krantz, Ian D.; Gruber, Peter J.; Epstein, Jonathan A.			Semaphorin 3d signaling defects are associated with anomalous pulmonary venous connections	NATURE MEDICINE			English	Article							ENDOTHELIAL-CELLS; MOUSE EMBRYOS; VEINS; GENE; NEUROPILIN-1; HEART; ARTERIAL; DOMAIN; RETURN	Total anomalous pulmonary venous connection (TAPVC) is a potentially lethal congenital disorder that occurs when the pulmonary veins do not connect normally to the left atrium, allowing mixing of pulmonary and systemic blood(1). In contrast to the extensive knowledge of arterial vascular patterning, little is known about the patterning of veins. Here we show that the secreted guidance molecule semaphorin 3d (Sema3d) is crucial for the normal patterning of pulmonary veins. Prevailing models suggest that TAPVC occurs when the midpharyngeal endothelial strand (MES), the precursor of the common pulmonary vein, does not form at the proper location on the dorsal surface of the embryonic common atrium(2,3). However, we found that TAPVC occurs in Sema3d mutant mice despite normal formation of the MES. In these embryos, the maturing pulmonary venous plexus does not anastomose uniquely with the properly formed MES. In the absence of Sema3d, endothelial tubes form in a region that is normally avascular, resulting in aberrant connections. Normally, Sema3d provides a repulsive cue to endothelial cells in this area, establishing a boundary. Sequencing of SEMA3D in individuals with anomalous pulmonary veins identified a phenylalanine-toleucine substitution that adversely affects SEMA3D function. These results identify Sema3d as a crucial pulmonary venous patterning cue and provide experimental evidence for an alternate developmental model to explain abnormal pulmonary venous connections.	[Degenhardt, Karl] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Cardiol, Philadelphia, PA 19104 USA; [Singh, Manvendra K.; Aghajanian, Haig; Massera, Daniele; Wang, Qiaohong; Li, Jun; Li, Li; Choi, Connie; Yzaguirre, Amanda D.; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Singh, Manvendra K.; Aghajanian, Haig; Massera, Daniele; Wang, Qiaohong; Li, Jun; Li, Li; Choi, Connie; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Singh, Manvendra K.; Aghajanian, Haig; Massera, Daniele; Wang, Qiaohong; Li, Jun; Li, Li; Choi, Connie; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Yzaguirre, Amanda D.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Francey, Lauren J.; Gallant, Emily; Krantz, Ian D.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Human Genet, Philadelphia, PA 19104 USA; [Gruber, Peter J.] Univ Utah, Sch Med, Dept Surg, Salt Lake City, UT USA; [Gruber, Peter J.] Univ Utah, Sch Med, Dept Mol Med, Salt Lake City, UT USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Epstein, JA (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	epsteinj@upenn.edu	Singh, Manvendra K./AHE-0676-2022	Francey, Lauren J/0000-0002-9700-2277; Singh, Manvendra K./0000-0002-2884-0074; Massera, Daniele/0000-0002-9499-6456; Aghajanian, Haig/0000-0002-8317-0157; Epstein, Jonathan/0000-0001-8637-4465	US National Institutes of Health (NIH) [NIH 5K12HD043245-07, NIH 5K08KL094763-02, NIH T32 GM07229, NIH UO1 HL100405]; Spain Fund; WW Smith Endowed Chair; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043245] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405, K08HL094763, R01HL118768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spain Fund; WW Smith Endowed Chair; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. B. Bleyl for helpful comments and critical reading of the manuscript, N.A. Speck for technical assistance and B. Gelb and V. Garg for assistance with genetic analyses. This work was supported by US National Institutes of Health (NIH) grants NIH 5K12HD043245-07 (K. D.), NIH 5K08KL094763-02 (K. D.), NIH T32 GM07229 (H. A.) and NIH UO1 HL100405 (J.A.E.), the Spain Fund (J.A.E.) and the WW Smith Endowed Chair (J.A.E.).	Adachi B, 1933, VENENSYSTEM JAPANER; AUER J, 1948, ANAT REC, V101, P581, DOI 10.1002/ar.1091010407; Berndt JD, 2006, DEVELOPMENT, V133, P3983, DOI 10.1242/dev.02583; BLEYL S, 1995, AM J HUM GENET, V56, P408; Bleyl SB, 2006, AM J MED GENET A, V140A, P2368, DOI 10.1002/ajmg.a.31471; Bleyl SB, 2010, HUM MOL GENET, V19, P1286, DOI 10.1093/hmg/ddq005; Brody H, 1942, ARCH PATHOL, V33, P221; BURROUGHS JT, 1960, AM HEART J, V59, P913, DOI 10.1016/0002-8703(60)90414-2; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cinquetti R, 2008, HUM MUTAT, V29, P468, DOI 10.1002/humu.20711; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; DERUITER MC, 1995, ANAT REC, V243, P84, DOI 10.1002/ar.1092430110; Douglas YL, 2011, INT J CARDIOL, V147, P13, DOI 10.1016/j.ijcard.2010.07.004; Evans IM, 2011, MOL CELL BIOL, V31, P1174, DOI 10.1128/MCB.00903-10; Feiner L, 2001, DEVELOPMENT, V128, P3061; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; HEALEY JE, 1952, J THORAC SURG, V23, P433; Herzog Y, 2005, DEV DYNAM, V232, P1047, DOI 10.1002/dvdy.20257; Hughes CW, 1944, ARCH PATHOL, V37, P0364; Jiang Q, 2012, HUM MUTAT, V33, P281, DOI 10.1002/humu.21602; KALKE BR, 1967, AM J CARDIOL, V20, P91, DOI 10.1016/0002-9149(67)90114-2; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Keane J, 2006, NADAS PEDIAT CARDIOL; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; LUCAS RV, 1988, AM J CARDIOL, V62, P292, DOI 10.1016/0002-9149(88)90227-5; LUCAS RV, 1962, J PEDIATR-US, V61, P281, DOI 10.1016/S0022-3476(62)80266-2; Luzon-Toro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054800; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Renzi MJ, 1999, J NEUROSCI, V19, P7870; Riccomagno MM, 2012, CELL, V149, P1594, DOI 10.1016/j.cell.2012.05.018; Sato M, 2006, DEV BIOL, V298, P12, DOI 10.1016/j.ydbio.2006.05.033; Seale AN, 2010, CIRCULATION, V122, P2718, DOI 10.1161/CIRCULATIONAHA.110.940825; Silversides CK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002843; Singh MK, 2011, J BIOL CHEM, V286, P41036, DOI 10.1074/jbc.M111.268573; Sizarov A, 2012, J ANAT, V220, P336, DOI 10.1111/j.1469-7580.2012.01474.x; van den Berg G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022055; Wernovsky G., 2008, MOSS ADAMSHEART DIS, V7th, P1039; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	45	55	57	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					760	+		10.1038/nm.3185	http://dx.doi.org/10.1038/nm.3185			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23685842	Green Accepted			2022-12-27	WOS:000319981600026
J	Edgerton, DS; Cherrington, AD				Edgerton, Dale S.; Cherrington, Alan D.			Glucagon's yin and yang effects on hepatic glucose production	NATURE MEDICINE			English	Editorial Material							CONSCIOUS DOG; HYPERGLYCEMIA; METABOLISM; INSULIN; LIVER; RAT	New insights into the actions of the hormone glucagon are provided by a recent study in rodents, which shows that glucagon can suppress hepatic glucose production by acting through the mediobasal hypothalamic region of the brain. This central regulatory mechanism is impaired in rats fed a high-fat diet, suggesting that hypothalamic glucagon resistance may be relevant to the hyperglycemia observed in obesity, diabetes or both (pages 766-772).	[Edgerton, Dale S.; Cherrington, Alan D.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Vanderbilt University	Edgerton, DS (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	alan.cherrington@vanderbilt.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018243] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK018243] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agarwala G C, 1989, Indian J Med Res, V90, P372; AMIR S, 1986, PHYSIOL BEHAV, V37, P563, DOI 10.1016/0031-9384(86)90286-6; ATRENS DM, 1993, BRAIN RES, V630, P245, DOI 10.1016/0006-8993(93)90663-8; CHERRINGTON AD, 1981, DIABETES, V30, P180, DOI 10.2337/diabetes.30.3.180; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; KRZESKI R, 1989, BRAIN RES, V504, P297, DOI 10.1016/0006-8993(89)91372-3; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; MARUBASHI S, 1985, ACTA ENDOCRINOL-COP, V108, P6, DOI 10.1530/acta.0.1080006; Mighiu PI, 2013, NAT MED, V19, P766, DOI 10.1038/nm.3115; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Ramnanan CJ, 2013, DIABETES, V62, P74, DOI 10.2337/db12-0148; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; WADA M, 1995, AM J PHYSIOL-ENDOC M, V268, pE194, DOI 10.1152/ajpendo.1995.268.2.E194; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0	16	6	6	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					674	675		10.1038/nm.3202	http://dx.doi.org/10.1038/nm.3202			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744146	Green Accepted			2022-12-27	WOS:000319981600013
J	Kim, M; Platt, MJ; Shibasaki, T; Quaggin, SE; Backx, PH; Seino, S; Simpson, JA; Drucker, DJ				Kim, Minsuk; Platt, Mathew J.; Shibasaki, Tadao; Quaggin, Susan E.; Backx, Peter H.; Seino, Susumu; Simpson, Jeremy A.; Drucker, Daniel J.			GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure	NATURE MEDICINE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CARDIOVASCULAR SAFETY; CYCLASE; EXPRESSION; SYSTEM; MUSCLE; NHE3	Glucagon-like peptide-1 receptor (GLP-1R) agonists exert antihypertensive actions through incompletely understood mechanisms. Here we demonstrate that cardiac Glp1r expression is localized to cardiac atria and that GLP-1R activation promotes the secretion of atrial natriuretic peptide (ANP) and a reduction of blood pressure. Consistent with an indirect ANP-dependent mechanism for the antihypertensive effects of GLP-1R activation, the GLP-1R agonist liraglutide did not directly increase the amount of cyclic GMP (cGMP) or relax preconstricted aortic rings; however, conditioned medium from liraglutide-treated hearts relaxed aortic rings in an endothelium-independent, GLP-1R-dependent manner. Liraglutide did not induce ANP secretion, vasorelaxation or lower blood pressure in Glplr(-/-) or Nppa(-/-) mice. Cardiomyocyte GLP-1R activation promoted the translocation of the Rap guanine nucleotide exchange factor Epac2 (also known as Rapgef4) to the membrane, whereas Epac2 deficiency eliminated GLP-1R-dependent stimulation of ANP secretion. Plasma ANP concentrations were increased after refeeding in wild-type but not Glplr(-/-) mice, and liraglutide increased urine sodium excretion in wild-type but not Nppa(-/-) mice. These findings define a gut-heart GLP-1R-dependent and ANP-dependent axis that regulates blood pressure.	[Kim, Minsuk; Quaggin, Susan E.; Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Platt, Mathew J.; Simpson, Jeremy A.] Univ Guelph, Dept Human Hlth & Nutrit Sci, Guelph, ON N1G 2W1, Canada; [Shibasaki, Tadao; Seino, Susumu] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Cellular & Mol Med,Chuo Ku, Kobe, Hyogo, Japan; [Backx, Peter H.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Backx, Peter H.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Guelph; Kobe University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Drucker, DJ (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada.	drucker@lunenfeld.ca	Drucker, Daniel J/A-4092-2010	Kim, Minsuk/0000-0003-0139-4067	Heart and Stroke Foundation of Ontario HSFO [NA6997]; Canada Research Chair in Regulatory Peptides; Banting and Best Diabetes Centre-Novo Nordisk Chair in incretin biology; Novo Nordisk Inc.; Canadian Institutes of Health Research [MOP 111159]; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan	Heart and Stroke Foundation of Ontario HSFO(Heart & Stroke Foundation of Ontario); Canada Research Chair in Regulatory Peptides(Canada Research Chairs); Banting and Best Diabetes Centre-Novo Nordisk Chair in incretin biology; Novo Nordisk Inc.(Novo Nordisk); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank G. Kabir for assistance with mouse telemetry and G. Holz (State University of New York Upstate Medical University) for the provision of Epac2 virus constructs. These studies were carried out with support from the Heart and Stroke Foundation of Ontario HSFO NA6997, the Canada Research Chair in Regulatory Peptides, the Banting and Best Diabetes Centre-Novo Nordisk Chair in incretin biology, a grant from Novo Nordisk Inc. to D.J.D., Canadian Institutes of Health Research grant MOP 111159 to J.A.S. and grants to S.S. from the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology, Japan.	BALLERMANN BJ, 1988, AM J PHYSIOL, V254, pF159, DOI 10.1152/ajprenal.1988.254.1.F159; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Birkenfeld AL, 2008, DIABETES, V57, P3199, DOI 10.2337/db08-0649; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Carraro-Lacroix LR, 2009, AM J PHYSIOL-RENAL, V297, pF1647, DOI 10.1152/ajprenal.00082.2009; Chai WD, 2012, DIABETES, V61, P888, DOI 10.2337/db11-1073; Chattington PD, 1998, DIABETIC MED, V15, P375, DOI 10.1002/(SICI)1096-9136(199805)15:5<375::AID-DIA585>3.0.CO;2-N; Crajoinas RO, 2011, AM J PHYSIOL-RENAL, V301, pF355, DOI 10.1152/ajprenal.00729.2010; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2010, NAT REV DRUG DISCOV, V9, P267, DOI 10.1038/nrd3148; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Engeli S, 2012, J CLIN INVEST, V122, P4675, DOI 10.1172/JCI64526; Fonseca VA, 2011, AM J CARDIOL, V108, p52B, DOI 10.1016/j.amjcard.2011.03.016; Fonseca VA, 2010, AM J MED, V123, pS2, DOI 10.1016/j.amjmed.2010.04.002; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; Golpon HA, 2001, REGUL PEPTIDES, V102, P81, DOI 10.1016/S0167-0115(01)00300-7; Gutzwiller JP, 2004, J CLIN ENDOCR METAB, V89, P3055, DOI 10.1210/jc.2003-031403; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kocinsky HS, 2007, AM J PHYSIOL-RENAL, V293, pF212, DOI 10.1152/ajprenal.00042.2007; Lonborg J, 2012, EUR HEART J, V33, P1491, DOI 10.1093/eurheartj/ehr309; Moore-Morris T, 2009, MOL PHARMACOL, V75, P1108, DOI 10.1124/mol.108.054155; Moro C, 2004, FASEB J, V18, P908, DOI 10.1096/fj.03-1086fje; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Padmanabhan S, 2012, TRENDS GENET, V28, P397, DOI 10.1016/j.tig.2012.04.001; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; RICHARDS AM, 1985, HYPERTENSION, V7, P812, DOI 10.1161/01.HYP.7.5.812; Ropero AB, 2010, ENDOCRINOLOGY, V151, P3665, DOI 10.1210/en.2010-0119; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Sivertsen J, 2012, NAT REV CARDIOL, V9, P209, DOI 10.1038/nrcardio.2011.211; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Vilsboll T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7771; WEI Y, 1995, FEBS LETT, V358, P219, DOI 10.1016/0014-5793(94)01430-9; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; Yu M, 2003, J HYPERTENS, V21, P1125, DOI 10.1097/00004872-200306000-00012	39	330	350	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					567	575		10.1038/nm.3128	http://dx.doi.org/10.1038/nm.3128			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23542788				2022-12-27	WOS:000318583000028
J	Luxan, G; Casanova, JC; Martinez-Poveda, B; Prados, B; D'Amato, G; MacGrogan, D; Gonzalez-Rajal, A; Dobarro, D; Torroja, C; Martinez, F; Izquierdo-Garcia, JL; Fernandez-Friera, L; Sabater-Molina, M; Kong, YY; Pizarro, G; Ibanez, B; Medrano, C; Garcia-Pavia, P; Gimeno, JR; Monserrat, L; Jimenez-Borreguero, LJ; de la Pompa, JL				Luxan, Guillermo; Casanova, Jesus C.; Martinez-Poveda, Beatriz; Prados, Belen; D'Amato, Gaetano; MacGrogan, Donal; Gonzalez-Rajal, Alvaro; Dobarro, David; Torroja, Carlos; Martinez, Fernando; Luis Izquierdo-Garcia, Jose; Fernandez-Friera, Leticia; Sabater-Molina, Maria; Kong, Young-Y; Pizarro, Gonzalo; Ibanez, Borja; Medrano, Constancio; Garcia-Pavia, Pablo; Gimeno, Juan R.; Monserrat, Lorenzo; Jimenez-Borreguero, Luis J.; Luis de la Pompa, Jose			Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy	NATURE MEDICINE			English	Article							CARDIAC DEVELOPMENT; DISTINCT CARDIOMYOPATHY; UBIQUITIN LIGASE; GENE-MUTATIONS; BARTH-SYNDROME; HEART; HYPERTRABECULATION/NONCOMPACTION; ACTIVATION; DISEASE; DELTA	Left ventricular noncompaction (LVNC) causes prominent ventricular trabeculations and reduces cardiac systolic function. The clinical presentation of LVNC ranges from asymptomatic to heart failure. We show that germline mutations in human MIB1 (mindbomb homolog 1), which encodes an E3 ubiquitin ligase that promotes endocytosis of the NOTCH ligands DELTA and JAGGED, cause LVNC in autosomal-dominant pedigrees, with affected individuals showing reduced NOTCH I activity and reduced expression of target genes. Functional studies in cells and zebrafish embryos and in silico modeling indicate that MIB1 functions as a dimer, which is disrupted by the human mutations. Targeted inactivation of Mib1 in mouse myocardium causes LVNC, a phenotype mimicked by inactivation of myocardial Jagged1 or endocardial Notch 1. Myocardial Mib1 mutants show reduced ventricular Notch1 activity, expansion of compact myocardium to proliferative, immature trabeculae and abnormal expression of cardiac development and disease genes. These results implicate NOTCH signaling in LVNC and indicate that MIB1 mutations arrest chamber myocardium development, preventing trabecular maturation and compaction.	[Luxan, Guillermo; Casanova, Jesus C.; Martinez-Poveda, Beatriz; Prados, Belen; D'Amato, Gaetano; MacGrogan, Donal; Gonzalez-Rajal, Alvaro; Dobarro, David; Luis de la Pompa, Jose] CNIC, Dept Cardiovasc Dev & Repair, Program Cardiovasc Dev Biol, Madrid, Spain; [Torroja, Carlos; Martinez, Fernando] CNIC, Bioinformat Unit, Madrid, Spain; [Luis Izquierdo-Garcia, Jose; Fernandez-Friera, Leticia; Pizarro, Gonzalo; Ibanez, Borja; Jimenez-Borreguero, Luis J.] CNIC, Department Epidemiol Atherothrombosis & Image, Madrid, Spain; [Sabater-Molina, Maria; Gimeno, Juan R.] Hosp Univ Virgen Arrixaca, Murcia, Spain; [Kong, Young-Y] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Pizarro, Gonzalo] Univ Europea Madrid, Hosp Univ Quiron Madrid, Madrid, Spain; [Ibanez, Borja] Hosp Clin San Carlos, Inst Cardiovasc, Madrid, Spain; [Medrano, Constancio] Hosp Gen Univ Gregorio Maranon, Dept Cardiol, Madrid, Spain; [Garcia-Pavia, Pablo] Hosp Univ Puerta Hierro, Dept Cardiol, Cardiomyopathy Unit, Majadahonda, Spain; [Monserrat, Lorenzo] Complejo Hosp Univ A Coruna, Inst Invest Biomed A Coruna, La Coruna, Spain; [Jimenez-Borreguero, Luis J.] Hosp Univ La Princesa, Inst Invest Sanitaria, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Clinico Universitario Virgen de la Arrixaca; Seoul National University (SNU); European University of Madrid; Hospital Clinico San Carlos; General University Gregorio Maranon Hospital; Hospital Puerta de Hierro-Majadahonda; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Hospital de La Princesa	de la Pompa, JL (corresponding author), CNIC, Dept Cardiovasc Dev & Repair, Program Cardiovasc Dev Biol, Madrid, Spain.	jlpompa@cnic.es	Blanes, Juan R Gimeno/I-4269-2015; Izquierdo-Garcia, Jose/L-3293-2013; Sabater-Molina, Maria/I-2722-2015; De La Pompa, José Luis/F-9719-2014; D'Amato, Gaetano/S-1847-2019; Ibáñez, Borja/J-6993-2014; Pizarro, Gonzalo/AAQ-8123-2020; Jiménez-Borreguero, Luis Jesús/L-8107-2014; Fernández Friera, Leticia/E-9931-2015; MacGrogan, Donal/E-8604-2016; Izquierdo Garcia, Jose/L-2654-2015; Garcia-Pavia, Pablo/T-9100-2019; MacGrogan, Donal/AAR-7392-2021; Martinez, Fernando/E-8026-2016; Gonzalez-Rajal, Alvaro/ABA-6874-2020; Martinez-Poveda, Beatriz/T-6973-2017; D'Amato, Gaetano/Q-3141-2019; Torroja, Carlos/N-6022-2014; Pizarro, Gonzalo/K-2438-2015	Blanes, Juan R Gimeno/0000-0001-5818-1754; Izquierdo-Garcia, Jose/0000-0002-7907-3776; Sabater-Molina, Maria/0000-0003-1352-1748; De La Pompa, José Luis/0000-0001-6761-7265; Ibáñez, Borja/0000-0002-5036-254X; Pizarro, Gonzalo/0000-0002-5082-3596; Jiménez-Borreguero, Luis Jesús/0000-0001-5870-237X; Fernández Friera, Leticia/0000-0002-4237-2166; MacGrogan, Donal/0000-0003-2808-8422; MacGrogan, Donal/0000-0003-2808-8422; Martinez, Fernando/0000-0003-1904-5164; Gonzalez-Rajal, Alvaro/0000-0002-9230-0339; Martinez-Poveda, Beatriz/0000-0003-3927-3877; D'Amato, Gaetano/0000-0003-2640-5826; Torroja, Carlos/0000-0001-8914-3400; Martinez Estrada, Fernando O/0000-0003-0908-9366; Monserrat, Lorenzo/0000-0001-5776-0623; Luxan, Guillermo/0000-0001-8350-8659; Prados, Belen/0000-0001-6240-5626; MEDRANO-LOPEZ, CONSTANCIO/0000-0003-4097-2448	Spanish Ministry of Economy and Competition (MINECO) [SAF2010-17555, RD06/0014/0038, RD06/0010/1013]; MINECO (FPI Program) [BES-2008-002904]; MINECO; Pro-CNIC Foundation	Spanish Ministry of Economy and Competition (MINECO)(Spanish Government); MINECO (FPI Program)(Spanish Government); MINECO(Spanish Government); Pro-CNIC Foundation	We thank P.J. Gallagher (Indiana University) for the Mib1-specific antibody, U. Lendahl (Karolinska Institute) for the Jag1- and Notch1-HEK293 cells, A. Martin-Pendas (Cancer Center, CSIC, Salamanca) for the pCELF plamid, D. Saura and J. Gonzalez for carrying out the CMRI of the patients, M. Manzanares, A. Martin-Pendas, J.M. Perez-Pomares, J.M. Redondo, J.J. Schott and M. Torres for critical reading of the manuscript and S. Bartlett (CNIC) for English editing. This study was funded by grants SAF2010-17555, RD06/0014/0038 (RECAVA) and RD06/0010/1013 (TERCEL) from the Spanish Ministry of Economy and Competition (MINECO) to J.L.d.l.P. G.L. has a PhD fellowship from the MINECO (FPI Program, BES-2008-002904). The CNIC is supported by the MINECO and the Pro-CNIC Foundation.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barsi JC, 2005, MECH DEVELOP, V122, P1106, DOI 10.1016/j.mod.2005.06.005; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Captur G, 2010, INT J CARDIOL, V140, P145, DOI 10.1016/j.ijcard.2009.07.003; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Hermida-Prieto M, 2004, AM J CARDIOL, V94, P50, DOI 10.1016/j.amjcard.2004.03.029; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Ichida F, 2001, CIRCULATION, V103, P1256; Ichida F, 2009, CIRC J, V73, P19, DOI 10.1253/circj.CJ-08-0995; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Klaassen S, 2008, CIRCULATION, V117, P2893, DOI 10.1161/CIRCULATIONAHA.107.746164; Koibuchi N, 2007, CIRC RES, V100, P850, DOI 10.1161/01.RES.0000261693.13269.bf; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; de la Pompa JL, 2012, DEV CELL, V22, P244, DOI 10.1016/j.devcel.2012.01.014; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5; Macias-Vidal J, 2009, MOL GENET METAB, V97, P60, DOI 10.1016/j.ymgme.2009.01.007; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; MOENS CB, 1993, DEVELOPMENT, V119, P485; Oechslin EN, 2000, J AM COLL CARDIOL, V36, P493, DOI 10.1016/S0735-1097(00)00755-5; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Ritter M, 1997, MAYO CLIN PROC, V72, P26, DOI 10.4065/72.1.26; Rodighiero S, 2008, CELL PHYSIOL BIOCHEM, V21, P489, DOI 10.1159/000129642; Sarma RJ, 2010, PROG CARDIOVASC DIS, V52, P264, DOI 10.1016/j.pcad.2009.11.001; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Stanley EG, 2002, INT J DEV BIOL, V46, P431; Stollberger C, 2004, J AM SOC ECHOCARDIOG, V17, P91, DOI 10.1016/S0894-7317(03)00514-5; Stollberger C, 2004, J AM SOC ECHOCARDIOG, V17, P1120, DOI 10.1016/j.echo.2004.06.018; Towbin Jeffrey A, 2010, Heart Fail Clin, V6, P453, DOI 10.1016/j.hfc.2010.06.005; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; VanKempen MJA, 1996, CARDIOVASC RES, V32, P886; ZELLER R, 1987, GENE DEV, V1, P693, DOI 10.1101/gad.1.7.693; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034	51	222	230	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					193	201		10.1038/nm.3046	http://dx.doi.org/10.1038/nm.3046			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23314057				2022-12-27	WOS:000314675900027
J	Chen, DH; Sun, YT; Wei, YK; Zhang, PJ; Rezaeian, AH; Teruya-Feldstein, J; Gupta, S; Liang, H; Lin, HK; Hung, MC; Ma, L				Chen, Dahu; Sun, Yutong; Wei, Yongkun; Zhang, Peijing; Rezaeian, Abdol Hossein; Teruya-Feldstein, Julie; Gupta, Sumeet; Liang, Han; Lin, Hui-Kuan; Hung, Mien-Chie; Ma, Li			LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker	NATURE MEDICINE			English	Article							GENE-EXPRESSION PATTERNS; E-CADHERIN; TUMOR INVASION; GROWTH-CONTROL; SIZE-CONTROL; MICRORNAS; CARCINOMAS; CELLS; ONCOPROTEIN; MECHANISM	There is a pressing need to identify prognostic markers of metastatic disease and targets for treatment. Combining high-throughput RNA sequencing, functional characterization, mechanistic studies and clinical validation, we identify leukemia inhibitory factor receptor (LIFR) as a breast cancer metastasis suppressor downstream of the microRNA miR-9 and upstream of Hippo signaling. Restoring LIFR expression in highly malignant tumor cells suppresses metastasis by triggering a Hippo kinase cascade that leads to phosphorylation, cytoplasmic retention and functional inactivation of the transcriptional coactivator YES-associated protein (YAP). Conversely, loss of LIFR in nonmetastatic breast cancer cells induces migration, invasion and metastatic colonization through activation of YAP. LIFR is downregulated in human breast carcinomas and inversely correlates with metastasis. Notably, in approximately 1,000 nonmetastatic breast tumors, LIFR expression status correlated with metastasis-free, recurrence-free and overall survival outcomes in the patients. These findings identify LIFR as a metastasis suppressor that functions through the Hippo-YAP pathway and has significant prognostic power.	[Chen, Dahu; Zhang, Peijing; Ma, Li] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Sun, Yutong; Wei, Yongkun; Rezaeian, Abdol Hossein; Lin, Hui-Kuan; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Gupta, Sumeet] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Lin, Hui-Kuan; Hung, Mien-Chie; Ma, Li] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan	Ma, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	lma4@mdanderson.org	Rezaeian, Abdol-Hossein/AAV-6900-2021; Ma, Li/GQR-1313-2022; Chen, Dahu/AAX-6349-2021; Hung, Mien-Chie/ABD-5911-2021	Ma, Li/0000-0001-9965-989X; Hung, Mien-Chie/0000-0003-4317-4740; Sun, Yutong/0000-0002-9368-2957; Liang, Han/0000-0001-7633-286X; Zhang, Peijing/0000-0003-1586-8710	US National Institutes of Health [R00CA138572, R01CA166051, R01CA109311, P01CA099031]; Cancer Prevention and Research Institute of Texas Scholar Award [R1004]; University of Texas STARS Award; Faculty Development Award; MD Anderson Cancer Center from the US National Institutes of Health, Center for Biological Pathways [CA016672]; Susan G. Komen for the Cure grant [SAC110016]; National Breast Cancer Foundation, Inc.; China Medical University and Hospital; MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R00CA138572, R01CA109311, R01CA166051, P01CA099031, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Scholar Award; University of Texas STARS Award; Faculty Development Award; MD Anderson Cancer Center from the US National Institutes of Health, Center for Biological Pathways; Susan G. Komen for the Cure grant(Susan G. Komen Breast Cancer Foundation); National Breast Cancer Foundation, Inc.; China Medical University and Hospital(China Medical University); MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to R. A. Weinberg for his advice and reagents. We thank S. Ethier for providing cell lines; F. Reinhardt for advice on mouse surgery; the Genome Technology Core at the Whitehead Institute, the ShRNA and ORFeome Core at MD Anderson Cancer Center and the Histology Core Laboratories at MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center for technical assistance; and members of the Ma Lab for discussion. We thank J. Chen, K. Muller, W. Pagel, K. Keyomarsi, L. Li and R. Cleveland for critical reading of the manuscript. This work is supported by the US National Institutes of Health grants R00CA138572 (to L. M.), R01CA166051 (to L. M.), R01CA109311 (to M.-C. H.) and P01CA099031 (to M.-C. H.), a Cancer Prevention and Research Institute of Texas Scholar Award R1004 (to L. M.), a University of Texas STARS Award (to L. M.), a Faculty Development Award (to L. M.) from the MD Anderson Cancer Center Support grant CA016672 from the US National Institutes of Health, Center for Biological Pathways (to Y. S. and M.-C. H.), a Susan G. Komen for the Cure grant SAC110016 (to M.-C. H.), the National Breast Cancer Foundation, Inc. and the Sister Institution Fund of China Medical University and Hospital and MD Anderson Cancer Center (to M.-C. H.).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chan JKC, 2001, ADV ANAT PATHOL, V8, P165, DOI 10.1097/00125480-200105000-00005; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; GEARING DP, 1993, ADV IMMUNOL, V53, P31, DOI 10.1016/S0065-2776(08)60497-6; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huntsman DG, 2001, NEW ENGL J MED, V344, P1904, DOI 10.1056/NEJM200106213442504; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; LEE YTNM, 1983, J SURG ONCOL, V23, P175, DOI 10.1002/jso.2930230311; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vaidya KS, 2007, J MAMMARY GLAND BIOL, V12, P175, DOI 10.1007/s10911-007-9049-1; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	42	306	311	0	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1511	U105		10.1038/nm.2940	http://dx.doi.org/10.1038/nm.2940			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23001183	Green Accepted			2022-12-27	WOS:000309587500029
J	Goldstein, JL				Goldstein, Joseph L.			Paradigm shifts in science: insights from the arts FOREWORD	NATURE MEDICINE			English	Editorial Material												joe.goldstein@utsouthwestern.edu						Bancroft S, 2007, J ROSENQUIST TIME BL; Kuhn T.S., 2012, STRUCTURE SCI REVOLU; Kuhn T.S., 1977, ESSENTIAL TENSION, V345; Mangini E, 2010, ARTFORUM INT, V49, P226	4	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1473	1477		10.1038/nm.2923	http://dx.doi.org/10.1038/nm.2923			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042355				2022-12-27	WOS:000309587500020
J	Humaidan, P; Polyzos, NP				Humaidan, Peter; Polyzos, Nikolaos P.			(Meta)analyze this: Systematic reviews might lose credibility	NATURE MEDICINE			English	Editorial Material							METAANALYSIS; TRIALS; CANCER		[Humaidan, Peter] Odense Univ Hosp, Fertil Clin, DK-5000 Odense, Denmark; [Polyzos, Nikolaos P.] Univ Libre Brussels, Ctr Reprod Med, Brussels, Belgium	University of Southern Denmark; Odense University Hospital; Universite Libre de Bruxelles	Humaidan, P (corresponding author), Odense Univ Hosp, Fertil Clin, DK-5000 Odense, Denmark.		Polyzos, Nikolaos P/O-5130-2014; Humaidan, Peter/AAB-4788-2020	Humaidan, Peter/0000-0001-6884-5366; Polyzos, Nikolaos/0000-0001-6161-0011				Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Seidenfeld J, 2001, J NATL CANCER I, V93, P1204, DOI 10.1093/jnci/93.16.1204	3	25	28	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1321	1321		10.1038/nm0912-1321	http://dx.doi.org/10.1038/nm0912-1321			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22961151	Bronze			2022-12-27	WOS:000308472300015
J	Zeissig, S; Murata, K; Sweet, L; Publicover, J; Hu, ZY; Kaser, A; Bosse, E; Iqbal, J; Hussain, MM; Balschun, K; Rocken, C; Arlt, A; Gunther, R; Hampe, J; Schreiber, S; Baron, JL; Moody, DB; Liang, TJ; Blumberg, RS				Zeissig, Sebastian; Murata, Kazumoto; Sweet, Lindsay; Publicover, Jean; Hu, Zongyi; Kaser, Arthur; Bosse, Esther; Iqbal, Jahangir; Hussain, M. Mahmood; Balschun, Katharina; Roecken, Christoph; Arlt, Alexander; Guenther, Rainer; Hampe, Jochen; Schreiber, Stefan; Baron, Jody L.; Moody, D. Branch; Liang, T. Jake; Blumberg, Richard S.			Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity	NATURE MEDICINE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; NKT CELLS; IN-VIVO; ANTIGEN PRESENTATION; PHOSPHOLIPASE A(2); MICROBIAL INFECTION; VIRAL CLEARANCE; SURFACE-ANTIGEN; MOUSE MODEL; INNATE	In most adult humans, hepatitis B is a self-limiting disease leading to life-long protective immunity, which is the consequence of a robust adaptive immune response occurring weeks after hepatitis B virus (HBV) infection. Notably, HBV-specific T cells can be detected shortly after infection, but the mechanisms underlying this early immune priming and its consequences for subsequent control of viral replication are poorly understood. Using primary human and mouse hepatocytes and mouse models of transgenic and adenoviral HBV expression, we show that HBV-expressing hepatocytes produce endoplasmic reticulum (ER)-associated endogenous antigenic lipids including lysophospholipids that are generated by HBV-induced secretory phospholipases and that lead to activation of natural killer T (NKT) cells. The absence of NKT cells or CD1d or a defect in ER-associated transfer of lipids onto CD1d results in diminished HBV-specific T and B cell responses and delayed viral control in mice. NKT cells may therefore contribute to control of HBV infection through sensing of HBV-induced modified self-lipids.	[Zeissig, Sebastian; Kaser, Arthur; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA; [Zeissig, Sebastian; Bosse, Esther; Arlt, Alexander; Guenther, Rainer; Hampe, Jochen; Schreiber, Stefan] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Murata, Kazumoto; Hu, Zongyi; Liang, T. Jake] NIDDK, Liver Dis Branch, US Natl Inst Hlth, Bethesda, MD USA; [Sweet, Lindsay; Moody, D. Branch] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Publicover, Jean; Baron, Jody L.] Univ Calif San Francisco, Ctr Liver, Dept Med, San Francisco, CA 94143 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] SUNY Hlth Sci Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Hussain, M. Mahmood] SUNY Hlth Sci Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Balschun, Katharina; Roecken, Christoph] Univ Kiel, Univ Med Ctr Schleswig Holstein, Dept Pathol, Kiel, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University of Kiel; Schleswig Holstein University Hospital	Blumberg, RS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA.	jliang@nih.gov; rblumberg@partners.org	Hampe, Jochen/A-2555-2010; Zeissig, Sebastian/B-6297-2012; Arlt, Alexander/G-7308-2019; Röcken, Christoph/A-9239-2010; Iqbal, Jahangir/B-3903-2014	Hampe, Jochen/0000-0002-2421-6127; Zeissig, Sebastian/0000-0001-5124-0897; Arlt, Alexander/0000-0002-6160-1059; Röcken, Christoph/0000-0002-6989-8002; Iqbal, Jahangir/0000-0002-9021-2271	US National Institutes of Health (NIH) [DK51362, DK44319, DK53056, DK88199]; Harvard Digestive Diseases Center [DK034854]; Deutsche Forschungsgemeinschaft [Ze 814/1-1, Ze 814/4-1]; Marie Curie International Reintegration Grant within the 7th European Community Framework Programme [256363]; Crohn's and Colitis Foundation of America; Austrian Science Fund; Max Kade Foundation; NIH [AR048632, AI049313]; Burroughs Wellcome Fund for Translational Research; NIH Intramural Research Program; Burroughs Wellcome Fund [AI068090, DK026743]; A.P. Gianinni Foundation;  [DK46900]; Austrian Science Fund (FWF) [P 21530] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049313, R01AI068090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R29DK046900, P30DK026743, R01DK093646, ZIADK054500, R01DK044319, R37DK044319, R56DK046900, R01DK051362, R01DK046900, R01DK053056, R01DK088199] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marie Curie International Reintegration Grant within the 7th European Community Framework Programme(European Commission); Crohn's and Colitis Foundation of America; Austrian Science Fund(Austrian Science Fund (FWF)); Max Kade Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund for Translational Research(Burroughs Wellcome Fund); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); A.P. Gianinni Foundation; ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health (NIH) grants DK51362, DK44319, DK53056, DK88199, the Harvard Digestive Diseases Center DK034854 (to R.S.B.); the Deutsche Forschungsgemeinschaft (Ze 814/1-1, Ze 814/4-1), a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (256363) and the Crohn's and Colitis Foundation of America (to S.Z.); the Crohn's and Colitis Foundation of America, Austrian Science Fund, and Max Kade Foundation (to A.K.); NIH AR048632, AI049313 and the Burroughs Wellcome Fund for Translational Research (to D.B.M.); DK46900 (to M.M.H.); the NIH Intramural Research Program (K.M., Z.H. and T.J.L.); NIH grants AI068090, DK026743 and the Burroughs Wellcome Fund (to J.L.B.); and the A.P. Gianinni Foundation (to J.P.). We thank D.E. Cohen, E. Scapa and S.K. Dougan for insightful discussions.	Arrenberg P, 2010, P NATL ACAD SCI USA, V107, P10984, DOI 10.1073/pnas.1000576107; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Calabrese LH, 2006, ANN RHEUM DIS, V65, P983, DOI 10.1136/ard.2005.043257; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; ERNSTER L, 1962, J CELL BIOL, V15, P541, DOI 10.1083/jcb.15.3.541; Esteve M, 2004, GUT, V53, P1363, DOI 10.1136/gut.2004.040675; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Guy CS, 2008, J VIROL, V82, P8579, DOI 10.1128/JVI.01022-08; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Isogawa M, 2005, VIROLOGY, V333, P293, DOI 10.1016/j.virol.2005.01.004; Ito M, 2004, J GASTROEN HEPATOL, V19, P1140, DOI 10.1111/j.1440-1746.2004.03435.x; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kaser A, 2008, EUR J IMMUNOL, V38, P2351, DOI 10.1002/eji.200738102; Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504; Kuwata H, 2004, BBA-MOL CELL BIOL L, V1686, P15, DOI 10.1016/j.bbalip.2004.07.002; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Ni Z, 2006, J BIOL CHEM, V281, P16245, DOI 10.1074/jbc.M513874200; Patient R, 2009, CELL MICROBIOL, V11, P1561, DOI 10.1111/j.1462-5822.2009.01363.x; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Publicover J, 2011, J CLIN INVEST, V121, P1154, DOI 10.1172/JCI44198; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; SATOH O, 1990, J LIPID RES, V31, P1293; Scapa EF, 2008, FASEB J, V22, P2579, DOI 10.1096/fj.07-105395; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Tischfield JA, 1996, GENOMICS, V32, P328, DOI 10.1006/geno.1996.0126; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vilarinho S, 2007, P NATL ACAD SCI USA, V104, P18187, DOI 10.1073/pnas.0708968104; von Freyend MJ, 2011, J VIRAL HEPATITIS, V18, P216, DOI 10.1111/j.1365-2893.2010.01302.x; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Zeissig S, 2010, J CLIN INVEST, V120, P2889, DOI 10.1172/JCI42703	55	167	178	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1060	+		10.1038/nm.2811	http://dx.doi.org/10.1038/nm.2811			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22706385	Green Accepted			2022-12-27	WOS:000306121600035
J	Karin, M; Jobin, C; Balkwill, F				Karin, Michael; Jobin, Christian; Balkwill, Frances			Chemotherapy, immunity and microbiota-a new triumvirate?	NATURE MEDICINE			English	Editorial Material							TUMOR-GROWTH; CANCER; RESISTANCE; THERAPY		[Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, San Diego, CA 92103 USA; [Jobin, Christian] Univ Florida, Dept Med, Gainesville, FL USA; [Jobin, Christian] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL USA; [Balkwill, Frances] Queen Mary Univ London, Barts Canc Inst, London, England	University of California System; University of California San Diego; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of London; Queen Mary University London	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, San Diego, CA 92103 USA.			Balkwill, Frances/0000-0002-5587-9759	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, R01DK073338] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK073338, R01 DK047700] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Kottke T, 2013, NAT MED, V19, P1625, DOI 10.1038/nm.3397; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Pidgeon GP, 1999, BRIT J CANCER, V81, P1311, DOI 10.1038/sj.bjc.6694369; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Taketomi A, 1997, HEPATO-GASTROENTEROL, V44, P477; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Velicer CM, 2004, JAMA-J AM MED ASSOC, V291, P827, DOI 10.1001/jama.291.7.827; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	14	41	42	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					126	127		10.1038/nm.3473	http://dx.doi.org/10.1038/nm.3473			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24504404	Green Accepted			2022-12-27	WOS:000330915000012
J	Pyonteck, SM; Akkari, L; Schuhmacher, AJ; Bowman, RL; Sevenich, L; Quail, DF; Olson, OC; Quick, ML; Huse, JT; Teijeiro, V; Setty, M; Leslie, CS; Oei, Y; Pedraza, A; Zhang, JA; Brennan, CW; Sutton, JC; Holland, EC; Daniel, D; Joyce, JA				Pyonteck, Stephanie M.; Akkari, Leila; Schuhmacher, Alberto J.; Bowman, Robert L.; Sevenich, Lisa; Quail, Daniela F.; Olson, Oakley C.; Quick, Marsha L.; Huse, Jason T.; Teijeiro, Virginia; Setty, Manu; Leslie, Christina S.; Oei, Yoko; Pedraza, Alicia; Zhang, Jianan; Brennan, Cameron W.; Sutton, James C.; Holland, Eric C.; Daniel, Dylan; Joyce, Johanna A.			CSF-1R inhibition alters macrophage polarization and blocks glioma progression	NATURE MEDICINE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; STIMULATING FACTOR-I; KINASE INHIBITOR; GENE-EXPRESSION; PROBE LEVEL; GLIOBLASTOMA; CANCER; GROWTH; CELLS; INFLAMMATION	Glioblastoma multiforme (GBM) comprises several molecular subtypes, including proneural GBM. Most therapeutic approaches targeting glioma cells have failed. An alternative strategy is to target cells in the glioma microenvironment, such as tumor-associated macrophages and microglia (TAMs). Macrophages depend on colony stimulating factor-1 (CSF-1) for differentiation and survival. We used an inhibitor of the CSF-1 receptor (CSF-1R) to target TAMs in a mouse proneural GBM model, which significantly increased survival and regressed established tumors. CSF-1R blockade additionally slowed intracranial growth of patient-derived glioma xenografts. Surprisingly, TAMs were not depleted in treated mice. Instead, glioma-secreted factors, including granulocyte-macrophage CSF (GM-CSF) and interferon-gamma (IFN-gamma), facilitated TAM survival in the context of CSF-1R inhibition. Expression of alternatively activated M2 markers decreased in surviving TAMs, which is consistent with impaired tumor-promoting functions. These gene signatures were associated with enhanced survival in patients with proneural GBM. Our results identify TAMs as a promising therapeutic target for proneural gliomas and establish the translational potential of CSF-1R inhibition for GBM.	[Pyonteck, Stephanie M.; Akkari, Leila; Schuhmacher, Alberto J.; Bowman, Robert L.; Sevenich, Lisa; Quail, Daniela F.; Olson, Oakley C.; Quick, Marsha L.; Teijeiro, Virginia; Setty, Manu; Leslie, Christina S.; Holland, Eric C.; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Huse, Jason T.; Pedraza, Alicia; Zhang, Jianan; Brennan, Cameron W.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Huse, Jason T.; Zhang, Jianan; Brennan, Cameron W.; Holland, Eric C.; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Oei, Yoko; Sutton, James C.; Daniel, Dylan] Novartis Inst Biomed Res, Emeryville, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Novartis	Joyce, JA (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	joycej@mskcc.org	Brennan, Cameron/R-7082-2019; Schuhmacher, Alberto J./R-6765-2019; J. Schuhmacher, Alberto/F-4028-2016; Bowman, Robert/ABF-1007-2021	Brennan, Cameron/0000-0003-4064-8891; Schuhmacher, Alberto J./0000-0002-0136-1049; Bowman, Robert/0000-0002-8294-8748; Setty, Manu/0000-0002-0344-2627; Akkari, Leila/0000-0001-5479-641X; Olson, Oakley/0000-0002-0716-5380; Pyonteck, Stephanie/0000-0002-4143-0969	US National Cancer Institute program grants of the Integrative Cancer Biology Program [CA148967]; Tumor Microenvironment Network [CA126518]; Cycle for Survival; Geoffrey Beene Foundation; MSKCC Brain Tumor Center; Fundacion Ramon Areces and Ibercaja; Deutsche Forschungsgemeinschaft; Canadian Institutes of Health Research; US National Institutes of Health T32 Institutional Research training grant [5T32GM008539]; US National Cancer Institute F31 fellowships [F31CA167863, F31CA171384]; Cornell and Gerstner Sloan Kettering graduate programs; NATIONAL CANCER INSTITUTE [F31CA171384, U54CA126518, U54CA148967, F31CA167863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008539] Funding Source: NIH RePORTER	US National Cancer Institute program grants of the Integrative Cancer Biology Program; Tumor Microenvironment Network; Cycle for Survival; Geoffrey Beene Foundation; MSKCC Brain Tumor Center; Fundacion Ramon Areces and Ibercaja; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health T32 Institutional Research training grant; US National Cancer Institute F31 fellowships; Cornell and Gerstner Sloan Kettering graduate programs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Simpson and X. Chen for excellent technical support, members of the Joyce and Holland labs, particularly T. Ozawa, K. Pitter and M. Squatrito, for technical advice and reagents and D. Chakravarti and the MSKCC Brain Tumor Center for assistance with patient and tumor sphere line information. We thank R. Benezra, K. Hunter and H.-W. Wang for reading the manuscript. We thank E. Pamer and T. Hohl (MSKCC) for providing CCR2-DTR mice and R. Lang (Cincinnati Children's Hospital Medical Center) for providing CD11b-DTR mice. We are grateful to the MSKCC Core Facilities of Genomics, Flow Cytometry and Small Animal Imaging, Geoffrey Beene Translational Oncology and the Novartis Institutes for BioMedical Research Emeryville Analytical Sciences group for technical assistance. This research was supported by US National Cancer Institute program grants of the Integrative Cancer Biology Program (CA148967; J.A.J. and C.S.L.) and Tumor Microenvironment Network (CA126518; J.A.J. and E.C.H.), Cycle for Survival (J.A.J.), the Geoffrey Beene Foundation (J.A.J., R.L.B. and O.C.O.), the MSKCC Brain Tumor Center (J.A.J. and L.A.), the Fundacion Ramon Areces and Ibercaja (A.J.S.), Deutsche Forschungsgemeinschaft (L.S.), Canadian Institutes of Health Research (D.F.Q.), US National Institutes of Health T32 Institutional Research training grant (5T32GM008539, S.M.P.), US National Cancer Institute F31 fellowships (F31CA167863, R.L.B.; F31CA171384, O.C.O.) and Cornell and Gerstner Sloan Kettering graduate programs (S.M.P., R.L.B., O.C.O. and V.T.).	Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Fomchenko EI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020605; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hambardzumyan D, 2011, GLIA, V59, P1155, DOI 10.1002/glia.21142; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Huse JT, 2009, BRAIN PATHOL, V19, P132, DOI 10.1111/j.1750-3639.2008.00234.x; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kennedy BC, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-11; Kilic T, 2000, CANCER RES, V60, P5143; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Luo J, 2013, J EXP MED, V210, P157, DOI 10.1084/jem.20120412; Manthey CL, 2009, MOL CANCER THER, V8, P3151, DOI 10.1158/1535-7163.MCT-09-0255; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Patel S, 2009, CURR TOP MED CHEM, V9, P599, DOI 10.2174/156802609789007327; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Probst-Cousin S, 1998, CLIN NEUROPATHOL, V17, P79; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Takeuchi H, 2004, BRIT J CANCER, V90, P1069, DOI 10.1038/sj.bjc.6601605; Tchougounova E, 2007, ONCOGENE, V26, P6289, DOI 10.1038/sj.onc.1210455; Therneau T, 2012, PACKAGE SURVIVAL ANA; Torocsik D, 2010, THROMB HAEMOSTASIS, V104, P709, DOI 10.1160/TH09-11-0805; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WALKER WS, 1994, J IMMUNOL METHODS, V174, P25, DOI 10.1016/0022-1759(94)90007-8; Wang T, 2011, INT J TOXICOL, V30, P300, DOI 10.1177/1091581811401920; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449	72	1335	1403	17	360	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1264	+		10.1038/nm.3337	http://dx.doi.org/10.1038/nm.3337			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24056773	Green Accepted			2022-12-27	WOS:000325531700025
J	Scheller, RH				Scheller, Richard H.			In search of the molecular mechanism of intracellular membrane fusion and neurotransmitter release	NATURE MEDICINE			English	Editorial Material							SNARE COMPLEX; SYNAPTIC EXOCYTOSIS; PROTEIN; ORGANIZATION; SPECIFICITY; RESOLUTION; RECEPTORS; TRANSPORT; SECRETION; VESICLES		Genentech Res & Early Dev, San Francisco, CA USA	Roche Holding; Genentech	Scheller, RH (corresponding author), Genentech Res & Early Dev, 1 DNA Way, San Francisco, CA USA.	scheller.richard@gene.com						BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HOOPER JE, 1980, J CELL BIOL, V87, P104, DOI 10.1083/jcb.87.1.104; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Scales SJ, 2001, P NATL ACAD SCI USA, V98, P14262, DOI 10.1073/pnas.251547598; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sudhof TC, 2013, NAT MED, V19, P1227, DOI 10.1038/nm.3338; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538	20	9	9	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1232	1235		10.1038/nm.3339	http://dx.doi.org/10.1038/nm.3339			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100993				2022-12-27	WOS:000325531700019
J	Chen, Y; Chi, P; Rockowitz, S; Iaquinta, PJ; Shamu, T; Shukla, S; Gao, D; Sirota, I; Carver, BS; Wongvipat, J; Scher, HI; Zheng, DY; Sawyers, CL				Chen, Yu; Chi, Ping; Rockowitz, Shira; Iaquinta, Phillip J.; Shamu, Tambudzai; Shukla, Shipra; Gao, Dong; Sirota, Inna; Carver, Brett S.; Wongvipat, John; Scher, Howard I.; Zheng, Deyou; Sawyers, Charles L.			ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss	NATURE MEDICINE			English	Article							GENE FUSIONS; HISTONE MODIFICATIONS; DISTINCT CLASSES; TRANSCRIPTION; CANCER; TMPRSS2-ERG; ERG; ENHANCERS; EXPRESSION; CHROMATIN	Studies of ETS-mediated prostate oncogenesis have been hampered by a lack of suitable experimental systems. Here we describe a new conditional mouse model that shows robust, homogenous ERG expression throughout the prostate. When combined with homozygous Pten loss, the mice developed accelerated, highly penetrant invasive prostate cancer. In mouse prostate tissue, ERG markedly increased androgen receptor (AR) binding. Robust ERG-mediated transcriptional changes, observed only in the setting of Pten loss, included the restoration of AR transcriptional output and upregulation of genes involved in cell death, migration, inflammation and angiogenesis. Similarly, ETS variant 1 (ETV1) positively regulated the AR cistrome and transcriptional output in ETV1-translocated, PTEN-deficient human prostate cancer cells. In two large clinical cohorts, expression of ERG and ETV1 correlated with higher AR transcriptional output in PTEN-deficient prostate cancer specimens. We propose that ETS factors cause prostate-specific transformation by altering the AR cistrome, priming the prostate epithelium to respond to aberrant upstream signals such as PTEN loss.	[Chen, Yu; Chi, Ping; Scher, Howard I.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Chen, Yu; Chi, Ping; Iaquinta, Phillip J.; Shamu, Tambudzai; Shukla, Shipra; Gao, Dong; Sirota, Inna; Carver, Brett S.; Wongvipat, John; Sawyers, Charles L.] MSKCC, Human Oncol & Pathogenesis Program, New York, NY USA; [Rockowitz, Shira; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), MSKCC, Human Oncol & Pathogenesis Program, New York, NY USA.	cheny1@mskcc.org; sawyersc@mskcc.org	Sawyers, Charles/G-5327-2016	Shukla, Shipra/0000-0001-9537-9540; Zheng, Deyou/0000-0003-4354-5337; Shamu, Tambudzai/0000-0001-8944-8079; Gao, Dong/0000-0003-1821-2741	Howard Hughes Medical Institute; US National Cancer Institute [K08CA140946, 1K08CA151660-01A1, U01 CA141502, P50CA092629]; US Department of Defense [W81XWH-10-1-0197]; Prostate Cancer Foundation; Starr Cancer Consortium; US National Institute of Mental Health [R21MH099452]; NATIONAL CANCER INSTITUTE [K08CA151660, P50CA092629, K08CA140946, U01CA141502, P30CA008748, R01CA155169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099452] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Starr Cancer Consortium; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the MSKCC Gene Targeting (C. Yang), Mouse Genetics Core (W. Mark and P. Romanienko), Genomics Core Laboratory (A. Viale), Molecular Cytogenetics (M. Leversha) and Molecular Cytology (K. Manova) core facilities and the Rockefeller University Genomics Core (S. Dewell). This work is supported in part by the Howard Hughes Medical Institute (C.L.S.), the US National Cancer Institute (K08CA140946, Y.C.; 1K08CA151660-01A1, P.C.; U01 CA141502, C.L.S.; and P50CA092629, C.L.S. and B.S.C.), the US Department of Defense (W81XWH-10-1-0197, Y.C.), the Prostate Cancer Foundation (Y.C. and B.S.C.), the Starr Cancer Consortium (Y.C., P.C., C.L.S. and D.Z.) and the US National Institute of Mental Health (R21MH099452, D.Z.). We thank J.P. Martinez-Barbera (University College London) for plasmids, C.D. Allis, F. Giancotti and J. Otero for conceptual input, N. Schultz for bioinformatics assistance and A. Gopalan and S. Couto for pathology input.	Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Casey OM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041668; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Clegg NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017449; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mosquera JM, 2008, CLIN CANCER RES, V14, P3380, DOI 10.1158/1078-0432.CCR-07-5194; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Paulo P, 2012, GENE CHROMOSOME CANC, V51, P240, DOI 10.1002/gcc.20948; Rickman DS, 2010, NEOPLASIA, V12, P1031, DOI 10.1593/neo.10866; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	42	199	206	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1023	+		10.1038/nm.3216	http://dx.doi.org/10.1038/nm.3216			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23817021	Green Accepted			2022-12-27	WOS:000322779600028
J	Addis, RC; Epstein, JA				Addis, Russell C.; Epstein, Jonathan A.			Induced regeneration-the progress and promise of direct reprogramming for heart repair	NATURE MEDICINE			English	Review							PLURIPOTENT STEM-CELLS; IN-VIVO; MOUSE FIBROBLASTS; DIRECT CONVERSION; ISCHEMIC CARDIOMYOPATHY; DOPAMINERGIC-NEURONS; CARDIAC FIBROBLASTS; MASTER REGULATOR; CARDIOMYOCYTES; TISSUE	Regeneration of cardiac tissue has the potential to transform cardiovascular medicine. Recent advances in stem cell biology and direct reprogramming, or transdifferentiation, have produced powerful new tools to advance this goal. In this Review we examine key developments in the generation of new cardiomyocytes in vitro as well as the exciting progress that has been made toward in vivo reprogramming of cardiac tissue. We also address controversies and hurdles that challenge the field.	[Epstein, Jonathan A.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Epstein, JA (corresponding author), Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.	raddis@mail.med.upenn.edu; epsteinj@upenn.edu		Epstein, Jonathan/0000-0001-8637-4465	American Heart Association Jon Holden DeHaan Cardiac Myogenesis Research Center, US National Institutes of Health [NIH U01 HL100405]; Spain Fund for Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405] Funding Source: NIH RePORTER	American Heart Association Jon Holden DeHaan Cardiac Myogenesis Research Center, US National Institutes of Health; Spain Fund for Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association Jon Holden DeHaan Cardiac Myogenesis Research Center, US National Institutes of Health grant NIH U01 HL100405 and the Spain Fund for Regenerative Medicine.	Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Addis RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028719; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.TEA.2011.0341, 10.1089/ten.tea.2011.0341]; Buganim Y, 2012, CELL STEM CELL, V11, P373, DOI 10.1016/j.stem.2012.07.019; Burridge PW, 2012, CELL STEM CELL, V10, P16, DOI 10.1016/j.stem.2011.12.013; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Chiu LLY, 2012, FRONT BIOSCI-LANDMRK, V17, P1533, DOI 10.2741/4002; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Chugh AR, 2012, CIRCULATION, V126, pS54, DOI 10.1161/CIRCULATIONAHA.112.092627; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Davies MP, 1996, CIRC RES, V78, P15, DOI 10.1161/01.RES.78.1.15; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEHAAN RL, 1968, J GEN PHYSIOL, V52, P643; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Elliott DA, 2011, NAT METHODS, V8, P1037, DOI [10.1038/NMETH.1740, 10.1038/nmeth.1740]; EVANS SM, 1994, MOL CELL BIOL, V14, P4269, DOI 10.1128/MCB.14.6.4269; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Hudson J, 2012, STEM CELLS DEV, V21, P1513, DOI 10.1089/scd.2011.0254; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2013, J CARDIOVASC TRANSL, V6, P37, DOI 10.1007/s12265-012-9412-5; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Islas JF, 2012, P NATL ACAD SCI USA, V109, P13016, DOI 10.1073/pnas.1120299109; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kim TK, 2011, P NATL ACAD SCI USA, V108, P11918, DOI 10.1073/pnas.1101223108; Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; Li RK, 1999, CIRCULATION, V100, P63; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Liu ZY, 2012, J NEUROSCI, V32, P6600, DOI 10.1523/JNEUROSCI.0818-12.2012; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Mathison M, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005652; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Otsuji TG, 2010, STEM CELL RES, V4, P201, DOI 10.1016/j.scr.2010.01.002; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213; Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2012, CIRC RES, V111, P5, DOI 10.1161/CIRCRESAHA.112.271452; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701; Wang B., 2011, PLOS CURR, V3; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Willems E, 2011, CIRC RES, V109, P360, DOI 10.1161/CIRCRESAHA.111.249540; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang QZ, 2011, CELL RES, V21, P579, DOI 10.1038/cr.2010.163; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	81	69	71	0	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					829	836		10.1038/nm.3225	http://dx.doi.org/10.1038/nm.3225			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836233	Green Accepted			2022-12-27	WOS:000321557700026
J	Gay, D; Kwon, O; Zhang, ZK; Spata, M; Plikus, MV; Holler, PD; Ito, M; Yang, ZX; Treffeisen, E; Kim, CD; Nace, A; Zhang, XH; Baratono, S; Wang, F; Ornitz, DM; Millar, SE; Cotsarelis, G				Gay, Denise; Kwon, Ohsang; Zhang, Zhikun; Spata, Michelle; Plikus, Maksim V.; Holler, Phillip D.; Ito, Mayumi; Yang, Zaixin; Treffeisen, Elsa; Kim, Chang D.; Nace, Arben; Zhang, Xiaohong; Baratono, Sheena; Wang, Fen; Ornitz, David M.; Millar, Sarah E.; Cotsarelis, George			Fgf9 from dermal gamma delta T cells induces hair follicle neogenesis after wounding	NATURE MEDICINE			English	Article							NORMAL HUMAN-SKIN; BETA-CATENIN; GENE-EXPRESSION; MORPHOGENESIS; RESIDENT; RECEPTOR; GROWTH; REPAIR; IDENTIFICATION; REGENERATION	Understanding molecular mechanisms for regeneration of hair follicles provides new opportunities for developing treatments for hair loss and other skin disorders. Here we show that fibroblast growth factor 9 (Fgf9), initially secreted by gamma delta T cells, modulates hair follicle regeneration after wounding the skin of adult mice. Reducing Fgf9 expression decreases this wound-induced hair neogenesis (WIHN). Conversely, overexpression of Fgf9 results in a two-to threefold increase in the number of neogenic hair follicles. We found that Fgf9 from gamma delta T cells triggers Wnt expression and subsequent Wnt activation in wound fibroblasts. Through a unique feedback mechanism, activated fibroblasts then express Fgf9, thus amplifying Wnt activity throughout the wound dermis during a crucial phase of skin regeneration. Notably, humans lack a robust population of resident dermal gamma delta T cells, potentially explaining their inability to regenerate hair after wounding. These findings highlight the essential relationship between the immune system and tissue regeneration. The importance of Fgf9 in hair follicle regeneration suggests that it could be used therapeutically in humans.	[Gay, Denise; Kwon, Ohsang; Zhang, Zhikun; Spata, Michelle; Plikus, Maksim V.; Holler, Phillip D.; Yang, Zaixin; Treffeisen, Elsa; Nace, Arben; Zhang, Xiaohong; Baratono, Sheena; Millar, Sarah E.; Cotsarelis, George] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Kwon, Ohsang] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Ito, Mayumi] NYU, Dept Dermatol, Langone Med Ctr, New York, NY 10016 USA; [Kim, Chang D.] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea; [Wang, Fen] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc Biol & Nutr, Houston, TX USA; [Ornitz, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Millar, Sarah E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Seoul National University (SNU); New York University; NYU Langone Medical Center; Chungnam National University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL); University of Pennsylvania	Cotsarelis, G (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.	cotsarel@mail.med.upenn.edu	Kwon, Ohsang/J-2733-2012	Kwon, Ohsang/0000-0003-0464-5124; Kim, Chang Deok/0000-0001-9341-6491; Plikus, Maksim/0000-0002-8845-2559; Millar, Sarah/0000-0001-8792-6890; Ornitz, David/0000-0003-1592-7629; Baratono, Sheena/0000-0003-4760-607X	US National Institutes of Health (NIH) [R01-AR46837]; NIH Skin Diseases Research Core [P30-AR057217]; Edwin and Fannie Gray Hall Center for Human Appearance at University of Pennsylvania Medical Center; Dermatology Foundation; NIH [5RO1 AR055309-4, 5T32AR007465-29, R01 HL105732]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR059346, R01AR055309, R01AR046837, P30AR057217, R37AR047709, T32AR007465] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Skin Diseases Research Core; Edwin and Fannie Gray Hall Center for Human Appearance at University of Pennsylvania Medical Center; Dermatology Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank R. L. O'Brien for thoughtful reading of the manuscript, P. Coulombe (Johns Hopkins University) for providing K17-specific antisera and members of A. Bhandoola's laboratory and The University of Pennsylvania Flow Cytometry and Cell Sorting Resource Laboratory for assistance with cell-sorting experiments. We also thank J. Tobias and D. Baldwin of the Penn Microarray Core Facility, L. Ash of the Dermatology Department Histology Core and the Penn Human Cooperative Tissue Network. Funding was provided by US National Institutes of Health (NIH) grant R01-AR46837, NIH Skin Diseases Research Core grant P30-AR057217, the Edwin and Fannie Gray Hall Center for Human Appearance at University of Pennsylvania Medical Center and The Dermatology Foundation. This work was also supported by NIH grant 5RO1 AR055309-4 and, for D.M.O., grant R01 HL105732. P. D. H. is supported by NIH training grant 5T32AR007465-29.	Andrew EM, 2005, J IMMUNOL, V175, P1741, DOI 10.4049/jimmunol.175.3.1741; BOS JD, 1990, J INVEST DERMATOL, V94, P37, DOI 10.1111/1523-1747.ep12873333; BOS JD, 1987, J INVEST DERMATOL, V88, P569, DOI 10.1111/1523-1747.ep12470172; Braissant O., 1998, BIOCHEMICA, V1, P11; BREEDIS C, 1954, CANCER RES, V14, P575; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; FOSTER CA, 1990, J EXP MED, V171, P997, DOI 10.1084/jem.171.4.997; Gray EE, 2011, J IMMUNOL, V186, P6091, DOI 10.4049/jimmunol.1100427; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Huang SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045904; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Huh SH, 2013, GENE DEV, V27, P450, DOI 10.1101/gad.198945.112; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Kim CH, 2008, J LEUKOCYTE BIOL, V84, P1259, DOI 10.1189/jlb.0108050; Lin YS, 2006, GENESIS, V44, P150, DOI 10.1002/gene.20194; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Shi G, 2010, EXP CELL RES, V316, P3263, DOI 10.1016/j.yexcr.2010.09.013; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Wells KL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-257; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; Widelitz RB, 2000, DEV BIOL, V219, P98, DOI 10.1006/dbio.1999.9580; Workalemahu G, 2004, J LEUKOCYTE BIOL, V75, P657, DOI 10.1189/jlb.0902471; Yin Y, 2008, DEV BIOL, V319, P426, DOI 10.1016/j.ydbio.2008.04.009; Yin YJ, 2011, DEVELOPMENT, V138, P3169, DOI 10.1242/dev.065110; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	38	191	201	3	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2013	19	7					916	+		10.1038/nm.3181	http://dx.doi.org/10.1038/nm.3181			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23727932	Green Accepted			2022-12-27	WOS:000321557700036
J	Engwerda, CR; Kumar, R				Engwerda, Christian R.; Kumar, Rajiv			Mast cells fuel the fire of malaria immunopathology	NATURE MEDICINE			English	Editorial Material							PLASMODIUM INFECTION; DENDRITIC CELLS; RESPONSES; CHILDREN; DISEASE	Malaria remains the most deadly human parasitic disease. A new study finds that malaria parasites signal to mast cells to promote disease through the expansion of specialist dendritic cells and the subsequent activation of pathogenic CD8(+) T cells (pages 730-738).	[Engwerda, Christian R.; Kumar, Rajiv] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute	Engwerda, CR (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	chrise@qimr.edu.au	Engwerda, Christian/I-3072-2015; Kumar, Rajiv/GSE-5530-2022	Kumar, Rajiv/0000-0003-2338-1494; Engwerda, Christian/0000-0003-2813-4804				Crozat K, 2010, IMMUNOL REV, V234, P177, DOI 10.1111/j.0105-2896.2009.00868.x; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Guermonprez P, 2013, NAT MED, V19, P730, DOI 10.1038/nm.3197; Hansen DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003045; Haque A, 2011, EUR J IMMUNOL, V41, P2688, DOI 10.1002/eji.201141539; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; WHO, 2012, WORLD MALARIA REPORT 2012, P1	12	5	5	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					672	674		10.1038/nm.3227	http://dx.doi.org/10.1038/nm.3227			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744145				2022-12-27	WOS:000319981600012
J	Mues, M; Bartholomaus, I; Thestrup, T; Griesbeck, O; Wekerle, H; Kawakami, N; Krishnamoorthy, G				Mues, Marsilius; Bartholomaeus, Ingo; Thestrup, Thomas; Griesbeck, Oliver; Wekerle, Hartmut; Kawakami, Naoto; Krishnamoorthy, Gurumoorthy			Real-time in vivo analysis of T cell activation in the central nervous system using a genetically encoded calcium indicator	NATURE MEDICINE			English	Article							GREEN-FLUORESCENT PROTEIN; AUTOIMMUNE CNS LESIONS; DENDRITIC CELLS; TRANSGENIC MICE; LYMPH-NODES; LYMPHOCYTES; ANTIGEN; SIGNALS; DISEASE	To study T cell activation in vivo in real time, we introduced a newly developed fluorescence resonance energy transfer-based, genetically encoded calcium indicator into autoantigen-specific and non-autoantigen-specific CD4(+) T cells. Using two-photon microscopy, we explored the responses of retrovirally transduced calcium indicator-expressing T cells to antigen in the lymph nodes and the central nervous system. In lymph nodes, the administration of exogenous antigen caused an almost immediate arrest of T cells around antigen-presenting cells and an instant rise of cytosolic calcium. In contrast, encephalitogenic T cells entering the leptomeningeal space, one main portal into the central nervous system parenchyma during experimental autoimmune encephalomyelitis, showed elevated intracellular calcium concentrations while still meandering through the space. This approach enabled us to follow the migration and activation patterns of T cells in vivo during the course of the disease.	[Mues, Marsilius; Bartholomaeus, Ingo; Wekerle, Hartmut; Kawakami, Naoto; Krishnamoorthy, Gurumoorthy] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany; [Thestrup, Thomas; Griesbeck, Oliver] Max Planck Inst Neurobiol, Res Grp Cellular Dynam, D-82152 Martinsried, Germany; [Kawakami, Naoto] Univ Munich, Inst Clin Neuroimmunol, Munich, Germany	Max Planck Society; Max Planck Society; University of Munich	Wekerle, H (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany.	hwekerle@neuro.mpg.de	Krishnamoorthy, Gurumoorthy/O-1650-2013	Krishnamoorthy, Gurumoorthy/0000-0002-7798-6707; Griesbeck, Oliver/0000-0001-5883-5594; Kawakami, Naoto/0000-0001-7693-3489	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 571, Sonderforschungsbereich 870]; German Competence Network on Multiple Sclerosis (KKNMS); Novartis Foundation for Therapeutic Research; Max Planck Society; Sonderforschungsbereich 870	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Competence Network on Multiple Sclerosis (KKNMS); Novartis Foundation for Therapeutic Research; Max Planck Society(Max Planck Society); Sonderforschungsbereich 870	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 571, projects B6 and C6), the German Competence Network on Multiple Sclerosis (KKNMS), the Novartis Foundation for Therapeutic Research and the Max Planck Society. O.G. and T. T. were supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 870) and the EuroV1sion EU FP7 grant. We thank I. Arnold-Ammer, L. Penner, and B. Kunkel for technical assistance.	Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Delviks-Frankenberry K, 2011, VIRUSES-BASEL, V3, P1650, DOI 10.3390/v3091650; Direnberger S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2035; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Hochweller K, 2010, P NATL ACAD SCI USA, V107, P5931, DOI 10.1073/pnas.0911877107; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Krishnamoorthy G, 2009, NAT MED, V15, P626, DOI 10.1038/nm.1975; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Nguyen QT, 2010, NAT NEUROSCI, V13, P127, DOI 10.1038/nn.2469; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P18625, DOI 10.1073/pnas.0705033104; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; OWEN CS, 1988, CELL CALCIUM, V9, P141, DOI 10.1016/0143-4160(88)90017-6; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; RHODE BW, 1987, J VIROL, V61, P925, DOI 10.1128/JVI.61.3.925-927.1987; Rosenthal KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032562; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Skokos D, 2007, NAT IMMUNOL, V8, P835, DOI 10.1038/ni1490; SOMMER F, 1994, J IMMUNOL, V153, P3523; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	38	69	71	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					778	+		10.1038/nm.3180	http://dx.doi.org/10.1038/nm.3180			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23685843				2022-12-27	WOS:000319981600029
J	Song, JJ; Guyette, JP; Gilpin, SE; Gonzalez, G; Vacanti, JP; Ott, HC				Song, Jeremy J.; Guyette, Jacques P.; Gilpin, Sarah E.; Gonzalez, Gabriel; Vacanti, Joseph P.; Ott, Harald C.			Regeneration and experimental orthotopic transplantation of a bioengineered kidney	NATURE MEDICINE			English	Article							DECELLULARIZED MATRIX; BASEMENT-MEMBRANE; ARTIFICIAL-KIDNEY; PORCINE KIDNEYS; RENAL-FUNCTION; CELLS; REPLACEMENT; PODOCYTES; SCAFFOLDS; ADHESION	Approximately 100,000 individuals in the United States currently await kidney transplantation, and 400,000 individuals live with end-stage kidney disease requiring hemodialysis. The creation of a transplantable graft to permanently replace kidney function would address donor organ shortage and the morbidity associated with immunosuppression. Such a bioengineered graft must have the kidney's architecture and function and permit perfusion, filtration, secretion, absorption and drainage of urine. We decellularized rat, porcine and human kidneys by detergent perfusion, yielding acellular scaffolds with vascular, cortical and medullary architecture, a collecting system and ureters. To regenerate functional tissue, we seeded rat kidney scaffolds with epithelial and endothelial cells and perfused these cell-seeded constructs in a whole-organ bioreactor. The resulting grafts produced rudimentary urine in vitro when perfused through their intrinsic vascular bed. When transplanted in an orthotopic position in rat, the grafts were perfused by the recipient's circulation and produced urine through the ureteral conduit in vivo.	[Song, Jeremy J.; Guyette, Jacques P.; Gilpin, Sarah E.; Gonzalez, Gabriel; Vacanti, Joseph P.; Ott, Harald C.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Song, Jeremy J.; Guyette, Jacques P.; Gilpin, Sarah E.; Gonzalez, Gabriel; Vacanti, Joseph P.; Ott, Harald C.] Harvard Univ, Sch Med, Boston, MA USA; [Vacanti, Joseph P.] Massachusetts Gen Hosp, Dept Surg, Div Pediat Surg, Boston, MA 02114 USA; [Ott, Harald C.] Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Ott, HC (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	hott@partners.org		Gilpin, Sarah/0000-0003-3560-6910; Gonzalez, Gabriel/0000-0003-1842-3119	US National Institutes of Health (NIH) [DP2 OD008749-01]; AOmegaA Research Fellowship; American Heart Association; NIH [DK43351, DK57521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008749] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AOmegaA Research Fellowship; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The present study was supported by the US National Institutes of Health (NIH) Director's New Innovator Award DP2 OD008749-01 and departmental funds. J.J.S. was supported by an A Omega A Research Fellowship and an American Heart Association Predoctoral Fellowship. The Program in Membrane Biology Microscopy Core is supported by NIH grants DK43351 and DK57521. We further thank Q.C. Ott for critical review and editing of the manuscript. We thank C. Hoffman, J. Beagle and M. Duggan for technical support with urine sample analysis. We thank M. McKee for her expert support with transmission electron microscopy and A. Tisdale for her expert support with scanning electron microscopy.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Borza CM, 2008, J AM SOC NEPHROL, V19, P677, DOI 10.1681/ASN.2007070793; BRAY J, 1984, KIDNEY INT, V25, P527, DOI 10.1038/ki.1984.49; Centers for Disease Control and Prevention, 2010, NATIONAL CHRONIC KID; CYBULSKY AV, 1992, KIDNEY INT, V42, P1099, DOI 10.1038/ki.1992.393; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Deen WM, 2001, AM J PHYSIOL-RENAL, V281, pF579; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; FALK G, 1955, AM J PHYSIOL, V181, P157, DOI 10.1152/ajplegacy.1955.181.1.157; Fissell WH, 2009, SEMIN DIALYSIS, V22, P665, DOI 10.1111/j.1525-139X.2009.00662.x; Gura V, 2009, CLIN J AM SOC NEPHRO, V4, P1441, DOI 10.2215/CJN.02790409; Humes HD, 1996, AM J PHYSIOL-RENAL, V271, pF42, DOI 10.1152/ajprenal.1996.271.1.F42; Humes HD, 2004, KIDNEY INT, V66, P1578, DOI 10.1111/j.1523-1755.2004.00923.x; Humes HD, 2004, BLOOD PURIFICAT, V22, P60, DOI 10.1159/000074925; HUMES HD, 1995, KIDNEY INT, V48, pS26; Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626; Humes HD, 1999, KIDNEY INT, V55, P2502, DOI 10.1046/j.1523-1755.1999.00486.x; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Kretzler M, 2002, MICROSC RES TECHNIQ, V57, P247, DOI 10.1002/jemt.10083; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; OLIVETTI G, 1977, J CELL BIOL, V75, P573, DOI 10.1083/jcb.75.2.573; Orlando G, 2012, ANN SURG, V256, P363, DOI 10.1097/SLA.0b013e31825a02ab; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108; Rogers Sharon A, 2004, Organogenesis, V1, P22; Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023; US Department of Health and Human Services, 2013, NATIONAL TRANSPLANTA; WELLING LW, 1972, J CLIN INVEST, V51, P1063, DOI 10.1172/JCI106898	31	530	554	9	254	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					646	651		10.1038/nm.3154	http://dx.doi.org/10.1038/nm.3154			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23584091	Green Accepted, Green Submitted			2022-12-27	WOS:000318583000040
J	Xu, ZL; Qiu, Q; Tian, J; Smith, JS; Conenello, GM; Morita, T; Byrnes, AP				Xu, Zhili; Qiu, Qi; Tian, Jie; Smith, Jeffrey S.; Conenello, Gina M.; Morita, Takashi; Byrnes, Andrew P.			Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement	NATURE MEDICINE			English	Article							TRANSGENE EXPRESSION; GENE DELIVERY; IN-VIVO; BINDING; HEXON; PROTEIN; VIRUS; CELLS; LIVER; MICE	Adenovirus type 5 (Ad5) specifically binds coagulation factor X (FX), and FX is normally essential for intravenously injected Ad5 vectors to transduce the liver. We demonstrate that the ability of FX to enhance liver transduction by Ad5 vectors is due to an unexpected ability of FX to protect Ad5 from attack by the classical complement pathway. In vitro, naive mouse serum neutralized Ad5 when FX was blocked from binding Ad5. This neutralization was mediated by natural IgM and the classical complement pathway. In vivo, FX was essential for Ad5 vectors to transduce the livers of wild-type mice, but FX was not required for liver transduction in mice that lack antibodies, C1q or C4. We conclude that Ad5 recruits FX as a defense against complement and that the sensitivity of Ad5 to inactivation by complement must be taken into account when designing vectors for systemic gene therapy.	[Xu, Zhili; Qiu, Qi; Tian, Jie; Smith, Jeffrey S.; Conenello, Gina M.; Byrnes, Andrew P.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Morita, Takashi] Meiji Pharmaceut Univ, Dept Biochem, Tokyo, Japan	US Food & Drug Administration (FDA); Meiji Pharmaceutical University	Byrnes, AP (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	andrew.byrnes@fda.hhs.gov	Byrnes, Andrew/D-2808-2013	Byrnes, Andrew/0000-0003-1135-2629	US Food and Drug Administration (FDA); Oak Ridge Institute for Science and Education	US Food and Drug Administration (FDA)(United States Department of Health & Human Services); Oak Ridge Institute for Science and Education(General Electric)	Funding was provided by the US Food and Drug Administration (FDA), including the FDA's Critical Path program. This project was supported in part by fellowships administered by the Oak Ridge Institute for Science and Education. We thank M. Barry (Mayo Clinic) for providing vectors, H. Mizuguchi (Osaka University) for providing plasmid pAdHM4-CMVL1 and M. Diamond (Washington University) for providing C1qa<SUP>-/-</SUP> mice. We thank M. Shlomchik (Yale University), S. Epstein (FDA) and J. Misplon (FDA) for providing J<INF>H</INF>D and mIg Tg mice. We thank the Center for Biologics Evaluation and Research animal facility staff for outstanding support. We thank S. Epstein, C. Kimchi-Sarfaty, G. Price and C. Wiethoff for helpful discussions or comments on the manuscript.	Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026; Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Atoda H, 1998, BIOCHEMISTRY-US, V37, P17361, DOI 10.1021/bi981177x; BEEBE DP, 1981, J IMMUNOL, V126, P1562; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Campos SK, 2004, HUM GENE THER, V15, P1125, DOI 10.1089/1043034042431182; Carlisle RC, 2009, BLOOD, V113, P1909, DOI 10.1182/blood-2008-09-178459; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; Cichon G, 2001, GENE THER, V8, P1794, DOI 10.1038/sj.gt.3301611; Coughlan L, 2010, VIRUSES-BASEL, V2, P2290, DOI 10.3390/v2102290; DePolo NJ, 2000, MOL THER, V2, P218, DOI 10.1006/mthe.2000.0116; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Duffy MR, 2011, J VIROL, V85, P10914, DOI 10.1128/JVI.05382-11; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; Hannum LG, 2000, J EXP MED, V192, P931, DOI 10.1084/jem.192.7.931; He JQ, 2013, J LEUKOCYTE BIOL, V93, P301, DOI 10.1189/jlb.0612311; Hoare J, 2005, J GENE MED, V7, P325, DOI 10.1002/jgm.671; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Jiang H, 2004, MOL THER, V10, P1140, DOI 10.1016/j.ymthe.2004.08.015; Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; KETTNER C, 1979, THROMB RES, V14, P969, DOI 10.1016/0049-3848(79)90014-8; KETTNER C, 1981, THROMB RES, V22, P645, DOI 10.1016/0049-3848(81)90062-1; Khare R, 2012, J VIROL, V86, P2293, DOI 10.1128/JVI.05760-11; KLEINSCHNEEGANS AS, 1990, THYMUS, V16, P45; Lachmann PJ, 2010, J IMMUNOL METHODS, V352, P195, DOI 10.1016/j.jim.2009.11.003; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Manickan E, 2006, MOL THER, V13, P108, DOI 10.1016/j.ymthe.2005.08.007; McCarthy DA, 1996, CYTOMETRY, V23, P196; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249; Notkins AL, 2004, TRENDS IMMUNOL, V25, P174, DOI 10.1016/j.it.2004.02.004; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; Perreau M, 2007, MOL THER, V15, P1998, DOI 10.1038/sj.mt.6300289; Prill JM, 2011, MOL THER, V19, P83, DOI 10.1038/mt.2010.229; Racine R, 2009, IMMUNOL LETT, V125, P79, DOI 10.1016/j.imlet.2009.06.003; Rambach Guenter, 2008, V15, P78, DOI 10.1159/000136316; ROTHER RP, 1995, J EXP MED, V182, P1345, DOI 10.1084/jem.182.5.1345; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2004, J VIROL, V78, P5368, DOI 10.1128/JVI.78.10.5368-5381.2004; Smith JS, 2004, GENE THER, V11, P431, DOI 10.1038/sj.gt.3302149; Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165; Sokoloff AV, 2001, MOL THER, V3, P821, DOI 10.1006/mthe.2001.0340; Stoermer KA, 2011, VIROLOGY, V411, P362, DOI 10.1016/j.virol.2010.12.045; Tian J, 2009, J VIROL, V83, P5648, DOI 10.1128/JVI.00082-09; Vigant F, 2008, MOL THER, V16, P1474, DOI 10.1038/mt.2008.132; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wakimoto H, 2002, MOL THER, V5, P275, DOI 10.1006/mthe.2002.0547; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Xu ZL, 2008, J VIROL, V82, P11705, DOI 10.1128/JVI.01320-08; Xu ZL, 2002, J CONTROL RELEASE, V81, P155, DOI 10.1016/S0168-3659(02)00059-7	54	112	116	1	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					452	+		10.1038/nm.3107	http://dx.doi.org/10.1038/nm.3107			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23524342				2022-12-27	WOS:000317109100030
J	Nie, H; Zheng, YX; Li, RS; Guo, TB; He, DY; Fang, L; Liu, XB; Xiao, LB; Chen, X; Wan, B; Chin, YE; Zhang, JWZ				Nie, Hong; Zheng, Yingxia; Li, Runsheng; Guo, Taylor B.; He, Dongyi; Fang, Lei; Liu, Xuebin; Xiao, Lianbo; Chen, Xi; Wan, Bing; Chin, Y. Eugene; Zhang, Jingwu Z.			Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis	NATURE MEDICINE			English	Article							NF-KAPPA-B; THERAPY; BINDING; GENES	Regulatory T (T-reg) cells suppress autoimmune disease, and impaired T-reg cell function is associated with rheumatoid arthritis. Here we demonstrate that forkhead box P3 (FOXP3) transcriptional activity and, consequently, T-reg cell suppressive function are regulated by phosphorylation at Ser418 in the C-terminal DNA-binding domain. In rheumatoid arthritis-derived T-reg cells, the Ser418 site was specifically dephosphorylated by protein phosphatase 1 (PP1), whose expression and enzymatic activity were induced in the inflamed synovium by tumor necrosis factor alpha (TNF-alpha), leading to impaired T-reg cell function. Moreover, TNF-alpha-induced T-reg cell dysfunction correlated with increased numbers of interleukin-17 (IL-17)(+) and interferon-gamma (IFN-gamma)(+)CD4(+) T cells within the inflamed synovium in rheumatoid arthritis. Treatment with a INF-alpha-specific antibody restored T-reg cell function in subjects with rheumatoid arthritis, which was associated with decreased PP1 expression and increased FOXP3 phosphorylation in T-reg cells. Thus, TNF-alpha controls the balance between T-reg cells and pathogenic T(H)17 and T(H)1 cells in the synovium of individuals with rheumatoid arthritis through FOXP3 dephosphorylation.	[Nie, Hong; Zheng, Yingxia; Zhang, Jingwu Z.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Li, Runsheng; Guo, Taylor B.; Fang, Lei; Chen, Xi; Wan, Bing; Chin, Y. Eugene; Zhang, Jingwu Z.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [He, Dongyi] Guanghua Rheumatol Hosp, Dept Med, Shanghai, Peoples R China; [Liu, Xuebin; Zhang, Jingwu Z.] GlaxoSmithKline Res & Dev Ctr, Shanghai, Peoples R China; [Xiao, Lianbo] Guanghua Rheumatol Hosp, Dept Surg, Shanghai, Peoples R China; [Chin, Y. Eugene] Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; GlaxoSmithKline; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Zhang, JWZ (corresponding author), GlaxoSmithKline Res & Dev Ctr, Zhangjiang Hitech Pk, Shanghai, Peoples R China.	jingwu.z.zang@gsk.com			National Natural Science Foundation of China [81072470]; Shanghai Municipal Education Commission [J50207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was partly supported by grants from National Natural Science Foundation of China (81072470) and the Shanghai Municipal Education Commission (J50207).	Ali M, 2001, J CLIN INVEST, V107, P519, DOI 10.1172/JCI8027; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Burstein E, 2008, J CLIN INVEST, V118, P464, DOI [10.1172/JC134831, 10.1172/JCI34831]; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Costantino CM, 2008, J CLIN IMMUNOL, V28, P697, DOI 10.1007/s10875-008-9236-x; de Zoeten EF, 2009, J BIOL CHEM, V284, P5709, DOI 10.1074/jbc.M807322200; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Kim JY, 2007, BIOCHEM BIOPH RES CO, V362, P44, DOI 10.1016/j.bbrc.2007.07.187; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lopes JE, 2006, J IMMUNOL, V177, P3133, DOI 10.4049/jimmunol.177.5.3133; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mihindukulasuriya KA, 2004, J BIOL CHEM, V279, P46588, DOI 10.1074/jbc.M408067200; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Puren AJ, 1998, J CLIN INVEST, V101, P711, DOI 10.1172/JCI1379; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Ranganathan A, 2005, PHARMACOGENOMICS, V6, P481, DOI 10.2217/14622416.6.5.481; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Schett G, 2003, CELL DEATH DIFFER, V10, P1126, DOI 10.1038/sj.cdd.4401276; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Suryaprasad AG, 2003, AUTOIMMUN REV, V2, P346, DOI 10.1016/S1568-9972(03)00048-X; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Wang LQ, 2009, IMMUNOL CELL BIOL, V87, P195, DOI 10.1038/icb.2008.106; Wicovsky A, 2009, ONCOGENE, V28, P1769, DOI 10.1038/onc.2009.29; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	36	363	393	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					322	328		10.1038/nm.3085	http://dx.doi.org/10.1038/nm.3085			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396208				2022-12-27	WOS:000316040700025
J	Gora, MJ; Sauk, JS; Carruth, RW; Gallagher, KA; Suter, MJ; Nishioka, NS; Kava, LE; Rosenberg, M; Bouma, BE; Tearney, GJ				Gora, Michalina J.; Sauk, Jenny S.; Carruth, Robert W.; Gallagher, Kevin A.; Suter, Melissa J.; Nishioka, Norman S.; Kava, Lauren E.; Rosenberg, Mireille; Bouma, Brett E.; Tearney, Guillermo J.			Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure	NATURE MEDICINE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; BARRETTS-ESOPHAGUS; INTESTINAL METAPLASIA; FEASIBILITY; ENDOSCOPY; DIAGNOSIS	Here we introduce tethered capsule endomicroscopy, which involves swallowing an optomechanically engineered pill that captures cross-sectional microscopic images of the gut wall at 30 mu m (lateral) x 7 mu m (axial) resolution as it travels through the digestive tract. Results in human subjects show that this technique rapidly provides three-dimensional, microstructural images of the upper gastrointestinal tract in a simple and painless procedure, opening up new opportunities for screening for internal diseases.	[Gora, Michalina J.; Carruth, Robert W.; Gallagher, Kevin A.; Nishioka, Norman S.; Kava, Lauren E.; Rosenberg, Mireille; Bouma, Brett E.; Tearney, Guillermo J.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Gora, Michalina J.; Sauk, Jenny S.; Carruth, Robert W.; Gallagher, Kevin A.; Nishioka, Norman S.; Kava, Lauren E.; Rosenberg, Mireille; Bouma, Brett E.; Tearney, Guillermo J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Sauk, Jenny S.; Nishioka, Norman S.] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA; [Suter, Melissa J.] Massachusetts Gen Hosp, Dept Pulmonol, Boston, MA 02114 USA; [Tearney, Guillermo J.] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA; [Tearney, Guillermo J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital	Tearney, GJ (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	gtearney@partners.org	Jovani, Manol/AAF-5333-2020		US National Institutes of Health [NIH R01DK091923, NIH R01CA103769]; NATIONAL CANCER INSTITUTE [R01CA103769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091923, P30DK043351] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank B. Puricelli for his valuable assistance in the conduct of the clinical studies and M. Shishkov for useful discussions pertaining to device design. This work was supported in part by US National Institutes of Health grants NIH R01DK091923 (G.J.T.) and NIH R01CA103769 (G.J.T.).	Cullen Karen A, 2009, Natl Health Stat Report, P1; Evans JA, 2006, CLIN GASTROENTEROL H, V4, P38, DOI 10.1016/S1542-3565(05)00746-9; Evans JA, 2007, GASTROINTEST ENDOSC, V65, P50, DOI 10.1016/j.gie.2006.04.027; Kiesslich Ralf, 2005, Gastrointest Endosc Clin N Am, V15, P715, DOI 10.1016/j.giec.2005.08.010; Kim B, 2006, SENSOR ACTUAT A-PHYS, V125, P429, DOI 10.1016/j.sna.2005.05.004; Maffei M, 2008, SWISS MED WKLY, V138, P658, DOI 2008/45/smw-12220; Poneros JM, 2001, GASTROENTEROLOGY, V120, P7, DOI 10.1053/gast.2001.20911; Quirini M, 2008, GASTROINTEST ENDOSC, V67, P1153, DOI 10.1016/j.gie.2007.11.052; Ramirez FC, 2005, GASTROINTEST ENDOSC, V61, P741, DOI 10.1016/S0016-5107(05)00322-6; Seibel EJ, 2008, IEEE T BIO-MED ENG, V55, P1032, DOI 10.1109/TBME.2008.915680; Vakoc BJ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714027; Wallace MB, 2009, GASTROENTEROLOGY, V136, P1509, DOI 10.1053/j.gastro.2009.03.034; Wasielica-Berger J, 2011, DIGEST DIS SCI, V56, P1987, DOI 10.1007/s10620-010-1551-4; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450	14	194	200	5	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					238	240		10.1038/nm.3052	http://dx.doi.org/10.1038/nm.3052			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23314056	Green Accepted, Green Submitted			2022-12-27	WOS:000314675900033
J	Devi, S; Li, AQ; Westhorpe, CLV; Lo, CY; Abeynaike, LD; Snelgrove, SL; Hall, P; Ooi, JD; Sobey, CG; Kitching, AR; Hickey, MJ				Devi, Sapna; Li, Anqi; Westhorpe, Clare L. V.; Lo, Camden Y.; Abeynaike, Latasha D.; Snelgrove, Sarah L.; Hall, Pam; Ooi, Joshua D.; Sobey, Christopher G.; Kitching, A. Richard; Hickey, Michael J.			Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus	NATURE MEDICINE			English	Article							NEUTROPHIL RESPIRATORY BURST; CRESCENTIC GLOMERULONEPHRITIS; P-SELECTIN; IN-VIVO; PULMONARY INFLAMMATION; INFLAMED GLOMERULUS; ADHESION MOLECULE-1; NOX2-DEFICIENT MICE; NADPH OXIDASE; RENAL INJURY	In contrast with many capillary beds, the glomerulus readily supports leukocyte recruitment. However, little is known regarding the actions of leukocytes following their recruitment to glomeruli. We used multiphoton confocal microscopy to examine leukocyte behavior in the glomerular microvasculature. In normal glomeruli, neutrophils and monocytes were retained in capillaries for several minutes, remaining static or migrating intravascularly. Induction of glomerular inflammation resulted in an increase in the duration of retention of static and migratory leukocytes. In response to immune complex deposition, both static and migratory neutrophils generated oxidants in inflamed glomeruli via a Mac-1-dependent mechanism. Our results describe a new paradigm for glomerular inflammation, suggesting that the major effect of acute inflammation is to increase the duration of leukocyte retention in the glomerulus. Moreover, these findings describe a previously unknown form of multicellular intravascular patrolling that involves both monocytes and neutrophils, which may underlie the susceptibility of the glomerulus to inflammation.	[Devi, Sapna; Li, Anqi; Westhorpe, Clare L. V.; Abeynaike, Latasha D.; Snelgrove, Sarah L.; Hall, Pam; Ooi, Joshua D.; Kitching, A. Richard; Hickey, Michael J.] Monash Univ, Monash Med Ctr, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia; [Lo, Camden Y.] Monash Univ, Monash Micro Imaging, Clayton, Vic, Australia; [Sobey, Christopher G.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia; [Kitching, A. Richard] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia; [Kitching, A. Richard] Monash Med Ctr, Dept Pediat Nephrol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University; Monash University; Monash University	Hickey, MJ (corresponding author), Monash Univ, Monash Med Ctr, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia.	michael.hickey@monash.edu	Sobey, Christopher G/A-2786-2008; Kitching, A Richard/B-6947-2013; Hickey, Michael/A-5429-2012	Sobey, Christopher G/0000-0001-6525-9097; Kitching, A Richard/0000-0002-2713-2391; Lo, Camden/0000-0002-6215-2363; Hickey, Michael/0000-0003-2354-357X; Devi, Sapna/0000-0003-4714-6018; Ooi, Joshua/0000-0003-3328-2561; Westhorpe, Clare/0000-0002-5789-0425	National Health and Medical Research Council (Australia) Program grant [334067]; National Health and Medical Research Council (Australia) Project grant [606564]; Genzyme Renal Innovations Program Project grant	National Health and Medical Research Council (Australia) Program grant; National Health and Medical Research Council (Australia) Project grant; Genzyme Renal Innovations Program Project grant	The authors gratefully acknowledge the assistance of J. Peti-Peterdi for advice on intravital imaging of the kidney, T. Graf (Center for Genomic Regulation) for LysM-eGFP mice, M. Tymms and E. Williams for assistance with fluorochrome labeling, D.-B. Borza (Vanderbilt University School of Medicine) for providing 8D1 monoclonal antibody, and C. Lo for technical assistance. This work was supported by a National Health and Medical Research Council (Australia) Program grant (#334067), a National Health and Medical Research Council (Australia) Project grant (#606564) and a Genzyme Renal Innovations Program Project grant. M.J.H. is a National Health and Medical Research Council (Australia) Senior Research Fellow.	Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BOYCE NW, 1986, KIDNEY INT, V30, P813, DOI 10.1038/ki.1986.260; Chen ZP, 2004, P NATL ACAD SCI USA, V101, P13014, DOI 10.1073/pnas.0405389101; COCHRANE CG, 1965, J EXP MED, V122, P99, DOI 10.1084/jem.122.1.99; DAPINO P, 1993, CLIN EXP IMMUNOL, V94, P533; Devi S, 2010, AM J PATHOL, V177, P1131, DOI 10.2353/ajpath.2010.091143; DOWNEY GP, 1993, AM REV RESPIR DIS, V147, P168, DOI 10.1164/ajrccm/147.1.168; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Huang XR, 1997, KIDNEY INT, V51, P94, DOI 10.1038/ki.1997.12; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jung U, 1997, MICROCIRCULATION-LON, V4, P311, DOI 10.3109/10739689709146794; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Kitching AR, 2000, HISTOL HISTOPATHOL, V15, P993, DOI 10.14670/HH-15.993; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Kuligowski MP, 2006, J IMMUNOL, V176, P6991, DOI 10.4049/jimmunol.176.11.6991; Kuligowski MP, 2009, BLOOD, V113, P6485, DOI 10.1182/blood-2008-12-192617; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Massberg S, 1998, BLOOD, V92, P507, DOI 10.1182/blood.V92.2.507; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Norman MU, 2003, AM J PATHOL, V163, P1491, DOI 10.1016/S0002-9440(10)63506-7; Odobasic D, 2007, J AM SOC NEPHROL, V18, P760, DOI 10.1681/ASN.2006040375; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Sipos A, 2007, KIDNEY INT, V72, P1188, DOI 10.1038/sj.ki.5002461; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; TIPPING PG, 1994, KIDNEY INT, V46, P79, DOI 10.1038/ki.1994.246; Tipping PG, 1998, AM J PATHOL, V152, P1541; Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468; ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407	36	134	137	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JAN	2013	19	1					107	112		10.1038/nm.3024	http://dx.doi.org/10.1038/nm.3024			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23242472				2022-12-27	WOS:000313230300032
J	Vanharanta, S; Shu, WP; Brenet, F; Hakimi, AA; Heguy, A; Viale, A; Reuter, VE; Hsieh, JJD; Scandura, JM; Massague, J				Vanharanta, Sakari; Shu, Weiping; Brenet, Fabienne; Hakimi, A. Ari; Heguy, Adriana; Viale, Agnes; Reuter, Victor E.; Hsieh, James J-D; Scandura, Joseph M.; Massague, Joan			Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer	NATURE MEDICINE			English	Article							TUMOR-SUPPRESSOR GENE; HIPPEL-LINDAU-DISEASE; CELL-CARCINOMA; T-CELL; CYTOHESIN BINDER; EXPRESSION; PROTEIN; ACTIVATION; CHROMATIN; RECEPTOR	Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-inducible transcription factors (HIFs). However, VHL mutation status in ccRCC is not correlated with clinical outcome. Here we show that during ccRCC progression, cancer cells exploit diverse epigenetic alterations to empower a branch of the VHL-HIF pathway for metastasis, and the strength of this activation is associated with poor clinical outcome. By analyzing metastatic subpopulations of VHL-deficient ccRCC cells, we discovered an epigenetically altered VHL-HIF response that is specific to metastatic ccRCC. Focusing on the two most prominent pro-metastatic VHL-HIF target genes, we show that loss of Polycomb repressive complex 2 (PRC2)-dependent histone H3 Lys27 trimethylation (H3K27me3) activates H IF-driven chemokine (C-X-C motif) receptor 4 (CXCR4) expression in support of chemotactic cell invasion, whereas loss of DNA methylation enables HIF-driven cytohesin 1 interacting protein (CYTIP) expression to protect cancer cells from death cytokine signals. Thus, metastasis in ccRCC is based on an epigenetically expanded output of the tumor-initiating pathway.	[Vanharanta, Sakari; Shu, Weiping; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Brenet, Fabienne; Scandura, Joseph M.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Hakimi, A. Ari; Hsieh, James J-D] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Heguy, Adriana] Mem Sloan Kettering Canc Ctr, Geoffrey Beene Translat Oncol Core Facil, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Facil, New York, NY 10021 USA; [Reuter, Victor E.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	massaguj@mskcc.org	Heguy, Adriana/GPP-3907-2022; Brenet, Fabienne/R-1881-2016	Brenet, Fabienne/0000-0003-4098-1096; Scandura, Joseph/0000-0002-9525-143X; Massague, Joan/0000-0001-9324-8408	Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; Paulo Foundation; Orion-Farmos Research Foundation; Instrumentarium Science Foundation; Finnish Medical Foundation; Academy of Finland; NATIONAL CANCER INSTITUTE [T32CA082088, P30CA008748, P01CA129243] Funding Source: NIH RePORTER	Maud Kuistila Memorial Foundation; Emil Aaltonen Foundation; Paulo Foundation; Orion-Farmos Research Foundation; Instrumentarium Science Foundation; Finnish Medical Foundation; Academy of Finland(Academy of Finland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Massague lab for discussion, J. Brooks (Stanford University, California) for clinical annotations, W. Krek (ETH, Swiss Federal Institute of Technology, Zurich, Switzerland) for CXCR4 promoter constructs and C. David and S. Malladi for critical review of the manuscript. Gene expression profiling and high-throughput sequencing were done at the Memorial Sloan-Kettering Cancer Center (MSKCC) Genomics Core Facility, immunohistochemical staining was done at the MSKCC Molecular Cytology Core Facility, and DNA methylation analysis, RNA analysis of clinical samples and Sanger sequencing were done at the MSKCC Geoffrey Beene Translational Oncology Core Facility. The GSE2109 dataset was provided by the International Genomics Consortium and Expression Project for Oncology. S.V. received postdoctoral support from the Maud Kuistila Memorial Foundation, the Emil Aaltonen Foundation, the Paulo Foundation, the Orion-Farmos Research Foundation, the Instrumentarium Science Foundation, The Finnish Medical Foundation and the Academy of Finland. J.M. is an investigator of the Howard Hughes Medical Institute.	Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Boehm T, 2003, EMBO J, V22, P1014, DOI 10.1093/emboj/cdg101; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chauveau D, 1996, KIDNEY INT, V50, P944, DOI 10.1038/ki.1996.395; Chen Q, 2006, J BIOL CHEM, V281, P19985, DOI 10.1074/jbc.M601629200; D'Alterio C, 2010, CELL CYCLE, V9, P4492, DOI 10.4161/cc.9.22.13680; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hofer S, 2006, BLOOD, V107, P1003, DOI 10.1182/blood-2005-01-0425; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Kashyap V, 2011, J BIOL CHEM, V286, P3250, DOI 10.1074/jbc.M110.157545; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McArthur M, 2001, J MOL BIOL, V313, P27, DOI 10.1006/jmbi.2001.4969; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Montani M, 2010, AM J SURG PATHOL, V34, P806, DOI 10.1097/PAS.0b013e3181ddf54d; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Schlesinger-Raab A, 2008, EUR J CANCER, V44, P2485, DOI 10.1016/j.ejca.2008.07.039; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; SHI J, 2012, ONCOGENE; Song L., 2010, COLD SPRING HARB PRO; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang LH, 2009, CLIN EXP METASTAS, V26, P1049, DOI 10.1007/s10585-009-9294-3; Watford WT, 2006, MOL CELL BIOL, V26, P6623, DOI 10.1128/MCB.02460-05; WILLIAMS RD, 1978, IN VITRO CELL DEV B, V14, P779, DOI 10.1007/BF02617972; Yao M, 2002, JNCI-J NATL CANCER I, V94, P1569; Young AC, 2009, CLIN CANCER RES, V15, P7582, DOI 10.1158/1078-0432.CCR-09-2131; Zagzag D, 2005, CANCER RES, V65, P6178, DOI 10.1158/0008-5472.CAN-04-4406; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	56	151	175	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					50	56		10.1038/nm.3029	http://dx.doi.org/10.1038/nm.3029			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23223005	Green Accepted, Green Submitted			2022-12-27	WOS:000313230300025
J	Wang, XG; Guo, BS; Li, Q; Peng, J; Yang, ZJ; Wang, AY; Li, D; Hou, ZB; Lv, K; Kan, GH; Cao, HQ; Wu, H; Song, JP; Pan, XH; Sun, Q; Ling, SK; Li, YH; Zhu, M; Zhang, PF; Peng, SL; Xie, XQ; Tang, T; Hong, A; Bian, ZX; Bai, YQ; Lu, AP; Li, YH; He, FC; Zhang, G; Li, YX				Wang, Xiaogang; Guo, Baosheng; Li, Qi; Peng, Jiang; Yang, Zhijun; Wang, Aiyuan; Li, Dong; Hou, Zhibo; Lv, Ke; Kan, Guanghan; Cao, Hongqing; Wu, Heng; Song, Jinping; Pan, Xiaohua; Sun, Qiao; Ling, Shukuan; Li, Yuheng; Zhu, Mu; Zhang, Pengfei; Peng, Songlin; Xie, Xiaoqing; Tang, Tao; Hong, An; Bian, Zhaoxiang; Bai, Yanqiang; Lu, Aiping; Li, Yinghui; He, Fuchu; Zhang, Ge; Li, Yingxian			miR-214 targets ATF4 to inhibit bone formation	NATURE MEDICINE			English	Article							OSTEOBLAST DIFFERENTIATION; PARATHYROID-HORMONE; OSTEOGENIC DIFFERENTIATION; OVARIAN-CANCER; CELL-SURVIVAL; ALENDRONATE; OSTEOPOROSIS; PROLIFERATION; CONTRIBUTES; EXPRESSION	Emerging evidence indicates that microRNAs (miRNAs) have important roles in regulating osteogenic differentiation and bone formation. Thus far, no study has established the pathophysiological role for miRNAs identified in human osteoporotic bone specimens. Here we found that elevated miR-214 levels correlated with a lower degree of bone formation in bone specimens from aged patients with fractures. We also found that osteoblast-specific manipulation of miR-214 levels by miR-214 antagomir treatment in miR-214 transgenic, ovariectomized, or hindlimb-unloaded mice revealed an inhibitory role of miR-214 in regulating bone formation. Further, in vitro osteoblast activity and matrix mineralization were promoted by antagomir-214 and decreased by agomir-214, and miR-214 directly targeted ATF4 to inhibit osteoblast activity. These data suggest that miR-214 has a crucial role in suppressing bone formation and that miR-214 inhibition in osteoblasts may be a potential anabolic strategy for ameliorating osteoporosis.	[Wang, Xiaogang; Li, Qi; Lv, Ke; Kan, Guanghan; Cao, Hongqing; Song, Jinping; Sun, Qiao; Ling, Shukuan; Li, Yuheng; Zhu, Mu; Zhang, Pengfei; Bai, Yanqiang; Li, Yinghui; Li, Yingxian] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Guo, Baosheng; Yang, Zhijun; Wu, Heng; Tang, Tao; Bian, Zhaoxiang; Lu, Aiping; Zhang, Ge] Hong Kong Baptist Univ, Inst Adv Translat Med Bone & Joint Dis, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Guo, Baosheng; Hou, Zhibo; Wu, Heng; Pan, Xiaohua; Peng, Songlin; Xie, Xiaoqing; Hong, An; Zhang, Ge] Jinan Univ, Dept Orthoped Hosp Med Coll Shenzhen 2, Natl Engn Res Ctr Genet Med Guangzhou, Jinan, Peoples R China; [Peng, Jiang; Wang, Aiyuan] Gen Hosp Chinese Peoples Liberat Army, Inst Orthoped, Beijing, Peoples R China; [Li, Dong; He, Fuchu] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China	Hong Kong Baptist University; University of Jinan; Academy of Military Medical Sciences - China	Li, YX (corresponding author), China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China.	zhangge@hkbu.edu.hk; yingxianli@yahoo.cn	Zhang, Ge/K-9118-2019; Guo, Baosheng/ABD-4800-2021; Zhang, Ge/N-4150-2013; wang, Xiaogang/J-5003-2017; Song, Jin/HHS-8731-2022; GUO, Baosheng/M-6023-2013	Zhang, Ge/0000-0002-7807-7695; Guo, Baosheng/0000-0002-4510-5418; Zhang, Ge/0000-0002-7807-7695; Yang, Zhijun/0000-0002-6094-0438; Wang, Xiaogang/0000-0001-9798-834X; Peng, Songlin/0000-0002-4042-7071; Ling, Shukuan/0000-0002-4622-4160	National Basic Research Program of China 973 program [2011CB711003, 2011CB707704]; State Key Lab of Space Medicine Fundamentals and Application [SMFA10A02, SMFA12B01]; National Natural Science Foundation [31170811, 31000386, 81272045]; Hong Kong General Research Fund [HKBU 479111, HKBU478312]; Research Grants Council/Natural Science Foundation Council Joint Research Scheme [N_HKBU435/12]	National Basic Research Program of China 973 program(National Basic Research Program of China); State Key Lab of Space Medicine Fundamentals and Application; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hong Kong General Research Fund; Research Grants Council/Natural Science Foundation Council Joint Research Scheme	We thank the academic staff (L. Qin and L. Hung) from the Chinese University of Hong Kong and the research staff from G.Z.'s lab (http://www.gezhanglab.com/index.php) at Hong Kong Baptist University for providing critical comments and technical support. We thank X. Yang (Institute of Biotechnology) for providing the Bglap2 promoter vector. We also thank L. Zhang, K. Guan and H. Ouyang for constructive suggestions and careful revisions to this manuscript. This work was supported by the National Basic Research Program of China 973 program (2011CB711003 and 2011CB707704), State Key Lab of Space Medicine Fundamentals and Application Grants (SMFA10A02 and SMFA12B01), National Natural Science Foundation Projects (31170811, 31000386 and 81272045), the Hong Kong General Research Fund (HKBU 479111 and HKBU478312) and the Research Grants Council/Natural Science Foundation Council Joint Research Scheme (N_HKBU435/12).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Fuller KE, 2004, NEW ENGL J MED, V350, P190; Furnari F, 2010, NATURE, V465, P1016, DOI 10.1038/4651016a; Gaur T, 2010, DEV BIOL, V340, P10, DOI 10.1016/j.ydbio.2010.01.008; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Itoh T, 2010, J BIOL CHEM, V285, P27745, DOI 10.1074/jbc.M110.105080; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Kapinas K, 2010, J BIOL CHEM, V285, P25221, DOI 10.1074/jbc.M110.116137; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Marx J, 2004, SCIENCE, V305, P1420, DOI 10.1126/science.305.5689.1420; Miller P.O., 2004, NEW ENGL J MED, V350, P189; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Tromans A, 2003, NATURE, V425, P909, DOI 10.1038/425909a; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yin G, 2010, ONCOGENE, V29, P3545, DOI 10.1038/onc.2010.111; Zhang G, 2012, NAT MED, V18, P307, DOI 10.1038/nm.2617; Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377	37	422	458	4	177	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					93	100		10.1038/nm.3026	http://dx.doi.org/10.1038/nm.3026			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23223004				2022-12-27	WOS:000313230300030
J	Kwong, LN; Costello, JC; Liu, HY; Jiang, S; Helms, TL; Langsdorf, AE; Jakubosky, D; Genovese, G; Muller, FL; Jeong, JH; Bender, RP; Chu, GC; Flaherty, KT; Wargo, JA; Collins, JJ; Chin, LD				Kwong, Lawrence N.; Costello, James C.; Liu, Huiyun; Jiang, Shan; Helms, Timothy L.; Langsdorf, Aliete E.; Jakubosky, David; Genovese, Giannicola; Muller, Florian L.; Jeong, Joseph H.; Bender, Ryan P.; Chu, Gerald C.; Flaherty, Keith T.; Wargo, Jennifer A.; Collins, James J.; Chin, Lynda			Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma	NATURE MEDICINE			English	Article							TUMOR PROGRESSION; PHASE-I; K-RAS; BRAF; INHIBITOR; MEK; PATHWAY; ARRY-142886; SELUMETINIB; AZD6244	The discovery of potent inhibitors of the BRAF proto-oncogene has revolutionized therapy for melanoma harboring mutations in BRAF, yet NRAS-mutant melanoma remains without an effective therapy. Because direct pharmacological inhibition of the RAS proto-oncogene has thus far been unsuccessful, we explored systems biology approaches to identify synergistic drug combination(s) that can mimic RAS inhibition. Here, leveraging an inducible mouse model of NRAS-mutant melanoma, we show that pharmacological inhibition of mitogen-activated protein kinase kinase (MEK) activates apoptosis but not cell-cycle arrest, which is in contrast to complete genetic neuroblastoma RAS homolog (NRAS) extinction, which triggers both of these effects. Network modeling pinpointed cyclin-dependent kinase 4 (CDK4) as a key driver of this differential phenotype. Accordingly, combined pharmacological inhibition of MEK and CDK4 in vivo led to substantial synergy in therapeutic efficacy. We suggest a gradient model of oncogenic NRAS signaling in which the output is gated, resulting in the decoupling of discrete downstream biological phenotypes as a result of incomplete inhibition. Such a gated signaling model offers a new framework to identify nonobvious coextinction target(s) for combined pharmacological inhibition in NRAS-mutant melanomas.	[Kwong, Lawrence N.; Liu, Huiyun; Jiang, Shan; Langsdorf, Aliete E.; Jakubosky, David; Genovese, Giannicola; Muller, Florian L.; Jeong, Joseph H.; Bender, Ryan P.; Chu, Gerald C.; Chin, Lynda] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kwong, Lawrence N.; Jiang, Shan; Helms, Timothy L.; Genovese, Giannicola; Muller, Florian L.; Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Costello, James C.; Collins, James J.] Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02115 USA; [Costello, James C.; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Chu, Gerald C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Div Med Oncol, Boston, MA 02114 USA; [Wargo, Jennifer A.] Massachusetts Gen Hosp, Div Surg Oncol, Boston, MA 02114 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; University of Texas System; UTMD Anderson Cancer Center	Chin, LD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	lchin@mdanderson.org		Costello, James/0000-0003-3158-9682; Genovese, Giannicola/0000-0003-1392-9954; Muller, Florian/0000-0001-7568-2948	American Cancer Society [117842-PF-09-261-01-TBG]; US National Institutes of Health Director's Pioneer Award Program; Howard Hughes Medical Institute; US National Institutes of Health [U01 CA141508]; Abby S. and Howard P. Milstein Innovation Award for Melanoma and Skin Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016672, U01CA141508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG031679] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); US National Institutes of Health Director's Pioneer Award Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abby S. and Howard P. Milstein Innovation Award for Melanoma and Skin Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Mills, Y. Lu and N. Shih at the MD Anderson Reverse Phase Protein Array core facility; E. Fox at the Dana-Farber Cancer Institute Microarray core facility; S. Zhou for mouse husbandry; R. DePinho and G. Draetta and members of the laboratory, including S. Quayle, M. Chen, A. Blanchette and J. Kamara, for insightful discussions; R. Kwong for manuscript proofreading; D. Camacho for helping develop the TRAP algorithm; and M. Bar-Eli (University of Texas MD Anderson Cancer Center, Houston, Texas) for the SB-2 cell line. L. N. K. is supported by the Postdoctoral Fellowship (117842-PF-09-261-01-TBG) from the American Cancer Society. J. J. C. is supported by the US National Institutes of Health Director's Pioneer Award Program and the Howard Hughes Medical Institute. This work was supported by funding from the US National Institutes of Health to L. C. (U01 CA141508). L. C. is a recipient of the Abby S. and Howard P. Milstein 2009 Innovation Award for Melanoma and Skin Cancer Research and a CPRIT (Cancer Prevention Research Institute of Texas) Scholar in Cancer Research.	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chiarion-Sileni V, 2013, J CLIN ONCOL, V31; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Della Gatta G, 2012, NAT MED, V18, P436, DOI 10.1038/nm.2610; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Falchook GS, 2012, LANCET ONCOL, V13, P782, DOI 10.1016/S1470-2045(12)70269-3; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jakob J.A, 2011, CANCER, V118, P4013; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Morris MK, 2010, BIOCHEMISTRY-US, V49, P3216, DOI 10.1021/bi902202q; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Paraiso KHT, 2010, BRIT J CANCER, V102, P1724, DOI 10.1038/sj.bjc.6605714; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Sachs Karen, 2002, Sci STKE, V2002, ppe38, DOI 10.1126/stke.2002.148.pe38; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; VanBrocklin MW, 2009, CANCER RES, V69, P1985, DOI 10.1158/0008-5472.CAN-08-3934; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	45	254	264	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1503	U96		10.1038/nm.2941	http://dx.doi.org/10.1038/nm.2941			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22983396	Green Accepted			2022-12-27	WOS:000309587500028
J	Yang, JM; Favazza, C; Chen, RM; Yao, JJ; Cai, X; Maslov, K; Zhou, QF; Shung, KK; Wang, LHV				Yang, Joon-Mo; Favazza, Christopher; Chen, Ruimin; Yao, Junjie; Cai, Xin; Maslov, Konstantin; Zhou, Qifa; Shung, K. Kirk; Wang, Lihong V.			Simultaneous functional photoacoustic and ultrasonic endoscopy of internal organs in vivo	NATURE MEDICINE			English	Article							FINE-NEEDLE ASPIRATION; CARBON NANOTUBES; MICROSCOPY; DIAGNOSIS; BIOPSY; RESOLUTION	At present, clinicians routinely apply ultrasound endoscopy in a variety of interventional procedures that provide treatment solutions for diseased organs. Ultrasound endoscopy not only produces high-resolution images, but also is safe for clinical use and broadly applicable. However, for soft tissue imaging, its mechanical wave-based image contrast fundamentally limits its ability to provide physiologically specific functional information. By contrast, photoacoustic endoscopy possesses a unique combination of functional optical contrast and high spatial resolution at clinically relevant depths, ideal for imaging soft tissues. With these attributes, photoacoustic endoscopy can overcome the current limitations of ultrasound endoscopy. Moreover, the benefits of photoacoustic imaging do not come at the expense of existing ultrasound functions; photoacoustic endoscopy systems are inherently compatible with ultrasound imaging, thereby enabling multimodality imaging with complementary contrast. Here we present simultaneous photoacoustic and ultrasonic dual-mode endoscopy and show its ability to image internal organs in vivo, thus illustrating its potential clinical application.	[Yang, Joon-Mo; Favazza, Christopher; Yao, Junjie; Cai, Xin; Maslov, Konstantin; Wang, Lihong V.] Washington Univ, Dept Biomed Engn, Opt Imaging Lab, St Louis, MO 63130 USA; [Chen, Ruimin; Zhou, Qifa; Shung, K. Kirk] Univ So Calif, Natl Inst Hlth Ultrason Transducer Resource Ctr, Dept Biomed Engn, Los Angeles, CA USA	Washington University (WUSTL); National Institutes of Health (NIH) - USA; University of Southern California	Wang, LHV (corresponding author), Washington Univ, Dept Biomed Engn, Opt Imaging Lab, St Louis, MO 63130 USA.	qifazhou@usc.edu; lhwang@biomed.wustl.edu	Yang, Joon-Mo/X-5629-2018; Chen, Ruimin/K-2854-2018; yao, junjie/G-9226-2014; Wang, Lihong V./A-7147-2009	Chen, Ruimin/0000-0002-5338-359X; yao, junjie/0000-0002-2847-5839; Wang, Lihong V./0000-0001-9783-4383; Maslov, KONSTANTIN/0000-0003-3408-8840	US National Institutes of Health [R01 CA157277, R01 EB000712, R01 EB008085, R01 CA134539, P41-EB2182, U54 CA136398]; Korea Research Foundation; Korean government [KRF-2007-357-C00039]; NATIONAL CANCER INSTITUTE [R01CA157277, R01CA134539, U54CA136398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002182, R01EB000712, R01EB008085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046214] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); Korean government(Korean Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Ballard for his attentive reading of the manuscript. We also thank J. Kalishman, P. Jimenez-Bluhm, and L. Andrews-Kaminsky for helping with animal preparation, surgery, and image interpretation. We thank B. Matthews, V. Tsytsarev, G. Lanza, R. Senior, and J. Atkinson for helpful discussion on the experimental results. This work was sponsored in part by US National Institutes of Health grants R01 CA157277, R01 EB000712, R01 EB008085, R01 CA134539, P41-EB2182, and U54 CA136398 (Network for Translational Research). J.-M.Y. was supported in part by a Korea Research Foundation Grant funded by the Korean government (KRF-2007-357-C00039).	Adler DC, 2007, NAT PHOTONICS, V1, P709, DOI 10.1038/nphoton.2007.228; Chang KJ, 1997, GASTROINTEST ENDOSC, V45, P387, DOI 10.1016/S0016-5107(97)70149-4; Chiasson R. B., 1987, LAB ANATOMY WHITE RA; De La Zerda A, 2008, NAT NANOTECHNOL, V3, P557, DOI 10.1038/nnano.2008.231; Dietrich C., 2006, ENDOSCOPIC ULTRASOUN; Erpelding TN, 2010, RADIOLOGY, V256, P102, DOI 10.1148/radiol.10091772; Fu KI, 2008, DIGEST DIS SCI, V53, P1886, DOI 10.1007/s10620-007-0104-y; Gress FG, 1997, GASTROINTEST ENDOSC, V45, P243, DOI 10.1016/S0016-5107(97)70266-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaul V, 2010, GASTROINTEST ENDOSC, V72, P1, DOI 10.1016/j.gie.2010.01.023; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Kim C, 2010, CHEM REV, V110, P2756, DOI 10.1021/cr900266s; Kim JW, 2009, NAT NANOTECHNOL, V4, P688, DOI 10.1038/nnano.2009.231; Larina IV, 2005, J PHYS D APPL PHYS, V38, P2633, DOI 10.1088/0022-3727/38/15/015; Laser Institute of America, 2007, Z13612007 ANSI INC; Menzel J, 2000, AM J GASTROENTEROL, V95, P605; Navani N, 2009, NAT REV CLIN ONCOL, V6, P278, DOI 10.1038/nrclinonc.2009.39; Oraevsky A. A., 2003, BIOMEDICAL PHOTONICS, VPM125, P3401; Popesko P., 2003, COLOUR ATLAS ANATOMY, V1; Qiu L, 2010, NAT MED, V16, P603, DOI 10.1038/nm.2138; ROSCH T, 1992, NEW ENGL J MED, V326, P1721, DOI 10.1056/NEJM199206253262601; Salomon G, 2008, EUR UROL, V54, P1354, DOI 10.1016/j.eururo.2008.02.035; Shah J, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940362; Silvestri GA, 1996, ANN THORAC SURG, V61, P1441, DOI 10.1016/0003-4975(95)00052-6; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Terry NG, 2011, GASTROENTEROLOGY, V140, P42, DOI 10.1053/j.gastro.2010.09.008; Trabulsi EJ, 2010, UROLOGY, V76, P1025, DOI 10.1016/j.urology.2010.05.022; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Wang LV, 2009, OPT SCI ENG-CRC, V144, P1, DOI 10.1201/9781420059922; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Xu Z, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3443793; Xuan JW, 2007, CANCER RES, V67, P2830, DOI 10.1158/0008-5472.CAN-06-3944; Yang JM, 2009, OPT LETT, V34, P1591, DOI 10.1364/OL.34.001591; Yao DK, 2010, OPT LETT, V35, P4139, DOI 10.1364/OL.35.004139; Yao JJ, 2010, OPT LETT, V35, P1419, DOI 10.1364/OL.35.001419; Yun SH, 2006, NAT MED, V12, P1429, DOI 10.1038/nm1450; Zhang C, 2010, OPT LETT, V35, P3195, DOI 10.1364/OL.35.003195; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	39	301	318	6	165	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1297	+		10.1038/nm.2823	http://dx.doi.org/10.1038/nm.2823			22	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22797808	Green Accepted			2022-12-27	WOS:000307469300038
J	Shichita, T; Hasegawa, E; Kimura, A; Morita, R; Sakaguchi, R; Takada, I; Sekiya, T; Ooboshi, H; Kitazono, T; Yanagawa, T; Ishii, T; Takahashi, H; Mori, S; Nishibori, M; Kuroda, K; Akira, S; Miyake, K; Yoshimura, A				Shichita, Takashi; Hasegawa, Eiichi; Kimura, Akihiro; Morita, Rimpei; Sakaguchi, Ryota; Takada, Ichiro; Sekiya, Takashi; Ooboshi, Hiroaki; Kitazono, Takanari; Yanagawa, Toru; Ishii, Tetsuro; Takahashi, Hideo; Mori, Shuji; Nishibori, Masahiro; Kuroda, Kazumichi; Akira, Shizuo; Miyake, Kensuke; Yoshimura, Akihiko			Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain	NATURE MEDICINE			English	Article							INNATE IMMUNE-RESPONSES; CRYSTAL-STRUCTURE; MAMMALIAN PEROXIREDOXIN; ANGSTROM RESOLUTION; PIVOTAL ROLE; RECEPTOR 4; ISCHEMIA; INJURY; STROKE; CELLS	Post-ischemic inflammation is an essential step in the progression of brain ischemia-reperfusion injury. However, the mechanism that activates infiltrating macrophages in the ischemic brain remains to be clarified. Here we demonstrate that peroxiredoxin (Prx) family proteins released extracellularly from necrotic brain cells induce expression of inflammatory cytokines including interleukin-23 in macrophages through activation of Toll-like receptor 2 (TLR2) and TLR4, thereby promoting neural cell death, even though intracellular Prxs have been shown to be neuroprotective. The extracellular release of Prxs in the ischemic core occurred 12 h after stroke onset, and neutralization of extracellular Prxs with antibodies suppressed inflammatory cytokine expression and infarct volume growth. In contrast, high mobility group box 1 (HMGB1), a well-known damage-associated molecular pattern molecule, was released before Prx and had a limited role in post-ischemic macrophage activation. We thus propose that extracellular Prxs are previously unknown danger signals in the ischemic brain and that its blocking agents are potent neuroprotective tools.	[Shichita, Takashi; Hasegawa, Eiichi; Kimura, Akihiro; Morita, Rimpei; Sakaguchi, Ryota; Takada, Ichiro; Sekiya, Takashi; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Shichita, Takashi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Shichita, Takashi; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Ooboshi, Hiroaki] Fukuoka Dent Coll Med & Dent Hosp, Dept Internal Med, Fukuoka, Japan; [Yanagawa, Toru; Ishii, Tetsuro] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Takahashi, Hideo; Mori, Shuji; Nishibori, Masahiro] Okayama Univ, Grad Sch Med, Dept Pharmacol, Okayama 7008530, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Div Microbiol, Tokyo, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Osaka, Japan; [Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Div Infect Genet, Tokyo, Japan; [Yoshimura, Akihiko] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Keio University; Japan Science & Technology Agency (JST); Kyushu University; Fukuoka Dental College (FDC); University of Tsukuba; Okayama University; Nihon University; Osaka University; University of Tokyo; Japan Science & Technology Agency (JST)	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013; Akira, Shizuo/C-3134-2009; Yanagawa, Toru/GYU-6448-2022	Yanagawa, Toru/0000-0003-0868-2563; Kimura, Akihiro/0000-0001-5614-8547; Takahashi, Hideo/0000-0001-9444-9746	Ministry of Education, Culture, Sports, Science and Technology of Japan; PRESTO from the Japan Science and Technology Agency; CREST from the Japan Science and Technology Agency; National Center of Neurology and Psychiatry (NCNP) [22-4]; SENSHIN Research Foundation; Takeda Science Foundation; Uehara Memorial Foundation; Mochida Memorial Foundation; Ministry of Health, Labor and Welfare of Japan [09156274]; National Institute of Biomedical Innovation; Grants-in-Aid for Scientific Research [24390061] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO from the Japan Science and Technology Agency; CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); National Center of Neurology and Psychiatry (NCNP); SENSHIN Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Mochida Memorial Foundation; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Saito, N. Shiino and M. Asakawa for technical assistance. This work was supported by special grants-in-aid (A) and open research for young academics and specialists from the Ministry of Education, Culture, Sports, Science and Technology of Japan, PRESTO and CREST from the Japan Science and Technology Agency, an Intramural Research Grant (22-4) for Neurological and Psychiatric Disorders of the National Center of Neurology and Psychiatry (NCNP), the SENSHIN Research Foundation, the Takeda Science Foundation, the Uehara Memorial Foundation, the Mochida Memorial Foundation, the Scientific Research Fund from the Ministry of Health, Labor and Welfare of Japan (09156274) and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation.	Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Brea D, 2011, J CEREBR BLOOD F MET, V31, P1424, DOI 10.1038/jcbfm.2010.231; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chesterman ES, 2001, DEV DYNAM, V222, P459, DOI 10.1002/dvdy.1198; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; Chou JLJ, 2011, PROTEOMICS, V11, P239, DOI 10.1002/pmic.201000438; Dayon L, 2011, J PROTEOME RES, V10, P1043, DOI 10.1021/pr101123t; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Eismann T, 2009, AM J PHYSIOL-GASTR L, V296, pG266, DOI 10.1152/ajpgi.90583.2008; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Patenaude A, 2005, CELL MOL LIFE SCI, V62, P1063, DOI 10.1007/s00018-005-4541-5; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Rashidian J, 2009, J NEUROSCI, V29, P12497, DOI 10.1523/JNEUROSCI.3892-09.2009; Ren XF, 2011, J NEUROSCI, V31, P8556, DOI 10.1523/JNEUROSCI.1623-11.2011; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Sugimori H, 2004, BRAIN RES PROTOC, V13, P189, DOI 10.1016/j.brainresprot.2004.06.001; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; TOOHEY JI, 1975, P NATL ACAD SCI USA, V72, P73, DOI 10.1073/pnas.72.1.73; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang QW, 2011, J CEREBR BLOOD F MET, V31, P593, DOI 10.1038/jcbfm.2010.129; Yi HF, 2009, BLOOD, V113, P5819, DOI 10.1182/blood-2008-11-190033; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	47	287	301	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					911	+		10.1038/nm.2749	http://dx.doi.org/10.1038/nm.2749			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22610280				2022-12-27	WOS:000305116600028
J	Seewaldt, V				Seewaldt, Victoria			ECM stiffness paves the way for tumor cells	NATURE MEDICINE			English	Editorial Material							BREAST-CANCER; MAMMOGRAPHIC DENSITY; PROGRESSION; CARCINOMA; COLLAGEN; RISK		Duke Univ, Dept Med, Durham, NC 27706 USA	Duke University	Seewaldt, V (corresponding author), Duke Univ, Dept Med, Durham, NC 27706 USA.	seewa001@mc.duke.edu						Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Cecchini RS, 2012, CANCER PREV RES, V5, P1321, DOI 10.1158/1940-6207.CAPR-12-0273; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gierach GL, 2012, J NATL CANCER I, V104, P1218, DOI 10.1093/jnci/djs327; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Grady D, 2012, NY TIMES; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lyons TR, 2011, NAT MED, V17, P1109, DOI 10.1038/nm.2416; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513	14	81	85	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					332	333		10.1038/nm.3523	http://dx.doi.org/10.1038/nm.3523			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710372				2022-12-27	WOS:000334361500008
J	Dolgin, E				Dolgin, Elie			ENCAPSULATE THIS	NATURE MEDICINE			English	News Item																		Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032; Ludwig B, 2013, P NATL ACAD SCI USA, V110, P19054, DOI 10.1073/pnas.1317561110; Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744; Weir GC, 2013, DIABETOLOGIA, V56, P1458, DOI 10.1007/s00125-013-2921-1	4	41	44	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					9	11		10.1038/nm0114-9	http://dx.doi.org/10.1038/nm0114-9			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398953				2022-12-27	WOS:000329349400007
J	Komatsu, N; Okamoto, K; Sawa, S; Nakashima, T; Oh-hora, M; Kodama, T; Tanaka, S; Bluestone, JA; Takayanagi, H				Komatsu, Noriko; Okamoto, Kazuo; Sawa, Shinichiro; Nakashima, Tomoki; Oh-hora, Masatsugu; Kodama, Tatsuhiko; Tanaka, Sakae; Bluestone, Jeffrey A.; Takayanagi, Hiroshi			Pathogenic conversion of Foxp3(+) T cells into T(H)17 cells in autoimmune arthritis	NATURE MEDICINE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; RHEUMATOID-ARTHRITIS; TNF-ALPHA; INDUCTION; PLASTICITY; IMMUNE; DIFFERENTIATION; POPULATION; ACTIVATION; EXPRESSION	Autoimmune diseases often result from an imbalance between regulatory T (T-reg) cells and interleukin-17 (IL-17)-producing T helper (T(H)17) cells; the origin of the latter cells remains largely unknown. Foxp3 is indispensable for the suppressive function of Treg cells, but the stability of Foxp3 has been under debate. Here we show that T(H)17 cells originating from Foxp3(+) T cells have a key role in the pathogenesis of autoimmune arthritis. Under arthritic conditions, CD25(lo)Foxp3(+)CD4(+) T cells lose Foxp3 expression (herein called exFoxp3 cells) and undergo transdifferentiation into T(H)17 cells. Fate mapping analysis showed that IL-17-expressing exFoxp3 T (exFoxp3 T(H)17) cells accumulated in inflamed joints. The conversion of Foxp3(+)CD4(+) T cells to T(H)17 cells was mediated by synovial fibroblast-derived IL-6. These exFoxp3 T(H)17 cells were more potent osteoclastogenic T cells than were naive CD4(+) T cell-derived T(H)17 cells. Notably, exFoxp3 T(H)17 cells were characterized by the expression of Sox4, chemokine (C-C motif) receptor 6 (CCR6), chemokine (C-C motif) ligand 20 (CCL20), IL-23 receptor (IL-23R) and receptor activator of NF-kappa B ligand (RANKL, also called TNFSF11). Adoptive transfer of autoreactive, antigen-experienced CD25(lo)Foxp3(+)CD4(+) T cells into mice followed by secondary immunization with collagen accelerated the onset and increased the severity of arthritis and was associated with the loss of Foxp3 expression in the majority of transferred T cells. We observed IL-17(+)Foxp3(+) T cells in the synovium of subjects with active rheumatoid arthritis (RA), which suggests that plastic Foxp3(+) T cells contribute to the pathogenesis of RA. These findings establish the pathological importance of Foxp3 instability in the generation of pathogenic T(H)17 cells in autoimmunity.	[Komatsu, Noriko; Okamoto, Kazuo; Sawa, Shinichiro; Takayanagi, Hiroshi] Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Komatsu, Noriko; Okamoto, Kazuo; Sawa, Shinichiro; Takayanagi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 113, Japan; [Komatsu, Noriko; Okamoto, Kazuo; Sawa, Shinichiro; Nakashima, Tomoki; Takayanagi, Hiroshi] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki; Oh-hora, Masatsugu] Tokyo Med & Dent Univ, Dept Cell Signaling, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Nakashima, Tomoki; Oh-hora, Masatsugu] JST, Precursory Res Embryon Sci & Technol Program, Bunkyo Ku, Tokyo, Japan; [Oh-hora, Masatsugu] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Bunkyo Ku, Tokyo, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Adv Sci & Technol Res Ctr, Lab Syst Biol & Med, Meguro Ku, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Takayanagi, Hiroshi] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Nedlands, WA 6009, Australia	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; University of California System; University of California San Francisco; University of Western Australia	Takayanagi, H (corresponding author), Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo, Japan.	takayana@m.u-tokyo.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	JST; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046643] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24117725] Funding Source: KAKEN	JST(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to S. Hori (RIKEN Center for Integrative Medical Sciences) and Y. Iwakura (Tokyo University of Science) for providing B6.Foxp3<SUP>hCD2</SUP> knock-in mice and Il17a<SUP>-/-</SUP> mice, respectively. We also thank T. Negishi-Koga, M. Shinohara, A. Terashima, M. Guerrini, L. Danks, M. Hayashi, T. Ando, Y. Ogiwara, N. Otsuka, T. Kato, C. Tsuda, T. Suda, A. Suematsu, S. Fukuse, Y. Wada, A. Izumi and K. Kaneki for discussion and assistance. This work was supported in part by a grant for the ERATO Takayanagi Osteonetwork Project from JST; a Grant-in-Aid for Challenging Exploratory Research from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for JSPS Fellows; and a grant for the GCOE Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan. N. K. was supported by JSPS Research Fellowships for Young Scientists.	Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Malhotra N, 2013, IMMUNITY, V38, P681, DOI 10.1016/j.immuni.2013.01.010; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Ramezani-Rad P, 2013, BLOOD, V121, P148, DOI 10.1182/blood-2012-05-428938; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wehrens EJ, 2013, NAT REV RHEUMATOL, V9, P34, DOI 10.1038/nrrheum.2012.149; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zaiss MM, 2007, ARTHRITIS RHEUM, V56, P4104, DOI 10.1002/art.23138; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	42	677	715	7	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					62	+		10.1038/nm.3432	http://dx.doi.org/10.1038/nm.3432			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24362934	Green Published			2022-12-27	WOS:000329349400020
J	Clarksound, GM				Clarksound, Graeme M.			The multichannel cochlear implant for severe-to-profound hearing loss	NATURE MEDICINE			English	Editorial Material							AUDITORY-NERVE FIBERS; STIMULATION; SPEECH		Univ Melbourne, Natl ICT Australia NICTA Victoria Res Lab, Melbourne, Vic, Australia	NICTA; University of Melbourne	Clarksound, GM (corresponding author), Univ Melbourne, Natl ICT Australia NICTA Victoria Res Lab, Melbourne, Vic, Australia.	gclark@unimelb.edu.au			TV Channel 10 Nerve Deafness Appeal; Australian government; Bionic Ear Institute; National Health & Medical Research Council of Australia; Australian Research Council; Cooperative Research Centres Program; US National Institutes of Health; NICTA	TV Channel 10 Nerve Deafness Appeal; Australian government(Australian GovernmentCGIAR); Bionic Ear Institute; National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICTA(NICTA)	First, I would like to express deep gratitude to my wife Margaret; our children: Sonya, Cecily, Roslyn, Merran and Jonathan, and their spouses; our grandchildren; and our parents. It has been exhilarating leading a talented research team and being part of a unique development by Cochlear Ltd. I would like to thank the Universities of Melbourne and Sydney and the Eye & Ear Hospital for crucial support. We were greatly helped by funding from the TV Channel 10 Nerve Deafness Appeal, a Public Interest Grant from the Australian government, the Bionic Ear Institute and many trusts and foundations. Our scientific studies and development were supported in particular by the National Health & Medical Research Council of Australia, the Australian Research Council, the Cooperative Research Centres Program and the US National Institutes of Health. I thank NICTA for support for research to develop more advanced cochlear implants to achieve high-fidelity sound and better hearing in noise. I would also like to thank David Lawrence, Debbie Mussett, Jonathan Clark and Ian Rutherford for help in completing this manuscript.	BLAMEY PJ, 1985, J ACOUST SOC AM, V77, P209, DOI 10.1121/1.392260; BUSBY PA, 1994, J ACOUST SOC AM, V95, P2658, DOI 10.1121/1.409835; Clark G M, 1988, Acta Otolaryngol Suppl, V448, P1; Clark G.M., 2003, SPRINGER HDB AUDITOR, P722; CLARK GM, 1987, AM J OTOL, V8, P234; Clark GM, 2008, J REHABIL RES DEV, V45, P651, DOI 10.1682/JRRD.2007.05.0064; Clark GM, 2006, PHILOS T R SOC B, V361, P791, DOI 10.1098/rstb.2005.1782; LAWRENCE M, 1964, ARCHIV OTOLARYNGOL, V80, P367; Shepherd R K, 1983, Acta Otolaryngol Suppl, V399, P19; TONG YC, 1982, J ACOUST SOC AM, V71, P153, DOI 10.1121/1.387342; TONG YC, 1983, SCIENCE, V219, P993, DOI 10.1126/science.6823564; TONG YC, 1983, J ACOUST SOC AM, V74, P73, DOI 10.1121/1.389620; TONG YC, 1979, J LARYNGOL OTOL, V93, P679, DOI 10.1017/S0022215100087545; vanHoesel RJM, 1997, J ACOUST SOC AM, V102, P495, DOI 10.1121/1.419611; WILLIAMS AJ, 1976, PHYSIOL PSYCHOL, V4, P23	15	10	11	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1236	1239		10.1038/nm.3340	http://dx.doi.org/10.1038/nm.3340			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100994				2022-12-27	WOS:000325531700020
J	Goldstein, JL				Goldstein, Joseph L.			Juxtapositions in Trafalgar Square: tip-offs to creativity in art and science Foreword	NATURE MEDICINE			English	Editorial Material												joe.goldstein@utsouthwestern.edu							0	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2013	19	10					1222	1226		10.1038/nm.3329	http://dx.doi.org/10.1038/nm.3329			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100991				2022-12-27	WOS:000325531700017
J	Winston, R				Winston, Robert			Animal experiments deserve a place on drug labels	NATURE MEDICINE			English	Editorial Material									[Winston, Robert] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Winston, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.								0	2	2	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2013	19	10					1204	1204		10.1038/nm1013-1204	http://dx.doi.org/10.1038/nm1013-1204			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100975	Bronze			2022-12-27	WOS:000325531700009
J	Brosens, JJ; Blanks, AM; Lucas, ES				Brosens, Jan J.; Blanks, Andrew M.; Lucas, Emma S.			LRH-1: orphaned, adopted and needed for pregnancy	NATURE MEDICINE			English	Editorial Material							STROMAL CELLS; PROGESTERONE; ENDOMETRIUM; RECEPTORS; PATHWAY	A new study shows that the orphan nuclear receptor liver receptor homolog 1 (LRH-1) wires the postovulatory rise in progesterone production to progesterone-dependent preparation of the endometrium for pregnancy, a process termed decidualization. Lack of Lrh-1 activity in either the ovary or uterus has catastrophic consequences for reproduction in mice (pages 1061-1066).	[Brosens, Jan J.; Blanks, Andrew M.; Lucas, Emma S.] Univ Hosp Coventry & Warwickshire, Warwick Med Sch, Biomed Res Unit Reprod Hlth, Coventry, W Midlands, England	University of Warwick	Brosens, JJ (corresponding author), Univ Hosp Coventry & Warwickshire, Warwick Med Sch, Biomed Res Unit Reprod Hlth, Coventry, W Midlands, England.	j.j.brosens@warwick.ac.uk	Lucas, Emma S/I-2719-2013	Lucas, Emma S/0000-0002-8571-8921; Brosens, Jan/0000-0003-0116-9329; Blanks, Andrew/0000-0003-1073-6081	MRC [G0901801] Funding Source: UKRI; Medical Research Council [G0901801] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Burris TP, 2012, CHEM BIOL, V19, P51, DOI 10.1016/j.chembiol.2011.12.011; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Corrigan E., 2008, CLICK LIVERPOOL; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Musille PM, 2012, NAT STRUCT MOL BIOL, V19, P532, DOI 10.1038/nsmb.2279; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Teklenburg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010258; Zhang C, 2013, NAT MED, V19, P1061, DOI 10.1038/nm.3192	12	3	3	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2013	19	8					968	969		10.1038/nm.3271	http://dx.doi.org/10.1038/nm.3271			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921740				2022-12-27	WOS:000322779600017
J	Dekkers, JF; Wiegerinck, CL; de Jonge, HR; Bronsveld, I; Janssens, HM; de Winter-de Groot, KM; Brandsma, AM; de Jong, NWM; Bijvelds, MJC; Scholte, BJ; Nieuwenhuis, EES; van den Brink, S; Clevers, H; van der Ent, CK; Middendorp, S; Beekman, JM				Dekkers, Johanna F.; Wiegerinck, Caroline L.; de Jonge, Hugo R.; Bronsveld, Inez; Janssens, Hettie M.; de Winter-de Groot, Karin M.; Brandsma, Arianne M.; de Jong, Nienke W. M.; Bijvelds, Marcel J. C.; Scholte, Bob J.; Nieuwenhuis, Edward E. S.; van den Brink, Stieneke; Clevers, Hans; van der Ent, Cornelis K.; Middendorp, Sabine; Beekman, Jeffrey M.			A functional CFTR assay using primary cystic fibrosis intestinal organoids	NATURE MEDICINE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; IN-VITRO; ION-TRANSPORT; STEM-CELLS; IDENTIFICATION; GENE; F508DEL-CFTR; MUTATION; DELTA-F508-CFTR; SECRETION	We recently established conditions allowing for long-term expansion of epithelial organoids from intestine, recapitulating essential features of the in vivo tissue architecture. Here we apply this technology to study primary intestinal organoids of people suffering from cystic fibrosis, a disease caused by mutations in CFTR, encoding cystic fibrosis transmembrane conductance regulator. Forskolin induces rapid swelling of organoids derived from healthy controls or wild-type mice, but this effect is strongly reduced in organoids of subjects with cystic fibrosis or in mice carrying the Cftr F508del mutation and is absent in Cftr-deficient organoids. This pattern is phenocopied by CFTR-specific inhibitors. Forskolin-induced swelling of in vitro-expanded human control and cystic fibrosis organoids corresponds quantitatively with forskolin-induced anion currents in freshly excised ex vivo rectal biopsies. Function of the CFTR F508del mutant protein is restored by incubation at low temperature, as well as by CFTR-restoring compounds. This relatively simple and robust assay will facilitate diagnosis, functional studies, drug development and personalized medicine approaches in cystic fibrosis.	[Dekkers, Johanna F.; de Winter-de Groot, Karin M.; Brandsma, Arianne M.; de Jong, Nienke W. M.; van der Ent, Cornelis K.; Beekman, Jeffrey M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands; [Dekkers, Johanna F.; Wiegerinck, Caroline L.; Middendorp, Sabine; Beekman, Jeffrey M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [Dekkers, Johanna F.; Brandsma, Arianne M.; de Jong, Nienke W. M.; Beekman, Jeffrey M.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Immunol, Utrecht, Netherlands; [Wiegerinck, Caroline L.; Nieuwenhuis, Edward E. S.; Middendorp, Sabine] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Gastroenterol, Utrecht, Netherlands; [de Jonge, Hugo R.; Bijvelds, Marcel J. C.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Bronsveld, Inez] Univ Med Ctr, Dept Pulmonol, Utrecht, Netherlands; [Janssens, Hettie M.] Erasmus MC, Dept Pediat Pulmonol, Rotterdam, Netherlands; [Scholte, Bob J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [van den Brink, Stieneke; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands; [van den Brink, Stieneke; Clevers, Hans] Univ Med Ctr, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Beekman, JM (corresponding author), Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands.	h.clevers@hubrecht.eu; jbeekman@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014; Middendorp, Sabine/J-8205-2012; Middendorp, Sabine/B-8357-2013	Beekman, Jeffrey M/0000-0003-4886-3756; Middendorp, Sabine/0000-0002-0925-0095; Middendorp, Sabine/0000-0002-0925-0095; Brandsma, Arianne/0000-0002-7969-4046; de Jong, Nienke/0000-0002-5807-4104; Van der Ent, Cornelis/0000-0002-2501-4121; Bijvelds, Marcel/0000-0003-0814-188X	WKZ [OZF-2010]; Dutch Cystic Fibrosis society (NCFS)	WKZ; Dutch Cystic Fibrosis society (NCFS)	We thank K. Schneeberger for technical assistance, the Department of Pediatric Gastroenterology of the Wilhelmina Children's Hospital for performing gastroduodenoscopy to obtain intestinal biopsies, K. Tenbrock (Department of Pediatrics, Rheinisch-Westtalische Technische Hochschule (RWTH) Aachen University) and J.C. Escher (Department of Pediatric Gastroenterology, Erasmus MC-Sophia Children's Hospital) for providing intestinal rest-material, C.J. Kuo (Department of Medicine, Stanford) for providing the R-spondin 1-producing cell line, J. Riordan (Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill) for CFTR-specific monoclonal antibodies, R. Bridges (Department of Rosalind Franklin University of Medicine and Science) and Cystic Fibrosis Foundation Therapeutics for providing CFTR-restoring compounds, P. W. van Leeuwen for assistance with statistical analyses and C. B. M. ten Brink for assistance with Volocity software. This research was partly funded by a grant from the WKZ research fund (OZF-2010) and the Dutch Cystic Fibrosis society (NCFS).	Beekman JM, 2012, ONCOGENE, V31, P2668, DOI 10.1038/onc.2011.445; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Clancy JP, 2012, AM J RESP CRIT CARE, V186, P593, DOI 10.1164/rccm.201204-0785PP; CUNNINGHAM SA, 1992, AM J PHYSIOL, V262, pC783, DOI 10.1152/ajpcell.1992.262.3.C783; Currid A, 2004, J PHYSIOL-LONDON, V555, P241, DOI 10.1113/jphysiol.2003.059295; De Boeck K, 2011, J CYST FIBROS, V10, pS53, DOI 10.1016/S1569-1993(11)60009-X; De Jonge Hugo R, 2004, J Cyst Fibros, V3 Suppl 2, P159, DOI 10.1016/j.jcf.2004.05.034; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Flume PA, 2012, CHEST, V142, P718, DOI 10.1378/chest.11-2672; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; Geborek A, 2011, J CYST FIBROS, V10, P187, DOI 10.1016/j.jcf.2011.01.005; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; HERMANS CJ, 1994, HUM MOL GENET, V3, P1199, DOI 10.1093/hmg/3.7.1199; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li HY, 2012, AM J PHYSIOL-RENAL, V303, pF1176, DOI 10.1152/ajprenal.00130.2012; Liu JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1492, DOI 10.1152/ajpcell.00392.2011; Loo TW, 2005, MOL PHARMACEUT, V2, P407, DOI 10.1021/mp0500521; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; SMITH JJ, 1993, J CLIN INVEST, V91, P1590, DOI 10.1172/JCI116365; Strandvik B, 2001, GENET TEST, V5, P235, DOI 10.1089/10906570152742290; SULLIVAN LP, 1994, KIDNEY INT, V45, P1369, DOI 10.1038/ki.1994.179; Thiagarajah JR, 2012, CLIN PHARMACOL THER, V92, P287, DOI 10.1038/clpt.2012.114; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	49	617	653	7	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					939	+		10.1038/nm.3201	http://dx.doi.org/10.1038/nm.3201			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23727931				2022-12-27	WOS:000321557700040
J	Gagliani, N; Magnani, CF; Huber, S; Gianolini, ME; Pala, M; Licona-Limon, P; Guo, BGG; Herbert, DR; Bulfone, A; Trentini, F; Di Serio, C; Bacchetta, R; Andreani, M; Brockmann, L; Gregori, S; Flavell, RA; Roncarolo, MG				Gagliani, Nicola; Magnani, Chiara F.; Huber, Samuel; Gianolini, Monica E.; Pala, Mauro; Licona-Limon, Paula; Guo, Binggege; Herbert, De'Broski R.; Bulfone, Alessandro; Trentini, Filippo; Di Serio, Clelia; Bacchetta, Rosa; Andreani, Marco; Brockmann, Leonie; Gregori, Silvia; Flavell, Richard A.; Roncarolo, Maria-Grazia			Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells	NATURE MEDICINE			English	Article							IN-VIVO; IMMUNE-RESPONSES; INTERLEUKIN-10; EXPRESSION; IL-10; TR1; DIFFERENTIATION; TRANSPLANTATION; ACTIVATION; TOLERANCE	CD4(+) type 1 T regulatory (Tr1) cells are induced in the periphery and have a pivotal role in promoting and maintaining tolerance. The absence of surface markers that uniquely identify Tr1 cells has limited their study and clinical applications. By gene expression profiling of human Tr1 cell clones, we identified the surface markers CD49b and lymphocyte activation gene 3 (LAG-3) as being stably and selectively coexpressed on mouse and human Tr1 cells. We showed the specificity of these markers in mouse models of intestinal inflammation and helminth infection and in the peripheral blood of healthy volunteers. The coexpression of CD49b and LAG-3 enables the isolation of highly suppressive human Tr1 cells from in vitro anergized cultures and allows the tracking of Tr1 cells in the peripheral blood of subjects who developed tolerance after allogeneic hematopoietic stem cell transplantation. The use of these markers makes it feasible to track Tr1 cells in vivo and purify Tr1 cells for cell therapy to induce or restore tolerance in subjects with immune-mediated diseases.	[Gagliani, Nicola; Magnani, Chiara F.; Gianolini, Monica E.; Bacchetta, Rosa; Gregori, Silvia; Roncarolo, Maria-Grazia] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy; [Gagliani, Nicola; Licona-Limon, Paula; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Huber, Samuel; Brockmann, Leonie] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 1, Hamburg, Germany; [Gianolini, Monica E.] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy; [Pala, Mauro; Bulfone, Alessandro] Bioflag, Pula, Italy; [Guo, Binggege] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Herbert, De'Broski R.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Trentini, Filippo; Di Serio, Clelia] Univ Vita Salute San Raffaele, Univ Ctr Stat Biomed Sci CUSSB, Milan, Italy; [Andreani, Marco] Fdn Ist Mediterraneo Ematol IME, Policlin Tor Vergata, Lab Immunogenet & Biol Trapianti, Rome, Italy; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Roncarolo, Maria-Grazia] Univ Vita Salute San Raffaele, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Yale University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Rome Tor Vergata; Peking University; University of California System; University of California San Francisco; Vita-Salute San Raffaele University; University of Rome Tor Vergata; Policlin Tor Vergata; Howard Hughes Medical Institute; Yale University; Vita-Salute San Raffaele University	Roncarolo, MG (corresponding author), Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy.	richard.flavell@yale.edu; m.roncarolo@hsr.it	Herbert, DeBroski/AAD-3035-2019; Magnani, Chiara Francesca/K-8977-2016; Di Serio, Clelia/AAO-5494-2020; Herbert, De'Broski/J-7357-2012; Pala, Mauro/AAY-4774-2020; Andreani, Marco/AAA-5208-2020; Magnani, Chiara F/AAP-7365-2020; SILVIA, GREGORI/J-7718-2016	Herbert, DeBroski/0000-0002-2449-5365; Magnani, Chiara Francesca/0000-0003-2474-2159; Herbert, De'Broski/0000-0002-2449-5365; Andreani, Marco/0000-0003-3451-3624; Magnani, Chiara F/0000-0003-2474-2159; SILVIA, GREGORI/0000-0002-3517-9683; Bacchetta, Rosa/0000-0002-0606-6268; trentini, filippo/0000-0001-6915-7282; Gagliani, Nicola/0000-0001-8514-1395; DI SERIO, Mariaclelia Stefania/0000-0001-6385-6058; Huber, Samuel/0000-0001-9325-8227; RONCAROLO, Maria Grazia/0000-0002-2193-9186; Pala, Mauro/0000-0002-3165-5291	Telethon Foundation 'Comitato Telethon Fondazione Onlus' Core Grant OSR-TIGET project (Rome) [E2]; EMBO long-term postdoctoral fellowship; 'Jung-Stiftung'; 'Stiftung Experimentelle Biomedizin'; Deutsche Forschungsgemeinschaft (DFG) [HU 1714/3-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095289] Funding Source: NIH RePORTER	Telethon Foundation 'Comitato Telethon Fondazione Onlus' Core Grant OSR-TIGET project (Rome)(Fondazione Telethon); EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); 'Jung-Stiftung'; 'Stiftung Experimentelle Biomedizin'; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank M. Battaglia (DRI, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute) for helpful scientific discussions and critical revision of the manuscript and we thank L. Passerini (HSR-TIGET, Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute) for providing human CD25<SUP>bright</SUP> T cell samples. This work was supported by Telethon Foundation 'Comitato Telethon Fondazione Onlus' Core Grant OSR-TIGET project E2 (Rome) to S. G. and M.-G.R. N.G. was supported by an EMBO long-term postdoctoral fellowship. S. H. was supported by the 'Jung-Stiftung', 'Stiftung Experimentelle Biomedizin' and the Deutsche Forschungsgemeinschaft (DFG) (HU 1714/3-1). R. A. F. is an investigator of the Howard Hughes Medical Institute.	Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Andreani Marco, 2011, Chimerism, V2, P21, DOI 10.4161/chim.2.1.15057; Andreani M, 2011, HAEMATOL-HEMATOL J, V96, P128, DOI 10.3324/haematol.2010.031013; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2; Bacchetta R, 2010, HAEMATOL-HEMATOL J, V95, P2134, DOI 10.3324/haematol.2010.025825; Bacchetta R, 2009, BLOOD, V114, P24, DOI 10.1182/blood.V114.22.45.45; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Boisvert M, 2010, EUR J IMMUNOL, V40, P2710, DOI 10.1002/eji.201040307; Brown DR, 1996, J EXP MED, V184, P1295, DOI 10.1084/jem.184.4.1295; Brun V, 2009, INT IMMUNOPHARMACOL, V9, P609, DOI 10.1016/j.intimp.2009.01.032; Bruniquel D, 1998, IMMUNOGENETICS, V48, P116, DOI 10.1007/s002510050411; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; de Marquesini LGP, 2010, DIABETOLOGIA, V53, P1451, DOI 10.1007/s00125-010-1739-3; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fowell DJ, 1999, BIOESSAYS, V21, P510, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;510::AID-BIES7&gt;3.0.CO;2-5; Gagliani N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028434; Gregori S, 2011, METHODS MOL BIOL, V677, P31, DOI 10.1007/978-1-60761-869-0_3; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Haringer B, 2009, J EXP MED, V206, P1009, DOI 10.1084/jem.20082238; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Huard B, 1997, P NATL ACAD SCI USA, V94, P5744, DOI 10.1073/pnas.94.11.5744; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kamanaka M, 2011, J EXP MED, V208, P1027, DOI 10.1084/jem.20102149; Kassiotis G, 2006, J IMMUNOL, V177, P968, DOI 10.4049/jimmunol.177.2.968; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Magnani CF, 2011, EUR J IMMUNOL, V41, P1652, DOI 10.1002/eji.201041120; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Pacciani V, 2010, J ALLERGY CLIN IMMUN, V125, P727, DOI 10.1016/j.jaci.2009.12.004; Passerini L, 2011, EUR J IMMUNOL, V41, P1120, DOI 10.1002/eji.201040909; Pot C, 2011, SEMIN IMMUNOL, V23, P202, DOI 10.1016/j.smim.2011.07.005; Rahmoun M, 2006, INT ARCH ALLERGY IMM, V140, P139, DOI 10.1159/000092533; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Roncarolo MG, 2011, IMMUNOL REV, V241, P145, DOI 10.1111/j.1600-065X.2011.01010.x; RONCAROLO MG, 1988, J EXP MED, V167, P1523, DOI 10.1084/jem.167.5.1523; Sanda S, 2008, CLIN IMMUNOL, V127, P138, DOI 10.1016/j.clim.2007.12.003; Serafini G, 2009, HAEMATOL-HEMATOL J, V94, P1415, DOI 10.3324/haematol.2008.003129; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wills-Karp M, 2012, J EXP MED, V209, P607, DOI 10.1084/jem.20110079; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688	55	520	557	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					739	+		10.1038/nm.3179	http://dx.doi.org/10.1038/nm.3179			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23624599				2022-12-27	WOS:000319981600023
J	Nedergaard, J; Cannon, B				Nedergaard, Jan; Cannon, Barbara			How brown is brown fat? It depends where you look	NATURE MEDICINE			English	Editorial Material							ADIPOSE-TISSUE; ADIPOCYTES; DISTINCT; ACTIVATION; CELL		[Nedergaard, Jan; Cannon, Barbara] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University	Nedergaard, J (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	jan@metabol.su.se	Nedergaard, Jan/Q-8286-2019; Nedergaard, Jan/A-1706-2010; Cannon, Barbara/B-3089-2016	Nedergaard, Jan/0000-0003-2070-1587; Cannon, Barbara/0000-0001-6594-2363				Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Lee P, 2011, ENDOCRINOLOGY, V152, P3597, DOI 10.1210/en.2011-1349; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; LIN CS, 1980, FEBS LETT, V113, P299, DOI 10.1016/0014-5793(80)80613-2; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SMITH RE, 1964, SCIENCE, V146, P1686, DOI 10.1126/science.146.3652.1686; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	15	49	49	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					540	541		10.1038/nm.3187	http://dx.doi.org/10.1038/nm.3187			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652104				2022-12-27	WOS:000318583000023
J	van Heijst, JWJ; Ceberio, I; Lipuma, LB; Samilo, DW; Wasilewski, GD; Gonzales, AMR; Nieves, JL; van den Brink, MRM; Perales, MA; Pamer, EG				van Heijst, Jeroen W. J.; Ceberio, Izaskun; Lipuma, Lauren B.; Samilo, Dane W.; Wasilewski, Gloria D.; Gonzales, Anne Marie R.; Nieves, Jimmy L.; van den Brink, Marcel R. M.; Perales, Miguel A.; Pamer, Eric G.			Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation	NATURE MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; IMMUNE RECONSTITUTION; THYMIC FUNCTION; DIVERSITY; MALIGNANCIES; SAMPLES; ADULTS	Delayed T cell recovery and restricted T cell receptor (TCR) diversity after allogeneic hematapoietic stem cell transplantation (allo-HSCT) are associated with increased risks of infection and cancer relapse. Technical challenges have limited faithful measurement of TCR diversity after allo-HSCT. Here we combined 5' rapid amplification of complementary DNA ends PCR with deep sequencing to quantify TCR diversity in 28 recipients of allo-HSCT using a single oligonucleotide pair. Analysis of duplicate blood samples confirmed that we accurately determined the frequency of individual TCRs. After 6 months, cord blood-graft recipients approximated the TCR diversity of healthy individuals, whereas recipients of T cell-depleted peripheral-blood stem cell grafts had 28-fold and 14-fold lower CD4(+) and CD8(+) T cell diversities, respectively. After 12 months, these deficiencies had improved for the CD4(+) but not the CD8(+) T cell compartment. Overall, this method provides unprecedented views of T cell repertoire recovery after allo-HSCT and may identify patients at high risk of infection or relapse.	[van Heijst, Jeroen W. J.; Samilo, Dane W.; van den Brink, Marcel R. M.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; [Ceberio, Izaskun; Wasilewski, Gloria D.; Gonzales, Anne Marie R.; Nieves, Jimmy L.; van den Brink, Marcel R. M.; Perales, Miguel A.] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplantat Serv, New York, NY 10021 USA; [Ceberio, Izaskun] Complejo Hosp Navarra, Pamplona, Spain; [Lipuma, Lauren B.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Mol Microbiol Core Facil, Lucille Castori Ctr, New York, NY 10021 USA; [van den Brink, Marcel R. M.; Perales, Miguel A.; Pamer, Eric G.] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Servicio Navarro de Salud - Osasunbidea; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	van Heijst, JWJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	vanheijj@mskcc.org; pamere@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022	CEBERIO, IZASKUN/0000-0001-8760-2714	Netherlands Organisation for Scientific Research (NWO); Asociacion Espanola Contra el Cancer (AECC); US National Institutes of Health (NIH) [HL069929, CA023766, AI080455, AI100288, AI101406, AI042135, AI039031]; Tow Foundation; US Department of Defense (USAMRAA Award) [W81XWH-09-1-0294]; Radiation Effects Research Foundation (RERF-NIAID); Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; Susan and Peter Solomon Divisional Genomics Program; Translational and Integrative Medicine Research Fund of Memorial Sloan-Kettering Cancer Center; Cycle for Survival; New York Community Trust; When Everyone Survives; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE [R01CA107096, P01CA023766, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100288, R01AI101406, R01AI039031, R01AI080455, R01AI042135, R37AI039031] Funding Source: NIH RePORTER	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Asociacion Espanola Contra el Cancer (AECC); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tow Foundation; US Department of Defense (USAMRAA Award); Radiation Effects Research Foundation (RERF-NIAID); Lymphoma Foundation; Alex's Lemonade Stand; Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center; Susan and Peter Solomon Divisional Genomics Program; Translational and Integrative Medicine Research Fund of Memorial Sloan-Kettering Cancer Center; Cycle for Survival; New York Community Trust; When Everyone Survives; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all patients and healthy donors who volunteered to participate in this study. We thank G. Redelman-Sidi for collection of blood samples, I. Leiner for processing of blood samples, C. Ubeda-Morant for assistance with data analysis, J. Li and A. Viale of the Memorial Sloan-Kettering Cancer Center Genomics Core Laboratory for performing Roche/454 sequencing and R. Jenq for critical reading of the manuscript. This work was supported by the Netherlands Organisation for Scientific Research (NWO) (Rubicon fellowship to J.W.J.v.H.), the Asociacion Espanola Contra el Cancer (AECC) (PAO grant to I.C.), the US National Institutes of Health (NIH) (grants HL069929, CA023766, AI080455, AI100288 and AI101406 to M.R.M.v.d.B. and AI042135, AI039031 and CA023766 to E.G.P.) and The Tow Foundation (to E.G.P.). Additional support was received from the US Department of Defense (USAMRAA Award W81XWH-09-1-0294), the Radiation Effects Research Foundation (RERF-NIAID), The Lymphoma Foundation, Alex's Lemonade Stand, The Geoffrey Beene Cancer Research Center at Memorial Sloan-Kettering Cancer Center and The Susan and Peter Solomon Divisional Genomics Program (to M.R.M.v.d.B.), The Translational and Integrative Medicine Research Fund of Memorial Sloan-Kettering Cancer Center, Cycle for Survival, The New York Community Trust and When Everyone Survives (to M.A.P.) and The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by W.H. Goodwin and A. Goodwin (to M.R.M.v.d.B. and M.A.P.).	Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Deeg HJ, 1998, BLOOD, V91, P1833, DOI 10.1182/blood.V91.6.1833.1833_1833_1844; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Dumont-Girard F, 1998, BLOOD, V92, P4464, DOI 10.1182/blood.V92.11.4464.423k32_4464_4471; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Goldberg GL, 2007, SEMIN IMMUNOL, V19, P289, DOI 10.1016/j.smim.2007.08.001; GORSKI J, 1994, J IMMUNOL, V152, P5109; Jacobson CA, 2012, BIOL BLOOD MARROW TR, V18, P565, DOI 10.1016/j.bbmt.2011.08.018; Jakubowski AA, 2007, BLOOD, V110, P4552, DOI 10.1182/blood-2007-06-093880; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Langerak AW, 2001, BLOOD, V98, P165, DOI 10.1182/blood.V98.1.165; Lim A, 2000, J IMMUNOL, V165, P2001, DOI 10.4049/jimmunol.165.4.2001; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Maury S, 2001, BRIT J HAEMATOL, V115, P630, DOI 10.1046/j.1365-2141.2001.03135.x; Memon SA, 2012, J IMMUNOL METHODS, V375, P84, DOI 10.1016/j.jim.2011.09.012; Nguyen Phuong, 2011, BMC Genomics, V12, P106, DOI 10.1186/1471-2164-12-106; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Ponce DM, 2011, BIOL BLOOD MARROW TR, V17, P1316, DOI 10.1016/j.bbmt.2011.01.006; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Roux E, 2000, BLOOD, V96, P2299; Sauter C, 2011, BIOL BLOOD MARROW TR, V17, P1460, DOI 10.1016/j.bbmt.2011.02.001; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Seggewiss R, 2010, BLOOD, V115, P3861, DOI 10.1182/blood-2009-12-234096; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Small TN, 1999, BLOOD, V93, P467, DOI 10.1182/blood.V93.2.467.402k22_467_480; Storek J, 2008, SEMIN IMMUNOPATHOL, V30, P425, DOI 10.1007/s00281-008-0132-5; Talvensarri K, 2002, BLOOD, V99, P1458, DOI 10.1182/blood.V99.4.1458; Venturi V, 2007, J IMMUNOL METHODS, V321, P182, DOI 10.1016/j.jim.2007.01.019; Venturi V, 2011, J IMMUNOL, V186, P4285, DOI 10.4049/jimmunol.1003898; Verfuerth S, 2000, BLOOD, V95, P3990; Wang CL, 2010, P NATL ACAD SCI USA, V107, P1518, DOI 10.1073/pnas.0913939107; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Weinberg K, 2001, BLOOD, V97, P1458, DOI 10.1182/blood.V97.5.1458; Wu CJ, 2000, BLOOD, V95, P352	34	134	148	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					372	377		10.1038/nm.3100	http://dx.doi.org/10.1038/nm.3100			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23435170	Green Accepted			2022-12-27	WOS:000316040700033
J	LeBleu, VS; Teng, YQ; O'Connell, JT; Charytan, D; Muller, GA; Muller, CA; Sugimoto, H; Kalluri, R				LeBleu, Valerie S.; Teng, Yingqi; O'Connell, Joyce T.; Charytan, David; Mueller, Gerhard A.; Mueller, Claudia A.; Sugimoto, Hikaru; Kalluri, Raghu			Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis	NATURE MEDICINE			English	Article							RENAL INTERSTITIAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; HE-4; INHIBITORS; MECHANISMS; EXPRESSION; HOMOLOGY; TISSUES; ORIGIN; LOCUS	The functional contribution of myofibroblasts in fibrosis is not well understood(1-3). Using a new genetic mouse model to track and isolate myofibroblasts, we performed gene expression profiling followed by biological validation to identify HE4 (encoding human epididymis protein 4, also known as WAP 4-disulfide core domain-2 or Wfdc2) as the most upregulated gene in fibrosis-associated myofibroblasts. The HE4 gene encodes for a putative serine protease inhibitor that is upregulated in human and mouse fibrotic kidneys and is elevated in the serum of patients with kidney fibrosis. HE4 suppresses the activity of multiple proteases, including serine proteases and matrix metalloproteinases, and specifically inhibits their capacity to degrade type I collagen. In particular, we identified two serine proteases, Prss35 and Prss23, as HE4 targets with functional relevance in kidney fibrosis. Administration of HE4-neutralizing antibodies accelerated collagen I degradation and inhibited fibrosis in three different mouse models of renal disease. Collectively these studies suggest that HE4 is a potential biomarker of renal fibrosis and a new therapeutic target.	[LeBleu, Valerie S.; Teng, Yingqi; O'Connell, Joyce T.; Sugimoto, Hikaru; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Charytan, David] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Mueller, Gerhard A.; Mueller, Claudia A.] Univ Gottingen, Med Ctr, Dept Nephrol & Rheumatol, D-37073 Gottingen, Germany; [Kalluri, Raghu] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kalluri, Raghu] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Boston, MA USA; [Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; University of Gottingen; Harvard University; Harvard Medical School; Harvard University; University of Texas System; UTMD Anderson Cancer Center	Kalluri, R (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA.	rkalluri@mdanderson.org	LeBleu, Valerie/E-2991-2015; Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; charytan, david/0000-0002-7695-3583	US National Institutes of Health (NIH) [DK55001, DK081976, CA125550, CA155370, CA151925, CA163191, 2T32DK007760-11, 5T32HL007374-30, GM07226]; Harvard Stem Cell Institute; Metastasis Research Center at the MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Department of Defense [BC083229]; NATIONAL CANCER INSTITUTE [R01CA155370, U01CA151925, R01CA125550, U54CA163191] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055001, T32DK007760, R01DK081576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007226] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Metastasis Research Center at the MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by US National Institutes of Health (NIH) grants DK55001, DK081976, CA125550, CA155370, CA151925 and CA163191, funding from the Harvard Stem Cell Institute, the Metastasis Research Center at the MD Anderson Cancer Center and the Cancer Prevention and Research Institute of Texas (all to R.K.). V.S.L. was funded from the NIH Research Training grant in Gastroenterology (2T32DK007760-11), H.S. was funded by the NIH Research Training grant in Cardiovascular Biology (5T32HL007374-30), and J.T.O. was funded by the NIH Cell and Development Biology Training grant GM07226 and the Department of Defense Breast Cancer Predoctoral Traineeship Award BC083229.	Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bignotti E, 2011, BRIT J CANCER, V104, P1418, DOI 10.1038/bjc.2011.109; Bingle L, 2002, ONCOGENE, V21, P2768, DOI 10.1038/sj.onc.1205363; Bingle L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-61; Bunnag S, 2009, J AM SOC NEPHROL, V20, P1149, DOI 10.1681/ASN.2008080863; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Clauss A, 2005, BIOCHEM BIOPH RES CO, V333, P383, DOI 10.1016/j.bbrc.2005.05.125; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Galgano MT, 2006, MODERN PATHOL, V19, P847, DOI 10.1038/modpathol.3800612; Greer KA, 2006, MAMM GENOME, V17, P976, DOI 10.1007/s00335-005-0179-8; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Kirchhoff C, 1998, REV REPROD, V3, P86; KIRCHHOFF C, 1991, BIOL REPROD, V45, P350, DOI 10.1095/biolreprod45.2.350; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Okada H, 1996, CONTRIB NEPHROL, V118, P147; Sivashanmugam P, 2003, GENE, V312, P125, DOI 10.1016/S0378-1119(03)00608-5; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Zeisberg M, 2000, J NEPHROL, V13, pS111; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB	26	131	142	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					227	231		10.1038/nm.2989	http://dx.doi.org/10.1038/nm.2989			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23353556	Green Accepted			2022-12-27	WOS:000314675900031
J	Kim, KH; Jeong, YT; Oh, H; Kim, SH; Cho, JM; Kim, YN; Kim, SS; Kim, DH; Hur, KY; Kim, HK; Ko, T; Han, J; Kim, HL; Kim, J; Back, SH; Komatsu, M; Chen, HC; Chan, DC; Konishi, M; Itoh, N; Choi, CS; Lee, MS				Kim, Kook Hwan; Jeong, Yeon Taek; Oh, Hyunhee; Kim, Seong Hun; Cho, Jae Min; Kim, Yo-Na; Kim, Su Sung; Kim, Do Hoon; Hur, Kyu Yeon; Kim, Hyoung Kyu; Ko, TaeHee; Han, Jin; Kim, Hong Lim; Kim, Jin; Back, Sung Hoon; Komatsu, Masaaki; Chen, Hsiuchen; Chan, David C.; Konishi, Morichika; Itoh, Nobuyuki; Choi, Cheol Soo; Lee, Myung-Shik			Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine	NATURE MEDICINE			English	Article							GROWTH-FACTOR 21; INTEGRATED STRESS-RESPONSE; INDUCED HEPATIC STEATOSIS; BETA-CELL MASS; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL DYSFUNCTION; ACID-METABOLISM; KNOCKOUT MICE; FATTY-ACIDS	Despite growing interest and a recent surge in papers, the role of autophagy in glucose and lipid metabolism is unclear. We produced mice with skeletal muscle specific deletion of Atg7 (encoding autophagy-related 7). Unexpectedly, these mice showed decreased fat mass and were protected from diet-induced obesity and insulin resistance; this phenotype was accompanied by increased fatty acid oxidation and browning of white adipose tissue (WAT) owing to induction of fibroblast growth factor 21 (Fgf21). Mitochondrial dysfunction induced by autophagy deficiency increased Fgf21 expression through induction of Atf4, a master regulator of the integrated stress response. Mitochondrial respiratory chain inhibitors also induced Fgf21 in an Atf4-dependent manner. We also observed induction of Fgf21, resistance to diet-induced obesity and amelioration of insulin resistance in mice with autophagy deficiency in the liver, another insulin target tissue. These findings suggest that autophagy deficiency and subsequent mitochondrial dysfunction promote Fgf21 expression, a hormone we consequently term a 'mitokine', and together these processes promote protection from diet-induced obesity and insulin resistance.	[Kim, Kook Hwan; Jeong, Yeon Taek; Cho, Jae Min; Kim, Do Hoon; Hur, Kyu Yeon; Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kim, Kook Hwan; Kim, Seong Hun; Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Oh, Hyunhee; Kim, Yo-Na; Kim, Su Sung; Choi, Cheol Soo] Gachon Univ, Grad Sch Med, Korea Mouse Metab Phenotyping Ctr, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Kim, Hyoung Kyu; Ko, TaeHee; Han, Jin] Inje Univ, FIRST Mitochondrial Res Grp, Natl Res Lab Mitochondrial Signaling, Dept Physiol,Coll Med,Cardiovasc & Metab Dis Ctr, Pusan, South Korea; [Kim, Hong Lim] Catholic Univ Korea, Coll Med, Integrat Res Support Ctr, Seoul, South Korea; [Kim, Jin] Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Jin] Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Seoul, South Korea; [Back, Sung Hoon] Univ Ulsan, Sch Biol Sci, Ulsan 680749, South Korea; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Tokyo 113, Japan; [Chen, Hsiuchen; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo 658, Japan; [Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genet Biochem, Kyoto, Japan; [Choi, Cheol Soo] Gachon Univ, Grad Sch Med, Gil Med Ctr, Dept Internal Med, Inchon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Gachon University; Inje University; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of Ulsan; Tokyo Metropolitan Institute of Medical Science; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Kobe Pharmaceutical University; Kyoto University; Gachon University	Choi, CS (corresponding author), Gachon Univ, Grad Sch Med, Korea Mouse Metab Phenotyping Ctr, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea.	cschoi@gachon.ac.kr; mslee0923@skku.edu	Komatsu, Masaaki/B-8321-2011; Lee, Myung Shik/C-9606-2011	Komatsu, Masaaki/0000-0001-7672-7722; Kim, Kook Hwan/0000-0003-2702-9156; Kim, Hyoung Kyu/0000-0002-1791-7865	Global Research Laboratory Grant of the National Research Foundation of Korea [K21004000003-10A0500-00310]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea [A080967, A102060]; Bio RD Program [2008-04090]; Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea [20110019335]	Global Research Laboratory Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea; Bio RD Program; Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea	We thank S.R. Farmer (Boston University) for pGL3B-Fgf21 (-1370/+129), D. Ron (University of Cambridge) for Atf4-null MEFs, R.J. Kaufman (University of Michigan Medical Center) for Eif2a<SUP>S/S</SUP> and Eif2a<SUP>A/A</SUP> MEFs, S.J. Burden (New York University) for Mlc1f-Cre mice, N. Mizushima (Tokyo Medical and Dental University) for Tet-off Atg5-null MEFs, and H.W. Virgin for insightful comments on the manuscript. This study was supported by the Global Research Laboratory Grant of the National Research Foundation of Korea (K21004000003-10A0500-00310 to M.-S.L. and M. Komatsu) and the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Korea (A080967 to M.-S.L. and A102060 to C.S.C). M.-S.L. received the Bio R&D Program (2008-04090) and the Bio & Medical Technology Development Program grant from the Ministry of Education, Science & Technology, Korea (20110019335).	BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; DANFORTH E, 1984, CLIN ENDOCRINOL META, V13, P581, DOI 10.1016/S0300-595X(84)80039-0; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1226, DOI 10.1167/iovs.10-5775; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Shibata M, 2009, BIOCHEM BIOPH RES CO, V382, P419, DOI 10.1016/j.bbrc.2009.03.039; Silva JM, 2009, NEUROBIOL DIS, V34, P357, DOI 10.1016/j.nbd.2009.02.005; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7; Tschop M., 2001, NAT METHODS, V9, P57; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	57	559	580	7	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					83	92		10.1038/nm.3014	http://dx.doi.org/10.1038/nm.3014			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23202295				2022-12-27	WOS:000313230300029
J	[Anonymous]				[Anonymous]			Unlocking the mysterious mechanisms of Myc	NATURE MEDICINE			English	Editorial Material							C-MYC; CELLS; P15(INK4B); EXPRESSION; TARGET; MIZ-1; GENE							Dang, Chi/0000-0002-4031-2522				Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Haggerty TJ, 2003, P NATL ACAD SCI USA, V100, P5313, DOI 10.1073/pnas.0931346100; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Sloan Elizabeth J, 2010, Genes Cancer, V1, P587, DOI 10.1177/1947601910377489; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710	15	10	10	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2013	19	1					26	26						1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	066OO	23296005				2022-12-27	WOS:000313230300016
J	Galban, CJ; Han, MLK; Boes, JL; Chughtai, KA; Meyer, CR; Johnson, TD; Galban, S; Rehemtulla, A; Kazerooni, EA; Martinez, FJ; Ross, BD				Galban, Craig J.; Han, Meilan K.; Boes, Jennifer L.; Chughtai, Komal A.; Meyer, Charles R.; Johnson, Timothy D.; Galban, Stefanie; Rehemtulla, Alnawaz; Kazerooni, Ella A.; Martinez, Fernando J.; Ross, Brian D.			Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression	NATURE MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FUNCTIONAL DIFFUSION MAP; PARAMETRIC RESPONSE MAP; QUANTITATIVE ASSESSMENT; IMAGE REGISTRATION; AIRWAY-OBSTRUCTION; CANCER-TREATMENT; FUNCTION TESTS; LUNG-FUNCTION; EMPHYSEMA	Chronic obstructive pulmonary disease (COPD) is increasingly being recognized as a highly heterogeneous disorder, composed of varying pathobiology. Accurate detection of COPD subtypes by image biomarkers is urgently needed to enable individualized treatment, thus improving patient outcome. We adapted the parametric response map (PRM), a voxel-wise image analysis technique, for assessing COPD phenotype. We analyzed whole-lung computed tomography (CT) scans acquired at inspiration and expiration of 194 individuals with COPD from the COPDGene study. PRM identified the extent of functional small airways disease (fSAD) and emphysema as well as provided CT-based evidence that supports the concept that fSAD precedes emphysema with increasing COPD severity. PRM is a versatile imaging biomarker capable of diagnosing disease extent and phenotype while providing detailed spatial information of disease distribution and location. PRM's ability to differentiate between specific COPD phenotypes will allow for more accurate diagnosis of individual patients, complementing standard clinical techniques.	[Galban, Craig J.; Boes, Jennifer L.; Chughtai, Komal A.; Meyer, Charles R.; Kazerooni, Ella A.; Ross, Brian D.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Galban, Craig J.; Boes, Jennifer L.; Chughtai, Komal A.; Meyer, Charles R.; Galban, Stefanie; Rehemtulla, Alnawaz; Ross, Brian D.] Univ Michigan, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Han, Meilan K.; Martinez, Fernando J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Johnson, Timothy D.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Galban, Stefanie; Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ross, BD (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	bdross@umich.edu			US National Institutes of Health [P50CA93990, T32EB005172]; COPDGene [U01HL089897, U01HL089856]; NATIONAL CANCER INSTITUTE [P50CA093990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856, U01HL089897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005172] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPDGene; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We would like to acknowledge S. Sarkar, M. Bule and S. A. Blanks for their indispensable contribution in processing the CT data sets. We would also like to acknowledge D. A. Lynch and the COPDGene investigators for providing the CT scans from National Jewish Health and recruiting the subjects included in this analysis. This work was supported by the US National Institutes of Health research grant P50CA93990 and COPDGene grants U01HL089897 and U01HL089856. J.L.B. is a recipient of support from the US National Institutes of Health training grant T32EB005172.	Agusti A, 2011, AM J RESP CRIT CARE, V184, P507, DOI 10.1164/rccm.201103-0405PP; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Eda S, 1997, AM J RESP CRIT CARE, V155, P1290, DOI 10.1164/ajrccm.155.4.9105069; Galban CJ, 2009, TRANSL ONCOL, V2, P184, DOI 10.1593/tlo.09175; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Gorbunova V, 2010, LECT NOTES COMPUT SC, V6362, P193; Gorbunova V, 2008, LECT NOTES COMPUT SC, V5242, P863, DOI 10.1007/978-3-540-85990-1_104; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Kohansal R, 2009, CHEST, V135, P1330, DOI 10.1378/chest.08-1750; Kubo K, 1999, EUR RESPIR J, V13, P252, DOI 10.1034/j.1399-3003.1999.13b06.x; Li BJ, 2008, MED PHYS, V35, P5575, DOI 10.1118/1.3005633; Ma B, 2009, LECT NOTES COMPUT SC, V5636, P276; Martinez FJ, 2011, LANCET, V378, P1027, DOI 10.1016/S0140-6736(11)61047-7; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Matsuoka S, 2007, J COMPUT ASSIST TOMO, V31, P384, DOI 10.1097/01.rct.0000243457.00437.10; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Meyer C R, 1997, Med Image Anal, V1, P195, DOI 10.1016/S1361-8415(97)85010-4; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; Oga Toru, 2010, Allergol Int, V59, P257, DOI 10.2332/allergolint.10-RA-0184; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Reinhardt JM, 2008, MED IMAGE ANAL, V12, P752, DOI 10.1016/j.media.2008.03.007; Reischauer C, 2010, RADIOLOGY, V257, P523, DOI 10.1148/radiol.10092469; Yamamoto T, 2011, PHYS MED BIOL, V56, P2279, DOI 10.1088/0031-9155/56/7/023	29	461	482	7	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1711	+		10.1038/nm.2971	http://dx.doi.org/10.1038/nm.2971			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23042237	Green Accepted			2022-12-27	WOS:000310837000034
J	Bal, NC; Maurya, SK; Sopariwala, DH; Sahoo, SK; Gupta, SC; Shaikh, SA; Pant, M; Rowland, LA; Goonasekera, SA; Molkentin, JD; Periasamy, M				Bal, Naresh C.; Maurya, Santosh K.; Sopariwala, Danesh H.; Sahoo, Sanjaya K.; Gupta, Subash C.; Shaikh, Sana A.; Pant, Meghna; Rowland, Leslie A.; Goonasekera, Sanjeewa A.; Molkentin, Jeffery D.; Periasamy, Muthu			Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; RETICULUM CALCIUM-TRANSPORT; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; HEAT-PRODUCTION; CA2+-ATPASE ISOFORMS; UNCOUPLING PROTEIN; MICE; CA2+; OVEREXPRESSION	The role of skeletal muscle in nonshivering thermogenesis (NST) is not well understood. Here we show that sarcolipin (Sln), a newly identified regulator of the sarco/endoplasmic reticulum Ca2+-ATPase (Serca) pump(1-5), is necessary for muscle-based thermogenesis. When challenged to acute cold (4 degrees C), Sln(-/-) mice were not able to maintain their core body temperature (37 degrees C) and developed hypothermia. Surgical ablation of brown adipose tissue and functional knockdown of Ucp1 allowed us to highlight the role of muscle in NST. Overexpression of Sln in the Sln-null background fully restored muscle-based thermogenesis, suggesting that Sln is the basis for Serca-mediated heat production. We show that ryanodine receptor 1 (Ryr1)-mediated Ca2+ leak is an important mechanism for Serca-activated heat generation. Here we present data to suggest that Sln can continue to interact with Serca in the presence of Ca2+, which can promote uncoupling of the Serca pump and cause futile cycling. We further show that loss of Sln predisposes mice to diet-induced obesity, which suggests that Sln-mediated NST is recruited during metabolic overload. These data collectively suggest that SLN is an important mediator of muscle thermogenesis and whole-body energy metabolism.	[Bal, Naresh C.; Maurya, Santosh K.; Sopariwala, Danesh H.; Sahoo, Sanjaya K.; Gupta, Subash C.; Shaikh, Sana A.; Pant, Meghna; Rowland, Leslie A.; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Goonasekera, Sanjeewa A.; Molkentin, Jeffery D.] Cincinnati Childrens Hosp Med Ctr, Howard Hughes Med Inst, Cincinnati, OH USA; [Periasamy, Muthu] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; Howard Hughes Medical Institute; University System of Ohio; Ohio State University	Periasamy, M (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	periasamy.1@osu.edu	Bal, Naresh/E-9377-2011; Maurya, Santosh/O-9066-2017; Gupta, Subash/AAF-2563-2019	Maurya, Santosh/0000-0002-7610-2463; Gupta, Subash/0000-0002-0418-1940; Periasamy, Muthu/0000-0001-8834-5975; Molkentin, Jeffery/0000-0002-3558-6529; Tupling, A. Russell/0000-0002-3895-6767	US National Institutes of Health [R01 (HL080551)]; American Physiological Society; American Heart Association [10POST3360007]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Physiological Society; American Heart Association(American Heart Association)	This work was supported in part by US National Institutes of Health grant R01 (HL080551) to M. Periasamy. N.C.B. was supported by a postdoctoral fellowship from the American Physiological Society and the American Heart Association (10POST3360007). We thank P. Mohler, J.A. Rafael-Fortney and J.E. Ostler, for comments on the manuscript. We thank N. Manivannan and K. Powell (Ohio State University Medical Center, Davis Heart and Lung Research Institute, Small Animal Imaging Facility, Columbus, Ohio, USA) for MRI of mice.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Arruda AP, 2008, ENDOCRINOLOGY, V149, P6262, DOI 10.1210/en.2008-0564; Asahi M, 2004, P NATL ACAD SCI USA, V101, P9199, DOI 10.1073/pnas.0402596101; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Babu GJ, 2006, J BIOL CHEM, V281, P3972, DOI 10.1074/jbc.M508998200; Babu GJ, 2005, CARDIOVASC RES, V65, P177, DOI 10.1016/j.cardiores.2004.08.012; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Babu GJ, 2007, J MOL CELL CARDIOL, V43, P215, DOI 10.1016/j.yjmcc.2007.05.009; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; Bicudo JEPW, 2001, BIOSCIENCE REP, V21, P181, DOI 10.1023/A:1013648208428; BLOCK BA, 1994, J CELL BIOL, V127, P1275, DOI 10.1083/jcb.127.5.1275; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; BLOCK BA, 1988, J CELL BIOL, V107, P1099, DOI 10.1083/jcb.107.3.1099; Bowman WC, 2006, BRIT J PHARMACOL, V147, pS277, DOI 10.1038/sj.bjp.0706404; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Cannon B, 2010, INT J OBESITY, V34, pS7, DOI 10.1038/ijo.2010.177; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; de Meis L, 2005, BIOSCIENCE REP, V25, P181, DOI 10.1007/s10540-005-2884-7; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; da Costa DCF, 2009, AM J PHYSIOL-REG I, V297, pR1460, DOI 10.1152/ajpregu.90993.2008; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; KASHIMURA O, 1992, AVIAT SPACE ENVIR MD, V63, P1082; Kjelstrup S, 2008, EUR BIOPHYS J BIOPHY, V38, P59, DOI 10.1007/s00249-008-0358-0; Kjelstrup S, 2009, BIOPHYS J, V96, P4376, DOI 10.1016/j.bpj.2009.02.070; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Mall S, 2006, J BIOL CHEM, V281, P36597, DOI 10.1074/jbc.M606869200; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Morrissette JM, 2003, J EXP BIOL, V206, P805, DOI 10.1242/jeb.00158; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; Silva J Enrique, 2011, Front Biosci (Schol Ed), V3, P352, DOI 10.2741/s156; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Tupling AR, 2011, AM J PHYSIOL-CELL PH, V301, pC841, DOI 10.1152/ajpcell.00409.2010; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316	38	353	362	3	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1575	U183		10.1038/nm.2897	http://dx.doi.org/10.1038/nm.2897			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22961106	Green Accepted			2022-12-27	WOS:000309587500037
J	Vale, RD				Vale, Ronald D.			How lucky can one be? A perspective from a young scientist at the right place at the right time	NATURE MEDICINE			English	Editorial Material							SQUID GIANT-AXON; MOVEMENT; TRANSPORT; AXOPLASM; MICROTUBULES; ORGANELLES; PROTEIN; INVITRO		[Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	vale@cmp.ucsf.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ALLEN RD, 1982, SCIENCE, V218, P1127, DOI 10.1126/science.6183744; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; SHEETZ MP, 1983, NATURE, V303, P31, DOI 10.1038/303031a0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALE RD, 1985, CELL, V43, P623, DOI 10.1016/0092-8674(85)90234-X; VALE RD, 1985, CELL, V40, P559, DOI 10.1016/0092-8674(85)90204-1; VALE RD, 1985, CELL, V40, P449, DOI 10.1016/0092-8674(85)90159-X	10	1	1	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1486	1488		10.1038/nm.2925	http://dx.doi.org/10.1038/nm.2925			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042358	Green Published			2022-12-27	WOS:000309587500023
J	Hersher, R				Hersher, Rebecca			Nurses on trial	NATURE MEDICINE			English	News Item											Hersher, R (corresponding author), Natl Publ Radio, Washington, DC USA.							Kaitin K., 2007, TUFTS CSDD IMPACT RE, V9, P1; Mitchell PH, 2009, STROKE, V40, P3073, DOI 10.1161/STROKEAHA.109.549808; Shalala DE, 2011, FUTURE OF NURSING: LEADING CHANGE, ADVANCING HEALTH, pXI	3	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1165	1167		10.1038/nm0812-1165	http://dx.doi.org/10.1038/nm0812-1165			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869176				2022-12-27	WOS:000307469300010
J	Breakefield, XO				Breakefield, Xandra O.			Refocus the Recombinant DNA Advisory Committee	NATURE MEDICINE			English	Editorial Material								The Recombinant DnA Advisory committee, formed in 1974, was originally charged with advising on potential risks of recombinant technology and took on review of clinical gene therapy protocols in the late 1980s. But as gene therapy has made headway with safety, it's time to shift the committee's mission toward broader ethical and technical issues linked to the field.	[Breakefield, Xandra O.] Amer Soc Gene & Cell Therapy, Boston, MA USA; [Breakefield, Xandra O.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Breakefield, XO (corresponding author), Amer Soc Gene & Cell Therapy, Boston, MA USA.								0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1007	1007		10.1038/nm0712-1007	http://dx.doi.org/10.1038/nm0712-1007			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772546	Bronze			2022-12-27	WOS:000306121600019
J	Holt, PG; Sly, PD				Holt, Patrick G.; Sly, Peter D.			Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment	NATURE MEDICINE			English	Review							FC-EPSILON-RI; RESPIRATORY SYNCYTIAL VIRUS; PLASMACYTOID DENDRITIC CELLS; HOUSE-DUST-MITE; INNATE IMMUNE-RESPONSE; MEMORY T-CELLS; LUNG-FUNCTION; BONE-MARROW; CHILDHOOD ASTHMA; ALLERGIC SENSITIZATION	Prospective birth cohort studies tracking asthma initiation and consolidation in community cohorts have identified viral infections occurring against a background of allergic sensitization to aeroallergens as a uniquely potent risk factor for the expression of acute severe asthma-like symptoms and for the ensuing development of asthma that can persist through childhood and into adulthood. A combination of recent experimental and human studies have suggested that underlying this bipartite process are a series of interactions between antiviral and atopic inflammatory pathways that are mediated by local activation of myeloid cell populations in the airway mucosa and the parallel programming and recruitment of their replacements from bone marrow. Targeting key components of these pathways at the appropriate stages of asthma provides new opportunities for the treatment of established asthma but, more crucially, for primary and secondary prevention of asthma during childhood.	[Holt, Patrick G.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Sly, Peter D.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia	Telethon Kids Institute; University of Western Australia; University of Queensland	Holt, PG (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	patrick@ichr.uwa.edu.au	Sly, Peter D/F-1486-2010; Holt, Patrick/H-1548-2011	Sly, Peter D/0000-0001-6305-2201; Holt, Patrick/0000-0003-1193-0935				Al-Garawi A, 2012, J IMMUNOL, V188, P832, DOI 10.4049/jimmunol.1102349; ALBLAS ABV, 1981, J EXP MED, V154, P235, DOI 10.1084/jem.154.2.235; Beyer M, 2004, J ALLERGY CLIN IMMUN, V113, P127, DOI 10.1016/j.jaci.2003.10.057; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Bosco A, 2010, MUCOSAL IMMUNOL, V3, P399, DOI 10.1038/mi.2010.13; Buhl R, 2002, EUR RESPIR J, V20, P73, DOI 10.1183/09031936.02.00278102; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; BUSSE WW, 1989, CLIN EXP ALLERGY, V19, P1, DOI 10.1111/j.1365-2222.1989.tb02336.x; Cavanagh LL, 2005, NAT IMMUNOL, V6, P1029, DOI 10.1038/ni1249; Cheung DS, 2010, J IMMUNOL, V185, P4983, DOI 10.4049/jimmunol.1002456; Choy DF, 2011, J IMMUNOL, V186, P1861, DOI 10.4049/jimmunol.1002568; Collet JP, 1997, AM J RESP CRIT CARE, V156, P1719, DOI 10.1164/ajrccm.156.6.9612096; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; de Vrese M, 2006, VACCINE, V24, P6670, DOI 10.1016/j.vaccine.2006.05.048; Demehri S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000067; Di Rosa F, 2005, TRENDS IMMUNOL, V26, P360, DOI 10.1016/j.it.2005.04.011; Durham SR, 2008, CURR OPIN ALLERGY CL, V8, P577, DOI 10.1097/ACI.0b013e3283196764; Gao LL, 2010, VACCINE, V28, P4445, DOI 10.1016/j.vaccine.2010.03.062; Gauvreau Gail M, 2005, Expert Rev Clin Immunol, V1, P87, DOI 10.1586/1744666X.1.1.87; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grayson MH, 2007, J EXP MED, V204, P2759, DOI 10.1084/jem.20070360; Hales BJ, 2008, THORAX, V63, P221, DOI 10.1136/thx.2006.069492; Hales BJ, 2006, J ALLERGY CLIN IMMUN, V118, P361, DOI 10.1016/j.jaci.2006.04.001; Hales BJ, 2012, THORAX, V67, P321, DOI 10.1136/thoraxjnl-2011-200650; Hermesh T, 2010, CELL HOST MICROBE, V7, P343, DOI 10.1016/j.chom.2010.04.006; HIBBERT ME, 1990, PEDIATR PULM, V8, P172, DOI 10.1002/ppul.1950080308; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Hollams EM, 2010, EUR RESPIR J, V36, P509, DOI 10.1183/09031936.00184109; Hollams EM, 2009, J ALLERGY CLIN IMMUN, V124, P463, DOI 10.1016/j.jaci.2009.06.019; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Holt PG, 2010, J ALLERGY CLIN IMMUN, V125, P653, DOI 10.1016/j.jaci.2009.12.018; HOPPER JL, 1991, J APPL PHYSIOL, V70, P770, DOI 10.1152/jappl.1991.70.2.770; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, pAB116, DOI 10.1016/j.jaci.2009.12.457; Jackson DJ, 2012, AM J RESP CRIT CARE, V185, P281, DOI 10.1164/rccm.201104-0660OC; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Johnston Sebastian L, 2007, Proc Am Thorac Soc, V4, P267, DOI 10.1513/pats.200701-030AW; Ker J, 2009, ANN ALLERG ASTHMA IM, V103, P282, DOI 10.1016/S1081-1206(10)60526-1; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Klemets P, 2010, THORAX, V65, P698, DOI 10.1136/thx.2009.132670; Koraka P, 2003, J MED VIROL, V70, P91, DOI 10.1002/jmv.10358; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Larsen GL, 1999, J PEDIATR-US, V135, pS21; Lloyd CM, 2010, NAT MED, V16, P273, DOI 10.1038/nm0310-273; Martinez Fernando D, 2005, Proc Am Thorac Soc, V2, P157, DOI 10.1513/pats.200504-044AW; Martinez FD, 2007, J ALLERGY CLIN IMMUN, V119, P30, DOI 10.1016/j.jaci.2006.10.020; Maurer D, 1996, J IMMUNOL, V157, P607; McWilliam AS, 1997, J VIROL, V71, P226, DOI 10.1128/JVI.71.1.226-236.1997; Miller EK, 2012, AM J RESP CRIT CARE, V185, P508, DOI 10.1164/rccm.201108-1462OC; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Navarro S, 2011, MUCOSAL IMMUNOL, V4, P53, DOI 10.1038/mi.2010.51; NELSON DJ, 1995, AM J RESP CRIT CARE, V151, P475, DOI 10.1164/ajrccm.151.2.7842209; Novak N, 2003, J CLIN INVEST, V111, P1047, DOI 10.1172/JCI200315932; Novak N, 2003, J ALLERGY CLIN IMMUN, V111, P38, DOI 10.1067/mai.2003.2; O'Byrne PM, 2009, AM J RESP CRIT CARE, V179, P19, DOI 10.1164/rccm.200807-1126OC; Oddy WH, 2002, EUR RESPIR J, V19, P899, DOI 10.1183/09031936.02.00103602; Olenec JP, 2010, J ALLERGY CLIN IMMUN, V125, P1001, DOI 10.1016/j.jaci.2010.01.059; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Razi CH, 2010, J ALLERGY CLIN IMMUN, V126, P763, DOI 10.1016/j.jaci.2010.07.038; Robays LJ, 2007, J IMMUNOL, V178, P5305, DOI 10.4049/jimmunol.178.8.5305; Schaad UB, 2002, CHEST, V122, P2042, DOI 10.1378/chest.122.6.2042; Semper AE, 2003, J ALLERGY CLIN IMMUN, V112, P411, DOI 10.1067/mai.2003.1626; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Sherrill DL, 2005, RESP MED, V99, P1377, DOI 10.1016/j.rmed.2005.03.025; Sihra BS, 1997, J ALLERGY CLIN IMMUN, V99, P699, DOI 10.1016/S0091-6749(97)70033-2; Simoes EAF, 2007, J PEDIATR-US, V151, P34, DOI 10.1016/j.jpeds.2007.02.032; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sly PD, 2008, ANN NY ACAD SCI, V1140, P163, DOI 10.1196/annals.1454.017; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Soto-Martinez Manuel, 2010, Chron Respir Dis, V7, P173, DOI 10.1177/1479972309345929; Stein RT, 2010, THORAX, V65, P1033, DOI 10.1136/thx.2009.133967; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Strickland DH, 2011, MUCOSAL IMMUNOL, V4, P43, DOI 10.1038/mi.2010.43; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Tandon MK, 2010, CHEST, V137, P805, DOI 10.1378/chest.09-1382; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weber KSC, 2001, EUR J IMMUNOL, V31, P2458, DOI 10.1002/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wood LJ, 2002, AM J RESP CRIT CARE, V166, P883, DOI 10.1164/rccm.2108015; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106	94	191	194	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					726	735		10.1038/nm.2768	http://dx.doi.org/10.1038/nm.2768			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561836				2022-12-27	WOS:000303763500040
J	Lokken, KL; Tsolis, RM; Baumler, AJ				Lokken, Kristen L.; Tsolis, Renee M.; Baeumler, Andreas J.			Hypoferremia of infection: a double-edged sword?	NATURE MEDICINE			English	Editorial Material							MACROPHAGE IRON HOMEOSTASIS; SALMONELLA-TYPHIMURIUM; FERROPORTIN; HEPCIDIN; GAMMA; AVAILABILITY; REGULATOR; ENTERICA; PROTEIN; EFFLUX		[Lokken, Kristen L.; Tsolis, Renee M.; Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Lokken, KL (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Baumler, Andreas J/H-2301-2011	Baumler, Andreas J/0000-0001-9152-7809; Tsolis, Renee/0000-0001-9131-6657				Abdullah Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037349; BAUMLER AJ, 1995, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 2ND EDITION, P115; CARTWRIGHT GE, 1946, J CLIN INVEST, V25, P65, DOI 10.1172/JCI101690; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Eisele NA, 2013, CELL HOST MICROBE, V14, P171, DOI 10.1016/j.chom.2013.07.010; Kim DK, 2014, NAT MED, V20, P419, DOI 10.1038/nm.3483; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Mair SM, 2011, J INFECT DIS, V204, P685, DOI 10.1093/infdis/jir395; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Nairz M, 2013, J EXP MED, V210, P855, DOI 10.1084/jem.20121946; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Xavier MN, 2013, CELL HOST MICROBE, V14, P159, DOI 10.1016/j.chom.2013.07.009	17	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					335	337		10.1038/nm.3526	http://dx.doi.org/10.1038/nm.3526			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710374				2022-12-27	WOS:000334361500010
J	Thierry, AR; Mouliere, F; El Messaoudi, S; Mollevi, C; Lopez-Crapez, E; Rolet, F; Gillet, B; Gongora, C; Dechelotte, P; Robert, B; Del Rio, M; Lamy, PJ; Bibeau, F; Nouaille, M; Loriot, V; Jarrousse, AS; Molina, F; Mathonnet, M; Pezet, D; Ychou, M				Thierry, Alain R.; Mouliere, Florent; El Messaoudi, Safia; Mollevi, Caroline; Lopez-Crapez, Evelyne; Rolet, Fanny; Gillet, Brigitte; Gongora, Celine; Dechelotte, Pierre; Robert, Bruno; Del Rio, Maguy; Lamy, Pierre-Jean; Bibeau, Frederic; Nouaille, Michelle; Loriot, Virginie; Jarrousse, Anne-Sophie; Molina, Franck; Mathonnet, Muriel; Pezet, Denis; Ychou, Marc			Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA	NATURE MEDICINE			English	Article							METASTATIC COLORECTAL-CANCER; K-RAS MUTATIONS; CELL-FREE DNA; ACQUIRED-RESISTANCE; PROGNOSTIC VALUE; MUTANT-DNA; CETUXIMAB; PLASMA; PROPORTION; PREDICTOR	Assessment of KRAS status is mandatory in patients with metastatic colorectal cancer (mCRC) before applying targeted therapy. We describe here a blinded prospective study to compare KRAS and BRAF mutation status data obtained from the analysis of tumor tissue by routine gold-standard methods and of plasma DNA using a quantitative PCR-based method specifically designed to analyze circulating cell-free DNA (cfDNA). The mutation status was determined by both methods from 106 patient samples. cfDNA analysis showed 100% specificity and sensitivity for the BRAF V600E mutation. For the seven tested KRAS point mutations, the method exhibited 98% specificity and 92% sensitivity with a concordance value of 96%. Mutation load, expressed as the proportion of mutant alleles in cfDNA, was highly variable (0.5-64.1%, median 10.5%) among mutated samples. CfDNA was detected in 100% of patients with mCRC. This study shows that liquid biopsy through cfDNA analysis could advantageously replace tumor-section analysis and expand the scope of personalized medicine for patients with cancer.	[Thierry, Alain R.; Mouliere, Florent; El Messaoudi, Safia; Gongora, Celine; Robert, Bruno; Del Rio, Maguy] Inst Rech Cancerol Montpellier, INSERM U896, Montpellier, France; [Thierry, Alain R.; Mouliere, Florent; El Messaoudi, Safia; Rolet, Fanny; Molina, Franck] CAP DELTA, Sysdiag CNRS UMR3145, Montpellier, France; [Mollevi, Caroline] Inst Canc Montpellier, Unite Biostat, Montpellier, France; [Lopez-Crapez, Evelyne; Lamy, Pierre-Jean] Inst Canc Montpellier, Lab Biol Specialisee, Montpellier, France; [Gillet, Brigitte; Pezet, Denis] Univ Auvergne, UMR Unite Inserm, Serv Chirurg Digest,U1071, Unite Oncol Digest,Ctr Hosp Univ Clermont Ferrand, Clermont Ferrand, France; [Dechelotte, Pierre; Jarrousse, Anne-Sophie] Ctr Hosp Univ Clermont Ferrand, Unite Oncol Mol, Clermont Ferrand, France; [Bibeau, Frederic] Inst Canc Montpellier, Unite Biopathol, Serv Pathol, Montpellier, France; [Nouaille, Michelle; Mathonnet, Muriel] Ctr Hosp Univ Limoges, Serv Chirurg Digest, Ctr Invest Clin, INSERM 0801, Limoges, France; [Loriot, Virginie; Ychou, Marc] Inst Canc Montpellier, Serv Chirurg Digest, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); CHU Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Thierry, AR (corresponding author), Inst Rech Cancerol Montpellier, INSERM U896, Montpellier, France.	alain.thierry@inserm.fr	Mollevi, Caroline/AAA-6839-2019; Mouliere, Florent/H-7119-2019; Lamy, Pierre-Jean/I-6077-2015; Mathonnet, Muriel/ABD-3021-2020; Pezet, Denis/I-4423-2017; thierry, alain/F-9492-2014; ROBERT, Bruno/AAB-7581-2020; Lamy, Pierre-Jean/AAZ-1696-2020	Mollevi, Caroline/0000-0003-4827-3684; Mouliere, Florent/0000-0001-7043-0514; Lamy, Pierre-Jean/0000-0002-5750-159X; Mathonnet, Muriel/0000-0002-9127-3068; Pezet, Denis/0000-0001-9416-2876; ROBERT, Bruno/0000-0001-5573-6945; Lamy, Pierre-Jean/0000-0002-5750-159X; Ychou, Marc/0000-0001-7378-9469; GONGORA, Celine/0000-0001-9034-4031; Crapez, evelyne/0000-0002-8261-3470	CNRS; Region of Languedoc-Roussillon [CNRS044406]; Fondation ARC pour la Recherche sur le Cancer; Association GEFLUC (France) [DCMLP10-184]; INSERM	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region of Languedoc-Roussillon(Region Occitanie); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association GEFLUC (France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank J. Robert, J. Dubois, A. Lievre, C. Theillet, S. Du Manoir, C. Sardet, D. Tousch and R. Gimbaud for helpful discussions. We would like to thank L. Kamraoui, A. Laybats, J.-Y. Cance and M. Cavalier for excellent technical assistance. F. Mouliere is supported by a grant from CNRS and the Region of Languedoc-Roussillon (CNRS044406). The study was funded by grants from the Fondation ARC pour la Recherche sur le Cancer and the Association GEFLUC (DCMLP10-184, France). We thank Bio-Rad for the qPCR thermocycler free loan. A.R.T. is supported by INSERM.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Artru P, 2012, J CLIN ONCOL, V30; Bando H, 2011, BRIT J CANCER, V105, P403, DOI 10.1038/bjc.2011.247; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Board RE, 2010, BREAST CANCER RES TR, V120, P461, DOI 10.1007/s10549-010-0747-9; Boissiere-Michot F, 2012, MODERN PATHOL, V25, P731, DOI 10.1038/modpathol.2011.210; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; El Messaoudi S, 2013, CLIN CHIM ACTA, V424, P222, DOI 10.1016/j.cca.2013.05.022; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-347; Knijn N, 2011, BRIT J CANCER, V104, P1020, DOI 10.1038/bjc.2011.26; Kobunai T, 2010, BIOCHEM BIOPH RES CO, V395, P158, DOI 10.1016/j.bbrc.2010.03.167; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lecomte T, 2002, INT J CANCER, V100, P542, DOI 10.1002/ijc.10526; Lefebure B, 2010, ANN SURG, V251, P275, DOI 10.1097/SLA.0b013e3181c35c87; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mouliere F, 2012, EXPERT OPIN BIOL TH, V12, pS209, DOI 10.1517/14712598.2012.688023; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Oltedal S, 2011, INT J COLORECTAL DIS, V26, P1271, DOI 10.1007/s00384-011-1233-5; Pinto P, 2011, CANCER GENET-NY, V204, P439, DOI 10.1016/j.cancergen.2011.07.003; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Ryan BM, 2003, GUT, V52, P101, DOI 10.1136/gut.52.1.101; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Soh J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007464; Solassol J, 2011, INT J MOL SCI, V12, P3191, DOI 10.3390/ijms12053191; Spindler KLG, 2012, CLIN CANCER RES, V18, P1177, DOI 10.1158/1078-0432.CCR-11-0564; STROUN M, 1987, EUR J CANCER CLIN ON, V23, P707, DOI 10.1016/0277-5379(87)90266-5; Thierry AR, 2010, NUCLEIC ACIDS RES, V38, P6159, DOI 10.1093/nar/gkq421; Trevisiol C, 2006, INT J BIOL MARKER, V21, P223, DOI 10.1177/172460080602100405; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Weichert W, 2010, J MOL DIAGN, V12, P35, DOI 10.2353/jmoldx.2010.090079; West NP, 2010, BRIT J CANCER, V102, P1519, DOI 10.1038/sj.bjc.6605674; Yen LC, 2009, CLIN CANCER RES, V15, P4508, DOI 10.1158/1078-0432.CCR-08-3179	42	461	479	5	166	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					430	+		10.1038/nm.3511	http://dx.doi.org/10.1038/nm.3511			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658074				2022-12-27	WOS:000334361500025
J	Atreya, R; Neumann, H; Neufert, C; Waldner, MJ; Billmeier, U; Zopf, Y; Willma, M; App, C; Munster, T; Kessler, H; Maas, S; Gebhardt, B; Heimke-Brinck, R; Reuter, E; Dorje, F; Rau, TT; Uter, W; Wang, TD; Kiesslich, R; Vieth, M; Hannappel, E; Neurath, MF				Atreya, Raja; Neumann, Helmut; Neufert, Clemens; Waldner, Maximilian J.; Billmeier, Ulrike; Zopf, Yurdaguel; Willma, Marcus; App, Christine; Muenster, Tino; Kessler, Hermann; Maas, Stefanie; Gebhardt, Bernd; Heimke-Brinck, Ralph; Reuter, Eva; Doerje, Frank; Rau, Tilman T.; Uter, Wolfgang; Wang, Thomas D.; Kiesslich, Ralf; Vieth, Michael; Hannappel, Ewald; Neurath, Markus F.			In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease	NATURE MEDICINE			English	Article							INFLAMMATORY BOWEL DISEASES; PROPRIA T-LYMPHOCYTES; INFLIXIMAB; APOPTOSIS; ENDOSCOPY; DYSPLASIA; CANCER; ENDOMICROSCOPY; IDENTIFICATION; CHEMOTHERAPY	As antibodies to tumor necrosis factor (TNF) suppress immune responses in Crohn's disease by binding to membrane-bound TNF (mTNF), we created a fluorescent antibody for molecular mTNF imaging in this disease. Topical antibody administration in 25 patients with Crohn's disease led to detection of intestinal mTNF(+) immune cells during confocal laser endomicroscopy. Patients with high numbers of mTNF(+) cells showed significantly higher short-term response rates (92%) at week 12 upon subsequent anti-TNF therapy as compared to patients with low amounts of mTNF(+) cells (15%). This clinical response in the former patients was sustained over a follow-up period of 1 year and was associated with mucosal healing observed in follow-up endoscopy. These data indicate that molecular imaging with fluorescent antibodies has the potential to predict therapeutic responses to biological treatment and can be used for personalized medicine in Crohn's disease and autoimmune or inflammatory disorders.	[Atreya, Raja; Neumann, Helmut; Neufert, Clemens; Waldner, Maximilian J.; Billmeier, Ulrike; Zopf, Yurdaguel; Willma, Marcus; Neurath, Markus F.] Univ Erlangen Nurnberg, Med Clin 1, D-91054 Erlangen, Germany; [App, Christine; Hannappel, Ewald] Univ Erlangen Nurnberg, Dept Biochem, D-91054 Erlangen, Germany; [Muenster, Tino] Univ Erlangen Nurnberg, Dept Anesthesiol, D-91054 Erlangen, Germany; [Kessler, Hermann] Univ Erlangen Nurnberg, Dept Surg, D-91054 Erlangen, Germany; [Maas, Stefanie; Gebhardt, Bernd] Univ Erlangen Nurnberg, Ctr Clin Studies, D-91054 Erlangen, Germany; [Heimke-Brinck, Ralph; Reuter, Eva; Doerje, Frank] Univ Erlangen Nurnberg, Erlangen Univ Hosp, Dept Pharm, D-91054 Erlangen, Germany; [Rau, Tilman T.] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; [Uter, Wolfgang] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany; [Wang, Thomas D.] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Kiesslich, Ralf] St Marys Hosp, Med Clin, Frankfurt, Germany; [Vieth, Michael] Klinikum Bayreuth, Inst Pathol, Bayreuth, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Michigan System; University of Michigan; St. Marien Hospital; Klinikum Bayreuth	Neurath, MF (corresponding author), Univ Erlangen Nurnberg, Med Clin 1, D-91054 Erlangen, Germany.	markus.neurath@uk-erlangen.de	Ralf Kiesslich, Dr./AAK-9313-2021		German Ministry for Science and Education [BMBF ZooMAP 01KI1003G]; Ludwig Demling Research Prize of the Deutsche Morbus Crohn/Colitis Ulcerosa Vereinigung; United European Gastroenterology Federation Research Prize; NATIONAL CANCER INSTITUTE [U54CA163059, P50CA093990, U54CA136429, R01CA142750] Funding Source: NIH RePORTER	German Ministry for Science and Education; Ludwig Demling Research Prize of the Deutsche Morbus Crohn/Colitis Ulcerosa Vereinigung; United European Gastroenterology Federation Research Prize; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Zoller-Utz, P. Drummer and G. Gohring-Waldeck for excellent technical support, A. May for monitoring our study and S. Brand and F. Kolligs (University Hospital Munich-Grosshadern) for their contribution to the follow-up endoscopies. We thank the whole team of the Endoscopy Unit of the Medical Clinic 1 of the University Erlangen-Nuremberg, which greatly supported this work. We thank all patients who participated in this study. This research was supported by the German Research Foundation (clinical research unit KFO257) and the Emerging Fields Initiative and the Interdisciplinary Center for Clinical Research of the University Erlangen-Nuremberg, which helped to establish the infrastructure needed to conduct this study. Funds from the German Ministry for Science and Education (BMBF ZooMAP 01KI1003G) were used for intestinal sample preparation. The infrastructure of the presented project was supported by the Ludwig Demling Research Prize of the Deutsche Morbus Crohn/Colitis Ulcerosa Vereinigung (R.A.) and the United European Gastroenterology Federation Research Prize (M.F.N.).	Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Atreya R, 2011, GASTROENTEROLOGY, V141, P2026, DOI 10.1053/j.gastro.2011.08.032; Bird-Lieberman EL, 2012, NAT MED, V18, P315, DOI 10.1038/nm.2616; Broadbridge VT, 2012, EXPERT REV ANTICANC, V12, P555, DOI [10.1586/era.12.25, 10.1586/ERA.12.25]; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Colombel JF, 2009, INFLAMM BOWEL DIS, V15, P1308, DOI 10.1002/ibd.20956; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Evans AT, 2012, EXPERT OPIN BIOL TH, V12, P363, DOI 10.1517/14712598.2012.658770; Evans JA, 2007, GASTROINTEST ENDOSC, V65, P50, DOI 10.1016/j.gie.2006.04.027; Foersch S, 2010, GUT, V59, P1046, DOI 10.1136/gut.2009.202986; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hlavaty T, 2007, INFLAMM BOWEL DIS, V13, P372, DOI 10.1002/ibd.20024; Hsiung PL, 2008, NAT MED, V14, P454, DOI 10.1038/nm1692; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Kendall C, 2003, J PATHOL, V200, P602, DOI 10.1002/path.1376; Kiesslich R, 2007, NAT CLIN PRACT ONCOL, V4, P480, DOI 10.1038/ncponc0881; Kiesslich R, 2007, GASTROENTEROLOGY, V132, P874, DOI 10.1053/j.gastro.2007.01.048; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Macedo LT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-89; Medarova Z, 2009, CANCER RES, V69, P1182, DOI 10.1158/0008-5472.CAN-08-2001; Mitoma H, 2005, GASTROENTEROLOGY, V128, P376, DOI 10.1053/j.gastro.2004.11.060; Monteleone G, 2011, CURR OPIN PHARMACOL, V11, P640, DOI 10.1016/j.coph.2011.09.013; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Peyrin-Biroulet L, 2010, AM J GASTROENTEROL, V105, P289, DOI 10.1038/ajg.2009.579; Qiu L, 2010, NAT MED, V16, P603, DOI 10.1038/nm.2138; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; ten Hove T, 2002, GUT, V50, P206, DOI 10.1136/gut.50.2.206; Van den Brande JMH, 2007, GUT, V56, P509, DOI 10.1136/gut.2006.105379; Van Den Brande JMH, 2003, GASTROENTEROLOGY, V124, P1774, DOI 10.1016/S0016-5085(03)00382-2; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Waldner MJ, 2011, NAT PROTOC, V6, P1471, DOI 10.1038/nprot.2011.377	37	250	257	1	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					313	318		10.1038/nm.3462	http://dx.doi.org/10.1038/nm.3462			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24562382	Green Accepted			2022-12-27	WOS:000332595600028
J	Balazs, AB; Ouyang, Y; Hong, CM; Chen, J; Nguyen, SM; Rao, DS; An, DS; Baltimore, D				Balazs, Alejandro B.; Ouyang, Yong; Hong, Christin M.; Chen, Joyce; Nguyen, Steven M.; Rao, Dinesh S.; An, Dong Sung; Baltimore, David			Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission	NATURE MEDICINE			English	Article							PREEXPOSURE PROPHYLAXIS; NEUTRALIZING ANTIBODIES; INFECTION; BROAD	The vast majority of new HIV infections result from relatively inefficient transmission(1,2) of the virus across mucosal surfaces during sexual intercourse(3). A consequence of this inefficiency is that small numbers of transmitted founder viruses initiate most heterosexual infections(4). This natural bottleneck to transmission has stimulated efforts to develop interventions that are aimed at blocking this step of the infection process(5). Despite the promise of this strategy, clinical trials of preexposure prophylaxis have had limited degrees of success in humans, in part because of lack of adherence to the recommended preexposure treatment regimens(6,7). In contrast, a number of existing vaccines elicit systemic immunity that protects against mucosal infections, such as the vaccines for influenza(8) and human papilloma virus(8). We recently demonstrated the ability of vectored immunoprophylaxis (VIP) to prevent intravenous transmission of HIV in humanized mice using broadly neutralizing antibodies(10). Here we demonstrate that VIP is capable of protecting humanized mice from intravenous as well as vaginal challenge with diverse HIV strains despite repeated exposures. Moreover, animals receiving VIP that expresses a modified VRC07 antibody were completely resistant to repetitive intravaginal challenge by a heterosexually transmitted founder HIV strain(11), suggesting that VI. may be effective in preventing vaginal transmission of HIV between humans.	[Balazs, Alejandro B.; Ouyang, Yong; Hong, Christin M.; Chen, Joyce; Nguyen, Steven M.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Rao, Dinesh S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [An, Dong Sung] Univ Calif Los Angeles, Sch Nursing, UCLA AIDS Inst, Dept Translat Sci, Los Angeles, CA 90024 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Rao, Dinesh/AAE-9625-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337; Balazs, Alejandro/0000-0002-1767-3944; Hong, Christin/0000-0003-1826-9246; Chen, Joyce/0000-0001-7851-8457	UCLA Center for AIDS Research (CFAR) [AI028697]; NIAID [1K22AI102769, 1R01AI100652-01A1]; Sidney Kimmel Foundation for Cancer Research [SKF-11-013]; NIH [1K08CA133521]; NIH through NIAID [HHSN266200500035C]; Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE [K08CA133521, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100652, P30AI028697, K22AI102769] Funding Source: NIH RePORTER	UCLA Center for AIDS Research (CFAR); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sidney Kimmel Foundation for Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Joint Center for Translational Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge G. Nabel (Sanofi-Pasteur) and J. Mascola (US National Institutes of Health (NIH) Vaccine Research Center) for VRC01, VRC-PG04, VRC07 and VRC07G54W expression plasmids and proteins, D. Burton (Scripps) for b12, PG9, PGT121 and PGT128 expression plasmids, M. Nussenzweig (Rockefeller) for 3BNC117 and 12A12 expression plasmids and P. Bjorkman (California Institute of Technology) for the NIH45-46W expression plasmid. We also thank the Caltech Protein Expression Center for providing purified antibodies. The following reagents were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), NIH: pYK-JRCSF from I.S.Y. Chen and Y. Koyanagi, pREJO.c/2864 from J. Kappes and C. Ochsenbauer and TZM-bl cells from J. Kappes and X. Wu. We thank J. Kim, D. Majumdar, M. Mann and A. So for their helpful comments and other members of the Baltimore lab, as well as R. Cortado and S. Shimizu in the An lab, for their assistance in carrying out this work. Preparation of human CD34<SUP>+</SUP> cells, tissue procurement and BLT mice were supported by the UCLA Center for AIDS Research (CFAR) AI028697. A.B.B. is supported by the NIAID Career Transition Award 1K22AI102769. D.S.R. was a Sidney Kimmel Scholar supported by the Sidney Kimmel Foundation for Cancer Research (Translational Award SKF-11-013) and is supported by career development award 1K08CA133521 from the NIH. D.S.A. is supported by NIAID grant 1R01AI100652-01A1. This project was supported by the NIH (HHSN266200500035C) through a contract from the NIAID and by the Joint Center for Translational Medicine.	Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Kwon Y, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-O34; LIM SG, 1993, CLIN EXP IMMUNOL, V92, P448, DOI 10.1111/j.1365-2249.1993.tb03419.x; Marrazzo M.J., 2013, 20 C RETR OPP INF; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6; Romanowski B, 2011, HUM VACCINES, V7, P161, DOI 10.4161/hv.7.2.13690; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	26	177	189	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					296	300		10.1038/nm.3471	http://dx.doi.org/10.1038/nm.3471			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24509526	Green Submitted, Green Accepted			2022-12-27	WOS:000332595600025
J	Hernandez, FJ; Huang, LY; Olson, ME; Powers, KM; Hernandez, LI; Meyerholz, DK; Thedens, DR; Behlke, MA; Horswill, AR; McNamara, JO				Hernandez, Frank J.; Huang, Lingyan; Olson, Michael E.; Powers, Kristy M.; Hernandez, Luiza I.; Meyerholz, David K.; Thedens, Daniel R.; Behlke, Mark A.; Horswill, Alexander R.; McNamara, James O., II			Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe	NATURE MEDICINE			English	Article							NEAR-INFRARED FLUORESCENCE; IN-VIVO; EXTRACELLULAR NUCLEASE; BACTERIAL-INFECTION; REAL-TIME; MICE; OLIGONUCLEOTIDES; IDENTIFICATION; OSTEOMYELITIS; STREPTOCOCCI	Technologies that enable the rapid detection and localization of bacterial infections in living animals could address an unmet need for infectious disease diagnostics. We describe a molecular imaging approach for the specific, noninvasive detection of S. aureus based on the activity of the S. aureus secreted nuclease, micrococcal nuclease (MN). Several short synthetic oligonucleotides, rendered resistant to mammalian serum nucleases by various chemical modifications and flanked with a fluorophore and quencher, were activated upon degradation by purified MN and in S. aureus culture supernatants. A probe consisting of a pair of deoxythymidines flanked by several 2'-o-methyl-modified nucleotides was activated in culture supernatants of S. aureus but not in culture supernatants of several other pathogenic bacteria. Systemic administration of this probe to mice bearing S. aureus muscle infections resulted in probe activation at the infection sites in an MN-dependent manner. This new bacterial imaging approach has potential clinical applicability for infections with S. aureus and several other medically important pathogens.	[Hernandez, Frank J.; Hernandez, Luiza I.; McNamara, James O., II] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Huang, Lingyan; Powers, Kristy M.; Behlke, Mark A.] Integrated DNA Technol IDT, Coralville, IA USA; [Olson, Michael E.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Thedens, Daniel R.] Univ Iowa, Dept Radiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	McNamara, JO (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	james-mcnamara@uiowa.edu	Hernandez, Frank J./G-5583-2017; Meyerholz, David/J-8131-2019; Hernandez, Frank J./AAR-9031-2021	Hernandez, Frank J./0000-0001-6308-8087; Meyerholz, David/0000-0003-1552-3253; Hernandez, Frank J./0000-0001-6308-8087; Behlke, Mark/0000-0002-4218-857X; McNamara, James/0000-0003-4091-618X	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [AI083211, AI101391]; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106738, P01AI083211, R21AI101391] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health under award numbers AI083211 (A.R.H.) and AI101391 (J.O.M. II). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. F.J.H. was supported by a postdoctoral fellowship from the American Heart Association. The authors thank J. Kavanaugh for technical assistance with bacterial cultures and R. Schmidt and J. Widness for sharing a Sysmex XT-200i Automated Hematology Analyzer.	Agarwal V, 2011, NEUROIMAG CLIN N AM, V21, P975, DOI 10.1016/j.nic.2011.07.011; ARNONE A, 1969, P NATL ACAD SCI USA, V64, P420, DOI 10.1073/pnas.64.2.420; Beenken KE, 2012, INFECT IMMUN, V80, P1634, DOI 10.1128/IAI.06134-11; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Boerlin P, 2003, J CLIN MICROBIOL, V41, P767, DOI 10.1128/JCM.41.2.767-771.2003; Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413; Clerc O, 2011, J ANTIMICROB CHEMOTH, V66, P1168, DOI 10.1093/jac/dkr047; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; CUATRECA.P, 1967, J BIOL CHEM, V242, P1541; CUNNINGHAM L, 1956, J AM CHEM SOC, V78, P4642, DOI 10.1021/ja01599a031; DEMARIE S, 1990, INTENS CARE MED, V16, pS239, DOI 10.1007/BF01709708; Elias DR, 2008, CANCER BIOMARK, V4, P287, DOI 10.3233/CBM-2008-4602; FERREIRA BT, 1992, ZBL BAKT-INT J MED M, V277, P493; FERRIERI P, 1980, J EXP MED, V151, P56, DOI 10.1084/jem.151.1.56; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Hatzenbuehler J, 2011, AM FAM PHYSICIAN, V84, P1027; Hernandez FJ, 2012, NUCLEIC ACID THER, V22, P58, DOI 10.1089/nat.2011.0316; Hope-Roberts M, 2011, BIOTECH HISTOCHEM, V86, P104, DOI 10.3109/10520295.2010.498295; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Kobayashi H, 2011, CHEM SOC REV, V40, P4626, DOI 10.1039/c1cs15077d; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; Leevy WM, 2008, BIOCONJUGATE CHEM, V19, P686, DOI 10.1021/bc700376v; Leevy WM, 2006, J AM CHEM SOC, V128, P16476, DOI 10.1021/ja0665592; Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x; Matsui A, 2010, SURGERY, V148, P78, DOI 10.1016/j.surg.2009.12.003; Moon AF, 2011, NUCLEIC ACIDS RES, V39, P2943, DOI 10.1093/nar/gkq1152; Ning XH, 2011, NAT MATER, V10, P602, DOI [10.1038/NMAT3074, 10.1038/nmat3074]; Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423; POCHON F, 1960, B SOC CHIM BIOL, V42, P795; Rasmussen JC, 2010, TRANSL ONCOL, V3, P362, DOI 10.1593/tlo.10190; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; White AG, 2010, BIOCONJUGATE CHEM, V21, P1297, DOI 10.1021/bc1000998; Wu PIK, 2008, J BIOMECH, V41, P2884, DOI 10.1016/j.jbiomech.2008.06.025; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	39	78	83	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					301	306		10.1038/nm.3460	http://dx.doi.org/10.1038/nm.3460			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24487433	Green Accepted			2022-12-27	WOS:000332595600026
J	Trompette, A; Gollwitzer, ES; Yadava, K; Sichelstiel, AK; Sprenger, N; Ngom-Bru, C; Blanchard, C; Junt, T; Nicod, LP; Harris, NL; Marsland, BJ				Trompette, Aurelien; Gollwitzer, Eva S.; Yadava, Koshika; Sichelstiel, Anke K.; Sprenger, Norbert; Ngom-Bru, Catherine; Blanchard, Carine; Junt, Tobias; Nicod, Laurent P.; Harris, Nicola L.; Marsland, Benjamin J.			Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis	NATURE MEDICINE			English	Article							CHAIN FATTY-ACIDS; DENDRITIC CELLS; FUNGAL MICROBIOTA; LARGE-INTESTINE; EARLY-LIFE; BACTERIA; INFLAMMATION; PROTEIN; ABSORPTION; INCREASE	Metabolites from intestinal microbiota are key determinants of host-microbe mutualism and, consequently, the health or disease of the intestinal tract. However, whether such host-microbe crosstalk influences inflammation in peripheral tissues, such as the lung, is poorly understood. We found that dietary fermentable fiber content changed the composition of the gut and lung microbiota, in particular by altering the ratio of Firmicutes to Bacteroidetes. The gut microbiota metabolized the fiber, consequently increasing the concentration of circulating short-chain fatty acids (SCFAs). Mice fed a high-fiber diet had increased circulating levels of SCFAs and were protected against allergic inflammation in the lung, whereas a low-fiber diet decreased levels of SCFAs and increased allergic airway disease. Treatment of mice with the SCFA propionate led to alterations in bone marrow hematopoiesis that were characterized by enhanced generation of macrophage and dendritic cell (DC) precursors and subsequent seeding of the lungs by DCs with high phagocytic capacity but an impaired ability to promote T helper type 2 (T(H)2) cell effector function. The effects of propionate on allergic inflammation were dependent on G protein-coupled receptor 41 (GPR41, also called free fatty acid receptor 3 or FFAR3), but not GPR43 (also called free fatty acid receptor 2 or FFAR2). Our results show that dietary fermentable fiber and SCFAs can shape the immunological environment in the lung and influence the severity of allergic inflammation.	[Trompette, Aurelien; Gollwitzer, Eva S.; Yadava, Koshika; Sichelstiel, Anke K.; Nicod, Laurent P.; Marsland, Benjamin J.] Univ Lausanne, Fac Biol & Med, Serv Pneumol, Ctr Hosp Univ Vaudois CHUV BH19 206, Lausanne, Switzerland; [Sprenger, Norbert; Ngom-Bru, Catherine; Blanchard, Carine] Nestle Res Ctr, CH-1000 Lausanne, Switzerland; [Junt, Tobias] Novartis Pharma AG, Basel, Switzerland; [Harris, Nicola L.] Ecole Polytech Fed Lausanne, Global Hlth Inst, SV Global Hlth Inst GHI Stn 19, CH-1015 Lausanne, Switzerland	University of Lausanne; Nestle SA; Novartis; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Marsland, BJ (corresponding author), Univ Lausanne, Fac Biol & Med, Serv Pneumol, Ctr Hosp Univ Vaudois CHUV BH19 206, Lausanne, Switzerland.	bemamin.marsland@chuv.ch	harris, nicola/E-5342-2019; Junt, Tobias/AAE-4389-2021; Nicod, Laurent/ABD-3360-2020	harris, nicola/0000-0003-2922-0210; yadava, koshika/0000-0002-5827-9177; Nicod, Laurent P/0000-0002-0905-916X	Swiss National Science Foundation [310030.130029]; Fondation Placide Nicod	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Placide Nicod	This work has been supported by the Swiss National Science Foundation grant 310030.130029 awarded to B.J.M. We thank R. Driscoll and the Fondation Placide Nicod for support and A. Genevaz, B. Berger and E. Rezzonico for scientific assistance related to microbiota analysis. B.J.M. is a Cloetta Medical Research Fellow.	Aoyama M, 2010, NUTRITION, V26, P653, DOI 10.1016/j.nut.2009.07.006; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; BINDER HJ, 1989, GASTROENTEROLOGY, V96, P989, DOI 10.1016/0016-5085(89)91614-4; Blainey P.C., 2012, SCI TRANSL MED, V4; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Greger J.L., 1999, J NUTR, V129, p1434S; Herbst T, 2011, AM J RESP CRIT CARE, V184, P198, DOI 10.1164/rccm.201010-1574OC; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Jansen MS, 2004, P NATL ACAD SCI USA, V101, P7199, DOI 10.1073/pnas.0402014101; KANEKO T, 1994, J DAIRY SCI, V77, P393, DOI 10.3168/jds.S0022-0302(94)76965-4; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Lambrecht BN, 2012, ANNU REV IMMUNOL, V30, P243, DOI 10.1146/annurev-immunol-020711-075021; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lambrecht BN, 1998, J IMMUNOL, V160, P4090; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nakaji S, 2002, EUR J NUTR, V41, P222, DOI 10.1007/s00394-002-0379-x; Noverr MC, 2005, INFECT IMMUN, V73, P30, DOI 10.1128/IAI.73.1.30-38.2005; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Plantinga M., 2013, IMMUNITY, V38, P322; Riedl J, 1999, J NUTR, V129, P2170, DOI 10.1093/jn/129.12.2170; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Scholz-Ahrens K.E., 2007, J NUTR, V137, p2513S; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Ulven Trond, 2012, Front Endocrinol (Lausanne), V3, P111, DOI 10.3389/fendo.2012.00111; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Xie S, 2009, J ENVIRON SCI, V21, P76, DOI 10.1016/S1001-0742(09)60014-0	43	1525	1606	27	507	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					159	166		10.1038/nm.3444	http://dx.doi.org/10.1038/nm.3444			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24390308				2022-12-27	WOS:000330915000017
J	Celedon, JC; Kolls, JK				Celedon, Juan C.; Kolls, Jay K.			An innate link between obesity and asthma	NATURE MEDICINE			English	Editorial Material							AIRWAY HYPERRESPONSIVENESS; MICE		[Celedon, Juan C.] UPMC, Div Pediat Pulm Med Allergy & Immunol, Pediat Environm Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Kolls, Jay K.] UPMC, Div Pediat Pulm Med Allergy & Immunol, Richard King Mellon Fdn, Pediat Res Inst,Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Celedon, JC (corresponding author), UPMC, Div Pediat Pulm Med Allergy & Immunol, Pediat Environm Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA.	juan.celedon@chp.edu; jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304				Akinbami LJ, 2012, NCHS DATA BRIEF; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Forno E, 2011, J ALLERGY CLIN IMMUN, V127, P741, DOI 10.1016/j.jaci.2010.12.010; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Ogden C., 2013, NCHS DATA BRIEF; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053	8	13	13	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					20	21		10.1038/nm.3433	http://dx.doi.org/10.1038/nm.3433			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398959				2022-12-27	WOS:000329349400012
J	Rahal, R; Frick, M; Romero, R; Korn, JM; Kridel, R; Chan, FC; Meissner, B; Bhang, HE; Ruddy, D; Kauffmann, A; Farsidjani, A; Derti, A; Rakiec, D; Naylor, T; Pfister, E; Kovats, S; Kim, S; Dietze, K; Dorken, B; Steidl, C; Tzankov, A; Hummel, M; Monahan, J; Morrissey, MP; Fritsch, C; Sellers, WR; Cooke, VG; Gascoyne, RD; Lenz, G; Stegmeier, F				Rahal, Rami; Frick, Mareike; Romero, Rodrigo; Korn, Joshua M.; Kridel, Robert; Chan, Fong Chun; Meissner, Barbara; Bhang, Hyo-eun; Ruddy, Dave; Kauffmann, Audrey; Farsidjani, Ali; Derti, Adnan; Rakiec, Daniel; Naylor, Tara; Pfister, Estelle; Kovats, Steve; Kim, Sunkyu; Dietze, Kerstin; Doerken, Bernd; Steidl, Christian; Tzankov, Alexandar; Hummel, Michael; Monahan, John; Morrissey, Michael P.; Fritsch, Christine; Sellers, William R.; Cooke, Vesselina G.; Gascoyne, Randy D.; Lenz, Georg; Stegmeier, Frank			Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma	NATURE MEDICINE			English	Article							GENE-EXPRESSION; IKK-ALPHA; ACTIVATION; KINASE; PATHWAYS; CANCER; NIK; PHOSPHORYLATION; MUTATIONS; DISCOVERY	Mantle cell lymphoma (MCL) is an aggressive malignancy that is characterized by poor prognosis(1). Large-scale pharmacological profiling across more than 100 hematological cell line models identified a subset of MCL cell lines that are highly sensitive to the B cell receptor (BCR) signaling inhibitors ibrutinib and sotrastaurin. Sensitive MCL models exhibited chronic activation of the BCR-driven classical nuclear factor-kappa B (NF-kappa B) pathway, whereas insensitive cell lines displayed activation of the alternative NF-kappa B pathway. Transcriptome sequencing revealed genetic lesions in alternative NF-kappa B pathway signaling components in ibrutinib-insensitive cell lines, and sequencing of 165 samples from patients with MCL identified recurrent mutations in TRAF2 or BIRC3 in 15% of these individuals. Although they are associated with insensitivity to ibrutinib, lesions in the alternative NF-kappa B pathway conferred dependence on the protein kinase NIK (also called mitogen-activated protein 3 kinase 14 or MAP3K14) both in vitro and in vivo. Thus, NIK is a new therapeutic target for MCL treatment, particularly for lymphomas that are refractory to BCR pathway inhibitors. Our findings reveal a pattern of mutually exclusive activation of the BCR-NF-kappa B or NIK-NF-kappa B pathways in MCL and provide critical insights into patient stratification strategies for NF-kappa B pathway-targeted agents.	[Rahal, Rami; Romero, Rodrigo; Korn, Joshua M.; Bhang, Hyo-eun; Ruddy, Dave; Farsidjani, Ali; Derti, Adnan; Rakiec, Daniel; Naylor, Tara; Kovats, Steve; Kim, Sunkyu; Monahan, John; Morrissey, Michael P.; Sellers, William R.; Cooke, Vesselina G.; Stegmeier, Frank] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Frick, Mareike; Dietze, Kerstin; Doerken, Bernd; Lenz, Georg] Charite, Dept Hematol Oncol & Tumor Immunol, Mol Canc Res Ctr, D-13353 Berlin, Germany; [Kridel, Robert; Chan, Fong Chun; Meissner, Barbara; Steidl, Christian; Gascoyne, Randy D.] BC Canc Agcy, Dept Pathol & Expt Therapeut, Vancouver, BC, Canada; [Kridel, Robert; Chan, Fong Chun; Meissner, Barbara; Steidl, Christian; Gascoyne, Randy D.] BC Canc Res Ctr, Vancouver, BC, Canada; [Kauffmann, Audrey; Pfister, Estelle; Fritsch, Christine] Novartis Inst Biomed Res, Basel, Switzerland; [Tzankov, Alexandar] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Hummel, Michael] Charite, Dept Pathol, D-13353 Berlin, Germany	Novartis; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; British Columbia Cancer Agency; British Columbia Cancer Agency; Novartis; University of Basel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stegmeier, F (corresponding author), Novartis Inst Biomed Res, Cambridge, MA 02139 USA.	georg.lenz@charite.de; frank.stegmeier@novartis.com	Lenz, Georg/I-6844-2012; Kridel, Robert/V-8739-2019; Gascoyne, Randy D/A-6009-2013; Tzankov, Alexandar/H-5656-2019	Gascoyne, Randy D/0000-0002-2610-5690; Tzankov, Alexandar/0000-0002-1100-3819; Kridel, Robert/0000-0003-0287-7124; Hummel, Michael/0000-0001-6717-605X; Romero, Rodrigo/0000-0002-9388-8306; /0000-0001-5216-0565; Monahan, John/0000-0002-3125-8704; Romero, Rodrigo/0000-0003-1689-0784	Else Kroner-Fresenius-Stiftung; German Research Foundation; Deutsche Krebshilfe; New Frontiers in Cancer Terry Fox program project grant [19001]; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; University of British Columbia	Else Kroner-Fresenius-Stiftung; German Research Foundation(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); New Frontiers in Cancer Terry Fox program project grant; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of British Columbia	We thank T. Haferlach and W. Kern from the Munich Leukemia Laboratory (MLL) for providing MCL samples. We thank N. Clipstone (Loyola University) for the pMSCV-IRES-GFP vector. We also thank M. Wartmann, M. Stump, T. Hood and S. Zhu for sharing technical advice. We are grateful to D. Weinstock, R. Pagliarini, D. Porter, S. Sharma, N. Wilson and N. Keen for their critical reading of this manuscript. All authors except M.F., R.K., F.C.C., B.M., K.D., B D., C. S., A.T., M.H., R.D.G. and G.L. are employees of Novartis Institutes for Biomedical Research. This work was supported by research grants to G.L. from the Else Kroner-Fresenius-Stiftung, the German Research Foundation and the Deutsche Krebshilfe. Additionally, this work was supported by a New Frontiers in Cancer Terry Fox program project grant (19001) to R.D.G. and a Career Investigator award by the Michael Smith Foundation for Health Research to C.S. R.K. is a recipient of fellowships from the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research and the University of British Columbia (Four Year Fellowship).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Ghielmini M, 2009, BLOOD, V114, P1469, DOI 10.1182/blood-2009-02-179739; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Jabbour E, 2012, AM J HEMATOL, V87, P1038, DOI 10.1002/ajh.23282; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Naylor TL, 2011, CANCER RES, V71, P2643, DOI 10.1158/0008-5472.CAN-10-2525; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Nogai H, 2013, BLOOD, V122, P2242, DOI 10.1182/blood-2013-06-508028; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; Ranuncolo SM, 2012, BLOOD, V120, P3756, DOI 10.1182/blood-2012-01-405951; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wagner J, 2011, J MED CHEM, V54, P6028, DOI 10.1021/jm200469u; Wagner J, 2009, J MED CHEM, V52, P6193, DOI 10.1021/jm901108b; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	46	242	250	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					87	+		10.1038/nm.3435	http://dx.doi.org/10.1038/nm.3435			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24362935				2022-12-27	WOS:000329349400024
J	Edelstein, LC; Simon, LM; Montoya, RT; Holinstat, M; Chen, ES; Bergeron, A; Kong, XG; Nagalla, S; Mohandas, N; Cohen, DE; Dong, JF; Shaw, C; Bray, PF				Edelstein, Leonard C.; Simon, Lukas M.; Montoya, Raul Teruel; Holinstat, Michael; Chen, Edward S.; Bergeron, Angela; Kong, Xianguo; Nagalla, Srikanth; Mohandas, Narla; Cohen, David E.; Dong, Jing-fei; Shaw, Chad; Bray, Paul F.			Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c	NATURE MEDICINE			English	Article							PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; GENETIC-STRUCTURE; SECONDARY PREVENTION; ACTIVATED RECEPTORS; TRANSCRIPTION; VORAPAXAR; MICRORNAS; DISEASE; AGGREGATION; MECHANISM	Racial differences in the pathophysiology of atherothrombosis are poorly understood. We explored the function and transcriptome of platelets in healthy black (n = 70) and white (n = 84) subjects. Platelet aggregation and calcium mobilization induced by the PAR4 thrombin receptor were significantly greater in black subjects. Numerous differentially expressed RNAs were associated with both race and PAR4 reactivity, including PCTP (encoding phosphatidylcholine transfer protein), and platelets from black subjects expressed higher levels of PC-TP protein. PC-TP inhibition or depletion blocked PAR4- but not PAR1-mediated activation of platelets and megakaryocytic cell lines. miR-376c levels were differentially expressed by race and PAR4 reactivity and were inversely correlated with PCTP mRNA levels, PC-TP protein levels and PAR4 reactivity. miR-376c regulated the expression of PC-TP in human megakaryocytes. A disproportionately high number of microRNAs that were differentially expressed by race and PAR4 reactivity, including miR-376c, are encoded in the DLK1-DIO3 locus and were expressed at lower levels in platelets from black subjects. These results suggest that PC-TP contributes to the racial difference in PAR4-mediated platelet activation, indicate a genomic contribution to platelet function that differs by race and emphasize a need to consider the effects of race when developing anti-thrombotic drugs.	[Edelstein, Leonard C.; Montoya, Raul Teruel; Holinstat, Michael; Kong, Xianguo; Nagalla, Srikanth; Bray, Paul F.] Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; [Edelstein, Leonard C.; Montoya, Raul Teruel; Holinstat, Michael; Kong, Xianguo; Nagalla, Srikanth; Bray, Paul F.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Philadelphia, PA 19107 USA; [Simon, Lukas M.; Chen, Edward S.; Shaw, Chad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bergeron, Angela] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10021 USA; [Cohen, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol, Boston, MA 02115 USA; [Dong, Jing-fei] Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Shaw, Chad] Rice Univ, Dept Stat, Houston, TX 77251 USA	Jefferson University; Jefferson University; Baylor College of Medicine; Baylor College of Medicine; New York Blood Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Puget Sound Blood Center; Rice University	Bray, PF (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA.	cashaw@bcm.tmc.edu; paul.bray@jefferson.edu	Teruel-Montoya, Raúl/H-9012-2017	Teruel-Montoya, Raúl/0000-0002-6741-9725; Shaw, Chad/0000-0001-7267-5398; Simon, Lukas/0000-0001-6148-8861; Edelstein, Leonard/0000-0002-8976-6410	US National Institutes of Health (NIH) [HL102482]; Cardeza Foundation for Hematologic Research; NIH [DK48873, DK56626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK048873, R01DK048873, R29DK048873, R01DK056626] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007880] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardeza Foundation for Hematologic Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank S. McKenzie for helpful discussions, S. Kunapuli (Temple University) for the PAR1 inhibitor, J. ltaliano (Harvard Medical School) for the antibody to tubulin, L. Ma for technical support, R. Baserga (Thomas Jefferson University) for the HCT116-Dicer knockout 2 cells and P. Yu for normalizing Affymetrix data. This work was supported by US National Institutes of Health (NIH) grant HL102482 (to P.F.B.) and the Cardeza Foundation for Hematologic Research. Compound A1 was developed with the support of NIH grants DK48873 and DK56626 (to D.E.C.).	Abrams C.S., 2006, HEMOSTASIS THROMBOSI, P617; Baez JM, 2005, BIOCHEM J, V388, P57, DOI 10.1042/BJ20041899; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Bray PF, 2007, J THROMB HAEMOST, V5, P1617, DOI 10.1111/j.1538-7836.2007.02618.x; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; CHO JH, 1995, HYPERTENSION, V25, P377, DOI 10.1161/01.HYP.25.3.377; Edelstein LC, 2011, BLOOD, V117, P5289, DOI 10.1182/blood-2011-01-292011; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Geijtenbeek TBH, 1996, BIOCHEM J, V316, P49; Goodall AH, 2010, BLOOD, V116, P4646, DOI 10.1182/blood-2010-04-280925; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Henriksen RA, 2002, ARTERIOSCL THROM VAS, V22, P861, DOI 10.1161/01.ATV.0000014742.56572.25; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Kang HW, 2010, TRENDS ENDOCRIN MET, V21, P449, DOI 10.1016/j.tem.2010.02.001; Kondkar AA, 2010, J THROMB HAEMOST, V8, P369, DOI 10.1111/j.1538-7836.2009.03700.x; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lova P, 2004, J BIOL CHEM, V279, P25299, DOI 10.1074/jbc.M313199200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; MAHADEVAPPA VG, 1984, J BIOL CHEM, V259, P9369; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; O'Brien KA, 2011, BLOOD, V118, P4215, DOI 10.1182/blood-2010-12-323204; O'Donnell CJ, 2001, CIRCULATION, V103, P3051, DOI 10.1161/01.CIR.103.25.3051; OZAKI Y, 1992, BIOCHEM BIOPH RES CO, V183, P864, DOI 10.1016/0006-291X(92)90563-Z; Phimister EG, 2003, NEW ENGL J MED, V348, P1081, DOI 10.1056/NEJMp030028; Ple H, 2012, THROMB HAEMOSTASIS, V108, P605, DOI 10.1160/TH12-03-0153; Quinton TM, 2004, J BIOL CHEM, V279, P18434, DOI 10.1074/jbc.M401431200; Risch N, 2002, GENOME BIOL, V3, pcomment2007; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Shishova EY, 2011, HEPATOLOGY, V54, P664, DOI 10.1002/hep.24393; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thomas KL, 2010, AM HEART J, V160, P744, DOI 10.1016/j.ahj.2010.06.014; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; Vergnolle N, 2009, PHARMACOL THERAPEUT, V123, P292, DOI 10.1016/j.pharmthera.2009.05.004; Wagle N, 2008, ANAL BIOCHEM, V383, P85, DOI 10.1016/j.ab.2008.07.039; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Xu QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026905; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	52	146	152	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1609	1616		10.1038/nm.3385	http://dx.doi.org/10.1038/nm.3385			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24216752	Green Accepted, Green Submitted			2022-12-27	WOS:000328181400029
J	Blennow, K; Zetterberg, H; Haass, C				Blennow, Kaj; Zetterberg, Henrik; Haass, Christian			Semagacestat's fall: where next for AD therapies?	NATURE MEDICINE			English	Editorial Material							GAMMA-SECRETASE INHIBITOR; ALZHEIMERS-DISEASE; PRESENILIN-1; TRIAL; BACE1; AGE		[Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal, Sweden; Univ Munich, Adolf Butenandt Inst, Munich, Germany; German Ctr Neurodegenerat Dis, Munich, Germany; Johns Hopkins Univ, Sch Med, Johns Hopkins Bayview Med Ctr, Baltimore, MD USA	University of Gothenburg; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Johns Hopkins University; Johns Hopkins Medicine	Blennow, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Clin Neurochem Lab, Molndal Campus, Molndal, Sweden.							Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Cheret C, 2013, EMBO J, V32, P2015, DOI 10.1038/emboj.2013.146; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Portelius E, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt30; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198	16	17	19	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1214	1215		10.1038/nm.3365	http://dx.doi.org/10.1038/nm.3365			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100981				2022-12-27	WOS:000325531700014
J	Pandey, GS; Yanover, C; Miller-Jenkins, LM; Garfield, S; Cole, SA; Curran, JE; Moses, EK; Rydz, N; Simhadri, V; Kimchi-Sarfaty, C; Lillicrap, D; Viel, KR; Przytycka, TM; Pierce, GF; Howard, TE; Sauna, ZE				Pandey, Gouri Shankar; Yanover, Chen; Miller-Jenkins, Lisa M.; Garfield, Susan; Cole, Shelley A.; Curran, Joanne E.; Moses, Eric K.; Rydz, Natalia; Simhadri, Vijaya; Kimchi-Sarfaty, Chava; Lillicrap, David; Viel, Kevin R.; Przytycka, Teresa M.; Pierce, Glenn F.; Howard, Tom E.; Sauna, Zuben E.		PATH Personalized Alternative	Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A	NATURE MEDICINE			English	Article							COAGULATION-FACTOR VIII; MONOCLONAL-ANTIBODIES; HUMAN-LIVER; INHIBITOR; ANTIGEN; HISTORY; GENE	Neutralizing antibodies (inhibitors) to replacement factor VIII (FVIII, either plasma derived or recombinant) impair the effective management of hemophilia A1. Individuals with hemophilia A due to major deletions of the FVIII gene (F8) lack antigenically cross-reactive material in their plasma ("CRM-negative"), and the prevalence of inhibitors in these individuals may be as high as 90%. Conversely, individuals with hemophilia A caused by F8 missense mutations are CRM-positive, and their overall prevalence of inhibitors is < 10% (ref. 2). Individuals with the F8 intron 22 inversion (found in similar to 50% of individuals with severe hemophilia A) have been grouped with the former on the basis of their genetic defect and CRM-negative status. However, only similar to 20% of these individuals develop inhibitors3. Here we demonstrate that the levels of F8 mRNA and intracellular FVIII protein in B lymphoblastoid cells and liver biopsies from individuals with the intron 22 inversion are comparable to those in healthy controls. These results support the hypothesis that most individuals with the intron 22 inversion are tolerized to FVIII and thus do not develop inhibitors. Furthermore, we developed a new pharmacogenetic algorithm that permits the stratification of inhibitor risk for individuals and subpopulations by predicting the immunogenicity of replacement FVIII using, as input, the number of putative T cell epitopes in the infused protein and the competence of major histocompatibility complex class II molecules to present such epitopes. This algorithm showed statistically significant accuracy in predicting the presence of inhibitors in 25 unrelated individuals with the intron 22 inversion.	[Pandey, Gouri Shankar; Simhadri, Vijaya; Kimchi-Sarfaty, Chava; Sauna, Zuben E.] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Lab Hemostasis, Bethesda, MD 20892 USA; [Yanover, Chen] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98104 USA; [Miller-Jenkins, Lisa M.] NCI, Lab Cell Biol, Expt Carcinogenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Garfield, Susan] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Cole, Shelley A.; Curran, Joanne E.; Moses, Eric K.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [Rydz, Natalia; Lillicrap, David] Queens Univ, Dept Pathol & Mol Med, Kingston, ON, Canada; [Viel, Kevin R.] Histonis, Atlanta, GA USA; [Przytycka, Teresa M.] Natl Ctr Biotechnol Informat, Natl Lib Med, NIH, Bethesda, MD USA; [Pierce, Glenn F.] Biogen Idec Hemophilia, Waltham, MA USA; [Howard, Tom E.] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Pathol & Lab Med, Los Angeles, CA USA; [Howard, Tom E.] Univ So Calif, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90033 USA; [Howard, Tom E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA	US Food & Drug Administration (FDA); Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Texas Biomedical Research Institute; McMaster University; Queens University - Canada; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sauna, ZE (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Hematol, Lab Hemostasis, Bethesda, MD 20892 USA.	tom.howard@va.gov; zuben.sauna@fda.hhs.gov	Yanover, Chen/A-3754-2012; Sauna, Zuben E./AAA-7149-2019; Krause, Amanda/AAQ-7038-2020	Yanover, Chen/0000-0003-3663-4286; Krause, Amanda/0000-0002-7157-0807; Goga, Yasmin/0000-0002-6740-2376; Moses, Eric/0000-0001-7781-4465; Kimchi-Sarfaty, Chava/0000-0002-9355-8585; Przytycka, Teresa/0000-0002-6261-277X; Pratt, Kathleen/0000-0001-6837-6133; Curran, Joanne/0000-0002-6898-155X; Carless, Melanie/0000-0001-8350-2302	US National Institute of Allergy and Infectious Diseases Committee on Human Research [10-01178]; modernization of science program of the Center for Biologics Evaluation and Research, US Food and Drug Administration; National Heart, Lung and Blood Institute, National Institutes of Health [1RC2-HL101851, HL-71130, HL-72533)]; Bayer Healthcare Corporation; Bayer Hemophilia Awards Program; Baxter Healthcare Corporation; Clinical Translational Science Institute at the University of Southern California; Intramural Program of the US National Library of Medicine, NIH; NATIONAL CANCER INSTITUTE [ZICBC010858] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101851, K08HL071130, R01HL072533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI052748] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200887] Funding Source: NIH RePORTER	US National Institute of Allergy and Infectious Diseases Committee on Human Research; modernization of science program of the Center for Biologics Evaluation and Research, US Food and Drug Administration; National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bayer Healthcare Corporation; Bayer Hemophilia Awards Program; Baxter Healthcare Corporation; Clinical Translational Science Institute at the University of Southern California; Intramural Program of the US National Library of Medicine, NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank P. Matzinger, B. Golding, J. Lozier, D. Levin, M. Carcao, V. Blanchette, G. Rivard and V. La Terza for helpful comments and J. Sauna for help with the graphics. We thank S. V. Ambudkar (US National Cancer Institute) for the use of facilities, M. J. Lenardo and K. Shafer-Weaver (US National Institute of Allergy and Infectious Diseases) for the gift of the purified C2 domain of FVIII and P. Stock (University of California, San Francisco) for liver tissue samples. These samples were obtained under the University of California University-Wide AIDS Research Program (TP-99-SF-001) Committee on Human Research (H802423454) and the Solid Organ Transplantation in HIV: Multi-Site Study (AI052748) funded by the US National Institute of Allergy and Infectious Diseases Committee on Human Research (10-01178). Research conducted in the laboratory of Z. E. S. is funded by the modernization of science program of the Center for Biologics Evaluation and Research, US Food and Drug Administration. Research conducted in the laboratory of T. E. H. is funded by grants from the National Heart, Lung and Blood Institute, National Institutes of Health (1RC2-HL101851, HL-71130 and HL-72533), the Bayer Healthcare Corporation, Bayer Hemophilia Awards Program, Baxter Healthcare Corporation and the Clinical Translational Science Institute at the University of Southern California. The work of T. M. P. is fully supported by the Intramural Program of the US National Library of Medicine, NIH.	Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Egler C, 2009, J MOL RECOGNIT, V22, P301, DOI 10.1002/jmr.947; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; GRIFFIN BD, 1986, THROMB HAEMOSTASIS, V55, P40; JENKINS PV, 1994, BLOOD, V84, P2197; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; LEWIS JH, 1985, NEW ENGL J MED, V312, P1189; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lillicrap D, 2010, CURR OPIN HEMATOL, V17, P393, DOI 10.1097/MOH.0b013e32833c06c6; Miller CH, 2012, HAEMOPHILIA, V18, P375, DOI 10.1111/j.1365-2516.2011.02700.x; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Pandey GS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003066; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Schwarz J., 2013, HAEMOPHILIA; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STEL HV, 1983, NATURE, V303, P530, DOI 10.1038/303530a0; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Viel KR, 2009, NEW ENGL J MED, V360, P1618, DOI 10.1056/NEJMoa075760; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x; WION KL, 1985, NATURE, V317, P726, DOI 10.1038/317726a0; Yanover C, 2011, NAT BIOTECHNOL, V29, P870, DOI 10.1038/nbt.2002	22	48	49	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2013	19	10					1318	+		10.1038/nm.3270	http://dx.doi.org/10.1038/nm.3270			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24037092	Green Accepted, Green Submitted			2022-12-27	WOS:000325531700032
J	Owen, BM; Bookout, AL; Ding, XS; Lin, VY; Atkin, SD; Gautron, L; Kliewer, SA; Mangelsdorf, DJ				Owen, Bryn M.; Bookout, Angie L.; Ding, Xunshan; Lin, Vicky Y.; Atkin, Stan D.; Gautron, Laurent; Kliewer, Steven A.; Mangelsdorf, David J.			FGF21 contributes to neuroendocrine control of female reproduction	NATURE MEDICINE			English	Article							GROWTH-FACTOR 21; METABOLIC REGULATOR; KISSPEPTIN NEURONS; PPAR-ALPHA; ACTIVATION; ESTROGEN; RECEPTOR; MICE; EXPRESSION; KLOTHO	Preventing reproduction during nutritional deprivation is an adaptive process that is conserved and essential for the survival of species. In mammals, the mechanisms that inhibit fertility during starvation are complex and incompletely understood(1-7). Here we show that exposure of female mice to fibroblast growth factor 21 (FGF21), a fasting-induced hepatokine, mimics infertility secondary to starvation. Mechanistically, FGF21 acts on the suprachiasmatic nucleus (SCN) in the hypothalamus to suppress the vasopressin-kisspeptin signaling cascade, thereby inhibiting the proestrus surge in luteinizing hormone. Mice lacking the FGF21 co-receptor, beta-Klotho, in the SCN are refractory to the inhibitory effect of FGF21 on female fertility. Thus, FGF21 defines an important liver-neuroendocrine axis that modulates female reproduction in response to nutritional challenge.	[Owen, Bryn M.; Bookout, Angie L.; Ding, Xunshan; Lin, Vicky Y.; Atkin, Stan D.; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Bookout, Angie L.; Gautron, Laurent] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Ding, Xunshan; Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mangelsdorf, DJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	steven.kliewer@utsouthwestern.edu; davo.mango@utsouthwestern.edu	gautron, laurent/AAQ-5983-2021	Owen, Bryn/0000-0001-5296-7553; Mangelsdorf, David/0000-0002-4355-0796	Howard Hughes Medical Institute; US National Institutes of Health [RL1GM084436, R01DK067158, R56DK089600, U19DK62434, GM007062]; Robert A. Welch Foundation [I-1275, I-1558]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (Specialized Cooperative Centers Program in Reproduction and Infertility Research (SCCPIR)) [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067158, R56DK089600, U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062, RL1GM084436] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (Specialized Cooperative Centers Program in Reproduction and Infertility Research (SCCPIR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our colleagues at the University of Texas Southwestern Medical Center, R. Hammer and members of the Mangelsdorf/Kliewer laboratory for discussion, Y. Thong, H. Lawrence and L. Harris for technical assistance, J. Shelton for imaging; and R. Goetz and M. Mohammadi (New York University) for FGF21 protein. This research was supported by the Howard Hughes Medical Institute (D.J.M.), US National Institutes of Health grants RL1GM084436, R01DK067158, and R56DK089600 (to D.J.M. and S.A.K.), U19DK62434 (to D.J.M.) and GM007062 (to A.L.B.) and the Robert A. Welch Foundation (I-1275 to D.J.M. and I-1558 to S.A.K.). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (Specialized Cooperative Centers Program in Reproduction and Infertility Research (SCCPIR)) grant U54-HD28934.	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Bookout AL, 2013, NAT MED, V19, P1147, DOI 10.1038/nm.3249; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Cardozo E, 2011, TRENDS ENDOCRIN MET, V22, P103, DOI 10.1016/j.tem.2010.12.002; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kalamatianos T, 2008, J NEUROENDOCRINOL, V20, P1089, DOI 10.1111/j.1365-2826.2008.01757.x; KALSBEEK A, 1992, BRAIN RES, V580, P62, DOI 10.1016/0006-8993(92)90927-2; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Mayer C, 2010, P NATL ACAD SCI USA, V107, P22693, DOI 10.1073/pnas.1012406108; Miller BH, 2006, BIOL REPROD, V75, P778, DOI 10.1095/biolreprod.106.052845; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Roa J, 2009, ENDOCRINOLOGY, V150, P5016, DOI 10.1210/en.2009-0096; Roa J, 2009, PEPTIDES, V30, P57, DOI 10.1016/j.peptides.2008.08.009; Roa J, 2011, BIOL REPROD, V85, P650, DOI 10.1095/biolreprod.111.091538; Vida B, 2010, J NEUROENDOCRINOL, V22, P1032, DOI 10.1111/j.1365-2826.2010.02045.x; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Zhang Y., ELIFE, V1	27	150	154	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2013	19	9					1153	1156		10.1038/nm.3250	http://dx.doi.org/10.1038/nm.3250			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23933983	Green Accepted			2022-12-27	WOS:000324083500030
J	Lucas, D; Scheiermann, C; Chow, A; Kunisaki, Y; Bruns, I; Barrick, C; Tessarollo, L; Frenette, PS				Lucas, Daniel; Scheiermann, Christoph; Chow, Andrew; Kunisaki, Yuya; Bruns, Ingmar; Barrick, Colleen; Tessarollo, Lino; Frenette, Paul S.			Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration	NATURE MEDICINE			English	Article							PROGENITOR CELLS; STEM; MICE; TRANSPLANTATION; ENGRAFTMENT; NEURONS; RECONSTITUTION; NEUROPATHIES; EXPRESSION; INDUCTION	Anticancer chemotherapy drugs challenge hematopoietic tissues to regenerate but commonly produce long-term sequelae. Chemotherapy-induced deficits in hematopoietic stem or stromal cell function have been described, but the mechanisms mediating hematopoietic dysfunction remain unclear. Administration of multiple cycles of cisplatin chemotherapy causes substantial sensory neuropathy. Here we demonstrate that chemotherapy-induced nerve injury in the bone marrow of mice is a crucial lesion impairing hematopoietic regeneration. Using pharmacological and genetic models, we show that the selective loss of adrenergic innervation in the bone marrow alters its regeneration after genotoxic insult. Sympathetic nerves in the marrow promote the survival of constituents of the stem cell niche that initiate recovery. Neuroprotection by deletion of Trp53 in sympathetic neurons or neuroregeneration by administration of 4-methylcatechol or glial-derived neurotrophic factor (GDNF) promotes hematopoietic recovery. These results demonstrate the potential benefit of adrenergic nerve protection for shielding hematopoietic niches from injury.	[Lucas, Daniel; Scheiermann, Christoph; Chow, Andrew; Kunisaki, Yuya; Bruns, Ingmar; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, New York, NY USA; [Chow, Andrew; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Bruns, Ingmar] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany; [Barrick, Colleen; Tessarollo, Lino] NCI Frederick, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD USA	Yeshiva University; Icahn School of Medicine at Mount Sinai; Heinrich Heine University Dusseldorf; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, New York, NY USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012; Scheiermann, Christoph/B-8261-2014; Lucas, Daniel/ABB-6893-2021	Frenette, Paul S/0000-0003-0862-9922; Scheiermann, Christoph/0000-0002-9212-0995; Lucas, Daniel/0000-0002-0147-5425; Chow, Andrew/0000-0003-1151-2450; Bruns, Ingmar/0000-0001-6316-8378	US National Institutes of Health (NIH) [DK056638, HL069438]; German Academic Exchange Service (DAAD); NIH National Heart, Lung and Blood Institute (NHLBI) [5F30HL099028-02]; American Society of Hematology-European Hematology Association (ASH-EHA) research exchange award; Japan Society for the Promotion of Science (JSPS); NIH intramural research program, Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE [ZIABC010390, ZIABC010391] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL099028, R01HL069438, R01HL097819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NIH National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Society of Hematology-European Hematology Association (ASH-EHA) research exchange award; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH intramural research program, Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Prophete, M. Huggins and N. Dholakia for technical assistance. We thank K. Ito for helpful discussions. We thank G. Karsenty (Columbia University) for providing Adrb2<SUP>tm1Bkk/J</SUP> mice and A. Ting (Mount Sinai School of Medicine) for the PCL5.1neg plasmid. This work was supported by the US National Institutes of Health to P. S. F. (NIH; R01 grants DK056638 and HL069438). D. L. was a fellow of Fundacion Ramon Areces. C. S. was supported by a fellowship from the German Academic Exchange Service (DAAD). A. C. is funded by a fellowship from the NIH National Heart, Lung and Blood Institute (NHLBI; 5F30HL099028-02). I. B. was the recipient of an American Society of Hematology-European Hematology Association (ASH-EHA) research exchange award. Y.K. was supported by the Japan Society for the Promotion of Science (JSPS). C. B. and L. T. are supported by the NIH intramural research program, Center for Cancer Research, NCI.	Aloe L, 2000, AUTON NEUROSCI-BASIC, V86, P84, DOI 10.1016/S1566-0702(00)00247-2; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Banfi A, 2001, CANCER, V92, P2419, DOI 10.1002/1097-0142(20011101)92:9<2419::AID-CNCR1591>3.0.CO;2-K; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Callizot N, 2008, CANCER CHEMOTH PHARM, V62, P995, DOI 10.1007/s00280-008-0689-7; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Coppola V, 2004, DEVELOPMENT, V131, P5185, DOI 10.1242/dev.01383; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Galotto M, 1999, EXP HEMATOL, V27, P1460, DOI 10.1016/S0301-472X(99)00076-4; HAAS R, 1994, BLOOD, V83, P3787; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kamei J, 2006, EUR J PHARMACOL, V536, P123, DOI 10.1016/j.ejphar.2006.02.033; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kemp K, 2010, ANN HEMATOL, V89, P701, DOI 10.1007/s00277-009-0896-2; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Levesque JP, 2002, EXP HEMATOL, V30, P440, DOI 10.1016/S0301-472X(02)00788-9; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Marino S, 2000, GENE DEV, V14, P994; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miller C.L., 2008, CURR PROTOC IMMUNOL, V80, p22B2; Noach EJK, 2003, EXP HEMATOL, V31, P528, DOI 10.1016/S0301-472X(03)00068-7; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Perseghin P, 2009, TRANSFUS APHER SCI, V41, P33, DOI 10.1016/j.transci.2009.05.011; Presley CA, 2005, CELL COMMUN ADHES, V12, P307, DOI 10.1080/15419060500514200; Rezaee F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009690; Robinson SN, 2000, EXP HEMATOL, V28, P1325, DOI 10.1016/S0301-472X(00)00547-6; Saita K, 1996, J PHARMACOL EXP THER, V276, P231; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Schober A, 1999, J NEUROSCI, V19, P2008; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; TRICOT G, 1995, BLOOD, V85, P588; Trimmer PA, 1996, NEURODEGENERATION, V5, P233, DOI 10.1006/neur.1996.0031; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yuan R, 2005, EXP HEMATOL, V33, P243, DOI 10.1016/j.exphem.2004.10.014	48	175	179	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					695	+		10.1038/nm.3155	http://dx.doi.org/10.1038/nm.3155			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23644514	Green Accepted			2022-12-27	WOS:000319981600018
J	Koeth, RA; Wang, ZE; Levison, BS; Buffa, JA; Org, E; Sheehy, BT; Britt, EB; Fu, XM; Wu, YP; Li, L; Smith, JD; DiDonato, JA; Chen, J; Li, HZ; Wu, GD; Lewis, JD; Warrier, M; Brown, JM; Krauss, RM; Tang, WHW; Bushman, FD; Lusis, AJ; Hazen, SL				Koeth, Robert A.; Wang, Zeneng; Levison, Bruce S.; Buffa, Jennifer A.; Org, Elin; Sheehy, Brendan T.; Britt, Earl B.; Fu, Xiaoming; Wu, Yuping; Li, Lin; Smith, Jonathan D.; DiDonato, Joseph A.; Chen, Jun; Li, Hongzhe; Wu, Gary D.; Lewis, James D.; Warrier, Manya; Brown, J. Mark; Krauss, Ronald M.; Tang, W. H. Wilson; Bushman, Frederic D.; Lusis, Aldons J.; Hazen, Stanley L.			Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis	NATURE MEDICINE			English	Article							REVERSE CHOLESTEROL TRANSPORT; CORONARY-HEART-DISEASE; BILE-ACID; GUT MICROBIOME; EXPRESSION; DIET; RECEPTORS; RISK; MICE; VEGETARIANS	Intestinal microbiota metabolism of choline and phosphatidylcholine produces trimethylamine (MA), which is further metabolized to a proatherogenic species, trimethylamine-N-oxide (TMAO). We demonstrate here that metabolism by intestinal microbiota of dietary L-carnitine, a trimethylamine abundant in red meat, also produces TMAO and accelerates atherosclerosis in mice. Omnivorous human subjects produced more TMAO than did vegans or vegetarians following ingestion of L-carnitine through a microbiota-dependent mechanism. The presence of specific bacterial taxa in human feces was associated with both plasma TMAO concentration and dietary status. Plasma L-carnitine levels in subjects undergoing cardiac evaluation (n = 2,595) predicted increased risks for both prevalent cardiovascular disease (CVD) and incident major adverse cardiac events (myocardial infarction, stroke or death), but only among subjects with concurrently high TMAO levels. Chronic dietary L-carnitine supplementation in mice altered cecal microbial composition, markedly enhanced synthesis of TMA and TMAO, and increased atherosclerosis, but this did not occur if intestinal microbiota was concurrently suppressed. In mice with an intact intestinal microbiota, dietary supplementation with TMAO or either carnitine or choline reduced in vivo reverse cholesterol transport. Intestinal microbiota may thus contribute to the well-established link between high levels of red meat consumption and CVD risk.	[Koeth, Robert A.; Wang, Zeneng; Levison, Bruce S.; Buffa, Jennifer A.; Sheehy, Brendan T.; Britt, Earl B.; Fu, Xiaoming; Li, Lin; Smith, Jonathan D.; DiDonato, Joseph A.; Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Koeth, Robert A.; Wang, Zeneng; Levison, Bruce S.; Buffa, Jennifer A.; Britt, Earl B.; Fu, Xiaoming; Li, Lin; Smith, Jonathan D.; DiDonato, Joseph A.; Tang, W. H. Wilson; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44106 USA; [Org, Elin; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Wu, Yuping] Cleveland State Univ, Dept Microbiol, Cleveland, OH 44115 USA; [Smith, Jonathan D.; Tang, W. H. Wilson; Bushman, Frederic D.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Chen, Jun; Li, Hongzhe; Lewis, James D.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Dept Microbiol, Philadelphia, PA 19104 USA; [Wu, Gary D.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Lewis, James D.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Warrier, Manya; Brown, J. Mark] Wake Forest Sch Med, Sect Lipid Sci, Dept Pathol, Winston Salem, NC USA; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Wake Forest University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	hazens@ccf.org	Tang, Wai Hong Wilson/I-1238-2013; Hazen, Stanley L/ABD-5845-2021; Org, Elin/AAJ-9631-2021; Wang, Zeneng/AAK-6119-2021; Smith, Jonathan D./H-9723-2013	Tang, W. H. Wilson/0000-0002-8335-735X; Levison, Bruce/0000-0002-1816-368X; Bushman, Frederic/0000-0003-4740-4056; Smith, Jonathan D./0000-0002-0415-386X; Sheehy, Brendan/0000-0002-9511-4291; Org, Elin/0000-0003-1451-9375; Org, Elin/0000-0001-8688-9717	US National Institutes of Health [R01 HL103866, P20 HL113452, PO1 HL30568, PO1 H28481, R00 HL096166, UH3-DK083981, 1RC1DK086472, T32 GM007250]; Leducq Foundation; Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award [1UL1RR024989]; American Heart Association; MOBILITAS Postdoctoral Research Grant [MJD252];  [P01 HL076491];  [P01 HL098055];  [R01 HL103931]; NATIONAL CANCER INSTITUTE [R01CA127334] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603, UL1RR024989] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103866, R01HL103931, P20HL113452, P01HL098055, P01HL028481, R01HL098193, P01HL030568, P01HL076491, R00HL096166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH3DK083981, P30DK034987, RC1DK086472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award; American Heart Association(American Heart Association); MOBILITAS Postdoctoral Research Grant; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Kerchenski and C. Stevenson for assistance in performing the clinical studies; A. Pratt, S. Neale, M. Pepoy and B. Sullivan for technical assistance with human specimen processing and routine clinical diagnostic testing; E. Klipfell, F. McNally and M. Berk for technical assistance; and the subjects who consented to participate in these studies. Mass spectrometry instrumentation used was housed within the Cleveland Clinic Mass Spectrometry Facility with partial support through a Center of Innovation by AB SCIEX. Germ-free mice were obtained from the University of North Carolina Gnotobiotic Facility, which is supported by P30-DK034987-25-28 and P40-RR018603-06-08. This research was supported by US National Institutes of Health grants R01 HL103866 (S.L.H.), P20 HL113452 (S.L.H. and W.H.WT.), PO1 HL30568 (A.J.L.), PO1 H28481 (A.J.L.), R00 HL096166 (J.M.B.), UH3-DK083981 (J.D.L), 1RC1DK086472 (R.M.K.) and the Leducq Foundation (S.L.H.). The clinical study GeneBank was supported in part by P01 HL076491, P01 HL098055, R01 HL103931 and the Cleveland Clinic Foundation General Clinical Research Center of the Cleveland Clinic/Case Western Reserve University Clinical and Translational Science Award (1UL1RR024989). S.L.H. is also partially supported by a gift from the Leonard Krieger Fund. Z.W. was partially supported by a Scientist Development Grant from the American Heart Association. E.O. was supported by a MOBILITAS Postdoctoral Research Grant (MJD252). R.A.K. was supported in part by US National Institutes of Health grant T32 GM007250.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; [Anonymous], [No title captured]; Bai CX, 1998, J PHARMACOL TOX MET, V40, P39, DOI 10.1016/S1056-8719(98)00034-3; Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brass EP, 2004, ANN NY ACAD SCI, V1033, P67, DOI 10.1196/annals.1320.006; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; Charach G, 1998, J MED, V29, P125; Charach G, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/949672; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; DELANY JP, 1986, FASEB J, V45, P815; Demarquoy J, 2004, FOOD CHEM, V86, P137, DOI 10.1016/j.foodchem.2003.09.023; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elssner T, 1999, FEMS MICROBIOL LETT, V174, P295; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; Goodman AL, 2010, CELL METAB, V12, P111, DOI 10.1016/j.cmet.2010.07.001; HANSEN ES, 1990, MUTAT RES, V239, P163, DOI 10.1016/0165-1110(90)90004-U; Hedayati SS, 2006, SEMIN DIALYSIS, V19, P323, DOI 10.1111/j.1525-139X.2006.00180.x; Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Kleber HP, 1997, FEMS MICROBIOL LETT, V147, P1; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liszt K, 2009, ANN NUTR METAB, V54, P253, DOI 10.1159/000229505; Lu YC, 2010, ATHEROSCLEROSIS, V210, P14, DOI 10.1016/j.atherosclerosis.2009.10.035; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mingorance C, 2011, VASC HEALTH RISK MAN, V7, P169, DOI 10.2147/VHRM.S14356; Miyake JH, 2002, ARTERIOSCL THROM VAS, V22, P121, DOI 10.1161/hq0102.102588; MOLLER B, 1986, ARCH MICROBIOL, V145, P85, DOI 10.1007/BF00413032; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Post SM, 2003, ARTERIOSCL THROM VAS, V23, P892, DOI 10.1161/01.ATV.0000067702.22390.20; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; REBOUCHE CJ, 1991, J NUTR, V121, P539, DOI 10.1093/jn/121.4.539; REBOUCHE CJ, 1984, BIOCHEMISTRY-US, V23, P6422, DOI 10.1021/bi00321a022; Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Rigault C, 2008, MEAT SCI, V78, P331, DOI 10.1016/j.meatsci.2007.06.011; Schwarz M, 1998, J LIPID RES, V39, P1833; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004; Suska A, 2009, BIOSENS BIOELECTRON, V25, P715, DOI 10.1016/j.bios.2009.08.012; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang AQ, 1999, FOOD CHEM TOXICOL, V37, P515, DOI 10.1016/S0278-6915(99)00028-9; Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141; Zong CL, 2012, EXP BIOL MED, V237, P194, DOI 10.1258/ebm.2011.011275	58	2520	2686	26	1013	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					576	585		10.1038/nm.3145	http://dx.doi.org/10.1038/nm.3145			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23563705	Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000318583000029
J	Riley, EM; Stewart, VA				Riley, Eleanor M.; Stewart, V. Ann			Immune mechanisms in malaria: new insights in vaccine development	NATURE MEDICINE			English	Review							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM INFECTION; T-CELL RESPONSES; CIRCUMSPOROZOITE PROTEIN; MOZAMBICAN CHILDREN; ACQUIRED-IMMUNITY; SYSTEMS BIOLOGY; LIVER STAGES; IFN-GAMMA; FOLLOW-UP	Early data emerging from the first phase 3 trial of a malaria vaccine are raising hopes that a licensed vaccine will soon be available for use in endemic countries, but given the relatively low efficacy of the vaccine, this needs to be seen as a major step forward on the road to a malaria vaccine rather than as arrival at the final destination. The focus for vaccine developers now moves to the next generation of malaria vaccines, but it is not yet clear what characteristics these new vaccines should have or how they can be evaluated. Here we briefly review the epidemiological and immunological requirements for malaria vaccines and the recent history of malaria vaccine development and then put forward a manifesto for future research in this area. We argue that rational design of more effective malaria vaccines will be accelerated by a better understanding of the immune effector mechanisms involved in parasite regulation, control and elimination.	[Riley, Eleanor M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England; [Stewart, V. Ann] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA	University of London; London School of Hygiene & Tropical Medicine; Uniformed Services University of the Health Sciences - USA	Riley, EM (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1, England.	eleanor.riley@lshtm.ac.uk	Riley, Eleanor M/C-8960-2013; Riley, Eleanor/AAL-1382-2020	Riley, Eleanor M/0000-0003-3447-3570; Riley, Eleanor/0000-0003-3447-3570				Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018559; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aide P, 2011, VACCINE, V29, P6059, DOI 10.1016/j.vaccine.2011.03.041; Alonso PL, 2013, NAT MED, V19, P150, DOI 10.1038/nm.3077; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Andersen-Nissen E, 2012, CURR OPIN HIV AIDS, V7, P32, DOI 10.1097/COH.0b013e32834ddcd9; Ansong D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018891; Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Berthoud TK, 2009, J IMMUNOL METHODS, V340, P33, DOI 10.1016/j.jim.2008.09.021; Bill and Melinda Gates Foundation, 2011, MAL STRAT OV; Bodescot M, 2004, PARASITOL RES, V92, P449, DOI 10.1007/s00436-003-1061-9; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2006, EXPERT REV VACCINES, V5, P611, DOI 10.1586/14760584.5.5.611; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014114; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Brice GT, 2007, MICROBES INFECT, V9, P1439, DOI 10.1016/j.micinf.2007.07.009; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Casares S, 2010, VACCINE, V28, P4880, DOI 10.1016/j.vaccine.2010.05.033; Chakravarty S, 2007, NAT MED, V13, P1035, DOI 10.1038/nm1628; Chen DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016629; Cockburn IA, 2007, CURR OPIN IMMUNOL, V19, P424, DOI 10.1016/j.coi.2007.05.008; Cockburn IA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001318; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Crispe IN, 2006, IMMUNOL REV, V213, P101, DOI 10.1111/j.1600-065X.2006.00435.x; Croom HA, 2011, EUR J IMMUNOL, V41, P682, DOI 10.1002/eji.201040625; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Doolan DL, 2011, INT J PARASITOL, V41, P3, DOI 10.1016/j.ijpara.2010.08.002; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Elnekave M, 2009, J IMMUNOL, V183, P1013, DOI 10.4049/jimmunol.0900283; Engwerda CR, 2005, TRENDS PARASITOL, V21, P75, DOI 10.1016/j.pt.2004.11.008; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Finney OC, 2010, TRENDS IMMUNOL, V31, P63, DOI 10.1016/j.it.2009.12.002; Forbes EK, 2011, J IMMUNOL, V187, P3738, DOI 10.4049/jimmunol.1003783; Fousteri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014502; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; Friesen J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001058; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Heppner DG, 1998, CURR OPIN INFECT DIS, V11, P519, DOI 10.1097/00001432-199810000-00002; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Horowitz A, 2012, J IMMUNOL, V188, P5054, DOI 10.4049/jimmunol.1102710; Huaman MC, 2008, J IMMUNOL, V180, P1451, DOI 10.4049/jimmunol.180.3.1451; Hugel FU, 1996, MOL BIOCHEM PARASIT, V81, P151, DOI 10.1016/0166-6851(96)02701-6; Hviid L, 2010, HUM VACCINES, V6, P84, DOI 10.4161/hv.6.1.9602; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; KHAN ZM, 1992, INT IMMUNOL, V4, P711, DOI 10.1093/intimm/4.7.711; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Liehl P, 2012, INT J PARASITOL, V42, P557, DOI 10.1016/j.ijpara.2012.04.006; Lindner SE, 2012, CELL MICROBIOL, V14, P316, DOI 10.1111/j.1462-5822.2011.01734.x; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Lumsden JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020775; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Malaria Vaccine Technology Roadmap, 2006, MAL VACC TECHN ROADM; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Matuschewski K, 2011, HUM VACCINES, V7, P16, DOI 10.4161/hv.7.0.14557; McKenzie FE, 2008, ADV PARASIT, V66, P1, DOI 10.1016/S0065-308X(08)00201-7; McNamara C, 2011, FUTURE MICROBIOL, V6, P693, DOI [10.2217/fmb.11.45, 10.2217/FMB.11.45]; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moormann AM, 2011, CURR OPIN INFECT DIS, V24, P435, DOI 10.1097/QCO.0b013e328349ac4f; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Niederwieser Igor, 2001, American Journal of Tropical Medicine and Hygiene, V64, P9; NUSSENZWEIG V, 1989, ADV IMMUNOL, V45, P283, DOI 10.1016/S0065-2776(08)60695-1; Nwuba RI, 2002, INFECT IMMUN, V70, P5328, DOI 10.1128/IAI.70.9.5328-5331.2002; O'Brien C, 2011, CURR OPIN INFECT DIS, V24, P570, DOI 10.1097/QCO.0b013e32834cd3ed; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Olotu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025786; Pasternak ND, 2009, INT J BIOCHEM CELL B, V41, P1463, DOI 10.1016/j.biocel.2008.12.012; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Regules JA, 2011, EXPERT REV VACCINES, V10, P589, DOI [10.1586/erv.11.57, 10.1586/ERV.11.57]; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; RILEY EM, 1988, CLIN EXP IMMUNOL, V71, P377; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Saul A, 2007, CURR OPIN INFECT DIS, V20, P476, DOI 10.1097/QCO.0b013e3282a95e12; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Todryk SM, 2009, EUR J IMMUNOL, V39, P3042, DOI 10.1002/eji.200939434; TROYEBLOMBERG M, 1990, P NATL ACAD SCI USA, V87, P5484, DOI 10.1073/pnas.87.14.5484; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Uthaipibull C, 2001, J MOL BIOL, V307, P1381, DOI 10.1006/jmbi.2001.4574; Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; VANDERBERG JP, 1993, J PARASITOL, V79, P763, DOI 10.2307/3283617; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Weedall GD, 2010, TRENDS PARASITOL, V26, P363, DOI 10.1016/j.pt.2010.04.002; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Weiss WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031247; WHO, 2011, WORLD MALARIA REPORT 2011, P1	130	137	140	0	136	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					168	178		10.1038/nm.3083	http://dx.doi.org/10.1038/nm.3083			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389617	hybrid			2022-12-27	WOS:000314675900025
J	Holland, JP; Evans, MJ; Rice, SL; Wongvipat, J; Sawyers, CL; Lewis, JS				Holland, Jason P.; Evans, Michael J.; Rice, Samuel L.; Wongvipat, John; Sawyers, Charles L.; Lewis, Jason S.			Annotating MYC status with Zr-89-transferrin imaging	NATURE MEDICINE			English	Article							TRANSFERRIN RECEPTOR; INFLAMMATION; CANCER; PET; EXPRESSION; ANTIBODIES; LOCALIZATION; INHIBITION; ACTIVATION; KINETICS	A noninvasive technology that quantitatively measures the activity of oncogenic signaling pathways could have a broad impact on cancer diagnosis and treatment with targeted therapies. Here we describe the development of Zr-89-desferrioxamine-labeled transferrin (Zr-89-transferrin), a new positron emission tomography (PET) radiotracer that binds the transferrin receptor 1 (TFRC, CD71) with high avidity. The use of Zr-89-transferrin produces high-contrast PET images that quantitatively reflect treatment-induced changes in MYC-regulated TFRC expression in a MYC-driven prostate cancer xenograft model. Moreover, Zr-89-transferrin imaging can detect the in situ development of prostate cancer in a transgenic MYC prostate cancer model, as well as in prostatic intraepithelial neoplasia (PIN) before histological or anatomic evidence of invasive cancer. These preclinical data establish Zr-89-transferrin as a sensitive tool for noninvasive measurement of oncogene-driven TFRC expression in prostate and potentially other cancers, with prospective near-term clinical application.	[Holland, Jason P.; Rice, Samuel L.; Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, New York, NY 10021 USA; [Evans, Michael J.; Wongvipat, John; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Lewis, JS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, 1275 York Ave, New York, NY 10021 USA.	sawyersc@mskcc.org; lewisj2@mskcc.org	Holland, Jason P./AAO-5718-2020; Sawyers, Charles/G-5327-2016	Holland, Jason P./0000-0002-0066-219X; Lewis, Jason/0000-0001-7065-4534; Rice, Samuel/0000-0002-0158-8921	Geoffrey Beene Cancer Research Center of MSKCC; Office of Science (BER)-US Department of Energy [DE-SC0002456]; US National Cancer Institute [2R25-CA096945]; US National Institutes of Health (NIH) [R24-CA83084]; NIH Center [P30-CA08748]; NIH Prostate SPORE [P50-CA92629]; NATIONAL CANCER INSTITUTE [P50CA092629, R25CA096945, P30CA008748, R24CA083084] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Center of MSKCC; Office of Science (BER)-US Department of Energy(United States Department of Energy (DOE)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Prostate SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Pillarsetty, B. Carver, D. Ulmert and P. Zanzonico for informative discussions, V. Longo for assistance with the in vivo studies, and M. Balbas for help with in vitro experiments. We thank C. Le and D. Winkleman for recording the MRI data and B. Beattie for assistance with co-registering PET/CT data. We thank M. McDevitt for assistance with HPLC stability studies. We also thank the staff of the Radiochemistry and Cyclotron Core at MSKCC. Funded in part by the Geoffrey Beene Cancer Research Center of MSKCC (J.S.L.), the Office of Science (BER)-US Department of Energy (Award DE-SC0002456, J.S.L.) and the R25T Molecular Imaging for Training in Oncology Program (2R25-CA096945; principal investigator H. Hricak; fellows: M.J.E. and S. L. R.) from the US National Cancer Institute. Technical services provided by the MSKCC Small-Animal Imaging Core Facility were supported in part by the US National Institutes of Health (NIH) grant R24-CA83084; NIH Center grant P30-CA08748; and NIH Prostate SPORE, P50-CA92629.	Abe N, 2008, J CELL SCI, V121, P1488, DOI 10.1242/jcs.020792; Aloj L, 1997, HEPATOLOGY, V25, P986, DOI 10.1002/hep.510250432; Aloj L, 1996, J NUCL MED, V37, P1408; Aloj L, 1999, J NUCL MED, V40, P1547; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beattie BJ, 2007, MOL IMAGING, V6, P108, DOI 10.2310/7290.2007.00008; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gayed I, 2004, J NUCL MED, V45, P17; Gotthardt M, 2010, J NUCL MED, V51, P1937, DOI 10.2967/jnumed.110.076232; HAYNES BF, 1981, J IMMUNOL, V126, P1409; Heneweer C, 2011, J NUCL MED, V52, P625, DOI 10.2967/jnumed.110.083998; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Holland J.P., 2010, TECHNETIUM OTHER RAD, P187; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Holland JP, 2010, MOL IMAGING, V9, P1, DOI 10.2310/7290.2010.00008; Holland JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008859; Holland JP, 2009, NUCL MED BIOL, V36, P729, DOI 10.1016/j.nucmedbio.2009.05.007; Kim S, 2006, FASEB J, V20, P2399, DOI 10.1096/fj.05-4621fje; LARSON SM, 1978, SEMIN NUCL MED, V8, P193, DOI 10.1016/S0001-2998(78)80028-2; Lee SI, 2008, RHEUMATOL INT, V29, P153, DOI 10.1007/s00296-008-0655-z; MEIJS WE, 1992, APPL RADIAT ISOTOPES, V43, P1443, DOI 10.1016/0883-2889(92)90170-J; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; OHKUBO Y, 1985, Radioisotopes, V34, P7; Pellegrino D, 2005, J NUCL MED, V46, P1522; Prost A C, 1990, Int J Rad Appl Instrum B, V17, P209, DOI 10.1016/0883-2897(90)90149-U; Richardson DR, 2002, ADV EXP MED BIOL, V509, P231; SOM P, 1983, EUR J NUCL MED, V8, P491, DOI 10.1007/BF00598908; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; TAETLE R, 1983, INT J CANCER, V32, P343, DOI 10.1002/ijc.2910320314; Vavere AL, 2005, J NUCL MED, V46, P683; Verel I, 2003, J NUCL MED, V44, P1271; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Weiner RE, 1996, NUCL MED BIOL, V23, P745, DOI 10.1016/0969-8051(96)00119-9; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	40	70	71	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1586	U197		10.1038/nm.2935	http://dx.doi.org/10.1038/nm.2935			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23001181	Green Submitted, Green Accepted			2022-12-27	WOS:000309587500039
J	Amanna, IJ; Raue, HP; Slifka, MK				Amanna, Ian J.; Raue, Hans-Peter; Slifka, Mark K.			Development of a new hydrogen peroxide-based vaccine platform	NATURE MEDICINE			English	Article							SYNCYTIAL VIRUS-DISEASE; T-CELL RESPONSES; ENCEPHALITIS-VIRUS; BETA-PROPIOLACTONE; MONKEYPOX VIRUS; IMMUNITY; MEMORY; IMMUNOGENICITY; PROTECTION; ANTIBODIES	Safe and effective vaccines are crucial for maintaining public health and reducing the global burden of infectious disease. Here we introduce a new vaccine platform that uses hydrogen peroxide (H2O2) to inactivate viruses for vaccine production. H2O2 rapidly inactivates both RNA and DNA viruses with minimal damage to antigenic structure or immunogenicity and is a highly effective method when compared with conventional vaccine inactivation approaches such as formaldehyde or beta-propiolactone. Mice immunized with H2O2-inactivated lymphocytic choriomeningitis virus (LCMV) generated cytolytic, multifunctional virus-specific CD8(+) T cells that conferred protection against chronic LCMV infection. Likewise, mice vaccinated with H2O2-inactivated vaccinia virus or H2O2-inactivated West Nile virus showed high virus-specific neutralizing antibody titers and were fully protected against lethal challenge. Together, these studies demonstrate that H2O2-based vaccines are highly immunogenic, provide protection against a range of viral pathogens in mice and represent a promising new approach to future vaccine development.	[Raue, Hans-Peter; Slifka, Mark K.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Amanna, Ian J.] Najit Technol, Beaverton, OR USA	Oregon Health & Science University; Oregon National Primate Research Center	Slifka, MK (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.	slifkam@ohsu.edu		Amanna, Ian/0000-0001-7545-4013	US National Institutes of Health [R56 AI076506, UO1 AI082196, R43 AI079898]; Oregon National Primate Research Center [8P51 OD011092-53]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI076506, R43AI079898, R44AI079898, U01AI082196] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Poore and M. Dubois for the growth of YFV and E. Hammarlund for the growth of monkeypox virus. This work was supported by US National Institutes of Health grants R56 AI076506 (to M. K. S.), UO1 AI082196 (to M. K. S.) and R43 AI079898 (to I.J.A. and M. K. S.) and Oregon National Primate Research Center grant 8P51 OD011092-53 (to M.K.S.).	Amanna IJ, 2008, HUM VACCINES, V4, P316, DOI 10.4161/hv.4.4.5751; Amanna IJ, 2009, ANTIVIR RES, V84, P119, DOI 10.1016/j.antiviral.2009.08.008; ANNUNZIATO D, 1982, PEDIATRICS, V70, P203; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; BROWN F, 1993, DEV BIOL STAND, V81, P103; CHANNON JY, 1985, PARASITOLOGY, V91, P197, DOI 10.1017/S0031182000057309; DeQueiroz GA, 2008, LETT APPL MICROBIOL, V46, P176, DOI 10.1111/j.1472-765X.2007.02283.x; Eckels Kenneth H, 2003, Adv Virus Res, V61, P395, DOI 10.1016/S0065-3527(03)61010-9; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Fiore AE, 2008, VACCINES; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Guenter T.E, 1988, ENCY CHEM PROCESSING, V27, P27; Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hammarlund E, 2008, P NATL ACAD SCI USA, V105, P14567, DOI 10.1073/pnas.0800589105; Hassett DE, 2000, J VIROL, V74, P8286, DOI 10.1128/JVI.74.18.8286-8291.2000; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LOGRIPPO GA, 1955, J IMMUNOL, V75, P123; Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303; Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023; NEIGHBOR NK, 1994, POULTRY SCI, V73, P1511, DOI 10.3382/ps.0731511; Ng T., 2003, VVolume 114, P221; Plotkin S, 2008, VACCINES; Plotkin S., 2008, VACCINES, P1; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Raue HP, 2007, J LEUKOCYTE BIOL, V81, P1165, DOI 10.1189/jlb.0806535; REED L. J., 1938, AMER JOUR HYG, V27, P493; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Schwarz K, 2005, EUR J IMMUNOL, V35, P816, DOI 10.1002/eji.200425755; Shrestha B, 2008, VACCINE, V26, P2020, DOI 10.1016/j.vaccine.2008.02.009; SIBER GR, 1991, VACCINE, V9, P735, DOI 10.1016/0264-410X(91)90289-I; Slifka MK, 1996, J VIROL, V70, P2902, DOI 10.1128/JVI.70.5.2902-2910.1996; Srivastava AK, 2001, VACCINE, V19, P4557, DOI 10.1016/S0264-410X(01)00208-0; Stauffer Fausto, 2006, Recent Pat Antiinfect Drug Discov, V1, P291, DOI 10.2174/157489106778777673; SWANSON MC, 1987, J INFECT DIS, V155, P909, DOI 10.1093/infdis/155.5.909; Sykes G, 1965, DISINFECTION STERILI; Termini J, 2000, MUTAT RES-FUND MOL M, V450, P107, DOI 10.1016/S0027-5107(00)00019-1; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001	40	79	86	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					974	+		10.1038/nm.2763	http://dx.doi.org/10.1038/nm.2763			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22635006	Bronze, Green Accepted			2022-12-27	WOS:000305116600037
J	Angelo, M; Bendall, SC; Finck, R; Hale, MB; Hitzman, C; Borowsky, AD; Levenson, RM; Lowe, JB; Liu, SD; Zhao, SC; Natkunam, Y; Nolan, GP				Angelo, Michael; Bendall, Sean C.; Finck, Rachel; Hale, Matthew B.; Hitzman, Chuck; Borowsky, Alexander D.; Levenson, Richard M.; Lowe, John B.; Liu, Scot D.; Zhao, Shuchun; Natkunam, Yasodha; Nolan, Garry P.			Multiplexed ion beam imaging of human breast tumors	NATURE MEDICINE			English	Article							MASS-SPECTROMETRY; PROTEIN EXPRESSION; CYTOMETRY; ANTIBODY; IMMUNOHISTOCHEMISTRY; QUANTIFICATION; CLUSTERS; TISSUES	Immunohistochemistry (IHC) is a tool for visualizing protein expression that is employed as part of the diagnostic workup for the majority of solid tissue malignancies. Existing IHC methods use antibodies tagged with fluorophores or enzyme reporters that generate colored pigments. Because these reporters exhibit spectral and spatial overlap when used simultaneously, multiplexed IHC is not routinely used in clinical settings. We have developed a method that uses secondary ion mass spectrometry to image antibodies tagged with isotopically pure elemental metal reporters. Multiplexed ion beam imaging (MIBI) is capable of analyzing up to 100 targets simultaneously over a five-log dynamic range. Here, we used MIBI to analyze formalin-fixed, paraffin-embedded human breast tumor tissue sections stained with ten labels simultaneously. The resulting data suggest that MIBI can provide new insights into disease pathogenesis that will be valuable for basic research, drug discovery and clinical diagnostics.	[Angelo, Michael; Bendall, Sean C.; Finck, Rachel; Hale, Matthew B.; Nolan, Garry P.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [Angelo, Michael] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Hitzman, Chuck] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Borowsky, Alexander D.; Levenson, Richard M.] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Lowe, John B.; Liu, Scot D.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Zhao, Shuchun; Natkunam, Yasodha] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University; University of California System; University of California Davis; Roche Holding; Genentech; Stanford University	Nolan, GP (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Bendall, Sean/AGG-0126-2022; Nolan, Garry/AAE-7903-2019; Natkunam, Yasodha/L-5454-2015; Borowsky, Alexander D/S-5404-2017	Natkunam, Yasodha/0000-0002-9816-1018; Angelo, Michael/0000-0003-1531-5067; Bendall, Sean/0000-0003-1341-2453; Nolan, Garry/0000-0002-8862-9043	Stanford Molecular Imaging Scholars Program through the US National Institutes of Health (NIH) [5R25CA11868107]; Damon Runyon Cancer Research Foundation [DRG-2017-09]; NIH [1K99 GM104148-01, 0158 G KB065, 1R01CA130826, 5U54CA143907, HHSN272200700038C, N01-HV-00242, 41000411217, 5-24927, P01 CA034233-22A1, PN2EY018228, RFA CA 09-009, RFA CA 09-011, U19 AI057229, U54CA149145]; Northrop-Grumman Corporation [7500108142 BISC]; US National Science Foundation [0922648]; California Institute for Regenerative Medicine [DR1-01477, RB2-01592]; European Commission [HEALTH.2010.1.2-1]; US FDA [HHSF223201210194C: BAA-12-00118]; US Department of Defense [W81XWH-12-1-0591 OCRP-TIA NWC]; Entertainment Industry Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA093373, U54CA149145, U54CA119367, F32CA009009, P50CA114747, F32CA009011, R25CA118681, R01CA130826, P01CA034233, U54CA143907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027582, S10RR027431] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI100627, U19AI057229, R01AI073724, P01AI036535, R01AI035304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM104148, K99GM104148] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016318] Funding Source: NIH RePORTER	Stanford Molecular Imaging Scholars Program through the US National Institutes of Health (NIH); Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northrop-Grumman Corporation; US National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); European Commission(European CommissionEuropean Commission Joint Research Centre); US FDA(United States Department of Health & Human Services); US Department of Defense(United States Department of Defense); Entertainment Industry Foundation; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Hubbard, C. Espiritu, S. Rost, L. Rangell and the Genentech Human Tissue Lab for assistance in preparing and processing tissue sections. We also thank A. Jager for technical support with CyTOF and antibody labeling. M.A. is supported by the Stanford Molecular Imaging Scholars Program through the US National Institutes of Health (NIH, 5R25CA11868107). S.C.B. is supported by the Damon Runyon Cancer Research Foundation Fellowship (DRG-2017-09) and NIH (1K99 GM104148-01). R.F. is supported by Northrop-Grumman Corporation (7500108142 BISC). This work was supported by a US National Science Foundation equipment grant (0922648) to the Stanford Nano Center for the NanoSIMS 50L analytical system used in the work here. This work was also supported by grants (to the Nolan lab) from the NIH (0158 G KB065, 1R01CA130826, 5U54CA143907, HHSN272200700038C, N01-HV-00242, 41000411217, 5-24927, P01 CA034233-22A1, P01 CA034233-22A1, PN2EY018228, RFA CA 09-009, RFA CA 09-011, U19 AI057229 and U54CA149145), the California Institute for Regenerative Medicine (DR1-01477 and RB2-01592), the European Commission (HEALTH.2010.1.2-1), the US FDA (HHSF223201210194C: BAA-12-00118), the US Department of Defense (W81XWH-12-1-0591 OCRP-TIA NWC) and the Entertainment Industry Foundation.	Aerni HR, 2009, ANAL CHEM, V81, P7490, DOI 10.1021/ac900974j; Anagnostou VK, 2010, CANCER EPIDEM BIOMAR, V19, P982, DOI 10.1158/1055-9965.EPI-10-0097; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Bodo J, 2009, J HISTOCHEM CYTOCHEM, V57, P701, DOI 10.1369/jhc.2009.953547; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Caprioli RM, 2008, PROTEOMICS, V8, P3679, DOI 10.1002/pmic.200890064; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Coons AH, 1942, J IMMUNOL, V45, P159; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Giesen C, 2011, ANAL CHEM, V83, P8177, DOI 10.1021/ac2016823; Glass G, 2009, J HISTOCHEM CYTOCHEM, V57, P899, DOI 10.1369/jhc.2009.953612; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Hasui K, 2003, J HISTOCHEM CYTOCHEM, V51, P1169, DOI 10.1177/002215540305100907; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lou XD, 2007, ANGEW CHEM INT EDIT, V46, P6111, DOI 10.1002/anie.200700796; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Ornatsky OI, 2008, J ANAL ATOM SPECTROM, V23, P463, DOI 10.1039/b710510j; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Rimm DL, 2006, NAT BIOTECHNOL, V24, P914, DOI 10.1038/nbt0806-914; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Schubert W, 2009, J PROTEOME RES, V8, P2696, DOI 10.1021/pr800944f; Seeley EH, 2008, PROTEOM CLIN APPL, V2, P1435, DOI 10.1002/prca.200800013; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Smith NS, 2008, APPL SURF SCI, V255, P1606, DOI 10.1016/j.apsusc.2008.05.141; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Tsurui H, 2000, J HISTOCHEM CYTOCHEM, V48, P653, DOI 10.1177/002215540004800509; Wahlby C, 2002, CYTOMETRY, V47, P32, DOI 10.1002/cyto.10026; Williams Peter, 2006, J Biol, V5, P18, DOI 10.1186/jbiol49; Wu B, 2011, INT J MASS SPECTROM, V307, P112, DOI 10.1016/j.ijms.2011.01.019	34	553	567	13	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					436	+		10.1038/nm.3488	http://dx.doi.org/10.1038/nm.3488			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24584119	Green Accepted			2022-12-27	WOS:000334361500026
J	Afshar-Sterle, S; Zotos, D; Bernard, NJ; Scherger, AK; Rodling, L; Alsop, AE; Walker, J; Masson, F; Belz, GT; Corcoran, LM; O'Reilly, LA; Strasser, A; Smyth, MJ; Johnstone, R; Tarlinton, DM; Nutt, SL; Kallies, A				Afshar-Sterle, Shoukat; Zotos, Dimitra; Bernard, Nicholas J.; Scherger, Anna K.; Roedling, Lisa; Alsop, Amber E.; Walker, Jennifer; Masson, Frederick; Belz, Gabrielle T.; Corcoran, Lynn M.; O'Reilly, Lorraine A.; Strasser, Andreas; Smyth, Mark J.; Johnstone, Ricky; Tarlinton, David M.; Nutt, Stephen L.; Kallies, Axel			Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas	NATURE MEDICINE			English	Article							NF-KAPPA-B; CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; PROTEIN EXPRESSION; GENE; PATHOGENESIS; MUTATIONS; RECEPTOR; CANCER	Loss of function of the tumor suppressor gene PRDM1 (also known as BLIMP1) or deregulated expression of the oncogene BCL6 occurs in a large proportion of diffuse large B cell lymphoma (DLBCL) cases. However, targeted mutation of either gene in mice leads to only slow and infrequent development of malignant lymphoma, and despite frequent mutation of BCL6 in activated B cells of healthy individuals, lymphoma development is rare. Here we show that T cells prevent the development of overt lymphoma in mice caused by Blimp1 deficiency or overexpression of Bcl6 in the B cell lineage. Impairment of T cell control results in rapid development of DLBCL-like disease, which can be eradicated by polyclonal CD8(+) T cells in a T cell receptor-, CD28- and Fas ligand-dependent manner. Thus, malignant transformation of mature B cells requires mutations that impair intrinsic differentiation processes and permit escape from T cell-mediated tumor surveillance.	[Afshar-Sterle, Shoukat; Zotos, Dimitra; Bernard, Nicholas J.; Scherger, Anna K.; Roedling, Lisa; Alsop, Amber E.; Walker, Jennifer; Masson, Frederick; Belz, Gabrielle T.; Corcoran, Lynn M.; O'Reilly, Lorraine A.; Strasser, Andreas; Tarlinton, David M.; Nutt, Stephen L.; Kallies, Axel] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Afshar-Sterle, Shoukat; Zotos, Dimitra; Bernard, Nicholas J.; Scherger, Anna K.; Roedling, Lisa; Alsop, Amber E.; Walker, Jennifer; Masson, Frederick; Belz, Gabrielle T.; Corcoran, Lynn M.; O'Reilly, Lorraine A.; Strasser, Andreas; Tarlinton, David M.; Nutt, Stephen L.; Kallies, Axel] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Johnstone, Ricky] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Johnstone, Ricky] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Queensland; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Kallies, A (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	kallies@wehi.edu.au	Strasser, Andreas/C-7581-2013; Nutt, Stephen L/C-9256-2013; Johnstone, Ricky w/H-3748-2014; Smyth, Mark J/H-8709-2014; Belz, Gabrielle T/C-9350-2013	Strasser, Andreas/0000-0002-5020-4891; Nutt, Stephen L/0000-0002-0020-6637; Johnstone, Ricky w/0000-0001-7053-9237; Smyth, Mark J/0000-0001-7098-7240; Belz, Gabrielle T/0000-0002-9660-9587; Tarlinton, David/0000-0001-9928-686X; Bernard, Nicholas/0000-0002-9483-7922; Kallies, Axel/0000-0002-6312-6968; Masson, Frederic/0000-0001-9909-2985	National Health and Medical Research Council of Australia; Australia Research Council; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute; Cancer Council Victoria; Cancer Australia; Cancer Council New South Wales; Leukemia & Lymphoma Society	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council(Australian Research Council); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Australia; Cancer Council New South Wales(Cancer Council New South Wales); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society)	We thank L. Pasqualucci (Columbia University) for Bcl6-transgenic mice, D. Yu (Monash University) for Cd28<SUP>-/-</SUP> mice, M. Reth (Albert-Ludwigs-Universitat) for Cd79a-Cre mice, L. Wu (Walter and Eliza Hall Institute of Medical Research (WEHI)) for MHC-I antibodies and A. Brooks (University of Melbourne) for antibodies, D. Gray (WEHI) for TCR antibodies, J. Markham for help with the statistical analysis, and P. Schneider (University of Lausanne) for the Fc-FasL. This work was supported by grants and fellowships from the National Health and Medical Research Council of Australia (G.T.B., L.M.C., S.L.N., D.M.T., A.K., A.S., M.J.S. and L.A.O.), the Australia Research Council (A.K., S.L.N.), the Sylvia and Charles Viertel Foundation and the Howard Hughes Medical Institute (A.K., G.T.B.), the Cancer Council Victoria (D.Z.), Cancer Australia and the Cancer Council New South Wales (L.A.O.), and the Leukemia & Lymphoma Society (A.K., L.A.O. and A.S.). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support scheme.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bolitho P, 2009, P NATL ACAD SCI USA, V106, P2723, DOI 10.1073/pnas.0809008106; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Challa-Malladi M, 2011, CANCER CELL, V20, P728, DOI 10.1016/j.ccr.2011.11.006; D'Costa K, 2009, BLOOD, V113, P5911, DOI 10.1182/blood-2008-08-172866; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Esser MT, 1996, J EXP MED, V183, P1697, DOI 10.1084/jem.183.4.1697; Frick M, 2012, BEST PRACT RES CL HA, V25, P3, DOI 10.1016/j.beha.2012.01.003; Harris J, 2012, HEMATOL ONCOL, V30, P8, DOI 10.1002/hon.996; He JS, 2010, J IMMUNOL, V184, P555, DOI 10.4049/jimmunol.0902465; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Kessler B, 1998, J IMMUNOL, V161, P6939; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Kojima Y, 2006, EUR J HAEMATOL, V76, P465, DOI 10.1111/j.1600-0609.2006.00631.x; Kolar GR, 2007, BLOOD, V109, P2545, DOI 10.1182/blood-2006-07-037150; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lee KS, 2009, CANCER RES, V69, P5481, DOI 10.1158/0008-5472.CAN-09-0291; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Marshall JL, 2011, EUR J IMMUNOL, V41, P3506, DOI 10.1002/eji.201141762; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2002, TRENDS IMMUNOL, V23, P75, DOI 10.1016/S1471-4906(01)02115-9; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Novac N, 2006, FASEB J, V20, P1074, DOI 10.1096/fj.05-5457com; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Salek-Ardakani S, 2011, J IMMUNOL, V186, P5294, DOI 10.4049/jimmunol.1100406; Schneider C, 2011, SEMIN DIAGN PATHOL, V28, P167, DOI 10.1053/j.semdp.2011.04.001; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Shanker A, 2009, CANCER RES, V69, P6615, DOI 10.1158/0008-5472.CAN-09-0685; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Stel AJ, 2007, J IMMUNOL, V178, P2287, DOI 10.4049/jimmunol.178.4.2287; Stopeck AT, 2000, CLIN CANCER RES, V6, P3904; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Willimsky G, 2007, IMMUNOL REV, V220, P102, DOI 10.1111/j.1600-065X.2007.00578.x; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031	59	67	70	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					283	290		10.1038/nm.3442	http://dx.doi.org/10.1038/nm.3442			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24487434				2022-12-27	WOS:000332595600023
J	Buzon, MJ; Sun, H; Li, C; Shaw, A; Seiss, K; Ouyang, ZY; Martin-Gayo, E; Leng, J; Henrich, TJ; Li, JZ; Pereyra, F; Zurakowski, R; Walker, BD; Rosenberg, ES; Yu, XG; Lichterfeld, M				Buzon, Maria J.; Sun, Hong; Li, Chun; Shaw, Amy; Seiss, Katherine; Ouyang, Zhengyu; Martin-Gayo, Enrique; Leng, Jin; Henrich, Timothy J.; Li, Jonathan Z.; Pereyra, Florencia; Zurakowski, Ryan; Walker, Bruce D.; Rosenberg, Eric S.; Yu, Xu G.; Lichterfeld, Mathias			HIV-1 persistence in CD4(+) T cells with stem cell like properties	NATURE MEDICINE			English	Article							MEMORY; DIFFERENTIATION; PRECURSORS; INFECTION; CURE	Cellular HIV-1 reservoirs that persist despite antiretroviral treatment are incompletely defined. We show that during suppressive antiretroviral therapy, CD4(+) T memory stem cells (T-SCM cells) harbor high per-cell levels of HIV-1 DNA and make increasing contributions to the total viral CD4(+) T cell reservoir over time. Moreover, we conducted phylogenetic studies that suggested long-term persistence of viral quasispecies in CD4(+) T-SCM cells. Thus, HIV-1 may exploit the stem cell characteristics of cellular immune memory to promote long-term viral persistence.	[Buzon, Maria J.; Rosenberg, Eric S.; Lichterfeld, Mathias] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Buzon, Maria J.; Sun, Hong; Li, Chun; Shaw, Amy; Seiss, Katherine; Ouyang, Zhengyu; Martin-Gayo, Enrique; Leng, Jin; Pereyra, Florencia; Walker, Bruce D.; Yu, Xu G.] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA; [Sun, Hong] China Med Univ, Affiliated Hosp 1, Key Lab AIDS Immunol, Dept Lab Med, Shenyang, Peoples R China; [Henrich, Timothy J.; Li, Jonathan Z.; Pereyra, Florencia] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Zurakowski, Ryan] Univ Delaware, Dept Elect & Comp Engn, Newark, DE USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; China Medical University; Harvard University; Brigham & Women's Hospital; University of Delaware; Howard Hughes Medical Institute	Lichterfeld, M (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	mlichterfeld@partners.org	Buzon, Maria J/G-8286-2015; Gayo, Enrique Martin/AAK-4273-2021; Ouyang, Zhengyu/P-3576-2014; Lichterfeld, Mathias/B-2042-2008	Buzon, Maria J/0000-0003-4427-9413; Lichterfeld, Mathias/0000-0001-9865-8350; Zurakowski, Ryan/0000-0003-3726-3114; Martin-Gayo, Enrique/0000-0002-2619-6086	American Foundation for AIDS Research [108302-51-RGRL]; US National Institutes of Health [AI098487, AI106468, AI089339, AI098480, AI100699, AI074415]; Clinical Scientist Development Award from the Doris Duke Charitable Foundation [2009034]; European Molecular Biology Laboratory; Tosteson postdoctoral fellowship award from Massachusetts General Hospital; Mark and Lisa Schwartz Foundation; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098487, R01AI089339, P01AI074415, K08AI100699, R21AI106468, K23AI098480] Funding Source: NIH RePORTER	American Foundation for AIDS Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Scientist Development Award from the Doris Duke Charitable Foundation; European Molecular Biology Laboratory; Tosteson postdoctoral fellowship award from Massachusetts General Hospital; Mark and Lisa Schwartz Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the American Foundation for AIDS Research (grant 108302-51-RGRL to M.L.) and by the US National Institutes of Health (grants AI098487 and AI106468 to M.L., AI089339 to X.G.Y., AI098480 to T.J.H. and AI100699 to J.Z.L.). M.L. is a recipient of the Clinical Scientist Development Award from the Doris Duke Charitable Foundation (grant number 2009034). M.J.B. is supported by a fellowship award from the European Molecular Biology Laboratory and by the Tosteson postdoctoral fellowship award from Massachusetts General Hospital. Patient blood sample collection was supported by the US National Institutes of Health (grant AI074415), by the Mark and Lisa Schwartz Foundation and by the Bill & Melinda Gates Foundation. Chronically infected 293T cells were kindly provided by F. Bushman (University of Pennsylvania). HIV-1 isolates were kindly provided by D. Littman (New York University).	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Cieri N, 2013, BLOOD, V121, P573, DOI 10.1182/blood-2012-05-431718; Emerson Stephen G, 2008, Trans Am Clin Climatol Assoc, V119, P289; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Papatriantafyllou M, 2011, NAT REV IMMUNOL, V11, P716, DOI 10.1038/nri3098; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478	18	303	312	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					139	142		10.1038/nm.3445	http://dx.doi.org/10.1038/nm.3445			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412925	Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000330915000014
J	Huang, Y; DiDonato, JA; Levison, BS; Schmitt, D; Li, L; Wu, YP; Buffa, J; Kim, T; Gerstenecker, GS; Gu, XD; Kadiyala, CS; Wang, ZN; Culley, MK; Hazen, JE; DiDonato, AJ; Fu, XM; Berisha, SZ; Peng, DQ; Nguyen, TT; Liang, SH; Chuang, CC; Cho, L; Plow, EF; Fox, PL; Gogonea, V; Tang, WHW; Parks, JS; Fisher, EA; Smith, JD; Hazen, SL				Huang, Ying; DiDonato, Joseph A.; Levison, Bruce S.; Schmitt, Dave; Li, Lin; Wu, Yuping; Buffa, Jennifer; Kim, Timothy; Gerstenecker, Gary S.; Gu, Xiaodong; Kadiyala, Chandra S.; Wang, Zeneng; Culley, Miranda K.; Hazen, Jennie E.; DiDonato, Anthony J.; Fu, Xiaoming; Berisha, Stela Z.; Peng, Daoquan; Nguyen, Truc T.; Liang, Shaohong; Chuang, Chia-Chi; Cho, Leslie; Plow, Edward F.; Fox, Paul L.; Gogonea, Valentin; Tang, W. H. Wilson; Parks, John S.; Fisher, Edward A.; Smith, Jonathan D.; Hazen, Stanley L.			An abundant dysfunctional apolipoprotein A1 in human atheroma	NATURE MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; RANDOMIZED CONTROLLED-TRIAL; HYPOCHLOROUS ACID; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ANTIINFLAMMATORY PROPERTIES; SERUM PARAOXONASE; ARTERY WALL; APOA-I	Recent studies have indicated that high-density lipoproteins (HDLs) and their major structural protein, apolipoprotein A1 (apoA1), recovered from human atheroma are dysfunctional and are extensively oxidized by myeloperoxidase (MPO). In vitro oxidation of either apoA1 or HDL particles by MPO impairs their cholesterol acceptor function. Here, using phage display affinity maturation, we developed a high-affinity monoclonal antibody that specifically recognizes both apoA1 and HDL that have been modified by the MPO-H2O2-Cl- system. An oxindolyl alanine (2-OH-Trp) moiety at Trp72 of apoA1 is the immunogenic epitope. Mutagenesis studies confirmed a critical role for apoAl Trp72 in MPO-mediated inhibition of the ATP-binding cassette transporter A1 (ABCA1)-dependent cholesterol acceptor activity of apoAl in vitro and in vivo. ApoA1 containing a 2-OH-Trp72 group (oxTrp72-apoA1) is in low abundance within the circulation but accounts for 20% of the apoA1 in atherosclerosis-laden arteries. OxTrp72-apoA1 recovered from human atheroma or plasma is lipid poor, virtually devoid of cholesterol acceptor activity and demonstrated both a potent proinflammatory activity on endothelial cells and an impaired HDL biogenesis activity in vivo. Elevated oxTrp72-apoA1 levels in subjects presenting to a cardiology clinic (n = 627) were associated with increased cardiovascular disease risk. Circulating oxTrp72-apoA1 levels may serve as a way to monitor a proatherogenic process in the artery wall.	[Huang, Ying; DiDonato, Joseph A.; Levison, Bruce S.; Schmitt, Dave; Li, Lin; Buffa, Jennifer; Kim, Timothy; Gerstenecker, Gary S.; Gu, Xiaodong; Kadiyala, Chandra S.; Wang, Zeneng; Culley, Miranda K.; Hazen, Jennie E.; DiDonato, Anthony J.; Fu, Xiaoming; Berisha, Stela Z.; Peng, Daoquan; Nguyen, Truc T.; Cho, Leslie; Fox, Paul L.; Gogonea, Valentin; Tang, W. H. Wilson; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Wu, Yuping] Cleveland State Univ, Dept Math, Cleveland, OH 44115 USA; [Gerstenecker, Gary S.; Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Liang, Shaohong] Cleveland Heart Lab, Cleveland, OH USA; [Chuang, Chia-Chi; Parks, John S.] Wake Forest Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC USA; [Cho, Leslie; Plow, Edward F.; Tang, W. H. Wilson; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Parks, John S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Fisher, Edward A.] NYU, Sch Med, Dept Cardiovasc Med, New York, NY USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University; Wake Forest University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Wake Forest University; New York University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.	hazens@ccf.org	Fisher, Edward/ABE-7469-2020; Wang, Zeneng/AAK-6119-2021; Hazen, Stanley L/ABD-5845-2021; Tang, Wai Hong Wilson/I-1238-2013; Smith, Jonathan D./H-9723-2013	Key, Chia-Chi/0000-0003-0669-2936; Levison, Bruce/0000-0002-1816-368X; Smith, Jonathan D./0000-0002-0415-386X; Tang, W. H. Wilson/0000-0002-8335-735X; Fisher, Edward/0000-0001-9802-143X	US National Institutes of Health (NIH) grants [P01HL098055, HL119962]; NIH [P01HL098055, P01HL076491, R01HL103866, P20HL113452, R01HL103931]; LeDucq Fondation; Leonard Krieger Fund; Center of Innovation; AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, R01HL103866, R01HL103931, R01HL017964, P20HL113452, P01HL076491, R01HL094525, R01HL119962] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LeDucq Fondation; Leonard Krieger Fund; Center of Innovation; AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Liang (Chinese Center for Disease Control and Prevention) for the gift of the dicistronic baculoviral shuttle vector used to subdone the scEv gene. This study was supported by US National Institutes of Health (NIH) grants P01HL098055 and HL119962. BioBank, the clinical study from which samples were analyzed, was supported in part from NIH grants P01HL098055, P01HL076491, R01HL103866, P20HL113452 and R01HL103931. This work was also supported in part by a grant from the LeDucq Fondation. S.L.H. is also partially supported by a gift from the Leonard Krieger Fund. Mass spectrometry instrumentation used was housed within the Cleveland Clinic Mass Spectrometry Facility, which is partially supported through a Center of Innovation Award by AB SCIEX.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; BADIMON JJ, 1989, LAB INVEST, V60, P455; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Baldus S, 2001, J CLIN INVEST, V108, P1759; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Barter PJ, 2006, J AM COLL CARDIOL, V47, P492, DOI 10.1016/j.jacc.2005.09.042; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Charles-Schoeman C, 2007, J RHEUMATOL, V34, P1459; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Gogonea V, 2013, J LIPID RES, V54, P966, DOI 10.1194/jlr.M032763; Gogonea V, 2010, BIOCHEMISTRY-US, V49, P7323, DOI 10.1021/bi100588a; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210; Hughes SD, 1997, ARTERIOSCL THROM VAS, V17, P1725, DOI 10.1161/01.ATV.17.9.1725; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Nahrendorf M, 2008, CIRCULATION, V117, P1153, DOI 10.1161/CIRCULATIONAHA.107.756510; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Ronald JA, 2009, CIRCULATION, V120, P592, DOI 10.1161/CIRCULATIONAHA.108.813998; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Sugiyama S, 2004, ARTERIOSCL THROM VAS, V24, P1309, DOI 10.1161/01.ATV.0000131784.50633.4f; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P2803, DOI 10.1161/ATVBAHA.112.253930; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	53	271	285	1	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					193	203		10.1038/nm.3459	http://dx.doi.org/10.1038/nm.3459			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24464187	Green Accepted, Green Submitted			2022-12-27	WOS:000330915000021
J	Haque, A; Engwerda, C				Haque, Ashraful; Engwerda, Christian			Hepatocytes break the silence during liver-stage malaria	NATURE MEDICINE			English	Editorial Material									[Haque, Ashraful; Engwerda, Christian] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute	Haque, A (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	christian.engwerda@qimrberghofer.edu.au	Engwerda, Christian/I-3072-2015; Haque, Ashraful/H-8697-2014	Haque, Ashraful/0000-0003-2260-0026; Engwerda, Christian/0000-0003-2813-4804				Ball EA, 2013, J IMMUNOL, V190, P5118, DOI 10.4049/jimmunol.1300114; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Engwerda CR, 2005, TRENDS PARASITOL, V21, P75, DOI 10.1016/j.pt.2004.11.008; Haque A, 2011, EUR J IMMUNOL, V41, P2688, DOI 10.1002/eji.201141539; Liehl P, 2014, NAT MED, V20, P47, DOI 10.1038/nm.3424; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824	8	3	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					17	20		10.1038/nm.3446	http://dx.doi.org/10.1038/nm.3446			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398958				2022-12-27	WOS:000329349400011
J	Obermeier, B; Daneman, R; Ransohoff, RM				Obermeier, Birgit; Daneman, Richard; Ransohoff, Richard M.			Development, maintenance and disruption of the blood-brain barrier	NATURE MEDICINE			English	Review							PROTEIN-COUPLED RECEPTOR; GROWTH-FACTOR-BETA; IN-VITRO MODEL; KINASE-C-DELTA; NEUROMYELITIS-OPTICA; ENDOTHELIAL-CELLS; MULTIPLE-SCLEROSIS; NEUROVASCULAR UNIT; PDGF-B; CEREBROVASCULAR INTEGRITY	The interface between the blood circulation and the neural tissue features unique characteristics that are encompassed by the term 'blood-brain barrier' (BBB). The main functions of this barrier, namely maintenance of brain homeostasis, regulation of influx and efflux transport, and protection from harm, are determined by its specialized multicellular structure. Every constituent cell type makes an indispensable contribution to the BBB's integrity. But if one member of the BBB fails, and as a result the barrier breaks down, there can be dramatic consequences and neuroinflammation and neurodegeneration can occur. In this Review, we highlight recently gained mechanistic insights into the development and maintenance of the BBB. We then discuss how BBB disruption can cause or contribute to neurological disease. Finally, we examine how this knowledge can be used to explore new possibilities for BBB repair.	[Obermeier, Birgit; Ransohoff, Richard M.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA; [Daneman, Richard] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Cleveland Clinic Foundation; University of California System; University of California San Francisco	Ransohoff, RM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA.	ransohr@ccf.org	Ritter, Stefanie L/D-9312-2012	Obermeier, Birgit/0000-0002-9248-684X	US National Insititutes of Health [R21 NS074820]; Guthy Jackson Charitable Foundation; Program for Breakthrough Biomedical Sciences; American Heart Association; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074820, K24NS051400] Funding Source: NIH RePORTER	US National Insititutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy Jackson Charitable Foundation; Program for Breakthrough Biomedical Sciences; American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	R.M.R. is supported by US National Insititutes of Health grant R21 NS074820 and the Guthy Jackson Charitable Foundation. R.D. is supported by the Program for Breakthrough Biomedical Sciences and the American Heart Association. B.O. is supported by a two-year Research Fellowship from the Deutsche Forschungsgemeinschaft.	Abbott NJ, 2012, METHODS MOL BIOL, V814, P415, DOI 10.1007/978-1-61779-452-0_28; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Allt G, 2001, CELLS TISSUES ORGANS, V169, P1, DOI 10.1159/000047855; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Auletta JJ, 2012, IMMUNOTHERAPY-UK, V4, P529, DOI [10.2217/IMT.12.41, 10.2217/imt.12.41]; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Bartels AL, 2008, J NEURAL TRANSM, V115, P1001, DOI 10.1007/s00702-008-0030-y; Bartynski WS, 2008, AM J NEURORADIOL, V29, P1036, DOI 10.3174/ajnr.A0928; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Blecharz KG, 2010, MULT SCLER J, V16, P293, DOI 10.1177/1352458509358189; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Cayrol R, 2009, ANN NY ACAD SCI, V1173, P478, DOI 10.1111/j.1749-6632.2009.04871.x; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chou WH, 2004, J CLIN INVEST, V114, P49, DOI 10.1172/JC1200421655; Combes V, 2012, TRENDS PARASITOL, V28, P311, DOI 10.1016/j.pt.2012.05.008; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Cree BAC, 2002, SEMIN NEUROL, V22, P105, DOI 10.1055/s-2002-36534; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Cristante E, 2013, P NATL ACAD SCI USA, V110, P832, DOI 10.1073/pnas.1209362110; Cucullo L, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-18; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Davis SM, 2012, NEW ENGL J MED, V366, P1914, DOI 10.1056/NEJMcp1107281; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dolghih E, 2013, ACS CHEM NEUROSCI, V4, P361, DOI 10.1021/cn3001922; Dong LJ, 2002, LAB INVEST, V82, P1617, DOI 10.1097/01.LAB.0000042240.52093.0F; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Evans MC, 2013, MOL CELL NEUROSCI, V53, P34, DOI 10.1016/j.mcn.2012.10.008; Fabene PF, 2013, MOL IMMUNOL, V55, P100, DOI 10.1016/j.molimm.2012.12.009; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; FIESCHI C, 1980, LIFE SCI, V27, P239, DOI 10.1016/0024-3205(80)90143-5; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Forster C, 2007, J PHYSIOL-LONDON, V580, P937, DOI 10.1113/jphysiol.2007.129007; French JA, 2008, NEW ENGL J MED, V359, P166, DOI 10.1056/NEJMcp0801738; Garbuzova-Davis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001205; Garbuzova-Davis S, 2011, BRAIN RES, V1398, P113, DOI 10.1016/j.brainres.2011.04.049; Gee JR, 2005, INT J BIOCHEM CELL B, V37, P1145, DOI 10.1016/j.biocel.2004.10.004; Geldenhuys WJ, 2012, EXPERT OPIN DRUG MET, V8, P647, DOI 10.1517/17425255.2012.677433; Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6; GO KG, 1994, ACTA NEUROCHIR, P101; Gowdie P, 2012, J CHILD NEUROL, V27, P1448, DOI 10.1177/0883073812459352; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; Gursoy-Ozdemir Y, 2012, J NEUROCHEM, V123, P2, DOI 10.1111/j.1471-4159.2012.07938.x; Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Hajj-Ali RA, 2013, AUTOIMMUN REV, V12, P463, DOI 10.1016/j.autrev.2012.08.004; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; Hosokawa T, 2011, J NEUROIMMUNOL, V236, P81, DOI 10.1016/j.jneuroim.2011.04.009; Igarashi Y, 1999, BIOCHEM BIOPH RES CO, V261, P108, DOI 10.1006/bbrc.1999.0992; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Janigro D, 2012, EPILEPSIA, V53, P26, DOI 10.1111/j.1528-1167.2012.03472.x; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Kim SH, 2013, J CLIN NEUROL, V9, P36, DOI 10.3988/jcn.2013.9.1.36; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Kleinschmidt-DeMasters BK, 2012, J NEUROPATH EXP NEUR, V71, P604, DOI 10.1097/NEN.0b013e31825caf2c; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liebner S, 2011, INT J DEV BIOL, V55, P467, DOI 10.1387/ijdb.103224sl; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu M, 2012, CLIN EXP PHARMACOL P, V39, P577, DOI 10.1111/j.1440-1681.2011.05650.x; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lyck R, 2009, J CEREBR BLOOD F MET, V29, P1491, DOI 10.1038/jcbfm.2009.72; Madden JA, 2012, NEUROLOGY, V79, pS58, DOI 10.1212/WNL.0b013e3182695836; Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; MILLER DH, 1992, J NEUROL NEUROSUR PS, V55, P450, DOI 10.1136/jnnp.55.6.450; Milner R, 2002, MOL CELL NEUROSCI, V20, P616, DOI 10.1006/mcne.2002.1151; MILSTED A, 1990, P NATL ACAD SCI USA, V87, P5720, DOI 10.1073/pnas.87.15.5720; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Miyazaki K, 2011, J NEUROSCI RES, V89, P718, DOI 10.1002/jnr.22594; Mogi M, 2011, CIRC J, V75, P1042, DOI 10.1253/circj.CJ-11-0121; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; NEUHAUS J, 1990, GLIA, V3, P241, DOI 10.1002/glia.440030403; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nicaise C, 2009, BRAIN RES, V1301, P152, DOI 10.1016/j.brainres.2009.09.018; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Olmez I, 2012, NEUROCHEM INT, V60, P208, DOI 10.1016/j.neuint.2011.11.009; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osada T, 2011, J CEREBR BLOOD F MET, V31, P1972, DOI 10.1038/jcbfm.2011.99; Palmer AM, 2010, NEUROBIOL DIS, V37, P3, DOI 10.1016/j.nbd.2009.07.029; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Raab S, 2004, THROMB HAEMOSTASIS, V91, P595, DOI 10.1160/TH03-09-0582; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Rapoport SI, 2000, CELL MOL NEUROBIOL, V20, P217, DOI 10.1023/A:1007049806660; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Robberecht W, 2000, J NEUROL, V247, P1; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sa-Pereira I, 2012, MOL NEUROBIOL, V45, P327, DOI 10.1007/s12035-012-8244-2; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sagare AP, 2012, COLD SPRING HARB PER, V2; Sanchez-del-Rio M, 2004, CURR OPIN NEUROL, V17, P289, DOI 10.1097/01.wco.0000130296.31707.a3; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shawahna R, 2011, MOL PHARMACEUT, V8, P1332, DOI 10.1021/mp200129p; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Shimizu F, 2012, J NEUROL NEUROSUR PS, V83, P288, DOI 10.1136/jnnp-2011-300434; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; Sohet F, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-3; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; STEWART PA, 1981, DEV BIOL, V84, P183, DOI 10.1016/0012-1606(81)90382-1; Sumi N, 2010, CELL MOL NEUROBIOL, V30, P247, DOI 10.1007/s10571-009-9446-7; Sun D, 1997, AM J PHYSIOL-CELL PH, V272, pC1829, DOI 10.1152/ajpcell.1997.272.6.C1829; SUZUKI R, 1983, ACTA NEUROPATHOL, V60, P207, DOI 10.1007/BF00691868; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Takeuchi H, 2007, J NEURO-ONCOL, V84, P141, DOI 10.1007/s11060-007-9363-x; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Thanabalasundaram G, 2011, METHODS MOL BIOL, V686, P379, DOI 10.1007/978-1-60761-938-3_19; Tomizawa Y, 2012, J INT MED RES, V40, P1483, DOI 10.1177/147323001204000427; Urich E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038149; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Vandenhaute E, 2011, CURR NEUROVASC RES, V8, P258, DOI 10.2174/156720211798121016; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Wang J, 2006, J NEUROCHEM, V96, P148, DOI 10.1111/j.1471-4159.2005.03521.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Williams K, 2001, GLIA, V36, P156, DOI 10.1002/glia.1105; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Wolburg H, 2012, MOL ASPECTS MED, V33, P579, DOI 10.1016/j.mam.2012.02.003; Wosik K, 2007, J NEUROSCI, V27, P9032, DOI 10.1523/JNEUROSCI.2088-07.2007; Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhu JW, 2002, DEVELOPMENT, V129, P2891; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	180	1236	1295	26	341	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1584	1596		10.1038/nm.3407	http://dx.doi.org/10.1038/nm.3407			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24309662	Green Accepted			2022-12-27	WOS:000328181400027
J	Qiang, XL; Yang, WL; Wu, RQ; Zhou, M; Jacob, A; Dong, WF; Kuncewitch, M; Ji, YX; Yang, H; Wang, HC; Fujita, J; Nicastro, J; Coppa, GF; Tracey, KJ; Wang, P				Qiang, Xiaoling; Yang, Weng-Lang; Wu, Rongqian; Zhou, Mian; Jacob, Asha; Dong, Weifeng; Kuncewitch, Michael; Ji, Youxin; Yang, Huan; Wang, Haichao; Fujita, Jun; Nicastro, Jeffrey; Coppa, Gene F.; Tracey, Kevin J.; Wang, Ping			Cold-inducible RNA-binding protein (CIRP) triggers inflammatory responses in hemorrhagic shock and sepsis	NATURE MEDICINE			English	Article							ACTIVATION; EXPRESSION; HMGB1; RECEPTORS; ENDOTOXIN; CELLS; TLR4; MD-2; ADRENOMEDULLIN; IDENTIFICATION	A systemic inflammatory response is observed in patients undergoing hemorrhagic shock and sepsis. Here we report increased levels of cold-inducible RNA-binding protein (CIRP) in the blood of individuals admitted to the surgical intensive care unit with hemorrhagic shock. In animal models of hemorrhage and sepsis, CIRP is upregulated in the heart and liver and released into the circulation. In macrophages under hypoxic stress, CIRP translocates from the nucleus to the cytosol and is released. Recombinant CIRP stimulates the release of tumor necrosis factor-alpha (TNF-alpha) and HMGB1 from macrophages and induces inflammatory responses and causes tissue injury when injected in vivo. Hemorrhage-induced TNF-alpha and HMGB1 release and lethality were reduced in CIRP-deficient mice. Blockade of CIRP using antisera to CIRP attenuated inflammatory cytokine release and mortality after hemorrhage and sepsis. The activity of extracellular CIRP is mediated through the Toll-like receptor 4 (TLR4)-myeloid differentiation factor 2 (MD2) complex. Surface plasmon resonance analysis indicated that CIRP binds to the TLR4-MD2 complex, as well as to TLR4 and MD2 individually. In particular, human CIRP amino acid residues 106-125 bind to MD2 with high affinity. Thus, CIRP is a damage-associated molecular pattern molecule that promotes inflammatory responses in shock and sepsis.	[Qiang, Xiaoling; Yang, Weng-Lang; Wu, Rongqian; Zhou, Mian; Jacob, Asha; Dong, Weifeng; Kuncewitch, Michael; Ji, Youxin; Nicastro, Jeffrey; Coppa, Gene F.; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA; [Yang, Huan; Wang, Haichao; Tracey, Kevin J.] Feinstein Inst Med Res, Ctr Biomed Sci, Manhasset, NY USA; [Fujita, Jun] Kyoto Univ, Dept Clin Mol Biol, Kyoto, Japan	Northwell Health; Northwell Health; Kyoto University	Wang, P (corresponding author), Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA.	pwang@nshs.edu	Wu, Rongqian/I-3614-2012; Wang, Haichao/AAU-2237-2021; ji, youxin/F-3802-2014; Qiang, Lynn Xiaoling/GRS-4786-2022; Varghese, Asha/AAK-4922-2021; Wang, Haichao/K-6310-2012; ji, youxin/F-3802-2014	Wu, Rongqian/0000-0003-0993-4531; Wang, Haichao/0000-0002-0211-9000; ji, youxin/0000-0003-2895-4730; Qiang, Lynn Xiaoling/0000-0001-9176-7407; Wang, Haichao/0000-0002-0211-9000; Wang, Ping/0000-0002-1557-0394; Tracey, Kevin J/0000-0003-1884-6314; ji, youxin/0000-0003-2303-8784	US National Institutes of Health (NIH) [HL076179, GM053008]; NIH [S10OD012042]; Smoking Research Foundation of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM053008, R01GM053008] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012042] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smoking Research Foundation of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health (NIH) grants HL076179 and GM053008 (P. W.). We thank H. Erlandsson-Harris (Karolinska Institute) for providing Ager<SUP>-/-</SUP>, Tlr2<SUP>-/-</SUP> and Tlr4<SUP>-/-</SUP> mice, M. Hu, J.H. Li and L. M. Corbo for technical assistance, L. Caracappa for editorial assistance and Y. Al-Abed and A. Ragab for assistance with SPR analysis. The BIAcore instrument was supported by NIH grant S10OD012042. J.F. was partly supported by the Smoking Research Foundation of Japan.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Benhamou Y, 2009, CRIT CARE MED, V37, P1724, DOI 10.1097/CCM.0b013e31819da805; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Brochu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057426; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Cammas A, 2008, BIOCHEM PHARMACOL, V76, P1395, DOI 10.1016/j.bcp.2008.05.022; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Henderson B, 2010, CELL STRESS CHAPERON, V15, P123, DOI 10.1007/s12192-009-0137-6; Holcomb JB, 2011, SHOCK, V35, P107, DOI 10.1097/SHK.0b013e3181f7fd01; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Kaczorowski DJ, 2008, J LEUKOCYTE BIOL, V83, P546, DOI 10.1189/jlb.0607374; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miksa M, 2009, J IMMUNOL, V183, P5983, DOI 10.4049/jimmunol.0802994; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nishiyama H, 1998, BIOCHEM BIOPH RES CO, V245, P534, DOI 10.1006/bbrc.1998.8482; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Nishiyama H, 1998, AM J PATHOL, V152, P289; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Qu Y, 2009, PURINERG SIGNAL, V5, P163, DOI 10.1007/s11302-009-9132-8; Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sheikh MS, 1997, J BIOL CHEM, V272, P26720, DOI 10.1074/jbc.272.42.26720; Shin HJ, 2007, MOL CELLS, V24, P119; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang Y, 2005, J IMMUNOL, V174, P3306, DOI 10.4049/jimmunol.174.6.3306; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Ward PA, 2009, NAT MED, V15, P497, DOI 10.1038/nm0509-497; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Wu RQ, 2005, ANN SURG, V242, P115, DOI 10.1097/01.sla.0000167849.10599.30; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Xue JH, 1999, FREE RADICAL BIO MED, V27, P1238, DOI 10.1016/S0891-5849(99)00158-6; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang RQ, 2010, J BIOL CHEM, V285, P8887, DOI 10.1074/jbc.M109.013128; Yang SL, 2002, ANN SURG, V236, P625, DOI 10.1097/00000658-200211000-00013; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	54	237	255	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1489	+		10.1038/nm.3368	http://dx.doi.org/10.1038/nm.3368			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24097189	Green Accepted			2022-12-27	WOS:000326920300026
J	Zouggari, Y; Ait-Oufella, H; Bonnin, P; Simon, T; Sage, AP; Guerin, C; Vilar, J; Caligiuri, G; Tsiantoulas, D; Laurans, L; Dumeau, E; Kotti, S; Bruneval, P; Charo, IF; Binder, CJ; Danchin, N; Tedgui, A; Tedder, TF; Silvestre, JS; Mallat, Z				Zouggari, Yasmine; Ait-Oufella, Hafid; Bonnin, Philippe; Simon, Tabassome; Sage, Andrew P.; Guerin, Coralie; Vilar, Jose; Caligiuri, Giuseppina; Tsiantoulas, Dimitrios; Laurans, Ludivine; Dumeau, Edouard; Kotti, Salma; Bruneval, Patrick; Charo, Israel F.; Binder, Christoph J.; Danchin, Nicolas; Tedgui, Alain; Tedder, Thomas F.; Silvestre, Jean-Sebastien; Mallat, Ziad			B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction	NATURE MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ANTI-C5 COMPLEMENT ANTIBODY; ADJUNCTIVE THERAPY; BONE-MARROW; PEXELIZUMAB; CELLS; IGM; INHIBITION; DISEASE; INJURY	Acute myocardial infarction is a severe ischemic disease responsible for heart failure and sudden death. Here, we show that after acute myocardial infarction in mice, mature B lymphocytes selectively produce Ccl7 and induce Ly6C(hi) monocyte mobilization and recruitment to the heart, leading to enhanced tissue injury and deterioration of myocardial function. Genetic (Baff receptor deficiency) or antibody-mediated (CD20- or Baff-specific antibody) depletion of mature B lymphocytes impeded Ccl7 production and monocyte mobilization, limited myocardial injury and improved heart function. These effects were recapitulated in mice with B cell-selective Ccl7 deficiency. We also show that high circulating concentrations of CCL7 and BAFF in patients with acute myocardial infarction predict increased risk of death or recurrent myocardial infarction. This work identifies a crucial interaction between mature B lymphocytes and monocytes after acute myocardial ischemia and identifies new therapeutic targets for acute myocardial infarction.	[Zouggari, Yasmine; Ait-Oufella, Hafid; Guerin, Coralie; Vilar, Jose; Laurans, Ludivine; Dumeau, Edouard; Bruneval, Patrick; Tedgui, Alain; Silvestre, Jean-Sebastien; Mallat, Ziad] INSERM, Paris Cardiovasc Res Ctr, Unit 970, Paris, France; [Zouggari, Yasmine; Ait-Oufella, Hafid; Guerin, Coralie; Vilar, Jose; Laurans, Ludivine; Dumeau, Edouard; Bruneval, Patrick; Tedgui, Alain; Silvestre, Jean-Sebastien] Univ Paris 05, Paris, France; [Ait-Oufella, Hafid; Simon, Tabassome] Univ Paris 06, AP HP, Paris, France; [Bonnin, Philippe] Univ Paris 06, Hop Lariboisiere, AP HP, Sorbonne Paris Cite,INSERM,Unit 965, Paris, France; [Simon, Tabassome; Kotti, Salma] Hop St Antoine, Unite Rech Clin Est Parisien, F-75571 Paris, France; [Sage, Andrew P.; Mallat, Ziad] Univ Cambridge, Addenbrookes Hosp, Div Cardiovasc Med, Cambridge CB2 2QQ, England; [Caligiuri, Giuseppina] INSERM, Unit 698, Paris, France; [Tsiantoulas, Dimitrios; Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Tsiantoulas, Dimitrios; Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria; [Bruneval, Patrick; Danchin, Nicolas] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Paris, France; [Charo, Israel F.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Tedder, Thomas F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); Medical University of Vienna; Austrian Academy of Sciences; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; The J David Gladstone Institutes; Duke University	Mallat, Z (corresponding author), INSERM, Paris Cardiovasc Res Ctr, Unit 970, Paris, France.	zm255@medschl.cam.ac.uk	Danchin, Nicolas/AAN-8291-2020; Caligiuri, Giuseppina/G-4810-2015; Bonnin, Philippe/Y-5872-2019; Tsiantoulas, Dimitrios/AAK-9521-2021; Mallat, Ziad/D-4041-2012; Silvestre, Jean-Sebastien/K-7695-2017	Caligiuri, Giuseppina/0000-0003-4973-2205; Bonnin, Philippe/0000-0003-3184-3740; Tsiantoulas, Dimitrios/0000-0002-7743-3192; Mallat, Ziad/0000-0003-0443-7878; Silvestre, Jean-Sebastien/0000-0003-3962-2205; Vilar, Jose/0000-0002-9136-7726; Sage, Andrew/0000-0001-7255-3497; Guerin, Coralie/0000-0002-1840-4017; SIMON, Tabassome/0000-0002-4550-0450; Binder, Christoph J./0000-0001-8313-7050	INSERM; British Heart Foundation; European Research Council; Fondation Coeur et Recherche; Fondation pour la Recherche Medicale; European Union Seven Framework programme TOLERAGE; Fondation Leducq Transatlantic Network; US National Institutes of Health [AI56363, AI057157]; Lymphoma Research Foundation; Fondation pour la Recherche Medicale and from Journes de Biologie Clinique; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, U19AI056363] Funding Source: NIH RePORTER; British Heart Foundation [PG/11/107/29236] Funding Source: researchfish	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); British Heart Foundation(British Heart Foundation); European Research Council(European Research Council (ERC)European Commission); Fondation Coeur et Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Union Seven Framework programme TOLERAGE; Fondation Leducq Transatlantic Network(Leducq Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Fondation pour la Recherche Medicale and from Journes de Biologie Clinique; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); British Heart Foundation(British Heart Foundation)	This work was supported by INSERM, the British Heart Foundation (Z. M.), the European Research Council (Z.M.), Fondation Coeur et Recherche (Z.M., T.S. and N.D.), Fondation pour la Recherche Medicale (J.-S.S.), European Union Seven Framework programme TOLERAGE (Z.M.), Fondation Leducq Transatlantic Network (C.J.B., D.T., A.T., J.-S.S. and Z.M.), US National Institutes of Health grants AI56363 and AI057157, and a grant from The Lymphoma Research Foundation (T.F. T.). We are indebted to M.O. Kozma, L. Baker and J. Harrison for excellent technical assistance. The Baff-specific antibody was a kind gift from Human Genome Sciences. Myd88<SUP>-/-</SUP>; Trif<SUP>-/-</SUP> mice were provided by B. Ryffel (Unite Mixte de Recherche 7355, Orleans, France). Y.Z. is a recipient of fellowships from Fondation pour la Recherche Medicale and from Journes de Biologie Clinique. We thank the physicians who cared for the patients at the participating institutions, the International Clinical Trials Association Contract Research Organization (Fontaine-les-Dijon, France), E. Drouet and the Clinical Research Assistant team of Unite de Recherche Clinique de l'Est Parisien (Assistance Publique-Hpitaux de Paris and UPMC Paris 06), B. Pace, V. Bataille and G. Mulak (French Society of Cardiology) for their assistance in designing the electronic case-record form and data management during the follow-up period.	Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Burne-Taney MJ, 2003, J IMMUNOL, V171, P3210, DOI 10.4049/jimmunol.171.6.3210; Busche MN, 2009, AM J PHYSIOL-HEART C, V297, pH1853, DOI 10.1152/ajpheart.00049.2009; Cochain C, 2010, CARDIOVASC RES, V88, P186, DOI 10.1093/cvr/cvq153; Eikelboom JW, 2007, JAMA-J AM MED ASSOC, V297, P91, DOI 10.1001/jama.297.1.91; Goodchild TT, 2009, JACC-CARDIOVASC INTE, V2, P1005, DOI 10.1016/j.jcin.2009.08.010; Granger CB, 2003, CIRCULATION, V108, P1184, DOI 10.1161/01.CIR.0000087447.12918.85; GRANGER DN, 1995, ANNU REV PHYSIOL, V57, P311, DOI 10.1146/annurev.ph.57.030195.001523; Haas MS, 2010, CARDIOVASC RES, V87, P618, DOI 10.1093/cvr/cvq141; Hamaguchi Y, 2005, J IMMUNOL, V174, P4389, DOI 10.4049/jimmunol.174.7.4389; Jang HR, 2010, J AM SOC NEPHROL, V21, P654, DOI 10.1681/ASN.2009020182; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kelly-Scumpia KM, 2011, J EXP MED, V208, P1673, DOI 10.1084/jem.20101715; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Kyaw T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029371; Kyaw T, 2010, J IMMUNOL, V185, P4410, DOI 10.4049/jimmunol.1000033; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mahaffey KW, 2003, CIRCULATION, V108, P1176, DOI 10.1161/01.CIR.0000087404.53661.F8; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Renner B, 2010, J IMMUNOL, V185, P4393, DOI 10.4049/jimmunol.0903239; Sage AP, 2012, ARTERIOSCL THROM VAS, V32, P1573, DOI 10.1161/ATVBAHA.111.244731; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Scholz JL, 2008, P NATL ACAD SCI USA, V105, P15517, DOI 10.1073/pnas.0807841105; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Taqueti VR, 2006, ANNU REV PHYSIOL, V68, P67, DOI 10.1146/annurev.physiol.68.040104.124611; Togbe D, 2006, LAB INVEST, V86, P1126, DOI 10.1038/labinvest.3700473; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Uchida J, 2004, INT IMMUNOL, V16, P119, DOI 10.1093/intimm/dxh009; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Yanaba K, 2008, IMMUNOL REV, V223, P284, DOI 10.1111/j.1600-065X.2008.00646.x; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhang M, 2006, J EXP MED, V203, P141, DOI 10.1084/jem.20050390; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101; Zhang M, 2006, J IMMUNOL, V177, P4727, DOI 10.4049/jimmunol.177.7.4727	44	329	342	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1273	+		10.1038/nm.3284	http://dx.doi.org/10.1038/nm.3284			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24037091	Green Accepted			2022-12-27	WOS:000325531700026
J	Nixon, RA				Nixon, Ralph A.			The role of autophagy in neurodegenerative disease	NATURE MEDICINE			English	Review							CHAPERONE-MEDIATED AUTOPHAGY; AMYLOID-BETA PEPTIDE; MOUSE MODEL; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MUTANT HUNTINGTIN; MAMMALIAN TARGET; PHARMACOLOGICAL CHAPERONES; INTRACELLULAR ACCUMULATION	Autophagy is a lysosomal degradative process used to recycle obsolete cellular constituents and eliminate damaged organelles and protein aggregates. These substrates reach lysosomes by several distinct mechanisms, including delivery within endosomes as well as autophagosomes. Completion of digestion involves dynamic interactions among compartments of the autophagic and endocytic pathways. Neurons are particularly vulnerable to disruptions of these interactions, especially as the brain ages. Not surprisingly, mutations of genes regulating autophagy cause neurodegenerative diseases across the age spectrum with exceptional frequency. In late-onset disorders such as Alzheimer's disease, amyotrophic lateral sclerosis and familial Parkinson's disease, defects arise at different stages of the autophagy pathway and have different implications for pathogenesis and therapy. This Review provides an overview of the role of autophagy in neurodegenerative disease, focusing particularly on less frequently considered lysosomal clearance mechanisms and their considerable impact on disease. Various therapeutic strategies for modulating specific stages of autophagy and the current state of drug development for this purpose are also evaluated.	[Nixon, Ralph A.] Nathan S Kline Inst, Ctr Dementia Res, Orangeburg, NY USA; [Nixon, Ralph A.] NYU, Dept Phys, New York, NY 10003 USA; [Nixon, Ralph A.] NYU, Dept Cell Biol, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; New York University; New York University	Nixon, RA (corresponding author), Nathan S Kline Inst, Ctr Dementia Res, Orangeburg, NY USA.	nixon@nki.rfmg.org			US National Institute on Aging [P01AG017617, R01AG005604]; NATIONAL INSTITUTE ON AGING [P01AG017617, R01AG005604] Funding Source: NIH RePORTER	US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I gratefully acknowledge the expert assistance of N. Piorkowski in manuscript preparation and C. Peterhoff in figure preparation and thank past and present lab members for contributing to the described work and for helpful discussions. Studies from this laboratory are supported by the US National Institute on Aging (P01AG017617 and R01AG005604).	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Appelqvist H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050262; Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bezprozvanny I, 2010, DRUG NEWS PERSPECT, V23, P518, DOI 10.1358/dnp.2010.23.8.1500435; Bhargava A, 2012, J BIOL CHEM, V287, P26829, DOI 10.1074/jbc.M112.345702; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Boland B, 2010, J BIOL CHEM, V285, P37415, DOI 10.1074/jbc.M110.186411; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 2008, AM J PATHOL, V173, P370, DOI 10.2353/ajpath.2008.071053; Chamoux E, 2013, BBA-MOL BASIS DIS, V1832, P475, DOI 10.1016/j.bbadis.2012.12.008; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Chatellier J, 1998, P NATL ACAD SCI USA, V95, P9861, DOI 10.1073/pnas.95.17.9861; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Cheng HC, 2011, J NEUROSCI, V31, P2125, DOI 10.1523/JNEUROSCI.5519-10.2011; Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524; Chiruta C, 2012, J MED CHEM, V55, P378, DOI 10.1021/jm2012563; Conn PM, 2011, ADV PHARMACOL, V62, P109, DOI 10.1016/B978-0-12-385952-5.00008-7; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Cortes CJ, 2012, J NEUROSCI, V32, P12396, DOI 10.1523/JNEUROSCI.6189-11.2012; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Curcio-Morelli C, 2010, NEUROBIOL DIS, V40, P370, DOI 10.1016/j.nbd.2010.06.010; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Dehay B, 2012, P NATL ACAD SCI USA, V109, P9611, DOI 10.1073/pnas.1112368109; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Deng XM, 2012, EXPERT OPIN THER PAT, V22, P1415, DOI 10.1517/13543776.2012.729041; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dodson MW, 2012, HUM MOL GENET, V21, P1350, DOI 10.1093/hmg/ddr573; Domanskyi A, 2011, FASEB J, V25, P2898, DOI 10.1096/fj.11-181958; Du GP, 2010, MOL BIOL CELL, V21, P2128, DOI 10.1091/mbc.E10-03-0200; Durcan TM, 2012, J BIOL CHEM, V287, P531, DOI 10.1074/jbc.M111.288449; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Echaniz-Laguna A, 2008, CURR MED CHEM, V15, P1263, DOI 10.2174/092986708784534974; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Ferrucci M, 2011, ARCH ITAL BIOL, V149, P121, DOI 10.4449/aib.v149i1.1258; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Forlenza OV, 2012, DRUG AGING, V29, P335, DOI 10.2165/11599180-000000000-00000; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Giri S, 2008, J NEUROCHEM, V105, P1820, DOI 10.1111/j.1471-4159.2008.05279.x; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; Gomez-Suaga P, 2012, HUM MOL GENET, V21, P511, DOI 10.1093/hmg/ddr481; Guha S, 2012, J NEUROCHEM, V122, P823, DOI 10.1111/j.1471-4159.2012.07804.x; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hadano S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009805; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harms MB, 2012, NEUROLOGY, V78, P1714, DOI 10.1212/WNL.0b013e3182556c05; HOLLENBECK PJ, 1993, J CELL BIOL, V121, P305, DOI 10.1083/jcb.121.2.305; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ito H, 2011, ACTA NEUROPATHOL, V122, P223, DOI 10.1007/s00401-011-0842-y; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Jia HQ, 2012, HUM MOL GENET, V21, P5280, DOI 10.1093/hmg/dds379; Jiang TF, 2013, J NEUROIMMUNE PHARM, V8, P356, DOI 10.1007/s11481-012-9431-7; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Johnson CW, 2012, FUTURE MED CHEM, V4, P1715, DOI [10.4155/FMC.12.112, 10.4155/fmc.12.112]; Jossin Y, 2007, MOL CELL BIOL, V27, P7113, DOI 10.1128/MCB.00928-07; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lafay-Chebassier C, 2005, J NEUROCHEM, V94, P215, DOI 10.1111/j.1471-4159.2005.03187.x; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Lan DM, 2012, NEUROCHEM RES, V37, P2025, DOI 10.1007/s11064-012-0823-0; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Magnaudeix A, 2013, NEUROBIOL AGING, V34, P770, DOI 10.1016/j.neurobiolaging.2012.06.026; Maher P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021226; Manzoni C, 2012, BIOCHEM SOC T, V40, P1147, DOI 10.1042/BST20120126; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Matsuo M, 2013, MOL GENET METAB, V108, P76, DOI 10.1016/j.ymgme.2012.11.005; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Nehru B, 2008, BRAIN RES, V1201, P122, DOI 10.1016/j.brainres.2008.01.074; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Nixon Ralph A, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a008839; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Otomo A, 2011, FEBS LETT, V585, P730, DOI 10.1016/j.febslet.2011.01.045; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Panza F, 2012, J ALZHEIMERS DIS, V30, pS31, DOI 10.3233/JAD-2012-111496; Parenti G, 2013, INT J MOL MED, V31, P11, DOI 10.3892/ijmm.2012.1187; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Pasquali L, 2010, CNS NEUROL DISORD-DR, V9, P268, DOI 10.2174/187152710791292594; PEK G, 1989, ARCH GERONTOL GERIAT, V9, P17, DOI 10.1016/0167-4943(89)90021-6; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Polymenidou M, 2012, J EXP MED, V209, P889, DOI 10.1084/jem.20120741; Qi L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046834, 10.1371/journal.pone.0029572]; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Rajan I, 2011, VET PATHOL, V48, P663, DOI 10.1177/0300985810370164; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reggiori Fulvio, 2012, ISRN Mol Biol, V2012, P738718, DOI 10.5402/2012/738718; Renna M, 2011, J CELL SCI, V124, P469, DOI 10.1242/jcs.076489; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rose C, 2010, HUM MOL GENET, V19, P2144, DOI 10.1093/hmg/ddq093; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Rudenko IN, 2012, BMC MED, V10, DOI [10.1186/PREACCEPT-3356971966272323, 10.1186/1741-7015-10-20]; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Salminen A, 2011, J NEUROCHEM, V118, P460, DOI 10.1111/j.1471-4159.2011.07331.x; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sasaki S, 2011, J NEUROPATH EXP NEUR, V70, P349, DOI 10.1097/NEN.0b013e3182160690; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107; Singh R., 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/282041; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Spampanato C, 2013, EMBO MOL MED, V5, P691, DOI 10.1002/emmm.201202176; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Steele JW, 2013, MOL PSYCHIATR, V18, P882, DOI 10.1038/mp.2012.115; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Steward CG, 2003, NEUROPATH APPL NEURO, V29, P87, DOI 10.1046/j.1365-2990.2003.00474.x; Stoica L, 2011, P NATL ACAD SCI USA, V108, P3791, DOI 10.1073/pnas.1014715108; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tabata K, 2010, MOL BIOL CELL, V21, P4162, DOI 10.1091/mbc.E10-06-0495; Tamboli IY, 2011, J NEUROSCI, V31, P1837, DOI 10.1523/JNEUROSCI.2954-10.2011; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Uusi-Rauva K, 2012, CELL MOL LIFE SCI, V69, P2075, DOI 10.1007/s00018-011-0913-1; Valenzano KJ, 2011, ASSAY DRUG DEV TECHN, V9, P213, DOI 10.1089/adt.2011.0370; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wartosch L, 2010, AUTOPHAGY, V6, P158, DOI 10.4161/auto.6.1.10590; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weishaupt JH, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.007; Westbroek W, 2011, TRENDS MOL MED, V17, P485, DOI 10.1016/j.molmed.2011.05.003; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yamashima T, 2012, J NEUROCHEM, V120, P477, DOI 10.1111/j.1471-4159.2011.07596.x; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yao JQ, 2012, J EXP MED, V209, P2501, DOI 10.1084/jem.20121239; Yogalingam G, 2008, DEV CELL, V15, P74, DOI 10.1016/j.devcel.2008.05.005; Yoshiike Y, 2012, AGING CELL, V11, P51, DOI 10.1111/j.1474-9726.2011.00756.x; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yu WH, 2009, AM J PATHOL, V175, P736, DOI 10.2353/ajpath.2009.080928; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang L, 2011, EYE, V25, P519, DOI 10.1038/eye.2011.7; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	228	1279	1330	18	561	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					983	997		10.1038/nm.3232	http://dx.doi.org/10.1038/nm.3232			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921753				2022-12-27	WOS:000322779600024
J	Cho, H; Proll, SC; Szretter, KJ; Katze, MG; Gale, M; Diamond, MS				Cho, Hyelim; Proll, Sean C.; Szretter, Kristy J.; Katze, Michael G.; Gale, Michael, Jr.; Diamond, Michael S.			Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; ALPHA/BETA-INTERFERON; I INTERFERON; ENCEPHALITIS; CYTOKINE; STAT1; SUPPRESSION; RECRUITMENT; ACTIVATION	Although susceptibility of neurons in the brain to microbial infection is a major determinant of clinical outcome, little is known about the molecular factors governing this vulnerability. Here we show that two types of neurons from distinct brain regions showed differential permissivity to replication of several positive-stranded RNA viruses. Granule cell neurons of the cerebellum and cortical neurons from the cerebral cortex have unique innate immune programs that confer differential susceptibility to viral infection ex vivo and in vivo. By transducing cortical neurons with genes that were expressed more highly in granule cell neurons, we identified three interferon-stimulated genes (ISGs; Ifi27, Irg1 and Rsad2 (also known as Viperin)) that mediated the antiviral effects against different neurotropic viruses. Moreover, we found that the epigenetic state and microRNA (miRNA)-mediated regulation of ISGs correlates with enhanced antiviral response in granule cell neurons. Thus, neurons from evolutionarily distinct brain regions have unique innate immune signatures, which probably contribute to their relative permissiveness to infection.	[Cho, Hyelim; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Proll, Sean C.; Katze, Michael G.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Szretter, Kristy J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Washington University (WUSTL); University of Washington; University of Washington Seattle; Washington University (WUSTL); University of Washington; University of Washington Seattle; Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu	Cho, Hyelim/C-7408-2014; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Gale, Michael/0000-0002-6332-7436; Szretter, Kristy/0000-0003-0391-2307	US National Institutes of Health [U54 AI081680, U19 AI083019, R01 AI074973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI081680, R01AI104002, U19AI083019, R01AI074973] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank O. Koues and E. Oltz for the experimental discussions and suggestions, J. Patel and R. Klein for their contribution to the initial phase of the study, B. Bradel-Tretheway for help with initial study design and microarray analysis, Y. Sasaki (Washington University) for the lentiviral plasmids, A. Barrett (University of Texas Medical Branch) for the SLEV, I. Frolov (University of Alabama, Birmingham) for the VEEV, H.W. Virgin (Washington University) for the Stat1<SUP>-/-</SUP> mice and B.K. Kleinschmidt-DeMasters (University of Colorado) and C.A. Wiley (University of Pittsburgh) for the human brain autopsy samples. US National Institutes of Health grants U54 AI081680 (Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research), U19 AI083019 (M.G. and M.S.D.) and R01 AI074973 (M.G. and M.S.D.) supported this work. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Chakraborty S, 2010, NEUROCHEM INT, V56, P727, DOI 10.1016/j.neuint.2010.02.016; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Coley SE, 2005, J VIROL, V79, P3097, DOI 10.1128/JVI.79.5.3097-3106.2005; Contestabile Antonio, 2002, Cerebellum, V1, P41, DOI 10.1080/147342202753203087; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Dellacasa-Lindberg I, 2007, MICROBES INFECT, V9, P1291, DOI 10.1016/j.micinf.2007.06.003; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Fine EJ, 2002, SEMIN NEUROL, V22, P375, DOI 10.1055/s-2002-36759; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; GORDON B, 1990, ARCH NEUROL-CHICAGO, V47, P646, DOI 10.1001/archneur.1990.00530060054017; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Ireland DDC, 2008, J VIROL, V82, P300, DOI 10.1128/JVI.01794-07; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Labrada L, 2002, J VIROL, V76, P11688, DOI 10.1128/JVI.76.22.11688-11703.2002; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11; Look DC, 1998, IMMUNITY, V9, P871, DOI 10.1016/S1074-7613(00)80652-4; McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Omalu BI, 2003, BRAIN PATHOL, V13, P465, DOI 10.1111/j.1750-3639.2003.tb00477.x; Parekh BS, 1999, MOL CELL, V3, P125, DOI 10.1016/S1097-2765(00)80181-1; Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schoneboom BA, 2000, J INTERF CYTOK RES, V20, P205, DOI 10.1089/107999000312621; Shestakova E, 2001, J VIROL, V75, P3444, DOI 10.1128/JVI.75.7.3444-3452.2001; Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; STRITTMATTER C, 1992, ACTA NEUROPATHOL, V83, P475, DOI 10.1007/BF00310023; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tal MC, 2011, IMMUNOL REV, V243, P215, DOI 10.1111/j.1600-065X.2011.01038.x; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang JP, 2005, J VIROL, V79, P8295, DOI 10.1128/JVI.79.13.8295-8302.2005; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	52	151	153	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					458	+		10.1038/nm.3108	http://dx.doi.org/10.1038/nm.3108			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23455712	Green Accepted, Green Published, Bronze			2022-12-27	WOS:000317109100031
J	Li, F; Lu, J; Cheng, J; Wang, LY; Matsubara, T; Csanaky, IL; Klaassen, CD; Gonzalez, FJ; Ma, XC				Li, Feng; Lu, Jie; Cheng, Jie; Wang, Laiyou; Matsubara, Tsutomu; Csanaky, Ivan L.; Klaassen, Curtis D.; Gonzalez, Frank J.; Ma, Xiaochao			Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy	NATURE MEDICINE			English	Article							PREGNANE-X-RECEPTOR; ERYTHROPOIETIC-PROTOPORPHYRIA; DRUG-INTERACTIONS; GENE-EXPRESSION; LIVER TOXICITY; GENOTYPE; DISEASE; DEFINES; INJURY; MODEL	Co-therapy with rifampicin (RIF) and isoniazid (INH) used to treat tuberculosis in humans frequently causes liver injury. Here, using a pregnane X receptor (PXR)-humanized mouse model, we found that co-treatment with RIF and INH causes accumulation of the endogenous hepatotoxin protoporphyrin IX in the liver through PXR-mediated alteration of the heme biosynthesis pathway. These results provide insight into the mechanism of liver injury induced by co-treatment with these compounds and may lead to their safer use in the clinic.	[Li, Feng; Lu, Jie; Wang, Laiyou; Csanaky, Ivan L.; Klaassen, Curtis D.; Ma, Xiaochao] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Cheng, Jie; Matsubara, Tsutomu; Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Kansas; University of Kansas Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ma, XC (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	xma2@kumc.edu	Li, Feng/M-5334-2016	Li, Feng/0000-0002-9680-4614	National Institute of Diabetes and Digestive and Kidney Diseases [DK090305]; National Cancer Institute Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090305] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (grant number DK090305) and the National Cancer Institute Intramural Research Program. We thank M. Montello for editing the manuscript.	Anstey AV, 2007, GUT, V56, P1009, DOI 10.1136/gut.2006.097576; Chowdhury A, 2006, J HEPATOL, V45, P117, DOI 10.1016/j.jhep.2006.01.027; Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200; GANGADHARAM PRJ, 1986, AM REV RESPIR DIS, V133, P963; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Casanova-Gonzalez MJ, 2010, WORLD J GASTROENTERO, V16, P4526, DOI 10.3748/wjg.v16.i36.4526; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Ma X, 2007, DRUG METAB DISPOS, V35, P194, DOI 10.1124/dmd.106.012831; Metushi IG, 2012, CHEM RES TOXICOL, V25, P2567, DOI 10.1021/tx300341r; MIGUET JP, 1977, GASTROENTEROLOGY, V72, P924; MITCHELL JR, 1976, ANN INTERN MED, V84, P181, DOI 10.7326/0003-4819-84-2-181; Ohno M, 2000, INT J TUBERC LUNG D, V4, P256; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; Sarich TC, 1996, ARCH TOXICOL, V70, P835, DOI 10.1007/s002040050347; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Slatter JG, 2006, XENOBIOTICA, V36, P938, DOI 10.1080/00498250600861728; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Tasduq SA, 2007, HEPATOL RES, V37, P845, DOI 10.1111/j.1872-034X.2007.00129.x; Xing T, 1997, Zhonghua Jie He He Hu Xi Za Zhi, V20, P33; Yew WW, 2006, RESPIROLOGY, V11, P699, DOI 10.1111/j.1440-1843.2006.00941.x	21	102	106	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					418	+		10.1038/nm.3104	http://dx.doi.org/10.1038/nm.3104			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23475203	Green Accepted			2022-12-27	WOS:000317109100025
J	Wang, W; Barnabei, MS; Asp, ML; Heinis, FI; Arden, E; Davis, J; Braunlin, E; Li, Q; Davis, JP; Potter, JD; Metzger, JM				Wang, Wang; Barnabei, Matthew S.; Asp, Michelle L.; Heinis, Frazer I.; Arden, Erik; Davis, Jennifer; Braunlin, Elizabeth; Li, Qi; Davis, Jonathan P.; Potter, James D.; Metzger, Joseph M.			Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance	NATURE MEDICINE			English	Article							CALCIUM-BINDING PROTEIN; DIASTOLIC DYSFUNCTION; TROPONIN-I; GENE-TRANSFER; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY; PARVALBUMIN ISOFORMS; HEART-FAILURE; ANIMAL-MODEL; ION-BINDING	EF-hand proteins are ubiquitous in cell signaling. Parvalbumin (Parv), the archetypal EF-hand protein, is a high-affinity Ca2+ buffer in many biological systems. Given the centrality of Ca2+ signaling in health and disease, EF-hand motifs designed to have new biological activities may have widespread utility. Here, an EF-hand motif substitution that had been presumed to destroy EF-hand function, that of glutamine for glutamate at position 12 of the second cation binding loop domain of Parv (ParvE101Q), markedly inverted relative cation affinities: Mg2+ affinity increased, whereas Ca2+ affinity decreased, forming a new ultra-delayed Ca2+ buffer with favorable properties for promoting cardiac relaxation. In therapeutic testing, expression of ParvE101Q fully reversed the severe myocyte intrinsic contractile defect inherent to expression of native Parv and corrected abnormal myocardial relaxation in diastolic dysfunction disease models in vitro and in vivo. Strategic design of new EF-hand motif domains to modulate intracellular Ca2+ signaling could benefit many biological systems with abnormal Ca2+ handling, including the diseased heart.	[Wang, Wang; Barnabei, Matthew S.; Asp, Michelle L.; Heinis, Frazer I.; Arden, Erik; Davis, Jennifer; Metzger, Joseph M.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Braunlin, Elizabeth] Univ Minnesota, Sch Med, Dept Pediat Cardiol, Minneapolis, MN 55455 USA; [Li, Qi; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Davis, Jonathan P.] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Miami; University System of Ohio; Ohio State University	Metzger, JM (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Mitochondria & Metab Ctr, Seattle, WA 98195 USA.	metzgerj@umn.edu	wang, wang/GWQ-7272-2022	DAVIS, JENNIFER/0000-0003-2380-1321; Wang, Wang/0000-0001-9093-412X	Lillehei Heart Institute; US National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL115876, R01HL059301, R01HL091986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034107, T32AG029796] Funding Source: NIH RePORTER	Lillehei Heart Institute; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Herron, E. Devaney, I. Turner, M. Maerz, F. Sjaastad, B. Liu, S. Little and T. Edwards for their assistance. We thank the Lillehei Heart Institute for support. We thank H Sabbah (Henry Ford Hospital Heart and Vascular Institute) for providing the canine failing myocytes. We thank K B. Andersson and G. Christensen (Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway) for providing the mice with inducible cardiac myocyte-specific excision of the SERCA2a. This work was supported by the US National Institutes of Health (J.M.M. and J.D.P.).	Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; BABU A, 1992, J BIOL CHEM, V267, P15469; Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Coutu P, 2004, CIRC RES, V94, P1235, DOI 10.1161/01.RES.0000126923.46786.FD; Coutu P, 2002, BIOPHYS J, V82, P2565, DOI 10.1016/S0006-3495(02)75599-9; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Davis J, 2012, J MOL CELL CARDIOL, V53, P446, DOI 10.1016/j.yjmcc.2012.05.018; Day SM, 2008, PHYSIOL GENOMICS, V33, P312, DOI 10.1152/physiolgenomics.00302.2007; DECLERCQ JP, 1991, J MOL BIOL, V220, P1017, DOI 10.1016/0022-2836(91)90369-H; Dzimiri N, 1999, PHARMACOL REV, V51, P465; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HARRISON SM, 1990, AM J PHYSIOL, V258, pC282, DOI 10.1152/ajpcell.1990.258.2.C282; HEIZMANN CW, 1984, EXPERIENTIA, V40, P910, DOI 10.1007/BF01946439; Hirsch JC, 2004, AM J PHYSIOL-HEART C, V286, pH2314, DOI 10.1152/ajpheart.01137.2003; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; HUTNIK CML, 1990, J BIOL CHEM, V265, P11456; Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Johnson JD, 1999, BIOPHYS J, V76, P1514, DOI 10.1016/S0006-3495(99)77310-8; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P305; Kaye DM, 2008, ANNU REV MED, V59, P13, DOI 10.1146/annurev.med.59.052407.103237; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Kitzman DW, 2007, HEART FAIL CLIN, V3, P437, DOI DOI 10.1016/J.HFC.2007.07.008; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; LORELL BH, 1991, ANNU REV MED, V42, P411, DOI 10.1146/annurev.med.42.1.411; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mann D.L., 2004, HEART FAILURE COMPAN; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Mogensen J, 2003, J CLIN INVEST, V111, P209, DOI 10.1172/JCI200316336; NEGELE JC, 1992, J BIOL CHEM, V267, P825; Pauls TL, 1996, BBA-GENE STRUCT EXPR, V1306, P39, DOI 10.1016/0167-4781(95)00221-9; Periasamy Muthu, 2008, Heart Fail Clin, V4, P13, DOI 10.1016/j.hfc.2007.10.007; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Rodenbaugh DW, 2007, AM J PHYSIOL-HEART C, V293, pH1705, DOI 10.1152/ajpheart.00232.2007; Rome LC, 2006, ANNU REV PHYSIOL, V68, P193, DOI 10.1146/annurev.physiol.68.040104.105418; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Schwartz A, 1984, METHOD PHARMACOL, V5, P63; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tang WHW, 2008, J AM COLL CARDIOL, V52, P1671, DOI 10.1016/j.jacc.2008.08.026; Townsend D, 2007, MOL THER, V15, P1086, DOI 10.1038/sj.mt.6300144; Wahr PA, 1999, P NATL ACAD SCI USA, V96, P11982, DOI 10.1073/pnas.96.21.11982; Wang W, 2008, CELL BIOCHEM BIOPHYS, V51, P1, DOI 10.1007/s12013-008-9011-x; Yang JJ, 2003, PROTEIN PEPTIDE LETT, V10, P331, DOI 10.2174/0929866033478852; Yano M, 2005, J CLIN INVEST, V115, P556, DOI 10.1172/JCI200524159; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	55	32	33	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					305	312		10.1038/nm.3079	http://dx.doi.org/10.1038/nm.3079			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396207	Green Accepted			2022-12-27	WOS:000316040700023
J	Moore, PL; Gray, ES; Wibmer, CK; Bhiman, JN; Nonyane, M; Sheward, DJ; Hermanus, T; Bajimaya, S; Tumba, NL; Abrahams, MR; Lambson, BE; Ranchobe, N; Ping, LH; Ngandu, N; Karim, QA; Karim, SSA; Swanstrom, RI; Seaman, MS; Williamson, C; Morris, L				Moore, Penny L.; Gray, Elin S.; Wibmer, C. Kurt; Bhiman, Jinal N.; Nonyane, Molati; Sheward, Daniel J.; Hermanus, Tandile; Bajimaya, Shringkhala; Tumba, Nancy L.; Abrahams, Melissa-Rose; Lambson, Bronwen E.; Ranchobe, Nthabeleng; Ping, Lihua; Ngandu, Nobubelo; Karim, Quarraisha Abdool; Karim, Salim S. Abdool; Swanstrom, Ronald I.; Seaman, Michael S.; Williamson, Carolyn; Morris, Lynn			Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUBTYPE-C INFECTION; MONOCLONAL-ANTIBODIES; SOUTH-AFRICA; ENVELOPE; POTENT; RESPONSES; GP120; INDIVIDUALS; GLYCOPROTEINS	Neutralizing antibodies are likely to play a crucial part in a preventative HIV-1 vaccine. Although efforts to elicit broadly cross-neutralizing (BCN) antibodies by vaccination have been unsuccessful(1-3), a minority of individuals naturally develop these antibodies after many years of infection(4-7). How such antibodies arise, and the role of viral evolution in shaping these responses, is unknown. Here we show, in two HIV-1-infected individuals who developed BCN antibodies targeting the glycan at Asn332 on the gp120 envelope, that this glycan was absent on the initial infecting virus. However, this BCN epitope evolved within 6 months, through immune escape from earlier strain-specific antibodies that resulted in a shift of a glycan to position 332. Both viruses that lacked the glycan at amino acid 332 were resistant to the Asn332-dependent BCN monoclonal antibody PGT128 (ref. 8), whereas escaped variants that acquired this glycan were sensitive. Analysis of large sequence and neutralization data sets showed the 332 glycan to be significantly under-represented in transmitted subtype C viruses compared to chronic viruses, with the absence of this glycan corresponding with resistance to PGT128. These findings highlight the dynamic interplay between early antibodies and viral escape in driving the evolution of conserved BCN antibody epitopes.	[Moore, Penny L.; Gray, Elin S.; Wibmer, C. Kurt; Bhiman, Jinal N.; Nonyane, Molati; Hermanus, Tandile; Tumba, Nancy L.; Lambson, Bronwen E.; Ranchobe, Nthabeleng; Morris, Lynn] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa; [Moore, Penny L.; Wibmer, C. Kurt; Bhiman, Jinal N.; Morris, Lynn] Univ Witwatersrand, Johannesburg, South Africa; [Sheward, Daniel J.; Abrahams, Melissa-Rose; Ngandu, Nobubelo; Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Bajimaya, Shringkhala; Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis,Dept Med, Boston, MA USA; [Ping, Lihua; Swanstrom, Ronald I.] Univ N Carolina, Chapel Hill, NC USA; [Karim, Quarraisha Abdool; Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa CAPRISA, Durban, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Cape Town; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of Kwazulu Natal	Morris, L (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa.	lynnm@nicd.ac.za	Karim, Salim Safurdeen Abdool/N-5947-2013; Morris, Lynn/V-3941-2018; Gray, Elin/V-6707-2019; Wibmer, Constantinos Kurt/AAO-3035-2021; Sheward, Daniel/GSJ-0708-2022; Karim, Salim Abdool/P-3117-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Bhiman, Jinal/ABA-6029-2021; Ngandu, Nobubelo/AAP-8543-2021; Wibmer, Constantinos Kurt/AAH-8669-2019; Karim, Salim Abdool/AAE-7118-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Morris, Lynn/0000-0003-3961-7828; Gray, Elin/0000-0002-8613-3570; Wibmer, Constantinos Kurt/0000-0003-2329-2280; Sheward, Daniel/0000-0002-0227-5636; Karim, Salim Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Bhiman, Jinal/0000-0001-6354-4003; Ngandu, Nobubelo/0000-0001-8883-3821; , Carolyn/0000-0003-0125-1226; Moore, Penny/0000-0001-8719-4028	CAPRISA; Centre for HIV/AIDS Vaccine Immunology; South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology; US National Institutes of Health [AI088610]; US Department of Health and Human Services; US National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services [U19 AI51794]; Bill & Melinda Gates Foundation; Vaccine Immune Monitoring Consortium of the Collaboration for AIDS Vaccine Discovery [1032144]; Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, National Institutes of Health [5 D43 TW000231]; Wellcome Trust [089933/Z/09/Z]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794, P01AI088610, P30AI050410] Funding Source: NIH RePORTER	CAPRISA; Centre for HIV/AIDS Vaccine Immunology; South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; US National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Vaccine Immune Monitoring Consortium of the Collaboration for AIDS Vaccine Discovery; Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, National Institutes of Health; Wellcome Trust(Wellcome TrustEuropean Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the participants in the CAPRISA 002 and 004 cohorts and the clinical and laboratory staff at CAPRISA for managing the cohort and providing specimens. 293T cells were obtained from G. Shaw (University of Alabama, Birmingham). We are grateful to D. Burton and W. Koff of the International AIDS Vaccine Initiative for providing the PGT monoclonal antibodies and to S. Gnanakaran (Los Alamos National Laboratories, Los Alamos, New Mexico) for providing transmitted/founder and chronic subtype B sequences. We thank Z. Valley-Omar and N. Ndabambi for generating some envelope sequences. We are grateful to B. Hahn and J. Kim, who contributed transmitted/founder subtype C clones to the Vaccine Immune Monitoring Core Standard Virus Panel Consortium. This work was funded by CAPRISA, the Centre for HIV/AIDS Vaccine Immunology, the South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology and by a US National Institutes of Health grant (number AI088610). CAPRISA was initially supported by the US National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services grant U19 AI51794. M. S. S. is funded by the Bill & Melinda Gates Foundation, Vaccine Immune Monitoring Consortium of the Collaboration for AIDS Vaccine Discovery (grant 1032144). P. L. M. and E. S. G. were supported by the Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, National Institutes of Health (grant 5 D43 TW000231). P. L. M. is a Wellcome Trust Intermediate Fellow in Public Health and Tropical Medicine (grant 089933/Z/09/Z).	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Frost SDW, 2005, P NATL ACAD SCI USA, V102, P18514, DOI 10.1073/pnas.0504658102; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Gorny MK, 2006, PLOS MED, V3, P966, DOI 10.1371/journal.pmed.0030259; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Gray ES, 2006, PLOS MED, V3, P1023, DOI 10.1371/journal.pmed.0030255; Haynes BF, 2006, EXPERT REV VACCINES, V5, P347, DOI 10.1586/14760584.5.3.347; Hu SL, 2007, CURR HIV RES, V5, P507, DOI 10.2174/157016207782418542; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Nandi A, 2010, VIROLOGY, V396, P339, DOI 10.1016/j.virol.2009.10.044; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	36	228	235	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1688	+		10.1038/nm.2985	http://dx.doi.org/10.1038/nm.2985			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23086475	Green Accepted, Green Submitted			2022-12-27	WOS:000310837000030
J	Heinecke, JW				Heinecke, Jay W.			A new era for quantifying HDL and cardiovascular risk?	NATURE MEDICINE			English	Editorial Material							DENSITY-LIPOPROTEIN CHOLESTEROL; EFFLUX; ATHEROSCLEROSIS; CAPACITY		Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Heinecke, JW (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	heinecke@u.washington.edu						Berard AM, 1997, NAT MED, V3, P744, DOI 10.1038/nm0797-744; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Green PS, 2008, CIRCULATION, V118, P1259, DOI 10.1161/CIRCULATIONAHA.108.770669; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206	10	49	51	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1346	1347		10.1038/nm.2930	http://dx.doi.org/10.1038/nm.2930			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22961165				2022-12-27	WOS:000308472300029
J	Balko, JM; Cook, RS; Vaught, DB; Kuba, MG; Miller, TW; Bhola, NE; Sanders, ME; Granja-Ingram, NM; Smith, JJ; Meszoely, IM; Salter, J; Dowsett, M; Stemke-Hale, K; Gonzalez-Angulo, AM; Mills, GB; Pinto, JA; Gomez, HL; Arteaga, CL				Balko, Justin M.; Cook, Rebecca S.; Vaught, David B.; Kuba, Maria G.; Miller, Todd W.; Bhola, Neil E.; Sanders, Melinda E.; Granja-Ingram, Nara M.; Smith, J. Joshua; Meszoely, Ingrid M.; Salter, Janine; Dowsett, Mitch; Stemke-Hale, Katherine; Gonzalez-Angulo, Ana M.; Mills, Gordon B.; Pinto, Joseph A.; Gomez, Henry L.; Arteaga, Carlos L.			Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance	NATURE MEDICINE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; STEM-CELLS; KINASE; RECURRENCE; KI67; MEK; METASTASIS; INHIBITION; PREDICTOR	Neoadjuvant chemotherapy (NAC) induces a pathological complete response (pCR) in similar to 30% of patients with breast cancer. However, many patients have residual cancer after chemotherapy, which correlates with a higher risk of metastatic recurrence and poorer outcome than those who achieve a pCR. We hypothesized that molecular profiling of tumors after NAC would identify genes associated with drug resistance. Digital transcript counting was used to profile surgically resected breast cancers after NAC. Low concentrations of dual specificity protein phosphatase 4 (DUSP4), an ERK phosphatase, correlated with high post-NAC tumor cell proliferation and with basal-like breast cancer (BLBC) status. BLBC had higher DUSP4 promoter methylation and gene expression patterns of Ras-ERK pathway activation relative to other breast cancer subtypes. DUSP4 overexpression increased chemotherapy-induced apoptosis, whereas DUSP4 depletion dampened the response to chemotherapy. Reduced DUSP4 expression in primary tumors after NAC was associated with treatment-refractory high Ki-67 scores and shorter recurrence-free survival. Finally, inhibition of mitogen-activated protein kinase kinase (MEK) synergized with docetaxel treatment in BLBC xenografts. Thus, DUSP4 downregulation activates the Ras-ERK pathway in BLBC, resulting in an attenuated response to anti-cancer chemotherapy.	[Balko, Justin M.; Bhola, Neil E.; Arteaga, Carlos L.] Vanderbilt Univ, Dept Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37235 USA; [Cook, Rebecca S.; Vaught, David B.; Miller, Todd W.; Arteaga, Carlos L.] Vanderbilt Univ, Dept Canc Biol, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN USA; [Cook, Rebecca S.; Miller, Todd W.; Sanders, Melinda E.; Meszoely, Ingrid M.; Arteaga, Carlos L.] Vanderbilt Univ, Vanderbilt Ingram Comprehens Canc Ctr, Breast Canc Res Program, Nashville, TN USA; Vanderbilt Univ, Dept Pathol, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN USA; [Smith, J. Joshua; Meszoely, Ingrid M.] Vanderbilt Univ, Dept Surg, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37240 USA; [Salter, Janine; Dowsett, Mitch] Royal Marsden Hosp, Inst Canc Res, Breakthrough Breast Canc Ctr, London SW3 6JJ, England; [Salter, Janine; Dowsett, Mitch] Royal Marsden Hosp, Acad Dept Biochem, London SW3 6JJ, England; [Stemke-Hale, Katherine; Gonzalez-Angulo, Ana M.; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Gonzalez-Angulo, Ana M.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Pinto, Joseph A.] Oncosalud, Div Invest, Lima, Peru; [Gomez, Henry L.] Inst Nacl Enfermedades Neoplas, Lima, Peru	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Instituto Nacional de Enfermedades Neoplasicas	Arteaga, CL (corresponding author), Vanderbilt Univ, Dept Med, Vanderbilt Ingram Comprehens Canc Ctr, Nashville, TN 37235 USA.	carlos.arteaga@vanderbilt.edu	Stemke-Hale, Katherine/K-9113-2013; Smith, Jesse Joshua/AAN-5440-2020; Pinto, Joseph/AAA-5379-2022	Stemke-Hale, Katherine/0000-0002-1231-4192; Smith, Jesse Joshua/0000-0003-2538-5456; Gomez, Henry/0000-0003-2660-1843; Vaught, David/0000-0002-3346-6769; Pinto, Joseph/0000-0002-7744-1635	Breast Cancer Specialized Program of Research Excellence (SPORE) grant [P50CA98131]; Vanderbilt-Ingram Cancer Center Support grant [P30CA68485]; Breast Cancer Research Foundation; American Cancer Society Clinical Research Professorship grant [CRP-07-234]; Lee Jeans Translational Breast Cancer Research Program; SU2C Dream Team award [PO1CA099031]; Komen Promise grant [KG 081694]; Breakthrough Breast Cancer; Royal Marsden National Institutes of Health Research Biomedical Research Centre; NATIONAL CANCER INSTITUTE [K99CA142899, P30CA016672, R00CA142899, P50CA098258, R01CA143126, P01CA099031, P50CA098131, P30CA068485] Funding Source: NIH RePORTER	Breast Cancer Specialized Program of Research Excellence (SPORE) grant; Vanderbilt-Ingram Cancer Center Support grant; Breast Cancer Research Foundation; American Cancer Society Clinical Research Professorship grant(American Cancer Society); Lee Jeans Translational Breast Cancer Research Program; SU2C Dream Team award; Komen Promise grant(Susan G. Komen Breast Cancer Foundation); Breakthrough Breast Cancer; Royal Marsden National Institutes of Health Research Biomedical Research Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank E. Penni Black (University of Kentucky), who provided the AdMEK1ca adenoviral construct. The authors would also like to thank P.D. Smith and AstraZeneca for supplying selumetinib utilized in the in vivo experiments. This work was supported by Breast Cancer Specialized Program of Research Excellence (SPORE) grant P50CA98131, Vanderbilt-Ingram Cancer Center Support grant P30CA68485, a grant from the Breast Cancer Research Foundation, the American Cancer Society Clinical Research Professorship grant CRP-07-234 and the Lee Jeans Translational Breast Cancer Research Program (to C.L.A.). G.B.M. was supported by the SU2C Dream Team award, PO1CA099031 and the Komen Promise grant KG 081694. J.S. and M.D. were funded by the Breakthrough Breast Cancer and the Royal Marsden National Institutes of Health Research Biomedical Research Centre.	Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; Balko JM, 2009, CANCER BIOL THER, V8, P522, DOI 10.4161/cbt.8.6.7690; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Britson JS, 2009, BIOCHEM BIOPH RES CO, V390, P849, DOI 10.1016/j.bbrc.2009.10.061; Brumby AM, 2011, GENETICS, V188, P105, DOI 10.1534/genetics.111.127910; Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003; Cadalbert LC, 2010, CELL SIGNAL, V22, P357, DOI 10.1016/j.cellsig.2009.10.002; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dowsett M, 2005, CLIN CANCER RES, V11, p951S; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guarneri V, 2009, ANN ONCOL, V20, P1193, DOI 10.1093/annonc/mdn761; Haibe-Kains B, 2009, GENEFU R PACKAGE REL; Hennessy BT, 2007, CLIN CANCER RES, V13, P7421, DOI 10.1158/1078-0432.CCR-07-0760; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Jones RL, 2009, BREAST CANCER RES TR, V116, P53, DOI 10.1007/s10549-008-0081-7; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Korde LA, 2010, BREAST CANCER RES TR, V119, P685, DOI 10.1007/s10549-009-0651-3; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Miller WR, 2009, J CLIN ONCOL, V27, P1382, DOI 10.1200/JCO.2008.16.8849; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Pusztai L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2430; Sanchez-Munoz A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-136; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stickeler E, 2011, ONCOL REP, V26, P1037, DOI 10.3892/or.2011.1392; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Waha A, 2010, CANCER RES, V70, P1689, DOI 10.1158/0008-5472.CAN-09-3218; Wang JH, 2010, MOL CANCER RES, V8, P266, DOI 10.1158/1541-7786.MCR-09-0221; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yacoub A, 2003, CANCER BIOL THER, V2, P670; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]	50	189	195	2	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1052	+		10.1038/nm.2795	http://dx.doi.org/10.1038/nm.2795			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22683778	Green Accepted			2022-12-27	WOS:000306121600034
J	Befroy, DE; Perry, RJ; Jain, N; Dufour, S; Cline, GW; Trimmer, JK; Brosnan, J; Rothman, DL; Petersen, KF; Shulman, GI				Befroy, Douglas E.; Perry, Rachel J.; Jain, Nimit; Dufour, Sylvie; Cline, Gary W.; Trimmer, Jeff K.; Brosnan, Julia; Rothman, Douglas L.; Petersen, Kitt Falk; Shulman, Gerald I.			Direct assessment of hepatic mitochondrial oxidative and anaplerotic fluxes in humans using dynamic C-13 magnetic resonance spectroscopy	NATURE MEDICINE			English	Article							CITRIC-ACID CYCLE; IN-VIVO; KREBS CYCLE; TCA CYCLE; GLUCONEOGENIC FLUXES; SUBSTRATE OXIDATION; HUMAN BRAIN; GLUCOSE; LIVER; RAT	Despite the central role of the liver in the regulation of glucose and lipid metabolism, there are currently no methods to directly assess hepatic oxidative metabolism in humans in vivo. By using a new C-13-labeling strategy in combination with C-13 magnetic resonance spectroscopy, we show that rates of mitochondrial oxidation and anaplerosis in human liver can be directly determined noninvasively. Using this approach, we found the mean rates of hepatic tricarboxylic acid (TCA) cycle flux (V-TCA) and anaplerotic flux (V-ANA) to be 0.43 +/- 0.04 mu mol g(-1) min(-1) and 0.60 +/- 0.11 mu mol g(-1) min(-1), respectively, in twelve healthy, lean individuals. We also found the V-ANA/V-TCA ratio to be 1.39 +/- 0.22, which is severalfold lower than recently published estimates using an indirect approach. This method will be useful for understanding the pathogenesis of nonalcoholic fatty liver disease and type 2 diabetes, as well as for assessing the effectiveness of new therapies targeting these pathways in humans.	[Befroy, Douglas E.; Rothman, Douglas L.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Befroy, Douglas E.; Perry, Rachel J.; Cline, Gary W.; Petersen, Kitt Falk; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Perry, Rachel J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Jain, Nimit; Rothman, Douglas L.] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Dufour, Sylvie; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Trimmer, Jeff K.; Brosnan, Julia] Pfizer Pharmaceut Inc, Groton, CT USA; [Petersen, Kitt Falk; Shulman, Gerald I.] Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Pfizer; Novo Nordisk Foundation	Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Jain, Nimit/HIK-2809-2022; Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064; , Nimit/0000-0001-8759-2456	US Public Health Service [R24 DK-085638, R01 AG-23686, R01 DK-49230, P30 DK-45735, UL1 RR-024139]; American Diabetes Association; Pfizer; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, U24DK059635, R01DK040936, T32DK101019, R01DK049230, R24DK085638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Diabetes Association(American Diabetes Association); Pfizer(Pfizer); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Impellizeri, Y. Kosover, I. Smolgovsky, M. Smolgovsky, G. Solomon, C. Parmelee and the staff of the Yale Center for Clinical Investigation Hospital Research Unit for their technical support and the volunteers for their participation in these studies. We also acknowledge the contributions of G. Mason, who assisted in the implementation and interpretation of the metabolic modeling of the rat [1-<SUP>13</SUP>C] acetate infusion data. This publication was supported by grants from the US Public Health Service (R24 DK-085638, R01 AG-23686, R01 DK-49230, P30 DK-45735 and UL1 RR-024139), a Distinguished Clinical Investigator Award from the American Diabetes Association (K.F.P.) and an investigator-initiated grant from Pfizer (K.F.P.). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of the US National Center for Research Resources or National Institutes of Health.	Alves TC, 2011, HEPATOLOGY, V53, P1175, DOI 10.1002/hep.24170; Befroy DE, 2008, P NATL ACAD SCI USA, V105, P16701, DOI 10.1073/pnas.0808889105; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; Befroy DE, 2012, DIABETES, V61, P2669, DOI 10.2337/db12-0558; BEYLOT M, 1995, J BIOL CHEM, V270, P1509, DOI 10.1074/jbc.270.4.1509; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; FERNANDEZ CA, 1995, J BIOL CHEM, V270, P10037, DOI 10.1074/jbc.270.17.10037; HEATH DF, 1985, BIOCHEM J, V227, P851, DOI 10.1042/bj2270851; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jones JG, 1998, ANAL BIOCHEM, V263, P39, DOI 10.1006/abio.1998.2796; Jones JG, 1998, AM J PHYSIOL-ENDOC M, V275, pE843, DOI 10.1152/ajpendo.1998.275.5.E843; Jones JG, 2001, AM J PHYSIOL-ENDOC M, V281, pE848, DOI 10.1152/ajpendo.2001.281.4.E848; Jones JG, 1997, FEBS LETT, V412, P131, DOI 10.1016/S0014-5793(97)00764-3; KATZ J, 1993, J BIOL CHEM, V268, P25509; LANDAU BR, 1993, AM J PHYSIOL, V265, pE636, DOI 10.1152/ajpendo.1993.265.4.E636; LANDAU BR, 1995, J CLIN INVEST, V95, P172, DOI 10.1172/JCI117635; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; Li SZ, 2007, MAGN RESON MED, V57, P265, DOI 10.1002/mrm.21148; Li SZ, 2009, MAGN RESON MED, V62, P565, DOI 10.1002/mrm.22044; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; Mason GF, 1999, J CEREBR BLOOD F MET, V19, P1179, DOI 10.1097/00004647-199911000-00002; Mitchell CS, 2010, J CLIN INVEST, V120, P1345, DOI 10.1172/JCI38793; Patel AB, 2010, J CEREBR BLOOD F MET, V30, P1200, DOI 10.1038/jcbfm.2010.2; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PETERSEN KF, 1995, METABOLISM, V44, P1380, DOI 10.1016/0026-0495(95)90133-7; Puchowicz MA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1022, DOI 10.1152/ajpendo.1999.277.6.E1022; Sailasuta N, 2008, J MAGN RESON, V195, P219, DOI 10.1016/j.jmr.2008.09.012; Schmid AI, 2011, DIABETES CARE, V34, P448, DOI 10.2337/dc10-1076; Shen J, 1997, MAGNET RESON MED, V38, P834, DOI 10.1002/mrm.1910380521; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093	33	72	73	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					98	+		10.1038/nm.3415	http://dx.doi.org/10.1038/nm.3415			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24317120	Green Accepted			2022-12-27	WOS:000329349400026
J	Verdin, E				Verdin, Eric			Coupling of NAD metabolism, sirtuins and lifespan	NATURE MEDICINE			English	Editorial Material							CALORIE RESTRICTION; DEACETYLASE; LONGEVITY; SIR2; MICE; ELEGANS		Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes	Verdin, E (corresponding author), Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.	everdin@gladstone.ucsf.edu	Verdin, Eric/AAB-7999-2019	Verdin, Eric/0000-0003-3703-3183				Banerjee KK, 2012, CELL REP, V2, P1485, DOI 10.1016/j.celrep.2012.11.013; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Lanska DJ, 2012, ANN NUTR METAB, V61, P246, DOI 10.1159/000343115; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Sinclair D, 2012, CELL REP, V2, P1473, DOI 10.1016/j.celrep.2012.12.004; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	18	46	48	3	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					25	27		10.1038/nm.3447	http://dx.doi.org/10.1038/nm.3447			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398962				2022-12-27	WOS:000329349400015
J	Tanaka, AJ; Sauer, MV; Egli, D; Kort, DH				Tanaka, Akemi J.; Sauer, Mark V.; Egli, Dieter; Kort, Daniel H.			The path to prevent mitochondrial disease	NATURE MEDICINE			English	Editorial Material							GENE-THERAPY; REPLACEMENT; EMBRYOS; MTDNA		[Tanaka, Akemi J.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Sauer, Mark V.; Kort, Daniel H.] Columbia Univ, Ctr Womens Reprod Care, New York, NY USA; [Egli, Dieter] New York Stem Cell Fdn, Res Inst, New York, NY USA	Yale University; Columbia University; The New York Stem Cell Foundation	Tanaka, AJ (corresponding author), Yale Univ, Dept Genet, New Haven, CT 06520 USA.	d.egli@nyscf.org						Baylis F, 2013, REPROD BIOMED ONLINE, V26, P531, DOI 10.1016/j.rbmo.2013.03.006; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Johnson MH, 2013, REPROD BIOMED ONLINE, V26, P516, DOI 10.1016/j.rbmo.2013.03.014; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Paull D, 2013, NATURE, V493, P632, DOI 10.1038/nature11800; Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Treff NR, 2012, FERTIL STERIL, V98, P1236, DOI 10.1016/j.fertnstert.2012.07.1119	15	11	11	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1578	1579		10.1038/nm.3422	http://dx.doi.org/10.1038/nm.3422			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24309656				2022-12-27	WOS:000328181400025
J	Trudu, M; Janas, S; Lanzani, C; Debaix, H; Schaeffer, C; Ikehata, M; Citterio, L; Demaretz, S; Trevisani, F; Ristagno, G; Glaudemans, B; Laghmani, K; Dell'Antonio, G; Loffing, J; Rastaldi, MP; Manunta, P; Devuyst, O; Rampoldi, L				Trudu, Matteo; Janas, Sylvie; Lanzani, Chiara; Debaix, Huguette; Schaeffer, Celine; Ikehata, Masami; Citterio, Lorena; Demaretz, Sylvie; Trevisani, Francesco; Ristagno, Giuseppe; Glaudemans, Bob; Laghmani, Kamel; Dell'Antonio, Giacomo; Loffing, Johannes; Rastaldi, Maria P.; Manunta, Paolo; Devuyst, Olivier; Rampoldi, Luca		Swiss Kidney Project Genes Hyperte	Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression	NATURE MEDICINE			English	Article							TAMM-HORSFALL PROTEIN; BLOOD-PRESSURE; COTRANSPORTER NKCC2; RENAL-FUNCTION; DISEASE; MICE; MOUSE; SPAK; NEPHROPATHY; ASSOCIATION	Hypertension and chronic kidney disease (CKD) are complex traits representing major global health problems(1,2). Multiple genome-wide association studies have identified common variants in the promoter of the UMOD gene(3-9), which encodes uromodulin, the major protein secreted in normal urine, that cause independent susceptibility to CKD and hypertension. Despite compelling genetic evidence for the association between UMOD risk variants and disease susceptibility in the general population, the underlying biological mechanism is not understood. Here, we demonstrate that UMOD risk variants increased UMOD expression in vitro and in vivo. Uromodulin overexpression in transgenic mice led to salt-sensitive hypertension and to the presence of age-dependent renal lesions similar to those observed in elderly individuals homozygous for UMOD promoter risk variants. The link between uromodulin and hypertension is due to activation of the renal sodium cotransporter NKCC2. We demonstrated the relevance of this mechanism in humans by showing that pharmacological inhibition of NKCC2 was more effective in lowering blood pressure in hypertensive patients who are homozygous for UMOD promoter risk variants than in other hypertensive patients. Our findings link genetic susceptibility to hypertension and CKD to the level of uromodulin expression and uromodulin's effect on salt reabsorption in the kidney. These findings point to uromodulin as a therapeutic target for lowering blood pressure and preserving renal function.	[Trudu, Matteo; Schaeffer, Celine; Rampoldi, Luca] Ist Sci San Raffaele, Div Genet & Cell Biol, Dulbecco Telethon Inst, I-20132 Milan, Italy; [Janas, Sylvie; Debaix, Huguette; Glaudemans, Bob; Devuyst, Olivier] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Janas, Sylvie; Debaix, Huguette; Devuyst, Olivier] Catholic Univ Louvain, Sch Med, Div Nephrol, B-1200 Brussels, Belgium; [Lanzani, Chiara; Citterio, Lorena] Ist Sci San Raffaele, Div Nephrol & Dialysis, I-20132 Milan, Italy; [Ikehata, Masami; Rastaldi, Maria P.] Osped Maggiore Policlin, Fdn Ist Ricovero & Cura Carattere Sci Ca Granda, Renal Res Lab, Milan, Italy; [Ikehata, Masami; Rastaldi, Maria P.] Fdn DAmico Ric Malattie Renali, Milan, Italy; [Demaretz, Sylvie; Laghmani, Kamel] INSERM, UMRS 872, Paris, France; [Trevisani, Francesco; Manunta, Paolo] Univ Vita Salute San Raffaele, Sch Nephrol, Milan, Italy; [Ristagno, Giuseppe] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Dell'Antonio, Giacomo] Ist Sci San Raffaele, Dept Pathol, I-20132 Milan, Italy; [Loffing, Johannes] Univ Zurich, Zurich Ctr Integrat Human Physiol, Inst Anat, Zurich, Switzerland	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Vita-Salute San Raffaele University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Rampoldi, L (corresponding author), Ist Sci San Raffaele, Div Genet & Cell Biol, Dulbecco Telethon Inst, I-20132 Milan, Italy.	olivier.devuyst@uzh.ch; rampoldi.luca@hsr.it	Rampoldi, Luca/L-3639-2018; Lanzani, Chiara Livia/AAN-2284-2020; Laghmani, Kamel/AIE-9621-2022; Bochud, Murielle/A-3981-2010; Manunta, Paolo/ABH-5476-2020; Citterio, Lorena/AAC-1589-2019; EHRET, Georg B/A-9532-2009; Loffing, Johannes/ABG-9973-2020; Vogt, Bruno/AAS-2876-2020; Schaeffer, Celine/AAC-5208-2022; Rampoldi, Luca/AAN-6228-2020; IKEHATA, Masami/HHR-9052-2022; Trudu, Matteo/K-2567-2018; Schaeffer, Celine/AAU-5713-2020	Rampoldi, Luca/0000-0002-0544-7042; Lanzani, Chiara Livia/0000-0002-5332-4012; Laghmani, Kamel/0000-0002-2167-5766; Bochud, Murielle/0000-0002-5727-0218; Manunta, Paolo/0000-0003-3976-9696; Citterio, Lorena/0000-0001-6455-2291; EHRET, Georg B/0000-0002-5730-0675; Vogt, Bruno/0000-0002-1548-6387; Schaeffer, Celine/0000-0001-5883-3951; Rampoldi, Luca/0000-0002-0544-7042; IKEHATA, Masami/0000-0001-9835-9991; Trudu, Matteo/0000-0002-4340-7738; Schaeffer, Celine/0000-0001-5883-3951; Ristagno, Giuseppe/0000-0002-9235-4820; Ackermann, Daniel/0000-0003-0550-354X; Devuyst, Olivier/0000-0003-3744-4767; Loffing, Johannes/0000-0002-9415-6588; Pruijm, Menno/0000-0003-1027-1851	Telethon-Italy [TCR08006]; Italian Ministry of Health [RF-2010-2319394]; Associazione per il Bambino Nefropatico; Belgian Fonds National de la Recherche Scientifique; Fonds pour la Recherche Scientifique Medicale; Concerted Research Action [10/15-029]; Interuniversity Attraction Pole program; Gebert Ruf Stiftung [GRS-038/12]; National Centre of Competence in Research Kidney; Swiss National Science Foundation [310030_146490, 33CM30-124087/1, 33CM30_140331]; European Community's Seventh Framework Programme [246539, 305608]	Telethon-Italy(Fondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); Associazione per il Bambino Nefropatico; Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Concerted Research Action; Interuniversity Attraction Pole program(Belgian Federal Science Policy Office); Gebert Ruf Stiftung; National Centre of Competence in Research Kidney; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community's Seventh Framework Programme(European Commission)	We thank M. Azizi, A. Blanchard, G. Capasso, M. Carrel, Y. Cnops, A. Creatore, S. Delli Carpini, P. Houillier, X. Jeunemaitre, R. Latini, N. Morel, S. Terryn and S. Youhanna for help, technical assistance and fruitful discussions. We are grateful to S. Bourgeois (University of Zurich) for providing MKTAL cells, to D. Alessi (University of Dundee) for antibodies to SPAK and phospho-SPAK/OSRI, to B. Forbush (Yale University) for antibody to phospho-NKCC2 and to D. Schock-Kusch and N. Gretz (University of Heidelberg) for FITC-sinistrin clearance reagents and technical assistance. This work was supported by Telethon-Italy (TCR08006), the Italian Ministry of Health (grant RF-2010-2319394), Associazione per il Bambino Nefropatico, the Belgian Fonds National de la Recherche Scientifique and Fonds pour la Recherche Scientifique Medicale, a Concerted Research Action (10/15-029), an Interuniversity Attraction Pole program initiated by the Belgian Science Policy Office, the Gebert Ruf Stiftung (Project GRS-038/12), the National Centre of Competence in Research Kidney. CH (Swiss National Science Foundation), the Swiss National Science Foundation project grant 310030_146490 and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 246539 (Marie Curie) and grant 305608 (EURenOmics). The SKIPOGH project is funded by the Swiss National Science Foundation (33CM30-124087/1 and 33CM30_140331). L.R. is an Associate Telethon Scientist.	Bachmann S, 2005, AM J PHYSIOL-RENAL, V288, pF559, DOI 10.1152/ajprenal.00143.2004; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Chen G, 2007, AM J PHYSIOL-RENAL, V293, pF1272, DOI 10.1152/ajprenal.00138.2007; Devuyst O, 2008, NAT GENET, V40, P495, DOI 10.1038/ng0508-495; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eddy AA, 2011, NAT MED, V17, P553, DOI 10.1038/nm0511-553; Ferrandi M, 2010, J MOL MED, V88, P203, DOI 10.1007/s00109-009-0549-x; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Han JX, 1998, LAB ANIM SCI, V48, P256; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Mulder W J., 2001, Eur J Intern Med, V12, P86, DOI 10.1016/S0953-6205(01)00121-2; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; O'Seaghdha CM, 2012, NAT REV NEPHROL, V8, P89, DOI 10.1038/nrneph.2011.189; Padmanabhan S, 2012, TRENDS GENET, V28, P397, DOI 10.1016/j.tig.2012.04.001; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Pattaro C, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-41; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Schaeffer C, 2009, MOL BIOL CELL, V20, P589, DOI 10.1091/mbc.E08-08-0876; Schreiber A, 2012, AM J PHYSIOL-RENAL, V303, pF783, DOI 10.1152/ajprenal.00279.2012; Simpson RU, 2007, J STEROID BIOCHEM, V103, P521, DOI 10.1016/j.jsbmb.2006.12.098; Stubbe J, 2006, AM J PHYSIOL-RENAL, V291, pF812, DOI 10.1152/ajprenal.00477.2005; Torffvit O, 2004, NEPHRON PHYSIOL, V97, pp31, DOI [DOI 10.1159/000077600, 10.1159/000077600]; Ying WZ, 1998, KIDNEY INT, V54, P1150, DOI 10.1046/j.1523-1755.1998.00117.x	40	236	240	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1655	1660		10.1038/nm.3384	http://dx.doi.org/10.1038/nm.3384			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24185693	Green Accepted			2022-12-27	WOS:000328181400036
J	Wei, K; Piecewicz, SM; McGinnis, LM; Taniguchi, CM; Wiegand, SJ; Anderson, K; Chan, CWM; Mulligan, KX; Kuo, D; Yuan, J; Vallon, M; Morton, LC; Lefai, E; Simon, MC; Maher, JJ; Mithieux, G; Rajas, F; Annes, JP; McGuinness, OP; Thurston, G; Giaccia, AJ; Kuo, CJ				Wei, Kevin; Piecewicz, Stephanie M.; McGinnis, Lisa M.; Taniguchi, Cullen M.; Wiegand, Stanley J.; Anderson, Keith; Chan, Carol W-M; Mulligan, Kimberly X.; Kuo, David; Yuan, Jenny; Vallon, Mario; Morton, Lori C.; Lefai, Etienne; Simon, M. Celeste; Maher, Jacquelyn J.; Mithieux, Gilles; Rajas, Fabienne; Annes, Justin P.; McGuinness, Owen P.; Thurston, Gavin; Giaccia, Amato J.; Kuo, Calvin J.			A liver Hif-2 alpha-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition	NATURE MEDICINE			English	Article							GLUCOSE-HOMEOSTASIS; LIPID-METABOLISM; GENE-EXPRESSION; IN-VIVO; HYPOXIA; GROWTH; ANGIOGENESIS; HIF-1-ALPHA; RECEPTOR; MICE	Insulin initiates diverse hepatic metabolic responses, including gluconeogenic suppression and induction of glycogen synthesis and lipogenesis1,2. The liver possesses a rich sinusoidal capillary network with a higher degree of hypoxia and lower gluconeogenesis in the perivenous zone as compared to the rest of the organ3. Here, we show that diverse vascular endothelial growth factor (VEGF) inhibitors improved glucose tolerance in nondiabetic C57BL/6 and diabetic db/db mice, potentiating hepatic insulin signaling with lower gluconeogenic gene expression, higher glycogen storage and suppressed hepatic glucose production. VEGF inhibition induced hepatic hypoxia through sinusoidal vascular regression and sensitized liver insulin signaling through hypoxia-inducible factor-2 alpha (Hif-2 alpha, encoded by Epas1) stabilization. Notably, liverspecific constitutive activation of HIF-2 alpha, but not HIF-1 alpha, was sufficient to augment hepatic insulin signaling through direct and indirect induction of insulin receptor substrate-2 (Irs2), an essential insulin receptor adaptor protein4-6. Further, liver Irs2 was both necessary and sufficient to mediate Hif-2 alpha and Vegf inhibition effects on glucose tolerance and hepatic insulin signaling. These results demonstrate an unsuspected intersection between Hif-2 alpha-mediated hypoxic signaling and hepatic insulin action through Irs2 induction, which can be co-opted by Vegf inhibitors to modulate glucose metabolism. These studies also indicate distinct roles in hepatic metabolism for Hif-1 alpha, which promotes glycolysis(7-9), and Hif-2 alpha, which suppresses gluconeogenesis, and suggest new treatment approaches for type 2 diabetes mellitus.	[Wei, Kevin; Piecewicz, Stephanie M.; McGinnis, Lisa M.; Chan, Carol W-M; Kuo, David; Yuan, Jenny; Vallon, Mario; Kuo, Calvin J.] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Taniguchi, Cullen M.; Giaccia, Amato J.] Stanford Univ, Sch Med, Div Radiat Oncol, Stanford, CA 94305 USA; [Wiegand, Stanley J.; Anderson, Keith; Morton, Lori C.; Thurston, Gavin] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Mulligan, Kimberly X.; McGuinness, Owen P.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Lefai, Etienne] Univ Lyon, INSERM, U1060, Inst Natl Rech Agron 1235, Lyon, France; [Simon, M. Celeste] Univ Penn, Sch Med, Howard Hughes Med Inst, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Maher, Jacquelyn J.] Univ Calif San Francisco, Ctr Liver, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Mithieux, Gilles; Rajas, Fabienne] Univ Lyon, INSERM, U855, Lyon, France; [Annes, Justin P.] Stanford Univ, Sch Med, Div Endocrinol & Metab, Stanford, CA 94305 USA	Stanford University; Stanford University; Regeneron; Vanderbilt University; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); Stanford University	Kuo, CJ (corresponding author), Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA.	cjkuo@stanford.edu	Lefai, Etienne/E-9615-2019; Lefai, Etienne/L-7961-2019; Simon, Celeste/AAG-3941-2021; RAJAS, Fabienne/P-4091-2016	Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; RAJAS, Fabienne/0000-0002-9233-7633; Thurston, Gavin/0000-0002-4105-5919; Kuo, Calvin/0000-0002-7427-5985; Gilles, Mithieux/0000-0003-3579-8529; Taniguchi, Cullen/0000-0002-8052-3316; Annes, Justin/0000-0001-8431-3589; Kuo, David/0000-0001-9003-9993	Stanford Medical Scientist Training Program; NIGMS US National Institutes of Health (NIH) [GM-07365]; Stanford Cardiovascular Institute [1K12HL087746]; Molecular and Cellular Immunobiology Program [5T32AI07290]; NIH American Recovery and Reinvestment Act Supplement [1R01HL074267]; Radiological Society of North America Research Resident [1018, 1111]; NIH [DK084206, RO1DK043748, P60 DK020593, U24DK059637]; Molecular Endocrinology Training Program [T32DK007563]; Cell Biology Core Facility, University of California-San Francisco Liver Center [P30 DK026743]; Sydney Frank Foundation; Stanford Developmental Cancer Research Award [NIH R01HL074267, R01NS064517, R01CA158528]; NATIONAL CANCER INSTITUTE [P01CA067166, R01CA158528] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087746, T32HL098049, R01HL074267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, K08DK084206, T32DK007563, P30DK026743, U24DK059637, R01DK043748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064517] Funding Source: NIH RePORTER	Stanford Medical Scientist Training Program; NIGMS US National Institutes of Health (NIH); Stanford Cardiovascular Institute; Molecular and Cellular Immunobiology Program; NIH American Recovery and Reinvestment Act Supplement; Radiological Society of North America Research Resident; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Endocrinology Training Program; Cell Biology Core Facility, University of California-San Francisco Liver Center; Sydney Frank Foundation; Stanford Developmental Cancer Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. DePinho, L. Harshman, B. Tam, C. Chartier, D. Suchet and members of the Kuo laboratory for insightful comments and C. Her, J. Kovalski, K. Thabet and D. Nandamundi for technical assistance. We thank G. Fuh (Genentech) for B20.4.1.1 antibody, C. Chartier (Stanford) for the human HIF1A allele lacking the inhibitory ODD (HIF-1 alpha.ODD) and M. Montminy (Salk) for Ad-IRS2. Fellowship support was from the Stanford Medical Scientist Training Program (K. W. and L. M. M.), NIGMS US National Institutes of Health (NIH) GM-07365 training grant (K. W.), Stanford Cardiovascular Institute T32 training grant 1K12HL087746 (S. M. P.), Molecular and Cellular Immunobiology Program training grant 5T32AI07290 (L. M. M.), NIH American Recovery and Reinvestment Act Supplement 1R01HL074267 (L. M. M.), Radiological Society of North America Research Resident grants 1018 and 1111 (C. M. T.), NIH DK084206 (J. P. A.) and Molecular Endocrinology Training Program grant T32DK007563 (K. X. M.). This work was supported by P30 DK026743 (Cell Biology Core Facility, University of California-San Francisco Liver Center) to J. J. M., NIH RO1DK043748, P60 DK020593 and U24DK059637 to O. P. M., NIH CA67166 and the Sydney Frank Foundation to A. J. G. and a Stanford Developmental Cancer Research Award and NIH R01HL074267, R01NS064517 and R01CA158528 to C. J. K.	Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Billemont B, 2008, BRIT J CANCER, V99, P1380, DOI 10.1038/sj.bjc.6604709; Bracken CP, 2006, J BIOL CHEM, V281, P22575, DOI 10.1074/jbc.M600288200; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Jacobi J, 2004, GENE THER, V11, P302, DOI 10.1038/sj.gt.3302162; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Mardilovich K, 2009, CANCER RES, V69, P8894, DOI 10.1158/0008-5472.CAN-09-1152; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Meng R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053557; Mulligan KX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030160; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prewett M, 1999, CANCER RES, V59, P5209; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Scully MS, 2011, EXP DIABETES RES, DOI 10.1155/2011/910159; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; STEELE R, 1956, AM J PHYSIOL, V187, P15, DOI 10.1152/ajplegacy.1956.187.1.15; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Yeo EJ, 2008, ANN HEMATOL, V87, P11, DOI 10.1007/s00277-007-0359-6; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	45	80	81	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1331	+		10.1038/nm.3295	http://dx.doi.org/10.1038/nm.3295			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24037094	Green Accepted, Green Submitted			2022-12-27	WOS:000325531700034
J	Chung, AS; Wu, XM; Zhuang, GL; Ngu, H; Kasman, I; Zhang, JH; Vernes, JM; Jiang, ZS; Meng, YG; Peale, FV; Ouyang, WJ; Ferrara, N				Chung, Alicia S.; Wu, Xiumin; Zhuang, Guanglei; Ngu, Hai; Kasman, Ian; Zhang, Jianhuan; Vernes, Jean-Michel; Jiang, Zhaoshi; Meng, Y. Gloria; Peale, Franklin V.; Ouyang, Wenjun; Ferrara, Napoleone			An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy	NATURE MEDICINE			English	Article							SUPPRESSOR-CELLS; MYELOID CELLS; VEGF TREATMENT; CANCER-CELLS; T-CELLS; IL-17; GROWTH; REFRACTORINESS; INDUCTION; MICROENVIRONMENT	Although angiogenesis inhibitors have provided substantial clinical benefit as cancer therapeutics, their use is limited by resistance to their therapeutic effects. While ample evidence indicates that such resistance can be influenced by the tumor microenvironment, the underlying mechanisms remain incompletely understood. Here, we have uncovered a paracrine signaling network between the adaptive and innate immune systems that is associated with resistance in multiple tumor models: lymphoma, lung and colon. Tumor-infiltrating T helper type 17 (T(H)17) cells and interleukin-17 (IL-17) induced the expression of granulocyte colony-stimulating factor (G-CSF) through nuclear factor KB (NE-kappa B) and extracellular-related kinase (ERK) signaling, leading to immature myeloid-cell mobilization and recruitment into the tumor microenvironment. The occurrence of T(H)17 cells and Bv8-positive granulocytes was also observed in clinical tumor specimens. Tumors resistant to treatment with antibodies to VEGF were rendered sensitive in IL-17 receptor (IL-17R)-knockout hosts deficient in T(H)17 effector function. Furthermore, pharmacological blockade of T(H)17 cell function sensitized resistant tumors to therapy with antibodies to VEGF. These findings indicate that IL-17 promotes tumor resistance to VEGF inhibition, suggesting that immunomodulatory strategies could improve the efficacy of anti-angiogenic therapy.	[Chung, Alicia S.; Wu, Xiumin; Zhuang, Guanglei; Ferrara, Napoleone] Genentech Inc, Dept Res Drug Discovery, San Francisco, CA 94080 USA; [Ngu, Hai; Peale, Franklin V.] Genentech Inc, Dept Pathol Res, San Francisco, CA 94080 USA; [Kasman, Ian] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Zhang, Jianhuan; Vernes, Jean-Michel; Meng, Y. Gloria] Genentech Inc, Biocellular & Cellular Pharmacol, San Francisco, CA 94080 USA; [Jiang, Zhaoshi] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Chung, AS (corresponding author), Genentech Inc, Dept Res Drug Discovery, San Francisco, CA 94080 USA.		Ouyang, Wenjun/ABA-8763-2020; Zhuang, Guanglei/K-6097-2013	Zhuang, Guanglei/0000-0001-8141-5096; Ouyang, Wenjun/0000-0002-1811-5864				Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Curd LM, 2012, CLIN EXP IMMUNOL, V168, P192, DOI 10.1111/j.1365-2249.2012.04570.x; Dirkx AEM, 2006, FASEB J, V20, P621, DOI 10.1096/fj.05-4493com; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Ebos JML, 2009, CLIN CANCER RES, V15, P5020, DOI 10.1158/1078-0432.CCR-09-0095; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gabnlovich D.I., 2012, NAT REV IMMUNOL, V12, P253; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gnvennikov S.I., 2012, NATURE, V491, P254; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Manning EA, 2007, CLIN CANCER RES, V13, P3951, DOI 10.1158/1078-0432.CCR-07-0374; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Qu XP, 2012, J BIOL CHEM, V287, P19574, DOI 10.1074/jbc.M111.326801; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shojaei F, 2010, CANCER RES, V70, P10090, DOI 10.1158/0008-5472.CAN-10-0489; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Tartour E, 1999, CANCER RES, V59, P3698; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557	44	318	330	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2013	19	9					1114	1123		10.1038/nm.3291	http://dx.doi.org/10.1038/nm.3291			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23913124	Green Published			2022-12-27	WOS:000324083500025
J	Backhed, F				Backhed, Fredrik			Meat-metabolizing bacteria in atherosclerosis	NATURE MEDICINE			English	Editorial Material							GUT MICROBIOTA; METAGENOME; MICE		[Backhed, Fredrik] Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden; [Backhed, Fredrik] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden	University of Gothenburg	Backhed, F (corresponding author), Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden.	fredrik.backhed@wlab.gu.se	Backhed, Fredrik/ABE-6613-2020	Backhed, Fredrik/0000-0002-4871-8818				Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Tang W. H. W., 2013, NEW ENGL J MED, DOI DOI 10.1056/NEJM0A1109400; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	12	33	33	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2013	19	5					533	534		10.1038/nm.3178	http://dx.doi.org/10.1038/nm.3178			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652100				2022-12-27	WOS:000318583000019
J	Buglioni, A; Burnett, JC				Buglioni, Alessia; Burnett, John C., Jr.			A gut-heart connection in cardiometabolic regulation	NATURE MEDICINE			English	Editorial Material							ATRIAL-NATRIURETIC-PEPTIDE; HUMAN ADIPOCYTES; BLOOD-PRESSURE		[Buglioni, Alessia; Burnett, John C., Jr.] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA	Mayo Clinic	Buglioni, A (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA.	burnett.john@mayo.edu			NHLBI NIH HHS [R01 HL083231, R01 HL036634] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036634, R01HL083231] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cannon W.B., 1932, WISDOM BODY; Cannone V, 2011, J AM COLL CARDIOL, V58, P629, DOI 10.1016/j.jacc.2011.05.011; Cataliotti A, 2012, MAYO CLIN PROC, V87, P413, DOI 10.1016/j.mayocp.2012.02.003; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Ingelsson E, 2007, CIRCULATION, V116, P984, DOI 10.1161/CIRCULATIONAHA.107.708537; Inoue T, 2001, CARDIOVASC RES, V51, P470, DOI 10.1016/S0008-6363(01)00248-6; Kim M, 2013, NAT MED, V19, P567, DOI 10.1038/nm.3128; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Wang B., 2013, DIABETES OBES METAB, DOI DOI 10.1111/D0M.12085; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA	12	16	17	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2013	19	5					534	536		10.1038/nm.3196	http://dx.doi.org/10.1038/nm.3196			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652101	Green Accepted			2022-12-27	WOS:000318583000020
J	Scholtysek, C; Katzenbeisser, J; Fu, H; Uderhardt, S; Ipseiz, N; Stoll, C; Zaiss, MM; Stock, M; Donhauser, L; Bohm, C; Kleyer, A; Hess, A; Engelke, K; David, JP; Djouad, F; Tuckermann, JP; Desvergne, B; Schett, G; Kronke, G				Scholtysek, Carina; Katzenbeisser, Julia; Fu, He; Uderhardt, Stefan; Ipseiz, Natacha; Stoll, Cornelia; Zaiss, Mario M.; Stock, Michael; Donhauser, Laura; Boehm, Christina; Kleyer, Arnd; Hess, Andreas; Engelke, Klaus; David, Jean-Pierre; Djouad, Farida; Tuckermann, Jan Peter; Desvergne, Beatrice; Schett, Georg; Kroenke, Gerhard			PPAR beta/delta governs Wnt signaling and bone turnover	NATURE MEDICINE			English	Article							ACTIVATED-RECEPTOR-DELTA; OSTEOCLAST FORMATION; METABOLIC SYNDROME; ADENOMA GROWTH; GAMMA; DIFFERENTIATION; ADIPOGENESIS; AGONISTS; TRANSACTIVATION; ROSIGLITAZONE	Peroxisome proliferator-activated receptors (PPARs) act as metabolic sensors and central regulators of fat and glucose homeostasis(1). Furthermore, PPAR gamma has been implicated as major catabolic regulator of bone mass in mice and humans(2-5). However, a potential involvement of other PPAR subtypes in the regulation of bone homeostasis has remained elusive. Here we report a previously unrecognized role of PPAR beta/delta as a key regulator of bone turnover and the crosstalk between osteoblasts and osteoclasts. In contrast to activation of PPAR gamma, activation of PPAR beta/delta amplified Wnt-dependent and beta-catenin-dependent signaling and gene expression in osteoblasts, resulting in increased expression of osteoprotegerin (OPG) and attenuation of osteoblast-mediated osteoclastogenesis. Accordingly, PPAR beta/delta-deficient mice had lower Wnt signaling activity, lower serum concentrations of OPG, higher numbers of osteoclasts and osteopenia. Pharmacological activation of PPAR beta/delta in a mouse model of postmenopausal osteoporosis led to normalization of the altered ratio of tumor necrosis factor superfamily, member 11 (RANKL, also called TNFSF11) to OPG, a rebalancing of bone turnover and the restoration of normal bone density. Our findings identify PPAR beta/delta as a promising target for an alternative approach in the treatment of osteoporosis and related diseases.	[Scholtysek, Carina; Katzenbeisser, Julia; Uderhardt, Stefan; Ipseiz, Natacha; Stoll, Cornelia; Zaiss, Mario M.; Stock, Michael; Donhauser, Laura; Boehm, Christina; Kleyer, Arnd; David, Jean-Pierre; Schett, Georg; Kroenke, Gerhard] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Scholtysek, Carina; Katzenbeisser, Julia; Uderhardt, Stefan; Ipseiz, Natacha; Stoll, Cornelia; Zaiss, Mario M.; Stock, Michael; Donhauser, Laura; Boehm, Christina; Kleyer, Arnd; David, Jean-Pierre; Schett, Georg; Kroenke, Gerhard] Univ Erlangen Nurnberg, Inst Clin Immunol, D-91054 Erlangen, Germany; [Scholtysek, Carina; Uderhardt, Stefan; Ipseiz, Natacha; Stoll, Cornelia; Stock, Michael; Donhauser, Laura; Kleyer, Arnd; Kroenke, Gerhard] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Fu, He; Desvergne, Beatrice] Univ Lausanne, Ctr Integrat Gen, Fac Biol & Med, Lausanne, Switzerland; [Hess, Andreas] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Engelke, Klaus] Univ Erlangen Nurnberg, Inst Med Phys, D-91054 Erlangen, Germany; [Djouad, Farida] Inst Natl Sante & Rech Med, U844, Montpellier, France; [Djouad, Farida] Univ Montpellier I, Unite Format & Rech UFR Medecine, Montpellier, France; [Tuckermann, Jan Peter] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Tuckermann, Jan Peter] Univ Ulm, Inst Gen Zool & Endocrinol, D-89069 Ulm, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Lausanne; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Ulm University	Kronke, G (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany.	gerhard.kroenke@uk-erlangen.de	Kleyer, Arnd/AAU-2689-2021; Ipseiz, Natacha/AAG-6390-2019; Zaiss, Mario M./ABE-7125-2021; Stock, Michael/B-9829-2009; Krönke, Gerhard/C-6615-2014; Desvergne, Beatrice/C-8892-2016	Kleyer, Arnd/0000-0002-2026-7728; Ipseiz, Natacha/0000-0001-5008-8889; Zaiss, Mario M./0000-0003-3844-1664; Krönke, Gerhard/0000-0002-7566-4325; Stock, Michael/0000-0002-3322-0961; Desvergne, Beatrice/0000-0001-5483-288X; Djouad, Farida/0000-0001-8248-6822	Deutsche Forschungsgemeinschaft [KR3523, FG 661, SFB643, SPP1468-IMMUNOBONE]; Bundesministerium fur Bildung und Forschung (BMBF); University of Erlangen-Nuremberg; European Union; Interdisciplinary Centre for Clinical Research (IZKF) Erlangen; Bayrische Forschungsstftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); University of Erlangen-Nuremberg; European Union(European Commission); Interdisciplinary Centre for Clinical Research (IZKF) Erlangen; Bayrische Forschungsstftung	We thank M. Steffen, U. Hillienhoff and I. Schmidt for technical assistance and J. Wittmann for his help during the analysis of the Lrp5 promoter. Wnt3a-expressing L cells were kindly provided by K. Tanneberger (Department of Experimental Medicine II, University of Erlangen). This study was supported by the Deutsche Forschungsgemeinschaft (KR3523, FG 661, SFB643 and SPP1468-IMMUNOBONE), the Bundesministerium fur Bildung und Forschung (BMBF; project ANCYLOSS); the ELAN Program of the University of Erlangen-Nuremberg; the MASTERS WITCH and IMI projects of the European Union; the Interdisciplinary Centre for Clinical Research (IZKF) Erlangen; and the Bayrische Forschungsstftung.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Chan BY, 2007, BONE, V40, P149, DOI 10.1016/j.bone.2006.07.029; Cho ES, 2012, MOL CELLS, V33, P173, DOI 10.1007/s10059-012-2240-z; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Giaginis C, 2007, FUND CLIN PHARMACOL, V21, P231, DOI 10.1111/j.1472-8206.2007.00486.x; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Grey A, 2008, OSTEOPOROSIS INT, V19, P129, DOI 10.1007/s00198-007-0477-y; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Kawai M, 2010, NAT REV ENDOCRINOL, V6, P629, DOI 10.1038/nrendo.2010.155; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nadra K, 2006, MOL CELL BIOL, V26, P3266, DOI 10.1128/MCB.26.8.3266-3281.2006; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; Olson EJ, 2012, ARTERIOSCL THROM VAS, V32, P2289, DOI 10.1161/ATVBAHA.112.247890; Still K, 2008, CALCIFIED TISSUE INT, V83, P285, DOI 10.1007/s00223-008-9175-9; Takada I, 2007, ANN NY ACAD SCI, V1116, P182, DOI 10.1196/annals.1402.034; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Viccica G, 2010, J Endocrinol Invest, V33, P9; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wang DZ, 2004, CELL CYCLE, V3, P1512, DOI 10.4161/cc.3.12.1288; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015	28	73	76	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2013	19	5					608	613		10.1038/nm.3146	http://dx.doi.org/10.1038/nm.3146			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23542786				2022-12-27	WOS:000318583000033
J	Collison, A; Hatchwell, L; Verrills, N; Wark, PAB; de Siqueira, AP; Tooze, M; Carpenter, H; Don, AS; Morris, JC; Zimmermann, N; Bartlett, NW; Rothenberg, ME; Johnston, SL; Foster, PS; Mattes, J				Collison, Adam; Hatchwell, Luke; Verrills, Nicole; Wark, Peter A. B.; de Siqueira, Ana Pereira; Tooze, Melinda; Carpenter, Helen; Don, Anthony S.; Morris, Jonathan C.; Zimmermann, Nives; Bartlett, Nathan W.; Rothenberg, Marc E.; Johnston, Sebastian L.; Foster, Paul S.; Mattes, Joerg			The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity	NATURE MEDICINE			English	Article							NF-KAPPA-B; SERINE/THREONINE PHOSPHATASE; AIRWAY HYPERRESPONSIVENESS; EPITHELIAL-CELLS; DENDRITIC CELLS; T(H)2 CELLS; KINASE; PP2A; MID1; ACTIVATION	Allergic airway inflammation is associated with activation of innate immune pathways by allergens. Acute exacerbations of asthma are commonly associated with rhinovirus infection. Here we show that, after exposure to house dust mite (HDM) or rhinovirus infection, the E3 ubiquitin ligase midline 1 (MID1) is upregulated in mouse bronchial epithelium. HDM regulates MIDI expression in a Toll-like receptor 4 (TLR4)- and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-dependent manner. MIDI decreases protein phosphatase 2A (PP2A) activity through association with its catalytic subunit PP2Ac. siRNA-mediated knockdown of MID1 or pharmacological activation of PP2A using a nonphosphorylatable FTY720 analog in mice exposed to HDM reduces airway hyperreactivity and inflammation, including the expression of interleukin-25 (IL-25), IL-33 and CCL20, IL-5 and IL-13 release, nuclear factor (NF)kappa B activity, p38 mitogen-activated protein kinase (MAPK) phosphorylation, accumulation of eosinophils, T lymphocytes and myeloid dendritic cells, and the number of mucus-producing cells. MID1 inhibition also limited rhinovirus-induced exacerbation of allergic airway disease. We found that MID1 was upregulated in primary human bronchial epithelial cells upon HDM or rhinovirus exposure, and this correlated with TRAIL and CCL20 expression. Together, these findings identify a key role of MID1 in allergic airway inflammation and links innate immune pathway activation to the development and exacerbation of asthma.	[Collison, Adam; Hatchwell, Luke; de Siqueira, Ana Pereira; Mattes, Joerg] Univ Newcastle, Expt & Translat Resp Grp, Newcastle, NSW 2300, Australia; [Collison, Adam; Hatchwell, Luke; Wark, Peter A. B.; de Siqueira, Ana Pereira; Tooze, Melinda; Mattes, Joerg] Hunter Med Res Inst, Newcastle, NSW, Australia; [Collison, Adam; Hatchwell, Luke; Wark, Peter A. B.; de Siqueira, Ana Pereira; Tooze, Melinda; Foster, Paul S.; Mattes, Joerg] Univ Newcastle, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW 2300, Australia; [Verrills, Nicole; Carpenter, Helen] Univ Newcastle, Discipline Med Biochem, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Wark, Peter A. B.; Tooze, Melinda] John Hunter Hosp, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Don, Anthony S.] Univ New S Wales, Prince Wales Clin Sch, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Morris, Jonathan C.] Univ New S Wales, Sch Chem, Sydney, NSW, Australia; [Zimmermann, Nives; Rothenberg, Marc E.] Univ Cincinnati, Dept Pediat, Div Allergy & Immunol, Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Bartlett, Nathan W.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Sect Airway Dis Infect, Natl Heart & Lung Inst, Med Res Council, London, England; [Bartlett, Nathan W.; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Asthma UK Ctr Allerg Mech Asthma, London, England; [Mattes, Joerg] Newcastle Childrens Hosp, Paediat Resp & Sleep Med Unit, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle; John Hunter Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Imperial College London; University of London; King's College London	Mattes, J (corresponding author), Univ Newcastle, Expt & Translat Resp Grp, Newcastle, NSW 2300, Australia.	joerg.mattes@newcastle.edu.au	Wark, Peter/G-7037-2013; Johnston, Sebastian Lennox/I-2423-2012; Morris, Jonathan C/A-9923-2008; MATTES, JOERG/M-5179-2019; Don, Anthony Simon/AAE-9687-2021; Foster, Paul/G-5057-2013; Collison, Adam/G-7718-2013	Wark, Peter/0000-0001-5676-6126; Johnston, Sebastian Lennox/0000-0003-3009-9200; Morris, Jonathan C/0000-0002-5109-9069; Don, Anthony Simon/0000-0003-1655-1184; Bartlett, Nathan/0000-0002-2715-5163; Verrills, Nicole/0000-0002-7894-0137; , Paul/0000-0002-0827-8299; Collison, Adam/0000-0002-3074-3046	National Health and Medical Research Council [NHMRC 631075, 1011153]; Hunter Medical Research Institute; Hunter Children's Research Foundation; NH&MRC Health Practitioner Research Fellowship [455623]; Asthma UK [06-050]; MRC Centre grant [G1000758]; ERC FP7 Advanced grant [233015]; Chair from Asthma UK [CH1155]; MRC [G1100168] Funding Source: UKRI; Medical Research Council [G1100168, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; Hunter Children's Research Foundation; NH&MRC Health Practitioner Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Asthma UK; MRC Centre grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC FP7 Advanced grant; Chair from Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the National Health and Medical Research Council (NH&MRC 631075 and 1011153) (J.M., P.S.F., N.V.), the Hunter Medical Research Institute (J.M., P.A.B.W., P.S.F.), the Hunter Children's Research Foundation (J.M., P.S.F., A.P.d.S.) and an NH&MRC Health Practitioner Research Fellowship to J.M. (455623). N.W.B. was supported by a project grant from Asthma UK (06-050) and S.L.J. by a Chair from Asthma UK (CH1155). This work was supported in part by MRC Centre grant G1000758 and ERC FP7 Advanced grant 233015 (to S.L.J.). We would like to thank M. Smyth, Peter MacCallum Cancer Centre, and J. Peschon, Amgen, for providing Tnfsf10<SUP>-/-</SUP> mice and S. Akira, Osaka University, for providing Tlr4<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice. We appreciate technical assistance from C. Cesar de Souza Alves, F. Eyers, J. Girkin, J. Grehan, H. MacDonald, M. Morten, K. Parsons, S. Reeves, L. Sokulsky and the staff from the animal care facilities of the contributing institutes.	Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Cornell TT, 2009, AM J PHYSIOL-LUNG C, V296, pL849, DOI 10.1152/ajplung.90516.2008; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Don AS, 2007, J BIOL CHEM, V282, P15833, DOI 10.1074/jbc.M609124200; Duan W, 2005, AM J RESP CRIT CARE, V171, P571, DOI 10.1164/rccm.200408-1006OC; Ehre C, 2012, P NATL ACAD SCI USA, V109, P16528, DOI 10.1073/pnas.1206552109; Fontanella B, 2008, HUM MUTAT, V29, P584, DOI 10.1002/humu.20706; Francis JN, 2008, CLIN EXP IMMUNOL, V152, P440, DOI 10.1111/j.1365-2249.2008.03657.x; Griego SD, 2000, J IMMUNOL, V165, P5211, DOI 10.4049/jimmunol.165.9.5211; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Holgate ST, 2010, DISCOV MED, V9, P439; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kobayashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027627; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Kuperman D, 1998, J EXP MED, V187, P939, DOI 10.1084/jem.187.6.939; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Latta EJ, 2012, MECH DEVELOP, V128, P560, DOI 10.1016/j.mod.2012.01.002; Lemanske RF, 2010, J ALLERGY CLIN IMMUN, V125, pS95, DOI 10.1016/j.jaci.2009.10.047; Liu WM, 2008, J ALLERGY CLIN IMMUN, V121, P893, DOI 10.1016/j.jaci.2008.02.004; Mattes J, 2001, J IMMUNOL, V167, P1683, DOI 10.4049/jimmunol.167.3.1683; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Miskolci V, 2003, ARCH BIOCHEM BIOPHYS, V417, P44, DOI 10.1016/S0003-9861(03)00336-9; Phipps S, 2009, AM J RESP CRIT CARE, V179, P883, DOI 10.1164/rccm.200806-974OC; Shanley TP, 2001, J IMMUNOL, V166, P966, DOI 10.4049/jimmunol.166.2.966; Sim ATR, 2006, PHARMACOL THERAPEUT, V112, P425, DOI 10.1016/j.pharmthera.2006.04.011; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wong WSF, 2005, CURR OPIN PHARMACOL, V5, P264, DOI 10.1016/j.coph.2005.01.009; Xatzipsalti Maria, 2007, V14, P33, DOI 10.1159/000107053	40	110	112	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					232	237		10.1038/nm.3049	http://dx.doi.org/10.1038/nm.3049			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23334847				2022-12-27	WOS:000314675900032
J	Steinman, L				Steinman, Lawrence			'Hub-and-spoke' T cell traffic in autoimmunity	NATURE MEDICINE			English	Editorial Material							MULTIPLE-SCLEROSIS; NATALIZUMAB; LYMPHOCYTES; DISCOVERY; RECEPTORS; ANTIGEN		Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu		Steinman, Lawrence/0000-0002-2437-2250				Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Odoardi F, 2012, NATURE, V488, P675, DOI 10.1038/nature11337; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Steinman L, 2012, J CELL BIOL, V199, P413, DOI 10.1083/jcb.201207175; Steinman L, 2009, NAT REV IMMUNOL, V9, P440, DOI 10.1038/nri2548; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725	13	9	9	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					139	141		10.1038/nm.3088	http://dx.doi.org/10.1038/nm.3088			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389609				2022-12-27	WOS:000314675900021
J	Shao, HL; Chung, J; Balaj, L; Charest, A; Bigner, DD; Carter, BS; Hochberg, FH; Breakefield, XO; Weissleder, R; Lee, H				Shao, Huilin; Chung, Jaehoon; Balaj, Leonora; Charest, Alain; Bigner, Darell D.; Carter, Bob S.; Hochberg, Fred H.; Breakefield, Xandra O.; Weissleder, Ralph; Lee, Hakho			Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; INTEGRATED GENOMIC ANALYSIS; PARAMETRIC RESPONSE MAP; MOLECULAR MARKER; EGFR; TARGET; EXPRESSION; BIOMARKERS; EXOSOMES	Glioblastomas shed large quantities of small, membrane-bound microvesicles into the circulation. Although these hold promise as potential biomarkers of therapeutic response, their identification and quantification remain challenging. Here, we describe a highly sensitive and rapid analytical technique for profiling circulating microvesicles directly from blood samples of patients with glioblastoma. Microvesicles, introduced onto a dedicated microfluidic chip, are labeled with target-specific magnetic nanoparticles and detected by a miniaturized nuclear magnetic resonance system. Compared with current methods, this integrated system has a much higher detection sensitivity and can differentiate glioblastoma multiforme (GBM) microvesicles from nontumor host cell-derived microvesicles. We also show that circulating GBM microvesicles can be used to analyze primary tumor mutations and as a predictive metric of treatment-induced changes. This platform could provide both an early indicator of drug efficacy and a potential molecular stratifier for human clinical trials.	[Shao, Huilin; Chung, Jaehoon; Weissleder, Ralph; Lee, Hakho] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Shao, Huilin] Harvard Univ, Sch Med, Harvard Biophys Program, Boston, MA USA; [Balaj, Leonora; Breakefield, Xandra O.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurosci, Boston, MA 02114 USA; [Charest, Alain] Tufts Univ, Sch Med, Mol Oncol Res Inst, Boston, MA 02111 USA; [Bigner, Darell D.] Duke Univ, Med Ctr, Dept Pathol, Brain Tumor Ctr, Durham, NC 27710 USA; [Carter, Bob S.] Univ Calif San Diego, Sch Med, Div Neurol Surg, San Diego, CA 92103 USA; [Hochberg, Fred H.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Breakefield, Xandra O.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Tufts University; Duke University; University of California System; University of California San Diego; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lee, H (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu; hlee@mgh.harvard.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324; Balaj, Leonora/0000-0003-0931-9715; /0000-0003-0828-4143; Chung, Jaehoon/0000-0003-1499-7449	NIH [U54CA151884, R01EB010011, R01EB004626, P01CA069246, P50CA86355, U01CA141556, U24CA092782, R21CA14122]; Singapore Agency for Science, Technology and Research; American Cancer Society Research Scholar Award [117409]; NATIONAL CANCER INSTITUTE [P50CA086355, U01CA141556, P01CA069246, U54CA151884, U24CA092782] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010011, R01EB004626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank T. Reiner (Massachusetts General Hospital (MGH)) for preparing TCO, N. Sergeyev (MGH) for synthesizing MNPs, S. Hilderbrand (MGH) for synthesizing reactive TZ, M. Pittet (MGH) for LNZ308 cells and T. Chan (Memorial Sloan-Kettering Cancer Center) for SkMG3 cells, as well as M. Liong and A. Ghazani for assay assistance, B. Marinelli for mu NMR measurements, C. Min for software implementation, M. McKee for transmission electron microscopy, J. Skog for advice on NTA measurements, L. Zhu and S. Sivaraman for technical assistance and Y. Fisher-Jeffes for critical reading of the manuscript. Special thanks to C. Castro, J. Carlson and clinical colleagues for many helpful discussions. This work was supported in part by NIH grants U54CA151884, R01EB010011, R01EB004626, P01CA069246, P50CA86355, U01CA141556, U24CA092782 and R21CA14122; H.S. received a BS-PhD National Science Scholarship awarded by the Singapore Agency for Science, Technology and Research; A.C. received an American Cancer Society Research Scholar Award 117409.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Elkhaled A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002796; FLEMING TP, 1992, CANCER RES, V52, P4550; Galban CJ, 2011, CLIN CANCER RES, V17, P4751, DOI 10.1158/1078-0432.CCR-10-2098; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Graner MW, 2009, FASEB J, V23, P1541, DOI 10.1096/fj.08-122184; Haun JB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002048; Haun JB, 2010, NAT NANOTECHNOL, V5, P660, DOI [10.1038/NNANO.2010.148, 10.1038/nnano.2010.148]; Issadore D, 2011, LAB CHIP, V11, P2282, DOI 10.1039/c1lc20177h; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Lee H, 2008, NAT MED, V14, P869, DOI 10.1038/nm.1711; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mishima K, 2006, ACTA NEUROPATHOL, V111, P483, DOI 10.1007/s00401-006-0063-y; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Pedersen NM, 2009, MOL CANCER RES, V7, P275, DOI 10.1158/1541-7786.MCR-07-2183; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsien C, 2010, J CLIN ONCOL, V28, P2293, DOI 10.1200/JCO.2009.25.3971; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Yoon TJ, 2011, ANGEW CHEM INT EDIT, V50, P4663, DOI 10.1002/anie.201100101; Zhu HH, 2010, MOL CANCER THER, V9, P2618, DOI 10.1158/1535-7163.MCT-10-0248; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	38	515	533	7	320	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1835	+		10.1038/nm.2994	http://dx.doi.org/10.1038/nm.2994			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142818	Green Accepted			2022-12-27	WOS:000311999800032
J	Bhargava, P; Li, CL; Stanya, KJ; Jacobi, D; Dai, LL; Liu, SH; Gangl, MR; Harn, DA; Lee, CH				Bhargava, Prerna; Li, Changlin; Stanya, Kristopher J.; Jacobi, David; Dai, Lingling; Liu, Sihao; Gangl, Matthew R.; Harn, Donald A.; Lee, Chih-Hao			Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways	NATURE MEDICINE			English	Article							SCHISTOSOMA-MANSONI; ADIPOSE-TISSUE; PROTEIN-KINASE; ALTERNATIVE ACTIVATION; IMMUNE-RESPONSES; DENDRITIC CELLS; TH2 RESPONSES; BILE-ACIDS; IKK-BETA; T-CELLS	Parasitic worms express host-like glycans to attenuate the immune response of human hosts. The therapeutic potential of this immunomodulatory mechanism in controlling the metabolic dysfunction that is associated with chronic inflammation remains unexplored. We demonstrate here that administration of lacto-N-fucopentaose III (LNFPIII), a Lewis(X)-containing immunomodulatory glycan found in human milk and on parasitic helminths, improves glucose tolerance and insulin sensitivity in diet-induced obese mice. This effect is mediated partly through increased interleukin-10 (Il-10) production by LNFPIII-activated macrophages and dendritic cells, which reduces white adipose tissue inflammation and sensitizes the insulin response of adipocytes. Concurrently, LNFPIII treatment upregulates nuclear receptor subfamily 1, group H, member 4 (Fxr-alpha, also known as Nr1h4) to suppress lipogenesis in the liver, conferring protection against hepatosteatosis. At the signaling level, the extracellular signal-regulated kinase (Erk)-activator protein 1 (Ap1) pathway seems to mediate the effects of LNFPIII on both inflammatory and metabolic pathways. Our results suggest that LNFPIII may provide new therapeutic approaches to treat metabolic diseases.	[Bhargava, Prerna; Stanya, Kristopher J.; Jacobi, David; Dai, Lingling; Liu, Sihao; Gangl, Matthew R.; Lee, Chih-Hao] Harvard Univ, Sch Med, Dept Genet & Complex Dis, Div Biol Sci, Boston, MA 02115 USA; [Li, Changlin; Harn, Donald A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Jacobi, David] Univ Tours, INSERM U1069, Ctr Hospr Reg, Serv Med Interne Nutr, Tours, France; [Dai, Lingling] Cent S Univ, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha, Hunan, Peoples R China	Harvard University; Harvard Medical School; University System of Georgia; University of Georgia; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Central South University	Lee, CH (corresponding author), Harvard Univ, Sch Med, Dept Genet & Complex Dis, Div Biol Sci, Boston, MA 02115 USA.	dharn@uga.edu; clee@hsph.harvard.edu	jacobi, david/J-1322-2014; jacobi, david/N-8553-2017; liu, sihao/A-8823-2015	jacobi, david/0000-0001-8674-223X; liu, sihao/0000-0002-4188-3693; Stanya, Kristopher/0000-0002-5369-729X	US National Institutes of Health [T32ES016645, R01AI056484, R01DK075046]; American Diabetes Association; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank E. Hu and S.M. Reilly for technical support and T. Horng (Harvard School of Public Health) for providing reagents. P. Bhargava and K. Stanya were supported by a US National Institutes of Health training grant (T32ES016645). This work was supported by the American Diabetes Association, the American Heart Association and a US National Institutes of Health grant (R01AI056484, D.A.H. and R01DK075046, C.-H.L.).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Atochina O, 2001, J IMMUNOL, V167, P4293, DOI 10.4049/jimmunol.167.8.4293; Atochina O, 2008, IMMUNOLOGY, V125, P111, DOI 10.1111/j.1365-2567.2008.02826.x; Badr SGE, 1999, PARASITOL RES, V85, P421, DOI 10.1007/s004360050570; Bassols J, 2010, OBESITY, V18, P611, DOI 10.1038/oby.2009.313; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chang YH, 2005, HUM IMMUNOL, V66, P1258, DOI 10.1016/j.humimm.2005.05.001; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Dutta P, 2010, TRANSPLANTATION, V90, P1071, DOI 10.1097/TP.0b013e3181f8f296; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Foss-Freitas MC, 2004, BRAZ J MED BIOL RES, V37, P663, DOI 10.1590/S0100-879X2004000500006; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; HARN DA, 1984, J EXP MED, V159, P1371, DOI 10.1084/jem.159.5.1371; Harn DA, 2009, IMMUNOL REV, V230, P247, DOI 10.1111/j.1600-065X.2009.00799.x; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; KO AI, 1990, P NATL ACAD SCI USA, V87, P4159, DOI 10.1073/pnas.87.11.4159; Kowalski GM, 2011, DIABETOLOGIA, V54, P888, DOI 10.1007/s00125-010-2020-5; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Liu SH, 2011, J BIOL CHEM, V286, P1237, DOI 10.1074/jbc.M110.138115; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Okano M, 1999, J IMMUNOL, V163, P6712; Porte D, 2005, DIABETES, V54, P1264, DOI 10.2337/diabetes.54.5.1264; Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; STAHL B, 1994, ANAL BIOCHEM, V223, P218, DOI 10.1006/abio.1994.1577; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; Van der Kleij D, 2002, J INFECT DIS, V185, P531, DOI 10.1086/338574; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zaccone P, 2006, PARASITE IMMUNOL, V28, P515, DOI 10.1111/j.1365-3024.2006.00879.x; Zhang YQ, 2003, J BIOL CHEM, V278, P104, DOI 10.1074/jbc.M209505200	60	89	94	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1665	+		10.1038/nm.2962	http://dx.doi.org/10.1038/nm.2962			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23104131	Green Submitted, Green Accepted			2022-12-27	WOS:000310837000027
J	Holland, AJ; Cleveland, DW				Holland, Andrew J.; Cleveland, Don W.			Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements	NATURE MEDICINE			English	Article							ONCOGENE-INDUCED SENESCENCE; BREAKPOINT CLUSTER REGION; MAMMALIAN-CELL FUSION; DNA-DAMAGE RESPONSE; GENOMIC REARRANGEMENTS; COLORECTAL CANCERS; CHROMOTHRIPSIS; INSTABILITY; REPLICATION; ANEUPLOIDY	Next-generation sequencing of DNA from human tumors or individuals with developmental abnormalities has led to the discovery of a process we term chromoanagenesis, in which large numbers of complex rearrangements occur at one or a few chromosomal loci in a single catastrophic event. Two mechanisms underlie these rearrangements, both of which can be facilitated by a mitotic chromosome segregation error to produce a micronucleus containing the chromosome to undergo rearrangement. In the first, chromosome shattering (chromothripsis) is produced by mitotic entry before completion of DNA replication within the micronucleus, with a failure to disassemble the micronuclear envelope encapsulating the chromosomal fragments for random reassembly in the subsequent interphase. Alternatively, locally defective DNA replication initiates serial, microhomology-mediated template switching (chromoanasynthesis) that produces local rearrangements with altered gene copy numbers. Complex rearrangements are present in a broad spectrum of tumors and in individuals with congenital or developmental defects, highlighting the impact of chromoanagenesis on human disease.	[Holland, Andrew J.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Holland, AJ (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	a1holland@ucsd.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	US National Institutes of Health [GM29513]; Ludwig Institute for Cancer Research; Leukemia AMP; Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029513, R37GM029513] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Leukemia AMP; Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We apologize to all whose work was not cited because of space restrictions. This work was supported by a grant (GM29513) from the US National Institutes of Health to D. W. C., who receives salary support from the Ludwig Institute for Cancer Research. A.J.H. is supported by a Leukemia & Lymphoma Society special fellowship.	Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chen JM, 2012, MUTAT RES-REV MUTAT, V750, P52, DOI 10.1016/j.mrrev.2011.10.002; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Eldredge N., 1972, P82; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; JOHNSON RT, 1970, NATURE, V226, P717, DOI 10.1038/226717a0; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Kloosterman WP, 2012, CELL REP, V1, P648, DOI 10.1016/j.celrep.2012.05.009; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Maher CA, 2012, CELL, V148, P29, DOI 10.1016/j.cell.2012.01.006; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Meyerson M, 2011, CELL, V144, P9, DOI 10.1016/j.cell.2010.12.025; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; SPERLING K, 1974, HUMANGENETIK, V23, P235, DOI 10.1007/BF00272508; Stanulla M, 1997, MOL CELL BIOL, V17, P4070, DOI 10.1128/MCB.17.7.4070; Stanulla M, 2001, HUM MOL GENET, V10, P2481, DOI 10.1093/hmg/10.22.2481; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Terradas M, 2012, MUTAT RES-FUND MOL M, V729, P35, DOI 10.1016/j.mrfmmm.2011.09.003; Terradas M, 2010, MUTAT RES-REV MUTAT, V705, P60, DOI 10.1016/j.mrrev.2010.03.004; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Tubio JMC, 2011, NATURE, V470, P476, DOI 10.1038/470476a; WAHL GM, 1989, CANCER RES, V49, P1333; Wu CX, 2012, GENE CHROMOSOME CANC, V51, P1144, DOI 10.1002/gcc.21999; Yap TA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003854; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang W, 2011, J BIOL CHEM, V286, P35899, DOI 10.1074/jbc.M111.267690	53	180	183	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1630	1638		10.1038/nm.2988	http://dx.doi.org/10.1038/nm.2988			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135524	Green Accepted			2022-12-27	WOS:000310837000022
J	Winkler, IG; Barbier, V; Nowlan, B; Jacobsen, RN; Forristal, CE; Patton, JT; Magnani, JL; Levesque, JP				Winkler, Ingrid G.; Barbier, Valerie; Nowlan, Bianca; Jacobsen, Rebecca N.; Forristal, Catherine E.; Patton, John T.; Magnani, John L.; Levesque, Jean-Pierre			Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance	NATURE MEDICINE			English	Article							BONE-MARROW; P-SELECTIN; PROGENITOR CELLS; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; DEFICIENT MICE; CANCER-CELLS; LIGANDS; EXPRESSION; RECEPTORS	The microenvironment, or niche, surrounding a stem cell largely governs its cellular fate. Two anatomical niches for hematopoietic stem cells (HSCs) have been reported in the bone marrow, but a distinct function for each of these niches remains unclear. Here we report a new role for the adhesion molecule E-selectin expressed exclusively by bone marrow endothelial cells in the vascular HSC niche. HSC quiescence was enhanced and self-renewal potential was increased in E-selectin knockout (Sele(-/-)) mice or after administration of an E-selectin antagonist, demonstrating that E-selectin promotes HSC proliferation and is a crucial component of the vascular niche. These effects are not mediated by canonical E-selectin ligands. Deletion or blockade of E-selectin enhances HSC survival threefold to sixfold after treatment of mice with chemotherapeutic agents or irradiation and accelerates blood neutrophil recovery. As bone marrow suppression is a severe side effect of high-dose chemotherapy, transient blockade of E-selectin is potentially a promising treatment for the protection of HSCs during chemotherapy or irradiation.	[Winkler, Ingrid G.; Barbier, Valerie] Mater Med Res Inst, Stem Cells & Canc Grp, Brisbane, Qld, Australia; [Nowlan, Bianca; Jacobsen, Rebecca N.; Forristal, Catherine E.; Levesque, Jean-Pierre] Mater Med Res Inst, Stem Cell Biol Grp, Brisbane, Qld, Australia; [Jacobsen, Rebecca N.; Levesque, Jean-Pierre] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Patton, John T.; Magnani, John L.] GlycoMimetics Inc, Gaithersburg, MD USA	Mater Research; Mater Research; University of Queensland	Winkler, IG (corresponding author), Mater Med Res Inst, Stem Cells & Canc Grp, Brisbane, Qld, Australia.	iwinkler@mmri.mater.org.au; jplevesque@mmri.mater.org.au	Levesque, Jean-Pierre/C-5426-2011; Jacobsen, Rebecca/D-5092-2012; Winkler, Ingrid G/F-3263-2011; Forristal, Catherine/B-6602-2013; , Catherine/D-9925-2019	Levesque, Jean-Pierre/0000-0002-7299-6025; Winkler, Ingrid G/0000-0001-6026-3572; Forristal, Catherine/0000-0002-6299-0885; Nowlan, Bianca/0000-0002-1049-5284; , Catherine/0000-0002-6304-1286	National Health and Medical Research Council of Australia [350406, 543706, 488817, APP1033736]; Cancer Council of Queensland; GlycoMimetics Inc	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland); GlycoMimetics Inc	The authors wish to thank R. Wadley for assistance with cell sorting, P. Frenette (Albert Einstein College of Medicine, New York) for providing selectin knockout mice, B. Furie (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston) for Selplg<SUP>-/-</SUP> mice, T. Mak (Ontario Cancer Institute, Toronto) for Cd44<SUP>-/-</SUP> mice, D. Vestweber (Max Planck Institute of Molecular Biomedicine, Munster, Germany) for antibody to ESL-1, K. Snapp (Northwestern University, Chicago) for selectin-IgM constructs and L. Purton, C. Walkley and C. Bonder for helpful discussions. This work was supported by project grants 350406 and 543706 (I. G. W. and J.-P.L.) and Career Development Fellowships 488817 and APP1033736 (I. G. W.) from the National Health and Medical Research Council of Australia, a Senior Research Fellowship from the Cancer Council of Queensland (J.-P.L.) and a research contract with GlycoMimetics Inc to generate the data in Figure 5.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barbier Valerie, 2012, Methods Mol Biol, V904, P117, DOI 10.1007/978-1-61779-943-3_11; Barbier V, 2012, METHODS MOL BIOL, V844, P31, DOI 10.1007/978-1-61779-527-5_3; Barbier V, 2012, METHODS MOL BIOL, V844, P45, DOI 10.1007/978-1-61779-527-5_4; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Dimitroff CJ, 2005, CANCER RES, V65, P5750, DOI 10.1158/0008-5472.CAN-04-4653; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Eto T, 2005, EXP HEMATOL, V33, P232, DOI 10.1016/j.exphem.2004.10.018; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Gout S, 2006, CANCER RES, V66, P9117, DOI 10.1158/0008-5472.CAN-05-4605; Hakomori S, 1996, CANCER RES, V56, P5309; Hidalgo A, 2002, J CLIN INVEST, V110, P559, DOI 10.1172/JCI200214047; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Huttmann A, 2001, EXP HEMATOL, V29, P1109, DOI 10.1016/S0301-472X(01)00684-1; Jacobsen K, 1996, BLOOD, V87, P73; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Levesque JP, 2007, STEM CELLS, V25, P1954, DOI 10.1634/stemcells.2006-0688; Levesque JP, 1999, IMMUNITY, V11, P369, DOI 10.1016/S1074-7613(00)80112-0; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; LORD BI, 1992, BLOOD, V79, P2605; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miyaoka Y, 2011, BIOCHEM J, V440, P33, DOI 10.1042/BJ20110318; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; Sandvig K, 1996, MOL BIOL CELL, V7, P1391, DOI 10.1091/mbc.7.9.1391; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Steegmaier M, 1997, J CELL SCI, V110, P687; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Todeschini AR, 2007, J BIOL CHEM, V282, P8123, DOI 10.1074/jbc.M611407200; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Wild MK, 2001, J BIOL CHEM, V276, P31602, DOI 10.1074/jbc.M104844200; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Winkler IG, 2004, BLOOD, V103, P1685, DOI 10.1182/blood-2003-06-1921; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zollner O, 1996, J BIOL CHEM, V271, P33002, DOI 10.1074/jbc.271.51.33002	56	289	297	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1651	+		10.1038/nm.2969	http://dx.doi.org/10.1038/nm.2969			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23086476				2022-12-27	WOS:000310837000025
J	Lakdawala, SS; Subbarao, K				Lakdawala, Seema S.; Subbarao, Kanta			The ongoing battle against influenza The challenge of flu transmission	NATURE MEDICINE			English	Editorial Material							VIRUS; FERRETS; MODEL	Influenza viruses can cause a broad spectrum of disease severity, including devastating cases in some people. Several factors influence the epidemiological success of the virus; the mechanisms of transmission and the strategies for prevention and treatment have an impact on the disease outcome and the incidence of flu infection in the population. Understanding how and why the viruses spread so efficiently among people and determining possible ways to harness this transmission have been arduous tasks, given the limitations of flu animal models. In 'Bedside to Bench', Kanta Subbarao and Seema S. Lakdawala peruse a study that used a human challenge model to assess influenza transmission; this experimental approach shows how transmission can be studied in humans and emphasizes factors that are different compared to animals, such as distinct disease severity and incidence. Lessons can be taken to optimize animal studies. Another issue that dictates the severity of flu episodes is the potential emergence of drug-resistant strains in treated individuals. In 'Bench to Bedside', Anne Kelso and Aeron C. Hurt discuss another concern-the presence of drug-resistant viruses with additional permissive mutations that make them fit to infect and compete with wild-type strains. The fact that these strains can be found in untreated people and can spread poses a public health concern and a challenge for scientists to find new drugs and assess antiviral combinations.	[Lakdawala, Seema S.; Subbarao, Kanta] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lakdawala, SS (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.	ksubbarao@niaid.nih.gov	Lakdawala, Seema/AAO-2217-2020	Lakdawala, Seema/0000-0002-7679-2150; Subbarao, Kanta/0000-0003-1713-3056				Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Killingley B, 2012, J INFECT DIS, V205, P35, DOI 10.1093/infdis/jir701; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; LITTLE JW, 1979, J MED VIROL, V3, P177, DOI 10.1002/jmv.1890030303; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Noti JD, 2012, CLIN INFECT DIS, V54, P1569, DOI 10.1093/cid/cis237; Powell TJ, 2012, J INFECT DIS, V205, P20, DOI 10.1093/infdis/jir689; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	19	19	19	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1468	1470		10.1038/nm.2953	http://dx.doi.org/10.1038/nm.2953			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042349	Bronze			2022-12-27	WOS:000309587500018
J	Li, GJ; Yu, MC; Lee, WW; Tsang, M; Krishnan, E; Weyand, CM; Goronzy, JJ				Li, Guangjin; Yu, Mingcan; Lee, Won-Woo; Tsang, Michael; Krishnan, Eswar; Weyand, Cornelia M.; Goronzy, Joerg J.			Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity	NATURE MEDICINE			English	Article							INFLUENZA VACCINE; CLONAL EXPANSIONS; REPERTOIRE; LYMPHOCYTES; NAIVE; IMMUNOSENESCENCE; PROLIFERATION; PHOSPHATASE; ACTIVATION; DIVERSITY	The ability of the human immune system to respond to vaccination declines with age. We identified an age-associated defect in T cell receptor (TCR)-induced extracellular signal-regulated kinase (ERK) phosphorylation in naive CD4(+) T cells, whereas other signals, such as z chain-associated protein kinase 70 (ZAP70) and phospholipase C-gamma 1 phosphorylation, were not impaired. The defective ERK signaling was caused by the dual specific phosphatase 6 (DUSP6), whose protein expression increased with age due to a decline in repression by miR-181a. Reconstitution of miR-181a lowered DUSP6 expression in naive CD4(+) T cells in elderly individuals. DUSP6 repression using miR-181a or specific siRNA and DUSP6 inhibition by the allosteric inhibitor (E)-2-benzylidene-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one improved CD4(+) T cell responses, as seen by increased expression of activation markers, improved proliferation and supported preferential T helper type 1 cell differentiation. DUSP6 is a potential intervention target for restoring T cell responses in the elderly, which may augment the effectiveness of vaccination.	[Li, Guangjin; Yu, Mingcan; Krishnan, Eswar; Weyand, Cornelia M.; Goronzy, Joerg J.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Li, Guangjin; Yu, Mingcan; Krishnan, Eswar; Weyand, Cornelia M.; Goronzy, Joerg J.] Palo Alto Dept Vet Affairs Hlth Care Syst, Palo Alto, CA USA; [Lee, Won-Woo] Seoul Natl Univ, Coll Med, Dept Immunol & Microbiol, Seoul, South Korea; [Tsang, Michael] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Stanford University; Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goronzy, JJ (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	jgoronzy@stanford.edu	Weyand, Cornelia/AAH-3343-2021; krishnan, Eswar/AAY-1269-2020; TSANG, Michael/E-2758-2013; Tsang, Michael W/I-9305-2014; Tsang, Michael/ABV-0504-2022; Tsang, Michael/AAG-9338-2020; Lee, Won-Woo/J-5588-2012	TSANG, Michael/0000-0001-6384-2422; Tsang, Michael W/0000-0001-7123-0063; Tsang, Michael/0000-0001-7123-0063; Goronzy, Jorg/0000-0001-7670-1856; Lee, Won-Woo/0000-0002-5347-9591	US National Institutes of Health [U19 AI090019, R01 AG015043, U19 AI057266, R01 AR042527, R01 EY011916, R01 AI044142, PO1 HL058000]; NATIONAL EYE INSTITUTE [R01EY011916] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, R01AI044142, U19AI090019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015043] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.J.G. was supported by US National Institutes of Health grants U19 AI090019, R01 AG015043 and U19 AI057266, and C. M. W. was supported by US National Institutes of Health grants R01 AR042527, R01 EY011916, R01 AI044142 and PO1 HL058000. Antibody to PTPN22 was a gift from A. C. Chan (Genentech).	Akha AAS, 2005, CURR OPIN IMMUNOL, V17, P486, DOI 10.1016/j.coi.2005.07.004; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Aspinall Richard, 2007, Immun Ageing, V4, P9, DOI 10.1186/1742-4933-4-9; Berg LJ, 2009, IMMUNITY, V31, P529, DOI 10.1016/j.immuni.2009.09.008; Bettini ML, 2007, P NATL ACAD SCI USA, V104, P16257, DOI 10.1073/pnas.0705321104; Boyman O, 2009, EUR J IMMUNOL, V39, P2088, DOI 10.1002/eji.200939444; Cicin-Sain L, 2010, J IMMUNOL, V184, P6739, DOI 10.4049/jimmunol.0904193; Clambey ET, 2005, IMMUNOL REV, V205, P170, DOI 10.1111/j.0105-2896.2005.00265.x; Couch RB, 2007, VACCINE, V25, P7656, DOI 10.1016/j.vaccine.2007.08.042; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Del Giudice G, 2006, VACCINE, V24, P3063, DOI 10.1016/j.vaccine.2006.01.015; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gorgas G, 1997, MECH AGEING DEV, V94, P71, DOI 10.1016/S0047-6374(96)01857-X; Goronzy J. J., 2012, SEMIN IMMUN IN PRESS; Goronzy JJ, 2005, CURR OPIN IMMUNOL, V17, P468, DOI 10.1016/j.coi.2005.07.020; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; GROSSMANN A, 1989, EXP CELL RES, V180, P367, DOI 10.1016/0014-4827(89)90064-5; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; LEDBETTER JA, 1988, EUR J IMMUNOL, V18, P525, DOI 10.1002/eji.1830180406; Lee WW, 2008, REJUV RES, V11, P1001, DOI 10.1089/rej.2008.0747; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Macallan DC, 2004, J EXP MED, V200, P255, DOI 10.1084/jem.20040341; Messaoudi I, 2004, J EXP MED, V200, P1347, DOI 10.1084/jem.20040437; Miller RA, 1997, IMMUNOL REV, V160, P79, DOI 10.1111/j.1600-065X.1997.tb01029.x; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	43	244	248	1	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1518	U113		10.1038/nm.2963	http://dx.doi.org/10.1038/nm.2963			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23023500	Green Accepted			2022-12-27	WOS:000309587500030
J	Sarruf, DA; Bonner-Weir, S; Schwartz, MW				Sarruf, David A.; Bonner-Weir, Susan; Schwartz, Michael W.			New clues to bariatric surgery's benefits	NATURE MEDICINE			English	Editorial Material							MEDICAL THERAPY	Bariatric surgery to treat obesity can also be effective against type 2 diabetes, but it is unclear how such surgical procedures improve glucose metabolism. A new study in rats suggests that nutrient sensing in the jejunum contributes to the antidiabetic effects of duodenal-jejeunal bypass (pages 950-955).	[Sarruf, David A.] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Bonner-Weir, Susan] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; [Schwartz, Michael W.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA USA; [Schwartz, Michael W.] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA	Novo Nordisk; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sarruf, DA (corresponding author), Novo Nordisk AS, Diabet Res Unit, Malov, Denmark.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012	Bonner-Weir, Susan/0000-0003-4682-0656	NIDDK NIH HHS [R01 DK090320, R01 DK083042, R01 DK052989] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090320, R01DK052989, R01DK083042] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Cheung GWC, 2009, CELL MOL LIFE SCI, V66, P3023, DOI 10.1007/s00018-009-0062-y; de Luis D, 2012, AM J SURG, V204, P242, DOI 10.1016/j.amjsurg.2011.07.020; Kindel TL, 2011, OBESITY, V19, P380, DOI 10.1038/oby.2010.263; Kindel TL, 2009, J GASTROINTEST SURG, V13, P1762, DOI 10.1007/s11605-009-0912-9; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Stefater MA, 2010, GASTROENTEROLOGY, V138, P2426, DOI 10.1053/j.gastro.2010.02.059; Strader AD, 2009, OBES SURG, V19, P96, DOI 10.1007/s11695-008-9754-x	9	6	6	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					860	861		10.1038/nm.2801	http://dx.doi.org/10.1038/nm.2801			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673995	Green Accepted			2022-12-27	WOS:000305116600020
J	Peyvandi, F; Rosendaal, FR; O'Mahony, B; Mannucci, PM				Peyvandi, Flora; Rosendaal, Frits R.; O'Mahony, Brian; Mannucci, Pier Mannuccio			Pediatric requirements in Europe stymie help for hemophilia	NATURE MEDICINE			English	Editorial Material							FC FUSION PROTEIN; PHASE-3	The European Medicines Agency requires that drug developers submit a 'pediatric investigational plan' to ensure that there is adequate information about how children fare on experimental medication for many indications before they go to market. But this requirement places an undue constraint on the makers of new hemophilia drugs and threatens to create an unreasonable delay in access to these therapies among adults with this disorder in the EU.	[Peyvandi, Flora; Mannucci, Pier Mannuccio] IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Milan, Italy; [Peyvandi, Flora] Univ Milan, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy; [Rosendaal, Frits R.] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Rosendaal, Frits R.] Leiden Univ Med Ctr, Dept Thrombosis & Haemostasis, Leiden, Netherlands; [O'Mahony, Brian] European Haemophilia Consortium, Brussels, Belgium	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Peyvandi, F (corresponding author), IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Milan, Italy.		Rosendaal, Frits/Q-3842-2017; Peyvandi, Flora/AAK-7437-2020	Rosendaal, Frits/0000-0003-2558-7496; Peyvandi, Flora/0000-0001-7423-9864				Mahlangu J, 2014, BLOOD, V123, P317, DOI 10.1182/blood-2013-10-529974; Powell JS, 2013, NEW ENGL J MED, V369, P2313, DOI 10.1056/NEJMoa1305074; ROSENDAAL FR, 1990, THROMB HAEMOSTASIS, V63, P145	3	8	8	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					117	117		10.1038/nm0214-117	http://dx.doi.org/10.1038/nm0214-117			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24504399	Bronze			2022-12-27	WOS:000330915000008
J	Honegger, JR; Kim, S; Price, AA; Kohout, JA; McKnight, KL; Prasad, MR; Lemon, SM; Grakoui, A; Walker, CM				Honegger, Jonathan R.; Kim, Seungtaek; Price, Aryn A.; Kohout, Jennifer A.; McKnight, Kevin L.; Prasad, Mona R.; Lemon, Stanley M.; Grakoui, Arash; Walker, Christopher M.			Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses	NATURE MEDICINE			English	Article							HEPATITIS-C-VIRUS; T-CELL RESPONSE; TRANSMISSION; MOTHER; RNA; EXPRESSION; EVOLUTION; PROTEINS; DOMINANT; EPITOPES	Globally, about 1% of pregnant women are persistently infected with the hepatitis C virus (HCV)(1). Mother-to-child transmission of HCV occurs in 3-5% of pregnancies(2) and accounts for most new childhood infections(1,3). HCV-specific CD8+ cytotoxic T lymphocytes (CTLs) are vital in the clearance of acute HCV infections(4-6), but in the 60-80% of infections that persist, these cells become functionally exhausted or select for mutant viruses that escape T cell recognition(7-9). Increased HCV replication during pregnancy(10,11) suggests that maternofetal immune tolerance mechanisms(12) may further impair HCV-specific CTLs, limiting their selective pressure on persistent viruses. To assess this possibility, we characterized circulating viral quasispecies during and after consecutive pregnancies in two women. This revealed a loss of some escape mutations in HLA class I epitopes during pregnancy that was associated with emergence of more fit viruses(13). CTL selective pressure was reimposed after childbirth, at which point escape mutations in these epitopes again predominated in the quasispecies and viral load dropped sharply(14). Importantly, the viruses transmitted perinatally were those with enhanced fitness due to reversion of escape mutations. Our findings indicate that the immunoregulatory changes of pregnancy reduce CTL selective pressure on HCV class I epitopes, thereby facilitating vertical transmission of viruses with optimized replicative fitness.	[Honegger, Jonathan R.; Kohout, Jennifer A.; Walker, Christopher M.] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH USA; [Honegger, Jonathan R.; Walker, Christopher M.] Ohio State Univ, Dept Pediat, Sch Med, Columbus, OH 43210 USA; [Kim, Seungtaek; McKnight, Kevin L.; Lemon, Stanley M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kim, Seungtaek] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kim, Seungtaek] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea; [Price, Aryn A.; Grakoui, Arash] Emory Univ, Sch Med, Div Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA USA; [Prasad, Mona R.] Ohio State Univ, Dept Obstet & Gynecol, Sch Med, Columbus, OH 43210 USA; [Lemon, Stanley M.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Lemon, Stanley M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Grakoui, Arash] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Emory University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Emory University	Honegger, JR (corresponding author), Nationwide Childrens Hosp, Ctr Vaccines & Immun, Columbus, OH USA.	jonathan.honegger@nationwidechildrens.org	Honegger, Jonathan/E-3264-2011	Honegger, Jonathan/0000-0002-3181-0554	US National Institutes of Health [R37-AI47367, R56-AI096882, R01-AI096882, RO1-DA024565, R01-AI95690, R01-AI070101, R01-DK083356, T32-HD043003, K12-HD043372]; US National Institutes of Health (Yerkes Research Center Base Grant) [P51RR-000165]; Research Institute at Nationwide Children's Hospital; University of North Carolina University Cancer Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043372, T32HD043003] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI096882, R37AI047367, R01AI070101, R01AI095690, R01AI096882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024565] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (Yerkes Research Center Base Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Institute at Nationwide Children's Hospital(Ohio State University); University of North Carolina University Cancer Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank J. Hunkler for coordination of the project at The Ohio State University STEPP Clinic and the Nationwide Children's Hospital FACES Clinic. The assistance of C. Potter of the Nationwide Children's Hospital Division of Gastroenterology and G. Mateu of the Emory Vaccine Center is also gratefully acknowledged. We especially thank the subjects and their families for their participation in this study. This work was supported by the US National Institutes of Health (R37-AI47367 to C. M. W., R56-AI096882 and R01-AI096882 to C. M. W. and J. R. H., RO1-DA024565 and R01-AI95690 to S. M. L., R01-AI070101 and R01-DK083356 to A. G., T32-HD043003 and K12-HD043372 to J. R. H., and the Yerkes Research Center Base Grant P51RR-000165 (A. G.)), the Research Institute at Nationwide Children's Hospital (C. M. W. and J. R. H.), and the University of North Carolina University Cancer Research Fund (S.M.L.).	Alegre E, 2007, HUM IMMUNOL, V68, P661, DOI 10.1016/j.humimm.2007.04.007; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arshad M, 2011, J VIRAL HEPATITIS, V18, P229, DOI 10.1111/j.1365-2893.2010.01413.x; Bigger CB, 2004, J VIROL, V78, P13779, DOI 10.1128/JVI.78.24.13779-13792.2004; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bortolotti F, 2007, J HEPATOL, V46, P783, DOI 10.1016/j.jhep.2006.12.014; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Callendret B, 2011, J VIROL, V85, P11833, DOI 10.1128/JVI.02654-10; Cox AL, 2005, J EXP MED, V201, P1741, DOI 10.1084/jem.20050121; Dal Molin G, 2002, J MED VIROL, V67, P137, DOI 10.1002/jmv.2202; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gervais A, 2000, J HEPATOL, V32, P293, DOI 10.1016/S0168-8278(00)80075-6; Guleria I, 2007, J IMMUNOL, V178, P3345, DOI 10.4049/jimmunol.178.6.3345; Kasprowicz V, 2010, J VIROL, V84, P1656, DOI 10.1128/JVI.01499-09; Kimura Y, 2005, J VIROL, V79, P4870, DOI 10.1128/JVI.79.8.4870-4876.2005; KOZIEL MJ, 1993, J VIROL, V67, P7522, DOI 10.1128/JVI.67.12.7522-7532.1993; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lin HH, 2000, BRIT J OBSTET GYNAEC, V107, P1503, DOI 10.1111/j.1471-0528.2000.tb11675.x; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Mok J, 2005, Arch Dis Child Fetal Neonatal Ed, V90, pF156, DOI 10.1136/adc.2004.059436; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nei M., 2000, MOL EVOLUTION PHYLOG; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Polanczyk MJ, 2006, J NEUROSCI RES, V84, P370, DOI 10.1002/jnr.20881; Rauch A, 2009, HEPATOLOGY, V50, P1017, DOI 10.1002/hep.23101; Ray SC, 2005, J EXP MED, V201, P1753, DOI 10.1084/jem.20050122; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Ruhl M, 2012, J VIROL, V86, P991, DOI 10.1128/JVI.05603-11; Ruhl M, 2011, GASTROENTEROLOGY, V140, P2064, DOI 10.1053/j.gastro.2011.02.060; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salloum S, 2008, J VIROL, V82, P11803, DOI 10.1128/JVI.00997-08; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ter Borg MJ, 2008, J VIRAL HEPATITIS, V15, P37, DOI 10.1111/j.1365-2893.2007.00894.x; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09; Timm J, 2004, J EXP MED, V200, P1593, DOI 10.1084/jem.20041006; Timm J, 2007, HEPATOLOGY, V46, P339, DOI 10.1002/hep.21702; Uebelhoer L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000143; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang C, 2009, IMMUNOLOGY, V126, P329, DOI 10.1111/j.1365-2567.2008.03051.x; Wejstal R, 1998, SCAND J INFECT DIS, V30, P111, DOI 10.1080/003655498750003456; Yusim Karina, 2005, Appl Bioinformatics, V4, P217, DOI 10.2165/00822942-200504040-00002	51	48	49	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1529	+		10.1038/nm.3351	http://dx.doi.org/10.1038/nm.3351			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24162814	Green Accepted, Green Submitted			2022-12-27	WOS:000326920300032
J	Czech, MP				Czech, Michael P.			Obesity Notches up fatty liver	NATURE MEDICINE			English	Editorial Material							INSULIN-RESISTANCE; LIPID-METABOLISM; ATHEROSCLEROSIS; SREBP1C	Pathologic fatty liver paradoxically accompanies obesity and type 2 diabetes despite the crippling of insulin signaling, which is normally required for fat synthesis. The developmental signaling protein Notch is a hidden regulator of lipogenesis that amplifies signal transmissions to fat production in these metabolic diseases (pages 1054-1060).	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	michael.czech@umassmed.edu						Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Liu ZJ, 2012, ATHEROSCLEROSIS, V225, P296, DOI 10.1016/j.atherosclerosis.2012.04.010; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Perdigoto CN, 2013, BBA-GEN SUBJECTS, V1830, P2307, DOI 10.1016/j.bbagen.2012.08.009; Purow B, 2012, ADV EXP MED BIOL, V727, P305, DOI 10.1007/978-1-4614-0899-4_23; Radtke F, 2013, NAT REV IMMUNOL, V13, P427, DOI 10.1038/nri3445; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002	14	13	14	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2013	19	8					969	971		10.1038/nm.3293	http://dx.doi.org/10.1038/nm.3293			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921741				2022-12-27	WOS:000322779600018
J	Song, XY; Qian, YC				Song, Xinyang; Qian, Youcun			Peli1 sets the CNS on fire	NATURE MEDICINE			English	Editorial Material							MULTIPLE-SCLEROSIS; ACTIVATION		[Song, Xinyang; Qian, Youcun] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Stem Cell Biol,Inst Hlth Sci,Sch Med, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Song, XY (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Stem Cell Biol,Inst Hlth Sci,Sch Med, Shanghai 200030, Peoples R China.	ycqian@sibs.ac.cn	Song, Xinyang/AAL-7495-2021	Song, Xinyang/0000-0002-3422-6927				Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Chang M, 2011, NAT IMMUNOL, V12, P1002, DOI 10.1038/ni.2090; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Eisele S, 2012, BRAIN PATHOL, V22, P607, DOI 10.1111/j.1750-3639.2012.00564.x; Jin W, 2012, CELL MOL IMMUNOL, V9, P113, DOI 10.1038/cmi.2011.60; Moynagh PN, 2009, TRENDS IMMUNOL, V30, P33, DOI 10.1016/j.it.2008.10.001; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Smith H, 2011, BIOCHEM J, V434, P537, DOI 10.1042/BJ20101421; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Xiao YC, 2013, NAT MED, V19, P595, DOI 10.1038/nm.3111; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	12	6	6	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					536	538		10.1038/nm.3176	http://dx.doi.org/10.1038/nm.3176			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652102				2022-12-27	WOS:000318583000021
J	Tzoneva, G; Perez-Garcia, A; Carpenter, Z; Khiabanian, H; Tosello, V; Allegretta, M; Paietta, E; Racevskis, J; Rowe, JM; Tallman, MS; Paganin, M; Basso, G; Hof, J; Kirschner-Schwabe, R; Palomero, T; Rabadan, R; Ferrando, A				Tzoneva, Gannie; Perez-Garcia, Arianne; Carpenter, Zachary; Khiabanian, Hossein; Tosello, Valeria; Allegretta, Maddalena; Paietta, Elisabeth; Racevskis, Janis; Rowe, Jacob M.; Tallman, Martin S.; Paganin, Maddalena; Basso, Giuseppe; Hof, Jana; Kirschner-Schwabe, Renate; Palomero, Teresa; Rabadan, Raul; Ferrando, Adolfo			Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE LYMPHOCYTIC-LEUKEMIA; TUMOR-SUPPRESSOR; 1ST RELAPSE; 5'-NUCLEOTIDASE; NELARABINE; CANCER; MERCAPTOPURINE; CHILDREN; ADULTS	Acute lymphoblastic leukemia (ALL) is an aggressive hematological tumor resulting from the malignant transformation of lymphoid progenitors. Despite intensive chemotherapy, 20% of pediatric patients and over 50% of adult patients with ALL do not achieve a complete remission or relapse after intensified chemotherapy, making disease relapse and resistance to therapy the most substantial challenge in the treatment of this disease(1,2). Using whole-exome sequencing, we identify mutations in the cytosolic 5'-nucleotidase II gene (NT5C2), which encodes a 5'-nucleotidase enzyme that is responsible for the inactivation of nucleoside-analog chemotherapy drugs, in 20/103 (19%) relapse T cell ALLs and 1/35 (3%) relapse B-precursor ALLs. NT5C2 mutant proteins show increased nucleotidase activity in vitro and conferred resistance to chemotherapy with 6-mercaptopurine and 6-thioguanine when expressed in ALL lymphoblasts. These results support a prominent role for activating mutations in NT5C2 and increased nucleoside-analog metabolism in disease progression and chemotherapy resistance in ALL.	[Tzoneva, Gannie; Perez-Garcia, Arianne; Allegretta, Maddalena; Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Inst Canc Genet, New York, NY 10027 USA; [Carpenter, Zachary; Khiabanian, Hossein; Rabadan, Raul] Columbia Univ, Joint Ctr Syst Biol, New York, NY USA; [Tosello, Valeria] IRCCS, Ist Oncol Veneto, Padua, Italy; [Paietta, Elisabeth; Racevskis, Janis] Albert Einstein Coll Med, New York, NY USA; [Rowe, Jacob M.] Technion Israel Inst Technol, Haifa, Israel; [Rowe, Jacob M.] Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Paganin, Maddalena; Basso, Giuseppe] Univ Padua, Dept Pediat, Hematooncol Lab, Padua, Italy; [Hof, Jana; Kirschner-Schwabe, Renate] Charite, Dept Pediat Oncol Hematol, D-13353 Berlin, Germany; [Palomero, Teresa; Ferrando, Adolfo] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA; [Ferrando, Adolfo] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10027 USA	Columbia University; Columbia University; IRCCS Istituto Oncologico Veneto (IOV); Yeshiva University; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Memorial Sloan Kettering Cancer Center; University of Padua; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Columbia University; Columbia University	Ferrando, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10027 USA.	tp2151@columbia.edu; rabadan@dbmi.columbia.edu; af2196@columbia.edu	Rabadan, Raul/AAZ-7367-2020; Khiabanian, Hossein/N-7207-2019; Tosello, Valeria/N-1010-2016	Khiabanian, Hossein/0000-0003-1446-4394; Tosello, Valeria/0000-0001-9560-340X; Tzoneva, Gannie/0000-0001-5784-7796; Rabadan, Raul/0000-0001-7946-9255; BASSO, GIUSEPPE/0000-0002-2634-9302; Kirschner-Schwabe, Renate/0000-0001-6335-3274	St. Baldrick's Foundation; Partnership for Cure Foundation; Innovative Research Award by the Stand Up to Cancer Foundation; Chemotherapy Foundation; Leukemia and Lymphoma Society Scholar Award; German Federal Ministry for Education and Research in the National Genome Research Network [01GS0870]; German Foundation for Childhood Cancer [DKS 2003.08, 2007.02]; US National Institutes of Health [U24 CA114737]; ECOG Leukemia Tissue Bank; Rally Foundation; NATIONAL CANCER INSTITUTE [U24CA114737, U10CA037403] Funding Source: NIH RePORTER	St. Baldrick's Foundation; Partnership for Cure Foundation; Innovative Research Award by the Stand Up to Cancer Foundation; Chemotherapy Foundation; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); German Federal Ministry for Education and Research in the National Genome Research Network; German Foundation for Childhood Cancer; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ECOG Leukemia Tissue Bank; Rally Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A.A. Da Silva for technical support in the production of recombinant NT5C2 proteins and R. Parsons for insightful comments and advice. We also thank P.H. Wiernik as the Eastern Cooperative Oncology Group (ECOG) leukemia committee chair at the time the E2993 study was initiated. This work was supported by the St. Baldrick's Foundation (A.F.), the Partnership for Cure Foundation (R.R.), the Innovative Research Award by the Stand Up to Cancer Foundation (A.F.), the Chemotherapy Foundation (A.F.), the Leukemia and Lymphoma Society Scholar Award (A.F.), the German Federal Ministry for Education and Research in the National Genome Research Network (grant 01GS0870 to R.K.-S.), the German Foundation for Childhood Cancer (grants DKS 2003.08 and 2007.02 to R.K.-S.), the US National Institutes of Health (U24 CA114737 to E.P.) and the ECOG Leukemia Tissue Bank. A.P.-G. is a postdoctoral researcher funded by the Rally Foundation.	Allegrini S, 2004, EUR J BIOCHEM, V271, P4881, DOI 10.1111/j.1432-1033.2004.04457.x; Berg SL, 2005, J CLIN ONCOL, V23, P3376, DOI 10.1200/JCO.2005.03.426; Bhatia S, 2012, J CLIN ONCOL, V30, P2094, DOI 10.1200/JCO.2011.38.9924; Brouwer C, 2005, CLIN CHIM ACTA, V361, P95, DOI 10.1016/j.cccn.2005.05.006; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; DeAngelo DJ, 2007, BLOOD, V109, P5136, DOI 10.1182/blood-2006-11-056754; Galmarini CM, 2003, LEUKEMIA LYMPHOMA, V44, P1105, DOI 10.1080/1042819031000077142; Gaynon PS, 1998, CANCER, V82, P1387, DOI 10.1002/(SICI)1097-0142(19980401)82:7<1387::AID-CNCR24>3.0.CO;2-1; Gokbuget N, 2011, BLOOD, V118, P3504, DOI 10.1182/blood-2011-01-329441; Hof J, 2011, J CLIN ONCOL, V29, P3185, DOI 10.1200/JCO.2011.34.8144; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; KOREN G, 1990, NEW ENGL J MED, V323, P17, DOI 10.1056/NEJM199007053230104; LUBBERT M, 1990, BLOOD, V75, P1163; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; OKA J, 1994, BIOCHEM BIOPH RES CO, V205, P917, DOI 10.1006/bbrc.1994.2752; PIETERS R, 1992, LEUKEMIA RES, V16, P873, DOI 10.1016/0145-2126(92)90033-4; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Relling MV, 1999, BLOOD, V93, P2817; Salzer WL, 2010, LEUKEMIA, V24, P355, DOI 10.1038/leu.2009.261; Sanford M, 2008, DRUGS, V68, P439, DOI 10.2165/00003495-200868040-00004; SPYCHALA J, 1988, J BIOL CHEM, V263, P18759; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	31	237	251	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					368	371		10.1038/nm.3078	http://dx.doi.org/10.1038/nm.3078			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23377281	Green Accepted			2022-12-27	WOS:000316040700032
J	Moore, MAS				Moore, Malcolm A. S.			Waking up HSCs: a new role for E-selectin	NATURE MEDICINE			English	Editorial Material							SELF-RENEWAL; HEMATOPOIESIS; DORMANCY	Two anatomical niches for hematopoietic stem cells (HSCs) have been reported in the bone marrow, but a distinct function for each of these niches has remained unclear. A new role in stem cell proliferation has now been identified for the adhesion molecule E-selectin expressed by bone marrow endothelial cells at the vascular niche (pages 1651-1657).	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Moore, MAS (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	m-moore@ski.mskcc.org						Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Fortunel NO, 2000, BLOOD, V96, P2022; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Miyaoka Y, 2011, BIOCHEM J, V440, P33, DOI 10.1042/BJ20110318; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Yang T, 2010, J CLIN INVEST, V120, P2474, DOI 10.1172/JCI42150; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566	10	5	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1613	1614		10.1038/nm.2992	http://dx.doi.org/10.1038/nm.2992			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135509				2022-12-27	WOS:000310837000014
J	Yan, N; Lieberman, J				Yan, Nan; Lieberman, Judy			SAMHD1 does it again, now in resting T cells	NATURE MEDICINE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; INNATE IMMUNE-RESPONSE; DENDRITIC CELLS; VPX; MACROPHAGES; PROTEIN	A long-standing question in the HIV field is why HIV-1 fails to replicate in resting CD4(+) T cells. A new study shows that host deoxynucleoside triphosphate triphosphohydrolase (dNTPase) sterile a motif and histidine/aspartic domain-containing protein 1 (SAMHD1), previously shown to block HIV infection in myeloid cells, also restricts HIV replication in resting CD4(+) T cells by hydrolyzing dNTPs, which are needed for reverse transcription of the virus (pages 1682-1687).	[Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Yan, Nan] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Lieberman, Judy] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Yan, N (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	nan.yan@utsouthwestern.edu; lieberman@idi.harvard.edu	Lieberman, Judy/A-2717-2015		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102816] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL066987] Funding Source: Medline; NIAID NIH HHS [R01 AI102816] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Plesa G, 2007, J VIROL, V81, P13938, DOI 10.1128/JVI.01745-07; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	14	5	6	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1611	1612		10.1038/nm.2980	http://dx.doi.org/10.1038/nm.2980			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135508	Green Accepted			2022-12-27	WOS:000310837000013
J	Katsnelson, A				Katsnelson, Alla			CONTROL ISSUES	NATURE MEDICINE			English	News Item							ANTIRETROVIRAL THERAPY; ELITE CONTROLLERS; HIV; ATHEROSCLEROSIS; ACTIVATION											Chun TW, 2013, J INFECT DIS, V208, P1443, DOI 10.1093/infdis/jit306; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hatano H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003691; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Pereyra F, 2012, AIDS, V26, P2409, DOI 10.1097/QAD.0b013e32835a9950	6	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					328	330		10.1038/nm0414-328	http://dx.doi.org/10.1038/nm0414-328			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710370				2022-12-27	WOS:000334361500007
J	Ablain, J; Rice, K; Soilihi, H; de Reynies, A; Minucci, S; de The, H				Ablain, Julien; Rice, Kim; Soilihi, Hassane; de Reynies, Aurelien; Minucci, Saverio; de The, Hugues			Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure	NATURE MEDICINE			English	Article							TRANS-RETINOIC ACID; AGENT ARSENIC TRIOXIDE; PML-RAR-ALPHA; INITIATING ACTIVITY; MYELOID-LEUKEMIA; P53 ACETYLATION; SUPPRESSOR GENE; THERAPY; SENESCENCE; COMBINATION	Acute promyelocytic leukemia (APL) is driven by the promyelocytic leukemia (PML)-retinoic acid receptor-a (PML-RARA) fusion protein, which interferes with nuclear receptor signaling and PML nuclear body (NB) assembly. APL is the only malignancy definitively cured by targeted therapies: retinoic acid (RA) and/or arsenic trioxide, which both trigger PML-RARA degradation through nonoverlapping pathways. Yet, the cellular and molecular determinants of treatment efficacy remain disputed. We demonstrate that a functional Pml-transformation-related protein 53 (Trp53) axis is required to eradicate leukemia-initiating cells in a mouse model of APL. Upon RA-induced PML-RARA degradation, normal Pml elicits NB reformation and induces a Trp53 response exhibiting features of senescence but not apoptosis, ultimately abrogating APL-initiating activity. Apart from triggering PML-RARA degradation, arsenic trioxide also targets normal PML to enhance NB reformation, which may explain its clinical potency, alone or with RA. This Pml-Trp53 checkpoint initiated by therapy-triggered NB restoration is specific for PML-RARA-driven APL, but not the RA-resistant promyelocytic leukemia zinc finger (PLZF)-RARA variant. Yet, as NB biogenesis is druggable, it could be therapeutically exploited in non-APL malignancies.	[Ablain, Julien; Rice, Kim; Soilihi, Hassane; de The, Hugues] Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis, Paris, France; [Ablain, Julien; Rice, Kim; Soilihi, Hassane; de The, Hugues] Hop St Louis, INSERM, UMR 944, Equipe Labellisee Ligue Natl Canc,Inst Univ Hemat, Paris, France; [Ablain, Julien; Rice, Kim; Soilihi, Hassane; de The, Hugues] Hop St Louis, CNRS, UMR 7212, Paris, France; [de Reynies, Aurelien] Ligue Natl Canc, Programme Cartes Identite Tumeurs, Paris, France; [Minucci, Saverio] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Minucci, Saverio] Univ Milan, Dept Biosci, Milan, Italy; [de The, Hugues] Hop St Louis, AP HP, Serv Biochim, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; IRCCS European Institute of Oncology (IEO); University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	de The, H (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Hop St Louis, Paris, France.	hugues.dethe@inserm.fr	de Reyniès, Aurélien/Q-8640-2017	de Reyniès, Aurélien/0000-0002-1328-5290; Ablain, Julien/0000-0002-4509-3568	Ligue Nationale contre le Cancer; Cartes d'Identite des Tumeurs program; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); University Paris Diderot; Institut Universitaire de France; Institut National du Cancer; Fondation Association pour la Recherche contre le Cancer (ARC) (Prix Griffuel); European Research Council [268729 - STEMAPL]; Ecole Polytechnique; Fondation ARC; Lady Tata Foundation; ARC Foundation; EPIGEN; Italian Association for Cancer Research (AIRC)	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Cartes d'Identite des Tumeurs program; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot; Institut Universitaire de France; Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation Association pour la Recherche contre le Cancer (ARC) (Prix Griffuel); European Research Council(European Research Council (ERC)European Commission); Ecole Polytechnique; Fondation ARC; Lady Tata Foundation; ARC Foundation(Australian Research Council); EPIGEN; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The laboratory of H.d.T. is supported by the Ligue Nationale contre le Cancer, the Cartes d'Identite des Tumeurs program, the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), University Paris Diderot, Institut Universitaire de France, Institut National du Cancer, Fondation Association pour la Recherche contre le Cancer (ARC) (Prix Griffuel) and the European Research Council (senior grant 268729 - STEMAPL). J.A. was supported by a fellowship from Ecole Polytechnique and Fondation ARC, K.R. by a fellowship from the Lady Tata and ARC Foundations. S.M. is supported by grants from EPIGEN and the Italian Association for Cancer Research (AIRC). We thank A. Janin, T. Bouhidel and P. Bertheau for assistance with mouse pathology; P. Chambon (Institut de Genetique et de Biologie Moleculaire et Cellulaire) for RARA-specific antibody; S. Lowe (Memorial Sloan-Kettering Cancer Center) for shRNA vectors and Pml-specific antibody; L. Peres and S. Gressens for technical help; M. Pla for the animal facility; N. Setterblad for imaging; E. Del Neyri and V. Dessirier for imaging statistical analysis; and I. Pallavicini and A. Marinelli for mouse work in Milan. We thank E. Raffoux, C. Bailly, P. Fenaux and N. Boissel (Hopital St. Louis) for providing the patients' blood samples. We thank R. Ohki and L. Attardi for sharing unpublished p53 ChIP-Seq data. We thank all members of the laboratory of H.d.T. for helpful discussions, J. Godet for continuous support and V. Lallemand-Breitenbach, U. Sahin, S. Benhenda, F. Sigaux and J.C. Gluckman for critical reading of the manuscript.	Ablain J, 2013, J EXP MED, V210, P647, DOI 10.1084/jem.20122337; Akagi T, 2009, BLOOD, V113, P1741, DOI 10.1182/blood-2007-12-130260; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bischof O, 2005, MOL CELL BIOL, V25, P1013, DOI 10.1128/MCB.25.3.1013-1024.2005; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; El Eit RM, 2014, INT J CANCER, V134, P988, DOI 10.1002/ijc.28427; El Hajj H, 2010, J EXP MED, V207, P2785, DOI 10.1084/jem.20101095; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Ferbeyre G, 2000, GENE DEV, V14, P2015; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Ghavamzadeh A, 2011, J CLIN ONCOL, V29, P2753, DOI 10.1200/JCO.2010.32.2107; Guidez F, 2007, P NATL ACAD SCI USA, V104, P18694, DOI 10.1073/pnas.0704433104; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, BLOOD, V103, P2358, DOI 10.1182/blood-2003-07-2200; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Insinga A, 2004, EMBO J, V23, P1144, DOI 10.1038/sj.emboj.7600109; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Kchour G, 2009, BLOOD, V113, P6528, DOI 10.1182/blood-2009-03-211821; Kogan SC, 2009, CANCER CELL, V15, P7, DOI 10.1016/j.ccr.2008.12.012; Koken MHM, 1999, ONCOGENE, V18, P1113, DOI 10.1038/sj.onc.1202414; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Licht JD, 2006, CANCER CELL, V9, P73, DOI 10.1016/j.ccr.2006.01.024; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; LVANOV AETA, 2013, J CELL BIOL, V202, P129; Mathews V, 2010, J CLIN ONCOL, V28, P3866, DOI 10.1200/JCO.2010.28.5031; Meani N, 2005, ONCOGENE, V24, P3358, DOI 10.1038/sj.onc.1208498; Minucci S, 2002, BLOOD, V100, P2989, DOI 10.1182/blood-2001-11-0089; MUINDI J, 1992, BLOOD, V79, P299; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Rego EM, 2000, P NATL ACAD SCI USA, V97, P10173, DOI 10.1073/pnas.180290497; Sahin U., J CELL BIOL IN PRESS; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Stadler M, 1995, ONCOGENE, V11, P2565; Stein E, 2009, BEST PRACT RES CL HA, V22, P153, DOI 10.1016/j.beha.2008.12.007; Tsimberidou AM, 2006, LEUKEMIA LYMPHOMA, V47, P1062, DOI 10.1080/10428190500463932; Vernier M, 2011, GENE DEV, V25, P41, DOI 10.1101/gad.1975111; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	56	127	130	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					167	174		10.1038/nm.3441	http://dx.doi.org/10.1038/nm.3441			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412926				2022-12-27	WOS:000330915000018
J	Rodrigues, TB; Serrao, EM; Kennedy, BWC; Hu, DE; Kettunen, MI; Brindle, KM				Rodrigues, Tiago B.; Serrao, Eva M.; Kennedy, Brett W. C.; Hu, De-En; Kettunen, Mikko I.; Brindle, Kevin M.			Magnetic resonance imaging of tumor glycolysis using hyperpolarized C-13-labeled glucose	NATURE MEDICINE			English	Article							PENTOSE-PHOSPHATE PATHWAY; IN-VIVO; BREAST-CANCER; METABOLISM; EXCHANGE; LACTATE; PYRUVATE; BRAIN; RATES; RATIO	In this study, we monitored glycolysis in mouse lymphoma and lung tumors by measuring the conversion of hyperpolarized [U-H-2, U-C-13]glucose to lactate using C-13 magnetic resonance spectroscopy and spectroscopic imaging. We observed labeled lactate only in tumors and not in surrounding normal tissue or other tissues in the body and found that it was markedly decreased at 24 h after treatment with a chemotherapeutic drug. We also detected an increase in a resonance assigned to 6-phosphogluconate in the pentose phosphate pathway. This technique could provide a new way of detecting early evidence of tumor treatment response in the clinic and of monitoring tumor pentose phosphate pathway activity.	[Rodrigues, Tiago B.; Serrao, Eva M.; Kettunen, Mikko I.; Brindle, Kevin M.] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England; [Kennedy, Brett W. C.; Hu, De-En; Kettunen, Mikko I.; Brindle, Kevin M.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Brindle, KM (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge, England.	kmb1001@cam.ac.uk	Kettunen, Mikko I/K-2299-2012	Kettunen, Mikko I/0000-0002-2004-660X; Rodrigues, Tiago/0000-0002-4474-0639; Mendes Serrao, Eva/0000-0002-1402-3444	Cancer Research UK Programme [C197/A3514]; Leukemia & Lymphoma Society; European Union Seventh Framework Programme under the Marie Curie Initial Training Network METAFLUX [264780]; Intra-European Marie Curie (FP7-PEOPLE-2009-IEF, Imaging Lymphoma) fellowship; Long-term European Molecular Biology Organization fellowship [EMBO-ALT-1145-2009]; Cancer Research UK [17242, 16465] Funding Source: researchfish	Cancer Research UK Programme(Cancer Research UK); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); European Union Seventh Framework Programme under the Marie Curie Initial Training Network METAFLUX; Intra-European Marie Curie (FP7-PEOPLE-2009-IEF, Imaging Lymphoma) fellowship; Long-term European Molecular Biology Organization fellowship; Cancer Research UK(Cancer Research UK)	The work was supported by a Cancer Research UK Programme grant (C197/A3514) and by a Translational Research Program Award from The Leukemia & Lymphoma Society to K.M.B. T.B.R. is a recipient of an Intra-European Marie Curie (FP7-PEOPLE-2009-IEF, Imaging Lymphoma) fellowship and a Long-term European Molecular Biology Organization (EMBO-ALT-1145-2009) fellowship. E.M.S. is a recipient of a fellowship from the European Union Seventh Framework Programme (FP7/2007-2013) under the Marie Curie Initial Training Network METAFLUX (project number 264780). E.M.S. acknowledges the educational support of Programme for Advanced Medical Education from Calouste Gulbenkian Foundation, Champalimaud Foundation, Ministerio de Saude and Fundacao para a Ciencia e Tecnologia, Portugal. The polarizer and related materials were provided by GE Healthcare. The authors thank F. Gallagher for help with the polarizer. The laboratory is a member of and receives support from the Cancer Research UK & Engineering and Physical Science Research Council Cancer Imaging Center in Cambridge and Manchester.	Allouche-Arnon H, 2013, CONTRAST MEDIA MOL I, V8, P72, DOI 10.1002/cmmi.1497; Allouche-Arnon H, 2011, CONTRAST MEDIA MOL I, V6, P499, DOI 10.1002/cmmi.452; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Brindle K, 2008, NAT REV CANCER, V8, P94, DOI 10.1038/nrc2289; Brindle KM, 2011, MAGN RESON MED, V66, P505, DOI 10.1002/mrm.22999; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GUMAA KA, 1969, BIOCHEM J, V115, P1009, DOI 10.1042/bj1151009; Harris T, 2013, NMR BIOMED, V26, P1831, DOI 10.1002/nbm.3024; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kennedy BWC, 2012, J AM CHEM SOC, V134, P4969, DOI 10.1021/ja300222e; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Lodi A, 2013, NMR BIOMED, V26, P299, DOI 10.1002/nbm.2848; Madsen PL, 1999, J CEREBR BLOOD F MET, V19, P393, DOI 10.1097/00004647-199904000-00005; Marin-Valencia I, 2012, NMR BIOMED, V25, P1177, DOI 10.1002/nbm.2787; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; Meier S, 2011, FEBS LETT, V585, P3133, DOI 10.1016/j.febslet.2011.08.049; Meier S, 2011, MOL BIOSYST, V7, P2834, DOI 10.1039/c1mb05202k; NEELY JR, 1975, CIRC RES, V37, P733, DOI 10.1161/01.RES.37.6.733; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Park JM, 2013, NEURO-ONCOLOGY, V15, P433, DOI 10.1093/neuonc/nos319; Poptani H, 2003, CANCER RES, V63, P8813; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Rivenzon-Segal D, 2002, AM J PHYSIOL-ENDOC M, V283, pE623, DOI 10.1152/ajpendo.00050.2002; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Weber WA, 2005, J NUCL MED, V46, P983; Witney TH, 2011, J BIOL CHEM, V286, P24572, DOI 10.1074/jbc.M111.237727	30	200	205	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					93	+		10.1038/nm.3416	http://dx.doi.org/10.1038/nm.3416			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24317119	Green Accepted			2022-12-27	WOS:000329349400025
J	Lord, CJ; Ashworth, A				Lord, Christopher J.; Ashworth, Alan			Mechanisms of resistance to therapies targeting BRCA-mutant cancers	NATURE MEDICINE			English	Article							PARP INHIBITOR RESISTANCE; CELL LUNG-CANCER; POLY(ADP-RIBOSE) POLYMERASE; BREAST-CANCER; HOMOLOGOUS RECOMBINATION; OVARIAN-CARCINOMA; SECONDARY MUTATIONS; MAMMARY-TUMORS; DNA-DAMAGE; 53BP1	Synthetic lethality provides a potential mechanistic framework for the therapeutic targeting of genetic and functional deficiencies in cancers and is now being explored widely. The first clinical exemplification of synthetic lethality in cancer has been the exploitation of inhibitors of poly-(ADP-ribose) polymerase (PARP) for the treatment of cancers with defects in the BRCA1 or BRCA2 tumor suppressor proteins, which are involved in the repair of DNA damage. Although this approach has shown promise, multiple potential resistance mechanisms have been identified. In this Perspective, we discuss these mechanisms and their relevance to the development of selective therapies for BRCA-deficient cancers.	[Lord, Christopher J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Inst Canc Res, Canc Res UK Gene Funct Lab, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Lord, CJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England.	chris.lord@icr.ac.uk; alan.ashworth@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012	Lord, Christopher J/0000-0002-3226-0515	Cancer Research UK; Breakthrough Breast Cancer; American Association for Cancer Research; Komen Foundation; Breast Cancer Research Foundation; Wellcome Trust; European Union; Cancer Research UK [14276] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breakthrough Breast Cancer; American Association for Cancer Research; Komen Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Cancer Research UK(Cancer Research UK)	We thank Cancer Research UK, Breakthrough Breast Cancer, the American Association for Cancer Research as part of the Stand Up to Cancer Breast Cancer Dream Team, The Komen Foundation, The Breast Cancer Research Foundation, The Wellcome Trust and the European Union as part of the FP7 DNA Damage Response (DDR) and EUROCAN programmes for funding our work.	Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Balmana J, 2011, CANCER DISCOV, V1, P29, DOI 10.1158/2159-8274.CD-11-0048; Barber LJ, 2013, J PATHOL, V229, P422, DOI 10.1002/path.4140; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Choi Y.H., 2013, CURR PHARM DESIGN, DOI [10.2174/13816128113199990005, DOI 10.2174/13816128113199990005]; Di Virgilio M, 2013, SCIENCE, V339, P711, DOI 10.1126/science.1230624; DOBZHANSKY T, 1946, GENETICS, V31, P269; Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Gottipati P, 2010, CANCER RES, V70, P5389, DOI 10.1158/0008-5472.CAN-09-4716; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Ikeda H, 2003, CANCER RES, V63, P2688; Issaeva N, 2010, CANCER RES, V70, P6268, DOI 10.1158/0008-5472.CAN-09-3416; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Klauke ML, 2012, VIRCHOWS ARCH, V461, P425, DOI 10.1007/s00428-012-1311-2; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Liu XS, 2009, MOL CANCER RES, V7, P1686, DOI 10.1158/1541-7786.MCR-09-0299; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; McCabe N, 2005, CANCER BIOL THER, V4, P934, DOI 10.4161/cbt.4.9.2141; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nakada S, 2012, CANCER RES, V72, P4974, DOI 10.1158/0008-5472.CAN-12-1057; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Oplustilova L, 2012, CELL CYCLE, V11, P3837, DOI 10.4161/cc.22026; Patel AG, 2012, J BIOL CHEM, V287, P4198, DOI 10.1074/jbc.M111.296475; Pennington KP, 2013, GYNECOL ONCOL, V128, P493, DOI 10.1016/j.ygyno.2012.12.007; Pettitt SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061520; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Swisher EM, 2008, CANCER RES, V68, P2581, DOI 10.1158/0008-5472.CAN-08-0088; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	56	302	315	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1381	1388		10.1038/nm.3369	http://dx.doi.org/10.1038/nm.3369			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202391				2022-12-27	WOS:000326920300016
J	Smith, LN; Cowan, CW				Smith, Laura N.; Cowan, Christopher W.			Striking a balance in fragile X	NATURE MEDICINE			English	Editorial Material							MESSENGER-RNAS; PROTEIN		[Smith, Laura N.; Cowan, Christopher W.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA	Harvard University; McLean Hospital	Smith, LN (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA.	cwcowan@mclean.harvard.edu	Smith, Laura/W-2716-2018; Cowan, Christopher W/I-2497-2014	Smith, Laura/0000-0003-3687-3148; 	NIDA NIH HHS [R01 DA027664] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027664] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Goebel-Goody SM, 2012, GENES BRAIN BEHAV, V11, P586, DOI 10.1111/j.1601-183X.2012.00781.x; Hall SS, 2008, AM J MENT RETARD, V113, P44, DOI 10.1352/0895-8017(2008)113[44:CSAABI]2.0.CO;2; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Merenstein SA, 1996, AM J MED GENET, V64, P388, DOI 10.1002/(SICI)1096-8628(19960809)64:2<388::AID-AJMG31>3.3.CO;2-S; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Udagawa T, 2013, NAT MED, V19, P1473, DOI 10.1038/nm.3353	15	0	0	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1370	1371		10.1038/nm.3383	http://dx.doi.org/10.1038/nm.3383			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202383				2022-12-27	WOS:000326920300012
J	Killeen, GF; Barillas-Mury, C; Thomas, MB; Greenwood, B				Killeen, Gerry F.; Barillas-Mury, C.; Thomas, M.B.; Greenwood, B.			Modulating malaria with Wolbachia	NATURE MEDICINE			English	Editorial Material							VECTOR MOSQUITOS; POPULATIONS; PLASMODIUM; INFECTION; TRANSMISSION; DENGUE	New control strategies for malaria are urgently required. One current area of investigation is blocking the transmission of the malaria parasite through its mosquito vector. Bian et al.(1) highlight the potential use of Wolbachia, symbiotic bacteria that infect insects, in control of malaria transmission. The authors describe the stable establishment of Wolbachia infection in Anopheles stephensi, an important malaria vector, and show that seeding of infected female A. stephensi into a population of uninfected mosquitoes resulted in invasion of Wolbachia into the uninfected population. Moreover, Wolbachia infection rendered A. stephensi refractory to infection with the malaria parasite. We asked four experts to comment on the implications of this study.										Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Blagborough AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2840; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11; Killeen GF, 2013, AM J TROP MED HYG, V88, P809, DOI 10.4269/ajtmh.13-0065; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900; Thomas MB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001262; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; WHO, 2012, WORLD MALARIA REPORT 2012, P1	10	4	4	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					974	975		10.1038/nm.3298	http://dx.doi.org/10.1038/nm.3298			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921743				2022-12-27	WOS:000322779600020
J	Swaminathan, S; Huang, CX; Geng, HM; Chen, ZS; Harvey, R; Kang, HN; Ng, C; Titz, B; Hurtz, C; Sadiyah, MF; Nowak, D; Thoennissen, GB; Rand, V; Graeber, TG; Koeffler, HP; Carroll, WL; Willman, CL; Hall, AG; Igarashi, K; Melnick, A; Muschen, M				Swaminathan, Srividya; Huang, Chuanxin; Geng, Huimin; Chen, Zhengshan; Harvey, Richard; Kang, Huining; Ng, Carina; Titz, Bjoern; Hurtz, Christian; Sadiyah, Mohammed Firas; Nowak, Daniel; Thoennissen, Gabriela B.; Rand, Vikki; Graeber, Thomas G.; Koeffler, H. Phillip; Carroll, William L.; Willman, Cheryl L.; Hall, Andrew G.; Igarashi, Kazuhiko; Melnick, Ari; Mueschen, Markus			BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; BCL6; IDENTIFICATION; TRANSCRIPTION; STAT5	The B cell-specific transcription factor BACH2 is required for affinity maturation of B cells. Here we show that Bach2-mediated activation of p53 is required for stringent elimination of pre-B cells that failed to productively rearrange immunoglobulin VH-DJH gene segments. After productive V-H-DJ(H) gene rearrangement, pre-B cell receptor signaling ends BACH2-mediated negative selection through B cell lymphoma 6 (BCL6)-mediated repression of p53. In patients with pre-B acute lymphoblastic leukemia, the BACH2-mediated checkpoint control is compromised by deletions, rare somatic mutations and loss of its upstream activator, PAX5. Low levels of BACH2 expression in these patients represent a strong independent predictor of poor clinical outcome. In this study, we demonstrate that Bach2(+/+) pre-B cells resist leukemic transformation by Myc through Bach2-dependent upregulation of p53 and do not initiate fatal leukemia in transplant-recipient mice. Chromatin immunoprecipitation sequencing and gene expression analyses carried out by us revealed that BACH2 competes with BCL6 for promoter binding and reverses BCL6-mediated repression of p53 and other cell cycle checkpoint-control genes. These findings identify BACH2 as a crucial mediator of negative selection at the pre-B cell receptor checkpoint and a safeguard against leukemogenesis.	[Swaminathan, Srividya; Geng, Huimin; Chen, Zhengshan; Ng, Carina; Hurtz, Christian; Sadiyah, Mohammed Firas; Mueschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Huang, Chuanxin; Melnick, Ari] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Huang, Chuanxin; Melnick, Ari] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Harvey, Richard; Kang, Huining; Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Titz, Bjoern; Graeber, Thomas G.] Univ Calif Los Angeles, Crump Inst Mol Imaging, Los Angeles, CA USA; [Nowak, Daniel; Thoennissen, Gabriela B.; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Thoennissen, Gabriela B.] Univ Munster, Dept Med, D-48149 Munster, Germany; [Rand, Vikki; Hall, Andrew G.] Newcastle Univ, Newcastle Canc Ctr, Northern Inst Canc Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Carroll, William L.] NYU, Inst Canc, Langone Med Ctr, New York, NY USA; [Igarashi, Kazuhiko] Tohoku Univ, Dept Biochem, Grad Sch Med, Sendai, Miyagi 980, Japan; [Igarashi, Kazuhiko] Japan Sci & Technol Agcy, CREST, Sendai, Miyagi, Japan	University of California System; University of California San Francisco; Cornell University; Cornell University; University of New Mexico; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of Munster; Newcastle University - UK; New York University; NYU Langone Medical Center; Tohoku University; Japan Science & Technology Agency (JST)	Muschen, M (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	markus.muschen@ucsf.edu	Melnick, Ari/AAA-5763-2020; Titz, Bjoern/G-6317-2017; Kang, Huining/AAM-7506-2021; Chen, Zhengshan/J-7499-2014	Titz, Bjoern/0000-0003-4414-4105; Kang, Huining/0000-0002-4415-3573; Igarashi, Kazuhiko/0000-0002-2470-2475; Nowak, Daniel/0000-0001-7130-7921; Harvey, Richard/0000-0002-4904-9767; Rand, Vikki/0000-0002-2198-8949; Graeber, Thomas/0000-0001-8574-9181	US National Institutes of Health National Cancer Institute [R01CA137060, R01CA139032, R01CA157644, R01CA172558, R01CA169458]; Leukemia and Lymphoma Society [6132-09, 6097-10]; Leukemia and Lymphoma Society Specialized Center of Research [7005-11]; William Lawrence and Blanche Hughes Foundation; Stand Up To Cancer-American Association for Cancer Research Innovative Research [IRG00909]; California Institute for Regenerative Medicine (CIRM) [TR2-01816]; Leukaemia and Lymphoma Research; Scholars of the Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA157644, R01CA137060, R01CA172558, R01CA169458, U01CA157937, R01CA139032] Funding Source: NIH RePORTER	US National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Leukemia and Lymphoma Society Specialized Center of Research(Leukemia and Lymphoma Society); William Lawrence and Blanche Hughes Foundation; Stand Up To Cancer-American Association for Cancer Research Innovative Research; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Leukaemia and Lymphoma Research; Scholars of the Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank H. Ye (Albert Einstein College of Medicine) for sharing Bcl6<SUP>-/-</SUP> mice and wild-type controls and L. Hennighausen (US National Institute of Diabetes and Digestive and Kidney Diseases) for Stat5<SUP>flox/flox</SUP> mice. Samples used in this research include those obtained from the Newcastle Haematology Biobank (http://www.ncl.ac.uk/nbb/collections/nhb/index.htm). We thank D.B. Kohn (University of California Los Angeles) for providing us with the retroviral envelope and packaging vectors used in this study. This work is supported by grants from the US National Institutes of Health National Cancer Institute through R01CA137060, R01CA139032, R01CA157644, R01CA172558, R01CA172558 and R01CA169458 (to M.M.), Translational Research Program grants from the Leukemia and Lymphoma Society (grants 6132-09 and 6097-10), a Leukemia and Lymphoma Society Specialized Center of Research (grant 7005-11, B.J. Druker (principal investigator)), the William Lawrence and Blanche Hughes Foundation and a Stand Up To Cancer-American Association for Cancer Research Innovative Research Grant (IRG00909 to M.M.), the California Institute for Regenerative Medicine (CIRM; TR2-01816 to M.M.) and Leukaemia and Lymphoma Research (V.R. and A.G.H.). A.M. and M.M. are Scholars of the Leukemia and Lymphoma Society. V.R. is a Leukaemia and Lymphoma Research Bennett Fellow.	Drayton S, 2003, CANCER CELL, V4, P301, DOI 10.1016/S1535-6108(03)00242-3; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Duy C, 2010, J EXP MED, V207, P1209, DOI 10.1084/jem.20091299; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Geng HM, 2012, CANCER DISCOV, V2, P1004, DOI 10.1158/2159-8290.CD-12-0208; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Kawamata N, 2012, ONCOGENE, V31, P966, DOI 10.1038/onc.2011.291; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Merup M, 1998, BLOOD, V91, P3397, DOI 10.1182/blood.V91.9.3397.3397_3397_3400; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Nahar R, 2011, BLOOD, V118, P4174, DOI 10.1182/blood-2011-01-331181; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trageser D, 2009, J EXP MED, V206, P1739, DOI 10.1084/jem.20090004; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	26	83	87	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1014	+		10.1038/nm.3247	http://dx.doi.org/10.1038/nm.3247			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23852341	Green Accepted, Green Submitted			2022-12-27	WOS:000322779600027
J	Guermonprez, P; Helft, J; Claser, C; Deroubaix, S; Karanje, H; Gazumyan, A; Darasse-Jeze, G; Telerman, SB; Breton, G; Schreiber, HA; Frias-Staheli, N; Billerbeck, E; Dorner, M; Rice, CM; Ploss, A; Klein, F; Swiecki, M; Colonna, M; Kamphorst, AO; Meredith, M; Niec, R; Takacs, C; Mikhail, F; Hari, A; Bosque, D; Eisenreich, T; Merad, M; Shi, Y; Ginhoux, F; Renia, L; Urban, BC; Nussenzweig, MC				Guermonprez, Pierre; Helft, Julie; Claser, Carla; Deroubaix, Stephanie; Karanje, Henry; Gazumyan, Anna; Darasse-Jeze, Guillaume; Telerman, Stephanie B.; Breton, Gaelle; Schreiber, Heidi A.; Frias-Staheli, Natalia; Billerbeck, Eva; Dorner, Marcus; Rice, Charles M.; Ploss, Alexander; Klein, Florian; Swiecki, Melissa; Colonna, Marco; Kamphorst, Alice O.; Meredith, Matthew; Niec, Rachel; Takacs, Constantin; Mikhail, Fadi; Hari, Aswin; Bosque, David; Eisenreich, Tom; Merad, Miriam; Shi, Yan; Ginhoux, Florent; Renia, Laurent; Urban, Britta C.; Nussenzweig, Michel C.			Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection	NATURE MEDICINE			English	Article							MAST-CELLS; URIC-ACID; MALARIA; PROGENITORS; LYMPHOCYTES; PRECURSORS; EXPRESSION; LIGAND; LEADS; IDENTIFICATION	Innate sensing mechanisms trigger a variety of humoral and cellular events that are essential to adaptive immune responses. Here we describe an innate sensing pathway triggered by Plasmodium infection that regulates dendritic cell homeostasis and adaptive immunity through Flt3 ligand (Flt3l) release. Plasmodium-induced Flt3l release in mice requires Toll-like receptor (TLR) activation and type I interferon (IFN) production. We found that type I IFN supports the upregulation of xanthine dehydrogenase, which metabolizes the xanthine accumulating in infected erythrocytes to uric acid. Uric acid crystals trigger mast cells to release soluble Flt3l from a pre-synthesized membrane-associated precursor. During infection, Flt3l preferentially stimulates expansion of the CD8-alpha(+) dendritic cell subset or its BDCA3(+) human dendritic cell equivalent and has a substantial impact on the magnitude of T cell activation, mostly in the CD8(+) compartment. Our findings highlight a new mechanism that regulates dendritic cell homeostasis and T cell responses to infection.	[Guermonprez, Pierre; Deroubaix, Stephanie; Gazumyan, Anna; Darasse-Jeze, Guillaume; Telerman, Stephanie B.; Breton, Gaelle; Schreiber, Heidi A.; Klein, Florian; Kamphorst, Alice O.; Meredith, Matthew; Niec, Rachel; Takacs, Constantin; Bosque, David; Eisenreich, Tom; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Helft, Julie; Merad, Miriam] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; [Helft, Julie; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY USA; [Claser, Carla; Ginhoux, Florent; Renia, Laurent] Biopolis, Agcy Sci Technol & Res, Singapore Immunol Network, Singapore, Singapore; [Karanje, Henry; Urban, Britta C.] Kenya Med Res Inst KEMRI, Wellcome Trust Res Program, Ctr Geog Med Res, Kilifi, Kenya; [Frias-Staheli, Natalia; Billerbeck, Eva; Dorner, Marcus; Rice, Charles M.; Ploss, Alexander] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10021 USA; [Swiecki, Melissa; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Mikhail, Fadi] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Hari, Aswin; Shi, Yan] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Hari, Aswin; Shi, Yan] Univ Calgary, Immunol Res Grp, Calgary, AB, Canada; [Eisenreich, Tom; Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Urban, Britta C.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Rockefeller University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Kenya Medical Research Institute; Rockefeller University; Washington University (WUSTL); Cornell University; University of Calgary; University of Calgary; Howard Hughes Medical Institute; Liverpool School of Tropical Medicine; University of Liverpool	Guermonprez, P (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	pierre.guermonprez@kcl.ac.uk	Guermonprez, Pierre/ABE-7718-2020; Renia, Laurent/E-2117-2011; Shi, Yan/Y-6642-2019; Urban, Britta/W-6087-2018; Nussenzweig, Michel/AAE-7292-2019; Darrasse-Jeze, Guillaume/AAG-5153-2020; Ploss, Alexander/ABG-2330-2020; Helft, Julie/ABE-6179-2020; Claser, Carla/P-2736-2018	Guermonprez, Pierre/0000-0001-5621-2262; Renia, Laurent/0000-0003-0349-1557; Urban, Britta/0000-0002-4197-8393; Darrasse-Jeze, Guillaume/0000-0003-3069-8211; Ploss, Alexander/0000-0001-9322-7252; Helft, Julie/0000-0002-2733-1972; Claser, Carla/0000-0002-5395-9632; Dorner, Marcus/0000-0003-0321-4226; Colonna, Marco/0000-0001-5222-4987; Niec, Rachel/0000-0002-8525-3693; Kamphorst, Alice/0000-0002-9230-9501	US National Institutes of Health [AI051573]; Agency for Science, Technology and Research (Singapore); Wellcome Trust [079082]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107301, P01AI051573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Steinman, M. P. Longhi, E. Pamer, I. Leiner and K. Marsh for helpful discussion and reagents or critical reading of the manuscript and Celldex for human recombinant FLT3L. We thank I. Lemischka (Mount Sinai School of Medicine) the for the Flt3<SUP>-/-</SUP> mice and B. Malissen (Centre d'Immunologie de Marseille-Luminy) for the langerin-DTR mice. We thank the children and their guardians for participation. This paper is published with the permission of the Director of the KEMRI. This work was supported in part by US National Institutes of Health grant number AI051573 and the Agency for Science, Technology and Research (Singapore). P. G. is a Centre National de la Recherche Scientifique (CNRS) investigator. B. C. U. is a Wellcome Trust Senior Research Fellow (grant 079082). M.C.N. is a Howard Hughes Medical Institute (HHMI) investigator.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Berrozpe G, 1999, BLOOD, V94, P2658, DOI 10.1182/blood.V94.8.2658.420k23_2658_2666; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Coban C, 2007, TRENDS MICROBIOL, V15, P271, DOI 10.1016/j.tim.2007.04.003; Crozat K, 2010, J EXP MED, V207, P1283, DOI 10.1084/jem.20100223; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; DAS BS, 1993, AM J TROP MED HYG, V49, P720, DOI 10.4269/ajtmh.1993.49.720; de Hoef DLV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055584; de Vries VC, 2009, AM J TRANSPLANT, V9, P2270, DOI 10.1111/j.1600-6143.2009.02755.x; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Diao J, 2004, J IMMUNOL, V173, P1826, DOI 10.4049/jimmunol.173.3.1826; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Eidenschenk C, 2010, P NATL ACAD SCI USA, V107, P9759, DOI 10.1073/pnas.1005186107; Farrand KJ, 2009, J IMMUNOL, V183, P7732, DOI 10.4049/jimmunol.0902707; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Franklin BS, 2007, MICROBES INFECT, V9, P881, DOI 10.1016/j.micinf.2007.03.007; Poulin LF, 2010, J EXP MED, V207, P1261, DOI 10.1084/jem.20092618; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Haque A, 2011, EUR J IMMUNOL, V41, P2688, DOI 10.1002/eji.201141539; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Leisewitz AL, 2004, INFECT IMMUN, V72, P4233, DOI 10.1128/IAI.72.7.4233-4239.2004; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lopera-Mesa TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046424; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Lundie RJ, 2010, EUR J IMMUNOL, V40, P1674, DOI 10.1002/eji.200939265; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Orengo JM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000013; Orengo JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005194; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Sanni LA, 1999, J INFECT DIS, V179, P217, DOI 10.1086/314552; Shelburne CP, 2009, CELL HOST MICROBE, V6, P331, DOI 10.1016/j.chom.2009.09.004; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Soule BP, 2007, J IMMUNOL, V179, P3276, DOI 10.4049/jimmunol.179.5.3276; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; STOCKER R, 1986, BIOCHEM BIOPH RES CO, V134, P152, DOI 10.1016/0006-291X(86)90540-1; SUSS G, 1988, INFECT IMMUN, V56, P3081; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Tamura T, 2011, INFECT IMMUN, V79, P3947, DOI 10.1128/IAI.01337-10; Urban BC, 2006, AM J TROP MED HYG, V74, P578, DOI 10.4269/ajtmh.2006.74.578; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Wykes MN, 2007, PLOS PATHOG, V3, P904, DOI 10.1371/journal.ppat.0030096	60	109	112	1	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					730	+		10.1038/nm.3197	http://dx.doi.org/10.1038/nm.3197			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23685841	Green Accepted			2022-12-27	WOS:000319981600022
J	Robbins, PF; Lu, YC; El-Gamil, M; Li, YF; Gross, C; Gartner, J; Lin, JC; Teer, JK; Cliften, P; Tycksen, E; Samuels, Y; Rosenberg, SA				Robbins, Paul F.; Lu, Yong-Chen; El-Gamil, Mona; Li, Yong F.; Gross, Colin; Gartner, Jared; Lin, Jimmy C.; Teer, Jamie K.; Cliften, Paul; Tycksen, Eric; Samuels, Yardena; Rosenberg, Steven A.			Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells	NATURE MEDICINE			English	Article							CLASS-I MOLECULES; METASTATIC MELANOMA; INFILTRATING LYMPHOCYTES; STANDARD PROTEASOME; TRANSFER THERAPY; BETA-CATENIN; HLA-A; REVEALS; IMMUNOPROTEASOME; IDENTIFICATION	Substantial regressions of metastatic lesions have been observed in up to 70% of patients with melanoma who received adoptively transferred autologous tumor-infiltrating lymphocytes (TILs) in phase 2 clinical trials(1,2). In addition, 40% of patients treated in a recent trial experienced complete regressions of all measurable lesions for at least 5 years following TIL treatment(3). To evaluate the potential association between the ability of TILs to mediate durable regressions and their ability to recognize potent antigens that presumably include mutated gene products, we developed a new screening approach involving mining whole-exome sequence data to identify mutated proteins expressed in patient tumors. We then synthesized and evaluated candidate mutated T cell epitopes that were identified using a major histocompatibility complex-binding algorithm(4) for recognition by TILs. Using this approach, we identified mutated antigens expressed on autologous tumor cells that were recognized by three bulk TIL lines from three individuals with melanoma that were associated with objective tumor regressions following adoptive transfer. This simplified approach for identifying mutated antigens recognized by T cells avoids the need to generate and laboriously screen cDNA libraries from tumors and may represent a generally applicable method for identifying mutated antigens expressed in a variety of tumor types.	[Robbins, Paul F.; Lu, Yong-Chen; El-Gamil, Mona; Li, Yong F.; Gross, Colin; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA; [Gartner, Jared; Samuels, Yardena] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Lin, Jimmy C.; Cliften, Paul; Tycksen, Eric] Washington Univ, Sch Med, Genome Technol Access Ctr, Genom Serv, St Louis, MO USA; [Lin, Jimmy C.; Cliften, Paul; Tycksen, Eric] Washington Univ, Sch Med, Genome Technol Access Ctr, Pathol Serv, St Louis, MO USA; [Teer, Jamie K.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Robbins, PF (corresponding author), NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	paulrobbins@mail.nih.gov	Lu, Yong-Chen/G-4520-2014	Lu, Yong-Chen/0000-0002-0275-9825; Tycksen, Eric/0000-0001-6362-0141; Samuels, Yardena/0000-0002-3349-7266; Gross, Colin/0000-0002-7061-5073	NATIONAL CANCER INSTITUTE [ZIABC010985, ZICBC010948, ZIABC010984] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200337] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kahle JJ, 2011, HUM MOL GENET, V20, P510, DOI 10.1093/hmg/ddq496; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Kvistborg P, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.18851; MARINCOLA FM, 1994, J IMMUNOTHER, V16, P13, DOI 10.1097/00002371-199407000-00002; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Pieper R, 1999, J EXP MED, V189, P757, DOI 10.1084/jem.189.5.757; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Robbins PF, 1996, J EXP MED, V183, P1185, DOI 10.1084/jem.183.3.1185; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; SALTER RD, 1986, EMBO J, V5, P943, DOI 10.1002/j.1460-2075.1986.tb04307.x; TOPALIAN SL, 1987, J IMMUNOL METHODS, V102, P127, DOI 10.1016/S0022-1759(87)80018-2; van der Bruggen P, 2013, CANC IMMUN; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Zhou JH, 2005, J IMMUNOTHER, V28, P53, DOI 10.1097/00002371-200501000-00007	31	763	812	2	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					747	+		10.1038/nm.3161	http://dx.doi.org/10.1038/nm.3161			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23644516	Green Accepted			2022-12-27	WOS:000319981600024
J	Rowe, I; Chiaravalli, M; Mannella, V; Ulisse, V; Quilici, G; Pema, M; Song, XWW; Xu, HX; Mari, S; Qian, F; Pei, Y; Musco, G; Boletta, A				Rowe, Isaline; Chiaravalli, Marco; Mannella, Valeria; Ulisse, Valeria; Quilici, Giacomo; Pema, Monika; Song, Xuewen W.; Xu, Hangxue; Mari, Silvia; Qian, Feng; Pei, York; Musco, Giovanna; Boletta, Alessandra			Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy	NATURE MEDICINE			English	Article							CYST FORMATION; MTOR; INHIBITION; ACTIVATION; PATHWAY; INACTIVATION; DOWNSTREAM; CLEAVAGE; GROWTH	Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder characterized by bilateral renal cyst formation(1). Recent identification of signaling cascades deregulated in ADPKD has led to the initiation of several clinical trials, but an approved therapy is still lacking(2,3). Using a metabolomic approach, we identify a pathogenic pathway in this disease that can be safely targeted for therapy. We show that mutation of PKD1 results in enhanced glycolysis in cells in a mouse model of PKD and in kidneys from humans with ADPKD. Glucose deprivation resulted in lower proliferation and higher apoptotic rates in PKD1-mutant cells than in nondeprived cells. Notably, two distinct PKD mouse models treated with 2-deoxyglucose (2DG), to inhibit glycolysis, had lower kidney weight, volume, cystic index and proliferation rates as compared to nontreated mice. These metabolic alterations depend on the extracellular signal-related kinase (ERK) pathway acting in a dual manner by inhibiting the liver kinase B1 (LKB1)-AMP-activated protein kinase (AMPK) axis on the one hand while activating the mTOR complex 1 (mTORC1)-glycolytic cascade on the other. Enhanced metabolic rates further inhibit AMPK. Forced activation of AMPK acts in a negative feedback loop, restoring normal ERK activity. Taken together, these data indicate that defective glucose metabolism is intimately involved in the pathobiology of ADPKD. Our findings provide a strong rationale for a new therapeutic strategy using existing drugs, either individually or in combination.	[Rowe, Isaline; Chiaravalli, Marco; Ulisse, Valeria; Pema, Monika; Boletta, Alessandra] Ist Sci San Raffaele, Div Genet & Cell Biol, Dulbecco Telethon Inst DTI Dibit, I-20132 Milan, Italy; [Mannella, Valeria; Quilici, Giacomo; Mari, Silvia; Musco, Giovanna] Ist Sci San Raffaele, Biomol NMR Lab, DTI, Ctr Translat Genom & Bioinformat, I-20132 Milan, Italy; [Song, Xuewen W.; Pei, York] Univ Toronto, Div Nephrol, Toronto, ON, Canada; [Xu, Hangxue; Qian, Feng] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Toronto; Johns Hopkins University	Boletta, A (corresponding author), Ist Sci San Raffaele, Div Genet & Cell Biol, Dulbecco Telethon Inst DTI Dibit, I-20132 Milan, Italy.	musco.giovanna@hsr.it; boletta.alessandra@hsr.it	rowe, isaline/AAN-1985-2020; musco, giovanna/I-7122-2012; Musco, Giovanna/Q-2756-2019; Quilici, Giacomo/AAA-5352-2019; Mannella, Valeria/AAN-1946-2020	rowe, isaline/0000-0002-5398-1776; musco, giovanna/0000-0002-0469-2994; Quilici, Giacomo/0000-0003-1379-3583; chiaravalli, marco/0000-0003-0369-1989	Telethon-Italy [TCR05007, TCP99035]; US National Institutes of Health [DK62199, DK090868]; Canadian Institutes of Health Research [MOP123429]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199, P30DK090868] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank other members of the lab Boletta and G. Di Grigoli for helpful discussion, R.M. Moresco for helpful suggestions and critically reading the manuscript, G. Casari and L. Cassina for help with the experiments on mitochondria, M. Giorgio for analysis of oxygen consumption and the San Raffaele microscopy facility (Alembic) for the electron microscopy studies (M.C. Panzeri) and tetramethylrhodamine (TMRM) analysis (M. Ascagni). V.M. is a student in the PhD Program of Biochemical, Nutritional and Metabolic Sciences, University of Milan. This work was supported by Telethon-Italy (TCR05007 to A.B. and TCP99035 to G.M.), US National Institutes of Health grants DK62199 (to F.Q.) and DK090868 (Johns Hopkins Polycystic Kidney Disease Research and Clinical Core Center, P30) and the Canadian Institutes of Health Research grant MOP123429 (to Y.P.). A.B. and G.M. are Associate Telethon Scientists. The lab Boletta is especially indebted to S. Bramani for her continuous, intelligent and motivating support.	Bastos AP, 2009, J AM SOC NEPHROL, V20, P2389, DOI 10.1681/ASN.2008040435; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Chiaradonna F, 2012, BIOTECHNOL ADV, V30, P30, DOI 10.1016/j.biotechadv.2011.07.006; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Csibi A, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-69; Distefano G, 2009, MOL CELL BIOL, V29, P2359, DOI 10.1128/MCB.01259-08; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Forseth RR, 2011, CURR OPIN CHEM BIOL, V15, P38, DOI 10.1016/j.cbpa.2010.10.010; FOXALL PJD, 1992, BIOCHIM BIOPHYS ACTA, V1138, P305, DOI 10.1016/0925-4439(92)90008-B; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; McCarty MF, 2009, MED HYPOTHESES, V73, P1008, DOI 10.1016/j.mehy.2009.05.043; Merrick D, 2012, DEV CELL, V22, P197, DOI 10.1016/j.devcel.2011.10.028; Serra Andreas L, 2007, BMC Nephrol, V8, P13, DOI 10.1186/1471-2369-8-13; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Takiar V, 2011, BBA-MOL BASIS DIS, V1812, P1337, DOI 10.1016/j.bbadis.2010.11.014; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Torres VE, 2010, CLIN J AM SOC NEPHRO, V5, P1312, DOI 10.2215/CJN.01360210; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wodarczyk C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012719; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	33	299	312	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					488	+		10.1038/nm.3092	http://dx.doi.org/10.1038/nm.3092			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23524344	Green Accepted			2022-12-27	WOS:000317109100035
J	Kiechl, S; Wittmann, J; Giaccari, A; Knoflach, M; Willeit, P; Bozec, A; Moschen, AR; Muscogiuri, G; Sorice, GP; Kireva, T; Summerer, M; Wirtz, S; Luther, J; Mielenz, D; Billmeier, U; Egger, G; Mayr, A; Oberhollenzer, F; Kronenberg, F; Orthofer, M; Penninger, JM; Meigs, JB; Bonora, E; Tilg, H; Willeit, J; Schett, G				Kiechl, Stefan; Wittmann, Juergen; Giaccari, Andrea; Knoflach, Michael; Willeit, Peter; Bozec, Aline; Moschen, Alexander R.; Muscogiuri, Giovanna; Sorice, Gian Pio; Kireva, Trayana; Summerer, Monika; Wirtz, Stefan; Luther, Julia; Mielenz, Dirk; Billmeier, Ulrike; Egger, Georg; Mayr, Agnes; Oberhollenzer, Friedrich; Kronenberg, Florian; Orthofer, Michael; Penninger, Josef M.; Meigs, James B.; Bonora, Enzo; Tilg, Herbert; Willeit, Johann; Schett, Georg			Blockade of receptor activator of nuclear factor-kappa B (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus	NATURE MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; IKK-BETA; OSTEOPROTEGERIN; RISK; LIGAND; OBESITY; LIVER; INFLAMMATION; OSTEOBLASTS; METABOLISM	Hepatic insulin resistance is a driving force in the pathogenesis of type 2 diabetes mellitus (T2DM) and is tightly coupled with excessive storage of fat and the ensuing inflammation within the liver(1-3). There is compelling evidence that activation of the transcription factor nuclear factor-kappa B (NF-kappa B) and downstream inflammatory signaling pathways systemically and in the liver are key events in the etiology of hepatic insulin resistance and p-cell dysfunction, although the molecular mechanisms involved are incompletely understood(3-6). We here test the hypothesis that receptor activator of NE-kappa B ligand (RANKL), a prototypic activator of NF-kappa B, contributes to this process using both an epidemiological and experimental approach. In the prospective population-based Bruneck Study, a high serum concentration of soluble RANKL emerged as a significant (P < 0.001) and independent risk predictor of T2DM manifestation. In close agreement, systemic or hepatic blockage of RANKL signaling in genetic and nutritional mouse models of T2DM resulted in a marked improvement of hepatic insulin sensitivity and amelioration or even normalization of plasma glucose concentrations and glucose tolerance. Overall, this study provides evidence for a role of RANKL signaling in the pathogenesis of T2DM. If so, translation to the clinic may be feasible given current pharmacological strategies to lower RANKL activity to treat osteoporosis.	[Kiechl, Stefan; Knoflach, Michael; Willeit, Peter; Willeit, Johann] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Wittmann, Juergen; Mielenz, Dirk] Univ Erlangen Nurnberg, Dept Internal Med 3, Div Mol Immunol, D-91054 Erlangen, Germany; [Giaccari, Andrea; Muscogiuri, Giovanna; Sorice, Gian Pio] Univ Cattolica Sacro Cuore, Div Endocrinol & Metab Dis, Policlin A Gemelli, Rome, Italy; [Giaccari, Andrea] Fdn Don C Gnocchi, Milan, Italy; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Bozec, Aline; Kireva, Trayana; Luther, Julia; Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Moschen, Alexander R.; Tilg, Herbert] Med Univ Innsbruck, Div Endocrinol Gastroenterol & Metab, Dept Med 1, A-6020 Innsbruck, Austria; [Summerer, Monika; Kronenberg, Florian] Med Univ Innsbruck, Div Genet Epidemiol Mol & Clin Pharmacol, Dept Med Genet, A-6020 Innsbruck, Austria; [Wirtz, Stefan; Billmeier, Ulrike] Univ Erlangen Nurnberg, Dept Internal Med 1, D-91054 Erlangen, Germany; [Egger, Georg; Oberhollenzer, Friedrich] Bruneck Hosp, Dept Internal Med, Brunico, Italy; [Mayr, Agnes] Bruneck Hosp, Dept Lab Med, Brunico, Italy; [Orthofer, Michael; Penninger, Josef M.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Meigs, James B.] Harvard Univ, Dept Internal Med, Boston, MA 02115 USA; [Meigs, James B.] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA; [Bonora, Enzo] Univ & Hosp Trust Verona, Div Endocrinol Diabet & Metab Dis, Verona, Italy	Medical University of Innsbruck; University of Erlangen Nuremberg; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Cambridge; University of Erlangen Nuremberg; Medical University of Innsbruck; Medical University of Innsbruck; University of Erlangen Nuremberg; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Harvard University; Harvard University; Massachusetts General Hospital; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Kiechl, S (corresponding author), Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria.	stefan.kiechl@i-med.ac.at; georg.schett@uk-erlangen.de	Moschen, Alexander/ABF-2267-2021; Muscogiuri, Giovanna/K-5817-2016; Willeit, Peter/HCI-7091-2022; Penninger, Josef M/I-6860-2013; Kronenberg, Florian/B-1736-2008; Bonora, Enzo/AAA-5300-2022; Meigs, James/P-3927-2019; Giaccari, Andrea/AAA-7824-2022	Willeit, Peter/0000-0002-1866-7159; Penninger, Josef M/0000-0002-8194-3777; Kronenberg, Florian/0000-0003-2229-1120; Meigs, James/0000-0002-2439-2657; Giaccari, Andrea/0000-0002-7462-7792; Knoflach, Michael/0000-0001-5576-6562; BONORA, Enzo/0000-0003-1074-5164; Wirtz, Stefan/0000-0001-6936-7431; , Agnes Mayr/0000-0001-9363-873X; Moschen, Alexander R/0000-0003-3598-7848; Muscogiuri, Giovanna/0000-0002-8809-4931	Deutsche Forschungsgemeinschaft [SPP1468-IMMUNOBONE]; Bundesministerium fur Bildung und Forschung (Bundesministerium fur Bildung und Forschung project ANCYLOSS); European Union; Innovative Medicines Initiative funded project BTCure; National Institute of Diabetes and Digestive and Kidney Diseases [K24 DK080140]; Genomics of Lipid-associated Disorders of the Austrian Genome Research Programme GEN-AU; 'Pustertaler Verein zur Pravention von Herz- und Hirngefasserkrankungen; Gesundheitsbetrieb Bruneck; Assessorat fur Gesundheitswesen, Familie und Soziales, Bolzand; Umberto Di Mario Prize by the Societa Italiana di Diabetologia; Fondazione Don Gnocchi; Universita Cattolica del Sacro Cuore (Fondi Ateneo Linea D.3.2 Sindrome Metabolica); Italian Ministry of Education, University and Research [PRIN 2010JS3PMZ_011]; Christian Doppler Research Society; Italian Ministry of Education, University and Research; University of Verona; European Research Council; Austrian Academy of Sciences; National Bank Foundation; Era of Hope/US Department of Defense; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (Bundesministerium fur Bildung und Forschung project ANCYLOSS); European Union(European Commission); Innovative Medicines Initiative funded project BTCure; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Genomics of Lipid-associated Disorders of the Austrian Genome Research Programme GEN-AU; 'Pustertaler Verein zur Pravention von Herz- und Hirngefasserkrankungen; Gesundheitsbetrieb Bruneck; Assessorat fur Gesundheitswesen, Familie und Soziales, Bolzand; Umberto Di Mario Prize by the Societa Italiana di Diabetologia; Fondazione Don Gnocchi; Universita Cattolica del Sacro Cuore (Fondi Ateneo Linea D.3.2 Sindrome Metabolica); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Christian Doppler Research Society; Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); University of Verona; European Research Council(European Research Council (ERC)European Commission); Austrian Academy of Sciences; National Bank Foundation; Era of Hope/US Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Deutsche Forschungsgemeinschaft (SPP1468-IMMUNOBONE to G.S.), the Bundesministerium fur Bildung und Forschung (Bundesministerium fur Bildung und Forschung project ANCYLOSS to G.S.), the European Union (Masterswitch to G.S.), the Innovative Medicines Initiative funded project BTCure (to G.S.), the National Institute of Diabetes and Digestive and Kidney Diseases (K24 DK080140 to J.B.M.), the Genomics of Lipid-associated Disorders of the Austrian Genome Research Programme GEN-AU (to EK.), the 'Pustertaler Verein zur Pravention von Herz- und Hirngefasserkrankungen; the 'Gesundheitsbetrieb Bruneck' and the Assessorat fur Gesundheitswesen, Familie und Soziales, Bolzand. G.M. is recipient of the Umberto Di Mario Prize by the Societa Italiana di Diabetologia 2011. A.G. was supported by grants from Fondazione Don Gnocchi, Universita Cattolica del Sacro Cuore (Fondi Ateneo Linea D.3.2 Sindrome Metabolica) and the Italian Ministry of Education, University and Research (PRIN 2010JS3PMZ_011). A.M. and H.T. were supported by the Christian Doppler Research Society. E.B. is recipient of grants from the Italian Ministry of Education, University and Research and the University of Verona. J.M.P. holds an advanced European Research Council grant and is supported by the Austrian Academy of Sciences, a Grant by the National Bank Foundation and Era of Hope/US Department of Defense. We thank B. Enrich for technical support.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BERTOLINI DR, 1986, NATURE, V319, P516, DOI 10.1038/319516a0; Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Goto H, 2011, CYTOKINE, V56, P662, DOI 10.1016/j.cyto.2011.09.005; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Jiang JJ, 2001, BIOCHEM BIOPH RES CO, V289, P1088, DOI 10.1006/bbrc.2001.6100; Kanazawa I, 2011, BONE, V48, P720, DOI 10.1016/j.bone.2010.12.020; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kiechl Stefan, 2006, Expert Rev Cardiovasc Ther, V4, P801, DOI 10.1586/14779072.4.6.801; Kiechl S, 2007, CIRCULATION, V116, P385, DOI 10.1161/CIRCULATIONAHA.106.686774; Kindle L, 2006, J BONE MINER RES, V21, P193, DOI 10.1359/JBMR.051027; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lieb W, 2010, ARTERIOSCL THROM VAS, V30, P1849, DOI 10.1161/ATVBAHA.109.199661; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu LS, 2012, J ENDODONT, V38, P943, DOI 10.1016/j.joen.2012.03.010; Mai QG, 2011, J CELL BIOCHEM, V112, P2902, DOI 10.1002/jcb.23206; Mauro C, 2011, NAT CELL BIOL, V13, P1272, DOI 10.1038/ncb2324; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Moschen AR, 2005, GUT, V54, P479, DOI 10.1136/gut.2004.044370; Nathan DM, 2010, NEW ENGL J MED, V362, P1533, DOI 10.1056/NEJMe1002322; Nishikawa M, 2008, HUM GENE THER, V19, P1009, DOI 10.1089/hum.2008.020; Schett G, 2004, JAMA-J AM MED ASSOC, V291, P1108, DOI 10.1001/jama.291.9.1108; Secchiero P, 2006, AM J PATHOL, V169, P2236, DOI 10.2353/ajpath.2006.060398; Semb AG, 2009, ARTERIOSCL THROM VAS, V29, P975, DOI 10.1161/ATVBAHA.109.184101; Sheng L, 2012, NAT MED, V18, P943, DOI 10.1038/nm.2756; Shimizu H, 2008, FASEB J, V22, P2465, DOI 10.1096/fj.07-098954; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Terpos E, 2003, BLOOD, V102, P1064, DOI 10.1182/blood-2003-02-0380; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Ziolkowska M, 2002, ARTHRITIS RHEUM-US, V46, P1744, DOI 10.1002/art.10388	40	168	191	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					358	363		10.1038/nm.3084	http://dx.doi.org/10.1038/nm.3084			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396210				2022-12-27	WOS:000316040700030
J	Cha, JY; Sun, XF; Dey, SK				Cha, Jeeyeon; Sun, Xiaofei; Dey, Sudhansu K.			Mechanisms of implantation: strategies for successful pregnancy	NATURE MEDICINE			English	Review							LEUKEMIA INHIBITORY FACTOR; EPIDERMAL-GROWTH-FACTOR; HUMAN BLASTOCYST DEVELOPMENT; HUMAN ENDOMETRIUM; EMBRYO IMPLANTATION; UTERINE RECEPTIVITY; MOUSE UTERUS; IN-VITRO; INDIAN HEDGEHOG; PRETERM BIRTH	Physiological and molecular processes initiated during implantation for pregnancy success are complex but highly organized. This review primarily highlights adverse ripple effects arising from defects during the peri-implantation period that perpetuate throughout pregnancy. These defects are reflected in aberrations in embryo spacing, decidualization, placentation and intrauterine embryonic growth, manifesting in preeclampsia, miscarriages and/or preterm birth. Understanding molecular signaling networks that coordinate strategies for successful implantation and decidualization may lead to approaches to improve the outcome of natural pregnancy and pregnancy conceived from in vitro fertilization.	[Cha, Jeeyeon; Sun, Xiaofei; Dey, Sudhansu K.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Perinatal Inst,Div Reprod Sci, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Dey, SK (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Perinatal Inst,Div Reprod Sci, Cincinnati, OH 45221 USA.	sk.dey@cchmc.org			US National Institutes of Health (NIH) [HD12304, HD068524, DA06668]; March of Dimes; Grand Challenges Explorations Initiative through the Bill & Melinda Gates Foundation; NIH National Research Service Award Fellowship [F30AG040858]; University of Cincinnati Medical Scientist Training Program [T32 GM063483]; Lalor Foundation Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068524] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD012304, R01HD012304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM063483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG040858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA006668, R01DA006668] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Grand Challenges Explorations Initiative through the Bill & Melinda Gates Foundation; NIH National Research Service Award Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Medical Scientist Training Program; Lalor Foundation Postdoctoral Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We regret that space limitations precluded us from citing many relevant references. We thank K. Yoshinaga and A. Erlebacher for helpful discussions. Work embodied in this article from S.K.D.'s group was supported in part by US National Institutes of Health (NIH) grants (HD12304, HD068524 and DA06668), the March of Dimes, and the Grand Challenges Explorations Initiative through the Bill & Melinda Gates Foundation. J.C. is supported by an NIH National Research Service Award Fellowship (F30AG040858) and the University of Cincinnati Medical Scientist Training Program (T32 GM063483), and X.S. is supported by a Lalor Foundation Postdoctoral Fellowship.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Arias-Stella J, 2002, ADV ANAT PATHOL, V9, P12, DOI 10.1097/00125480-200201000-00003; Benson GV, 1996, DEVELOPMENT, V122, P2687; Bilinski P, 1998, GENE DEV, V12, P2234, DOI 10.1101/gad.12.14.2234; BRAR AK, 1995, J CELL PHYSIOL, V163, P30, DOI 10.1002/jcp.1041630105; Brinsden PR, 2009, FERTIL STERIL, V91, P1445, DOI 10.1016/j.fertnstert.2008.06.047; Burnum KE, 2008, ENDOCRINOLOGY, V149, P3274, DOI 10.1210/en.2008-0309; Burnum KE, 2009, J LIPID RES, V50, P2290, DOI 10.1194/jlr.M900100-JLR200; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chobotova K, 2002, MECH DEVELOP, V119, P137, DOI 10.1016/S0925-4773(02)00342-8; CNATTINGIUS S, 1992, JAMA-J AM MED ASSOC, V268, P886; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Critchley HOD, 1999, J CLIN ENDOCR METAB, V84, P240, DOI 10.1210/jc.84.1.240; Cross JC, 2003, CLIN GENET, V64, P96, DOI 10.1034/j.1399-0004.2003.00127.x; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; DAS SK, 1994, DEVELOPMENT, V120, P1071; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diaz-Gimeno P, 2011, FERTIL STERIL, V95, P50, DOI 10.1016/j.fertnstert.2010.04.063; DiIorio R, 1997, LANCET, V349, P328; Doring B, 2006, J CELL SCI, V119, P1715, DOI 10.1242/jcs.02892; Dokras A, 2006, BIOL REPROD, V75, P899, DOI 10.1095/biolreprod.106.053603; Dunlap KA, 2011, BIOL REPROD, V85, P386, DOI 10.1095/biolreprod.111.091769; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Gendron RL, 1997, BIOL REPROD, V56, P1097, DOI 10.1095/biolreprod56.5.1097; GHOSH D, 1994, HUM REPROD, V9, P629, DOI 10.1093/oxfordjournals.humrep.a138561; Giudice LC, 1999, HUM REPROD, V14, P3, DOI 10.1093/humrep/14.suppl_2.3; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Groom KM, 2005, BJOG-INT J OBSTET GY, V112, P725, DOI 10.1111/j.1471-0528.2005.00539.x; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Hambartsoumian E, 1998, AM J REPROD IMMUNOL, V39, P137; Hamilton S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095505; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hayashi K, 2009, BIOL REPROD, V80, P989, DOI 10.1095/biolreprod.108.075416; Hess AP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P337; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hirota Y, 2010, P NATL ACAD SCI USA, V107, P15577, DOI 10.1073/pnas.1009324107; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Hirota Y, 2008, AM J PATHOL, V173, P1747, DOI 10.2353/ajpath.2008.080527; Horne AW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003969; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Hunkapiller NM, 2011, DEVELOPMENT, V138, P2987, DOI 10.1242/dev.066589; Huyen DV, 2011, REPRODUCTION, V142, P353, DOI 10.1530/REP-11-0060; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jeong JW, 2009, ONCOGENE, V28, P31, DOI 10.1038/onc.2008.363; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P9761, DOI 10.1073/pnas.0904280106; Kawagoe J, 2012, DEV CELL, V23, P858, DOI 10.1016/j.devcel.2012.09.002; Kim JJ, 1999, ENDOCRINOLOGY, V140, P2672, DOI 10.1210/en.140.6.2672; Krieg SA, 2008, FERTIL STERIL, V90, P65, DOI 10.1016/j.fertnstert.2007.06.014; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Laird SM, 1997, HUM REPROD, V12, P569; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Leach RE, 2002, LANCET, V360, P1215, DOI 10.1016/S0140-6736(02)11283-9; Lee JE, 2011, ENDOCRINOLOGY, V152, P2067, DOI 10.1210/en.2010-1456; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lee KY, 2007, MOL CELL BIOL, V27, P5468, DOI 10.1128/MCB.00342-07; LEJEUNE B, 1981, J REPROD FERTIL, V61, P235; Lessey BA, 2011, FERTIL STERIL, V96, P522, DOI 10.1016/j.fertnstert.2011.07.1095; Li MY, 2006, J CLIN INVEST, V116, P2653, DOI 10.1172/JC128462; Li MY, 2008, BIOL REPROD, V79, P1169, DOI 10.1095/biolreprod.108.069336; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Liu R, 2011, MOL ENDOCRINOL, V25, P1137, DOI 10.1210/me.2010-0497; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; Marions L, 1999, MOL HUM REPROD, V5, P961, DOI 10.1093/molehr/5.10.961; Martin KL, 1998, HUM REPROD, V13, P1645, DOI 10.1093/humrep/13.6.1645; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; MCLAREN A, 1968, J ENDOCRINOL, V42, P453, DOI 10.1677/joe.0.0420453; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Melin J, 2009, DEV DYNAM, V238, P950, DOI 10.1002/dvdy.21918; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Mori M, 2011, J CLIN INVEST, V121, P318, DOI 10.1172/JCI44723; Mukherjee Atish, 2007, Nucl Recept Signal, V5, pe011, DOI 10.1621/nrs.05011; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Nikas G, 1997, ANN NY ACAD SCI, V816, P129, DOI 10.1111/j.1749-6632.1997.tb52136.x; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Paria BC, 1999, DEVELOPMENT, V126, P1997; PARIA BC, 1990, P NATL ACAD SCI USA, V87, P4756, DOI 10.1073/pnas.87.12.4756; Paria BC, 2001, P NATL ACAD SCI USA, V98, P1047, DOI 10.1073/pnas.98.3.1047; Park CB, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098277; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Patounakis G, 2009, FERTIL STERIL, V92, P1290, DOI 10.1016/j.fertnstert.2008.07.1783; PAVLOVA A, 1994, DEVELOPMENT, V120, P335; Petit FG, 2007, P NATL ACAD SCI USA, V104, P6293, DOI 10.1073/pnas.0702039104; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Prakobphol A, 2006, DEV BIOL, V298, P107, DOI 10.1016/j.ydbio.2006.06.020; PSYCHOYOS A, 1973, ENDOCRINE CONTROL EG; Raab G, 1996, DEVELOPMENT, V122, P637; Rao AJ, 2007, REPROD BIOMED ONLINE, V14, P563, DOI 10.1016/S1472-6483(10)61047-4; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Roizen JD, 2008, MOL ENDOCRINOL, V22, P105, DOI 10.1210/me.2007-0178; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; SCHLAFKE S, 1975, BIOL REPROD, V12, P41, DOI 10.1095/biolreprod12.1.41; Simon C, 1998, FERTIL STERIL, V70, P234, DOI 10.1016/S0015-0282(98)00140-X; Simon L, 2009, ENDOCRINOLOGY, V150, P3871, DOI 10.1210/en.2008-1691; Sjoblom C, 1999, HUM REPROD, V14, P3069, DOI 10.1093/humrep/14.12.3069; SMITZ J, 1993, HUM REPROD, V8, P40, DOI 10.1093/oxfordjournals.humrep.a137871; Song H, 2006, REPRODUCTION, V131, P341, DOI 10.1530/rep.1.00956; Song H, 2002, DEVELOPMENT, V129, P2879; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; Stavreus-Evers A, 2005, FERTIL STERIL, V83, P156, DOI 10.1016/j.fertnstert.2004.06.057; Stavreus-Evers A, 2002, MOL HUM REPROD, V8, P765, DOI 10.1093/molehr/8.8.765; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun XF, 2012, P NATL ACAD SCI USA, V109, P1145, DOI 10.1073/pnas.1118411109; Sun XF, 2010, P NATL ACAD SCI USA, V107, P16887, DOI 10.1073/pnas.1010892107; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Taylor HS, 1998, J CLIN INVEST, V101, P1379, DOI 10.1172/JCI1057; Taylor HS, 1999, J CLIN ENDOCR METAB, V84, P1129, DOI 10.1210/jc.84.3.1129; THOMAS K, 1973, INT J FERTIL, V18, P65; Trabucco E, 2009, PLACENTA, V30, P516, DOI 10.1016/j.placenta.2009.03.015; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Tranguch S, 2007, J CLIN INVEST, V117, P1824, DOI 10.1172/JCI31622; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620; Wang H, 2006, J CLIN INVEST, V116, P2122, DOI 10.1172/JCI28621; Wang HB, 2007, J BIOL CHEM, V282, P37770, DOI 10.1074/jbc.M706577200; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2004, J BIOL CHEM, V279, P10649, DOI 10.1074/jbc.M312203200; Wei QX, 2010, J CLIN ENDOCR METAB, V95, P5330, DOI 10.1210/jc.2010-0637; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yang H, 2012, REPRODUCTION, V143, P531, DOI 10.1530/REP-11-0438; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yoo HJ, 1997, DEV GENET, V21, P102, DOI 10.1002/(SICI)1520-6408(1997)21:1<102::AID-DVG12>3.0.CO;2-C; YOSHINAG.K, 1966, J REPROD FERTIL, V12, P593, DOI 10.1530/jrf.0.0120593; Yotsumoto S, 1998, DEV BIOL, V203, P264, DOI 10.1006/dbio.1998.9073	170	761	811	9	233	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1754	1767		10.1038/nm.3012	http://dx.doi.org/10.1038/nm.3012			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23223073	Green Accepted			2022-12-27	WOS:000311999800023
J	Finan, B; Yang, B; Ottaway, N; Stemmer, K; Muller, TD; Yi, CX; Habegger, K; Schriever, SC; Garcia-Caceres, C; Kabra, DG; Hembree, J; Holland, J; Raver, C; Seeley, RJ; Hans, W; Irmler, M; Beckers, J; de Angelis, MH; Tiano, JP; Mauvais-Jarvis, F; Perez-Tilve, D; Pfluger, P; Zhang, LS; Gelfanov, V; DiMarchi, RD; Tschop, MH				Finan, Brian; Yang, Bin; Ottaway, Nickki; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Habegger, Kirk; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; de Angelis, Martin Hrabe; Tiano, Joseph P.; Mauvais-Jarvis, Franck; Perez-Tilve, Diego; Pfluger, Paul; Zhang, Lianshan; Gelfanov, Vasily; DiMarchi, Richard D.; Tschoep, Matthias H.			Targeted estrogen delivery reverses the metabolic syndrome	NATURE MEDICINE			English	Article							LEPTIN RESPONSIVENESS; DIABETES-MELLITUS; RECEPTOR-ALPHA; GLUCAGON; BINDING; OBESITY; CELLS; BETA; EXTRANUCLEAR; MECHANISMS	We report the development of a new combinatorial approach that allows for peptide-mediated selective tissue targeting of nuclear hormone pharmacology while eliminating adverse effects in other tissues. Specifically, we report the development of a glucagon-like peptide-1 (GLP-1)-estrogen conjugate that has superior sex-independent efficacy over either of the individual hormones alone to correct obesity, hyperglycemia and dyslipidemia in mice. The therapeutic benefits are driven by pleiotropic dual hormone action to improve energy, glucose and lipid metabolism, as shown by loss-of-function models and genetic action profiling. Notably, the peptide-based targeting strategy also prevents hallmark side effects of estrogen in male and female mice, such as reproductive endocrine toxicity and oncogenicity. Collectively, selective activation of estrogen receptors in GLP-1-targeted tissues produces unprecedented efficacy to enhance the metabolic benefits of GLP-1 agonism. This example of targeting the metabolic syndrome represents the discovery of a new class of therapeutics that enables synergistic co-agonism through peptide-based selective delivery of small molecules. Although our observations with the GLP-1-estrogen conjugate justify translational studies for diabetes and obesity, the multitude of other possible combinations of peptides and small molecules may offer equal promise for other diseases.	[Finan, Brian; Yang, Bin; Gelfanov, Vasily; DiMarchi, Richard D.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Finan, Brian; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Pfluger, Paul; Tschoep, Matthias H.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Diabet & Obes, Neuherberg, Germany; [Finan, Brian; Stemmer, Kerstin; Mueller, Timo D.; Yi, Chun-Xia; Schriever, Sonja C.; Garcia-Caceres, Cristina; Kabra, Dhiraj G.; Pfluger, Paul; Tschoep, Matthias H.] Tech Univ Munich, Div Metabol Dis, Dept Med, Munich, Germany; [Ottaway, Nickki; Habegger, Kirk; Hembree, Jazzminn; Holland, Jenna; Raver, Christine; Seeley, Randy J.; Perez-Tilve, Diego; Pfluger, Paul; Tschoep, Matthias H.] Univ Cincinnati, Coll Med, Dept Internal Med, Metabol Dis Inst,Div Endocrinol, Cincinnati, OH USA; [Hans, Wolfgang; Irmler, Martin; Beckers, Johannes; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen GmbH, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany; [Tiano, Joseph P.; Mauvais-Jarvis, Franck] Northwestern Univ, Div Endocrinol Metab & Mol Med, Feinberg Sch Med, Comprehens Ctr Obes,Dept Med, Chicago, IL 60611 USA; [Zhang, Lianshan] Jiangsu Hengrui Med Co Ltd, Nanjing, Jiangsu Provinc, Peoples R China	Indiana University System; Indiana University Bloomington; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University System of Ohio; University of Cincinnati; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Northwestern University; Feinberg School of Medicine	DiMarchi, RD (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.	rdimarch@indiana.edu; tschoep@helmholtz-muenchen.de	Tschoep, Matthias H/I-5443-2014; Yang, Bin/J-4044-2015; Pfluger, Paul T/A-3770-2019; Irmler, Martin/B-3317-2013; García-Cáceres, Cristina/O-6601-2016; de Angelis, Martin Hrabe/F-5531-2012; Müller, Timo D./AAZ-4445-2020; Yang, Bin/W-7014-2019; Yi, Chun-Xia/J-4068-2016; Beckers, Johannes/K-7237-2012	Yang, Bin/0000-0003-4110-1513; Pfluger, Paul T/0000-0002-8118-7588; Irmler, Martin/0000-0003-3169-479X; García-Cáceres, Cristina/0000-0001-6376-9448; de Angelis, Martin Hrabe/0000-0002-7898-2353; Yang, Bin/0000-0003-1180-6184; Yi, Chun-Xia/0000-0003-1184-4615; Beckers, Johannes/0000-0001-7874-3822; Muller, Timo/0000-0002-0624-9339; Tschoep, Matthias/0000-0002-4744-371X; Habegger, Kirk/0000-0002-0342-5480; Stemmer, Kerstin/0000-0002-7526-2326; Perez-Tilve, Diego/0000-0002-0351-4133; Gelfanov, Vasily/0000-0001-5216-5227; Seeley, Randy/0000-0002-3721-5625; Schriever, Sonja C./0000-0001-5461-3214	Marcadia Biotech; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093848] Funding Source: NIH RePORTER	Marcadia Biotech; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Smiley and J. Levy for assistance in peptide synthesis, purification and characterization; J. Patterson and J. Day for their contribution to optimizing the peptide sequences; J. Ford for cell culture maintenance; J. Gidda and S. Vignati for their expert advice on pharmacology studies; and Y.-X. Li (Medpace Bioanalytical Labs) for assistance with in vivo pharmacokinetic studies. Partial research funding was provided by Marcadia Biotech, which has been acquired by Roche Pharma.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Cho MA, 2007, J ENDOCRINOL, V195, P255, DOI 10.1677/JOE-06-0193; Cvetkovic RS, 2007, DRUGS, V67, P935, DOI 10.2165/00003495-200767060-00008; Davies MJ, 2011, DIABETES OBES METAB, V13, P207, DOI 10.1111/j.1463-1326.2010.01330.x; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Erickson HK, 2006, CANCER RES, V66, P4426, DOI 10.1158/0008-5472.CAN-05-4489; Gao Q, 2008, AM J PHYSIOL-ENDOC M, V294, pE817, DOI 10.1152/ajpendo.00733.2007; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Grundy SM, 2006, NAT REV DRUG DISCOV, V5, P294, DOI 10.1038/nrd2005; Harrington WR, 2006, MOL ENDOCRINOL, V20, P491, DOI 10.1210/me.2005-0186; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Jankowski M, 2001, P NATL ACAD SCI USA, V98, P11765, DOI 10.1073/pnas.201394198; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Krop IE, 2010, J CLIN ONCOL, V28, P2698, DOI 10.1200/JCO.2009.26.2071; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lee KW, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-158; Liu SH, 2009, DIABETES, V58, P2292, DOI 10.2337/db09-0257; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; Muller TD, 2012, J PEPT SCI, V18, P383, DOI 10.1002/psc.2408; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Papageorgiou A, 2007, ENDOCRINOLOGY, V148, P1384, DOI 10.1210/en.2006-1198; Park CJ, 2011, J CLIN INVEST, V121, P604, DOI 10.1172/JCI41702; Patterson JT, 2011, ACS CHEM BIOL, V6, P135, DOI 10.1021/cb1002015; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; Shughrue PJ, 2002, ENDOCRINOLOGY, V143, P1643, DOI 10.1210/en.143.5.1643; Son S, 2009, J MED CHEM, V52, P6889, DOI 10.1021/jm901153x; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Tiano JP, 2011, J CLIN INVEST, V121, P3331, DOI 10.1172/JCI44564; Williams DL, 2006, DIABETES, V55, P3387, DOI 10.2337/db06-0558; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009	40	205	213	1	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1847	+		10.1038/nm.3009	http://dx.doi.org/10.1038/nm.3009			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142820	Green Accepted			2022-12-27	WOS:000311999800034
J	Scott, RC; Holmes, GL				Scott, Rod C.; Holmes, Gregory L.			Opening up the potassium door in neonatal seizures	NATURE MEDICINE			English	Editorial Material							RETIGABINE EZOGABINE; DEVELOPING BRAIN; KCNQ2; CONVULSIONS; SPECTRUM; EPILEPSY; MODELS; DRUGS		[Scott, Rod C.] UCL, Inst Child Hlth, London, England; [Scott, Rod C.; Holmes, Gregory L.] Geisel Sch Med Dartmouth, Hanover, NH USA	University of London; University College London; Dartmouth College	Scott, RC (corresponding author), UCL, Inst Child Hlth, London, England.	gregory.l.holmes@dartmouth.edu		Scott, Rod/0000-0002-8944-928X				Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Lanska MJ, 1996, NEUROEPIDEMIOLOGY, V15, P117, DOI 10.1159/000109898; Large CH, 2012, EPILEPSIA, V53, P425, DOI 10.1111/j.1528-1167.2011.03364.x; Mazarati A, 2008, EPILEPSIA, V49, P1777, DOI 10.1111/j.1528-1167.2008.01674.x; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Painter MJ, 1999, NEW ENGL J MED, V341, P485, DOI 10.1056/NEJM199908123410704; Ronen GM, 2007, NEUROLOGY, V69, P1816, DOI 10.1212/01.wnl.0000279335.85797.2c; Sankar R, 2010, EPILEPSIA, V51, P39, DOI 10.1111/j.1528-1167.2010.02607.x; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644	18	6	6	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1624	1625		10.1038/nm.2987	http://dx.doi.org/10.1038/nm.2987			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135515				2022-12-27	WOS:000310837000020
J	Tenbaum, SP; Ordonez-Moran, P; Puig, I; Chicote, I; Arques, O; Landolfi, S; Fernandez, Y; Herance, JR; Gispert, JD; Mendizabal, L; Aguilar, S; Cajal, SRY; Schwartz, S; Vivancos, A; Espin, E; Rojas, S; Baselga, J; Tabernero, J; Munoz, A; Palmer, HG				Tenbaum, Stephan P.; Ordonez-Moran, Paloma; Puig, Isabel; Chicote, Irene; Arques, Oriol; Landolfi, Stefania; Fernandez, Yolanda; Raul Herance, Jose; Gispert, Juan D.; Mendizabal, Leire; Aguilar, Susana; Ramon y Cajal, Santiago; Schwartz, Simo, Jr.; Vivancos, Ana; Espin, Eloy; Rojas, Santiago; Baselga, Jose; Tabernero, Josep; Munoz, Alberto; Palmer, Hector G.			beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer	NATURE MEDICINE			English	Article							STEM-CELLS; E-CADHERIN; PHASE-I; TRANSCRIPTION; EXPRESSION; INDUCTION; PROTEINS; INVASION; KINASE; GROWTH	The Wnt-beta-catenin and PI3K-AKT-FOXO3a pathways have a central role in cancer. AKT phosporylates FOXO3a, relocating it from the cell nucleus to the cytoplasm, an effect that is reversed by PI3K and AKT inhibitors. Simultaneous hyperactivation of the Wnt-beta-catenin pathway and inhibition of PI3K-AKT signaling promote nuclear accumulation of beta-catenin and FOXO3a, respectively, promoting cell scattering and metastasis by regulating a defined set of target genes. Indeed, the anti-tumoral AKT inhibitor API-2 promotes nuclear FOXO3a accumulation and metastasis of cells with high nuclear beta-catenin content. Nuclear beta-catenin confers resistance to the FOXO3a-mediated apoptosis induced by PI3K and AKT inhibitors in patient-derived primary cultures and in corresponding xenograft tumors in mice. This resistance is reversed by XAV-939, an inhibitor of Wnt-beta-catenin signaling. In the presence of high nuclear beta-catenin content, activation of FOXO3a by PI3K or AKT inhibitors makes it behave as a metastasis inductor rather than a proapoptotic tumor suppressor. We show that it is possible to evaluate the beta-catenin status of patients' carcinomas and the response of patient-derived cells to target-directed drugs that accumulate FOXO3a in the nucleus before deciding on a course of treatment. We propose that this evaluation could be essential to the provision of a safer and more effective personalized treatment.	[Tenbaum, Stephan P.; Puig, Isabel; Chicote, Irene; Arques, Oriol; Palmer, Hector G.] VHIO, Stem Cell & Canc Lab, Barcelona, Spain; [Ordonez-Moran, Paloma; Munoz, Alberto] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Landolfi, Stefania; Ramon y Cajal, Santiago] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Pathol, E-08193 Barcelona, Spain; [Fernandez, Yolanda; Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Hosp Univ Vall Hebron,Inst Recerca Vall Hebron, Nanomed & Networking Biomed Res Ctr Bioengn Bioma, Ctr Invest Bioquim & Biol Mol CIBBIM,Grp Drug Del, E-08193 Barcelona, Spain; [Raul Herance, Jose; Gispert, Juan D.; Rojas, Santiago] Ctr Imatge Mol CRC Corp Sanitaria, Barcelona, Spain; [Mendizabal, Leire; Vivancos, Ana] VHIO, Genom Canc Grp, Barcelona, Spain; [Aguilar, Susana] UCL, Rayne Inst, Ctr Resp Res, London, England; [Aguilar, Susana] Canc Res UK, London Res Inst, Hematopoiet Stem Cell Lab, London, England; [Espin, Eloy] Hosp Univ Vall Hebron, Gen Surg Serv, Barcelona, Spain; [Baselga, Jose] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Baselga, Jose] Howard Hughes Med Inst, Chevy Chase, MD USA; [Tabernero, Josep] Hosp Univ Vall Hebron, Dept Med Oncol, Barcelona, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of London; King's College London; University College London; Cancer Research UK; Hospital Universitari Vall d'Hebron; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Hospital Universitari Vall d'Hebron	Palmer, HG (corresponding author), VHIO, Stem Cell & Canc Lab, Barcelona, Spain.	hgpalmer@vhio.net	Camacho, José Raul Herance/Q-3416-2016; Vivancos, Ana/AAG-8331-2019; Munoz, Alberto/O-6393-2014; Gispert, Juan Domingo/C-6355-2008; Palmer, Héctor G./AAG-8332-2019; Schwartz, Simo/H-7776-2012; Tabernero, Josep/AAG-5026-2019; Ramon y Cajal, Santiago/H-4955-2016; Ordonez-Moran, Paloma/B-6371-2016; Seoane, Joan/AAG-9173-2019	Camacho, José Raul Herance/0000-0001-7178-3290; Vivancos, Ana/0000-0003-2888-6512; Munoz, Alberto/0000-0003-3890-4251; Gispert, Juan Domingo/0000-0002-6155-0642; Tabernero, Josep/0000-0002-2495-8139; Ramon y Cajal, Santiago/0000-0002-3867-1390; Schwartz, Simo/0000-0001-8297-7971; Espin-Basany, Eloy/0000-0002-9139-4548; Ordonez-Moran, Paloma/0000-0001-7688-1252; Landolfi, Stefania/0000-0002-1059-635X; Palmer, Hector/0000-0002-9823-5638; Puig Borreil, Isabel/0000-0001-5614-4298; Arques, Oriol/0000-0003-2603-3874; Seoane, Joan/0000-0002-6541-5974	VHIO; Instituto de Salud Carlos III (ISCIII) [FIS-PI081356, RETICC-RD06/0020/0075, RETICC-RD06/0020/0009]; Ministerio de Ciencia e Innovacion [SAF-18302]; Fundacio Olga Torres Fellowship; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC)	VHIO; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio Olga Torres Fellowship; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC)	We thank W. Shao (Novartis Institutes for BioMedical Research, Inc.) for providing the experimental drug, XAV-939, and its inactive analog, LDW-643, and we thank K. F. Becker (Technische Universitat Munchen, Germany) for providing the antibody to Snail1. We also thank P.J. Coffer (Utrecht, Netherlands) for providing the pcDNA3-FOXO3a(A3):ER (TM) expression plasmid, as well as H. Clevers (Utrecht, Netherlands) for providing L8 colon cancer cells. J. Seoane and G. Folch (VHIO, Barcelona, Spain) provided technical advice and reagents. We thank R. Luthra (Molecular Diagnostics Laboratory, MD Anderson Cancer Center, Houston, Texas, USA) for providing the CLIA panel of somatic mutations. We thank M.J. Larriba (Instituto de Investigaciones Biomedicas 'Alberto Sols', Consejo Superior de Investigaciones Cientificas-Universidad Autonoma de Madrid, Madrid, Spain) for providing the reagents necessary for the analysis of Zeb1 and Slug expression and M. Scaltriti (Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts, USA) for supplying the lentiviruses used to knock down IQGAP2 expression. We acknowledge R. Rycroft and A. Wren for their valuable assistance in the preparation of the English version of the manuscript. Experiments were supported by a VHIO starting grant and grants from Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III (ISCIII) (FIS-PI081356, RETICC-RD06/0020/0075 and RETICC-RD06/0020/0009), and Plan Nacional de Biomedicina, Ministerio de Ciencia e Innovacion (SAF-18302). S. P. T. was supported by a Fundacio Olga Torres Fellowship, I. P. was funded by the Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (AECC), and H. G. P. was supported by the Miguel Servet Program, ISCIII.	Aguilar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008013; Arques O., 2012, PROTOCOL EXCHANGE, DOI [10.1038/protex.2012.008, DOI 10.1038/PROTEX.2012.008]; Barbachano A, 2010, ONCOGENE, V29, P4800, DOI 10.1038/onc.2010.225; Barde I, 2006, MOL THER, V13, P382, DOI 10.1016/j.ymthe.2005.09.012; Bendell JC, 2012, J CLIN ONCOL, V30, P282, DOI 10.1200/JCO.2011.36.1360; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dehner M, 2008, J BIOL CHEM, V283, P19201, DOI 10.1074/jbc.M710366200; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dienstmann R, 2011, RECENT PAT ANTI-CANC, V6, P210, DOI 10.2174/157489211795328503; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gomes AR, 2008, CELL CYCLE, V7, P3133, DOI 10.4161/cc.7.20.6920; Hoffman K, 1996, CANCER CHEMOTH PHARM, V37, P254; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jun T., 1999, SCI STKE, V1999, pPE1; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kreso A., 2008, CURR PROTOC STEM CEL, V7, P311; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Natale David R., 2002, Gene Expression Patterns, V2, P17, DOI 10.1016/S0925-4773(02)00350-7; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rochat-Steiner V, 2000, J EXP MED, V192, P1165, DOI 10.1084/jem.192.8.1165; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tourneur L, 2010, TRENDS IMMUNOL, V31, P260, DOI 10.1016/j.it.2010.05.005; Tsai MS, 2000, CANCER RES, V60, P5603; Ueno H, 2002, HISTOPATHOLOGY, V40, P127, DOI 10.1046/j.1365-2559.2002.01324.x; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Yamashiro S, 2007, DEV BIOL, V308, P485, DOI 10.1016/j.ydbio.2007.06.001; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zheng Y., 2011, J MOL MED BERL; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	61	282	291	0	93	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					892	+		10.1038/nm.2772	http://dx.doi.org/10.1038/nm.2772			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22610277	Green Submitted			2022-12-27	WOS:000305116600026
J	Guarente, L				Guarente, Leonard			Sirtuins and the Warburg effect	NATURE MEDICINE			English	Editorial Material							HISTONE DEACETYLASE SIRT6; GLUTAMINE-METABOLISM; CALORIE RESTRICTION; TUMOR-SUPPRESSOR; HIF1-ALPHA; OPPOSES		[Guarente, Leonard] MIT, Dept Biol, Glenn Lab Sci Aging, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, Glenn Lab Sci Aging, Cambridge, MA 02139 USA.	leng@mit.edu						Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006783; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	15	27	27	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					24	25		10.1038/nm.3438	http://dx.doi.org/10.1038/nm.3438			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398961				2022-12-27	WOS:000329349400014
J	Gagnon, M; Bergeron, MJ; Lavertu, G; Castonguay, A; Tripathy, S; Bonin, RP; Perez-Sanchez, J; Boudreau, D; Wang, B; Dumas, L; Valade, I; Bachand, K; Jacob-Wagner, M; Tardif, C; Kianicka, I; Isenring, P; Attardo, G; Coull, JAM; De Koninck, Y				Gagnon, Martin; Bergeron, Marc J.; Lavertu, Guillaume; Castonguay, Annie; Tripathy, Sasmita; Bonin, Robert P.; Perez-Sanchez, Jimena; Boudreau, Dominic; Wang, Bin; Dumas, Lionel; Valade, Isabelle; Bachand, Karine; Jacob-Wagner, Marieve; Tardif, Christian; Kianicka, Irenej; Isenring, Paul; Attardo, Giorgio; Coull, Jeffrey A. M.; De Koninck, Yves			Chloride extrusion enhancers as novel therapeutics for neurological diseases	NATURE MEDICINE			English	Article							LAMINA-I NEURONS; COTRANSPORTER KCC2; NEUROPATHIC PAIN; DOWN-REGULATION; ANION GRADIENT; CL; RAT; EXPRESSION; HOMEOSTASIS; MECHANISM	The K+-Cl- cotransporter KCC2 is responsible for maintaining low Cl- concentration in neurons of the central nervous system (CNS), which is essential for postsynaptic inhibition through GABA(A) and glycine receptors. Although no CNS disorders have been associated with KCC2 mutations, loss of activity of this transporter has emerged as a key mechanism underlying several neurological and psychiatric disorders, including epilepsy, motor spasticity, stress, anxiety, schizophrenia, morphine-induced hyperalgesia and chronic pain(1-9). Recent reports indicate that enhancing KCC2 activity may be the favored therapeutic strategy to restore inhibition and normal function in pathological conditions involving impaired Cl- transport(10-12). We designed an assay for high-throughput screening that led to the identification of KCC2 activators that reduce intracellular chloride concentration ([Cl-](i)). Optimization of a first-in-class arylmethylidine family of compounds resulted in a KCC2-selective analog (CLP257) that lowers [Cl-](i). CLP257 restored impaired Cl- transport in neurons with diminished KCC2 activity. The compound rescued KCC2 plasma membrane expression, renormalized stimulus-evoked responses in spinal nociceptive pathways sensitized after nerve injury and alleviated hypersensitivity in a rat model of neuropathic pain. Oral efficacy for analgesia equivalent to that of pregabalin but without motor impairment was achievable with a CLP257 prodrug. These results validate KCC2 as a druggable target for CNS diseases.	[Gagnon, Martin; Bergeron, Marc J.; Lavertu, Guillaume; Castonguay, Annie; Bonin, Robert P.; Perez-Sanchez, Jimena; Boudreau, Dominic; Bachand, Karine; Tardif, Christian; De Koninck, Yves] Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Gagnon, Martin; Bergeron, Marc J.; Lavertu, Guillaume; Castonguay, Annie; Bonin, Robert P.; Perez-Sanchez, Jimena; Boudreau, Dominic; Bachand, Karine; De Koninck, Yves] Univ Laval, Quebec City, PQ, Canada; [Gagnon, Martin; Tripathy, Sasmita; Wang, Bin; Dumas, Lionel; Valade, Isabelle; Kianicka, Irenej; Attardo, Giorgio; Coull, Jeffrey A. M.] Chlor Pharma, Laval, PQ, Canada; [Tardif, Christian; De Koninck, Yves] Univ Laval, Grad Program Biophoton, Quebec City, PQ, Canada; [Jacob-Wagner, Marieve; Isenring, Paul] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	De Koninck, Y (corresponding author), Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada.	yves.dekoninck@crulrg.ulaval.ca	De Koninck, Yves/C-2659-2008; Castonguay, Annie/E-4068-2010	De Koninck, Yves/0000-0002-5779-9330; Gagnon, Martin/0000-0002-3920-4858; Bonin, Robert/0000-0002-3287-6803; Castonguay, Annie/0000-0001-8065-3359; Perez-Sanchez, Jimena/0000-0002-4967-5418	Canadian Institutes for Health Research; Krembil Foundation; Savoy Foundation; Fonds de la recherche en sante du Quebec Chercheur National Program	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; Savoy Foundation; Fonds de la recherche en sante du Quebec Chercheur National Program	This work was supported by grants from the Canadian Institutes for Health Research and the Krembil Foundation to Y.D.K., a fellowship from the Savoy Foundation to M.J.B. and the Fonds de la recherche en sante du Quebec Chercheur National Program to Y.D.K. We thank T. Kuner, University of Heidelberg, for the generous gift of the Clomeleon plasmid.	Arion D, 2011, ARCH GEN PSYCHIAT, V68, P21, DOI 10.1001/archgenpsychiatry.2010.114; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bonin RP, 2011, PAIN, V152, P1317, DOI 10.1016/j.pain.2011.02.011; Bos R, 2013, P NATL ACAD SCI USA, V110, P348, DOI 10.1073/pnas.1213680110; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chorin E, 2011, J NEUROSCI, V31, P12916, DOI 10.1523/JNEUROSCI.2205-11.2011; Cordero-Erausquin M, 2005, J NEUROSCI, V25, P9613, DOI 10.1523/JNEUROSCI.1488-05.2005; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cramer SW, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-36; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Dharmshaktu P, 2012, J CLIN PHARMACOL, V52, P6, DOI 10.1177/0091270010394852; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Doyon N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002149; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Garbarini N, 2008, CELL PHYSIOL BIOCHEM, V22, P31, DOI 10.1159/000149781; Gilron I, 2007, CURR OPIN ANESTHESIO, V20, P456, DOI 10.1097/ACO.0b013e3282effaa7; Hewitt SA, 2009, NAT NEUROSCI, V12, P438, DOI 10.1038/nn.2274; Hiki K, 1999, J BIOL CHEM, V274, P10661, DOI 10.1074/jbc.274.15.10661; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Hyde TM, 2011, J NEUROSCI, V31, P11088, DOI 10.1523/JNEUROSCI.1234-11.2011; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Jolivalt CG, 2008, PAIN, V140, P48, DOI 10.1016/j.pain.2008.07.005; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kanaka C, 2001, NEUROSCIENCE, V104, P933, DOI 10.1016/S0306-4522(01)00149-X; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Labrakakis C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-24; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lu Y, 2008, J PHYSIOL-LONDON, V586, P5701, DOI 10.1113/jphysiol.2008.152348; Mercado A, 2004, NEUROCHEM RES, V29, P17, DOI 10.1023/B:NERE.0000010432.44566.21; Mosconi T, 1996, PAIN, V64, P37, DOI 10.1016/0304-3959(95)00077-1; Nightingale S, 2012, NAT REV DRUG DISCOV, V11, P101, DOI 10.1038/nrd3624; Pitcher GM, 1999, PAIN, V83, P37, DOI 10.1016/S0304-3959(99)00085-8; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Smith HS, 2012, PAIN PHYSICIAN, V15, pES93; Tornberg J, 2005, EUR J NEUROSCI, V21, P1327, DOI 10.1111/j.1460-9568.2005.03959.x; Vargas-Espinosa ML, 2012, MED ORAL PATOL ORAL, V17, pE786, DOI 10.4317/medoral.18001; Yang K, 2008, NEUROSCI LETT, V441, P205, DOI 10.1016/j.neulet.2008.06.038; Zhang W, 2008, NEUROSCIENCE, V152, P502, DOI 10.1016/j.neuroscience.2007.12.037	45	196	201	3	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1524	+		10.1038/nm.3356	http://dx.doi.org/10.1038/nm.3356			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24097188	Green Accepted			2022-12-27	WOS:000326920300031
J	Maejima, Y; Kyoi, S; Zhai, PY; Liu, T; Li, H; Ivessa, A; Sciarretta, S; Del Re, DP; Zablocki, DK; Hsu, CP; Lim, DS; Isobe, M; Sadoshima, J				Maejima, Yasuhiro; Kyoi, Shiori; Zhai, Peiyong; Liu, Tong; Li, Hong; Ivessa, Andreas; Sciarretta, Sebastiano; Del Re, Dominic P.; Zablocki, Daniela K.; Hsu, Chiao-Po; Lim, Dae-Sik; Isobe, Mitsuaki; Sadoshima, Junichi			Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2	NATURE MEDICINE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; PROTEIN AGGREGATION; X-L; APOPTOSIS; PATHWAY; KINASE; ATG14L; DOMAIN; PHOSPHORYLATION; REGULATOR	Here we show that Mst1, a proapoptotic kinase, impairs protein quality control mechanisms in the heart through inhibition of autophagy. Stress-induced activation of Mst1 in cardiomyocytes promoted accumulation of p62 and aggresome formation, accompanied by the disappearance of autophagosomes. Mst1 phosphorylated the Thr108 residue in the BH3 domain of Beclin1, which enhanced the interaction between Beclin1 and Bcl-2 and/or Bcl-xL, stabilized the Beclin1 homodimer, inhibited the phosphatidylinositide 3-kinase activity of the Atg14L-Beclin1-Vps34 complex and suppressed autophagy. Furthermore, Mst1-induced sequestration of Bcl-2 and Bcl-xL by Beclin1 allows Bax to become active, thereby stimulating apoptosis. Mst1 promoted cardiac dysfunction in mice subjected to myocardial infarction by inhibiting autophagy, associated with increased levels of Thr108-phosphorylated Beclin1. Moreover, dilated cardiomyopathy in humans was associated with increased levels of Thr108-phosphorylated Beclin1 and signs of autophagic suppression. These results suggest that Mst1 coordinately regulates autophagy and apoptosis by phosphorylating Beclin1 and consequently modulating a three-way interaction among Bcl-2 proteins, Beclin1 and Bax.	[Maejima, Yasuhiro; Kyoi, Shiori; Zhai, Peiyong; Ivessa, Andreas; Sciarretta, Sebastiano; Del Re, Dominic P.; Zablocki, Daniela K.; Sadoshima, Junichi] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ USA; [Maejima, Yasuhiro; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Liu, Tong; Li, Hong] Rutgers New Jersey Med Sch, Ctr Adv Prote Res, Newark, NJ USA; [Liu, Tong; Li, Hong] Rutgers New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA; [Hsu, Chiao-Po] Natl Yang Ming Univ, Sch Med, Taipei Vet Gen Hosp, Div Cardiovasc Surg,Dept Surg, Taipei 112, Taiwan; [Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Creat Res Ctr Cell Div & Differentiat, Taejon 305701, South Korea	Rutgers State University New Brunswick; Rutgers State University Medical Center; Tokyo Medical & Dental University (TMDU); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Korea Advanced Institute of Science & Technology (KAIST)	Sadoshima, J (corresponding author), Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ USA.	sadoshju@njms.rutgers.edu	Lim, Dae-Sik/C-1599-2011; Maejima, Yasuhiro/AAG-5580-2020; Sciarretta, Sebastiano/K-5161-2016	Lim, Dae-Sik/0000-0003-2356-7555; Sadoshima, Junichi/0000-0003-3724-4132; Sciarretta, Sebastiano/0000-0002-8633-6896; Del Re, Dominic/0000-0002-5504-9114; Ivessa, Andreas/0000-0002-7578-1337; Li, Hong/0000-0001-5731-5335	US Public Health Service [HL59139, HL67724, HL69020, HL91469, HL102738, AG27211]; Foundation of Leducq Transatlantic Network of Excellence; American Heart Association [12SDG12070262]; Banyu Fellowship Program; Banyu Life Science Foundation International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059139, R01HL102738, R01HL091469, R01HL112330, R01HL067724, P01HL069020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211, R21AG042678, R01AG023039] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Foundation of Leducq Transatlantic Network of Excellence; American Heart Association(American Heart Association); Banyu Fellowship Program; Banyu Life Science Foundation International(Banyu Life Science Foundation International); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Brady for critical reading of the manuscript and Y. Ikeda, Y. Matsuda and N. Tamura for their excellent technical assistance. We also thank N. Mizushima (University of Tokyo) for Tg-GFP-LC3 mice, T. Yoshimori (Osaka University) for mRFP-GFP-LC3 plasmid, C. Kojima (Nara Institute of Science and Technology) for pCold-GST plasmid, M. Komatsu (Tokyo Metropolitan Institute of Medical Science) for Atg7<SUP>flox/flox</SUP> mice, R. Kitsis (Albert Einstein College of Medicine) for Bax<SUP>-/-</SUP>; Bak1<SUP>-/-</SUP> MEFs, and B. Levine (University of Texas Southwestern) for Becn1<SUP>+/-</SUP> mice. This work was supported in part by US Public Health Service grants HL59139, HL67724, HL69020, HL91469, HL102738 and AG27211, the Foundation of Leducq Transatlantic Network of Excellence (J.S.), American Heart Association Scientist Development Grant 12SDG12070262 and the Banyu Fellowship Program sponsored by Banyu Life Science Foundation International (Y.M.).	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gautreau A, 2003, J BIOL CHEM, V278, P6235, DOI 10.1074/jbc.M210639200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hariharan N, 2010, CIRC RES, V107, P1470, DOI 10.1161/CIRCRESAHA.110.227371; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Maejima Y, 2003, CARDIOVASC RES, V59, P308, DOI 10.1016/S0008-6363(03)00425-5; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Noble CG, 2008, J BIOL CHEM, V283, P26274, DOI 10.1074/jbc.M804723200; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; ROTE KV, 1983, J CELL PHYSIOL, V116, P103, DOI 10.1002/jcp.1041160116; Sciarretta S, 2012, CIRCULATION, V125, P1134, DOI 10.1161/CIRCULATIONAHA.111.078212; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shih H, 2011, J AM COLL CARDIOL, V57, P9, DOI 10.1016/j.jacc.2010.08.623; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	48	357	379	2	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1478	+		10.1038/nm.3322	http://dx.doi.org/10.1038/nm.3322			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24141421	Green Accepted			2022-12-27	WOS:000326920300025
J	Tam, WL; Weinberg, RA				Tam, Wai Leong; Weinberg, Robert A.			The epigenetics of epithelial-mesenchymal plasticity in cancer	NATURE MEDICINE			English	Review							HUMAN BREAST-CANCER; E-CADHERIN REPRESSION; HISTONE DEACETYLASE INHIBITION; SQUAMOUS-CELL CARCINOMA; STEM-CELLS; DNA METHYLATION; GROWTH-FACTOR; SELF-RENEWAL; BETA-CATENIN; TGF-BETA	During the course of malignant cancer progression, neoplastic cells undergo dynamic and reversible transitions between multiple phenotypic states, the extremes of which are defined by the expression of epithelial and mesenchymal phenotypes. This plasticity is enabled by underlying shifts in epigenetic regulation. A small cohort of pleiotropically acting transcription factors is widely recognized to effect these shifts by controlling the expression of a constituency of key target genes. These master regulators depend on complex epigenetic regulatory mechanisms, notably the induction of changes in the modifications of chromatin-associated histones, in order to achieve the widespread changes in gene expression observed during epithelial-mesenchymal transitions (EMTs). These associations indicate that an understanding of the functional interactions between such EMT-inducing transcription factors and the modulators of chromatin configuration will provide crucial insights into the fundamental mechanisms underlying cancer progression and may, in the longer term, generate new diagnostic and therapeutic modalities for treating high-grade malignancies.	[Tam, Wai Leong; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Tam, Wai Leong; Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Tam, Wai Leong/P-1497-2019	Tam, Wai Leong/0000-0003-2365-5264	US National Institutes of Health [P01 CA080111]; Breast Cancer Research Foundation; MIT Ludwig Center for Molecular Oncology; Cotswold Trust; NATIONAL CANCER INSTITUTE [P01CA080111] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; MIT Ludwig Center for Molecular Oncology; Cotswold Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J.A. Krall for helpful comments and T. DiCesare for illustrations. Research in the Weinberg laboratory is supported by grants from the US National Institutes of Health (P01 CA080111), the Breast Cancer Research Foundation, MIT Ludwig Center for Molecular Oncology and the Cotswold Trust. R.A.W. is an American Cancer Society and Ludwig Foundation professor. W.L.T. is supported by the MIT Ludwig Center for Molecular Oncology.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Arnoux V, 2008, MOL BIOL CELL, V19, P4738, DOI 10.1091/mbc.E07-10-1078; Bednarz-Knoll N, 2012, CANCER METAST REV, V31, P673, DOI 10.1007/s10555-012-9370-z; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bert SA, 2013, CANCER CELL, V23, P9, DOI 10.1016/j.ccr.2012.11.006; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Brabletz S, 2011, EMBO J, V30, P770, DOI 10.1038/emboj.2010.349; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Ceppi P, 2010, MOL CANCER RES, V8, P1207, DOI 10.1158/1541-7786.MCR-10-0052; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chao Y, 2012, CANCER MICROENVIRON, V5, P19, DOI 10.1007/s12307-011-0085-4; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Easwaran H, 2013, CANCER CELL, V23, P1, DOI 10.1016/j.ccr.2012.12.018; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Frisch SM, 1997, BIOESSAYS, V19, P705, DOI 10.1002/bies.950190811; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gao MQ, 2010, J CELL SCI, V123, P3507, DOI 10.1242/jcs.072900; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gilles C, 2003, CANCER RES, V63, P2658; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Jiang GM, 2013, BBA-MOL CELL RES, V1833, P663, DOI 10.1016/j.bbamcr.2012.12.002; Kaimori A, 2010, HEPATOLOGY, V52, P1033, DOI 10.1002/hep.23765; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Kong DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045045; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Lei WW, 2010, INT J BIOCHEM CELL B, V42, P1489, DOI 10.1016/j.biocel.2010.05.006; Lengauer C, 2003, SCIENCE, V300, P442, DOI 10.1126/science.1084468; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim S, 2010, CARCINOGENESIS, V31, P512, DOI 10.1093/carcin/bgp324; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin A, 2010, NAT CELL BIOL, V12, P924, DOI 10.1038/ncb1010-924; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; McDonald OG, 2011, NAT STRUCT MOL BIOL, V18, P867, DOI 10.1038/nsmb.2084; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morel AP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002723; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Neves Rui, 2010, BMC Res Notes, V3, P219, DOI 10.1186/1756-0500-3-219; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Petti MC, 2002, BLOOD, V100, P1065, DOI 10.1182/blood-2001-12-0368; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Puppe J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2354; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shaker S, 2003, LEUKEMIA RES, V27, P437, DOI 10.1016/S0145-2126(02)00222-9; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Taketo MM, 2004, NAT GENET, V36, P320, DOI 10.1038/ng0404-320; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; TRELSTAD RL, 1967, DEV BIOL, V16, P78, DOI 10.1016/0012-1606(67)90018-8; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VALLES AM, 1990, P NATL ACAD SCI USA, V87, P1124, DOI 10.1073/pnas.87.3.1124; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wang ZW, 2013, J CELL PHYSIOL, V228, P556, DOI 10.1002/jcp.24162; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Yang AS, 2003, SCIENCE, V302; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	169	855	878	4	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1438	1449		10.1038/nm.3336	http://dx.doi.org/10.1038/nm.3336			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202396	Green Accepted, Green Published			2022-12-27	WOS:000326920300021
J	Harms, M; Seale, P				Harms, Matthew; Seale, Patrick			Brown and beige fat: development, function and therapeutic potential	NATURE MEDICINE			English	Review							ACTIVATED-RECEPTOR-GAMMA; WHITE ADIPOSE-TISSUE; ENDOTHELIAL GROWTH-FACTOR; DIET-INDUCED OBESITY; MITOCHONDRIAL UNCOUPLING PROTEIN; IMPROVES INSULIN SENSITIVITY; MICE LACKING; ENERGY-EXPENDITURE; GENE-EXPRESSION; PPAR-GAMMA	Adipose tissue, best known for its role in fat storage, can also suppress weight gain and metabolic disease through the action of specialized, heat-producing adipocytes. Brown adipocytes are located in dedicated depots and express constitutively high levels of thermogenic genes, whereas inducible 'brown-like' adipocytes, also known as beige cells, develop in white fat in response to various activators. The activities of brown and beige fat cells reduce metabolic disease, including obesity, in mice and correlate with leanness in humans. Many genes and pathways that regulate brown and beige adipocyte biology have now been identified, providing a variety of promising therapeutic targets for metabolic disease.	[Harms, Matthew; Seale, Patrick] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Seale, P (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.	sealep@upenn.edu			National Institute of General Medicine Sciences, US National Institutes of Health [DP2OD007288]; Searle Scholars Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007288] Funding Source: NIH RePORTER	National Institute of General Medicine Sciences, US National Institutes of Health; Searle Scholars Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Because of space limitations, we respectfully note that we were unable to comprehensively cite many worthy contributions to the field. We would like to thank members of the Seale lab for helpful comments and discussion. This work is supported by National Institute of General Medicine Sciences, US National Institutes of Health award DP2OD007288 and a Searle Scholars Award to P.S.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Armengol J, 2012, BIOCHEM J, V443, P799, DOI 10.1042/BJ20111714; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; Auffret J, 2012, FASEB J, V26, P3728, DOI 10.1096/fj.12-204958; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Bakopanos E, 2000, DIABETES, V49, P2108, DOI 10.2337/diabetes.49.12.2108; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bale TL, 2003, ENDOCRINOLOGY, V144, P2580, DOI 10.1210/en.2002-0091; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Bjursell M, 2011, AM J PHYSIOL-ENDOC M, V300, pE211, DOI 10.1152/ajpendo.00229.2010; Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Buemann B, 2000, INT J OBESITY, V24, P1553, DOI 10.1038/sj.ijo.0801452; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; Cai LM, 2010, MED CARE, V48, P510, DOI 10.1097/MLR.0b013e3181dbdb20; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chainani-Wu N, 2010, AM J CARDIOL, V105, P1570, DOI 10.1016/j.amjcard.2010.01.016; Chang L, 2012, CIRCULATION, V126, P1067, DOI 10.1161/CIRCULATIONAHA.112.104489; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; COUSIN B, 1992, J CELL SCI, V103, P931; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Czyzyk TA, 2012, FASEB J, V26, P3483, DOI 10.1096/fj.12-208041; Dahle MK, 2002, J BIOL CHEM, V277, P22902, DOI 10.1074/jbc.M200131200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; DESAUTELS M, 1986, BIOCHEM CELL BIOL, V64, P1125, DOI 10.1139/o86-148; Digby JE, 1998, DIABETES, V47, P138, DOI 10.2337/diabetes.47.1.138; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; FOSTER DO, 1978, CAN J PHYSIOL PHARM, V56, P110, DOI 10.1139/y78-015; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSOTT.S7384, 10.2147/DMSO.S7384]; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; HEATON JM, 1972, J ANAT, V112, P35; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Huang W, 2012, J LIPID RES, V53, P368, DOI 10.1194/jlr.M019687; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Jastroch M, 2012, BBA-BIOENERGETICS, V1817, P1660, DOI 10.1016/j.bbabio.2012.05.014; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kang HW, 2009, J LIPID RES, V50, P2212, DOI 10.1194/jlr.M900013-JLR200; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kim JK, 2005, DIABETES, V54, P1657, DOI 10.2337/diabetes.54.6.1657; KLAUS S, 1995, J CELL SCI, V108, P3171; Kleiner S, 2012, P NATL ACAD SCI USA, V109, P9635, DOI 10.1073/pnas.1207287109; Koncarevic A, 2012, ENDOCRINOLOGY, V153, P3133, DOI 10.1210/en.2012-1016; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lee P, 2011, J CLIN ENDOCR METAB, V96, P2450, DOI 10.1210/jc.2011-0487; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2013, NAT MED, V19, P631, DOI 10.1038/nm.3017; Lidell ME, 2011, DIABETES, V60, P427, DOI 10.2337/db10-0409; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Liu WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003626; Liu WZ, 2012, J BIOL CHEM, V287, P7213, DOI 10.1074/jbc.M111.286724; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lu XD, 2012, ENDOCRINOLOGY, V153, P3123, DOI 10.1210/en.2012-1151; MA SWY, 1988, CAN J PHYSIOL PHARM, V66, P1347, DOI 10.1139/y88-221; Meakin PJ, 2012, BIOCHEM J, V441, P285, DOI 10.1042/BJ20110512; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Mori M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001314; Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Pan DN, 2009, CELL, V137, P73, DOI 10.1016/j.cell.2009.01.051; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Perwitz N, 2010, DIABETES OBES METAB, V12, P158, DOI 10.1111/j.1463-1326.2009.01133.x; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Ricquier D, 2012, FRONT ENDOCRINOL, V2, P85; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Satyanarayana A, 2012, FASEB J, V26, P309, DOI 10.1096/fj.11-190892; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Sell H, 2004, ENDOCRINOLOGY, V145, P3925, DOI 10.1210/en.2004-0321; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P773, DOI 10.1016/j.bbabio.2010.04.007; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Siersbaek MS, 2012, MOL CELL BIOL, V32, P3452, DOI 10.1128/MCB.00526-12; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Stefl B, 1998, AM J PHYSIOL-ENDOC M, V274, pE527, DOI 10.1152/ajpendo.1998.274.3.E527; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Tai TAC, 1996, J BIOL CHEM, V271, P29909, DOI 10.1074/jbc.271.47.29909; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Tonello C, 1999, FEBS LETT, V442, P167, DOI 10.1016/S0014-5793(98)01627-5; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Vila-Bedmar R, 2012, FASEB J, V26, P3503, DOI 10.1096/fj.11-202267; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang H, 2008, MOL CELL BIOL, V28, P2187, DOI 10.1128/MCB.01479-07; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Watson Elizabeth, 2009, BMC Physiology, V9, P19, DOI 10.1186/1472-6793-9-19; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wulf A, 2008, MOL CELL ENDOCRINOL, V287, P90, DOI 10.1016/j.mce.2008.01.017; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue Y, 2008, P NATL ACAD SCI USA, V105, P10167, DOI 10.1073/pnas.0802486105; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Yu XX, 2008, AM J PHYSIOL-ENDOC M, V294, pE530, DOI 10.1152/ajpendo.00350.2007; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4; Zhang W, 2010, J PHYSIOL-LONDON, V588, P4117, DOI 10.1113/jphysiol.2010.195099; Zhang YZ, 2012, P NATL ACAD SCI USA, V109, P5417, DOI 10.1073/pnas.1116011109; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	188	1475	1557	20	360	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1252	1263		10.1038/nm.3361	http://dx.doi.org/10.1038/nm.3361			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100998	Bronze			2022-12-27	WOS:000325531700024
J	Torisu, T; Torisu, K; Lee, IH; Liu, J; Malide, D; Combs, CA; Wu, XFS; Rovira, II; Fergusson, MM; Weigert, R; Connelly, PS; Daniels, MP; Komatsu, M; Cao, L; Finkel, T				Torisu, Takehiro; Torisu, Kumiko; Lee, In Hye; Liu, Jie; Malide, Daniela; Combs, Christian A.; Wu, Xufeng S.; Rovira, Ilsa I.; Fergusson, Maria M.; Weigert, Roberto; Connelly, Patricia S.; Daniels, Mathew P.; Komatsu, Masaaki; Cao, Liu; Finkel, Toren			Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor	NATURE MEDICINE			English	Article							WEIBEL-PALADE BODIES; UNCONVENTIONAL SECRETION; VONWILLEBRAND-FACTOR; GENE ATG16L1; MICE; DISEASE; PROTEIN; MOUSE; ANGIOGENESIS; BIOGENESIS	Endothelial secretion of von Willebrand factor (VWF) from intracellular organelles known as Weibel-Palade bodies (WPBs) is required for platelet adhesion to the injured vessel wall. Here we demonstrate that WPBs are often found near or within autophagosomes and that endothelial autophagosomes contain abundant VWF protein. Pharmacological inhibitors of autophagy or knockdown of the essential autophagy genes Atg5 or Atg7 inhibits the in vitro secretion of VWF. Furthermore, although mice with endothelial-specific deletion of Atg7 have normal vessel architecture and capillary density, they exhibit impaired epinephrine-stimulated VWF release, reduced levels of high-molecular weight VWF multimers and a corresponding prolongation of bleeding times. Endothelial-specific deletion of Atg5 or pharmacological inhibition of autophagic flux results in a similar in vivo alteration of hemostasis. Thus, autophagy regulates endothelial VWF secretion, and transient pharmacological inhibition of autophagic flux may be a useful strategy to prevent thrombotic events.	[Torisu, Takehiro; Torisu, Kumiko; Lee, In Hye; Liu, Jie; Rovira, Ilsa I.; Fergusson, Maria M.; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Malide, Daniela; Combs, Christian A.] NHLBI, Light Microscopy Core, NIH, Bethesda, MD 20892 USA; [Wu, Xufeng S.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Weigert, Roberto] Natl Inst Dent & Craniofacial Res, Intracellular Membrane Trafficking Unit, NIH, Bethesda, MD USA; [Connelly, Patricia S.; Daniels, Mathew P.] NHLBI, Electron Microscopy Core Facil, NIH, Bethesda, MD 20892 USA; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Tokyo 113, Japan; [Cao, Liu] China Med Univ, Key Lab Med Cell Biol, Shenyang, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Tokyo Metropolitan Institute of Medical Science; China Medical University	Finkel, T (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov	Komatsu, Masaaki/B-8321-2011; LEE, IN HYE/T-2714-2019; Torisu, Kumiko/ABE-7626-2021	Komatsu, Masaaki/0000-0001-7672-7722; LEE, IN HYE/0000-0003-2334-3594; 	NIH Intramural Funds; Japan Society for the Promotion of Science Research Fellowship in Biomedical and Behavioral Research at the NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZICHL006019, ZICHL005906, ZIAHL005012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000717] Funding Source: NIH RePORTER	NIH Intramural Funds; Japan Society for the Promotion of Science Research Fellowship in Biomedical and Behavioral Research at the NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to S. Gutkind (NIH) for help with primary endothelial cell isolation, T. Carter for the gift of the VWF monomeric GFP plasmid (VWF-mGFP), J. Lippincott-Schwartz (NIH) for the LC3-mCherry plasmid and Y. Fitz (NIH) for help with coagulation measurements. We thank B. Zinselmeyer (NIH) for assistance with the spot cluster analysis and C. A. Brantner (NIH) for help performing cryo-immunogold electron microscopy. This work was supported by NIH Intramural Funds. T.T. is a recipient of a Japan Society for the Promotion of Science Research Fellowship in Biomedical and Behavioral Research at the NIH.	Abrahamsen H, 2010, CURR BIOL, V20, pR415, DOI 10.1016/j.cub.2010.03.011; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Babich V, 2008, BLOOD, V111, P5282, DOI 10.1182/blood-2007-09-113746; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Denis CV, 2001, P NATL ACAD SCI USA, V98, P4072, DOI 10.1073/pnas.061307098; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Enayat MS, 1999, METH MOLEC MED, V31, P187, DOI 10.1385/1-59259-248-1:187; Erent A, 2007, J PHYSIOL-LONDON, V583, P195, DOI 10.1113/jphysiol.2007.132993; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Haberichter SL, 2005, BLOOD, V105, P145, DOI 10.1182/blood-2004-02-0464; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jia W, 2011, J IMMUNOL, V186, P1564, DOI 10.4049/jimmunol.1001822; JOHNSON R, 1979, CLIN ORTHOP RELAT R, P174; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanaji S, 2012, J THROMB HAEMOST, V10, P1646, DOI 10.1111/j.1538-7836.2012.04797.x; Kim JH, 2010, AUTOPHAGY, V6, P922, DOI [10.4161/auto.6.7.13306, 10.4161/auto.6.8.13306]; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Lee SJ, 2011, AUTOPHAGY, V7, P829, DOI 10.4161/auto.7.8.15598; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Metcalf DJ, 2008, J CELL SCI, V121, P19, DOI 10.1242/jcs.03494; Michaux G, 2006, DEV CELL, V10, P223, DOI 10.1016/j.devcel.2005.12.012; Mijaljica D, 2006, TRAFFIC, V7, P1590, DOI 10.1111/j.1600-0854.2006.00495.x; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Pallet N, 2013, PROTEOMICS, V13, P1108, DOI 10.1002/pmic.201200531; Pfeffer SR, 2010, J CELL BIOL, V188, P451, DOI 10.1083/jcb.201001121; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; RODEGHIERO F, 1987, BLOOD, V69, P454; Sirois I, 2012, AUTOPHAGY, V8, P927, DOI 10.4161/auto.19768; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; Ushio H, 2011, J ALLERGY CLIN IMMUN, V127, P1267, DOI 10.1016/j.jaci.2010.12.1078; Valentijn KM, 2011, BLOOD, V117, P5033, DOI 10.1182/blood-2010-09-267492; VOORBERG J, 1993, EMBO J, V12, P749, DOI 10.1002/j.1460-2075.1993.tb05709.x; WAGNER DD, 1986, J CELL BIOL, V102, P1320, DOI 10.1083/jcb.102.4.1320; WAGNER DD, 1985, J CELL BIOL, V101, P112, DOI 10.1083/jcb.101.1.112; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Zenner HL, 2007, J CELL SCI, V120, P2117, DOI 10.1242/jcs.007781; Zhao BQ, 2009, BLOOD, V114, P3329, DOI 10.1182/blood-2009-03-213264; Zhou YF, 2011, EMBO J, V30, P4098, DOI 10.1038/emboj.2011.297; Zinselmeyer BH, 2009, METHOD ENZYMOL, V461, P349, DOI 10.1016/S0076-6879(09)05416-0	57	169	176	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1281	+		10.1038/nm.3288	http://dx.doi.org/10.1038/nm.3288			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24056772	Green Accepted			2022-12-27	WOS:000325531700027
J	Liu, YJ; Wang, LQ; Predina, J; Han, RX; Beier, UH; Wang, LCS; Kapoor, V; Bhatti, TR; Akimova, T; Singhal, S; Brindle, PK; Cole, PA; Albelda, SM; Hancock, WW				Liu, Yujie; Wang, Liqing; Predina, Jarrod; Han, Rongxiang; Beier, Ulf H.; Wang, Liang-Chuan S.; Kapoor, Veena; Bhatti, Tricia R.; Akimova, Tatiana; Singhal, Sunil; Brindle, Paul K.; Cole, Philip A.; Albelda, Steven M.; Hancock, Wayne W.			Inhibition of p300 impairs Foxp3(+) T regulatory cell function and promotes antitumor immunity	NATURE MEDICINE			English	Article							EXPRESSION	Forkhead box P3 (Foxp3)(+) T regulatory (T-reg) cells maintain immune homeostasis and limit autoimmunity but can also curtail host immune responses to various types of tumors(1,2). Foxp3(+) T-reg cells are therefore considered promising targets to enhance antitumor immunity, and approaches for their therapeutic modulation are being developed. However, although studies showing that experimentally depleting Foxp3(+) T-reg cells can enhance antitumor responses provide proof of principle, these studies lack clear translational potential and have various shortcomings. Histone/protein acetyltransferases (HATs) promote chromatin accessibility, gene transcription and the function of multiple transcription factors and nonhistone proteins(3,4). We now report that conditional deletion or pharmacologic inhibition of one HAT, p300 (also known as Ep300 or KAT3B), in Foxp3(+) T-reg cells increased T cell receptor induced apoptosis in T-reg cells, impaired T-reg cell suppressive function and peripheral T-reg cell induction, and limited tumor growth in immunocompetent but not in immunodeficient mice. Our data thereby demonstrate that p300 is important for Foxp3(+) T-reg cell function and homeostasis in vivo and in vitro, and identify mechanisms by which appropriate small-molecule inhibitors can diminish T-reg cell function without overtly impairing T effector cell responses or inducing autoimmunity. Collectively, these data suggest a new approach for cancer immunotherapy.	[Liu, Yujie; Wang, Liqing; Han, Rongxiang; Bhatti, Tricia R.; Akimova, Tatiana; Hancock, Wayne W.] Univ Penn, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA; [Liu, Yujie; Wang, Liqing; Han, Rongxiang; Bhatti, Tricia R.; Akimova, Tatiana; Hancock, Wayne W.] Univ Penn, Childrens Hosp Philadelphia, Biesecker Ctr Study Pediat Liver Dis, Philadelphia, PA 19104 USA; [Liu, Yujie; Wang, Liqing; Han, Rongxiang; Beier, Ulf H.; Bhatti, Tricia R.; Akimova, Tatiana; Hancock, Wayne W.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Predina, Jarrod; Singhal, Sunil] Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA; [Beier, Ulf H.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Div Nephrol, Philadelphia, PA 19104 USA; [Wang, Liang-Chuan S.; Kapoor, Veena; Albelda, Steven M.] Univ Penn, Pulm Allergy & Crit Care Div, Perelman Sch Med, Philadelphia, PA 19104 USA; [Brindle, Paul K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Cole, Philip A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; St Jude Children's Research Hospital; Johns Hopkins University	Hancock, WW (corresponding author), Univ Penn, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA.	whancock@mail.med.upenn.edu		Akimova, Tatiana/0000-0003-2767-8762; Beier, Ulf/0000-0002-3672-572X; Brindle, Paul/0000-0001-7172-8478	US National Institutes of Health [K08AI095353, P01AI073489, 1R01CA158941]; NATIONAL CANCER INSTITUTE [R01CA158941, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI095353, P01AI073489] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Verdin (Gladstone Institute of Virology and Immunology, University of California-San Francisco) for antibody to acetylated Foxp3; X.-J. Yang (Department of Medicine, McGill University) for p300 expression vector; Y. Paterson (Department of Microbiology, University of Pennsylvania) for TC1 cell lines; and D. Nelson (Department of Medicine, University of Western Australia) for the AE17.OVA mesothelioma cell line. This work was supported by grants from the US National Institutes of Health (K08AI095353 to U.H.B. and P01AI073489 and 1R01CA158941 to W.W.H.).	Anz D, 2011, INT J CANCER, V129, P2417, DOI 10.1002/ijc.25902; Beier UH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002873; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Zoeten EF, 2011, MOL CELL BIOL, V31, P2066, DOI 10.1128/MCB.05155-11; Dranoff G, 2005, J CLIN ONCOL, V23, P662, DOI 10.1200/JCO.2005.09.923; Fietta AM, 2009, HUM IMMUNOL, V70, P477, DOI 10.1016/j.humimm.2009.03.012; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Liu YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029035; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Powell DJ, 2007, J IMMUNOL, V179, P4919, DOI 10.4049/jimmunol.179.7.4919; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Ye OR, 2004, EUR J IMMUNOL, V34, P2750, DOI 10.1002/eji.200425198; Zhou G, 2007, J IMMUNOL, V178, P2155, DOI 10.4049/jimmunol.178.4.2155; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	26	141	154	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1173	1177		10.1038/nm.3286	http://dx.doi.org/10.1038/nm.3286			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23955711	Green Accepted			2022-12-27	WOS:000324083500034
J	Noti, M; Wojno, EDT; Kim, BS; Siracusa, MC; Giacomin, PR; Nair, MG; Benitez, AJ; Ruymann, KR; Muir, AB; Hill, DA; Chikwava, KR; Moghaddam, AE; Sattentau, QJ; Alex, A; Zhou, C; Yearley, JH; Menard-Katcher, P; Kubo, M; Obata-Ninomiya, K; Karasuyama, H; Comeau, MR; Brown-Whitehorn, T; Malefyt, RDW; Sleiman, PM; Hakonarson, H; Cianferoni, A; Falk, GW; Wang, ML; Spergel, JM; Artis, D				Noti, Mario; Wojno, Elia D. Tait; Kim, Brian S.; Siracusa, Mark C.; Giacomin, Paul R.; Nair, Meera G.; Benitez, Alain J.; Ruymann, Kathryn R.; Muir, Amanda B.; Hill, David A.; Chikwava, Kudakwashe R.; Moghaddam, Amin E.; Sattentau, Quentin J.; Alex, Aneesh; Zhou, Chao; Yearley, Jennifer H.; Menard-Katcher, Paul; Kubo, Masato; Obata-Ninomiya, Kazushige; Karasuyama, Hajime; Comeau, Michael R.; Brown-Whitehorn, Terri; Malefyt, Rene De Waal; Sleiman, Patrick M.; Hakonarson, Hakon; Cianferoni, Antonella; Falk, Gary W.; Wang, Mei-Lun; Spergel, Jonathan M.; Artis, David			Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis	NATURE MEDICINE			English	Article							CYTOKINE EXPRESSION; ATOPIC-DERMATITIS; CHILDREN; FOOD; ASTHMA; CELLS; TSLP; KERATINOCYTES; VARIANTS; ADULT	Eosinophilic esophagitis (EoE) is a food allergy-associated inflammatory disease characterized by esophageal eosinophilia. Current management strategies for EoE are nonspecific, and thus there is a need to identify specific immunological pathways that could be targeted to treat this disease. EoE is associated with polymorphisms in the gene that encodes thymic stromal lymphopoietin (TSLP), a cytokine that promotes allergic inflammation, but how TSLP might contribute to EoE disease pathogenesis has been unclear. Here, we describe a new mouse model of EoE-like disease that developed independently of IgE, but was dependent on TSLP and basophils, as targeting TSLP or basophils during the sensitization phase limited disease. Notably, therapeutic TSLP neutralization or basophil depletion also ameliorated established EoE-like disease. In human subjects with EoE, we observed elevated TSLP expression and exaggerated basophil responses in esophageal biopsies, and a gain-of-function TSLP polymorphism was associated with increased basophil responses in patients with EoE. Together, these data suggest that the TSLP-basophil axis contributes to the pathogenesis of EoE and could be therapeutically targeted to treat this disease.	[Noti, Mario; Wojno, Elia D. Tait; Kim, Brian S.; Siracusa, Mark C.; Giacomin, Paul R.; Nair, Meera G.; Hill, David A.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Noti, Mario; Wojno, Elia D. Tait; Kim, Brian S.; Siracusa, Mark C.; Giacomin, Paul R.; Nair, Meera G.; Hill, David A.; Spergel, Jonathan M.; Artis, David] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Kim, Brian S.] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Giacomin, Paul R.] James Cook Univ, Queensland Trop Hlth Alliance, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Qld, Australia; [Nair, Meera G.] Univ Calif Riverside, Div Biomed Sci, Sch Med, Riverside, CA 92521 USA; [Benitez, Alain J.; Muir, Amanda B.; Wang, Mei-Lun] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Ruymann, Kathryn R.; Hill, David A.; Brown-Whitehorn, Terri; Cianferoni, Antonella; Spergel, Jonathan M.] Childrens Hosp Philadelphia, Dept Pediat, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Chikwava, Kudakwashe R.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Moghaddam, Amin E.; Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Alex, Aneesh; Zhou, Chao] Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA; [Alex, Aneesh; Zhou, Chao] Lehigh Univ, Ctr Photon & Nanoelect, Bethlehem, PA 18015 USA; [Alex, Aneesh; Zhou, Chao] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA; [Yearley, Jennifer H.] Merck Res Labs, Dept Pathol, Palo Alto, CA USA; [Menard-Katcher, Paul; Falk, Gary W.] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Kubo, Masato] RIKEN, Yokohama Inst, Res Ctr Integrat Med Sci, Lab Cytokine Regulat, Yokohama, Kanagawa, Japan; [Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Pathol, Chiba, Japan; [Obata-Ninomiya, Kazushige; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch, Dept Immune Regulat, Tokyo, Japan; [Obata-Ninomiya, Kazushige; Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch, Core Res Evolutionary Sci & Technol, Japan Sci & Technol Agcy, Tokyo, Japan; [Comeau, Michael R.] Amgen Inc, Inflammat Res, Seattle, WA USA; [Malefyt, Rene De Waal] Merck Res Labs, Therapeut Area Biol & Pharmacol, Palo Alto, CA USA; [Sleiman, Patrick M.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Sleiman, Patrick M.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Abramson Res Ctr, Div Human Genet, Philadelphia, PA 19104 USA; [Sleiman, Patrick M.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Falk, Gary W.; Wang, Mei-Lun; Spergel, Jonathan M.; Artis, David] Univ Penn, Perelman Sch Med, Joint Penn Childrens Hosp Philadelphia Ctr Digest, Philadelphia, PA 19104 USA; [Falk, Gary W.; Wang, Mei-Lun; Spergel, Jonathan M.; Artis, David] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Falk, Gary W.; Wang, Mei-Lun; Spergel, Jonathan M.; Artis, David] Univ Penn, Dept Med, Perelman Sch Med, Ctr Mol Studies Digest & Liver Dis,Div Gastroente, Philadelphia, PA 19104 USA; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; James Cook University; University of California System; University of California Riverside; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Oxford; Lehigh University; Lehigh University; Lehigh University; Merck & Company; University of Pennsylvania; Pennsylvania Medicine; RIKEN; Tokyo University of Science; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Amgen; Merck & Company; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Artis, D (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Zhou, Chao/A-1327-2007; Noti, Mario/I-6581-2019; Moghaddam, Amin/N-2300-2014; Kim, Brian/GZK-6649-2022; Kubo, Masato/A-5918-2016; Karasuyama, Hajime/A-7966-2011	Noti, Mario/0000-0001-9386-1245; Moghaddam, Amin/0000-0001-8668-1609; Kim, Brian/0000-0002-8100-7161; Karasuyama, Hajime/0000-0003-0689-0836; Zhou, Chao/0000-0002-8679-3413; Giacomin, Paul/0000-0002-6326-6792; Falk, Gary/0000-0002-7143-1436; Tait Wojno, Elia/0000-0003-2822-296X; Obata-Ninomiya, Kazushige/0000-0002-0984-6518; Spergel, Jonathan/0000-0002-4658-5353; Hill, David/0000-0001-9286-4268; de Waal Malefyt, Rene/0000-0002-2663-383X; Nair, Meera/0000-0002-1807-5161; Artis, David/0000-0002-1753-4100	US National Institutes of Health [AI061570, AI087990, AI074878, AI095776, AI102942, AI095466, AI09560, AI097333, T32-AI060516, F32-AI098365, T32-AR007465, KL2-RR024132, F32-AI085828, AI091759, K08-AI089982, R00EB010071]; Swiss National Science Foundation Prospective and Advanced Research Fellowships [PBBEP3_130438, PA00P3_136468]; Australian National Health and Medical Research Council Overseas Biomedical Fellowship [613718]; State of Pennsylvania [SAP 4100042728]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Crohn's and Colitis Foundation of America; US National Institutes of Health/US National Institute of Diabetes and Digestive and Kidney Diseases P30 Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; Joint Penn-Children's Hospital of Philadelphia Center in Digestive, Liver and Pancreatic Medicine; US National Cancer Institute Comprehensive Cancer Center [P30-CA016520]; Skin Disease Research Center [P30-AR057217]; Electron Microscopy Resource Laboratory; Children's Hospital of Philadelphia Institutional Development Fund; US Department of Defense [A-16809.2]; Abbot Nutrition [ANUS1013]; Lehigh University start-up fund; Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (from the US National Center for Research Resources) [UL1-RR024134]; Ruiz at eBioscience for samples of flow cytometry reagents for human basophil panel development; MRC [G0000635] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, KL2RR024132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087990, R01AI074878, R01AI102942, R01AI061570, U01AI095608, R01AI091759, K08AI089982, R01AI095466, T32AI060516, F32AI098365, U01AI095776, F32AI085828, R01AI097333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007465, P30AR057217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R00EB010071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087789, F32DK100088, P30DK050306] Funding Source: NIH RePORTER; Medical Research Council [G0000635] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation Prospective and Advanced Research Fellowships; Australian National Health and Medical Research Council Overseas Biomedical Fellowship(National Health and Medical Research Council (NHMRC) of Australia); State of Pennsylvania; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Crohn's and Colitis Foundation of America; US National Institutes of Health/US National Institute of Diabetes and Digestive and Kidney Diseases P30 Center for Molecular Studies in Digestive and Liver Diseases; Joint Penn-Children's Hospital of Philadelphia Center in Digestive, Liver and Pancreatic Medicine; US National Cancer Institute Comprehensive Cancer Center; Skin Disease Research Center; Electron Microscopy Resource Laboratory; Children's Hospital of Philadelphia Institutional Development Fund; US Department of Defense(United States Department of Defense); Abbot Nutrition; Lehigh University start-up fund; Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (from the US National Center for Research Resources); Ruiz at eBioscience for samples of flow cytometry reagents for human basophil panel development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Artis laboratory for discussions and critical reading of the manuscript. Research in the Artis lab is supported by the US National Institutes of Health (AI061570, AI087990, AI074878, AI095776, AI102942, AI095466, AI09560 and AI097333 to D.A.), the Swiss National Science Foundation Prospective and Advanced Research Fellowships (PBBEP3_130438 and PA00P3_136468 to M.N.), the US National Institutes of Health (T32-AI060516 and F32-AI098365 to E.D.T.W., T32-AR007465 and KL2-RR024132 to B.S.K., F32-AI085828 to M.C.S., AI091759 to M.G.N. and K08-AI089982 to A.C.), the Australian National Health and Medical Research Council Overseas Biomedical Fellowship (613718 to P.R.G.), the State of Pennsylvania (SAP 4100042728 to P.M.S. and H. H.), the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D.A.) and the Crohn's and Colitis Foundation of America (D.A.). This work was supported by the US National Institutes of Health/US National Institute of Diabetes and Digestive and Kidney Diseases P30 Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306), its pilot grant program and scientific core facilities (Molecular Pathology and Imaging, Molecular Biology, Cell Culture and Mouse) and the Joint Penn-Children's Hospital of Philadelphia Center in Digestive, Liver and Pancreatic Medicine and its pilot grant program. We also thank the Matthew J. Ryan Veterinary Hospital Pathology Lab and the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory (partially supported by US National Cancer Institute Comprehensive Cancer Center Support Grant (P30-CA016520)), the Skin Disease Research Center (supported by P30-AR057217) and the Electron Microscopy Resource Laboratory for technical advice and support. J.M.S. and K.R.R. acknowledge support from The Children's Hospital of Philadelphia Institutional Development Fund, and J.M.S. also acknowledges support from the US Department of Defense (A-16809.2). Human tissue samples were obtained by M.-L.W. and A.J.B., funded by Abbot Nutrition (ANUS1013). Research in the Zhou lab is supported by the US National Institutes of Health (R00EB010071) and the Lehigh University start-up fund. The studies described here were supported in part by the Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (UL1-RR024134 from the US National Center for Research Resources). The authors also wish to thank P. Just and N. Ruiz at eBioscience for samples of flow cytometry reagents for human basophil panel development, support and invaluable technical advice. CD200R3-specific mAb (clone Ba103) was provided by H. Karasuyama (Tokyo Medical and Dental University Graduate School). The content is solely the responsibility of the authors and does not represent the official views of the US National Center for Research Resources or the US National Institutes of Health.	Abonia JP, 2012, ANNU REV MED, V63, P421, DOI 10.1146/annurev-med-041610-134138; Bhattacharya B, 2007, HUM PATHOL, V38, P1744, DOI 10.1016/j.humpath.2007.05.008; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Blatman KSH, 2011, J ALLERGY CLIN IMMUN, V127, P1307, DOI 10.1016/j.jaci.2010.12.1118; Brown-Whitehorn TF, 2010, EXPERT REV CLIN IMMU, V6, P101, DOI [10.1586/eci.09.74, 10.1586/ECI.09.74]; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; DeBrosse CW, 2011, J ALLERGY CLIN IMMUN, V128, P132, DOI 10.1016/j.jaci.2011.05.006; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Foroughi S, 2007, J ALLERGY CLIN IMMUN, V120, P594, DOI 10.1016/j.jaci.2007.06.015; Giacomin PR, 2012, J IMMUNOL, V189, P4371, DOI 10.4049/jimmunol.1200691; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hsieh KY, 2003, CLIN EXP ALLERGY, V33, P1067, DOI 10.1046/j.1365-2222.2003.01724.x; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hunninghake GM, 2010, ALLERGY, V65, P1566, DOI 10.1111/j.1398-9995.2010.02415.x; Jessup HK, 2008, J IMMUNOL, V181, P4311, DOI 10.4049/jimmunol.181.6.4311; Justinich CJ, 1997, J PEDIATR GASTR NUTR, V25, P194, DOI 10.1097/00005176-199708000-00011; Kapel RC, 2008, GASTROENTEROLOGY, V134, P1316, DOI 10.1053/j.gastro.2008.02.016; Lack G, 2012, J ALLERGY CLIN IMMUN, V129, P1187, DOI 10.1016/j.jaci.2012.02.036; Li M, 2006, P NATL ACAD SCI USA, V103, P11736, DOI 10.1073/pnas.0604575103; Li M, 2009, J INVEST DERMATOL, V129, P498, DOI 10.1038/jid.2008.232; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Liu ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025099; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lucendo AJ, 2007, AM J SURG PATHOL, V31, P598, DOI 10.1097/01.pas.0000213392.49698.8c; Markowitz JE, 2003, AM J GASTROENTEROL, V98, P777, DOI 10.1111/j.1572-0241.2003.07390.x; Mavi P, 2012, AM J PHYSIOL-GASTR L, V302, pG1347, DOI 10.1152/ajpgi.00013.2012; Mishra A, 2003, GASTROENTEROLOGY, V125, P1419, DOI 10.1016/j.gastro.2003.07.007; Mishra A, 2002, J IMMUNOL, V168, P2464, DOI 10.4049/jimmunol.168.5.2464; Mishra A, 2007, J LEUKOCYTE BIOL, V81, P916, DOI 10.1189/jlb.1106653; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Mulder DJ, 2010, GUT, V59, P6, DOI 10.1136/gut.2009.189316; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Rajavelu P, 2012, AM J PHYSIOL-GASTR L, V302, pG645, DOI 10.1152/ajpgi.00223.2011; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Renz H, 2011, NAT IMMUNOL, V12, P273, DOI 10.1038/ni0411-273; Rocha R, 2011, EUR J PEDIATR, V170, P1471, DOI 10.1007/s00431-011-1540-4; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Sampson HA, 2011, J ALLERGY CLIN IMMUN, V127, P1309, DOI 10.1016/j.jaci.2011.01.051; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Siracusa MC, 2012, ADV IMMUNOL, V115, P141, DOI 10.1016/B978-0-12-394299-9.00005-9; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spergel JM, 2007, CURR OPIN ALLERGY CL, V7, P274, DOI 10.1097/ACI.0b013e32813aee4a; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V129, P456, DOI 10.1016/j.jaci.2011.11.044; Stone KD, 2008, CLIN EXP ALLERGY, V38, P1858, DOI 10.1111/j.1365-2222.2008.03122.x; Straumann A, 2005, INFLAMM BOWEL DIS, V11, P720, DOI 10.1097/01.MIB.0000172557.39767.53; Straumann A, 2005, J ALLERGY CLIN IMMUN, V115, P418, DOI 10.1016/j.jaci.2004.11.006; Straumann A, 2012, NAT REV GASTRO HEPAT, V9, P697, DOI 10.1038/nrgastro.2012.182; Sun LL, 2011, CURR OPIN GASTROEN, V27, P321, DOI 10.1097/MOG.0b013e32834661b4; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Vicario M, 2010, GUT, V59, P12, DOI 10.1136/gut.2009.178020; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P1536, DOI 10.1073/pnas.0812668106; Zhou C, 2012, GASTROINTEST ENDOSC, V76, P32, DOI 10.1016/j.gie.2012.02.003; Ziegler SF, 2010, CURR OPIN IMMUNOL, V22, P795, DOI 10.1016/j.coi.2010.10.020	58	258	261	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1005	+		10.1038/nm.3281	http://dx.doi.org/10.1038/nm.3281			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23872715	Green Accepted			2022-12-27	WOS:000322779600026
J	Horner, SM; Gale, M				Horner, Stacy M.; Gale, Michael, Jr.			Regulation of hepatic innate immunity by hepatitis C virus	NATURE MEDICINE			English	Article							INTERFERON-STIMULATED GENES; ANTIVIRAL SIGNALING PROTEIN; RIG-I; ADAPTER PROTEIN; MEMBRANE ASSOCIATION; RIBAVIRIN THERAPY; NS3/4A PROTEASE; INTERLEUKIN 28B; ISG EXPRESSION; IL28B	Hepatitis C virus (HCV) is a global public health problem involving chronic infection of the liver, which can cause liver disease and is linked with liver cancer. Viral innate immune evasion strategies and human genetic determinants underlie the transition of acute HCV infection to viral persistence and the support of chronic infection. Host genetic factors, such as sequence polymorphisms in IFNL3, a gene in the host interferon system, can influence both the outcome of the infection and the response to antiviral therapy. Recent insights into how HCV regulates innate immune signaling within the liver reveal a complex interaction of patient genetic background with viral and host factors of innate immune triggering and control that imparts the outcome of HCV infection and immunity.	[Horner, Stacy M.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gale, M (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mgale@uw.edu		Gale, Michael/0000-0002-6332-7436; Horner, Stacy/0000-0002-9351-7409	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI088778, R56AI060389, R01AI060389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024563] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060389, U19 AI088778, R56 AI060389, R01 AI060389, AI88778] Funding Source: Medline; NIDA NIH HHS [R01 DA024563, DA024563] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Bellecave P, 2010, HEPATOLOGY, V51, P1127, DOI 10.1002/hep.23426; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; de Castellarnau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031016; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; di Iulio J, 2011, HEPATOLOGY, V53, P1446, DOI 10.1002/hep.24263; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gale M, 1998, MOL CELL BIOL, V18, P5208, DOI 10.1128/MCB.18.9.5208; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Horner SM, 2012, J VIROL, V86, P3112, DOI 10.1128/JVI.06727-11; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Ishibashi M, 2010, BIOCHEM BIOPH RES CO, V392, P397, DOI 10.1016/j.bbrc.2010.01.034; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Iwasaki Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00240; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kanazawa N, 2004, J VIROL, V78, P9713, DOI 10.1128/JVI.78.18.9713-9720.2004; Kelly C, 2011, GUT, V60, P1284, DOI 10.1136/gut.2010.222976; Koev G, 2002, VIROLOGY, V297, P195, DOI 10.1006/viro.2002.1455; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; Lange CM, 2013, J HEPATOL, V58, P583, DOI 10.1016/j.jhep.2012.10.019; Langhans B, 2011, J HEPATOL, V54, P859, DOI 10.1016/j.jhep.2010.08.020; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Lau DTY, 2013, GASTROENTEROLOGY, V144, P402, DOI 10.1053/j.gastro.2012.10.044; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin RT, 2006, J VIROL, V80, P6072, DOI 10.1128/JVI.02495-05; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; Liu L, 2012, HEPATOLOGY, V55, P1684, DOI 10.1002/hep.25575; Liu XY, 2011, J IMMUNOL, V187, P2559, DOI 10.4049/jimmunol.1100963; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; McAllister CS, 2009, J BIOL CHEM, V284, P1644, DOI 10.1074/jbc.M807888200; McGilvray I, 2012, GASTROENTEROLOGY, V142, P1122, DOI 10.1053/j.gastro.2012.01.028; Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Nishitsuji H, 2013, J VIROL, V87, P8169, DOI 10.1128/JVI.00974-13; Noguchi T, 2001, MICROBIOL IMMUNOL, V45, P829, DOI 10.1111/j.1348-0421.2001.tb01322.x; Pagliaccetti NE, 2008, J BIOL CHEM, V283, P30079, DOI 10.1074/jbc.M804296200; Pang PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006579; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Raglow Z, 2013, LIVER INT, V33, P991, DOI 10.1111/liv.12148; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimoike T, 2009, ANTIVIR RES, V83, P228, DOI 10.1016/j.antiviral.2009.05.004; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Soriano V, 2009, CLIN INFECT DIS, V48, P313, DOI 10.1086/595848; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Sugiyama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026620; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Yang Y, 2007, P NATL ACAD SCI USA, V104, P7253, DOI 10.1073/pnas.0611506104; Yao L, 2011, J VIRAL HEPATITIS, V18, pE523, DOI 10.1111/j.1365-2893.2011.01452.x; You S, 2008, J VIROL, V82, P184, DOI 10.1128/JVI.01796-07; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027	116	205	218	0	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2013	19	7					879	888		10.1038/nm.3253	http://dx.doi.org/10.1038/nm.3253			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836238	Green Accepted			2022-12-27	WOS:000321557700031
J	Nestler, EJ				Nestler, Eric J.			Treating the Brain Deep Down Brain surgery for anorexia nervosa?	NATURE MEDICINE			English	Editorial Material							NEURAL CIRCUITS; ANIMAL-MODELS; STIMULATION; REWARD; DISORDERS	Using brain surgery, specific areas in the brain can be stimulated with electrical impulses to reversibly change their activity and alleviate symptoms related to mental illnesses. This so-called deep brain stimulation and other methodological advances that even more selectively activate specific groups of neurons can give us clues as to what neural circuitry is involved in a particular mental disorder and whether therapeutic activation of these brain areas and neurons may be effective. In 'Bedside to Bench', Eric Nestler discusses two trials of individuals with anorexia nervosa in which deep brain stimulation of different brain areas resulted in improvement of behavioral domains associated with the syndrome. The results and potential of this technique in animals and humans may bring us closer to understanding the neurobiology of anorexia nervosa, which still remains a mystery and poses a challenge for treatment. In 'Bench to Bedside', Jennifer Warner-Schmidt peruses recent findings that uncover the functional connectivity of brain regions involved in depression and how activation of cortical regions can result in antidepressant effects that can compensate for the malfunction of other brain circuits that results in depression.	[Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA; [Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu			NIMH NIH HHS [R01 MH051399, P50 MH096890, P50 MH090963, P50 MH066172] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890, R01MH051399, P50MH066172, P50MH090963] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010; Goodman WK, 2012, ANNU REV MED, V63, P511, DOI 10.1146/annurev-med-052209-100401; Kaye WH, 2013, TRENDS NEUROSCI, V36, P110, DOI 10.1016/j.tins.2013.01.003; Keating C, 2012, NEUROPSYCHOLOGIA, V50, P567, DOI 10.1016/j.neuropsychologia.2012.01.036; Lipsman N, 2013, LANCET, V381, P1361, DOI 10.1016/S0140-6736(12)62188-6; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Rogan SC, 2011, PHARMACOL REV, V63, P291, DOI 10.1124/pr.110.003020; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; van der Plasse G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033455; Wu H., WORLD NEURO IN PRESS	13	7	8	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					678	679		10.1038/nm.3223	http://dx.doi.org/10.1038/nm.3223			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744148	Green Accepted			2022-12-27	WOS:000319981600015
J	Miller, JE				Miller, Jennifer E.			Bioethical accreditation or rating needed to restore trust in pharma	NATURE MEDICINE			English	Editorial Material								After years of decline in the public eye, drug companies should implment a bioethics accreditation or rating program to help appropriately restore the industry's good name and improve its effectiveness in advancing global health and new treatments.	[Miller, Jennifer E.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA	Harvard University		jmiller@ethics.harvard.edu		Miller, Jennifer/0000-0002-3591-369X				Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373	2	5	5	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					261	261		10.1038/nm0313-261	http://dx.doi.org/10.1038/nm0313-261			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23467229				2022-12-27	WOS:000316040700011
J	Unger, RH; Berglund, ED; Habener, JF; Cherrington, AD				Unger, Roger H.; Berglund, Eric D.; Habener, Joel F.; Cherrington, Alan D.			Dissecting the actions of widely used diabetes drugs	NATURE MEDICINE			English	Editorial Material							GLUCAGON	The biguanides, first discovered as glucose-lowering agents isolated from French lilac (Galega officinalis) plants, are one of the most effective first-line drugs to treat type 2 diabetes. Despite the wide use of the biguanides metformin and phenformin, their mechanism of action has been unclear. In a recent study, Miller et al.(1) describe a new mechanism through which metformin antagonizes the hormone glucagon, thus reducing fasting glucose concentrations. The authors' findings add further support to the notion that glucagon is a major player in the pathogenesis of diabetes. We asked three experts to comment on these results and on how they might be applied to develop new, more efficacious therapies to target diabetes.	[Unger, Roger H.] Univ Texas SW Med Ctr Dallas, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA; [Berglund, Eric D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Habener, Joel F.] Harvard Univ, Sch Med, Boston, MA USA; [Habener, Joel F.] Massachusetts Gen Hosp, Mol Endocrinol Lab, Boston, MA 02114 USA; [Habener, Joel F.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Cherrington, Alan D.] Vanderbilt Univ, Sch Med, Jacquelyn A Turner & Dr Dorothy J Turner Chair Di, Nashville, TN 37212 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Vanderbilt University	Unger, RH (corresponding author), Univ Texas SW Med Ctr Dallas, Touchstone Ctr Diabet Res, Dallas, TX 75390 USA.							BRAATEN JT, 1974, J CLIN INVEST, V53, P1017, DOI 10.1172/JCI107638; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Prince MJ, 2011, DIABETOLOGIA, V54, pS86; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Shah P, 2000, J CLIN ENDOCR METAB, V85, P4053, DOI 10.1210/jc.85.11.4053; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	10	0	0	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					272	273		10.1038/nm.3123	http://dx.doi.org/10.1038/nm.3123			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23467236				2022-12-27	WOS:000316040700017
J	Fukazawa, Y; Park, H; Cameron, MJ; Lefebvre, F; Lum, R; Coombes, N; Mahyari, E; Hagen, SI; Bae, JY; Delos Reyes, M; Swanson, T; Legasse, AW; Sylwester, A; Hansen, SG; Smith, AT; Stafova, P; Shoemaker, R; Li, Y; Oswald, K; Axthelm, MK; McDermott, A; Ferrari, G; Montefiori, DC; Edlefsen, PT; Piatak, M; Lifson, JD; Sekaly, RP; Picker, LJ				Fukazawa, Yoshinori; Park, Haesun; Cameron, Mark J.; Lefebvre, Francois; Lum, Richard; Coombes, Noel; Mahyari, Eisa; Hagen, Shoko I.; Bae, Jin Young; Delos Reyes, Marcelo, III; Swanson, Tonya; Legasse, Alfred W.; Sylwester, Andrew; Hansen, Scott G.; Smith, Andrew T.; Stafova, Petra; Shoemaker, Rebecca; Li, Yuan; Oswald, Kelli; Axthelm, Michael K.; McDermott, Adrian; Ferrari, Guido; Montefiori, David C.; Edlefsen, Paul T.; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Sekaly, Rafick P.; Picker, Louis J.			Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines	NATURE MEDICINE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; FOLLICULAR HELPER; CONTROL REPLICATION; MEMORY; PROTECTION; EFFECTOR; CHALLENGE; DEPLETION; HIV-1; MACROPHAGES	Live attenuated simian immunodeficiency virus (SIV) vaccines (LAVs) remain the most efficacious of all vaccines in nonhuman primate models of HIV and AIDS, yet the basis of their robust protection remains poorly understood. Here we show that the degree of LAV-mediated protection against intravenous wild-type SIVmac239 challenge strongly correlates with the magnitude and function of SIV-specific, effector-differentiated T cells in the lymph node but not with the responses of such T cells in the blood or with other cellular, humoral and innate immune parameters. We found that maintenance of protective T cell responses is associated with persistent LAV replication in the lymph node, which occurs almost exclusively in follicular helper T cells. Thus, effective LAVs maintain lymphoid tissue-based, effector-differentiated, SIV-specific T cells that intercept and suppress early wild-type SIV amplification and, if present in sufficient frequencies, can completely control and perhaps clear infection, an observation that provides a rationale for the development of safe, persistent vectors that can elicit and maintain such responses.	[Fukazawa, Yoshinori; Park, Haesun; Lum, Richard; Coombes, Noel; Mahyari, Eisa; Hagen, Shoko I.; Bae, Jin Young; Delos Reyes, Marcelo, III; Swanson, Tonya; Legasse, Alfred W.; Sylwester, Andrew; Hansen, Scott G.; Axthelm, Michael K.; Picker, Louis J.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Fukazawa, Yoshinori; Park, Haesun; Lum, Richard; Coombes, Noel; Mahyari, Eisa; Hagen, Shoko I.; Bae, Jin Young; Delos Reyes, Marcelo, III; Swanson, Tonya; Legasse, Alfred W.; Sylwester, Andrew; Hansen, Scott G.; Axthelm, Michael K.; Edlefsen, Paul T.; Picker, Louis J.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Cameron, Mark J.; Lefebvre, Francois; Smith, Andrew T.; Stafova, Petra; Sekaly, Rafick P.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL USA; [Shoemaker, Rebecca; Li, Yuan; Oswald, Kelli; Piatak, Michael, Jr.; Lifson, Jeffrey D.] SAIC Frederick Inc, Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [McDermott, Adrian] US NIAID, Vaccine Res Inst, Bethesda, MD USA; [Ferrari, Guido; Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Edlefsen, Paul T.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Vaccine & Gene Therapy Institute of Florida; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; Fred Hutchinson Cancer Center	Picker, LJ (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.	pickerl@ohsu.edu	Ferrari, Guido/A-6088-2015; Ferrari, Guido/Z-2137-2019; Cameron, Mark/O-6775-2019; mahyari, eisa/L-2002-2016; Wilkinson, Peter/AAK-6426-2020	Ferrari, Guido/0000-0001-7747-3349; Cameron, Mark/0000-0003-4768-4094; mahyari, eisa/0000-0002-5613-3131; Wilkinson, Peter/0000-0002-1365-0470; McDermott, Adrian/0000-0003-0616-9117	Bill and Melinda Gates Foundation [41185]; International AIDS Vaccine Initiative (IAVI); National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028871] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U24OD010850, P51OD011092] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative (IAVI); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Bill and Melinda Gates Foundation (grant #41185), the International AIDS Vaccine Initiative (IAVI), the National Institute of Allergy and Infectious Diseases (including the US National Institutes of Health (NIH) kits (Ambion). The microarray analysis was conducted using 750 ng of biotinylated complementary RNA hybridized to HumanHT-12_V4 BeadChips (Illumina) at 58 degrees C for 20 h. The arrays were scanned using Illumina's iSCAN and quantified using Genome Studio (Illumina). The analysis of the GenomeStudio output data was conducted using the R<SUP>54</SUP> and Bioconductor<SUP>55</SUP> software packages. Quantile normalization was applied, followed by a log<INF>2</INF> transformation. The LIMMA package<SUP>56</SUP> was used to fit a linear model to each probe and perform (moderated) t tests or F tests on the groups being compared. To control the expected proportions of false positives, the FDR for each unadjusted P value was calculated using the Benjamini and Hochberg method implemented in LIMMA. Multidimensional scaling was used as a dimensionality reduction method in R to generate plots for the evaluation of similarities or dissimilarities between datasets. Ingenuity Pathway Analysis software (IPA, Ingenuity Systems) was used to annotate genes and rank canonical pathways. An immune response gene filter, constructed from innate and adaptive immune response gene queries of Gene Ontology (http://www.geneontology.org/),T cell activation and complement pathway genes from IPA and our own IFN- and inflammasomeresponse gene lists<SUP>57</SUP>, was used where noted to reduce datasets for visualization before FDR estimation. The microarray data are available through the National Center for Biotechnology Information Gene Expression Omnibus (GEO superseries GSE40006).	Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; CHACKERIAN B, 1995, VIROLOGY, V213, P386, DOI 10.1006/viro.1995.0011; Cline AN, 2005, J MED PRIMATOL, V34, P303; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grossman Z, 2008, CURR OPIN HIV AIDS, V3, P380, DOI 10.1097/COH.0b013e3282fbaae6; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000272; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Kallies A, 2008, IMMUNOL CELL BIOL, V86, P325, DOI 10.1038/icb.2008.16; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Kirmaier A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000462; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; Martins MA, 2010, J VIROL, V84, P4352, DOI 10.1128/JVI.02365-09; Metzner KJ, 2000, J EXP MED, V191, P1921, DOI 10.1084/jem.191.11.1921; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; PICKER LJ, 1993, J IMMUNOL, V150, P1105; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Picker LJ, 2012, ANNU REV MED, V63, P95, DOI 10.1146/annurev-med-042010-085643; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; R Core Team, 2011, R LANG ENV STAT COMP; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Schmitz JE, 2000, J IMMUNOL, V164, P6015, DOI 10.4049/jimmunol.164.11.6015; Shen AD, 2007, J VIROL, V81, P1660, DOI 10.1128/JVI.01396-06; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stebbings R, 2005, J VIROL, V79, P12264, DOI 10.1128/JVI.79.19.12264-12272.2005; Stebbings R, 2004, VIROLOGY, V330, P249, DOI 10.1016/j.virol.2004.09.026; Sugimoto C, 2003, J VIROL, V77, P4169, DOI 10.1128/JVI.77.7.4169-4180.2003; Sugimoto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011678; Taylor JJ, 2011, CURR OPIN IMMUNOL, V23, P319, DOI 10.1016/j.coi.2011.03.010; Todd CA, 2012, J IMMUNOL METHODS, V375, P57, DOI 10.1016/j.jim.2011.09.007; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Venneti S, 2008, AM J PATHOL, V172, P1603, DOI 10.2353/ajpath.2008.070967; Verdeil G, 2006, J IMMUNOL, V176, P4834, DOI 10.4049/jimmunol.176.8.4834; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Walker JM, 2004, METHOD CELL BIOL, V75, P535; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Whitney JB, 2004, CURR OPIN INFECT DIS, V17, P17, DOI 10.1097/00001432-200402000-00004; Wolfe D. A., 1973, NONPARAMETRIC STAT M	57	110	111	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1673	+		10.1038/nm.2934	http://dx.doi.org/10.1038/nm.2934			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	22961108	Green Accepted			2022-12-27	WOS:000310837000028
J	Calne, RY				Calne, Roy Y.			"It can't be done"	NATURE MEDICINE			English	Editorial Material							LIVER-TRANSPLANTATION; PROPE TOLERANCE; RECIPIENTS; IMMUNOSUPPRESSION		Univ Cambridge, Cambridge, England	University of Cambridge	Calne, RY (corresponding author), Univ Cambridge, Cambridge, England.	ryc1000@cam.ac.uk						[Anonymous], 1969, LANCET, V294, P940; Benseler V, 2007, SEMIN LIVER DIS, V27, P194, DOI 10.1055/s-2007-979471; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Calne R, 1998, LANCET, V351, P1701, DOI 10.1016/S0140-6736(05)77739-4; CALNE R. Y., 1961, TRANSPLANTATION BULL, V28, P65; Calne R, 2011, CURR OPIN ORGAN TRAN, V16, P353, DOI 10.1097/MOT.0b013e328348b44c; CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0; CALNE RY, 1968, BMJ-BRIT MED J, V4, P535, DOI 10.1136/bmj.4.5630.535; CALNE RY, 1960, LANCET, V1, P417; CALNE RY, 1989, LANCET, V2, P227; CALNE RY, 1979, LANCET, V2, P1033; Mazariegos GV, 1997, TRANSPL P, V29, P1174, DOI 10.1016/S0041-1345(96)00535-0; Merrill John P, 1955, SURG FORUM, V6, P432; Ringe B, 2008, AM J TRANSPLANT, V8, P1557, DOI 10.1111/j.1600-6143.2008.02261.x; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5	16	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1493	1495		10.1038/nm.2926	http://dx.doi.org/10.1038/nm.2926			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042360				2022-12-27	WOS:000309587500025
J	Kusminski, CM; Holland, WL; Sun, K; Park, J; Spurgin, SB; Lin, Y; Askew, GR; Simcox, JA; McClain, DA; Li, C; Scherer, PE				Kusminski, Christine M.; Holland, William L.; Sun, Kai; Park, Jiyoung; Spurgin, Stephen B.; Lin, Ying; Askew, G. Roger; Simcox, Judith A.; McClain, Don A.; Li, Cai; Scherer, Philipp E.			MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity	NATURE MEDICINE			English	Article							HUMAN SKELETAL-MUSCLE; OXIDATIVE STRESS; ADIPOSE-TISSUE; MEMBRANE PROTEIN; METABOLIC SYNDROME; GENE-EXPRESSION; RESISTANCE; ADIPONECTIN; DYSFUNCTION; MECHANISMS	We examined mouse models with altered adipocyte expression of mitoNEET, a protein residing in the mitochondrial outer membrane, to probe its impact on mitochondrial function and subsequent cellular responses. We found that overexpression of mitoNEET enhances lipid uptake and storage, leading to an expansion of the mass of adipose tissue. Despite the resulting massive obesity, benign aspects of adipose tissue expansion prevail, and insulin sensitivity is preserved. Mechanistically, we also found that mitoNEET inhibits mitochondrial iron transport into the matrix and, because iron is a rate-limiting component for electron transport, lowers the rate of beta-oxidation. This effect is associated with a lower mitochondrial membrane potential and lower levels of reactive oxygen species-induced damage, along with increased production of adiponectin. Conversely, a reduction in mitoNEET expression enhances mitochondrial respiratory capacity through enhanced iron content in the matrix, ultimately corresponding to less weight gain on a high-fat diet. However, this reduction in mitoNEET expression also causes heightened oxidative stress and glucose intolerance. Thus, manipulation of mitochondrial function by varying mitoNEET expression markedly affects the dynamics of cellular and whole-body lipid homeostasis.	[Kusminski, Christine M.; Holland, William L.; Sun, Kai; Park, Jiyoung; Spurgin, Stephen B.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Lin, Ying] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Askew, G. Roger; Li, Cai] Merck Res Labs, Dept Metab Disorders, Rahway, NJ USA; [Simcox, Judith A.; McClain, Don A.] Univ Utah, Sch Med, Dept Med & Biochem, Salt Lake City, UT USA; [McClain, Don A.] Virginia Med Ctr, Res Serv, Salt Lake City, UT USA; [Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yeshiva University; Albert Einstein College of Medicine; Merck & Company; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scherer, PE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	philipp.scherer@utsouthwestern.edu	park, Jiyoung/G-4592-2013; Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392; Sun, Kai/0000-0002-4778-4549; Simcox, Judith/0000-0001-7350-6342; Spurgin, Stephen/0000-0003-0615-7626; McClain, Don/0000-0002-3310-2359	US National Institutes of Health [R01-DK55758, RC1-DK086629, P01-DK088761, K99-DK094973]; American Heart Association [12BGIA8910006, R01-DK081842, T32-DK091317]; Department of Defense [USAMRMC-BC085909]; Juvenile Diabetes Foundation [JDRF 3-2008-130]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088761, R01DK055758, R01DK081842, T32DK091317, RC1DK086629, K99DK094973] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. D. Neufer, G. Schatz and C. B. Newgard for helpful comments and suggestions. We also thank J. Song and J. Xia for technical assistance, in addition to the rest of the Scherer laboratory, R. Unger and D. Clegg for helpful discussions. We also thank P. Blanchard and Y. Deshaies for kindly providing LPL activity measurements, R. Hammer and the University of Texas Southwestern (UTSW) Transgenic Core Facility for the generation of mouse models, as well as the UTSW Metabolic Core Facility for help in the phenotypic characterization of the mice and G. Milne from Vanderbilt University Medical Center for the F2-isoprostane analysis. The authors were supported by US National Institutes of Health grants R01-DK55758, RC1-DK086629 and P01-DK088761 (P. E. S.), K99-DK094973 and an American Heart Association Beginning Grant in Aid 12BGIA8910006 (W. L. H.), R01-DK081842 (D. A. M.), T32-DK091317 (J. A. S.) and Department of Defense Fellowship USAMRMC-BC085909 (J. P.). C. M. K. was supported by a fellowship from the Juvenile Diabetes Foundation (JDRF 3-2008-130).	Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Asterholm IW, 2010, AM J PATHOL, V176, P1364, DOI 10.2353/ajpath.2010.090647; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Combs TP, 2004, ENDOCRINOLOGY, V145, P367, DOI 10.1210/en.2003-1068; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Frizzell N, 2009, J BIOL CHEM, V284, P25772, DOI 10.1074/jbc.M109.019257; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; Hanson RW, 2003, BIOCHIMIE, V85, P1199, DOI 10.1016/j.biochi.2003.10.022; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang JY, 2011, DIABETES, V60, P80, DOI 10.2337/db10-0593; HULTIN M, 1995, J LIPID RES, V36, P2174; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jornayvaz FR, 2012, CELL METAB, V15, P574, DOI 10.1016/j.cmet.2012.03.005; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Laplante M, 2009, AM J PHYSIOL-REG I, V296, pR57, DOI 10.1152/ajpregu.90552.2008; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MACDONALD VW, 1985, J LAB CLIN MED, V105, P11; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mehta JL, 2006, INT J BIOCHEM CELL B, V38, P794, DOI 10.1016/j.biocel.2005.12.008; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SHERRATT HSA, 1991, REV NEUROL, V147, P417; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Wiley SE, 2007, J BIOL CHEM, V282, P23745, DOI 10.1074/jbc.C700107200; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	57	306	314	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1539	U144		10.1038/nm.2899	http://dx.doi.org/10.1038/nm.2899			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22961109	Green Accepted			2022-12-27	WOS:000309587500033
J	Maniatis, T				Maniatis, Tom			On the road from classical to modern molecular biology	NATURE MEDICINE			English	Editorial Material							BETA-GLOBIN GENE; NF-KAPPA-B; INVITRO; RNA; DNA; TRANSCRIPTION; EXPRESSION; SEQUENCES; PROTEIN; PATHWAY		Columbia Univ, Dept Biochem & Biophys, New York, NY 10027 USA	Columbia University	Maniatis, T (corresponding author), Columbia Univ, Dept Biochem & Biophys, New York, NY 10027 USA.	tm2472@columbia.edu						Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; FRITSCH EF, 1980, CELL, V19, P959, DOI 10.1016/0092-8674(80)90087-2; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; MANIATIS T, 1976, CELL, V8, P163, DOI 10.1016/0092-8674(76)90001-5; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; Maniatis T, 2008, LIFE ILLUMINATED SEL, P227; Maniatis T., 1982, MOL CLONING LAB MANU; MELLON P, 1981, CELL, V27, P279, DOI 10.1016/0092-8674(81)90411-6; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; RUSKIN B, 1984, CELL, V38, P317, DOI 10.1016/0092-8674(84)90553-1; Sanchez-Serrano I, 2006, NAT REV DRUG DISCOV, V5, P107, DOI 10.1038/nrd1959; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; TIAN M, 1993, CELL, V74, P105, DOI 10.1016/0092-8674(93)90298-5; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WOLD B, 1979, P NATL ACAD SCI USA, V76, P5684, DOI 10.1073/pnas.76.11.5684	18	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1499	1502		10.1038/nm.2931	http://dx.doi.org/10.1038/nm.2931			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042362				2022-12-27	WOS:000309587500027
J	Islam, SA; Luster, AD				Islam, Sabina A.; Luster, Andrew D.			T cell homing to epithelial barriers in allergic disease	NATURE MEDICINE			English	Review							CHEMOKINE RECEPTORS CCR4; ACTIVATION-REGULATED CHEMOKINE; CUTANEOUS LYMPHOCYTE ANTIGEN; ATOPIC-DERMATITIS; DENDRITIC CELLS; MOUSE MODEL; CUTTING EDGE; DIFFERENTIAL EXPRESSION; AIRWAY INFLAMMATION; CYTOKINE PRODUCTION	Allergic inflammation develops in tissues that have large epithelial surface areas that are exposed to the environment, such as the lung, skin and gut. In the steady state, antigen-experienced memory T cells patrol these peripheral tissues to facilitate swift immune responses against invading pathogens. In at least two allergy-prone organs, the skin and the gut, memory T cells are programmed during the initial antigen priming to express trafficking receptors that enable them to preferentially home to these organs. In this review we propose that tissue-specific memory and inflammation-specific T cell trafficking facilitates the development of allergic disease in these organs. We thus review recent advances in our understanding of tissue-specific T cell trafficking and how regulation of T cell trafficking by the chemokine system contributes to allergic inflammation in mouse models and in human allergic diseases of the skin, lung and gut. Inflammation-and tissue-specific T lymphocyte trafficking pathways are currently being targeted as new treatments for non-allergic inflammatory diseases and may yield effective new therapeutics for allergic diseases.	[Islam, Sabina A.; Luster, Andrew D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Luster, AD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02115 USA.	aluster@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	US National Institutes of Health [R37AI040618, U19AI095261]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040618, U19AI095261] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors were supported by US National Institutes of Health grants R37AI040618 and U19AI095261 to A.D.L.	Abe H, 1999, GENE, V227, P71, DOI 10.1016/S0378-1119(98)00599-X; ABERNATHYCARVER KJ, 1995, J CLIN INVEST, V95, P913, DOI 10.1172/JCI117743; Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x; Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; BABI LFS, 1995, J EXP MED, V181, P1935, DOI 10.1084/jem.181.5.1935; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bentley AM, 1997, CLIN EXP ALLERGY, V27, P71, DOI 10.1111/j.1365-2222.1997.tb01830.x; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Beyer K, 2002, J ALLERGY CLIN IMMUN, V109, P707, DOI 10.1067/mai.2002.122503; Beyer K, 2002, J ALLERGY CLIN IMMUN, V109, P688, DOI 10.1067/mai.2002.123235; Blazquez AB, 2010, GASTROENTEROLOGY, V138, P275, DOI 10.1053/j.gastro.2009.09.016; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Briskin M, 1997, AM J PATHOL, V151, P97; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; CAHILL RNP, 1977, J EXP MED, V145, P420, DOI 10.1084/jem.145.2.420; Cameron L, 2009, ALLERGY, V64, P1478, DOI 10.1111/j.1398-9995.2009.02053.x; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Campbell JJ, 2001, J IMMUNOL, V166, P2842, DOI 10.4049/jimmunol.166.4.2842; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; Chung CD, 2003, J IMMUNOL, V170, P581, DOI 10.4049/jimmunol.170.1.581; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Conrad C, 2007, NAT MED, V13, P836, DOI 10.1038/nm1605; Conroy DM, 2003, J LEUKOCYTE BIOL, V74, P558, DOI 10.1189/jlb.0103030; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; DeLong JH, 2011, J ALLERGY CLIN IMMUN, V127, P1211, DOI 10.1016/j.jaci.2011.02.028; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Echigo T, 2004, J ALLERGY CLIN IMMUN, V113, P940, DOI 10.1016/S0091-6749(04)01061-9; Edele F, 2008, J IMMUNOL, V181, P3745, DOI 10.4049/jimmunol.181.6.3745; Eigenmann PA, 1999, J ALLERGY CLIN IMMUN, V103, P931, DOI 10.1016/S0091-6749(99)70441-0; Eiwegger T, 2011, EUR J IMMUNOL, V41, P1535, DOI 10.1002/eji.201141668; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Fairs A, 2010, AM J RESP CRIT CARE, V182, P1362, DOI 10.1164/rccm.201001-0087OC; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Fuhlbrigge RC, 1997, NATURE, V389, P978, DOI 10.1038/40166; Fulkerson PC, 2004, J IMMUNOL, V173, P7565, DOI 10.4049/jimmunol.173.12.7565; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Gonzalo JA, 2007, J IMMUNOL, V179, P1740, DOI 10.4049/jimmunol.179.3.1740; Goya I, 2003, J IMMUNOL, V170, P2138, DOI 10.4049/jimmunol.170.4.2138; Gunther C, 2005, J IMMUNOL, V174, P1723, DOI 10.4049/jimmunol.174.3.1723; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harper EG, 2008, J INVEST DERMATOL, V128, P1173, DOI 10.1038/sj.jid.5701169; Harris NL, 2002, J EXP MED, V195, P317, DOI 10.1084/jem.20011558; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hijnen D, 2005, J INVEST DERMATOL, V125, P1149, DOI 10.1111/j.0022-202X.2005.23932.x; Hijnen DJ, 2004, J ALLERGY CLIN IMMUN, V113, P334, DOI 10.1016/j.jaci.2003.12.007; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Huang JL, 2004, HUM MOL GENET, V13, P2691, DOI 10.1093/hmg/ddh279; Hvid M, 2011, J INVEST DERMATOL, V131, P150, DOI 10.1038/jid.2010.277; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kakinuma T, 2003, J ALLERGY CLIN IMMUN, V111, P592, DOI 10.1067/mai.2003.114; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim CH, 2003, J IMMUNOL, V171, P152, DOI 10.4049/jimmunol.171.1.152; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Klonowski KD, 2004, IMMUNITY, V20, P551, DOI 10.1016/S1074-7613(04)00103-7; Knight AK, 2007, AM J PHYSIOL-GASTR L, V293, pG1234, DOI 10.1152/ajpgi.00323.2007; Koelle DM, 2002, J CLIN INVEST, V110, P537, DOI [10.1172/JCI200215537, 10.1172/JCI0215537]; Kraft M, 2011, NEW ENGL J MED, V365, P1141, DOI 10.1056/NEJMe1108666; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Lambrecht BN, 2009, IMMUNITY, V31, P412, DOI 10.1016/j.immuni.2009.08.008; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Leung TF, 2002, J ALLERGY CLIN IMMUN, V110, P404, DOI 10.1067/mai.2002.126378; Lin XP, 2002, J ALLERGY CLIN IMMUN, V109, P879, DOI 10.1067/mai.2002.123238; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lonsdorf AS, 2009, J INVEST DERMATOL, V129, P2552, DOI 10.1038/jid.2009.122; Lukacs NW, 2001, J EXP MED, V194, P551, DOI 10.1084/jem.194.4.551; Lundy SK, 2005, J IMMUNOL, V174, P2054, DOI 10.4049/jimmunol.174.4.2054; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mathew A, 2002, J IMMUNOL, V169, P651, DOI 10.4049/jimmunol.169.2.651; Mathew A, 2001, J EXP MED, V193, P1087, DOI 10.1084/jem.193.9.1087; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Medoff BD, 2006, AM J PHYSIOL-LUNG C, V290, pL170, DOI 10.1152/ajplung.00212.2005; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Meisel C, 2001, J IMMUNOL, V166, P3143, DOI 10.4049/jimmunol.166.5.3143; Mikhak Z, 2009, J ALLERGY CLIN IMMUN, V123, P67, DOI 10.1016/j.jaci.2008.09.049; Mionnet C, 2010, NAT MED, V16, P1305, DOI 10.1038/nm.2253; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mora JR, 2005, J EXP MED, V201, P303, DOI 10.1084/jem.20041645; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muro S, 2000, CLIN CHEST MED, V21, P225, DOI 10.1016/S0272-5231(05)70263-X; Mutalithas K, 2010, CLIN EXP ALLERGY, V40, P1175, DOI 10.1111/j.1365-2222.2010.03504.x; Nouri-Aria KT, 2002, EUR J IMMUNOL, V32, P1933, DOI 10.1002/1521-4141(200207)32:7<1933::AID-IMMU1933>3.0.CO;2-R; Ohmichi Y, 2011, J EXP MED, V208, P1015, DOI 10.1084/jem.20101786; Oliveira SHP, 2001, INFLAMM RES, V50, P168, DOI 10.1007/s000110050741; Oyoshi MK, 2011, J CLIN INVEST, V121, P2210, DOI 10.1172/JCI43586; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Perros F, 2009, ALLERGY, V64, P995, DOI 10.1111/j.1398-9995.2009.02095.x; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Pichavant M, 2005, J ALLERGY CLIN IMMUN, V115, P771, DOI 10.1016/j.jaci.2004.11.043; PICKER LJ, 1990, J IMMUNOL, V145, P3247; PICKER LJ, 1991, NATURE, V349, P796, DOI 10.1038/349796a0; Pilette C, 2004, EUR RESPIR J, V23, P876, DOI 10.1183/09031936.04.00102504; Pivarcsi A, 2004, J IMMUNOL, V173, P5810, DOI 10.4049/jimmunol.173.9.5810; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Prussin C, 2009, J ALLERGY CLIN IMMUN, V124, P1326, DOI 10.1016/j.jaci.2009.09.048; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Reekers R, 1996, BRIT J DERMATOL, V135, P935, DOI 10.1046/j.1365-2133.1996.d01-1098.x; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Robinson DS, 2010, J ALLERGY CLIN IMMUN, V126, P1081, DOI 10.1016/j.jaci.2010.06.025; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Sallusto F, 2000, ANNU REV IMMUNOL, V18, P593, DOI 10.1146/annurev.immunol.18.1.593; Sallusto F, 2004, CURR OPIN IMMUNOL, V16, P724, DOI 10.1016/j.coi.2004.09.012; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Schaerli P, 2004, J EXP MED, V199, P1265, DOI 10.1084/jem.20032177; Schuh JM, 2002, FASEB J, V16, P1313, DOI 10.1096/fj.02-0193fje; Schulten V, 2009, J ALLERGY CLIN IMMUN, V124, P100, DOI 10.1016/j.jaci.2009.02.010; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Shimada Y, 2004, J DERMATOL SCI, V34, P201, DOI 10.1016/j.jdermsci.2004.01.001; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Tremblay K, 2006, GENES IMMUN, V7, P632, DOI 10.1038/sj.gene.6364340; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Upadhyaya B, 2011, J IMMUNOL, V187, P3111, DOI 10.4049/jimmunol.1101283; VanSnick J, 1996, J IMMUNOL, V157, P2570; Vestergaard C, 2003, BRIT J DERMATOL, V149, P457, DOI 10.1046/j.1365-2133.2003.05505.x; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Vijayanand P, 2010, J IMMUNOL, V184, P4568, DOI 10.4049/jimmunol.0901342; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Woodward AL, 2001, J ALLERGY CLIN IMMUN, V107, P359, DOI 10.1067/mai.2001.112695; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Worbs T, 2007, TRENDS IMMUNOL, V28, P274, DOI 10.1016/j.it.2007.04.002; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu JF, 2010, IMMUNITY, V32, P11, DOI 10.1016/j.immuni.2010.01.001	167	165	172	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					705	715		10.1038/nm.2760	http://dx.doi.org/10.1038/nm.2760			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561834	Green Accepted			2022-12-27	WOS:000303763500038
J	Helming, KC; Wang, XF; Wilson, BG; Vazquez, F; Haswell, JR; Manchester, HE; Kim, Y; Kryukov, GV; Ghandi, M; Aguirre, AJ; Jagani, Z; Wang, Z; Garraway, LA; Hahn, WC; Roberts, CWM				Helming, Katherine C.; Wang, Xiaofeng; Wilson, Boris G.; Vazquez, Francisca; Haswell, Jeffrey R.; Manchester, Haley E.; Kim, Youngha; Kryukov, Gregory V.; Ghandi, Mahmoud; Aguirre, Andrew J.; Jagani, Zainab; Wang, Zhong; Garraway, Levi A.; Hahn, William C.; Roberts, Charles W. M.			ARID1B is a specific vulnerability in ARID1A-mutant cancers	NATURE MEDICINE			English	Article							CHROMATIN REMODELING FACTOR; TUMOR-SUPPRESSOR	Recent studies have revealed that ARID1A, encoding AT-rich interactive domain 1A (SWI-like), is frequently mutated across a variety of human cancers and also has bona fide tumor suppressor properties. Consequently, identification of vulnerabilities conferred by ARID1A mutation would have major relevance for human cancer. Here, using a broad screening approach, we identify ARID1B, an ARID1A homolog whose gene product is mutually exclusive with ARID1A in SWI/SNF complexes, as the number 1 gene preferentially required for the survival of ARID1A-mutant cancer cell lines. We show that loss of ARID1B in ARID1A-deficient backgrounds destabilizes SWI/SNF and impairs proliferation in both cancer cells and primary cells. We also find that ARID1A and ARID1B are frequently co-mutated in cancer but that ARID14-deficient cancers retain at least one functional ARID1B allele. These results suggest that loss of ARID1A and ARID1B alleles cooperatively promotes cancer formation but also results in a unique functional dependence. The results further identify ARID1B as a potential therapeutic target for ARID1A-mutant cancers.	[Helming, Katherine C.; Wang, Xiaofeng; Wilson, Boris G.; Haswell, Jeffrey R.; Manchester, Haley E.; Kim, Youngha; Roberts, Charles W. M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Helming, Katherine C.; Wang, Xiaofeng; Wilson, Boris G.; Haswell, Jeffrey R.; Manchester, Haley E.; Kim, Youngha; Roberts, Charles W. M.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Helming, Katherine C.; Wang, Xiaofeng; Wilson, Boris G.; Haswell, Jeffrey R.; Manchester, Haley E.; Kim, Youngha; Roberts, Charles W. M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Helming, Katherine C.] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA USA; [Vazquez, Francisca; Kryukov, Gregory V.; Ghandi, Mahmoud; Aguirre, Andrew J.; Garraway, Levi A.; Hahn, William C.; Roberts, Charles W. M.] Broad Inst Harvard & MIT, Boston, MA USA; [Vazquez, Francisca; Garraway, Levi A.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Aguirre, Andrew J.; Garraway, Levi A.; Hahn, William C.; Roberts, Charles W. M.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Jagani, Zainab] Novartis Inst Biomed Res, Cambridge, MA USA; [Wang, Zhong] Univ Michigan, Dept Cardiac Surg, Ann Arbor, MI 48109 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Novartis; University of Michigan System; University of Michigan	Roberts, CWM (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	charles_roberts@dfci.harvard.edu	Vazquez, Francisca/AAA-3751-2020; Kryukov, Gregory V/A-9592-2008; Manchester, Haley/AAK-5916-2020; Vazquez, Francisca/ABC-4620-2020; Roberts, Charles/N-2541-2018	Vazquez, Francisca/0000-0002-2857-4685; Roberts, Charles/0000-0003-1135-1896; Ghandi, Mahmoud/0000-0003-1897-2265; Kryukov, Gregory/0000-0002-6131-9483	David Abraham Foundation; Rally Foundation; St. Baldrick's Foundation; Pablove Foundation; US National Institutes of Health [R01HL109054, R01CA172152, R01CA113794]; U01 NCI Mouse Models of Cancer Consortium Award; Garrett B. Smith Foundation; Miles for Mary; Cure AT/RT Now foundation; NATIONAL CANCER INSTITUTE [U01CA105423, R01CA172152, R01CA113794, U01CA176058, T32CA009172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109054] Funding Source: NIH RePORTER	David Abraham Foundation; Rally Foundation; St. Baldrick's Foundation; Pablove Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U01 NCI Mouse Models of Cancer Consortium Award; Garrett B. Smith Foundation; Miles for Mary; Cure AT/RT Now foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Ping Lu for technical assistance with the setup of the sucrose sedimentation assay. X.W. was supported by a post-doctoral fellowship from David Abraham Foundation and Rally Foundation and a research grant from St. Baldrick's Foundation. B.G.W. was supported by a Childhood Cancer Research Grant from the Pablove Foundation. Z.W. is supported by US National Institutes of Health grant R01HL109054. This work was supported by US National Institutes of Health grants R01CA172152 (C.W.M.R.) and R01CA113794 (C.W.M.R.) and a U01 NCI Mouse Models of Cancer Consortium Award (C.W.M.R.). The Garrett B. Smith Foundation, Miles for Mary and the Cure AT/RT Now foundation (C.W.M.R.) provided additional support.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Buitman S., 2000, MOL CELL, V6, P1287; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Ryme J, 2009, J CELL BIOCHEM, V108, P565, DOI 10.1002/jcb.22288; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Wang X, 2009, CANCER RES, V69, P8094, DOI 10.1158/0008-5472.CAN-09-0733; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361	20	247	254	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					251	254		10.1038/nm.3480	http://dx.doi.org/10.1038/nm.3480			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24562383	Green Accepted, Green Submitted			2022-12-27	WOS:000332595600019
J	Ley, RE				Ley, Ruth E.			The sweet tooth of Clostridium difficile	NATURE MEDICINE			English	Editorial Material							MICROBIOTA		Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University	Ley, RE (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	rel222@cornell.edu	Ley, Ruth E/M-8542-2014	Ley, Ruth E/0000-0002-9087-1672				Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duan FP, 2010, P NATL ACAD SCI USA, V107, P11260, DOI 10.1073/pnas.1001294107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hwang IY, 2014, ACS SYNTH BIOL, V3, P228, DOI 10.1021/sb400077j; Karadsheh Z., 2013, AM J MED SCI, V5, P339; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; TVEDE M, 1989, LANCET, V1, P1156; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499	14	17	32	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2014	20	3					248	249		10.1038/nm.3494	http://dx.doi.org/10.1038/nm.3494			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AC5XZ	24603797				2022-12-27	WOS:000332595600018
J	DiLillo, DJ; Tan, GS; Palese, P; Ravetch, JV				DiLillo, David J.; Tan, Gene S.; Palese, Peter; Ravetch, Jeffrey V.			Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc gamma R interactions for protection against influenza virus in vivo	NATURE MEDICINE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; INDUCED CONFORMATIONAL-CHANGES; MONOCLONAL-ANTIBODY; UNIVERSAL VACCINE; RECEPTOR-BINDING; CONSTANT-REGION; ANTIGEN; IDENTIFICATION; EPITOPES; IMMUNITY	Neutralizing antibodies against influenza viruses have traditionally been thought to provide protection exclusively through their variable region; the contributions of mechanisms conferred by the Fc domain remain controversial. We investigated the in vivo contributions of Fc interactions with their cognate receptors for a collection of neutralizing anti-influenza antibodies. Whereas five broadly neutralizing monoclonal antibodies (bNAbs) targeting the conserved stalk region of hemagglutinin (HA) required interactions between the antibody Fc and Fc receptors for IgG (Fc gamma Rs) to confer protection from lethal H1N1 challenge, three strain-specific monoclonal Abs (mAbs) against the variable head domain of HA were equally protective in the presence or absence of Fc gamma R interactions. Although all antibodies blocked infection, only anti-stalk bNAbs were capable of mediating cytotoxicity of infected cells, which accounts for their Fc gamma R dependence. Immune complexes generated with anti-HA stalk mAb efficiently interacted with Fc gamma Rs, but anti-HA head immune complexes did not. These results suggest that Fc gamma R binding capacity by anti-HA antibodies was dependent on the interaction of the cognate Fab with antigen. We exploited these disparate mechanisms of mAb-mediated protection to reengineer an anti-stalk bNAb to selectively enhance Fc gamma R engagement to augment its protective activity. These findings reveal a previously uncharacterized property of bNAbs and guide an approach toward enhancing mAb-mediated antiviral therapeutics.	[DiLillo, David J.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; [Tan, Gene S.; Palese, Peter] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.	ravetch@rockefeller.edu	Koyuncu, ayfer/M-3872-2015; Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Tan, Gene/0000-0002-0975-0719; Palese, Peter/0000-0002-0337-5823	National Institute of Allergy and Infectious Disease of the US National Institutes of Health (NIH) [P01AI081677, R01AI035875, U54AI057158, AI097092]; Bill & Melinda Gates Foundation [OPP1033115]; US Army Research Laboratory; US Army Research Office [W911NF-13-2-0036]; Program for Appropriate Technology in Health; NIH [HHSN266200700010C]; Leukemia and Lymphoma Society; New York Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092, P01AI081677, U54AI057158, R01AI035875, U19AI109946] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease of the US National Institutes of Health (NIH); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); US Army Research Office; Program for Appropriate Technology in Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); New York Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Wilson (University of Chicago), J. Wrammert (Emory University) and R. Ahmed (Emory University) for providing mAb constructs, E Krammer (Mt. Sinai Medical Center) for providing recombinant soluble HA protein, S. Bournazos for assistance with surface plasmon resonance studies and J. Carron and P. Smith for technical assistance. We also thank the Biodefense and Emerging Infections Research Resources Repository for supplying recombinant soluble HA protein. Research reported in this publication was partially supported by the National Institute of Allergy and Infectious Disease of the US National Institutes of Health (NIH) under award numbers P01AI081677, R01AI035875 and U54AI057158 to J.V.R. and AI097092 to P.P. Research support was also provided by the Bill & Melinda Gates Foundation grant OPP1033115 to J.V.R. This work was also supported in part by the US Army Research Laboratory and the US Army Research Office under contract number W911NF-13-2-0036 (to J.V.R.). Partial support for PP. was provided by the Program for Appropriate Technology in Health and by the NIH-funded Center for Research on Influenza Pathogenesis (HHSN266200700010C). D.J.D. received fellowship support from the Leukemia and Lymphoma Society and received funding support from the New York Community Trust.	Abboud N, 2010, J EXP MED, V207, P2395, DOI 10.1084/jem.20100995; Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; BARKAS T, 1979, IMMUNOLOGY, V36, P557; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; KILAR F, 1987, EUR J BIOCHEM, V162, P57, DOI 10.1111/j.1432-1033.1987.tb10541.x; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Manicassamy B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000745; Martinez O, 2009, INT REV IMMUNOL, V28, P69, DOI 10.1080/08830180802593540; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Nimmerjahn F, 2011, CURR TOP MICROBIOL, V350, P105, DOI 10.1007/82_2010_86; Nimmerjahn Falk, 2008, V415, P151, DOI 10.1007/978-1-59745-570-1_9; Nordstrom JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3069; Oda M, 2003, INT IMMUNOL, V15, P417, DOI 10.1093/intimm/dxg036; REALE MA, 1986, J IMMUNOL, V137, P1352; SCHLESSINGER J, 1975, P NATL ACAD SCI USA, V72, P2775, DOI 10.1073/pnas.72.7.2775; Schmitz N, 2012, EUR J IMMUNOL, V42, P863, DOI 10.1002/eji.201041225; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith P, 2012, P NATL ACAD SCI USA, V109, P6181, DOI 10.1073/pnas.1203954109; Srivastava V, 2013, J VIROL, V87, P5831, DOI 10.1128/JVI.00273-13; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Tedder TF, 2006, SPRINGER SEMIN IMMUN, V28, P351, DOI 10.1007/s00281-006-0057-9; Tong HM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01089; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Wang TT, 2011, SCIENCE, V333, P834, DOI 10.1126/science.1210724; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yang XM, 2013, MOL THER, V21, P91, DOI 10.1038/mt.2012.184	43	530	545	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2014	20	2					143	151		10.1038/nm.3443	http://dx.doi.org/10.1038/nm.3443			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AA2HF	24412922	Green Accepted			2022-12-27	WOS:000330915000015
J	Reed, SG; Orr, MT; Fox, CB				Reed, Steven G.; Orr, Mark T.; Fox, Christopher B.			Key roles of adjuvants in modern vaccines	NATURE MEDICINE			English	Review							T-CELL RESPONSES; PLASMACYTOID DENDRITIC CELLS; YELLOW-FEVER VACCINE; HEPATITIS-B-VACCINE; INFLUENZA VACCINE; ALUM ADJUVANT; CIRCUMSPOROZOITE PROTEIN; SEASONAL INFLUENZA; NLRP3 INFLAMMASOME; CROSS-PRESENTATION	Vaccines containing novel adjuvant formulations are increasingly reaching advanced development and licensing stages, providing new tools to fill previously unmet clinical needs. However, many adjuvants fail during product development owing to factors such as manufacturability, stability, lack of effectiveness, unacceptable levels of tolerability or safety concerns. This Review outlines the potential benefits of adjuvants in current and future vaccines and describes the importance of formulation and mechanisms of action of adjuvants. Moreover, we emphasize safety considerations and other crucial aspects in the clinical development of effective adjuvants that will help facilitate effective next-generation vaccines against devastating infectious diseases.	[Reed, Steven G.; Orr, Mark T.; Fox, Christopher B.] Infect Dis Res Inst, Seattle, WA USA		Reed, SG (corresponding author), Infect Dis Res Inst, Seattle, WA USA.	steven.reed@idri.org		Orr, Mark/0000-0003-2684-4722; Fox, Christopher/0000-0002-4644-2619	NIAID/US National Institutes of Health; US Department of Health and Human Services [HHSN272200800045C]; Bill & Melinda Gates Foundation [42387]	NIAID/US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Health and Human Services; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We thank M. Friede for his helpful discussions and preparation of Figure 1. This project has been funded in part with funds from NIAID/US National Institutes of Health, the US Department of Health and Human Services, under Contract No. HHSN272200800045C. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. This work was also supported with funding from the Bill & Melinda Gates Foundation, under grant 42387.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; [Anonymous], 2011, EUR MED AG REC RESTR; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Baldwin SL, 2012, J IMMUNOL, V188, P2189, DOI 10.4049/jimmunol.1102696; Baldwin SL, 2011, VACCINE, V29, P644, DOI 10.1016/j.vaccine.2010.11.043; Barchet W, 2008, CURR OPIN IMMUNOL, V20, P389, DOI 10.1016/j.coi.2008.07.007; Baudner BC, 2009, PHARM RES-DORDR, V26, P1477, DOI 10.1007/s11095-009-9859-5; Beaudette TT, 2009, MOL PHARMACEUT, V6, P1160, DOI 10.1021/mp900038e; Bertholet S, 2009, VACCINE, V27, P7036, DOI 10.1016/j.vaccine.2009.09.066; Bowen WS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001963; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Caux C, 1997, BLOOD, V90, P1458, DOI 10.1182/blood.V90.4.1458.1458_1458_1470; Chua BY, 2012, MOL PHARMACEUT, V9, P81, DOI 10.1021/mp200264m; Clapp T, 2011, J PHARM SCI-US, V100, P388, DOI 10.1002/jps.22284; Cox M., 2011, 7 WHO M EV PAND INFL, P17; De Gregorio E, 2008, EUR J IMMUNOL, V38, P2068, DOI 10.1002/eji.200838648; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Draper E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061825; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Ellebedy AH, 2011, P NATL ACAD SCI USA, V108, P2927, DOI 10.1073/pnas.1012455108; Eng NF, 2013, HUM VACC IMMUNOTHER, V9, P1661, DOI 10.4161/hv.24715; European Medicines Agency, 2012, EUR MED AG REV HYP P; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Fonteneau JF, 2003, BLOOD, V101, P3520, DOI 10.1182/blood-2002-10-3063; Fox C. B., 2012, EMULSION BASED VACCI, P38; Fox CB, 2011, VACCINE, V29, P9563, DOI 10.1016/j.vaccine.2011.08.089; Fox CB, 2010, SUBCELL BIOCHEM, V53, P303, DOI 10.1007/978-90-481-9078-2_14; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Ghimire TR, 2012, IMMUNOL LETT, V147, P55, DOI 10.1016/j.imlet.2012.06.002; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Guan HH, 1998, BIOCONJUGATE CHEM, V9, P451, DOI 10.1021/bc970183n; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Henriksen-Lacey M, 2011, J CONTROL RELEASE, V154, P131, DOI 10.1016/j.jconrel.2011.05.019; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V145, P102, DOI 10.1016/j.jconrel.2010.03.027; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Kim H, 2010, ADV FUNCT MATER, V20, P3925, DOI 10.1002/adfm.201000021; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Klechevsky E, 2010, BLOOD, V116, P1685, DOI 10.1182/blood-2010-01-264960; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kool M, 2012, J MED MICROBIOL, V61, P927, DOI 10.1099/jmm.0.038943-0; Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lencer WI, 2011, NEW ENGL J MED, V365, P1151, DOI 10.1056/NEJMcibr1107816; Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035; Levie K, 2002, SCAND J INFECT DIS, V34, P610, DOI 10.1080/00365540110080881; Li XR, 2011, EUR J PHARM BIOPHARM, V78, P107, DOI 10.1016/j.ejpb.2010.12.017; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mbow ML, 2011, NAT MED, V17, P415, DOI 10.1038/nm0411-415; McCluskie MJ, 2013, INT IMMUNOPHARMACOL, V16, P50, DOI 10.1016/j.intimp.2013.03.021; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Mettens P, 2008, VACCINE, V26, P1072, DOI 10.1016/j.vaccine.2007.12.018; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Morris K, 2013, LANCET INFECT DIS, V13, P396, DOI 10.1016/S1473-3099(13)70117-8; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Moser C, 2011, EXPERT REV VACCINES, V10, P437, DOI [10.1586/erv.11.15, 10.1586/ERV.11.15]; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061; Orr M.T., 2013, J CONTROL R IN PRESS; Orr MT, 2013, EUR J IMMUNOL, V43, P2398, DOI 10.1002/eji.201243124; Owusu-Agyei S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007302; Oyewumi MO, 2010, EXPERT REV VACCINES, V9, P1095, DOI 10.1586/ERV.10.89; Pal I, 2011, ADV DRUG DELIVER REV, V63, P909, DOI 10.1016/j.addr.2011.05.018; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]; Rumke HC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-348; Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]; Sablan BP, 2012, VACCINE, V30, P2689, DOI 10.1016/j.vaccine.2012.02.001; Saxena M, 2013, MICROBIOL-SGM, V159, P1, DOI 10.1099/mic.0.049601-0; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Schweneker K, 2013, IMMUNOBIOLOGY, V218, P664, DOI 10.1016/j.imbio.2012.07.029; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Seubert A, 2011, P NATL ACAD SCI USA, V108, P11169, DOI 10.1073/pnas.1107941108; Shah HB, 2012, J LEUKOCYTE BIOL, V92, P883, DOI 10.1189/jlb.0412177; SHAHUM E, 1988, IMMUNOLOGY, V65, P315; Sharma G, 2010, J CONTROL RELEASE, V147, P408, DOI 10.1016/j.jconrel.2010.07.116; Singh M, 2012, HUM VACC IMMUNOTHER, V8, P486, DOI 10.4161/hv.19229; Slutter B, 2011, J CONTROL RELEASE, V154, P123, DOI 10.1016/j.jconrel.2011.02.007; Smirnov D, 2011, VACCINE, V29, P5434, DOI 10.1016/j.vaccine.2011.05.061; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Szakacs A, 2013, NEUROLOGY, V80, P1315, DOI 10.1212/WNL.0b013e31828ab26f; Teo BKK, 2011, BIOMATERIALS, V32, P9866, DOI 10.1016/j.biomaterials.2011.08.088; The President's Council of Advisors on Science and Technology, 2010, REP PRES REENG INFL; Tong NKC, 2005, KIDNEY INT, V68, P2298, DOI 10.1111/j.1523-1755.2005.00689.x; Tritto E, 2009, VACCINE, V27, P3331, DOI 10.1016/j.vaccine.2009.01.084; Tsai TF, 2011, SCAND J INFECT DIS, V43, P702, DOI 10.3109/00365548.2011.580777; Ueno H, 2011, SEMIN IMMUNOL, V23, P21, DOI 10.1016/j.smim.2011.01.004; US Food and Drug Administration Center for Biologics Evaluation and Review, 2012, SUMM MIN VACC REL BI; Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310; Vogelbruch M, 2000, ALLERGY, V55, P883; Wack A, 2008, VACCINE, V26, P552, DOI 10.1016/j.vaccine.2007.11.054; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Wang HB, 2008, J LEUKOCYTE BIOL, V83, P817, DOI 10.1189/jlb.0607392; Wang YF, 2012, J BIOL CHEM, V287, P17152, DOI 10.1074/jbc.M112.347179; Watson DS, 2011, CLIN VACCINE IMMUNOL, V18, P289, DOI 10.1128/CVI.00425-10; Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135; Yanasarn N, 2011, MOL PHARMACEUT, V8, P1174, DOI 10.1021/mp200016d; Yang M, 2012, INT IMMUNOPHARMACOL, V13, P408, DOI 10.1016/j.intimp.2012.05.003; Zhang HZ, 2011, PROTEOMICS, V11, P4569, DOI 10.1002/pmic.201100037	128	788	834	17	347	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1597	1608		10.1038/nm.3409	http://dx.doi.org/10.1038/nm.3409			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24309663	Bronze			2022-12-27	WOS:000328181400028
J	Krause, DS; Fulzele, K; Catic, A; Sun, CC; Dombkowski, D; Hurley, MP; Lezeau, S; Attar, E; Wu, JY; Lin, HY; Divieti-Pajevic, P; Hasserjian, RP; Schipani, E; Van Etten, RA; Scadden, DT				Krause, Daniela S.; Fulzele, Keertik; Catic, Andre; Sun, Chia Chi; Dombkowski, David; Hurley, Michael P.; Lezeau, Sanon; Attar, Eyal; Wu, Joy Y.; Lin, Herbert Y.; Divieti-Pajevic, Paola; Hasserjian, Robert P.; Schipani, Ernestina; Van Etten, Richard A.; Scadden, David T.			Differential regulation of myeloid leukemias by the bone marrow microenvironment	NATURE MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; STEM-CELLS; MICE; PROGENITOR; ENGRAFTMENT; EXPRESSION; INDUCTION; RECEPTOR; HORMONE; MLL-AF9	Like their normal hematopoietic stem cell counterparts, leukemia stem cells (LSCs) in chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML) are presumed to reside in specific niches in the bone marrow microenvironment (BMM)(1) and may be the cause of relapse following chemotherapy(2). Targeting the niche is a new strategy to eliminate persistent and drug-resistant LSCs. CD44 (refs. 3,4) and interleukin-6 (ref. 5) have been implicated previously in the LSC niche. Transforming growth factor-beta 1 (TGF-beta 1) is released during bone remodeling(6) and plays a part in maintenance of CML LSCs7, but a role for TGF-beta 1 from the BMM has not been defined. Here, we show that alteration of the BMM by osteoblastic cell-specific activation of the parathyroid hormone (PTH) receptor(8,9) attenuates BCR-ABL1 oncogene-induced CML-like myeloproliferative neoplasia (MPN)(10) but enhances MLL-AF9 oncogene-induced AML(11) in mouse transplantation models, possibly through opposing effects of increased TGF-beta 1 on the respective LSCs. PTH treatment caused a 15-fold decrease in LSCs in wild-type mice with CML-like MPN and reduced engraftment of immune-deficient mice with primary human CML cells. These results demonstrate that LSC niches in CML and AML are distinct and suggest that modulation of the BMM by PTH may be a feasible strategy to reduce LSCs, a prerequisite for the cure of CML.	[Krause, Daniela S.; Catic, Andre; Hurley, Michael P.; Lezeau, Sanon; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Krause, Daniela S.; Catic, Andre; Hurley, Michael P.; Lezeau, Sanon; Scadden, David T.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Krause, Daniela S.; Catic, Andre; Hurley, Michael P.; Lezeau, Sanon; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Krause, Daniela S.; Catic, Andre; Hurley, Michael P.; Lezeau, Sanon; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA USA; [Krause, Daniela S.; Dombkowski, David; Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Fulzele, Keertik; Wu, Joy Y.; Divieti-Pajevic, Paola] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Sun, Chia Chi; Lin, Herbert Y.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Attar, Eyal; Scadden, David T.] Massachusetts Gen Hosp, Dept Med, Div Hematol & Oncol, Boston, MA 02114 USA; [Schipani, Ernestina] Indiana Univ Sch Med, Div Endocrinol, Indianapolis, IN 46202 USA; [Van Etten, Richard A.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington; Tufts Medical Center	Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	rvanetten@tuftsmedicalcenter.org; dscadden@mgh.harvard.edu		Divieti Pajevic, Paola/0000-0001-9853-9837; Catic, Andre/0000-0002-3572-7598	Ellison Medical Foundation; US National Institute on Aging [K01AG036744];  [K08 CA138916-02];  [T32 CA009216];  [AR060221];  [R21AR060689];  [R01 CA090576];  [R01 HL089747];  [R01 HL044851];  [R01 CA148180]; NATIONAL CANCER INSTITUTE [K08CA138916, U54CA163191, T32CA009216, R01CA090576] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851, R01HL089747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060221, R21AR060689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG036744] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008466] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank A. Legedza and D. Neuberg for advice on statistical analysis and H.-H. Chen for helpful discussions. This work was supported by grants K08 CA138916-02 and T32 CA009216 to D. S. K., grant AR060221 to K. F. and P. D. P., grant R21AR060689 to E. S., grants R01 CA090576 and R01 HL089747 to R. A. V., grants R01 HL044851 and R01 CA148180 and a grant from The Ellison Medical Foundation to D.T.S. A.C. was supported by US National Institute on Aging grant K01AG036744.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Burgess TL, 1999, J CELL BIOL, V145, P527, DOI 10.1083/jcb.145.3.527; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Heaney NB, 2010, BLOOD, V115, P2241, DOI 10.1182/blood-2008-06-164582; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Li SG, 2001, BLOOD, V97, P1442, DOI 10.1182/blood.V97.5.1442; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Wang JCY, 1998, BLOOD, V91, P2406, DOI 10.1182/blood.V91.7.2406.2406_2406_2414; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012	25	177	186	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1513	+		10.1038/nm.3364	http://dx.doi.org/10.1038/nm.3364			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24162813	Green Submitted, Green Accepted			2022-12-27	WOS:000326920300029
J	Wilsonto, BS				Wilsonto, Blake S.			Toward better representations of sound with cochlear implants	NATURE MEDICINE			English	Editorial Material							SPEECH RECOGNITION		[Wilsonto, Blake S.] Duke Univ, Med Ctr, Duke Hearing Ctr, Durham, NC 27710 USA; [Wilsonto, Blake S.] Duke Univ, Dept Surg, Durham, NC USA; [Wilsonto, Blake S.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Wilsonto, Blake S.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Wilsonto, BS (corresponding author), Duke Univ, Med Ctr, Duke Hearing Ctr, Durham, NC 27710 USA.	blake.wilson@duke.edu			NIH; RTI; Duke University; UCSF; University of Iowa; MED-EL; Cochlear Americas; Advanced Bionics; Storz Instrument Company	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RTI; Duke University; UCSF; University of Iowa; MED-EL; Cochlear Americas; Advanced Bionics; Storz Instrument Company	The principal support for our work was provided by the NIH. This support included funding for the seven projects described in this essay plus additional projects also in the field of cochlear implants. Further financial and other support was provided by the RTI, Duke University, UCSF, the University of Iowa, MED-EL, Cochlear Americas, Advanced Bionics and the Storz Instrument Company. Of course, we could not have done anything without our research subjects, and we were blessed with some of the best. Indeed, we were continually amazed by their engagement in the studies, and by their generosity in spending time with us and in helping to improve the human condition. Many sponsors, research subjects, administrators, collaborating investigators and colleagues at the cochlear-implant companies made essential contributions to our shared efforts. The most important source of support for me is my wonderful family. We have had spectacularly good times together, and my wife and our two daughters have tolerated with gracious good humor my 'daydreams' and my time away in intense work or protracted travel. I am so very lucky.	Bilger RC, 1977, ANN OTOL RHINOL  S38, V86, P1, DOI 10.1177/00034894770860S303; Gifford RH, 2008, AUDIOL NEURO-OTOL, V13, P193, DOI 10.1159/000113510; *NAT I HLTH, 1995, NIH CONSENSUS STATE, V13, P1; National Institutes of Health, 1988, NCI MON, V7, P1; Vale RD, 2012, NAT MED, V18, P1486, DOI 10.1038/nm.2925; Wilson B.S., 2012, BETTER HEARING COCHL; Wilson B.S., 2012, COCHLEAR IMPLANTS OT; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Wilson BS, 2011, PROG BRAIN RES, V194, P117, DOI 10.1016/B978-0-444-53815-4.00012-1; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0	10	10	10	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1245	1248		10.1038/nm.3343	http://dx.doi.org/10.1038/nm.3343			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100996	Green Submitted			2022-12-27	WOS:000325531700022
J	Delorme, R; Ey, E; Toro, R; Leboyer, M; Gillberg, C; Bourgeron, T				Delorme, Richard; Ey, Elodie; Toro, Roberto; Leboyer, Marion; Gillberg, Christopher; Bourgeron, Thomas			Progress toward treatments for synaptic defects in autism	NATURE MEDICINE			English	Article							FRAGILE-X-SYNDROME; TUBEROUS SCLEROSIS COMPLEX; BTBR MOUSE MODEL; SPECTRUM DISORDERS; RETT-SYNDROME; DEVELOPMENTAL TRAJECTORIES; BEHAVIORAL ABNORMALITIES; MINOCYCLINE TREATMENT; SOCIAL-BEHAVIOR; PARTIAL RESCUE	Autism spectrum disorder (ASD) encompasses a range of disorders that are characterized by social and communication deficits and repetitive behaviors. For the majority of affected individuals, the cause of ASD remains unknown, but in at least 20% of the cases, a genetic cause can be identified. There is currently no cure for ASD; however, results from mouse models indicate that some forms of the disorder could be alleviated even at the adult stage. Genes involved in ASD seem to converge on common pathways altering synaptic homeostasis. We propose, given the clinical heterogeneity of ASD, that specific 'synaptic clinical trials' should be designed and launched with the aim of establishing whether phenotype 'reversals' could also occur in humans.	[Delorme, Richard; Ey, Elodie; Toro, Roberto; Bourgeron, Thomas] Inst Pasteur, Human Genet & Cognit Funct Unit, Paris, France; [Delorme, Richard; Ey, Elodie; Toro, Roberto; Bourgeron, Thomas] Inst Pasteur, CNRS, Associated Res Unit Genes Synapses & Cognit 2182, Paris, France; [Delorme, Richard; Ey, Elodie; Toro, Roberto; Bourgeron, Thomas] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Delorme, Richard] Robert Debre Hosp, AP HP, Dept Child & Adolescent Psychiat, Paris, France; [Leboyer, Marion] Hop Henri Mondor, INSERM, Psychiat Genet Team, U955, F-94010 Creteil, France; [Leboyer, Marion; Bourgeron, Thomas] Fondat FondaMental, Creteil, France; [Gillberg, Christopher] Univ Gothenburg, Gillberg Neuropsychiat Ctr, Gothenburg, Sweden; [Gillberg, Christopher] UCL, Inst Child Hlth, London, England; [Gillberg, Christopher] Univ Glasgow, Glasgow, Lanark, Scotland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Gothenburg; University of London; University College London; University of Glasgow	Bourgeron, T (corresponding author), Inst Pasteur, Human Genet & Cognit Funct Unit, Paris, France.	thomasb@pasteur.fr	Leboyer, Marion/AAW-3648-2021	Leboyer, Marion/0000-0001-5473-3697; Ey, Elodie/0000-0002-8202-3163; Toro, Roberto/0000-0002-6671-858X; Delorme, Richard/0000-0002-5614-3663; Bourgeron, Thomas/0000-0001-8164-9220	Institut Pasteur; Bettencourt-Schueller foundation; Centre National de la Recherche Scientifique; University Paris Diderot; Agence Nationale de la Recherche [ANR-08-MNPS-037-01-SynGen]; Neuron-ERANET (EUHF-AUTISM); Fondation de France; Conny-Maeva Charitable Foundation; Cognacq Jay Foundation; Orange Foundation; Fondamental Foundation; Innovative Medicines Initiative Joint Undertaking [115300]; European Union; European Federation of Pharmaceutical Industries and Associations	Institut Pasteur(European Commission); Bettencourt-Schueller foundation; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot; Agence Nationale de la Recherche(French National Research Agency (ANR)); Neuron-ERANET (EUHF-AUTISM); Fondation de France(Fondation de France); Conny-Maeva Charitable Foundation; Cognacq Jay Foundation; Orange Foundation; Fondamental Foundation; Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations	We thank D. DiGregorio and I. Cloez-Tayarini for critical reading of the manuscript and G. Huguet for the illustrations. This work was funded by the Institut Pasteur, the Bettencourt-Schueller foundation, Centre National de la Recherche Scientifique, University Paris Diderot, Agence Nationale de la Recherche (ANR-08-MNPS-037-01-SynGen), Neuron-ERANET (EUHF-AUTISM), the Fondation de France, the Conny-Maeva Charitable Foundation, the Cognacq Jay Foundation, the Orange Foundation, the Fondamental Foundation and the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115300, the resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007 - 2013) and European Federation of Pharmaceutical Industries and Associations companies in kind contribution.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Berry-Kravis EM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004214; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Bilousova TV, 2009, J MED GENET, V46, P94, DOI 10.1136/jmg.2008.061796; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Castren E, 2012, J NEUROSCI, V32, P14074, DOI 10.1523/JNEUROSCI.3287-12.2012; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Clement JP, 2012, CELL, V151, P709, DOI 10.1016/j.cell.2012.08.045; Constantino JN, 2009, DEV PSYCHOPATHOL, V21, P127, DOI 10.1017/S095457940900008X; Conti S, 2012, J CHILD NEUROL, V27, P392, DOI 10.1177/0883073811420296; Dahlhaus R, 2010, BEHAV BRAIN RES, V208, P96, DOI 10.1016/j.bbr.2009.11.019; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dawson G, 2012, J AM ACAD CHILD PSY, V51, P1150, DOI 10.1016/j.jaac.2012.08.018; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Ey E, 2012, GENES BRAIN BEHAV, V11, P928, DOI 10.1111/j.1601-183X.2012.00849.x; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; Fountain C, 2012, PEDIATRICS, V129, pE1112, DOI 10.1542/peds.2011-1601; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gillberg C, 2010, RES DEV DISABIL, V31, P1543, DOI 10.1016/j.ridd.2010.06.002; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goebel-Goody SM, 2012, GENES BRAIN BEHAV, V11, P586, DOI 10.1111/j.1601-183X.2012.00781.x; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Henderson C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004218; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Howard MA, 2010, P NATL ACAD SCI USA, V107, P3805, DOI 10.1073/pnas.0914422107; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kamio Y, 2013, AUTISM, V17, P15, DOI 10.1177/1362361312436848; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; King BH, 2009, ARCH GEN PSYCHIAT, V66, P583, DOI 10.1001/archgenpsychiatry.2009.30; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; Lacaria M, 2012, HUM MOL GENET, V21, P3083, DOI 10.1093/hmg/dds124; Landa RJ, 2013, CHILD DEV, V84, P429, DOI 10.1111/j.1467-8624.2012.01870.x; Lang M, 2013, HUM MOL GENET, V22, P358, DOI 10.1093/hmg/dds433; LeBlanc JJ, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/921680; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lemonnier E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.124; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; McCleery JP, 2009, BIOL PSYCHIAT, V66, P950, DOI 10.1016/j.biopsych.2009.07.031; McCracken JT, 2002, NEW ENGL J MED, V347, P314, DOI 10.1056/NEJMoa013171; McPheeters ML, 2011, PEDIATRICS, V127, pE1312, DOI 10.1542/peds.2011-0427; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ogier M, 2007, J NEUROSCI, V27, P10912, DOI 10.1523/JNEUROSCI.1869-07.2007; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Paribello C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-91; Paylor R, 2008, BEHAV NEUROSCI, V122, P1371, DOI 10.1037/a0013047; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Percy AK, 2010, ANN NEUROL, V68, P951, DOI 10.1002/ana.22154; Phelan K, 2011, MOL SYNDROMOL, V2, P186, DOI 10.1159/000334260; Pitcher MR, 2013, HUM MOL GENET, V22, P2626, DOI 10.1093/hmg/ddt111; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rotschafer SE, 2012, BRAIN RES, V1439, P7, DOI 10.1016/j.brainres.2011.12.041; Roux JC, 2007, M S-MED SCI, V23, P805, DOI 10.1051/medsci/20072310805; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Silverman JL, 2013, NEUROPHARMACOLOGY, V64, P268, DOI 10.1016/j.neuropharm.2012.07.013; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Spencer CA, 2008, BEHAV NEUROSCI, V122, P710, DOI 10.1037/0735-7044.122.3.710; Spooren W, 2012, TRENDS PHARMACOL SCI, V33, P669, DOI 10.1016/j.tips.2012.09.004; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Swangera SA, 2013, NEUROSCIENCE, V232, P106, DOI 10.1016/j.neuroscience.2012.12.003; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tambuyzer E, 2010, NAT REV DRUG DISCOV, V9, P921, DOI 10.1038/nrd3275; Tierney AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039127; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Utari A, 2010, AJIDD-AM J INTELLECT, V115, P433, DOI 10.1352/1944-7558-115.5.433; Veeraragavan S, 2012, BEHAV BRAIN RES, V228, P1, DOI 10.1016/j.bbr.2011.11.018; Verhoeven WMA, 2012, NEUROPSYCH DIS TREAT, V8, P175, DOI 10.2147/NDT.S30506; Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27; Westmark CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026549; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yang M, 2011, AUTISM RES, V4, P17, DOI 10.1002/aur.163; Yu TW, 2013, NEURON, V77, P259, DOI 10.1016/j.neuron.2012.11.002; Zanella S, 2008, RESP PHYSIOL NEUROBI, V160, P116, DOI 10.1016/j.resp.2007.08.009; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	116	132	135	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					685	694		10.1038/nm.3193	http://dx.doi.org/10.1038/nm.3193			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744158	Green Submitted			2022-12-27	WOS:000319981600017
J	Schumacker, PT				Schumacker, Paul T.			Nitric oxide quenches the fire in heart mitochondria	NATURE MEDICINE			English	Editorial Material							REPERFUSION; ISCHEMIA		Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Schumacker, PT (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.	p-schumacker@northwestern.edu		Schumacker, Paul T/0000-0001-9591-2034				AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Iwase H, 2007, FREE RADICAL BIO MED, V43, P590, DOI 10.1016/j.freeradbiomed.2007.05.017; Jones SP, 2006, J MOL CELL CARDIOL, V40, P16, DOI 10.1016/j.yjmcc.2005.09.011; Schriewer JM, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000159	8	6	6	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					666	667		10.1038/nm.3224	http://dx.doi.org/10.1038/nm.3224			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744141				2022-12-27	WOS:000319981600008
J	Lidell, ME; Betz, MJ; Leinhard, OD; Heglind, M; Elander, L; Slawik, M; Mussack, T; Nilsson, D; Romu, T; Nuutila, P; Virtanen, KA; Beuschlein, F; Persson, A; Borga, M; Enerback, S				Lidell, Martin E.; Betz, Matthias J.; Leinhard, Olof Dahlqvist; Heglind, Mikael; Elander, Louise; Slawik, Marc; Mussack, Thomas; Nilsson, Daniel; Romu, Thobias; Nuutila, Pirjo; Virtanen, Kirsi A.; Beuschlein, Felix; Persson, Anders; Borga, Magnus; Enerback, Sven			Evidence for two types of brown adipose tissue in humans	NATURE MEDICINE			English	Article							ADULT HUMANS; WHITE; FAT; IDENTIFICATION; ADIPOCYTES; PREVALENCE; ACTIVATION; INFANT; MOUSE; CELLS	The previously observed supraclavicular depot of brown adipose tissue (BAT) in adult humans was commonly believed to be the equivalent of the interscapular thermogenic organ of small mammals. This view was recently disputed(1) on the basis of the demonstration that this depot consists of beige (also called brite) brown adipocytes, a newly identified type of brown adipocyte that is distinct from the classical brown adipocytes that make up the interscapular thermogenic organs of other mammals. A combination of high-resolution imaging techniques and histological and biochemical analyses showed evidence for an anatomically distinguishable interscapular BAT (iBAT) depot in human infants that consists of classical brown adipocytes, a cell type that has so far not been shown to exist in humans. On the basis of these findings, we conclude that infants, similarly to rodents, have the bona fide iBAT thermogenic organ consisting of classical brown adipocytes that is essential for the survival of small mammals in a cold environment.	[Lidell, Martin E.; Betz, Matthias J.; Heglind, Mikael; Nilsson, Daniel; Enerback, Sven] Univ Gothenburg, Dept Med & Clin Genet, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden; [Betz, Matthias J.; Slawik, Marc; Beuschlein, Felix] Klinikum Ludwig Maximilians Univ LMU, Endocrine Res Unit, Med Klin & Poliklin 4, Munich, Germany; [Leinhard, Olof Dahlqvist; Elander, Louise; Romu, Thobias; Persson, Anders; Borga, Magnus] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Leinhard, Olof Dahlqvist] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Elander, Louise; Persson, Anders] Linkoping Univ Hosp, Cty Council Ostergotland, S-58185 Linkoping, Sweden; [Mussack, Thomas] Klinikum LMU, Dept Surg Innenstadt, Munich, Germany; [Romu, Thobias; Borga, Magnus] Linkoping Univ, Dept Biomed Engn, IMT, Linkoping, Sweden; [Nuutila, Pirjo; Virtanen, Kirsi A.] Univ Turku, Turku PET Ctr, Turku, Finland	University of Gothenburg; University of Munich; Linkoping University; Linkoping University; City Council Ostergotland; Linkoping University; University of Munich; Linkoping University; University of Turku	Enerback, S (corresponding author), Univ Gothenburg, Dept Med & Clin Genet, Inst Biomed, Sahlgrenska Acad, Gothenburg, Sweden.	sven.enerback@medgen.gu.se	Borga, Magnus/O-1903-2015; Nuutila, Pirjo/J-2087-2012; Dahlqvist Leinhard, Olof/K-4228-2013; Persson, Anders s/L-1004-2013	Dahlqvist Leinhard, Olof/0000-0002-6189-0807; Persson, Anders s/0000-0002-9446-6981; Betz, Matthias Johannes/0000-0002-6946-1871; Nuutila, Pirjo/0000-0001-9597-338X; Beuschlein, Felix/0000-0001-7826-3984	S.E. from the Swedish Research Council [2009-2590, 2010-3281]; Knut and Alice Wallenberg Foundation; Sahlgrenska's University Hospital (LUA-ALF); EU [HEALTH-F2-2011-278373]; IngaBritt and Arne Lundgren Foundation; Soderberg Foundation; King Gustaf V and Queen Victoria Freemason Foundation; Swedish Foundation for Strategic Research through the Center for Cardiovascular and Metabolic Research; Fritz Thyssen Stiftung	S.E. from the Swedish Research Council(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sahlgrenska's University Hospital (LUA-ALF); EU(European Commission); IngaBritt and Arne Lundgren Foundation; Soderberg Foundation; King Gustaf V and Queen Victoria Freemason Foundation; Swedish Foundation for Strategic Research through the Center for Cardiovascular and Metabolic Research(Swedish Foundation for Strategic Research); Fritz Thyssen Stiftung	This work was supported by grants to S.E. from the Swedish Research Council (grant numbers 2009-2590 and 2010-3281), The Knut and Alice Wallenberg Foundation, Sahlgrenska's University Hospital (LUA-ALF), EU grants (HEALTH-F2-2011-278373; DIABAT), The IngaBritt and Arne Lundgren Foundation, The Soderberg Foundation, The King Gustaf V and Queen Victoria Freemason Foundation and the Swedish Foundation for Strategic Research through the Center for Cardiovascular and Metabolic Research. M.J.B. was supported by a postdoctoral fellowship from the Fritz Thyssen Stiftung. We thank B. Mauracher (Medizinische Klinik und Poliklinik IV, Klinikum der LMU) for excellent technical assistance and acknowledge the Centre for Cellular Imaging and the Genomics Core Facility at Sahlgrenska Academy for technical assistance and use of equipment. We also acknowledge assistance from J. Kilberg and P. Quick (radiology technicians at CMIV) and J. Berge, E. Edston and H. Bengtsson (forensic pathologists) at the National Board of Forensic Medicine, Linkoping Division, Department of Forensic Medicine, Linkoping.	AHERNE W, 1966, J PATHOL BACTERIOL, V91, P223, DOI 10.1002/path.1700910126; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Cannon B, 2012, NATURE, V488, P286, DOI 10.1038/488286a; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; HEATON JM, 1972, J ANAT, V112, P35; HOUSTEK J, 1993, J CLIN ENDOCR METAB, V77, P382, DOI 10.1210/jc.77.2.382; Hu HCH, 2012, J MAGN RESON IMAGING, V35, P938, DOI 10.1002/jmri.23531; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	21	470	483	1	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					631	634		10.1038/nm.3017	http://dx.doi.org/10.1038/nm.3017			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23603813	Green Submitted			2022-12-27	WOS:000318583000037
J	Sadanandam, A; Lyssiotis, CA; Homicsko, K; Collisson, EA; Gibb, WJ; Wullschleger, S; Ostos, LCG; Lannon, WA; Grotzinger, C; Del Rio, M; Lhermitte, B; Olshen, AB; Wiedenmann, B; Cantley, LC; Gray, JW; Hanahan, D				Sadanandam, Anguraj; Lyssiotis, Costas A.; Homicsko, Krisztian; Collisson, Eric A.; Gibb, William J.; Wullschleger, Stephan; Ostos, Liliane C. Gonzalez; Lannon, William A.; Grotzinger, Carsten; Del Rio, Maguy; Lhermitte, Benoit; Olshen, Adam B.; Wiedenmann, Bertram; Cantley, Lewis C.; Gray, Joe W.; Hanahan, Douglas			A colorectal cancer classification system that associates cellular phenotype and responses to therapy	NATURE MEDICINE			English	Article							III COLON-CANCER; GENE-EXPRESSION; ADJUVANT TREATMENT; IRINOTECAN; CETUXIMAB; SUBTYPES; TUMORIGENESIS; LEUCOVORIN; SIGNATURES; DIAGNOSIS	Colorectal cancer (CRC) is a major cause of cancer mortality. Whereas some patients respond well to therapy, others do not, and thus more precise, individualized treatment strategies are needed. To that end, we analyzed gene expression profiles from 1,290 CRC tumors using consensus-based unsupervised clustering. The resultant clusters were then associated with therapeutic response data to the epidermal growth factor receptor-targeted drug cetuximab in 80 patients. The results of these studies define six clinically relevant CRC subtypes. Each subtype shares similarities to distinct cell types within the normal colon crypt and shows differing degrees of 'sternness' and Wnt signaling. Subtype-specific gene signatures are proposed to identify these subtypes. Three subtypes have markedly better disease-free survival (DES) after surgical resection, suggesting these patients might be spared from the adverse effects of chemotherapy when they have localized disease. One of these three subtypes, identified by filamin A expression, does not respond to cetuximab but may respond to cMET receptor tyrosine kinase inhibitors in the metastatic setting. Two other subtypes, with poor and intermediate DFS, associate with improved response to the chemotherapy regimen FOLFIRI1 in adjuvant or metastatic settings. Development of clinically deployable assays for these subtypes and of subtype-specific therapies may contribute to more effective management of this challenging disease.	[Sadanandam, Anguraj] Swiss Inst Bioinformat, Lausanne, Switzerland; [Sadanandam, Anguraj; Homicsko, Krisztian; Wullschleger, Stephan; Ostos, Liliane C. Gonzalez; Hanahan, Douglas] Swiss Fed Inst Technol Lausanne EPFL, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Lyssiotis, Costas A.; Lannon, William A.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Homicsko, Krisztian] CHU Vaudois, Dept Oncol, Med Oncol Serv, Lausanne, Switzerland; [Collisson, Eric A.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Gibb, William J.] Gen Hlth, Redwood City, CA USA; [Grotzinger, Carsten; Wiedenmann, Bertram] Univ Med Berlin, Dept Gastroenterol & Hepatol, Charite, Berlin, Germany; [Del Rio, Maguy] Univ Montpellier, Ctr Reg Lutte Canc Val Aurelle Paul Lamarque, Inst Rech Cancerol Montpellier, Inst Natl Sante & Rech Med,U896, F-34059 Montpellier, France; [Lhermitte, Benoit] Univ Inst Pathol, CHUV, Lausanne, Switzerland; [Olshen, Adam B.] Univ Calif San Francisco, Dept Epidemiol & Biostatist, San Francisco, CA 94143 USA; [Olshen, Adam B.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA USA; [Gray, Joe W.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA	Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California San Francisco; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Oregon Health & Science University	Gray, JW (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	grayjo@oshu.edu; douglas.hanahan@epfl.ch	Lyssiotis, Costas A/AAI-1923-2019; Cantley, Lewis C/D-1800-2014; Grötzinger, Carsten/B-6938-2008; Gray, Joe/AAX-9549-2020	Lyssiotis, Costas A/0000-0001-9309-6141; Cantley, Lewis C/0000-0002-1298-7653; Grötzinger, Carsten/0000-0001-9872-3087; Wullschleger, Stephan/0000-0002-5521-2276; Sadanandam, Anguraj/0000-0001-8485-5150; Wiedenmann, Bertram/0000-0002-7890-2552; Homicsko, Krisztian/0000-0003-0912-6198	US Department of Defense [BC087768]; US National Institutes of Health [U54 CA 112970]; Stand Up To Cancer-AACR Dream Team Translational Cancer Research [SU2C-AACR-DT0409]; Swiss National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA112970, K08CA137153] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up To Cancer-AACR Dream Team Translational Cancer Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank P. Schulz (Charite, Universitatsmedizin) for providing RNA from xenograft tumors and for comments of the manuscript. We thank R.A. Du Pasquier (CHUV) for providing the HT29 cell line, P. Depeille (University of California-San Francisco) for the SW480, SW48, HCT8, LS174T and SW948 cell lines, and H. Ying (MD Anderson Medical Center) for the NCI-H508, LS1034, SW620, COLO320, SW1417, HCT116, RKO and DLD1 cell lines. The TOP/FOP-flash and Renilla constructs were a generous gift from S. Kobayashi (Beth Israel Deaconess Medical Center). We particularly acknowledge G. Poulogiannis for insightful feedback and assistance with statistical analysis of survival data. We also thank C. Fuerer, S.S. Sidhu, J. Yun and N. Divorne-Formenton for advice on the experimental design, C.R. Thomas for help with editing the manuscript, the Histology Core Facility of EPFL for help with immunohistochemistry. AS. was partially supported by a US Department of Defense Postdoctoral Fellowship (BC087768). CAL. is the Amgen Fellow of the Damon Runyon Cancer Research Foundation (DRG-2056-10). J.W.G. is supported by the US National Institutes of Health grant U54 CA 112970 and by the Stand Up To Cancer-AACR Dream Team Translational Cancer Research Grant SU2C-AACR-DT0409. This work was supported by a Swiss National Science Foundation project grant awarded to D.H.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Andre T, 1999, EUR J CANCER, V35, P1343, DOI 10.1016/S0959-8049(99)00150-1; Banerjea A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-21; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Del Rio M, 2007, J CLIN ONCOL, V25, P773, DOI 10.1200/JCO.2006.07.4187; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hoshida Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015543; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Jorissen RN, 2008, CLIN CANCER RES, V14, P8061, DOI 10.1158/1078-0432.CCR-08-1431; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ogino S, 2009, CLIN CANCER RES, V15, P7322, DOI 10.1158/1078-0432.CCR-09-1570; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Perez-Villamil B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-260; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Cutsem E, 2009, ANN ONCOL, V20, P49, DOI 10.1093/annonc/mdp126; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Zhou AX, 2011, INT J CANCER, V128, P839, DOI 10.1002/ijc.25417	38	672	698	0	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2013	19	5					619	625		10.1038/nm.3175	http://dx.doi.org/10.1038/nm.3175			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23584089	Green Published, Green Accepted			2022-12-27	WOS:000318583000035
J	Han, GW; Bian, L; Li, FL; Cotrim, A; Wang, DN; Lu, JB; Deng, Y; Bird, G; Sowers, A; Mitchell, JB; Gutkind, JS; Zhao, R; Raben, D; ten Dijke, P; Refaeli, Y; Zhang, QH; Wang, XJ				Han, Gangwen; Bian, Li; Li, Fulun; Cotrim, Ana; Wang, Donna; Lu, Jianbo; Deng, Yu; Bird, Gregory; Sowers, Anastasia; Mitchell, James B.; Gutkind, J. Silvio; Zhao, Rui; Raben, David; ten Dijke, Peter; Refaeli, Yosef; Zhang, Qinghong; Wang, Xiao-Jing			Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis	NATURE MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; TGF-BETA; NECK-CANCER; SIGNALING PATHWAY; MICE; PALIFERMIN; DISEASE; CHEMOTHERAPY; CHEMORADIOTHERAPY	We report that K5.Smad7 mice, which express a Smad7 transgene under the control of a keratin 5 promoter, were resistant to radiation-induced oral mucositis, a painful oral ulceration. In addition to nuclear factor kappa B (NF-kappa B) activation, which is known to contribute to oral mucositis, we found activated transforming growth factor beta (TGF-beta) signaling in cells from this condition. Smad7 dampened both pathways to attenuate inflammation, growth inhibition and apoptosis. Additionally, Smad7 promoted oral epithelial migration to close the wound. Further analyses revealed that TGF-beta signaling Smads and their co-repressor C-terminal binding protein 1 (CtBP1) transcriptionally repressed Rac1, and that Smad7 abrogated this repression. Knocking down Rac1 expression in mouse keratinocytes abrogated Smad7-induced migration. Topical application of Smad7 protein conjugated with a cell-permeable Tat tag to oral mucosa showed prophylactic and therapeutic effects on radiation-induced oral mucositis in mice. Thus, we have identified new molecular mechanisms involved in oral mucositis pathogenesis, and our data suggest an alternative therapeutic strategy to block multiple pathological processes in this condition.	[Han, Gangwen; Bian, Li; Li, Fulun; Wang, Donna; Wang, Xiao-Jing] Univ Colorado Denver, Dept Pathol, Aurora, CO 80045 USA; [Bian, Li; Lu, Jianbo] Kunming Med Univ, Dept Pathol, Affiliated Hosp 1, Kunming, Peoples R China; [Li, Fulun] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Dermatol, Shanghai, Peoples R China; [Cotrim, Ana; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA; [Deng, Yu; Bird, Gregory; Refaeli, Yosef; Zhang, Qinghong] Univ Colorado Denver, Dept Dermatol, Aurora, CO USA; [Sowers, Anastasia; Mitchell, James B.] NCI, Radiat Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Zhao, Rui] Univ Colorado, Dept Mol Genet & Biochem, Aurora, CO USA; [Raben, David] Univ Colorado Denver, Dept Radiat Oncol, Aurora, CO USA; [ten Dijke, Peter] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kunming Medical University; Shanghai University of Traditional Chinese Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Wang, XJ (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA.	qinghong.zhang@ucdenver.edu; xj.wang@ucdenver.edu	Gutkind, J. Silvio/J-1201-2016; Dijke, Peter ten/AAG-4660-2021; Han, Gangwen/A-1773-2014	Gutkind, J. Silvio/0000-0002-5150-4482; Dijke, Peter ten/0000-0002-7234-342X; bian, li/0000-0001-9916-3720	NIH [AR061792, DE015953, R01CA115468, R03DA033982, P30CA046934]; Colorado State/University of Colorado Bioscience Discovery Evaluation grant; National Natural Science Foundation of China (NSFC) [81060189]; NSFC [81102596]; Shanghai Rising-Star Program [12QA1403300]; Innovation Program of Shanghai Municipal Education Commission [12YZ067]; NATIONAL CANCER INSTITUTE [R01CA115468, ZIASC006321, ZIASC006387, P30CA046934, T32CA082086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015953, ZIADE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA033982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado State/University of Colorado Bioscience Discovery Evaluation grant; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants AR061792 and DE015953 to X.-J.W., R01CA115468 to Q.Z. and R03DA033982 to R.Z. and Q.Z. and the Colorado State/University of Colorado Bioscience Discovery Evaluation grant to X.-J.W., Q.Z. and Y.R. and was partially supported by NIH grant P30CA046934 to the University of Colorado Cancer Center. L.B. was supported by a grant (81060189) from The National Natural Science Foundation of China (NSFC). F.L. was supported by grants from the NSFC (81102596), The Shanghai Rising-Star Program (12QA1403300) and The Innovation Program of Shanghai Municipal Education Commission (12YZ067). The authors thank S. Said, C. Marshall and C. Liu for searching human oral mucositis clinical samples and C.Y. Li and G. Gang for their input on radiotherapy in patients with oral cancer. The authors also thank P. Garl for proofreading the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Ashcroft GS, 2000, CYTOKINE GROWTH F R, V11, P125, DOI 10.1016/S1359-6101(99)00036-2; Bergman LM, 2009, MOL CELL BIOL, V29, P4539, DOI 10.1128/MCB.00439-09; Bornstein S, 2009, J CLIN INVEST, V119, P3408, DOI 10.1172/JCI38854; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Castilho RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010503; Cotrim AP, 2012, INT J RADIAT ONCOL, V83, P1284, DOI 10.1016/j.ijrobp.2011.09.026; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dorr W, 2005, INT J RADIAT BIOL, V81, P557, DOI 10.1080/09553000500196136; Dorr W, 2005, RADIOTHER ONCOL, V75, P99, DOI 10.1016/j.radonc.2004.12.006; Elad S, 2011, EXPERT OPIN EMERG DR, V16, P183, DOI 10.1517/14728214.2011.528390; Elad S, 2010, EXPERT OPIN EMERG DR, V15, P713, DOI 10.1517/14728214.2010.528389; Fistarol SK, 2011, CURR PROBL DERMATOL, V40, P58, DOI 10.1159/000321051; Fowler JF, 2003, RADIOTHER ONCOL, V69, P161, DOI 10.1016/S0167-8140(03)00231-7; Haddad R, 2009, CANCER, V115, P4514, DOI 10.1002/cncr.24525; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Han GW, 2011, AM J PATHOL, V179, P1768, DOI 10.1016/j.ajpath.2011.06.003; He W, 2002, EMBO J, V21, P2580, DOI 10.1093/emboj/21.11.2580; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Henke M, 2011, J CLIN ONCOL, V29, P2815, DOI 10.1200/JCO.2010.32.4103; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Hoot KE, 2010, J CLIN INVEST, V120, P3606, DOI 10.1172/JCI43304; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Kalvala A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq486; Koch RM, 2000, WOUND REPAIR REGEN, V8, P179, DOI 10.1046/j.1524-475x.2000.00179.x; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Le QT, 2011, J CLIN ONCOL, V29, P2808, DOI 10.1200/JCO.2010.32.4095; Li AG, 2004, CANCER RES, V64, P7836, DOI 10.1158/0008-5472.CAN-04-1331; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Lu SL, 2004, CANCER RES, V64, P4405, DOI 10.1158/0008-5472.CAN-04-1032; Maier P, 2011, EXPERT OPIN BIOL TH, V11, P1135, DOI 10.1517/14712598.2011.580271; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Munshi A, 2005, METH MOLEC MED, V110, P21; O'Neill ID, 2008, J ORAL PATHOL MED, V37, P575, DOI 10.1111/j.1600-0714.2008.00693.x; Owens P, 2008, DEV BIOL, V322, P156, DOI 10.1016/j.ydbio.2008.07.020; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Qiu W, 2007, CANCER LETT, V245, P163, DOI 10.1016/j.canlet.2006.01.003; Scully C, 2006, ORAL DIS, V12, P229, DOI 10.1111/j.1601-0825.2006.01258.x; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Singh B, 2001, CANCER RES, V61, P4506; Sonis ST, 2009, CORE EVID, V4, P199; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Vagliano L, 2011, BONE MARROW TRANSPL, V46, P727, DOI 10.1038/bmt.2010.184; Weigelt C, 2011, EXPERT OPIN DRUG MET, V7, P505, DOI 10.1517/17425255.2011.566556; Wu HG, 2009, CANCER-AM CANCER SOC, V115, P3699, DOI 10.1002/cncr.24414; Wu JC, 2010, FUTURE ONCOL, V6, P1751, DOI 10.2217/FON.10.133; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106; Zheng CY, 2009, CLIN CANCER RES, V15, P4641, DOI 10.1158/1078-0432.CCR-09-0819	56	59	62	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					421	+		10.1038/nm.3118	http://dx.doi.org/10.1038/nm.3118			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23475202	Green Accepted			2022-12-27	WOS:000317109100026
J	Heo, J; Reid, T; Ruo, L; Breitbach, CJ; Rose, S; Bloomston, M; Cho, M; Lim, HY; Chung, HC; Kim, CW; Burke, J; Lencioni, R; Hickman, T; Moon, A; Lee, YS; Kim, MK; Daneshmand, M; Dubois, K; Longpre, L; Ngo, M; Rooney, C; Bell, JC; Rhee, BG; Patt, R; Hwang, TH; Kirn, DH				Heo, Jeong; Reid, Tony; Ruo, Leyo; Breitbach, Caroline J.; Rose, Steven; Bloomston, Mark; Cho, Mong; Lim, Ho Yeong; Chung, Hyun Cheol; Kim, Chang Won; Burke, James; Lencioni, Riccardo; Hickman, Theresa; Moon, Anne; Lee, Yeon Sook; Kim, Mi Kyeong; Daneshmand, Manijeh; Dubois, Kara; Longpre, Lara; Ngo, Minhtran; Rooney, Cliona; Bell, John C.; Rhee, Byung-Geon; Patt, Richard; Hwang, Tae-Ho; Kirn, David H.			Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer	NATURE MEDICINE			English	Article							ADVANCED HEPATOCELLULAR-CARCINOMA; MODIFIED RECIST; POXVIRUS; SORAFENIB; VIROTHERAPY; DELIVERY; CRITERIA; THERAPY	Oncolytic viruses and active immunotherapeutics have complementary mechanisms of action (MOA) that are both self amplifying in tumors, yet the impact of dose on subject outcome is unclear. JX-594 (Pexa-Vec) is an oncolytic and immunotherapeutic vaccinia virus. To determine the optimal JX-594 dose in subjects with advanced hepatocellular carcinoma (HCC), we conducted a randomized phase 2 dose-finding trial (n = 30). Radiologists infused low- or high-dose JX-594 into liver tumors (days 1, 15 and 29); infusions resulted in acute detectable intravascular JX-594 genomes. Objective intrahepatic Modified Response Evaluation Criteria in Solid Tumors (mRECIST) (15%) and Choi (62%) response rates and intrahepatic disease control (50%) were equivalent in injected and distant noninjected tumors at both doses. JX-594 replication and granulocyte-macrophage colony-stimulating factor (GM-CSF) expression preceded the induction of anticancer immunity. In contrast to tumor response rate and immune endpoints, subject survival duration was significantly related to dose (median survival of 14.1 months compared to 6.7 months on the high and low dose, respectively; hazard ratio 0.39; P = 0.020). JX-594 demonstrated oncolytic and immunotherapy MOA, tumor responses and dose-related survival in individuals with HCC.	[Heo, Jeong; Cho, Mong; Kim, Chang Won] Pusan Natl Univ, Dept Internal Med, Pusan, South Korea; [Heo, Jeong; Cho, Mong; Kim, Chang Won] Pusan Natl Univ Hosp, Med Res Inst, Pusan, South Korea; [Reid, Tony; Rose, Steven] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Ruo, Leyo] McMaster Univ, Dept Surg, Med Ctr, Hamilton, ON L8S 4L8, Canada; [Breitbach, Caroline J.; Burke, James; Hickman, Theresa; Moon, Anne; Dubois, Kara; Longpre, Lara; Bell, John C.; Kirn, David H.] Jennerex Inc, San Francisco, CA USA; [Bloomston, Mark] Ohio State Univ, Dept Surg, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Lim, Ho Yeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea; [Chung, Hyun Cheol] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Yongdong Severance Hosp, Seoul, South Korea; [Lencioni, Riccardo] Univ Pisa, Sch Med, Div Diagnost Imaging & Intervent, I-56100 Pisa, Italy; [Lee, Yeon Sook; Kim, Mi Kyeong; Hwang, Tae-Ho] SillaJen Inc, Pusan, South Korea; [Daneshmand, Manijeh; Bell, John C.] Ottawa Hosp Res Inst, Ctr Innovat Canc Therapeut, Ottawa, ON, Canada; [Ngo, Minhtran; Rooney, Cliona] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Ngo, Minhtran; Rooney, Cliona] Baylor Coll Med, Houston, TX 77030 USA; [Rooney, Cliona] Texas Childrens Hosp, Houston, TX 77030 USA; [Rhee, Byung-Geon] Green Cross Co, Yongin, South Korea; [Patt, Richard] RadMD, Doylestown, PA USA; [Hwang, Tae-Ho] Pusan Natl Univ, Dept Pharmacol, Pusan, South Korea	Pusan National University; Pusan National University; Pusan National University Hospital; University of California System; University of California San Diego; McMaster University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System; University of Pisa; University of Ottawa; Ottawa Hospital Research Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Green Cross Corporation; Pusan National University	Kirn, DH (corresponding author), Jennerex Inc, San Francisco, CA USA.	thhwang@pusan.ac.kr; dkirn@jennerex.com	Bloomston, Mark/E-2767-2011; Rooney, Cliona/ABD-5475-2021; Lencioni, Riccardo/AAC-4723-2022	Chung, Hyun/0000-0002-0920-9471; LENCIONI, RICCARDO ANTONIO/0000-0002-8535-6449	Korea Healthcare technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A091047]; Dan Duncan Cancer Center; Robert and Janice McNair Foundation; Baylor Research Advocates for Student Scientists Fund; Ontario Institute for Cancer Research; Terry Fox Foundation; Jennerex, Transgene SA (Illkirch, France); Green Cross Corporation; Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; Canadian Institute for Health Research (CIHR); NATIONAL CANCER INSTITUTE [P30CA016058, P30CA023100] Funding Source: NIH RePORTER	Korea Healthcare technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; Dan Duncan Cancer Center; Robert and Janice McNair Foundation; Baylor Research Advocates for Student Scientists Fund; Ontario Institute for Cancer Research; Terry Fox Foundation; Jennerex, Transgene SA (Illkirch, France); Green Cross Corporation; Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.-M. Limacher, M. Homerin, B.M. Bastien and M. Lusky (all from Transgene SA) gave insightful comments On the manuscript. T.-H.H. and M.K.K. were supported by a grant of the Korea Healthcare technology Research and Development Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A091047). C.R. was supported by a pilot grant from the Dan Duncan Cancer Center. M.N. was supported by the Robert and Janice McNair Foundation and Baylor Research Advocates for Student Scientists Fund. J.C.B. is supported by the Ontario Institute for Cancer Research and the Terry Fox Foundation. Funding was provided by Jennerex, Transgene SA (Illkirch, France) and the Green Cross Corporation; grants to T.-H.H. from Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; to J.C.B. from the Terry Fox Foundation and the Canadian Institute for Health Research (CIHR); and a pilot grant to C.R. from the Dan Duncan Cancer Center. This trial was registered with ClinicalTrials.gov, number NCT00554372.	Breitbach CJ, 2011, NATURE, V477, P99, DOI 10.1038/nature10358; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chiocca EA, 2002, NAT REV CANCER, V2, P938, DOI 10.1038/nrc948; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Edeline J, 2012, CANCER-AM CANCER SOC, V118, P147, DOI 10.1002/cncr.26255; Faivre S, 2011, CLIN CANCER RES, V17, P4504, DOI 10.1158/1078-0432.CCR-10-1708; Heise C, 2000, J CLIN INVEST, V105, P847, DOI 10.1172/JCI9762; Heo J, 2011, MOL THER, V19, P1170, DOI 10.1038/mt.2011.39; Hwang TH, 2011, MOL THER, V19, P1913, DOI 10.1038/mt.2011.132; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kim JH, 2006, MOL THER, V14, P361, DOI 10.1016/j.ymthe.2006.05.008; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Liu TC, 2008, MOL THER, V16, P1637, DOI 10.1038/mt.2008.143; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Parato KA, 2012, MOL THER, V20, P749, DOI 10.1038/mt.2011.276; Park BH, 2008, LANCET ONCOL, V9, P533, DOI 10.1016/S1470-2045(08)70107-4; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Thorne SH, 2007, J CLIN INVEST, V117, P3350, DOI 10.1172/JCI32727; Wein LM, 2003, CANCER RES, V63, P1317	22	509	552	2	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAR	2013	19	3					329	336		10.1038/nm.3089	http://dx.doi.org/10.1038/nm.3089			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396206	Green Accepted			2022-12-27	WOS:000316040700026
J	Paschos, GK; Ibrahim, S; Song, WL; Kunieda, T; Grant, G; Reyes, TM; Bradfield, CA; Vaughan, CH; Eiden, M; Masoodi, M; Griffin, JL; Wang, FF; Lawson, JA; FitzGerald, GA				Paschos, Georgios K.; Ibrahim, Salam; Song, Wen-Liang; Kunieda, Takeshige; Grant, Gregory; Reyes, Teresa M.; Bradfield, Christopher A.; Vaughan, Cheryl H.; Eiden, Michael; Masoodi, Mojgan; Griffin, Julian L.; Wang, Fenfen; Lawson, John A.; FitzGerald, Garret A.			Obesity in mice with adipocyte-specific deletion of clock component Arntl	NATURE MEDICINE			English	Review							CIRCADIAN CLOCK; FOOD-INTAKE; METABOLIC SYNDROME; SHIFT WORK; LEPTIN; RECEPTOR; FAT; TRANSCRIPTION; RESISTANCE; ENERGY	Adipocytes store excess energy in the form of triglycerides and signal the levels of stored energy to the brain. Here we show that adipocyte-specific deletion of Arntl (also known as Bmal1), a gene encoding a core molecular clock component, results in obesity in mice with a shift in the diurnal rhythm of food intake, a result that is not seen when the gene is disrupted in hepatocytes or pancreatic islets. Changes in the expression of hypothalamic neuropeptides that regulate appetite are consistent with feedback from the adipocyte to the central nervous system to time feeding behavior. Ablation of the adipocyte clock is associated with a reduced number of polyunsaturated fatty acids in adipocyte triglycerides. This difference between mutant and wild-type mice is reflected in the circulating concentrations of polyunsaturated fatty acids and nonesterified polyunsaturated fatty acids in hypothalamic neurons that regulate food intake. Thus, this study reveals a role for the adipocyte clock in the temporal organization of energy regulation, highlights timing as a modulator of the adipocyte-hypothalamic axis and shows the impact of timing of food intake on body weight.	[Paschos, Georgios K.; Ibrahim, Salam; Song, Wen-Liang; Kunieda, Takeshige; Grant, Gregory; Reyes, Teresa M.; Lawson, John A.; FitzGerald, Garret A.] Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab, Madison, WI USA; [Vaughan, Cheryl H.] Georgia State Univ, Ctr Obes Reversal, Dept Biol, Atlanta, GA 30303 USA; [Eiden, Michael; Masoodi, Mojgan; Griffin, Julian L.] Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Wang, Fenfen] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; Georgia State University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; University of Pennsylvania; Pennsylvania Medicine	FitzGerald, GA (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	garret@upenn.edu	Grant, Gregory Robert/I-3599-2019; Reyes, Teresa/GYI-8942-2022; Paschos, Georgios K/F-2802-2011; MASOODI, MOJGAN/P-1499-2019	Grant, Gregory Robert/0000-0002-0139-7658; Reyes, Teresa/0000-0003-3009-3749; MASOODI, MOJGAN/0000-0001-9840-1731; Song, Wenliang/0000-0002-1866-0635	US National Institutes of Health (NIH) [RO1 HL097800]; Medical Research Council [UD99999906]; NIH [R01 DK45586]; BBSRC [BB/H013539/2, BB/H013539/1] Funding Source: UKRI; MRC [MC_EX_G0800783, MC_UP_A090_1006] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H013539/1, BB/H013539/2] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006, MC_EX_G0800783] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK045586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES005703] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by US National Institutes of Health (NIH) grant RO1 HL097800 and Medical Research Council grant UD99999906. We thank M. Lazar for help with the ChIP experiments (funded by NIH R01 DK45586). We thank R. Ahima and the Mouse Phenotyping, Physiology and Metabolism Core of the Penn Diabetes Research Center (P30 DK19525) for performing body composition and behavioral analysis; D. Baldwin's Microarray Core Facility for performing the microarray analysis; and R. Freer and M. Adam for technical assistance. G.A.F. is the McNeil Professor of Translational Medicine and Therapeutics.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Cintra DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030571; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Ellingsen T, 2007, J R SOC PROMO HEALTH, V127, P265, DOI 10.1177/1466424007083702; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reyes TM, 2003, J NEUROSCI, V23, P5607; Roberts LD, 2009, GENOME MED, V1, DOI 10.1186/gm115; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Spiegel K, 2009, NAT REV ENDOCRINOL, V5, P253, DOI 10.1038/nrendo.2009.23; Stucchi P, 2012, ENDOCRINOLOGY, V153, P690, DOI 10.1210/en.2011-1023; Stunkard A, 1996, INT J OBESITY, V20, P1; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wei EH, 2010, CELL METAB, V11, P183, DOI 10.1016/j.cmet.2010.02.005; Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227	50	287	296	4	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1768	+		10.1038/nm.2979	http://dx.doi.org/10.1038/nm.2979			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142819	Green Accepted			2022-12-27	WOS:000311999800024
J	vom Berg, J; Prokop, S; Miller, KR; Obst, J; Kalin, RE; Lopategui-Cabezas, I; Wegner, A; Mair, F; Schipke, CG; Peters, O; Winter, Y; Becher, B; Heppner, FL				vom Berg, Johannes; Prokop, Stefan; Miller, Kelly R.; Obst, Juliane; Kaelin, Roland E.; Lopategui-Cabezas, Ileana; Wegner, Anja; Mair, Florian; Schipke, Carola G.; Peters, Oliver; Winter, York; Becher, Burkhard; Heppner, Frank L.			Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T-CELLS; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; PLAQUE PSORIASIS; CROHNS-DISEASE; IL-12 RECEPTOR; DOUBLE-BLIND; MOUSE MODEL; IFN-GAMMA	The pathology of Alzheimer's disease has an inflammatory component that is characterized by upregulation of proinflammatory cytokines, particularly in response to amyloid-beta (A beta). Using the APPPS1 Alzheimer's disease mouse model, we found increased production of the common interleukin-12 (IL-12) and IL-23 subunit p40 by microglia. Genetic ablation of the IL-12/IL-23 signaling molecules p40, p35 or p19, in which deficiency of p40 or its receptor complex had the strongest effect, resulted in decreased cerebral amyloid load. Although deletion of IL-12/IL-23 signaling from the radiation-resistant glial compartment of the brain was most efficient in mitigating cerebral amyloidosis, peripheral administration of a neutralizing p40-specific antibody likewise resulted in a reduction of cerebral amyloid load in APPPS1 mice. Furthermore, intracerebroventricular delivery of antibodies to p40 significantly reduced the concentration of soluble Ab species and reversed cognitive deficits in aged APPPS1 mice. The concentration of p40 was also increased in the cerebrospinal fluid of subjects with Alzheimer's disease, which suggests that inhibition of the IL-12/IL-23 pathway may attenuate Alzheimer's disease pathology and cognitive deficits.	[Prokop, Stefan; Miller, Kelly R.; Obst, Juliane; Kaelin, Roland E.; Lopategui-Cabezas, Ileana; Wegner, Anja; Schipke, Carola G.; Heppner, Frank L.] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [vom Berg, Johannes; Mair, Florian; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Schipke, Carola G.; Peters, Oliver] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Winter, York] Humboldt Univ, Cognit Neurobiol & Berlin Mouse Clin Neurol & Psy, D-10099 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Heppner, FL (corresponding author), Charite, Dept Neuropathol, D-13353 Berlin, Germany.	becher@immunology.uzh.ch; frank.heppner@charite.de	Becher, Burkhard/ABE-4225-2020; Wegner, Anja/AAD-2685-2019; Kälin, Roland/AAG-9161-2020; Wegner, Anja/AAL-8877-2021; Berg, Johannes vom/B-8983-2018; Prokop, Stefan/Y-1257-2019; Heppner, Frank/ABH-8393-2020	Becher, Burkhard/0000-0002-1541-7867; Wegner, Anja/0000-0003-0086-2498; Berg, Johannes vom/0000-0002-4086-1564; Prokop, Stefan/0000-0002-5633-2149; Heppner, Frank/0000-0001-9816-8917; Winter, York/0000-0002-7828-1872; Obst, Juliane/0000-0001-9534-8488; Mair, Florian/0000-0001-6732-5449; Peters, Oliver/0000-0003-0568-2998	Deutsche Forschungsgemeinschaft [SFB TRR 43]; Swiss national science foundation; Koetzer foundation; NeuroCure Exc 257 visiting fellowship; US National Institutes of Health [NINDS R01 NS046006]; European Union; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046006] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission); Koetzer foundation; NeuroCure Exc 257 visiting fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB TRR 43 to F.L.H. and NeuroCure Exc 257 to F.L.H. and Y.W.), the Swiss national science foundation (B.B.), the Koetzer foundation (B.B.), a NeuroCure Exc 257 visiting fellowship (B.B.), the US National Institutes of Health (NINDS R01 NS046006 to F.L.H.) and the European Union (FP7 HEALTH, Project LUPAS to F.L.H.). J.v.B. is a member of the Neuroscience Center Zurich, and F.M. is a member of the Molecular Life Sciences Zurich. We thank P. Matylewski, C. Hempt, C. Klatt and C. Gehlhaar for excellent technical help, F. Hiemeyer for performing the ANOVA statistics, K. Saeger for scanning and processing of histological mouse slides and M. Jucker, University of Tubingen, for generously providing APPPS1 mice.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Becher B, 2003, J CLIN INVEST, V112, P1186, DOI 10.1172/JCI200319079; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Eisenring M, 2010, NAT IMMUNOL, V11, P1030, DOI 10.1038/ni.1947; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Ghoreschi K, 2007, CLIN DERMATOL, V25, P574, DOI 10.1016/j.clindermatol.2007.08.012; Gottlieb AB, 2007, CURR MED RES OPIN, V23, P1081, DOI 10.1185/030079907X182112; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Guerreiro RJ, 2007, NEURODEGENER DIS, V4, P406, DOI 10.1159/000107700; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Ireland DDC, 2004, VIRAL IMMUNOL, V17, P411, DOI 10.1089/vim.2004.17.411; Jucker M, 2008, NEURON, V59, P8, DOI 10.1016/j.neuron.2008.06.014; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kornhuber J, 2009, DEMENT GERIATR COGN, V27, P404, DOI 10.1159/000210388; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Magram J, 1996, ANN NY ACAD SCI, V795, P60, DOI 10.1111/j.1749-6632.1996.tb52655.x; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Matthys P, 1998, EUR J IMMUNOL, V28, P2143, DOI 10.1002/(SICI)1521-4141(199807)28:07<2143::AID-IMMU2143>3.0.CO;2-C; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Rentzos M, 2006, J NEUROL SCI, V249, P110, DOI 10.1016/j.jns.2006.05.063; Romagnani P, 1997, CURR OPIN IMMUNOL, V9, P793, DOI 10.1016/S0952-7915(97)80180-X; Rota E, 2006, NEUROL SCI, V27, P33, DOI 10.1007/s10072-006-0562-6; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schipke CG, 2011, DEMENT GERIATR COGN, V31, P139, DOI 10.1159/000322588; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Szekely CA, 2010, CNS NEUROL DISORD-DR, V9, P132, DOI 10.2174/187152710791012026; Town T, 2005, NEUROMOL MED, V7, P255, DOI 10.1385/NMM:7:3:255; Town T, 2002, J NEUROIMMUNOL, V132, P49, DOI 10.1016/S0165-5728(02)00307-7; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Wu CY, 1997, J IMMUNOL, V159, P1658; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	51	271	278	3	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	DEC	2012	18	12					1812	+		10.1038/nm.2965	http://dx.doi.org/10.1038/nm.2965			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23178247				2022-12-27	WOS:000311999800029
J	Brumm, AJ; Carmichael, ST				Brumm, Andrew J.; Carmichael, S. Thomas			Not just a rush of blood to the head	NATURE MEDICINE			English	Editorial Material							SPINAL-CORD; STROKE; NEUROGENESIS; ANGIOGENESIS; RECOVERY	Angiogenesis is a key feature of central nervous system injury. A neovessel-derived signal mediated by prostacyclin triggers axonal sprouting and functional recovery in a mouse model of inflammatory spinal cord injury (pages 1658-1664). Are such angiocrine signals relevant to neurovascular remodeling and recovery in other neurological contexts?	[Brumm, Andrew J.; Carmichael, S. Thomas] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Brumm, AJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	scarmichael@mednet.ucla.edu		Carmichael, S Thomas/0000-0002-1169-9203	NINDS NIH HHS [R01 NS081055] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081055] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168; Muramatsu R, 2012, NAT MED, V18, P1658, DOI 10.1038/nm.2943; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Oudega M, 2012, CELL TISSUE RES, V349, P269, DOI 10.1007/s00441-012-1440-6; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Thiyagarajan M, 2008, J NEUROSCI, V28, P12788, DOI 10.1523/JNEUROSCI.3485-08.2008; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	14	14	14	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1609	1610		10.1038/nm.2990	http://dx.doi.org/10.1038/nm.2990			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135507	Green Accepted			2022-12-27	WOS:000310837000012
J	Vezzani, A				Vezzani, Annamaria			Finding the epileptogenesis switch	NATURE MEDICINE			English	Editorial Material							MAMMALIAN TARGET; TUBEROUS SCLEROSIS; SEIZURE FREQUENCY; RAPAMYCIN MTOR; MOUSE MODEL; INHIBITION; PATHWAY; EPILEPSY		Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Vezzani, A (corresponding author), Mario Negri Inst Pharmacol Res, Dept Neurosci, Via Eritrea 62, Milan, Italy.	annamaria.vezzani@marionegri.it	Vezzani, Annamaria/AAB-1882-2020	Vezzani, Annamaria/0000-0003-0573-6175				Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Krueger D.A., 2012, NEW ENGL J MED, V363, P1801; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lalis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037068; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Muncy J, 2009, J CHILD NEUROL, V24, P477, DOI 10.1177/0883073808324535; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Ryther RCC, 2012, CURR NEUROL NEUROSCI, V12, P410, DOI 10.1007/s11910-012-0276-5; Sha LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039152; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Zeng LH, 2010, CELL CYCLE, V9, P2281, DOI 10.4161/cc.9.12.11866; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	17	24	24	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1626	1627		10.1038/nm.2982	http://dx.doi.org/10.1038/nm.2982			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135516				2022-12-27	WOS:000310837000021
J	Duffield, JS				Duffield, Jeremy S.			The elusive source of myofibroblasts: problem solved?	NATURE MEDICINE			English	Editorial Material							FIBROSIS; ORIGIN; LIVER	Fibrosis is omnipresent and contributes to a substantial proportion of all natural deaths. A recent study (pages 1262-1270) provides evidence that the mysterious perivascular cell, also known as the pericyte, is the cell type responsible for fibrotic disease in skin and skeletal muscle.	[Duffield, Jeremy S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Duffield, Jeremy S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Duffield, JS (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	jeremysd@uw.edu						Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BRUNS RR, 1968, J CELL BIOL, V37, P244, DOI 10.1083/jcb.37.2.244; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; GRILLO HC, 1963, ANN SURG, V157, P453; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hung C., 2012, AM J RESP CRIT CARE, V185; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; ROSS R, 1970, Journal of Cell Biology, V44, P645, DOI 10.1083/jcb.44.3.645; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zimmermann K. W., 1923, Zeitschrift Ges Anat Munchen Abt 1, V68, P29, DOI 10.1007/BF02593544	12	21	22	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2012	18	8					1178	1180		10.1038/nm.2867	http://dx.doi.org/10.1038/nm.2867			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22869183				2022-12-27	WOS:000307469300016
J	Quail, DF; Joyce, JA				Quail, Daniela F.; Joyce, Johanna A.			Microenvironmental regulation of tumor progression and metastasis	NATURE MEDICINE			English	Review							MESENCHYMAL STEM-CELLS; BREAST-CANCER CELLS; BONE-MARROW; SUPPRESSOR-CELLS; PROGENITOR CELLS; MYELOID CELLS; T-CELLS; CHRONIC INFLAMMATION; CARCINOMA CELLS; M1 MACROPHAGES	Cancers develop in complex tissue environments, which they depend on for sustained growth, invasion and metastasis. Unlike tumor cells, stromal cell types within the tumor microenvironment (TME) are genetically stable and thus represent an attractive therapeutic target with reduced risk of resistance and tumor recurrence. However, specifically disrupting the pro-tumorigenic TME is a challenging undertaking, as the TME has diverse capacities to induce both beneficial and adverse consequences for tumorigenesis. Furthermore, many studies have shown that the microenvironment is capable of normalizing tumor cells, suggesting that re-education of stromal cells, rather than targeted ablation per se, may be an effective strategy for treating cancer. Here we discuss the paradoxical roles of the TME during specific stages of cancer progression and metastasis, as well as recent therapeutic attempts to re-educate stromal cells within the TME to have anti-tumorigenic effects.	[Quail, Daniela F.; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Joyce, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	johanna@joycelab.org			Canadian Institutes of Health Research; National Cancer Institute; American Cancer Society; Breast Cancer Research Foundation; Cycle for Survival; NATIONAL CANCER INSTITUTE [U54CA126518, U54CA148967] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Breast Cancer Research Foundation; Cycle for Survival; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We apologize to the many authors whose work we could not cite because of space constraints. D.F.Q. is supported by a Canadian Institutes of Health Research fellowship. Research in J.A.J.'s lab is supported by the National Cancer Institute, the American Cancer Society, the Breast Cancer Research Foundation and Cycle for Survival.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Amirkhosravi A, 2002, THROMB HAEMOSTASIS, V87, P930; Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Behan JW, 2009, CANCER RES, V69, P7867, DOI 10.1158/0008-5472.CAN-09-0800; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Bos PD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005283; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Brockmann MA, 2007, NEURO-ONCOLOGY, V9, P335, DOI 10.1215/15228517-2007-013; Brown KM, 2005, AM J SURG, V189, P278, DOI 10.1016/j.amjsurg.2004.11.014; Cai X, 2012, J MOL CELL BIOL, V4, P341, DOI 10.1093/jmcb/mjs044; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calvo F, 2013, NAT CELL BIOL, V15, P637, DOI 10.1038/ncb2756; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Catena R, 2013, CANCER DISCOV, V3, P578, DOI 10.1158/2159-8290.CD-12-0476; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chambers A F, 2001, Surg Oncol Clin N Am, V10, P243; Chao Y, 2012, CANCER MICROENVIRON, V5, P19, DOI 10.1007/s12307-011-0085-4; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Chouaib S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00021; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Cook J, 2013, CURR OPIN PHARMACOL, V13, P595, DOI 10.1016/j.coph.2013.05.017; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Cuiffo BG, 2012, CELL ADHES MIGR, V6, P220, DOI 10.4161/cam.20875; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; De Palma M, 2009, BBA-REV CANCER, V1796, P5, DOI 10.1016/j.bbcan.2009.04.001; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Demir IE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00097; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dumont N, 2013, NEOPLASIA, V15, P249, DOI 10.1593/neo.121950; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Escribese MM, 2012, IMMUNOBIOLOGY, V217, P1233, DOI 10.1016/j.imbio.2012.07.002; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fang H, 2013, CANCER RES, V73, P4965, DOI 10.1158/0008-5472.CAN-13-0661; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gallagher B, 2001, AM J EPIDEMIOL, V154, P544, DOI 10.1093/aje/154.6.544; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gasteiger G, 2013, J EXP MED, V210, P1179, DOI 10.1084/jem.20122571; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hensel JA, 2013, NAT REV CLIN ONCOL, V10, P41, DOI 10.1038/nrclinonc.2012.207; Ho IAW, 2013, STEM CELLS, V31, P146, DOI 10.1002/stem.1247; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Hunter K.E., 2013, ONCOGENE        0506, DOI [10.1038/onc.2013.142, DOI 10.1038/0NC.2013.142]; Hwu P, 2010, NEW ENGL J MED, V363, P779, DOI 10.1056/NEJMe1006416; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kerbel Robert S, 2008, Proc Natl Acad Sci U S A, V105, pE55, DOI 10.1073/pnas.0804876105; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Khazaie K, 2011, CANCER METAST REV, V30, P45, DOI 10.1007/s10555-011-9286-z; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Krishnamurthy S, 2010, CANCER-AM CANCER SOC, V116, P3330, DOI 10.1002/cncr.25145; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lewis C, 2005, AM J PATHOL, V167, P627, DOI 10.1016/S0002-9440(10)62038-X; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lugini L, 2012, J IMMUNOL, V189, P2833, DOI 10.4049/jimmunol.1101988; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mantovani G, 1997, INT J CANCER, V71, P724, DOI 10.1002/(SICI)1097-0215(19970529)71:5<724::AID-IJC6>3.0.CO;2-T; Marsh T, 2013, BBA-MOL BASIS DIS, V1832, P1070, DOI 10.1016/j.bbadis.2012.10.013; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Morse MA, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-9; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Naslund TI, 2013, J IMMUNOL, V190, P2712, DOI 10.4049/jimmunol.1203082; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Naumov GN, 2002, CANCER RES, V62, P2162; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nishimura K, 2012, PATHOBIOLOGY, V79, P290, DOI 10.1159/000337296; Olumi AF, 1999, CANCER RES, V59, P5002; Orr B, 2012, ONCOGENE, V31, P1130, DOI 10.1038/onc.2011.312; Palumbo JS, 2008, SEMIN THROMB HEMOST, V34, P154, DOI 10.1055/s-2008-1079255; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Pierga JY, 2003, BRIT J CANCER, V89, P539, DOI 10.1038/sj.bjc.6601121; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Ranganathan AC, 2006, CELL CYCLE, V5, P1799, DOI 10.4161/cc.5.16.3109; Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330; Redente EF, 2010, AM J PATHOL, V176, P2972, DOI 10.2353/ajpath.2010.090879; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Sceneay J, 2012, CANCER RES, V72, P3906, DOI 10.1158/0008-5472.CAN-11-3873; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schulz TF, 2009, INT J CANCER, V125, P1755, DOI 10.1002/ijc.24741; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Semenza GL, 2013, ONCOGENE, V32, P4057, DOI 10.1038/onc.2012.578; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Shime H, 2012, P NATL ACAD SCI USA, V109, P2066, DOI 10.1073/pnas.1113099109; Shirota Y, 2012, J IMMUNOL, V188, P1592, DOI 10.4049/jimmunol.1101304; Sidani M, 2006, J MAMMARY GLAND BIOL, V11, P151, DOI 10.1007/s10911-006-9021-5; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; STEWART T, 1995, LANCET, V346, P796, DOI 10.1016/S0140-6736(95)91618-0; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Taucher S, 2003, THROMB HAEMOSTASIS, V89, P1098; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; von Boehmer H, 2013, NAT REV DRUG DISCOV, V12, P51, DOI 10.1038/nrd3683; Vonderheide RH, 2013, CLIN CANCER RES, V19, P1035, DOI 10.1158/1078-0432.CCR-12-2064; Wang HW, 2010, CELL CYCLE, V9, P4824, DOI 10.4161/cc.9.24.14322; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Whiteside TL, 2012, EXPERT OPIN BIOL TH, V12, P1383, DOI 10.1517/14712598.2012.707184; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yoshikawa K, 2012, CANCER SCI, V103, P2012, DOI 10.1111/j.1349-7006.2012.02411.x; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang Y, 2012, CANCER RES, V72, P5198, DOI 10.1158/0008-5472.CAN-12-0294; Zhu W, 2006, EXP MOL PATHOL, V80, P267, DOI 10.1016/j.yexmp.2005.07.004; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	191	4169	4310	159	1763	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1423	1437		10.1038/nm.3394	http://dx.doi.org/10.1038/nm.3394			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202395	Green Accepted			2022-12-27	WOS:000326920300020
J	Sridhar, S; Begom, S; Bermingham, A; Hoschler, K; Adamson, W; Carman, W; Bean, T; Barclay, W; Deeks, JJ; Lalvani, A				Sridhar, Saranya; Begom, Shaima; Bermingham, Alison; Hoschler, Katja; Adamson, Walt; Carman, William; Bean, Thomas; Barclay, Wendy; Deeks, Jonathan J.; Lalvani, Ajit			Cellular immune correlates of protection against symptomatic pandemic influenza	NATURE MEDICINE			English	Article							TOXIC LYMPHOCYTES-T; A VIRUS-INFECTION; H5N1 INFLUENZA; CROSS-REACT; SELECTIVE ACCUMULATION; LETHAL INFECTION; CELLS; H1N1; MEMORY; MICE	The role of T cells in mediating heterosubtypic protection against natural influenza illness in humans is uncertain. The 2009 H1N1 pandemic (pH1N1) provided a unique natural experiment to determine whether crossreactive cellular immunity limits symptomatic illness in antibody-naive individuals. We followed 342 healthy adults through the UK pandemic waves and correlated the responses of pre-existing T cells to the pH1N1 virus and conserved core protein epitopes with clinical outcomes after incident pH1N1 infection. Higher frequencies of pre-existing T cells to conserved CD8 epitopes were found in individuals who developed less severe illness, with total symptom score having the strongest inverse correlation with the frequency of interferon-g (IFN-g)+ interleukin-2 (IL-2)-CD8+ T cells (r = -0.6, P = 0.004). Within this functional CD8+ IFN-g+ IL-2population, cells with the CD45RA+ chemokine (C-C) receptor 7 (CCR7)-phenotype inversely correlated with symptom score and had lung-homing and cytotoxic potential. In the absence of crossreactive neutralizing antibodies, CD8+ T cells specific to conserved viral epitopes correlated with crossprotection against symptomatic influenza. This protective immune correlate could guide universal influenza vaccine development.	[Sridhar, Saranya; Begom, Shaima; Lalvani, Ajit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Infect Sect, London, England; [Bermingham, Alison; Hoschler, Katja] Publ Hlth England, Ctr Infect, Resp Virus Unit, London, England; [Adamson, Walt] West Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland; [Carman, William] Univ Glasgow, Ctr Virus Res, Glasgow, Lanark, Scotland; [Bean, Thomas] Publ Hlth England Microbiol Serv, Porton Down, England; [Barclay, Wendy] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Virol, London, England; [Deeks, Jonathan J.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England	Imperial College London; Public Health England; University of Glasgow; Imperial College London; University of Birmingham	Lalvani, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Infect Sect, London, England.	a.lalvani@imperial.ac.uk	Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971; Sridhar, Saranya/0000-0002-4267-3102; Barclay, Wendy/0000-0002-3948-0895; Adamson, Walt/0000-0002-9786-2349; Lalvani, Ajit/0000-0002-2396-246X	Imperial College National Health Service Healthcare Trust; Medical Research Council PhD studentship; Medical Research Council [1252302] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10179] Funding Source: researchfish	Imperial College National Health Service Healthcare Trust; Medical Research Council PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank all the willing participants of the study, with special thanks to M. Blokpoel and T. Williams. We also thank M. Bautista, S. Bowes, B. Fortunaso and S. Lloyd-James for processing all the samples and M. Magtoto, S. Bremang, L. Grass and L. Potiphar for recruiting the participants. We thank S. Ritter (University of California, Berkeley) for his contribution to the figures, K. Roberts and P. Stilwell from Imperial College London for help with growing the virus and E. Rubin (Harvard University), E. Tchillian and P. Beverley (University of Oxford) for their input and insightful discussions S. S. is supported by the Imperial College National Health Service Healthcare Trust. S. B. is supported by a Medical Research Council PhD studentship. A. L. is a Wellcome Trust Senior Research Fellow in Clinical Science and a National Institute of Health Research Senior Investigator. The funders had no input in the design or conduct of the study, the collection, management, analysis or interpretation of the data or the preparation, review or approval of the manuscript. A. L. and S. S. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.	Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bodewes R, 2011, J VIROL, V85, P11995, DOI 10.1128/JVI.05213-11; Bodewes R, 2009, LANCET INFECT DIS, V9, P784, DOI 10.1016/S1473-3099(09)70263-4; Bratke K, 2005, EUR J IMMUNOL, V35, P2608, DOI 10.1002/eji.200526122; Casey R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015619; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; COUCH RB, 1974, J INFECT DIS, V129, P411, DOI 10.1093/infdis/129.4.411; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Gunson RN, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-192; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hillaire MLB, 2011, J VIROL, V85, P12057, DOI 10.1128/JVI.05204-11; Hillaire MLB, 2013, J GEN VIROL, V94, P583, DOI 10.1099/vir.0.048652-0; Hillaire MLB, 2011, J GEN VIROL, V92, P2339, DOI 10.1099/vir.0.033076-0; Ip DKM, 2012, J INFECT DIS, V205, P631, DOI 10.1093/infdis/jir803; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Keynan Y, 2010, EMERG INFECT DIS, V16, P1621, DOI 10.3201/eid1610.100108; Kohlmeier JE, 2008, IMMUNITY, V29, P101, DOI 10.1016/j.immuni.2008.05.011; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Kreijtz JHCM, 2009, VACCINE, V27, P4983, DOI 10.1016/j.vaccine.2009.05.079; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; MCMICHAEL AJ, 1977, NATURE, V270, P524, DOI 10.1038/270524a0; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; MONTO AS, 1975, AM J EPIDEMIOL, V102, P553, DOI 10.1093/oxfordjournals.aje.a112193; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palendira U, 2008, BLOOD, V112, P3293, DOI 10.1182/blood-2008-02-138040; Picton ACP, 2012, IMMUNOLOGY, V136, P397, DOI 10.1111/j.1365-2567.2012.03592.x; REAY PA, 1989, VIROLOGY, V170, P477, DOI 10.1016/0042-6822(89)90439-X; Riley S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000442; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Scheible K, 2011, VACCINE, V29, P2159, DOI 10.1016/j.vaccine.2010.12.073; SCHULMAN JL, 1965, J BACTERIOL, V89, P170, DOI 10.1128/JB.89.1.170-174.1965; SLEPUSHKIN A N, 1959, Bull World Health Organ, V20, P297; Sridhar S, 2012, EUR J IMMUNOL, V42, P2913, DOI 10.1002/eji.201242504; Stephenson I, 2004, LANCET INFECT DIS, V4, P499, DOI 10.1016/S1473-3099(04)01105-3; TAYLOR PM, 1986, IMMUNOLOGY, V58, P417; TOWNSEND A, 1989, PHILOS T ROY SOC B, V323, P527, DOI 10.1098/rstb.1989.0032; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; YAP KL, 1978, NATURE, V273, P238, DOI 10.1038/273238a0; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; ZWEERINK HJ, 1977, NATURE, V267, P354, DOI 10.1038/267354a0	57	560	569	2	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1305	+		10.1038/nm.3350	http://dx.doi.org/10.1038/nm.3350			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24056771	Bronze			2022-12-27	WOS:000325531700030
J	Barker, RW; Brindley, DA; Schuh, A				Barker, Richard W.; Brindley, David A.; Schuh, Anna			Establish good genomic. practice to guide medicine forward	NATURE MEDICINE			English	Editorial Material									[Barker, Richard W.; Brindley, David A.] Univ Oxford, Oxford UCL Ctr Adv Sustainable Med Innovat, Oxford, England; [Brindley, David A.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England; [Brindley, David A.] Harvard Stem Cell Inst, Cambridge, MA USA; [Schuh, Anna] Oxford Biomed Res Ctr, Haematomol Diagnost Ctr, Oxford, England	University of Oxford; University of Oxford; Harvard University; University of Oxford	Barker, RW (corresponding author), Univ Oxford, Oxford UCL Ctr Adv Sustainable Med Innovat, Oxford, England.		Schuh, Anna/D-8954-2014	Anna, schuh/0000-0002-3938-8490					0	8	8	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2013	19	5					530	530		10.1038/nm0513-530	http://dx.doi.org/10.1038/nm0513-530			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652098	Bronze			2022-12-27	WOS:000318583000018
J	Harris, E; Ennis, FA; Diamond, MS				Harris, Eva; Ennis, Francis A.; Diamond, Michael S.			Defeating dengue: a challenge for a vaccine	NATURE MEDICINE			English	Editorial Material							VIRUS-INFECTIONS; DISEASE SEVERITY; NEUTRALIZATION	Dengue poses a substantial clinical problem, with the four serotypes of dengue viruses infecting 50-100 million people per year and approximately half the world's population estimated to be at risk. As there is no specific treatment for dengue, the development of an effective vaccine will be an important measure for controlling this disease. A phase 2b trial testing a recombinant live, attenuated tetravalent dengue-yellow fever chimeric virus vaccine in Thai schoolchildren of 4-11 years of age has recently been reported(1). The vaccine showed an overall efficacy of 30.2%, and one or more doses of the vaccine reduced the incidence of disease caused by the DENV3 and DENV4 dengue virus serotypes by 80-90%, with less reduction of disease caused by DENV1; however, there was no efficacy against DENV2. We asked three experts to comment on the results of this trial and how they might influence the landscape of dengue vaccine development.	[Harris, Eva] Univ Calif Berkeley, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Harris, Eva] Univ Calif Berkeley, Ctr Global Publ Hlth, Sch Publ Hlth, Berkeley, CA 94720 USA; [Ennis, Francis A.] Univ Massachusetts, Sch Med, Worcester, MA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester	Harris, E (corresponding author), Univ Calif Berkeley, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.		Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165				Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x	10	8	9	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1622	1623		10.1038/nm.2997	http://dx.doi.org/10.1038/nm.2997			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135514	Bronze			2022-12-27	WOS:000310837000019
J	Starzl, TE				Starzl, Thomas E.			The long reach of liver transplantation	NATURE MEDICINE			English	Editorial Material							HOMOTRANSPLANTATION; MIGRATION		[Starzl, Thomas E.] Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA; [Starzl, Thomas E.] Univ Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Starzl, TE (corresponding author), Thomas E Starzl Transplantat Inst, Pittsburgh, PA USA.	mangantl@upmc.edu						Starzl T.E., 1969, EXPERIENCE HEPATIC T; STARZL TE, 1989, LANCET, V2, P1000; STARZL TE, 1968, ANN SURG, V168, P392, DOI 10.1097/00000658-196809000-00009; STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; STARZL TE, 1973, SURG GYNECOL OBSTET, V137, P179; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; STARZL TE, 1960, SURG GYNECOL OBSTET, V111, P733; STARZL TE, 1962, AM J SURG, V103, P219, DOI 10.1016/0002-9610(62)90491-9; Starzl TE, 1998, NEW ENGL J MED, V339, P1905, DOI 10.1056/NEJM199812243392607	10	28	46	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1489	1492		10.1038/nm.2927	http://dx.doi.org/10.1038/nm.2927			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042359	Green Accepted			2022-12-27	WOS:000309587500024
J	Boshoff, C				Boshoff, Chris			Ephrin receptor: a door to KSHV infection	NATURE MEDICINE			English	Editorial Material							CELLULAR RECEPTOR; ENTRY RECEPTOR; SARCOMA; VIRUS; CELLS; EPHA2; HUMAN-HERPESVIRUS-8; ALPHA-3-BETA-1	Kaposi's sarcoma-associated herpesvirus is a major oncogenic virus that has been implicated in human cancers. A new study identifies ephrin receptor A2 as a key host receptor for this virus that permits infection of endothelial cells (pages 961-966).	UCL, UCL Canc Inst, London WC1E 6BT, England	University of London; University College London	Boshoff, C (corresponding author), UCL, UCL Canc Inst, London WC1E 6BT, England.	c.boshoff@ucl.ac.uk			Cancer Research UK [13100] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Bonaparte MI, 2005, P NATL ACAD SCI USA, V102, P10652, DOI 10.1073/pnas.0504887102; Chakraborty S, 2012, P NATL ACAD SCI USA, V109, pE1163, DOI 10.1073/pnas.1119592109; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Hahn AS, 2012, NAT MED, V18, P961, DOI 10.1038/nm.2805; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Zelinski DP, 2001, CANCER RES, V61, P2301	16	7	7	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					861	863		10.1038/nm.2803	http://dx.doi.org/10.1038/nm.2803			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673996				2022-12-27	WOS:000305116600021
J	Liu, Z; Davidson, A				Liu, Zheng; Davidson, Anne			Taming lupus-a new understanding of pathogenesis is leading to clinical advances	NATURE MEDICINE			English	Review							TOLL-LIKE RECEPTORS; AUTOREACTIVE B-CELLS; HELPER T-CELLS; GELATINASE-ASSOCIATED LIPOCALIN; ERYTHEMATOSUS DISEASE-ACTIVITY; PLASMACYTOID DENDRITIC CELLS; SPLEEN TYROSINE KINASE; MURINE LUPUS; THERAPEUTIC TARGETS; AUTOIMMUNE-DISEASES	Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by the loss of tolerance to nuclear self antigens, the production of pathogenic autoantibodies and damage to multiple organ systems. Over the years, patients with SLE have been managed largely with empiric immunosuppressive therapies, which are associated with substantial toxicities and do not always provide adequate control of the disease. The development of targeted therapies that specifically address disease pathogenesis or progression has lagged, largely because of the complex and heterogeneous nature of the disease, as well as difficulties in designing uniform outcome measures for clinical trials. Recent advances that could improve the treatment of SLE include the identification of genetic variations that influence the risk of developing the disease, an enhanced understanding of innate and adaptive immune activation and regulation of tolerance, dissection of immune cell activation and inflammatory pathways and elucidation of mechanisms and markers of tissue damage. These discoveries, together with improvements in clinical trial design, form a platform from which to launch the development of a new generation of lupus therapies.	[Liu, Zheng; Davidson, Anne] Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, Manhasset, NY USA	Northwell Health	Davidson, A (corresponding author), Feinstein Inst Med Res, Ctr Autoimmun & Musculoskeletal Dis, Manhasset, NY USA.	adavidson1@nshs.edu		Davidson, Anne/0000-0002-4081-6464	US National Institutes of Health [R01 DK085241-01, R01 AI083901, R21 AR057930]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085241] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health grants R01 DK085241-01, R01 AI083901 and R21 AR057930. The authors thank T. Rothstein and A. Boneparth for critical reading of the manuscript.	Agrawal H, 2009, J IMMUNOL, V183, P6021, DOI 10.4049/jimmunol.0803872; Alarcon GS, 2006, PLOS MED, V3, P1949, DOI 10.1371/journal.pmed.0030396; Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Aringer M, 2012, LUPUS, V21, P386, DOI 10.1177/0961203311426569; Askanase AD, 2009, J RHEUMATOL, V36, P89, DOI 10.3899/jrheum.070968; Bahjat FR, 2008, ARTHRITIS RHEUM-US, V58, P1433, DOI 10.1002/art.23428; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Bauer JW, 2009, ARTHRITIS RHEUM-US, V60, P3098, DOI 10.1002/art.24803; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Bergtold A, 2006, J IMMUNOL, V177, P7287, DOI 10.4049/jimmunol.177.10.7287; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bethunaickan R, 2011, J IMMUNOL, V186, P4994, DOI 10.4049/jimmunol.1003010; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Bloom O, 2011, P NATL ACAD SCI USA, V108, P10255, DOI 10.1073/pnas.1103555108; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; Campbell DJ, 2011, NAT MED, V17, P929, DOI 10.1038/nm.2433; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Cappione A, 2005, J CLIN INVEST, V115, P3205, DOI 10.1172/JCI24179; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; Ceribelli A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3377; Ceribelli A, 2011, ARTHRITIS RHEUM-US, V63, P1177, DOI 10.1002/art.30192; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Choi EW, 2012, ARTHRITIS RHEUM-US, V64, P243, DOI 10.1002/art.33313; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Dai R, 2011, TRANSL RES, V157, P163, DOI 10.1016/j.trsl.2011.01.007; Daikh DI, 2001, J IMMUNOL, V166, P2913, DOI 10.4049/jimmunol.166.5.2913; de Laat B, 2008, NAT CLIN PRACT RHEUM, V4, P192, DOI 10.1038/ncprheum0740; Deelman L, 2009, CURR OPIN NEPHROL HY, V18, P85, DOI 10.1097/MNH.0b013e32831c50a1; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Deng GM, 2010, ARTHRITIS RHEUM-US, V62, P2086, DOI 10.1002/art.27452; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Faust TW, 2010, P NATL ACAD SCI USA, V107, P18569, DOI 10.1073/pnas.1006980107; Flesher DLT, 2010, EXPERT REV CLIN IMMU, V6, P461, DOI [10.1586/ECI.10.8, 10.1586/eci.10.8]; Fossati L, 1995, EUR J IMMUNOL, V25, P3412, DOI 10.1002/eji.1830251231; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gambaro G, 2010, J NEPHROL, V23, P244; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gonzalez SF, 2011, ANNU REV IMMUNOL, V29, P215, DOI 10.1146/annurev-immunol-031210-101255; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Guiducci C, 2010, NATURE, V465, P937, DOI 10.1038/nature09102; Hahn BH, 2011, ANN RHEUM DIS, V70, pI64, DOI 10.1136/ard.2010.142208; Harley JB, 2006, LUPUS, V15, P768, DOI 10.1177/0961203306070009; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; Hill GS, 2001, KIDNEY INT, V59, P304, DOI 10.1046/j.1523-1755.2001.00492.x; Hinze CH, 2009, ARTHRITIS RHEUM-US, V60, P2772, DOI 10.1002/art.24751; Ichinose K, 2011, ARTHRITIS RHEUM-US, V63, P523, DOI 10.1002/art.30085; Illei GG, 2011, ANN RHEUM DIS, V70, P2071, DOI 10.1136/ard.2010.148049; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Jacobi AM, 2010, ARTHRITIS RHEUM-US, V62, P201, DOI 10.1002/art.27189; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim HJ, 2011, P NATL ACAD SCI USA, V108, P2010, DOI 10.1073/pnas.1018974108; Kim SJ, 2008, J EXP MED, V205, P2437, DOI 10.1084/jem.20070731; Kitching AR, 2011, J AM SOC NEPHROL, V22, P235, DOI 10.1681/ASN.2010050536; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Kyttaris VC, 2011, CURR OPIN RHEUMATOL, V23, P449, DOI 10.1097/BOR.0b013e328349a242; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lateef A, 2010, CURR OPIN RHEUMATOL, V22, P504, DOI 10.1097/BOR.0b013e32833b475e; Lauvsnes MB, 2012, J NEUROL, V259, P622, DOI 10.1007/s00415-011-6232-5; Lauwerys B, 2005, LUPUS, V14, P2, DOI 10.1191/0961203305lu2052oa; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Liang J, 2010, ANN RHEUM DIS, V69, P1423, DOI 10.1136/ard.2009.123463; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Liu K, 2009, J CLIN INVEST, V119, P911, DOI 10.1172/JCI36728; Liu Z, 2011, TRENDS IMMUNOL, V32, P388, DOI 10.1016/j.it.2011.06.004; Liu Z, 2011, EXP CELL RES, V317, P1270, DOI 10.1016/j.yexcr.2011.02.005; Looney RJ, 2010, MOD RHEUMATOL, V20, P1, DOI 10.1007/s10165-009-0213-x; Lopez LR, 2006, LUPUS, V15, P80, DOI 10.1191/0961203306lu2267oa; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Manderson AP, 2004, ANNU REV IMMUNOL, V22, P431, DOI 10.1146/annurev.immunol.22.012703.104549; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Matsuura E, 2006, LUPUS, V15, P478, DOI 10.1191/0961203306lu2337oa; Matus S, 2007, J EXP MED, V204, P3221, DOI 10.1084/jem.20071285; McMahon M, 2011, EXPERT REV CLIN IMMU, V7, P227, DOI [10.1586/eci.10.98, 10.1586/ECI.10.98]; McMahon M, 2009, ARTHRITIS RHEUM-US, V60, P2428, DOI 10.1002/art.24677; Menard L, 2011, J CLIN INVEST, V121, P3635, DOI 10.1172/JCI45790; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Nacionales DC, 2007, ARTHRITIS RHEUM, V56, P3770, DOI 10.1002/art.23023; Narshi CB, 2011, LUPUS, V20, P5, DOI 10.1177/0961203310382429; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Ng KP, 2007, ANN RHEUM DIS, V66, P1259, DOI 10.1136/ard.2006.067124; Nguyen TQ, 2008, PHARM RES-DORDR, V25, P2416, DOI 10.1007/s11095-008-9548-9; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Pan Y, 2009, TRANSL RES, V153, P4, DOI 10.1016/j.trsl.2008.10.007; Perl A, 2009, CURR OPIN RHEUMATOL, V21, P454, DOI 10.1097/BOR.0b013e32832e977c; Petri MA, 2011, ANN RHEUM DIS, V70, P760, DOI 10.1136/ard.2010.136762; Ramanujam Meera, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000562; Ramanujam M, 2009, ARTHRITIS RHEUM-US, V60, P1096, DOI 10.1002/art.24414; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Renner B, 2011, KIDNEY INT, V80, P166, DOI 10.1038/ki.2011.115; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Ronnblom L, 2002, HUM IMMUNOL, V63, P1181, DOI 10.1016/S0198-8859(02)00757-7; Ronnblom L, 2010, NAT REV RHEUMATOL, V6, P339, DOI 10.1038/nrrheum.2010.64; Rovin BH, 2005, J AM SOC NEPHROL, V16, P467, DOI 10.1681/ASN.2004080658; Rubinstein T, 2010, RHEUMATOLOGY, V49, P960, DOI 10.1093/rheumatology/kep468; Rubtsov AV, 2010, AUTOIMMUN REV, V9, P494, DOI 10.1016/j.autrev.2010.02.008; Sanchez E, 2011, ANN RHEUM DIS, V70, P1752, DOI 10.1136/ard.2011.154104; Schanberg LE, 2012, ARTHRITIS RHEUM-US, V64, P285, DOI 10.1002/art.30645; Schiffer L, 2003, J IMMUNOL, V171, P489, DOI 10.4049/jimmunol.171.1.489; Schlondorff DO, 2008, KIDNEY INT, V74, P860, DOI 10.1038/ki.2008.351; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Skaggs BJ, 2010, CLIN IMMUNOL, V137, P147, DOI 10.1016/j.clim.2010.06.014; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Symmons DPM, 2011, NAT REV RHEUMATOL, V7, P399, DOI 10.1038/nrrheum.2011.75; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Taylor KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001311; Thacker SG, 2010, J IMMUNOL, V185, P4457, DOI 10.4049/jimmunol.1001782; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tse KC, 2005, LUPUS, V14, P947, DOI 10.1191/0961203305lu2249oa; Turnberg D, 2005, CURR OPIN NEPHROL HY, V14, P223, DOI 10.1097/01.mnh.0000165887.75501.24; Valle FM, 2008, AUTOIMMUN REV, V7, P359, DOI 10.1016/j.autrev.2008.02.002; Vielhauer V, 2007, SEMIN NEPHROL, V27, P81, DOI 10.1016/j.semnephrol.2006.09.010; Wardemann H, 2007, ADV IMMUNOL, V95, P83, DOI 10.1016/S0065-2776(07)95003-8; Wofsy D.S., 2011, ABATACEPT LUPUS NEPH; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Yuan WJ, 2011, ARTHRITIS RHEUM-US, V63, P212, DOI 10.1002/art.30083; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	144	289	305	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2012	18	6					871	882		10.1038/nm.2752	http://dx.doi.org/10.1038/nm.2752			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22674006	Green Accepted			2022-12-27	WOS:000305116600024
J	Akdis, CA				Akdis, Cezmi A.			Therapies for allergic inflammation: refining strategies to induce tolerance	NATURE MEDICINE			English	Review							REGULATORY T-CELLS; FC-EPSILON-RI; POLLEN-INDUCED RHINOCONJUNCTIVITIS; ANTI-CD20 RITUXIMAB TREATMENT; SEVERE PERSISTENT ASTHMA; NECROSIS-FACTOR-ALPHA; DOUBLE-BLIND; IMMUNE-RESPONSES; FUSION PROTEIN; BEE VENOM	Current therapies for asthma and allergy are relatively safe and effective at controlling symptoms but do not change the chronic course of disease. There is no established method to prevent asthma and allergy, and major unmet needs in this area include the better control of the severe forms of these diseases and the developments of curative therapies. Two major therapeutic strategies for asthma and allergy are currently being developed, and I here discuss the advances and challenges for future therapeutic development in these two areas. The first approach, allergen-specific immunotherapy, aims to induce specific immune tolerance and has a long-term disease-modifying effect. The second approach is the use of biological immune response modifiers to decrease pathological immune responses. Combination strategies using both of these approaches may also provide a route for addressing the unmet clinical needs in allergic diseases.	Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Zurich, Switzerland	Swiss Institute of Allergy & Asthma Research; University of Zurich	Akdis, CA (corresponding author), Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Zurich, Switzerland.	akdisac@siaf.uzh.ch	Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X	Swiss National Science Foundation [320030-132899]; Christine Kuhne-Center for Allergy Research and Education (CK-CARE) [261357, 260895]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christine Kuhne-Center for Allergy Research and Education (CK-CARE)	The author's laboratory is supported by the Swiss National Science Foundation grant 320030-132899 and the Christine Kuhne-Center for Allergy Research and Education (CK-CARE) European 7th frame work projects MeDALL (Mechanisms of the Development of Allergy) (261357) and PREDICTA (Post-Infectious Immune Reprogramming and Its Association with Persistence and Chronicity of Respiratory Allergic Diseases) (260895).	Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 1996, J CLIN INVEST, V98, P1676, DOI 10.1172/JCI118963; Akdis CA, 2001, TRENDS IMMUNOL, V22, P175, DOI 10.1016/S1471-4906(01)01862-2; Akdis CA, 2006, CURR OPIN IMMUNOL, V18, P718, DOI 10.1016/j.coi.2006.09.016; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Akdis M, 2009, NAT REV DRUG DISCOV, V8, P645, DOI 10.1038/nrd2653; Allakhverdi Z, 2006, ANN NY ACAD SCI, V1082, P62, DOI 10.1196/annals.1348.047; Allam JP, 2008, J ALLERGY CLIN IMMUN, V121, P368, DOI 10.1016/j.jaci.2007.09.045; Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Angeli W, 2004, J IMMUNOL, V172, P3822, DOI 10.4049/jimmunol.172.6.3822; Antoniu SA, 2010, CURR OPIN MOL THER, V12, P770; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011028; Asturias JA, 2009, CLIN EXP ALLERGY, V39, P1088, DOI 10.1111/j.1365-2222.2009.03264.x; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Ballantyne SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1324, DOI 10.1016/j.jaci.2007.07.051; Bargagli E, 2008, J ASTHMA, V45, P115, DOI 10.1080/02770900701767704; Barnes N, 2012, CLIN EXP ALLERGY, V42, P38, DOI 10.1111/j.1365-2222.2011.03813.x; Basinski TM, 2009, J ALLERGY CLIN IMMUN, V124, P74, DOI 10.1016/j.jaci.2009.04.019; Beck LA, 2004, J ALLERGY CLIN IMMUN, V114, P527, DOI 10.1016/j.jaci.2004.06.032; Belloni B, 2007, J ALLERGY CLIN IMMUN, V120, P1223, DOI 10.1016/j.jaci.2007.08.060; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Biggs L, 2010, J EXP MED, V207, P455, DOI 10.1084/jem.20091725; Blanchard C, 2005, CLIN EXP ALLERGY, V35, P1096, DOI 10.1111/j.1365-2222.2005.02299.x; Bochner BS, 2010, J ALLERGY CLIN IMMUN, V126, P16, DOI 10.1016/j.jaci.2010.02.026; Borish LC, 1999, AM J RESP CRIT CARE, V160, P1816, DOI 10.1164/ajrccm.160.6.9808146; Bousquet J, 2009, J ALLERGY CLIN IMMUN, V124, P428, DOI 10.1016/j.jaci.2009.06.027; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bufe A, 2009, J ALLERGY CLIN IMMUN, V123, P167, DOI 10.1016/j.jaci.2008.10.044; Burgler S, 2009, J ALLERGY CLIN IMMUN, V123, P588, DOI 10.1016/j.jaci.2008.12.017; Busse WW, 2008, AM J RESP CRIT CARE, V178, P1002, DOI 10.1164/rccm.200708-1200OC; Busse WW, 2011, NEW ENGL J MED, V364, P1005, DOI 10.1056/NEJMoa1009705; Busse WW, 2010, J ALLERGY CLIN IMMUN, V125, P1237, DOI 10.1016/j.jaci.2010.04.005; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Carter MC, 2007, J ALLERGY CLIN IMMUN, V119, P1550, DOI 10.1016/j.jaci.2007.03.032; Casale TB, 2001, JAMA-J AM MED ASSOC, V286, P2956, DOI 10.1001/jama.286.23.2956; Casale TB, 2008, J ALLERGY CLIN IMMUN, V121, P288, DOI 10.1016/j.jaci.2007.11.040; Castro M, 2011, AM J RESP CRIT CARE, V184, P1125, DOI 10.1164/rccm.201103-0396OC; Catley MC, 2010, IDRUGS, V13, P601; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Corren J, 2010, AM J RESP CRIT CARE, V181, P788, DOI 10.1164/rccm.200909-1448OC; Crameri R, 2009, CURR OPIN ALLERGY CL, V9, P568, DOI 10.1097/ACI.0b013e3283310fdf; Creticos PS, 2006, NEW ENGL J MED, V355, P1445, DOI 10.1056/NEJMoa052916; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Doherty TA, 2011, NAT MED, V17, P596, DOI 10.1038/nm.2356; Durham SR, 2010, J ALLERGY CLIN IMMUN, V125, P131, DOI 10.1016/j.jaci.2009.10.035; EBERLEINKONIG B, 1995, CLIN EXP ALLERGY, V25, P704, DOI 10.1111/j.1365-2222.1995.tb00007.x; Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Gri G, 2008, IMMUNITY, V29, P771, DOI 10.1016/j.immuni.2008.08.018; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Harper EG, 2008, J INVEST DERMATOL, V128, P1173, DOI 10.1038/sj.jid.5701169; Hart TK, 2002, CLIN EXP IMMUNOL, V130, P93, DOI 10.1046/j.1365-2249.2002.01973.x; Heil PM, 2010, J DTSCH DERMATOL GES, V8, P990, DOI 10.1111/j.1610-0387.2010.07497.x; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hitomi K, 2010, NAT IMMUNOL, V11, P601, DOI 10.1038/ni.1886; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; Ibler K, 2010, J EUR ACAD DERMATOL, V24, P837, DOI 10.1111/j.1468-3083.2009.03202.x; Jacobi A, 2005, J AM ACAD DERMATOL, V52, P522, DOI 10.1016/j.jaad.2004.11.022; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Jartti T, 2007, J ALLERGY CLIN IMMUN, V120, P177, DOI 10.1016/j.jaci.2007.03.008; Jutel M, 2003, EUR J IMMUNOL, V33, P1205, DOI 10.1002/eji.200322919; Jutel M, 2005, J ALLERGY CLIN IMMUN, V116, P608, DOI 10.1016/j.jaci.2005.06.004; Karamloo F, 2005, EUR J IMMUNOL, V35, P3268, DOI 10.1002/eji.200425522; Karlsson MR, 2004, J EXP MED, V199, P1679, DOI 10.1084/jem.20032121; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kips JC, 2003, AM J RESP CRIT CARE, V167, P1655, DOI 10.1164/rccm.200206-525OC; Klunker S, 2007, J ALLERGY CLIN IMMUN, V120, P688, DOI 10.1016/j.jaci.2007.05.034; Klunker S, 2009, J EXP MED, V206, P2701, DOI 10.1084/jem.20090596; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Kundig TM, 2006, J ALLERGY CLIN IMMUN, V117, P1470, DOI 10.1016/j.jaci.2006.01.040; Kussebi F, 2005, J ALLERGY CLIN IMMUN, V115, P323, DOI 10.1016/j.jaci.2004.11.041; Lei LY, 2011, J IMMUNOL, V186, P2254, DOI 10.4049/jimmunol.1002503; Lin H, 2004, J ALLERGY CLIN IMMUN, V113, P297, DOI 10.1016/j.jaci.2003.11.044; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Marshall JS, 1996, J CLIN INVEST, V97, P1122, DOI 10.1172/JCI118506; Massanari M, 2010, J ALLERGY CLIN IMMUN, V125, P383, DOI 10.1016/j.jaci.2009.11.022; Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x; Meiler F, 2008, J EXP MED, V205, P2887, DOI 10.1084/jem.20080193; Melendez AJ, 2007, NAT MED, V13, P1375, DOI 10.1038/nm1654; Mionnet C, 2010, NAT MED, V16, P1305, DOI 10.1038/nm.2253; Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nelson HS, 2005, J ALLERGY CLIN IMM S, V115, pS134; Nicholson GC, 2011, J ALLERGY CLIN IMMUN, V128, P800, DOI 10.1016/j.jaci.2011.05.013; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Niespodziana K, 2011, J ALLERGY CLIN IMMUN, V127, P1562, DOI 10.1016/j.jaci.2011.02.004; Norman PS, 1996, AM J RESP CRIT CARE, V154, P1623, DOI 10.1164/ajrccm.154.6.8970345; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Orihara K, 2007, J ALLERGY CLIN IMMUN, V120, P960, DOI 10.1016/j.jaci.2007.05.036; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Parker JM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-14; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Pierkes M, 1999, J ALLERGY CLIN IMMUN, V103, P326, DOI 10.1016/S0091-6749(99)70509-9; Platts-Mills TAE, 2011, IMMUNOL REV, V242, P51, DOI 10.1111/j.1600-065X.2011.01021.x; Plewako H, 2008, CLIN EXP ALLERGY, V38, P1124, DOI 10.1111/j.1365-2222.2008.03005.x; Plewako H, 2006, INT ARCH ALLERGY IMM, V141, P346, DOI 10.1159/000095461; Pree I, 2007, J IMMUNOL, V179, P5309, DOI 10.4049/jimmunol.179.8.5309; Prussin C, 2003, J ALLERGY CLIN IMMUN, V112, P1147, DOI 10.1016/j.jaci.2003.10.003; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Rodrigo GJ, 2011, CHEST, V139, P28, DOI 10.1378/chest.10-1194; Romano A, 2011, J ALLERGY CLIN IMMUN, V127, pS67, DOI 10.1016/j.jaci.2010.11.047; Rosewich M, 2010, CLIN EXP IMMUNOL, V160, P403, DOI 10.1111/j.1365-2249.2010.04106.x; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; Rullan P, 2009, J DRUGS DERMATOL, V8, P873; Sands MF, 2007, J ALLERGY CLIN IMMUN, V120, P979, DOI 10.1016/j.jaci.2007.07.041; Sato T, 2009, PHARMACOLOGY, V84, P171, DOI 10.1159/000235748; Scadding GW, 2010, CLIN EXP ALLERGY, V40, P598, DOI 10.1111/j.1365-2222.2010.03462.x; Sediva A, 2008, J ALLERGY CLIN IMMUN, V121, P1515, DOI 10.1016/j.jaci.2008.03.007; Senti G., J ALLERGY C IN PRESS; Senti G, 2012, J ALLERGY CLIN IMMUN, V129, P128, DOI 10.1016/j.jaci.2011.08.036; Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Simon D, 2008, J ALLERGY CLIN IMMUN, V121, P122, DOI 10.1016/j.jaci.2007.11.016; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V129, P456, DOI 10.1016/j.jaci.2011.11.044; Straumann A, 2010, GUT, V59, P21, DOI 10.1136/gut.2009.178558; Thunberg S, 2009, ALLERGY, V64, P919, DOI 10.1111/j.1398-9995.2008.01905.x; Turner JD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001269; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; VanRee R, 1997, CLIN EXP ALLERGY, V27, P68, DOI 10.1046/j.1365-2222.1997.d01-416.x; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Vlad G, 2007, TRANSPL IMMUNOL, V18, P13, DOI 10.1016/j.trim.2007.03.001; Wenzel S, 2012, NAT MED, V18, paaa; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wilson DR, 2005, ALLERGY, V60, P4, DOI 10.1111/j.1398-9995.2005.00699.x; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Worm M, 2011, J ALLERGY CLIN IMMUN, V127, P89, DOI 10.1016/j.jaci.2010.11.029; Wu AC, 2007, J ALLERGY CLIN IMMUN, V120, P1146, DOI 10.1016/j.jaci.2007.07.055; Yong PFK, 2009, NEW ENGL J MED, V360, P1045, DOI 10.1056/NEJMc0808282; Zaidi AK, 2010, J ALLERGY CLIN IMMUN, V125, P902, DOI 10.1016/j.jaci.2009.12.996; Zhang F, 2011, CLIN EXP IMMUNOL, V164, P256, DOI 10.1111/j.1365-2249.2011.04328.x; Zhou YF, 2010, NAT MED, V16, P1128, DOI 10.1038/nm.2201; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219; Zhu DC, 2002, NAT MED, V8, P518, DOI 10.1038/nm0502-518; Zimmermann M, 2011, J ALLERGY CLIN IMMUN, V127, P200, DOI 10.1016/j.jaci.2010.11.005; Zirbes JM, 2008, PEDIATR PULM, V43, P607, DOI 10.1002/ppul.20804	149	208	220	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2012	18	5					736	749		10.1038/nm.2754	http://dx.doi.org/10.1038/nm.2754			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	938WE	22561837	Bronze			2022-12-27	WOS:000303763500041
J	Dussiot, M; Maciel, TT; Fricot, A; Chartier, C; Negre, O; Veiga, J; Grapton, D; Paubelle, E; Payen, E; Beuzard, Y; Leboulch, P; Ribeil, JA; Arlet, JB; Cote, F; Courtois, G; Ginzburg, YZ; Daniel, TO; Chopra, R; Sung, V; Hermine, O; Moura, IC				Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Negre, Olivier; Veiga, Joel; Grapton, Damien; Paubelle, Etienne; Payen, Emmanuel; Beuzard, Yves; Leboulch, Philippe; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Ginzburg, Yelena Z.; Daniel, Thomas O.; Chopra, Rajesh; Sung, Victoria; Hermine, Olivier; Moura, Ivan C.			An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia	NATURE MEDICINE			English	Article							ALPHA-GLOBIN; OXIDATIVE STRESS; PROTEIN; PROLIFERATION; DIFFERENTIATION; PATHOPHYSIOLOGY; PROGENITORS; EXPANSION; ACE-011; MODEL	The pathophysiology of ineffective erythropoiesis in beta-thalassemia is poorly understood. We report that RAP-011, an activin receptor IIA (ActRIIA) ligand trap, improved ineffective erythropoiesis, corrected anemia and limited iron overload in a mouse model of beta-thalassemia intermedia. Expression of growth differentiation factor 11 (GDF11), an ActRIIA ligand, was increased in splenic erythroblasts from thalassemic mice and in erythroblasts and sera from subjects with beta-thalassemia. Inactivation of GDF11 decreased oxidative stress and the amount of alpha-globin membrane precipitates, resulting in increased terminal erythroid differentiation. Abnormal GDF11 expression was dependent on reactive oxygen species, suggesting the existence of an autocrine amplification loop in beta-thalassemia. GDF11 inactivation also corrected the abnormal ratio of immature/mature erythroblasts by inducing apoptosis of immature erythroblasts through the Fas-Fas ligand pathway. Taken together, these observations suggest that ActRIIA ligand traps may have therapeutic relevance in beta-thalassemia by suppressing the deleterious effects of GDF11, a cytokine which blocks terminal erythroid maturation through an autocrine amplification loop involving oxidative stress and alpha-globin precipitation.	[Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Grapton, Damien; Paubelle, Etienne; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Hermine, Olivier; Moura, Ivan C.] INSERM, UMR 1163, Lab Cellular & Mol Mech Hematol Disorders & Thera, Paris, France; [Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Grapton, Damien; Paubelle, Etienne; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Hermine, Olivier; Moura, Ivan C.] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Paris, France; [Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Grapton, Damien; Paubelle, Etienne; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Hermine, Olivier; Moura, Ivan C.] CNRS, ERL 8254, Paris, France; [Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Veiga, Joel; Grapton, Damien; Paubelle, Etienne; Ribeil, Jean-Antoine; Arlet, Jean-Benoit; Cote, Francine; Courtois, Genevieve; Hermine, Olivier; Moura, Ivan C.] Lab Excellence GR Ex, Paris, France; [Dussiot, Michael; Maciel, Thiago T.; Fricot, Aurelie; Chartier, Celine; Grapton, Damien; Paubelle, Etienne; Moura, Ivan C.] INSERM, U1149, Ctr Res Inflammat, Paris, France; [Negre, Olivier; Payen, Emmanuel; Beuzard, Yves; Leboulch, Philippe] CEA, Inst Malad Emergentes & Therapies Innovantes iMET, Fontenay Aux Roses, France; [Negre, Olivier; Payen, Emmanuel; Beuzard, Yves; Leboulch, Philippe] Univ Paris 11, CEA, INSERM, UMR 962, Fontenay Aux Roses, France; [Ribeil, Jean-Antoine] Hop Necker Enfants Malad, Dept Biotherapie, Paris, France; [Ginzburg, Yelena Z.] New York Blood Ctr, Lindsley F Kimball Res Inst, Erythropoiesis Lab, New York, NY 10021 USA; [Daniel, Thomas O.; Chopra, Rajesh] Celgene, Summit, NJ USA; [Sung, Victoria] Celgene, San Francisco, CA USA; [Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Serv Hematol Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; New York Blood Center; Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Moura, IC (corresponding author), INSERM, UMR 1163, Lab Cellular & Mol Mech Hematol Disorders & Thera, Paris, France.	olivier.hermine@nck.aphp.fr; ivan.moura@inserm.fr	Maciel, Thiago Trovati/AAF-5462-2021; Arlet, Jean Benoit/D-3124-2016; Ribeil, Jean-Antoine/AAK-7979-2020; Moura, Ivan C/A-9510-2013; Ribeil, Jean-Antoine/F-7896-2017; Maciel, Thiago/A-4475-2013; Payen, Emmanuel/S-5357-2018; Hermine, Olivier/Q-7072-2018; NEGRE, Olivier/AAA-2027-2022; Cruz Moura, Ivan/A-9510-2013	Maciel, Thiago Trovati/0000-0002-9347-981X; Ribeil, Jean-Antoine/0000-0002-4549-4783; Moura, Ivan C/0000-0002-2977-0354; Ribeil, Jean-Antoine/0000-0002-5733-9123; Maciel, Thiago/0000-0002-9347-981X; Payen, Emmanuel/0000-0002-1329-2327; Cruz Moura, Ivan/0000-0002-8418-2803; courtois, genevieve/0000-0001-6370-5575; Hermine, Olivier/0000-0003-2574-3874	Agence Nationale de la Recherche [ANR-10-JCJC-1108, ANR-12-BSV1-0039, ANR-11-LABX-0051, ANR-10-BLAN-1109]; Assistance Publique Hopitaux de Paris-CNRS Contrats Hospitaliers de Recherche Translationnelle; Institut National du Cancer; Canceropole Ile-de-France; Fondation pour la Recherche Medicale; Fondation de France; Association Laurette Fugain; Association pour la Recherche sur le Cancer; French National Research Agency [ANR-10-IAHU-01, ANR-11-IDEX-0005-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105682] Funding Source: NIH RePORTER	Agence Nationale de la Recherche(French National Research Agency (ANR)); Assistance Publique Hopitaux de Paris-CNRS Contrats Hospitaliers de Recherche Translationnelle; Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de France(Fondation de France); Association Laurette Fugain; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); French National Research Agency(French National Research Agency (ANR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Agence Nationale de la Recherche (grants ANR-10-JCJC-1108, ANR-12-BSV1-0039, ANR-11-LABX-0051 and ANR-10-BLAN-1109), Assistance Publique Hopitaux de Paris-CNRS Contrats Hospitaliers de Recherche Translationnelle, Institut National du Cancer, Canceropole Ile-de-France, Fondation pour la Recherche Medicale, Fondation de France, Association Laurette Fugain and Association pour la Recherche sur le Cancer. The Imagine Institute and the Laboratory of Excellence GR-Ex are funded by the program 'Investissements d'avenir' of the French National Research Agency (ANR-10-IAHU-01 and ANR-11-IDEX-0005-02, respectively). We thank S. Nelson and J. Bex for technical assistance, C. Brouzes for cytological advice, M.G. Traore and N. Goudin for assistance with confocal microscopy and O. Thibaudeau, F. Watier and N. Gadessaud for assistance in histological sample processing. 34-3C IgG2a antibody was provided by S. Izui (University Medical Center, University of Geneva).	Bader-Meunier B, 2000, BRIT J HAEMATOL, V108, P300; BROXMEYER HE, 1988, P NATL ACAD SCI USA, V85, P9052, DOI 10.1073/pnas.85.23.9052; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Coulon S, 2011, NAT MED, V17, P1456, DOI 10.1038/nm.2462; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Dolznig H, 2001, FASEB J, V15, P1442, DOI 10.1096/fj.00-0705fje; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Hegde S, 2007, MAMM GENOME, V18, P852, DOI 10.1007/s00335-007-9074-9; Higgs DR, 2012, LANCET, V379, P373, DOI 10.1016/S0140-6736(11)60283-3; Iancu-Rubin C, 2013, EXP HEMATOL, V41, P155, DOI 10.1016/j.exphem.2012.12.002; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; MIZUGUCHI T, 1993, BLOOD, V81, P2891; NAKAO K, 1991, EXP HEMATOL, V19, P1090; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; Ramos P, 2010, ANN NY ACAD SCI, V1202, P24, DOI 10.1111/j.1749-6632.2010.05596.x; ReemKalma Y, 1995, P NATL ACAD SCI USA, V92, P12141, DOI 10.1073/pnas.92.26.12141; Ribeil JA, 2013, SCI WORLD J, DOI 10.1155/2013/394295; Rivella S, 2012, BLOOD REV, V26, pS12, DOI 10.1016/S0268-960X(12)70005-X; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; Schrier SL, 2002, CURR OPIN HEMATOL, V9, P123, DOI 10.1097/00062752-200203000-00007; Shiozaki M, 1998, BIOCHEM BIOPH RES CO, V242, P631, DOI 10.1006/bbrc.1997.8020; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; SORENSEN S, 1990, BLOOD, V75, P1333; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; Utsugisawa T, 2006, STEM CELLS, V24, P1128, DOI 10.1634/stemcells.2005-0263; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Weiss MJ, 2009, BLOOD, V113, P2136, DOI 10.1182/blood-2008-09-115238; YU J, 1987, NATURE, V330, P765, DOI 10.1038/330765a0; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zermati Y, 2000, EXP HEMATOL, V28, P885, DOI 10.1016/S0301-472X(00)00488-4	42	211	239	3	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					398	+		10.1038/nm.3468	http://dx.doi.org/10.1038/nm.3468			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658077	Green Accepted			2022-12-27	WOS:000334361500020
J	Cubas, RA; Mudd, JC; Savoye, AL; Perreau, M; van Grevenynghe, J; Metcalf, T; Connick, E; Meditz, A; Freeman, GJ; Abesada-Terk, G; Jacobson, JM; Brooks, AD; Crotty, S; Estes, JD; Pantaleo, G; Lederman, MM; Haddad, EK				Cubas, Rafael A.; Mudd, Joseph C.; Savoye, Anne-Laure; Perreau, Matthieu; van Grevenynghe, Julien; Metcalf, Talibah; Connick, Elizabeth; Meditz, Amie; Freeman, Gordon J.; Abesada-Terk, Guillermo, Jr.; Jacobson, Jeffrey M.; Brooks, Ari D.; Crotty, Shane; Estes, Jacob D.; Pantaleo, Giuseppe; Lederman, Michael M.; Haddad, Elias K.			Inadequate T follicular cell help impairs B cell immunity during HIV infection	NATURE MEDICINE			English	Article							HUMORAL IMMUNITY; LYMPH-NODES; C-MAF; MEMORY; RESPONSES; IL-21; ANTIBODIES; DIFFERENTIATION; NEUTRALIZATION; PERSISTENCE	The majority of HIV-infected individuals fail to produce protective antibodies and have diminished responses to new immunizations(1-3). We report here that even though there is an expansion of follicular helper T (T-FH) cells in HIV-infected individuals, the cells are unable to provide adequate B cell help. We found a higher frequency of programmed cell death ligand 1 (PD-L1)(+) germinal center B cells from lymph nodes of HIV-infected individuals suggesting a potential role for PD-1-PD-L1 interaction in regulating T-FH cell function. In fact, we show that engagement of PD-1 on T-FH cells leads to a reduction in cell proliferation, activation, inducible T-cell co-stimulator (ICOS) expression and interleukin-21 (IL-21) cytokine secretion. Blocking PD-1 signaling enhances HIV-specific immunoglobulin production in vitro. We further show that at least part of this defect involves IL-21, as addition of this cytokine rescues antibody responses and plasma cell generation in vitro. Our results suggest that deregulation of T-FH cell-mediated B cell help diminishes B cell responses during HIV infection and may be related to PD-1 triggering on T-FH cells. These results demonstrate a role for T-FH cell impairment in HIV pathogenesis and suggest that enhancing their function could have a major impact on the outcome and control of HIV infection, preventing future infections and improving immune responses to vaccinations.	[Cubas, Rafael A.; van Grevenynghe, Julien; Metcalf, Talibah; Haddad, Elias K.] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL 34987 USA; [Mudd, Joseph C.; Lederman, Michael M.] Case Western Reserve Univ, Div Infect Dis, Ctr AIDS Res, Univ Hosp,Case Med Ctr, Cleveland, OH 44106 USA; [Savoye, Anne-Laure; Perreau, Matthieu; Pantaleo, Giuseppe] Univ Lausanne, Lausanne Univ Hosp, Swiss Vaccine Res Inst, Div Immunol & Allergy, Lausanne, Switzerland; [Connick, Elizabeth; Meditz, Amie] Univ Colorado Denver, Div Infect Dis, Denver, CO USA; [Freeman, Gordon J.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Abesada-Terk, Guillermo, Jr.] Martin Mem Hlth Syst, Robert & Carol Weissman Canc Ctr, Stuart, FL USA; [Jacobson, Jeffrey M.] Drexel Univ, Coll Med, Div Infect Dis & HIV Med, Philadelphia, PA 19104 USA; [Brooks, Ari D.] Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19104 USA; [Crotty, Shane] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Crotty, Shane] Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA USA; [Estes, Jacob D.] SAIC Frederick Inc, AIDS & Canc Virus Program, Frederick Natl Lab Canc Res, Frederick, MD USA	Vaccine & Gene Therapy Institute of Florida; Case Western Reserve University; University Hospitals of Cleveland; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Drexel University; Drexel University; La Jolla Institute for Immunology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Haddad, EK (corresponding author), Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL 34987 USA.	ehaddad@vgtifl.org	Crotty, Shane/AAE-8446-2019; Freeman, Gordon/AAC-5380-2019; Perreau, Matthieu/D-6309-2017; Crotty, Shane/AAC-6703-2019; Pantaleo, Giuseppe/K-6163-2016	Freeman, Gordon/0000-0002-7210-5616; Crotty, Shane/0000-0002-6484-6262; Cubas, Rafael/0000-0002-3450-9054	US National Institutes of Health (NIH) [HHSN272201100017C, NIH-1P01 AI080192, U19AI082630, 2P01 AI056299, R01 AI096966]; Case Western Reserve University Center for AIDS Research [AI 36219]; Cleveland Immunopathogenesis Consortium [AI 76174]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076174, R01AI096966, P30AI036219, P01AI056299, U19AI082630, T32AI089474, P01AI080192] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University Center for AIDS Research; Cleveland Immunopathogenesis Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Ryzner, R. Bordi and D. Brown for sample collection. We also thank K. Kusser and Y. Shi from the Flow Cytometry Core at Vaccine & Gene Therapy Institute Florida for their help with sorting all the samples. We are grateful to R. Debernardo (Case Western Reserve University and University Hospitals Case Medical Center) for obtaining the HIV-uninfected lymph nodes and to B. Rodriguez for his help with the infected lymph node samples. This study was supported in part by US National Institutes of Health (NIH) contract HHSN272201100017C, NIH-1P01 AI080192, U19AI082630, 2P01 AI056299 and R01 AI096966. This work was also supported by the Case Western Reserve University Center for AIDS Research (AI 36219) and by the Cleveland Immunopathogenesis Consortium (AI 76174).	Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bekker V, 2006, PEDIATRICS, V118, pE315, DOI 10.1542/peds.2005-2616; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Haase AT, 1996, SCIENCE, V274, P985, DOI 10.1126/science.274.5289.985; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Iannello A, 2008, VIRAL IMMUNOL, V21, P385, DOI 10.1089/vim.2008.0025; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874; Konforte D, 2009, J IMMUNOL, V182, P1781, DOI 10.4049/jimmunol.0803009; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Malaspina A, 2008, J IMMUNOL, V181, P1199, DOI 10.4049/jimmunol.181.2.1199; Mehta N, 2010, VACCINE, V28, P3672, DOI 10.1016/j.vaccine.2010.03.022; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Van Grevenynghe J, 2011, J CLIN INVEST, V121, P3877, DOI 10.1172/JCI59211; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	40	284	298	0	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					494	+		10.1038/nm.3109	http://dx.doi.org/10.1038/nm.3109			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23475201	Green Accepted, Green Submitted			2022-12-27	WOS:000317109100036
J	Alonso, PL; Tanner, M				Alonso, Pedro L.; Tanner, Marcel			Public health challenges and prospects for malaria control and elimination	NATURE MEDICINE			English	Article							VACCINE; COMBINATION; MOZAMBIQUE; RESISTANCE; MORTALITY; DECLINE; BURDEN; SAFETY	The past decade witnessed unprecedented efforts to control malaria, including renewed political and financial commitment and increased availability of both old and new strategies and tools. However, malaria still represents a major health burden, particularly in Africa. Important challenges such as the fragility of many health systems, the rise of insecticide and drug resistance, and particularly the expected decline both in funding and in the coverage of key interventions if they are not replaced as needed, urgently need to be addressed. Further research and development is also becoming increasingly crucial. Among other needs, common methodologies for estimating and tracking the malaria burden, new strategies to measure transmission, better understanding of immunity, and increased knowledge of the mechanisms and effects of resistance to drugs and insecticides stand out. The ongoing efforts in research and development for new antimalarial drugs, more sensitive point-of-care rapid diagnostic tests and new insecticides need further innovation and substantial strengthening. Clearly, efforts should focus not only on Plasmodium falciparum but also and increasingly on Plasmodium vivax, the neglected human malaria parasite. Addressing these challenges in a comprehensive and timely way will allow us to sustain the gains made so far and make further progress in control and progressive elimination.	[Alonso, Pedro L.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, E-08007 Barcelona, Spain; [Alonso, Pedro L.] Manhica Hlth Res Ctr, Manhica, Mozambique; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tanner, Marcel] Univ Basel, Fac Sci Infect Biol & Epidemiol, CH-4003 Basel, Switzerland	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Alonso, PL (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, E-08007 Barcelona, Spain.	pedro.alonso@isglobal.org	Alonso, Pedro L/AAZ-3645-2020	Alonso, Pedro L/0000-0003-3292-3443				Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Aide P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013838; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2008, GLOB MAL ACT PLAN; [Anonymous], 2011, GLOB PLAN ART RES CO; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Cech PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022273; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Davies TGE, 2008, PEST MANAG SCI, V64, P1126, DOI 10.1002/ps.1617; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; GREENWOOD BM, 1988, LANCET, V1, P1121; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; *MALERA CONS GROUP, 2011, PLOS MED, V0008; *MALERA CONS GROUP, 2011, PLOS MED, V0008; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moran M., 2011, POLICY CURES; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Roll Back Malaria Partnership, 2011, REF UPD GMAP OBJ TAR; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, GUID TREATM MAL, V2nd; WHO Global Malaria Programme, 2012, WHO POL REC SEAS MAL; WHO/GMP, 2011, REP TECHN CONS SEAS; World Health Organization, 2012, WHO GLOB MAL PROGR G	40	89	93	2	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					150	155		10.1038/nm.3077	http://dx.doi.org/10.1038/nm.3077			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389615				2022-12-27	WOS:000314675900023
J	Rosenbloom, DIS; Hill, AL; Rabi, SA; Siliciano, RF; Nowak, MA				Rosenbloom, Daniel I. S.; Hill, Alison L.; Rabi, S. Alireza; Siliciano, Robert F.; Nowak, Martin A.			Antiretroviral dynamics determines HIV evolution and predicts therapy outcome	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MUTANT SELECTION WINDOW; REVERSE-TRANSCRIPTASE INHIBITORS; RESPONSE CURVE SLOPE; DRUG-RESISTANCE; HIV-1-INFECTED PATIENTS; VIROLOGICAL FAILURE; ANTIVIRAL THERAPY; ADHERENCE; PROTEASE	Despite the high inhibition of viral replication achieved by current anti-HIV drugs, many patients fail treatment, often with emergence of drug-resistant virus. Clinical observations show that the relationship between adherence and likelihood of resistance differs dramatically among drug classes. We developed a mathematical model that explains these observations and predicts treatment outcomes. Our model incorporates drug properties, fitness differences between susceptible and resistant strains, mutations and adherence. We show that antiviral activity falls quickly for drugs with sharp dose-response curves and short half-lives, such as boosted protease inhibitors, limiting the time during which resistance can be selected for. We find that poor adherence to such drugs causes treatment failure via growth of susceptible virus, explaining puzzling clinical observations. Furthermore, our model predicts that certain single-pill combination therapies can prevent resistance regardless of patient adherence. Our approach represents a first step for simulating clinical trials of untested anti-HIV regimens and may help in the selection of new drug regimens for investigation.	[Rabi, S. Alireza; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Rosenbloom, Daniel I. S.; Hill, Alison L.; Nowak, Martin A.] Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Hill, Alison L.] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Hill, Alison L.] Harvard Univ, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02138 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Harvard University; Harvard University; Harvard University	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsiliciano@jhmi.edu; martin_nowak@harvard.edu	Nowak, Martin A/A-6977-2008; Hill, Alison Lynn/W-7839-2019	Hill, Alison Lynn/0000-0002-6583-3623	US National Institutes of Health [R01 MH054907, R01 AI081600, R01 GM078986]; Research Computing Group of Harvard University; Bill & Melinda Gates Foundation; Cancer Research Institute Fellowship; US National Science Foundation; Howard Hughes Medical Institute; Canadian Natural Sciences and Engineering Research Council; John Templeton Foundation; J. Epstein; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081600, T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Computing Group of Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Cancer Research Institute Fellowship; US National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); John Templeton Foundation; J. Epstein; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Antal, I. Bozic, F. Fu, M. Sampah and L. Shen for discussion during the conception of this work, and we thank J. Gallant, J.-B. Michel and P. Pennings for their comments on the manuscript. We thank D. Bangsberg of Massachusetts General Hospital for supplying adherence data from the REACH study (supported by US National Institutes of Health grant R01 MH054907). Simulations were run on the Odyssey cluster supported by the Research Computing Group of Harvard University. We are grateful for support from the US National Institutes of Health (R01 AI081600 (R.F.S., S.A.R.), R01 GM078986 (M.A.N., A.L.H.)), the Bill & Melinda Gates Foundation (M.A.N., A.L.H.), a Cancer Research Institute Fellowship (S.A.R.), a US National Science Foundation Graduate Research Fellowship (D.I.S.R.), the Howard Hughes Medical Institute (R.F.S., S.A.R.), a Canadian Natural Sciences and Engineering Research Council Post-Graduate Scholarship (A.L.H.), the John Templeton Foundation (M.A.N.) and J. Epstein (M.A.N.).	Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Best BM, 2011, J ANTIMICROB CHEMOTH, V66, P354, DOI 10.1093/jac/dkq434; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Bonhoeffer S, 1997, P ROY SOC B-BIOL SCI, V264, P631; CHEESEMAN SH, 1995, J ACQ IMMUN DEF SYND, V8, P141; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; Condra JH, 1998, HAEMOPHILIA, V4, P610, DOI 10.1046/j.1365-2516.1998.440610.x; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Drlica K, 2003, J ANTIMICROB CHEMOTH, V52, P11, DOI 10.1093/jac/dkg269; Drlica K, 2007, CLIN INFECT DIS, V44, P681, DOI 10.1086/511642; Gardner EA, 2008, AIDS, V22, P75, DOI 10.1097/QAD.0b013e3282f366ff; Gardner EM, 2009, AIDS, V23, P1035, DOI 10.1097/QAD.0b013e32832ba8ec; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gupta RK, 2010, AIDS, V24, P1651, DOI 10.1097/QAD.0b013e3283398216; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Hill AL, 2012, J MOL MED, V90, P543, DOI 10.1007/s00109-012-0892-1; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Jourdain G, 2010, CLIN INFECT DIS, V50, P1397, DOI 10.1086/652148; Kastrissios H, 1998, AIDS, V12, P2295, DOI 10.1097/00002030-199817000-00011; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; Kepler TB, 1998, P NATL ACAD SCI USA, V95, P11514, DOI 10.1073/pnas.95.20.11514; Lima VD, 2008, AIDS, V22, P2371, DOI 10.1097/QAD.0b013e328315cdd3; Liu HH, 2007, STAT MED, V26, P991, DOI 10.1002/sim.2592; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Nijhuis M, 2007, PLOS MED, V4, P152, DOI 10.1371/journal.pmed.0040036; Noe A, 2005, J ANTIMICROB CHEMOTH, V55, P410, DOI 10.1093/jac/dki038; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; Nowak MA., 2000, VIRUS DYNAMICS MATH; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Parienti JJ, 2010, CLIN INFECT DIS, V50, P1192, DOI 10.1086/651419; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Parry CM, 2009, J VIROL, V83, P9094, DOI 10.1128/JVI.02356-08; Perez-Valero I, 2011, CURR OPIN INFECT DIS, V24, P7, DOI 10.1097/QCO.0b013e3283422cdf; Pulido F, 2012, AIDS RES HUM RETROV, V28, P1167, DOI 10.1089/aid.2011.0256; Ribeiro RM, 1998, AIDS, V12, P461, DOI 10.1097/00002030-199805000-00006; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rong LB, 2007, B MATH BIOL, V69, P2027, DOI 10.1007/s11538-007-9203-3; Ruxrungtham K, 2008, HIV MED, V9, P883, DOI 10.1111/j.1468-1293.2008.00644.x; Sampah MES, 2011, P NATL ACAD SCI USA, V108, P7613, DOI 10.1073/pnas.1018360108; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Shen L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002304; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Smith RJ, 2006, P ROY SOC B-BIOL SCI, V273, P617, DOI 10.1098/rspb.2005.3352; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; van Marle G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-87; Vanhove GF, 1996, JAMA-J AM MED ASSOC, V276, P1955, DOI 10.1001/jama.276.24.1955; Wahl LM, 2000, P ROY SOC B-BIOL SCI, V267, P835, DOI 10.1098/rspb.2000.1079; Wu HL, 2005, JAIDS-J ACQ IMM DEF, V39, P272, DOI 10.1097/01.qai.0000165907.04710.da; Zhao XL, 2002, J INFECT DIS, V185, P561, DOI 10.1086/338571	65	113	114	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1378	+		10.1038/nm.2892	http://dx.doi.org/10.1038/nm.2892			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22941277	Green Accepted, Green Submitted			2022-12-27	WOS:000308472300033
J	Vakoc, CR; Garcia-Manero, G; Look, AT				Vakoc, Christopher R.; Garcia-Manero, Guillermo; Look, A. Thomas			Cancer therapy resistance: chasing epigenetics	NATURE MEDICINE			English	Editorial Material									[Vakoc, Christopher R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Look, A. Thomas] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Look, A. Thomas] Harvard Univ, Childrens Hosp Boston, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA	Cold Spring Harbor Laboratory; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.				NCI NIH HHS [R01 CA174793] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA174793] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))			0	5	5	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					340	341		10.1038/nm.3528	http://dx.doi.org/10.1038/nm.3528			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24710376				2022-12-27	WOS:000334361500012
J	Shuchman, M; Wondimagegn, D; Pain, C; Alem, A				Shuchman, Miriam; Wondimagegn, Dawit; Pain, Clare; Alem, Atalay			Partnering with local scientists should be mandatory	NATURE MEDICINE			English	Editorial Material									[Shuchman, Miriam; Pain, Clare] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Shuchman, Miriam] SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14260 USA; [Wondimagegn, Dawit; Alem, Atalay] Univ Addis Ababa, Coll Hlth Sci, Addis Ababa, Ethiopia; [Wondimagegn, Dawit; Alem, Atalay] Univ Addis Ababa, Dept Psychiat, Addis Ababa, Ethiopia; [Pain, Clare] Mt Sinai Hosp, Dept Psychiat, Toronto, ON M5G 1X5, Canada	University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Addis Ababa University; Addis Ababa University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Shuchman, M (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.		Pain, Clare/N-9182-2016					2012, CLIN ORTHOP RELAT RE, V470, P2313; 2007, BR J PSYCHIAT, V190, P77; 2013, LANCET, V381, P278	3	9	9	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2014	20	1					12	12		10.1038/nm0114-12	http://dx.doi.org/10.1038/nm0114-12			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	284VN	24398954	Bronze			2022-12-27	WOS:000329349400008
J	Kottke, T; Boisgerault, N; Diaz, RM; Donnelly, O; Rommelfanger-Konkol, D; Pulido, J; Thompson, J; Mukhopadhyay, D; Kaspar, R; Coffey, M; Pandha, H; Melcher, A; Harrington, K; Selby, P; Vile, R				Kottke, Timothy; Boisgerault, Nicolas; Diaz, Rosa Maria; Donnelly, Oliver; Rommelfanger-Konkol, Diana; Pulido, Jose; Thompson, Jill; Mukhopadhyay, Debabrata; Kaspar, Roger; Coffey, Matt; Pandha, Hardev; Melcher, Alan; Harrington, Kevin; Selby, Peter; Vile, Richard			Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence	NATURE MEDICINE			English	Article							T-CELL THERAPY; VESICULAR STOMATITIS-VIRUS; ONCOLYTIC VIROTHERAPY; CDNA LIBRARIES; DORMANT STATE; GENE-THERAPY; L5178Y CELLS; ANTIGEN LOSS; IN-VIVO; CANCER	Tumor recurrence represents a major clinical challenge. Our data show that emergent recurrent tumors acquire a phenotype radically different from that of their originating primary tumors. This phenotype allows them to evade a host-derived innate immune response elicited by the progression from minimal residual disease (MRD) to actively growing recurrence. Screening for this innate response predicted accurately in which mice recurrence would occur. Premature induction of recurrence resensitized MRD to the primary therapy, suggesting a possible paradigm shift for clinical treatment of dormant disease in which the current expectant approach is replaced with active attempts to uncover MRD before evolution of the escape phenotype is complete. By combining screening with second-line treatments targeting innate insensitivity, up to 100% of mice that would have otherwise relapsed were cured. These data may open new avenues for early detection and appropriately timed, highly targeted treatment of tumor recurrence irrespective of tumor type or frontline treatment.	[Kottke, Timothy; Boisgerault, Nicolas; Diaz, Rosa Maria; Rommelfanger-Konkol, Diana; Pulido, Jose; Thompson, Jill; Vile, Richard] Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA; [Donnelly, Oliver; Melcher, Alan; Selby, Peter; Vile, Richard] St James Univ Hosp, Canc Res UK Ctr, Leeds, W Yorkshire, England; [Pulido, Jose] Mayo Clin, Dept Ophthalmol & Ocular Oncol, Rochester, MN USA; [Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Kaspar, Roger] TransDerm, Santa Cruz, CA USA; [Coffey, Matt] Oncolyt Biotech, Calgary, AB, Canada; [Pandha, Hardev] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England; [Harrington, Kevin] Inst Canc Res, London SW3 6JB, England; [Vile, Richard] Mayo Clin, Dept Immunol, Rochester, MN USA	Mayo Clinic; Cancer Research UK; Saint James's University Hospital; Mayo Clinic; Mayo Clinic; Oncolytics Biotech; University of Surrey; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Mayo Clinic	Vile, R (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55905 USA.	vile.richard@mayo.edu	Boisgerault, Nicolas/L-7949-2015; Donnelly, Oliver/G-7382-2012	Boisgerault, Nicolas/0000-0002-3391-6504; Donnelly, Oliver/0000-0001-8613-6686; Melcher, Alan/0000-0002-2042-3380; Harrington, Kevin/0000-0002-6014-348X	Richard M. Schulze Family Foundation; Mayo Foundation; Cancer Research UK; US National Institutes of Health [R01 CA107082, R01CA130878, R01 CA132734]; Cancer Research UK [13244] Funding Source: researchfish; Medical Research Council [G0900324] Funding Source: researchfish; National Institute for Health Research [CL-2012-02-002] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA132734, R01CA107082, R01CA175386, R01CA130878] Funding Source: NIH RePORTER; MRC [G0900324] Funding Source: UKRI	Richard M. Schulze Family Foundation; Mayo Foundation; Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Higgins for expert secretarial assistance and M. Behrens and K. Knutson for help with Her-2-neu mice. This work was supported by the Richard M. Schulze Family Foundation, the Mayo Foundation, Cancer Research UK, US National Institutes of Health grants R01 CA107082, R01CA130878 and R01 CA132734 and a grant from T. and J. Paul.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Aguirre-Ghiso JA, 2013, NAT MED, V19, P276, DOI 10.1038/nm.3120; Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Boisgerault N, 2013, MOL THER, V21, P1507, DOI 10.1038/mt.2013.116; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cray C, 2012, PROG MOL BIOL TRANSL, V105, P113, DOI 10.1016/B978-0-12-394596-9.00005-6; Cray C, 2009, COMPARATIVE MED, V59, P517; Drake CG, 2006, ADV IMMUNOL, V90, P51, DOI 10.1016/S0065-2776(06)90002-9; Dranoff G, 2012, NAT REV IMMUNOL, V12, P61, DOI 10.1038/nri3129; Duren M, 1999, SURGERY, V126, P13, DOI 10.1067/msy.1999.98849; Garrido F, 2010, INT J CANCER, V127, P249, DOI 10.1002/ijc.25270; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Gonzalez-Gonzalez E, 2011, SCI REP-UK, V1, DOI 10.1038/srep00158; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Hensel JA, 2013, NAT REV CLIN ONCOL, V10, P41, DOI 10.1038/nrclinonc.2012.207; Indraccolo S, 2006, P NATL ACAD SCI USA, V103, P4216, DOI 10.1073/pnas.0506200103; Kaluza KM, 2012, HUM GENE THER, V23, P1054, DOI 10.1089/hum.2012.030; Kaluza KM, 2012, INT J CANCER, V131, P844, DOI 10.1002/ijc.26447; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kloos RT, 2005, J CLIN ENDOCR METAB, V90, P5047, DOI 10.1210/jc.2005-0492; Kottke T, 2011, MOL THER, V19, P1802, DOI 10.1038/mt.2011.147; Kottke T, 2011, NAT MED, V17, P854, DOI 10.1038/nm.2390; Kottke T, 2010, J CLIN INVEST, V120, P1551, DOI 10.1172/JCI41431; Kottke T, 2008, MOL THER, V16, P1910, DOI 10.1038/mt.2008.212; Kovacs AF, 2003, J CHEMOTHERAPY, V15, P495, DOI 10.1179/joc.2003.15.5.495; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Liu KB, 2006, J IMMUNOL, V176, P3374, DOI 10.4049/jimmunol.176.6.3374; McGowan PM, 2009, FUTURE ONCOL, V5, P1083, DOI [10.2217/fon.09.73, 10.2217/FON.09.73]; Melcher A, 1998, NAT MED, V4, P581, DOI 10.1038/nm0598-581; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609; Ossowski L, 2010, PIGM CELL MELANOMA R, V23, P41, DOI 10.1111/j.1755-148X.2009.00647.x; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Polzer B, 2013, NAT MED, V19, P274, DOI 10.1038/nm.3121; Pulido J, 2012, NAT BIOTECHNOL, V30, P336, DOI 10.1038/nbt.2157; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; Rommelfanger DM, 2012, CANCER RES, V72, P4753, DOI 10.1158/0008-5472.CAN-12-0600; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sanchez-Perez L, 2007, GENE THER, V14, P998, DOI 10.1038/sj.gt.3302935; Sanchez-Perez L, 2005, CANCER RES, V65, P2009, DOI 10.1158/0008-5472.CAN-04-3216; STADNYK AW, 1991, IMMUNOPARASITOL TOD, pA7, DOI 10.1016/S0167-5699(05)80004-0; Tarhini AA, 2012, J IMMUNOL, V189, P3789, DOI 10.4049/jimmunol.1290060; VILE RG, 1994, CANCER RES, V54, P6228; Vile RG, 1997, INT J CANCER, V71, P267; WEINHOLD KJ, 1979, J EXP MED, V149, P745, DOI 10.1084/jem.149.3.745; WEINHOLD KJ, 1979, J EXP MED, V149, P732, DOI 10.1084/jem.149.3.732; WEINHOLD KJ, 1977, NATURE, V270, P59, DOI 10.1038/270059a0; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Wongthida P, 2011, HUM GENE THER, V22, P1343, DOI 10.1089/hum.2010.216	53	46	47	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1625	1631		10.1038/nm.3397	http://dx.doi.org/10.1038/nm.3397			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24240185	Green Accepted			2022-12-27	WOS:000328181400031
J	Mezer, A; Yeatman, JD; Stikov, N; Kay, KN; Cho, NJ; Dougherty, RF; Perry, ML; Parvizi, J; Hua, LH; Butts-Pauly, K; Wandell, BA				Mezer, Aviv; Yeatman, Jason D.; Stikov, Nikola; Kay, Kendrick N.; Cho, Nam-Joon; Dougherty, Robert F.; Perry, Michael L.; Parvizi, Josef; Hua, Le H.; Butts-Pauly, Kim; Wandell, Brian A.			Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging	NATURE MEDICINE			English	Article							MULTIPLE-SCLEROSIS; WATER-CONTENT; DIFFUSION; RELAXATION; MYELIN; CORTEX; T-2; T1	Here, we describe a quantitative neuroimaging method to estimate the macromolecular tissue volume (MTV), a fundamental measure of brain anatomy. By making measurements over a range of field strengths and scan parameters, we tested the key assumptions and the robustness of the method. The measurements confirm that a consistent quantitative estimate of MTV can be obtained across a range of scanners. MTV estimates are sufficiently precise to enable a comparison between data obtained from an individual subject with control population data. We describe two applications. First, we show that MTV estimates can be combined with T1 and diffusion measurements to augment our understanding of the tissue properties. Second, we show that MTV provides a sensitive measure of disease status in individual patients with multiple sclerosis. The MTV maps are obtained using short clinically appropriate scans that can reveal how tissue changes influence behavior and cognition.	[Mezer, Aviv; Yeatman, Jason D.; Kay, Kendrick N.; Perry, Michael L.; Wandell, Brian A.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Stikov, Nikola] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Cho, Nam-Joon] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Cho, Nam-Joon] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Dougherty, Robert F.; Wandell, Brian A.] Stanford Univ, Ctr Cognit & Neurobiol Imaging, Stanford, CA USA; [Parvizi, Josef; Hua, Le H.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA USA; [Butts-Pauly, Kim] Stanford Univ, Dept Radiol, Stanford, CA USA	Stanford University; McGill University; Stanford University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University; Stanford University; Stanford University	Mezer, A (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	avivmezer@gmail.com	Cho, Nam-Joon/J-7816-2012; Stikov, Nikola Aleksandar/I-5292-2015; Hua, Le/S-4930-2019; Cho, Nam-Joon/A-3475-2019; Kay, Kendrick/A-4344-2009	Cho, Nam-Joon/0000-0002-8692-8955; Stikov, Nikola Aleksandar/0000-0002-8480-5230; Kay, Kendrick/0000-0001-6604-9155; Mezer, Aviv/0000-0002-1916-1854; Hua, Le/0000-0002-0535-3978; Yeatman, Jason/0000-0002-2686-1293	US National Institutes of Health [RO1-EY15000]; NSF [BCS-1228397]; Human Frontier Science Program; Jewish Community Federation Program Machiah Foundation Fellowship; Singapore National Research Foundation [NRF-NRFF2011-01]; NATIONAL EYE INSTITUTE [R01EY003164, R01EY015000] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1228397] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); Jewish Community Federation Program Machiah Foundation Fellowship; Singapore National Research Foundation(National Research Foundation, Singapore); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We acknowledge J. Barrel, M. Gutman, H. Horiguchi, I. Levesque, A. Sherbondy and A. Takahashi for helpful advice and feedback. We thank S. Phipps, I. Levesque and A. Kerr for help in data analysis and acquisition. This work was supported by the US National Institutes of Health research grants RO1-EY15000 and NSF grant BCS-1228397. A.M. is the recipient of support from the Human Frontier Science Program and a Jewish Community Federation Program Machiah Foundation Fellowship. N.-J.C. is the recipient of support from the Singapore National Research Foundation (NRF-NRFF2011-01).	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; Deoni SCL, 2011, METHODS MOL BIOL, V711, P65, DOI 10.1007/978-1-61737-992-5_4; Does MD, 2002, MAGNET RESON MED, V47, P274, DOI 10.1002/mrm.10060; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; Filippi M, 2011, RADIOLOGY, V259, P659, DOI 10.1148/radiol.11101362; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FRAM EK, 1987, MAGN RESON IMAGING, V5, P201, DOI 10.1016/0730-725X(87)90021-X; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Kakeda S, 2010, NEURORADIOLOGY, V52, P711, DOI 10.1007/s00234-010-0717-2; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; KOENIG SH, 1991, MAGNET RESON MED, V20, P285, DOI 10.1002/mrm.1910200210; KUCHARCZYK W, 1994, RADIOLOGY, V192, P521, DOI 10.1148/radiology.192.2.8029426; Laule C, 2004, J NEUROL, V251, P284, DOI 10.1007/s00415-004-0306-6; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lovblad KO, 2010, AM J NEURORADIOL, V31, P983, DOI 10.3174/ajnr.A1906; MacKay AL, 2009, NEUROIMAG CLIN N AM, V19, P1, DOI 10.1016/j.nic.2008.09.007; Mansfield P., 1982, NMR IMAGING BIOMEDIC; May A, 2011, TRENDS COGN SCI, V15, P475, DOI 10.1016/j.tics.2011.08.002; Neeb H, 2006, NEUROIMAGE, V31, P1156, DOI 10.1016/j.neuroimage.2005.12.063; NORTON WT, 1966, J NEUROCHEM, V13, P213, DOI 10.1111/j.1471-4159.1966.tb06794.x; Noterdaeme O, 2009, PHYS MED BIOL, V54, P3473, DOI 10.1088/0031-9155/54/11/013; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Poloni G, 2011, NEUROLOGIST, V17, P185, DOI 10.1097/NRL.0b013e31821a2643; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; Rooney WD, 2007, MAGN RESON MED, V57, P308, DOI 10.1002/mrm.21122; Stikov N, 2011, NEUROIMAGE, V54, P1112, DOI 10.1016/j.neuroimage.2010.08.068; Thomas C, 2012, TRENDS COGN SCI, V16, P96, DOI 10.1016/j.tics.2011.12.005; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV; Volz S, 2012, MAGN RESON MED, V68, P74, DOI 10.1002/mrm.23206; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790	40	170	172	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1667	1672		10.1038/nm.3390	http://dx.doi.org/10.1038/nm.3390			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24185694	Green Accepted			2022-12-27	WOS:000328181400038
J	Dhingra, R; Kirshenbaum, LA				Dhingra, Rimpy; Kirshenbaum, Lorrie A.			Mst-1 switches between cardiac cell life and death	NATURE MEDICINE			English	Editorial Material							AUTOPHAGY; DISEASE; APOPTOSIS		[Dhingra, Rimpy] Univ Manitoba, Dept Physiol, St Boniface Hosp Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada; [Kirshenbaum, Lorrie A.] Univ Manitoba, Dept Physiol, St Boniface Hosp Res Ctr, Inst Cardiovasc Sci,Fac Med, Winnipeg, MB, Canada; [Kirshenbaum, Lorrie A.] Univ Manitoba, Dept Pharmacol, St Boniface Hosp Res Ctr, Inst Cardiovasc Sci,Fac Med, Winnipeg, MB, Canada; [Kirshenbaum, Lorrie A.] Univ Manitoba, Dept Therapeut, St Boniface Hosp Res Ctr, Inst Cardiovasc Sci,Fac Med, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Dhingra, R (corresponding author), Univ Manitoba, Dept Physiol, St Boniface Hosp Res Ctr, Inst Cardiovasc Sci, Winnipeg, MB, Canada.	lorrie@sbrc.ca	Kirshenbaum, Lorrie A./F-5742-2014	Ryplanski, Kairee/0000-0002-3737-7181				He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Kaushik S, 2012, PHARMACOL RES, V66, P484, DOI 10.1016/j.phrs.2012.10.002; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maejima Y, 2013, NAT MED, V19, P1478, DOI 10.1038/nm.3322; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Sciarretta S, 2011, PEDIATR CARDIOL, V32, P275, DOI 10.1007/s00246-010-9855-x; WYLLIE AH, 1995, CURR OPIN GENET DEV, V5, P97, DOI 10.1016/S0959-437X(95)90060-8; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	12	9	9	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1367	1368		10.1038/nm.3371	http://dx.doi.org/10.1038/nm.3371			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202381				2022-12-27	WOS:000326920300010
J	Hasegawa, K; Wakino, S; Simic, P; Sakamaki, Y; Minakuchi, H; Fujimura, K; Hosoya, K; Komatsu, M; Kaneko, Y; Kanda, T; Kubota, E; Tokuyama, H; Hayashi, K; Guarente, L; Itoh, H				Hasegawa, Kazuhiro; Wakino, Shu; Simic, Petra; Sakamaki, Yusuke; Minakuchi, Hitoshi; Fujimura, Keiko; Hosoya, Kozi; Komatsu, Motoaki; Kaneko, Yuka; Kanda, Takeshi; Kubota, Eiji; Tokuyama, Hirobumi; Hayashi, Koichi; Guarente, Leonard; Itoh, Hiroshi			Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes	NATURE MEDICINE			English	Article							PARIETAL EPITHELIAL-CELLS; STIMULATED INSULIN-SECRETION; DE-NOVO EXPRESSION; GENE-EXPRESSION; NICOTINAMIDE MONONUCLEOTIDE; CALORIE RESTRICTION; OXIDATIVE DAMAGE; DNA-METHYLATION; TRANSGENIC MICE; KIDNEY-DISEASE	Sirtuin 1 (Sirt1), a NAD(+)-regulated deacetylase with numerous known positive effects on cellular and whole-body metabolism, is expressed in the renal cortex and medulla. It is known to have protective effects against age-related disease, including diabetes. Here we investigated the protective role of Sirt1 in diabetic renal damage. We found that Sirt1 in proximal tubules (PTs) was downregulated before albuminuria occurred in streptozotocin-induced or obese (db/db) diabetic mice. PT-specific SIRT1 transgenic and Sirt1 knockout mice showed prevention and aggravation of the glomerular changes that occur in diabetes, respectively, and nondiabetic knockout mice exhibited albuminuria, suggesting that Sirt1 in PTs affects glomerular function. Downregulation of Sirt1 and upregulation of the tight junction protein Claudin-1 by SIRT1-mediated epigenetic regulation in podocytes contributed to albuminuria. We did not observe these phenomena in 5/6 nephrectomized mice. We also demonstrated retrograde interplay from PTs to glomeruli using nicotinamide mononucleotide (NMN) from conditioned medium, measurement of the autofluorescence of photoactivatable NMN and injection of fluorescence-labeled NMN. In human subjects with diabetes, the levels of SIRT1 and Claudin-1 were correlated with proteinuria levels. These results suggest that Sirt1 in PTs protects against albuminuria in diabetes by maintaining NMN concentrations around glomeruli, thus influencing podocyte function.	[Hasegawa, Kazuhiro; Wakino, Shu; Minakuchi, Hitoshi; Fujimura, Keiko; Hosoya, Kozi; Komatsu, Motoaki; Kaneko, Yuka; Kanda, Takeshi; Tokuyama, Hirobumi; Hayashi, Koichi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Simic, Petra; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA USA; [Sakamaki, Yusuke; Kubota, Eiji] Shizuoka Red Cross Hosp, Dept Internal Med, Shizuoka, Japan	Keio University; Massachusetts Institute of Technology (MIT)	Wakino, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan.	swakino@sc.itc.keio.ac.jp			Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan [22790800]; NATIONAL INSTITUTE ON AGING [R01AG015339, R01AG011119] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24591210, 25293197] Funding Source: KAKEN	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank P. Mundel (Division of Nephrology, Massachusetts General Hospital and Harvard Medical School) and K. Asanuma (Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine) for providing cultured podocytes. We also thank S.J. Shankland and C. Campbell (Division of Nephrology, University of Washington) for providing culture PECs. This work was supported by the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant 22790800).	Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Boireau S, 2007, CARCINOGENESIS, V28, P246, DOI 10.1093/carcin/bgl120; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Clodfelder-Miller B, 2005, J BIOL CHEM, V280, P39723, DOI 10.1074/jbc.M508824200; Cohen CD, 2002, KIDNEY INT, V61, P125, DOI 10.1046/j.1523-1755.2002.00112.x; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Formentini L, 2009, BIOCHEM PHARMACOL, V77, P1612, DOI 10.1016/j.bcp.2009.02.017; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; GIBB DM, 1989, ARCH DIS CHILD, V64, P129, DOI 10.1136/adc.64.1.129; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Hasegawa K, 2008, BIOCHEM BIOPH RES CO, V372, P51, DOI 10.1016/j.bbrc.2008.04.176; Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Kitada M, 2011, EXP DIABETES RES, DOI 10.1155/2011/908185; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Kohda Y, 2000, KIDNEY INT, V57, P321, DOI 10.1046/j.1523-1755.2000.00824.x; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lai LW, 1997, GENE THER, V4, P426, DOI 10.1038/sj.gt.3300406; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V294, pE668, DOI 10.1152/ajpendo.00640.2007; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; Ohse T, 2010, AM J PHYSIOL-RENAL, V298, pF702, DOI 10.1152/ajprenal.00428.2009; Ohse T, 2009, AM J PHYSIOL-RENAL, V297, pF1566, DOI 10.1152/ajprenal.00214.2009; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Rincon-Choles H, 2006, DIABETES, V55, P894, DOI 10.2337/diabetes.55.04.06.db05-0355; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Roxburgh SA, 2009, DIABETES, V58, P1641, DOI 10.2337/db08-1365; Sung SH, 2006, J AM SOC NEPHROL, V17, P3093, DOI 10.1681/ASN.2006010064; Taha HM, 2009, MOL PHARMACOL, V75, P693, DOI 10.1124/mol.108.052340; Terasawa K, 2004, CLIN CANCER RES, V10, P2000, DOI 10.1158/1078-0432.CCR-0932-03; Tikoo K, 2008, FREE RADICAL RES, V42, P397, DOI 10.1080/10715760801998646; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Vaidya VS, 2011, KIDNEY INT, V79, P464, DOI 10.1038/ki.2010.404; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Xu Y, 2012, TOXICOL APPL PHARM, V259, P395, DOI 10.1016/j.taap.2011.09.028; Zhang J, 2012, AM J PHYSIOL-RENAL, V302, pF571, DOI 10.1152/ajprenal.00516.2011; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zorzano A, 2010, BBA-BIOENERGETICS, V1797, P1028, DOI 10.1016/j.bbabio.2010.02.017	52	288	311	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1496	+		10.1038/nm.3363	http://dx.doi.org/10.1038/nm.3363			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24141423	Green Accepted, Green Submitted			2022-12-27	WOS:000326920300027
J	Vaishnavi, A; Capelletti, M; Le, AT; Kako, S; Butaney, M; Ercan, D; Mahale, S; Davies, KD; Aisner, DL; Pilling, AB; Berge, EM; Kim, J; Sasaki, H; Park, SI; Kryukov, G; Garraway, LA; Hammerman, PS; Haas, J; Andrews, SW; Lipson, D; Stephens, PJ; Miller, VA; Varella-Garcia, M; Janne, PA; Doebele, RC				Vaishnavi, Aria; Capelletti, Marzia; Le, Anh T.; Kako, Severine; Butaney, Mohit; Ercan, Dalia; Mahale, Sakshi; Davies, Kurtis D.; Aisner, Dara L.; Pilling, Amanda B.; Berge, Eamon M.; Kim, Jhingook; Sasaki, Hidefumi; Park, Seung-il; Kryukov, Gregory; Garraway, Levi A.; Hammerman, Peter S.; Haas, Julia; Andrews, Steven W.; Lipson, Doron; Stephens, Philip J.; Miller, Vince A.; Varella-Garcia, Marileila; Jaenne, Pasi A.; Doebele, Robert C.			Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer	NATURE MEDICINE			English	Article							GENE FUSIONS; KINASE INHIBITORS; CELL-LINES; RET; ADENOCARCINOMA; IDENTIFICATION; ALK; PROTEIN; GENOME; ROS1	We identified new gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the high-affinity nerve growth factor receptor (TRKA protein). Both the MPRIP-NTRK1 and CD74-NTRK1 fusions lead to constitutive TRKA kinase activity and are oncogenic. Treatment of cells expressing NTRK1 fusions with inhibitors of TRKA kinase activity inhibited autophosphorylation of TRKA and cell growth. Tumor samples from 3 of 91 patients with lung cancer (3.3%) without known oncogenic alterations assayed by next-generation sequencing or fluorescence in situ hybridization demonstrated evidence of NTRK1 gene fusions.	[Vaishnavi, Aria; Le, Anh T.; Davies, Kurtis D.; Pilling, Amanda B.; Berge, Eamon M.; Varella-Garcia, Marileila; Doebele, Robert C.] Univ Colorado, Sch Med, Div Med Oncol, Dept Med, Aurora, CO USA; [Capelletti, Marzia; Butaney, Mohit; Ercan, Dalia; Hammerman, Peter S.; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Kako, Severine; Mahale, Sakshi; Aisner, Dara L.; Varella-Garcia, Marileila; Doebele, Robert C.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Aisner, Dara L.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Kim, Jhingook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Sasaki, Hidefumi] Nagoya City Univ, Grad Sch Med Sci, Dept Oncol Immunol & Surg, Nagoya, Aichi, Japan; [Park, Seung-il] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Kryukov, Gregory; Garraway, Levi A.] Broad Inst, Cambridge, MA USA; [Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Haas, Julia; Andrews, Steven W.] Array BioPharma, Boulder, CO USA; [Lipson, Doron; Stephens, Philip J.; Miller, Vince A.] Fdn Med, Boston, MA USA; [Vaishnavi, Aria; Jaenne, Pasi A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Dana-Farber Cancer Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Sungkyunkwan University (SKKU); Samsung Medical Center; Nagoya City University; University of Ulsan; Asan Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Pfizer; Array BioPharma; Foundation Medicine; Harvard University; Dana-Farber Cancer Institute	Doebele, RC (corresponding author), Univ Colorado, Sch Med, Div Med Oncol, Dept Med, Aurora, CO USA.	pasi_janne@dfci.harvard.edu; robert.doebele@ucdenver.edu	Doebele, Robert C./I-8230-2019; Kryukov, Gregory V/A-9592-2008; Butaney, Mohit/O-5511-2019; Capelletti, Marzia/L-6317-2016	Doebele, Robert C./0000-0001-6728-6857; Butaney, Mohit/0000-0002-4760-4026; Kryukov, Gregory/0000-0002-6131-9483; Capelletti, Marzia/0000-0001-5095-7060	Colorado Bioscience Discovery Evaluation Grant Program; National Institutes of Health (NIH) NCATS Colorado Clinical and Translational Sciences Institute [UL1 TR000154]; Boettcher Foundation's Webb-Waring Biomedical Research Program; Dana-Farber/Harvard Cancer Center Lung Cancer Specialized Programs of Research Excellence (SPORE) [P50 CA090578]; Cammarata Family Foundation Research Fund; Dana-Farber Cancer Institute; University of Colorado Lung Cancer SPORE [P50CA058187]; US National Cancer Institute Cancer Center [P30CA46934]; NATIONAL CANCER INSTITUTE [P50CA058187, P50CA090578, K08CA163677, P30CA046934, K12CA086913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	Colorado Bioscience Discovery Evaluation Grant Program; National Institutes of Health (NIH) NCATS Colorado Clinical and Translational Sciences Institute; Boettcher Foundation's Webb-Waring Biomedical Research Program; Dana-Farber/Harvard Cancer Center Lung Cancer Specialized Programs of Research Excellence (SPORE); Cammarata Family Foundation Research Fund; Dana-Farber Cancer Institute; University of Colorado Lung Cancer SPORE; US National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Colorado Bioscience Discovery Evaluation Grant Program, the National Institutes of Health (NIH) NCATS Colorado Clinical and Translational Sciences Institute Grant UL1 TR000154 (contents are the authors' sole responsibility and do not necessarily represent official NIH views) and the Boettcher Foundation's Webb-Waring Biomedical Research Program (R.C.D.), as well as the Dana-Farber/Harvard Cancer Center Lung Cancer Specialized Programs of Research Excellence (SPORE) P50 CA090578 (P.A.J.), the Cammarata Family Foundation Research Fund (M.C. and P.A.J.), the Nirenberg Fellowship at the Dana-Farber Cancer Institute (M.C. and P.A.J.) and the University of Colorado Lung Cancer SPORE grant P50CA058187 and the US National Cancer Institute Cancer Center Support Grant P30CA46934 (M.V.-G.). Ba/F3 cells were a gift from D. Theodorescu (University of Colorado, Anschutz Medical Campus). The cell lines KM12, HCT116, HCT15, HT29 and SW837 were gifts from S.G. Eckhardt (University of Colorado, Anschutz Medical Campus). The cell lines H3122, H1650, H1299 and HCC78 were gifts from J.D. Minna (University of Texas Southwestern). Aythymic nude mice were a gift from J. DeGregori (University of Colorado, Anschutz Medical Campus).	Albert L, 2003, J CELL PHYSIOL, V195, P168, DOI 10.1002/jcp.10252; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; Davies KD, 2013, CLIN CANCER RES, V19, P4040, DOI 10.1158/1078-0432.CCR-12-2851; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; George DJ, 1999, CANCER RES, V59, P2395; Gerlinger M, 2013, NEW ENGL J MED, V369, P1172, DOI 10.1056/NEJMc1309091; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Majewski IJ, 2013, J PATHOL, V230, P270, DOI 10.1002/path.4209; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Oie HK, 1996, J CELL BIOCHEM, P24; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pitts TM, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00035; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Surks HK, 2003, J BIOL CHEM, V278, P51484, DOI 10.1074/jbc.M305622200; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	35	421	483	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1469	+		10.1038/nm.3352	http://dx.doi.org/10.1038/nm.3352			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24162815	Green Accepted			2022-12-27	WOS:000326920300023
J	Wan, LL; Pantel, K; Kang, YB				Wan, Liling; Pantel, Klaus; Kang, Yibin			Tumor metastasis: moving new biological insights into the clinic	NATURE MEDICINE			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER METASTASIS; LUNG ADENOCARCINOMA METASTASIS; MINIMAL RESIDUAL CANCER; BONE-MARROW; PROSTATE-CANCER; COLORECTAL-CANCER; STEM-CELLS; EXTRACELLULAR-MATRIX; PANCREATIC-CANCER	As the culprit behind most cancer-related deaths, metastasis is the ultimate challenge in our effort to fight cancer as a life-threatening disease. The explosive growth of metastasis research in the past decade has yielded an unprecedented wealth of information about the tumor-intrinsic and tumor-extrinsic mechanisms that dictate metastatic behaviors, the molecular and cellular basis underlying the distinct courses of metastatic progression in different cancers and what renders metastatic cancer refractory to available therapies. However, integration of such new knowledge into an improved, metastasis-oriented oncological drug development strategy is needed to thwart the development of metastatic disease at every stage of progression.	[Wan, Liling; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Pantel, Klaus; Kang, Yibin] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Dept Tumour Biol, Ctr Med Expt, Hamburg, Germany; [Kang, Yibin] Canc Inst New Jersey, New Brunswick, NJ USA	Princeton University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ykang@princeton.edu		Kang, Yibin/0000-0002-1626-6730	Charlotte Elizabeth Procter Fellowship; European Research Council; Deutsche Forschungsgemeinschaft; BMBF; Brewster Foundation; Champalimaud Foundation; US Department of Defense; Komen for the Cure; US National Institutes of Health	Charlotte Elizabeth Procter Fellowship; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Brewster Foundation; Champalimaud Foundation; US Department of Defense(United States Department of Defense); Komen for the Cure(Susan G. Komen Breast Cancer Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of our laboratories for helpful discussions and H.A. Smith for critical reading of the manuscript. We also apologize to the many investigators whose important studies could not be cited directly here because of space limitations. The work was supported by a Charlotte Elizabeth Procter Fellowship to L.W., grants from the European Research Council (Advanced Investigator Grant 'DISSECT'), the Deutsche Forschungsgemeinschaft and the German Minister of Education and Research (BMBF) to K.P. and grants from the Brewster Foundation, the Champalimaud Foundation, the US Department of Defense, Komen for the Cure and the US National Institutes of Health to Y.K.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Banys M, 2012, BREAST CANCER RES TR, V131, P801, DOI 10.1007/s10549-011-1478-2; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Barton MK, 2011, CA-CANCER J CLIN, V61, P135, DOI 10.3322/caac.20116; Bednarz-Knoll N, 2012, CANCER METAST REV, V31, P673, DOI 10.1007/s10555-012-9370-z; Benz MR, 2011, J NUCL MED, V52, P1684, DOI 10.2967/jnumed.111.095257; Bidard FC, 2008, CLIN CANCER RES, V14, P3306, DOI 10.1158/1078-0432.CCR-07-4749; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Braun S, 2001, CANCER RES, V61, P1890; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Braun S, 2000, J CLIN ONCOL, V18, P80, DOI 10.1200/JCO.2000.18.1.80; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cao PD, 2011, DISCOV MED, V12, P329; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Catena R, 2013, CANCER DISCOV, V3, P578, DOI 10.1158/2159-8290.CD-12-0476; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen HB, 2008, J CLIN ONCOL, V26, P3284, DOI 10.1200/JCO.2008.16.3543; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; Choe YS, 2007, CURR PHARM DESIGN, V13, P17; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Comen E, 2011, NAT REV CLIN ONCOL, V8, P369, DOI 10.1038/nrclinonc.2011.64; Cook LM, 2011, SEMIN CANCER BIOL, V21, P113, DOI 10.1016/j.semcancer.2010.12.005; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Deneve E, 2013, CLIN CHEM, V59, P1384, DOI 10.1373/clinchem.2013.202846; Diaz LA, 2013, NAT MED, V19, P676, DOI 10.1038/nm.3233; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Ell B., CANC CELL IN PRESS; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Faraji F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002926; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Frisch SM, 1997, BIOESSAYS, V19, P705, DOI 10.1002/bies.950190811; Gangnus R, 2004, CLIN CANCER RES, V10, P3457, DOI 10.1158/1078-0432.CCR-03-0818; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Gao YJ, 2010, P NATL ACAD SCI USA, V107, P18892, DOI 10.1073/pnas.1004952107; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Gnant M, 2009, CURR CANCER DRUG TAR, V9, P824, DOI 10.2174/156800909789760267; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Goldberger N, 2013, CANCER RES, V73, P2671, DOI 10.1158/0008-5472.CAN-12-3513; Goss GD, 2010, J CLIN ONCOL, V28, P49, DOI 10.1200/JCO.2009.22.9427; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Grabinski N, 2011, CELL SIGNAL, V23, P1952, DOI 10.1016/j.cellsig.2011.07.003; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hanahan D, 2000, J CLIN INVEST, V105, P1045, DOI 10.1172/JCI9872; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hannemann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026362; HEISS MM, 1995, NAT MED, V1, P1035, DOI 10.1038/nm1095-1035; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hensel JA, 2013, NAT REV CLIN ONCOL, V10, P41, DOI 10.1038/nrclinonc.2012.207; Hicke BJ, 2006, J NUCL MED, V47, P668; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Horak CE, 2008, APMIS, V116, P586, DOI 10.1111/j.1600-0463.2008.01213.x; Horak CE, 2007, CANCER RES, V67, P11751, DOI 10.1158/0008-5472.CAN-07-3175; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Hunter K, 2006, NAT REV CANCER, V6, P141, DOI 10.1038/nrc1803; Ithimakin S, 2013, CANCER RES, V73, P1635, DOI 10.1158/0008-5472.CAN-12-3349; Jaini R, 2010, NAT MED, V16, P799, DOI 10.1038/nm.2161; Joosse SA, 2012, CLIN CANCER RES, V18, P993, DOI 10.1158/1078-0432.CCR-11-2100; Kamiya N, 2012, INT J UROL, V19, P968, DOI 10.1111/j.1442-2042.2012.03098.x; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kelloff G, 2005, CLIN CANCER RES, V11, P2785, DOI 10.1158/1078-0432.CCR-04-2626; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; Klotz L, 2013, CURR UROL REP, V14, P159, DOI 10.1007/s11934-013-0325-x; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Kwong GA, 2013, NAT BIOTECHNOL, V31, P63, DOI 10.1038/nbt.2464; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lipton A, 2011, BONE, V48, P96, DOI 10.1016/j.bone.2010.10.161; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lussier YA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050141; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Makohon-Moore A, 2013, GENOME MED, V5, DOI 10.1186/gm430; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Moy B, 2007, CLIN BREAST CANCER, V7, P489, DOI 10.3816/CBC.2007.n.007; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Parkinson DR, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-138; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polzer B, 2013, NAT MED, V19, P274, DOI 10.1038/nm.3121; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Quesnel B, 2008, APMIS, V116, P685, DOI 10.1111/j.1600-0463.2008.01163.x; Ranganathan AC, 2006, CANCER BIOL THER, V5, P729, DOI 10.4161/cbt.5.7.2968; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Ryu S, 2013, CANCER CELL, V23, P63, DOI 10.1016/j.ccr.2012.11.019; Sabnis G, 2010, MOL CANCER THER, V9, P46, DOI 10.1158/1535-7163.MCT-09-0696; Sanger N, 2011, INT J CANCER, V129, P2522, DOI 10.1002/ijc.25895; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Seruga B, 2008, NAT CLIN PRACT ONCOL, V5, P574, DOI 10.1038/ncponc1180; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shibue T, 2012, CANCER DISCOV, V2, P706, DOI 10.1158/2159-8290.CD-11-0239; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Steeg PS, 2012, NATURE, V485, pS58, DOI 10.1038/485S58a; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; SUGARBAKER PH, 1993, J SURG ONCOL, P158; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tabaries S, 2011, ONCOGENE, V30, P1318, DOI 10.1038/onc.2010.518; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiolloy S, 2011, SEMIN CANCER BIOL, V21, P89, DOI 10.1016/j.semcancer.2010.12.008; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Townson JL, 2009, CANCER RES, V69, P8326, DOI 10.1158/0008-5472.CAN-09-1496; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van de Wouw AJ, 2002, EUR J CANCER, V38, P409, DOI 10.1016/S0959-8049(01)00378-1; Vermaat JS, 2012, CLIN CANCER RES, V18, P688, DOI 10.1158/1078-0432.CCR-11-1965; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walker-Samuel S, 2013, NAT MED, V19, P1067, DOI 10.1038/nm.3252; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Weichselbaum RR, 2011, NAT REV CLIN ONCOL, V8, P378, DOI 10.1038/nrclinonc.2011.44; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Winter SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002735; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yates CC, 2007, BRIT J CANCER, V96, P1246, DOI 10.1038/sj.bjc.6603700; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006376; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	236	557	573	12	251	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1450	1464		10.1038/nm.3391	http://dx.doi.org/10.1038/nm.3391			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202397				2022-12-27	WOS:000326920300022
J	Albacker, LA; Chaudhary, V; Chang, YJ; Kim, HY; Chuang, YT; Pichavant, M; DeKruyff, RH; Savage, PB; Umetsu, DT				Albacker, Lee A.; Chaudhary, Vinod; Chang, Ya-Jen; Kim, Hye Young; Chuang, Ya-Ting; Pichavant, Muriel; DeKruyff, Rosemarie H.; Savage, Paul B.; Umetsu, Dale T.			Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity	NATURE MEDICINE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ACTIVATE NKT CELLS; LYMPHOID-CELLS; ADAPTIVE IMMUNITY; RECEPTOR DECTIN-1; TYPE-2 IMMUNITY; AIRBORNE FUNGI; SEVERE ASTHMA; BETA-GLUCANS; MURINE MODEL	Aspergillus fumigatus is a saprophytic fungus that is ubiquitous in the environment and is commonly associated with allergic sensitization and severe asthma in humans. Although A. fumigatus is recognized by multiple microbial pattern-recognition receptors, we found that an A. fumigatus-derived glycosphingolipid, asperamide B, directly activates invariant natural killer T (iNKT) cells in vitro in a CD1d-restricted, MyD88-independent and dectin-1-independent fashion. Moreover, asperamide B, when loaded onto CD1d, directly stained, and was sufficient to activate, human and mouse iNKT cells. In vivo, asperamide B rapidly induced airway hyperreactivity, which is a cardinal feature of asthma, by activating pulmonary iNKT cells in an interleukin-33 (IL-33)-ST2-dependent fashion. Asperamide B is thus the first fungal glycolipid found to directly activate iNKT cells. These results extend the range of microorganisms that can be directly detected by iNKT cells to the kingdom of fungi and may explain how A. fumigatus can induce severe chronic respiratory diseases in humans.	[Albacker, Lee A.; Chang, Ya-Jen; Kim, Hye Young; Chuang, Ya-Ting; Pichavant, Muriel; DeKruyff, Rosemarie H.; Umetsu, Dale T.] Harvard Univ, Childrens Hosp, Sch Med, Div Immunol & Allergy, Boston, MA 02115 USA; [Chaudhary, Vinod; Savage, Paul B.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Brigham Young University	Umetsu, DT (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Immunol & Allergy, Boston, MA 02115 USA.	dale.umetsu@childrens.harvard.edu	Chaudhary, Vinod/N-3853-2014; Savage, Paul B/HGB-3414-2022; Chang, Ya-Jen/O-1584-2018; Savage, Paul B/E-1448-2011; Pichavant, Muriel/B-9036-2018; Kim, Hye Young/AAF-7609-2020	Chaudhary, Vinod/0000-0003-1545-5051; Savage, Paul B/0000-0002-4642-6109; Chang, Ya-Jen/0000-0003-1377-6142; Savage, Paul B/0000-0002-4642-6109; Pichavant, Muriel/0000-0002-1315-4397; Kim, Hye Young/0000-0001-5978-512X; Albacker, Lee/0000-0002-5070-1783	US National Institutes of Health (NIH) [RO1AI026322, RC1HL099839, R21AI083523]; Bunning Food Allergy Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026322, R21AI083523, P01AI054456] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bunning Food Allergy Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by US National Institutes of Health (NIH) grants RO1AI026322, RC1HL099839 and R21AI083523 to D.T.U. and by the Bunning Food Allergy Project to D.T.U.L.A.A. was a graduate student in the Program in Immunology, Division of Medical Sciences, Harvard University. We would also like to acknowledge the NIH National Institute of Allergy and Infectious Diseases (NIAID) research reagent program that provided the A. fumigatus lysates used in this study. We thank the NIH NIAID Tetramer Facility for providing CD1d monomers and tetramers for this study, D.B. Moody for help with plate-bound CD1d assays and M. Grusby (Harvard School of Public Health), M. Taniguchi and T. Nakayama (Chiba University), S. Akira (Osaka University), R. Geha (Boston Children's Hospital) and A. McKenzie (Medical Research Council, Laboratory of Molecular Biology) for providing genetically modified mice.	Agarwal R, 2011, CURR ALLERGY ASTHM R, V11, P403, DOI 10.1007/s11882-011-0217-4; Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Arshad MI, 2011, EUR J IMMUNOL, V41, P2341, DOI 10.1002/eji.201041332; Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002; Barrett NA, 2011, J EXP MED, V208, P593, DOI 10.1084/jem.20100793; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Blackstock R, 2004, INFECT IMMUN, V72, P5175, DOI 10.1128/IAI.72.9.5175-5180.2004; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brigl M, 2011, J EXP MED, V208, P1163, DOI 10.1084/jem.20102555; Broadfield E, 2002, J ALLERGY CLIN IMMUN, V109, P969, DOI 10.1067/mai.2002.124772; Chan-Yeung M, 2010, ALLERGY, V65, P1404, DOI 10.1111/j.1398-9995.2010.02399.x; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chang YJ, 2011, J CLIN INVEST, V121, P57, DOI 10.1172/JCI44845; Cohen NR, 2011, CELL HOST MICROBE, V10, P437, DOI 10.1016/j.chom.2011.09.011; Fairs A, 2010, AM J RESP CRIT CARE, V182, P1362, DOI 10.1164/rccm.201001-0087OC; Godfrey DI, 2010, SEMIN IMMUNOL, V22, P61, DOI 10.1016/j.smim.2009.10.004; Greenberger PA, 2002, J ALLERGY CLIN IMMUN, V110, P685, DOI 10.1067/mai.2002.130179; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Iwamura C, 2010, CURR OPIN IMMUNOL, V22, P807, DOI 10.1016/j.coi.2010.10.008; Jyonouchi S, 2011, J ALLERGY CLIN IMMUN, V128, P102, DOI 10.1016/j.jaci.2011.02.026; Karp CL, 2010, J ALLERGY CLIN IMMUN, V125, P955, DOI 10.1016/j.jaci.2010.03.002; Kawakami K, 2001, J IMMUNOL, V167, P6525, DOI 10.4049/jimmunol.167.11.6525; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; KURUP VP, 1992, J IMMUNOL, V148, P3783; Kurup VP, 2002, MYCOPATHOLOGIA, V153, P165, DOI 10.1023/A:1014963600314; Lee HH, 2010, J IMMUNOL, V185, P5225, DOI 10.4049/jimmunol.1001116; Lilly LM, 2012, J IMMUNOL, V189, P3653, DOI 10.4049/jimmunol.1201797; Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; Matangkasombut P, 2009, MUCOSAL IMMUNOL, V2, P383, DOI 10.1038/mi.2009.96; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Menzies D, 2011, ALLERGY, V66, P679, DOI 10.1111/j.1398-9995.2010.02542.x; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Murdock BJ, 2012, INFECT IMMUN, V80, P1424, DOI 10.1128/IAI.05529-11; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Connor GT, 2004, J ALLERGY CLIN IMMUN, V114, P599, DOI 10.1016/j.jaci.2004.05.064; O'Driscoll BR, 2009, CLIN EXP ALLERGY, V39, P1677, DOI 10.1111/j.1365-2222.2009.03339.x; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Ramaprakash H, 2011, AM J PATHOL, V179, P104, DOI 10.1016/j.ajpath.2011.03.032; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Scanlon ST, 2011, J EXP MED, V208, P2113, DOI 10.1084/jem.20110522; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Sherif R, 2010, CURR OPIN PULM MED, V16, P242, DOI 10.1097/MCP.0b013e328337d6de; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhang Y, 2007, LIPIDS, V42, P759, DOI 10.1007/s11745-007-3079-8	57	107	107	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1297	+		10.1038/nm.3321	http://dx.doi.org/10.1038/nm.3321			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	23995283	Green Accepted, Green Submitted			2022-12-27	WOS:000325531700029
J	Falzarano, D; de Wit, E; Rasmussen, AL; Feldmann, F; Okumura, A; Scott, DP; Brining, D; Bushmaker, T; Martellaro, C; Baseler, L; Benecke, AG; Katze, MG; Munster, VJ; Feldmann, H				Falzarano, Darryl; de Wit, Emmie; Rasmussen, Angela L.; Feldmann, Friederike; Okumura, Atsushi; Scott, Dana P.; Brining, Doug; Bushmaker, Trenton; Martellaro, Cynthia; Baseler, Laura; Benecke, Arndt G.; Katze, Michael G.; Munster, Vincent J.; Feldmann, Heinz			Treatment with interferon-alpha 2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques	NATURE MEDICINE			English	Article							ACUTE RESPIRATORY SYNDROME; SONIC HEDGEHOG; CONVALESCENT PLASMA; HUMAN CORONAVIRUS; TGF-BETA; SARS; PNEUMONIA; GROWTH; EXPRESSION; INFLUENZA	The emergence of Middle East respiratory syndrome coronavirus (MERS-CoV) is of global concern: the virus has caused severe respiratory illness, with 111 confirmed cases and 52 deaths1 at the time of this article's publication. Therapeutic interventions have not been evaluated in vivo; thus, patient management relies exclusively on supportive care, which, given the high case-fatality rate, is not highly effective. The rhesus macaque is the only known model organism for MERS-CoV infection, developing an acute localized to widespread pneumonia with transient clinical disease(2,3) that recapitulates mild to moderate human MERSCoV cases(4,5). The combination of interferon-alpha 2b and ribavirin was effective in reducing MERS-CoV replication in vitro(6); therefore, we initiated this treatment 8 h after inoculation of rhesus macaques. In contrast to untreated, infected macaques, treated animals did not develop breathing abnormalities and showed no or very mild radiographic evidence of pneumonia. Moreover, treated animals showed lower levels of systemic (serum) and local (lung) proinflammatory markers, in addition to fewer viral genome copies, distinct gene expression and less severe histopathological changes in the lungs. Taken together, these data suggest that treatment of MERS-CoV infected rhesus macaques with IFN-alpha 2b and ribavirin reduces virus replication, moderates the host response and improves clinical outcome. As these two drugs are already used in combination in the clinic for other infections, IFN-alpha 2b and ribavirin should be considered for the management of MERS-CoV cases.	[Falzarano, Darryl; de Wit, Emmie; Martellaro, Cynthia; Baseler, Laura; Feldmann, Heinz] NIAID, Dis Modeling & Transmiss Unit, Virol Lab, Div Intramural Res,NIH,Rocky Mt Labs, Hamilton, MT USA; [Rasmussen, Angela L.; Okumura, Atsushi; Benecke, Arndt G.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Feldmann, Friederike; Scott, Dana P.; Brining, Doug] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA; [Bushmaker, Trenton; Munster, Vincent J.] NIAID, Virus Ecol Unit, Virol Lab, Div Intramural Res,NIH,Rocky Mt Labs, Hamilton, MT USA; [Baseler, Laura] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Benecke, Arndt G.] Univ Paris 06, CNRS, UMR7224, Paris, France; [Katze, Michael G.] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Feldmann, Heinz] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle; University of Manitoba	Feldmann, H (corresponding author), NIAID, Dis Modeling & Transmiss Unit, Virol Lab, Div Intramural Res,NIH,Rocky Mt Labs, Hamilton, MT USA.	feldmannh@niaid.nih.gov	Munster, Vincent/I-7607-2018; de Wit, Emmie/A-1549-2019; Benecke, Arndt G./T-1079-2019; Okumura, Atsushi/E-8012-2015	Munster, Vincent/0000-0002-2288-3196; de Wit, Emmie/0000-0002-9763-7758; Okumura, Atsushi/0000-0002-7779-3059; Rasmussen, Angela/0000-0001-9462-3169	Intramural Research Program, NIAID, NIH; NIAID Regional Centers of Excellence [U54 AI081680]; Systems Virology (NIH/ NIAID) [HHSN272200800060C]; Washington National Primate Research Center [P51OD010425]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001088, ZIAAI001179, U54AI081680] Funding Source: NIH RePORTER	Intramural Research Program, NIAID, NIH; NIAID Regional Centers of Excellence; Systems Virology (NIH/ NIAID); Washington National Primate Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	D.F., E.d.W., V.J.M. and H.F. conceived of and designed the study. D.F., E.d.W., A.L.R., F.F., A.O., D.P.S., T.B., C.M. and D.B. performed the experiments. D.F., E.d.W., A.L.R., A.O., D.P.S., L.B., A.G.B., V.J.M., M.G.K. and H.F. analyzed the data. D.F., A.L.R., M.G.K. and H.F. wrote the manuscript. This work was supported in part by the Intramural Research Program, NIAID, NIH, in addition to the NIAID Regional Centers of Excellence (U54 AI081680), Systems Virology (NIH/ NIAID contract number HHSN272200800060C) and Washington National Primate Research Center (P51OD010425) to M.G.K.	[Anonymous], 2013, PROMED; Becavin C, 2011, BIOINFORMATICS, V27, P1413, DOI 10.1093/bioinformatics/btr143; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Brining DL, 2010, COMPARATIVE MED, V60, P389; Chan K. S., 2003, Hong Kong Medical Journal, V9, P399; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; de Wit E., PROC NATL ACAD SCI U; Falzarano D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01686; Fitch PM, 2011, INT J EXP PATHOL, V92, P8, DOI 10.1111/j.1365-2613.2010.00743.x; Gastanaduy PA, 2013, MMWR-MORBID MORTAL W, V62, P480; Ho JC, 2004, INT J TUBERC LUNG D, V8, P1173; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Li M, 2008, J BIOL CHEM, V283, P36257, DOI 10.1074/jbc.M806786200; Liu L, 2013, AM J RESP CELL MOL, V48, P703, DOI 10.1165/rcmb.2012-0347OC; Loutfy MR, 2003, JAMA-J AM MED ASSOC, V290, P3222, DOI 10.1001/jama.290.24.3222; Menshykau D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002377; Munster VJ, 2013, NEW ENGL J MED, V368, P1560, DOI 10.1056/NEJMc1215691; Noth Sebastian, 2006, Genomics Proteomics & Bioinformatics, V4, P90, DOI 10.1016/S1672-0229(06)60021-1; Omrani AS, 2013, INT J INFECT DIS, V17, pE668, DOI 10.1016/j.ijid.2013.07.001; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Pogach MS, 2007, J CELL BIOCHEM, V100, P1415, DOI 10.1002/jcb.21142; Sarasin-Filipowicz M., 2013, P NATL ACAD SCI USA, V105, P7034; Soo YOY, 2004, CLIN MICROBIOL INFEC, V10, P676, DOI 10.1111/j.1469-0691.2004.00956.x; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Sung JJY, 2004, THORAX, V59, P414, DOI 10.1136/thx.2003.014076; Tahir M, 2013, EUROSURVEILLANCE, V18, P4; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; Wang GS, 2010, BBA-MOL CELL RES, V1803, P1359, DOI 10.1016/j.bbamcr.2010.09.002; White AC, 2006, DEVELOPMENT, V133, P1507, DOI 10.1242/dev.02313; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Yang Y, 2011, MOL BIOL REP, V38, P3615, DOI 10.1007/s11033-010-0473-8; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang MF, 2010, HISTOCHEM CELL BIOL, V134, P327, DOI 10.1007/s00418-010-0738-2	37	327	368	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1313	+		10.1038/nm.3362	http://dx.doi.org/10.1038/nm.3362			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24013700	Green Accepted, Green Published, Bronze			2022-12-27	WOS:000325531700031
J	Thorek, DLJ; Ogirala, A; Beattie, BJ; Grimm, J				Thorek, Daniel L. J.; Ogirala, Anuja; Beattie, Bradley J.; Grimm, Jan			Quantitative imaging of disease signatures through radioactive decay signal conversion	NATURE MEDICINE			English	Article							CERENKOV LUMINESCENCE; GENE-EXPRESSION; PROTEASE ACTIVITY; BREAST-CANCER; QUANTUM DOTS; PROBES; RADIATION; MMP-2; PET; RADIOTRACERS	In the era of personalized medicine, there is an urgent need for in vivo techniques able to sensitively detect and quantify molecular activities. Sensitive imaging of gamma rays is widely used; however, radioactive decay is a physical constant, and its signal is independent of biological interactions. Here, we introduce a framework of previously uncharacterized targeted and activatable probes that are excited by a nuclear decay- derived signal to identify and measure molecular signatures of disease. We accomplished this by using Cerenkov luminescence, the light produced by b- particle- emitting radionuclides such as clinical positron emission tomography (PET) tracers. Disease markers were detected using nanoparticles to produce secondary Cerenkov- induced fluorescence. This approach reduces background signal compared to conventional fluorescence imaging. In addition to tumor identification from a conventional PET scan, we demonstrate the medical utility of our approach by quantitatively determining prognostically relevant enzymatic activity. This technique can be applied to monitor other markers and represents a shift toward activatable nuclear medicine agents.	[Thorek, Daniel L. J.; Ogirala, Anuja; Grimm, Jan] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Beattie, Bradley J.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Grimm, Jan] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Grimm, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA.	grimmj@mskcc.org	Grimm, Jan/B-1937-2008; Beattie, Bradley J/K-8981-2012	Beattie, Bradley J/0000-0001-9891-8271; Grimm, Jan/0000-0002-5282-9385	US National Institutes of Health (NIH) [5R25CA096945-07]; US Department of Defense [PC111667]; Starr Cancer Consortium [I4-A427]; NIH [1R01EB014944-01]; American Recovery and Reinvestment Act [73950]; Louis V. Gerstner Young Investigator Award; NATIONAL CANCER INSTITUTE [R25CA096945, P30CA008748, R24CA083084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014944] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Starr Cancer Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Louis V. Gerstner Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank the staff of the Radiopharmacy at Memorial Sloan-Kettering Cancer Center ( MSKCC). Scientific input was provided by M. McDevitt, N. V. K. Pillarsetty, P. Zanzonico, J. Holland and J. Lewis (of MSKCC, who also generously provided radiolabeled trastuzumab). D. L. J. T. and this work were supported by US National Institutes of Health (NIH) through the R25T Molecular Imaging Fellowship of the Molecular Imaging: Training for Oncology (MITO) Program (5R25CA096945-07; principal investigator H. Hricak). J. G. was supported by the US Department of Defense (PC111667), the Starr Cancer Consortium (I4-A427), NIH (1R01EB014944-01), the American Recovery and Reinvestment Act (73950) and the Louis V. Gerstner Young Investigator Award. Technical services provided by the Animal Imaging Core Facility were supported in part by grants from the NIH (R24 CA083084 and P30 CA008748). We thank R. Weissleder for suggestions and L. Cosgrave at MSKCC and N. Sela-Passwell of the Weizmann Institute of Science for their help.	Beattie BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031402; Cai WB, 2008, NAT PROTOC, V3, P89, DOI 10.1038/nprot.2007.478; Chuang CH, 2012, CLIN CANCER RES, V18, P238, DOI 10.1158/1078-0432.CCR-11-0608; Davidson B, 1999, GYNECOL ONCOL, V73, P372, DOI 10.1006/gyno.1999.5381; Dijkers EC, 2010, CLIN PHARMACOL THER, V87, P586, DOI 10.1038/clpt.2010.12; Dothager RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013300; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; FLOCK ST, 1992, LASER SURG MED, V12, P510, DOI 10.1002/lsm.1900120510; Frank I, 1937, CR ACAD SCI URSS, V14, P109; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Holland JP, 2011, MOL IMAGING, V10, P177, DOI 10.2310/7290.2010.00047; Holland JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008859; Holland JP, 2009, NUCL MED BIOL, V36, P729, DOI 10.1016/j.nucmedbio.2009.05.007; Institute of Laboratory Animal Resources (U.S.). Committee on Care and Use of Laboratory Animals, NIH PUBLICATION; JELLEY JV, 1955, BRIT J APPL PHYS, V6, P227, DOI 10.1088/0508-3443/6/7/301; Kothapalli SR, 2012, BIOMED OPT EXPRESS, V3, P1215, DOI 10.1364/BOE.3.001215; L'Annunziata M.F., 2007, RADIOACTIVITY INTROD, V429; Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240; Liu HG, 2010, SMALL, V6, P1087, DOI 10.1002/smll.200902408; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Maatta M, 2000, CLIN CANCER RES, V6, P2726; Miyagawa T, 2008, J NUCL MED, V49, P637, DOI 10.2967/jnumed.107.046227; Quon A, 2005, J CLIN ONCOL, V23, P1664, DOI 10.1200/JCO.2005.11.024; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Rosenblum G, 2003, J BIOL CHEM, V278, P27009, DOI 10.1074/jbc.M301139200; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188; Thorek DLJ, 2012, CURR PHARM BIOTECHNO, V13, P523; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Vaisanen A, 1998, J PATHOL, V186, P51; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	34	114	121	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2013	19	10					1345	+		10.1038/nm.3323	http://dx.doi.org/10.1038/nm.3323			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24013701	Green Accepted			2022-12-27	WOS:000325531700036
J	Dranoff, G				Dranoff, Glenn			Balancing tumor immunity and inflammatory pathology	NATURE MEDICINE			English	Editorial Material							CANCER-IMMUNOTHERAPY; SAFETY; ANTI-PD-1; ANTIBODY; MELANOMA		[Dranoff, Glenn] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Dranoff, Glenn] Dana Farber Canc Inst, Canc Vaccine Ctr, Boston, MA 02115 USA; [Dranoff, Glenn] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Dranoff, Glenn] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Dranoff, G (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	glenn_dranoff@dfci.harvard.edu			NCI NIH HHS [P01 CA155258, P01 CA078378, R01 CA143083, P50 CA100707] Funding Source: Medline; NIBIB NIH HHS [R01 EB015498] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA100707, R01CA143083, P01CA155258, P01CA078378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015498] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Brahmer JR, 2013, CANCER IMMUNOL RES, V1, P85, DOI 10.1158/2326-6066.CIR-13-0078; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Dranoff G, 2012, NAT REV IMMUNOL, V12, P61, DOI 10.1038/nri3129; ELION GB, 1985, CANCER RES, V45, P2943; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2013, J CLIN ONCOL, V31; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Nowarski R, 2013, CANCER IMMUNOL RES, V1, P77, DOI 10.1158/2326-6066.CIR-13-0081; Ploegh HL, 2013, CANCER IMMUNOL RES, V1, P5, DOI 10.1158/2326-6066.CIR-13-0023; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	16	23	24	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1100	1101		10.1038/nm.3335	http://dx.doi.org/10.1038/nm.3335			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	24013749	Green Accepted			2022-12-27	WOS:000324083500019
J	Pethe, K; Bifani, P; Jang, JC; Kang, S; Park, S; Ahn, S; Jiricek, J; Jung, JY; Jeon, HK; Cechetto, J; Christophe, T; Lee, H; Kempf, M; Jackson, M; Lenaerts, AJ; Pham, H; Jones, V; Seo, MJ; Kim, YM; Seo, M; Seo, JJ; Park, D; Ko, Y; Choi, I; Kim, R; Kim, SY; Lim, S; Yim, SA; Nam, J; Kang, H; Kwon, H; Oh, CT; Cho, Y; Jang, Y; Kim, J; Chua, A; Tan, BH; Nanjundappa, MB; Rao, SPS; Barnes, WS; Wintjens, R; Walker, JR; Alonso, S; Lee, S; Kim, J; Oh, S; Oh, T; Nehrbass, U; Han, SJ; No, Z; Lee, J; Brodin, P; Cho, SN; Nam, K; Kim, J				Pethe, Kevin; Bifani, Pablo; Jang, Jichan; Kang, Sunhee; Park, Seijin; Ahn, Sujin; Jiricek, Jan; Jung, Juyoung; Jeon, Hee Kyoung; Cechetto, Jonathan; Christophe, Thierry; Lee, Honggun; Kempf, Marie; Jackson, Mary; Lenaerts, Anne J.; Ha Pham; Jones, Victoria; Seo, Min Jung; Kim, Young Mi; Seo, Mooyoung; Seo, Jeong Jea; Park, Dongsik; Ko, Yoonae; Choi, Inhee; Kim, Ryangyeo; Kim, Se Yeon; Lim, SeungBin; Yim, Seung-Ae; Nam, Jiyoun; Kang, Hwankyu; Kwon, Haejin; Oh, Chun-Taek; Cho, Yoojin; Jang, Yunhee; Kim, Junghwan; Chua, Adeline; Tan, Bee Huat; Nanjundappa, Mahesh B.; Rao, Srinivasa P. S.; Barnes, Whitney S.; Wintjens, Rene; Walker, John R.; Alonso, Sylvie; Lee, Saeyeon; Kim, Jungjun; Oh, Soohyun; Oh, Taegwon; Nehrbass, Ulf; Han, Sung-Jun; No, Zaesung; Lee, Jinhwa; Brodin, Priscille; Cho, Sang-Nae; Nam, Kiyean; Kim, Jaeseung			Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis	NATURE MEDICINE			English	Article							CYTOCHROME BC(1) COMPLEX; MYCOBACTERIUM-TUBERCULOSIS; RESISTANT TUBERCULOSIS; DRUG DISCOVERY; INHIBITORS; INFECTION; TMC207; SITE	New therapeutic strategies are needed to combat the tuberculosis pandemic and the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) forms of the disease, which remain a serious public health challenge worldwide(1,2). The most urgent clinical need is to discover potent agents capable of reducing the duration of MDR and XDR tuberculosis therapy with a success rate comparable to that of current therapies for drug-susceptible tuberculosis. The last decade has seen the discovery of new agent classes for the management of tuberculosis(3-5), several of which are currently in clinical trials(6-8). However, given the high attrition rate of drug candidates during clinical development and the emergence of drug resistance, the discovery of additional clinical candidates is clearly needed. Here, we report on a promising class of imidazopyridine amide (IPA) compounds that block Mycobacterium tuberculosis growth by targeting the respiratory cytochrome bc(1) complex. The optimized IPA compound Q203 inhibited the growth of MDR and XDR M. tuberculosis clinical isolates in culture broth medium in the low nanomolar range and was efficacious in a mouse model of tuberculosis at a dose less than 1 mg per kg body weight, which highlights the potency of this compound. In addition, Q203 displays pharmacokinetic and safety profiles compatible with once-daily dosing. Together, our data indicate that Q203 is a promising new clinical candidate for the treatment of tuberculosis.	[Pethe, Kevin; Jang, Jichan; Kang, Sunhee; Park, Seijin; Ahn, Sujin; Jeon, Hee Kyoung; Cechetto, Jonathan; Christophe, Thierry; Lee, Honggun; Seo, Min Jung; Kim, Young Mi; Seo, Mooyoung; Seo, Jeong Jea; Park, Dongsik; Ko, Yoonae; Choi, Inhee; Kim, Ryangyeo; Kim, Se Yeon; Lim, SeungBin; Yim, Seung-Ae; Nam, Jiyoun; Kang, Hwankyu; Kwon, Haejin; Oh, Chun-Taek; Cho, Yoojin; Jang, Yunhee; Kim, Junghwan; Lee, Saeyeon; Nehrbass, Ulf; Han, Sung-Jun; No, Zaesung; Lee, Jinhwa; Brodin, Priscille; Kim, Jaeseung] Inst Pasteur Korea, Songnam, Gyeonggi Do, South Korea; [Bifani, Pablo; Jiricek, Jan; Chua, Adeline; Tan, Bee Huat; Nanjundappa, Mahesh B.; Rao, Srinivasa P. S.] Novartis Inst Trop Dis, Singapore, Singapore; [Jung, Juyoung] Chungnam Natl Univ, Coll Vet Med, Dept Vet Histol, Taejon, South Korea; [Kempf, Marie] Univ Angers, Grp Etud Interact Hote Pathogene, Angers, France; [Kempf, Marie] CHU Angers, Bacteriol Lab, Angers, France; [Jackson, Mary; Lenaerts, Anne J.; Ha Pham; Jones, Victoria] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Barnes, Whitney S.; Walker, John R.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Wintjens, Rene] Univ Libre Bruxelles, Inst Mol Biol & Med, Struct Biol Unit, Gosselies, Belgium; [Alonso, Sylvie] Natl Univ Singapore, Inst Life Sci, Yong Loo Lin Sch Med, Dept Microbiol & Immunol Programme, Singapore 117548, Singapore; [Kim, Jungjun; Oh, Soohyun; Nam, Kiyean] Qurient, Songnam, Gyeonggi Do, South Korea; [Oh, Taegwon; Cho, Sang-Nae] Yonsei Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea	Institut Pasteur Korea; Novartis; Chungnam National University; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Colorado State University; Novartis; Universite Libre de Bruxelles; National University of Singapore; Yonsei University; Yonsei University Health System	Pethe, K (corresponding author), Inst Pasteur Korea, Songnam, Gyeonggi Do, South Korea.	kevin.pethe@ip-korea.org; knam@qurient.com; jskim@ip-korea.org	Pethe, Kevin/L-1199-2013; Jackson, Mary/D-5345-2017; Pethe, Kevin/F-9495-2015; Jiricek, Jan/AAA-4701-2021; kang, sunhee/AAM-9148-2020; Lenaerts, Anne/F-1353-2017; Brodin, Priscille/E-5802-2014	Pethe, Kevin/0000-0003-0297-0150; Jackson, Mary/0000-0002-9212-0258; KEMPF, Marie/0000-0002-2943-7500; Pethe, Kevin/0000-0003-0916-8873; Bifani, Pablo/0000-0001-9651-6439; Nehrbass, Ulf/0000-0002-7028-8076; Brodin, Priscille/0000-0003-0991-7344; deboosere, Nathalie/0000-0002-2873-5485	National Research Foundation of Korea; Korean government Ministry of Education, Science and Technology [2012-00011]; Korea Institute of Science and Technology Information; Gyeonggi-do and Institut National de la Sante et de la Recherche Medicale-Avenir; Belgian Fund for Scientific Research	National Research Foundation of Korea(National Research Foundation of Korea); Korean government Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Institute of Science and Technology Information(Korea Institute of Science & Technology Information (KISTI)); Gyeonggi-do and Institut National de la Sante et de la Recherche Medicale-Avenir; Belgian Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS)	This work was supported by a National Research Foundation of Korea grant funded by the Korean government Ministry of Education, Science and Technology (2012-00011), the Korea Institute of Science and Technology Information, Gyeonggi-do and Institut National de la Sante et de la Recherche Medicale-Avenir. R.W. received support from the Belgian Fund for Scientific Research.	Abrahams KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052951; Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Chaisson RE, 2012, NEW ENGL J MED, V366, P2223, DOI 10.1056/NEJMe1204478; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11; Diacon AH, 2010, ANTIMICROB AGENTS CH, V54, P3402, DOI 10.1128/AAC.01354-09; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Katritzky AR, 2003, J ORG CHEM, V68, P4935, DOI 10.1021/jo026797p; Kleinschroth T, 2011, BBA-BIOENERGETICS, V1807, P1606, DOI 10.1016/j.bbabio.2011.09.017; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lin PL, 2012, P NATL ACAD SCI USA, V109, P14188, DOI 10.1073/pnas.1121497109; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Matsoso LG, 2005, J BACTERIOL, V187, P6300, DOI 10.1128/JB.187.18.6300-6308.2005; Moraski GC, 2011, ACS MED CHEM LETT, V2, P466, DOI 10.1021/ml200036r; No Z., 2011, [No title captured], Patent No. [2011/113606, 2011113606, WO 2011113606]; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Rullas J, 2010, ANTIMICROB AGENTS CH, V54, P2262, DOI 10.1128/AAC.01423-09; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shang SB, 2011, ANTIMICROB AGENTS CH, V55, P124, DOI 10.1128/AAC.00978-10; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	29	401	429	0	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2013	19	9					1157	1160		10.1038/nm.3262	http://dx.doi.org/10.1038/nm.3262			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23913123				2022-12-27	WOS:000324083500031
J	Woldt, E; Sebti, Y; Solt, LA; Duhem, C; Lancel, S; Eeckhoute, J; Hesselink, MKC; Paquet, C; Delhaye, S; Shin, YS; Kamenecka, TM; Schaart, G; Lefebvre, P; Neviere, R; Burris, TP; Schrauwen, P; Staels, B; Duez, H				Woldt, Estelle; Sebti, Yasmine; Solt, Laura A.; Duhem, Christian; Lancel, Steve; Eeckhoute, Jerome; Hesselink, Matthijs K. C.; Paquet, Charlotte; Delhaye, Stephane; Shin, Youseung; Kamenecka, Theodore M.; Schaart, Gert; Lefebvre, Philippe; Neviere, Remi; Burris, Thomas P.; Schrauwen, Patrick; Staels, Bart; Duez, Helene			Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOCYTE DIFFERENTIATION; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; CIRCADIAN BEHAVIOR; TARGET GENE; METABOLISM; EXERCISE; EXPRESSION; CLOCK	The nuclear receptor Rev-erb-alpha modulates hepatic lipid and glucose metabolism, adipogenesis and the inflammatory response in macrophages. We show here that Rev-erb-alpha is highly expressed in oxidative skeletal muscle and that its deficiency in muscle leads to reduced mitochondrial content and oxidative function, as well as upregulation of autophagy. These cellular effects resulted in both impaired mitochondrial biogenesis and increased clearance of this organelle, leading to compromised exercise capacity. On a molecular level, Rev-erb-alpha deficiency resulted in deactivation of the Lkb1-Ampk-Sirt1-Ppargc-1 alpha signaling pathway. These effects were recapitulated in isolated fibers and in muscle cells after knockdown of the gene encoding Rev-erb-alpha, Nr1d1. In complementary experiments, Rev-erb-alpha overexpression in vitro increased the number of mitochondria and improved respiratory capacity, whereas muscle overexpression or pharmacological activation of Rev-erb-alpha in vivo increased exercise capacity. This study identifies Rev-erb-alpha as a pharmacological target that improves muscle oxidative function by modulating gene networks controlling mitochondrial number and function.	[Woldt, Estelle; Sebti, Yasmine; Duhem, Christian; Eeckhoute, Jerome; Paquet, Charlotte; Delhaye, Stephane; Lefebvre, Philippe; Staels, Bart; Duez, Helene] Inst Pasteur, F-59019 Lille, France; [Woldt, Estelle; Sebti, Yasmine; Duhem, Christian; Eeckhoute, Jerome; Paquet, Charlotte; Delhaye, Stephane; Lefebvre, Philippe; Staels, Bart; Duez, Helene] INSERM, UMR Nucl Receptors Cardiovasc Dis & Diabet 1011, F-59045 Lille, France; [Woldt, Estelle; Sebti, Yasmine; Duhem, Christian; Eeckhoute, Jerome; Paquet, Charlotte; Delhaye, Stephane; Lefebvre, Philippe; Staels, Bart; Duez, Helene] Univ Lille Nord France, Fac Sci Pharmaceut & Biol, Lille, France; [Woldt, Estelle; Sebti, Yasmine; Duhem, Christian; Eeckhoute, Jerome; Paquet, Charlotte; Delhaye, Stephane; Lefebvre, Philippe; Staels, Bart; Duez, Helene] Univ Lille Nord France, Fac Med, Lille, France; [Woldt, Estelle; Sebti, Yasmine; Duhem, Christian; Lancel, Steve; Eeckhoute, Jerome; Paquet, Charlotte; Delhaye, Stephane; Lefebvre, Philippe; Neviere, Remi; Staels, Bart; Duez, Helene] Univ Droit & Sante Lille, Lille, France; [Woldt, Estelle; Sebti, Yasmine; Duhem, Christian; Eeckhoute, Jerome; Paquet, Charlotte; Delhaye, Stephane; Lefebvre, Philippe; Staels, Bart; Duez, Helene] European Genom Inst Diabet, Lille, France; [Solt, Laura A.; Shin, Youseung; Kamenecka, Theodore M.; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Lancel, Steve; Neviere, Remi] Univ Lille Nord France, Fac Med, Dept Physiol, Equipe Accueil 4484, Lille, France; [Hesselink, Matthijs K. C.; Schaart, Gert; Schrauwen, Patrick] Maastricht Univ, Med Ctr, Dept Human Biol, Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Hesselink, Matthijs K. C.; Schaart, Gert; Schrauwen, Patrick] Maastricht Univ, Med Ctr, Dept Human Movement Sci, Maastricht, Netherlands	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Scripps Research Institute; Universite de Lille - ISITE; Universite de Lille; Maastricht University; Maastricht University	Duez, H (corresponding author), Inst Pasteur, F-59019 Lille, France.	bart.staels@pasteur-lille.fr; helene.duez@pasteur-lille.fr	, Lancel/H-9047-2019; Staels, Bart/N-9497-2016; Duez, Helene/M-7609-2017; Duez, Helene/AAC-3217-2019; Burris, Thomas P/B-3886-2016; Lefebvre, Philippe/F-2685-2010; Eeckhoute, Jerome/AAN-8219-2021	, Lancel/0000-0002-3292-5433; Staels, Bart/0000-0002-3784-1503; Duez, Helene/0000-0002-4130-7987; Burris, Thomas P/0000-0003-2922-4449; Lefebvre, Philippe/0000-0002-9366-5129; Eeckhoute, Jerome/0000-0002-7222-9264; schrauwen, patrick/0000-0002-0973-847X; Schaart, Gert/0000-0003-4259-9528; Neviere, Remi/0000-0002-7966-0110; Duhem, Christian/0000-0003-0931-3815; Sebti, Yasmine/0000-0002-1813-810X; delhaye, stephane/0000-0001-9438-6730	Marie Curie International Reintegration Grant; European Commission (FP7) consortium Eurhythdia; Region Nord Pas-de-Calais/Fonds Europeen de Developpement Regional; Contrat de Projet Etat-Region 'starting grant'; European Genomic Institute for Diabetes (EGID) [ANR-10-LABX-46]; joint Societe Francophone du Diabete/Merck Sharp & Dohme research fellowship; European Foundation for the Study of Diabetes/Lilly; US National Institutes of Health [MH093429, DK080201]; National Research Service Award [DK088499]; Netherlands Organization for Scientific Research [918.96.618]; Institut Universitaire de France; Instituts Thematiques Multi-Organismes/Astra Zeneca grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088499, R01DK080201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093429] Funding Source: NIH RePORTER	Marie Curie International Reintegration Grant(European Commission); European Commission (FP7) consortium Eurhythdia(European Commission); Region Nord Pas-de-Calais/Fonds Europeen de Developpement Regional(Region Hauts-de-France); Contrat de Projet Etat-Region 'starting grant'; European Genomic Institute for Diabetes (EGID); joint Societe Francophone du Diabete/Merck Sharp & Dohme research fellowship; European Foundation for the Study of Diabetes/Lilly(Eli Lilly); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Institut Universitaire de France; Instituts Thematiques Multi-Organismes/Astra Zeneca grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a Marie Curie International Reintegration Grant (FP7) (to H.D.), the European Commission (FP7) consortium Eurhythdia (to B.S.), Region Nord Pas-de-Calais/Fonds Europeen de Developpement Regional (to B.S.), a Contrat de Projet Etat-Region 'starting grant' (to H.D.), the European Genomic Institute for Diabetes (EGID, ANR-10-LABX-46) (to B.S.), an unrestricted Instituts Thematiques Multi-Organismes/Astra Zeneca grant (to B.S.), a joint Societe Francophone du Diabete/Merck Sharp & Dohme research fellowship (to H. D.), a research grant from the European Foundation for the Study of Diabetes/Lilly (to H.D.), US National Institutes of Health grants (MH093429 and DK080201) (to T.P.B.), a National Research Service Award (DK088499) (to L.A.S.) and a VICI research grant for innovative research from the Netherlands Organization for Scientific Research (918.96.618) (to P.S.). B.S. receives support from the Institut Universitaire de France.	Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Delhaas T, 2013, ANAT REC, V296, P192, DOI 10.1002/ar.22631; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Duez H, 2010, ARTERIOSCL THROM VAS, V30, P1529, DOI 10.1161/ATVBAHA.110.209098; Eeckhoute J, 2009, METHODS MOL BIOL, V556, P155, DOI 10.1007/978-1-60327-192-9_11; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaminskyy V, 2011, AUTOPHAGY, V7, P83, DOI 10.4161/auto.7.1.13893; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Thomson DM, 2010, J APPL PHYSIOL, V108, P1775, DOI 10.1152/japplphysiol.01293.2009; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	44	281	294	2	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1039	+		10.1038/nm.3213	http://dx.doi.org/10.1038/nm.3213			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23852339	Green Accepted, Green Published			2022-12-27	WOS:000322779600030
J	Li, QS; Pene, V; Krishnamurthy, S; Cha, H; Liang, TJ				Li, Qisheng; Pene, Veronique; Krishnamurthy, Siddharth; Cha, Helen; Liang, T. Jake			Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly	NATURE MEDICINE			English	Article							NF-KAPPA-B; WEST-NILE-VIRUS; INDUCED INSULIN-RESISTANCE; FATTY-ACID SYNTHESIS; GENE-EXPRESSION; DENGUE VIRUS; RNA REPLICATION; BINDING PROTEIN; HOST FACTORS; BETA	Hepatitis C virus (HCV) interacts extensively with host factors to not only establish productive infection but also trigger unique pathological processes. Our recent genome-wide siRNA screen demonstrated that I kappa B kinase-alpha (IKK-alpha) is a crucial host factor for HCV. Here we describe a new nuclear factor kappa B (NF-kappa B)-independent and kinase-mediated nuclear function of IKK-a in HCV assembly. HCV, through its 3' untranslated region, interacts with DEAD box polypeptide 3, X-linked (DDX3X) to activate IKK-alpha, which translocates to the nucleus and induces a CBP/p300-mediated transcriptional program involving sterol regulatory element-binding proteins (SREBPs). This innate pathway induces lipogenic genes and enhances core-associated lipid droplet formation to facilitate viral assembly. Chemical inhibitors of IKK-alpha suppress HCV infection and IKK-alpha-induced lipogenesis, offering a proof-of-concept approach for new HCV therapeutic development. Our results show that HCV uses a novel mechanism to exploit intrinsic innate responses and hijack lipid metabolism, which may contribute to high chronicity rates and the pathological hallmark of steatosis in HCV infection.	[Li, Qisheng; Pene, Veronique; Krishnamurthy, Siddharth; Cha, Helen; Liang, T. Jake] NIDDKD, Liver Dis Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liang, TJ (corresponding author), NIDDKD, Liver Dis Branch, US Natl Inst Hlth, Bethesda, MD 20892 USA.	jakel@bdg10.niddk.nih.gov	Li, Qisheng/K-1909-2013	Krishnamurthy, Siddharth/0000-0003-1777-8292	Intramural Research Program of the NIDDK, US National Institutes of Health (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054504, ZIADK054503, ZIADK054511] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK, US National Institutes of Health (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Z. Hu, Y.-Y. Zhang, Y.-M. Li, E. Thomas, V. Gonzalez-Munoz and L. Holz for technical assistance, Y.-P. Wu of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Confocal Microscopy Core for helping with confocal imaging and W.-P. Chen of the NIDDK Microarray Core Facility for DNA microarray analysis. We also thank A. Patel of the University of Glasgow for providing the HCV core mutant (F24Y) virus and C. Rice (Rockefeller University) for the 9E10 NS5A antibody and other reagents. This work was supported by the Intramural Research Program of the NIDDK, US National Institutes of Health (NIH). Primary human hepatocytes were provided by the NIH-funded Liver Tissue Procurement and Cell Distribution System (N01-DK-7-0004/HHSN26700700004C, principal investigator, S. Strom, University of Pittsburgh).	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Angus AGN, 2010, J GEN VIROL, V91, P122, DOI 10.1099/vir.0.015909-0; Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Asselah T, 2006, GUT, V55, P123, DOI 10.1136/gut.2005.069757; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Ericsson J, 1998, J BIOL CHEM, V273, P17865, DOI 10.1074/jbc.273.28.17865; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Herker E, 2010, NAT MED, V16, P1295, DOI 10.1038/nm.2238; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Lerat H, 2009, J BIOL CHEM, V284, P33466, DOI 10.1074/jbc.M109.019810; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Oshiumi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014258; Oshiumi H, 2010, EUR J IMMUNOL, V40, P940, DOI 10.1002/eji.200940203; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027	55	135	137	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2013	19	6					722	+		10.1038/nm.3190	http://dx.doi.org/10.1038/nm.3190			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23708292	Green Accepted			2022-12-27	WOS:000319981600021
J	Podrez, EA				Podrez, Eugene A.			Bad versus good cholesterol in the bone marrow	NATURE MEDICINE			English	Editorial Material							ATP-BINDING CASSETTE; STEM-CELL PROLIFERATION; TRANSPORTERS; DISEASE		Cleveland Clin Fdn, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Podrez, EA (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	podreze@ccf.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL073311] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Coller BS, 2011, J THROMB HAEMOST, V9, P374, DOI 10.1111/j.1538-7836.2011.04356.x; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Italiano JE, 2013, SEMIN THROMB HEMOST, V39, P15, DOI 10.1055/s-0032-1331157; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Kusuhara H, 2007, PFLUG ARCH EUR J PHY, V453, P735, DOI 10.1007/s00424-006-0134-x; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Oram JF, 2006, CIRC RES, V99, P1031, DOI 10.1161/01.RES.0000250171.54048.5c; Pang LY, 2005, J CLIN INVEST, V115, P3332, DOI 10.1172/JCI26720; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	12	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	2013	19	5					541	543		10.1038/nm.3188	http://dx.doi.org/10.1038/nm.3188			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	139LA	23652105	Green Accepted			2022-12-27	WOS:000318583000024
J	Reilly, SM; Chiang, SH; Decker, SJ; Chang, L; Uhm, M; Larsen, MJ; Rubin, JR; Mowers, J; White, NM; Hochberg, I; Downes, M; Yu, RT; Liddle, C; Evans, RM; Oh, D; Li, PP; Olefsky, JM; Saltiel, AR				Reilly, Shannon M.; Chiang, Shian-Huey; Decker, Stuart J.; Chang, Louise; Uhm, Maeran; Larsen, Martha J.; Rubin, John R.; Mowers, Jonathan; White, Nicole M.; Hochberg, Irit; Downes, Michael; Yu, Ruth T.; Liddle, Christopher; Evans, Ronald M.; Oh, Dayoung; Li, Pingping; Olefsky, Jerrold M.; Saltiel, Alan R.			An inhibitor of the protein kinases TBK1 and IKK-epsilon improves obesity-related metabolic dysfunctions in mice	NATURE MEDICINE			English	Article							DIET-INDUCED OBESITY; NF-KAPPA-B; INSULIN-RESISTANCE; T-CELLS; MAST-CELLS; CROSS-TALK; FAT; INFLAMMATION; LINKS; ACTIVATION	Emerging evidence suggests that inflammation provides a link between obesity and insulin resistance. The noncanonical I kappa B kinases IKK-epsilon and TANK-binding kinase 1 (TBK1) are induced in liver and fat by NF-kappa B activation upon high-fat diet feeding and in turn initiate a program of counterinflammation that preserves energy storage. Here we report that amlexanox, an approved small-molecule therapeutic presently used in the clinic to treat aphthous ulcers and asthma, is an inhibitor of these kinases. Treatment of obese mice with amlexanox elevates energy expenditure through increased thermogenesis, producing weight loss, improved insulin sensitivity and decreased steatosis. Because of its record of safety in patients, amlexanox may be an interesting candidate for clinical evaluation in the treatment of obesity and related disorders.	[Reilly, Shannon M.; Chiang, Shian-Huey; Decker, Stuart J.; Chang, Louise; Uhm, Maeran; Larsen, Martha J.; Rubin, John R.; Mowers, Jonathan; White, Nicole M.; Hochberg, Irit; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Uhm, Maeran; Mowers, Jonathan; Saltiel, Alan R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Uhm, Maeran; Mowers, Jonathan; Saltiel, Alan R.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Downes, Michael; Yu, Ruth T.; Liddle, Christopher; Evans, Ronald M.] Salk Inst Biol Sci, Gene Express Lab, La Jolla, CA USA; [Liddle, Christopher] Westmead Millennlum Inst, Storr Liver Unit, Westmead, NSW, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Evans, Ronald M.] Salk Inst Biol Sci, Howard Hughes Med Inst, La Jolla, CA USA; [Oh, Dayoung; Li, Pingping; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Salk Institute; University of Sydney; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@umich.edu	Li, Pingping/F-1109-2019; Saltiel, Alan/L-3632-2019; Evans, Ronald/AAF-4001-2019; Reilly, Shannon Marie/ABB-6473-2021	Li, Pingping/0000-0003-0679-270X; Evans, Ronald/0000-0002-9986-5965; Reilly, Shannon Marie/0000-0003-0412-2446; Yu, Ruth/0000-0002-9527-9627; Hochberg, Irit/0000-0002-4232-5191; White, Nicole/0000-0003-3928-9502; Chang, Louise/0000-0001-5501-4774; Saltiel, Alan/0000-0002-9726-9828	US National Institutes of Health [DK60597, 60591, F32DK09685101, F30DK089687, R24DK090962]; Leona M. and Harry B. Helmsley Charitable Trust; Michigan Diabetes Research and Training Center [DK020572]; Michigan Institute for Clinical and Health Research [UL1-RR024986]; Nathan Shock Center; Michigan Metabolic Phenotyping Core; Michigan Nutritional Obesity Research Center [DK089503]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK061618, F32DK096851, R01DK060591, R01DK060597, F30DK089687, R24DK090962, P60DK020572, P30DK063491, P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Michigan Diabetes Research and Training Center; Michigan Institute for Clinical and Health Research; Nathan Shock Center; Michigan Metabolic Phenotyping Core; Michigan Nutritional Obesity Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Hung and X. Peng for excellent technical assistance and members of the Saltiel laboratory for helpful discussions. This work was supported by US National Institutes of Health grants DK60597 and 60591 to A.R.S., F32DK09685101 to S.M.R., F30DK089687 to J.M. and R24DK090962 to A.R.S., J.M.O. and R.M.E. R.M.E., M.D. and R.T.Y. are supported by the Leona M. and Harry B. Helmsley Charitable Trust. We thank S. Akira (Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan) for providing MEFs. We also acknowledge support from the Michigan Diabetes Research and Training Center (DK020572), Michigan Institute for Clinical and Health Research (UL1-RR024986), Nathan Shock Center, Michigan Metabolic Phenotyping Core and Michigan Nutritional Obesity Research Center (DK089503).	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bamborough P, 2006, BIOORG MED CHEM LETT, V16, P6236, DOI 10.1016/j.bmcl.2006.09.018; Bell J, 2005, CLIN DRUG INVEST, V25, P555, DOI 10.2165/00044011-200525090-00001; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Blackburn P, 2006, OBESITY, V14, P1747, DOI 10.1038/oby.2006.201; Chariot A, 2009, TRENDS CELL BIOL, V19, P404, DOI 10.1016/j.tcb.2009.05.006; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2007, AM J PHYSIOL-ENDOC M, V292, pE166, DOI 10.1152/ajpendo.00284.2006; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; MAKINO H, 1987, INT ARCH ALLER A IMM, V82, P66, DOI 10.1159/000234292; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Reaven GM, 2005, CELL METAB, V1, P9, DOI 10.1016/j.cmet.2004.12.001; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shigeharu, 1985, JPN PHARMACOL THER, V13, P4933; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4	60	302	321	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					313	321		10.1038/nm.3082	http://dx.doi.org/10.1038/nm.3082			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396211	Green Accepted			2022-12-27	WOS:000316040700024
J	Souers, AJ; Leverson, JD; Boghaert, ER; Ackler, SL; Catron, ND; Chen, J; Dayton, BD; Ding, H; Enschede, SH; Fairbrother, WJ; Huang, DCS; Hymowitz, SG; Jin, S; Khaw, SL; Kovar, PJ; Lam, LT; Lee, J; Maecker, HL; Marsh, KC; Mason, KD; Mitten, MJ; Nimmer, PM; Oleksijew, A; Park, CH; Park, CM; Phillips, DC; Roberts, AW; Sampath, D; Seymour, JF; Smith, ML; Sullivan, GM; Tahir, SK; Tse, C; Wendt, MD; Xiao, Y; Xue, JC; Zhang, HC; Humerickhouse, RA; Rosenberg, SH; Elmore, SW				Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Fairbrother, Wayne J.; Huang, David C. S.; Hymowitz, Sarah G.; Jin, Sha; Khaw, Seong Lin; Kovar, Peter J.; Lam, Lloyd T.; Lee, Jackie; Maecker, Heather L.; Marsh, Kennan C.; Mason, Kylie D.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Roberts, Andrew W.; Sampath, Deepak; Seymour, John F.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.			ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets	NATURE MEDICINE			English	Article							B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMA; FAMILY INHIBITOR; INDUCE APOPTOSIS; HIGH-AFFINITY; IN-VIVO; EXPRESSION; CANCER	Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are key regulators of the apoptotic process. This family comprises proapoptotic and prosurvival proteins, and shifting the balance toward the latter is an established mechanism whereby cancer cells evade apoptosis. The therapeutic potential of directly inhibiting prosurvival proteins was unveiled with the development of navitoclax, a selective inhibitor of both BCL-2 and BCL-2-like 1 (BCL-X-L), which has shown clinical efficacy in some BCL-2-dependent hematological cancers. However, concomitant on-target thrombocytopenia caused by BCL-X-L inhibition limits the efficacy achievable with this agent. Here we report the re-engineering of navitoclax to create a highly potent, orally bioavailable and BCL-2-selective inhibitor, ABT-199. This compound inhibits the growth of BCL-2-dependent tumors in vivo and spares human platelets. A single dose of ABT-199 in three patients with refractory chronic lymphocytic leukemia resulted in tumor lysis within 24 h. These data indicate that selective pharmacological inhibition of BCL-2 shows promise for the treatment of BCL-2-dependent hematological cancers.	[Souers, Andrew J.; Leverson, Joel D.; Boghaert, Erwin R.; Ackler, Scott L.; Catron, Nathaniel D.; Chen, Jun; Dayton, Brian D.; Ding, Hong; Enschede, Sari H.; Jin, Sha; Kovar, Peter J.; Lam, Lloyd T.; Marsh, Kennan C.; Mitten, Michael J.; Nimmer, Paul M.; Oleksijew, Anatol; Park, Chang H.; Park, Cheol-Min; Phillips, Darren C.; Smith, Morey L.; Sullivan, Gerard M.; Tahir, Stephen K.; Tse, Chris; Wendt, Michael D.; Xiao, Yu; Xue, John C.; Zhang, Haichao; Humerickhouse, Rod A.; Rosenberg, Saul H.; Elmore, Steven W.] AbbVie Inc, N Chicago, IL USA; [Fairbrother, Wayne J.; Hymowitz, Sarah G.; Lee, Jackie; Maecker, Heather L.; Sampath, Deepak] Genentech Inc, San Francisco, CA 94080 USA; [Huang, David C. S.; Khaw, Seong Lin; Mason, Kylie D.; Roberts, Andrew W.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Huang, David C. S.; Khaw, Seong Lin; Mason, Kylie D.; Roberts, Andrew W.; Seymour, John F.] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic, Australia; [Mason, Kylie D.; Roberts, Andrew W.] Royal Melbourne Hosp, Dept Clin Hematol & Bone Marrow Transplant, Parkville, Vic 3050, Australia; [Seymour, John F.] Peter MacCallum Canc Ctr, Dept Hematol, Melbourne, Vic, Australia	AbbVie; Roche Holding; Genentech; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Royal Melbourne Hospital; Peter Maccallum Cancer Center	Souers, AJ (corresponding author), AbbVie Inc, N Chicago, IL USA.	andrew.souers@abbvie.com	Jones, Jeffrey A/E-9827-2013; Seymour, John/K-7326-2019; Roberts, Andrew W./C-6736-2012; Huang, David C. S./C-7586-2013; Park, Cheol-Min/G-2688-2010	Seymour, John/0000-0003-2188-6835; Roberts, Andrew W./0000-0002-7341-5720; Huang, David C. S./0000-0002-3101-4873; Mason, Kylie/0000-0002-6238-4092; Maecker, Heather/0000-0002-5378-1141	Australian National Health and Medical Research Council (NHMRC); Australian Cancer Research Foundation; Leukaemia Foundation of Australia; Cancer Council of Victoria; Victorian Cancer Agency; Victorian State Government Operational Infrastructure Support; Leukemia Lymphoma Society	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Leukaemia Foundation of Australia; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Cancer Agency; Victorian State Government Operational Infrastructure Support; Leukemia Lymphoma Society(Leukemia and Lymphoma Society)	We thank M. Bruncko, E. Fry, L. Hasvold, L. Hexamer, A. Kunzer, A. Petros, X. Song, Z. Tao, L. Wang and X. Wang for contributions to the generation of ABT-199 and related analogs and J. Bouska, and D. Osterling for analytical support. The authors acknowledge G. Chiang and A. Vasudevan for critical reading of this manuscript, L. Belmont, I. Wertz, J. Adams, S. Cory, P. Colman, P. Czabotar and G. Lessene for useful discussions and K. Lowes, E. Litvinovich and L. Roberts for technical analysis. Research performed at the Walter and Eliza Hall Institute (WEHI) was supported by grants and fellowships from the Australian National Health and Medical Research Council (NHMRC, including an Independent Research Institutes Infrastructure Support Scheme (IRIISS) grant), the Australian Cancer Research Foundation, the Leukaemia Foundation of Australia, the Cancer Council of Victoria, the Victorian Cancer Agency, the Victorian State Government Operational Infrastructure Support and the Leukemia Lymphoma Society. The authors acknowledge L.M. Staudt (US National Institutes of Health) for DLBCL cell lines.	Ackler S, 2012, BRIT J PHARMACOL, V167, P881, DOI 10.1111/j.1476-5381.2012.02048.x; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; American Cancer Society, 2011, CANC FACTS FIG 2011; Amundson SA, 2000, CANCER RES, V60, P6101; Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Campas C, 2006, EXP HEMATOL, V34, P1663, DOI 10.1016/j.exphem.2006.07.008; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CoustanSmith E, 1996, BLOOD, V87, P1140, DOI 10.1182/blood.V87.3.1140.bloodjournal8731140; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Huang JZ, 2002, BLOOD, V99, P2285, DOI 10.1182/blood.V99.7.2285; Iqbal J, 2006, J CLIN ONCOL, V24, P961, DOI 10.1200/JCO.2005.03.4264; Irish JM, 2007, BLOOD, V109, P2589, DOI 10.1182/blood-2006-02-004234; La Thangue NB, 2011, NAT REV CLIN ONCOL, V8, P587, DOI 10.1038/nrclinonc.2011.121; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Marschitz I, 2000, AM J CLIN PATHOL, V113, P219, DOI 10.1309/491W-L1TN-UFQX-T61B; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Matsumura N, 2010, FASEB J, V24, P2201, DOI 10.1096/fj.09-143008; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Park CM, 2008, J MED CHEM, V51, P6902, DOI 10.1021/jm800669s; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Rampello E, 2006, NAT CLIN PRACT ONCOL, V3, P438, DOI 10.1038/ncponc0581; Roberts A.W., 2012, EUR HEM ASS 2012 AMS; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Samuel S, 2010, MOL THER, V18, P2094, DOI 10.1038/mt.2010.188; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Sawas A, 2011, CURR OPIN HEMATOL, V18, P280, DOI 10.1097/MOH.0b013e328347786d; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Singh RR, 2010, LEUKEMIA, V24, P1025, DOI 10.1038/leu.2010.35; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wendt MD, 2006, J MED CHEM, V49, P1165, DOI 10.1021/jm050754u; Wendt MD, 2008, EXPERT OPIN DRUG DIS, V3, P1123, DOI 10.1517/17460441.3.9.1123; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang H, 2007, CELL DEATH DIFFER, V14, P943, DOI 10.1038/sj.cdd.4402081	46	1917	2002	32	427	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					202	208		10.1038/nm.3048	http://dx.doi.org/10.1038/nm.3048			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23291630				2022-12-27	WOS:000314675900028
J	Sundaresan, NR; Vasudevan, P; Zhong, L; Kim, G; Samant, S; Parekh, V; Pillai, VB; Ravindra, PV; Gupta, M; Jeevanandam, V; Cunningham, JM; Deng, CX; Lombard, DB; Mostoslavsky, R; Gupta, MP				Sundaresan, Nagalingam R.; Vasudevan, Prabhakaran; Zhong, Lei; Kim, Gene; Samant, Sadhana; Parekh, Vishwas; Pillai, Vinodkumar B.; Ravindra, P. V.; Gupta, Madhu; Jeevanandam, Valluvan; Cunningham, John M.; Deng, Chu-Xia; Lombard, David B.; Mostoslavsky, Raul; Gupta, Mahesh P.			The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun	NATURE MEDICINE			English	Article							FOCAL ADHESION KINASE; REGULATES LIFE-SPAN; CALORIE RESTRICTION; HISTONE DEACETYLASE; GENE-EXPRESSION; HEART; ACTIVATION; AP-1; INDUCTION; RECEPTOR	Abnormal activation of insulin-like growth factor (IGF)-Akt signaling is implicated in the development of various diseases, including heart failure. However, the molecular mechanisms that regulate activation of this signaling pathway are not completely understood. Here we show that sirtuin 6 (SIRT6), a nuclear histone deacetylase, functions at the level of chromatin to directly attenuate IGF-Akt signaling. SIRT6-deficient mice developed cardiac hypertrophy and heart failure, whereas SIRT6 transgenic mice were protected from hypertrophic stimuli, indicating that SIRT6 acts as a negative regulator of cardiac hypertrophy. SIRT6-deficient mouse hearts showed hyperactivation of IGF signaling-related genes and their downstream targets. Mechanistically, SIRT6 binds to and suppresses the promoter of IGF signaling-related genes by interacting with c-Jun and deacetylating histone 3 at Lys9 (H3K9). We also found reduced SIRT6 expression in human failing hearts. These findings disclose a new link between SIRT6 and IGF-Akt signaling and implicate SIRT6 in the development of cardiac hypertrophy and failure.	[Sundaresan, Nagalingam R.; Samant, Sadhana; Pillai, Vinodkumar B.; Ravindra, P. V.; Jeevanandam, Valluvan; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Comm Cellular & Mol Physiol, Chicago, IL 60637 USA; [Vasudevan, Prabhakaran; Parekh, Vishwas; Cunningham, John M.] Univ Chicago, Dept Pediat, Comm Dev Biol, Chicago, IL 60637 USA; [Zhong, Lei; Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Kim, Gene] Univ Chicago, Cardiol Sect, Dept Med, Chicago, IL 60637 USA; [Gupta, Madhu] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Deng, Chu-Xia] NIDDKD, US NIH, Bethesda, MD 20892 USA; [Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Chicago; University of Chicago; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gupta, MP (corresponding author), Univ Chicago, Dept Surg, Comm Cellular & Mol Physiol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu	deng, chuxia/N-6713-2016; Parekh, Vishwas/B-7162-2014	Parekh, Vishwas/0000-0003-3131-2958; Kim, Gene/0000-0001-6461-1992; Lombard, David/0000-0002-4292-0185; Veeranna, Ravindra/0000-0003-4228-1843	US National Institutes of Health [RO1 HL-117041, HL-83423, 111455]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117041, R01HL111455, R01HL077788, R01HL083423] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank F. Alt, Harvard Medical School, for providing SIRT6 knockout mice, E. Verdin, University of California, San Francisco, for providing Flag-SIRT6 wild-type and mutant plasmids, F. VanGool, Institut de Biologie, Universite Libre de Bruxelles, Gosselies, Belgium, for providing mouse-SIRT6 expression plasmid and K. Chua, Stanford University, for providing SIRT6 retroviral vectors and SIRT6 knockout MEFs. The alpha-MHC promoter vector used to make cardiac-specific SIRT6 transgenic mice was provided by J. Robbins, University of Cincinnati. This study was supported by US National Institutes of Health grants RO1 HL-117041, HL-83423 and 111455 to M. P. G. N.R.S. was supported by a postdoctoral fellowship from the American Heart Association.	Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chiu YC, 2009, J IMMUNOL, V183, P2785, DOI 10.4049/jimmunol.0802826; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Freire G, 2007, J MOL CELL CARDIOL, V43, P465, DOI 10.1016/j.yjmcc.2007.07.046; Freude S, 2009, CURR ALZHEIMER RES, V6, P213, DOI 10.2174/156720509788486527; Gallagher EJ, 2010, TRENDS ENDOCRIN MET, V21, P610, DOI 10.1016/j.tem.2010.06.007; Gatenby VK, 2010, EXPERT OPIN THER TAR, V14, P1333, DOI 10.1517/14728222.2010.528930; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haq S, 2001, CIRCULATION, V103, P670; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; KAHN AJ, 1972, AM J CLIN NUTR, V25, P822; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HJ, 2002, MECH AGEING DEV, V123, P1589, DOI 10.1016/S0047-6374(02)00094-5; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kostin S, 2000, Heart Fail Rev, V5, P271; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; Matsui T, 2003, CELL CYCLE, V2, P220, DOI 10.4161/cc.2.3.381; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Pillai JB, 2008, AM J PHYSIOL-HEART C, V294, pH1388, DOI 10.1152/ajpheart.01339.2007; REISS K, 1993, AM J PHYSIOL, V264, pH760, DOI 10.1152/ajpheart.1993.264.3.H760; SCHUNKERT H, 1991, P NATL ACAD SCI USA, V88, P11480, DOI 10.1073/pnas.88.24.11480; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Takemoto Y, 1999, J MOL CELL CARDIOL, V31, P2017, DOI 10.1006/jmcc.1999.1033; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; Wu CL, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016171, 10.1371/journal.pone.0022314]; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Zaina S, 2003, ENDOCRINOLOGY, V144, P2695, DOI 10.1210/en.2002-220944; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	46	332	341	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1643	+		10.1038/nm.2961	http://dx.doi.org/10.1038/nm.2961			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23086477	Green Accepted			2022-12-27	WOS:000310837000024
J	Webster, KA				Webster, Keith A.			A sirtuin link between metabolism and heart disease	NATURE MEDICINE			English	Editorial Material							DEACETYLASE; GROWTH; MICE	The sirtuins (SIRTs) have gained preeminence for their roles in the response to caloric restriction and the regulation of aging and lifespan. A new study now identifies gene promoters that bind the transcription factor AP1 as targets for silencing by SIRT6, providing possible links between SIRT6 deficiency and dysregulation of insulin-like growth factor signaling, hypertrophic cardiomyopathy and heart failure (pages 1643-1650).	[Webster, Keith A.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Webster, Keith A.] Univ Miami, Miller Sch Med, Vasc Biol Inst, Miami, FL 33136 USA	University of Miami; University of Miami	Webster, KA (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	kwebster@med.miami.edu		Webster, Keith A/0000-0002-6431-3642	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044578, R01HL072924] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL072924, R01 HL044578] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chu CH, 2009, ENDOCRINOLOGY, V150, P2723, DOI 10.1210/en.2008-0975; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Oellerich MF, 2012, CIRC RES, V110, P1238, DOI 10.1161/CIRCRESAHA.111.246488; Ralser M, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00032; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	12	12	13	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1617	1619		10.1038/nm.2983	http://dx.doi.org/10.1038/nm.2983			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135512	Green Accepted			2022-12-27	WOS:000310837000017
J	Sheetz, MP; Kenan, WR				Sheetz, Michael P.; Kenan, William R.			Following nature's challenges	NATURE MEDICINE			English	Editorial Material							MEMBRANE; MOVEMENT; PROTEINS		[Sheetz, Michael P.] Natl Univ Singapore, Mechanobiol Inst Singapore, Singapore 117548, Singapore; [Kenan, William R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	National University of Singapore; Columbia University	Sheetz, MP (corresponding author), Natl Univ Singapore, Mechanobiol Inst Singapore, Singapore 117548, Singapore.	ms2001@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036277] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM036277] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ghassemi S, 2012, P NATL ACAD SCI USA, V109, P5328, DOI 10.1073/pnas.1119886109; GLASER M, 1970, P NATL ACAD SCI USA, V65, P721, DOI 10.1073/pnas.65.3.721; SCHNAPP BJ, 1985, CELL, V40, P455, DOI 10.1016/0092-8674(85)90160-6; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; SHEETZ MP, 1972, BIOCHEMISTRY-US, V11, P4573, DOI 10.1021/bi00774a024; SHEETZ MP, 1983, NATURE, V303, P31, DOI 10.1038/303031a0; SHEETZ MP, 1980, NATURE, V285, P510, DOI 10.1038/285510a0; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002	10	0	0	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1483	1485		10.1038/nm.2957	http://dx.doi.org/10.1038/nm.2957			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042357	Green Accepted			2022-12-27	WOS:000309587500022
J	Sun, Y; Campisi, J; Higano, C; Beer, TM; Porter, P; Coleman, I; True, L; Nelson, PS				Sun, Yu; Campisi, Judith; Higano, Celestia; Beer, Tomasz M.; Porter, Peggy; Coleman, Ilsa; True, Lawrence; Nelson, Peter S.			Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B	NATURE MEDICINE			English	Article							CELL-CYCLE ARREST; DRUG-RESISTANCE; BREAST-CANCER; SENESCENCE; MECHANISMS; CHEMOTHERAPY; MITOXANTRONE; PROGRESSION; CHEMORESISTANCE; INHIBITION	Acquired resistance to anticancer treatments is a substantial barrier to reducing the morbidity and mortality that is attributable to malignant tumors. Components of tissue microenvironments are recognized to profoundly influence cellular phenotypes, including susceptibilities to toxic insults. Using a genome-wide analysis of transcriptional responses to genotoxic stress induced by cancer therapeutics, we identified a spectrum of secreted proteins derived from the tumor microenvironment that includes the Wnt family member wingless-type MMTV integration site family member 16B (WNT16B). We determined that WNT16B expression is regulated by nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kappa B) after DNA damage and subsequently signals in a paracrine manner to activate the canonical Wnt program in tumor cells. The expression of WNT16B in the prostate tumor microenvironment attenuated the effects of cytotoxic chemotherapy in vivo, promoting tumor cell survival and disease progression. These results delineate a mechanism by which genotoxic therapies given in a cyclical manner can enhance subsequent treatment resistance through cell nonautonomous effects that are contributed by the tumor microenvironment.	[Sun, Yu; Porter, Peggy; Coleman, Ilsa; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; [Campisi, Judith] Buck Inst Res Aging, Novato, CA USA; [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Higano, Celestia; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Higano, Celestia; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA USA; [Beer, Tomasz M.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Beer, Tomasz M.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [True, Lawrence; Nelson, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle	Nelson, PS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.	pnelson@fhcrc.org		sun, yu/0000-0001-7121-9112	POCRC SPORE grant [P50CA83636]; Department of Defense [PC073217, R01CA119125]; National Cancer Institute Tumor Microenvironment Network [U54126540]; Pacific Northwest Prostate Cancer SPORE [P50CA097186]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [U54CA126540, P50CA083636, P50CA097186, R01CA119125, U01CA164188, P50CA138293] Funding Source: NIH RePORTER	POCRC SPORE grant; Department of Defense(United States Department of Defense); National Cancer Institute Tumor Microenvironment Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Dean and D. Bianchi-Frias for helpful comments, A. Moreno for administrative assistance and N. Clegg for bioinformatics support. S. Hayward, Vanderbilt University, and J. Ware, Medical College of Virginia, provided BPH1 and M12 cells, respectively. Primary human prostate (PSC27), ovarian (OVF28901) and breast (HBF1203) fibroblasts were provided by B. Knudsen, Cedars Sinai Medical Center, E. Swisher, University of Washington, and P. Porter through the Seattle Breast SPORE (P50 CA138293), Fred Hutchinson Cancer Research Center, respectively. B. Torok-Strorb, Fred Hutchinson Cancer Research Center, provided HS5 and HS27A HPV E6/E7 immortalized human bone marrow stromal cells. We thank the clinicians who participated in the trials of neoadjuvant chemotherapy: M. Garzotto, T. Takayama, P. Lange, W. Ellis, S. Lieberman and B. A. Lowe. We are also grateful for the participation of the patients and their families in these studies. Breast cancer specimens were obtained from the Fred Hutchinson Cancer Research Center/University of Washington Medical Center Breast Specimen Repository. We thank N. Urban, Fred Hutchinson Cancer Research Center, for providing ovarian cancer biospecimens funded through the POCRC SPORE grant P50CA83636. This work was supported by a fellowship from the Department of Defense (PC073217), R01CA119125, the National Cancer Institute Tumor Microenvironment Network U54126540, the Pacific Northwest Prostate Cancer SPORE P50CA097186 and the Prostate Cancer Foundation.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; ALDERTON PM, 1992, CANCER RES, V52, P194; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Beer TM, 2004, CLIN CANCER RES, V10, P1306, DOI 10.1158/1078-0432.CCR-1021-03; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Binet R, 2009, CANCER RES, V69, P9183, DOI 10.1158/0008-5472.CAN-09-1016; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Davis A J, 2000, Lancet Oncol, V1, P86, DOI 10.1016/S1470-2045(00)00019-X; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; Garzotto M, 2006, UROL ONCOL-SEMIN ORI, V24, P254, DOI 10.1016/j.urolonc.2005.11.034; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Helmrich A, 2005, ONCOGENE, V24, P4174, DOI 10.1038/sj.onc.1208600; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kerbel RS, 2001, CANCER METAST REV, V20, P1, DOI 10.1023/A:1013129128673; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lee S, 2003, CURR OPIN GENET DEV, V13, P90, DOI 10.1016/S0959-437X(02)00014-X; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Samson DJ, 2004, J CLIN ONCOL, V22, P3618, DOI 10.1200/JCO.2004.04.077; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; StCroix B, 1996, JNCI-J NATL CANCER I, V88, P1285, DOI 10.1093/jnci/88.18.1285; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Vincan E, 2008, CLIN EXP METASTAS, V25, P657, DOI 10.1007/s10585-008-9156-4; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034; Wang F, 2002, JNCI-J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494; Wang TL, 2004, P NATL ACAD SCI USA, V101, P3089, DOI 10.1073/pnas.0308716101; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	46	538	560	9	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1359	+		10.1038/nm.2890	http://dx.doi.org/10.1038/nm.2890			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22863786	Green Accepted			2022-12-27	WOS:000308472300031
J	Zeybel, M; Hardy, T; Wong, YK; Mathers, JC; Fox, CR; Gackowska, A; Oakley, F; Burt, AD; Wilson, CL; Anstee, QM; Barter, MJ; Masson, S; Elsharkawy, AM; Mann, DA; Mann, J				Zeybel, Muejdat; Hardy, Timothy; Wong, Yi K.; Mathers, John C.; Fox, Christopher R.; Gackowska, Agata; Oakley, Fiona; Burt, Alastair D.; Wilson, Caroline L.; Anstee, Quentin M.; Barter, Matt J.; Masson, Steven; Elsharkawy, Ahmed M.; Mann, Derek A.; Mann, Jelena			Multigenerational epigenetic adaptation of the hepatic wound-healing response	NATURE MEDICINE			English	Article							STELLATE CELL ACTIVATION; DNA METHYLATION; CHROMATIN-STRUCTURE; GENE-EXPRESSION; NONCODING RNAS; LIVER FIBROSIS; FATTY LIVER; TGF-BETA; HISTONE; PROGRESSION	We investigated whether ancestral liver damage leads to heritable reprogramming of hepatic wound healing in male rats. We found that a history of liver damage corresponds with transmission of an epigenetic suppressive adaptation of the fibrogenic component of wound healing to the male F-1 and F-2 generations. Underlying this adaptation was less generation of liver myofibroblasts, higher hepatic expression of the antifibrogenic factor peroxisome proliferator-activated receptor gamma (PPAR-gamma) and lower expression of the profibrogenic factor transforming growth factor beta 1 (TGF-beta 1) compared to rats without this adaptation. Remodeling of DNA methylation and histone acetylation underpinned these alterations in gene expression. Sperm from rats with liver fibrosis were enriched for the histone variant H2A.Z and trimethylation of histone H3 at Lys27 (H3K27me3) at PPAR-gamma chromatin. These modifications to the sperm chromatin were transmittable by adaptive serum transfer from fibrotic rats to naive rats and similar modifications were induced in mesenchymal stem cells exposed to conditioned media from cultured rat or human myofibroblasts. Thus, it is probable that a myofibroblast-secreted soluble factor stimulates heritable epigenetic signatures in sperm so that the resulting offspring better adapt to future fibrogenic hepatic insults. Adding possible relevance to humans, we found that people with mild liver fibrosis have hypomethylation of the PPARG promoter compared to others with severe fibrosis.	[Zeybel, Muejdat; Hardy, Timothy; Fox, Christopher R.; Gackowska, Agata; Oakley, Fiona; Burt, Alastair D.; Wilson, Caroline L.; Anstee, Quentin M.; Barter, Matt J.; Masson, Steven; Elsharkawy, Ahmed M.; Mann, Derek A.; Mann, Jelena] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wong, Yi K.; Mathers, John C.] Newcastle Univ, Inst Ageing & Hlth, Ctr Brain Ageing & Vital, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Mann, DA (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	derek.mann@ncl.ac.uk; jelena.mann@ncl.ac.uk	Anstee, Quentin M./L-2981-2013; Burt, Alastair D/D-3634-2013	Anstee, Quentin M./0000-0002-9518-0088; Burt, Alastair D/0000-0002-3011-7774; Zeybel, Mujdat/0000-0002-1542-117X; , Caroline/0000-0002-9016-6025; Elsharkawy, Ahmed Mohamed/0000-0001-5369-3734; Oakley, Fiona/0000-0001-8692-1836; Mathers, John/0000-0003-3406-3002; Mann, Derek/0000-0003-0950-243X; Hardy, Timothy/0000-0001-9777-9134; Masson, Steven/0000-0003-1041-9844	US National Institutes of Health National Institute of Alcohol Abuse and Alcoholism [1U01AA018663-01, R21AA016682]; Wellcome Trust [WT086755MA, WT074472MA]; Newcastle Biomedical Research Centre; Lifelong Health and Wellbeing cross council initiative by the Medical Research Council; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Turkish Association For The Study Of The Liver; National Institute for Health Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA016682, U01AA018663] Funding Source: NIH RePORTER; MRC [G0900686, G0900535, G0700890] Funding Source: UKRI; Medical Research Council [G0700718B, G0900535, G0700890, G0900686] Funding Source: researchfish; National Institute for Health Research [ACF-2010-01-007] Funding Source: researchfish	US National Institutes of Health National Institute of Alcohol Abuse and Alcoholism; Wellcome Trust(Wellcome TrustEuropean Commission); Newcastle Biomedical Research Centre; Lifelong Health and Wellbeing cross council initiative by the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Turkish Association For The Study Of The Liver; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank A. Cheshire for technical assistance and N. Perkins for helpful suggestions with writing the manuscript, M. Bashton for bioinformatic support with microarray analysis and R. Kendall for assistance with rat studies. We also thank J. Kirby and J. Brain for their help with obtaining ethical approval for the retrospective patient study. This work was supported by grants from US National Institutes of Health National Institute of Alcohol Abuse and Alcoholism (to J.M. and D.A.M.) grant numbers 1U01AA018663-01 and R21AA016682; Wellcome Trust grant numbers WT086755MA (to D.A.M.) and WT074472MA (to A.M.E.) and Newcastle Biomedical Research Centre and National Institute for Health Research (to J.M.). The Centre for Brain Ageing and Vitality is funded through the Lifelong Health and Wellbeing cross council initiative by the Medical Research Council, the Biotechnology and Biological Sciences Research Council, the Engineering and Physical Sciences Research Council and the Economic and Social Research Council (to J.C.M.) and the Turkish Association For The Study Of The Liver (to M.Z.).	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; BURD DAR, 1990, J PEDIATR SURG, V25, P898, DOI 10.1016/0022-3468(90)90199-J; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chou S T, 1971, J Pathol, V103, P163, DOI 10.1002/path.1711030305; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; GATEWOOD JM, 1990, J BIOL CHEM, V265, P20662; Ghosh S, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12228; Gieling RG, 2010, HEPATOLOGY, V51, P922, DOI 10.1002/hep.23385; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; HARRISON MR, 1991, ANN SURG, V213, P279, DOI 10.1097/00000658-199104000-00002; Hazra S, 2004, J BIOL CHEM, V279, P11392, DOI 10.1074/jbc.M310284200; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia CK, 2011, EXPERT REV GASTROENT, V5, P105, DOI [10.1586/egh.10.87, 10.1586/EGH.10.87]; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kobor MS, 2009, TRENDS BIOCHEM SCI, V34, P158, DOI 10.1016/j.tibs.2008.12.006; Lavrov SA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1422, DOI 10.1134/S0006297907130020; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; McKay JA, 2011, MOL NUTR FOOD RES, V55, P1717, DOI 10.1002/mnfr.201100150; McKay JA, 2011, MOL NUTR FOOD RES, V55, P1026, DOI 10.1002/mnfr.201100008; Miller D, 2010, REPRODUCTION, V139, P287, DOI 10.1530/REP-09-0281; Miyahara T, 2000, J BIOL CHEM, V275, P35715, DOI 10.1074/jbc.M006577200; Nagase H, 2008, FEBS J, V275, P1617, DOI 10.1111/j.1742-4658.2008.06330.x; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Oakley F, 2005, AM J PATHOL, V166, P695, DOI 10.1016/S0002-9440(10)62291-2; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; RAUCY JL, 1993, CRIT REV TOXICOL, V23, P1, DOI 10.3109/10408449309104072; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; YOKOI Y, 1984, HEPATOLOGY, V4, P709, DOI 10.1002/hep.1840040425; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	54	193	203	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1369	+		10.1038/nm.2893	http://dx.doi.org/10.1038/nm.2893			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22941276	Green Accepted			2022-12-27	WOS:000308472300032
J	Plotkin, SA; Robinson, HL; Davenport, MP				Plotkin, Stanley A.; Robinson, Harriet L.; Davenport, Miles P.			Mining the mechanisms of an HIV vaccine	NATURE MEDICINE			English	Editorial Material							PROTECTION; ANTIBODIES; INFECTION; TRIAL	Despite the existence of antiretroviral drugs that can combat HIV, it is thought that the development of an effective vaccine will be required to control the spread of this deadly virus. In 2009, the results from a phase 3 trial (RV144) of a vaccine consisting of a combination of a canarypox vector expressing HIV-1 immunogens and a recombinant HIV-1 envelope protein offered some hope, as the vaccine showed modest efficacy in preventing HIV-1 infection (31.2%) in a Thai population. Barton Haynes et al.(1) have now performed a case-control analysis to investigate the immune correlates of protection provided by this vaccine. They found that IgG antibody binding of the variable regions 1 and 2 (V1 and V2) of the HIV-1 envelope (Env) glycoprotein 120 inversely correlated with the rate of HIV-1 infection, and plasma IgA antibody binding to Env directly correlated with the rate of infection. We asked three experts to comment on how these results affect our understanding of immune-mediated protection from HIV and how they might be used to design future vaccine strategies against this virus. [GRAPHICS] .						Davenport, Miles/0000-0002-4751-1831				Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Burton DR, 2004, SCIENCE, V303, P316, DOI 10.1126/science.1094620; Doria-Rose NA, 2012, J VIROL, V86, P3393, DOI 10.1128/JVI.06745-11; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Grove J, 2011, J CELL BIOL, V195, P1071, DOI 10.1083/jcb.201108131; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Plotkin SA, 2012, CLIN INFECT DIS, V54, P1615, DOI 10.1093/cid/cis238; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012	10	3	3	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1020	1021		10.1038/nm.2858	http://dx.doi.org/10.1038/nm.2858			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772554				2022-12-27	WOS:000306121600026
J	Kunisaki, Y; Frenette, PS				Kunisaki, Yuya; Frenette, Paul S.			Enigmatic niche brings challenge for HSC expansion	NATURE MEDICINE			English	Editorial Material							HEMATOPOIETIC STEM-CELL; BONE-MARROW NICHE	The bone marrow niche keeps puzzling scientists in cancer and regenerative medicine. What elements constitute the niche and how it affects neighbor cells in different disease contexts remain to be a matter of debate and extensive investigation. The translational use of hematopoietic stem cells (HSCs) in transplantation biology poses a challenge, given the propensity of these cells to remain quiescent. Although the niche is a good candidate to exploit for reprogramming HSCs and controlling their expansion, new studies have added to its complexity. In 'Bench to Bedside', Paul S. Frenette and Yuya Kunisaki examine these studies to discuss how new players and their signals are involved in HSC maintenance and what the implications are for the development of HSC-based therapies. Among the alterations occurring in leukemias, metabolic events seem to foster cancer progression but may also be involved in cancer predisposition. Rushdia Z. Yusuf, Ying-Hua Wang and David T. Scadden peruse recent clinical and experimental studies that look at myelodysplastic syndromes and secondary leukemias and argue how metabolic changes in these cancers may not only be cell autonomous but also can emanate from the bone marrow stroma. Targeting this niche may open new avenues to reduce the risk for secondary leukemias in cancer survivors.	[Kunisaki, Yuya; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA; [Kunisaki, Yuya; Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Kunisaki, Yuya; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kunisaki, Y (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10467 USA.	paul.frenette@einstein.yu.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069438] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; Byrd DT, 2009, SEMIN CELL DEV BIOL, V20, P1107, DOI 10.1016/j.semcdb.2009.09.005; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480	12	23	25	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					864	865		10.1038/nm.2825	http://dx.doi.org/10.1038/nm.2825			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673997	Green Accepted			2022-12-27	WOS:000305116600022
J	Ardestani, A; Paroni, F; Azizi, Z; Kaur, S; Khobragade, V; Yuan, T; Frogne, T; Tao, WF; Oberholzer, J; Pattou, F; Conte, JK; Maedler, K				Ardestani, Amin; Paroni, Federico; Azizi, Zahra; Kaur, Supreet; Khobragade, Vrushali; Yuan, Ting; Frogne, Thomas; Tao, Wufan; Oberholzer, Jose; Pattou, Francois; Conte, Julie Kerr; Maedler, Kathrin			MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes	NATURE MEDICINE			English	Article							CASPASE-MEDIATED ACTIVATION; TRANSCRIPTION FACTOR PDX-1; PROTEIN-KINASE; PANCREATIC-ISLETS; MICE; PHOSPHORYLATION; SURVIVAL; PATHWAY; DEATH; HYPERTROPHY	Apoptotic cell death is a hallmark of the loss of insulin-producing beta cells in all forms of diabetes mellitus. Current treatments fail to halt the decline in functional beta cell mass, and strategies to prevent beta cell apoptosis and dysfunction are urgently needed. Here, we identified mammalian sterile 20-like kinase-1 (MST1) as a critical regulator of apoptotic beta cell death and function. Under diabetogenic conditions, MST1 was strongly activated in beta cells in human and mouse islets and specifically induced the mitochondrial-dependent pathway of apoptosis through upregulation of the BCL-2 homology-3 (BH3)-only protein BIM. MST1 directly phosphorylated the beta cell transcription factor PDX1 at T11, resulting in the latter's ubiquitination and degradation and thus in impaired insulin secretion. MST1 deficiency completely restored normoglycemia, beta cell function and survival in vitro and in vivo. We show MST1 as a proapoptotic kinase and key mediator of apoptotic signaling and beta cell dysfunction and suggest that it may serve as target for the development of new therapies for diabetes.	[Ardestani, Amin; Paroni, Federico; Azizi, Zahra; Kaur, Supreet; Khobragade, Vrushali; Yuan, Ting; Maedler, Kathrin] Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany; [Frogne, Thomas] Novo Nordisk AS, Dept Incretin & Islet Biol, As, Denmark; [Tao, Wufan] Fudan Univ, Inst Dev Biol & Mol Med, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Tao, Wufan] Fudan Univ, Inst Dev Biol & Mol Med, Natl Ctr Int Res Dev & Dis, Shanghai 200433, Peoples R China; [Oberholzer, Jose] Univ Illinois, Div Transplantat, Chicago, IL USA; [Pattou, Francois; Conte, Julie Kerr] Univ Lille, Lille Reg Hosp Ctr, European Genom Inst Diabet, INSERM Biotherapies Diabet U859, Lille, France	University of Bremen; Novo Nordisk; Fudan University; Fudan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Maedler, K (corresponding author), Univ Bremen, Ctr Biomol Interact Bremen, D-28359 Bremen, Germany.	ardestani.amin@gmail.com; kmaedler@uni-bremen.de	Azizi, Zahra/AAL-4334-2021; Azizi, Zahra/AAA-5276-2022; Azizi, Zahra/AAL-4359-2021; Maedler, Kathrin/ABE-3022-2021; Pattou, Francois/O-6151-2017	Azizi, Zahra/0000-0002-5456-6881; Maedler, Kathrin/0000-0002-7436-1197; Pattou, Francois/0000-0001-8388-3766; Ardestani, Amin/0000-0002-0685-8564	JDRF; German Research Foundation [MA4172/1-1]; European Research Council; German Federal Ministry of Science (Diabetes Competence Network); European Federation for the Study of Diabetes; University of Bremen; Juvenile Diabetes Research Foundation [31-2008-413]; US National Institutes of Health	JDRF(Juvenile Diabetes Research Foundation); German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Federal Ministry of Science (Diabetes Competence Network); European Federation for the Study of Diabetes; University of Bremen; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the JDRF, the German Research Foundation (Emmy Noether Programm MA4172/1-1), the European Research Council, the German Federal Ministry of Science (Diabetes Competence Network), the European Federation for the Study of Diabetes and University of Bremen Research Funds (all to K.M.). We thank J. Bergemann for excellent technical assistance, G. Dharmadhikari and M. Panse for help with the analyses and G. Rutter and D. Schumann for critical discussion. Human islets were provided through the Juvenile Diabetes Research Foundation award 31-2008-413 (European Consortium for Islet Transplantation Islets for Basic Research Program) and by the Integrated Islet Distribution Program. Human pancreatic sections were obtained from the National Disease Research Interchange, which is supported by the US National Institutes of Health. MST1 and dn-MST1 plasmids and adenoviruses were provided by J. Sadoshima and Y. Maejima (Rutgers New Jersey Medical School), PDX1-WT plasmids and pGEX bacterial expression vector by R. Walther (University of Greifswald), INS-1E cells by C. Wollheim (Lund and Geneva Universities), RIP-Cre mice by P. Herrera (University of Geneva) and A. Mansouri (Max Planck Institute for Biophysical Chemistry), mouse pB.RSV.PDX1-GFP plasmid by I. Leibiger (Karolinska University) and rat insulin-2 promoter plasmid by R. Zinkernagel (University of Zurich). Adenovirus carrying eGFP as a control was provided by A.E. Karlsen (Novo Nordisk A/S).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ardestani A, 2011, J BIOL CHEM, V286, P17144, DOI 10.1074/jbc.M110.210526; Arnoult D, 2008, METHODS, V44, P229, DOI 10.1016/j.ymeth.2007.11.003; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Carew RM, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-73; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Choi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008011; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Claiborn KC, 2010, J CLIN INVEST, V120, P3713, DOI 10.1172/JCI40440; Costes S, 2011, DIABETES, V60, P227, DOI 10.2337/db10-0522; Del Re DP, 2010, J CLIN INVEST, V120, P3555, DOI 10.1172/JCI43569; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dong YL, 2009, J IMMUNOL, V183, P3865, DOI 10.4049/jimmunol.0900678; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Frogne T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035233; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kakeya H, 1998, CANCER RES, V58, P4888; Kang HC, 2009, DIABETES TECHNOL THE, V11, P443, DOI 10.1089/dia.2008.0117; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kawano Y, 2012, DIABETES, V61, P1935, DOI 10.2337/db11-0770; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Lebrun P, 2005, J BIOL CHEM, V280, P38203, DOI 10.1074/jbc.M504842200; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Odashima M, 2007, CIRC RES, V100, P1344, DOI 10.1161/01.RES.0000265846.23485.7a; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Shu L, 2012, DIABETOLOGIA, V55, P3296, DOI 10.1007/s00125-012-2693-z; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; Trumper K, 2000, ANN NY ACAD SCI, V921, P242; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Ueda Y, 2012, PROC IUTAM, V5, P3, DOI 10.1016/j.piutam.2012.06.002; Valis K, 2011, CANCER RES, V71, P946, DOI 10.1158/0008-5472.CAN-10-2203; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Yun HJ, 2011, EMBO J, V30, P2465, DOI 10.1038/emboj.2011.152; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	69	140	146	3	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					385	+		10.1038/nm.3482	http://dx.doi.org/10.1038/nm.3482			16	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24633305	Green Accepted			2022-12-27	WOS:000334361500019
J	Rognoni, E; Widmaier, M; Jakobson, M; Ruppert, R; Ussar, S; Katsougkri, D; Bottcher, RT; Lai-Cheong, JE; Rifkin, DB; McGrath, JA; Fassler, R				Rognoni, Emanuel; Widmaier, Moritz; Jakobson, Madis; Ruppert, Raphael; Ussar, Siegfried; Katsougkri, Despoina; Boettcher, Ralph T.; Lai-Cheong, Joey E.; Rifkin, Daniel B.; McGrath, John A.; Faessler, Reinhard			Kindlin-1 controls Wnt and TGF-beta availability to regulate cutaneous stem cell proliferation	NATURE MEDICINE			English	Article							FOCAL ADHESION; COMPREHENSIVE GUIDE; HAIR-FOLLICLES; EXPRESSION; CATENIN; SKIN; BETA-1-INTEGRIN; ACTIVATION; GROWTH; CLASSIFICATION	Kindlin-1 is an integrin tail binding protein that controls integrin activation. Mutations in the FERMT-1 gene, which encodes for Kindlin-1, lead to Kindler syndrome in man, which is characterized by skin blistering, premature skin aging and skin cancer of unknown etiology. Here we show that loss of Kindlin-1 in mouse keratinocytes recapitulates Kindler syndrome and also produces enlarged and hyperactive stem cell compartments, which lead to hyperthickened epidermis, ectopic hair follicle development and increased skin tumor susceptibility. Mechanistically, Kindlin-1 controls keratinocyte adhesion through beta 1-class integrins and proliferation and differentiation of cutaneous epithelial stem cells by promoting alpha(nu)beta(6) integrin-mediated transforming growth factor-beta (TGF-beta) activation and inhibiting Wnt-beta-catenin signaling through integrin-independent regulation of Wnt ligand expression. Our findings assign Kindlin-1 the previously unknown and essential task of controlling cutaneous epithelial stem cell homeostasis by balancing TGF-beta-mediated growth-inhibitory signals and Wnt-beta-catenin-mediated growth-promoting signals.	[Rognoni, Emanuel; Widmaier, Moritz; Jakobson, Madis; Ruppert, Raphael; Ussar, Siegfried; Katsougkri, Despoina; Boettcher, Ralph T.; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Lai-Cheong, Joey E.] King Edward VII Hosp, Dept Dermatol, Windsor, England; [Lai-Cheong, Joey E.; McGrath, John A.] Kings Coll London, St Johns Inst Dermatol, London, England; [Rifkin, Daniel B.] NYU, Langone Sch Med, New York, NY USA	Max Planck Society; University of London; King's College London; New York University; NYU Langone Medical Center	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18A, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de	Ussar, Siegfried/AAL-4331-2021; Rognoni, Emanuel/M-3024-2019; McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	Ussar, Siegfried/0000-0001-7575-0920; Rognoni, Emanuel/0000-0001-6050-2860; McGrath, John/0000-0002-3708-9964	US National Institutes of Health [CA034282]; Wellcome Trust; UK National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' National Health Service Foundation Trust; King's College London; Advanced European Research Council (ERC) [322652]; Max Planck Society; NATIONAL CANCER INSTITUTE [R01CA034282] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); UK National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' National Health Service Foundation Trust; King's College London; Advanced European Research Council (ERC)(European Research Council (ERC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Polleux for generating gold nanoarrays, S. Bach for expert technical assistance, C. Mein (Barts and the London Genome Centre) for generating the human microarray data and R. Zent and R. Paus for carefully reading the manuscript. We thank M. Aumailley (University of Cologne), R. Grosschedl (Max Planck Institute (MPI) Immunobiology), S. Violette (Biogen Idec), D. Sheppard (University of California, San Francisco) and M. Wegner (University of Erlangen) for providing antibodies and I. Thesleff (University of Helsinki), R. Kageyama (Kyoto University), A. Kispert (University of Hannover) and J. Behrens (University of Erlangen) for sending essential constructs. This work was funded by the US National Institutes of Health (CA034282) to D.B.R., the Wellcome Trust (PhD studentship to J.E.L.-C.) and the UK National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St. Thomas' National Health Service Foundation Trust and King's College London to J.A.M., the Advanced European Research Council (ERC) Grant (ERC Grant Agreement 322652) and the Max Planck Society to R.F.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arita K, 2007, BRIT J DERMATOL, V157, P1252, DOI 10.1111/j.1365-2133.2007.08159.x; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Blummel J, 2007, BIOMATERIALS, V28, P4739, DOI 10.1016/j.biomaterials.2007.07.038; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brown JK, 2006, J HISTOCHEM CYTOCHEM, V54, P807, DOI 10.1369/jhc.5A6854.2006; Chaudhury A, 2009, IUBMB LIFE, V61, P929, DOI 10.1002/iub.239; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Dowling JJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-36; Emanuel Patrick O, 2006, Skinmed, V5, P305, DOI 10.1111/j.1540-9740.2006.05369.x; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Ferreira M, 2009, CANCER RES, V69, P1334, DOI 10.1158/0008-5472.CAN-08-3051; Fujiwara H, 2011, CELL, V144, P577, DOI 10.1016/j.cell.2011.01.014; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; He YH, 2011, AM J PATHOL, V178, P975, DOI 10.1016/j.ajpath.2010.11.053; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Lai-Cheong JE, 2009, BRIT J DERMATOL, V160, P233, DOI 10.1111/j.1365-2133.2008.08976.x; Lai-Cheong JE, 2009, AM J PATHOL, V175, P1431, DOI 10.2353/ajpath.2009.081154; Li L, 2011, CLIN CANCER RES, V17, P4936, DOI 10.1158/1078-0432.CCR-10-1499; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Montanez E, 2007, METHOD ENZYMOL, V426, P239, DOI 10.1016/S0076-6879(07)26012-4; Morales-Avila E, 2011, BIOCONJUGATE CHEM, V22, P913, DOI 10.1021/bc100551s; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Sin S, 2011, J NATL CANCER I, V103, P1323, DOI 10.1093/jnci/djr290; Sundberg JP, 1997, MOL CARCINOGEN, V20, P19, DOI 10.1002/(SICI)1098-2744(199709)20:1<19::AID-MC4>3.0.CO;2-D; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Watt FM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005124; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Woo WM, 2011, CELL, V146, P334, DOI 10.1016/j.cell.2011.07.001; Xie YS, 2012, J INVEST DERMATOL, V132, P547, DOI 10.1038/jid.2011.381; Yu Y, 2012, EMBO REP, V13, P750, DOI 10.1038/embor.2012.88; Zhang JW, 2006, STEM CELLS, V24, P2826, DOI 10.1634/stemcells.2005-0544; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	71	93	101	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					350	+		10.1038/nm.3490	http://dx.doi.org/10.1038/nm.3490			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24681597	Green Accepted, Green Submitted			2022-12-27	WOS:000334361500015
J	Kobayashi, E; Mizukoshi, E; Kishi, H; Ozawa, T; Hamana, H; Nagai, T; Nakagawa, H; Jin, AS; Kaneko, S; Muraguchi, A				Kobayashi, Eiji; Mizukoshi, Eishiro; Kishi, Hiroyuki; Ozawa, Tatsuhiko; Hamana, Hiroshi; Nagai, Terumi; Nakagawa, Hidetoshi; Jin, Aishun; Kaneko, Shuichi; Muraguchi, Atsushi			A new cloning and expression system yields and validates TCRs from blood lymphocytes of patients with cancer within 10 days	NATURE MEDICINE			English	Article							RECEPTOR GENE-THERAPY; EPSTEIN-BARR-VIRUS; SINGLE-CELL LEVEL; HEPATOCELLULAR-CARCINOMA; T-CELLS; ANTIGEN; IDENTIFICATION; REPERTOIRE; RETROVIRUS; REGRESSION	Antigen-specific T cell therapy, or T cell receptor (TCR) gene therapy, is a promising immunotherapy for infectious diseases and cancers. However, a suitable rapid and direct screening system for antigen-specific TCRs is not available. Here, we report an efficient cloning and functional evaluation system to determine the antigen specificity of TCR cDNAs derived from single antigen-specific human T cells within 10 d. Using this system, we cloned and analyzed 380 Epstein-Barr virus-specific TCRs from ten healthy donors with latent Epstein-Barr virus infection and assessed the activity of cytotoxic T lymphocytes (CTLs) carrying these TCRs against antigenic peptide-bearing target cells. We also used this system to clone tumor antigen-specific TCRs from peptide-vaccinated patients with cancer. We obtained 210 tumor-associated antigen-specific TCRs and demonstrated the cytotoxic activity of CTLs carrying these TCRs against peptide-bearing cells. This system may provide a fast and powerful approach for TCR gene therapy for infectious diseases and cancers.	[Kobayashi, Eiji; Kishi, Hiroyuki; Ozawa, Tatsuhiko; Hamana, Hiroshi; Nagai, Terumi; Jin, Aishun; Muraguchi, Atsushi] Toyama Univ, Dept Immunol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan; [Mizukoshi, Eishiro; Nakagawa, Hidetoshi; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Jin, Aishun] Harbin Med Univ, Coll Basic Med Sci, Harbin, Peoples R China	University of Toyama; Kanazawa University; Harbin Medical University	Kishi, H (corresponding author), Toyama Univ, Dept Immunol, Grad Sch Med & Pharmaceut Sci, Toyama 930, Japan.	immkishi@med.u-toyama.ac.jp		Kobayashi, Eiji/0000-0002-7303-2797; Nagai, Terumi/0000-0003-1603-2480; Ozawa, Tatsuhiko/0000-0002-3112-452X; Hamana, Hiroshi/0000-0002-6964-1020	Hokuriku Innovation Cluster for Health Science; Ministry of Education, Culture, Sports, Science and Technology in Japan [11F01415, 24650630]	Hokuriku Innovation Cluster for Health Science; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank S. Hirota, A. Takishita, K. Shitaoka and M. Horii for technical assistance and K. Hata for secretarial work. This research was supported by grants from the Hokuriku Innovation Cluster for Health Science and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan (11F01415 and 24650630). Retroviral pMX vector, pMX-IRES-EGFP vector and PLAT-E cell line were kindly provided by T. Kitamura (University of Tokyo), human CD8-expressing TG40 cell line by T. Ueno and C. Motozono (Kumamoto University) with permission from T. Saito (Riken), T2-A24 cell line by K. Kuzushima (Aichi Cancer Center Research Institute), Phoenix-A cell line by G. Nolan (Stanford University) and C1R-A24 cell line from M. Takiguchi (Kumamoto University).	ARGAET VP, 1994, J EXP MED, V180, P2335, DOI 10.1084/jem.180.6.2335; Butterfield LH, 2006, CLIN CANCER RES, V12, P2817, DOI 10.1158/1078-0432.CCR-05-2856; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Giudicelli V, 2004, NUCLEIC ACIDS RES, V32, pW435, DOI 10.1093/nar/gkh412; Goldstein A, 1964, BIOSTATISTICS INTRO; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kuzushima K, 2003, BLOOD, V101, P1460, DOI 10.1182/blood-2002-04-1240; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Lim A, 2000, J IMMUNOL, V165, P2001, DOI 10.4049/jimmunol.165.4.2001; Linnemann C, 2011, J INVEST DERMATOL, V131, P1806, DOI 10.1038/jid.2011.160; Miyahara Y, 2005, CLIN CANCER RES, V11, P5581, DOI 10.1158/1078-0432.CCR-04-2585; Mizukoshi E, 2006, INT J CANCER, V118, P1194, DOI 10.1002/ijc.21468; Mizukoshi E, 2006, HEPATOLOGY, V43, P1284, DOI 10.1002/hep.21203; Mizukoshi E, 2011, HEPATOLOGY, V53, P1206, DOI 10.1002/hep.24149; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Onishi M, 1996, EXP HEMATOL, V24, P324; Ozawa T, 2008, BIOCHEM BIOPH RES CO, V367, P820, DOI 10.1016/j.bbrc.2008.01.011; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Ueno T, 2004, J IMMUNOL, V173, P5451, DOI 10.4049/jimmunol.173.9.5451; Uttenthal BJ, 2012, J GENE MED, V14, P386, DOI 10.1002/jgm.2637; Zhou JH, 2004, J IMMUNOL, V173, P7622, DOI 10.4049/jimmunol.173.12.7622	26	63	74	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1542	+		10.1038/nm.3358	http://dx.doi.org/10.1038/nm.3358			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24121927				2022-12-27	WOS:000326920300034
J	Ward, PA				Ward, Peter A.			An endogenous factor mediates shock-induced injury	NATURE MEDICINE			English	Editorial Material							SEVERE SEPSIS; INFLAMMASOME; TRIAL; TLR4		Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@med.umich.edu						Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Darwiche SS, 2013, J TRAUMA ACUTE CARE, V74, P1454, DOI 10.1097/TA.0b013e3182905ed2; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; Huang H, 2013, J IMMUNOL, V191, P2665, DOI 10.4049/jimmunol.1202733; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Qiang XL, 2013, NAT MED, V19, P1489, DOI 10.1038/nm.3368; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x	11	12	12	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1368	1369		10.1038/nm.3387	http://dx.doi.org/10.1038/nm.3387			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202382				2022-12-27	WOS:000326920300011
J	Houghton, M				Houghton, Michael			Three isn't the magic number	NATURE MEDICINE			English	Editorial Material							NON-A; HEPATITIS		[Houghton, Michael] Univ Alberta, Edmonton, AB, Canada; [Houghton, Michael] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Houghton, Michael] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Houghton, M (corresponding author), Univ Alberta, Edmonton, AB, Canada.			Houghton, Michael/0000-0003-3762-6771				CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467	2	0	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2013	19	7					807	807		10.1038/nm0713-807	http://dx.doi.org/10.1038/nm0713-807			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836211				2022-12-27	WOS:000321557700012
J	[Anonymous]				[Anonymous]			A brighter future in the fight against hepatitis	NATURE MEDICINE			English	Editorial Material																		2013, N ENGL J MED, V368, P1685; 2012, HEPATOLOGY, V55, P1652; 2013, N ENGL J MED, V368, P1867	3	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2013	19	7					791	791		10.1038/nm.3269	http://dx.doi.org/10.1038/nm.3269			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	179YB	23836199	Bronze			2022-12-27	WOS:000321557700001
J	Aguirre-Ghiso, JA; Bragado, P; Sosa, MS				Aguirre-Ghiso, Julio A.; Bragado, Paloma; Sosa, Maria Soledad			Targeting dormant cancer	NATURE MEDICINE			English	Editorial Material							METASTASIS; CELLS; BONE		[Aguirre-Ghiso, Julio A.; Bragado, Paloma; Sosa, Maria Soledad] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Otolaryngol,Tisch Canc Inst, Div Hematol & Oncol,Dept Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Aguirre-Ghiso, JA (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Otolaryngol,Tisch Canc Inst, Div Hematol & Oncol,Dept Med, New York, NY 10029 USA.	julio.aguirre-ghiso@mssm.edu	Bragado Domingo, Paloma/A-8679-2015	Bragado Domingo, Paloma/0000-0002-7642-1245; Aguirre-Ghiso, Julio/0000-0002-6694-6507	NCI NIH HHS [R01 CA109182, U54 CA163131, CA109182, CA163131] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109182, U54CA163131] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adam AP, 2009, CANCER RES, V69, P5664, DOI 10.1158/0008-5472.CAN-08-3820; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Marshall JCA, 2012, JNCI-J NATL CANCER I, V104, P1306, DOI 10.1093/jnci/djs319; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Steeg PS, 2012, NATURE, V485, pS58, DOI 10.1038/485S58a; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Thompson VC, 2012, INT J CANCER, V131, P662, DOI 10.1002/ijc.26414; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	14	77	80	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					276	277		10.1038/nm.3120	http://dx.doi.org/10.1038/nm.3120			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23467238	Green Accepted			2022-12-27	WOS:000316040700019
J	Dendrou, CA; Bell, JI; Fugger, L				Dendrou, Calliope A.; Bell, John I.; Fugger, Lars			Weighing in on autoimmune disease	NATURE MEDICINE			English	Editorial Material							ANKYLOSING-SPONDYLITIS; SUSCEPTIBILITY LOCI; PSORIASIS	Modern medicine keeps unraveling new ways to investigate autoimmunity, leading to the production of boundless amounts of genetic, cellular and imaging data. Although the precision with which this information can define the etiology and mechanisms of a particular autoimmune disease is encouraging, much work lies ahead until all the knowledge acquired can be translated into the clinic. In 'Bedside to Bench', Calliope A. Dendrou, John I. Bell and Lars Fugger discuss the promises and limitations of genome-wide and next-generation genetic studies to provide further understanding of mechanisms driving autoimmune disorders and the role of experimental medicine in the new era of integrative clinical practice and personalized medicine. In 'Bench to Bedside', Lawrence Steinman argues the concept of a 'hub and spoke' pattern of T cell activation and organ targeting in multiple sclerosis, inflammatory bowel disease and type 1 diabetes. This paradigm suggests new ways to develop drugs to keep autoreactive T cells in the organ where activation occurs and preclude them from reaching the target organ and cause disease.	[Dendrou, Calliope A.; Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Bell, John I.] Univ Oxford, Off Regius Prof Med, Oxford, England; [Fugger, Lars] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council,Human Immunol Unit, Oxford OX3 9DU, England; [Fugger, Lars] Skejby Sygehus, Aarhus Univ Hosp, Inst Clin, DK-8200 Aarhus, Denmark	University of Oxford; University of Oxford; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford; Aarhus University	Dendrou, CA (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	lars.fugger@imm.ox.ac.uk		Dendrou, Calliope/0000-0003-1179-4021	Medical Research Council [G1000800i] Funding Source: researchfish; Medical Research Council [G1000800I] Funding Source: Medline; Wellcome Trust [100308] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Cortes A, 2012, ARTHRITIS RHEUM-US, V64, pS1053; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Kitley J, 2012, BRAIN, V135, P1834, DOI 10.1093/brain/aws109; Klareskog L, 2010, ANN RHEUM DIS, V69, P2062, DOI 10.1136/ard.2010.142109; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lewis T., 1944, LANCET, V243, P649; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	12	7	7	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	FEB	2013	19	2					138	139		10.1038/nm.3087	http://dx.doi.org/10.1038/nm.3087			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389608				2022-12-27	WOS:000314675900020
J	Kelso, A; Hurt, AC				Kelso, Anne; Hurt, Aeron C.			Drug-resistant influenza viruses: why fitness matters	NATURE MEDICINE			English	Editorial Material							OSELTAMIVIR-RESISTANT; TRANSMISSION; H1N1		[Kelso, Anne; Hurt, Aeron C.] WHO, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia	World Health Organization	Kelso, A (corresponding author), WHO, Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia.	Anne.Kelso@influenzacentre.org		Kelso, Anne/0000-0002-3166-3267; Hurt, Aeron/0000-0003-1826-4314				Bloom JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022201; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Hurt AC, 2011, NEW ENGL J MED, V365, P2541, DOI 10.1056/NEJMc1111078; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Lackenby A, 2011, EUROSURVEILLANCE, V16, P10; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Storms AD, 2012, EMERG INFECT DIS, V18, P308, DOI 10.3201/eid1802.111466; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132	14	28	30	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1470	1471		10.1038/nm.2954	http://dx.doi.org/10.1038/nm.2954			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042350				2022-12-27	WOS:000309587500019
J	Skokowa, J; Klimiankou, M; Klimenkova, O; Lan, D; Gupta, K; Hussein, K; Carrizosa, E; Kusnetsova, I; Li, ZX; Sustmann, C; Ganser, A; Zeidler, C; Kreipe, HH; Burkhardt, J; Grosschedl, R; Welte, K				Skokowa, Julia; Klimiankou, Maxim; Klimenkova, Olga; Lan, Dan; Gupta, Kshama; Hussein, Kais; Carrizosa, Esteban; Kusnetsova, Inna; Li, Zhixiong; Sustmann, Claudio; Ganser, Arnold; Zeidler, Cornelia; Kreipe, Hans-Heinrich; Burkhardt, Janis; Grosschedl, Rudolf; Welte, Karl			Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; SEVERE CONGENITAL NEUTROPENIA; ACUTE MYELOBLASTIC-LEUKEMIA; CELL-SPECIFIC PROTEIN-1; INDUCED TYROSINE PHOSPHORYLATION; ENHANCER FACTOR-I; FACTOR-RECEPTOR; HEMATOPOIETIC LINEAGE; HS1 PROTEIN; PROXIMITY LIGATION	We found that hematopoietic cell-specific Lyn substrate 1 (HCLS1 or HS1) is highly expressed in human myeloid cells and that stimulation with granulocyte colony-stimulating factor (G-CSF) leads to HCLS1 phosphorylation. HCLS1 binds the transcription factor lymphoid-enhancer binding factor 1 (LEF-1), transporting LEF-1 into the nucleus upon G-CSF stimulation and inducing LEF-1 autoregulation. In patients with severe congenital neutropenia, inherited mutations in the gene encoding HCLS1-associated protein X-1 (HAX1) lead to profound defects in G-CSF-triggered phosphorylation of HCLS1 and subsequently to reduced autoregulation and expression of LEF-1. Consistent with these results, HCLS1-deficient mice are neutropenic. In bone marrow biopsies of the majority of tested patients with acute myeloid leukemia, HCLS1 protein expression is substantially elevated, associated with high levels of G-CSF synthesis and, in some individuals, a four-residue insertion in a proline-rich region of HCLS1 protein known to accelerate intracellular signaling. These data demonstrate the importance of HCLS1 in myelopoiesis in vitro and in vivo.	[Skokowa, Julia; Klimiankou, Maxim; Klimenkova, Olga; Lan, Dan; Gupta, Kshama; Kusnetsova, Inna; Zeidler, Cornelia; Welte, Karl] Hannover Med Sch, Dept Mol Hematopoiesis, D-3000 Hannover, Germany; [Lan, Dan] GuangXi Med Univ, Affiliated Hosp 1, Dept Pediat, Nanning, Peoples R China; [Hussein, Kais; Kreipe, Hans-Heinrich] Hannover Med Sch, Dept Pathol, D-3000 Hannover, Germany; [Carrizosa, Esteban; Burkhardt, Janis] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Carrizosa, Esteban; Burkhardt, Janis] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Li, Zhixiong] Hannover Med Sch, Inst Expt Hematol, D-3000 Hannover, Germany; [Ganser, Arnold] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-3000 Hannover, Germany; [Sustmann, Claudio; Grosschedl, Rudolf] Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, Freiburg, Germany	Hannover Medical School; Guangxi Medical University; Hannover Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Hannover Medical School; Hannover Medical School; Max Planck Society	Skokowa, J (corresponding author), Hannover Med Sch, Dept Mol Hematopoiesis, D-3000 Hannover, Germany.	skokowa.julia@mh-hannover.de; Welte.Karl.H@mh-hannover.de	Skokowa, Julia/AAU-3622-2021; Gupta, Kshama/GRS-8778-2022	Skokowa, Julia/0000-0002-4399-2324; Burkhardt, Janis/0000-0002-8176-1375	German Jose Carreras Leukemia Foundation; REBIRTH Cluster of Excellence of the Hannover Medical School; Madeleine Schickedanz-KinderKrebs-Stiftung; Deutsche Forschungsgemeinschaft (DFG) [Li 1608/2-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088376] Funding Source: NIH RePORTER	German Jose Carreras Leukemia Foundation; REBIRTH Cluster of Excellence of the Hannover Medical School; Madeleine Schickedanz-KinderKrebs-Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Gigina, K. Cherkaoui, A. Muller Brechlin, M. Reuter and A.-L. Hagemann for technical assistance. We thank J. Klupp for assistance in generation of LEF-1 Ala16 mutant; D. D. Billadeau (Department of Immunology, Schulze Center for Novel Therapeutics, College of Medicine, Mayo Clinic) for providing us with the rabbit polyclonal HCLS1-specific antibody; L. Naldini (San Raffaele Telethon Institute for Gene Therapy, Division of Regenerative Medicine, Gene Therapy and Stem Cells, San Raffaele Institute) for pRRL.PPT.PGK.GFPpre vector; A. Schambach (Department of Experimental Hematology, Hannover Medical School) for VSVg envelope plasmid; Thomas J. Hope (University of Illinois at Chicago) for pRSV-Rev plasmid; and O. Tetsu (Department of Otolaryngology-Head and Neck Surgery, University of California-San Francisco) for the CCND1 reporter construct. We also thank the physicians within the Severe Chronic Neutropenia International Registry for providing patient material. We thank study subjects for their cooperation. This work was partially supported by German Jose Carreras Leukemia Foundation (J. S., M. K.), by REBIRTH Cluster of Excellence of the Hannover Medical School (J. S.), by Madeleine Schickedanz-KinderKrebs-Stiftung (J. S.), and by the Deutsche Forschungsgemeinschaft (Z.L.; DFG grant Li 1608/2-1).	Akbarzadeh S, 2002, BLOOD, V99, P879, DOI 10.1182/blood.V99.3.879; Al-Maghrebi M, 2002, NUCLEIC ACIDS RES, V30, P5017, DOI 10.1093/nar/gkf656; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Basu S, 2002, INT J MOL MED, V10, P3; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Brunati AM, 2005, J BIOL CHEM, V280, P21029, DOI 10.1074/jbc.M412634200; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Corey SJ, 1998, J BIOL CHEM, V273, P3230, DOI 10.1074/jbc.273.6.3230; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; Coyle-Rink J, 2002, CANCER BIOL THER, V1, P640, DOI 10.4161/cbt.313; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; ELSNER J, 1993, EXP HEMATOL, V21, P38; ERNST TJ, 1989, LEUKEMIA, V3, P620; Fonseca AV, 2010, J BIOL CHEM, V285, P31661, DOI 10.1074/jbc.M110.145037; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hagiwara S, 1998, INT J HEMATOL, V68, P387; Hao JJ, 2004, J BIOL CHEM, V279, P33413, DOI 10.1074/jbc.M313564200; Huang YP, 2008, BLOOD, V112, P111, DOI 10.1182/blood-2007-10-118232; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Ingley E, 2000, J BIOL CHEM, V275, P7887, DOI 10.1074/jbc.275.11.7887; Kahner BN, 2007, BLOOD, V110, P2449, DOI 10.1182/blood-2006-11-056069; Kendrick TS, 2007, FRONT BIOSCI-LANDMRK, V12, P591, DOI 10.2741/2085; KITAMURA D, 1989, NUCLEIC ACIDS RES, V17, P9367; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Luderer HF, 2011, J BIOL CHEM, V286, P18444, DOI 10.1074/jbc.M110.188219; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Otsuka J, 2004, ARTHRITIS RHEUM-US, V50, P871, DOI 10.1002/art.20192; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; Prieve MG, 1996, J BIOL CHEM, V271, P7654, DOI 10.1074/jbc.271.13.7654; Prieve MG, 1998, MOL CELL BIOL, V18, P4819, DOI 10.1128/MCB.18.8.4819; Scielzo C, 2005, J CLIN INVEST, V115, P1644, DOI 10.1172/JCI24276; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Suzuki Y, 1997, J IMMUNOL, V158, P2736; Takemoto Y, 1998, J IMMUNOL, V161, P625; TANIUCHI I, 1995, EMBO J, V14, P3664, DOI 10.1002/j.1460-2075.1995.tb00036.x; Timm A, 2005, CURR TOP MICROBIOL, V290, P225; Uruno T, 2003, BIOCHEM J, V371, P485, DOI 10.1042/BJ20021791; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; van Rossum AGSH, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-15; Ward AC, 1998, BBA-MOL CELL RES, V1448, P70, DOI 10.1016/S0167-4889(98)00120-7; Ward AC, 2000, LEUKEMIA, V14, P1284, DOI 10.1038/sj.leu.2401822; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; Welte K, 2006, SEMIN HEMATOL, V43, P189, DOI 10.1053/j.seminhematol.2006.04.004; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; YAMANASHI Y, 1993, P NATL ACAD SCI USA, V90, P3631, DOI 10.1073/pnas.90.8.3631; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387; YOUNG DC, 1987, J CLIN INVEST, V79, P100, DOI 10.1172/JCI112769; YOUNG DC, 1988, EXP HEMATOL, V16, P378; Zeidler C, 2009, BRIT J HAEMATOL, V144, P459, DOI 10.1111/j.1365-2141.2008.07425.x; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612; Zhu QS, 2004, BLOOD, V103, P3305, DOI 10.1182/blood-2003-06-1861	59	58	62	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1550	U157		10.1038/nm.2958	http://dx.doi.org/10.1038/nm.2958			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23001182	Green Accepted			2022-12-27	WOS:000309587500034
J	Okuno, Y; Nakamura-Ishizu, A; Otsu, K; Suda, T; Kubota, Y				Okuno, Yuji; Nakamura-Ishizu, Ayako; Otsu, Kinya; Suda, Toshio; Kubota, Yoshiaki			Pathological neoangiogenesis depends on oxidative stress regulation by ATM	NATURE MEDICINE			English	Article							OXYGEN-INDUCED RETINOPATHY; ATAXIA-TELANGIECTASIA; PROTEIN-KINASE; DNA-DAMAGE; TUMOR ANGIOGENESIS; HISTONE H2AX; MOUSE MODEL; MECHANISMS; CELLS; VEGF	The ataxia telangiectasia mutated (ATM) kinase, a master regulator of the DNA damage response (DDR), acts as a barrier to cellular senescence and tumorigenesis. Aside from DDR signaling, ATM also functions in oxidative defense. Here we show that Atm in mice is activated specifically in immature vessels in response to the accumulation of reactive oxygen species (ROS). Global or endothelial-specific Atm deficiency in mice blocked pathological neoangiogenesis in the retina. This block resulted from increased amounts of ROS and excessive activation of the mitogen activated kinase p38 alpha rather than from defects in the canonical DDR pathway. Atm deficiency also lowered tumor angiogenesis and enhanced the antiangiogenic action of vascular endothelial growth factor (Vegf) blockade. These data suggest that pathological neoangiogenesis requires ATM-mediated oxidative defense and that agents that promote excessive ROS generation may have beneficial effects in the treatment of neovascular disease.	[Okuno, Yuji; Kubota, Yoshiaki] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Nakamura-Ishizu, Ayako; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab, Dept Cell Differentiat, Tokyo, Japan; [Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka, Japan	Keio University; Keio University; Osaka University	Kubota, Y (corresponding author), Kings Coll London, Div Cardiovasc, London WC2R 2LS, England.	ykubo33@a3.keio.jp	Kubota, Yoshiaki/L-2231-2013; Suda, Toshio/H-6761-2013	Suda, Toshio/0000-0001-7540-1771; Okuno, Yuji/0000-0001-7345-4618	Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; AstraZeneca Virtual Research Institute Research Grant; Keio Kanrinmaru Project	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); AstraZeneca Virtual Research Institute Research Grant; Keio Kanrinmaru Project	We thank S. Kobayashi for outstanding technical support. We also thank F.W. Alt (Howard Hughes Medical Institute, Children's Hospital, Immune Disease Institute and Harvard Medical School) for providing Atm<SUP>flox/flox</SUP> mice, P.J. McKinnon (St. Jude Children's Research Hospital) for providing Atm<SUP>-/-</SUP> mice and H. Saya (Division of Gene Regulation, Keio University) for providing p53<SUP>-/-</SUP> mice. This work was supported by Grants-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by a research grant from Takeda Science Foundation, by the AstraZeneca Virtual Research Institute Research Grant and by the Keio Kanrinmaru Project.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BODER E, 1958, PEDIATRICS, V21, P526; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; GRANGER DN, 1995, ANNU REV PHYSIOL, V57, P311, DOI 10.1146/annurev.ph.57.030195.001523; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Hida K, 2005, CANCER RES, V65, P2507, DOI 10.1158/0008-5472.CAN-05-0002; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kubota Y, 2009, J EXP MED, V206, P1089, DOI 10.1084/jem.20081605; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P1205, DOI 10.1007/s00417-009-1116-4; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Pan H, 2004, INVEST OPHTH VIS SCI, V45, P2413, DOI 10.1167/iovs.03-1001; Ratner M, 2004, NAT BIOTECHNOL, V22, P1198, DOI 10.1038/nbt1004-1198; Raz-Prag D, 2011, AM J PATHOL, V179, P1533, DOI 10.1016/j.ajpath.2011.05.026; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Zha S, 2011, P NATL ACAD SCI USA, V108, P2028, DOI 10.1073/pnas.1019293108; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138; Zhang DW, 2004, ONCOGENE, V23, P8720, DOI 10.1038/sj.onc.1208153	46	111	113	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1208	+		10.1038/nm.2846	http://dx.doi.org/10.1038/nm.2846			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22797809				2022-12-27	WOS:000307469300026
J	Pal, D; Dasgupta, S; Kundu, R; Maitra, S; Das, G; Mukhopadhyay, S; Ray, S; Majumdar, SS; Bhattacharya, S				Pal, Durba; Dasgupta, Suman; Kundu, Rakesh; Maitra, Sudipta; Das, Gobardhan; Mukhopadhyay, Satinath; Ray, Sukanta; Majumdar, Subeer S.; Bhattacharya, Samir			Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance	NATURE MEDICINE			English	Article							SATURATED FATTY-ACIDS; FACTOR-KAPPA-B; ADIPOSE-TISSUE; OBESITY; EXPRESSION; INFLAMMATION; ADIPOCYTES; ADIPONECTIN; MECHANISMS; PATHWAY	Toll-like receptor 4 (TLR4) has a key role in innate immunity by activating an inflammatory signaling pathway. Free fatty acids (FFAs) stimulate adipose tissue inflammation through the TLR4 pathway, resulting in insulin resistance(1-7). However, current evidence suggests that FFAs do not directly bind to TLR4(8,9), but an endogenous ligand for TLR4 remains to be identified. Here we show that fetuin-A (FetA) could be this endogenous ligand and that it has a crucial role in regulating insulin sensitivity via Tlr4 signaling in mice. FetA (officially known as Ahsg) knockdown in mice with insulin resistance caused by a high-fat diet (HFD) resulted in downregulation of Tlr4-mediated inflammatory signaling in adipose tissue, whereas selective administration of FetA induced inflammatory signaling and insulin resistance. FFA-induced proinflammatory cytokine expression in adipocytes occurred only in the presence of both FetA and Tlr4; removing either of them prevented FFA-induced insulin resistance. We further found that FetA, through its terminal galactoside moiety, directly binds the residues of Leu100-Gly123 and Thr493-Thr516 in Tlr4. FFAs did not produce insulin resistance in adipocytes with mutated Tlr4 or galactoside-cleaved FetA. Taken together, our results suggest that FetA fulfills the requirement of an endogenous ligand for TLR4 through which lipids induce insulin resistance. This may position FetA as a new therapeutic target for managing insulin resistance and type 2 diabetes.	[Pal, Durba; Dasgupta, Suman; Kundu, Rakesh; Maitra, Sudipta; Bhattacharya, Samir] Visva Bharati, Sch Life Sci, Ctr Adv Studies Zool, Cellular & Mol Endocrinol Lab, Santini Ketan, W Bengal, India; [Dasgupta, Suman; Bhattacharya, Samir] NEIST, CSIR, Jorhat, Assam, India; [Das, Gobardhan] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Mukhopadhyay, Satinath] Seth Sukhlal Karnani Mem Hosp IPGME&R SSKM Hosp, Postgrad Inst Med Educ & Res, Dept Endocrinol & Metab, Kolkata, India; [Ray, Sukanta] IPGME&R SSKM Hosp, Div Surg Gastroenterol, Kolkata, India; [Majumdar, Subeer S.] Natl Inst Immunol, Div Cellular Endocrinol, New Delhi 110067, India	Visva Bharati University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Bhattacharya, S (corresponding author), Visva Bharati, Sch Life Sci, Ctr Adv Studies Zool, Cellular & Mol Endocrinol Lab, Santini Ketan, W Bengal, India.	bhattacharyasa@gmail.com	MAITRA, SUDIPTA/P-3858-2017; Kundu, Rakesh Kundu/AAC-3543-2019; Dasgupta, Suman/B-8808-2013; Kundu, Rakesh/AAG-2582-2021; Kundu, Rakesh/ABE-3083-2021	MAITRA, SUDIPTA/0000-0002-1167-9333; Kundu, Rakesh Kundu/0000-0001-8871-0565; Dasgupta, Suman/0000-0003-2599-2299; Mukhopadhyay, Satinath/0000-0001-8033-5748; Majumdar, Subeer/0000-0003-1724-7483	CSIR; Department of Science and Technology, Ministry of Science and Technology, New Delhi; CSIR, New Delhi; University Grants Commission (UGC), New Delhi; CSIR-NEIST	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Ministry of Science and Technology, New Delhi(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), New Delhi(University Grants Commission, India); CSIR-NEIST	This research was financially supported by a grant from the CSIR and Department of Science and Technology, Ministry of Science and Technology, New Delhi. We thank the National Centre for Cell Science, Pune, India, for providing the 3T3L1 cell line; A. Bandyopadhyay and S. Roy of the Indian Institute of Chemical Biology, Kolkata for their help in the confocal and SPR work, respectively. D.P. is thankful to CSIR, New Delhi, for the award of Senior Research Fellowship. S.D. thanks the University Grants Commission (UGC), New Delhi, for the award of a UGC-Dr. D.S. Kothari postdoctoral fellowship and CSIR-NEIST for a Quick Hire Fellowship. S.B. thanks the Indian National Science Academy for his Senior Scientist position. G.D. gratefully acknowledges the gift of Tlr4<SUP>-/-</SUP> mice from R. Medzhitov, Yale School of Medicine. The authors appreciate the use of facilities as extended to us by the head of the Department of Zoology, Visva-Bharati University, Santiniketan; the director of IICB, director of IPGME&R-SSKM Hospital, Kolkata; the director of the National Institute of Immunology, director of ICGEB, New Delhi and the director of NEIST, Jorhat, India.	Barata TS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002095; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; CAYATTE AJ, 1990, J BIOL CHEM, V265, P5883; Dasgupta S, 2011, BBA-MOL BASIS DIS, V1812, P495, DOI 10.1016/j.bbadis.2011.01.001; Dasgupta S, 2010, BIOCHEM J, V429, P451, DOI 10.1042/BJ20100330; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; de Luca C, 2006, NAT MED, V12, P41, DOI 10.1038/nm0106-41; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Erridge C, 2009, ARTERIOSCL THROM VAS, V29, P1944, DOI 10.1161/ATVBAHA.109.194050; Fessler MB, 2009, CURR OPIN LIPIDOL, V20, P379, DOI 10.1097/MOL.0b013e32832fa5c4; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ix JH, 2010, J AM SOC NEPHROL, V21, P406, DOI 10.1681/ASN.2009080820; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim JK, 2006, CELL METAB, V4, P417, DOI 10.1016/j.cmet.2006.11.008; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; Mathews ST, 2006, BIOCHEM BIOPH RES CO, V350, P437, DOI 10.1016/j.bbrc.2006.09.071; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mellgren RL, 2007, J BIOL CHEM, V282, P35868, DOI 10.1074/jbc.M706929200; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Orr JS, 2012, DIABETES, V61, P2718, DOI 10.2337/db11-1595; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Suganami T, 2017, BIOCH BIOPHYS RES CO, V354, P45; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	42	586	610	0	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1279	+		10.1038/nm.2851	http://dx.doi.org/10.1038/nm.2851			21	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22842477				2022-12-27	WOS:000307469300035
J	Bianchi, DW				Bianchi, Diana W.			From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges	NATURE MEDICINE			English	Review							GENE-EXPRESSION ANALYSIS; PLACENTAL MESSENGER-RNA; CELL-FREE DNA; PREGNANCY-ASSOCIATED MICRORNAS; AMNIOTIC-FLUID CELL; MATERNAL PLASMA; DOWN-SYNDROME; HYBRIDIZATION ACGH; OXIDATIVE STRESS; CHROMOSOMAL MICROARRAY	Thus far, the focus of personalized medicine has been the prevention and treatment of conditions that affect adults. Although advances in genetic technology have been applied more frequently to prenatal diagnosis than to fetal treatment, genetic and genomic information is beginning to influence pregnancy management. Recent developments in sequencing the fetal genome combined with progress in understanding fetal physiology using gene expression arrays indicate that we could have the technical capabilities to apply an individualized medicine approach to the fetus. Here I review recent advances in prenatal genetic diagnostics, the challenges associated with these new technologies and how the information derived from them can be used to advance fetal care. Historically, the goal of prenatal diagnosis has been to provide an informed choice to prospective parents. We are now at a point where that goal can and should be expanded to incorporate genetic, genomic and transcriptomic data to develop new approaches to fetal treatment.	[Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA; [Bianchi, Diana W.] Floating Hosp Children, Dept Pediat, Div Genet, Boston, MA USA	Tufts Medical Center; Floating Hospital For Children	Bianchi, DW (corresponding author), Tufts Med Ctr, Mother Infant Res Inst, Boston, MA USA.	dbianchi@tuftsmedicalcenter.org			US National Institutes of Health grant [HD42053-09]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042053] Funding Source: NIH RePORTER	US National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The author would like to thank D. Walt, E. Norwitz, J. Maron and L. Hui for their critical reading of the manuscript and their suggestions. In addition, she is grateful for the administrative support provided by R. Forman. The author's time and effort in writing this manuscript was partially supported by the US National Institutes of Health grant HD42053-09.	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; [Anonymous], 2009, Obstet Gynecol, V114, P1161, DOI 10.1097/AOG.0b013e3181c33cad; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Barrett A.N., 2012, CLIN CHEM; Beaudet AL, 2010, GENOME MED, V2, DOI 10.1186/gm163; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Benn PA, 2010, CURR OPIN OBSTET GYN, V22, P128, DOI 10.1097/GCO.0b013e3283372352; Benn PA, 2009, JAMA-J AM MED ASSOC, V301, P2154, DOI 10.1001/jama.2009.707; BENNETT PR, 1993, NEW ENGL J MED, V329, P607, DOI 10.1056/NEJM199308263290903; Bianchi DW, 2006, OBSTET GYNECOL, V107, P216, DOI 10.1097/01.AOG.0000199427.83503.d0; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Bianchi DW, 2010, EARLY HUM DEV, V86, P747, DOI 10.1016/j.earlhumdev.2010.08.001; Bianchi DW, 2006, J MATERN-FETAL NEO M, V19, P199, DOI 10.1080/14767050600676851; Bianchi DW, 2005, OBSTET GYNECOL, V106, P841, DOI 10.1097/01.AOG.0000179477.59385.93; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Bischoff FZ, 2005, HUM REPROD UPDATE, V11, P59, DOI 10.1093/humupd/dmh053; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Chiu RWK, 2006, CLIN CHEM, V52, P313, DOI 10.1373/clinchem.2005.059691; Chung IH, 2005, J KOREAN MED SCI, V20, P82, DOI 10.3346/jkms.2005.20.1.82; Clausen FB, 2012, TRANSFUSION, V52, P752, DOI 10.1111/j.1537-2995.2011.03362.x; Coppinger J, 2009, PRENATAL DIAG, V29, P1156, DOI 10.1002/pd.2371; D'Amours G, 2012, CLIN GENET, V81, P128, DOI 10.1111/j.1399-0004.2011.01687.x; Daniels G, 2010, CLIN LAB MED, V30, P431, DOI 10.1016/j.cll.2010.02.006; Deans Z, 2011, HEALTH CARE ANAL, V19, P122, DOI 10.1007/s10728-010-0146-8; Devaney SA, 2011, JAMA-J AM MED ASSOC, V306, P627, DOI 10.1001/jama.2011.1114; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Faas BHW, 2010, J MED GENET, V47, P586, DOI 10.1136/jmg.2009.075853; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2007, ANAL CHEM, V79, P7576, DOI 10.1021/ac0709394; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Ferguson-Smith MA, 2010, PRENATAL DIAG, V30, P601, DOI 10.1002/pd.2574; Finning KM, 2002, TRANSFUSION, V42, P1079, DOI 10.1046/j.1537-2995.2002.00165.x; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Friedman JM, 2009, PRENATAL DIAG, V29, P20, DOI 10.1002/pd.2129; Ghanta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013184; Gracie SK, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-87; Greely HT, 2011, NATURE, V469, P289, DOI 10.1038/469289a; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Hall A, 2010, PUBLIC HEALTH GENOM, V13, P246, DOI 10.1159/000279626; Harris RA, 2011, PRENATAL DIAG, V31, P932, DOI 10.1002/pd.2817; Hawkins AK, 2012, J GENET COUNS, V21, P367, DOI 10.1007/s10897-012-9488-8; Heung MMS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005858; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Hill M, 2011, PRENATAL DIAG, V31, P267, DOI 10.1002/pd.2680; Hui L, 2012, OBSTET GYNECOL, V119, P111, DOI 10.1097/AOG.0b013e31823d4150; Khoury MJ, 2009, GENET MED, V11, P559, DOI 10.1097/GIM.0b013e3181b13a6c; Kleeman L, 2009, PRENATAL DIAG, V29, P1213, DOI 10.1002/pd.2367; Koide K, 2011, HUM GENET, V129, P295, DOI 10.1007/s00439-010-0923-3; Kotlabova K, 2011, J REPROD IMMUNOL, V89, P185, DOI 10.1016/j.jri.2011.02.006; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larrabee PB, 2005, JAMA-J AM MED ASSOC, V293, P836, DOI 10.1001/jama.293.7.836; Liao GJW, 2011, CLIN CHEM, V57, P92, DOI 10.1373/clinchem.2010.154336; Lo YMD, 2009, BJOG-INT J OBSTET GY, V116, P152, DOI 10.1111/j.1471-0528.2008.02010.x; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; Lui YNYN, 2002, CLIN CHEM, V48, P421; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Lun FMF, 2011, CLIN CHEM, V57, P917, DOI 10.1373/clinchem.2011.161844; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Maron JL, 2007, J CLIN INVEST, V117, P3007, DOI 10.1172/JCI29959; Massingham LJ, 2011, J MOL DIAGN, V13, P565, DOI 10.1016/j.jmoldx.2011.05.008; Masuzaki H, 2004, J MED GENET, V41, P289, DOI 10.1136/jmg.2003.015784; Maya I, 2010, PRENATAL DIAG, V30, P1131, DOI 10.1002/pd.2626; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Miura K, 2008, PRENATAL DIAG, V28, P805, DOI 10.1002/pd.2056; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Miura K, 2010, PRENATAL DIAG, V30, P849, DOI 10.1002/pd.2570; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Ng EKO, 2003, P NATL ACAD SCI USA, V100, P4748, DOI 10.1073/pnas.0637450100; Okazaki S, 2007, OBSTET GYNECOL, V110, P1130, DOI 10.1097/01.AOG.0000286761.11436.67; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Papageorgiou EA, 2011, NAT MED, V17, P510, DOI 10.1038/nm.2312; Park JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-102; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Poon LLM, 2000, CLIN CHEM, V46, P1832; Purwosunu Y, 2007, PRENATAL DIAG, V27, P772, DOI 10.1002/pd.1780; Raca G, 2009, AM J MED GENET A, V149A, P2437, DOI 10.1002/ajmg.a.33083; Rozovski U, 2007, HUM REPROD, V22, P2538, DOI 10.1093/humrep/dem214; Schaeffer AJ, 2004, AM J HUM GENET, V74, P1168, DOI 10.1086/421250; Scheffer PG, 2011, BJOG-INT J OBSTET GY, V118, P1340, DOI 10.1111/j.1471-0528.2011.03028.x; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Sekizawa A, 2003, HUM GENET, V113, P307, DOI 10.1007/s00439-003-0987-4; Shaffer LG, 2008, PRENATAL DIAG, V28, P789, DOI 10.1002/pd.2053; Sitras V, 2009, REPROD SCI, V16, P701, DOI 10.1177/1933719109334256; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; Susman MR, 2010, GENET MED, V12, P298, DOI 10.1097/GIM.0b013e3181d5d022; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; Tsui NBY, 2010, CLIN CHEM, V56, P73, DOI 10.1373/clinchem.2009.132662; Tsui NBY, 2004, J MED GENET, V41, P461, DOI 10.1136/jmg.2003.016881; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482; Van den Veyver IB, 2009, PRENATAL DIAG, V29, P29, DOI 10.1002/pd.2127; Wapner R, 2012, AM J OBSTET GYNECOL, V206, pS2, DOI 10.1016/j.ajog.2011.10.027; Wolfberg AJ, 2006, NEW ENGL J MED, V355, P543, DOI 10.1056/NEJMp068079; Zana M, 2007, NEUROBIOL AGING, V28, P648, DOI 10.1016/j.neurobiolaging.2006.03.008	117	99	102	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1041	1051		10.1038/nm.2829	http://dx.doi.org/10.1038/nm.2829			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22772565	Green Accepted			2022-12-27	WOS:000306121600033
J	Clement, K; Gewirtz, A				Clement, Karine; Gewirtz, Andrew			Slimming down via the microbiota	NATURE MEDICINE			English	Editorial Material									[Clement, Karine] Univ Paris 06, Paris, France; [Clement, Karine] Inst Cardiometab & Nutr, Paris, France; [Gewirtz, Andrew] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University System of Georgia; Georgia State University	Clement, K (corresponding author), Univ Paris 06, Paris, France.		Clément, karine/R-1120-2017						0	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2013	19	11					1374	1375		10.1038/nm.3398	http://dx.doi.org/10.1038/nm.3398			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	251IF	24202385				2022-12-27	WOS:000326920300014
J	Maratos-Flier, E				Maratos-Flier, Eleftheria			Microbes, metabolism and medications	NATURE MEDICINE			English	Editorial Material							METFORMIN		Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol,Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Maratos-Flier, E (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol,Dept Med, Boston, MA 02215 USA.	emaratos@bidmc.harvard.edu						Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Borody TJ, 2012, GASTROENTEROL CLIN N, V41, P781, DOI 10.1016/j.gtc.2012.08.008; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322	12	6	6	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2013	19	10					1218	1219		10.1038/nm.3373	http://dx.doi.org/10.1038/nm.3373			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	232YW	24100983				2022-12-27	WOS:000325531700016
J	Wehrl, HF; Hossain, M; Lankes, K; Liu, CC; Bezrukov, I; Martirosian, P; Schickt, F; Reischl, G; Pichler, BJ				Wehrl, Hans F.; Hossain, Mosaddek; Lankes, Konrad; Liu, Chih-Chieh; Bezrukov, Ilja; Martirosian, Petros; Schickt, Fritz; Reischl, Gerald; Pichler, Bernd J.			Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales	NATURE MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RAT-BRAIN; GLUCOSE CONSUMPTION; BLOOD OXYGENATION; ANESTHETIZED RAT; BOLD FMRI; PLASTICITY; SIGNALS; PAIN; FLOW	Combined positron emission tomography (PET) and magnetic resonance imaging (MRI) is a new tool to study functional processes in the brain. Here we study brain function in response to a barrel-field stimulus simultaneously using PET, which traces changes in glucose metabolism on a slow time scale, and functional MRI (fMRI), which assesses fast vascular and oxygenation changes during activation. We found spatial and quantitative discrepancies between the PET and the fMRI activation data. The functional connectivity of the rat brain was assessed by both modalities: the fMRI approach determined a total of nine known neural networks, whereas the PET method identified seven glucose metabolism related networks. These results demonstrate the feasibility of combined PET-MRI for the simultaneous study of the brain at activation and rest, revealing comprehensive and complementary information to further decode brain function and brain networks.	[Wehrl, Hans F.; Hossain, Mosaddek; Lankes, Konrad; Liu, Chih-Chieh; Bezrukov, Ilja; Reischl, Gerald; Pichler, Bernd J.] Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Lankes, Konrad] Bruker BioSpin MRI, Ettlingen, Germany; [Bezrukov, Ilja] Max Planck Inst Intelligent Syst, Tubingen, Germany; [Martirosian, Petros; Schickt, Fritz] Univ Tubingen, Sect Expt Radiol, Dept Diagnost & Intervent Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Siemens AG; Bruker Corporation; Bruker BioSpin GmbH; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Pichler, BJ (corresponding author), Univ Tubingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany.	bernd.pichler@med.uni-tuebingen.de	Liu, Chih-Chieh/ABA-2011-2020; Pichler, Bernd J/B-4483-2012; Martirosian, Petros/AAA-8834-2019	Liu, Chih-Chieh/0000-0003-1968-8346; Schick, Fritz/0000-0002-4231-3406; Bezrukov, Ilja/0000-0003-0420-4329	German Research Foundation [Deutsche Forschungsgemeinschaft PI 771/1-1, PI 771/5-1]; Wilhelm Schuler-Foundation; Werner Siemens-Foundation	German Research Foundation(German Research Foundation (DFG)); Wilhelm Schuler-Foundation; Werner Siemens-Foundation	We thank F. Cay and M. Koenig for excellent technical support during this project. This study was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft PI 771/1-1, PI 771/5-1), the Wilhelm Schuler-Foundation and the Werner Siemens-Foundation.	Backes H, 2011, J NUCL MED, V52, P1252, DOI 10.2967/jnumed.110.085266; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bosshard SC, 2010, PAIN, V151, P655, DOI 10.1016/j.pain.2010.08.025; Buxton Richard B, 2010, Front Neuroenergetics, V2, P8, DOI 10.3389/fnene.2010.00008; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; Hjornevik T, 2008, PAIN, V140, P456, DOI 10.1016/j.pain.2008.09.029; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; Jonckers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018876; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Kennerley Aneurin J, 2010, Open Neuroimag J, V4, P1, DOI 10.2174/1874440001004010001; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kinahan PE, 1999, NEUROIMAGE, V9, P430, DOI 10.1006/nimg.1998.0420; Kornblum HI, 2000, NAT BIOTECHNOL, V18, P655, DOI 10.1038/76509; Koyama Y, 2004, PAIN, V107, P256, DOI 10.1016/j.pain.2003.11.007; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Paxinos G, 1998, RAT BRAIN STEROTAXIC; PHELPS ME, 1985, SCIENCE, V228, P799, DOI 10.1126/science.2860723; Ravasi L, 2011, NUCL MED COMMUN, V32, P336, DOI 10.1097/MNM.0b013e3283447292; Sanganahalli BG, 2008, NMR BIOMED, V21, P410, DOI 10.1002/nbm.1259; Schlemmer HPW, 2008, RADIOLOGY, V248, P1028, DOI 10.1148/radiol.2483071927; Shih YYI, 2011, J CEREBR BLOOD F MET, V31, P832, DOI 10.1038/jcbfm.2010.173; Shimoji K, 2004, J NUCL MED, V45, P665; Tran TD, 2010, PAIN, V150, P93, DOI 10.1016/j.pain.2010.04.001; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Wehrl HF, 2011, MAGN RESON MED, V65, P269, DOI 10.1002/mrm.22591; Yu X, 2012, NEUROIMAGE, V59, P1451, DOI 10.1016/j.neuroimage.2011.08.001; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	30	111	111	4	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2013	19	9					1184	1189		10.1038/nm.3290	http://dx.doi.org/10.1038/nm.3290			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	213TP	23975025				2022-12-27	WOS:000324083500036
J	Dobs, AS				Dobs, Adrian S.			A little better than placebo is still better than nothing	NATURE MEDICINE			English	Editorial Material								Doctors often dismiss drugs as ineffective if they fail to outperform dummy pills in randomized trials. That's a mistake. When active medicines have few side effects and produce a strong placebo effect, such drugs, even if they prove just slightly better than placebo, should be embraced for the relief they can bring to patients who have few safe alternatives.	[Dobs, Adrian S.] Johns Hopkins Univ, Sch Med, Johns Hopkins Clin Res Network, Baltimore, MD 21218 USA; [Dobs, Adrian S.] Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Reduct Canc Disparities, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Dobs, AS (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Clin Res Network, Baltimore, MD 21218 USA.	adobs@jhu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK079637] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006; Pae CU, 2010, EXPERT OPIN PHARMACO, V11, P185, DOI 10.1517/14656560903451708; Stearns V, 2003, JAMA-J AM MED ASSOC, V289, P2827, DOI 10.1001/jama.289.21.2827	3	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	2013	19	8					962	962		10.1038/nm0813-962	http://dx.doi.org/10.1038/nm0813-962			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23921736	Bronze			2022-12-27	WOS:000322779600014
J	Pajvani, UB; Qiang, L; Kangsamaksin, T; Kitajewski, J; Ginsberg, HN; Accili, D				Pajvani, Utpal B.; Qiang, Li; Kangsamaksin, Thaned; Kitajewski, Jan; Ginsberg, Henry N.; Accili, Domenico			Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR FOXO1; INSULIN-RESISTANCE; MAMMALIAN TARGET; PHOSPHORYLATION; LIPOGENESIS; PATHWAY; COMPLEX; LIVER; DIFFERENTIATION; GLUCONEOGENESIS	Increased hepatic lipid content is an early correlate of insulin resistance and can be caused by nutrient-induced activation of mammalian target of rapamycin (mTor). This activation of mTor increases basal Akt activity, leading to a self-perpetuating lipogenic cycle. We have previously shown that the developmental Notch pathway has metabolic functions in adult mouse liver. Acute or chronic inhibition of Notch dampens hepatic glucose production and increases Akt activity and may therefore be predicted to increase hepatic lipid content. Here we now show that constitutive liver-specific ablation of Notch signaling, or its acute inhibition with a decoy Notch1 receptor, prevents hepatosteatosis by blocking mTor complex 1 (mTorc1) activity. Conversely, Notch gain of function causes fatty liver through constitutive activation of mTorc1, an effect that is reversible by treatment with rapamycin. We demonstrate that Notch signaling increases mTorc1 complex stability, augmenting mTorc1 function and sterol regulatory element binding transcription factor 1c (Srebp1c)-mediated lipogenesis. These data identify Notch as a therapeutically actionable branch point of metabolic signaling at which Akt activation in the liver can be uncoupled from hepatosteatosis.	[Pajvani, Utpal B.; Qiang, Li; Ginsberg, Henry N.; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10027 USA; [Kangsamaksin, Thaned; Kitajewski, Jan] Columbia Univ, Dept Pathol, New York, NY USA; [Kangsamaksin, Thaned; Kitajewski, Jan] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA	Columbia University; Columbia University; Columbia University	Pajvani, UB (corresponding author), Columbia Univ, Dept Med, New York, NY 10027 USA.	up2104@columbia.edu; da230@columbia.edu		Qiang, Li/0000-0001-8322-1797	US National Institutes of Health [DK093604, DK57539, HL062454, DK63608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062454, R01HL112626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093604, P30DK063608, R01DK057539, P30DK026687] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health grants DK093604 (U.B.P.), DK57539 (D.A.), HL062454 (J.K.) and DK63608 (Columbia Diabetes Research Center). We thank D. Conlon, C. Eng, I. Goldberg, R. Haeusler and I. Tabas, as well as members of the Accili, Kitajewski and Ginsberg laboratories, for insightful discussion of the data. We acknowledge excellent technical support from A. Flete, T. Kolar and J. Lee, as well as plasmids from D. Sabatini (Whitehead Institute) and B. Spiegelman (Dana-Farber Cancer Institute).	Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227; Efferson CL, 2010, CANCER RES, V70, P2476, DOI 10.1158/0008-5472.CAN-09-3114; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Fujikura J, 2006, CELL METAB, V3, P59, DOI 10.1016/j.cmet.2005.12.005; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Funahashi Y, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-2; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Kim-Muller JY, 2011, SCIENCE, V331, P1529, DOI 10.1126/science.1204504; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Li GP, 2011, J LIPID RES, V52, P971, DOI 10.1194/jlr.M013748; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; OKA C, 1995, DEVELOPMENT, V121, P3291; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Savage DB, 2010, CURR OPIN LIPIDOL, V21, P329, DOI 10.1097/MOL.0b013e32833b7782; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Weinmaster G, 2006, DEVELOPMENT, V133, P3277, DOI 10.1242/dev.02515; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200	54	104	111	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1055	+		10.1038/nm.3259	http://dx.doi.org/10.1038/nm.3259			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23832089	Green Accepted			2022-12-27	WOS:000322779600032
J	Zhang, C; Large, MJ; Duggavathi, R; DeMayo, FJ; Lydon, JP; Schoonjans, K; Kovanci, E; Murphy, BD				Zhang, Cong; Large, Michael J.; Duggavathi, Raj; DeMayo, Francesco J.; Lydon, John P.; Schoonjans, Kristina; Kovanci, Ertug; Murphy, Bruce D.			Liver receptor homolog-1 is essential for pregnancy	NATURE MEDICINE			English	Article							UTERINE DECIDUALIZATION; SIGNALING PATHWAY; MOUSE; LOCALIZATION; EXPRESSION; PROLACTIN; LRH-1; WNT4	Successful pregnancy requires coordination of an array of signals and factors from multiple tissues. One such element, liver receptor homolog-1 (Lrh-1), is an orphan nuclear receptor that regulates metabolism and hormone synthesis(1). It is strongly expressed in granulosa cells of ovarian follicles and in the corpus luteum of rodents(2) and humans. Germline ablation of Nr5a2 (also called Lrh-1), the gene coding for Lrh-1, in mice is embryonically lethal at gastrulation(3). Depletion of Lrh-1 in the ovarian follicle shows that it regulates genes required for both steroid synthesis and ovulation(4) . To study the effects of Lrh-1 on mouse gestation, we genetically disrupted its expression in the corpus luteum, resulting in luteal insufficiency. Hormone replacement permitted embryo implantation but was followed by gestational failure with impaired endometrial decidualization, compromised placental formation, fetal growth retardation and fetal death. Lrh-1 is also expressed in the mouse and human endometrium, and in a primary culture of human endometrial stromal cells, reduction of NR5A2 transcript abundance by RNA interference abrogated decidualization. These findings show that Lrh-1 is necessary for maintenance of the corpus luteum, for promotion of decidualization and for formation of the placenta. It therefore has multiple, indispensible roles in establishing and sustaining pregnancy.	[Zhang, Cong; Murphy, Bruce D.] Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada; [Zhang, Cong] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Shandong, Peoples R China; [Large, Michael J.; DeMayo, Francesco J.; Lydon, John P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Duggavathi, Raj] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada; [Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland; [Kovanci, Ertug] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	Universite de Montreal; Shandong Normal University; Baylor College of Medicine; McGill University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Baylor College of Medicine	Murphy, BD (corresponding author), Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada.	bruce.d.murphy@umontreal.ca	DeMayo, Francesco/C-6255-2019; Duggavathi, Raj/GSJ-3503-2022	DeMayo, Francesco/0000-0002-9480-7336; Murphy, Bruce/0000-0001-7158-3360; Schoonjans, Kristina/0000-0003-1247-4265; Large, Michael/0000-0002-0170-3918; Zhang, Cong/0000-0002-9650-4398	Canadian Institutes of Health Research [OPG 11018]; National Natural Science Foundation of China [31172040]; Shangdong Natural Science Foundation [ZR2011CM047]; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation (SNF); Swiss Cancer League; US National Institutes of Health (NIH) [R01CA77530]; NIH [U54 HD07495-31, 5T32HD007165]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495, T32HD007165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA077530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047898] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shangdong Natural Science Foundation; Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Cancer League; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by OPG 11018 from the Canadian Institutes of Health Research to B.D.M. C.Z. was supported by the National Natural Science Foundation of China (31172040) and Shangdong Natural Science Foundation (ZR2011CM047). K.S. was supported by grants from the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation (SNF) and the Swiss Cancer League, J.P.L. by US National Institutes of Health (NIH) R01CA77530 and F.J.D. by NIH U54 HD07495-31. M.J.L. is supported by NIH 5T32HD007165. We are grateful to V. Roussel for preparation of the figures, M. Dobias for hormone analyses, S. Ruiz Orduna for human endometrial stromal cell line experiments, J. Fenelon and K. Bertolin for aid with transcript studies, L. Lian for aid with oviduct transfer, X. Tang for statistical analyses, L. Giudice for coordinating acquisition of human endometrium from the NIH-University of California at San Francisco (UCSF) Endometrium Tissue Bank and J. Auwerx for Nr5a2 floxed (Nr5a2<SUP>fl/fl</SUP>) mice.	Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Cartwright JE, 2010, REPRODUCTION, V140, P803, DOI 10.1530/REP-10-0294; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chalkiadaki A, 2005, MOL CELL BIOL, V25, P5095, DOI 10.1128/MCB.25.12.5095-5105.2005; Chop JH, 2008, J REPROD DEVELOP, V54, P408, DOI 10.1262/jrd.20045; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; Das SK, 2010, MOL REPROD DEV, V77, P387, DOI 10.1002/mrd.21133; Das SK, 2009, REPRODUCTION, V137, P889, DOI 10.1530/REP-08-0539; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Franco HL, 2011, FASEB J, V25, P1176, DOI 10.1096/fj.10-175349; Hinshelwood MM, 2003, MOL CELL ENDOCRINOL, V207, P39, DOI 10.1016/S0303-7207(03)00257-0; Huyen DV, 2011, REPRODUCTION, V142, P353, DOI 10.1530/REP-11-0060; Jimenez LM, 2010, J LIPID RES, V51, P2362, DOI 10.1194/jlr.M006973; Kessler CA, 2006, MOL HUM REPROD, V12, P71, DOI 10.1093/molehr/gal008; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Labelle-Dumais C, 2006, DEV DYNAM, V235, P3359, DOI 10.1002/dvdy.20996; Lee YK, 2008, FRONT BIOSCI, V13, P5950, DOI 10.2741/3128; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lynch VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006845; MARKOFF E, 1983, J CLIN ENDOCR METAB, V56, P962, DOI 10.1210/jcem-56-5-962; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Shaw Jillian M, 2002, Methods Mol Biol, V180, P229; Sheldon E, 2011, FERTIL STERIL, V95, P2120, DOI 10.1016/j.fertnstert.2011.01.164; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Tang MY, 2010, ENDOCRINOLOGY, V151, P1320, DOI 10.1210/en.2009-1081; Wang HB, 2006, AAPS J, V8, pE425; Yang FM, 2009, FEBS J, V276, P425, DOI 10.1111/j.1742-4658.2008.06785.x	31	75	79	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2013	19	8					1061	+		10.1038/nm.3192	http://dx.doi.org/10.1038/nm.3192			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	196ML	23817023	Green Accepted			2022-12-27	WOS:000322779600033
J	Ramos, P; Casu, C; Gardenghi, S; Breda, L; Crielaard, BJ; Guy, E; Marongiu, MF; Gupta, R; Levine, RL; Abdel-Wahab, O; Ebert, BL; Van Rooijen, N; Ghaffari, S; Grady, RW; Giardina, PJ; Rivella, S				Ramos, Pedro; Casu, Carla; Gardenghi, Sara; Breda, Laura; Crielaard, Bart J.; Guy, Ella; Marongiu, Maria Franca; Gupta, Ritama; Levine, Ross L.; Abdel-Wahab, Omar; Ebert, Benjamin L.; Van Rooijen, Nico; Ghaffari, Saghi; Grady, Robert W.; Giardina, Patricia J.; Rivella, Stefano			Macrophages support pathological erythropoiesis in polycythemia vera and beta-thalassemia	NATURE MEDICINE			English	Article							TYROSINE KINASE JAK2; INEFFECTIVE ERYTHROPOIESIS; STRESS ERYTHROPOIESIS; MOUSE MODEL; DICHLOROMETHYLENE DIPHOSPHONATE; ERYTHROBLASTIC ISLANDS; IRON OVERLOAD; BONE-MARROW; CELLS; MUTATION	Regulation of erythropoiesis is achieved by the integration of distinct signals. Among them, macrophages are emerging as erythropoietin-complementary regulators of erythroid development, particularly under stress conditions. We investigated the contribution of macrophages to physiological and pathological conditions of enhanced erythropoiesis. We used mouse models of induced anemia, polycythemia vera and beta-thalassemia in which macrophages were chemically depleted. Our data indicate that macrophages contribute decisively to recovery from induced anemia, as well as the pathological progression of polycythemia vera and b-thalassemia, by modulating erythroid proliferation and differentiation. We validated these observations in primary human cultures, showing a direct impact of macrophages on the proliferation and enucleation of erythroblasts from healthy individuals and patients with polycythemia vera or b-thalassemia. The contribution of macrophages to stress and pathological erythropoiesis, which we have termed stress erythropoiesis macrophage-supporting activity, may have therapeutic implications.	[Ramos, Pedro; Casu, Carla; Gardenghi, Sara; Breda, Laura; Crielaard, Bart J.; Guy, Ella; Marongiu, Maria Franca; Gupta, Ritama; Grady, Robert W.; Giardina, Patricia J.; Rivella, Stefano] Weill Cornell Med Coll, Dept Pediat, Div Hematol Oncol, New York, NY 10021 USA; [Levine, Ross L.; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Levine, Ross L.; Abdel-Wahab, Omar] Weill Cornell Med Coll, New York, NY USA; [Ebert, Benjamin L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA; [Van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Med Ctr, Amsterdam, Netherlands; [Ghaffari, Saghi] Mt Sinai Sch Med, Div Hematol Oncol, Dept Med, New York, NY USA; [Rivella, Stefano] Weill Cornell Med Coll, Dept Cell & Biol Dev, New York, NY USA	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Vrije Universiteit Amsterdam; Icahn School of Medicine at Mount Sinai; Cornell University	Rivella, S (corresponding author), Weill Cornell Med Coll, Dept Pediat, Div Hematol Oncol, New York, NY 10021 USA.	str2010@med.cornell.edu	levine, ross/AAE-7658-2019; Van Rooijen, Nico/Z-1578-2019; MARONGIU, MARIAFRANCA/AAC-3152-2021; Crielaard, Bart/K-9225-2014; Breda, Laura/T-3997-2017	MARONGIU, MARIAFRANCA/0000-0003-3363-8046; Crielaard, Bart/0000-0002-2289-2033; Rivella, Stefano/0000-0002-0938-6558; Breda, Laura/0000-0003-2133-4432; Abdel-Wahab, Omar/0000-0002-3907-6171	US National Institutes of Health [NIDDK-1R01DK090554, NIDDK-1R01DK095112]; European Community; Rofar (The Roche Foundation for Anemia Research); Children's Cancer and Blood Foundation; American Portuguese biomedical research fund (APBRF, USA)/Inova grant; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/24813/2005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095112, R01DK090554] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Rofar (The Roche Foundation for Anemia Research); Children's Cancer and Blood Foundation; American Portuguese biomedical research fund (APBRF, USA)/Inova grant; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. de Sousa and the members of the Pasta and Red Cells Society of New York for technical support and helpful discussions. In addition, we thank T. Ganz and E. Nemeth (University of California Los Angeles), R. Fleming (St. Louis University), C. Enns (Oregon Health and Science University) and N. Mohandas and Y. Ginzburg (New York Blood Center) for their very valuable expertise on iron metabolism and erythropoiesis and helpful discussions. This work was supported by the US National Institutes of Health (NIDDK-1R01DK090554 and NIDDK-1R01DK095112), FP7-HEALTH-2012-INNOVATION from the European Community, Rofar (The Roche Foundation for Anemia Research) and the Children's Cancer and Blood Foundation (S.R.), the American Portuguese biomedical research fund (APBRF, USA)/Inova grant (P.R.) and the Fundacao para a Ciencia e Tecnologia, Portugal (P.R., fellowship SFRH/BD/24813/2005). Hamp knockout mice were a gift from S. Vaulont (Institut National de la Sante et de la Recherche Medicale), S. Rivera and T. Ganz (University of California Los Angeles).	Angelillo-Scherrer A, 2008, J CLIN INVEST, V118, P583, DOI 10.1172/JCI30375; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BESSIS M, 1958, Rev Hematol, V13, P8; Cerdan C, 2004, BLOOD, V103, P2504, DOI 10.1182/blood-2003-07-2563; Cervi D, 2007, BLOOD, V109, P2139, DOI 10.1182/blood-2005-11-026823; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Gardenghi S, 2007, BLOOD, V109, P5027, DOI 10.1182/blood-2006-09-048868; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Giuliani AL, 2005, EUR J HAEMATOL, V75, P406, DOI 10.1111/j.1600-0609.2005.00521.x; Giuliani AL, 2001, EUR J HAEMATOL, V66, P221, DOI 10.1034/j.1600-0609.2001.066004221.x; HANSPAL M, 1994, BLOOD, V84, P3494; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Li HH, 2010, NAT MED, V16, P177, DOI 10.1038/nm.2073; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Liu XS, 2007, BLOOD, V110, P870, DOI 10.1182/blood-2007-01-068528; Longmore GD, 2006, J CLIN INVEST, V116, P626, DOI 10.1172/JCI27988; Melchiori L, 2010, ADV HEMATOL, V2010, DOI DOI 10.1155/2010/93864020508726; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Millot S, 2010, BLOOD, V116, P6072, DOI 10.1182/blood-2010-04-281840; Miyagawa S, 2000, BRIT J HAEMATOL, V109, P555, DOI 10.1046/j.1365-2141.2000.02047.x; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Porayette P, 2008, DEV BIOL, V317, P24, DOI 10.1016/j.ydbio.2008.01.047; Ramos E, 2012, BLOOD, V120, P3829, DOI 10.1182/blood-2012-07-440743; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Ramos P, 2011, BLOOD, V117, P1379, DOI 10.1182/blood-2010-09-307462; Rhodes MM, 2008, BLOOD, V111, P1700, DOI 10.1182/blood-2007-06-098178; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rivella S, 2009, CURR OPIN HEMATOL, V16, P187, DOI 10.1097/MOH.0b013e32832990a4; SADAHIRA Y, 1995, J EXP MED, V181, P411, DOI 10.1084/jem.181.1.411; Sadahira Y, 2000, J LEUKOCYTE BIOL, V68, P464; Santos FPS, 2011, BLOOD REV, V25, P53, DOI 10.1016/j.blre.2010.10.004; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; SEKI M, 1965, ACTA PATHOL JAPON, V15, P387; Shaked Y, 2005, BLOOD, V105, P4500, DOI 10.1182/blood-2004-08-3210; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Soni S, 2006, J BIOL CHEM, V281, P20181, DOI 10.1074/jbc.M603226200; SORENSEN S, 1990, BLOOD, V75, P1333; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Ulyanova T, 2011, BLOOD, V117, P975, DOI 10.1182/blood-2010-05-283218; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vemula S, 2010, BLOOD, V116, P4103, DOI 10.1182/blood-2010-01-262790; Verstovsek Srdan, 2009, Hematology Am Soc Hematol Educ Program, P636, DOI 10.1182/asheducation-2009.1.636; Wojchowski DM, 2006, BLOOD CELL MOL DIS, V36, P232, DOI 10.1016/j.bcmd.2006.01.007; WU H, 1995, NATURE, V377, P242, DOI 10.1038/377242a0; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964	62	163	167	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2013	19	4					437	+		10.1038/nm.3126	http://dx.doi.org/10.1038/nm.3126			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23502961	Green Accepted, Green Submitted			2022-12-27	WOS:000317109100028
J	Shi, LH; Cui, SY; Engel, JD; Tanabe, O				Shi, Lihong; Cui, Shuaiying; Engel, James D.; Tanabe, Osamu			Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction	NATURE MEDICINE			English	Article							NUCLEAR RECEPTORS; GLOBIN; MICE; TR2	Enhanced fetal gamma-globin synthesis alleviates symptoms of beta-globinopathies such as sickle cell disease and beta-thalassemia, but current gamma-globin-inducing drugs offer limited beneficial effects. We show here that lysine-specific demethylase 1 (LSD1) inhibition by RNAi in human erythroid cells or by the monoamine oxidase inhibitor tranylcypromine in human erythroid cells or beta-type globin-transgenic mice enhances gamma-globin expression. LSD1 is thus a promising therapeutic target for gamma-globin induction, and tranylcypromine may serve as a lead compound for the development of a new gamma-globin inducer.	[Shi, Lihong; Cui, Shuaiying; Engel, James D.; Tanabe, Osamu] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Tanabe, Osamu] Tohoku Univ, Tohoku Med Megabank, Dept Integrat Genom, Sendai, Miyagi 980, Japan	University of Michigan System; University of Michigan; Tohoku University	Engel, JD (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	engel@umich.edu; otanabe@umich.edu	Cui, Shuaiying/C-1154-2011	xing zhi, shi zhi/0000-0003-3289-5681	US National Institutes of Health [DK086956, HL24415]; American Heart Association postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health grants DK086956 (to O.T. and J.D.E.) and HL24415 (to J.D.E.) and an American Heart Association postdoctoral fellowship to L.S. We thank D. Giacherio and D. Harro for hemoglobin HPLC analysis; C. Yu, A.D. Campbell, K.C. Lim, T. Hosoya, B. Godfrey and M. Sierant for discussions, comments and technical assistance; and D. Lavelle and J. DeSimone for discussions regarding the inductive properties of decitabine. Lentiviruses were produced by the University of Michigan Vector Core. Microarray analysis was performed at the University of Michigan Microarray Core.	Banzon V, 2011, EXP HEMATOL, V39, P26, DOI 10.1016/j.exphem.2010.10.003; Buller AM, 1999, BLOOD CELL MOL DIS, V25, P255, DOI 10.1006/bcmd.1999.0252; Cui SAY, 2011, MOL CELL BIOL, V31, P3298, DOI 10.1128/MCB.05310-11; Eyer F, 2008, CLIN TOXICOL, V46, P261, DOI 10.1080/15563650601118085; Frieling H, 2006, EUR ARCH PSY CLIN N, V256, P268, DOI 10.1007/s00406-006-0660-8; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; MALLINGER AG, 1991, PSYCHOPHARMACOL BULL, V27, P493; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Parseval LAM, 2008, J CLIN INVEST, V118, P248, DOI 10.1172/JCI32322; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sprussel A, 2012, LEUKEMIA, V26, P2039, DOI 10.1038/leu.2012.157; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Testa U, 2009, ANN HEMATOL, V88, P505, DOI 10.1007/s00277-008-0637-y; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893; Xu J, 2011, SCIENCE, V334, P993, DOI 10.1126/science.1211053	20	125	149	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					291	294		10.1038/nm.3101	http://dx.doi.org/10.1038/nm.3101			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23416702	Green Accepted			2022-12-27	WOS:000316040700021
J	Huang, J; Nguyen-McCarty, M; Hexner, EO; Danet-Desnoyers, G; Klein, PS				Huang, Jian; Nguyen-McCarty, Michelle; Hexner, Elizabeth O.; Danet-Desnoyers, Gwenn; Klein, Peter S.			Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways	NATURE MEDICINE			English	Article							EX-VIVO EXPANSION; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; SELF-RENEWAL; WNT/BETA-CATENIN; PROGENITOR CELLS; QUIESCENCE; RECEPTOR; DEFECTS; REGENERATION	Hematopoietic stem cell (HSC) self renewal and lineage commitment depend on complex interactions with the microenvironment. The ability to maintain or expand HSCs for clinical applications or basic research has been substantially limited because these interactions are not well defined. Recent evidence suggests that HSCs reside in a low-perfusion, reduced-nutrient niche and that nutrient-sensing pathways contribute to HSC homeostasis. Here we report that suppression of the mTOR pathway, an established nutrient sensor, combined with activation of canonical Wnt-beta-catenin signaling, allows for the ex vivo maintenance of human and mouse long-term HSCs under cytokine-free conditions. We also show that the combination of two clinically approved medications that together activate Wnt-beta-catenin and inhibit mTOR signaling increases the number (but not the proportion) of long-term HSCs in vivo.	[Huang, Jian; Hexner, Elizabeth O.; Danet-Desnoyers, Gwenn; Klein, Peter S.] Univ Penn, Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA; [Nguyen-McCarty, Michelle; Klein, Peter S.] Univ Penn, Sch Med, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Hexner, Elizabeth O.] Univ Penn, Abramson Canc Ctr, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Klein, PS (corresponding author), Univ Penn, Sch Med, Dept Med Hematol Oncol, Philadelphia, PA 19104 USA.	pklein@mail.med.upenn.edu	Hexner, Elizabeth/AAC-1442-2020	Hexner, Elizabeth/0000-0002-1125-4060	Institute for Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania; US National Institutes of Health [1R21HL107968-01, 1R01HL110806-01, K99, 1K99HL10774701, 1-K23-HL-093366-01A1]; Leukemia and Lymphoma Society; University of Pennsylvania; Human Hematopoietic Stem Cell Center of Excellence at the Children's Hospital of Philadelphia [5P30DK090969-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093366, R01HL110806, R21HL107968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090969] Funding Source: NIH RePORTER	Institute for Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); University of Pennsylvania; Human Hematopoietic Stem Cell Center of Excellence at the Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank W. Tong, N. Speck, A. Bhandoola, A. Chi and H.-C. Huang for insightful comments and discussion. We also thank A. Bhandoola (University of Pennsylvania) for providing OP9 and OP9-DL1 cells. We thank J. Garskof, A. Christian and A. Mezochow for technical help and all members of the Klein lab for help and discussions. We specially thank A. Secreto and C. Keefer of the Stem Cell and Xenograft Core and Flow Cytometry and Cell Sorting Facility at the University of Pennsylvania for technical support. This study was supported by a grant from the Institute for Translational Medicine and Therapeutics (ITMAT) at the University of Pennsylvania and by grants from the US National Institutes of Health to P.S.K. (1R21HL107968-01 and 1R01HL110806-01). J.H. was supported by a Leukemia and Lymphoma Society Career Development Award and a K99 award from the US National Institutes of Health (1K99HL10774701). E.O.H. was supported by a grant from the US National Institutes of Health (1-K23-HL-093366-01A1). We also appreciate support from the Human Hematopoietic Stem Cell Center of Excellence (5P30DK090969-02) at the Children's Hospital of Philadelphia and the University of Pennsylvania.	Ballin A, 1998, BRIT J HAEMATOL, V100, P219, DOI 10.1046/j.1365-2141.1998.00537.x; BOGGS DR, 1983, SEMIN HEMATOL, V20, P129; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bowman Teresa V, 2009, Drug Discov Today Ther Strateg, V6, P135, DOI 10.1016/j.ddstr.2009.06.003; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chou S, 2010, CELL STEM CELL, V7, P427, DOI 10.1016/j.stem.2010.09.001; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000302; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Holmes Roxanne, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5156; Holmes T, 2008, STEM CELLS, V26, P1288, DOI 10.1634/stemcells.2007-0600; Huang J, 2009, J CLIN INVEST, V119, P3519, DOI 10.1172/JCI40572; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; KODAMA H, 1994, EXP HEMATOL, V22, P979; Krock B, 2011, CELL METAB, V13, P8, DOI 10.1016/j.cmet.2010.12.015; Luis TC, 2011, CELL STEM CELL, V9, P345, DOI 10.1016/j.stem.2011.07.017; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Miharada K, 2011, CELL STEM CELL, V9, P330, DOI 10.1016/j.stem.2011.07.016; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Polakis P, 2000, GENE DEV, V14, P1837; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zediak VP, 2007, BLOOD, V110, P1161, DOI 10.1182/blood-2007-01-071605; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	60	160	172	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1778	+		10.1038/nm.2984	http://dx.doi.org/10.1038/nm.2984			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142822	Green Accepted			2022-12-27	WOS:000311999800025
J	Robinson, HL; Amara, RR				Robinson, Harriet L.; Amara, Rama Rao			Protective immunity from a germinal center sanctuary	NATURE MEDICINE			English	Editorial Material							FOLLICULAR HELPER; T-CELLS; VACCINE	A new study provides mechanistic insights into how live attenuated simian immunodeficiency virus (SIV) vaccines (LAVs) can protect monkeys from infection with pathogenic SIV. The authors show that replicating LAVs stimulate a protective immune response from a safe haven in the germinal centers of lymph nodes (pages 1673-1681).	[Robinson, Harriet L.] Geovax, Smyrna, GA USA; [Amara, Rama Rao] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University	Robinson, HL (corresponding author), Geovax, Smyrna, GA USA.	hrobinson@geovax.com; ramara@emory.edu	Amara, Rama/AAO-8136-2021	Robinson, Harriet/0000-0001-6380-3458				Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Hong JJ, 2012, J IMMUNOL, V188, P3247, DOI 10.4049/jimmunol.1103138; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Vojnov L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023515	9	4	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1614	1616		10.1038/nm.2986	http://dx.doi.org/10.1038/nm.2986			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135510				2022-12-27	WOS:000310837000015
J	Wilson, RH; Maruoka, S; Whitehead, GS; Foley, JF; Flake, GP; Sever, ML; Zeldin, DC; Kraft, M; Garantziotis, S; Nakano, H; Cook, DN				Wilson, Rhonda H.; Maruoka, Shuichiro; Whitehead, Gregory S.; Foley, Julie F.; Flake, Gordon P.; Sever, Michelle L.; Zeldin, Darryl C.; Kraft, Monica; Garantziotis, Stavros; Nakano, Hideki; Cook, Donald N.			The Toll-like receptor 5 ligand flagellin promotes asthma by priming allergic responses to indoor allergens	NATURE MEDICINE			English	Article							ENDOTOXIN EXPOSURE; IMMUNE-RESPONSES; AIRWAY HYPERRESPONSIVENESS; BACTERIAL FLAGELLIN; INNATE; SALMONELLA; INTERLEUKIN-1-BETA; RADIORESISTANT; SENSITIZATION; INFLAMMATION	Allergic asthma is a complex disease characterized by eosinophilic pulmonary inflammation, mucus production and reversible airway obstruction(1). Exposure to indoor allergens is a risk factor for asthma, but this disease is also associated with high household levels of total and particularly Gram-negative bacteria(2). The ability of bacterial products to act as adjuvants(3) suggests they might promote asthma by priming allergic sensitization to inhaled allergens. In support of this idea, house dust extracts (HDEs) can activate antigen-presenting dendritic cells (DCs) in vitro and promote allergic sensitization to inhaled innocuous proteins in vivo(4). It is unknown which microbial products provide most of the adjuvant activity in HDEs. A screen for adjuvant activity of microbial products revealed that the bacterial protein flagellin (FLA) stimulated strong allergic airway responses to an innocuous inhaled protein, ovalbumin (OVA). Moreover, Toll-like receptor 5 (TLR5), the mammalian receptor for FLA(5,6), was required for priming strong allergic responses to natural indoor allergens present in HDEs. In addition, individuals with asthma have higher serum levels of FLA-specific antibodies as compared to nonasthmatic individuals. Together, these findings suggest that household FLA promotes the development of allergic asthma by TLR5-dependent priming of allergic responses to indoor allergens.	[Wilson, Rhonda H.; Maruoka, Shuichiro; Whitehead, Gregory S.; Foley, Julie F.; Flake, Gordon P.; Sever, Michelle L.; Zeldin, Darryl C.; Garantziotis, Stavros; Nakano, Hideki; Cook, Donald N.] NIEHS, Biol Res Lab, NIH, Res Triangle Pk, NC 27709 USA; [Maruoka, Shuichiro] Nihon Univ, Sch Med, Div Resp Med, Tokyo, Japan; [Kraft, Monica] Duke Univ, Med Ctr, Duke Asthma Allergy & Airway Ctr, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Nihon University; Duke University	Cook, DN (corresponding author), NIEHS, Biol Res Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	cookd@niehs.nih.gov	Cook, Donald/E-5079-2019; Garantziotis, Stavros/A-6903-2009; Zeldin, Darryl C/Y-7091-2018	Cook, Donald/0000-0002-0052-3755; Garantziotis, Stavros/0000-0003-4007-375X; Zeldin, Darryl C/0000-0002-2087-7307; Sever, Michelle/0000-0002-2435-1214	Intramural Research Program of the US National Institutes of Health NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIDES102465, ZIAES025041, ZIAES102025, ZIAES102605, ZICES102546] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Intramural Research Program of the US National Institutes of Health NIEHS. We thank the human subjects for their blood donations and B. Yingling, J. Marshburn and A. Rice of the NIEHS Clinical Research Unit and D. Beaver of Duke University for assistance with patient recruitment and serum isolation. J. Hollingsworth (Duke University) with permission from R. Medzhitov (Yale University) provided CD11c-Myd88 transgenic mice on a Myd88<SUP>-/-</SUP> background. S. Akira (Osaka University) provided Tlr2<SUP>-/-</SUP>, Tlr4<SUP>-/-</SUP> and Myd88<SUP>-/-</SUP> mice and J. Ting (University of North Carolina) provided Nlrc4<SUP>-/-</SUP> mice. D. Wozniak (Ohio State University) provided both strains of P. aeruginosa, F.-S. Shu (Wayne State University) provided purified FLA from P. aeruginosa and A. Gewirtz (Emory University) provided FLA from Escherichia coli. We also thank NIEHS members K. Nakano for genotyping, L. Perrow for mouse colony management, N. Flagler for histology, J. Aloor for measuring endotoxin levels in HDEs, M. Sifre and C. Bortner for help with FACS-based cell sorting, J. Ciencewicki for advice on airway epithelial cell culture and M. Fessler and S. London for suggestions on the manuscript.	Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Bolte G, 2003, CLIN EXP ALLERGY, V33, P770, DOI 10.1046/j.1365-2222.2003.01665.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Custovic A, 2011, J ALLERGY CLIN IMMUN, V127, P390, DOI 10.1016/j.jaci.2010.10.050; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Eder W, 2005, J ALLERGY CLIN IMMUN, V116, P601, DOI 10.1016/j.jaci.2005.05.003; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; El-Sharif N, 2006, J ASTHMA, V43, P241, DOI 10.1080/02770900600567122; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gehring U, 2004, ALLERGY, V59, P946, DOI 10.1111/j.1398-9995.2004.00551.x; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Janot L, 2009, EUR J IMMUNOL, V39, P1587, DOI 10.1002/eji.200838907; Karp CL, 2010, J ALLERGY CLIN IMMUN, V125, P955, DOI 10.1016/j.jaci.2010.03.002; Lam D, 2008, J IMMUNOL, V181, P2925, DOI 10.4049/jimmunol.181.4.2925; MCDONOUGH MW, 1976, MICROBIOS, V16, P49; Mckinley L, 2004, CLIN EXP IMMUNOL, V136, P224, DOI 10.1111/j.1365-2249.2004.02461.x; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Merx Sabine, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9409; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mijares LA, 2011, J IMMUNOL, V186, P7080, DOI 10.4049/jimmunol.1003687; Ng N, 2006, J ALLERGY CLIN IMMUN, V117, P1074, DOI 10.1016/j.jaci.2006.03.025; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Ross MA, 2000, ALLERGY, V55, P705, DOI 10.1034/j.1398-9995.2000.00551.x; Sanders CJ, 2008, J IMMUNOL, V180, P7184, DOI 10.4049/jimmunol.180.11.7184; Schulke S, 2011, J ALLERGY CLIN IMMUN, V128, P1340, DOI 10.1016/j.jaci.2011.07.036; Sever ML, 2007, J ALLERGY CLIN IMMUN, V120, P849, DOI 10.1016/j.jaci.2007.07.003; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Strindelius L, 2004, VACCINE, V22, P3797, DOI 10.1016/j.vaccine.2003.12.035; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	41	90	112	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2012	18	11					1705	+		10.1038/nm.2920	http://dx.doi.org/10.1038/nm.2920			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23064463	Green Accepted			2022-12-27	WOS:000310837000033
J	Krishnamoorthy, N; Khare, A; Oriss, TB; Raundhal, M; Morse, C; Yarlagadda, M; Wenzel, SE; Moore, ML; Peebles, RS; Ray, A; Ray, P				Krishnamoorthy, Nandini; Khare, Anupriya; Oriss, Timothy B.; Raundhal, Mahesh; Morse, Christina; Yarlagadda, Manohar; Wenzel, Sally E.; Moore, Martin L.; Peebles, R. Stokes, Jr.; Ray, Anuradha; Ray, Prabir			Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma	NATURE MEDICINE			English	Article							TRANSCRIPTION FACTOR GATA-3; MEDIATED DISEASE; BREAST-MILK; TH2 CELLS; EXPRESSION; DIFFERENTIATION; RESPONSES; IMMUNITY; INFANCY; ANTIGEN	Immune tolerance is instituted early in life, during which time regulatory T (T-reg) cells have an important role. Recurrent infections with respiratory syncytial virus (RSV) in early life increase the risk for asthma in adult life. Repeated infection of infant mice tolerized to ovalbumin (OVA) through their mother's milk with RSV induced allergic airway disease in response to OVA sensitization and challenge, including airway inflammation, hyper-reactivity and higher OVA-specific IgE, as compared to uninfected tolerized control mice. Virus infection induced GATA-3 expression and T helper type 2 (T(H)2) cytokine production in forkhead box P3 (FOXP3)(+) T-reg cells and compromised the suppressive function of pulmonary T-reg cells in a manner that was dependent on interleukin-4 receptor alpha (IL-4R alpha) expression in the host. Thus, by promoting a T(H)2-type inflammatory response in the lung, RSV induced a T(H)2-like effector phenotype in T-reg cells and attenuated tolerance to an unrelated antigen (allergen). Our findings highlight a mechanism by which viral infection targets a host-protective mechanism in early life and increases susceptibility to allergic disease.	[Krishnamoorthy, Nandini; Khare, Anupriya; Oriss, Timothy B.; Raundhal, Mahesh; Morse, Christina; Yarlagadda, Manohar; Wenzel, Sally E.; Ray, Anuradha; Ray, Prabir] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Raundhal, Mahesh; Ray, Anuradha; Ray, Prabir] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Moore, Martin L.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Peebles, R. Stokes, Jr.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; Children's Healthcare of Atlanta (CHOA); Vanderbilt University	Ray, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	raya@pitt.edu; rayp@pitt.edu		Wenzel, Sally/0000-0002-4242-0164	NIH [HL060207, AI093116, HL 077430, AI048927, U19 AI095227]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077430, R01HL060207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100012, R01AI048927, R01AI087798, R21AI093116, U19AI095227] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Shevach and G. Chattopadhyay (Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (NIH)) for providing spleens of OT-II x FOXP3-eGFP knock-in mice and J. Zhu (Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, NIH) for his efforts in identifying the source of these mice. DO11.10 transgenic mice were originally provided by K. Murphy (Washington University, St. Louis). This work was supported by NIH grants HL060207 and AI093116 (to P. R.), HL 077430 and AI048927 (to A. R.) and U19 AI095227 (to R.S.P.).	Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Domachowske JB, 1998, BIOTECHNIQUES, V25, P644, DOI 10.2144/98254dt01; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Forsthuber T, 1996, SCIENCE, V271, P1728, DOI 10.1126/science.271.5256.1728; Graham BS, 2000, IMMUNOPHARMACOLOGY, V48, P237, DOI 10.1016/S0162-3109(00)00233-2; Johnson TR, 1998, J VIROL, V72, P2871, DOI 10.1128/JVI.72.4.2871-2880.1998; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lukacs NW, 2006, AM J PATHOL, V169, P977, DOI 10.2353/ajpath.2006.051055; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Moore ML, 2007, J IMMUNOL, V178, P2651, DOI 10.4049/jimmunol.178.5.2651; Moore ML, 2009, J IMMUNOL, V183, P2016, DOI 10.4049/jimmunol.0803167; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Noble V, 1997, ARCH DIS CHILD, V76, P315, DOI 10.1136/adc.76.4.315; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; OPENSHAW PJM, 1995, AM J RESP CRIT CARE, V152, pS59, DOI 10.1164/ajrccm/152.4_Pt_2.S59; Oriss TB, 2005, J IMMUNOL, V174, P854, DOI 10.4049/jimmunol.174.2.854; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Ostroukhova TY, 2006, B EXP BIOL MED+, V141, P364, DOI 10.1007/s10517-006-0172-6; Polte T, 2008, CLIN EXP ALLERGY, V38, P1950, DOI 10.1111/j.1365-2222.2008.03096.x; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Ray A, 1999, J CLIN INVEST, V104, P985, DOI 10.1172/JCI8204; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Singleton R, 2003, J VIROL, V77, P11303, DOI 10.1128/JVI.77.21.11303-11311.2003; Sly PD, 2010, J ALLERGY CLIN IMMUN, V125, P1202, DOI 10.1016/j.jaci.2010.01.024; Takaki H, 2008, J BIOL CHEM, V283, P14955, DOI 10.1074/jbc.M801123200; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Verhasselt V, 2008, NAT MED, V14, P170, DOI 10.1038/nm1718; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Xu H, 2008, P NATL ACAD SCI USA, V105, P6690, DOI 10.1073/pnas.0708809105; Yung RL, 2008, AUTOIMMUNITY, V41, P329, DOI 10.1080/08916930802024889; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	52	172	180	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1525	U121		10.1038/nm.2896	http://dx.doi.org/10.1038/nm.2896			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22961107	Green Accepted			2022-12-27	WOS:000309587500031
J	Spudich, JA				Spudich, James A.			One path to understanding energy transduction in biological systems	NATURE MEDICINE			English	Editorial Material							ACTIN-FILAMENTS; MYOSIN SUBFRAGMENT-1; DICTYOSTELIUM; MOVEMENT; CONTRACTION; ACTOMYOSIN; MECHANISM; INVITRO; BEADS; MOTOR		Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Spudich, JA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	jspudich@stanford.edu			NIGMS NIH HHS [R01 GM033289] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; KERSEY YM, 1976, P NATL ACAD SCI USA, V73, P165, DOI 10.1073/pnas.73.1.165; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SHEETZ MP, 1983, NATURE, V303, P31, DOI 10.1038/303031a0; SPUDICH J, 1963, J BIOL CHEM, V238, P3106; SPUDICH JA, 1974, J BIOL CHEM, V249, P6013; SPUDICH JA, 1972, J MOL BIOL, V72, P619, DOI 10.1016/0022-2836(72)90180-5; SPUDICH JA, 1985, NATURE, V315, P584, DOI 10.1038/315584a0; Spudich JL, 2006, TRENDS MICROBIOL, V14, P480, DOI 10.1016/j.tim.2006.09.005; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0	18	10	10	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1478	1482		10.1038/nm.2924	http://dx.doi.org/10.1038/nm.2924			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23042356	Green Accepted			2022-12-27	WOS:000309587500021
J	McCurley, A; Pires, PW; Bender, SB; Aronovitz, M; Zhao, MJ; Metzger, D; Chambon, P; Hill, MA; Dorrance, AM; Mendelsohn, ME; Jaffe, IZ				McCurley, Amy; Pires, Paulo W.; Bender, Shawn B.; Aronovitz, Mark; Zhao, Michelle J.; Metzger, Daniel; Chambon, Pierre; Hill, Michael A.; Dorrance, Anne M.; Mendelsohn, Michael E.; Jaffe, Iris Z.			Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors	NATURE MEDICINE			English	Article							ANGIOTENSIN-II; GENE-TRANSCRIPTION; VASCULAR FUNCTION; MICE DEFICIENT; KNOCKOUT MICE; ALDOSTERONE; HYPERTENSION; TONE; SPIRONOLACTONE; DYSFUNCTION	Hypertension is a cardiovascular risk factor present in over two-thirds of people over age 60 in North America; elevated blood pressure correlates with increased risk of heart attack, stroke and progression to heart and kidney failure. Current therapies are insufficient to control blood pressure in almost half of these patients(1,2). The mineralocorticoid receptor (MR), acting in the kidney, is known to regulate blood pressure through aldosterone binding and stimulation of sodium retention(3). However, recent studies support the concept that the MR also has extrarenal actions(4-7) and that defects in sodium handling alone do not fully explain the development of hypertension and associated cardiovascular mortality(8,9). We and others have identified functional MR in human vascular smooth muscle cells (SMCs)(10,11), suggesting that vascular MR might directly regulate blood pressure. Here we show that mice with SMC-specific deficiency of the MR have decreased blood pressure as they age without defects in renal sodium handling or vascular structure. Aged mice lacking MR in SMCs (SMC-MR) have reduced vascular myogenic tone, agonist-dependent contraction and expression and activity of L-type calcium channels. Moreover, SMC-MR contributes to angiotensin II-induced vascular oxidative stress, vascular contraction and hypertension. This study identifies a new role for vascular MR in blood pressure control and in vascular aging and supports the emerging hypothesis that vascular tone contributes directly to systemic blood pressure.	[McCurley, Amy; Aronovitz, Mark; Mendelsohn, Michael E.; Jaffe, Iris Z.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Pires, Paulo W.; Dorrance, Anne M.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Bender, Shawn B.] Univ Missouri, Sch Med, Dept Internal Med, Columbia, MO USA; [Zhao, Michelle J.] Nova SE Univ, Coll Med Sci, Ft Lauderdale, FL 33314 USA; [Metzger, Daniel; Chambon, Pierre] Univ Strasbourg, Coll France, Inst Natl Sante & Rech Med, Inst Genet & Biol Mol & Cellulaire,Ctr Natl Rech, Illkirch Graffenstaden, France; [Hill, Michael A.] Univ Missouri, Sch Med, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Hill, Michael A.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Mendelsohn, Michael E.] Merck Res Labs, Rahway, NJ USA	Tufts Medical Center; Michigan State University; University of Missouri System; University of Missouri Columbia; Nova Southeastern University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Merck & Company	Jaffe, IZ (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA USA.	ijaffe@tuftsmedicalcenter.org	Hill, Michael/AAV-5350-2020; Pires, Paulo Wagner/I-8542-2014	Pires, Paulo Wagner/0000-0001-5972-4554; Metzger, Daniel/0000-0002-5555-046X; Hill, Michael/0000-0002-4455-2072; Dorrance, Anne/0000-0001-6573-2729	US National Institutes of Health [HL095590, HL092241, T32 HL069770]; American Heart Association [11GRNT7240000, 11POST7590096]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069770, R01HL095590] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Mouse Clinical Institute (Illkirch) for help in generating MR<SUP>f/f</SUP> mice, Y. Yang, A. Stupica and Z. Nourian for technical assistance, and J.D. Jaffe for assistance with figures. This work was supported by grants from the US National Institutes of Health (HL095590 to I.Z.J., HL092241 to M.A.H. and T32 HL069770) and the American Heart Association (11GRNT7240000 to I.Z.J. and 11POST7590096 to A.M.).	Ambroisine ML, 2007, CIRCULATION, V116, P2435, DOI 10.1161/CIRCULATIONAHA.107.722009; Berger S, 1998, P NATL ACAD SCI USA, V95, P9424, DOI 10.1073/pnas.95.16.9424; Berger S, 2000, KIDNEY INT, V57, P1295, DOI 10.1046/j.1523-1755.2000.00965.x; Bhargava A, 2004, MOL CELL ENDOCRINOL, V217, P189, DOI 10.1016/j.mce.2003.10.020; Cassis P, 2010, PFLUG ARCH EUR J PHY, V459, P325, DOI 10.1007/s00424-009-0725-4; Cat AND, 2010, FASEB J, V24, P2454, DOI 10.1096/fj.09-147926; Funder JW, 2009, MOL CELL ENDOCRINOL, V301, P2, DOI 10.1016/j.mce.2008.10.029; FUNDER JW, 1989, ENDOCRINOLOGY, V125, P2224, DOI 10.1210/endo-125-4-2224; Gradman AH, 2009, DRUG AGING, V26, P751, DOI 10.2165/11316790-000000000-00000; Id D, 2010, J CARDIOVASC SURG, V51, P721; Jaffe IZ, 2010, J CLIN INVEST, V120, P3891, DOI 10.1172/JCI40205; Jaffe IZ, 2005, CIRC RES, V96, P643, DOI 10.1161/01.RES.0000159937.05502.d1; Krug AW, 2010, HYPERTENSION, V55, P1476, DOI 10.1161/HYPERTENSIONAHA.109.148783; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Levy DG, 2004, J CLIN ENDOCR METAB, V89, P2736, DOI 10.1210/jc.2003-032149; Logan AG, 2011, EXPERT REV CARDIOVAS, V9, P113, DOI 10.1586/ERC.10.171; McCurley A, 2012, MOL CELL ENDOCRINOL, V350, P256, DOI 10.1016/j.mce.2011.06.014; Mendelsohn ME, 2005, J CLIN INVEST, V115, P840, DOI 10.1172/JCI200524806; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Newfell BG, 2011, ARTERIOSCL THROM VAS, V31, P1871, DOI 10.1161/ATVBAHA.111.229070; Pires PW, 2011, AM J PHYSIOL-HEART C, V301, pH87, DOI 10.1152/ajpheart.01206.2010; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poulsen CB, 2011, KIDNEY INT, V79, P443, DOI 10.1038/ki.2010.429; Rautureau Y, 2011, STEROIDS, V76, P834, DOI 10.1016/j.steroids.2011.02.015; Rigsby CS, 2007, MICROVASC RES, V73, P198, DOI 10.1016/j.mvr.2006.12.001; Rogerson FM, 2000, STEROIDS, V65, P61, DOI 10.1016/S0039-128X(99)00087-2; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Ronzaud C, 2011, AM J PHYSIOL-RENAL, V300, pF756, DOI 10.1152/ajprenal.00728.2009; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113; Wang WZ, 2011, J VASC RES, V48, P67, DOI 10.1159/000318776; Wendling O, 2009, GENESIS, V47, P14, DOI 10.1002/dvg.20448; Xue BJ, 2005, AM J PHYSIOL-HEART C, V288, pH2177, DOI 10.1152/ajpheart.00969.2004; Yang Y, 2009, J PHYSIOL-LONDON, V587, P3025, DOI 10.1113/jphysiol.2009.169920; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	40	233	236	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1429	+		10.1038/nm.2891	http://dx.doi.org/10.1038/nm.2891			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22922412	Green Accepted			2022-12-27	WOS:000308472300041
J	Purwar, R; Schlapbach, C; Xiao, S; Kang, HS; Elyaman, W; Jiang, XD; Jetten, AM; Khoury, SJ; Fuhlbrigge, RC; Kuchroo, VK; Clark, RA; Kupper, TS				Purwar, Rahul; Schlapbach, Christoph; Xiao, Sheng; Kang, Hong Soon; Elyaman, Wassim; Jiang, Xiaodong; Jetten, Anton M.; Khoury, Samia J.; Fuhlbrigge, Robert C.; Kuchroo, Vijay K.; Clark, Rachael A.; Kupper, Thomas S.			Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells	NATURE MEDICINE			English	Article							IN-VIVO; IL-9 PRODUCTION; T(H)17 CELLS; TGF-BETA; DIFFERENTIATION; RECEPTOR; CANCER; LUNG; IMMUNOTHERAPY; THERAPY	Interleukin-9 (IL-9) is a T cell cytokine that acts through a gamma C-family receptor on target cells and is associated with inflammation and allergy. We determined that T cells from mice deficient in the T helper type 17 (T(H)17) pathway genes encoding retinoid-related orphan receptor gamma (ROR-gamma) and IL-23 receptor (IL-23R) produced abundant IL-9, and we found substantial growth inhibition of B16F10 melanoma in these mice. IL-9-blocking antibodies reversed this tumor growth inhibition and enhanced tumor growth in wild-type (WT) mice. Il9r(-/-) mice showed accelerated tumor growth, and administration of recombinant IL-9 (rIL-9) to tumor-bearing WT and Rag1(-/-) mice inhibited melanoma as well as lung carcinoma growth. Adoptive transfer of tumor-antigen-specific T(H)9 cells into both WT and Rag1(-/-) mice suppressed melanoma growth; this effect was abrogated by treatment with neutralizing antibodies to IL-9. Exogenous rIL-9 inhibited tumor growth in Rag1(-/-) mice but not in mast-cell-deficient mice, suggesting that the targets of IL-9 in this setting include mast cells but not T or B cells. In addition, we found higher numbers of T(H)9 cells in normal human skin and blood compared to metastatic lesions of subjects with progressive stage IV melanoma. These results suggest a role for IL-9 in tumor immunity and offer insight into potential therapeutic strategies.	[Purwar, Rahul; Schlapbach, Christoph; Jiang, Xiaodong; Fuhlbrigge, Robert C.; Clark, Rachael A.; Kupper, Thomas S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Xiao, Sheng; Elyaman, Wassim; Khoury, Samia J.; Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Kang, Hong Soon; Jetten, Anton M.] NIEHS, Cell Biol Sect, NIH, Res Triangle Pk, NC 27709 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Kupper, TS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Dermatol, Boston, MA 02115 USA.	tkupper@partners.org	Schlapbach, Christoph/I-4608-2019; Jetten, Anton/C-3736-2019; Kupper, Thomas/O-4962-2019; Elyaman, Wassim/AAJ-1562-2021	Schlapbach, Christoph/0000-0003-0258-1243; Jetten, Anton/0000-0003-0954-4445; khoury, samia/0000-0003-3198-6063; Elyaman, Wassim/0000-0001-7238-374X	US National Institutes of Health [R01 AI-041707, R01 AI-097128, P50 CA-093683, R01-AR-056720, R03-MH-095529, Z01-ES-101586]; Skin Cancer Foundation; Swiss National Science Foundation; Foundation Rene Touraine; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI058680, R01AI097128, R01AI067472, R01AI041707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056720, R01AR065807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK090105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101586, ZIAES101586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH095529] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skin Cancer Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Rene Touraine; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from US National Institutes of Health to T.S.K. (R01 AI-041707, R01 AI-097128 and P50 CA-093683), R.A.C. (R01-AR-056720 and R03-MH-095529) and A.M.J. (Z01-ES-101586). R.P. received a Research Grant Award from The Skin Cancer Foundation. The authors thank K. Gerrish (US National Institutes of Health) with his help with the microarray analysis. J.-C. Renauld<SUP>39</SUP> (Ludwig Institute, Belgium) provided Il9r<SUP>-/-</SUP> mice and the corresponding control mice (Il9r<SUP>+/-</SUP>). Neutralizing antibodies to IL-9 (MM9C1) were a kind gift from J.v. Snick (Ludwig Institute, Belgium). Salary support for C.S. was provided by the Swiss National Science Foundation and the Foundation Rene Touraine and for R.A.C. from a Damon Runyon Clinical Investigator Award.	Amos SM, 2011, CANCER IMMUNOL IMMUN, V60, P671, DOI 10.1007/s00262-011-0984-8; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Jetten AM, 2006, AD DEV BIOL, V16, P313, DOI 10.1016/S1574-3349(06)16010-X; Kearley J, 2011, AM J RESP CRIT CARE, V183, P865, DOI 10.1164/rccm.200909-1462OC; Knoops L, 2004, GROWTH FACTORS, V22, P207, DOI 10.1080/08977190410001720879; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Ma HL, 2003, J IMMUNOL, V171, P608, DOI 10.4049/jimmunol.171.2.608; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Oldford SA, 2010, J IMMUNOL, V185, P7067, DOI 10.4049/jimmunol.1001137; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schumacher TNM, 2009, CURR OPIN IMMUNOL, V21, P187, DOI 10.1016/j.coi.2009.03.006; Smith SE, 2011, CANCER IMMUNOL IMMUN, V60, P1775, DOI 10.1007/s00262-011-1075-6; Steenwinckel V, 2007, J IMMUNOL, V178, P3244, DOI 10.4049/jimmunol.178.5.3244; Tilley SL, 2007, J IMMUNOL, V178, P3208, DOI 10.4049/jimmunol.178.5.3208; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yang XR, 2009, INT J CANCER, V125, P2912, DOI 10.1002/ijc.24622; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	39	289	317	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1248	+		10.1038/nm.2856	http://dx.doi.org/10.1038/nm.2856			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22772464	Green Accepted			2022-12-27	WOS:000307469300031
J	Dominici, N; Keller, U; Vallery, H; Friedli, L; van den Brand, R; Starkey, ML; Musienko, P; Riener, R; Courtine, G				Dominici, Nadia; Keller, Urs; Vallery, Heike; Friedli, Lucia; van den Brand, Rubia; Starkey, Michelle L.; Musienko, Pavel; Riener, Robert; Courtine, Gregoire			Versatile robotic interface to evaluate, enable and train locomotion and balance after neuromotor disorders	NATURE MEDICINE			English	Article							LUMBOSACRAL SPINAL-CORD; GAIT; RECOVERY; WALKING; INJURY; STROKE	Central nervous system (CNS) disorders distinctly impair locomotor pattern generation and balance, but technical limitations prevent independent assessment and rehabilitation of these subfunctions. Here we introduce a versatile robotic interface to evaluate, enable and train pattern generation and balance independently during natural walking behaviors in rats. In evaluation mode, the robotic interface affords detailed assessments of pattern generation and dynamic equilibrium after spinal cord injury (SCI) and stroke. In enabling mode, the robot acts as a propulsive or postural neuroprosthesis that instantly promotes unexpected locomotor capacities including overground walking after complete SCI, stair climbing following partial SCI and precise paw placement shortly after stroke. In training mode, robot-enabled rehabilitation, epidural electrical stimulation and monoamine agonists reestablish weight-supported locomotion, coordinated steering and balance in rats with a paralyzing SCI. This new robotic technology and associated concepts have broad implications for both assessing and restoring motor functions after CNS disorders, both in animals and in humans.	[Dominici, Nadia; Friedli, Lucia; van den Brand, Rubia; Musienko, Pavel; Courtine, Gregoire] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Dominici, Nadia; Friedli, Lucia; van den Brand, Rubia; Musienko, Pavel; Courtine, Gregoire] Swiss Fed Inst Technol, Sch Life Sci, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [Dominici, Nadia; Friedli, Lucia; van den Brand, Rubia; Musienko, Pavel; Courtine, Gregoire] Swiss Fed Inst Technol, Sch Life Sci, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Keller, Urs; Vallery, Heike; Riener, Robert] Swiss Fed Inst Technol, Inst Robot & Intelligent Syst, Sensory Motor Syst Lab, Zurich, Switzerland; [Vallery, Heike] Khalifa Univ, Dept Biomed Engn, Abu Dhabi, U Arab Emirates; [Starkey, Michelle L.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Starkey, Michelle L.; Riener, Robert] Univ Zurich, Balgrist Univ Hosp, Spinal Cord Injury Ctr, Zurich, Switzerland; [Musienko, Pavel] IP Pavlov Physiol Inst, St Petersburg 199034, Russia	University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Khalifa University of Science & Technology; University of Zurich; University of Zurich; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences	Courtine, G (corresponding author), Univ Zurich, Dept Neurol, Zurich, Switzerland.	gregoire.courtine@epfl.ch	Vallery, Heike/A-4254-2013; courtine, gregoire/AAJ-1694-2020; Riener, Robert/B-9868-2016; Musienko, Pavel/L-6677-2015	Vallery, Heike/0000-0002-0305-398X; courtine, gregoire/0000-0002-5744-4142; Keller, Urs/0000-0001-6615-6452; Dominici, Nadia/0000-0003-2312-915X; Musienko, Pavel/0000-0002-7324-9021	National Centers of Competence in Research "Neural Plasticity and Repair" and "Robotics" of the Swiss National Science Foundation; European Research Council [ERC 261247]; European Community's Seventh Framework Programme [CP-IP 258654]; Christopher and Dana Reeve Foundation; Swiss National Science Foundation [310030_130850]	National Centers of Competence in Research "Neural Plasticity and Repair" and "Robotics" of the Swiss National Science Foundation; European Research Council(European Research Council (ERC)European Commission); European Community's Seventh Framework Programme(European Commission); Christopher and Dana Reeve Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We would like to acknowledge the excellent technical help provided by J. Heutschi, N. Wenger, M. Hurlimann, Q. Barraud and S. Duis for data collection and care of the rats, as well as A.S. Tafreshi for the design of the user interface to control the robotic system and A. Brunschweiler, A. Rotta and M. Fritschi for the realization of the suspension system. This work was supported by the National Centers of Competence in Research "Neural Plasticity and Repair" and "Robotics" of the Swiss National Science Foundation, the European Research Council (ERC 261247, "Walk Again"), European Community's Seventh Framework Programme (CP-IP 258654, NeuWALK), the Christopher and Dana Reeve Foundation and the Swiss National Science Foundation (subside 310030_130850).	Ada L, 2010, J PHYSIOTHER, V56, P153, DOI 10.1016/S1836-9553(10)70020-5; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; COLGATE E, 1989, PROCEEDINGS - 1989 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOL 1-3, P404, DOI 10.1109/ROBOT.1989.100021; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Duschau-Wicke A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-43; Edgerton VR, 2009, BRAIN RES BULL, V78, P4, DOI 10.1016/j.brainresbull.2008.09.018; Frey M, 2006, IEEE T NEUR SYS REH, V14, P311, DOI 10.1109/TNSRE.2006.881556; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Hidler J, 2011, J REHABIL RES DEV, V48, P287, DOI 10.1682/JRRD.2010.05.0098; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Musienko P, 2011, J NEUROSCI, V31, P9264, DOI 10.1523/JNEUROSCI.5796-10.2011; Musselman K, 2011, NEUROREHAB NEURAL RE, V25, P285, DOI 10.1177/1545968310381250; Nessler JA, 2005, IEEE T NEUR SYS REH, V13, P497, DOI 10.1109/TNSRE.2005.858432; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; Pratt G., 1995, INT S EXP ROB, DOI 10.1.1.26.3136; Reinkensmeyer DJ, 2006, J REHABIL RES DEV, V43, P657, DOI 10.1682/JRRD.2005.04.0073; Shetty D., 2008, uS Patent, Patent No. [7,462,138, 7462138]; Timoszyk WK, 2005, BRAIN RES, V1050, P180, DOI 10.1016/j.brainres.2005.05.041; Vallery H, 2008, IEEE ROBOT AUTOM MAG, V15, P60, DOI 10.1109/MRA.2008.927689; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Wessels M, 2010, J REHABIL MED, V42, P513, DOI 10.2340/16501977-0525; Winter DA, 1993, PROG BRAIN RES, V97, P359, DOI 10.1016/s0079-6123(08)62295-5; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	26	77	84	3	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2012	18	7					1142	+		10.1038/nm.2845	http://dx.doi.org/10.1038/nm.2845			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22653117	Green Published, Green Submitted			2022-12-27	WOS:000306121600046
J	Xian, LL; Wu, XW; Pang, LJ; Lou, M; Rosen, CJ; Qiu, T; Crane, J; Frassica, F; Zhang, LM; Rodriguez, JP; Jia, XF; Yakar, S; Xuan, SH; Efstratiadis, A; Wan, M; Cao, X				Xian, Lingling; Wu, Xiangwei; Pang, Lijuan; Lou, Michael; Rosen, Clifford J.; Qiu, Tao; Crane, Janet; Frassica, Frank; Zhang, Liming; Pablo Rodriguez, Juan; Jia, Xiaofeng; Yakar, Shoshana; Xuan, Shouhong; Efstratiadis, Argiris; Wan, Mei; Cao, Xu			Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells	NATURE MEDICINE			English	Article							GROWTH-FACTOR-I; POSTMENOPAUSAL WOMEN; OSTEOBLAST PROGENITORS; INSULIN-RECEPTOR; LIFE-SPAN; OSTEOPOROSIS; RESORPTION; PHYSIOLOGY; FRACTURES; RELEVANCE	Insulin-like growth factor 1 (IGF-1), the most abundant growth factor in the bone matrix, maintains bone mass in adulthood. We now report that IGF-1 released from the bone matrix during bone remodeling stimulates osteoblastic differentiation of recruited mesenchymal stem cells (MSCs) by activation of mammalian target of rapamycin (mTOR), thus maintaining proper bone microarchitecture and mass. Mice with knockout of the IGF-1 receptor (Igf1r) in their pre-osteoblastic cells showed lower bone mass and mineral deposition rates than wild-type mice. Further, MSCs from Igf1r(flox/flox) mice with Igf1r deleted by a Cre adenovirus in vitro, although recruited to the bone surface after implantation, were unable to differentiate into osteoblasts. We also found that the concentrations of IGF-1 in the bone matrix and marrow of aged rats were lower than in those of young rats and directly correlated with the age-related decrease in bone mass. Likewise, in age-related osteoporosis in humans, we found that bone marrow IGF-1 concentrations were 40% lower in individuals with osteoporosis than in individuals without osteoporosis. Notably, injection of IGF-1 plus IGF binding protein 3 (IGFBP3), but not injection of IGF-1 alone, increased the concentration of IGF-1 in the bone matrix and stimulated new bone formation in aged rats. Together, these results provide mechanistic insight into how IGF-1 maintains adult bone mass, while also providing a further rationale for its therapeutic targeting to treat age-related osteoporosis.	[Xian, Lingling; Wu, Xiangwei; Pang, Lijuan; Lou, Michael; Qiu, Tao; Crane, Janet; Frassica, Frank; Zhang, Liming; Wan, Mei; Cao, Xu] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21218 USA; [Xian, Lingling; Wu, Xiangwei; Pang, Lijuan] Shihezi Univ, Sch Med, Shihezi, Xinjiang, Peoples R China; [Rosen, Clifford J.] Maine Med Ctr Res Inst, Ctr Clin & Translat Res, Scarborough, ME USA; [Crane, Janet] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Pablo Rodriguez, Juan] Univ Chile, INTA, Lab Biol Celular, Santiago, Chile; [Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Yakar, Shoshana] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, New York, NY USA; [Xuan, Shouhong; Efstratiadis, Argiris] Columbia Univ, Dept Genet & Dev, New York, NY USA	Johns Hopkins University; Shihezi University; Maine Medical Center; Johns Hopkins University; Universidad de Chile; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Columbia University	Cao, X (corresponding author), Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21218 USA.	xcao11@jhmi.edu	zhang, xu/GRX-9733-2022; Jia, Xiaofeng/B-2145-2008; zhang, xu/GYE-3558-2022; Sui, Yanwei/AAH-9928-2021; Zhang, Li/GWM-7501-2022; Rodríguez, J. Pablo/I-2155-2013	Jia, Xiaofeng/0000-0003-1445-8525; Crane, Janet/0000-0001-7713-0936	NIAMS/NIH [AR 053973]; US National Institutes of Health [T32DK007751v]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045433, K01AR060433, R01AR053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007751, R01DK057501, R01DK080898] Funding Source: NIH RePORTER	NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by grant AR 053973 (X.C.) from NIAMS/NIH. J.C. is supported by grant T32DK007751v from the US National Institutes of Health. The authors thank B.J. Canning (Asthma and Allergy Center, Johns Hopkins University) for providing guinea pig marrow cells.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Agnusdei D, 2005, J Endocrinol Invest, V28, P32; Amin S, 2007, J BONE MINER RES, V22, P799, DOI 10.1359/JBMR.070306; BAUTISTA CM, 1990, METABOLISM, V39, P96, DOI 10.1016/0026-0495(90)90154-5; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5; Boonen S, 2002, J CLIN ENDOCR METAB, V87, P1593, DOI 10.1210/jc.87.4.1593; Callewaert F, 2010, J ENDOCRINOL, V207, P127, DOI 10.1677/JOE-10-0209; CANALIS E, 1993, ENDOCRINOLOGY, V133, P33, DOI 10.1210/en.133.1.33; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; HAYDEN JM, 1995, BONE, V17, P93; Hill P A, 1998, Br J Orthod, V25, P101; Kuznetsov S, 1996, CALCIFIED TISSUE INT, V59, P265, DOI 10.1007/s002239900121; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Liu JM, 2008, J BONE MINER METAB, V26, P159, DOI 10.1007/s00774-007-0799-z; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Mohan S, 1997, ENDOCRINE, V7, P87, DOI 10.1007/BF02778070; Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015; Ohlsson C, 2011, J BONE MINER RES, V26, P865, DOI 10.1002/jbmr.281; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; PFEILSCHIFTER J, 1995, J CLIN INVEST, V96, P767, DOI 10.1172/JCI118121; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Schettler Andrea Elise, 2004, J Am Acad Nurse Pract, V16, P274, DOI 10.1111/j.1745-7599.2004.tb00450.x; Seck T, 1998, J CLIN ENDOCR METAB, V83, P2331, DOI 10.1210/jc.83.7.2331; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yakar S, 2005, ENDOCR DEV, V9, P11, DOI 10.1159/000085718; Yakar S, 2003, EXP BIOL MED, V228, P245, DOI 10.1177/153537020322800302; Yamaguchi T, 2006, CALCIFIED TISSUE INT, V78, P18, DOI 10.1007/s00223-005-0163-z; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Ziv E, 2011, AGEING RES REV, V10, P201, DOI 10.1016/j.arr.2010.09.002	40	400	424	3	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUL	2012	18	7					1095	+		10.1038/nm.2793	http://dx.doi.org/10.1038/nm.2793			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	970IM	22729283	Green Accepted			2022-12-27	WOS:000306121600039
J	Heger, M				Heger, Monica			Clinical trial website struggles to serve as research data hub	NATURE MEDICINE			English	News Item																		2012, JAMA, V307, P1838; 2012, JAMA, V307, P1861; 2012, BMJ, V344, P7373	3	3	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	JUN	2012	18	6					837	837		10.1038/nm0612-837	http://dx.doi.org/10.1038/nm0612-837			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	956VD	22673976	Bronze			2022-12-27	WOS:000305116600002
J	Suragani, RNVS; Cadena, SM; Cawley, SM; Sako, D; Mitchell, D; Li, R; Davies, MV; Alexander, MJ; Devine, M; Loveday, KS; Underwood, KW; Grinberg, AV; Quisel, JD; Chopra, R; Pearsall, RS; Seehra, J; Kumar, R				Suragani, Rajasekhar N. V. S.; Cadena, Samuel M.; Cawley, Sharon M.; Sako, Dianne; Mitchell, Dianne; Li, Robert; Davies, Monique V.; Alexander, Mark J.; Devine, Matthew; Loveday, Kenneth S.; Underwood, Kathryn W.; Grinberg, Asya V.; Quisel, John D.; Chopra, Rajesh; Pearsall, R. Scott; Seehra, Jasbir; Kumar, Ravindra			Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis	NATURE MEDICINE			English	Article							INEFFECTIVE ERYTHROPOIESIS; DIFFERENTIATION FACTOR; ACTIVIN-A; CELL PROLIFERATION; STEM-CELL; HEMATOPOIESIS; PROTEIN; STRESS; MICE; INHIBITION	Erythropoietin (EPO) stimulates proliferation of early-stage erythrocyte precursors and is widely used for the treatment of chronic anemia. However, several types of EPO-resistant anemia are characterized by defects in late-stage erythropoiesis(1,2), which is EPO independent(2,3). Here we investigated regulation of erythropoiesis using a ligand-trapping fusion protein (ACE-536) containing the extracellular domain of human activin receptor type IIB (ActRIIB) modified to reduce activin binding. ACE-536, or its mouse version RAP-536, produced rapid and robust increases in erythrocyte numbers in multiple species under basal conditions and reduced or prevented anemia in murine models. Unlike EPO, RAP-536 promoted maturation of late-stage erythroid precursors in vivo. Cotreatment with ACE-536 and EPO produced a synergistic erythropoietic response. ACE-536 bound growth differentiation factor-11 (GDF11) and potently inhibited GDF11-mediated Smad2/3 signaling. GDF11 inhibited erythroid maturation in mice in vivo and ex vivo. Expression of GDF11 and ActRIIB in erythroid precursors decreased progressively with maturation, suggesting an inhibitory role for GDF11 in late-stage erythroid differentiation. RAP-536 treatment also reduced Smad2/3 activation, anemia, erythroid hyperplasia and ineffective erythropoiesis in a mouse model of myelodysplastic syndromes (MDS). These findings implicate transforming growth factor-beta (TGF-beta) superfamily signaling in erythroid maturation and identify ACE-536 as a new potential treatment for anemia, including that caused by ineffective erythropoiesis.	[Suragani, Rajasekhar N. V. S.; Cadena, Samuel M.; Cawley, Sharon M.; Sako, Dianne; Mitchell, Dianne; Li, Robert; Davies, Monique V.; Alexander, Mark J.; Devine, Matthew; Loveday, Kenneth S.; Underwood, Kathryn W.; Grinberg, Asya V.; Quisel, John D.; Pearsall, R. Scott; Seehra, Jasbir; Kumar, Ravindra] Acceleron Pharma, Cambridge, MA 02139 USA; [Chopra, Rajesh] Celgene, Translat Dev Dept, San Francisco, CA USA	Acceleron Pharma; Bristol-Myers Squibb; Celgene Corporation	Kumar, R (corresponding author), Acceleron Pharma, Cambridge, MA 02139 USA.	rkumar@acceleronpharma.com		Suragani, Rajasekhar NVS/0000-0003-2754-1782	Protein Purification group at Acceleron Pharma; Preclinical Pharmacology group at Acceleron Pharma; Cell Biology group at Acceleron Pharma; Cancer Research UK [11566] Funding Source: researchfish	Protein Purification group at Acceleron Pharma; Preclinical Pharmacology group at Acceleron Pharma; Cell Biology group at Acceleron Pharma; Cancer Research UK(Cancer Research UK)	We thank J. Knopf for critical review and T. Ahern for editorial contributions. We acknowledge the Cell Biology, Protein Purification and Preclinical Pharmacology groups at Acceleron Pharma for their contributions in support of this work. We also thank G. Paradis and A. Parmelee for their assistance with flow cytometry. NUP98-HOXD13 MDS mice and age-matched FVB wild-type mice were obtained from P. Aplan's laboratory at the US National Institutes of Health. Inhbc<SUP>tm1Zuk</SUP> and Inhbc<SUP>tm2Zuk</SUP> mice were obtained from M. Matzuk, Baylor College of Medicine.	Akel S, 2003, STEM CELLS, V21, P557, DOI 10.1634/stemcells.21-5-557; Blank U, 2011, LEUKEMIA, V25, P1379, DOI 10.1038/leu.2011.95; BOWEN D, 1995, LEUKEMIA LYMPHOMA, V18, P243, DOI 10.3109/10428199509059614; BROXMEYER HE, 1988, P NATL ACAD SCI USA, V85, P9052, DOI 10.1073/pnas.85.23.9052; Cadena SM, 2010, J APPL PHYSIOL, V109, P635, DOI 10.1152/japplphysiol.00866.2009; Camaschella C, 2009, NAT GENET, V41, P386, DOI 10.1038/ng0409-386; Cao Antonio, 2011, Pediatr Rep, V3, pe17, DOI 10.4081/pr.2011.e17; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Ginzburg Y, 2011, BLOOD, V118, P4321, DOI 10.1182/blood-2011-03-283614; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Iancu-Rubin C, 2013, EXP HEMATOL, V41, P155, DOI 10.1016/j.exphem.2012.12.002; Ignotz RA, 2000, J CELL BIOCHEM, V78, P588, DOI 10.1002/1097-4644(20000915)78:4<588::AID-JCB8>3.0.CO;2-6; Jabbour E, 2008, CANCER-AM CANCER SOC, V112, P1089, DOI 10.1002/cncr.23280; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Lau AL, 2000, MOL CELL BIOL, V20, P6127, DOI 10.1128/MCB.20.16.6127-6137.2000; LEE HB, 1985, J NUCL MED, V26, P72; Libani IV, 2008, BLOOD, V112, P875, DOI 10.1182/blood-2007-12-126938; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Maguer-Satta W, 2003, EXP CELL RES, V282, P110, DOI 10.1016/S0014-4827(02)00013-7; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Rider CC, 2010, BIOCHEM J, V429, P1, DOI 10.1042/BJ20100305; Roy CN, 2007, BLOOD, V109, P4038, DOI 10.1182/blood-2006-10-051755; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Shav-Tal Y, 2002, STEM CELLS, V20, P493, DOI 10.1634/stemcells.20-6-493; Sherman ML, 2013, J CLIN PHARMACOL, V53, P1121, DOI 10.1002/jcph.160; Shiozaki M, 1998, BIOCHEM BIOPH RES CO, V242, P631, DOI 10.1006/bbrc.1997.8020; SHIOZAKI M, 1992, P NATL ACAD SCI USA, V89, P1553, DOI 10.1073/pnas.89.5.1553; Smith RE, 2010, AM J MANAG CARE, V16, pS59; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Soderberg SS, 2009, ANN NY ACAD SCI, V1176, P55, DOI 10.1111/j.1749-6632.2009.04569.x; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Tanno Toshihiko, 2010, Adv Hematol, V2010, P358283, DOI 10.1155/2010/358283; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; YU J, 1987, NATURE, V330, P765, DOI 10.1038/330765a0; Zhou L, 2008, BLOOD, V112, P3434, DOI 10.1182/blood-2008-02-139824	42	274	294	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2014	20	4					408	+		10.1038/nm.3512	http://dx.doi.org/10.1038/nm.3512			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	AE9WF	24658078				2022-12-27	WOS:000334361500021
J	Fullerton, MD; Galic, S; Marcinko, K; Sikkema, S; Pulinilkunnil, T; Chen, ZP; O'Neill, HM; Ford, RJ; Palanivel, R; O'Brien, M; Hardie, DG; Macaulay, SL; Schertzer, JD; Dyck, JRB; van Denderen, BJ; Kemp, BE; Steinberg, GR				Fullerton, Morgan D.; Galic, Sandra; Marcinko, Katarina; Sikkema, Sarah; Pulinilkunnil, Thomas; Chen, Zhi-Ping; O'Neill, Hayley M.; Ford, Rebecca J.; Palanivel, Rengasamy; O'Brien, Matthew; Hardie, D. Grahame; Macaulay, S. Lance; Schertzer, Jonathan D.; Dyck, Jason R. B.; van Denderen, Bryce J.; Kemp, Bruce E.; Steinberg, Gregory R.			Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; ACETYL-COA CARBOXYLASE-1; GLUCOSE-UPTAKE; HEPATIC GLUCONEOGENESIS; ENERGY-EXPENDITURE; AMPK; INHIBITION; RESISTANCE; IDENTIFICATION	The obesity epidemic has led to an increased incidence of nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. AMP-activated protein kinase (Ampk) regulates energy homeostasis and is activated by cellular stress, hormones and the widely prescribed type 2 diabetes drug metformin(1,2). Ampk phosphorylates mouse acetyl-CoA carboxylase 1 (Acc1; refs. 3,4) at Ser79 and Acc2 at Ser212, inhibiting the conversion of acetyl-CoA to malonyl-CoA. The latter metabolite is a precursor in fatty acid synthesis(5) and an allosteric inhibitor of fatty acid transport into mitochondria for oxidation(6). To test the physiological impact of these phosphorylation events, we generated mice with alanine knock-in mutations in both Acc1 (at Ser79) and Acc2 (at Ser212) (Acc double knock-in, AccDKI). Compared to wild-type mice, these mice have elevated lipogenesis and lower fatty acid oxidation, which contribute to the progression of insulin resistance, glucose intolerance and NAFLD, but not obesity. Notably, AccDKI mice made obese by high-fat feeding are refractory to the lipid-lowering and insulin-sensitizing effects of metformin. These findings establish that inhibitory phosphorylation of Acc by Ampk is essential for the control of lipid metabolism and, in the setting of obesity, for mefformin-induced improvements in insulin action.	[Fullerton, Morgan D.; Marcinko, Katarina; Sikkema, Sarah; O'Neill, Hayley M.; Ford, Rebecca J.; Palanivel, Rengasamy; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Div Endocrinol & Metab, Hamilton, ON, Canada; [Fullerton, Morgan D.; Marcinko, Katarina; Sikkema, Sarah; O'Neill, Hayley M.; Ford, Rebecca J.; Palanivel, Rengasamy; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Galic, Sandra; Chen, Zhi-Ping; O'Neill, Hayley M.; O'Brien, Matthew; van Denderen, Bryce J.; Kemp, Bruce E.; Steinberg, Gregory R.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Pulinilkunnil, Thomas; Dyck, Jason R. B.] Univ Alberta, Fac Med & Dent, Dept Pediat, Mazankowski Alberta Heart Inst,Cardiovasc Res Ctr, Edmonton, AB, Canada; [O'Neill, Hayley M.; O'Brien, Matthew; Kemp, Bruce E.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia; [Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Div Cell Signaling & Immunol, Dundee, Scotland; [Macaulay, S. Lance] CSIRO, Preventat Hlth Flagship, Parkville, Vic, Australia; [Schertzer, Jonathan D.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University; St. Vincent's Institute of Medical Research; University of Alberta; University of Melbourne; University of Dundee; Commonwealth Scientific & Industrial Research Organisation (CSIRO); McMaster University	Steinberg, GR (corresponding author), McMaster Univ, Dept Med, Div Endocrinol & Metab, Hamilton, ON, Canada.	gsteinberg@mcmaster.ca	Macaulay, Stuart Lance/A-6086-2008; Kemp, Bruce/G-9602-2019; Pulinilkunnil, Thomas/H-4387-2019; van Denderen, Bryce/AAW-5454-2021; Kemp, Bruce E/L-2633-2014; Pulinilkunnil, Thomas C/L-5511-2016; Galic, Sandra/C-6098-2014; Hardie, David/Z-1979-2019; RENGASAMY, PALANIVEL/GMW-4099-2022; Schertzer, Jonathan/P-3395-2017	Macaulay, Stuart Lance/0000-0001-5069-9516; Kemp, Bruce/0000-0001-6735-5082; Pulinilkunnil, Thomas/0000-0003-1228-893X; Kemp, Bruce E/0000-0001-6735-5082; Pulinilkunnil, Thomas C/0000-0003-1228-893X; Galic, Sandra/0000-0002-7611-5619; Schertzer, Jonathan/0000-0002-1547-5856; Hardie, Grahame/0000-0002-8373-7379; Steinberg, Gregory/0000-0001-5425-8275; O'Neill, Hayley/0000-0001-6812-6580; Dyck, Jason/0000-0002-7045-2884	Australian Research Council; Commonwealth Scientific and Industrial Research Organisation; Australian National Health and Medical Research Council; Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR); Victorian Government Operational Infrastructure Support Program; Canadian Foundation for Innovation; CIHR Banting Postdoctoral Fellowship; Canadian Diabetes Association Scholar Award	Australian Research Council(Australian Research Council); Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Canadian Diabetes Association; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Victorian Government Operational Infrastructure Support Program; Canadian Foundation for Innovation(Canada Foundation for Innovation); CIHR Banting Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association Scholar Award	We thank C. Saab from the McMaster Centre for Translational Imaging for completing the computed tomography analysis and S. Stypa and E. Day for technical assistance. This study was supported by grants and fellowships from the Australian Research Council and the Commonwealth Scientific and Industrial Research Organisation (B.E.K.), the Australian National Health and Medical Research Council (B.E.K., B.J.v.D. and G.R.S.), the Canadian Diabetes Association (G.R.S., J.R.B.D. and J.D.S.) and the Canadian Institutes of Health Research (CIHR) (G.R.S. and J.R.B.D.) and was supported in part by the Victorian Government Operational Infrastructure Support Program (B.E.K.) and the Canadian Foundation for Innovation (G.R.S.). M.D.F. is supported by a CIHR Banting Postdoctoral Fellowship, J.D.S. is supported by a Canadian Diabetes Association Scholar Award and G.R.S. holds a Canada Research Chair in Metabolism and Obesity.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Gomez-Samano MA, 2012, ENDOCR PRACT, V18, P8, DOI 10.4158/EP11072.OR; BAILEY CJ, 1994, BRIT J PHARMACOL, V111, P793, DOI 10.1111/j.1476-5381.1994.tb14807.x; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Harada N, 2007, MOL CELL BIOL, V27, P1881, DOI 10.1128/MCB.01122-06; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lalau JD, 2011, CLIN DRUG INVEST, V31, P435, DOI 10.2165/11588310-000000000-00000; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Natali A, 2006, DIABETOLOGIA, V49, P434, DOI 10.1007/s00125-006-0141-7; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Olson DP, 2010, P NATL ACAD SCI USA, V107, P7598, DOI 10.1073/pnas.0913492107; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	38	505	516	9	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1649	1654		10.1038/nm.3372	http://dx.doi.org/10.1038/nm.3372			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24185692	Green Accepted			2022-12-27	WOS:000328181400035
J	Jenkins, A				Jenkins, Annalisa			Advancing women in R&D will help accelerate medicine	NATURE MEDICINE			English	Editorial Material									Merck Serono, Res & Dev, Darmstadt, Germany	Merck KGaA; EMD Serono Inc.	Jenkins, A (corresponding author), Merck Serono, Res & Dev, Darmstadt, Germany.							Preston A, 2006, ACS SYM SER, V929, P129, DOI 10.1021/bk-2006-0929.ch010; U.S. Department of Labor, 2013, GEN FACTS WOM JOB BA	2	0	0	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2013	19	12					1559	1559		10.1038/nm1213-1559	http://dx.doi.org/10.1038/nm1213-1559			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	268OW	24309645	Bronze			2022-12-27	WOS:000328181400019
J	Diaz, LA; Polyak, K				Diaz, Luis A., Jr.; Polyak, Kornelia			Tracking tumor resistance using 'liquid biopsies'	NATURE MEDICINE			English	Editorial Material							ACQUIRED-RESISTANCE; PLASMA; DNA	Cancers are known to evolve in response to therapy, which may result in drug resistance. However, following this process in patients is challenging, as repeated biopsies of tumor tissue involves invasive procedures and tumor heterogeneity confounds interpretation of analyses. A recent study by Murtaza et al. 1 describes an approach to trace the genomic evolution of tumors in response to therapy by sampling circulating cell-free tumor DNA (ctDNA) from patient plasma at different time points during treatment. This strategy allowed the authors to detect mutations associated with therapy resistance. We asked three experts to comment on this study and its implications for studying and treating tumors in the clinic.	[Diaz, Luis A., Jr.] Johns Hopkins, Swim Across Amer Lab, Baltimore, MD 21218 USA; [Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Johns Hopkins University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Diaz, LA (corresponding author), Johns Hopkins, Swim Across Amer Lab, Baltimore, MD 21218 USA.			Diaz, Luis/0000-0002-7079-8914				Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Leary RJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004742; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066	14	25	25	1	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2013	19	6					676	677		10.1038/nm.3233	http://dx.doi.org/10.1038/nm.3233			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	158OK	23744147				2022-12-27	WOS:000319981600014
J	Bishai, W; Sullivan, Z; Bloom, BR; Andersen, P				Bishai, William; Sullivan, Zuri; Bloom, Barry R.; Andersen, Peter			Bettering BCG: a tough task for a TB vaccine?	NATURE MEDICINE			English	Editorial Material							TUBERCULOSIS VACCINE		[Bishai, William] KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Bishai, William] Johns Hopkins Univ, Baltimore, MD USA; [Sullivan, Zuri] K RITH, Durban, South Africa; [Bloom, Barry R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Andersen, Peter] Univ Copenhagen, Copenhagen, Denmark; [Andersen, Peter] Statens Serum Inst, DK-2300 Copenhagen, Denmark	Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; University of Copenhagen; Statens Serum Institut	Bishai, W (corresponding author), KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa.			Sullivan, Zuri/0000-0002-6111-6512; Andersen, Peter/0000-0002-5869-2551				Andrews JR, 2013, AM J EPIDEMIOL, V177, P556, DOI 10.1093/aje/kws331; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Scriba TJ, 2011, J INFECT DIS, V203, P1832, DOI 10.1093/infdis/jir195; Tameris MD, 2013, LANCET; Teles R.M., 2013, SCIENCE; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264	9	21	24	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2013	19	4					410	411		10.1038/nm.3153	http://dx.doi.org/10.1038/nm.3153			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23558628				2022-12-27	WOS:000317109100022
J	Hailemichael, Y; Dai, ZM; Jaffarzad, N; Ye, Y; Medina, MA; Huang, XF; Dorta-Estremera, SM; Greeley, NR; Nitti, G; Peng, WY; Liu, CW; Lou, YY; Wang, ZQ; Ma, WC; Rabinovich, B; Schluns, KS; Davis, RE; Hwu, P; Overwijk, WW				Hailemichael, Yared; Dai, Zhimin; Jaffarzad, Nina; Ye, Yang; Medina, Miguel A.; Huang, Xue-Fei; Dorta-Estremera, Stephanie M.; Greeley, Nathaniel R.; Nitti, Giovanni; Peng, Weiyi; Liu, Chengwen; Lou, Yanyan; Wang, Zhiqiang; Ma, Wencai; Rabinovich, Brian; Schluns, Kimberly S.; Davis, Richard E.; Hwu, Patrick; Overwijk, Willem W.			Persistent antigen at vaccination sites induces tumor-specific CD8(+) T cell sequestration, dysfunction and deletion	NATURE MEDICINE			English	Article							CHRONIC VIRAL-INFECTION; LONG PEPTIDE VACCINE; MELANOMA PATIENTS; IMMUNE-RESPONSES; CANCER PATIENTS; CTL IMMUNITY; HIGH-AVIDITY; INDUCTION; TOLERANCE; EXHAUSTION	To understand why cancer vaccine-induced T cells often do not eradicate tumors, we studied immune responses in mice vaccinated with gp100 melanoma peptide in incomplete Freund's adjuvant (peptide/IFA), which is commonly used in clinical cancer vaccine trials. Peptide/IFA vaccination primed tumor-specific CD8(+) T cells, which accumulated not in tumors but rather at the persisting, antigen-rich vaccination site. Once there, primed T cells became dysfunctional and underwent antigen-driven, interferon-gamma (IFN-gamma)- and Fas ligand (FasL)-mediated apoptosis, resulting in hyporesponsiveness to subsequent vaccination. Provision of CD40-specific antibody, Toll-like receptor 7 (TLR7) agonist and interleukin-2 (IL-2) reduced T cell apoptosis but did not prevent vaccination-site sequestration. A nonpersisting vaccine formulation shifted T cell localization toward tumors, inducing superior antitumor activity while reducing systemic T cell dysfunction and promoting memory formation. These data show that persisting vaccine depots can induce specific T cell sequestration, dysfunction and deletion at vaccination sites; short-lived formulations may overcome these limitations and result in greater therapeutic efficacy of peptide-based cancer vaccines.	[Hailemichael, Yared; Dai, Zhimin; Jaffarzad, Nina; Ye, Yang; Medina, Miguel A.; Huang, Xue-Fei; Dorta-Estremera, Stephanie M.; Greeley, Nathaniel R.; Nitti, Giovanni; Peng, Weiyi; Liu, Chengwen; Lou, Yanyan; Rabinovich, Brian; Hwu, Patrick; Overwijk, Willem W.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Dorta-Estremera, Stephanie M.; Greeley, Nathaniel R.; Nitti, Giovanni; Schluns, Kimberly S.; Davis, Richard E.; Hwu, Patrick; Overwijk, Willem W.] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA; [Wang, Zhiqiang; Ma, Wencai; Davis, Richard E.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Schluns, Kimberly S.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Overwijk, WW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA.	woverwijk@mdanderson.org	Ma, Wencai/K-3684-2013; Schluns, Kimberly/R-5635-2019	Dorta-Estremera, Stephanie/0000-0003-4440-6806	National Institutes of Health (NIH) [R01 1CA143077, P01 CA128913]; Melanoma Research Alliance Established Investigator Award; NATIONAL CANCER INSTITUTE [P01CA128913, P30CA016672, R01CA143077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance Established Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank G. Lizee, N. Martin-Orozco and J. Khalili for their helpful comments on this manuscript. This work was supported by the National Institutes of Health (NIH) grants R01 1CA143077 (W.W.O.) and P01 CA128913 (P.H. and W.W.O.) and a Melanoma Research Alliance Established Investigator Award (W.W.O.).	Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; Appay V, 2006, J IMMUNOL, V177, P1670, DOI 10.4049/jimmunol.177.3.1670; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Bonhoure F, 2006, J IMMUNOTHER, V29, P647; CRITCHFIELD JM, 1994, SCIENCE, V263, P1139, DOI 10.1126/science.7509084; den Boer AT, 2001, J IMMUNOL, V167, P2522; den Boer AT, 2004, J IMMUNOL, V172, P6074, DOI 10.4049/jimmunol.172.10.6074; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gajewski TF, 2011, CURR OPIN IMMUNOL, V23, P286, DOI 10.1016/j.coi.2010.11.013; Graham B.S., 2010, PLOS ONE, V5; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Jakt LM, 2001, GENOME RES, V11, P112, DOI 10.1101/gr.148301; Janicki CN, 2008, CANCER RES, V68, P2993, DOI 10.1158/0008-5472.CAN-07-5008; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kedl RM, 2001, P NATL ACAD SCI USA, V98, P10811, DOI 10.1073/pnas.191371898; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Leffers N, 2009, INT J CANCER, V125, P2104, DOI 10.1002/ijc.24597; Lizee G, 2006, CLIN CANCER RES, V12, P4794, DOI 10.1158/1078-0432.CCR-06-0944; Lizee G, 2013, ANNU REV MED, V64, P71, DOI 10.1146/annurev-med-112311-083918; Ly LV, 2010, CANCER RES, V70, P8339, DOI 10.1158/0008-5472.CAN-10-2288; Ma WC, 2010, CANCER EPIDEM BIOMAR, V19, P2445, DOI 10.1158/1055-9965.EPI-10-0565; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Muraoka D, 2010, J IMMUNOL, V185, P3768, DOI 10.4049/jimmunol.0903649; Overwijk WW, 2006, J IMMUNOL, V176, P5213, DOI 10.4049/jimmunol.176.9.5213; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Rabinovich BA, 2008, P NATL ACAD SCI USA, V105, P14342, DOI 10.1073/pnas.0804105105; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Reinhardt RL, 2003, J EXP MED, V197, P751, DOI 10.1084/jem.20021690; Rezvani K, 2011, HAEMATOL-HEMATOL J, V96, P432, DOI 10.3324/haematol.2010.031674; Riquelme E, 2009, EUR J IMMUNOL, V39, P2259, DOI 10.1002/eji.200939341; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Schaefer JT, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-79; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; SMITH RT, 1958, J EXP MED, V108, P227, DOI 10.1084/jem.108.2.227; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Speetjens FM, 2009, CLIN CANCER RES, V15, P1086, DOI 10.1158/1078-0432.CCR-08-2227; Speiser DE, 2005, J CLIN INVEST, V115, P1467, DOI 10.1172/JCI25427; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Ugel S, 2012, CELL REP, V2, P628, DOI 10.1016/j.celrep.2012.08.006; van Heijst JWJ, 2009, SCIENCE, V325, P1265, DOI 10.1126/science.1175455; Verdeil G, 2008, P NATL ACAD SCI USA, V105, P16683, DOI 10.1073/pnas.0805054105; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wojciechowski S, 2007, J EXP MED, V204, P1665, DOI 10.1084/jem.20070618; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Yamshchikov GV, 2001, INT J CANCER, V92, P703, DOI 10.1002/1097-0215(20010601)92:5<703::AID-IJC1250>3.0.CO;2-5; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	60	329	335	0	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	APR	2013	19	4					465	+		10.1038/nm.3105	http://dx.doi.org/10.1038/nm.3105			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	119PF	23455713	Green Accepted			2022-12-27	WOS:000317109100032
J	Chatterjee, SS; Joo, HS; Duong, AC; Dieringer, TD; Tan, VY; Song, Y; Fischer, ER; Cheung, GYC; Li, M; Otto, M				Chatterjee, Som S.; Joo, Hwang-Soo; Duong, Anthony C.; Dieringer, Thomas D.; Tan, Vee Y.; Song, Yan; Fischer, Elizabeth R.; Cheung, Gordon Y. C.; Li, Min; Otto, Michael			Essential Staphylococcus aureus toxin export system	NATURE MEDICINE			English	Article							PHENOL-SOLUBLE MODULINS; VIRULENCE DETERMINANTS; BACTERIAL VIRULENCE; EPIDERMIDIS; PEPTIDES; INACTIVATION; EXPRESSION; BIOFILMS; TARGET; AGR	Widespread antibiotic resistance among important bacterial pathogens such as Staphylococcus aureus(1) calls for alternative routes of drug development. Interfering with crucial virulence determinants is considered a promising new approach to control bacterial infection(2). Phenol-soluble modulins (PSMs) are peptide toxins with multiple key roles in pathogenesis(3-5) and have a major impact on the ability of highly virulent S. aureus to cause disease(3,6). However, targeting PSMs for therapeutic intervention is hampered by their multitude and diversity. Here we report that an ATP-binding cassette transporter with previously unknown function is responsible for the export of all PSMs, thus representing a single target for complete obstruction of PSM production. The transporter had a strong effect on virulence phenotypes, such as neutrophil lysis, and the extent of its effect on the development of S. aureus infection was similar to that of the sum of all PSMs. Notably, the transporter was essential for bacterial growth. Furthermore, it contributed to producer immunity toward secreted PSMs and defense against PSM-mediated bacterial interference. Our study reveals a noncanonical, dedicated secretion mechanism for an important class of toxins and identifies this mechanism as a comprehensive potential target for the development of drugs to efficiently inhibit the growth and virulence of pathogenic staphylococci.	[Chatterjee, Som S.; Joo, Hwang-Soo; Duong, Anthony C.; Dieringer, Thomas D.; Tan, Vee Y.; Cheung, Gordon Y. C.; Otto, Michael] NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Song, Yan; Li, Min] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China; [Fischer, Elizabeth R.] NIAID, Microscopy Unit, Rocky Mt Labs, NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fudan University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Otto, M (corresponding author), NIAID, Pathogen Mol Genet Sect, Lab Human Bacterial Pathogenesis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	motto@niaid.nih.gov		JOO, HWANG-SOO/0000-0003-4668-3225; Otto, Michael/0000-0002-2222-4115	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); US National Institutes of Health (NIH) [ZIA AI000904-10]; National Natural Science Foundation of China [30900026, 81171623, 81261120387]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000904] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), US National Institutes of Health (NIH) (grant ZIA AI000904-10) to M.O. and the National Natural Science Foundation of China (grants 30900026, 81171623 and 81261120387) to M.L. We thank J. Kok (University of Groningen), F. Lowy (Columbia University) and G. Dunny (University of Minnesota) for lactococcal strains and plasmids and A. Peschel for critically reading the manuscript.	Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5; Cheung GYC, 2012, MICROBES INFECT, V14, P380, DOI 10.1016/j.micinf.2011.11.013; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Forsman H, 2012, INFECT IMMUN, V80, P1987, DOI 10.1128/IAI.05906-11; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Peterson MM, 2008, CELL HOST MICROBE, V4, P555, DOI 10.1016/j.chom.2008.10.001; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Rothfork JM, 2004, P NATL ACAD SCI USA, V101, P13867, DOI 10.1073/pnas.0402996101; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945; Zolnerciks JK, 2011, ESSAYS BIOCHEM, V50, P43, DOI [10.1042/bse0500043, 10.1042/BSE0500043]	29	118	120	3	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2013	19	3					364	367		10.1038/nm.3047	http://dx.doi.org/10.1038/nm.3047			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	105BN	23396209	Green Accepted			2022-12-27	WOS:000316040700031
J	Baron, R; Kneissel, M				Baron, Roland; Kneissel, Michaela			WNT signaling in bone homeostasis and disease: from human mutations to treatments	NATURE MEDICINE			English	Review							FRIZZLED-RELATED PROTEIN-1; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; RECEPTOR-RELATED PROTEIN-5; PARATHYROID-HORMONE; BETA-CATENIN; OSTEOBLAST DIFFERENTIATION; SCLEROSTIN ANTIBODY; MINERAL DENSITY; MORPHOGENETIC PROTEIN; TYROSINE KINASE	Low bone mass and strength lead to fragility fractures, for example, in elderly individuals affected by osteoporosis or children with osteogenesis imperfecta. A decade ago, rare human mutations affecting bone negatively (osteoporosis-pseudoglioma syndrome) or positively (high bone mass phenotype, sclerosteosis and Van Buchem disease) have been identified and found to all reside in components of the canonical WNT signaling machinery. Mouse genetics confirmed the importance of canonical Wnt signaling in the regulation of bone homeostasis, with activation of the pathway leading to increased, and inhibition leading to decreased, bone mass and strength. The importance of WNT signaling for bone has also been highlighted since then in the general population in numerous genome-wide association studies. The pathway is now the target for therapeutic intervention to restore bone strength in millions of patients at risk for fracture. This paper reviews our current understanding of the mechanisms by which WNT signalng regulates bone homeostasis.	[Baron, Roland] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med, Boston, MA 02115 USA; [Kneissel, Michaela] Novartis Inst BioMed Res, Musculoskeletal Dis Area, Basel, Switzerland	Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Novartis	Baron, R (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	roland_baron@hsdm.harvard.edu			US National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases); US National Institutes of Health (National Institute on Aging)	US National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	R.B. is supported in part by grants from the US National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases and National Institute on Aging).	Agholme F, 2011, BONE, V48, P988, DOI 10.1016/j.bone.2011.02.008; Agholme F, 2010, J BONE MINER RES, V25, P2412, DOI 10.1002/jbmr.135; Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; Ai MR, 2005, AM J HUM GENET, V77, P741, DOI 10.1086/497706; Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Appel H, 2009, ARTHRITIS RHEUM-US, V60, P3257, DOI 10.1002/art.24888; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Barros ER, 2008, J PEDIATR ENDOCR MET, V21, P811; Baud'huin M, 2012, P NATL ACAD SCI USA, V109, P12207, DOI 10.1073/pnas.1204929109; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Berndt T, 2003, J CLIN INVEST, V112, P785, DOI 10.1172/JC1200318563; Bianco P, 2011, ENDOCRINOLOGY, V152, P2957, DOI 10.1210/en.2011-0217; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Bodine PVN, 2009, BONE, V44, P1063, DOI 10.1016/j.bone.2009.02.013; Bodine PVN, 2007, J CELL PHYSIOL, V210, P352, DOI 10.1002/jcp.20834; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bolton JM, 2008, J CLIN PSYCHOPHARM, V28, P384, DOI 10.1097/JCP.0b013e31817d5943; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Borchert KM, 2005, ASSAY DRUG DEV TECHN, V3, P133, DOI 10.1089/adt.2005.3.133; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; CABRERA CV, 1987, CELL, V50, P659, DOI 10.1016/0092-8674(87)90039-0; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Canalis E, 2012, ENDOCRINOLOGY, V153, P1616, DOI 10.1210/en.2011-1604; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Cheung WMW, 2006, BONE, V39, P470, DOI 10.1016/j.bone.2006.02.069; Cho HY, 2010, BONE, V47, P263, DOI 10.1016/j.bone.2010.05.010; Cho SW, 2009, BONE, V44, P1069, DOI 10.1016/j.bone.2009.02.012; Choi HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007930; Christov M, 2011, ENDOCRINOLOGY, V152, P2031, DOI 10.1210/en.2010-1351; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Collette NM, 2010, DEV BIOL, V342, P169, DOI 10.1016/j.ydbio.2010.03.021; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Costa AG, 2011, J CLIN ENDOCR METAB, V96, P3804, DOI 10.1210/jc.2011-0566; Crabtree N, 2001, J BONE MINER RES, V16, P1318, DOI 10.1359/jbmr.2001.16.7.1318; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Drake MT, 2010, J CLIN ENDOCR METAB, V95, P5056, DOI 10.1210/jc.2010-0720; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Epstein S, 2007, BONE, V41, pS3, DOI 10.1016/j.bone.2007.03.006; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fox J, 2007, BONE, V41, P321, DOI 10.1016/j.bone.2007.04.197; Friedman MS, 2009, J BIOL CHEM, V284, P14117, DOI 10.1074/jbc.M808337200; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gaudio A, 2010, J CLIN ENDOCR METAB, V95, P2248, DOI 10.1210/jc.2010-0067; Gaur T, 2009, J CELL PHYSIOL, V220, P174, DOI 10.1002/jcp.21747; Glantschnig H, 2011, J PHARMACOL EXP THER, V338, P568, DOI 10.1124/jpet.111.181404; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Guo J, 2010, CELL METAB, V11, P161, DOI 10.1016/j.cmet.2009.12.007; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hall CL, 2006, J CELL BIOCHEM, V97, P661, DOI 10.1002/jcb.20735; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hausler KD, 2004, J BONE MINER RES, V19, P1873, DOI 10.1359/JBMR.040807; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Hoeppner LH, 2011, J BIOL CHEM, V286, P10950, DOI 10.1074/jbc.M110.165100; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Huang QY, 2009, BONE, V45, P289, DOI 10.1016/j.bone.2009.03.676; Jenny A, 2010, CURR TOP DEV BIOL, V93, P189, DOI [10.1016/B978-0-12-385044-7.00007-2, 10.1016/S0070-2153(10)93007-X]; Jin YR, 2011, DEV BIOL, V352, P1, DOI 10.1016/j.ydbio.2011.01.004; Joeng KS, 2011, DEV BIOL, V359, P222, DOI 10.1016/j.ydbio.2011.08.020; Johnson EB, 2005, HUM MOL GENET, V14, P3523, DOI 10.1093/hmg/ddi381; Kaji H, 2011, EXP CLIN ENDOCR DIAB, V119, P440, DOI 10.1055/s-0031-1275661; Kamiya Nobuhiro, 2012, Curr Mol Pharmacol, V5, P153; Kamiya N, 2011, BIOCHEM BIOPH RES CO, V414, P326, DOI 10.1016/j.bbrc.2011.09.060; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Kaplan FS, 2010, METHOD ENZYMOL, V484, P357, DOI [10.1016/S0076-6879(10)84018-2, 10.1016/B978-0-12-381298-8.00018-6]; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim SJ, 2011, HUM GENET, V129, P497, DOI 10.1007/s00439-011-0947-3; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; Korvala J, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-26; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Kramer I, 2010, TRENDS ENDOCRIN MET, V21, P237, DOI 10.1016/j.tem.2009.12.002; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Krause C, 2010, J BIOL CHEM, V285, P41614, DOI 10.1074/jbc.M110.153890; Kronke G, 2010, ARTHRITIS RHEUM-US, V62, P2303, DOI 10.1002/art.27496; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Kulkarni NH, 2006, J BONE MINER RES, V21, P910, DOI 10.1359/JBMR.060316; Laine CM, 2011, EUR J HUM GENET, V19, P875, DOI 10.1038/ejhg.2011.42; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Leupin O, 2011, J BIOL CHEM, V286, P19489, DOI 10.1074/jbc.M110.190330; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li WF, 2010, HUM GENET, V127, P249, DOI 10.1007/s00439-009-0773-z; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2011, J BONE MINER RES, V26, P2610, DOI 10.1002/jbmr.472; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Lindsay R, 2007, J BONE MINER RES, V22, P495, DOI 10.1359/JBMR.070104; Lintern KB, 2009, J BIOL CHEM, V284, P23159, DOI 10.1074/jbc.M109.025478; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Lu WY, 2008, FEBS LETT, V582, P643, DOI 10.1016/j.febslet.2008.01.035; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Lyashenko N, 2010, DEV DYNAM, V239, P2266, DOI 10.1002/dvdy.22362; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mbalaviele G, 2006, J BONE MINER RES, V21, P1821, DOI 10.1359/JBMR.060811; McClung MR, 2005, ARCH INTERN MED, V165, P1762, DOI 10.1001/archinte.165.15.1762; Miclea RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-26; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Miller PD, 2010, OSTEOPOROSIS INT, V21, P1793, DOI 10.1007/s00198-010-1208-3; Moisan A, 2011, DEV CELL, V20, P583, DOI 10.1016/j.devcel.2011.03.013; Moore WJ, 2010, BIOORGAN MED CHEM, V18, P190, DOI 10.1016/j.bmc.2009.11.002; Morello R, 2008, J CELL PHYSIOL, V217, P127, DOI 10.1002/jcp.21483; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P65, DOI 10.1016/j.bbrc.2009.09.067; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Niemann S, 2004, AM J HUM GENET, V74, P558, DOI 10.1086/382196; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Ominsky MS, 2011, J BONE MINER RES, V26, P1012, DOI 10.1002/jbmr.307; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Pangrazio A, 2011, BONE, V49, P568, DOI 10.1016/j.bone.2011.05.006; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Perdu B, 2010, J BONE MINER RES, V25, P82, DOI 10.1359/jbmr.090707; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Qin L, 2004, TRENDS ENDOCRIN MET, V15, P60, DOI 10.1016/j.tem.2004.01.006; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rickels MR, 2005, J BONE MINER RES, V20, P878, DOI 10.1359/JBMR.041223; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Robling AG, 2011, ENDOCRINOLOGY, V152, P2963, DOI 10.1210/en.2011-0049; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rubin MR, 2005, DRUGS, V65, P2481, DOI 10.2165/00003495-200565170-00005; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Santiago F, 2012, BIOCHEM BIOPH RES CO, V417, P223, DOI 10.1016/j.bbrc.2011.11.089; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Schaniel C, 2011, BLOOD, V118, P2420, DOI 10.1182/blood-2010-09-305664; Schulze J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010309; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Shi MX, 2009, BIOORG MED CHEM LETT, V19, P6337, DOI 10.1016/j.bmcl.2009.09.085; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Sieper J, 2011, NAT REV RHEUMATOL, V7, P78, DOI 10.1038/nrrheum.2010.224; Sims AM, 2008, J BONE MINER RES, V23, P499, DOI 10.1359/JBMR.071113; Sinder BP, 2013, J BONE MINER RES, V28, P73, DOI 10.1002/jbmr.1717; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Streeten EA, 2008, BONE, V43, P584, DOI 10.1016/j.bone.2008.04.020; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Tian XY, 2011, BONE, V48, P197, DOI 10.1016/j.bone.2010.09.009; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Turner CH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268pt3; Uderhardt S, 2010, ANN RHEUM DIS, V69, P592, DOI 10.1136/ard.2008.102046; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Lierop AH, 2010, EUR J ENDOCRINOL, V163, P833, DOI 10.1530/EJE-10-0699; van Lierop AH, 2011, J BONE MINER RES, V26, P2804, DOI 10.1002/jbmr.474; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Verkaar F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019185; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P1, DOI 10.1007/s00223-004-0258-y; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang B, 2011, HUM MOL GENET, V20, P271, DOI 10.1093/hmg/ddq462; Wang FS, 2007, BONE, V40, P485, DOI 10.1016/j.bone.2006.09.004; Warden SJ, 2010, BONE, V46, P985, DOI 10.1016/j.bone.2009.12.031; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Witte F, 2010, P NATL ACAD SCI USA, V107, P14211, DOI 10.1073/pnas.1009314107; Woods CG, 2006, AM J HUM GENET, V79, P402, DOI 10.1086/506332; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yan Y, 2009, J CELL SCI, V122, P3566, DOI 10.1242/jcs.051904; Yao W, 2010, J BONE MINER RES, V25, P190, DOI 10.1359/jbmr.090719; Yerges LM, 2009, J BONE MINER RES, V24, P2039, DOI [10.1359/JBMR.090524, 10.1359/jbmr.090524]; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109	225	1271	1332	18	373	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2013	19	2					179	192		10.1038/nm.3074	http://dx.doi.org/10.1038/nm.3074			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	086HY	23389618				2022-12-27	WOS:000314675900026
J	Graham, RL; Becker, MM; Eckerle, LD; Bolles, M; Denison, MR; Baric, RS				Graham, Rachel L.; Becker, Michelle M.; Eckerle, Lance D.; Bolles, Meagan; Denison, Mark R.; Baric, Ralph S.			A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease	NATURE MEDICINE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; MURINE HEPATITIS-VIRUS; REPLICATION FIDELITY; SARS-CORONAVIRUS; EXORIBONUCLEASE; RECOMBINATION; PATHOGENESIS; EXONUCLEASE; SITES; MICE	Live, attenuated RNA virus vaccines are efficacious but subject to reversion to virulence. Among RNA viruses, replication fidelity is recognized as a key determinant of virulence and escape from antiviral therapy; increased fidelity is attenuating for some viruses. Coronavirus (CoV) replication fidelity is approximately 20-fold greater than that of other RNA viruses and is mediated by a 3'-> 5' exonuclease (ExoN) activity that probably functions in RNA proofreading. In this study we demonstrate that engineered inactivation of severe acute respiratory syndrome (SARS)-CoV ExoN activity results in a stable mutator phenotype with profoundly decreased fidelity in vivo and attenuation of pathogenesis in young, aged and immunocompromised mice. The ExoN inactivation genotype and mutator phenotype are stable and do not revert to virulence, even after serial passage or long-term persistent infection in vivo. ExoN inactivation has potential for broad applications in the stable attenuation of CoVs and, perhaps, other RNA viruses.	[Graham, Rachel L.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Becker, Michelle M.; Eckerle, Lance D.; Denison, Mark R.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Bolles, Meagan; Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Denison, Mark R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN USA	University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University	Baric, RS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	rbaric@email.unc.edu	Graham, Rachel/AAM-9048-2020; Deming, Meagan/AEX-6400-2022; Denison, Mark R/O-7258-2018	Graham, Rachel/0000-0002-3143-6515; Deming, Meagan/0000-0003-2574-0542; Denison, Mark R/0000-0003-2655-0900	US National Institutes of Health [U54-AI057157, AI075297, 5F32AI080148, HHSN272200900007C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075297, F32AI080148, U54AI057157] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank R. Halpin, C. Town (US National Institutes of Health Microbial Genome Sequencing Contract HHSN272200900007C) and X. Lu for their assistance in sequencing in vitro isolates. This work was funded by US National Institutes of Health grants U54-AI057157 (SERCEB; R.S.B. and M.R.D.), AI075297 (R.S.B.) and 5F32AI080148 (R.L.G.).	Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Chey S, 2010, J CELL BIOCHEM, V110, P118, DOI 10.1002/jcb.22518; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Frieman MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000849; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005; HOLLAND JJ, 1990, J VIROL, V64, P3960, DOI 10.1128/JVI.64.8.3960-3962.1990; Johnson AA, 2001, J BIOL CHEM, V276, P38097; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Nga PT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002215; Roberts A, 2007, PLOS PATHOG, V3, P23, DOI 10.1371/journal.ppat.0030005; Sessa R, 1999, PANMINERVA MED, V41, P78; Sheahan T, 2011, J VIROL, V85, P217, DOI 10.1128/JVI.01805-10; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Subbarao K, 2004, J VIROL, V78, P3572, DOI 10.1128/JVI.78.7.3572-3577.2004; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Vignuzzi M, 2008, NAT MED, V14, P154, DOI 10.1038/nm1726; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yount B, 2006, P NATL ACAD SCI USA, V103, P12546, DOI 10.1073/pnas.0605438103; Zhao JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000636	42	166	173	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1820	+		10.1038/nm.2972	http://dx.doi.org/10.1038/nm.2972			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23142821	Green Published, Bronze, Green Accepted			2022-12-27	WOS:000311999800030
J	Krueger, JG				Krueger, James G.			A welcome surprise in psoriasis	NATURE MEDICINE			English	Editorial Material							INFLAMMATION; ANTIBODY; CYTOKINE; T(H)17; SKIN		Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA	Rockefeller University	Krueger, JG (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave, New York, NY 10021 USA.	jgk@mail.rockefeller.edu						Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Ding HS, 2012, MOL BIOL REP, V39, P7473, DOI 10.1007/s11033-012-1580-5; Farley E, 2011, GIORN ITAL DERMAT V, V146, P9; Johnson-Huang LM, 2012, DIS MODEL MECH, V5, P423, DOI 10.1242/dmm.009092; Krueger JG, 2012, J ALLERGY CLIN IMMUN, V130, P145, DOI 10.1016/j.jaci.2012.04.024; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Suarez-Farinas M, 2012, J INVEST DERMATOL, V132, P2552, DOI 10.1038/jid.2012.184; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	12	38	55	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2012	18	12					1750	1751		10.1038/nm.3025	http://dx.doi.org/10.1038/nm.3025			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	049QZ	23223064				2022-12-27	WOS:000311999800022
J	Wittes, J				Wittes, Janet			Clinical trials must cope better with multiplicity	NATURE MEDICINE			English	Editorial Material								Clinical trials typically address more than one question. But in attempting to protect against misleading results that are due to chance when multiple interrelated tests are run simultaneously, researchers sometimes apply overly strict statistical devices that mask true effects. They should give more consideration to choosing the type of statistical analysis that fits best.	[Wittes, Janet] Stat Collaborat, Washington, DC USA		Wittes, J (corresponding author), Stat Collaborat, Washington, DC USA.							Beck Melinda, 2012, WALL STREET J, pD1; RIOS, 2012, JAMA-J AM MED ASSOC, V308, P1024	2	4	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	NOV	2012	18	11					1607	1607		10.1038/nm1112-1607	http://dx.doi.org/10.1038/nm1112-1607			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	033YJ	23135505				2022-12-27	WOS:000310837000011
J	Kitazawa, T; Igawa, T; Sampei, Z; Muto, A; Kojima, T; Soeda, T; Yoshihashi, K; Okuyama-Nishida, Y; Saito, H; Tsunoda, H; Suzuki, T; Adachi, H; Miyazaki, T; Ishii, S; Kamata-Sakurai, M; Iida, T; Harada, A; Esaki, K; Funaki, M; Moriyama, C; Tanaka, E; Kikuchi, Y; Wakabayashi, T; Wada, M; Goto, M; Toyoda, T; Ueyama, A; Suzuki, S; Haraya, K; Tachibana, T; Kawabe, Y; Shima, M; Yoshioka, A; Hattori, K				Kitazawa, Takehisa; Igawa, Tomoyuki; Sampei, Zenjiro; Muto, Atsushi; Kojima, Tetsuo; Soeda, Tetsuhiro; Yoshihashi, Kazutaka; Okuyama-Nishida, Yukiko; Saito, Hiroyuki; Tsunoda, Hiroyuki; Suzuki, Tsukasa; Adachi, Hideki; Miyazaki, Taro; Ishii, Shinya; Kamata-Sakurai, Mika; Iida, Takeo; Harada, Aya; Esaki, Keiko; Funaki, Miho; Moriyama, Chifumi; Tanaka, Eriko; Kikuchi, Yasufumi; Wakabayashi, Tetsuya; Wada, Manabu; Goto, Masaaki; Toyoda, Takeshi; Ueyama, Atsunori; Suzuki, Sachiyo; Haraya, Kenta; Tachibana, Tatsuhiko; Kawabe, Yoshiki; Shima, Midori; Yoshioka, Akira; Hattori, Kunihiro			A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model	NATURE MEDICINE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; RECOMBINANT FACTOR-VIII; THERAPEUTIC ANTIBODIES; INHIBITOR DEVELOPMENT; VARIABLE REGION; IGG ANTIBODIES; BINDING-SITE; FULLY HUMAN; PHARMACOKINETICS; PHARMACODYNAMICS	Hemophilia A is a bleeding disorder resulting from coagulation factor VIII (FVIII) deficiency. Exogenously provided FVIII effectively reduces bleeding complications in patients with severe hemophilia A. In approximately 30% of such patients, however, the 'foreignness' of the FVIII molecule causes them to develop inhibitory antibodies against FVIII (inhibitors), precluding FVIII treatment in this set of patients(1-3). Moreover, the poor pharmacokinetics of FVIII, attributed to low subcutaneous bioavailability and a short half-life of 0.5 d, necessitates frequent intravenous injections(3-5). To overcome these drawbacks, we generated a humanized bispecific antibody to factor IXa (FIXa) and factor X (FX), termed hBS23, that places these two factors into spatially appropriate positions and mimics the cofactor function of FVIII. hBS23 exerted coagulation activity in FVIII-deficient plasma, even in the presence of inhibitors, and showed in vivo hemostatic activity in a nonhuman primate model of acquired hemophilia A. Notably, hBS23 had high subcutaneous bioavailability and a 2-week half-life and would not be expected to elicit the development of FVIII-specific inhibitory antibodies, as its molecular structure, and hence antigenicity, differs from that of FVIII. A long-acting, subcutaneously injectable agent that is unaffected by the presence of inhibitors could markedly reduce the burden of care for the treatment of hemophilia A.	[Kitazawa, Takehisa; Igawa, Tomoyuki; Sampei, Zenjiro; Muto, Atsushi; Kojima, Tetsuo; Soeda, Tetsuhiro; Yoshihashi, Kazutaka; Okuyama-Nishida, Yukiko; Saito, Hiroyuki; Tsunoda, Hiroyuki; Suzuki, Tsukasa; Adachi, Hideki; Miyazaki, Taro; Ishii, Shinya; Kamata-Sakurai, Mika; Iida, Takeo; Harada, Aya; Esaki, Keiko; Funaki, Miho; Moriyama, Chifumi; Tanaka, Eriko; Kikuchi, Yasufumi; Wakabayashi, Tetsuya; Wada, Manabu; Goto, Masaaki; Toyoda, Takeshi; Ueyama, Atsunori; Suzuki, Sachiyo; Haraya, Kenta; Tachibana, Tatsuhiko; Kawabe, Yoshiki; Hattori, Kunihiro] Chugai Pharmaceut, Fuji Gotemba Res Labs, Shizuoka, Japan; [Shima, Midori] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Nara Medical University	Kitazawa, T (corresponding author), Chugai Pharmaceut, Fuji Gotemba Res Labs, Shizuoka, Japan.	kitazawatkh@chugai-pharm.co.jp	HARAYA, KENTA/AAW-4267-2020	HARAYA, KENTA/0000-0002-9142-5607; Sampei, Zenjiro/0000-0001-5343-4468; Tachibana, Tatsuhiko/0000-0001-8339-3986; Kawabe, Yoshiki/0000-0002-6465-7146				Astermark J, 2007, BLOOD, V109, P546, DOI 10.1182/blood-2006-04-017988; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Baker Matthew P, 2010, Self Nonself, V1, P314, DOI 10.4161/self.1.4.13904; Beck A, 2010, NAT REV IMMUNOL, V10, P345, DOI 10.1038/nri2747; Benincosa LJ, 2000, J PHARMACOL EXP THER, V292, P810; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; Bhaskar V, 2012, DIABETES, V61, P1263, DOI 10.2337/db11-1578; Bjorkman S, 2012, BLOOD, V119, P612, DOI 10.1182/blood-2011-07-360594; Bloom JW, 1997, PROTEIN SCI, V6, P407; Deng R, 2011, MABS-AUSTIN, V3, P61, DOI 10.4161/mabs.3.1.13799; Fay PJ, 1998, J BIOL CHEM, V273, P19049, DOI 10.1074/jbc.273.30.19049; Fay PJ, 2004, BLOOD REV, V18, P1, DOI 10.1016/S0268-960X(03)00025-0; Fischer K, 2012, HAEMOPHILIA, V18, pe241, DOI 10.1111/j.1365-2516.2011.02687.x; Geraghty S, 2006, HAEMOPHILIA, V12, P75, DOI 10.1111/j.1365-2516.2006.01189.x; Harding FA, 2010, MABS-AUSTIN, V2, P256, DOI 10.4161/mabs.2.3.11641; Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; Healey JF, 1996, BLOOD, V88, P4209; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; High KA, 2011, J THROMB HAEMOST, V9, P2, DOI 10.1111/j.1538-7836.2011.04369.x; Igawa T, 2010, PROTEIN ENG DES SEL, V23, P385, DOI 10.1093/protein/gzq009; Igawa T, 2011, MABS-AUSTIN, V3, P243, DOI 10.4161/mabs.3.3.15234; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Lapan KA, 1997, J BIOL CHEM, V272, P2082; Leissinger C, 2011, NEW ENGL J MED, V365, P1684, DOI 10.1056/NEJMoa1104435; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lillicrap D, 2010, CURR OPIN HEMATOL, V17, P393, DOI 10.1097/MOH.0b013e32833c06c6; Lin YS, 1999, J PHARMACOL EXP THER, V288, P371; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Mayorov AV, 2008, P NATL ACAD SCI USA, V105, P17487, DOI 10.1073/pnas.0711808105; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Okuda M, 2004, CLIN LAB HAEMATOL, V26, P215, DOI 10.1111/j.1365-2257.2004.00605.x; Oldenburg J, 2002, HAEMOPHILIA, V8, P23, DOI 10.1046/j.1351-8216.2001.00134.x; Powell JS, 2012, BLOOD, V119, P3031, DOI 10.1182/blood-2011-09-382846; Ragni MV, 2012, HAEMOPHILIA, V18, P63, DOI 10.1111/j.1365-2516.2011.02554.x; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Shetty S, 2011, AUTOIMMUN REV, V10, P311, DOI 10.1016/j.autrev.2010.11.005; Shi Q, 2012, HAEMOPHILIA, V18, P639, DOI 10.1111/j.1365-2516.2011.02735.x; Shima M, 2008, HAEMOPHILIA, V14, P83, DOI 10.1111/j.1365-2516.2008.01737.x; Stonebraker JS, 2010, HAEMOPHILIA, V16, P20, DOI 10.1111/j.1365-2516.2009.02127.x; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; YONEMURA H, 1993, PROTEIN ENG, V6, P669, DOI 10.1093/protein/6.6.669; Young G, 2011, HAEMOPHILIA, V17, pE849, DOI 10.1111/j.1365-2516.2011.02494.x	46	296	327	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	OCT	2012	18	10					1570	U177		10.1038/nm.2942	http://dx.doi.org/10.1038/nm.2942			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	23023498				2022-12-27	WOS:000309587500036
J	Yoshioka, K; Yoshida, K; Cui, H; Wakayama, T; Takuwa, N; Okamoto, Y; Du, W; Qi, X; Asanuma, K; Sugihara, K; Aki, S; Miyazawa, H; Biswas, K; Nagakura, C; Ueno, M; Iseki, S; Schwartz, RJ; Okamoto, H; Sasaki, T; Matsui, O; Asano, M; Adams, RH; Takakura, N; Takuwa, Y				Yoshioka, Kazuaki; Yoshida, Kotaro; Cui, Hong; Wakayama, Tomohiko; Takuwa, Noriko; Okamoto, Yasuo; Du, Wa; Qi, Xun; Asanuma, Ken; Sugihara, Kazushi; Aki, Sho; Miyazawa, Hidekazu; Biswas, Kuntal; Nagakura, Chisa; Ueno, Masaya; Iseki, Shoichi; Schwartz, Robert J.; Okamoto, Hiroshi; Sasaki, Takehiko; Matsui, Osamu; Asano, Masahide; Adams, Ralf H.; Takakura, Nobuyuki; Takuwa, Yoh			Endothelial PI3K-C2 alpha, a class II PI3K, has an essential role in angiogenesis and vascular barrier function	NATURE MEDICINE			English	Article							3-KINASE ALPHA-ISOFORM; PHOSPHOINOSITIDE 3-KINASE; MYOSIN PHOSPHATASE; RHO-KINASE; IN-VIVO; MEMBRANE; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; RECEPTOR; GROWTH	The class II alpha-isoform of phosphatidylinositol 3-kinase (PI3K-C2 alpha) is localized in endosomes, the trans-Golgi network and clathrin-coated vesicles; however, its functional role is not well understood. Global or endothelial-cell-specific deficiency of PI3K-C2 alpha resulted in embryonic lethality caused by defects in sprouting angiogenesis and vascular maturation. PI3K-C2 alpha knockdown in endothelial cells resulted in a decrease in the number of PI3-phosphate-enriched endosomes, impaired endosomal trafficking, defective delivery of VE-cadherin to endothelial cell junctions and defective junction assembly. PI3K-C2 alpha knockdown also impaired endothelial cell signaling, including vascular endothelial growth factor receptor internalization and endosomal RhoA activation. Together, the effects of PI3K-C2 alpha knockdown led to defective endothelial cell migration, proliferation, tube formation and barrier integrity. Endothelial PI3K-C2 alpha deficiency in vivo suppressed postischemic and tumor angiogenesis and diminished vascular barrier function with a greatly augmented susceptibility to anaphylaxis and a higher incidence of dissecting aortic aneurysm formation in response to angiotensin II infusion. Thus, PI3K-C2 alpha has a crucial role in vascular formation and barrier integrity and represents a new therapeutic target for vascular disease.	[Yoshioka, Kazuaki; Yoshida, Kotaro; Cui, Hong; Takuwa, Noriko; Okamoto, Yasuo; Du, Wa; Qi, Xun; Aki, Sho; Miyazawa, Hidekazu; Biswas, Kuntal; Nagakura, Chisa; Takuwa, Yoh] Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 920, Japan; [Yoshida, Kotaro; Matsui, Osamu] Kanazawa Univ, Sch Med, Dept Radiol, Kanazawa, Ishikawa 920, Japan; [Wakayama, Tomohiko; Iseki, Shoichi] Kanazawa Univ, Sch Med, Dept Histol & Embryol, Kanazawa, Ishikawa 920, Japan; [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa, Japan; [Asanuma, Ken; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 010, Japan; [Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa, Japan; [Ueno, Masaya; Takakura, Nobuyuki] Osaka Univ, Dept Signal Transduct, Microbial Dis Res Inst, Osaka, Japan; [Schwartz, Robert J.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Okamoto, Hiroshi] Tohoku Univ, Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Sasaki, Takehiko] Akita Univ, Res Ctr Biosignal, Akita 010, Japan; [Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany; [Adams, Ralf H.] Univ Munster, Fac Med, Munster, Germany	Kanazawa University; Kanazawa University; Kanazawa University; Akita University; Kanazawa University; Osaka University; University of Houston System; University of Houston; Tohoku University; Akita University; Max Planck Society; University of Munster	Takuwa, Y (corresponding author), Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 920, Japan.	ytakuwa@med.kanazawa-u.ac.jp	OKAMOTO, Yasuo/J-8438-2015; Adams, Ralf H/AAE-9274-2019; Yoshioka, Kazuaki/G-1038-2013; Du, Wa/I-8453-2019; UENO, Masaya/D-8464-2015	Yoshioka, Kazuaki/0000-0002-8631-3846; Du, Wa/0000-0002-1518-7301; UENO, Masaya/0000-0001-9177-8640; TAKUWA, Noriko/0000-0002-4278-2704; Sasaki, Takehiko/0000-0003-1837-3748	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Honjin Foundation; Mitsubishi Pharma Research Foundation; SENSIN Medical Research Foundation; Grants-in-Aid for Scientific Research [23590257, 23500493] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Honjin Foundation; Mitsubishi Pharma Research Foundation; SENSIN Medical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank K. Mitsumori for comments on the histological study. We thank N. Mochizuki and K. Ando for assistance with the FRET imaging analysis. We thank N. Furusawa, K. Sunagawa and E. Kaneko for assistance with live-cell imaging using a Yokogawa confocal microscope system. We also thank Y. Ohta and T. Murakawa for technical assistance and T. Hirose for administrative assistance. C2 alpha complementary DNA was obtained from J. Domin (Imperial College London). GFP-2 x FYVE and mRFP-2 x FYVE expression vectors were obtained from H. Stenmark (Oslo University Hospital) and Y. Ohsumi (Tokyo Institute of Technology), respectively. VE-cadherin-GFP expression vectors were obtained from N. Mochizuki (National Cerebral and Cardiovascular Center). The pRaichu-RhoA probe was obtained from M. Matsuda (Kyoto University). GFP-RhoA<SUP>Asn19</SUP> and GFP-RhoA<SUP>Val14</SUP> expression vectors were obtained from F. Valderrama (King's College London). This work was supported in part by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japan Society for the Promotion of Science (to K. Yoshioka, N. Takuwa, Y.O. and Y. T.), the Honjin Foundation, the Mitsubishi Pharma Research Foundation and the SENSIN Medical Research Foundation (to K. Yoshioka).	Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deng GG, 2003, CIRC RES, V92, P510, DOI 10.1161/01.RES.0000061571.49375.E1; Di Gennaro A, 2010, P NATL ACAD SCI USA, V107, P21093, DOI 10.1073/pnas.1015166107; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; El Sheikh Soha Salama, 2003, BMC Clin Pathol, V3, P4, DOI 10.1186/1472-6890-3-4; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Falasca M, 2007, BIOCHEM SOC T, V35, P211, DOI 10.1042/BST0350211; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Harris DP, 2011, MOL CELL BIOL, V31, P63, DOI 10.1128/MCB.00468-10; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Linassier C, 1997, BIOCHEM J, V321, P849, DOI 10.1042/bj3210849; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pannekoek WJ, 2009, BBA-BIOMEMBRANES, V1788, P790, DOI 10.1016/j.bbamem.2008.12.010; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Shivas JM, 2010, TRENDS CELL BIOL, V20, P445, DOI 10.1016/j.tcb.2010.04.003; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Traer Colin J, 2006, Bull Cancer, V93, pE53; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wheeler M, 2006, J CELL PHYSIOL, V206, P586, DOI 10.1002/jcp.20507; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yoshioka K, 2007, MOL PHARMACOL, V71, P912, DOI 10.1124/mol.106.032599; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	61	144	153	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2012	18	10					1560	U170		10.1038/nm.2928	http://dx.doi.org/10.1038/nm.2928			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	017JZ	22983395	Green Submitted			2022-12-27	WOS:000309587500035
J	Rader, DJ; Tall, AR				Rader, Daniel J.; Tall, Alan R.			The not-so-simple HDL story Is it time to revise the HDL cholesterol hypothesis?	NATURE MEDICINE			English	Editorial Material							HIGH-DENSITY-LIPOPROTEIN; TRANSPORT IN-VIVO; ACCELERATES ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; HEMATOPOIETIC STEM; NIACIN; TRIAL; ABCA1; ABCG1; MICE	Formation of plaques in artery walls, or atherogenesis, is known to lead to cardiovascular disease risk and heart disease. Low-density lipoproteins (LDLs), which deliver cholesterol to inflammatory cells in blood vessels, are linked to disease, which is commonly managed using cholesterol-lowering therapies. Whether increasing levels of high-density lipoproteins (HDLs), which remove cholesterol from the circulation, can be cardioprotective has not been clear, despite early clinical studies showing evidence for a positive effect in cardiovascular disease. In 'Bench to Bedside', Daniel J. Rader and Alan R. Tall discuss how the field should focus on promoting reverse cholesterol transport that would result in cholesterol efflux from macrophages to biliary excretion rather than simply trying to increase HDL cholesterol levels. Understanding how different molecular mechanisms operate in this 'HDL flux hypothesis' will uncover ways to develop HDL-targeted therapeutics that will protect from cardiovascular and heart disease. In 'Bedside to Bench', Jay W. Heinecke peruses clinical studies to propose better and simpler ways to measure reverse cholesterol transport in the clinic. Genetic alterations and factors involved in HDL functionality may be useful for quantifying HDL function and finding effective drugs to lower cardiovascular disease risk.	[Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Tall, Alan R.] Columbia Univ, Dept Med, Div Mol Med, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Columbia University	Rader, DJ (corresponding author), Univ Penn, Cardiovasc Inst, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu; art1@columbia.edu	Tall, Alan/AAT-8528-2021					Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Murphy AJ, 2012, BBA-MOL CELL BIOL L, V1821, P513, DOI 10.1016/j.bbalip.2011.08.003; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Schwartz GG, 2009, AM HEART J, V158, P896, DOI 10.1016/j.ahj.2009.09.017; Steinberg D, 2006, J LIPID RES, V47, P1339, DOI 10.1194/jlr.R600009-JLR200; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0	18	211	215	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	SEP	2012	18	9					1344	1346		10.1038/nm.2937	http://dx.doi.org/10.1038/nm.2937			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22961164				2022-12-27	WOS:000308472300028
J	Yipp, BG; Petri, B; Salina, D; Jenne, CN; Scott, BNV; Zbytnuik, LD; Pittman, K; Asaduzzaman, M; Wu, KY; Meijndert, HC; Malawista, SE; Chevance, AD; Zhang, KY; Conly, J; Kubes, P				Yipp, Bryan G.; Petri, Bjoern; Salina, Davide; Jenne, Craig N.; Scott, Brittney N. V.; Zbytnuik, Lori D.; Pittman, Keir; Asaduzzaman, Muhammad; Wu, Kaiyu; Meijndert, H. Christopher; Malawista, Stephen E.; Chevance, Anne de Boisfleury; Zhang, Kunyan; Conly, John; Kubes, Paul			Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo	NATURE MEDICINE			English	Article							BLOOD POLYMORPHONUCLEAR LEUKOCYTES; RESISTANT STAPHYLOCOCCUS-AUREUS; GROUP-A STREPTOCOCCUS; EXTRACELLULAR TRAPS; MITOCHONDRIAL-DNA; UNITED-STATES; CYTOPLASTS; KILL; EPIDEMIOLOGY; MECHANISMS	Neutrophil extracellular traps (NETs) are released as neutrophils die in vitro in a process requiring hours, leaving a temporal gap that invasive microbes may exploit. Neutrophils capable of migration and phagocytosis while undergoing NETosis have not been documented. During Gram-positive skin infections, we directly visualized live polymorphonuclear cells (PMNs) in vivo rapidly releasing NETs, which prevented systemic bacterial dissemination. NETosis occurred during crawling, thereby casting large areas of NETs. NET-releasing PMNs developed diffuse decondensed nuclei, ultimately becoming devoid of DNA. Cells with abnormal nuclei showed unusual crawling behavior highlighted by erratic pseudopods and hyperpolarization consistent with the nucleus being a fulcrum for crawling. A requirement for both Toll-like receptor 2 and complement-mediated opsonization tightly regulated NET release. Additionally, live human PMNs injected into mouse skin developed decondensed nuclei and formed NETS in vivo, and intact anuclear neutrophils were abundant in Gram-positive human abscesses. Therefore early in infection NETosis involves neutrophils that do not undergo lysis and retain the ability to multitask.	[Yipp, Bryan G.; Jenne, Craig N.; Scott, Brittney N. V.; Kubes, Paul] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Yipp, Bryan G.; Petri, Bjoern; Jenne, Craig N.; Scott, Brittney N. V.; Zbytnuik, Lori D.; Pittman, Keir; Meijndert, H. Christopher; Zhang, Kunyan; Conly, John; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Chron Dis, Calgary, AB, Canada; [Petri, Bjoern; Wu, Kaiyu; Zhang, Kunyan; Conly, John] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Salina, Davide; Wu, Kaiyu; Zhang, Kunyan; Conly, John] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Scott, Brittney N. V.; Zbytnuik, Lori D.; Pittman, Keir; Asaduzzaman, Muhammad; Kubes, Paul] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada; [Malawista, Stephen E.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Chevance, Anne de Boisfleury] Hop La Pitie Salpetriere, Ctr Ecol Cellulaire, Paris, France; [Zhang, Kunyan; Conly, John; Kubes, Paul] Univ Calgary, Dept Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	pkubes@ucalgary.ca	Jenne, Craig/HCH-3413-2022	Zhang, Kunyan/0000-0003-1078-6011; Yipp, Bryan/0000-0002-5887-9551	Canada Foundation for Innovation; Canadian Institute of Health Research (CIHR); AIHS postdoctoral fellowship; Rockefeller University from the National Center for Research Resources (NCRR) [UL1RR024143]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); AIHS postdoctoral fellowship; Rockefeller University from the National Center for Research Resources (NCRR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The pBT2 was a gift from R. Bruckner (University of Kaiserslautern). Myd88<SUP>-/-</SUP> and Tlr2<SUP>-/-</SUP> mice were provided by S. Akira (Osaka University). T. Graf (Barcelona, Spain) provided the Tg(LysMeGFP). We thank D. Knight and C. Baddick for technical assistance and ongoing support. We acknowledge P. Colarusso and the support staff of the Snyder Institute Live Cell Imaging Facility for assisting in the image capturing and analysis (Canada Foundation for Innovation funded). We also thank the University of Calgary Flow Cytometry Facility and L. Kennedy for their assistance. We are grateful to P. Forsyth for use of the IVIS 200. We thank the physicians, nurses and support staff in the Division of Infectious Diseases in the Department of Medicine, Alberta Health Services-Calgary and Area for assistance in obtaining clinical samples. We thank E. Yung, C. Horn, K. Nelson and K. Headley from Calgary Lab Services for assistance with the electron microscopy experiments. The Canadian Institute of Health Research (CIHR) provided the operating grants to support this work. P. K. is an Alberta Innovates-Health Solutions (AIHS) Scientist, Canada Research Chair and the Snyder Chair in Critical Care Medicine. B. Petri received an AIHS postdoctoral fellowship. B. Yipp is a Clinical Scholar (Department of Critical Care Medicine, Calgary), an AIHS clinical fellow and a CIHR fellow. During a portion of this study he received salary support from the Rockefeller University by Grant Award Number UL1RR024143 from the National Center for Research Resources (NCRR), a component of the US National Institutes of Health (NIH) and NIH Roadmap for Medical Research. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or the NIH.	Amulic B, 2011, CURR BIOL, V21, pR297, DOI 10.1016/j.cub.2011.03.021; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Berends ETM, 2010, J INNATE IMMUN, V2, P576, DOI 10.1159/000319909; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Dahl KN, 2010, J BIOMECH, V43, P2, DOI 10.1016/j.jbiomech.2009.09.002; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Ho M, 2000, J EXP MED, V192, P1205, DOI 10.1084/jem.192.8.1205; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Ji P, 2011, TRENDS CELL BIOL, V21, P409, DOI 10.1016/j.tcb.2011.04.003; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kollef MH, 2006, CURR OPIN INFECT DIS, V19, P161, DOI 10.1097/01.qco.0000216627.13445.e2; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; MALAWISTA SE, 1989, J CLIN INVEST, V83, P728, DOI 10.1172/JCI113939; MALAWISTA SE, 1986, BLOOD CELLS, V12, P167; MALAWISTA SE, 1992, J CLIN INVEST, V90, P631, DOI 10.1172/JCI115903; MALAWISTA SE, 1987, P NATL ACAD SCI USA, V84, P454, DOI 10.1073/pnas.84.2.454; MALAWISTA SE, 1982, J CELL BIOL, V95, P960, DOI 10.1083/jcb.95.3.960; Manzenreiter R, 2012, J CYST FIBROS, V11, P84, DOI 10.1016/j.jcf.2011.09.008; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Skrupky LP, 2009, CRIT CARE, V13, DOI 10.1186/cc8028; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wu K, 2010, CLIN MICROBIOL INFEC, V16, P245, DOI 10.1111/j.1469-0691.2009.02765.x; Yan J, 2012, J IMMUNOL, V188, P2316, DOI 10.4049/jimmunol.1102683; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	48	672	697	9	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	2012	18	9					1386	+		10.1038/nm.2847	http://dx.doi.org/10.1038/nm.2847			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	001PJ	22922410	Green Accepted			2022-12-27	WOS:000308472300034
J	Stock, K; Kumar, J; Synowitz, M; Petrosino, S; Imperatore, R; Smith, ES; Wend, P; Purfurst, B; Nuber, UA; Gurok, U; Matyash, V; Walzlein, JH; Chirasani, SR; Dittmar, G; Cravatt, BF; Momma, S; Lewin, GR; Ligresti, A; De Petrocellis, L; Cristino, L; Di Marzo, V; Kettenmann, H; Glass, R				Stock, Kristin; Kumar, Jitender; Synowitz, Michael; Petrosino, Stefania; Imperatore, Roberta; Smith, Ewan St J.; Wend, Peter; Purfuerst, Bettina; Nuber, Ulrike A.; Gurok, Ulf; Matyash, Vitali; Waelzlein, Joo-Hee; Chirasani, Sridhar R.; Dittmar, Gunnar; Cravatt, Benjamin F.; Momma, Stefan; Lewin, Gary R.; Ligresti, Alessia; De Petrocellis, Luciano; Cristino, Luigia; Di Marzo, Vincenzo; Kettenmann, Helmut; Glass, Rainer			Neural precursor cells induce cell death of high-grade astrocytomas through stimulation of TRPV1	NATURE MEDICINE			English	Article							ENDOPLASMIC-RETICULUM STRESS; STEM-CELLS; VANILLOID RECEPTORS; GLIAL PROGENITORS; MICE LACKING; ANANDAMIDE; GLIOBLASTOMA; BRAIN; MECHANISMS; NEUROGENESIS	Primary astrocytomas of grade 3 or 4 according to the classification system of the World Health Organization (high-grade astrocytomas or HGAs) are preponderant among adults and are almost invariably fatal despite the use of multimodal therapy. Here we show that the juvenile brain has an endogenous defense mechanism against HGAs. Neural precursor cells (NPCs) migrate to HGAs, reduce glioma expansion and prolong survival time by releasing endovanilloids that activate the vanilloid receptor (transient receptor potential vanilloid subfamily member-1 or TRPV1) on HGA cells. TRPV1 is highly expressed in tumor and weakly expressed in tumor-free brain. TRPV1 stimulation triggers tumor cell death through the branch of the endoplasmic reticulum stress pathway that is controlled by activating transcription factor-3 (ATF3). The antitumorigenic response of NPCs is lost with aging. NPC-mediated tumor suppression can be mimicked in the adult brain by systemic administration of the synthetic vanilloid arvanil, suggesting that TRPV1 agonists have potential as new HGA therapeutics.	[Stock, Kristin; Kumar, Jitender; Synowitz, Michael; Matyash, Vitali; Waelzlein, Joo-Hee; Chirasani, Sridhar R.; Kettenmann, Helmut; Glass, Rainer] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Synowitz, Michael] Univ Med Berlin, Charite, Dept Neurosurg, Berlin, Germany; [Petrosino, Stefania; Ligresti, Alessia; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy; [Imperatore, Roberta; De Petrocellis, Luciano; Cristino, Luigia] CNR, Inst Cybernet, Endocannabinoid Res Grp, Pozzuoli, Italy; [Purfuerst, Bettina] MDC, Cent Facil Electron Microscopy, Berlin, Germany; [Smith, Ewan St J.] NYU, Langone Med Ctr, Skirball Inst Biomol Med, New York, NY USA; [Nuber, Ulrike A.] Lund Univ, Lund Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden; [Gurok, Ulf] Max Planck Inst Mol Genet, Berlin, Germany; [Dittmar, Gunnar] MDC, Cent Facil Mass Spectrometry, Berlin, Germany; [Cravatt, Benjamin F.] Scripps Res Inst, La Jolla, CA 92037 USA; [Momma, Stefan] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, Frankfurt, Germany; [Glass, Rainer] Univ Munich, Clin Neurosurg, Munich, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); New York University; NYU Langone Medical Center; Lund University; Max Planck Society; Scripps Research Institute; Goethe University Frankfurt; University of Munich	Glass, R (corresponding author), Max Delbruck Ctr Mol Med MDC, Berlin, Germany.	rainer.glass@med.uni-muenchen.de	Glass, Rainer/GMW-7952-2022; Cristino, Luigia/AAE-3934-2020; Ligresti, Alessia/B-7564-2015; St. John Smith, Ewan/G-1776-2011; Di Marzo, Vincenzo/AAD-7742-2019; Kettenmann, Helmut/AAJ-5142-2021; Synowitz, Michael/G-2596-2012; Lewin, Gary R/B-8028-2011; Dittmar, Gunnar/B-6383-2016; Dittmar, Gunnar/C-6333-2019	Cristino, Luigia/0000-0002-0182-4699; Ligresti, Alessia/0000-0003-1787-3900; St. John Smith, Ewan/0000-0002-2699-1979; Di Marzo, Vincenzo/0000-0002-1490-3070; Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Lewin, Gary/0000-0002-2890-6352; Kettenmann, Helmut/0000-0001-8208-0291; IMPERATORE, Roberta/0000-0003-3609-2771	Helios Clinics [HeFoFo-ID1148]; US National Institutes of Health [DA-009789]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	Helios Clinics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Gargiulo, O. Daumke and J. Kurreck for discussion of the manuscript, S. Kitajima (Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan) for ATF3 constructs and L. Kaczmarek and M. Szymanska (Nencki Institute, Warsaw, Poland) for providing Ccnd2<SUP>-/-</SUP> mice. We acknowledge funding from the Helios Clinics (HeFoFo-ID1148) and the US National Institutes of Health (DA-009789 to V.D.M.).	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bisogno T, 1997, J BIOL CHEM, V272, P3315, DOI 10.1074/jbc.272.6.3315; Bode AM, 2009, CANCER RES, V69, P905, DOI 10.1158/0008-5472.CAN-08-3263; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Chirasani SR, 2010, BRAIN, V133, P1961, DOI 10.1093/brain/awq128; Conover JC, 2011, AGING DIS, V2, P49; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P594, DOI 10.1016/j.tips.2008.09.004; Fisher T, 2007, CANCER J, V13, P335, DOI 10.1097/PPO.0b013e318157053f; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Grunweller A, 2003, NUCLEIC ACIDS RES, V31, P3185, DOI 10.1093/nar/gkg409; Gurok U, 2004, J NEUROSCI, V24, P5982, DOI 10.1523/JNEUROSCI.0809-04.2004; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Izzo AA, 2008, J MOL MED, V86, P89, DOI 10.1007/s00109-007-0248-4; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Khan MA, 2011, AGING-US, V3, P182, DOI 10.18632/aging.100297; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Lambert DM, 1999, CURR MED CHEM, V6, P757; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Melck D, 1999, BIOCHEM BIOPH RES CO, V262, P275, DOI 10.1006/bbrc.1999.1105; Morelli MB, 2012, INT J CANCER, V131, pE1067, DOI 10.1002/ijc.27588; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Okano H, 2002, J CELL SCI, V115, P1355; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Reimer TA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-47; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Staflin K, 2004, CANCER RES, V64, P5347, DOI 10.1158/0008-5472.CAN-03-1246; Staflin K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-206; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Sturzebecher AS, 2010, J PHYSIOL-LONDON, V588, P1695, DOI 10.1113/jphysiol.2010.187112; Suzuki T, 2005, J NEURO-ONCOL, V74, P233, DOI 10.1007/s11060-004-7118-5; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Toth A, 2009, VITAM HORM, V81, P389, DOI 10.1016/S0083-6729(09)81015-7; Ueda N, 2000, CHEM PHYS LIPIDS, V108, P107, DOI 10.1016/S0009-3084(00)00190-0; Veldhuis WB, 2003, J NEUROSCI, V23, P4127; Visnyei K, 2011, MOL CANCER THER, V10, P1818, DOI 10.1158/1535-7163.MCT-11-0268; Walzlein JH, 2008, STEM CELLS, V26, P2945, DOI 10.1634/stemcells.2008-0307; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	54	125	128	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2012	18	8					1232	+		10.1038/nm.2827	http://dx.doi.org/10.1038/nm.2827			26	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	988DU	22820645	Green Accepted			2022-12-27	WOS:000307469300029
J	Lowy, DR; Kim, J; Smith-McCune, KK; Melief, CJM				Lowy, Douglas R.; Kim, Jane; Smith-McCune, Karen K.; Melief, Cornelis J. M.			The value of HPV vaccination	NATURE MEDICINE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS INFECTION; IMMUNOGENICITY; IMPACT		[Lowy, Douglas R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Lowy, Douglas R.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Lowy, DR (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.			Chun, Hyung/0000-0003-3508-2678	Howard Hughes Medical Institute Funding Source: Medline; NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NHLBI NIH HHS [R37 HL060917, P30 HL101284, HL101284, HL093362, R01 HL113005, R01 HL069170, HL113005, K08 HL095654, K08 HL093362, HL069170, HL095654, U10 HL109250] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Barr E, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.001; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282; Gee J, 2011, VACCINE, V29, P8279, DOI 10.1016/j.vaccine.2011.08.106; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Hoy T, 2009, CURR MED RES OPIN, V25, P2343, DOI 10.1185/03007990903136378; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lowy DR, 2008, CANCER-AM CANCER SOC, V113, P1980, DOI 10.1002/cncr.23704; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X	14	35	39	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2012	18	1					28	29						2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	875GO	22227663				2022-12-27	WOS:000299018600021
